FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Ramacciotti, E
   Agati, L
   Aguiar, V
   Wakefield, T
   Comerota, A
   Walenga, J
   Jeske, W
   Fareed, J
AF Ramacciotti, Eduardo
   Agati, Leandro
   Aguiar, Valeria
   Wakefield, Thomas
   Comerota, Anthony
   Walenga, Jeanine
   Jeske, Walter
   Fareed, Jawed
TI Zika and Chikungunya Virus and Risk for Venous Thromboembolism
SO BLOOD
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the American-Society-of-Hematology (ASH)
CY DEC 09-12, 2017
CL Atlanta, GA
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD DEC 7
PY 2017
VL 130
SU 1
MA 4883
PG 2
WC Hematology
SC Hematology
GA GG1DG
UT WOS:000432419705060
DA 2020-07-08
ER

PT J
AU Van Dyne, EA
   Neaterour, P
   Rivera, A
   Bello-Pagan, M
   Adams, L
   Munoz-Jordan, J
   Baez-Merced, P
   Garcia, M
   Waterman, SH
   Reyes, N
   Richardson, LC
   Sharp, TM
AF Van Dyne, Elizabeth A.
   Neaterour, Paige
   Rivera, Aidsa
   Bello-Pagan, Melissa
   Adams, Laura
   Munoz-Jordan, Jorge
   Baez-Merced, Priscilla
   Garcia, Myriam
   Waterman, Stephen H.
   Reyes, Nimia
   Richardson, Lisa C.
   Sharp, Tyler M.
TI Incidence and Outcome of Severe Thrombocytopenia Associated with Zika
   Virus Infection - Puerto Rico, 2016
SO BLOOD
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the American-Society-of-Hematology (ASH)
CY DEC 09-12, 2017
CL Atlanta, GA
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD DEC 7
PY 2017
VL 130
SU 1
MA 2325
PG 2
WC Hematology
SC Hematology
GA GG1DF
UT WOS:000432419405379
DA 2020-07-08
ER

PT J
AU Rabelo, K
   Fernandes, RCDC
   de Souza, LJ
   de Souza, TL
   dos Santos, FB
   Nunes, PCG
   de Azeredo, EL
   Salomao, NG
   Trindade, GF
   Basilio-de-Oliveira, CA
   de Carvalho, JJ
   Medina-Acosta, E
   Paes, MV
AF Rabelo, Kissila
   de Souza Campos Fernandes, Regina Celia
   de Souza, Luiz Jose
   de Souza, Thais Louvain
   dos Santos, Flavia Barreto
   Guerra Nunes, Priscila Conrado
   de Azeredo, Elzinandes Leal
   Salomao, Natalia Gedeao
   Trindade, Gisela Freitas
   Basilio-de-Oliveira, Carlos A.
   de Carvalho, Jorge Jose
   Medina-Acosta, Enrique
   Paes, Marciano Viana
TI Placental Histopathology and Clinical Presentation of Severe Congenital
   Zika Syndrome in a Human Immunodeficiency Virus-Exposed Uninfected
   Infant
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Zika virus; placenta; congenital Zika syndrome; histopathology;
   microcephaly; human immunodeficiency virus
ID DENGUE VIRUS; INFECTION; PATHOLOGY; CELLS; TRANSMISSION; ANTIBODIES;
   FETUSES; REPAIR; BRAZIL; BRAIN
AB In the large Zika virus (ZIKV) epidemic that occurred in Brazil in 2015, the intrauterine fetal exposure to ZIKV was associated with a significant risk of developing microcephaly and neurological disorders in the infected infants. ZIKV-associated disease has since been reported in 24 countries in the Americas. At present, definitive evidence is lacking regarding the intrauterine co-exposure to ZIKV and other viral infections and whether the coinfection impacts the risk of acquiring either infection or disease severity. Here, we provide evidence of intrauterine exposure to both ZIKV and human immunodeficiency virus (HIV) infections, causing congenital Zika syndrome in an HIV-exposed uninfected infant. Clinical, imaging and laboratory examinations of the pregnant woman and the newborn were performed. Histopathology, ZIKV/HIV-specific immunoassays, and ultrastructural evaluation of the placenta were performed. The Zika-asymptomatic, HIV-positive pregnant woman underwent ultrasounds revealing fetal cerebral ventriculomegaly, microcephaly, and brain atrophy. Her baby girl was born small for gestational age and with the neurological sequelae of congenital Zika syndrome. The evaluation of the abnormally large term placenta revealed severe damage to the maternal decidua and chorionic villi, cells positive for ZIKV-specific antigens but not for HIV antigens, and intracellular membranous clusters of virus-like particles approximately 25 nm in diameter. The rapid progression and severity of the congenital Zika syndrome may be related to the uncontrolled HIV disease in the mother. The poor inflammatory response observed in the placenta may have reduced the inherent risk of mother-to-child transmission of HIV.
C1 [Rabelo, Kissila; de Carvalho, Jorge Jose] Univ Estado Rio de Janeiro, Lab Ultraestrut & Biol Tecidual, Rio De Janeiro, Brazil.
   [de Souza Campos Fernandes, Regina Celia; de Souza, Luiz Jose; de Souza, Thais Louvain] Fac Med Campos, Campos Dos Goytacazes, Brazil.
   [de Souza Campos Fernandes, Regina Celia; de Souza, Thais Louvain; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Lab Biotechnol, Campos Dos Goytacazes, Brazil.
   [dos Santos, Flavia Barreto; Guerra Nunes, Priscila Conrado; de Azeredo, Elzinandes Leal] Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Salomao, Natalia Gedeao; Paes, Marciano Viana] Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
   [Trindade, Gisela Freitas] Biomanguinhos, Lab Tecnol Virol, Rio De Janeiro, Brazil.
   [Basilio-de-Oliveira, Carlos A.] Univ Fed Estado Rio De Janeiro, Anat Patol, Rio De Janeiro, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Lab Biotechnol, Campos Dos Goytacazes, Brazil.; Paes, MV (corresponding author), Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
EM quique@uenf.br; marciano@ioc.fiocruz.br
RI Trindade, Gustavo Ferraz/O-9107-2016; amsalu, ribka/G-8780-2019;
   Medina-Acosta, Enrique/G-3041-2010
OI Trindade, Gustavo Ferraz/0000-0001-6998-814X; Medina-Acosta,
   Enrique/0000-0002-2529-0548; Paes, Marciano/0000-0002-2266-2801;
   Trindade, Gisela/0000-0002-1630-4143; Rabelo,
   Kissila/0000-0001-7579-7788; Carvalho, Jorge/0000-0002-9426-6381
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [308780/2015-9]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/110.511/2014,
   E-26/010.001.498/2016, E26/202.003/2016]
FX The authors thank the Hospital Plantadores de Cana for the care of the
   patient and the assistance with sample collection, and the Platform of
   Confocal and Electron Microscopy at the State University of Rio de
   Janeiro and the Platform of Electron Microscopy in Fiocruz. This work
   was supported by the CNPq (308780/2015-9) and the FAPERJ
   (E-26/110.511/2014, E-26/010.001.498/2016 and E26/202.003/2016).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eaton JW, 2014, AIDS, V28, pS507, DOI 10.1097/QAD.0000000000000412
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fu D, 2015, DNA REPAIR, V35, P13, DOI 10.1016/j.dnarep.2015.09.008
   GOFF SP, 2001, FIELDS VIROLOGY, V2, P1871
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Inoue A, 2014, J BIOL CHEM, V289, P7109, DOI 10.1074/jbc.M113.520429
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Joao Esau Custodio, 2017, Pediatr Infect Dis J, V36, P500, DOI 10.1097/INF.0000000000001482
   Johnson EL, 2016, CURR OPIN INFECT DIS, V29, P248, DOI 10.1097/QCO.0000000000000267
   Kalk E, 2017, TROP MED INT HEALTH, V22, P604, DOI 10.1111/tmi.12858
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Schonenberger F, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0618-9
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Torrentes-Carvalho A, 2016, CLIN IMMUNOL, V164, P95, DOI 10.1016/j.clim.2016.01.005
NR 28
TC 8
Z9 8
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD DEC 7
PY 2017
VL 8
AR 1704
DI 10.3389/fimmu.2017.01704
PG 8
WC Immunology
SC Immunology
GA FO9XH
UT WOS:000417251200001
PM 29270171
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chiu, CY
   Martin, CSS
   Bouquet, J
   Li, T
   Yagi, S
   Tamhankar, M
   Hodara, VL
   Parodi, LM
   Somasekar, S
   Yu, GX
   Giavedoni, LD
   Tardif, S
   Patterson, J
AF Chiu, Charles Y.
   Martin, Claudia Sanchez-San
   Bouquet, Jerome
   Li, Tony
   Yagi, Shigeo
   Tamhankar, Manasi
   Hodara, Vida L.
   Parodi, Laura M.
   Somasekar, Sneha
   Yu, Guixia
   Giavedoni, Luis D.
   Tardif, Suzette
   Patterson, Jean
TI Experimental Zika Virus Inoculation in a New World Monkey Model
   Reproduces Key Features of the Human Infection
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SEXUAL TRANSMISSION; CALLITHRIX-JACCHUS; NONHUMAN PRIMATE; DENGUE VIRUS;
   RHESUS; MACAQUES; DISEASE; RNA; PATHOGENESIS; MICRONESIA
AB A monkey model of Zika virus (ZIKV) infection is urgently needed to better understand transmission and pathogenesis, given its proven association with fetal brain defects in pregnant women and acute neurological illness. Here we experimentally infected 4 male marmosets with ZIKV (prototype 1947 African strain) and monitored them clinically with sampling of various body fluids and tissues for nearly 3 months. We show that the course of acute infection with ZIKV in these New World monkeys resembles the human illness in many respects, including (1) lack of apparent clinical symptoms in most cases, (2) persistence of the virus in body fluids such as semen and saliva for longer periods of time than in serum, and (3) generation of neutralizing antibodies as well as an antiviral immunological host response. Importantly, ZIKV-infected saliva samples (in addition to serum) were found to be infectious, suggesting potential capacity for viral transmission by the oral route. Re-challenge of a previously infected marmoset with a contemporary outbreak strain SPH2015 from Brazil resulted in continued protection against infection, no viral shedding, and boosting of the immune response. Given the key similarities to human infection, a marmoset model of ZIKV infection may be useful for testing of new drugs and vaccines.
C1 [Chiu, Charles Y.; Martin, Claudia Sanchez-San; Bouquet, Jerome; Li, Tony; Somasekar, Sneha; Yu, Guixia] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA.
   [Chiu, Charles Y.; Martin, Claudia Sanchez-San; Bouquet, Jerome; Li, Tony; Somasekar, Sneha; Yu, Guixia] UCSF, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 91407 USA.
   [Chiu, Charles Y.] Univ Calif San Francisco, Div Infect Dis, Dept Med, San Francisco, CA 94107 USA.
   [Yagi, Shigeo] Calif Dept Publ Hlth, Richmond, CA USA.
   [Tamhankar, Manasi; Hodara, Vida L.; Parodi, Laura M.; Giavedoni, Luis D.; Tardif, Suzette; Patterson, Jean] Texas Biomed Res Inst, San Antonio, TX USA.
RP Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA.; Chiu, CY (corresponding author), UCSF, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 91407 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Div Infect Dis, Dept Med, San Francisco, CA 94107 USA.
EM charles.chiu@ucsf.edu
RI amsalu, ribka/G-8780-2019
OI Chiu, Charles/0000-0003-2915-2094
FU Southwest National Primate Research Center [P51-OD011133]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01-HL105704, R21-AI129455]; Abbott Laboratories,
   Inc.Abbott Laboratories
FX We would like to acknowledge the veterinary and pathology staff at the
   Southwest National Primate Research Center (SNPRC) for their assistance
   in taking care of the marmosets and collecting/analyzing samples for
   this study. The animal work in this study was supported by the Southwest
   National Primate Research Center (P51-OD011133). This study was also
   supported NIH grants R01-HL105704 (CYC) and R21-AI129455 (CYC) and an
   award from Abbott Laboratories, Inc. (CYC). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carrion R, 2007, J VIROL, V81, P6482, DOI 10.1128/JVI.02876-06
   Carrion R, 2012, CURR OPIN VIROL, V2, P357, DOI 10.1016/j.coviro.2012.02.007
   Carrion R, 2011, VIROLOGY, V420, P117, DOI 10.1016/j.virol.2011.08.022
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha M. S., 2016, GENOME ANNOUNC, V4
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Favoretto S, 2016, BIORXIV
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Giavedoni LD, 2005, J IMMUNOL METHODS, V301, P89, DOI 10.1016/j.jim.2005.03.015
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moi ML, 2015, AM J TROP MED HYG, V92, P370, DOI 10.4269/ajtmh.14-0455
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rosenfeld A. B., 2017, P NATL ACAD SCI US
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Verstrepen BE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002797
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Weitzel T, 2016, AM J TROP MED HYG, V95, P255, DOI 10.4269/ajtmh.16-0096
   Yu GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068558
NR 46
TC 25
Z9 27
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 7
PY 2017
VL 7
AR 17126
DI 10.1038/s41598-017-17067-w
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FP1EG
UT WOS:000417353600020
PM 29215081
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schandock, F
   Riber, CF
   Rocker, A
   Muller, JA
   Harms, M
   Gajda, P
   Zuwala, K
   Andersen, AHF
   Lovschall, KB
   Tolstrup, M
   Kreppel, F
   Munch, J
   Zelikin, AN
AF Schandock, Franziska
   Riber, Camilla Frich
   Roecker, Annika
   Mueller, Janis A.
   Harms, Mirja
   Gajda, Paulina
   Zuwala, Kaja
   Andersen, Anna H. F.
   Lovschall, Kaja Borup
   Tolstrup, Martin
   Kreppel, Florian
   Muench, Jan
   Zelikin, Alexander N.
TI Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other
   Pathogenic Viruses
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE broad spectrum antivirals; microbicides; polyanions; polymers; Zika
   virus
ID HCV GENOTYPE 1; POLYMETHACRYLIC ACIDS; PEPTIDE NANOFIBRILS;
   GENE-TRANSFER; INFECTION; TYPE-1; HIV; POLYMERS; BLOCKING; DRUGS
AB Viral pathogens continue to constitute a heavy burden on healthcare and socioeconomic systems. Efforts to create antiviral drugs repeatedly lag behind the advent of pathogens and growing understanding is that broad-spectrum antiviral agents will make strongest impact in future antiviral efforts. This work performs selection of synthetic polymers as novel broadly active agents and demonstrates activity of these polymers against Zika, Ebola, Lassa, Lyssa, Rabies, Marburg, Ebola, influenza, herpes simplex, and human immunodeficiency viruses. Results presented herein offer structure-activity relationships for these pathogens in terms of their susceptibility to inhibition by polymers, and for polymers in terms of their anionic charge and hydrophobicity that make up broad-spectrum antiviral agents. The identified leads cannot be predicted based on prior data on polymer-based antivirals and represent promising candidates for further development as preventive microbicides.
C1 [Schandock, Franziska; Roecker, Annika; Mueller, Janis A.; Harms, Mirja; Kreppel, Florian; Muench, Jan] Ulm Univ, Med Ctr, Inst Mol Virol, Meyerhofstr 1, D-89081 Ulm, Germany.
   [Riber, Camilla Frich; Lovschall, Kaja Borup; Zelikin, Alexander N.] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark.
   [Gajda, Paulina; Zuwala, Kaja; Andersen, Anna H. F.; Tolstrup, Martin] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark.
   [Zelikin, Alexander N.] Aarhus Univ, iNano Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark.
RP Munch, J (corresponding author), Ulm Univ, Med Ctr, Inst Mol Virol, Meyerhofstr 1, D-89081 Ulm, Germany.; Zelikin, AN (corresponding author), Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark.; Zelikin, AN (corresponding author), Aarhus Univ, iNano Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark.
EM Jan.Muench@uni-ulm.de; zelikin@chem.au.dk
RI Zuwala, Kaja/L-6124-2017; Zelikin, Alexander/J-3659-2012
OI Zuwala, Kaja/0000-0001-6585-4259; Zelikin,
   Alexander/0000-0002-9864-321X; Jan, Munch/0000-0001-7316-7141; Tolstrup,
   Martin/0000-0001-7020-5173; Frich, Camilla Kaas/0000-0002-9664-3830;
   Gajda, Paulina/0000-0001-9643-357X
FU Danish Council for Independent Research, Technology and Production
   Sciences, DenmarkDet Frie Forskningsrad (DFF) [DFF: 4184-00177];
   Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [CRC
   1279]
FX F.S., C.F.R., A.R., and J.A.M. contributed equally to this work. The
   authors wish to acknowledge financial support from the Danish Council
   for Independent Research, Technology and Production Sciences, Denmark
   (ANZ; project DFF: 4184-00177) and a grant from Deutsche
   Forschungsgemeinschaft (JM, project CRC 1279).
CR Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454
   Al-Mahtab M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156667
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   BABA M, 1990, J INFECT DIS, V161, P208, DOI 10.1093/infdis/161.2.208
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Bernstein DI, 2008, ANTIMICROB AGENTS CH, V52, P2727, DOI 10.1128/AAC.00279-08
   Burnouf T, 2000, BLOOD REV, V14, P94, DOI 10.1054/blre.2000.0129
   Burnouf T, 2014, LANCET, V384, P1347, DOI 10.1016/S0140-6736(14)61693-7
   Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002
   CORNETTA K, 1989, J VIROL METHODS, V23, P187, DOI 10.1016/0166-0934(89)90132-8
   Danial M, 2015, MACROMOL BIOSCI, V15, P9, DOI 10.1002/mabi.201400298
   De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   DECLERCQ E, 1991, J ACQ IMMUN DEF SYND, V4, P207
   DESOMER P, 1968, J VIROL, V2, P886, DOI 10.1128/JVI.2.9.886-893.1968
   DESOMER P, 1968, J VIROL, V2, P878, DOI 10.1128/JVI.2.9.878-885.1968
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Federici Thais, 2009, Genet Vaccines Ther, V7, P1, DOI 10.1186/1479-0556-7-1
   Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610
   Ghezzi S, 2017, ANTIVIR RES, V140, P13, DOI 10.1016/j.antiviral.2016.12.023
   Gramberg T, 2005, VIROLOGY, V340, P224, DOI 10.1016/j.virol.2005.06.026
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992
   Hsu BB, 2011, P NATL ACAD SCI USA, V108, P61, DOI 10.1073/pnas.1017012108
   Ichiyama K, 2016, MACROMOLECULES, V49, P2618, DOI 10.1021/acs.macromol.6b00091
   ITO M, 1989, EUR J CLIN MICROBIOL, V8, P171, DOI 10.1007/BF01963907
   Ji X, 2005, J GEN VIROL, V86, P2535, DOI 10.1099/vir.0.81199-0
   KAPLAN M. M., 1967, J VIROL, V1, P145
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kreppel F, 2002, HUM GENE THER, V13, P1151, DOI 10.1089/104303402320138934
   KRUST B, 1993, AIDS RES HUM RETROV, V9, P1087, DOI 10.1089/aid.1993.9.1087
   Lion T, 2014, CLIN MICROBIOL REV, V27, P441, DOI 10.1128/CMR.00116-13
   Liu G, 2011, ARCH VIROL, V156, P1359, DOI 10.1007/s00705-011-0989-9
   Liu SW, 2011, EUR J PHARMACOL, V660, P460, DOI 10.1016/j.ejphar.2011.04.013
   Luscher-Mattli M, 2000, ANTIVIR CHEM CHEMOTH, V11, P249
   MALDARELLI F, 1991, J VIROL, V65, P5732, DOI 10.1128/JVI.65.11.5732-5743.1991
   MANNING JS, 1971, APPL MICROBIOL, V22, P1162, DOI 10.1128/AEM.22.6.1162-1163.1971
   Meier C, 2014, WIRES NANOMED NANOBI, V6, P438, DOI 10.1002/wnan.1275
   Moad G, 2012, AUST J CHEM, V65, P985, DOI 10.1071/CH12295
   Monge S, 2011, BIOMACROMOLECULES, V12, P1973, DOI 10.1021/bm2004803
   Muller JA, 2017, MED MICROBIOL IMMUN, V206, P175, DOI 10.1007/s00430-017-0493-2
   Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014
   Noordeen F, 2013, ANTIMICROB AGENTS CH, V57, P5291, DOI 10.1128/AAC.01003-13
   Papkalla A, 2002, J VIROL, V76, P8455, DOI 10.1128/JVI.76.16.8455-8459.2002
   Patrick GL, 2013, INTRO MED CHEM
   PROFFITT MR, 1995, CLIN DIAGN VIROL, V4, P175, DOI 10.1016/0928-0197(95)00011-V
   Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417
   Sepulveda-Crespo D, 2015, NANOMED-NANOTECHNOL, V11, P1481, DOI 10.1016/j.nano.2015.03.008
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith AAA, 2014, POLYM CHEM-UK, V5, P6407, DOI 10.1039/c4py00624k
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Telwatte S, 2011, ANTIVIR RES, V90, P195, DOI 10.1016/j.antiviral.2011.03.186
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Urbinati C, 2008, MOLECULES, V13, P2758, DOI 10.3390/molecules13112758
   Vaillant A, 2006, ANTIMICROB AGENTS CH, V50, P1393, DOI 10.1128/AAC.50.4.1393-1401.2006
   Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002
   Whitby LR, 2009, BIOORG MED CHEM LETT, V19, P3771, DOI 10.1016/j.bmcl.2009.04.098
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yolamanova M, 2013, NAT NANOTECHNOL, V8, P130, DOI [10.1038/nnano.2012.248, 10.1038/NNANO.2012.248]
   Zelikin AN, 2003, J AM CHEM SOC, V125, P13693, DOI 10.1021/ja036387y
   Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817
   Zydney AL, 2009, BIOTECHNOL BIOENG, V103, P227, DOI 10.1002/bit.22308
NR 66
TC 5
Z9 5
U1 2
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD DEC 6
PY 2017
VL 6
IS 23
AR 1700748
DI 10.1002/adhm.201700748
PG 14
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA FP3UL
UT WOS:000417543400009
PM 28945945
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ochmann, SE
   Vietz, C
   Trofymchuk, K
   Acuna, GP
   Lalkens, B
   Tinnefeld, P
AF Ochmann, Sarah E.
   Vietz, Carolin
   Trofymchuk, Kateryna
   Acuna, Guillermo P.
   Lalkens, Birka
   Tinnefeld, Philip
TI Optical Nanoantenna for Single Molecule-Based Detection of Zika Virus
   Nucleic Acids without Molecular Multiplication
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID PLASMONIC FLUORESCENCE ENHANCEMENT; DNA ORIGAMI; NANOSTRUCTURES;
   HYBRIDIZATION; PROBES; QUANTIFICATION; MICROSCOPY; PATTERNS; ANTENNAS;
   BEACONS
AB Because of the limited signal-to-background ratio, molecular diagnostics requires molecular amplification of the target molecules or molecular signal amplification after target recognition. For direct molecular detection, we demonstrate a purely physical fluorescence enhancement process which can elevate the fluorescence signal of single fluorescent dyes by several orders of magnitude. To this end, DNA origami-based optical antennas with a height of around 125 nm are used, which utilize metallic nanoparticles to create a hotspot where fluorescence signals are enhanced by plasmonic effects. By equipping the hotspot with a molecular beacon-like structure, we combine the plasmonic signal enhancement with a specific signal generation, leading to an enhanced and therefore easy to detect signal only in the presence of the specific target nucleic acid. Exemplified with Zika virus detection, we show the applicability of this approach by detecting Zika-specific artificial DNA and RNA both in buffer and in heat-inactivated human blood serum. We show the sensitivity against small nucleotide variations of this approach, allowing the discrimination of closely related pathogens. Furthermore, we show how the modularity offered by DNA nanotechnology enables multiplexing by incorporating orthogonal fluorescent labels for the simultaneous detection of different sequences. The achieved signal enhancement will allow technically simplified signal detection, paving the way for single molecule-based point-of-care diagnosis.
C1 [Ochmann, Sarah E.; Vietz, Carolin; Trofymchuk, Kateryna; Acuna, Guillermo P.; Lalkens, Birka; Tinnefeld, Philip] Braunschweig Univ Technol, Inst Phys & Theoret Chem, Rebenring 56, D-38106 Braunschweig, Germany.
   [Ochmann, Sarah E.; Vietz, Carolin; Trofymchuk, Kateryna; Acuna, Guillermo P.; Lalkens, Birka; Tinnefeld, Philip] Braunschweig Univ Technol, Braunschweig Integrated Ctr Syst Biol BRICS, Rebenring 56, D-38106 Braunschweig, Germany.
   [Ochmann, Sarah E.; Vietz, Carolin; Trofymchuk, Kateryna; Acuna, Guillermo P.; Lalkens, Birka; Tinnefeld, Philip] Braunschweig Univ Technol, Lab Emerging Nanometrol LENA, Rebenring 56, D-38106 Braunschweig, Germany.
   [Tinnefeld, Philip] Ludwig Maximilians Univ Muenchen, Dept Chem, Butenandtstr 5-13, D-81377 Munich, Germany.
   [Tinnefeld, Philip] Ludwig Maximilians Univ Muenchen, Ctr NanoSci, Butenandtstr 5-13, D-81377 Munich, Germany.
RP Tinnefeld, P (corresponding author), Braunschweig Univ Technol, Inst Phys & Theoret Chem, Rebenring 56, D-38106 Braunschweig, Germany.; Tinnefeld, P (corresponding author), Braunschweig Univ Technol, Braunschweig Integrated Ctr Syst Biol BRICS, Rebenring 56, D-38106 Braunschweig, Germany.; Tinnefeld, P (corresponding author), Braunschweig Univ Technol, Lab Emerging Nanometrol LENA, Rebenring 56, D-38106 Braunschweig, Germany.; Tinnefeld, P (corresponding author), Ludwig Maximilians Univ Muenchen, Dept Chem, Butenandtstr 5-13, D-81377 Munich, Germany.; Tinnefeld, P (corresponding author), Ludwig Maximilians Univ Muenchen, Ctr NanoSci, Butenandtstr 5-13, D-81377 Munich, Germany.
EM philip.tinnefeld@cup.uni-muenchen.de
FU BMBFFederal Ministry of Education & Research (BMBF) [13N14336,
   03VP03891]; Deutsche ForschungsgesellschaftGerman Research Foundation
   (DFG) [AC 279/2-1, TI 329/9-1]; German Excellence Initiative via the
   program Nanosystems Initiative Munich (NIM); Studienstiftung des
   deutschen Volkes; state ministry for research of lower saxony
FX We thank Dr. Henk Garritsen, Klinikum Braunschweig, for the blood
   samples and Johann Bohlen, TU Braunschweig, for AFM images. We are
   grateful to Bettina Wunsch, Kristina Hubner, and Katharina Kraatz for
   fruitful discussions. This work was funded by the BMBF (Grants POCEMON,
   13N14336 and SIBOF, 03VP03891) and the Deutsche Forschungsgesellschaft
   (Grants AC 279/2-1 and TI 329/9-1). We further acknowledge support by
   the German Excellence Initiative via the program Nanosystems Initiative
   Munich (NIM). C.V. is grateful to the Studienstiftung des deutschen
   Volkes for a scholarship. K.T. and G.P.A. acknowledge funding of the
   state ministry for research of lower saxony in the frame of the
   "Quantum- and Nanometrology" (QUANOMET) strategic research area.
   Quanomet is part of the LUH-TUBS research alliance.
CR Acuna GP, 2012, SCIENCE, V338, P506, DOI 10.1126/science.1228638
   Acuna GP, 2012, ACS NANO, V6, P3189, DOI 10.1021/nn2050483
   Collins ML, 1997, NUCLEIC ACIDS RES, V25, P2979, DOI 10.1093/nar/25.15.2979
   Csaki Andrea, 2002, Expert Rev Mol Diagn, V2, P187, DOI 10.1586/14737159.2.2.187
   Darvill D, 2013, PHYS CHEM CHEM PHYS, V15, P15709, DOI 10.1039/c3cp50415h
   Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Frankel MB, 2017, J VIROL METHODS, V246, P117, DOI 10.1016/j.jviromet.2017.05.002
   Hahn J, 2014, ACS NANO, V8, P8765, DOI 10.1021/nn503513p
   HIGUCHI R, 1992, BIO-TECHNOL, V10, P413, DOI 10.1038/nbt0492-413
   HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026
   Holland NT, 2003, MUTAT RES-REV MUTAT, V543, P217, DOI 10.1016/S1383-5742(02)00090-X
   Holzmeister P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6356
   Holzmeister P, 2014, CHEM SOC REV, V43, P1014, DOI 10.1039/c3cs60207a
   Horn T, 1997, NUCLEIC ACIDS RES, V25, P4842, DOI 10.1093/nar/25.23.4842
   Kaltenboeck B, 2005, ADV CLIN CHEM, V40, P219, DOI 10.1016/S0065-2423(05)40006-2
   Korobchevskaya K, 2017, PHOTONICS-BASEL, V4, DOI 10.3390/photonics4030041
   Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889
   Lin CX, 2012, NAT CHEM, V4, P832, DOI 10.1038/NCHEM.1451
   Lobenhofer EK, 2001, ENVIRON HEALTH PERSP, V109, P881, DOI 10.2307/3454988
   Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p
   Novotny L, 2011, NAT PHOTONICS, V5, P83, DOI 10.1038/NPHOTON.2010.237
   Pellegrotti JV, 2014, NANO LETT, V14, P2831, DOI 10.1021/nl500841n
   Reichert J, 2000, ANAL CHEM, V72, P6025, DOI 10.1021/ac000567y
   Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Schmied JJ, 2014, NAT PROTOC, V9, P1367, DOI 10.1038/nprot.2014.079
   Thacker VV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4448
   Tyagi S, 2000, NAT BIOTECHNOL, V18, P1191, DOI 10.1038/81192
   Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303
   URDEA MS, 1987, GENE, V61, P253, DOI 10.1016/0378-1119(87)90189-2
   Vietz C, 2017, NANO LETT, V17, P6496, DOI 10.1021/acs.nanolett.7b03844
   Vietz C, 2017, ACS NANO, V11, P4969, DOI 10.1021/acsnano.7b01621
   Wang DF, 2017, NANO LETT, V17, P5368, DOI 10.1021/acs.nanolett.7b01829
NR 34
TC 23
Z9 22
U1 4
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD DEC 5
PY 2017
VL 89
IS 23
BP 13000
EP 13007
DI 10.1021/acs.analchem.7b04082
PG 8
WC Chemistry, Analytical
SC Chemistry
GA FP3WV
UT WOS:000417549600055
PM 29144729
OA Bronze
DA 2020-07-08
ER

PT J
AU Baylis, M
AF Baylis, Matthew
TI Potential impact of climate change on emerging vector-borne and other
   infections in the UK
SO ENVIRONMENTAL HEALTH
LA English
DT Review
DE Climate; Climate change; Disease; Vector; Mosquito; Tick; Sandfly; West
   nile; Lyme; malaria; Zika
ID CONGO HEMORRHAGIC-FEVER; ZIKA VIRUS; AEDES-ALBOPICTUS; UNITED-KINGDOM;
   RISK; LEISHMANIASIS; TRANSMISSION; MOSQUITO; MALARIA; EUROPE
AB Climate is one of several causes of disease emergence. Although half or more of infectious diseases are affected by climate it appears to be a relatively infrequent cause of human disease emergence. Climate mostly affects diseases caused by pathogens that spend part of their lifecycle outside of the host, exposed to the environment. The most important routes of transmission of climate sensitive diseases are by arthropod (insect and tick) vectors, in water and in food. Given the sensitivity of many diseases to climate, it is very likely that at least some will respond to future climate change. In the case of vector-borne diseases this response will include spread to new areas. Several vector-borne diseases have emerged in Europe in recent years; these include vivax malaria, West Nile fever, dengue fever, Chikungunya fever, leishmaniasis, Lyme disease and tick-borne encephalitis. The vectors of these diseases are mosquitoes, sand flies and ticks. The UK has endemic mosquito species capable of transmitting malaria and probably other pathogens, and ticks that transmit Lyme disease. The UK is also threatened by invasive mosquito species known to be able to transmit West Nile, dengue, chikungunya and Zika, and sand flies that spread leishmaniasis. Warmer temperatures in the future will increase the suitability of the UK's climate for these invasive species, and increase the risk that they may spread disease. While much attention is on invasive species, it is important to recognize the threat presented by native species too. Proposed actions to reduce the future impact of emerging vector-borne diseases in the UK include insect control activity at points of entry of vehicles and certain goods, wider surveillance for mosquitoes and sand flies, research into the threat posed by native species, increased awareness of the medical profession of the threat posed by specific diseases, regular risk assessments, and increased preparedness for the occurrence of a disease emergency.
C1 [Baylis, Matthew] Univ Liverpool, Inst Infect & Global Hlth, Liverpool Univ Climate & Infect Dis Anim Grp, Liverpool, Merseyside, England.
   [Baylis, Matthew] Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
RP Baylis, M (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool Univ Climate & Infect Dis Anim Grp, Liverpool, Merseyside, England.; Baylis, M (corresponding author), Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
EM matthew.baylis@liverpool.ac.uk
OI Baylis, Matthew/0000-0003-0335-187X
FU UK Living With Environmental Change (LWEC) Network
FX Publication of this article was funded by the UK Living With
   Environmental Change (LWEC) Network. LWEC was succeeded in 2016 by the
   Research and Innovation for our Dynamic Environment (RIDE) Forum
   (http://www.nerc.ac.uk/research/partnerships/ride/).
CR Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Almeida APG, 2007, EUROSURVEILLANCE, V12, P6
   Angelini R, 2007, EUROSURVEILLANCE, V12, P47
   Atkinson B, 2012, EUROSURVEILLANCE, V17, P7
   Ayres JG, 2009, EUR RESPIR J, V34, P295, DOI 10.1183/09031936.00003409
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Danis K, 2011, EURO SURVEILL, V16
   Dujardin JC, 2008, EMERG INFECT DIS, V14, P1013, DOI 10.3201/eid1407.071589
   European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547
   Eze JI, 2014, EPIDEMIOL INFECT, V142, P1289, DOI 10.1017/S0950268813002148
   Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Hales S., 2014, QUANTITATIVE RISK AS
   Jameson LJ, 2012, TICKS TICK-BORNE DIS, V3, P95, DOI 10.1016/j.ttbdis.2011.12.002
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kuhn KG, 2003, P NATL ACAD SCI USA, V100, P9997, DOI 10.1073/pnas.1233687100
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509
   Lindgren E, 2006, LYME BORRELIOSIS EUR, pP 1
   Lindgren E, 2012, SCIENCE, V336, P418, DOI 10.1126/science.1215735
   Lindsay SW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-70
   LINDSAY SW, 2001, GLOB CHANGE HUM HLTH, V2, P80, DOI DOI 10.1023/A:1011995115713
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lukan M, 2010, EMERG INFECT DIS, V16, P524, DOI 10.3201/eid1603.081364
   Mackenzie-Impoinvil L, 2015, MED VET ENTOMOL, V29, P1, DOI 10.1111/mve.12083
   Maltezou HC, 2010, EUROSURVEILLANCE, V15, P48
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   McIntyre KM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06948-9
   McMichael A.J., 2004, COMP QUANTIFICATION, V2, P1543
   Medlock JM, 2017, LANCET INFECT DIS, V17, P140, DOI 10.1016/S1473-3099(17)30024-5
   Medlock JM, 2012, VET REC, V171, DOI 10.1136/vr.e6123
   Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Morin CW, 2013, P NATL ACAD SCI USA, V110, P15620, DOI 10.1073/pnas.1307135110
   Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016
   PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402
   Pradier S, 2012, REV SCI TECH OIE, V31, P829
   Randolph SE, 2004, INT J MED MICROBIOL, V293, P5, DOI 10.1016/S1433-1128(04)80004-4
   Ready PD, 2010, EUROSURVEILLANCE, V15, P29
   Rizzoli A, 2011, EUROSURVEILLANCE, V16, P2
   Rogers D, 2012, ECDC TECHNICAL REPOR, P1
   Shaw SE, 2009, VET PARASITOL, V163, P281, DOI 10.1016/j.vetpar.2009.03.025
   Sousa CA, 2012, EUROSURVEILLANCE, V17, P15
   Stefanoff P, 2012, ECDC TECHNICAL REPOR
   Sudre B, 2013, EMERG INFECT DIS, V19, P784, DOI 10.3201/eid1905.120811
   Sumilo D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000500
   Thomas SM, 2011, ERDKUNDE, V65, P137, DOI 10.3112/erdkunde.2011.02.03
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
NR 56
TC 16
Z9 17
U1 7
U2 60
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1476-069X
J9 ENVIRON HEALTH-GLOB
JI Environ. Health
PD DEC 5
PY 2017
VL 16
SU 1
SI SI
BP 45
EP 51
AR 112
DI 10.1186/s12940-017-0326-1
PG 7
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FO9ID
UT WOS:000417200300005
PM 29219091
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Paules, CI
   Eisinger, RW
   Marston, HD
   Fauci, AS
AF Paules, Catharine I.
   Eisinger, Robert W.
   Marston, Hilary D.
   Fauci, Anthony S.
TI What Recent History Has Taught Us About Responding to Emerging
   Infectious Disease Threats
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Editorial Material
ID ACUTE RESPIRATORY SYNDROME; CORONAVIRUS SPIKE PROTEIN; INFLUENZA-A H5N1;
   NEW-YORK-CITY; VIRUS-INFECTION; ZIKA VIRUS; AIDS; EXPERIENCE; TRIAL;
   RISK
AB Presidential administrations face any number of unexpected crises during their tenure, and global pandemics are among the most challenging. As of January 2017, one of the authors had served under 5 presidents as the director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. During each administration, the government faced unexpected pandemics, ranging from the HIV/AIDS pandemic, which began during the Reagan administration, to the recent Zika outbreak in the Americas, which started during the Obama administration. These experiences underscored the need to optimize preparation for and response to these threats whenever and wherever they emerge. This article recounts selected outbreaks occurring during this period and highlights lessons that were learned that can be applied to the infectious disease threats that will inevitably be faced in the current presidential administration and beyond.
C1 [Paules, Catharine I.; Eisinger, Robert W.; Marston, Hilary D.; Fauci, Anthony S.] NIAID, NIH, 9000 Rockville Pike,Bldg 31,Suite 7A03, Bethesda, MD 20892 USA.
RP Paules, CI (corresponding author), NIAID, NIH, 9000 Rockville Pike,Bldg 31,Suite 7A03, Bethesda, MD 20892 USA.
EM catharine.paules@nih.gov
CR BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183
   Bisht H, 2004, P NATL ACAD SCI USA, V101, P6641, DOI 10.1073/pnas.0401939101
   Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391
   Bukreyev A, 2004, LANCET, V363, P2122, DOI 10.1016/S0140-6736(04)16501-X
   BURNET M, 1972, NATURAL HIST INFECT
   Centers for Disease Control and Prevention, 2017, CHIK VIR
   Centers for Disease Control and Prevention, 2017, 2009 H1N1 PAND SUMM
   Centers for Disease Control and Prevention, 2017, ANTHR THREAT
   Centers for Disease Control and Prevention, 2017, ZIK CAS US
   Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P305
   Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P250
   Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5
   Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Fabian Jordan, 2017, HILL
   FAUCI AS, 1982, ANN INTERN MED, V96, P777, DOI 10.7326/0003-4819-96-6-777
   Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936
   HELLINGER FJ, 1993, JAMA-J AM MED ASSOC, V270, P474, DOI 10.1001/jama.270.4.474
   Hirschberg R, 2004, NEW ENGL J MED, V350, P2119, DOI 10.1056/NEJMp048123
   *HOM SEC COUNC, 2005, NAT STRAT PAND INFL
   Lane HC, 2001, NAT MED, V7, P1271, DOI 10.1038/nm1201-1271
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V73, P39, DOI 10.1097/QAI.0000000000001014
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Office of the U.S. Global AIDS Coordinator, 2014, 30 PEPFAR OFF US GLO
   Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498
   PETERSDORF RG, 1978, NEW ENGL J MED, V299, P628, DOI 10.1056/NEJM197809212991204
   Piot P, 2007, AM J PUBLIC HEALTH, V97, P1934, DOI 10.2105/AJPH.2007.121418
   ROTHENBERG R, 1987, NEW ENGL J MED, V317, P1297, DOI 10.1056/NEJM198711193172101
   Scheer R., 1986, LOS ANGELES TIMES
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Steele RW, 2016, CLIN PEDIATR, V55, P698, DOI 10.1177/0009922816638660
   Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393
   U.S. Department of Health and Human Services, 2002, NIAID BIOD RES AG CD
   U.S. Department of Health and Human Services, 2002, NIAID STRAT PLAN BIO
   U.S. President's Emergency Plan for AIDS Relief (PEPFAR), 2016, FACT SHEET PEPFAR LA
   UNAIDS, 2017, FACT SHEET LAT GLOB
   Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021
   *US PHS, 1986, SURG GEN REP ACQ IMM
   Vice President Bush Visits Clinical Center, 1987, NIH RECORD, V39, P1
   WHO, 2017, EB VIR DIS
   *WHO, SUMM PROB SARS CAS O
   World Health Organization, 2014, H5N1 HIGHL PATH AV I
   Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463
NR 46
TC 7
Z9 7
U1 1
U2 7
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD DEC 5
PY 2017
VL 167
IS 11
BP 805
EP +
DI 10.7326/M17-2496
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA FO8KS
UT WOS:000417135900009
DA 2020-07-08
ER

PT J
AU Bradrick, SS
AF Bradrick, Shelton S.
TI Causes and Consequences of Flavivirus RNA Methylation
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE methylation; flavivirus; Zika virus; dengue virus; hepatitis C virus
ID MESSENGER-RNA; DEPENDENT TRANSLATION; EXPRESSION; PROTEIN; METHYLOMES;
   DYNAMICS; ENTRY; CELL; NS5
AB Mosquito-borne flaviviruses are important human pathogens that represent global threats to human health. The genomes of these positive-strand RNA viruses have been shown to be substrates of both viral and cellular methyltransferases. N-7-methylation of the 5 0 cap structure is essential for infection whereas 2'-O-methylation of the penultimate nucleotide is required for evasion of host innate immunity. N-6-methylation of internal adenosine nucleotides has also been shown to impact flavivirus infection. Here, I summarize recent progress made in understanding roles for methylation in the flavivirus life-cycle and discuss relevant emerging hypotheses.
C1 [Bradrick, Shelton S.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
RP Bradrick, SS (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
EM ssbradri@utmb.edu
FU Mariano Garcia-Blanco; University of Texas Medical Branch
FX The author acknowledges Mariano Garcia-Blanco and the University of
   Texas Medical Branch for support.
CR Abbas YM, 2017, P NATL ACAD SCI USA, V114, pE2106, DOI 10.1073/pnas.1612444114
   Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BOTH GW, 1975, P NATL ACAD SCI USA, V72, P1189, DOI 10.1073/pnas.72.3.1189
   BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0
   Campos RK, 2018, CURR TOP MICROBIOL, V419, P43, DOI 10.1007/82_2017_26
   Chang DC, 2016, VIROLOGY, V499, P259, DOI 10.1016/j.virol.2016.09.022
   Courtney DG, 2017, CELL HOST MICROBE, V22, P377, DOI 10.1016/j.chom.2017.08.004
   Cowling VH, 2010, BIOCHEM J, V425, P295, DOI 10.1042/BJ20091352
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Dong HP, 2008, VIROLOGY, V377, P1, DOI 10.1016/j.virol.2008.04.026
   Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528
   HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826
   Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002
   Kumar P, 2014, NUCLEIC ACIDS RES, V42, P3228, DOI 10.1093/nar/gkt1321
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]
   Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631
   MUTHUKRISHNAN S, 1975, NATURE, V255, P33, DOI 10.1038/255033a0
   PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6
   Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Saletore Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-175
   Schmid B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005345
   SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8
   Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698
   Tirumuru N, 2016, ELIFE, V5, DOI 10.7554/eLife.15528
   TSUKIYAMAKOHARA K, 1992, J VIROL, V66, P1476, DOI 10.1128/JVI.66.3.1476-1483.1992
   Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599
   WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0
   WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0
   WEI CM, 1975, P NATL ACAD SCI USA, V72, P318, DOI 10.1073/pnas.72.1.318
   WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587
   Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025
   Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156
   Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 55
TC 6
Z9 6
U1 3
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD DEC 5
PY 2017
VL 8
AR 2374
DI 10.3389/fmicb.2017.02374
PG 6
WC Microbiology
SC Microbiology
GA FO7HU
UT WOS:000417045300001
PM 29259584
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Iakobachvili, N
   Peters, PJ
AF Iakobachvili, Nino
   Peters, Peter J.
TI Humans in a Dish: The Potential of Organoids in Modeling Immunity and
   Infectious Diseases
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE organoids; disease model; infection; macrophages; monocytes; dendritic
   cells; MPS; tuberculosis
ID IN-VITRO EXPANSION; STEM-CELLS; ZIKA VIRUS; EPITHELIAL ORGANOIDS; NEURAL
   PROGENITORS; HUMAN COLON; LONG-TERM; DIFFERENTIATION; IDENTIFICATION;
   DIVERSITY
AB For many decades, human infectious diseases have been studied in immortalized cell lines, isolated primary cells from blood and a range of animal hosts. This research has been of fundamental importance in advancing our understanding of host and pathogen responses but remains limited by the absence of multicellular context and inherent differences in animal immune systems that result in altered immune responses. Recent developments in stem cell biology have led to the in vitro growth of organoids that faithfully recapitulate a variety of human tissues including lung, intestine and brain amongst many others. Organoids are derived from human stem cells and retain the genomic background, cellular organization and functionality of their tissue of origin. Thus they have been widely used to characterize stem cell development, numerous cancers and genetic diseases. We believe organoid technology can be harnessed to study host-pathogen interactions resulting in a more physiologically relevant model that yields more predictive data of human infectious diseases than current systems. Here, we highlight recent work and discuss the potential of human stem cell-derived organoids in studying infectious diseases and immunity.
C1 [Iakobachvili, Nino; Peters, Peter J.] Maastricht Univ, Maastricht Multimodal Mol Imaging Inst, Div Nanoscopy, Maastricht, Netherlands.
RP Peters, PJ (corresponding author), Maastricht Univ, Maastricht Multimodal Mol Imaging Inst, Div Nanoscopy, Maastricht, Netherlands.
EM peter.peters@maastrichtuniversity.nl
FU ZonMWNetherlands Organization for Health Research and Development
   [114021005]
FX NI is supported by a grant from ZonMW (project number 114021005).
CR Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196
   Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721
   Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013
   Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042
   Chaikin P, 2017, J CLIN PHARMACOL, V57, P690, DOI 10.1002/jcph.889
   Chow A, 2011, NAT REV IMMUNOL, V11, P788, DOI 10.1038/nri3087
   Cristobal A, 2017, CELL REP, V18, P263, DOI 10.1016/j.celrep.2016.12.016
   Cseh B, 2014, FEBS LETT, V588, P2398, DOI 10.1016/j.febslet.2014.06.025
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705
   Dekkers J. F., 2012, NAT MED, V11, P939, DOI [10.1016/S1569-1993(12)60101-5, DOI 10.1016/S1569-1993(12)60101-5]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211
   Finkbeiner SR, 2012, MBIO, V3, DOI 10.1128/mBio.00159-12
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527
   Glorevski N, 2016, NATURE, V539, P560, DOI 10.1038/nature20168
   Hisha H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03224
   Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x
   Huang L, 2015, NAT MED, V21, P1364, DOI 10.1038/nm.3973
   Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204
   Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826
   Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017
   Karve SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178966
   Kessler M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9989
   Klotz C, 2012, INT J MED MICROBIOL, V302, P203, DOI 10.1016/j.ijmm.2012.07.010
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802
   McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863
   Melton D., 2014, ESSENTIALS STEM CELL, P7, DOI [10.1016/B978-0-12-409503-8.00002-0, DOI 10.1016/B978-0-12-409503-8.00002-0]
   Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016
   Mullard A, 2016, NAT REV DRUG DISCOV, V15, P447, DOI 10.1038/nrd.2016.136
   Nadauld LD, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0428-9
   Natl Res Council, 2011, ANIMAL MODELS FOR ASSESSING COUNTERMEASURES TO BIOTERRORISM AGENTS, P1
   Nozaki K, 2016, J GASTROENTEROL, V51, P206, DOI 10.1007/s00535-016-1170-8
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Russell W.M.S., 1959, PRINCIPLES HUMANE EX
   Saini A, 2016, CELL STEM CELL, V19, P425, DOI 10.1016/j.stem.2016.09.001
   Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852
   Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Scanu T, 2015, CELL HOST MICROBE, V17, P763, DOI 10.1016/j.chom.2015.05.002
   Schlaermann P, 2016, GUT, V65, P202, DOI 10.1136/gutjnl-2014-307949
   Shyer AE, 2015, CELL, V161, P569, DOI 10.1016/j.cell.2015.03.041
   Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691
   Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Turco MY, 2017, NAT CELL BIOL, V19, P568, DOI 10.1038/ncb3516
   van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053
   van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059
   Volkner M, 2016, STEM CELL REP, V6, P525, DOI 10.1016/j.stemcr.2016.03.001
   Weeber F, 2015, P NATL ACAD SCI USA, V112, P13308, DOI 10.1073/pnas.1516689112
   World Health Organization (WHO), 2017, TOP 10 CAUS DEATH
   Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737
   Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695
   Zhu S, 2017, NATURE, V546, P667, DOI 10.1038/nature22967
NR 60
TC 9
Z9 9
U1 1
U2 17
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD DEC 5
PY 2017
VL 8
AR 2402
DI 10.3389/fmicb.2017.02402
PG 7
WC Microbiology
SC Microbiology
GA FO7IK
UT WOS:000417046900001
PM 29259597
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Goldfarb, IT
   Jaffe, E
   Lyerly, AD
AF Goldfarb, Ilona Telefus
   Jaffe, Elana
   Lyerly, Anne Drapkin
TI Responsible Care in the Face of Shifting Recommendations and Imperfect
   Diagnostics for Zika Virus
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
ID INFECTION; INFANTS; WOMEN; BIRTH
C1 [Goldfarb, Ilona Telefus] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, Boston, MA 02114 USA.
   [Jaffe, Elana; Lyerly, Anne Drapkin] Univ North Carolina Chapel Hill, Ctr Bioeth, Chapel Hill, NC USA.
   [Jaffe, Elana; Lyerly, Anne Drapkin] Univ North Carolina Chapel Hill, Dept Social Med, Chapel Hill, NC USA.
RP Goldfarb, IT (corresponding author), Massachusetts Gen Hosp, Dept Obstet & Gynecol, 55 Fruit St, Boston, MA 02114 USA.
EM igoldfarb@mgh.harvard.edu
FU Wellcome TrustWellcome Trust; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01AI108368]
FX Ms Jaffe and Dr Lyerly receive grant support from Wellcome Trust and
   grant R01AI108368 from the National Institutes of Health.
CR Ethics Working Group on ZIKV Research & Pregnancy, 2017, PREGN WOM ZIK VIR VA
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Rabin RC., 2016, NY TIMES, pD1
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 6
TC 5
Z9 5
U1 1
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD DEC 5
PY 2017
VL 318
IS 21
BP 2075
EP 2076
DI 10.1001/jama.2017.15680
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA FO7XT
UT WOS:000417093500007
PM 29084310
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Lee, KH
   Zeng, HQ
AF Lee, Kyung Hyun
   Zeng, Huaqiang
TI Aptamer-Based ELISA Assay for Highly Specific and Sensitive Detection of
   Zika NS1 Protein
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID SANDWICH ASSAY; VIRUS; ANTIBODIES; INFECTION; DIAGNOSIS; SELECTION;
   LIGANDS; BIND
AB We report here a few Zika NS1-binding ssDNA aptamers selected using the conventional SELEX protocol, and their application in an ELISA assay for sensitive diagnosis of Zika NS1 protein. Among the aptamers identified, aptamers 2 and 10 could recognize different binding epitopes of Zika NS1 protein. This complementary in binding site, when coupled with an extraordinarily high binding affinity by 2 (41-nt, K-D = 45 pM) and high specificity by 10, was used successfully to construct an ELISA-based assay where 2 and 10 serve as the capture and detection agents, respectively, giving rise to a highly specific detection of Zika NS1 with a detection limit of 100 ng/mL in buffer. Further testing of a few in-house anti-Zika NS1 antibodies show that 2 could also pair with an anti-Zika NS1 antibody. Such aptamer-antibody pairing not only lowers the detection sensitivity by 3 orders of magnitude to 0.1 ng/mL in buffer but also enable highly sensitive detection of as low as 1 and 10 ng/mL of Zika NS1 to be carried out in 10% and 100% human serum, respectively. These results suggest that the selected aptamers would be useful for medical diagnosis of Zika virus infection in various aptamer-based diagnostic devices including ELISA assay.
C1 [Lee, Kyung Hyun; Zeng, Huaqiang] Inst Bioengn & Nanotechnol, 31 Biopolis Way, Singapore 138669, Singapore.
RP Zeng, HQ (corresponding author), Inst Bioengn & Nanotechnol, 31 Biopolis Way, Singapore 138669, Singapore.
EM hqzeng@ibn.a-star.edu.sg
RI Zeng, Huaqiang/B-8540-2014
OI Zeng, Huaqiang/0000-0002-8246-2000; Lee, Kyung Hyun/0000-0001-8246-7592
FU Institute of Bioengineering and Nanotechnology (Biomedical Research
   Council, Agency for Science, Technology and Research, Singapore)Agency
   for Science Technology & Research (ASTAR)
FX This work was supported by the Institute of Bioengineering and
   Nanotechnology (Biomedical Research Council, Agency for Science,
   Technology and Research, Singapore). Deep sequencing analysis was
   performed under the kind help from Dr. Michiko Kimoto and Dr. Ichiro
   Hirao, and rabbit Anti-Zika NS1 monoclonal antibody was kindly provided
   by Dr. Thai Leong Yap and Dr. William Sun in the Institute of
   Bioengineering and Nanotechnology.
CR Aimaiti R, 2015, APPL MICROBIOL BIOT, V99, P9073, DOI 10.1007/s00253-015-6815-7
   Aydin S, 2015, PEPTIDES, V72, P4, DOI 10.1016/j.peptides.2015.04.012
   Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a
   Bruno JG, 2012, LUMINESCENCE, V27, P51, DOI 10.1002/bio.1324
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Edwards KA, 2010, ANAL BIOANAL CHEM, V398, P2645, DOI 10.1007/s00216-010-3920-4
   ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0
   Famulok M, 2014, CHEM BIOL, V21, P1055, DOI 10.1016/j.chembiol.2014.08.003
   Gong Q, 2012, ANAL CHEM, V84, P5365, DOI 10.1021/ac300873p
   Knight R, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng030
   Lee KA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10897
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Matsunaga K, 2017, J AM CHEM SOC, V139, P324, DOI 10.1021/jacs.6b10767
   Modh HB, 2016, J BIOTECHNOL, V238, P15, DOI 10.1016/j.jbiotec.2016.09.004
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Park JH, 2013, VIROLOGY, V439, P13, DOI 10.1016/j.virol.2013.01.014
   Parkash O, 2015, VIRUSES-BASEL, V7, P5410, DOI 10.3390/v7102877
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Syedmoradi L, 2017, BIOSENS BIOELECTRON, V87, P373, DOI 10.1016/j.bios.2016.08.084
   Tennico YH, 2010, ANAL CHEM, V82, P5591, DOI 10.1021/ac101269u
   Toh SY, 2015, BIOSENS BIOELECTRON, V64, P392, DOI 10.1016/j.bios.2014.09.026
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 25
TC 36
Z9 38
U1 9
U2 53
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD DEC 5
PY 2017
VL 89
IS 23
BP 12743
EP 12748
DI 10.1021/acs.analchem.7b02862
PG 6
WC Chemistry, Analytical
SC Chemistry
GA FP3WV
UT WOS:000417549600021
PM 29120623
DA 2020-07-08
ER

PT J
AU Tang, XJ
   Zhao, S
   Chiu, APY
   Wang, X
   Yang, L
   He, DH
AF Tang, Xiujuan
   Zhao, Shi
   Chiu, Alice P. Y.
   Wang, Xin
   Yang, Lin
   He, Daihai
TI Analysing increasing trends of Guillain-Barre A Syndrome (GBS) and
   dengue cases in Hong Kong using meteorological data
SO PLOS ONE
LA English
DT Article
ID BURDEN; FEVER
AB Background
   Guillain-Barre A Syndrome (GBS) is a severe paralytic neuropathy associated with virus infections such as Zika virus and Chikungunya virus. There were also case reports of dengue fever preceding GBS. With the aim to understand the mechanisms of GBS and dengue outbreaks, this ecological study investigates the relationships between GBS, dengue, meteorological factors in Hong Kong and global climatic factors from January 2000 to June 2016.
   Methods
   The correlations between GBS, dengue, Multivariate El Nino Southern Oscillation Index (MEI) and local meteorological data were explored by Spearman's Rank correlations and cross-correlations. Three Poisson regression models were fitted to identify non-linear associations among GBS, dengue and MEI. Cross wavelet analyses were applied to infer potential non-stationary oscillating associations among GBS, dengue and MEI.
   Findings and conclusion
   We report a substantial increasing of local GBS and dengue cases (mainly imported) in recent year in Hong Kong. The seasonalities of GBS and dengue are different, in particular, GBS is low while dengue is high in the summer. We found weak but significant correlations between GBS and local meteorological factors. MEI could explain over 17% of dengue's variations based on Poisson regression analyses. We report a possible non-stationary oscillating association between dengue fever and GBS cases in Hong Kong. This study has led to an improved understanding about the timing and ecological relationships between MEI, GBS and dengue.
C1 [Tang, Xiujuan; Wang, Xin] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China.
   [Zhao, Shi; Chiu, Alice P. Y.; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China.
   [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China.
RP Chiu, APY; He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China.
EM alice.py.chiu@polyu.edu.hk; daihai.he@polyu.edu.hk
RI YANG, Lin/F-9601-2014
OI YANG, Lin/0000-0002-5964-3233
FU Shenzhen Science and Technology Innovation Project Grant
   [JCYJ20150402102135501]; Start-up Fund for New Recruits from the Hong
   Kong Polytechnic University
FX This study was supported by Shenzhen Science and Technology Innovation
   Project Grant (JCYJ20150402102135501) and Start-up Fund for New Recruits
   from the Hong Kong Polytechnic University. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; This study was supported by Shenzhen
   Science and Technology Innovation Project Grant (JCYJ20150402102135501)
   and Start-up Fund for New Recruits from the Hong Kong Polytechnic
   University.
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170
   Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106
   Centre for Health Protection, COMM DIS WATCH 2013
   Centre for Health Protection, COMM DIS WATCH 2014
   Centre for Health Protection, COMM DIS WATCH 2012
   Centre for Health Protection, COMM DIS WATCH 2015
   Chen TY, 2007, ANN EMERG MED, V50, P94, DOI 10.1016/j.annemergmed.2007.02.026
   Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Goncalves E, 2011, REV INST MED TROP SP, V53, P223, DOI 10.1590/S0036-46652011000400009
   Hay SI, 2000, P NATL ACAD SCI USA, V97, P9335, DOI 10.1073/pnas.97.16.9335
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Hui ACF, 2005, J CLIN NEUROSCI, V12, P134, DOI 10.1016/j.jocn.2003.10.018
   Hurtado-Diaz M, 2007, TROP MED INT HEALTH, V12, P1327, DOI 10.1111/j.1365-3156.2007.01930.x
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168
   Kumar Sudhir, 2005, Neurol India, V53, P250
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Ma YM, 2010, PEDIATR INT, V52, P13, DOI 10.1111/j.1442-200X.2009.02951.x
   Mazzarella A, 2013, THEOR APPL CLIMATOL, V111, P601, DOI 10.1007/s00704-012-0696-9
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Qureshi N. K., 2012, Journal of Medicine, V13, P246
   Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0
   Santos NQ, 2004, ARQ NEURO-PSIQUIAT, V62, P144, DOI 10.1590/S0004-282X2004000100025
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   Sulekha C, 2004, INDIAN PEDIAT
   Thai KTD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000747
   Tipayamongkholgul M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-422
   Tsuda Y, 2016, JPN J INFECT DIS, V69, P1, DOI 10.7883/yoken.JJID.2014.576
   van Panhuis WG, 2015, P NATL ACAD SCI USA, V112, P13069, DOI 10.1073/pnas.1501375112
   Villamil-Gomez W, 2016, ENFERM INFEC MICR CL, V34, P140, DOI 10.1016/j.eimc.2015.05.012
   Wang SY, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/3159805
   Webb AJS, 2015, J NEUROL NEUROSUR PS, V86, P1196, DOI 10.1136/jnnp-2014-309056
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114
NR 42
TC 5
Z9 5
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 4
PY 2017
VL 12
IS 12
AR e0187830
DI 10.1371/journal.pone.0187830
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FO7EC
UT WOS:000417033200002
PM 29200423
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Campbell, CL
   Dickson, LB
   Lozano-Fuentes, S
   Juneja, P
   Jiggins, FM
   Black, WC
AF Campbell, Corey L.
   Dickson, Laura B.
   Lozano-Fuentes, Saul
   Juneja, Punita
   Jiggins, Francis M.
   Black, William C.
TI Alternative patterns of sex chromosome differentiation in Aedes aegypti
   (L)
SO BMC GENOMICS
LA English
DT Article
DE Population genetics; Arbovirus vector; Dimorphic traits; Genomics;
   Evolution of reproductive proteins; Sex determination
ID YELLOW-FEVER MOSQUITO; MEIOTIC DRIVE; GENETIC DIFFERENTIATION;
   MUSCA-DOMESTICA; Y-CHROMOSOME; EVOLUTION; POPULATIONS; RATIO;
   MECHANISMS; DISTORTION
AB Background: Some populations of West African Aedes aegypti, the dengue and zika vector, are reproductively incompatible; our earlier study showed that divergence and rearrangements of genes on chromosome 1, which bears the sex locus (M), may be involved. We also previously described a proposed cryptic subspecies SenAae (PK10, Senegal) that had many more high inter-sex FST genes on chromosome 1 than did Ae. aegypti aegypti (Aaa, Pai Lom, Thailand). The current work more thoroughly explores the significance of those findings.
   Results: Intersex standardized variance (FST) of single nucleotide polymorphisms (SNPs) was characterized from genomic exome capture libraries of both sexes in representative natural populations of Aaa and SenAae. Our goal was to identify SNPs that varied in frequency between males and females, and most were expected to occur on chromosome 1. Use of the assembled AaegL4 reference alleviated the previous problem of unmapped genes. Because the M locus gene nix was not captured and not present in AaegL4, the male-determining locus, per se, was not explored. Sex-associated genes were those with FST values >= 0.100 and/or with increased expected heterozygosity (Hexp, one-sided T-test, p < 0.05) in males. There were 85 genes common to both collections with high inter-sex FST values; all genes but one were located on chromosome 1. Aaa showed the expected cluster of high inter-sex FST genes proximal to the M locus, whereas SenAae had inter-sex FST genes along the length of chromosome 1. In addition, the Aaa M-locus proximal region showed increased Hexp levels in males, whereas SenAae did not. In SenAae, chromosomal rearrangements and subsequent suppressed recombination may have accelerated X-Y differentiation.
   Conclusions: The evidence presented here is consistent with differential evolution of proto-Y chromosomes in Aaa and SenAae.
C1 [Campbell, Corey L.; Dickson, Laura B.; Lozano-Fuentes, Saul; Black, William C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Campus Delivery 1692, Ft Collins, CO 80523 USA.
   [Juneja, Punita; Jiggins, Francis M.] Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.
RP Campbell, CL (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Campus Delivery 1692, Ft Collins, CO 80523 USA.
EM corey.campbell@colostate.edu
OI Campbell, Corey L./0000-0002-6384-1259
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01AI0833680]
FX This work was supported by National Institutes of Health (NIH)
   R01AI0833680 to WCB4. The funding body had no role in the study,
   collection, analysis, interpretation of data or in writing the
   manuscript.
CR Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366
   Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78
   Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720
   Bosio CF, 2005, AM J TROP MED HYG, V72, P434, DOI 10.4269/ajtmh.2005.72.434
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7
   Cheng CD, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006170
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Clark NL, 2006, REPRODUCTION, V131, P11, DOI 10.1530/rep.1.00357
   Coolon JD, 2015, MOL BIOL EVOL, V32, P2605, DOI 10.1093/molbev/msv135
   Coyne J. A., 2004, SPECIATION
   CRAIG GB, 1961, B WORLD HEALTH ORGAN, V24, P527
   CRAIG GB, 1960, SCIENCE, V132, P1887, DOI 10.1126/science.132.3443.1887
   Crawford JE, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0351-0
   Dickson LB, 2017, G3-GENES GENOM GENET, V7, P571, DOI 10.1534/g3.116.036053
   Dickson LB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004626
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Dubendorfer A, 2002, INT J DEV BIOL, V46, P75
   Dudchenko O, 2017, SCIENCE, V356, P92, DOI 10.1126/science.aal3327
   Ebbert MTW, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1097-3
   Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167
   Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196
   Fontaine A, 2017, GENOME BIOL EVOL, V9, P2322, DOI 10.1093/gbe/evx171
   FRANCO MG, 1982, GENET RES, V40, P279, DOI 10.1017/S0016672300019157
   Frascaroli E, 2013, THEOR APPL GENET, V126, P133, DOI 10.1007/s00122-012-1968-6
   Fumagalli M, 2013, GENETICS, V195, P979, DOI 10.1534/genetics.113.154740
   Graham DH, 2004, J HERED, V95, P35, DOI 10.1093/jhered/esh014
   Haerty W, 2007, GENETICS, V177, P1321, DOI 10.1534/genetics.107.078865
   Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Hall AB, 2014, GENOME BIOL EVOL, V6, P179, DOI 10.1093/gbe/evu002
   HICKEY WA, 1966, CAN J GENET CYTOL, V8, P260, DOI 10.1139/g66-033
   HICKEY WA, 1966, GENETICS, V53, P1177
   Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012
   Huber K, 2008, AM J TROP MED HYG, V79, P218, DOI 10.4269/ajtmh.2008.79.218
   Juneja P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004765
   Hoang KP, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1331-x
   Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111
   Krzywinska E, 2016, HEREDITY, V117, P408, DOI 10.1038/hdy.2016.57
   Krzywinska E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-300
   Lahn BT, 2001, NAT REV GENET, V2, P207, DOI 10.1038/35056058
   Lemaitre C, 2009, GENOME BIOL EVOL, V1, P56, DOI 10.1093/gbe/evp006
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lucotte EA, 2016, GENOME BIOL EVOL, V8, P1489, DOI 10.1093/gbe/evw090
   Marinho J, 2013, DEV BIOL, V377, P154, DOI 10.1016/j.ydbio.2013.02.003
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392
   MATTINGLY PF, 1967, B WORLD HEALTH ORGAN, V36, P552
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   MCCLELLA.GA, 1966, CAN J GENET CYTOL, V8, P192, DOI 10.1139/g66-024
   MCCLELLAND GA, 1974, T ROY ENT SOC LONDON, V126, P239, DOI 10.1111/j.1365-2311.1974.tb00853.x
   Mori A, 2004, J MED ENTOMOL, V41, P1027, DOI 10.1603/0022-2585-41.6.1027
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   NEWTON ME, 1974, CHROMOSOMA, V49, P41, DOI 10.1007/BF00284986
   NEWTON ME, 1976, GENETICA, V46, P297, DOI 10.1007/BF00055473
   OwusuDaaku KO, 1997, HEREDITY, V79, P388, DOI 10.1038/hdy.1997.172
   Presgraves DC, 1998, SCIENCE, V282, P952, DOI 10.1126/science.282.5390.952
   Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275
   Salvemini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048554
   Salvemini M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-41
   Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x
   Sirot LK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000989
   Sparks JT, 2014, INSECT BIOCHEM MOLEC, V48, P8, DOI 10.1016/j.ibmb.2014.02.004
   SUGUNA SG, 1977, GENET RES, V29, P123, DOI 10.1017/S0016672300017195
   Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733
   Sylla M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000408
   TABACHNICK WJ, 1979, GENET RES, V34, P215, DOI 10.1017/S0016672300019467
   THOMPSON PE, 1972, GENETICS, V70, P491
   WOOD RJ, 1976, GENETICA, V46, P345, DOI 10.1007/BF00055477
   WOOD RJ, 1987, GENETICA, V72, P69, DOI 10.1007/BF00126980
   WOOD RJ, 1991, AM NAT, V137, P379, DOI 10.1086/285171
   WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534
   Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057
NR 74
TC 3
Z9 3
U1 0
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD DEC 4
PY 2017
VL 18
AR 943
DI 10.1186/s12864-017-4348-4
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA FO6IR
UT WOS:000416967200003
PM 29202694
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Seltsam, A
AF Seltsam, Axel
TI Pathogen Inactivation of Cellular Blood Products-An Additional Safety
   Layer in Transfusion Medicine
SO FRONTIERS IN MEDICINE
LA English
DT Review
DE transfusion; platelets; pathogen inactivation; ultraviolet light; red
   blood cells
ID REDUCTION TECHNOLOGY TREATMENT; ACUTE LUNG INJURY; PLATELET
   TRANSFUSIONS; ZIKA VIRUS; CLINICAL EFFECTIVENESS; THERAPEUTIC-EFFICACY;
   COST-EFFECTIVENESS; PLASMA; COMPONENTS; TRIAL
AB In line with current microbial risk reduction efforts, pathogen inactivation (PI) technologies for blood components promise to reduce the residual risk of known and emerging infectious agents. The implementation of PI of labile blood components is slowly but steadily increasing. This review discusses the relevance of PI for the field of transfusion medicine and describes the available and emerging PI technologies that can be used to treat cellular blood products such as platelet and red blood cell units. In collaboration with the French medical device manufacturer Macopharma, the German Red Cross Blood Services developed a new UVC light-based PI method for platelet units, which is currently being investigated in clinical trials.
C1 [Seltsam, Axel] German Red Cross Blood Serv NSTOB, Inst Springe, Springe, Germany.
RP Seltsam, A (corresponding author), German Red Cross Blood Serv NSTOB, Inst Springe, Springe, Germany.
EM axel.seltsam@bsd-nstob.de
CR [Anonymous], 2016, BACT RISK CONTR STRA
   Benjamin RJ, 2005, TRANSFUSION, V45, P1739, DOI 10.1111/j.1537-2995.2005.00583.x
   Blanco C, 2008, TRANSFUSION, V48, P1279, DOI 10.1111/j.1537-2995.2008.01806.x
   Cazenave JP, 2010, TRANSFUSION, V50, P2362, DOI 10.1111/j.1537-2995.2010.02694.x
   Cazenave JP, 2011, TRANSFUSION, V51, P622, DOI 10.1111/j.1537-2995.2010.02873.x
   Corash L, 2011, BLOOD, V117, P1014, DOI 10.1182/blood-2010-06-293399
   Custer B, 2010, TRANSFUSION, V50, P2461, DOI 10.1111/j.1537-2995.2010.02704.x
   Devine DV, 1999, TRANSFUSION, V39, P724, DOI 10.1046/j.1537-2995.1999.39070724.x
   Engelfriet CP, 1998, VOX SANG, V75, P308, DOI 10.1046/j.1423-0410.1998.75403081.x
   Gelderman MP, 2011, TRANSFUSION, V51, P2343, DOI 10.1111/j.1537-2995.2011.03135.x
   Goodrich RP, 2009, TRANSFUSION, V49, P1205, DOI 10.1111/j.1537-2995.2009.02126.x
   Harrington T, 2003, TRANSFUSION, V43, P1018, DOI 10.1046/j.1537-2995.2003.00481.x
   Hauser L, 2014, BLOOD, V123, P796, DOI 10.1182/blood-2013-09-524348
   Henschler R, 2011, TRANSFUS MED HEMOTH, V38, P33, DOI 10.1159/000324458
   Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937
   Kerkhoffs JLH, 2010, BRIT J HAEMATOL, V150, P209, DOI 10.1111/j.1365-2141.2010.08227.x
   Klein HG, 2007, TRANSFUSION, V47, P2338, DOI 10.1111/j.1537-2995.2007.01512.x
   Kleinman S, 2010, TRANSFUSION, V50, P2592, DOI 10.1111/j.1537-2995.2010.02724.x
   Kuehnert MJ, 2016, TRANSFUSION, V56, P1669, DOI 10.1111/trf.13673
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Marschner S, 2011, TRANSFUS MED HEMOTH, V38, P8, DOI 10.1159/000324160
   McCullough J, 2004, BLOOD, V104, P1534, DOI 10.1182/blood-2003-12-4443
   McCullough J, 2015, TRANSFUSION, V55, P2312, DOI 10.1111/trf.13149
   Mohr H, 2009, TRANSFUSION, V49, P2612, DOI 10.1111/j.1537-2995.2009.02334.x
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   North AK, 2010, TRANSFUSION, V50, p38A
   Pelletier JPR, 2006, BEST PRACT RES CL HA, V19, P205, DOI 10.1016/j.beha.2005.04.001
   Pereira A, 2004, TRANSFUSION, V44, P948, DOI 10.1111/j.0041-1132.2004.359_6.x
   Postma MJ, 2005, TRANSFUSION MED, V15, P379, DOI 10.1111/j.1365-3148.2005.00609.x
   Rasongles P, 2009, TRANSFUSION, V49, P1083, DOI 10.1111/j.1537-2995.2009.02111.x
   Rebulla P, 2017, TRANSFUSION, V57, P1171, DOI 10.1111/trf.14042
   Sachais BS, 2017, BLOOD ADV, V1, P1142, DOI 10.1182/bloodadvances.2017008334
   Seltsam A, 2013, BRIT J HAEMATOL, V162, P442, DOI 10.1111/bjh.12403
   Seltsam A, 2011, TRANSFUS MED HEMOTH, V38, P43, DOI 10.1159/000323845
   van Rhenen D, 2003, BLOOD, V101, P2426, DOI 10.1182/blood-2002-03-0932
   Ypma PF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010156
NR 36
TC 9
Z9 9
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-858X
J9 FRONT MED-LAUSANNE
JI Front. Med.
PD DEC 4
PY 2017
VL 4
AR 219
DI 10.3389/fmed.2017.00219
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA FO5WJ
UT WOS:000416931900001
PM 29255710
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU DeSilva, M
   Munoz, FM
   Sell, E
   Marshall, H
   Kawai, AT
   Kachikis, A
   Heath, P
   Klein, NP
   Oleske, JM
   Jehan, F
   Spiegel, H
   Nesin, M
   Tagbo, BN
   Shrestha, A
   Cutland, CL
   Eckert, LO
   Kochhar, S
   Bardaji, A
AF DeSilva, Malini
   Munoz, Flor M.
   Sell, Erick
   Marshall, Helen
   Kawai, Alison Tse
   Kachikis, Alisa
   Heath, Paul
   Klein, Nicola P.
   Oleske, James M.
   Jehan, Fyezah
   Spiegel, Hans
   Nesin, Mirjana
   Tagbo, Beckie N.
   Shrestha, Anju
   Cutland, Clare L.
   Eckert, Linda O.
   Kochhar, Sonali
   Bardaji, Azucena
CA Brighton Collaboration Congenital
TI Congenital microcephaly: Case definition & guidelines for data
   collection, analysis, and presentation of safety data after maternal
   immunisation
SO VACCINE
LA English
DT Article
DE Congenital microcephaly; Adverse event; Immunisation; Guidelines; Case
   definition; Brighton Collaboration; GALA
ID ZIKA VIRUS-INFECTION; REPORTING SYSTEM VAERS; HUMAN-PAPILLOMAVIRUS;
   INFLUENZA VACCINATION; INTERIM GUIDANCE; INJECTION SITE; PREGNANT-WOMEN;
   TETANUS; DIPHTHERIA; FETAL
C1 [DeSilva, Malini] Hlth Partners Inst Educ & Res, Houston, TX USA.
   [Munoz, Flor M.] Baylor Coll Med, Houston, TX 77030 USA.
   [Sell, Erick] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada.
   [Marshall, Helen] Univ Adelaide, Womens & Childrens Hlth Network, Vaccinol & Immunol Res Trials Unit, South Adelaide, Australia.
   [Marshall, Helen] Univ Adelaide, Robinson Res Inst, South Adelaide, Australia.
   [Marshall, Helen] Univ Adelaide, Sch Med, South Adelaide, Australia.
   [Kawai, Alison Tse] Harvard Med Sch, Dept Populat Med, Boston, MA USA.
   [Kawai, Alison Tse] Harvard Pilgrim Hlth, Boston, MA USA.
   [Kachikis, Alisa] Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
   [Heath, Paul; Eckert, Linda O.] St Georges Univ London, St Georges Vaccine Inst, Inst Infect & Immun, London, England.
   [Klein, Nicola P.] Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA.
   [Oleske, James M.] Rutgers New Jersey Med Sch, Newark, NJ USA.
   [Jehan, Fyezah] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan.
   [Spiegel, Hans] Kelly Govt Solut KGS, Rockville, MD USA.
   [Spiegel, Hans] NIAID, DAIDS, NIH, Rockville, MD USA.
   [Nesin, Mirjana] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Tagbo, Beckie N.] Univ Nigeria Teaching Hosp, Inst Child Hlth, Enugu, Nigeria.
   [Tagbo, Beckie N.] Univ Nigeria Teaching Hosp, Dept Paediat, Enugu, Nigeria.
   [Shrestha, Anju] Sanofi Pasteur, Global Pharmacovigilance, Swiftwater, PA USA.
   [Cutland, Clare L.] MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Cutland, Clare L.] Univ Witwatersrand, Fac Hlth Sci, Vaccine Preventable Dis, Dept Sci & Technol Natl Res Fdn, Johannesburg, South Africa.
   [Kochhar, Sonali] Global Healthcare Consulting, Delhi, India.
   [Bardaji, Azucena] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Hosp Clin, Barcelona, Spain.
   [Kochhar, Sonali] Erasmus Univ, Med Ctr, Rotterdam, Netherlands.
RP Bardaji, A (corresponding author), Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Hosp Clin, Barcelona, Spain.
EM contact@brightoncollaboration.org
RI Alonso, Azucena Bardaji/V-5978-2018; Bardaji, Azucena/AAE-9145-2019;
   Spiegel, Hans/AAC-4220-2020; TAGBO, Beckie Nnenna/O-3232-2019
OI Alonso, Azucena Bardaji/0000-0002-5135-0540; Bardaji,
   Azucena/0000-0002-5135-0540; TAGBO, Beckie Nnenna/0000-0002-3590-2691;
   Cutland, Clare/0000-0001-8250-8307; Marshall, Helen/0000-0003-2521-5166;
   Kharbanda, Elyse/0000-0003-1806-6502; Kochhar,
   Sonali/0000-0002-1150-5691; Kawai, Alison/0000-0002-2923-2169; Kachikis,
   Alisa B/0000-0003-0358-5107; Heath, Paul/0000-0002-7540-7433
FU Brighton Collaboration; Bill and Melinda Gates FoundationGates
   Foundation
FX The authors are grateful for the support and helpful comments provided
   by the Brighton Collaboration and the reference group (see
   https://brightoncollaboration.org/public/what-we-do/settingstandards/cas
   e-definitions/groups.html for reviewers), as well as other experts
   consulted as part of the process (Elyse Kharbanda). The authors are also
   grateful to Jan Bonhoeffer, Jorgen Bauwens of the Brighton Collaboration
   Secretariat and Sonali Kochhar of Global Healthcare Consulting for final
   revisions of the final document. Finally, we would like to acknowledge
   the Global Alignment of Immunization Safety Assessment in Pregnancy
   (GAIA) project, funded by the Bill and Melinda Gates Foundation.
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Angelo MG, 2014, PHARMACOEPIDEM DR S, V23, P456, DOI 10.1002/pds.3593
   Angelo MG, 2014, PHARMACOEPIDEM DR S, V23, P466, DOI 10.1002/pds.3554
   [Anonymous], 2002, CHIME PUBLICATIONS
   [Anonymous], 2016, ONLINE MENDELIAN INH
   Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d
   Bhide PICA, BIRTH PREVALENCE OF
   Cauchemez S, 2016, LANCET
   CDC National Birth Defects Prevention Network, 2013, BIRTH DEFECTS RES A, V97, pS1
   Czeizel AE, 1999, INT J GYNECOL OBSTET, V64, P253, DOI 10.1016/S0020-7292(99)00008-9
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010
   DeSilva M, 2016, VACCINE
   Division of Birth Defects and Developmental Disabilities N Centers for Disease Control and Prevention, 2016, FACTS MICR
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Fabiani M, 2015, VACCINE, V33, P2240, DOI 10.1016/j.vaccine.2015.03.041
   Garland SM, 2009, OBSTET GYNECOL, V114, P1179, DOI 10.1097/AOG.0b013e3181c2ca21
   Goss MA, 2015, VACCINE, V33, P3422, DOI 10.1016/j.vaccine.2015.04.014
   HARJULEHTOMERVAALA T, 1994, CLIN INFECT DIS, V18, P414, DOI 10.1093/clinids/18.3.414
   Heikkinen T, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.007
   Heinonen OP, 1977, BIRTH DEFECTS DRUGS
   Huang WT, 2014, VACCINE, V32, P6463, DOI 10.1016/j.vaccine.2014.09.054
   Kallen B, 2012, BJOG-INT J OBSTET GY, V119, P1583, DOI 10.1111/j.1471-0528.2012.03470.x
   Keller-Stanislawski B, 2014, VACCINE, V32, P7057, DOI 10.1016/j.vaccine.2014.09.052
   Kohl KS, 2007, VACCINE, V25, P5858, DOI 10.1016/j.vaccine.2007.04.056
   Kohl KS, 2007, VACCINE, V25, P5839, DOI 10.1016/j.vaccine.2007.04.062
   Kohl KS, 2007, VACCINE, V25, P5671, DOI 10.1016/j.vaccine.2007.02.063
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Louis GMB, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.032
   McMillan M, 2015, VACCINE, V33, P2108, DOI 10.1016/j.vaccine.2015.02.068
   Morgan JL, 2015, OBSTET GYNECOL, V125, P1433, DOI 10.1097/AOG.0000000000000862
   Moro PL, 2016, VACCINE, V34, P2349, DOI 10.1016/j.vaccine.2016.03.049
   Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633
   Nakalembe M, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0012-2
   National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) CfDCaP, 2016, CONG MICR CAS DEF
   Obican S, 2011, AM J MED GENET C, V157C, P150, DOI 10.1002/ajmg.c.30310
   OPITZ JM, 1990, J CRAN GENET DEV BIO, V10, P175
   Oppermann M, 2012, VACCINE, V30, P4445, DOI 10.1016/j.vaccine.2012.04.081
   Organization WH, 2016, CHILD GROWTH STAND H
   Organization WH, 2016, ASS INF MICR CONT ZI
   Ouandaogo CR, 2012, VACCINE, V30, pB46, DOI 10.1016/j.vaccine.2011.12.112
   Oxford Uo, INT FET STAND HEAD C
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Papageorghiou AT, 2013, BJOG-INT J OBSTET GY, V120, P27, DOI 10.1111/1471-0528.12313
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Pasternak B, 2012, OBSTET GYNECOL SURV, V67, P683
   Prevention CfDCa, 2016, MEAS HEAD CIRC CDCS
   Quinn J, VACCINE
   Rasmussen SA, 2016, N ENGL J MED
   ROCHE AF, 1987, PEDIATRICS, V79, P706
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Santa Cruz G, 1983, Zentralbl Allg Pathol, V127, P163
   Shakib JH, 2013, J PEDIATR-US, V163, P1422, DOI 10.1016/j.jpeds.2013.06.021
   Silveira CM, 1995, B WORLD HEALTH ORGAN, V73, P605
   Soares deAradjo JSRC, 2016, B WHO
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Sukumaran L, 2015, CLIN INFECT DIS, V60, pE58, DOI 10.1093/cid/civ061
   Swaiman KF, 2012, SWAIMANS PEDIAT NEUR
   Trotta F, 2014, BMJ-BRIT MED J, P348
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Wilson E, 2008, OBSTET GYNECOL SURV, V63, P486
   Zheteyeva Y, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.027
NR 66
TC 14
Z9 14
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 4
PY 2017
VL 35
IS 48
SI SI
BP 6472
EP 6482
DI 10.1016/j.vaccine.2017.01.044
PN A
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FQ2WW
UT WOS:000418219700002
PM 29150052
OA Green Published, Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU Duarte, EC
   Garcia, LP
   De Araujo, WN
   Velez, MP
AF Duarte, Elisabeth Carmen
   Garcia, Leila Posenato
   de Araujo, Wildo Navegantes
   Velez, Maria P.
TI Outcomes of Zika virus infection during pregnancy: contributions to the
   debate on the efficiency of cohort studies
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Zika virus infection; Cohort studies; Efficiency; Pregnancy outcome;
   Congenital abnormalities; Epidemiologic studies
AB Background: Zika infection during pregnancy (ZIKVP) is known to be associated with adverse outcomes. Studies on this matter involve both rare outcomes and rare exposures and methodological choices are not straightforward. Cohort studies will surely offer more robust evidences, but their efficiency must be enhanced. We aim to contribute to the debate on sample selection strategies in cohort studies to assess outcomes associated with ZKVP.
   Main body of the abstract: A study can be statistically more efficient than another if its estimates are more accurate (precise and valid), even if the studies involve the same number of subjects. Sample size and specific design strategies can enhance or impair the statistical efficiency of a study, depending on how the subjects are distributed in subgroups pertinent to the analysis. In most ZIKVP cohort studies to date there is an a priori identification of the source population (pregnant women, regardless of their exposure status) which is then sampled or included in its entirety (census). Subsequently, the group of pregnant women is classified according to exposure (presence or absence of ZIKVP), respecting the exposed: unexposed ratio in the source population. We propose that the sample selection be done from the a priori identification of groups of pregnant women exposed and unexposed to ZIKVP. This method will allow for an oversampling (even 100%) of the pregnant women with ZKVP and a optimized sampling from the general population of pregnant women unexposed to ZIKVP, saving resources in the unexposed group and improving the expected number of incident cases (outcomes) overall.
   Conclusion: We hope that this proposal will broaden the methodological debate on the improvement of statistical power and protocol harmonization of cohort studies that aim to evaluate the association between Zika infection during pregnancy and outcomes for the offspring, as well as those with similar objectives.
C1 [Duarte, Elisabeth Carmen] Univ Brasilia UnB, Med Sch, Brasilia, DF, Brazil.
   [Duarte, Elisabeth Carmen; de Araujo, Wildo Navegantes] Nucleo Med Trop, Campus Univ Darcy Ribeiro,Caixa Postal 4517, BR-70910900 Brasilia, DF, Brazil.
   [Garcia, Leila Posenato] Inst Appl Econ Res IPEA, Brasilia, DF, Brazil.
   [Garcia, Leila Posenato] Inst Appl Econ Res, SBS Quadra 1,Bloco J,Ed BNDES Ipea, BR-70076900 Brasilia, DF, Brazil.
   [de Araujo, Wildo Navegantes] Univ Brasilia UnB, Fac Ceilandia, Brasilia, DF, Brazil.
   [Velez, Maria P.] Queens Univ, Dept Obstet & Gynaecol, Sch Med, 99 Univ Ave, Kingston, ON K7L 3N6, Canada.
RP Duarte, EC (corresponding author), Univ Brasilia UnB, Med Sch, Brasilia, DF, Brazil.; Duarte, EC (corresponding author), Nucleo Med Trop, Campus Univ Darcy Ribeiro,Caixa Postal 4517, BR-70910900 Brasilia, DF, Brazil.
EM eduarte@unb.br
OI Velez, Maria P./0000-0003-4834-8279
CR Awadh A, 2017, PLOS CURRENTS
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY
   StataCorp, 2007, STAT STAT SOFTW REL
   WALTER SD, 1977, AM J EPIDEMIOL, V105, P387, DOI 10.1093/oxfordjournals.aje.a112395
   WHO, 2017, HARM ZIKV RES PROT A
   World Health Organization, 2016, WHOZIKVLAB161
NR 6
TC 0
Z9 0
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD DEC 2
PY 2017
VL 17
AR 924
DI 10.1186/s12889-017-4915-2
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FO6LD
UT WOS:000416973700001
PM 29197364
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, CX
   Yang, SNY
   Smith, K
   Forwood, JK
   Jans, DA
AF Wang, Chunxiao
   Yang, Sundy N. Y.
   Smith, Kate
   Forwood, Jade K.
   Jans, David A.
TI Nuclear import inhibitor N-(4-hydroxyphenyl) retinamide targets Zika
   virus (ZIKV) nonstructural protein 5 to inhibit ZIKV infection
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Zika virus; Nuclear transport inhibitors; Importins; Viral infection;
   Flavivirus
ID LOCALIZATION SEQUENCE; CRYSTAL-STRUCTURE; DENGUE; NS5; PHOSPHORYLATION;
   NEUROBLASTOMA; PROTECTION; REVEALS; KINASE
AB In the absence of approved therapeutics, Zika virus (ZIKV)'s recent prolific outbreaks in the Americas, together with impacts on unborn fetuses of infected mothers, make it a pressing human health concern worldwide. Although a key player in viral replication in the infected host cell cytoplasm, ZIKV nonstructural protein 5 (NS5) appears to contribute integrally to pathogenesis by localising in the host cell nucleus, in similar fashion to NS5 from Dengue virus (DENV). We show here for the first time that ZIKV NS5 is recognized with high nanomolar affinity by the host cell importin alpha/beta 1 heterodimer, and that this interaction can be blocked by the novel DENV NS5 targeting inhibitor N-(4-hydroxyphenyl) retinamide (4-HPR). Importantly, we show that 4-HPR has potent anti-ZIKV activity at low 1 mu M concentrations. With an established safety profile for human use, 4-HPR represents an exciting possibility as an anti-ZIKV agent. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Wang, Chunxiao; Yang, Sundy N. Y.; Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Nucl Signaling Lab, Clayton, Vic 3800, Australia.
   [Smith, Kate; Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2650, Australia.
RP Jans, DA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Nucl Signaling Lab, Clayton, Vic 3800, Australia.
EM David.Jans@monash.edu
OI Jans, David/0000-0001-5115-4745; Forwood, Jade/0000-0003-3267-9997
FU National Health and Medical Research Council AustraliaNational Health
   and Medical Research Council of Australia [APP1002486/APP1103050,
   APP1043511]
FX The authors acknowledge Julian Druce (VIDRL) for providing ZIKV (Asian
   strain/Cook Islands/2014), and the financial support of the National
   Health and Medical Research Council Australia (Senior Principal Research
   Fellowship APP1002486/APP1103050 and Project grant APP1043511) to DAJ.
   Prof. S. Vasudevan (Duke NUS) and Dr. K. Wagstaff are thanked for
   helpful discussions.
CR Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   BUCKLEY A, 1992, J GEN VIROL, V73, P1125, DOI 10.1099/0022-1317-73-5-1125
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   COSTA A, 1989, EUR J CANCER CLIN ON, V25, P805, DOI 10.1016/0277-5379(89)90124-7
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   EDWARD Z, 1993, MICROBIOL IMMUNOL, V37, P239, DOI 10.1111/j.1348-0421.1993.tb03206.x
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200
   Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370
   Fraser JE, 2016, ANTIVIR RES, V130, P1, DOI 10.1016/j.antiviral.2016.03.006
   Fraser JE, 2014, J INFECT DIS, V210, P1780, DOI 10.1093/infdis/jiu319
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Maurer BJ, 2013, PEDIATR BLOOD CANCER, V60, P1801, DOI 10.1002/pbc.24643
   Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Villablanca JG, 2011, CLIN CANCER RES, V17, P6858, DOI 10.1158/1078-0432.CCR-11-0995
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wagstaff KM, 2011, J BIOMOL SCREEN, V16, P192, DOI 10.1177/1087057110390360
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Ye J, 2017, J VIROL, V91, DOI [10.1128/jvi.00039-17, 10.1128/JVI.00039-17]
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 33
TC 21
Z9 21
U1 0
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD DEC 2
PY 2017
VL 493
IS 4
BP 1555
EP 1559
DI 10.1016/j.bbrc.2017.10.016
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FL1RK
UT WOS:000413991900029
PM 28988109
DA 2020-07-08
ER

PT J
AU Werner, H
   Daltro, P
   Fazecas, T
   Mehrjardi, MZ
   Araujo, E
AF Werner, Heron
   Daltro, Pedro
   Fazecas, Tatiana
   Mehrjardi, Mohammad Zare
   Araujo Junior, Edward
TI Neuroimaging Findings of Congenital Toxoplasmosis, Cytomegalovirus, and
   Zika Virus Infections: A Comparison of Three Cases
SO JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA
LA English
DT Article
DE Toxoplasmosis; cytomegalovirus; Zika virus; ultrasound; magnetic
   resonance imaging
ID BRAIN
AB OBJECTIVE: Toxoplasmosis, cytomegalovirus (CMV), and Zika virus (ZIKV) are among the common infectious agents that may infect the fetuses vertically. Clinical presentations of these congenital infections overlap significantly, and it is usually impossible to determine the causative agent clinically. The objective was the comparison of neuroimaging findings in three fetuses who underwent intrauterine infection by toxoplasmosis, CMV, and ZIKV.
   METHODS: Three confirmed cases of congenital toxoplasmosis, CMV, and ZIKV infections were included in the study over 7 months prospectively. Prenatal ultrasound, fetal brain MRI, and postnatal neuroimaging (CT or MRI) were performed on all of the included cases and interpreted by an expert radiologist.
   RESULTS: The mean GA at the time of prenatal imaging was 34.5 +/- 3.5 weeks. The main neuroimaging findings in congenital toxoplasmosis were randomly distributed brain calcifications and ventricular dilatation on ultrasounds (US), as well as white matter signal change on fetal brain MRI. The main neuroimaging findings of congenital CMV infection included microcephaly, ventriculomegaly, and periventricular calcifications on US, as well as pachygyria revealed by fetal MRI. The case of congenital ZIKV infection showed microcephaly, ventriculomegaly, and periventricular calcifications on ultrasound, as well as brain atrophy and brain surface smoothness on fetal MRI.
   CONCLUSION: Although the neuroimaging findings in congenital infections are not pathognomonic, in combination with the patient history may be suggestive of one of the infectious agents, which will guide the management strategy. Copyright (C) 2017 The Society of Obstetricians and Gynaecologists of Canada/La Societe des obstetriciens et gynecologues du Canada. Published by Elsevier Inc. All rights reserved.
C1 [Werner, Heron; Daltro, Pedro; Fazecas, Tatiana] Clin Diagnost Imagem CDPI, Dept Radiol, Rio De Janeiro, Brazil.
   [Mehrjardi, Mohammad Zare] Shahid Beheshti Univ Med Sci, Sch Med, Shohada Tajrish Hosp, Dept Radiol, Tehran, Iran.
   [Mehrjardi, Mohammad Zare] Climax Radiol Educ Fdn, Div Clin Res, Sect Neuroimaging, Tehran, Iran.
   [Araujo Junior, Edward] Univ Fed Sao Paulo, UNIFESP, EPM, Dept Obstet,Paulista Sch Med, Sao Paulo, Brazil.
RP Araujo, E (corresponding author), Univ Fed Sao Paulo, UNIFESP, EPM, Dept Obstet,Paulista Sch Med, Sao Paulo, Brazil.
EM araujojred@terra.com.br
RI Junior, Edward Araujo/E-1228-2012; Mehrjardi, Mohammad Zare/G-8980-2017;
   Werner, Heron/W-1578-2019
OI Junior, Edward Araujo/0000-0002-6145-2532; Mehrjardi, Mohammad
   Zare/0000-0001-5793-5323; 
CR Antsaklis A, 2002, PRENATAL DIAG, V22, P1107, DOI 10.1002/pd.476
   Boppana SB, 1997, PEDIATRICS, V99, P409, DOI 10.1542/peds.99.3.409
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Doneda C, 2010, RADIOLOGY, V255, P613, DOI 10.1148/radiol.10090749
   Farkas Natalie, 2010, Harefuah, V149, P45
   HOHLFELD P, 1991, ULTRASOUND OBST GYN, V1, P241, DOI 10.1046/j.1469-0705.1991.01040241.x
   Malinger G, 2011, PRENATAL DIAG, V31, P881, DOI 10.1002/pd.2795
   Malinger G, 2003, AM J NEURORADIOL, V24, P28
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P87, DOI 10.1007/s11604-016-0605-8
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   van der Knaap MS, 2004, RADIOLOGY, V230, P529, DOI 10.1148/radiol.2302021459
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
NR 15
TC 8
Z9 8
U1 0
U2 1
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1701-2163
J9 J OBSTET GYNAECOL CA
JI J. Obstet. Gynaecol. Can.
PD DEC
PY 2017
VL 39
IS 12
BP 1150
EP 1155
DI 10.1016/j.jogc.2017.05.013
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GS4CI
UT WOS:000443579800012
PM 28780216
DA 2020-07-08
ER

PT J
AU Sun, JF
   Wu, D
   Ke, CW
AF Sun, Jiufeng
   Wu, De
   Ke, Changwen
TI Molecular phylogenetic analyses of imported Zika virus genomes in China
SO LANCET
LA English
DT Meeting Abstract
CT Lancet-Chinese-Academy-of-Medical-Sciences (CAMS) Health Summit
CY OCT 13-14, 2017
CL Beijing, PEOPLES R CHINA
SP Lancet, Chinese Acad Med Sci
C1 [Sun, Jiufeng; Wu, De; Ke, Changwen] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.
   [Sun, Jiufeng; Wu, De; Ke, Changwen] WHO Collaborating Ctr Surveillance Res & Training, Guangzhou, Guangdong, Peoples R China.
EM kecw1965@aliyun.com
FU Guangdong Provincial Science and Technology Program [2015A020213004];
   Guangdong Provincial Science and Technology [2016A020251001]; National
   Key RD Program [2016YFC1200201]
FX Guangdong Provincial Science and Technology Program (2015A020213004),
   Guangdong Provincial Science and Technology (2016A020251001), and
   National Key R&D Program (2016YFC1200201).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD DEC
PY 2017
VL 390
SU 4
BP S36
EP S36
DI 10.1016/S0140-6736(17)33174-4
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA GO9WS
UT WOS:000440459400037
OA Bronze
DA 2020-07-08
ER

PT J
AU Manrique, PD
   Beier, JC
   Johnson, NF
AF Manrique, P. D.
   Beier, J. C.
   Johnson, N. F.
TI Simple visit behavior unifies complex Zika outbreaks
SO HELIYON
LA English
DT Article
DE Infectious disease; Public health; Applied mathematics
ID NETWORKS; MODEL
AB New outbreaks of Zika in the U.S. are imminent. Human nature dictates that many individuals will continue to revisit affected 'Ground Zero' patches, whether out of choice, work or family reasons - yet this feature is missing from traditional epidemiological analyses. Here we show that this missing visit-revisit mechanism is by itself capable of explaining quantitatively the 2016 human Zika outbreaks in all three Ground Zero patches. Our findings reveal counterintuitive ways in which this human flow can be managed to tailor any future outbreak's duration, severity and time-to-peak. Effective public health planning can leverage these results to impact the evolution of future outbreaks via soft control of the overall human flow, as well as to suggest best-practice visitation behavior for local residents.
C1 [Manrique, P. D.; Johnson, N. F.] Univ Miami, Dept Phys, Coral Gables, FL 33126 USA.
   [Beier, J. C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Coral Gables, FL 33126 USA.
RP Manrique, PD (corresponding author), Univ Miami, Dept Phys, Coral Gables, FL 33126 USA.
EM p.manriquecharry@umiami.edu
FU CDC grant [1U01CK000510-01]; National Science FoundationNational Science
   Foundation (NSF) [CNS 1522693]; Air Force (AFOSR) [FA9550-16-1-0247];
   Miami Clinical and Translational Science Institute; National Center for
   Advancing Translational SciencesUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Advancing Translational Sciences (NCATS); National Institute
   on Minority Health and Health DisparitiesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute on Minority Health & Health Disparities (NIMHD); 
   [UL1TR000460]
FX This work was supported by CDC grant 1U01CK000510-01: Southeastern
   Regional Center of Excellence in Vector-Borne Diseases: the Gateway
   Program. Neil Johnson was supported by National Science Foundation grant
   CNS 1522693 and Air Force (AFOSR) grant FA9550-16-1-0247. John Beier was
   supported by Grant Number UL1TR000460, Miami Clinical and Translational
   Science Institute, from the National Center for Advancing Translational
   Sciences and the National Institute on Minority Health and Health
   Disparities.
CR Alimi TO, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2902-7
   Zuzek LGA, 2015, SCI REP-UK, V5, DOI 10.1038/srep12151
   Barrat A, 2008, DYNAMICAL PROCESSES
   CANTRELL S, 2009, SPATIAL ECOLOGY
   Florida Department of Health, 2017, MOSQ BORN DIS SURV
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Jo HH, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011041
   Karsai M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04001
   Liu S, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022122
   Manrique PD, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.022304
   Manrique PD, 2016, EPL-EUROPHYS LETT, V115, DOI 10.1209/0295-5075/115/18001
   Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925
   Perra N., 2011, PLOS ONE
   Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102
NR 14
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD DEC
PY 2017
VL 3
IS 12
AR e00482
DI 10.1016/j.heliyon.2017.e00482
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GF5SZ
UT WOS:000432029400022
PM 29322105
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sudeep, AB
   Shil, P
AF Sudeep, A. B.
   Shil, P.
TI Aedes vittatus (Bigot) mosquito: An emerging threat to public health
SO JOURNAL OF VECTOR BORNE DISEASES
LA English
DT Review
DE Aedes vittatus; chikungunya; dengue; Zika; yellow fever
ID CHIKUNGUNYA-VIRUS; YELLOW-FEVER; VECTORS; SENEGAL; TRANSMISSION;
   PREVALENCE; CULICIDAE; DIPTERA
AB Aedes vittatus (Bigot) mosquito is a voracious biter of humans and has a geographical distribution throughout tropical Asia, Africa and the Mediterranean region of Europe. It is predominantly a rock-hole breeder, though it can breed in diverse macro-and micro-habitats. The mosquito plays an important role in the maintenance and transmission of yellow fever (YFV), dengue (DENV), chikungunya (CHIKV) and Zika (ZIKV) viruses. It has been implicated as an important vector of YFV in several African countries as evidenced by repeated virus isolations from the mosquito and its potential to transmit the virus experimentally. Similarly, DENV-2 has been isolated from wild caught Ae. vittatus mosquitoes in Senegal, Africa which has been shown to circulate the virus in sylvatic populations without causing human infection. Experimental studies have shown replication of the virus at a low scale in naturally infected mosquitoes while high rate of infection and dissemination have been reported in parenterally infected mosquitoes. Natural isolation of ZIKV has been reported from Senegal and Cote d'Ivoire from these mosquitoes. They were found highly competent to transmit the virus experimentally and the transmission rate is at par with Ae. leuteocephalus, the primary vector of ZIKV. A few CHIKV isolations have also been reported from the mosquitoes in Senegal and other countries in Africa. Experimental studies have demonstrated high susceptibility, early dissemination and efficient transmission of CHIKV by Ae. vittatus mosquitoes. The mosquitoes with their high susceptibility and competence to transmit important viruses, viz. YFV, DENV, CHIKV and ZIKV pose a major threat to public health due to their abundance and anthropophilic behaviour.
C1 [Sudeep, A. B.; Shil, P.] Natl Inst Virol, ICMR, Microbial Containment Complex,Sus Rd, Pune 411021, Maharashtra, India.
RP Sudeep, AB (corresponding author), Natl Inst Virol, ICMR, Microbial Containment Complex,Sus Rd, Pune 411021, Maharashtra, India.
EM sudeepmcc@yahoo.co.in
RI Shil, Pratip/M-8986-2019
CR Adebote David A., 2008, Journal of Vector Borne Diseases, V45, P21
   Adeleke Monsuru Adebayo, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P673, DOI 10.1016/S2221-1691(13)60137-9
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alikhan M, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.69
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CORDELLIER R, 1983, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V21, P165
   Diagne CT, 2014, AM J TROP MED HYG, V91, P635, DOI 10.4269/ajtmh.13-0627
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-286
   Diallo M, 2005, AM J TROP MED HYG, V73, P445, DOI 10.4269/ajtmh.2005.73.445
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   GERMAIN M, 1980, AM J TROP MED HYG, V29, P929, DOI 10.4269/ajtmh.1980.29.929
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HUANG Y-M, 1977, Contributions of the American Entomological Institute, V14, P1
   IRVINGBELL RJ, 1991, TROP MED PARASITOL, V42, P63
   JUPP PG, 1990, J AM MOSQUITO CONTR, V6, P415
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   MAVALE MS, 1992, ACTA VIROL, V36, P412
   Melero-Alcibar R., 2006, European Mosquito Bulletin, V21, P19
   MOURYA DT, 1987, INDIAN J MED RES, V86, P269
   Ngoagouni C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-175
   Petersen Lyle R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7171.1
   Rajavel AR, 2006, J AM MOSQUITO CONTR, V22, P582, DOI 10.2987/8756-971X(2006)22[582:MOTMFO]2.0.CO;2
   Reinert John F., 2000, European Mosquito Bulletin, V6, P1
   SERVICE MW, 1974, B WORLD HEALTH ORGAN, V50, P487
   Service MW, 1970, T R SOC ENTOMOL SOC, V122, P101
   Sudeep AB, 2008, J BIOSCIENCES, V33, P443, DOI 10.1007/s12038-008-0063-2
   Tewari SC, 2004, TROP MED INT HEALTH, V9, P499, DOI 10.1111/j.1365-3156.2004.01103.x
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Zahouli JBZ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1778-9
NR 36
TC 2
Z9 2
U1 0
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0972-9062
J9 J VECTOR DIS
JI J. Vector Borne Dis.
PD DEC
PY 2017
VL 54
IS 4
BP 295
EP 300
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FW2WQ
UT WOS:000425166000001
PM 29460858
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Stewart-Ibarra, AM
   Hargrave, A
   Diaz, A
   Kenneson, A
   Madden, D
   Romero, MM
   Molina, JP
   Saltos, DM
AF Stewart-Ibarra, Anna M.
   Hargrave, Anita
   Diaz, Avriel
   Kenneson, Aileen
   Madden, David
   Romero, Moory M.
   Pablo Molina, Juan
   Macias Saltos, David
TI Psychological Distress and Zika, Dengue and Chikungunya Symptoms
   Following the 2016 Earthquake in Bahia de Caraquez, Ecuador
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Zika virus; dengue; chikungunya; arbovirus; psychological distress;
   earthquake; Ecuador; natural disaster
ID POSTTRAUMATIC-STRESS-DISORDER; HAIR CORTISOL; MENTAL-HEALTH;
   VIRUS-INFECTION; SURVIVORS; SEVERITY; EXPOSURE; TAIWAN; EPIDEMIOLOGY;
   ADOLESCENTS
AB On 16 April 2016, a 7.8 magnitude earthquake struck coastal Ecuador, resulting in significant mortality and morbidity, damages to infrastructure, and psychological trauma. This event coincided with the first outbreak of Zika virus (ZIKV) and co-circulation with dengue virus (DENV) and chikungunya virus (CHIKV). We tested whether the degree of psychological distress was associated with the presence of suspected DENV, CHIKV, ZIKV (DCZ) infections three months after the earthquake. In July 2016, 601 household members from four communities in Bahia de Caraquez, Manabi Province, Ecuador, were surveyed in a post-disaster health evaluation. Information was collected on demographics, physical damages and injuries, chronic diseases, self-reported psychological distress, and DCZ symptoms. We calculated the prevalence of arbovirus and distress symptoms by community. ANOVA was used to compare the mean number of psychological distress symptoms between people with versus without suspected DCZ infections by age, gender, community and the need to sleep outside of the home due to damages. The prevalence of suspected DCZ infections was 9.7% and the prevalence of psychological distress was 58.1%. The average number of psychological distress symptoms was significantly higher among people with suspected DCZ infections in the periurban community of Bella Vista, in women, in adults 40-64 years of age and in individuals not sleeping at home (p < 0.05). The results of this study highlight the need to investigate the interactions between psychological distress and arboviral infections following natural disasters.
C1 [Stewart-Ibarra, Anna M.; Kenneson, Aileen; Romero, Moory M.] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, 750 East Adams St, Syracuse, NY 13210 USA.
   [Hargrave, Anita] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Diaz, Avriel] Columbia Univ, Dept Ecol Evolut & Conservat Biol, New York, NY 10025 USA.
   [Madden, David] Walking Palms Global Initiat, Bahia De Caraquez 131401, Manabi Province, Ecuador.
   [Pablo Molina, Juan; Macias Saltos, David] Minist Hlth, San Vicente 131458, Manabi Province, Ecuador.
RP Stewart-Ibarra, AM (corresponding author), SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, 750 East Adams St, Syracuse, NY 13210 USA.
EM stewarta@upstate.edu; anita.hargrave@ucsf.edu; avriel.diaz@gmail.com;
   aileen.kenneson@yahoo.com; davidpatrickmadden@gmail.com;
   romero.moory@gmail.com; molinajp2014@hotmail.com;
   davidmacias126@gmail.com
OI Stewart-Ibarra, Anna/0000-0002-3383-4672
CR Alava A., 2005, REV ECUAT HIG MED TR, V42, P11
   Alava A., 1992, REV ECUAT HIG MED TR, V40, P5
   American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU
   Beckwith Jessica, 2006, Mcgill J Med, V9, P119
   BONNEAU RH, 1991, BRAIN BEHAV IMMUN, V5, P170, DOI 10.1016/0889-1591(91)90015-3
   Cairo JB, 2010, DISASTER MED PUBLIC, V4, P39, DOI 10.1001/dmp.2010.15
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao H, 2003, SOC PSYCH PSYCH EPID, V38, P204, DOI 10.1007/s00127-003-0619-2
   Carr VJ, 1997, PSYCHOL MED, V27, P167, DOI 10.1017/S0033291796004278
   Chang CM, 2005, J NERV MENT DIS, V193, P40, DOI 10.1097/01.nmd.0000149217.67211.ab
   Chen CC, 2001, PSYCHIAT RES, V105, P13, DOI 10.1016/S0165-1781(01)00334-1
   Chen SH, 2006, NAT HAZARDS, V37, P225, DOI 10.1007/s11069-005-4671-y
   Christ-Crain M, 2007, AM J RESP CRIT CARE, V176, P913, DOI 10.1164/rccm.200702-307OC
   COHEN S, 1991, PSYCHOL BULL, V109, P5, DOI 10.1037/0033-2909.109.1.5
   COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903
   Del Brutto OH, 2015, GERIATR GERONTOL INT, V15, P508, DOI 10.1111/ggi.12305
   Domercant JW, 2015, MMWR-MORBID MORTAL W, V64, P137
   Eksi A, 2007, INT J PSYCHIAT CLIN, V11, P190, DOI 10.1080/13651500601017548
   Farooqui M, 2017, TRENDS PSYCHIATR PSY, V39, P135, DOI 10.1590/2237-6089-2016-0029
   Finerman R, 1989, Health Care Women Int, V10, P141
   Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003
   GLASER R, 1987, Brain Behavior and Immunity, V1, P7, DOI 10.1016/0889-1591(87)90002-X
   Goenjian AK, 2000, AM J PSYCHIAT, V157, P911, DOI 10.1176/appi.ajp.157.6.911
   Gonzalez V., 2007, GUAYAQUIL AEDES AEGY
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Gulati S, 2012, SCAND J INFECT DIS, V44, P522, DOI 10.3109/00365548.2012.669044
   Gutierrez E., 2005, REV ECUAT HIG MED TR, V42, P35
   Handel Andrew S, 2016, Trop Dis Travel Med Vaccines, V2, P8, DOI 10.1186/s40794-016-0024-y
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   Hayes CG, 1996, AM J TROP MED HYG, V55, P459, DOI 10.4269/ajtmh.1996.55.459
   Hsu CC, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00022
   IRWIN M, 1994, ADV NEUROIMMUNOL, V4, P29, DOI 10.1016/S0960-5428(06)80188-9
   Johnson RR, 2004, J NEUROIMMUNOL, V148, P74, DOI 10.1016/j.jneuroim.2003.11.009
   Joob B., 2014, Asian Pacific Journal of Tropical Disease, V4, P313, DOI 10.1016/S2222-1808(14)60579-X
   Karakaya Isil, 2004, Turk Psikiyatri Derg, V15, P257
   Kouadio IK, 2012, EXPERT REV ANTI-INFE, V10, P95, DOI [10.1586/ERI.11.155, 10.1586/eri.11.155]
   KUSNECOV AV, 1992, J NEUROIMMUNOL, V38, P129, DOI 10.1016/0165-5728(92)90097-5
   Lima B R, 1992, Bull Pan Am Health Organ, V26, P60
   Lima B. R, 1986, PRIMARY MENTAL HLTH
   LIMA BR, 1989, ACTA PSYCHIAT SCAND, V79, P74, DOI 10.1111/j.1600-0447.1989.tb09236.x
   Mordecai E, 2016, BIORXIV, P63735
   Munoz AG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01291
   Namazi MR, 2003, NEUROENDOCRINOL LETT, V24, P468
   National Sub-Secretary for Public Health Surveillance, 2017, ZIK GAZ SE 38 3017
   National Sub-Secretary for Public Health Surveillance, 2017, WEEKL EP GAZ NO 52 2
   National Sub-Secretary for Public Health Surveillance, 2017, AN VIG EP 1994 2016
   Ortiz-Prado E, 2017, PRAGMAT OBS RES, V8, P129, DOI 10.2147/POR.S129464
   Pan American Health Organization, CHIK DAT MAPS STAT
   Pan American Health Organization, ZIK CUM CAS
   Pan American Health Organization; World Health Organization, DENG ANN CAS REP DEN
   Qadri F, 2005, EMERG INFECT DIS, V11, P1104, DOI 10.3201/eid1107.041266
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009
   Sahin NH, 2007, J TRAUMA STRESS, V20, P335, DOI 10.1002/jts.20217
   Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601
   Sharan P, 1996, AM J PSYCHIAT, V153, P556
   Sorenson C. J., 2017, GEOHEALTH, V1
   Staufenbiel SM, 2013, PSYCHONEUROENDOCRINO, V38, P1220, DOI 10.1016/j.psyneuen.2012.11.015
   Steudte S, 2013, BIOL PSYCHIAT, V74, P639, DOI 10.1016/j.biopsych.2013.03.011
   Ibarra AMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1135
   Stewart-Ibarra AM, 2017, BIORXIV
   Stewart-Ibarra AM, 2013, PLOS ONE, V8
   Vasquez D, 2017, AM J PUBLIC HEALTH, V107, P1137, DOI 10.2105/AJPH.2017.303769
   W.H.O, CHIK
   Waring Stephen C, 2005, Disaster Manag Response, V3, P41, DOI 10.1016/j.dmr.2005.02.003
   WHO, ZIK VIR
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zhang WQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088263
   Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008
NR 69
TC 5
Z9 5
U1 1
U2 5
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD DEC
PY 2017
VL 14
IS 12
AR 1516
DI 10.3390/ijerph14121516
PG 16
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FU2SD
UT WOS:000423699400079
PM 29206195
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aplin, JD
   Beristain, A
   DaSilva-Arnold, S
   Dunk, C
   Duzyj, C
   Golos, TG
   Kemmerling, U
   Knofler, M
   Mitchell, MD
   Olson, DM
   Petroff, M
   Pollheimer, J
   Reyes, L
   Schedin, P
   Soares, MJ
   Stencel-Baerenwald, J
   Thornburg, KL
   Lash, GE
AF Aplin, John D.
   Beristain, Alexander
   DaSilva-Arnold, Sonia
   Dunk, Caroline
   Duzyj, Christina
   Golos, Thaddeus G.
   Kemmerling, Ulrike
   Knoefler, Martin
   Mitchell, Murray D.
   Olson, David M.
   Petroff, Margaret
   Pollheimer, Juergen
   Reyes, Leticia
   Schedin, Pepper
   Soares, Michael J.
   Stencel-Baerenwald, Jennifer
   Thornburg, Kent L.
   Lash, Gendie E.
TI IFPA meeting 2016 workshop report III: Decidua-trophoblast interactions;
   trophoblast implantation and invasion; immunology at the maternal-fetal
   interface; placental inflammation
SO PLACENTA
LA English
DT Article
DE Decidua; Trophoblast; Uterine natural killer cells; Macrophages; Zika
   virus; P. gingivalis; Placenta; Inflammation; Invasion
AB Workshops are an important part of the IFPA annual meeting as they allow for discussion of specialised topics. At IFPA meeting 2016 there were twelve themed workshops, four of which are summarized in this report. These workshops related to various aspects of placental biology but collectively covered areas of decidual-trophoblast interaction, regulation of trophoblast invasion, immune cells at the maternal-fetal interface, and placental inflammation. (c) 2017 IFPA and Elsevier Ltd. All rights reserved.
C1 [Aplin, John D.] Univ Manchester, Inst Human Dev, Manchester, Lancs, England.
   [Beristain, Alexander] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC, Canada.
   [DaSilva-Arnold, Sonia] Hackensack Univ, Med Ctr, Hackensack, NJ USA.
   [Dunk, Caroline] Samuel Lunenfeld Res Inst, Res Ctr Womens & Infants Hlth, Toronto, ON, Canada.
   [Duzyj, Christina] Rutgers Robert Wood Johnson Med Sch, Div Maternal Fetal Med, New Brunswick, NJ USA.
   [Golos, Thaddeus G.] Univ Wisconsin, Dept Comparat Biosci, Wisconsin Natl Primate Res Ctr, 2015 Linden Dr W, Madison, WI 53706 USA.
   [Kemmerling, Ulrike] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Anat & Biol Desarrollo, Santiago, Chile.
   [Knoefler, Martin; Pollheimer, Juergen] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria.
   [Mitchell, Murray D.] Univ Queensland, Ctr Clin Res, RBWH Campus, Brisbane, Qld, Australia.
   [Olson, David M.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada.
   [Olson, David M.] Univ Alberta, Dept Pediat & Physiol, Edmonton, AB, Canada.
   [Petroff, Margaret] Michigan State Univ, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA.
   [Petroff, Margaret] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.
   [Reyes, Leticia] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Schedin, Pepper] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA.
   [Schedin, Pepper] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.
   [Soares, Michael J.] Univ Kansas, Med Ctr, Inst Reprod Hlth & Regenerat Med, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.
   [Stencel-Baerenwald, Jennifer] Univ Washington, Dept Immunol, Seattle, WA 98195 USA.
   [Thornburg, Kent L.] Oregon Hlth & Sci Univ, Ctr Dev Hlth, Knight Cardiovasc Inst, Portland, OR 97201 USA.
   [Lash, Gendie E.] Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Pediat, 9 Jinsui Rd, Guangzhou 510623, Guangdong, Peoples R China.
RP Lash, GE (corresponding author), Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Pediat, 9 Jinsui Rd, Guangzhou 510623, Guangdong, Peoples R China.
EM gendie.lash@hotmail.com
RI Reyes, Leticia/H-7338-2019; Schedin, Pepper/C-2532-2009; Kemmerling,
   Ulrike/H-8783-2013; Mitchell, Murray/A-8639-2010
OI Pollheimer, Jurgen/0000-0001-8440-5221; Duzyj,
   Christina/0000-0002-7060-8308; Kemmerling, Ulrike/0000-0002-0201-1665;
   Aplin, John/0000-0001-8777-9261; DaSilva-Arnold,
   Sonia/0000-0003-2721-4626; Mitchell, Murray/0000-0002-6167-7176;
   Beristain, Alexander/0000-0002-1117-6242
FU NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R01 HD020676, P01
   HD079363]; NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P51 OD011106]
NR 0
TC 1
Z9 1
U1 2
U2 7
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD DEC
PY 2017
VL 60
SU 1
BP S15
EP S19
DI 10.1016/j.placenta.2017.04.019
PG 5
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA FU0KS
UT WOS:000423540400005
PM 28456431
DA 2020-07-08
ER

PT J
AU Dibernardo, A
   Turell, MJ
   Lindsay, LR
   Loomer, C
   Iranpour, M
AF Dibernardo, Antonia
   Turell, Michael J.
   Lindsay, L. Robbin
   Loomer, Courtney
   Iranpour, Mahmood
TI VECTOR COMPETENCE OF SOME MOSQUITO SPECIES FROM CANADA FOR ZIKA VIRUS
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE artificial blood meal; intrathoracic inoculation; pathogen; transmission
ID AEDES-VEXANS; CULICIDAE; DIPTERA; TRANSMISSION; CONNECTICUT; BLOODMEALS;
   CULEX
AB The recent introduction of Zika virus (ZIKV) into the Americas and the occurrence of birth defects associated with infection during pregnancy have created a concern about the spread of this virus into more northern countries in the Americas. Therefore, we examined several species of mosquitoes found in southern Manitoba, Canada, for their susceptibility to infection and their ability to transmit ZIKV. Aedes cinereus, Ae. euedes, Ae. fitchii, Ae. sticticus, Ae. vexans, Coquillettidia perturbans, Culex restuans, and Cx. tarsalis were captured in the vicinity of Winnipeg, Manitoba; brought to the laboratory; and allowed to feed on a ZIKV-sheep blood suspension to determine oral susceptibility. In addition, some of the nonfed individuals were inoculated intrathoracically to examine for the presence of a salivary gland barrier. Despite ingesting blood containing 10(5.4) plaque-forming units/ml, infection rates were very low, and infected individuals were only detected for Ae. vexans. Transmission was observed for Ae. vexans, Cq. perturbans, and Cx. restuans that had been inoculated with ZIKV, although rates were low. Based on the extremely low vector competence found in this study and the lack of a preferential feeding on humans, it is unlikely than any of the mosquito species tested in this study would be involved in any large-scale transmission of ZIKV in Canada.
C1 [Dibernardo, Antonia; Lindsay, L. Robbin; Loomer, Courtney; Iranpour, Mahmood] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada.
   [Turell, Michael J.] VectorID LLC, Frederick, MD 21702 USA.
RP Lindsay, LR (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada.
OI Lindsay, Robbin/0000-0001-7236-2930
CR AITKEN THG, 1977, MOSQ NEWS, V37, P130
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   CDC, 2017, ZIK VIR
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Darsie R, 2005, IDENTIFICATION GEOGR, P383
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Government of Canada, 2017, SURV ZIK VIR HAS ZIK
   Greenberg JA, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.7501
   GRIMSTAD PR, 1985, J MED ENTOMOL, V22, P447, DOI 10.1093/jmedent/22.4.447
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Molaei G, 2008, J MED ENTOMOL, V45, P1143, DOI 10.1603/0022-2585(2008)45[1143:HPOPMV]2.0.CO;2
   Molaei G, 2006, J MED ENTOMOL, V43, P1088, DOI 10.1603/0022-2585(2006)43[1088:IOAAMB]2.0.CO;2
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   O'Donnell KL, 2017, J MED ENTOMOL, V54, P1354, DOI 10.1093/jme/tjx087
   PAHO, 2017, REG ZIK EP UPD AM
   ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Thielman Aynsley C., 2007, Canadian Journal of Arthropod Identification, V4, P1
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO [World Health Organisation], 2017, ZIK VIR FACT SHEET T
   WOOD DM, 1979, PUBLICATION BIOSYSTE, V1686
NR 34
TC 3
Z9 3
U1 1
U2 7
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD DEC
PY 2017
VL 33
IS 4
BP 276
EP 281
PG 6
WC Entomology
SC Entomology
GA FT9XM
UT WOS:000423505800003
PM 29369018
DA 2020-07-08
ER

PT J
AU Sabalza, M
   Barber, CA
   Abrams, WR
   Montagna, R
   Malamud, D
AF Sabalza, Maite
   Barber, Cheryl A.
   Abrams, William R.
   Montagna, Richard
   Malamud, Daniel
TI Zika Virus Specific Diagnostic Epitope Discovery
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Immunology; Issue 130; Microarray; high-throughput screening; diagnostic
   peptides; Zika; immunoassay; IgM; IgG
ID LYME-DISEASE; PEPTIDES; LIBRARY; DETECT
AB High-density peptide microarrays allow screening of more than six thousand peptides on a single standard microscopy slide. This method can be applied for drug discovery, therapeutic target identification, and developing of diagnostics. Here, we present a protocol to discover specific Zika virus (ZIKV) diagnostic peptides using a high-density peptide microarray. A human serum sample validated for ZIKV infection was incubated with a high-density peptide microarray containing the entire ZIKV protein translated into 3,423 unique 15 linear amino acid (aa) residues with a 14-aa residue overlap printed in duplicate. Staining with different secondary antibodies within the same array, we detected peptides that bind to Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies present in serum. These peptides were selected for further validation experiments. In this protocol, we describe the strategy followed to design, process, and analyze a high-density peptide microarray.
C1 [Sabalza, Maite; Barber, Cheryl A.; Abrams, William R.; Malamud, Daniel] NYU, Coll Dent, Dept Basic Sci & Craniofacial Dev, New York, NY 10003 USA.
   [Montagna, Richard] Rheonix Inc, Lansing, NY USA.
   [Malamud, Daniel] NYU, Langone Sch Med, Dept Med, New York, NY 10003 USA.
RP Sabalza, M (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Dev, New York, NY 10003 USA.
EM ms10129@nyu.edu
RI Abrams, William R/A-5782-2008
OI Malamud, Daniel/0000-0002-9094-4122
FU SBIR (Small Business Innovation Research) [NIDCRR44 DE024456]; NIDCR
   grant [U01 DE017855]
FX Current support is provided by an SBIR (Small Business Innovation
   Research) administrative supplement grant from NIDCRR44 DE024456. NIDCR
   HIV grant that evolved out of NIDCR grant U01 DE017855 for the
   development of a confirmatory point-of-care diagnostic for HIV. We
   gratefully acknowledge Silke Weisenburger(PEPperPRINT Heidelberg,
   Germany) for her technical assistance and kind support. We also thank
   NYU Langone Medical Center for the LI-COR Odyssey Imaging System.
CR Basile AJ, 2015, J VIROL METHODS, V225, P41, DOI 10.1016/j.jviromet.2015.08.025
   Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800
   Carmona SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050748
   Duarte G, 2016, REV BRAS GINECOL OBS, V38, P263, DOI 10.1055/s-0036-1584206
   Gardner TJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13627
   Hamby CV, 2005, CLIN DIAGN LAB IMMUN, V12, P801, DOI 10.1128/CDLI.12.7.801-807.2005
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kouzmitcheva GA, 2001, CLIN DIAGN LAB IMMUN, V8, P150, DOI 10.1128/CDLI.8.1.150-160.2001
   Lagatie O, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005330
   Madden T., 2013, NCBI HDB
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nixon CE, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00068-17
   Pellois JP, 2002, NAT BIOTECHNOL, V20, P922, DOI 10.1038/nbt723
   Services U. S. D. o. H. a. H., 2009, HHS PUBL, V21-1112
   Siqueira W. L., 2016, ORAL HLTH
   Stafford P, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011593
   't Hoen PAC, 2012, ANAL BIOCHEM, V421, P622, DOI 10.1016/j.ab.2011.11.005
   Townend JE, 2016, ACS CHEM BIOL, V11, P1624, DOI 10.1021/acschembio.6b00095
   Turchetto J, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-016-0617-1
NR 19
TC 2
Z9 2
U1 1
U2 5
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD DEC
PY 2017
IS 130
AR e56784
DI 10.3791/56784
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT6CN
UT WOS:000423240800083
PM 29286404
OA Green Published
DA 2020-07-08
ER

PT J
AU Zhao, M
   Zhang, HJ
   Liu, KF
   Gao, GF
   Liu, WJ
AF Zhao, Min
   Zhang, Hangjie
   Liu, Kefang
   Gao, George F.
   Liu, William J.
TI Human T-cell immunity against the emerging and re-emerging viruses
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Review
DE emerging viruses; avian influenza; H7N9; MERS-CoV; Zika; Ebola; human
   immunity; T-cell; cross-reactivity
ID RESPIRATORY SYNDROME-CORONAVIRUS; INFLUENZA-A VIRUS; ORIGINAL ANTIGENIC
   SIN; ZIKA VIRUS; EBOLA-VIRUS; LYMPHOCYTE RESPONSES; CROSS-REACT; H7N9;
   INFECTION; MERS
AB Over the past decade, we have seen an alarming number of high-profile outbreaks of newly emerging and re-emerging viruses. Recent outbreaks of avian influenza viruses, Middle East respiratory syndrome coronaviruses, Zika virus and Ebola virus present great threats to global health. Considering the pivotal role of host T-cell immunity in the alleviation of symptoms and the clearance of viruses in patients, there are three issues to be primarily concerned about T-cell immunity when a new virus emerges: first, does the population possess pre-existing T-cells against the new virus through previous infections of genetically relevant viruses; second, does a proper immune response arise in the patients to provide protection through an immunopathogenic effect; lastly, how long can the virus-specific immune memory persist. Herein, we summarize the current updates on the characteristics of human T-cell immunological responses against recently emerged or re-emerged viruses, and emphasize the necessity for timely investigation on the T-cell features of these viral diseases, which may provide beneficial recommendations for clinical diagnosis and vaccine development.
C1 [Zhao, Min; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China.
   [Zhang, Hangjie; Liu, Kefang; Gao, George F.; Liu, William J.] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol & Viral Dis, Minist Hlth Peoples Republ China, Beijing 102206, Peoples R China.
   [Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
RP Liu, WJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol & Viral Dis, Minist Hlth Peoples Republ China, Beijing 102206, Peoples R China.
EM liujun@ivdc.chinacdc.cn
FU National Key Research and Development Program of China [2017YFC1200202];
   China Mega-Project on Infectious Disease Prevention
   [2016ZX10004222-003]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [81401312, 81373141];
   National Natural Science Foundation of China Innovative Research Group
   [81621091]
FX We are grateful to Professor Fuping Zhang, Ms. Huarong Huang, Mr. Kun
   Xu, and Ms. Yongli Zhang for their kind assistance with the preparation
   of this manuscript. This work was supported by the National Key Research
   and Development Program of China (2017YFC1200202), the China
   Mega-Project on Infectious Disease Prevention (2016ZX10004222-003), and
   the National Natural Science Foundation of China (81401312, 81373141).
   George F. Gao is a leading principal investigator at the National
   Natural Science Foundation of China Innovative Research Group
   (81621091).
CR Al-Qahtani AA, 2017, ONCOTARGET, V8, P9053, DOI 10.18632/oncotarget.14754
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422
   Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Blom K, 2017, J INTERN MED, V282, P206, DOI 10.1111/joim.12638
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cha RH, 2015, J KOREAN MED SCI, V30, P1807, DOI 10.3346/jkms.2015.30.12.1807
   Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x
   Chen JN, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002606
   Chowell G, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0196-0
   Chu KH, 2005, KIDNEY INT, V67, P698, DOI 10.1111/j.1523-1755.2005.67130.x
   Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Diao HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092823
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duan SS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004642
   Duvvuri VR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091273
   Faure E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088716
   Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584
   Gao HN, 2016, FRONT MED-PRC, V10, P377, DOI 10.1007/s11684-016-0466-7
   Goraya MU, 2015, PROTEIN CELL, V6, P712, DOI 10.1007/s13238-015-0191-z
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant EJ, 2016, CURR OPIN VIROL, V16, P132, DOI 10.1016/j.coviro.2016.01.016
   Guan WD, 2015, EMERG INFECT DIS, V21, P2278, DOI 10.3201/eid2112.151232
   Guo J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10942
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hong K.H., 2017, THORAX IN PRESS, DOI [10.1136/thoraxjnl-2016-209-313, DOI 10.1136/THORAXJNL-2016-209-313]
   Huang FM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4595
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Klenerman P, 1998, NATURE, V394, P482
   Kun Xu Y.S., 2017, J VIROL IN PRESS
   Lai L., 2017, CLIN INFECT DIS, DOI [10.1093/cid/cix732, DOI 10.1093/CID/CIX732]
   Lan JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112602
   Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460
   Liu J, 2014, CURR OPIN VIROL, V5, P91, DOI 10.1016/j.coviro.2014.03.001
   Liu J, 2013, EUR J IMMUNOL, V43, P2055, DOI 10.1002/eji.201343417
   Liu J, 2012, J VIROL, V86, P13281, DOI 10.1128/JVI.01841-12
   Liu J, 2011, EXP BIOL MED, V236, P253, DOI 10.1258/ebm.2010.010278
   Liu J, 2010, J VIROL, V84, P11849, DOI 10.1128/JVI.01464-10
   Liu J, 2010, J INFECT DIS, V202, P1171, DOI 10.1086/656315
   Liu WJ, 2017, ANTIVIR RES, V137, P82, DOI 10.1016/j.antiviral.2016.11.006
   Liu WJ, 2017, J IMMUNOL, V198, P873, DOI 10.4049/jimmunol.1601542
   Liu WJ, 2016, J INFECT DIS, V214, P1937, DOI 10.1093/infdis/jiw471
   Liu WJ, 2016, PROTEIN CELL, V7, P621, DOI 10.1007/s13238-016-0305-2
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mandl JN, 2015, CELL, V160, P20, DOI 10.1016/j.cell.2014.12.003
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McElroy AK, 2015, P NATL ACAD SCI USA, V112, P4719, DOI 10.1073/pnas.1502619112
   McElroy AK, 2014, EMERG INFECT DIS, V20, P1683, DOI 10.3201/eid2010.140430
   McMaster SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115725
   McMichael AJ, 1998, NATURE, V394, P421, DOI 10.1038/28738
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Ng OW, 2016, VACCINE, V34, P2008, DOI 10.1016/j.vaccine.2016.02.063
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Paquin-Proulx Dominic, 2017, Pathog Immun, V2, P274, DOI 10.20411/pai.v2i2.188
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Quinones-Parra S, 2014, P NATL ACAD SCI USA, V111, P1049, DOI 10.1073/pnas.1322229111
   Quinones-Parra SM, 2016, J VIROL, V90, P6936, DOI 10.1128/JVI.00349-16
   Ruibal P, 2016, NATURE, V533, P100, DOI 10.1038/nature17949
   Sanchez A, 2007, J INFECT DIS, V196, pS329, DOI 10.1086/520588
   Sobarzo A, 2013, NEW ENGL J MED, V369, P492, DOI 10.1056/NEJMc1300266
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Su S, 2015, LANCET, V385, P2349, DOI 10.1016/S0140-6736(15)60859-5
   Tan SG, 2017, VACCINE, V35, P5644, DOI 10.1016/j.vaccine.2017.08.061
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Thorson A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008859
   van de Sandt CE, 2015, J INFECT DIS, V212, P81, DOI 10.1093/infdis/jiv018
   van de Sandt CE, 2014, J VIROL, V88, P1684, DOI 10.1128/JVI.02843-13
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang ZF, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00060
   Wang ZF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7833
   Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111
   Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Wong G, 2016, PROTEIN CELL, V7, P4, DOI 10.1007/s13238-015-0231-8
   Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013
   Wu Y, 2013, SCI CHINA LIFE SCI, V56, P493, DOI 10.1007/s11427-013-4496-y
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zeng XK, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.113
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhao JC, 2016, IMMUNITY, V44, P1379, DOI 10.1016/j.immuni.2016.05.006
NR 93
TC 8
Z9 10
U1 3
U2 10
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD DEC
PY 2017
VL 60
IS 12
BP 1307
EP 1316
DI 10.1007/s11427-017-9241-3
PG 10
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA FT1QG
UT WOS:000422910700003
PM 29294219
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Felix, A
   Hallet, E
   Favre, A
   Kom-Tchameni, R
   Defo, A
   Flechelles, O
   Rosenthal, JM
   Douine, M
   Nacher, M
   Elenga, N
AF Felix, Arthur
   Hallet, Edouard
   Favre, Anne
   Kom-Tchameni, Remi
   Defo, Antoine
   Flechelles, Olivier
   Rosenthal, Jean-Marc
   Douine, Maylis
   Nacher, Mathieu
   Elenga, Narcisse
TI Cerebral injuries associated with Zika virus in utero exposure in
   children without birth defects in French Guiana: Case report
SO MEDICINE
LA English
DT Article
DE birth defects; neurological disorders; Zika virus
ID INFECTION; BRAZIL
AB Rationale:A major epidemic of Zika virus (ZIKV) infection occurred in French Guiana and West Indies. French national epidemiological surveillance estimated that 1650 pregnant women contracted the ZIKV during epidemic period from January 2016 to October 2016 in French Guiana.Patient concerns:ZIKV infection during pregnancy is a cause of microcephaly and birth defects.Diagnoses:In this report, we describe 2 children with proven in utero ZIKV exposure. Their mothers were both symptomatic and ZIKV infection occurred early in pregnancy. Ultrasonography monitoring in utero did not show any abnormality for both patient. They were born at full-term, healthy, without any birth defects and no sign of congenital ZIKV infection.Interventions:ZIKV was neither found on placenta fragments nor children blood and urine at birth. Their neurodevelopment outcomes in early-life fitted the expectations. As recommended in national guidelines, we performed cerebral MRIs at 2 months old, showing severe brain abnormalities, especially of white matter areas. After a large screening, we did not find any differential diagnosis for their brain lesions.Outcomes:We concluded it was due to their in utero ZIKV exposure.Lessons:In this report, pathogenicity of ZIKV may involve mother's immunological response or metabolic disorder during the infection.
C1 [Felix, Arthur; Kom-Tchameni, Remi; Defo, Antoine; Elenga, Narcisse] Andree Rosemon Hosp, Dept Pediat, France Ave Flamboyants Cayenne, Cayenne, French Guiana.
   [Hallet, Edouard; Douine, Maylis; Nacher, Mathieu] INSERM, Ctr Invest Clin Antilles Guyane, CIC 1424, Paris, France.
   [Favre, Anne] Andree Rosemon Hosp, Dept Neonatal Pediat & Intens Care, Cayenne, French Guiana.
   [Flechelles, Olivier] MFME Hosp, Pediat & Neonatal Intens Care Unit, Fort De France, Martinique, France.
   [Rosenthal, Jean-Marc] Pointe A Pitre Hosp, Neonatal Intens Care, Pointe a Pitre, Guadeloupe, France.
RP Felix, A (corresponding author), Andree Rosemon Hosp, Dept Pediat, France Ave Flamboyants Cayenne, Cayenne, French Guiana.
EM arthur.felix@bluewin.ch
OI Douine, Maylis/0000-0003-4616-6690
CR [Anonymous], 2017, INFECT VIRUS ZIKA PR
   [Anonymous], 2017, SITUATION EPIDEMIOLO
   Mawson AR, 2016, BIORESEARCH OPEN ACC, V5, P171, DOI 10.1089/biores.2016.0004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 9
TC 1
Z9 1
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD DEC
PY 2017
VL 96
IS 51
AR e9178
DI 10.1097/MD.0000000000009178
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA FT2QY
UT WOS:000422992300042
PM 29390455
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shi, WF
   Li, J
   Zhou, H
   Gao, GF
AF Shi, Weifeng
   Li, Juan
   Zhou, Hong
   Gao, George F.
TI Pathogen genomic surveillance elucidates the origins, transmission and
   evolution of emerging viral agents in China
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Review
DE emerging infectious diseases; SARS-CoV; MERS-CoV; genomic surveillance;
   H7N9; Zika; Ebola
ID EAST RESPIRATORY SYNDROME; A H7N9 VIRUS; AVIAN INFLUENZA-VIRUS;
   RIFT-VALLEY FEVER; ZIKA VIRUS; HUMAN INFECTION; EBOLA-VIRUS; SYNDROME
   CORONAVIRUS; GENETIC DIVERSITY; SARS CORONAVIRUS
AB In the past twenty years, numerous novel zoonotic viral agents with pandemic potential have emerged in China, such as the severe acute respiratory syndrome (SARS) coronavirus and, more recently, the avian-origin influenza A/H7N9 virus, which have caused outbreaks among humans with high morbidity and mortality. In addition, several emerging and re-emerging viral pathogens have also been imported into China from travelers, e.g. the Middle East respiratory syndrome (MERS) coronavirus and Zika virus (ZIKV). Herein, we review these emerging viral pathogens in China and focus on how surveillance by pathogen genomics has been employed to discover and annotate novel pathogenic agents, identify natural reservoirs, monitor the transmission events and delineate their evolution and adaption to the human host. We also highlight the application of genomic sequencing in the recent Ebola epidemics in Western Africa. In summary, genomic sequencing has become a standard research tool in the field of emerging infectious diseases which has been proven invaluable in containing these viral infections and reducing burden of disease in humans and animals. Genomic surveillance of pathogenic agents will serve as a key epidemiological and research tool in the modern era of precision infectious diseases and in the future studies of virosphere.
C1 [Shi, Weifeng; Li, Juan; Zhou, Hong] Taishan Med Coll, Key Lab Etiol & Epidemiol Emerging Infect Dis Uni, Tai An 271000, Shandong, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.
   [Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
RP Shi, WF (corresponding author), Taishan Med Coll, Key Lab Etiol & Epidemiol Emerging Infect Dis Uni, Tai An 271000, Shandong, Peoples R China.
EM shiwf@ioz.ac.cn
FU China Ministry of Science and Technology (MOST) Key Research and
   Development Program [2017ZX10104001]; Taishan Scholars program of
   Shandong province [ts201511056]
FX We were grateful to Dr. Michael J. Carr (Hokkaido University) for review
   of the manuscript. This work was supported by the China Ministry of
   Science and Technology (MOST) Key Research and Development Program
   (2017ZX10104001) and the Taishan Scholars program of Shandong province
   (ts201511056 to Weifeng Shi).
CR de Carcer DA, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400127
   Amimo JO, 2016, ARCH VIROL, V161, P887, DOI 10.1007/s00705-016-2819-6
   Anderson NG, 2003, EMERG INFECT DIS, V9, P768
   Ash C, 2006, SCIENCE, V312, P869, DOI 10.1126/science.312.5775.869
   Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100
   Bellas CM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00656
   Bi YH, 2016, CELL HOST MICROBE, V20, P810, DOI 10.1016/j.chom.2016.10.022
   Bi YH, 2015, J GEN VIROL, V96, P975, DOI 10.1099/vir.0.000056
   Bodewes R, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-89
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007
   Boonham N, 2007, ANNU REV PHYTOPATHOL, V45, P307, DOI 10.1146/annurev.phyto.45.062806.094349
   Breiman RF, 2003, EMERG INFECT DIS, V9, P1037
   Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x
   Check Hayden E., 2015, NATURE IN PRESS, DOI [10.1038/nature.2015.17554, DOI 10.1038/NATURE.2015.17554]
   Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2
   Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4
   Chowell G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0450-0
   Cui LB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4142
   Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418
   del Rio C, 2014, ANN INTERN MED, V161, P746, DOI 10.7326/M14-1880
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Enserink M, 2003, SCIENCE, V301, P294, DOI 10.1126/science.301.5631.294
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gao GF, 2014, SCIENCE, V344, P235, DOI 10.1126/science.1254664
   Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Guan WD, 2015, EMERG INFECT DIS, V21, P2278, DOI 10.3201/eid2112.151232
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Haagmans BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000557
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hannigan GD, 2017, PEERJ, V5, DOI 10.7717/peerj.2959
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Hsu BM, 2010, WATER RES, V44, P949, DOI 10.1016/j.watres.2009.10.004
   Jiang H, 2017, CLIN INFECT DIS, V65, P383, DOI 10.1093/cid/cix334
   Jiang XQ, 2015, SCI CHINA LIFE SCI, V58, P682, DOI 10.1007/s11427-015-4857-9
   Jiao PR, 2012, J VIROL, V86, P7716, DOI 10.1128/JVI.00959-12
   Ke CW, 2017, EMERG INFECT DIS, V23, P1332, DOI 10.3201/eid2308.170600
   Kim JI, 2016, SCI REP-UK, V6, DOI 10.1038/srep18825
   Krishna NK, 2012, MED CLIN N AM, V96, P1067, DOI 10.1016/j.mcna.2012.08.005
   Lam TTY, 2015, NATURE, V522, P102, DOI 10.1038/nature14348
   Lee JY, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2576-5
   Lee J, 2016, J THEOR BIOL, V408, P118, DOI 10.1016/j.jtbi.2016.08.009
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Li XB, 2014, EMERG INFECT DIS, V20, P1287, DOI 10.3201/eid2008.130910
   Li XF, 2016, SCI CHINA LIFE SCI, V59, P440, DOI 10.1007/s11427-016-5020-y
   Linsuwanon P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135573
   Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1
   Liu JY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.136
   Liu L, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00291-16
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953
   McHardy AC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000566
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mushegian A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0288-8
   Nanyingi Mark O., 2015, Infection Ecology & Epidemiology, V5, P28024, DOI 10.3402/iee.v5.28024
   Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157
   Ni M, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.151, 10.1038/NMICROBIOL.2016.151]
   Oh MD, 2015, J KOREAN MED SCI, V30, P1701, DOI 10.3346/jkms.2015.30.11.1701
   Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094
   Pan M, 2016, J INFECTION, V72, P52, DOI 10.1016/j.jinf.2015.06.009
   Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143
   Qi W, 2014, EUROSURVEILLANCE, V19, P50, DOI 10.2807/1560-7917.ES2014.19.25.20841
   Qi WB, 2014, PROTEIN CELL, V5, P878, DOI 10.1007/s13238-014-0084-6
   Qin E, 2003, CHINESE SCI BULL, V48, P941, DOI [10.1360/03wc0186, 10.1007/BF03184203]
   Qin E'de, 2003, Genomics Proteomics & Bioinformatics, V1, P101
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Robertson BH, 2005, ANNU REV PUBL HEALTH, V26, P281, DOI 10.1146/annurev.publhealth.26.021304.144522
   Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952
   Roux S, 2016, NATURE, V537, P689, DOI 10.1038/nature19366
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Shi WF, 2013, PROTEIN CELL, V4, P846, DOI 10.1007/s13238-013-3083-0
   Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Sun HL, 2016, J VIROL, V90, P6235, DOI 10.1128/JVI.00127-16
   Sun J., 2017, J INFECTION, VS0163-4453, P30231
   Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang DY, 2016, J VIROL, V90, P5561, DOI 10.1128/JVI.03173-15
   Wang J, 2014, ACTA VIROL, V58, P223, DOI 10.4149/av_2014_03_223
   Wang Y, 2015, BIOMED RES INT, V2015, P6, DOI DOI 10.1128/MBI0.01280-15
   Wei SH, 2013, LANCET RESP MED, V1, P771, DOI 10.1016/S2213-2600(13)70221-2
   Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013
   Wu B, 2010, J INFECT DIS, V202, P452, DOI 10.1086/653709
   Wu J, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21158
   Xia QK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25416
   Xie Q, 2015, SCI CHINA LIFE SCI, V58, P818, DOI 10.1007/s11427-015-4903-7
   Yang JR, 2017, J FORMOS MED ASSOC, V116, P210, DOI 10.1016/j.jfma.2017.02.011
   Yuan J, 2013, CLIN INFECT DIS, V57, P1367, DOI 10.1093/cid/cit479
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang FC, 2017, J INFECTION, V75, P71, DOI 10.1016/j.jinf.2017.04.001
   Zhang HB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-42
   Zhang LS, 2013, CLIN INFECT DIS, V57, P1213, DOI 10.1093/cid/cit447
   Zhang RS, 2016, INFECT GENET EVOL, V40, P236, DOI 10.1016/j.meegid.2016.03.010
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhu FC, 2017, LANCET, V389, P621, DOI [10.1016/S0140-6736(16)32617-4, 10.1016/s0140-6736(16)32617-4]
   Zhu FC, 2015, LANCET, V385, P2272, DOI 10.1016/S0140-6736(15)60553-0
   Zhu W, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.19.30533
NR 107
TC 7
Z9 7
U1 4
U2 21
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD DEC
PY 2017
VL 60
IS 12
BP 1317
EP 1330
DI 10.1007/s11427-017-9211-0
PG 14
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA FT1QG
UT WOS:000422910700004
PM 29270793
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Fu, SH
   Song, S
   Liu, H
   Li, YY
   Li, XL
   Gao, XY
   Xu, ZQ
   Liu, GP
   Wang, DM
   Tian, ZZ
   Zhou, JZ
   He, Y
   Lei, WW
   Wang, HY
   Wang, B
   Lu, XQ
   Liang, GD
AF Fu, Shihong
   Song, Song
   Liu, Hong
   Li, Yuanyuan
   Li, Xiaolong
   Gao, Xiaoyan
   Xu, Ziqian
   Liu, Guoping
   Wang, Dingming
   Tian, Zhenzao
   Zhou, Jingzhu
   He, Ying
   Lei, Wenwen
   Wang, Huanyu
   Wang, Bin
   Lu, Xiaoqing
   Liang, Guodong
TI ZIKA virus isolated from mosquitoes: a field and laboratory
   investigation in China, 2016
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Article
DE arbovirus surveillance; mosquito-borne arbovirus; Japanese encephalitis
   virus; Zika virus
ID JAPANESE-ENCEPHALITIS; GUIZHOU PROVINCE; EVOLUTION; ARBOVIRUSES;
   INFECTION; EMERGENCE; SPREAD; FUTURE
AB A field investigation of arboviruses was conducted in Dejiang, Guizhou Province in the summer of 2016. A total of 8,795 mosquitoes, belonging to four species of three genera, and 1,300 midges were collected. The mosquito samples were identified on site according to their morphology, and the pooled samples were ground and centrifuged in the laboratory. The supernatant was incubated with mosquito tissue culture cells (C6/36) and mammalian cells (BHK-21) for virus isolation. The results indicated that 40% (3,540/8,795) were Anopheles sinensis, 30% (2,700/8,795) were Culex pipiens quinquefasciatus, and 29% (2,530/8,795) were Armigeres subbalbeatus. Furthermore, a total of eight virus isolates were obtained, and genome sequencing revealed two Zika viruses (ZIKVs) isolated from Culex pipiens quinquefasciatus and Armigeres subbalbeatus, respectively; three Japanese encephalitis viruses (JEVs) isolated from Culex pipiens quinquefasciatus; two Banna viruses (BAVs) isolated from Culex pipiens quinquefasciatus and Anopheles sinensis, respectively; and one densovirus (DNV) isolated from Culex pipiens quinquefasciatus. The ZIKVs isolated from the Culex pipiens quinquefasciatus and Armigeres subbalbeatus mosquitoes represent the first ZIKV isolates in mainland China. This discovery presents new challenges for the prevention and control of ZIKV in China, and prompts international cooperation on this global issue.
C1 [Fu, Shihong; Song, Song; Li, Yuanyuan; Li, Xiaolong; Gao, Xiaoyan; Xu, Ziqian; He, Ying; Lei, Wenwen; Wang, Huanyu; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.
   [Fu, Shihong; Song, Song; Li, Yuanyuan; Li, Xiaolong; Gao, Xiaoyan; Xu, Ziqian; He, Ying; Lei, Wenwen; Wang, Huanyu; Liang, Guodong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China.
   [Song, Song; Wang, Bin; Lu, Xiaoqing] Qingdao Univ, Qingdao 266071, Peoples R China.
   [Liu, Hong] Shandong Univ Technol, Sch Life Sci, Shandong Prov Res Ctr Bioinformat Engn & Tech, Zibo 255049, Peoples R China.
   [Li, Yuanyuan] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, WHO Collaborating Ctr Trop Dieases, Key Lab Parasite & Vector Biol,Minist Hlth, Shanghai 200025, Peoples R China.
   [Liu, Guoping] Ctr Dis Control & Prevent Shenyang Command, Shenyang 110034, Liaoning, Peoples R China.
   [Wang, Dingming; Tian, Zhenzao; Zhou, Jingzhu] Guizhou Prov Ctr Dis Control & Prevent, Guiyang 550004, Guizhou, Peoples R China.
RP Liang, GD (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.; Liang, GD (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China.; Lu, XQ (corresponding author), Qingdao Univ, Qingdao 266071, Peoples R China.
EM Luxq532@126.com; gdliang@hotmail.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81290342, 81501757]; Special National Project on
   Research and Development of Key Biosafety Technologies [2016YFC1201904];
   National Key Plan for Scientific Research and Development of China
   [2016YFD0500300]; Development Grants of State Key Laboratory of
   Infectious Disease Prevention and Control [2014SKLID103, 2015SKLID505];
   National Key Research and Development Program of China [2017YFC1200202];
   Open Research Fund Program of Wuhan National Bio-Safety Level 4 Lab of
   CAS [2017SPCAS003]
FX We appreciate the help provided by the staff of Dejiang County CDC
   during the collection of mosquito samples. This work was supported by
   the National Natural Science Foundation of China (81290342, 81501757),
   the Special National Project on Research and Development of Key
   Biosafety Technologies (2016YFC1201904), the National Key Plan for
   Scientific Research and Development of China (2016YFD0500300), the
   Development Grants of State Key Laboratory of Infectious Disease
   Prevention and Control (2014SKLID103, 2015SKLID505), the National Key
   Research and Development Program of China (2017YFC1200202) and the Open
   Research Fund Program of Wuhan National Bio-Safety Level 4 Lab of CAS
   (2017SPCAS003).
CR [Anonymous], WHO STRENGTH IMPL GL
   Attoui H, 2005, EMERG INFECT DIS, V11, P1673, DOI 10.3201/eid1111.050868
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hills SL, 2009, EMERG INFECT DIS, V15, P1333, DOI 10.3201/eid1508.090149
   Karabatsos N., 1985, INT CATALOGUE ARTHRO
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Li Ming-hua, 2012, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V23, P417
   Li XF, 2016, SCI CHINA LIFE SCI, V59, P440, DOI 10.1007/s11427-016-5020-y
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Liu H, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.109
   Liu H, 2016, INFECT GENET EVOL, V45, P250, DOI 10.1016/j.meegid.2016.08.034
   Liu H, 2010, EMERG INFECT DIS, V16, P514, DOI 10.3201/eid1603.091160
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005511
   Lu Z, 2014, EMERG INFECT DIS, V20, P1421, DOI 10.3201/eid2008.131433
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   National Health and Family Planning Commission (NHFPC), 2016, NOT REL NAT STRAT PR
   Ogden SC, 2016, SCI CHINA LIFE SCI, V59, P536, DOI 10.1007/s11427-016-5053-2
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Qin XF, 2016, SCI CHINA LIFE SCI, V59, P737, DOI 10.1007/s11427-016-5069-7
   Rahman NA, 2017, SCI CHINA LIFE SCI, V60, P324, DOI 10.1007/s11427-016-0414-4
   Song S, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.80
   Su S, 2016, J INFECTION, V73, P289, DOI 10.1016/j.jinf.2016.06.004
   Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0
   Wang JL, 2011, AM J TROP MED HYG, V84, P738, DOI 10.4269/ajtmh.2011.10-0294
   Wang LH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-345
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09
   Ye XuFang, 2012, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V23, P428
   Zhai YG, 2008, J GEN VIROL, V89, P195, DOI 10.1099/vir.0.83221-0
   Zhang JK, 2015, VECTOR-BORNE ZOONOT, V15, P423, DOI 10.1089/vbz.2014.1767
NR 42
TC 12
Z9 15
U1 1
U2 4
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD DEC
PY 2017
VL 60
IS 12
BP 1364
EP 1371
DI 10.1007/s11427-017-9196-8
PG 8
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA FT1QG
UT WOS:000422910700009
PM 29058107
DA 2020-07-08
ER

PT J
AU Li, M
   Wang, X
   Wang, QH
   Yu, L
   Wang, LF
   Yan, JH
   Zhang, FC
   Zhang, LQ
   Gao, GF
   Jin, X
AF Li, Min
   Wang, Xin
   Wang, Qihui
   Yu, Lei
   Wang, Lanfeng
   Yan, Jinghua
   Zhang, Fuchun
   Zhang, Linqi
   Gao, George F.
   Jin, Xia
TI Both structure and function of human monoclonal antibodies contribute to
   enhancement of Zika virus infectivity in vitro
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Letter
ID CROSS-REACTIVITY
C1 [Li, Min; Wang, Xin; Wang, Lanfeng; Jin, Xia] Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
   [Li, Min; Wang, Xin; Wang, Lanfeng; Gao, George F.; Jin, Xia] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Wang, Qihui; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing 100101, Peoples R China.
   [Yu, Lei; Zhang, Fuchun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
   [Zhang, Linqi] Tsinghua Univ, Sch Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China.
RP Jin, X (corresponding author), Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.; Jin, X (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
EM xjin@ips.ac.cn
FU National Key Program Project Grant of Ministry of Science and Technology
   of China [2016YFC1201000]; Strategic Priority Research Program of the
   Chinese Academy of SciencesChinese Academy of Sciences [XDBP 030405];
   Municipal Science and Technology Bureau Foundation of Guangzhou
   [2014Y2-00550, 201508020263]
FX The work was supported by National Key Program Project Grant of Ministry
   of Science and Technology of China (2016YFC1201000), the Strategic
   Priority Research Program of the Chinese Academy of Sciences (XDBP
   030405) and grants from the Municipal Science and Technology Bureau
   Foundation of Guangzhou (2014Y2-00550, 201508020263).
CR Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
NR 5
TC 3
Z9 3
U1 0
U2 4
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD DEC
PY 2017
VL 60
IS 12
BP 1396
EP 1398
DI 10.1007/s11427-017-9192-0
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA FT1QG
UT WOS:000422910700014
PM 29134418
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Fung, ICH
   Blankenship, EB
   Goff, ME
   Mullican, LA
   Chan, KC
   Saroha, N
   Duke, CH
   Eremeeva, ME
   Fu, KW
   Tse, ZTH
AF Fung, Isaac Chun-Hai
   Blankenship, Elizabeth B.
   Goff, M. Elizabeth
   Mullican, Lindsay A.
   Chan, Kwun Cheung
   Saroha, Nitin
   Duke, Carmen H.
   Eremeeva, Marina E.
   Fu, King-Wa
   Tse, Zion Tsz Ho
TI Zika-Virus-Related Photo Sharing on Pinterest and Instagram
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE health communication; health education; social media; Zika virus disease
AB Objective: Pinterest (San Francisco, CA) and Instagram (Menlo Park, CA) are 2 popular photo-sharing social media platforms among young individuals. We assessed differences between Instagram and Pinterest in relaying photographic information regarding Zika virus. Specifically, we investigated whether the percentage of Zika-virus-related photos with Spanish or Portuguese texts embedded therein was higher for Instagram than for Pinterest and whether the contents of Zika-virus-related photos shared on Pinterest were different from those shared on Instagram.
   Methods: We retrieved and manually coded 616 Pinterest (key words: "zika" AND "virus") and 616 Instagram (hashtag: #zikavirus) photos.
   Results: Among the manually coded samples, 47% (290/616) of Pinterest photos and 23% (144/616) of Instagram photos were relevant to Zika virus. Words were embedded in 57% (164/290) of relevant Pinterest photos and all 144 relevant Instagram photos. Among the photos with embedded words, photos in Spanish or Portuguese were more prevalent on Instagram (77/144, 53%) than on Pinterest (14/164, 9%). There were more Zika-virus-related photos on Instagram than on Pinterest pertinent to Zika virus prevention (59/144, 41%, versus 41/290, 14%; P<0.0001), the effects of Zika virus on pregnancy (27/144, 19%, versus 32/290, 11%; P = 0.04), and Zika-virus-associated deaths (4/144, 2%, versus 0/290, 0%; P = 0.01).
   Conclusions: Pinterest and Instagram are similar platforms for Zika virus prevention communication.
C1 [Fung, Isaac Chun-Hai; Blankenship, Elizabeth B.; Goff, M. Elizabeth; Mullican, Lindsay A.; Duke, Carmen H.] Georgia Southern Univ, Jiann Ping Hsu Coll Publ Hlth, Dept Epidemiol, Statesboro, GA 30460 USA.
   [Chan, Kwun Cheung; Fu, King-Wa] Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China.
   [Saroha, Nitin] Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA.
   [Eremeeva, Marina E.] Georgia Southern Univ, Jiann Ping Hsu Coll Publ Hlth, Dept Environm Hlth Sci, Statesboro, GA 30460 USA.
   [Tse, Zion Tsz Ho] Univ Georgia, Coll Engn, Athens, GA 30602 USA.
RP Fung, ICH (corresponding author), Georgia Southern Univ, Jiann Ping Hsu Coll Publ Hlth, POB 8015, Statesboro, GA 30460 USA.
EM cfung@georgiasouthern.edu
RI Fu, King-wa/A-2385-2010
OI Fu, King-wa/0000-0001-8157-5276
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [15IPA1509134, 16IPA1619505]
FX We thank Keri Lubell, PhD, for her feedback on our preliminary codebook.
   ICHF and ZTHT received salary support from the Centers for Disease
   Control and Prevention (15IPA1509134 and 16IPA1619505). This article is
   not related to their CDC-funded projects. This article does not
   represent the official positions of the CDC or the US Government.
CR Beck M, PINTEREST SAYS IT HA
   Duggan M, DEMOGRAPHICS SOCIAL
   Guidry JPD, 2015, VACCINE, V33, P5051, DOI 10.1016/j.vaccine.2015.08.064
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Instagram, CEL COMM 400 MILL
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Seltzer EK, 2015, PUBLIC HEALTH, V129, P1273, DOI 10.1016/j.puhe.2015.07.025
   Statista, INT US LAT AM
   World Health Organization, WHO STAT 1 M INT HLT
   Xanthopoulos P, 2016, J DIGITAL SOCIAL MED, V3, P353
NR 10
TC 6
Z9 6
U1 2
U2 8
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD DEC
PY 2017
VL 11
IS 6
BP 656
EP 659
DI 10.1017/dmp.2017.23
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FS6AF
UT WOS:000419879600006
DA 2020-07-08
ER

PT J
AU Singh, A
   Jana, NK
AF Singh, Anjali
   Jana, Nandan Kumar
TI Discovery of potential Zika virus RNA polymerase inhibitors by
   docking-based virtual screening
SO COMPUTATIONAL BIOLOGY AND CHEMISTRY
LA English
DT Article
DE Zika virus; Docking; Virtual screening; RNA polymerase; Inhibitors
ID IN-VITRO; WEB; IDENTIFICATION; RECOGNITION; NUCLEOTIDE; PREDICTION;
   INITIATION; INFECTION; DRUGS; SITE
AB Zika virus (ZIKV) infection has been associated with Guillain-Barre syndrome in adults and microcephaly in infants. The existence of insufficient structural data in most of the protein databases hinders the synthesis of anti-ZIKV pharmaceutics. In this work, we attempted to model the catalytic domain of the ZIKV RNA polymerase (RdRpC) along with a detailed assessment of conserved aspartates in ZIKV RdRpC palm domain as potential drug targets. The conserved and catalytically active aspartate residues present in the predicted RdRpC protein were virtually screened against a ZINC database for inhibitors, and the selected potential drug candidates were further filtered based on their ADMET profiles. One of the pharmacokinetically active compounds (Ligand 6) showed a remarkable docking profile against the strictly conserved aspartate residues of the RdRpC active site. We hypothesize that the Ligand 6 may form a potential drug candidate for RdRpC inhibition in the clinical treatment of ZIKV infection. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Singh, Anjali; Jana, Nandan Kumar] Heritage Inst Technol, Dept Biotechnol, Kolkata 700107, India.
RP Singh, A; Jana, NK (corresponding author), Heritage Inst Technol, Dept Biotechnol, Kolkata 700107, India.
EM anjalibiotech123@gmail.com; nandankumar.jana@heritageit.edu
RI Jana, Nandan Kumar/A-2248-2017
FU Department of Biotechnology, Heritage Institute of Technology, Kolkata
FX The support of the Department of Biotechnology, Heritage Institute of
   Technology, Kolkata is gratefully acknowledged. We also acknowledge Dr.
   Dipankar Chaudhuri, Associate Professor, Department of Biotechnology,
   Heritage Institute of Technology for his valuable insights. This work
   received no specific grant from any funding agency.
CR Adiga R, 2016, J MED VIROL, V88, P1821, DOI 10.1002/jmv.24615
   Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408
   Baez CF, 2017, MOL BIOSYST, V13, P122, DOI 10.1039/c6mb00645k
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Budryn G, 2015, FOOD CHEM, V168, P276, DOI 10.1016/j.foodchem.2014.07.056
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Ceron-Carrasco JP, 2016, COMPUT THEOR CHEM, V1077, P65, DOI 10.1016/j.comptc.2015.10.028
   Ceron-Carrasco JP, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2401-7
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a
   Choi KH, 2009, CURR OPIN STRUC BIOL, V19, P746, DOI 10.1016/j.sbi.2009.10.015
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Martinez-Ballesta MD, 2016, COLLOID SURFACE B, V143, P318, DOI 10.1016/j.colsurfb.2016.03.056
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ekins S., 2016, F1000RESEARCH, V5, P1
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002
   Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681
   Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Hongjian Li, 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), P77, DOI 10.1109/CIBCB.2012.6217214
   Imbernon B, 2017, INT J HIGH PERFORM C
   Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+
   Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085
   Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Li HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085678
   Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Maunz A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00038
   Moghadam SRJ, 2016, ASIAN PAC J TROP BIO, V6, P989, DOI 10.1016/j.apjtb.2016.09.007
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Navarro-Fernandez J, 2012, J MED CHEM, V55, P6403, DOI 10.1021/jm300621j
   Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003
   O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463
   Perez-Sanchez H, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2914-x
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Ramharack P, 2016, RSC ADV, V6, P68719, DOI 10.1039/c6ra12142j
   Sanchez-Linares I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S13
   Shi XN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132072
   Surana P, 2014, NUCLEIC ACIDS RES, V42, P2758, DOI 10.1093/nar/gkt1106
   te Velthuis AJW, 2014, CELL MOL LIFE SCI, V71, P4403, DOI 10.1007/s00018-014-1695-z
   Thompson M. A., 2004, ARGUSLAB 4 0 1
   van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0
   Wang W, 2016, DATA BRIEF, V9, P345, DOI 10.1016/j.dib.2016.05.025
   Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943
   Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024
   Xu H, 2016, ADV METEOROL, V2016, DOI 10.1155/2016/1246590
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 63
TC 10
Z9 11
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1476-9271
EI 1476-928X
J9 COMPUT BIOL CHEM
JI Comput. Biol. Chem.
PD DEC
PY 2017
VL 71
BP 144
EP 151
DI 10.1016/j.compbiolchem.2017.10.007
PG 8
WC Biology; Computer Science, Interdisciplinary Applications
SC Life Sciences & Biomedicine - Other Topics; Computer Science
GA FR9RT
UT WOS:000419411500015
PM 29096380
DA 2020-07-08
ER

PT J
AU Kazmirchuk, T
   Dick, K
   Burnside, DJ
   Barnes, B
   Moteshareie, H
   Hajikarimlou, M
   Omidi, K
   Ahmed, D
   Low, A
   Lettl, C
   Hooshyar, M
   Schoenrock, A
   Pitre, S
   Babu, M
   Cassol, E
   Samanfar, B
   Wong, A
   Dehne, F
   Green, JR
   Golshani, A
AF Kazmirchuk, Tom
   Dick, Kevin
   Burnside, Daniel. J.
   Barnes, Brad
   Moteshareie, Houman
   Hajikarimlou, Maryam
   Omidi, Katayoun
   Ahmed, Duale
   Low, Andrew
   Lettl, Clara
   Hooshyar, Mohsen
   Schoenrock, Andrew
   Pitre, Sylvain
   Babu, Mohan
   Cassol, Edana
   Samanfar, Bahram
   Wong, Alex
   Dehne, Frank
   Green, James. R.
   Golshani, Ashkan
TI Designing anti-Zika virus peptides derived from predicted human-Zika
   virus protein-protein interactions
SO COMPUTATIONAL BIOLOGY AND CHEMISTRY
LA English
DT Article
DE Synthetic peptide design; Anti-Zika virus peptides; In silico drug
   design; Protein-protein interaction prediction; Host-virus interactions
ID CYSTIC LEUKOENCEPHALOPATHY; TRANSMISSION; RNASET2; RISK;
   SPERMATOGENESIS; IDENTIFICATION; NEUROGENESIS; CHAPERONES; OUTBREAK;
   ENOLASE
AB The production of anti-Zika virus (ZIKV) therapeutics has become increasingly important as the propagation of the devastating virus continues largely unchecked. Notably, a causal relationship between ZIKV infection and neurodevelopmental abnormalities has been widely reported, yet a specific mechanism underlying impaired neurological development has not been identified. Here, we report on the design of several synthetic competitive inhibitory peptides against key pathogenic ZIKV proteins through the prediction of protein -protein interactions (PPIs). Often, PPIs between host and viral proteins are crucial for infection and pathogenesis, making them attractive targets for therapeutics. Using two complementary sequence-based PPI prediction tools, we first produced a comprehensive map of predicted human-ZIKV PPIs (involving 209 human protein candidates). We then designed several peptides intended to disrupt the corresponding host-pathogen interactions thereby acting as anti-ZIKV therapeutics. The data generated in this study constitute a foundational resource to aid in the multidisciplinary effort to combat ZIKV infection, including the design of additional synthetic proteins. (C) 2017 Published by Elsevier Ltd.
C1 [Kazmirchuk, Tom; Burnside, Daniel. J.; Moteshareie, Houman; Hajikarimlou, Maryam; Omidi, Katayoun; Ahmed, Duale; Low, Andrew; Lettl, Clara; Hooshyar, Mohsen; Wong, Alex; Golshani, Ashkan] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.
   [Kazmirchuk, Tom; Burnside, Daniel. J.; Moteshareie, Houman; Hajikarimlou, Maryam; Omidi, Katayoun; Ahmed, Duale; Low, Andrew; Lettl, Clara; Hooshyar, Mohsen; Wong, Alex; Golshani, Ashkan] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada.
   [Kazmirchuk, Tom; Burnside, Daniel. J.; Moteshareie, Houman; Hajikarimlou, Maryam; Omidi, Katayoun; Ahmed, Duale; Low, Andrew; Lettl, Clara; Hooshyar, Mohsen; Wong, Alex; Golshani, Ashkan] Carleton Univ, Ottawa Inst Syst Biol, Ottawa, ON K1S 5B6, Canada.
   [Dick, Kevin; Barnes, Brad; Green, James. R.] Carleton Univ, Dept Syst & Comp Engn, Ottawa, ON K1S 5B6, Canada.
   [Ahmed, Duale; Cassol, Edana; Dehne, Frank] Carleton Univ, Dept Hlth Sci, Ottawa, ON K1S 5B6, Canada.
   [Schoenrock, Andrew; Pitre, Sylvain] Carleton Univ, Sch Comp Sci, Ottawa, ON K1S 5B6, Canada.
   [Babu, Mohan] Univ Regina, Dept Biochem, Regina, SK S4S 0A2, Canada.
   [Samanfar, Bahram] Agr & Agri Food Canada, ORDC, Ottawa, ON K1A 0C6, Canada.
RP Golshani, A (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.; Golshani, A (corresponding author), Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada.; Golshani, A (corresponding author), Carleton Univ, Ottawa Inst Syst Biol, Ottawa, ON K1S 5B6, Canada.
EM ashkan_golshani@carleton.ca
RI Cassol, Edana/Z-6301-2019; Mohan, Babu P./I-7362-2019
OI Green, James/0000-0002-6039-2355; Ahmed, Duale/0000-0002-0319-6614;
   Dick, Kevin/0000-0003-3931-523X
FU Natural Sciences and Engineering Research Council of Canada
   (NSERC)Natural Sciences and Engineering Research Council of Canada
FX This work was funded by the Natural Sciences and Engineering Research
   Council of Canada (NSERC). The authors claim no conflict of interest.
CR Amos-Binks A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-225
   Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821
   Awasthi S., 2016, J ANTIVIR ANTIRETROV, V8, P61, DOI DOI 10.4172/JAA.1000E130
   Bauer H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002567
   Calderone A, 2015, NUCLEIC ACIDS RES, V43, pD588, DOI 10.1093/nar/gku830
   Calderwood DA, 2015, BLOOD, V126, P2658, DOI 10.1182/blood-2015-09-668962
   Campomenosi P, 2006, ARCH BIOCHEM BIOPHYS, V449, P17, DOI 10.1016/j.abb.2006.02.022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Comi GP, 2001, ANN NEUROL, V50, P202, DOI 10.1002/ana.1095
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dandouh F., 2007, PSYCHIAT GENET, V19, P59
   de Chassey B, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0115-1
   Dolan PT, 2013, MOL BIOSYST, V9, P3199, DOI 10.1039/c3mb70343f
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dun MD, 2012, HUM REPROD UPDATE, V18, P420, DOI 10.1093/humupd/dms009
   Eid FE, 2016, BIOINFORMATICS, V32, P1144, DOI 10.1093/bioinformatics/btv737
   Ekins S., 2016, F1000RESEARCH, V5, P1
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fukasaka M, 2013, J IMMUNOL, V190, P5702, DOI 10.4049/jimmunol.1203155
   Gerardin P, 2017, LANCET, V389, P151, DOI 10.1016/S0140-6736(17)30014-4
   Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263
   Hamza I, 2002, J BIOENERG BIOMEMBR, V34, P381, DOI 10.1023/A:1021254104012
   Haud N., 2010, PNAS, P1
   Haud N, 2011, P NATL ACAD SCI USA, V108, P1099, DOI 10.1073/pnas.1009811107
   Henneke M, 2009, NAT GENET, V41, P773, DOI 10.1038/ng.398
   Hsu SH, 2004, EXP CELL RES, V294, P185, DOI 10.1016/j.yexcr.2003.10.029
   Hu W, 2003, LANCET ONCOL, V4, P721, DOI 10.1016/S1470-2045(03)01277-4
   Hu YQ, 2004, INT J ANDROL, V27, P343, DOI 10.1111/j.1365-2605.2004.00492.x
   Irie S., 2011, OPEN ANDROL J, V3, P30
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kalkan T, 2009, MOL BIOL CELL, V20, P3436, DOI 10.1091/mbc.E08-03-0325
   Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]
   Konstantinou EA, 2008, BR J ANAESTH RECOVER, V9, P22
   Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422
   London N, 2013, CURR OPIN CHEM BIOL, V17, P952, DOI 10.1016/j.cbpa.2013.10.011
   Marjanovic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8676
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morales D, 2013, J NEUROVIROL, V19, P471, DOI 10.1007/s13365-013-0200-z
   Munoz M. D. L., 2013, BIOMED RES INT, V2013, P1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nian H, 2007, ARCH BIOCHEM BIOPHYS, V465, P157, DOI 10.1016/j.abb.2007.05.013
   Novak M, 2015, EXP DERMATOL, V24, P455, DOI 10.1111/exd.12697
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oglesbee M, 2011, FUTURE VIROL, V6, P85, DOI 10.2217/FVL.10.70
   Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006
   Overend C, 2012, TRENDS BIOTECHNOL, V30, P497, DOI 10.1016/j.tibtech.2012.06.002
   Park Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-419
   Pitre S, 2008, NUCLEIC ACIDS RES, V36, P4286, DOI 10.1093/nar/gkn390
   Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365
   Pitre S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00239
   Quintero-Rivera F, 2015, HUM MOL GENET, V24, P2375, DOI 10.1093/hmg/ddv004
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   SCHMECHEL DE, 1980, BRAIN RES, V190, P195, DOI 10.1016/0006-8993(80)91169-5
   Schoenrock A., 2011, P INT C SUP ICS 11, P327, DOI 10.1145/1995896.1995946
   Schormann N, 2011, ANTIMICROB AGENTS CH, V55, P5054, DOI 10.1128/AAC.00278-11
   Shoji-Kawata S, 2007, VIROLOGY, V368, P191, DOI 10.1016/j.virol.2007.06.028
   Smith R, 2007, J NEUROCHEM, V103, P115, DOI 10.1111/j.1471-4159.2007.04703.x
   Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048
   Staretz-Chacham O, 2009, PEDIATRICS, V123, P1191, DOI 10.1542/peds.2008-0635
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tokuhiro K., 2015, SCI REP, V5, P1
   Tonduti D, 2016, EUR J PAEDIATR NEURO, V20, P604, DOI 10.1016/j.ejpn.2016.03.009
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Van Gele M, 2009, PIGM CELL MELANOMA R, V22, P268, DOI 10.1111/j.1755-148X.2009.00558.x
   Vidalino L, 2012, BIOL CELL, V104, P13, DOI 10.1111/boc.201100092
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Yung E, 2001, NAT MED, V7, P920, DOI 10.1038/90959
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 72
TC 10
Z9 10
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1476-9271
EI 1476-928X
J9 COMPUT BIOL CHEM
JI Comput. Biol. Chem.
PD DEC
PY 2017
VL 71
BP 180
EP 187
DI 10.1016/j.compbiolchem.2017.10.011
PG 8
WC Biology; Computer Science, Interdisciplinary Applications
SC Life Sciences & Biomedicine - Other Topics; Computer Science
GA FR9RT
UT WOS:000419411500019
PM 29112936
DA 2020-07-08
ER

PT J
AU Platt, DJ
   Miner, JJ
AF Platt, Derek J.
   Miner, Jonathan J.
TI Consequences of congenital Zika virus infection
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID JAPANESE ENCEPHALITIS-VIRUS; WEST-NILE-VIRUS; VERTICAL INFECTION; FETAL
   INFECTION; YELLOW-FEVER; SOUTH-AFRICA; MICE; PREGNANCY; TRANSMISSION;
   PLACENTA
AB The 2015 Zika virus (ZIKV) epidemic in the Americas led to the discovery that ZIKV causes congenital abnormalities including microcephaly, intrauterine growth restriction, and eye disease that can result in blindness. Studies in animal models and human organoid cultures, together with human epidemiological studies, have shown that ZIKV crosses the placenta and subsequently replicates within fetal tissues including the developing brain. Preferential infection of neural cell precursors causes damage to the developing fetal brain. However, a majority of congenitally infected humans do not develop microcephaly or other overt congenital abnormalities, so longitudinal epidemiological studies are necessary to more completely define the long-term consequences of in utero ZIKV infection.
C1 [Miner, Jonathan J.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63110 USA.
   [Platt, Derek J.; Miner, Jonathan J.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA.
   [Miner, Jonathan J.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.
RP Miner, JJ (corresponding author), Washington Univ, Dept Med, Sch Med, St Louis, MO 63110 USA.; Miner, JJ (corresponding author), Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA.; Miner, JJ (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.
EM jonathan.miner@wustl.edu
OI Platt, Derek/0000-0003-0766-4590
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [K08AR070918, R21EY027870];
   Rheumatology Research Foundation; Children's Discovery Institute
   [MIII2017646]; Mid-America Transplant; Department of DefenseUnited
   States Department of Defense [W81XWH171011]; NIH Initiative to Maximize
   Student Development [5R25GM103757]; Washington University Chancellors
   Graduate Fellowship Program
FX J.J.M. is supported by grants from the NIH (K08AR070918 and
   R21EY027870), a Department of Defense Discovery Award (W81XWH171011),
   Mid-America Transplant, the Children's Discovery Institute
   (MIII2017646), and the Rheumatology Research Foundation. D.J. P. is
   supported by the Washington University Chancellors Graduate Fellowship
   Program and the NIH Initiative to Maximize Student Development
   (5R25GM103757).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   ANDERSEN A A, 1970, Infection and Immunity, V2, P320
   ANDERSEN AA, 1975, INFECT IMMUN, V12, P1173, DOI 10.1128/IAI.12.5.1173-1183.1975
   [Anonymous], 2002, JAMA-J AM MED ASSOC, V289, P295
   BARNARD BJH, 1986, ONDERSTEPOORT J VET, V53, P235
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2016, EURO SURVEILL, V21
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowen RA, 2007, CURR OPIN INFECT DIS, V20, P293, DOI 10.1097/QCO.0b013e32816b5cad
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BURNS KF, 1950, P SOC EXP BIOL MED, V75, P621, DOI 10.3181/00379727-75-18285
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   CHESS S, 1977, J AUTISM CHILD SCHIZ, V7, P69, DOI 10.1007/BF01531116
   Cordoba L, 2007, J GEN VIROL, V88, P476, DOI 10.1099/vir.0.82439-0
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira WK, 2017, LANCET
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   FUJISAKI Y, 1977, NATL I ANIM HEALTH Q, V17, P39
   FUJISAKI Y, 1976, NATL I ANIM HEALTH Q, V16, P97
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Heck E, 2017, AM J TRANSPLANT, V17, P2227, DOI 10.1111/ajt.14334
   Henry CR, 2017, JAMA OPHTHALMOL, V135, P386, DOI 10.1001/jamaophthalmol.2017.0098
   Ho CY, 2017, ANN NEUROL, V82, P121, DOI 10.1002/ana.24968
   Icheku V, 2017, J MOL PATHOL EPIDEMI, V2
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Julander JG, 2005, ANTIVIR RES, V65, P79, DOI 10.1016/j.antiviral.2004.10.005
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu H, 2013, VECTOR-BORNE ZOONOT, V13, P41, DOI 10.1089/vbz.2012.1016
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211
   MATHUR A, 1981, INFECT IMMUN, V34, P26, DOI 10.1128/IAI.34.1.26-29.1981
   MATHUR A, 1986, J GEN VIROL, V67, P381, DOI 10.1099/0022-1317-67-2-381
   MATHUR A, 1982, J GEN VIROL, V59, P213, DOI 10.1099/0022-1317-59-1-213
   MATHUR A, 1983, J GEN VIROL, V64, P2027, DOI 10.1099/0022-1317-64-9-2027
   Merle H, 2017, JAMA OPHTHALMOL, V135, P284, DOI 10.1001/jamaophthalmol.2016.5689
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nishioka SD, 1998, TROP MED INT HEALTH, V3, P29, DOI 10.1046/j.1365-3156.1998.00164.x
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   REAGAN R L, 1955, Tex Rep Biol Med, V13, P934
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   SEVER JL, 1985, REV INFECT DIS, V7, pS164
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   SULKIN SE, 1964, AM J TROP MED HYG, V13, P475, DOI 10.4269/ajtmh.1964.13.475
   Sun J, 2017, J INFECT
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TSAI TF, 1993, J INFECT DIS, V168, P1520, DOI 10.1093/infdis/168.6.1520
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Venter M, 2011, EMERG INFECT DIS, V17, P1534, DOI 10.3201/eid1708.101794
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura L. O., 2017, J AAPOS
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 83
TC 14
Z9 14
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD DEC
PY 2017
VL 27
BP 1
EP 7
DI 10.1016/j.coviro.2017.09.005
PG 7
WC Virology
SC Virology
GA FR9SL
UT WOS:000419413300002
PM 29080429
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Barr, KL
AF Barr, Kelli L.
TI Vertical transmission of positive-sense single-stranded RNA viruses in
   plants as a model for arboviral induced teratogenesis
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID IMPRINTED GENES; ARABIDOPSIS; PROTEINS; BINDING; INFECTION; DNA;
   LANDSCAPE; MOSQUITOS; DISEASES; BIOLOGY
AB Teratogenic viruses have increased public health importance with the emergence of Zika virus and a recent decline in rubella virus vaccination. Of the seven viruses known to cause birth defects in humans, three are mosquito-borne pathogens. Ethical oversight, compliance, rising costs, and the need for specialized training slow the pace of study of these human pathogens compared to study of similar teratogenic viruses in plants. Plant viruses have served as models for human viruses which can be applied to animal systems. This review describes the similar features of plant and animal teratogenic arboviruses and the common systems and barriers that are encountered during vertical transmission in the host.
C1 [Barr, Kelli L.] Univ Florida, Coll Vet Med, Dept Comparat Diagnost & Populat Med, Gainesville, FL 32611 USA.
RP Barr, KL (corresponding author), Univ Florida, Coll Vet Med, Dept Comparat Diagnost & Populat Med, Gainesville, FL 32611 USA.
EM kellilbarr@ufl.edu
RI Barr, Kelli L./I-7508-2019
OI Barr, Kelli L./0000-0001-7943-7181
CR Ahola T, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0050-0
   Bagga S, 2014, METHODS MOL BIOL, V1170, P165, DOI 10.1007/978-1-4939-0888-2_10
   Bartolini F, 2010, BBA-MOL CELL RES, V1803, P164, DOI 10.1016/j.bbamcr.2009.07.006
   Bressan FF, 2009, PLACENTA, V30, P823, DOI 10.1016/j.placenta.2009.07.007
   Brown DT, 1986, VIRUSES TOGAVIRRIDAE
   Chin WX, 2017, DRUG DISCOV TODAY, V22, P17, DOI 10.1016/j.drudis.2016.08.008
   Ciota AT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-58
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108
   Costa LM, 2012, CURR BIOL, V22, P1980, DOI 10.1016/j.cub.2012.10.012
   Covey SN, 1997, NATURE, V385, P781, DOI 10.1038/385781a0
   Csaba G, 2016, CURR PEDIATR REV, V12, P222, DOI 10.2174/1573396312666160709031510
   Dader B, 2017, INSECT SCI, V24, P929, DOI 10.1111/1744-7917.12470
   Diaz A, 2014, CURR OPIN VIROL, V9, P104, DOI 10.1016/j.coviro.2014.09.018
   Fowden AL, 2011, PROG BIOPHYS MOL BIO, V106, P281, DOI 10.1016/j.pbiomolbio.2010.11.005
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Fresard L, 2014, NUCLEIC ACIDS RES, V42, P3768, DOI 10.1093/nar/gkt1390
   Gerald JNF, 2009, DEVELOPMENT, V136, P3399, DOI 10.1242/dev.036921
   GOLDBACH R, 1987, MICROBIOL SCI, V4, P197
   Gouveia BC, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02139
   Guan HC, 2003, VIROLOGY, V309, P114, DOI 10.1016/S0042-6822(02)00135-6
   Gutierrez-Marcos JF, 2012, PLACENTA, V33, pE3, DOI 10.1016/j.placenta.2012.08.006
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Hitchins MP, 2001, EUR J HUM GENET, V9, P82, DOI 10.1038/sj.ejhg.5200583
   Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135
   Ivanov KI, 2012, CURR OPIN VIROL, V2, P712, DOI 10.1016/j.coviro.2012.10.001
   Jasik KP, 2015, VECTOR-BORNE ZOONOT, V15, P637, DOI 10.1089/vbz.2015.1815
   Jungfleisch J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120340
   Kennedy EM, 2017, J VIROL, V91, DOI 10.1128/JVI.02263-16
   Knipe D., 2007, FIELDS VIROLOGY
   Kohler C, 2012, ANNU REV PLANT BIOL, V63, P331, DOI 10.1146/annurev-arplant-042811-105514
   KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679
   Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546
   Lindner M, 2013, DEV BIOL, V379, P28, DOI 10.1016/j.ydbio.2013.03.005
   Linz LB, 2015, J VIROL, V89, P11203, DOI 10.1128/JVI.01479-15
   Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296
   May B, 2017, BIOCHEM SOC T, V45, P731, DOI 10.1042/BST20160178
   Miri K, 2013, DEVELOPMENT, V140, P4480, DOI 10.1242/dev.096511
   Monteiro JT, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030059
   Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692
   Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005
   Nelson RS, 2005, PLANT PHYSIOL, V138, P1809, DOI 10.1104/pp.104.900167
   Noack J, 2014, J VIROL, V88, P10272, DOI 10.1128/JVI.00801-14
   Peters J, 2014, NAT REV GENET, V15, P517, DOI 10.1038/nrg3766
   Puschnik AS, 2017, NAT REV MICROBIOL, V15, P351, DOI 10.1038/nrmicro.2017.29
   Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018
   Razonable RR, 2011, MAYO CLIN PROC, V86, P1009, DOI 10.4065/mcp.2011.0309
   Rotenberg D, 2015, CURR OPIN VIROL, V15, P80, DOI 10.1016/j.coviro.2015.08.003
   Rozen-Gagnon K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003877
   Sastry S, 2017, INT J INFECT DIS, V57, P138, DOI 10.1016/j.ijid.2017.01.040
   Satyaki PRV, 2017, CRIT REV BIOCHEM MOL, V52, P163, DOI 10.1080/10409238.2017.1279119
   Schroeder SJ, 2014, BIOCHEMISTRY-US, V53, P6728, DOI 10.1021/bi501051k
   Sharma M, 2010, J VIROL, V84, P2270, DOI 10.1128/JVI.02003-09
   Singh P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00124
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Tiwari S, 2008, PLANT CELL, V20, P2387, DOI 10.1105/tpc.108.061929
   van Zuylen WJ, 2016, REV MED VIROL, V26, P340, DOI 10.1002/rmv.1892
   Viktorovskaya OV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004921
   Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0
   Weber PH, 2015, VIRUS RES, V196, P140, DOI 10.1016/j.virusres.2014.11.014
   Whitfield AE, 2005, VIRUS RES, V110, P183, DOI 10.1016/j.virusres.2005.01.007
   Whitfield AE, 2015, VIROLOGY, V479, P278, DOI 10.1016/j.virol.2015.03.026
   Wijetunga NA, 2017, ONCOGENE, V36, P2030, DOI 10.1038/onc.2016.340
   Wilkins JF, 2016, BIOESSAYS, V38, P482, DOI 10.1002/bies.201500198
   Xu K, 2017, J VIROL, V91, DOI [10.1128/JVI.01984-16, 10.1128/jvi.01984-16]
   Xu K, 2015, P NATL ACAD SCI USA, V112, pE1782, DOI 10.1073/pnas.1418971112
   Zaitlin M, 1998, DISCOVERIES PLANT BI, P105
   Zhao P, 2017, J BIOL CHEM, V292, P5921, DOI [10.1074/jbc.M116.764902, 10.1074/jbc.m116.764902]
NR 71
TC 0
Z9 0
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD DEC
PY 2017
VL 27
BP 42
EP 47
DI 10.1016/j.coviro.2017.11.010
PG 6
WC Virology
SC Virology
GA FR9SL
UT WOS:000419413300007
PM 29172070
DA 2020-07-08
ER

PT J
AU Petitt, M
   Tabata, T
   Puerta-Guardo, H
   Harris, E
   Pereira, L
AF Petitt, Matthew
   Tabata, Takako
   Puerta-Guardo, Henry
   Harris, Eva
   Pereira, Lenore
TI Zika virus infection of first-trimester human placentas: utility of an
   explant model of replication to evaluate correlates of immune protection
   &ITex vivo &IT
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID HUMAN CYTOMEGALOVIRUS-INFECTION; TROPHOBLAST PROGENITOR CELLS; DENGUE
   VIRUS; VIRAL-INFECTION; AMNIOTIC-FLUID; MEMBRANE ASSOCIATION; 1ST
   TRIMESTER; ANTIBODY; VACCINE; BRAZIL
AB The emergence of congenital Zika virus (ZIKV) disease, with its devastating effects on the fetus, has prompted development of vaccines and examination of how ZIKV breaches the maternal-fetal barrier. Infection of placental and decidual tissue explants has demonstrated cell types at the uterine-placental interface susceptible to infection and suggests routes for transmission across the placenta and amniochorionic membrane. ZIKV replicates in proliferating Hofbauer cells within chorionic villi in placentas from severe congenital infection. Explants of anchoring villi recapitulate placental architecture and early-stage development and suggest infected Hofbauer cells disseminate virus to fetal blood vessels. ZIKV infection of explants represents a surrogate human model for evaluating protection against transmission by antibodies in vaccine recipients and passive immune formulations and novel therapeutics.
C1 [Petitt, Matthew; Tabata, Takako; Pereira, Lenore] Univ Calif San Francisco, Sch Dent, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.
   [Puerta-Guardo, Henry; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Pereira, L (corresponding author), Univ Calif San Francisco, Sch Dent, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.
EM lenore.pereira@ucsf.edu
FU NIH Institute for Allergy and Infectious Diseases [RO1AI04667, R21
   AI129508, RO1AI124493]
FX This work was supported by grants from the NIH Institute for Allergy and
   Infectious Diseases: RO1AI04667 (L.P.), R21 AI129508 (L.P., E.H.) and RO
   1AI124493 (E.H.)
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Adler SP, 2008, J CLIN VIROL, V41, P231, DOI 10.1016/j.jcv.2007.11.008
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   BENIRSCHKE K, 2000, PATHOLOGY HUMAN PLAC
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   de Carvalho NS, 2017, AM J REPROD IMMUNOL, P77
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Devakumar D, 2017, LANCET INFECT DIS
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dulay AT, 2009, J IMMUNOL, V182, P7244, DOI 10.4049/jimmunol.0803517
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GENBACEV O, 1992, PLACENTA, V13, P439, DOI 10.1016/0143-4004(92)90051-T
   Genbacev O, 2015, PLACENTA, V36, P716, DOI 10.1016/j.placenta.2015.05.002
   Gervasi MT, 2012, J PERINAT MED, V40, P329, DOI 10.1515/jpm-2012-0034
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Iwamoto K, 2007, BIOPHYS J, V93, P1608, DOI 10.1529/biophysj.106.101584
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kauvar LM, 2015, ANTIMICROB AGENTS CH, V59, P1563, DOI 10.1128/AAC.04295-14
   Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007
   Lai CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002451
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lee SY, 2011, J IMMUNOL, V186, P3226, DOI 10.4049/jimmunol.1003587
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Maidji E, 2007, J VIROL, V81, P4701, DOI 10.1128/JVI.02748-06
   Maidji E, 2010, AM J PATHOL, V177, P1298, DOI 10.2353/ajpath.2010.091210
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nozawa N, 2009, J CLIN VIROL, V46, pS58, DOI 10.1016/j.jcv.2009.10.004
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Pacheco O, 2016, N ENGL J MED
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009
   Pereira L, 2003, J VIROL, V77, P13301, DOI 10.1128/JVI.77.24.13301-13314.2003
   Pereira L, 2014, J INFECT DIS, V209, P1573, DOI 10.1093/infdis/jiu019
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tabata T, 2007, PLACENTA, V28, P527, DOI 10.1016/j.placenta.2006.05.006
   Tabata T, 2017, J INFECT DIS
   Tabata T, 2016, AM J PATHOL, V186, P2970, DOI 10.1016/j.ajpath.2016.07.016
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tabata T, 2015, J VIROL, V89, P5134, DOI 10.1128/JVI.03674-14
   Tabata T, 2012, AM J PATHOL, V181, P1540, DOI 10.1016/j.ajpath.2012.08.003
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Weisblum Y, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01905-16
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yamamoto AY, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.018
   Zydek M, 2014, VIRUSES-BASEL, V6, P1346, DOI 10.3390/v6031346
NR 89
TC 7
Z9 7
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD DEC
PY 2017
VL 27
BP 48
EP 56
DI 10.1016/j.coviro.2017.11.008
PG 9
WC Virology
SC Virology
GA FR9SL
UT WOS:000419413300008
PM 29172071
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wong, G
   He, SH
   Siragam, V
   Bi, YH
   Mbikay, M
   Chretien, M
   Qiu, XG
AF Wong, Gary
   He, Shihua
   Siragam, Vinayakumar
   Bi, Yuhai
   Mbikay, Majambu
   Chretien, Michel
   Qiu, Xiangguo
TI Antiviral activity of quercetin-3-beta-O-D-glucoside against Zika virus
   infection
SO VIROLOGICA SINICA
LA English
DT Letter
ID QUERCETIN; MICE
AB Q3G is a natural derivative of quercetin and is already widely used in various foods and drinks. Our results clearly demonstrated that Q3G exerts antiviral activity against ZIKV in both tissue culture and knockout mice, and that post-exposure in vivo treatment with Q3G could have a beneficial effect. In the future, Q3G should be tested in human cell lines (such as Huh-7, HeLa, or K048, a fetal brain neural stem cell line) to provide further data supporting its potential efficacy in humans; in addition, live viral loads or viremia should be tested in treated animals to supplement the survival results observed in this study. Although the treatment regimens will need to be further optimized (i.e., dosage, frequency of treatment, and administration routes), our results support the results of Q3G efficacy studies in nonhuman primates against ZIKV infection. Further studies will also be needed to investigate the mechanism of Q3G antiviral action, in order to obtain valuable insights into the design of novel targets for antiviral therapeutics in the future.
C1 [Wong, Gary; He, Shihua; Siragam, Vinayakumar; Qiu, Xiangguo] Publ Hlth Agcy Canada, Special Pathogens Program, Winnipeg, MB R3E 3R2, Canada.
   [Wong, Gary; Bi, Yuhai] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, State Key Discipline Infect Dis, Shenzhen 511700, Peoples R China.
   [Wong, Gary; Bi, Yuhai] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
   [Wong, Gary; Qiu, Xiangguo] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada.
   [Mbikay, Majambu; Chretien, Michel] Clin Res Inst Montreal, Funct Endoproteolysis Lab, Montreal, PQ H2W 1R7, Canada.
   [Mbikay, Majambu; Chretien, Michel] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON K1H 8L6, Canada.
RP Qiu, XG (corresponding author), Publ Hlth Agcy Canada, Special Pathogens Program, Winnipeg, MB R3E 3R2, Canada.; Qiu, XG (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada.
EM xiangguo.qiu@phac-aspc.gc.ca
FU Public Health Agency of Canada (PHAC); Canadian Institute for Health
   Research (CIHR)Canadian Institutes of Health Research (CIHR)
   [LDI-003893-CIHR-IER-143487]; National Institutes of Health (NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [1U19AI109762-01]; Fondation Merieux (France);
   Richard and Edith Strauss Canada Foundation et la Fondation J-Louis
   Levesque; CIHRCanadian Institutes of Health Research (CIHR); Chinese
   Academy of Sciences (CAS)Chinese Academy of Sciences
FX This work was supported by the Public Health Agency of Canada (PHAC) as
   well as grants from the Canadian Institute for Health Research (CIHR,
   LDI-003893-CIHR-IER-143487) and the National Institutes of Health (NIH,
   1U19AI109762-01) to XQ, and supported by the Fondation Merieux (France),
   the Richard and Edith Strauss Canada Foundation et la Fondation J-Louis
   Levesque to MM and MC. GW is the recipient of a Banting Postdoctoral
   Fellowship from CIHR and the President's International Fellowship
   Initiative from the Chinese Academy of Sciences (CAS). All experiments
   were conducted in the Biosafety Level 2 (BSL-2) Laboratory at the
   National Microbiology Laboratory, Winnipeg, Canada, and animal
   experiments were carried out in strict accordance with the
   recommendations of Canadian Council on Animal Care (CCAC), with approval
   from the Animal Care Committee (ACC). All institutional and national
   guidelines for the care and use of laboratory animals were followed. The
   authors declare no competing interests.
CR Cheng ZK, 2015, VIROL SIN, V30, P261, DOI 10.1007/s12250-015-3584-5
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hollman PCH, 1997, BIOMED PHARMACOTHER, V51, P305, DOI 10.1016/S0753-3322(97)88045-6
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Qiu XG, 2016, ANTIMICROB AGENTS CH, V60, P5182, DOI 10.1128/AAC.00307-16
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Wong G, 2015, CLIN MICROBIOL REV, V28, P593, DOI 10.1128/CMR.00014-15
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 7
Z9 7
U1 4
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD DEC
PY 2017
VL 32
IS 6
BP 545
EP 547
DI 10.1007/s12250-017-4057-9
PG 3
WC Virology
SC Virology
GA FR6OZ
UT WOS:000419186700013
PM 28884445
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Sriwijitalai, W
   Wiwanitkit, V
AF Sriwijitalai, W.
   Wiwanitkit, V.
TI Zika Virus Iceberg: Very Large
SO AMERICAN JOURNAL OF NEURORADIOLOGY
LA English
DT Letter
C1 [Sriwijitalai, W.] RVT Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, V.] Joseph Ayobabalola Univ, Lagos, Nigeria.
RP Sriwijitalai, W (corresponding author), RVT Med Ctr, Bangkok, Thailand.
CR Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 4
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC NEURORADIOLOGY
PI DENVILLE
PA PO BOX 3000, DENVILLE, NJ 07834-9349 USA
SN 0195-6108
EI 1936-959X
J9 AM J NEURORADIOL
JI Am. J. Neuroradiol.
PD DEC
PY 2017
VL 38
IS 12
BP E102
EP E102
DI 10.3174/ajnr.A5351
PG 1
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA FR7OD
UT WOS:000419258900001
PM 28751513
OA Other Gold
DA 2020-07-08
ER

PT J
AU Rocha, LB
   Alves, RPD
   Caetano, BA
   Pereira, LR
   Mitsunari, T
   Amorim, JH
   Polatto, JM
   Botosso, VF
   Gallina, NMF
   Palacios, R
   Precioso, AR
   Granato, CFH
   Oliveira, DBL
   da Silveira, VB
   Luz, D
   Ferreira, LCD
   Piazza, RMF
AF Rocha, Leticia Barboza
   dos Santos Alves, Rubens Prince
   Caetano, Bruna Alves
   Pereira, Lennon Ramos
   Mitsunari, Thais
   Amorim, Jaime Henrique
   Polatto, Juliana Moutinho
   Botosso, Viviane Fongaro
   Frazatti Gallina, Neuza Maria
   Palacios, Ricardo
   Precioso, Alexander Roberto
   Hernandes Granato, Celso Francisco
   Leal Oliveira, Danielle Bruna
   da Silveira, Vanessa Barbosa
   Luz, Daniela
   de Souza Ferreira, Luis Carlos
   Fontes Piazza, Roxane Maria
TI Epitope Sequences in Dengue Virus NS1 Protein Identified by Monoclonal
   Antibodies
SO ANTIBODIES
LA English
DT Article
DE dengue virus; NS1; Zika virus; mAbs; antibody recognition; amino acid
   sequences
ID GLYCOPROTEIN; REPLICATION; REGION
AB Dengue nonstructural protein 1 (NS1) is a multi-functional glycoprotein with essential functions both in viral replication and modulation of host innate immune responses. NS1 has been established as a good surrogate marker for infection. In the present study, we generated four anti-NS1 monoclonal antibodies against recombinant NS1 protein from dengue virus serotype 2 (DENV2), which were used to map three NS1 epitopes. The sequence (193)AVHADMGYWIESALNDT(209) was recognized by monoclonal antibodies 2H5 and 4H1BC, which also cross-reacted with Zika virus (ZIKV) protein. On the other hand, the sequence (25)VHTWTEQYKFQPES(38) was recognized by mAb 4F6 that did not cross react with ZIKV. Lastly, a previously unidentified DENV2 NS1-specific epitope, represented by the sequence (127)ELHNQTFLIDGPETAEC(143), is described in the present study after reaction with mAb 4H2, which also did not cross react with ZIKV. The selection and characterization of the epitope, specificity of anti-NS1 mAbs, may contribute to the development of diagnostic tools able to differentiate DENV and ZIKV infections.
C1 [Rocha, Leticia Barboza; Caetano, Bruna Alves; Mitsunari, Thais; Polatto, Juliana Moutinho; Luz, Daniela; Fontes Piazza, Roxane Maria] Inst Butantan, Lab Bacteriol, BR-05503900 Sao Paulo, SP, Brazil.
   [dos Santos Alves, Rubens Prince; Pereira, Lennon Ramos; Amorim, Jaime Henrique; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Lab Dev Vacinas, Inst Ciencias Biomed, BR-05508000 Sao Paulo, SP, Brazil.
   [Botosso, Viviane Fongaro] Inst Butantan, Lab Virol, BR-05503900 Sao Paulo, SP, Brazil.
   [Frazatti Gallina, Neuza Maria] Div Dev Tecnol & Prod, BR-05503 Sao Paulo, SP, Brazil.
   [Frazatti Gallina, Neuza Maria] Inst Butantan, BR-05503 Sao Paulo, SP, Brazil.
   [Palacios, Ricardo; Precioso, Alexander Roberto] Inst Butantan, Div Ensaios Clin & Farmacovigilancia, BR-05503900 Sao Paulo, SP, Brazil.
   [Hernandes Granato, Celso Francisco] Univ Fed Sao Paulo, Dept Medicina, Disciplina Doencas Infecciosas & Parasitarias, BR-04023062 Sao Paulo, SP, Brazil.
   [Leal Oliveira, Danielle Bruna; da Silveira, Vanessa Barbosa] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Lab Virol Mol & Clin, BR-05508000 Sao Paulo, SP, Brazil.
   [Amorim, Jaime Henrique] Univ Fed Oeste Bahia, Ctr Ciencias Biol & Saude, Lab Microbiol, BR-47805100 Barreiras, Bahia, Brazil.
RP Piazza, RMF (corresponding author), Inst Butantan, Lab Bacteriol, BR-05503900 Sao Paulo, SP, Brazil.
EM leticia.rocha@butantan.gov.br; rubens.bmc@gmail.com;
   bruna.caetano@butantan.gov.br; lennon_rp@usp.br;
   thais.mitsunari@butantan.gov.br; jh.biomedico@gmail.com;
   juliana.yassuda@butantan.gov.br; viviane.botosso@butantan.gov.br;
   neuza.gallina@butantan.gov.br; ricardo.palacios@butantan.gov.br;
   alexander.precioso@butantan.gov.br; celso.granato@grupofleury.com.br;
   danibruna@gmail.com; vanessa.silveirabio@gmail.com;
   daniedaluz@yahoo.com.br; lcsf@usp.br; roxane@butantan.gov.br
RI Palacios, Ricardo/B-7248-2018; Palacios, Ricardo/AAN-7606-2020;
   Silveira, Vanessa/AAJ-9535-2020; Precioso, Alexander
   Roberto/A-9712-2013; Oliveira, Danielle BL/H-8030-2015; Botosso,
   Viviane/I-5591-2014; Amorim, Jaime Henrique/O-9222-2017
OI Palacios, Ricardo/0000-0002-1410-8579; Palacios,
   Ricardo/0000-0002-1410-8579; Precioso, Alexander
   Roberto/0000-0001-8657-9292; Oliveira, Danielle BL/0000-0002-3452-1336;
   Botosso, Viviane/0000-0002-7876-3687; Alves Caetano,
   Bruna/0000-0002-0484-2243; Amorim, Jaime Henrique/0000-0002-0623-2879
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2009/53894-3, 2011/51761-6, 2014/17595-0,
   2013/06589-6, 2013/50955-7]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq); FAPESP fellowshipFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2012/09096-8]
FX We would like to thank Pedro Vasconcelos, from Evandro Chagas Institute,
   Belem, PA, Brazil for providing a lyophilized ZIKVBR seed. This work was
   supported by grants from Sao Paulo Research Foundation (FAPESP):
   2009/53894-3; 2011/51761-6; 2014/17595-0 to L.C.S.F. 2013/06589-6;
   2013/50955-7 to R.M.F.P and from Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) awarded to R.M.F.P. LBR was a recipient
   of post-doctoral FAPESP fellowship (2012/09096-8).
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Amorim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044984
   Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blaney JE, 2002, VIROLOGY, V300, P125, DOI 10.1006/viro.2002.1528
   Blaney JE, 2008, VACCINE, V26, P817, DOI 10.1016/j.vaccine.2007.11.082
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chaudhury S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005395
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   FALCONAR AKI, 1994, ARCH VIROL, V137, P315, DOI 10.1007/BF01309478
   FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4
   Gelanew T, 2015, J VIROL METHODS, V222, P214, DOI 10.1016/j.jviromet.2015.06.003
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Jiang L, 2010, VIRUS RES, V150, P49, DOI 10.1016/j.virusres.2010.02.012
   Jiao Y., 2014, PLOS ONE, V2, DOI 10.1371/journal.pone.008819124516609
   Jones ML, 2017, MOLECULES, V22, DOI 10.3390/molecules22040607
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kochakarn T, 2016, ASIAN PAC J TROP MED, V9, P1026, DOI 10.1016/j.apjtm.2016.10.002
   Kohler G, 1975, BIOTECHNOLOGY, V24, P524
   Lebani K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180669
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Rocha LB, 2012, TOXINS, V4, P729, DOI 10.3390/toxins4090729
   Salvador FS, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.00779-15
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2017, B EPIDEMIOL, V48, P2358
   Silva EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057514
   Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048
   Whitehead SS, 2003, J VIROL, V77, P1653, DOI 10.1128/JVI.77.2.1653-1657.2003
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
NR 30
TC 6
Z9 7
U1 1
U2 2
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4468
J9 ANTIBODIES
JI Antibodies
PD DEC
PY 2017
VL 6
IS 4
AR 14
DI 10.3390/antib6040014
PG 13
WC Immunology
SC Immunology
GA FR6KQ
UT WOS:000419175100001
PM 31548529
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Monsalve, DM
   Pacheco, Y
   Acosta-Ampudia, Y
   Rodriguez, Y
   Ramirez-Santana, C
   Anaya, JM
AF Monsalve, Diana M.
   Pacheco, Yovana
   Acosta-Ampudia, Yeny
   Rodriguez, Yhojan
   Ramirez-Santana, Carolina
   Anaya, Juan-Manuel
TI Zika virus and autoimmunity. One-step forward
SO AUTOIMMUNITY REVIEWS
LA English
DT Review
DE Zika virus; Autoimmunity; Autoantibodies; Guillain-Barre syndrome;
   Idiopathic thrombocytopenic purpura; Thrombocytopenia
ID GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS; THROMBOCYTOPENIC PURPURA;
   UNCOMMON PRESENTATION; MOLECULAR MIMICRY; INFECTION; ANTIBODIES;
   DISEASE; PATHOGENESIS; MORTALITY
AB Zika virus (ZIKV) infection has been associated with the development of Guillain-Barre syndrome (GBS) and idiopathic thrombocytopenic purpura (ITP). Whether ZIKV infection is related to other autoimmune diseases is unknown. Therefore, an association study to evaluate rheumatic and thyroid autoimmunity in patients with ZIKV disease was conducted through a panel of 14 autoantibodies. In addition, a literature review on ZIKV, and GBS and ITP was performed. Our results disclosed a lack of association of rheumatoid and thyroid autoimmunity with ZIKV disease. A total of 272 cases of GBS related to ZIKV were retrieved from the literature, the majority of them being males (54.8%). Electrophysiological findings indicated acute inflammatory demyelinating polyneuropathy as the most frequent subphenotype (75.7%). Up to date, twenty-four cases of ITP in patients with ZIKV disease have been published. Although a few fatal cases have been observed, most of the reported patients responded well to immunomodulatory treatment. A review of the mechanisms incriminated into the development of autoimmune phenomenon in ZIKV disease indicates molecular mimicry as the most plausible one. Nevertheless, more research aimed at deciphering ZIKV disease pathogenesis and its relationship with auto immunity is warranted. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Monsalve, Diana M.; Pacheco, Yovana; Acosta-Ampudia, Yeny; Rodriguez, Yhojan; Ramirez-Santana, Carolina; Anaya, Juan-Manuel] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 24 63-C-69, Bogota 111221, Colombia.
RP Anaya, JM (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 24 63-C-69, Bogota 111221, Colombia.
EM juan.anaya@urosario.edu.co
RI Monsalve, Diana M./J-2374-2016; Ramirez-Santana, Carolina/J-2363-2016;
   Acosta-Ampudia, Yeny/J-2401-2016
OI Monsalve, Diana M./0000-0002-1145-1312; Ramirez-Santana,
   Carolina/0000-0003-2137-4899; Rodriguez, Yhojan/0000-0002-0956-1491;
   Acosta-Ampudia, Yeny/0000-0001-8491-9134
FU Universidad del Rosario [ABN011]; COLCIENCIAS, Bogota,
   ColombiaDepartamento Administrativo de Ciencia, Tecnologia e Innovacion
   Colciencias [747-2016]
FX The authors thank all the members of the CREA for fruitful discussions
   and contributions. This work was supported by the Universidad del
   Rosario (ABN011) and COLCIENCIAS (747-2016), Bogota, Colombia.
CR Abeles AM, 2013, AM J MED, V126, P342, DOI 10.1016/j.amjmed.2012.09.014
   Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Ali A, 2017, NEUROLOGY, V88, P540
   Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Bougouin W, 2017, ANN INTENSIVE CARE, V7, P33
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   Chuang YC, 2014, J VIROL, V88, P13759, DOI 10.1128/JVI.02166-14
   Cooper N, 2006, BRIT J HAEMATOL, V133, P364, DOI 10.1111/j.1365-2141.2006.06024.x
   Dar H, 2016, ASIAN PAC J TROP MED, V9, P822, DOI 10.1016/j.apjtm.2016.07.004
   Deane S, 2010, AUTOIMMUN REV, V9, pA342, DOI 10.1016/j.autrev.2009.11.020
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y
   Fabrizius RG, 2016, AM J TROP MED HYG, V95, P1161, DOI 10.4269/ajtmh.16-0397
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Franco JS, 2015, CLIN ENDOCRINOL, V83, P943, DOI 10.1111/cen.12662
   Gonzalez-Barreto W, 2016, CRIT CARE MED, V44
   Grobusch MP, 2016, LANCET, V387, P1813, DOI 10.1016/S0140-6736(16)30178-7
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kamilia C, 2017, ANN INTENSIVE CARE, V7, P164
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lambert MP, 2017, BLOOD, V129, P2829, DOI 10.1182/blood-2017-03-754119
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langerak T, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00233
   Leis AA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00170
   Lin YS, 2011, EXP BIOL MED, V236, P515, DOI 10.1258/ebm.2011.010339
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Miller E, 2017, J NEUROL SCI, V375, P367, DOI 10.1016/j.jns.2017.02.029
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Moher D, 2009, J CHIN INTEGR MED, V7, P889, DOI DOI 10.3736/JCIM20090918
   Musso D, 2016, LANCET, V387, P1812, DOI 10.1016/S0140-6736(16)30317-8
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pefiuelas O, 2017, J CLIN APHERESIS, V32, P111
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Rinaldi M, 2014, LUPUS, V23, P554, DOI 10.1177/0961203313499959
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Skrove JL, 2016, AM J GASTROENTEROL, V111, pS975, DOI 10.14309/00000434-201610001-02043
   Song BH, 2017, J NEUROIMMUNOL
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x
   Sun DS, 2015, J IMMUNOL, V195, P2743, DOI 10.4049/jimmunol.1500136
   Tantillo G, 2017, NEUROLOGY, V88, pP2
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   van den Berg B, 2016, Ned Tijdschr Geneeskd, V160, pD155
   Villamil-Gomez WE, 2017, TRAVEL MED INFECT DI, V16, P62, DOI 10.1016/j.tmaid.2017.03.012
   Wan SW, 2013, J FORMOS MED ASSOC, V112, P3, DOI 10.1016/j.jfma.2012.11.006
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Willison H.J., 2016, LANCET, V6736, P1, DOI DOI 10.1016/S0140-6736(16)00339-1.ELSEVIER
   Yin Y, 2013, VIRAL IMMUNOL, V26, P185, DOI 10.1089/vim.2012.0063
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zea-Vera AF, 2017, LUPUS, V26, P890, DOI 10.1177/0961203316671816
NR 76
TC 9
Z9 10
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1568-9972
EI 1873-0183
J9 AUTOIMMUN REV
JI Autoimmun. Rev.
PD DEC
PY 2017
VL 16
IS 12
BP 1237
EP 1245
DI 10.1016/j.autrev.2017.10.008
PG 9
WC Immunology
SC Immunology
GA FR3SJ
UT WOS:000418986500008
PM 29037898
DA 2020-07-08
ER

PT J
AU Kenneson, A
   Beltran-Ayala, E
   Borbor-Cordova, MJ
   Polhemus, ME
   Ryan, SJ
   Endy, TP
   Stewart-Ibarra, AM
AF Kenneson, Aileen
   Beltran-Ayala, Efrain
   Borbor-Cordova, Mercy J.
   Polhemus, Mark E.
   Ryan, Sadie J.
   Endy, Timothy P.
   Stewart-Ibarra, Anna M.
TI Social-ecological factors and preventive actions decrease the risk of
   dengue infection at the household-level: Results from a prospective
   dengue surveillance study in Machala, Ecuador
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID BREEDING CONTROL MEASURES; AEDES-AEGYPTI; HEMORRHAGIC-FEVER; KNOWLEDGE;
   VECTOR; ATTITUDES; COMMUNITIES; PREVALENCE; BEHAVIORS; EPIDEMIC
AB Background
   In Ecuador, dengue virus (DENV) infections transmitted by the Aedes aegypti mosquito are among the greatest public health concerns in urban coastal communities. Community-and household-level vector control is the principal means of controlling disease outbreaks. This study aimed to assess the impact of knowledge, attitudes, and practices (KAPs) and socialecological factors on the presence or absence of DENV infections in the household.
   Methods
   In 2014 and 2015, individuals with DENV infections from sentinel clinics in Machala, Ecuador, were invited to participate in the study, as well as members of their household and members of four neighboring households located within 200 meters. We conducted diagnostic testing for DENV on all study participants; we surveyed heads of households (HOHs) regarding demographics, housing conditions and KAPs. We compared KAPs and social-ecological factors between households with (n = 139) versus without (n = 80) DENV infections, using bivariate analyses and multivariate logistic regression models with and without interactions.
   Results
   Significant risk factors in multivariate models included proximity to abandoned properties, interruptions in piped water, and shaded patios (p< 0.05). Significant protective factors included the use of mosquito bed nets, fumigation inside the home, and piped water inside the home (p< 0.05). In bivariate analyses (but not multivariate modeling), DENV infections were positively associated with HOHs who were male, employed, and of younger age than households without infections (p< 0.05). DENV infections were not associated with knowledge, attitude, or reported barriers to prevention activities.
   Discussion
   Specific actions that can be considered to decrease the risk of DENV infections in the household include targeting vector control in highly shaded properties, fumigating inside the home, and use of mosquito bed nets. Community-level interventions include cleanup of abandoned properties, daily garbage collection, and reliable piped water inside houses. These findings can inform interventions to reduce the risk of other diseases transmitted by the Ae. aegypti mosquito, such as chikungunya and Zika fever.
C1 [Kenneson, Aileen; Polhemus, Mark E.; Ryan, Sadie J.; Endy, Timothy P.; Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Beltran-Ayala, Efrain] Univ Tecn Machala, Fac Med, Machala, El Oro Province, Ecuador.
   [Borbor-Cordova, Mercy J.] Escuela Super Politecn Litoral ESPOL, Fac Ingn Maritima Ciencias Biol Ocean & Recursos, Guayaquil, Ecuador.
   [Polhemus, Mark E.; Endy, Timothy P.; Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Ryan, Sadie J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA.
   [Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Ryan, Sadie J.] Univ Kwazulu Natal, Coll Life Sci, Durban, South Africa.
   [Endy, Timothy P.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.
RP Stewart-Ibarra, AM (corresponding author), SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA.; Stewart-Ibarra, AM (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
EM stewarta@upstate.edu
RI Ryan, Sadie Jane/H-7488-2019
OI Ryan, Sadie Jane/0000-0002-4308-6321; Borbor, Mercy/0000-0002-7418-141X
FU U.S. Department of Defense Global Emerging Infection Surveillance (GEIS)
   grant [P0220_13_OT]; Department of Medicine of SUNY Upstate Medical
   University; NSF DEB EEID [1518681]; NSF DEB RAPID [1641145]; National
   Secretary of Higher Education, Science, Technology, and Innovation
   (SENESCYT) of Ecuador
FX This study was supported in part by the U.S. Department of Defense
   Global Emerging Infection Surveillance (GEIS) grant (P0220_13_OT) and
   the Department of Medicine of SUNY Upstate Medical University. AMSI and
   SJR were additionally supported by NSF DEB EEID 1518681 and NSF DEB
   RAPID 1641145. Additional support was provided to AMSI through the
   Prometeo program of the National Secretary of Higher Education, Science,
   Technology, and Innovation (SENESCYT) of Ecuador. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Al-Dubai SAR, 2013, SE ASIAN J TROP MED, V44, P37
   Lorono-Pino MA, 2013, AM J TROP MED HYG, V89, P385, DOI 10.4269/ajtmh.12-0772
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Alves AC, 2016, REV SOC BRAS MED TRO, V49, P222, DOI 10.1590/0037-8682-0240-2015
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Arellano C, 2015, FRONT PUBLIC HEALTH, P3
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Chandren JR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003954
   Chanyasanha C, 2015, ASIA-PAC J PUBLIC HE, V27, P96, DOI 10.1177/1010539514545646
   Chen B, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070712
   Demanou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002950
   Dhar-Chowdhury P, 2016, AM J TROP MED HYG, V94, P1223, DOI 10.4269/ajtmh.15-0639
   Dhimal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102028
   Dom NC, 2016, T ROY SOC TROP MED H, V110, P237, DOI 10.1093/trstmh/trw015
   Espinosa M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004621
   Espinosa Manuel O, 2016, Geospat Health, V11, P471, DOI 10.4081/gh.2016.471
   Garcia-Betancourt T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129054
   Garg S, 2017, INT J INFECT DIS, V54, P25, DOI 10.1016/j.ijid.2016.10.030
   Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L
   Handel Andrew S, 2016, Trop Dis Travel Med Vaccines, V2, P8, DOI 10.1186/s40794-016-0024-y
   Heydari N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020196
   Jentes ES, 2016, J TRAVEL MED, P23
   Jiggins FM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002780
   KENDALL C, 1991, MED ANTHROPOL Q, V5, P257, DOI 10.1525/maq.1991.5.3.02a00050
   Kendall C, 1998, HUM ORGAN, V57, P217, DOI 10.17730/humo.57.2.t40528rlr2212mvu
   Khan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147416
   Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x
   MANDERSON L, 1992, HEALTH POLICY PLANN, V7, P46, DOI 10.1093/heapol/7.1.46
   MANDERSON L, 1992, SOC SCI MED, V35, P839, DOI 10.1016/0277-9536(92)90098-B
   Manrique-Saide P, 2013, J AM MOSQUITO CONTR, V29, P337, DOI 10.2987/13-6350.1
   Maoz D, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005651
   Mboera LEG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004313
   Messenger AM, 2014, VECTOR-BORNE ZOONOT, V14, P783, DOI 10.1089/vbz.2014.1665
   Mitchell C., 2016, PAN AM HLTH ORG WORL
   Mitchell-Foster K., 2013, THESIS
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Nading AM, 2017, MED ANTHROPOL, V36, P141, DOI 10.1080/01459740.2016.1186672
   Naing C, 2011, J COMMUN HEALTH, V36, P1044, DOI 10.1007/s10900-011-9407-1
   Ong DQR, 2010, ANN ACAD MED SINGAP, V39, P146
   PAHO, NUMB REP CAS CHIK FE
   Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020
   Paz-Soldan VA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004409
   Paz-Soldan VA, 2015, AM J TROP MED HYG, V93, P1330, DOI 10.4269/ajtmh.15-0096
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Saied KG, 2015, INT HEALTH, V7, P420, DOI 10.1093/inthealth/ihv021
   Samuel M, 2017, PLOS NEGLECT TROP D, V11
   Sayavong C, 2015, J INFECT PUBLIC HEAL, V8, P466, DOI 10.1016/j.jiph.2015.03.005
   Siddiqui TR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005129
   Soghaier MA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1913-0
   Ibarra AMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1135
   Stewart-Ibarra AM, 2017, BIORXIV
   Stewart-Ibarra AM, 2013, PLOS ONE, V8
   Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4
   STONE L, 1984, HUM ORGAN, V43, P27, DOI 10.17730/humo.43.1.6wl5k01724878166
   Suarez MR, 2005, SOC SCI MED, V61, P495, DOI 10.1016/j.socscimed.2004.11.069
   Syed M, 2010, J PAK MED ASSOC, V60, P243
   Thomas SJ, 2015, AM J TROP MED HYG, V93, P24, DOI 10.4269/ajtmh.14-0242
   TRPIS M, 1973, B WORLD HEALTH ORGAN, V48, P623
   Tsuzuki A, 2010, AM J TROP MED HYG, V82, P1157, DOI 10.4269/ajtmh.2010.09-0724
   Tun-Lin W, 2009, TROP MED INT HEALTH, V14, P1143, DOI 10.1111/j.1365-3156.2009.02341.x
   TunLin W, 1995, AM J TROP MED HYG, V53, P591, DOI 10.4269/ajtmh.1995.53.591
   Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5
   VAZQUEZPROKOPEC GM, 2010, PLOS NEGLECT TROP D, V4, P45825
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   WHO, CONTROL STRATEGIES
   WINCH P, 1991, J TROP MED HYG, V94, P377
   Wong LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122890
   Wong LP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002789
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
NR 72
TC 10
Z9 10
U1 3
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2017
VL 11
IS 12
AR e0006150
DI 10.1371/journal.pntd.0006150
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FR5LR
UT WOS:000419108500045
PM 29253873
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ricciardi, MJ
   Magnani, DM
   Grifoni, A
   Kwon, YC
   Gutman, MJ
   Grubaugh, ND
   Gangavarapu, K
   Sharkey, M
   Silveira, CGT
   Bailey, VK
   Pedreno-Lopez, N
   Gonzalez-Nieto, L
   Maxwell, HS
   Domingues, A
   Martins, MA
   Pham, J
   Weiskopf, D
   Altman, J
   Kallas, EG
   Andersen, KG
   Stevenson, M
   Lichtenberger, P
   Choe, H
   Whitehead, SS
   Sette, A
   Watkins, DI
AF Ricciardi, Michael J.
   Magnani, Diogo M.
   Grifoni, Alba
   Kwon, Young-Chan
   Gutman, Martin J.
   Grubaugh, Nathan D.
   Gangavarapu, Karthik
   Sharkey, Mark
   Silveira, Cassia G. T.
   Bailey, Varian K.
   Pedreno-Lopez, Nuria
   Gonzalez-Nieto, Lucas
   Maxwell, Helen S.
   Domingues, Aline
   Martins, Mauricio A.
   Pham, John
   Weiskopf, Daniela
   Altman, John
   Kallas, Esper G.
   Andersen, Kristian G.
   Stevenson, Mario
   Lichtenberger, Paola
   Choe, Hyeryun
   Whitehead, Stephen S.
   Sette, Alessandro
   Watkins, David I.
TI Ontogeny of the B- and T-cell response in a primary Zika virus infection
   of a dengue-naive individual during the 2016 outbreak in Miami, FL
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CROSS-REACTIVITY; STRUCTURAL BASIS; ENHANCEMENT; TRANSMISSION;
   NEUTRALIZATION; RHESUS; REPLICATION; EMERGENCE; MODEL
AB Zika virus (ZIKV) is a mosquito-borne flavivirus of significant public health concern. In the summer of 2016, ZIKV was first detected in the contiguous United States. Here we present one of the first cases of a locally acquired ZIKV infection in a dengue-naive individual. We collected blood from a female with a maculopapular rash at day (D) 5 and D7 post onset of symptoms (POS) and we continued weekly blood draws out to D148 POS. To establish the ontogeny of the immune response against ZIKV, lymphocytes and plasma were analyzed in a longitudinal fashion. The plasmablast response peaked at D7 POS (19.6% of CD19(+) B-cells) and was undetectable by D15 POS. ZIKV-specific IgM was present at D5 POS, peaked between D15 and D21 POS, and subsequently decreased. The ZIKV-specific IgG response, however, was not detected until D15 POS and continued to increase after that. Interestingly, even though the patient had never been infected with dengue virus (DENV), cross-reactive IgM and IgG binding against each of the four DENV serotypes could be detected. The highest plasma neutralization activity against ZIKV peaked between D15 and D21 POS, and even though DENV binding antibodies were present in the plasma of the patient, there was neither neutralization nor antibody dependent enhancement (ADE) of DENV. Interestingly, ADE against ZIKV arose at D48 POS and continued until the end of the study. CD4(+) and CD8(+) T-cells recognized ZIKV-NS2A and ZIKV-E, respectively. The tetramer positive CD8(+) T-cell response peaked at D21 POS with elevated levels persisting for months. In summary, this is the first study to establish the timing of the ontogeny of the immune response against ZIKV.
C1 [Ricciardi, Michael J.; Magnani, Diogo M.; Gutman, Martin J.; Bailey, Varian K.; Pedreno-Lopez, Nuria; Gonzalez-Nieto, Lucas; Maxwell, Helen S.; Domingues, Aline; Martins, Mauricio A.; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
   [Grifoni, Alba; Pham, John; Weiskopf, Daniela; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.
   [Kwon, Young-Chan; Choe, Hyeryun] Scripps Res Inst, Dept Immunol & Microbial Sci, Jupiter, FL USA.
   [Grubaugh, Nathan D.; Gangavarapu, Karthik; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
   [Sharkey, Mark; Stevenson, Mario; Lichtenberger, Paola] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA.
   [Silveira, Cassia G. T.; Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, SP, Brazil.
   [Altman, John] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Altman, John] Emory Univ, Emory Vaccine Res Ctr, Atlanta, GA 30322 USA.
   [Whitehead, Stephen S.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Ricciardi, MJ (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
EM mricciardi@med.miami.edu
RI Whitehead, Stephen/AAG-2787-2019
OI Grubaugh, Nathan/0000-0003-2031-1933; Magnani,
   Diogo/0000-0002-1773-2406; , Alba/0000-0002-2209-5966; Weiskopf,
   Daniela/0000-0003-2968-7371; Martins, Mauricio/0000-0001-8336-216X;
   Kallas, Esper/0000-0003-2026-6925
FU U.S. National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
   [1P01AI094420-05]; University of Miami Clinical Translational Research
   Institute (CTSI); U.S, National Institutes for HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [HHSN27220140045C, 1P01AI106695-01A1, U19AI118626-01]; EUEuropean
   Union (EU) [734584]
FX This work was supported by a grant from the U.S. National Institutes of
   Health supplement to 1P01AI094420-05 awarded to D.I.W., and an internal
   grant from the University of Miami Clinical Translational Research
   Institute (CTSI) [http://www.miamictsi.org]. Additional support was
   provided by the U.S, National Institutes for Health grants
   HHSN27220140045C, 1P01AI106695-01A1, U19AI118626-01, and the EU-grant
   734584 to A.S. The views expressed are those of the authors and not
   necessarily those of the funding bodies. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   [Anonymous], 2016, FLOR INV LINKS 4 REC
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bierlaire D, 2017, TRANSFUSION
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Pro SC, 2015, J IMMUNOL RES, DOI 10.1155/2015/763461
   Case Counts in the US, 2016, THE CENTERS FOR DISE
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Alwis R, 2014, METHODS MOL BIOL, V1138, P27, DOI 10.1007/978-1-4939-0348-1_3
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405
   Fields B., 1990, FIELDS VIROLOGY
   Friberg H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00051
   Grifoni A, J VIROL IN PRESS
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   HALSTEAD SB, 1976, P SOC EXP BIOL MED, V151, P136, DOI 10.3181/00379727-151-39160
   HALSTEAD SB, 1973, NATURE-NEW BIOL, V243, P24
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monaghan AJ, 2016, PLOS CURR, V16, P8
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   MORLAN HB, 1965, AM J TROP MED HYG, V14, P892, DOI 10.4269/ajtmh.1965.14.892
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nguyen TPD, 2010, J IMMUNOL, V184, P7281, DOI 10.4049/jimmunol.0903262
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2017, N ENGL J MED
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Xu MH, 2012, J IMMUNOL, V189, P5877, DOI 10.4049/jimmunol.1201688
   YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 82
TC 19
Z9 19
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2017
VL 11
IS 12
AR e0006000
DI 10.1371/journal.pntd.0006000
PG 23
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FR5LR
UT WOS:000419108500004
PM 29267278
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shan, JY
   Zhao, BB
   Shan, Z
   Nie, J
   Deng, R
   Xiong, R
   Tsun, A
   Pan, WQ
   Zhao, HZ
   Chen, L
   Jin, Y
   Qian, ZK
   Lui, KW
   Liang, R
   Li, D
   Sun, B
   Lavillette, D
   Xu, K
   Li, B
AF Shan, Jiaoyu
   Zhao, Binbin
   Shan, Zhao
   Nie, Jia
   Deng, Rong
   Xiong, Rui
   Tsun, Andy
   Pan, Weiqi
   Zhao, Hanzhi
   Chen, Ling
   Jin, Ying
   Qian, Zhikang
   Lui, Kawing
   Liang, Rui
   Li, Dan
   Sun, Bing
   Lavillette, Dimitri
   Xu, Ke
   Li, Bin
TI Histone demethylase LSD1 restricts influenza A virus infection by
   erasing IFITM3-K88 monomethylation
SO PLOS PATHOGENS
LA English
DT Article
ID INDUCED TRANSMEMBRANE PROTEIN-3; ANTIVIRAL ACTIVITY; CHROMATIN CONTROL;
   ZIKA VIRUS; REPLICATION; INHIBITION; CELLS; ENTRY
AB The histone demethylase LSD1 has been known as a key transcriptional coactivator for DNA viruses such as herpes virus. Inhibition of LSD1 was found to block viral genome transcription and lytic replication of DNA viruses. However, RNA virus genomes do not rely on chromatin structure and histone association, and the role of demethylase activity of LSD1 in RNA virus infections is not anticipated. Here, we identify that, contrary to its role in enhancing DNA virus replication, LSD1 limits RNA virus replication by demethylating and activating IFITM3 which is a host restriction factor for many RNA viruses. We have found that LSD1 is recruited to demethylate IFITM3 at position K88 under IFNa treatment. However, infection by either Vesicular Stomatitis Virus (VSV) or Influenza A Virus (IAV) triggers methylation of IFITM3 by promoting its disassociation from LSD1. Accordingly, inhibition of the enzymatic activity of LSD1 by Trans-2-phenylcyclopropylamine hydrochloride (TCP) increases IFITM3 monomethylation which leads to more severe disease outcomes in IAV-infected mice. In summary, our findings highlight the opposite role of LSD1 in fighting RNA viruses comparing to DNA viruses infection. Our data suggest that the demethylation of IFITM3 by LSD1 is beneficial for the host to fight against RNA virus infection.
C1 [Shan, Jiaoyu; Zhao, Binbin; Shan, Zhao; Nie, Jia; Deng, Rong; Tsun, Andy; Lui, Kawing; Liang, Rui; Xu, Ke; Li, Bin] Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, CAS Key Lab Mol Virol & Immunol, Unit Mol Immunol,Inst Pasteur Shanghai,Shanghai I, Shanghai, Peoples R China.
   [Shan, Jiaoyu] Xinjiang Med Univ, Human Parasitol Dept, Basic Med Coll, Urumqi, Peoples R China.
   [Zhao, Binbin; Liang, Rui; Li, Dan; Li, Bin] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai, Peoples R China.
   [Zhao, Binbin; Liang, Rui; Li, Dan; Li, Bin] Shanghai Jiao Tong Univ, Dept Immunol & Microbiol, Sch Med, Shanghai, Peoples R China.
   [Xiong, Rui; Lavillette, Dimitri; Xu, Ke] Chinese Acad Sci, CAS Key Lab Mol Virol & Immunol, Unit Interspecies Transmiss Arboviruses & Therape, Inst Pasteur Shanghai,Shanghai Inst Biol Sci, Shanghai, Peoples R China.
   [Pan, Weiqi; Chen, Ling] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.
   [Zhao, Hanzhi; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci,Inst Hlth Sci,Shanghai Inst Biol, CAS Ctr Excellence Mol Cell Sci,Key Lab Stem Cell, Shanghai, Peoples R China.
   [Qian, Zhikang] Chinese Acad Sci, CAS Key Lab Mol Virol & Immunol, Unit Herpesvirus & Mol Virol Res, Inst Pasteur Shanghai,Shanghai Inst Biol Sci, Shanghai, Peoples R China.
   [Sun, Bing] Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, CAS Key Lab Mol Virol & Immunol, Unit Mol Virol,Inst Pasteur Shanghai,Shanghai Ins, Shanghai, Peoples R China.
RP Xu, K; Li, B (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, CAS Key Lab Mol Virol & Immunol, Unit Mol Immunol,Inst Pasteur Shanghai,Shanghai I, Shanghai, Peoples R China.; Li, B (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai, Peoples R China.; Li, B (corresponding author), Shanghai Jiao Tong Univ, Dept Immunol & Microbiol, Sch Med, Shanghai, Peoples R China.; Xu, K (corresponding author), Chinese Acad Sci, CAS Key Lab Mol Virol & Immunol, Unit Interspecies Transmiss Arboviruses & Therape, Inst Pasteur Shanghai,Shanghai Inst Biol Sci, Shanghai, Peoples R China.
EM kxu@sibs.ac.cn; binli@shsmu.edu.cn
OI Lavillette, Dimitri/0000-0002-4706-1519
FU National Science Foundation for Distinguished Young ScholarsNational
   Natural Science Foundation of ChinaNational Science Fund for
   Distinguished Young Scholars [31525008]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [81590766, 81330072, 81360250, 31500714, 31370863, 81772202, 31570171];
   Chinese National Program on Key Basic Research Project Grants
   [2014CB541803, 2014CB541903]; National Key Research and Development
   Program of China [2016YFC1200403]; Rising Star Talent Program from the
   Science and Technology Commission of Shanghai Municipality
   [15QA1404000]; Youth Innovation Promotion Association CAS; 100 Talent
   from CAS; 1000 Talent from Science and Technology Commission of Shanghai
   Municipality;  [16XD1403800]
FX Our research is supported by National Science Foundation for
   Distinguished Young
   Scholars(http://www.nsfc.gov.cn/publish/portal1/tab158/info39460.htm)
   31525008; National Natural Science Foundation of China
   (http://www.nsfc.gov.cn/publish/portal1/tab158/info39460.htm); 81590766,
   81330072, 81360250, 31500714, 31370863, 81772202, 31570171; Chinese
   National Program on Key Basic Research Project Grants
   (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm)
   2014CB541803 and 2014CB541903; The National Key Research and Development
   Program of China (http://www.most.gov.cn/eng/) 2016YFC1200403; Shanghai
   Academic Research Leader (http://www.stcsm.gov.cn/english/) 16XD1403800;
   Rising Star Talent Program from the Science and Technology Commission of
   Shanghai Municipality (http://www.stcsm.gov.cn/english/) 15QA1404000 and
   the Youth Innovation Promotion Association CAS (http://www.yicas.cn/),
   and the 100 Talent from CAS (http://www.cas.ac.cn/) and 1000 Talent from
   Science and Technology Commission of Shanghai Municipality to DL
   (http://www.1000plan.org/qrjh/section/2). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alarcon V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25901
   Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537
   Bailey CC, 2013, J BIOL CHEM, V288, P32184, DOI 10.1074/jbc.M113.514356
   Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909
   Boritz E, 1999, J VIROL, V73, P6937, DOI 10.1128/JVI.73.8.6937-6945.1999
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Chesarino NM, 2014, FUTURE MICROBIOL, V9, P1151, DOI [10.2217/FMB.14.65, 10.2217/fmb.14.65]
   Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344
   Erich H, 2007, DNA TRANSFECTION SYS
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Hill J.M., 2014, FRONT AGING NEUROSCI, V6, P1, DOI DOI 10.1126/SCITRANSLMED.3010643
   John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13
   Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014
   Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794
   Knipe DM, 2013, VIROLOGY, V435, P141, DOI 10.1016/j.virol.2012.09.023
   Lange UC, ELECTRONIC, P1098
   Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124
   Liang Y, 2013, MBIO, V4, DOI 10.1128/mBio.00558-12
   Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051
   Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024
   Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Shan Z, 2013, J BIOL CHEM, V288, P35093, DOI 10.1074/jbc.M113.511949
   Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112
   Smith SE, 2014, CURR OPIN VIROL, V4, P71, DOI 10.1016/j.coviro.2013.11.004
   Xie MR, 2015, J VIROL, V89, P3049, DOI 10.1128/JVI.03416-14
   Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]
   Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4
   Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433
   Zhou Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.195
NR 34
TC 6
Z9 7
U1 3
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD DEC
PY 2017
VL 13
IS 12
AR e1006773
DI 10.1371/journal.ppat.1006773
PG 22
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FR4EZ
UT WOS:000419019800025
PM 29281729
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bernstein, K
   Bowen, VB
   Kim, CR
   Counotte, MJ
   Kirkcaldy, RD
   Karat, E
   Bolan, G
   Low, N
   Broutet, N
AF Bernstein, Kyle
   Bowen, Virginia B.
   Kim, Caron R.
   Counotte, Michel J.
   Kirkcaldy, Robert D.
   Karat, Edna
   Bolan, Gail
   Low, Nicola
   Broutet, Nathalie
TI Re-emerging and newly recognized sexually transmitted infections: Can
   prior experiences shed light on future identification and control?
SO PLOS MEDICINE
LA English
DT Article
ID RESISTANT SHIGELLA-SONNEI; EBOLA-VIRUS RNA; ZIKA VIRUS;
   NEISSERIA-MENINGITIDIS; UNITED-STATES; VENEREAL TRANSMISSION; ENTERIC
   PATHOGENS; HOMOSEXUAL MEN; YORK-CITY; SEX
C1 [Bernstein, Kyle; Bowen, Virginia B.; Kirkcaldy, Robert D.; Bolan, Gail] Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA 30333 USA.
   [Kim, Caron R.; Karat, Edna; Broutet, Nathalie] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Counotte, Michel J.; Low, Nicola] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
RP Bernstein, K (corresponding author), Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA 30333 USA.
EM kio8@cdc.gov
RI Counotte, Michel Jacques/K-6735-2019
OI Counotte, Michel Jacques/0000-0003-1039-6873; Bernstein,
   Kyle/0000-0001-8455-899X; Bowen, Virginia/0000-0001-7379-8621
FU SNSFSwiss National Science Foundation (SNSF); WHOWorld Health
   Organization; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF) [320030_170069, 320030_176233]; World Health
   OrganizationWorld Health Organization [2017/733494-0]
FX MJC received salary support from SNSF and WHO. Grants were received from
   the Swiss National Science Foundation (www.snf.ch, project grants
   320030_170069 and 320030_176233) and World Health Organization
   (www.who.int, contract number 2017/733494-0). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Aragon TJ, 2007, CLIN INFECT DIS, V44, P327, DOI 10.1086/510593
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Aubert L, 2015, EURO SURVEILL, V20
   BADER M, 1977, SEX TRANSM DIS, V4, P89, DOI 10.1097/00007435-197707000-00003
   Baker KS, 2015, LANCET INFECT DIS, V15, P913, DOI 10.1016/S1473-3099(15)00002-X
   Barre-Sinoussi F, 2004, REV INVEST CLIN, V56, P126
   Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545
   Bowen A., 2016, SHIGELLOSIS 2016
   Bowen A, 2015, MMWR-MORBID MORTAL W, V64, P318
   BROWN WJ, 1973, BRIT J VENER DIS, V49, P88
   Carpenter CM, 1942, AM J PUBLIC HEALTH N, V32, P640, DOI 10.2105/AJPH.32.6.640
   [CDC] Centers for Disease Control and Prevention. FoodNet Fast, 2017, FOODNET FAST
   Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P250
   Chiou CS, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.12.021
   Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479
   Deen GF, 2015, NEW ENGLAND J MED
   DRITZ SK, 1974, NEW ENGL J MED, V291, P1194
   Euopean Center for Disease Control, 2013, INV MEN DIS MEN WHO
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gaudreau C, 2014, EMERG INFECT DIS, V20, P854, DOI 10.3201/eid2005.130966
   Gaudreau C, 2011, EMERG INFECT DIS, V17, P1747, DOI 10.3201/eid1709.102034
   Gilbart VL, 2015, SEX TRANSM INFECT, V91, P598, DOI 10.1136/sextrans-2015-052014
   Heiman KE, 2014, MMWR-MORBID MORTAL W, V63, P132
   JANDA WM, 1980, JAMA-J AM MED ASSOC, V244, P2060, DOI 10.1001/jama.244.18.2060
   Kamiya H, 2015, MMWR-MORBID MORTAL W, V64, P1256, DOI 10.15585/mmwr.mm6444a6
   Kratz MM, 2015, EMERG INFECT DIS, V21, P1379, DOI 10.3201/eid2108.141837
   Lane CR, 2016, CLIN INFECT DIS, V62, P722, DOI 10.1093/cid/civ1018
   Marcus U, 2013, EURO SURVEILL, V18
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   MILDVAN D, 1977, JAMA-J AM MED ASSOC, V238, P1387, DOI 10.1001/jama.238.13.1387
   Mook P, 2016, EMERG INFECT DIS, V22, P1948, DOI 10.3201/eid2211.160653
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   MOST H, 1968, AM J TROP MED HYG, V17, P333, DOI 10.4269/ajtmh.1968.17.333
   Nanduri S, 2016, MMWR-MORBID MORTAL W, V65, P939, DOI 10.15585/mmwr.mm6535e1
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Paz-Bailey G, 2017, NEW ENGLAND J MED
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246
   Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318
   SALIT IE, 1982, CAN MED ASSOC J, V126, P38
   SCHMERIN MJ, 1977, JAMA-J AM MED ASSOC, V238, P1386, DOI 10.1001/jama.238.13.1386
   Simms I, 2015, EURO SURVEILL, V20
   Sissoko D, 2017, LANCET GLOB HEALTH, V5, pE80, DOI 10.1016/S2214-109X(16)30243-1
   Soka MJ, 2016, LANCET GLOB HEALTH, V4, pE736, DOI 10.1016/S2214-109X(16)30175-9
   Taha MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154047
   TALBOT MD, 1981, J INFECTION, V3, P273, DOI 10.1016/S0163-4453(81)90957-9
   TAUXE RV, 1988, AM J PUBLIC HEALTH, V78, P1432, DOI 10.2105/AJPH.78.11.1432
   Thorson A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008859
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   TULLY JG, 1981, LANCET, V1, P1288
   Vetter Pauline, 2016, Lancet Infect Dis, V16, pe82, DOI 10.1016/S1473-3099(16)00077-3
   WILLIAM DC, 1977, NEW YORK STATE J MED, V77, P2050
   WILSON APR, 1989, GENITOURIN MED, V65, P122
   World Health Organization, 2017, WHO SEX TRANSM INF S
   World Health Organization, 2016, R D BLUEPR ACT PREV
   World Health Organization, 2017, EB OUTBR 2014 2015
   World Health Organization, 2017, EM HIST ZIK VIR
   World Health Organization, 2017, SIT REP ZIK VIR
   World Health Organization, 2016, CLIN CAR SURV EB VIR
NR 61
TC 2
Z9 2
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1676
J9 PLOS MED
JI PLos Med.
PD DEC
PY 2017
VL 14
IS 12
AR e1002474
DI 10.1371/journal.pmed.1002474
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA FR3DO
UT WOS:000418946400011
PM 29281630
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Martins, A
   Martins, I
   Faustino, A
   Nascimento, A
   Carvalho, F
   Santos, N
AF Martins, Ana
   Martins, Ivo
   Faustino, Andre
   Nascimento, Andre
   Carvalho, Filomena
   Santos, Nuno
TI Understanding the structure and function of the capsid protein of Zika,
   West-Nile and Dengue viruses, namely their ability to interact with host
   lipid systems
SO PROTEIN SCIENCE
LA English
DT Meeting Abstract
CT 31st Annual Symposium of the Protein-Society
CY JUL 24-27, 2017
CL Montreal, CANADA
C1 [Martins, Ana; Martins, Ivo; Faustino, Andre; Nascimento, Andre; Carvalho, Filomena; Santos, Nuno] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.
NR 0
TC 1
Z9 1
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0961-8368
EI 1469-896X
J9 PROTEIN SCI
JI Protein Sci.
PD DEC
PY 2017
VL 26
SU 1
SI SI
MA POS278
BP 150
EP 150
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FR0ZY
UT WOS:000418795900301
DA 2020-07-08
ER

PT J
AU Chow, FC
AF Chow, Felicia C.
TI Sex Matters in Neuroinfectious Diseases
SO SEMINARS IN NEUROLOGY
LA English
DT Review
DE sex differences; women's health; HIV infection; stroke; zika virus
ID HUMAN-IMMUNODEFICIENCY-VIRUS; INACTIVATED INFLUENZA VACCINE; SUPPRESSIVE
   ANTIRETROVIRAL THERAPY; CORONARY ATHEROSCLEROTIC PLAQUE;
   POPULATION-BASED COHORT; HIV-INFECTED PATIENTS; ZIKA VIRUS;
   IMMUNE-RESPONSES; GENDER-DIFFERENCES; ISCHEMIC-STROKE
AB Although sex and gender have a major impact on the susceptibility and immunologic response to infectious diseases, these factors are often neglected. Identifying the mechanisms underlying sex-based differences in infectious diseases will facilitate the rational design and implementation of preventive and therapeutic strategies that reduce risk and improve outcomes for women and men. In this article, we discuss two examples in neuroinfectious diseases of how sex matters: (1) the heightened risk of cerebrovascular disease in women living with HIV infection and (2) the implications of Zika virus infection on sexual and reproductive health and vaccine development for women.
C1 [Chow, Felicia C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA.
   [Chow, Felicia C.] Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA.
RP Chow, FC (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Neurol, 1001 Potrero Ave,Box 0870, San Francisco, CA 94110 USA.; Chow, FC (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Div Infect Dis, 1001 Potrero Ave,Box 0870, San Francisco, CA 94110 USA.
EM felicia.chow@ucsf.edu
OI Chow, Felicia/0000-0001-9440-9349
FU NIH/NCATSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [KL2TR000143]
FX This work was supported by NIH/NCATS KL2TR000143.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Agarwal A, 2017, J NEUROVIROL, V23, P504, DOI 10.1007/s13365-017-0516-1
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Baker JV, 2014, AIDS, V28, P831, DOI 10.1097/QAD.0000000000000145
   Barbour JD, 2014, ATHEROSCLEROSIS, V232, P52, DOI 10.1016/j.atherosclerosis.2013.10.021
   Baynam G, 2008, VACCINE, V26, P3574, DOI 10.1016/j.vaccine.2008.05.011
   Beigi RH, 2017, OBSTET GYNECOL, V129, P896, DOI [10.1097/AOG.0000000000001978, 10.1097/aog.0000000000001978]
   Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088
   Bernin H, 2014, J INFECT DIS, V209, pS107, DOI 10.1093/infdis/jit610
   Beyer WEP, 1996, EUR J CLIN MICROBIOL, V15, P65, DOI 10.1007/BF01586187
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Borges AH, 2016, J INFECT DIS, V214, P408, DOI 10.1093/infdis/jiw173
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chow F C, 2016, C RETR OPP INF FEBR
   Chow FC, 2018, AIDS, V32, P59, DOI [10.1097/QAD.0000000000001650, 10.1097/qad.0000000000001650]
   Chow FC, 2017, J STROKE CEREBROVASC, V26, P1154, DOI 10.1016/j.jstrokecerebrovasdis.2017.02.010
   Chow FC, 2014, NEUROLOGY, V83, P1705, DOI 10.1212/WNL.0000000000000958
   Chow FC, 2012, JAIDS-J ACQ IMM DEF, V60, P351, DOI 10.1097/QAI.0b013e31825c7f24
   Cioffi M, 2002, MATURITAS, V41, P187, DOI 10.1016/S0378-5122(01)00286-9
   Cook IF, 2007, VACCINE, V25, P4767, DOI 10.1016/j.vaccine.2007.04.017
   Cook IF, 2008, VACCINE, V26, P3551, DOI 10.1016/j.vaccine.2008.04.054
   Cook IF, 2006, VACCINE, V24, P2395, DOI 10.1016/j.vaccine.2005.11.057
   Corral I, 2009, CEREBROVASC DIS, V27, P559, DOI 10.1159/000214219
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Curno MJ, 2016, JAIDS-J ACQ IMM DEF, V71, P181, DOI 10.1097/QAI.0000000000000842
   Cuzin L, 2015, AIDS, V29, P1665, DOI 10.1097/QAD.0000000000000723
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454
   Durand M, 2013, J STROKE CEREBROVASC, V22, pE34, DOI 10.1016/j.jstrokecerebrovasdis.2012.03.014
   Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513
   Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1
   Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394
   Fitch KV, 2013, J INFECT DIS, V208, P1737, DOI 10.1093/infdis/jit508
   Forster A, 2009, STROKE, V40, P2428, DOI 10.1161/STROKEAHA.109.548750
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Frisancho-Kiss S, 2006, BRAIN RES, V1126, P139, DOI 10.1016/j.brainres.2006.08.003
   Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946
   Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249
   Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326
   Goldthwaite LM, 2016, CURR OPIN OBSTET GYN, V28, P499, DOI 10.1097/GCO.0000000000000323
   Greenblatt RM, 2000, J INFECT DIS, V181, P82, DOI 10.1086/315207
   Griesbeck M, 2016, CLIN SCI, V130, P1435, DOI 10.1042/CS20160112
   Grinsztejn B, 2011, ANTIVIR THER, V16, P1057, DOI 10.3851/IMP1872
   Grund B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155100
   Harkonen PL, 2006, ANN NY ACAD SCI, V1089, P218, DOI 10.1196/annals.1386.045
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Justice AC, 2008, CLIN INFECT DIS, V47, P1226, DOI 10.1086/592302
   Kanapathipillai R, 2013, MENOPAUSE, V20, P983, DOI [10.1097/gme.0b013e318282aa57, 10.1097/GME.0b013e318282aa57]
   Karim R, 2013, J CLIN ENDOCR METAB, V98, pE610, DOI 10.1210/jc.2012-3195
   Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90
   Klein SL, 2014, J INFECT DIS, V209, pS114, DOI 10.1093/infdis/jiu066
   Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9
   Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5
   Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f
   Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lindsey NP, 2008, VACCINE, V26, P6077, DOI 10.1016/j.vaccine.2008.09.009
   Looby SE, 2016, AIDS, V30, P383, DOI 10.1097/QAD.0000000000000902
   Loupa CV, 2006, CLIN MICROBIOL INFEC, V12, P389, DOI 10.1111/j.1469-0691.2006.01368.x
   Marcus JL, 2014, AIDS, V28, P1911, DOI 10.1097/QAD.0000000000000352
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Martin GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055279
   Meditz AL, 2011, J INFECT DIS, V203, P442, DOI 10.1093/infdis/jiq085
   Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004
   Moniz MH, 2016, OBSTET GYNECOL SURV, V71, P178, DOI 10.1097/OGX.0000000000000283
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152
   Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nhamoyebonde S, 2014, J INFECT DIS, V209, pS100, DOI 10.1093/infdis/jiu147
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Omer SB, 2016, JAMA-J AM MED ASSOC, V315, P1227, DOI 10.1001/jama.2016.2237
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petty GW, 1999, STROKE, V30, P2513, DOI 10.1161/01.STR.30.12.2513
   Poland GA, 2008, EXPERT OPIN BIOL TH, V8, P1659, DOI [10.1517/14712598.8.11.1659, 10.1517/14712598.8.11.1659 ]
   Rasmussen LD, 2011, AIDS, V25, P1637, DOI 10.1097/QAD.0b013e3283493fb0
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019
   Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844
   Sico JJ, 2015, NEUROLOGY, V84, P1933, DOI 10.1212/WNL.0000000000001560
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003
   Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719
   Thomas SJ, 2017, NEW ENGL J MED, V376, P1883, DOI 10.1056/NEJMcibr1701402
   Tirschwell D, 2017, 69 ANN AM AC NEUR M
   Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van Lunzen J, 2014, J INFECT DIS, V209, pS79, DOI 10.1093/infdis/jiu159
   Vinikoor MJ, 2013, AIDS RES HUM RETROV, V29, P1068, DOI [10.1089/aid.2012.0334, 10.1089/AID.2012.0334]
   Yasui T, 2007, MATURITAS, V56, P396, DOI 10.1016/j.maturitas.2006.11.002
NR 111
TC 0
Z9 0
U1 0
U2 3
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0271-8235
EI 1098-9021
J9 SEMIN NEUROL
JI Semin. Neurol.
PD DEC
PY 2017
VL 37
IS 6
BP 694
EP 704
DI 10.1055/s-0037-1607397
PG 11
WC Clinical Neurology
SC Neurosciences & Neurology
GA FR0ED
UT WOS:000418733000013
PM 29270943
DA 2020-07-08
ER

PT J
AU Royle, J
   Donald, CL
   Merits, A
   Kohl, A
   Varjak, M
AF Royle, Jamie
   Donald, Claire L.
   Merits, Andres
   Kohl, Alain
   Varjak, Margus
TI Differential effects of lipid biosynthesis inhibitors on Zika and
   Semliki Forest viruses
SO VETERINARY JOURNAL
LA English
DT Article
DE Zika virus; Semliki Forest virus; Lipid biosynthesis; Antiviral agent
ID FATTY-ACID SYNTHASE; INFECTION; DENGUE
AB The recent outbreak of infection with Zika virus (ZIKV; Flaviviridae) has attracted attention to this previously neglected mosquito-borne pathogen and the need for efficient therapies. Since flavivirus replication is generally known to be dependent on fatty acid biosynthesis, two inhibitors of this pathway, 5-(tetradecyloxyl)-2-furoic acid (TOFA) and cerulenin, were tested for their potentiality to inhibit virus replication. At concentrations previously shown to inhibit the replication of other flaviviruses, neither drug had a significant antiviral affect against ZIKV, but reduced the replication of the non-related mosquito-borne Semliki Forest virus (Togaviridae). (C) 2017 The Authors. Published by Elsevier Ltd.
C1 [Royle, Jamie; Donald, Claire L.; Kohl, Alain; Varjak, Margus] Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland.
   [Merits, Andres] Univ Tartu, Inst Technol, Nooruse 1, EE-50411 Tartu, Estonia.
RP Varjak, M (corresponding author), Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland.
EM margus.varjak@glasgow.ac.uk
RI Royle, Jamie/AAQ-4241-2020; Donald, Claire/AAC-7556-2019; Merits,
   Andres/H-3125-2015
OI Royle, Jamie/0000-0002-5227-4105; Donald, Claire/0000-0002-4370-0707;
   Merits, Andres/0000-0001-8193-0071; Varjak, Margus/0000-0003-2608-5148
FU UK Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014, MR/N017552/1]
FX This work was funded by UK Medical Research Council (MC_UU_12014,
   MR/N017552/1) (AK).
CR Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Karlas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11320
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508
NR 8
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-0233
EI 1532-2971
J9 VET J
JI Vet. J.
PD DEC
PY 2017
VL 230
BP 62
EP 64
DI 10.1016/j.tvjl.2017.10.009
PG 3
WC Veterinary Sciences
SC Veterinary Sciences
GA FR3OL
UT WOS:000418975900011
PM 29102599
OA Green Published, Other Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Hidalgo, J
   Richards, GA
   Jimenez, JIS
   Baker, T
   Amin, P
AF Hidalgo, Jorge
   Richards, Guy A.
   Silesky Jimenez, Juan Ignacio
   Baker, Tim
   Amin, Pravin
TI Viral hemorrhagic fever in the tropics: Report from the task force on
   tropical diseases by the World Federation of Societies of Intensive and
   Critical Care Medicine
SO JOURNAL OF CRITICAL CARE
LA English
DT Article
DE Viral hemorrhagic fevers (VHF); Zika; Dengue; Hantavirus; Yellow fever;
   Lassa fever; Rift Valley fever; Crimean-Congo hemorrhagic fever;
   Hantavirus; Kyasanur Forest disease; Marburgvirus and Ebolavirus
ID KYASANUR-FOREST-DISEASE; RIFT-VALLEY FEVER; REVERSE TRANSCRIPTION-PCR;
   WEST NILE VIRUS; EBOLA-VIRUS; DENGUE VIRUS; RISK-FACTORS; LASSA-VIRUS;
   INFECTIONS; RIBAVIRIN
AB Viral hemorrhagic fevers (VHFs) are a group of illnesses caused by four families of viruses namely Arenaviruses, Filoviruses, Bunyaviruses, and Flaviviruses. Humans are not the natural reservoir for any of these organisms and acquire the disease through vectors from animal reservoirs. In some conditions human to human transmission is possible increasing the risk to healthy individuals in the vicinity, more so to Health Care Workers (HCW). The pathogenesis of VHF, though poorly understood, varies according to the viruses involved. The resultant microvascular damage leads to increased vascular permeability, organ dysfunction and even death. The management is generally supportive but antiviral agents are of benefit in certain circumstances. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Hidalgo, Jorge] Belize Healthcare Partners Belize, Karl Heusner Mem Hosp, Div Crit Care, Belize City, Belize.
   [Richards, Guy A.] Univ Witwatersrand, Charlotte Maxeke Hosp, Div Crit Care, Johannesburg, South Africa.
   [Richards, Guy A.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa.
   [Silesky Jimenez, Juan Ignacio] Hosp San Juan Dios, Crit Care Unit, San Jose, Costa Rica.
   [Silesky Jimenez, Juan Ignacio] Hosp CIMA, San Jose, Costa Rica.
   [Baker, Tim] Queen Elizabeth Cent Hosp, Dept Anaesthesia & Intens Care, Blantyre, Malawi.
   [Baker, Tim] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth Hlth Syst & Policy, Stockholm, Sweden.
   [Amin, Pravin] Bombay Hosp & Med Res Ctr, Inst Med Sci, Dept Crit Care Med, Bombay, Maharashtra, India.
RP Amin, P (corresponding author), 12 New Marine Lines,C113,1st Floor, Bombay 400020, Maharashtra, India.
EM pamin@vsnl.com
CR Al-Hazmi M, 2003, CLIN INFECT DIS, V36, P245, DOI 10.1086/345671
   [Anonymous], 2014, CHRON MARB HEM FEV O
   Barrette RW, 2011, INFECT GENET EVOL, V11, P1514, DOI 10.1016/j.meegid.2011.06.017
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blow JA, 2004, J VIROL METHODS, V119, P195, DOI 10.1016/j.jviromet.2004.03.015
   Celikbas AK, 2014, EMERG INFECT DIS, V20, P477, DOI 10.3201/eid2003.131353
   Center for Disease Control and Prevention (CDC), 2015, GUID PERS PROT EQ PP
   Charrel RN, 2003, ANTIVIR RES, V57, P89, DOI 10.1016/S0166-3542(02)00202-4
   Cikman A, 2016, VECTOR-BORNE ZOONOT, V16, P199, DOI 10.1089/vbz.2015.1879
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Enria DA, 2000, INFECT DIS CLIN N AM, V14, P167, DOI 10.1016/S0891-5520(05)70223-3
   Ergonul O, 2006, CLIN MICROBIOL INFEC, V12, P551, DOI 10.1111/j.1469-0691.2006.01445.x
   Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2
   Ergonul O, 2014, INT J INFECT DIS, V29, P296, DOI 10.1016/j.ijid.2014.08.016
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   Evans A, 2008, EPIDEMIOL INFECT, V136, P1261, DOI 10.1017/S0950268807009806
   Ghosh S, 2014, J VECTOR DIS, V51, P259
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Groseth A, 2007, TRENDS MICROBIOL, V15, P408, DOI 10.1016/j.tim.2007.08.001
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Hayden FG, 2017, J INFECT DIS, V215, P167, DOI 10.1093/infdis/jiw496
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Holbrook MR, 2012, ANTIVIR RES, V96, P353, DOI 10.1016/j.antiviral.2012.10.005
   Hunt L, 2015, LANCET INFECT DIS, V15, P1292, DOI 10.1016/S1473-3099(15)00144-9
   Ibekwe Titus S, 2012, Niger Med J, V53, P196, DOI 10.4103/0300-1652.107552
   Jeffs B, 2006, TROP DOCT, V36, P1, DOI 10.1258/004947506775598914
   Jentes ES, 2010, AM J TROP MED HYG, V83, P388, DOI 10.4269/ajtmh.2010.09-0688
   Kilgore PE, 1997, CLIN INFECT DIS, V24, P718, DOI 10.1093/clind/24.4.718
   Kilinc C, 2016, J VECTOR DIS, V53, P162
   Leblebicioglu H, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.11.024
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Leski TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006569
   MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104
   Meltzer E, 2012, INFECT DIS CLIN N AM, V26, P479, DOI 10.1016/j.idc.2012.02.003
   Mourya DT, 2016, INDIAN J MED RES, V144, P633, DOI 10.4103/0971-5916.200892
   Papa A, 2011, J MED VIROL, V83, P1861, DOI 10.1002/jmv.22180
   Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347
   PAVRI K, 1989, REV INFECT DIS, V11, pS854
   Petersen LR, 2008, MED CLIN N AM, V92, P1307, DOI 10.1016/j.mcna.2008.07.004
   Racsa LD, 2016, CLIN INFECT DIS, V62, P214, DOI 10.1093/cid/civ792
   Rougeron V, 2015, J CLIN VIROL, V64, P111, DOI 10.1016/j.jcv.2015.01.014
   Sprung CL, 2010, INTENS CARE MED, V36, P428, DOI 10.1007/s00134-010-1759-y
   Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764
   Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004
   Wernly JA, 2011, EUR J CARDIO-THORAC, V40, P1334, DOI 10.1016/j.ejcts.2011.01.089
   Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001
   World Health Organization, 2017, LASS FEV FACT SHEET
   World Health Organization, 2014, LAB DIAGN EB VIR DIS
   World Health Organization (WHO), 2015, HLTH WORK EB INF GUI
   Zaki SR, 1999, J INFECT DIS, V179, pS36, DOI 10.1086/514319
   Zumla A, 2012, INFECT DIS CLIN N AM, V26, P195, DOI 10.1016/j.idc.2012.02.007
NR 51
TC 8
Z9 8
U1 0
U2 16
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0883-9441
EI 1557-8615
J9 J CRIT CARE
JI J. Crit. Care
PD DEC
PY 2017
VL 42
BP 366
EP 372
DI 10.1016/j.jcrc.2017.11.006
PG 7
WC Critical Care Medicine
SC General & Internal Medicine
GA FQ7CN
UT WOS:000418520500071
PM 29128377
DA 2020-07-08
ER

PT J
AU Okuneye, KO
   Velasco-Hernandez, JX
   Gumel, AB
AF Okuneye, Kamaldeen O.
   Velasco-Hernandez, Jorge X.
   Gumel, Abba B.
TI THE "UNHOLY" CHIKUNGUNYA-DENGUE-ZIKA TRINITY: A THEORETICAL ANALYSIS
SO JOURNAL OF BIOLOGICAL SYSTEMS
LA English
DT Article
DE Chikungunya; Dengue; Zika Virus; Stability; Aedes Aegypti; Reproduction
   Number; Sensitivity Analysis; Persistence
ID AEDES-AEGYPTI; MATHEMATICAL-ANALYSIS; VIRUS TRANSMISSION; MODEL;
   TEMPERATURE; VECTOR; UNCERTAINTY; SENSITIVITY; POPULATION; EVOLUTION
AB Aedes aegypti is the vector for numerous diseases in humans and other (reservoir) hosts, such as chikungunya, dengue fever and Zika virus. A new deterministic model is designed and used to assess the dynamics of the three diseases in a population where Aedes mosquitoes are abundant. The model to be designed incorporates the recently-released imperfect vaccine against dengue virus (Dengvaxia (R) vaccine by Sanofi Pasteur) as well as allow for sexual transmission of Zika. Further, the model allows for the assessment of the population-level impact of three biological hypotheses, namely a competitive dengue-chikungunya-Zika superinfection hierarchy, an antibody-dependent enhancement of dengue over Zika and that the Dengvaxia vaccine can induce reduced susceptibility to Zika infection in vaccinated individuals. After carrying out detailed theoretical analyses to gain insight into its qualitative features, the model is then fitted to the data recorded during the 2015-2016 outbreaks of the three diseases in Mexico. Simulations of the model show a reasonable fit to observed dynamics consistent with the competitive hierarchy assumed for the interactions of the viruses. Furthermore, Zika transmission dynamics is only mildly affected by changes in the parameter related to the infectiousness of Zika in relation to dengue, even in the region where antibody-dependent enhancement is assumed. The dengue vaccine has a very marginal impact on Zika transmission dynamics (and that the vaccine, no matter the coverage and efficacy levels, is unable to reduce the reproduction number for Zika transmission to a value less than unity). The model is extended to include the effect of seasonality and local weather variability (temperature and rainfall) on the dynamics of the three diseases. Simulations of the resulting non-autonomous model, using weather and demographic data for Mexico, show that for the current mean monthly rainfall value for Mexico, the burden of the three diseases increases with increasing mean monthly temperature in the range 16-29 degrees C, and decreases with increasing mean monthly temperature thereafter. Additionally, for the current fixed mean monthly temperature and rainfall data for Mexico, simulations show maximum transmission activity of all three diseases if the temperature and rainfall values lie in the range 25-26.4. degrees C and 90-128mm, respectively (these values are typically recorded in Mexico during the months of June, July and September). Simulations for two Mexican states (Oaxaca and Chiapas) where the three diseases are endemic show maximum transmission activity for all three diseases when temperature and rainfall lie in the ranges 20-25 degrees C and 51-102mm for Oaxaca (these ranges are recorded during the months of May through September) and 19-21 degrees C and 85-107mm for Chiapas (there ranges are recorded during the months of May, July, August and October), respectively. These simulations suggest suitable time when anti-mosquito control efforts should be intensified in Mexico (and the two selected states).
C1 [Okuneye, Kamaldeen O.; Gumel, Abba B.] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ 85287 USA.
   [Velasco-Hernandez, Jorge X.] UNAM Juriquilla, Inst Matemat, Queretaro 76230, Mexico.
RP Gumel, AB (corresponding author), Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ 85287 USA.
EM agumel@asu.edu
RI Velasco-Hernandez, Jorge/A-5391-2008
OI Velasco-Hernandez, Jorge/0000-0002-5604-7719; Gumel,
   Abba/0000-0002-8413-1248
FU National Institute for Mathematical and Biological Synthesis
   (NIMBioS)National Science Foundation (NSF)NSF - Directorate for
   Biological Sciences (BIO); National Science FoundationNational Science
   Foundation (NSF); U.S. Department of Homeland SecurityUnited States
   Department of Homeland Security (DHS); U.S. Department of Agriculture
   through NSF Award [EF-0832858]; University of Tennessee, Knoxville;
   Global Security Initiative, Arizona State University; PAPIIT
   grantPrograma de Apoyo a Proyectos de Investigacion e Innovacion
   Tecnologica (PAPIIT) [IN110917]
FX Two of the authors (JXV and ABG) are grateful to National Institute for
   Mathematical and Biological Synthesis (NIMBioS) for funding the Working
   Group on Climate Change and Vector-borne Diseases (VBDs). NIMBioS is an
   Institute sponsored by the National Science Foundation, the U.S.
   Department of Homeland Security, and the U.S. Department of Agriculture
   through NSF Award #EF-0832858, with additional support from The
   University of Tennessee, Knoxville. One of the authors (KO)
   acknowledges, in part, the support of the Global Security Initiative,
   Arizona State University. The authors are grateful to the anonymous
   reviewers and the Handling Editor for their constructive comments. JXVH
   acknowledges support from PAPIIT grant IN110917.
CR Abdelrazec A, 2017, J MATH BIOL, V74, P1351, DOI 10.1007/s00285-016-1054-9
   Acosta EG, 2016, EXPERT REV VACCINES, V15, P467, DOI 10.1586/14760584.2016.1121814
   Agusto FB, 2015, J BIOL SYST, V23, P597, DOI 10.1142/S0218339015500308
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Betancourt-Cravioto M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003009
   BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510
   Cao-Lormeau V. M., 2016, LANCET
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Carrillo-Valenzo E, 2010, ARCH VIROL, V155, P1401, DOI 10.1007/s00705-010-0721-1
   Castillo-Chavez C, 1998, J THEOR BIOL, V192, P437, DOI 10.1006/jtbi.1998.0661
   Cohen J, SCIENCE, DOI [10.1126/science.aaf4154, DOI 10.1126/SCIENCE.AAF4154]
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Forouzannia F, 2014, MATH BIOSCI, V247, P80, DOI 10.1016/j.mbs.2013.10.011
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Garba SM, 2008, MATH BIOSCI, V215, P11, DOI 10.1016/j.mbs.2008.05.002
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Isea R., 2016, ARXIV160608233
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lakshmikantham V, DIFFERENTIAL INTEGRA
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   LaSalle j. P., 1976, REGIONAL C SERIES AP
   LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708
   Lou YJ, 2010, SIAM J APPL MATH, V70, P2023, DOI 10.1137/080744438
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522
   McLeod RG, 2006, MATH BIOSCI ENG, V3, P527, DOI 10.3934/mbe.2006.3.527
   Mena-Lorca J, 2006, MATH BIOSCI, V202, P42, DOI 10.1016/j.mbs.2006.04.005
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   NOWAK MA, 1994, P ROY SOC B-BIOL SCI, V255, P81, DOI 10.1098/rspb.1994.0012
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Okuneye K, 2018, MATH BIOSCI ENG, V15, P57, DOI 10.3934/mbe.2018003
   Okuneye K, 2017, MATH BIOSCI, V287, P72, DOI 10.1016/j.mbs.2016.03.013
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2016, CUM ZIK SUSP CONF CA
   Parham PE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-271
   Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Polwiang S, 2015, PEERJ, V3, DOI 10.7717/peerj.1069
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Salceanu PL, 2010, J DIFFER EQU APPL, V16, P73, DOI 10.1080/10236190802400733
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Shuai ZS, 2013, J MATH BIOL, V67, P1067, DOI 10.1007/s00285-012-0579-9
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Soucheray S, 2016, CONTRARY DENGUE VACC
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
   TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   World Bank Group Climate Change Knowledge Portal, 2016, CLIM CHANG KNOWL POR
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Zhang P, 2007, J THEOR BIOL, V248, P225, DOI 10.1016/j.jtbi.2007.05.011
   Zhao XQ, 2003, DYNAMICAL SYSTEMS PO
   Zhao XQ, 1995, CANAD APPL MATH Q, V3, P473
NR 70
TC 5
Z9 5
U1 0
U2 18
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-3390
EI 1793-6470
J9 J BIOL SYST
JI J. Biol. Syst.
PD DEC
PY 2017
VL 25
IS 4
SI SI
BP 545
EP 585
DI 10.1142/S0218339017400046
PG 41
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA FQ9PA
UT WOS:000418693000002
DA 2020-07-08
ER

PT J
AU Clayton, RF
   Armstrong, AA
   Zmurko, J
AF Clayton, R. F.
   Armstrong, A. A.
   Zmurko, J.
TI Detection of Zika virus in raw materials and cell banks for use in the
   manufacture of biologicals and novel ATMPs
SO HUMAN GENE THERAPY
LA English
DT Meeting Abstract
CT European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress
CY 2017
CL Berlin, GERMANY
SP European Soc Gene & Cell Therapy
C1 [Clayton, R. F.; Armstrong, A. A.; Zmurko, J.] Bioreliance, Rockville, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1043-0342
EI 1557-7422
J9 HUM GENE THER
JI Hum. Gene Ther.
PD DEC
PY 2017
VL 28
IS 12
MA P364
BP A117
EP A117
PG 1
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA FQ5OP
UT WOS:000418410700372
DA 2020-07-08
ER

PT J
AU Ventura, LO
   Lawrence, L
   Ventura, CV
   Dutton, GN
   Marinho, P
   Ferro, PF
   Gois, AL
   Dias, NC
   Ventura, L
   Moore, CA
   Hyvarinen, L
AF Ventura, Liana O.
   Lawrence, Linda
   Ventura, Camila V.
   Dutton, Gordon N.
   Marinho, Polyana
   Ferro, Priscila F.
   Gois, Adriana L.
   Dias, Natalia C.
   Ventura, Larissa
   Moore, Cynthia A.
   Hyvaerinen, Lea
TI Response to correction of refractive errors and hypoaccommodation in
   children with congenital Zika syndrome
SO JOURNAL OF AAPOS
LA English
DT Article
ID VISUAL IMPAIRMENT; CEREBRAL-PALSY; VIRUS; INFANTS; BRAIN; INFECTION
AB PURPOSE To describe the immediate response to correction of refractive errors and hypoaccommodation in children with congenital Zika syndrome (CZS).
   METHODS Children born between May and December 2015 with a confirmed diagnosis of CZS and enrolled in a multidisciplinary early intervention program were included in this study. All children received a comprehensive ophthalmic examination, including dynamic retinoscopy and cycloplegic refraction. Children were prescribed their full correction if they met the criteria for refractive error, and additional plus 3.00 overcorrection for strabismus, accommodative dysfunction, and/or low vision. Monocular and binocular visual responses to Lea Grating Test at 30 cm, with and without eyeglasses, were measured on day 1 of glasses wear.
   RESULTS A total of 60 children were evaluated (mean age at evaluation, 11.5 +/- 1.1 months; range, 9.0-16.0 months). Lea Grating Test responses were abnormal in all children prior to spectacle correction. Hypoaccommodation was present in 17 of 21 children (81%). Overcorrection was prescribed for all children. Visual responses were subnormal even with glasses use; however, immediate improvement in binocular vision was found in 37 children (62%) and in 74 of 119 eyes (62.2%). For the monocular visual improvement, 27 of 115 eyes (23.5%) had structural abnormalities, and 44 of 115 eyes (38.3%) were structurally normal. There was a statistical difference between the cycloplegic refraction of the children in August and in November, including emmetropia (P = 0.001), hyperopia (P = 0.000), myopia (P = 0.007), and astigmatism (P = 0.004).
   CONCLUSIONS Eyeglasses can improve visual acuity in children with CZS. Significant changes in their refractive status over time requires periodic updates.
C1 [Ventura, Liana O.; Ventura, Camila V.; Marinho, Polyana; Ferro, Priscila F.; Gois, Adriana L.; Dias, Natalia C.; Ventura, Larissa] FAV, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Liana O.; Ventura, Camila V.; Gois, Adriana L.] HOPE Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
   [Dutton, Gordon N.] Glasgow Caledonian Univ, Dept Optometry & Visual Sci, Glasgow, Lanark, Scotland.
   [Moore, Cynthia A.] Ctr Dis Control & Prevent, Natl Off Publ Hlth Genom, Atlanta, GA USA.
   [Hyvaerinen, Lea] Univ Dortmund, Fac Rehabil Sci, Dortmund, Germany.
RP Lawrence, L (corresponding author), 1410 East Iron 6, Salina, KS 67401 USA.
EM lmlawrencemd@gmail.com
RI Ventura, Liana Vieira O/N-6151-2018; Ventura, Camila V/N-2654-2018
OI Ventura, Liana Vieira O/0000-0001-6529-6883; Ventura, Camila
   V/0000-0002-2927-4684; Dutton, Gordon N/0000-0003-2516-5795; Gois,
   Adriana/0000-0001-5542-1097
CR Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Dale N, 2002, DEV MED CHILD NEUROL, V44, P613
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Erkkila H, 1996, ACTA OPHTHALMOL SCAN, V74, P636
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Good WV, 2001, DEV MED CHILD NEUROL, V43, P56, DOI 10.1017/S0012162201000093
   Guzzetta A, 2001, Eur J Paediatr Neurol, V5, P115, DOI 10.1053/ejpn.2001.0481
   Hunter DG, 2001, SURV OPHTHALMOL, V46, P269, DOI 10.1016/S0039-6257(01)00260-0
   Hyvarinen L, 2014, CURR OPHTHALMOL REP, V2, P142
   Jacobson L, 2002, Strabismus, V10, P179
   McClelland JF, 2006, INVEST OPHTH VIS SCI, V47, P1824, DOI 10.1167/iovs.05-0825
   Mody KH, 2012, INDIAN J OPHTHALMOL, V60, P541, DOI 10.4103/0301-4738.103791
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Salomao SR, 2008, INVEST OPHTH VIS SCI, V49, P4308, DOI 10.1167/iovs.08-2073
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
NR 24
TC 9
Z9 9
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD DEC
PY 2017
VL 21
IS 6
BP 480
EP 484
DI 10.1016/j.jaapos.2017.07.206
PG 5
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA FQ2SZ
UT WOS:000418209600013
PM 29066355
DA 2020-07-08
ER

PT J
AU Perry, H
   Khalil, A
   Aarons, E
   Russell, K
   O'Brien, P
AF Perry, Helen
   Khalil, Asma
   Aarons, Emma
   Russell, Katherine
   O'Brien, Patrick
TI Management of Zika virus in pregnancy: a review
SO BRITISH MEDICAL BULLETIN
LA English
DT Review
DE Zika virus; pregnancy; microcephaly
ID SEXUAL TRANSMISSION; DENGUE VIRUS; INFECTION; INFANTS; BIRTH; WOMEN
AB Introduction/background: Since 2015, an epidemic of Zika virus spread across the Americas. This coincided with an increased incidence of microcephaly reported at birth in Brazil, with subsequent evidence of a causal association.
   Sources of data: Systemic reviews, observational studies, public health organizations.
   Areas of agreement: Zika virus causes microcephaly and brain abnormalities in infants born to mothers infected during or shortly before pregnancy. Zika virus is a trigger for Guillain Barre Syndrome. Whilst mosquito bite is the main route of transmission, sexual transmission is another confirmed route.
   Areas of controversy: Uncertainty remains regarding the proportion of Zika-infected pregnancies that will give rise to a significantly affected infant.
   Growing points: The development of a vaccine remains a priority whilst public health efforts continue to educate at risk populations on reducing transmission.
   Areas timely for developing research: Follow-up studies of affected infants are vital to inform on prognosis and guide screening programmes of the future.
C1 [Perry, Helen; Khalil, Asma] St Georges Univ London, Mol & Clin Sci Res Inst, Vasc Biol Res Ctr, Cranmer Terrace, London SW17 0RE, England.
   [Perry, Helen; Khalil, Asma] St Georges Univ Hosp NHS Fdn Trust, Dept Obstet & Gynaecol, Fetal Med Unit, Blackshaw Rd, London SW17 0QT, England.
   [Aarons, Emma] Publ Hlth England, Rare & Imported Pathogens Lab, Manor Farm Rd, Salisbury SP4 0JG, Wilts, England.
   [Russell, Katherine] Publ Hlth England, Natl Infect Serv, Emerging Infect & Zoonoses, 61 Colindale Ave, London NW9 5EQ, England.
   [O'Brien, Patrick] Univ Coll London Hosp, Inst Womens Hlth, 74 Huntley St, London WC1E 6AU, England.
RP Khalil, A (corresponding author), St Georges Univ Hosp NHS Fdn Trust, Dept Obstet & Gynaecol, Fetal Med Unit, Blackshaw Rd, London SW17 0QT, England.
EM akhalil@sgul.ac.uk
RI Khall, Asma/AAC-1459-2020
OI Khall, Asma/0000-0003-2802-7670; Perry, Helen/0000-0003-0334-045X
CR [Anonymous], 2016, VECT CONTR OP FRAM Z
   [Anonymous], 2017, PHE ADVICE WOMEN RET
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Besnard M, 2014, EURO SURVEILL, V19
   Bingham AM, 2016, MMWR MORB MORTAL WKL, V65
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Paula Frietas B, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMAOPHTHALMOL.2016.0267]
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2017, ZIK VIR INF
   Farkas N, 2011, PRENATAL DIAG, V31, P360, DOI 10.1002/pd.2694
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   ISUOG, 2016, ULTRASOUND OBST GYN, DOI [10.1002/uog.15896, DOI 10.1002/UOG.15896]
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   KURTZ AB, 1980, J CLIN ULTRASOUND, V8, P11, DOI 10.1002/jcu.1870080104
   Malinger G, 2011, PRENATAL DIAG, V31, P881, DOI 10.1002/pd.2795
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Morrison TE, 2017, J VIROL, DOI [10.1128/JV.00009-17, DOI 10.1128/JV.00009-17]
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   National Institute of Allergy and Infectious Diseases, 2017, ZIK VIR VACC
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Public Health England, 2017, ZIK VIR SEX TRANSM A
   Public Health England, 2017, ZIK VIR SAMPL TEST A
   Public Health England, 2016, ZIK VIR COUNTR SPEC
   Public Health England, 2016, ZIK VIR CONG INF INT
   Public Health England, 2016, MOSQ BIT AV TRAV
   Report S, 2017, ZIK VIR MICR GUILL B
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Royal College of Obstetricians and Gynaecologists, 2017, INT RCOG RCM PHE HPS
   Scott TW, 1997, AM J TROP MED HYG, V57, P235, DOI 10.4269/ajtmh.1997.57.235
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   [UNICEF WHO], 2017, WHO UNICEF ZIKA VIRU
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   WHO, 2016, PREV SEX TRANSM ZIK
   WHO, 2016, PREGN MAN CONT ZIK V
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   World Health Organisation, 2016, INF FEED AR ZIK TRAN
   World Health Organization, 2016, INF TRAV VIS ZIK AFF
   World Health Organization, 2016, ZIK VIR
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 75
TC 4
Z9 5
U1 1
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-1420
EI 1471-8391
J9 BRIT MED BULL
JI Br. Med. Bull.
PD DEC
PY 2017
VL 124
IS 1
BP 157
EP 169
DI 10.1093/bmb/ldx038v1
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA FQ4XA
UT WOS:000418360700012
PM 29253151
DA 2020-07-08
ER

PT J
AU Perry, H
   Khalil, A
   Aarons, E
   Russell, K
   O'Brien, P
AF Perry, Helen
   Khalil, Asma
   Aarons, Emma
   Russell, Katherine
   O'Brien, Patrick
TI RETRACTION: Management of Zika virus in pregnancy: a review (Retraction
   of Vol 124, Pg 157, 2017)
SO BRITISH MEDICAL BULLETIN
LA English
DT Retraction
RI Khall, Asma/AAC-1459-2020
OI Khall, Asma/0000-0003-2802-7670
CR Perry H, 2017, BRIT MED BULL, V124, P157, DOI 10.1093/bmb/ldx038v1
NR 1
TC 0
Z9 0
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-1420
EI 1471-8391
J9 BRIT MED BULL
JI Br. Med. Bull.
PD DEC
PY 2017
VL 124
IS 1
BP E1
EP E1
DI 10.1093/brimed/ldx038
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA FQ4XA
UT WOS:000418360700001
OA Bronze
DA 2020-07-08
ER

PT J
AU Heller, BJ
   Weiner, MM
   Heller, JA
AF Heller, Benjamin J.
   Weiner, Menachem M.
   Heller, Joshua A.
TI Impact of the Zika Virus for Anesthesiologists: A Review of Current
   Literature and Practices
SO JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
LA English
DT Review
DE anesthesia; general; transfusion medicine; Zika virus infection
ID GUILLAIN-BARRE-SYNDROME; INFECTION; TRANSMISSION; PATHOLOGY; HEALTH
AB Zika virus disease is of growing concern to all clinicians. There is a at-owing concern with regards to the neurologic sequela of the virus, particularly for infants born to women infected while pregnant. The continued spread of this virus throughout North and South America requires all anesthesiologists to maintain vigilance on this issue. This article addresses some of the key issues that pertain to anesthesiologists with regards to the Zika virus including the risks of perioperative management of patients with Zika virus. A discussion of the risks of transfusion and current blood management practices also is included in this review. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Heller, Benjamin J.; Weiner, Menachem M.] Icahn Sch Med Mt Sinai, Dept Anesthesiol, 1 Gustave L Levy Pl, New York, NY 10029 USA.
   [Heller, Joshua A.] Mt Sinai St Lukes & Mt Sinai Roosevelt, Dept Anesthesiol, New York, NY USA.
RP Heller, BJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Anesthesiol, 1 Gustave L Levy Pl, New York, NY 10029 USA.
EM Benjamin.Heller@mountsinai.org
CR BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Boadle A, BRAZIL REPORTS ZIKA
   Centers for Disease Control and Prevention, HEALTHC EXP ZIK INF
   Centers for Disease Control and Prevention, GUID US LAB TEST ZIK
   Centers for Disease Control and Prevention, DIAGN TESTS ZIK VIR
   Chan LYS, 2004, ACTA OBSTET GYN SCAN, V83, P319, DOI 10.1111/j.0001-6349.2004.0473.x
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   European Centre for Disease Prevention and Control (ECDC), FACTSH HLTH PROF
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Food and Drug Administration, REC DON SCREEN DEF P
   Jimenez A, 2017, TRANSFUS MED REV, V31, P1, DOI 10.1016/j.tmrv.2016.08.001
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Krittanawong C, 2016, INT J CARDIOL, V221, P859, DOI 10.1016/j.ijcard.2016.06.293
   Leao JC, 2017, ORAL DIS, V23, P12, DOI 10.1111/odi.12512
   LEE C, 2016, ANN OCCUP ENV MED, V28
   Lin TC, 2015, AM J EMERG MED, V33, DOI 10.1016/j.ajem.2015.03.039
   Martines Roosecelis Brasil, 2016, MMWR Morb Mortal Wkly Rep, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miranda CH, 2013, CLIN INFECT DIS, V57, P812, DOI 10.1093/cid/cit403
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Mumtaz N, 2016, CURR TREAT OPTIONS I, V8, P208, DOI [10.1007/s40506-016-0083-7, DOI 10.1007/S40506-016-0083-7]
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Pierson TC, 2013, FIELDS VIROL, P748
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Silveira FP, 2016, J HEART LUNG TRANSPL, V35, P560, DOI 10.1016/j.healun.2016.03.010
   Situation report Zika virus microcephaly Guillain Barre syndrome, SIT REP ZIK VIR MICR
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   Tilak Rina, 2016, Med J Armed Forces India, V72, P157, DOI 10.1016/j.mjafi.2016.02.017
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Vinay B, 2015, INDIAN J ANAESTH, V59, P391, DOI 10.4103/0019-5049.158782
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wipfli M, 2013, J CLIN ANESTH, V25, P409, DOI 10.1016/j.jclinane.2013.01.017
   Wiwanitkit V, 2016, BRIT J ORAL MAX SURG, V54, P1145, DOI 10.1016/j.bjoms.2016.04.001
   Wiwanitkit V, 2016, SURG INFECT, V17, P498, DOI 10.1089/sur.2016.060
   Yacoub S, 2014, NAT REV CARDIOL, V11, P335, DOI 10.1038/nrcardio.2014.40
NR 50
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1053-0770
EI 1532-8422
J9 J CARDIOTHOR VASC AN
JI J. Cardiothorac. Vasc. Anesth.
PD DEC
PY 2017
VL 31
IS 6
BP 2245
EP 2250
DI 10.1053/j.jvca.2016.11.042
PG 6
WC Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System;
   Peripheral Vascular Disease
SC Anesthesiology; Cardiovascular System & Cardiology; Respiratory System
GA FQ2TL
UT WOS:000418210800052
PM 28262449
DA 2020-07-08
ER

PT J
AU Shutt, DP
   Manore, CA
   Pankavich, S
   Porter, AT
   Del Valle, SY
AF Shutt, Deborah P.
   Manore, Carrie A.
   Pankavich, Stephen
   Porter, Aaron T.
   Del Valle, Sara Y.
TI Estimating the reproductive number, total outbreak size, and reporting
   rates for Zika epidemics in South and Central America
SO EPIDEMICS
LA English
DT Article
ID SEXUAL TRANSMISSION; VIRUS OUTBREAK; AEDES-AEGYPTI; MODEL; VECTOR;
   DENGUE; IDENTIFIABILITY; CHIKUNGUNYA; WOMEN
AB As South and Central American countries prepare for increased birth defects from Zika virus outbreaks and plan for mitigation strategies to minimize ongoing and future outbreaks, understanding important characteristics of Zika outbreaks and how they vary across regions is a challenging and important problem. We developed a mathematical model for the 2015/2016 Zika virus outbreak dynamics in Colombia, El Salvador, and Suriname. We fit the model to publicly available data provided by the Pan American Health Organization, using Approximate Bayesian Computation to estimate parameter distributions and provide uncertainty quantification. The model indicated that a country-level analysis was not appropriate for Colombia. We then estimated the basic reproduction number to range between 4 and 6 for El Salvador and Suriname with a median of 4.3 and 5.3, respectively. We estimated the reporting rate to be around 16% in El Salvador and 18% in Suriname with estimated total outbreak sizes of 73,395 and 21,647 people, respectively. The uncertainty in parameter estimates highlights a need for research and data collection that will better constrain parameter ranges. (C) 2017 The Authors. Published by Elsevier B.V.
C1 [Shutt, Deborah P.] Virginia Mil Inst, Dept Appl Math, Lexington, VA 24450 USA.
   [Pankavich, Stephen; Porter, Aaron T.] Colorado Sch Mines, Dept Appl Math & Stat, Golden, CO 80401 USA.
   [Manore, Carrie A.] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87544 USA.
   [Manore, Carrie A.; Del Valle, Sara Y.] Los Alamos Natl Lab, Informat Syst & Modeling, Los Alamos, NM 87544 USA.
   [Manore, Carrie A.] New Mexico Consortium, Los Alamos, NM 87544 USA.
RP Shutt, DP (corresponding author), Virginia Mil Inst, Dept Appl Math, Lexington, VA 24450 USA.
EM shuttda@vmi.edu
FU NSF SEES grantNational Science Foundation (NSF)NSF - Office of the
   Director (OD) [CHE-1314029]; NSF RAPID [DEB 1641130]; NSF EDT grant
   [DMS-1551229]; NSFNational Science Foundation (NSF) [DMS-1614586];
   NIH/NIGMS/MIDASUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [U01-GM097658-01]; Department of
   EnergyUnited States Department of Energy (DOE) [DE-AC52-06NA25396]
FX This work was supported by NSF SEES grant CHE-1314029, NSF RAPID (DEB
   1641130), and NSF EDT grant DMS-1551229. SP was partially supported by
   NSF under grant DMS-1614586. SD was partially supported by
   NIH/NIGMS/MIDAS under grant U01-GM097658-01. LANL is operated by Los
   Alamos National Security, LLC for the Department of Energy under
   contract DE-AC52-06NA25396. Approved for public release: LA-UR-17-20963.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Boorman J., 1956, T R SOC TROP MED HYG, V50, P218
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, ZIK VIR
   Center for Disease Control, 2016, ZIK TRANSM RISK
   Chapman JD, 2009, BIOMED SIGNAL PROCES, V4, P278, DOI 10.1016/j.bspc.2009.02.003
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Countrymeters, 2016, COUNTR MET WORLD POP
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eisenberg MC, 2013, J THEOR BIOL, V324, P84, DOI 10.1016/j.jtbi.2012.12.021
   ELDERD BD, 2006, P NATL ACAD SCI USA, V101, P15693, DOI DOI 10.1016/J.JTBI.2012.12.021
   Evans ND, 2005, MATH BIOSCI, V194, P175, DOI 10.1016/j.mbs.2004.10.011
   FAY RICHARD W., 1964, MOSQUITO NEWS, V24, P300
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao  Daozhou, 2016, ARXIV160404008
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   HYER R, 2017, TOP QUESTIONS ZIKA S
   King A. A., 2015, P R SOC B, V282
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lekone PE, 2006, BIOMETRICS, V62, P1170, DOI 10.1111/j.1541-0420.2006.00609.x
   Lessler J., 2016, BIORXIV
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Manore C, 2016, BIORXIV, DOI DOI 10.1016/J.JTBI.2014.04.033
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   MODE CJ, 2000, STOCHASTIC PROCESSES
   Moreno V., 2016, ARXIV160300442
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   *PAN AM HLTH ORG, 2016, NUMB REP CAS DENG SE, DOI DOI 10.1007/S11538-006-9067-Y
   Pan American Health Organization, 2017, ZIK CAS CONG SYNDR A
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2016, CUM ZIK SUSP CONF CA
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Porter AT, 2016, STAT MED, V35, P721, DOI 10.1002/sim.6730
   Porter AT, 2013, BIOMETRICS, V69, P101, DOI 10.1111/j.1541-0420.2012.01809.x
   Rojas DP, 2016, EURO SURVEILL, V21
   RUBIN DB, 1984, ANN STAT, V12, P1151, DOI 10.1214/aos/1176346785
   Sivanathan M.M., 2006, THESIS
   Towers S, 2016, ARXIV2016
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Villela DA, 2017, EPIDEMIOL INFECT, P1
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2017, HIST ZIK VIR
   World Health Organization, 2016, WEST PAC REG ZIK VIR
   World Health Organization, 2017, 1 YEAR ZIK OUTBR OBS
NR 54
TC 10
Z9 10
U1 2
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD DEC
PY 2017
VL 21
BP 63
EP 79
DI 10.1016/j.epidem.2017.06.005
PG 17
WC Infectious Diseases
SC Infectious Diseases
GA FQ0RW
UT WOS:000418065400008
PM 28803069
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Karam, E
   Giraldo, J
   Rodriguez, F
   Hernandez-Pereira, CE
   Rodriguez-Morales, AJ
   Blohm, GM
   Paniz-Mondolfi, AE
AF Karam, Emely
   Giraldo, Jose
   Rodriguez, Flor
   Hernandez-Pereira, Carlos E.
   Rodriguez-Morales, Alfonso J.
   Blohm, Gabriela M.
   Paniz-Mondolfi, Alberto E.
TI Ocular flutter following Zika virus infection
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Zika virus; Ocular flutter; Viral; Guillain-Barre syndrome
ID OPSOCLONUS; MYOCLONUS; ATAXIA
AB Zika virus (ZIKV) is an emerging flavivirus which has been linked to a number of neurologic manifestations such as Guillain-Barr, syndrome (GBS), transverse myelitis, and meningo-encephalitis. Ophthalmologic manifestations are increasingly being reported; however, ocular dyskinesias have not been described in this context to date. Herein, we report a case of a 22-year-old female who presented with ocular flutter and associated Guillain-Barr, syndrome following acute ZIKV infection. We speculate that although such symptoms may have originated from a direct viral insult, a post-infectious autoimmune mechanism may not be excluded. Physicians should include ZIKV as well as other flaviviruses in their diagnostic workup for all patients with ocular flutter/opsoclonus, after excluding other non-infectious causes of central nervous system pathology. To the best of our knowledge, this is the first report on the association of ocular flutter, GBS, and ZIKV infection.
C1 [Karam, Emely] Ctr Med Docente La Trinidad, Dept Ophtalmol, Caracas, Venezuela.
   [Giraldo, Jose] Hosp Int Barquisimeto, Dept Ophtalmol, Barquisimeto, Lara, Venezuela.
   [Rodriguez, Flor] Grp Med La Sagrada Familia, Dept Ophtalmol, Lecheria, Anzoategui, Venezuela.
   [Hernandez-Pereira, Carlos E.] Infect Dis Res Incubator & Zoonosis & Emerging Pa, Barquisimeto, Lara, Venezuela.
   [Hernandez-Pereira, Carlos E.] Univ Centroccidental Lisandro Alvarado, Coll Med, Dept Hlth Sci, Barquisimeto, Lara, Venezuela.
   [Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Colombia.
   [Blohm, Gabriela M.] Univ Florida, Coll Liberal Arts & Sci, Dept Biol, Gainesville, FL USA.
   [Paniz-Mondolfi, Alberto E.] Hosp Int Barquisimeto, Dept Infect Dis & Trop Med, Barquisimeto, Lara, Venezuela.
   [Paniz-Mondolfi, Alberto E.] IVSS, Dept Hlth, Caracas, Venezuela.
   [Paniz-Mondolfi, Alberto E.] Hosp Int Barquisimeto, Dept Trop Med & Infect Dis, Ave Intercomunal Barquisimeto Cabudare, Cabudare 3023, Estado Lara, Venezuela.
RP Paniz-Mondolfi, AE (corresponding author), Hosp Int Barquisimeto, Dept Infect Dis & Trop Med, Barquisimeto, Lara, Venezuela.; Paniz-Mondolfi, AE (corresponding author), IVSS, Dept Hlth, Caracas, Venezuela.; Paniz-Mondolfi, AE (corresponding author), Hosp Int Barquisimeto, Dept Trop Med & Infect Dis, Ave Intercomunal Barquisimeto Cabudare, Cabudare 3023, Estado Lara, Venezuela.
EM alberto.paniz-mondolfi@yale.edu
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   BERGENIUS J, 1986, ACTA OTO-LARYNGOL, V102, P228, DOI 10.3109/00016488609108671
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   FURMAN JMR, 1988, NEUROLOGY, V38, P499
   Guidance for U. S, 2017, GUID US LAB TEST ZIK
   HANKEY GJ, 1987, J NEUROL NEUROSUR PS, V50, P1235, DOI 10.1136/jnnp.50.9.1235
   Hebert J, 2017, J NEUROVIROL, V23, P158, DOI 10.1007/s13365-016-0470-3
   Leigh LJ, 1999, NEUROLOGY EYE MOVEME, P133
   Mahale RR, 2016, ANN INDIAN ACAD NEUR, V19, P159, DOI 10.4103/0972-2327.173300
   Nakayasu Koki, 2010, Nippon Ganka Gakkai Zasshi, V114, P539
   Pieret F, 1996, ACTA NEUROL BELG, V96, P108
   Ramat S, 2005, EXP BRAIN RES, V160, P89, DOI 10.1007/s00221-004-1989-8
   Slenczka W, 2016, ZIKA VIRUS DIS MICRO, V4
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Wiest G, 1997, J NEUROL, V244, P288, DOI 10.1007/s004150050088
   Wong A, 2007, CURR OPIN NEUROL, V20, P25, DOI 10.1097/WCO.0b013e3280126b51
   Zaro-Weber O, 2008, ARCH NEUROL-CHICAGO, V65, P659, DOI 10.1001/archneur.65.5.659
NR 17
TC 2
Z9 2
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD DEC
PY 2017
VL 23
IS 6
BP 932
EP 934
DI 10.1007/s13365-017-0585-1
PG 3
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA FP6NF
UT WOS:000417742100016
PM 29147884
DA 2020-07-08
ER

PT J
AU Mora-Cardenas, E
   Marcello, A
AF Mora-Cardenas, Erick
   Marcello, Alessandro
TI Switch-on the LAMP to spot Zika
SO ANNALS OF TRANSLATIONAL MEDICINE
LA English
DT Editorial Material
ID DEVELOPING-WORLD; WHOLE-BLOOD; VIRUS; DIAGNOSTICS; CELLS
C1 [Mora-Cardenas, Erick; Marcello, Alessandro] ICGEB, Lab Mol Virol, Padriciano 99, I-34149 Trieste, Italy.
RP Marcello, A (corresponding author), ICGEB, Lab Mol Virol, Padriciano 99, I-34149 Trieste, Italy.
EM marcello@icgeb.org
FU Beneficientia Stiftung, Vaduz Lichtenstein; FLAVIPOC project from the
   Regione FVG of Italy; SEVARE project from the Regione FVG of Italy
FX Work on flaviviruses is supported by the Beneficientia Stiftung, Vaduz
   Lichtenstein and by the FLAVIPOC and SEVARE projects from the Regione
   FVG of Italy.
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Baba MM, 2014, FUTURE VIROL, V9, P595, DOI 10.2217/FVL.14.33
   Baud D, 2017, LANCET
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Caracciolo I, 2015, J CLIN VIROL, V69, P48, DOI 10.1016/j.jcv.2015.05.019
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Lustig Y, 2016, EURO SURVEILL, V21
   Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841
   Maistriau M, 2017, VIRUS RES, V237, P1, DOI 10.1016/j.virusres.2017.05.004
   Marcello A, 2013, BIOSENS BIOELECTRON, V46, P44, DOI 10.1016/j.bios.2013.02.017
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tagliabue G, 2017, BIOCHEM BIOPH RES CO, V492, P558, DOI 10.1016/j.bbrc.2017.05.025
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wilson HL, 2017, J CLIN MICROBIOL, V55, P3104, DOI [10.1128/JCM.00673-17, 10.1128/jcm.00673-17]
NR 26
TC 1
Z9 1
U1 0
U2 4
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2305-5839
EI 2305-5847
J9 ANN TRANSL MED
JI ANN. TRANSL. MED.
PD DEC
PY 2017
VL 5
IS 24
AR 500
DI 10.21037/atm.2017.10.19
PG 4
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA FP9QM
UT WOS:000417983600020
PM 29299461
OA Green Published
DA 2020-07-08
ER

PT J
AU Thompson, SJ
   Pearce, JM
   Ramey, AM
AF Thompson, Sarah J.
   Pearce, John M.
   Ramey, Andrew M.
TI Vectors, Hosts, and Control Measures for Zika Virus in the Americas
SO ECOHEALTH
LA English
DT Review
DE Aedes aegypti; reservoir host; vector control; transmission; wildlife;
   Zika virus
ID AEDES-ALBOPICTUS DIPTERA; THURINGIENSIS VAR. ISRAELENSIS; BLOOD-FEEDING
   PATTERNS; MOSQUITO-CONTROL; YELLOW-FEVER; PYRETHROID INSECTICIDES;
   NONTARGET ORGANISMS; HABITAT SEGREGATION; DOMESTIC-ANIMALS; MIDGES
   DIPTERA
AB We examine Zika virus (ZIKV) from an ecological perspective and with a focus on the Americas. We assess (1) the role of wildlife in ZIKV disease ecology, (2) how mosquito behavior and biology influence disease dynamics, and (3) how nontarget species and ecosystems may be impacted by vector control programs. Our review suggests that free-ranging, non-human primates may be involved in ZIKV transmission in the Old World; however, other wildlife species likely play a limited role in maintaining or transmitting ZIKV. In the Americas, a zoonotic cycle has not yet been definitively established. Understanding behaviors and habitat tolerances of Aedes aegypti and Aedes albopictus, two ZIKV competent vectors in the Americas, will allow more accurate modeling of disease spread and facilitate targeted and effective control efforts. Vector control efforts may have direct and indirect impacts to wildlife, particularly invertebrate feeding species; however, strategies could be implemented to limit detrimental ecological effects.
C1 [Thompson, Sarah J.; Pearce, John M.; Ramey, Andrew M.] US Geol Survey, Alaska Sci Ctr, 4210 Univ Dr, Anchorage, AK 99508 USA.
RP Thompson, SJ (corresponding author), US Geol Survey, Alaska Sci Ctr, 4210 Univ Dr, Anchorage, AK 99508 USA.
EM sjthompson@usgs.gov
FU Wildlife Program of the US Geological Survey, Ecosystems Mission Area
FX We thank C. Handel and M. Reeves for conversations that were important
   in drafting this manuscript. M. Smith and two anonymous reviewers
   provided helpful comments on an earlier draft of the paper. This work
   was supported by the Wildlife Program of the US Geological Survey,
   Ecosystems Mission Area. Any use of trade, firm, or product names is for
   descriptive purposes only and does not imply endorsement by the US
   Government.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Ali A, 2000, J AM MOSQUITO CONTR, V16, P313
   ALI A, 1991, J AM MOSQUITO CONTR, V7, P616
   AMCA, 2009, BEST MAN PRACT INT M
   ANDRAL L, 1968, B WORLD HEALTH ORGAN, V38, P855
   Antwi FB, 2015, ENVIRON TOXICOL PHAR, V40, P915, DOI 10.1016/j.etap.2015.09.023
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   BERRILL M, 1993, ENVIRON TOXICOL CHEM, V12, P525, DOI 10.1002/etc.5620120313
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boisvert M, 2000, BIOCONTROL SCI TECHN, V10, P517, DOI 10.1080/095831500750016361
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   BRADBURY SP, 1989, REV ENVIRON CONTAM T, V108, P133
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Breidenbaugh MS, 2010, ENVIRON ENTOMOL, V39, P591, DOI 10.1603/EN09087
   Brooks M, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2548
   Brown MD, 2002, J ECON ENTOMOL, V95, P294, DOI 10.1603/0022-0493-95.2.294
   Bukhari T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021713
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CAREY DE, 1972, B WORLD HEALTH ORGAN, V46, P645
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Chadee DD, 1998, J AM MOSQUITO CONTR, V14, P5
   Champion SR, 2014, ENVIRON HEALTH INSIG, V8, P35, DOI 10.4137/EHI.S16004
   CHAN KL, 1971, B WORLD HEALTH ORGAN, V44, P629
   Chang LH, 2015, J EXP BIOL, V218, P1715, DOI 10.1242/jeb.119198
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CLARK JR, 1989, ENVIRON TOXICOL CHEM, V8, P393, DOI 10.1002/etc.5620080505
   COOPER RJ, 1990, J WILDLIFE MANAGE, V54, P486, DOI 10.2307/3809663
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443
   Davis RS, 2008, J AM MOSQUITO CONTR, V24, P270, DOI 10.2987/5654.1
   DeBoo RF, 1980, FPMX41 CAN FOR SERV
   Degitz SJ, 2003, AQUAT TOXICOL, V64, P97, DOI 10.1016/S0166-445X(03)00022-5
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FAIRCHILD WL, 1993, ARCH ENVIRON CON TOX, V25, P170, DOI 10.1007/BF00212128
   Fang J, 2010, NATURE, V466, P432, DOI 10.1038/466432a
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   FARMER D, 1995, ECOTOXICOLOGY, V4, P219, DOI 10.1007/BF00116342
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Favoretto S, 2016, BIORXIV, P49395
   Fayolle S, 2015, ANN LIMNOL-INT J LIM, V51, P189, DOI 10.1051/limn/2015013
   Ghekiere A, 2006, J EXP MAR BIOL ECOL, V332, P226, DOI 10.1016/j.jembe.2005.11.021
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Greulich K, 2003, AQUAT TOXICOL, V65, P329, DOI 10.1016/S0166-445X(03)00153-X
   Groner ML, 2011, FRESHWATER BIOL, V56, P2391, DOI 10.1111/j.1365-2427.2011.02667.x
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 2011, ASIA PACIFIC J MOL B, V19, P111
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hahn MB, 2016, J MED ENTOMOL, V2016, P1
   Hartley D., 1984, AGROCHEMICALS HDB
   Healy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108504
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Henrick CA, 2007, J AM MOSQUITO CONTR, V23, P225, DOI 10.2987/8756-971X(2007)23[225:M]2.0.CO;2
   Hershey AE, 1998, ECOL APPL, V8, P41, DOI 10.1890/1051-0761(1998)008[0041:EOBTIB]2.0.CO;2
   HESS AD, 1970, AM J TROP MED HYG, V19, P327, DOI 10.4269/ajtmh.1970.19.327
   HESTER PG, 1991, J AM MOSQUITO CONTR, V7, P48
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hoang TC, 2011, ENVIRON TOXICOL CHEM, V30, P997, DOI 10.1002/etc.462
   Hoffman DJ, 2004, ENVIRON POLLUT, V127, P353, DOI 10.1016/j.envpol.2003.08.021
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jakob C, 2016, INSECT CONSERV DIVER, V9, P161, DOI 10.1111/icad.12155
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   Liber K, 1998, ECOTOXICOLOGY, V7, P343, DOI 10.1023/A:1008867815244
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lundstrom JO, 2010, B ENTOMOL RES, V100, P117, DOI 10.1017/S0007485309990137
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Miles AK, 2002, WILDLIFE SOC B, V30, P675
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mortimer MR, 1995, AUST J ECOTOXICOL, V1, P107
   Mulla MS, 1981, P ANN C CAL MOSQ VEC
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nayar JK, 2003, J VECTOR ECOL, V28, P190
   NEBEKER A V, 1983, Environmental Toxicology and Chemistry, V2, P329, DOI 10.1897/1552-8618(1983)2[329:AACEOD]2.0.CO;2
   Niemi GJ, 1999, ENVIRON TOXICOL CHEM, V18, P549, DOI [10.1002/etc.5620180325, 10.1897/1551-5028(1999)018&lt;0549:EEOMCO&gt;2.3.CO;2]
   NORLAND RL, 1975, ENVIRON ENTOMOL, V4, P145, DOI 10.1093/ee/4.1.145
   Nowogrodski A, 2016, NEW SCI
   Okia N O, 1971, East Afr Med J, V48, P725
   PANKIW T, 1992, J ECON ENTOMOL, V85, P692, DOI 10.1093/jee/85.3.692
   Pinkney AE, 2000, ENVIRON TOXICOL CHEM, V19, P678, DOI [10.1897/1551-5028(2000)019&lt;0678:EOTMLT&gt;2.3.CO;2, 10.1002/etc.5620190320]
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Poulin B, 2012, ACTA OECOL, V44, P28, DOI 10.1016/j.actao.2011.11.005
   Poulin B, 2010, J APPL ECOL, V47, P884, DOI 10.1111/j.1365-2664.2010.01821.x
   PRESING M, 1993, ARCH ENVIRON CON TOX, V25, P387, DOI 10.1007/BF00210731
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rey JR, 2006, J MED ENTOMOL, V43, P1134, DOI 10.1603/0022-2585(2006)43[1134:HSOMAV]2.0.CO;2
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Saha S, 2008, B ENVIRON CONTAM TOX, V80, P49, DOI 10.1007/s00128-007-9314-4
   Sanchez R, 2016, ZIKA VIRUS IS DDT OP
   SAVAGE HM, 1993, J MED ENTOMOL, V30, P27, DOI 10.1093/jmedent/30.1.27
   SCHLIESSMANN DJ, 1974, MOSQ NEWS, V34, P1
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   SIMPSON DIH, 1968, ANN TROP MED PARASIT, V62, P432, DOI 10.1080/00034983.1968.11686580
   Smith PN, 2007, ENVIRON POLLUT, V150, P41, DOI 10.1016/j.envpol.2007.06.009
   SPEHAR RL, 1983, AQUAT TOXICOL, V3, P171, DOI 10.1016/0166-445X(83)90038-3
   Story P, 2001, WILDLIFE RES, V28, P179, DOI 10.1071/WR99060
   Su TY, 2005, J VECTOR ECOL, V30, P107
   TAKAHASHI RM, 1984, MOSQ NEWS, V44, P363
   TEMPELIS CH, 1970, AM J TROP MED HYG, V19, P335, DOI 10.4269/ajtmh.1970.19.335
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Thavara U, 2001, J VECTOR ECOL, V26, P172
   Vinnersten TZP, 2010, B ENTOMOL RES, V100, P715, DOI 10.1017/S0007485310000076
   WEBBER LA, 1984, MOSQ NEWS, V44, P68
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 123
TC 3
Z9 3
U1 5
U2 32
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD DEC
PY 2017
VL 14
IS 4
BP 821
EP 839
DI 10.1007/s10393-017-1277-2
PG 19
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA FP6HC
UT WOS:000417724800017
PM 29150828
DA 2020-07-08
ER

PT J
AU Weber, DS
   Alroy, KA
   Scheiner, SM
AF Weber, Diana S.
   Alroy, Karen A.
   Scheiner, Samuel M.
TI Phylogenetic Insight into Zika and Emerging Viruses for a Perspective on
   Potential Hosts (vol 14, pg 214, 2017)
SO ECOHEALTH
LA English
DT Correction
C1 [Weber, Diana S.] Amer Assoc Advancement Sci, S&T Policy Fellowship, 1200 New York Ave NW, Washington, DC 20005 USA.
   [Alroy, Karen A.; Scheiner, Samuel M.] Natl Sci Fdn, Div Environm Biol, 4201 Wilson Blvd, Arlington, VA 22230 USA.
RP Weber, DS (corresponding author), Amer Assoc Advancement Sci, S&T Policy Fellowship, 1200 New York Ave NW, Washington, DC 20005 USA.
EM diana.weber@gmail.com
CR Weber DS, 2017, ECOHEALTH, V14, P214, DOI 10.1007/s10393-017-1237-x
NR 1
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD DEC
PY 2017
VL 14
IS 4
BP 873
EP 873
DI 10.1007/s10393-017-1279-0
PG 1
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA FP6HC
UT WOS:000417724800021
PM 29150825
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Kotsakiozi, P
   Richardson, JB
   Pichler, V
   Favia, G
   Martins, AJ
   Urbanelli, S
   Armbruster, PA
   Caccone, A
AF Kotsakiozi, Panayiota
   Richardson, Joshua B.
   Pichler, Verena
   Favia, Guido
   Martins, Ademir J.
   Urbanelli, Sandra
   Armbruster, Peter A.
   Caccone, Adalgisa
TI Population genomics of the Asian tiger mosquito, Aedes albopictus:
   insights into the recent worldwide invasion
SO ECOLOGY AND EVOLUTION
LA English
DT Article
DE arboviruses vector; ddRAD; genetic structure; phylogeography; SNPs
ID YELLOW-FEVER MOSQUITO; UNITED-STATES; DIPTERA-CULICIDAE;
   MITOCHONDRIAL-DNA; GENETIC DIVERSITY; AE.-ALBOPICTUS; PHOTOPERIODIC
   DIAPAUSE; INSECT VECTORS; PUBLIC-HEALTH; HUMAN-DISEASE
AB Aedes albopictus, the Asian tiger mosquito, is an aggressive biting mosquito native to Asia that has colonized all continents except Antarctica during the last similar to 30-40years. The species is of great public health concern as it can transmit at least 26 arboviruses, including dengue, chikungunya, and Zika viruses. In this study, using double-digest Restriction site-Associated DNA (ddRAD) sequencing, we developed a panel of similar to 58,000 single nucleotide polymorphisms (SNPs) based on 20 worldwide Ae.albopictus populations representing both the invasive and the native range. We used this genomic-based approach to study the genetic structure and the differentiation of Ae.albopictus populations and to understand origin(s) and dynamics of the recent invasions. Our analyses indicated the existence of two major genetically differentiated population clusters, each one including both native and invasive populations. The detection of additional genetic structure within each major cluster supports that these SNPs can detect differentiation at a global and local scale, while the similar levels of genomic diversity between native and invasive range populations support the scenario of multiple invasions or colonization by a large number of propagules. Finally, our results revealed the possible source(s) of the recent invasion in Americas, Europe, and Africa, a finding with important implications for vector-control strategies.
C1 [Kotsakiozi, Panayiota; Richardson, Joshua B.; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
   [Pichler, Verena] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.
   [Favia, Guido] Univ Camerino, Sch Biosci & Vet Med, Camerino, Italy.
   [Martins, Ademir J.] Fiocruz MS, IOC, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, Brazil.
   [Urbanelli, Sandra] Sapienza Univ Rome, Dept Environm Biol, Rome, Italy.
   [Armbruster, Peter A.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA.
RP Kotsakiozi, P (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
EM panagiota.kotsakiozi@yale.edu
RI Martins, Ademir/W-3251-2019; Martins, Ademir J./B-4117-2009; URBANELLI,
   Sandra/N-8821-2016
OI Martins, Ademir/0000-0001-5739-1215; URBANELLI,
   Sandra/0000-0003-1183-0344
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R15 AI111328, 5T32AI007404-2];
   Institute for Biospheric Studies, Yale University; Bodossaki Foundation
FX NIH, Grant/Award Number: R15 AI111328; Institute for Biospheric Studies,
   Yale University; Bodossaki Foundation; NIH, Grant/Award Number:
   5T32AI007404-2
CR Aguirre-Obando OA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2089-5
   Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109
   Armbruster PA, 2016, J MED ENTOMOL, V53, P1013, DOI 10.1093/jme/tjw037
   Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376
   Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Chen HY, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0125-x
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Damal K, 2013, AM J TROP MED HYG, V89, P482, DOI 10.4269/ajtmh.13-0102
   Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330
   Das B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094094
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105
   Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111
   Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023
   Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121
   Egizi A, 2016, MOL ECOL, V25, P3033, DOI 10.1111/mec.13653
   Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   Flacio E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1577-3
   Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221
   Frichot E, 2015, METHODS ECOL EVOL, V6, P925, DOI 10.1111/2041-210X.12382
   Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x
   Gloria-Soria A., 2016, G3 BETHESDA 6, V157, P3
   Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056
   Invasive Species Specialist Group, 2017, GLOBAL INVASIVE SPEC
   Ismail NA, 2015, J AM MOSQUITO CONTR, V31, P305, DOI 10.2987/moco-31-04-305-312.1
   Jackson H, 2015, MOL ECOL, V24, P4269, DOI 10.1111/mec.13307
   Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94
   KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67
   KAMBHAMPATI S, 1990, HEREDITY, V64, P281, DOI 10.1038/hdy.1990.34
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kenned D, 2002, SCIENCE, V297, P1445, DOI 10.1126/science.297.5586.1445
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lounibos LP, 2003, ANN ENTOMOL SOC AM, V96, P512, DOI 10.1603/0013-8746(2003)096[0512:AEOPDI]2.0.CO;2
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Luu K, 2017, MOL ECOL RESOUR, V17, P67, DOI 10.1111/1755-0998.12592
   Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332
   Manni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0794-5
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546
   Medley KA, 2015, MOL ECOL, V24, P284, DOI 10.1111/mec.12925
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Minard G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00970
   Morens DM, 2008, JAMA-J AM MED ASSOC, V299, P214, DOI 10.1001/jama.2007.31-a
   MORI A, 1981, Tropical Medicine, V23, P79
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Nazareno A. G., 2017, MOL ECOLOGY RESOURCE
   O'Donnell D, 2009, ANN ENTOMOL SOC AM, V102, P1135, DOI 10.1603/008.102.0623
   Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pech-May A, 2016, ACTA TROP, V157, P30, DOI 10.1016/j.actatropica.2016.01.021
   Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135
   Porretta D, 2006, MOL ECOL NOTES, V6, P880, DOI 10.1111/j.1471-8286.2006.01384.x
   Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   POZZA GLD, 1994, J AM MOSQUITO CONTR, V10, P589
   Puckett EE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1762
   REITER P, 1984, MOSQ NEWS, V44, P396
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Trucchi E, 2016, MOL ECOL, V25, P3527, DOI 10.1111/mec.13698
   Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x
   Urbanski JM, 2010, P ROY SOC B-BIOL SCI, V277, P2683, DOI 10.1098/rspb.2010.0362
   Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wray GA, 2013, ANNU REV ECOL EVOL S, V44, P51, DOI 10.1146/annurev-ecolsys-110512-135828
   Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755
   Xu JB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004696
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068586
NR 89
TC 22
Z9 22
U1 0
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2045-7758
J9 ECOL EVOL
JI Ecol. Evol.
PD DEC
PY 2017
VL 7
IS 23
BP 10143
EP 10157
DI 10.1002/ece3.3514
PG 15
WC Ecology; Evolutionary Biology
SC Environmental Sciences & Ecology; Evolutionary Biology
GA FP6RT
UT WOS:000417754100025
PM 29238544
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jankowski, MD
   Moore, ME
   Hofmeister, EK
AF Jankowski, Mark D.
   Moore, Murray E.
   Hofmeister, Erik K.
TI An examination of the effect of aerosolized Permanone insecticide on
   zebra finch susceptibility to West Nile virus
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE Pyrethroid; West Nile virus; Zebra finch; Immunotoxicity; Insecticide;
   Permethrin
ID PYRETHROID INSECTICIDES; MANAGEMENT STRATEGIES; RESPIRATORY-TRACT;
   GAS-EXCHANGE; IN-VITRO; TOXICITY; PERMETHRIN; BIRDS; EXPOSURE;
   DEPOSITION
AB West Nile virus (WNV) is maintained cryptically primarily in avian (passerine) populations, where it is transmitted by Culex spp. mosquitoes. Mosquito-control measures currently include physical activities to reduce mosquito-breeding sites and the application of mosquito larvicides or aerosolized insecticides to kill adults (adulticides) when arboviral diseases such as WNV or Zika virus are detected in mosquito populations. Organochlorine, organophosphorus, carbamate, and pyrethroid insecticides are often used. Previous work suggests an effect of pyrethroids on the immune system in a variety of vertebrates. We examined the effects of exposure to aerosolized Permanone (R) 30:30 insecticide (permethrin and piperonyl butoxide in soy oil vehicle) at approximately 10(3) to 10(6) times potential environmental concentrations on the response of captive zebra finches (Taeniopygia guttata) to experimental challenge with WNV. Compared to vehicle control birds, WNV outcome was unchanged (65% of birds produced a viremia) in the low exposure (9.52 +/- 3.13mg/m(3) standard deviation [SD] permethrin) group but reduced in the high exposure (mean 376.5 +/- 27.9mg/m(3) SD permethrin) group (30% were viremic; p<0.05). After clearing WNV infection, birds treated with Permanone regained less body mass than vehicle-treated birds (p<0.001). The present study suggests that exposure to aerosolized Permanone insecticide at levels exceeding typical application rates has the potential to not change or to mildly enhance a bird's resistance to WNV. Environ Toxicol Chem 2017;36:3376-3386. Published 2017 Wiley Periodicals Inc. on behalf of SETAC. This article is a US government work and, as such, is in the public domain in the United States of America.
C1 [Jankowski, Mark D.; Moore, Murray E.] Los Alamos Natl Lab, Los Alamos, NM USA.
   [Jankowski, Mark D.] US EPA, Reg 10, Seattle, WA USA.
   [Hofmeister, Erik K.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA.
RP Hofmeister, EK (corresponding author), US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA.
EM ehofmeister@usgs.gov
CR Abbene I, 2005, CONCENTRATIONS INSEC
   American Conference of Governmental Industrial Hygienists, 2016, ACGIH 2016 THRESH LI
   ANADON A, 1991, TOXICOL APPL PHARM, V110, P1, DOI 10.1016/0041-008X(91)90284-L
   Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797
   BLAYLOCK BL, 1995, B ENVIRON CONTAM TOX, V54, P768, DOI 10.1007/BF00206111
   Brown RE, 1997, ENVIRON HEALTH PERSP, V105, P188, DOI 10.1289/ehp.97105188
   BUCKPITT AR, 1982, TOXICOL APPL PHARM, V65, P38, DOI 10.1016/0041-008X(82)90360-X
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   CARLSON JE, 1977, JAMA-J AM MED ASSOC, V237, P1718, DOI 10.1001/jama.237.16.1718
   CASIDA JE, 1980, ENVIRON HEALTH PERSP, V34, P189, DOI 10.2307/3428960
   Centers for Disease Control and Prevention, 2012, MOSQ SPEC WHICH W NI
   Cui J, 2016, ECOTOXICOLOGY, V25, P439, DOI 10.1007/s10646-015-1601-y
   Davis RS, 2007, INTEGR ENVIRON ASSES, V3, P373, DOI 10.1002/ieam.5630030308
   Davison F, 2008, AVIAN IMMUNOLOGY, P1, DOI 10.1016/B978-012370634-8.50004-4
   DAYNES RA, 1989, EUR J IMMUNOL, V19, P2319, DOI 10.1002/eji.1830191221
   Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003
   Diel F, 1998, ALLERGY, V53, P1052, DOI 10.1111/j.1398-9995.1998.tb03814.x
   Diel F, 1999, TOXICOL LETT, V107, P65, DOI 10.1016/S0378-4274(99)00032-6
   Dinsmore SJ, 2013, ECOTOXICOLOGY, V22, P415, DOI 10.1007/s10646-012-1035-8
   Ebel GD, 2002, EMERG INFECT DIS, V8, P979, DOI 10.3201/eid0809.020152
   Ferdous F, 2015, IMMUNOL LETT, V163, P32, DOI 10.1016/j.imlet.2014.11.010
   Flagan RC, 1988, FUNDAMENTALS AIR POL
   Garg UK, 2004, INT IMMUNOPHARMACOL, V4, P1709, DOI 10.1016/j.intimp.2004.08.002
   Gaunt A., 1986, BIRD RESPIRATION, P71
   Goldfrank L., 2011, GOLDFRANKS TOXOCOLOG
   HAYA K, 1989, ENVIRON TOXICOL CHEM, V8, P381, DOI 10.1002/etc.5620080504
   HAYTER RB, 1974, POULTRY SCI, V53, P1507, DOI 10.3382/ps.0531507
   Hinds W.C., 1999, AEROSOL TECHNOLOGY P
   HOELLINGER H, 1987, DRUG CHEM TOXICOL, V10, P291, DOI 10.3109/01480548709042988
   Hofmeister EK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167876
   Hofmeister EK, 2016, J WILDLIFE DIS, V52, P345, DOI 10.7589/2015-06-148
   Hofmeister EK, 2016, J WILDLIFE DIS, V52, P354, DOI 10.7589/2015-06-137
   Imgrund H, 2003, ENV FATE PERMETHRIN
   Jankowski MD, 2010, TOXICOLOGY, V269, P81, DOI 10.1016/j.tox.2010.01.010
   Juul-Madsen H, 2013, AVIAN IMMUNOLOGY, p[121, 2nd]
   Kaiser P, 2007, CYTOGENET GENOME RES, V117, P221, DOI 10.1159/000103183
   Klaassen CD, 2008, CASARETT DOULLS TOXI
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   LaPointe DA, 2009, J WILDLIFE DIS, V45, P257, DOI 10.7589/0090-3558-45.2.257
   Leslie TW, 2010, ENVIRON ENTOMOL, V39, P2045, DOI 10.1603/EN10049
   MENSAH GA, 1982, J APPL PHYSIOL, V53, P1423
   Mineau P, 2012, ENVIRON TOXICOL PHAR, V34, P416, DOI 10.1016/j.etap.2012.05.010
   Moore A, 2001, AQUAT TOXICOL, V52, P1, DOI 10.1016/S0166-445X(00)00133-8
   Moore C.G., 1993, GUIDELINES ARBOVIRUS
   Naddy RB, 2001, CHEMOSPHERE, V45, P497, DOI 10.1016/S0045-6535(01)00019-4
   National Pesticide Information Center, 2017, PEST US MOSQ CONTR
   Owen JA, 2013, KUBY IMMUNOLOGY
   Paul EA, 2005, ARCH ENVIRON CON TOX, V48, P251, DOI 10.1007/s00244-003-0110-9
   Pierce RH, 2005, REV BIOL TROP, V53, P117
   Prater MR, 2003, INT J TOXICOL, V22, P35, DOI 10.1080/10915810305070
   Punareewattana K, 2001, FOOD CHEM TOXICOL, V39, P133, DOI 10.1016/S0278-6915(00)00116-2
   R CORE TEAM, 2014, R LANG ENV STAT COMP
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   Scheid P, 1979, Rev Physiol Biochem Pharmacol, V86, P137, DOI 10.1007/BFb0031533
   Schleier JJ, 2010, ARCH ENVIRON CON TOX, V58, P105, DOI 10.1007/s00244-009-9353-4
   Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06
   STEARNS RC, 1987, RESP PHYSIOL, V67, P23, DOI 10.1016/0034-5687(87)90004-1
   Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208
   TAYLOR RM, 1956, AM J TROP MED HYG, V5, P579, DOI 10.4269/ajtmh.1956.5.579
   US Army, 2011, DISP ULTR VOL ULV IN
   US Environmental Protection Agency, 2017, PREF REC MOD AERMOD
   US Environmental Protection Agency, 2006, RER EL DEC PIP BUT P
   USEPA, 2009, RER EL DEC RED PERM
   Varian-Ramos CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095674
   Wagner S. L., 1994, Journal of Agromedicine, V1, P39, DOI 10.1300/J096v01n01_04
   Warnes GR, 2015, VARIOUS R PROGRAMMIN
   WORK TH, 1955, AM J TROP MED HYG, V4, P872, DOI 10.4269/ajtmh.1955.4.872
   Yu MS, 2016, ENVIRON TOXICOL CHEM, V35, P1534, DOI 10.1002/etc.3307
   Zhao YA, 2004, ENVIRON TOXICOL CHEM, V23, P2147, DOI 10.1897/03-557
   Zhu F, 2016, INSECTS, V7, DOI 10.3390/insects7010002
NR 71
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7268
EI 1552-8618
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD DEC
PY 2017
VL 36
IS 12
BP 3376
EP 3386
DI 10.1002/etc.3918
PG 11
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA FP6SZ
UT WOS:000417757700023
PM 28722808
DA 2020-07-08
ER

PT J
AU Aubry, M
   Laughhunn, A
   Santa Maria, F
   Lanteri, MC
   Stassinopoulos, A
   Musso, D
AF Aubry, Maite
   Laughhunn, Andrew
   Santa Maria, Felicia
   Lanteri, Marion C.
   Stassinopoulos, Adonis
   Musso, Didier
TI Pathogen inactivation of Dengue virus in red blood cells using
   amustaline and glutathione
SO TRANSFUSION
LA English
DT Article
ID WASTAGE; PROGRAM
AB BACKGROUND: Dengue virus (DENV) is an arbovirus primarily transmitted through mosquito bite; however, DENV transfusion-transmitted infections (TTIs) have been reported and asymptomatic DENV RNA-positive blood donors have been identified in endemic countries. DENV is considered a high-risk pathogen for blood safety. One of the mitigation strategies to prevent arbovirus TTIs is pathogen inactivation. In this study we demonstrate that the amustaline and glutathione (S-303/GSH) treatment previously found effective against Zika virus in red blood cells (RBCs) is also effective in inactivating DENV.
   STUDY DESIGN AND METHODS: Red blood cells were spiked with high levels of DENV. Viral RNA loads and infectious titers were measured in the untreated control and before and after pathogen inactivation treatment of RBC samples. DENV infectivity was also assessed over five successive cell culture passages to detect any potential residual replicative virus.
   RESULTS: The mean6SD DENV titer in RBCs before inactivation was 6.61 +/- 0.19 log 50% tissue culture infectious dose (TCID50)/mL and the mean viral RNA load was 8.42 log genome equivalents/mL. No replicative DENV was detected either immediately after completion of treatment using S-303/GSH or after cell culture passages.
   CONCLUSION: Treatment using S-303/GSH inactivated high levels of DENV in RBCs to the limit of detection. In combination with previous studies showing the effective inactivation of DENV in plasma and platelets using the licensed amotosalen/UVA system, this study demonstrates that high levels of DENV can be inactivated in all blood components.
C1 [Aubry, Maite; Musso, Didier] Inst Louis Malarde, Pole Rech & Veille Sur Malad Infect Emergentes, Tahiti, French Polynesi, France.
   [Laughhunn, Andrew; Santa Maria, Felicia] Cerus Corp, Dept Microbiol, Concord, CA USA.
   [Lanteri, Marion C.; Stassinopoulos, Adonis] Cerus Corp, Sci Affairs Dept, Concord, CA USA.
RP Stassinopoulos, A (corresponding author), Cerus Corp, 2550 Stanwell Dr, Concord, CA 94520 USA.
EM adonis@cerus.com
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Aubry, Maite/0000-0002-9913-5794
FU Cerus Corporation (USA)
FX This study was partially funded by Cerus Corporation (USA).
CR [Anonymous], NAT BLOOD PROD LIST
   [Anonymous], 2017, 7 HOSP INV MAN TECHN
   [Anonymous], MAN BLOOD BLOOD PROD
   [Anonymous], 2017, COMP COMP
   [Anonymous], 2017, RED BLOOD CELL WAST
   [Anonymous], IMPL HUB SPOK ARR
   Anthes E, 2015, NATURE, V520, P24, DOI 10.1038/520024a
   Australian Red Cross Blood service, PIL REP FIND I DOC N
   Barty RL, 2015, TRANSFUSION, V55, P1621, DOI 10.1111/trf.13055
   Blood facts and statistics, BLOOD FACTS STAT
   Budget, 2016, BUDG 2016 17 STAT 5
   Chapman J, 2007, TRANSFUSION, V47, p190S, DOI 10.1111/j.1537-2995.2007.01384.x
   Chen S, 2015, PATHOLOGY, V47, pS89
   Cheng CK, 2010, TRANSFUSION, V50, P160, DOI 10.1111/j.1537-2995.2009.02375.x
   Collins RA, 2015, AM J CLIN PATHOL, V143, P329, DOI 10.1309/AJCP42WMHSSTPHXI
   Far RM, 2014, TURK J HEMATOL, V31, P161, DOI 10.4274/tjh.2012.0105
   Hasegawa J, 2016, J OBSTET GYNAECOL RE, V42, P1637, DOI 10.1111/jog.13136
   Heitmiller ES, 2010, TRANSFUSION, V50, P1887, DOI 10.1111/j.1537-2995.2010.02679.x
   Hirani R, 2017, TRANSFUSION, V57, P1254, DOI 10.1111/trf.14012
   Hopewell S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002154
   Hunter New England, HUNT NEW ENGL
   Kendall KE, 1980, J OPER MANAG, V1, P77
   Kurup Rajini, 2016, BMC Res Notes, V9, P307, DOI 10.1186/s13104-016-2112-5
   Murphy MF, 2015, TRANSFUSION MED, V25, P287, DOI 10.1111/tme.12256
   National blood and blood product wastage reduction strategy, 2013, NAT BLOOD BLOOD PROD
   Novis DA, 2002, ARCH PATHOL LAB MED, V126, P150
   Objective 1, 2014, OBJ 1 SEC SUPPL BLOO
   Perera G, 2009, TRANSFUSION MED, V19, P99, DOI 10.1111/j.1365-3148.2009.00914.x
   Stanger SHW, 2012, TRANSFUS MED REV, V26, P153, DOI 10.1016/j.tmrv.2011.09.001
   Sullivan P, 2005, TRANSFUSION, V45, pS224, DOI 10.1111/j.1537-2995.2005.00621.x
   Zarbo RJ, 2002, ARCH PATHOL LAB MED, V126, P1036
NR 31
TC 4
Z9 4
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD DEC
PY 2017
VL 57
IS 12
BP 2888
EP 2896
DI 10.1111/trf.14318
PG 9
WC Hematology
SC Hematology
GA FP5AW
UT WOS:000417630900011
PM 28921542
OA Other Gold
DA 2020-07-08
ER

PT J
AU Slavov, SN
   Hespanhol, MR
   Rodrigues, ES
   Levi, JE
   Ubiali, EMA
   Covas, DT
   Kashima, S
AF Slavov, Svetoslav N.
   Hespanhol, Marta R.
   Rodrigues, Evandra S.
   Levi, Jose E.
   Ubiali, Eugenia M. A.
   Covas, Dimas T.
   Kashima, Simone
TI Zika virus RNA detection in asymptomatic blood donors during an outbreak
   in the northeast region of Sao Paulo State, Brazil, 2016
SO TRANSFUSION
LA English
DT Article
AB BACKGROUND: In 2015, there was a large Zika virus (ZIKV) outbreak in Brazil. The proportion of asymptomatic infections is very high, and it is possible for transfusion-transmitted ZIKV (TT-ZIKV) infection to occur. The prevalence of asymptomatic ZIKV infection among Brazilian blood donors during this epidemic outbreak is unknown.
   STUDY DESIGN AND METHODS: Plasma samples obtained between October 2015 and May 2016 from 1393 volunteer blood donors were tested for ZIKV RNA. The viral load was quantified using an in-house standard curve. Additionally, positive ZIKV RNA samples were tested for anti-ZIKV immunoglobulin (Ig)M and anti-ZIKV IgG.
   RESULTS: Of the 1393 blood samples, ZIKV RNA was detected in 37 (n = 37/1393; 2.7%). The median infection viral load detected was 7714 copies/mL (ranging from 135-124,220 copies/mL). The majority of the positive samples (70.3%) exhibited a viral load of approximately 10(3) copies/mL. Six samples that were positive for ZIKV RNA were also positive for anti-ZIKV IgM and IgG (n = 6/37; 13.5%).
   CONCLUSION: This is the first study evaluating the prevalence of ZIKV RNA among Brazilian blood donors, which was relatively high and might lead to TT-ZIKV infection. It is unclear whether the simultaneous presence of anti-ZIKV IgM and IgG in RNA-positive donations or the viral load influences transfusion transmission of the infection. This study also adds to the global understanding of ZIKV prevalence in blood donors during outbreaks and the transfusion impact of the infection.
C1 [Slavov, Svetoslav N.; Hespanhol, Marta R.; Rodrigues, Evandra S.; Ubiali, Eugenia M. A.; Covas, Dimas T.; Kashima, Simone] Univ Sao Paulo, Fac Med Ribeirao Preto, Blood Ctr Ribeirao Preto, Sao Paulo, Brazil.
   [Levi, Jose E.] Univ Sao Paulo, Virol Lab, Inst Trop Med, Sao Paulo, Brazil.
   [Kashima, Simone] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Sao Paulo, Brazil.
RP Slavov, SN (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Blood Ctr Ribeirao Preto, Lab Mol Biol, 2501 Tenente Catao Roxo St, BR-14051140 Sao Paulo, Brazil.
EM svetoslav.slavov@hemocentro.fmrp.usp.br
RI N, Svetoslav/M-5416-2017; Rodrigues, Evandra/L-6094-2017; Covas, Dimas
   T/C-5431-2013; Kashima, Simone/G-4876-2012
OI Rodrigues, Evandra/0000-0003-0964-9554; Covas, Dimas
   T/0000-0002-7364-2595; Kashima, Simone/0000-0002-1487-0141
FU Fundacao de Amparo e Pesquisa do Estado de Sao Paulo-FAPESP, Brazil
   [2009/16623-1, CTC-2013/081352]; Conselho Nacional do Desenvolvimento
   Cientifico e Tecnologico, Brazil [INCTC-573.754/2008-0,
   INCTC-2008/57.877-3]; FINEP, BrazilCiencia Tecnologia e Inovacao (FINEP)
   [245/2016]
FX This study was supported by the Fundacao de Amparo e Pesquisa do Estado
   de Sao Paulo-FAPESP, Brazil (Grant 2009/16623-1, CTC-2013/081352); the
   Conselho Nacional do Desenvolvimento Cientifico e Tecnologico, Brazil
   (INCTC-573.754/2008-0 and INCTC-2008/57.877-3); and FINEP, Brazil
   (245/2016).
NR 0
TC 11
Z9 12
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD DEC
PY 2017
VL 57
IS 12
BP 2897
EP 2901
DI 10.1111/trf.14322
PG 5
WC Hematology
SC Hematology
GA FP5AW
UT WOS:000417630900012
PM 28921551
OA Bronze
DA 2020-07-08
ER

PT J
AU Karafin, MS
   Bruhn, R
   Westlake, M
   Sullivan, MT
   Bialkowski, W
   Edgren, G
   Roubinian, NH
   Hauser, RG
   Kor, DJ
   Fleischmann, D
   Gottschall, JL
   Murphy, EL
   Triulzi, DJ
AF Karafin, Matthew S.
   Bruhn, Roberta
   Westlake, Matt
   Sullivan, Marian T.
   Bialkowski, Walter
   Edgren, Gustaf
   Roubinian, Nareg H.
   Hauser, Ronald G.
   Kor, Daryl J.
   Fleischmann, Debra
   Gottschall, Jerome L.
   Murphy, Edward L.
   Triulzi, Darrell J.
CA Natl Heart Lung Blood Inst
TI Demographic and epidemiologic characterization of transfusion recipients
   from four US regions: evidence from the REDS-III recipient database
SO TRANSFUSION
LA English
DT Article
ID ZIKA VIRUS; BLOOD-TRANSFUSION; TRANSMISSION; MICRONESIA; MARTINIQUE;
   OUTBREAK; DENGUE; STATES
AB BACKGROUND: Blood transfusion is one of the most common medical procedures during hospitalization in the United States. To understand the benefits of transfusion while mitigating potential risks, a multicenter database containing detailed information on transfusion incidence and recipient outcomes would facilitate research.
   STUDY DESIGN AND METHODS: The Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) program has developed a comprehensive transfusion recipient database utilizing data from hospital electronic health records at 12 participating hospitals in four geographic regions. Inpatient and outpatient data on transfusion recipients from January 1, 2013 to December 31, 2014 included patient age, sex, ethnicity, primary diagnosis, type of blood product provided, issue location, pretransfusion and post-transfusion hemoglobin (Hgb), and hospital outcomes. Transfusion incidence per encounter was calculated by blood product and various patient characteristics.
   RESULTS: During the 2-year study period, 80,362 (12.5%) inpatient encounters involved transfusion. Among inpatients, the most commonly transfused blood products were red blood cells (RBCs; 10.9% of encounters), followed by platelets (3.2%) and plasma (2.9%). Among patients who received transfusions, the median number of RBC units was one, the pretransfusion Hgb level was 7.6 g/dL, and the Hgb increment per unit was 1.4 g/dL. Encounter mortality increased with patient age, the number of units transfused, and the use of platelet or plasma products. The most commonly reported transfusion reaction was febrile nonhemolytic.
   CONCLUSION: The database contains comprehensive data regarding transfusion use and patient outcomes. The current report describes an evaluation of the first 2 years of a planned, 4-year, linked blood donor-component-recipient database, which represents a critical new resource for transfusion medicine researchers.
C1 [Karafin, Matthew S.; Bialkowski, Walter; Gottschall, Jerome L.] BloodCtr Wisconsin BCW, Milwaukee, WI USA.
   [Bruhn, Roberta; Roubinian, Nareg H.; Murphy, Edward L.] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA.
   [Westlake, Matt; Sullivan, Marian T.; Fleischmann, Debra] RTI Int, Rockville, MD USA.
   [Westlake, Matt; Sullivan, Marian T.; Fleischmann, Debra] RTI Int, Res Triangle Pk, NC USA.
   [Edgren, Gustaf] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.
   [Edgren, Gustaf] Karolinska Univ Hosp, Hematol Ctr, Stockholm, Sweden.
   [Hauser, Ronald G.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA.
   [Kor, Daryl J.] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA.
   [Triulzi, Darrell J.] Inst Transfus Med ITXM, Pittsburgh, PA USA.
   [Triulzi, Darrell J.] Univ Pittsburgh, Pittsburgh, PA USA.
RP Karafin, MS (corresponding author), BloodCtr Wisconsin, Inst Med Sci, 8733 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Karafin, MS (corresponding author), Med Coll Wisconsin, 8733 Watertown Plank Rd, Milwaukee, WI 53226 USA.
EM matthew.karafin@bcw.edu
RI Edgren, Gustaf/F-4013-2014
OI Edgren, Gustaf/0000-0002-2198-4745; Bruhn, Roberta/0000-0002-5898-8168
FU National Heart, Lung, and Blood InstituteUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [HHSN268201100001I]
FX This study was supported by the National Heart, Lung, and Blood
   Institute (grant HHSN268201100001I).
CR Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Candotti D, 2013, BLOOD TRANSFUS-ITALY, V11, P203, DOI 10.2450/2012.0219-12
   Duca LM, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0557-x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Levi JE, 2016, J INFECT DIS, V213, P689, DOI 10.1093/infdis/jiv322
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Paz-Bailey G, 2017, N ENGL J MED
NR 14
TC 28
Z9 28
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD DEC
PY 2017
VL 57
IS 12
BP 2903
EP 2913
DI 10.1111/trf.14370
PG 11
WC Hematology
SC Hematology
GA FP5AW
UT WOS:000417630900013
PM 29067705
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Subissi, L
   Daudens-Vaysse, E
   Cassadou, S
   Ledrans, M
   Bompard, P
   Gustave, J
   Aubry, M
   Cao-Lormeau, VM
   Mallet, HP
AF Subissi, Lorenzo
   Daudens-Vaysse, Elise
   Cassadou, Sylvie
   Ledrans, Martine
   Bompard, Priscillia
   Gustave, Joel
   Aubry, Maite
   Cao-Lormeau, Van-Mai
   Mallet, Henri-Pierre
TI Revising rates of asymptomatic Zika virus infection based on sentinel
   surveillance data from French Overseas Territories
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Sentinel surveillance; Asymptomatic infections; Pacific
   islands; Caribbean region; Vector-borne infections
AB French Polynesia and the French Territories of the Americas (FTAs) have experienced outbreaks of Zika virus (ZIKV) infection. These territories used similar sentinel syndromic surveillance to follow the epidemics. However, the surveillance system only takes into account consulting patients diagnosed with ZIKV disease, while non-consulting cases, as well as asymptomatic cases, are not taken into account. In the French territories under study, the ratio of consulting to non-consulting patients was found to likely be as low as 1/3 to 1/4, and rough estimates of the ZIKV asymptomatic infections indicated a lower rate than previously reported (i.e., not more than half). (C) 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Subissi, Lorenzo] Sante Publ France, EPRUS, St Maurice, France.
   [Subissi, Lorenzo] WHO, European Ctr Dis Control, Papeete, French Polynesi, France.
   [Daudens-Vaysse, Elise; Cassadou, Sylvie; Ledrans, Martine] Sante Publ France, Reg Unit, St Maurice, France.
   [Bompard, Priscillia; Mallet, Henri-Pierre] Direct Hlth, Papeete, French Polynesi, France.
   [Bompard, Priscillia] Univ Paris 06, UPMC, Sorbonne Univ,IPLESP UMRS 1136, INSERM,Inst Pierre Louis Epidemiol & Sante Publ, Paris, France.
   [Gustave, Joel] Reg Hlth Agcy, Vector Control Unit, Guadeloupe, France.
   [Aubry, Maite; Cao-Lormeau, Van-Mai] Inst Louis Malarde, Papeete, French Polynesi, France.
RP Subissi, L (corresponding author), Sci Inst Publ Hlth, Viral Dis Dept, Brussels, Belgium.
EM lorenzo.subissi@wiv-isp.be
RI Cao-Lormeau, Van-Mai/H-4879-2018; Subissi, Lorenzo/A-6553-2017
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Aubry,
   Maite/0000-0002-9913-5794; Subissi, Lorenzo/0000-0001-5147-575X
FU World Health OrganizationWorld Health Organization [001]
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chow A, 2017, EMERG INFECT DIS, V23, P677, DOI 10.3201/eid2304.161716
   Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   IPSOS Antilles, 2016, STUD IMP PREV COMM I
   Kucharski Adam J, 2016, PLOS NEGL TROP DIS, V10
   Maite Aubry, 2017, EMERG INFECT DIS, V23
   Mallet HP, 2016, B EPIDEMIOL HEBD, V367, P20
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pierre Gallian, 2017, BLOOD, V129, P263
   WHO, 2017, ZIK SIT REP
NR 12
TC 10
Z9 10
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2017
VL 65
BP 116
EP 118
DI 10.1016/j.ijid.2017.10.009
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA FP5AH
UT WOS:000417628500025
PM 29081369
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Morano, JP
   Holt, DA
AF Morano, Jamie P.
   Holt, Douglas A.
TI The social determinants of health contextualized for the Zika virus
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Morano, Jamie P.; Holt, Douglas A.] Univ S Florida, Div Infect Dis & Int Med, Morsani Coll Med, Tampa, FL USA.
   [Morano, Jamie P.; Holt, Douglas A.] Florida Dept Hlth Hillsborough Cty, Tampa, FL USA.
   [Morano, Jamie P.] Univ S Florida, Dept Hlth Policy & Management, Coll Publ Hlth, Tampa, FL USA.
RP Morano, JP (corresponding author), 1 Tampa Gen Circle,G318, Tampa, FL 33606 USA.
EM jmorano@health.usf.edu
FU Steering Board of the University of South Florida Zika Clinical Research
   Network (ZiCRN) Grant (FL-Department of Health) [7ZK19]; Steering Board
   of the University of South Florida Zika Clinical Research Network
   (ZiCRN) Grant (USF) [6123-1207]
FX DH and JM serve on the Steering Board of the University of South Florida
   Zika Clinical Research Network (ZiCRN) Grant (FL-Department of Health
   #7ZK19; USF #6123-1207).
CR Centers for Diease Control and Prevention, 2017, EL MAL US
   History Channel Editors, 2017, 1 VICTIM MEMPHIS YEL
   US Department of Health and Human Services, 2017, HLTH PEOPL 2020
   World Health Organization, 2017, SOC DET HLTH
NR 4
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2017
VL 65
BP 142
EP 143
DI 10.1016/j.ijid.2017.10.006
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA FP5AH
UT WOS:000417628500031
PM 29081365
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rodriguez-Diaz, CE
   Garriga-Lopez, A
   Malave-Rivera, SM
   Vargas-Molinaa, RL
AF Rodriguez-Diaz, Carlos E.
   Garriga-Lopez, Adriana
   Malave-Rivera, Souhail M.
   Vargas-Molinaa, Ricardo L.
TI Zika virus epidemic in Puerto Rico: Health justice too long delayed
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID MALE SEXUAL TRANSMISSION; CONDOM-USE; ACCESS; WOMEN
AB Over the course of 16 months, more than 35 400 cases of Zika virus infection have been confirmed in Puerto Rico. This represents 85% of all cases reported in the USA and its territories. The Zika epidemic is exposing the profound failure of socioeconomic policies, as well as the failure to protect sexual and reproductive health rights in Puerto Rico. Considering the high poverty rates, high levels of sexualityrelated stigma, poor quality sex education, limited access to contraception, and limited participation in the allocation of resources for prevention, it is unreasonable to focus public health efforts to prevent Zika virus infection on vector control. The allocation and equitable management of resources for research and intervention are required in order to understand and address the barriers to and facilitators of prevention at the individual, social, and structural levels. Further, the impact of efforts to tackle the social determinants of the Zika virus epidemic on the island should be assessed. (C) 2017 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Rodriguez-Diaz, Carlos E.; Malave-Rivera, Souhail M.; Vargas-Molinaa, Ricardo L.] Univ Puerto Rico, Sch Publ Hlth, Ctr Sociomed Res & Evaluat, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
   [Rodriguez-Diaz, Carlos E.; Malave-Rivera, Souhail M.] Univ Puerto Rico, Sch Publ Hlth, Dept Social Sci, Doctoral Program Publ Hlth Specialty Social Deter, Med Sci Campus, San Juan, PR 00936 USA.
   [Garriga-Lopez, Adriana] Columbia Univ, Dept Anthropol, New York, NY 10027 USA.
   [Garriga-Lopez, Adriana] Kalamazoo Coll, Dept Anthropol & Sociol, Kalamazoo, MI 49007 USA.
RP Rodriguez-Diaz, CE (corresponding author), Univ Puerto Rico, Sch Publ Hlth, Ctr Sociomed Res & Evaluat, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
EM carlos.rodriguez64@upr.edu
OI Rodriguez-Diaz, Carlos/0000-0001-6333-0654; Garriga-Lopez, Adriana
   Maria/0000-0002-3243-7237; Malave-Rivera, Souhail/0000-0003-3446-4869
FU National Institutes of Health (NIH) - National Institute of Minority
   Health and Health Disparities (NIMHD), RCMI grant [G12MD007600]
FX This manuscript was partially supported by the National Institutes of
   Health (NIH) - National Institute of Minority Health and Health
   Disparities (NIMHD), RCMI grant number G12MD007600. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the NIH-NIMHD.
CR Allen G, DTFJIITGJK
   [Anonymous], 1931, OLPDGOGKL, P2017
   [Anonymous], 2016, MIAMI HERALD
   [Anonymous], 2016, KFG
   Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5
   Centers for Disease Control and Prevention, 2017, JIEGIUJ
   Centers for Disease Control and Prevention, 2017, LRKGOKL
   Centers for Disease Control and Prevention, 2016, EJTIJ
   Centers for Disease Control and Prevention, 2017, IKJJMGL
   Centers for Disease Control and Prevention, 2017, KRGL
   Colon Malieri, 2014, Bol Asoc Med P R, V106, P12
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   De Malave L., 1999, EJTI
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dia El Nuevo, 2016, CUMPLE AO ZIKA PUERT
   Freour T., 2016, EURO SURVEILL, V21
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Garriga-Lopez A, 2016, REV 80 GRADOS
   Garriga-Lopez A, 2016, SAVAGE MINDS
   Hoang TC, 2015, CHEMOSPHERE, V120, P714, DOI 10.1016/j.chemosphere.2014.10.040
   Jokanovic M, 2001, TOXICOLOGY, V166, P139, DOI 10.1016/S0300-483X(01)00463-2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1212
   Murillo M., 2001, ISLAND RESISTANCE VI
   Norman LR, 2011, J HEALTH CARE POOR U, V22, P122, DOI 10.1353/hpu.2011.0160
   Ortiz-Sanchez EJ, 2017, J HIV-AIDS SOC SERV, V16, P143, DOI 10.1080/15381501.2016.1169467
   Otero-Rivera CA, 2008, P 136 ANN M AM PUBL
   Portela M, 2015, MILBANK Q, V93, P584, DOI 10.1111/1468-0009.12138
   Puerto Rico Department of Health, 2012, ANN REP VIT STAT
   Puerto Rico Department of Health, 2017, WEEKL REP ARB DIS
   Puerto Rico Police Department, 2016, DOM VIOL STAT, P2016
   Puerto Rico Statistics Institute, 2016, EMPL UN PUERT RIC
   Puerto Rico Statistics Institute, 2015, DEM PROF EL DISTR 1
   Rivera YM, 2016, SEX RES SOC POLICY, V10, P208
   Rodriguez Melissa Marzan, 2013, Rev Cienc Soc, V26, P50
   Rodriguez-Diaz CE, 2014, J SEX MED, V11, P2385, DOI 10.1111/jsm.12642
   Roman J., 2015, ANN AM THORAC SOC, V12, P760
   Santelli J, 2006, J ADOLESCENT HEALTH, V38, P72, DOI 10.1016/j.jadohealth.2005.10.006
   STAT, 2017, PUERT RIC DECL ITS O
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   United States Census Bureau. Selected characteristics of the native and foreign-born populations, 2014, JIDGJ
   United States Department of Energy, 1995, HUM RAD EXPT
   Varas-Diaz N., 2014, Journal of the International Association of Providers of AIDS Care, V13, P305, DOI 10.1177/2325957412472935
   Villanueva V, 2015, J CULT ECON-UK, V8, P62, DOI 10.1080/17530350.2014.942348
   World Health Organization, 2016, PREV POT TRANSM ZIK
NR 47
TC 6
Z9 6
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2017
VL 65
BP 144
EP 147
DI 10.1016/j.ijid.2017.07.017
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA FP5AH
UT WOS:000417628500032
PM 29153921
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Das, M
   Helbig, K
   O'Shea, R
AF Das, Mithun
   Helbig, Karla
   O'Shea, Ross
TI Differential antiviral cytokine responses in human astrocyte cells
   following infection with different Zika virus strains
SO CYTOKINE
LA English
DT Meeting Abstract
CT 5th Annual Meeting of the International-Cytokine-and-Interferon-Society
   (ICIS)
CY OCT 29-NOV 02, 2017
CL Int Cytokine & Interferon Soc, Kanazawa, JAPAN
SP Japanese Soc Interferon & Cytokine Res, Japanese Soc Mol Cellular Biol Macrophages
HO Int Cytokine & Interferon Soc
C1 [Das, Mithun; Helbig, Karla; O'Shea, Ross] La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia.
RI Helbig, Karla/AAC-5515-2019
OI Helbig, Karla/0000-0001-6306-2821
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD DEC
PY 2017
VL 100
SI SI
MA Mo-WS4-7
BP 38
EP 38
PG 1
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA FM2LZ
UT WOS:000414817600079
DA 2020-07-08
ER

PT J
AU Taft, J
   Altman, J
   Buta, S
   Martin-Fernandez, M
   Bogunovic, D
AF Taft, Justin
   Altman, Jennie
   Buta, Sofija
   Martin-Fernandez, Marta
   Bogunovic, Dusan
TI Regulation and Genetic Heterogeneity of Select Interferon Stimulated
   Genes Independently Restrict ZIKV Infection
SO CYTOKINE
LA English
DT Meeting Abstract
CT 5th Annual Meeting of the International-Cytokine-and-Interferon-Society
   (ICIS)
CY OCT 29-NOV 02, 2017
CL Int Cytokine & Interferon Soc, Kanazawa, JAPAN
SP Japanese Soc Interferon & Cytokine Res, Japanese Soc Mol Cellular Biol Macrophages
HO Int Cytokine & Interferon Soc
C1 [Taft, Justin; Altman, Jennie; Buta, Sofija; Martin-Fernandez, Marta; Bogunovic, Dusan] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD DEC
PY 2017
VL 100
SI SI
MA Mo-P5-6
BP 93
EP 93
PG 1
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA FM2LZ
UT WOS:000414817600257
DA 2020-07-08
ER

PT J
AU Julkunen, I
   Lundberg, R
   Melen, K
   Jiang, M
   Westenius, V
   Vapalahti, O
   Osterlund, P
   Kakkola, L
AF Julkunen, Ilkka
   Lundberg, Rickard
   Melen, Krister
   Jiang, Miao
   Westenius, Veera
   Vapalahti, Olli
   Osterlund, Pamela
   Kakkola, Laura
TI Zika virus NS5 protein interferes with the RIG-I signaling pathway and
   inhibits the expression of interferon lambda1 gene
SO CYTOKINE
LA English
DT Meeting Abstract
CT 5th Annual Meeting of the International-Cytokine-and-Interferon-Society
   (ICIS)
CY OCT 29-NOV 02, 2017
CL Int Cytokine & Interferon Soc, Kanazawa, JAPAN
SP Japanese Soc Interferon & Cytokine Res, Japanese Soc Mol Cellular Biol Macrophages
HO Int Cytokine & Interferon Soc
C1 [Julkunen, Ilkka; Lundberg, Rickard; Melen, Krister; Kakkola, Laura] Univ Turku, Inst Biomed Virol, Turku, Finland.
   [Melen, Krister; Jiang, Miao; Westenius, Veera; Osterlund, Pamela] Natl Inst Hlth & Welf, Expert Microbiol Unit, Helsinki, Finland.
   [Vapalahti, Olli] Univ Helsinki, Deaprtment Virol, Helsinki, Finland.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD DEC
PY 2017
VL 100
SI SI
MA Mo-P7-16
BP 101
EP 102
PG 2
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA FM2LZ
UT WOS:000414817600284
DA 2020-07-08
ER

PT J
AU Swartwout, BK
   Zlotnick, MG
   Saver, AE
   McKenna, CM
   Bertke, AS
AF Swartwout, Brianna K.
   Zlotnick, Marta G.
   Saver, Ashley E.
   McKenna, Caroline M.
   Bertke, Andrea S.
TI Zika Virus Persistently and Productively Infects Primary Adult Sensory
   Neurons In Vitro
SO PATHOGENS
LA English
DT Article
DE Zika virus; sensory; autonomic; neurons; Guillain-Barre; satellite glial
   cells
ID HERPES-SIMPLEX-VIRUS; SEXUAL TRANSMISSION; CELLS; EMERGENCE; LESIONS;
   RHESUS; WOMEN; MODEL; RNA
AB Zika virus (ZIKV) has recently surged in human populations, causing an increase in congenital and Guillain-Barre syndromes. While sexual transmission and presence of ZIKV in urine, semen, vaginal secretions, and saliva have been established, the origin of persistent virus shedding into biological secretions is not clear. Using a primary adult murine neuronal culture model, we have determined that ZIKV persistently and productively infects sensory neurons of the trigeminal and dorsal root ganglia, which innervate glands and mucosa of the face and the genitourinary tract, respectively, without apparent injury. Autonomic neurons that innervate these regions are not permissive for infection. However, productive ZIKV infection of satellite glial cells that surround and support sensory and autonomic neurons in peripheral ganglia results in their destruction. Persistent infection of sensory neurons, without affecting their viability, provides a potential reservoir for viral shedding in biological secretions for extended periods of time after infection. Furthermore, viral destruction of satellite glial cells may contribute to the development of Guillain-Barre Syndrome via an alternative mechanism to the established autoimmune response.
C1 [Swartwout, Brianna K.] Virginia Tech, Caril Res Inst, Translat Biol Med & Hlth, Roanoke, VA 24016 USA.
   [Zlotnick, Marta G.; Saver, Ashley E.] Virginia Maryland Coll Vet Med, Blacksburg, VA 22406 USA.
   [McKenna, Caroline M.] Virginia Tech, Sch Neurosci, Blacksburg, VA 24061 USA.
   [Bertke, Andrea S.] Virginia Maryland Coll Vet Med, Populat Hlth Sci, Blacksburg, VA 24061 USA.
RP Bertke, AS (corresponding author), Virginia Maryland Coll Vet Med, Populat Hlth Sci, Blacksburg, VA 24061 USA.
EM bkswart@vt.edu; marta1@vt.edu; aes27@vt.edu; mckennac@vt.edu;
   asbertke@vt.edu
OI Bertke, Andrea/0000-0002-8941-8010
FU Virginia-Maryland College of Veterinary Medicine
FX Funding was provided by startup funding for Andrea S Bertke from
   Virginia-Maryland College of Veterinary Medicine. We would like to
   acknowledge Rebecca Powell-Doherty and Angela Ives for assistance with
   neuronal cultures and critical review of the manuscript, and Emily Price
   (spectacular high school summer intern) for her contribution to this
   project.
CR Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Barzon L., 2016, EUROSURVEILL, V2016
   Bertke AS, 2011, J VIROL, V85, P6669, DOI 10.1128/JVI.00204-11
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   COREY L, 1986, NEW ENGL J MED, V314, P749, DOI 10.1056/NEJM198603203141205
   COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duca LM, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0557-x
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Emery Vincent C, 2017, F1000Res, V6, P138, DOI 10.12688/f1000research.10276.1
   Esposito S, 2017, AUTOIMMUN REV, V16, P96, DOI 10.1016/j.autrev.2016.09.022
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Forman MS, 2017, J INFECT DIS, V215, P1523, DOI 10.1093/infdis/jix188
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Strachan E, 2011, BRAIN BEHAV IMMUN, V25, P1475, DOI 10.1016/j.bbi.2011.06.003
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tanaka K, 2006, J MED VIROL, V78, P757, DOI 10.1002/jmv.20619
   Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
   Tronstein E, 2011, JAMA-J AM MED ASSOC, V305, P1441, DOI 10.1001/jama.2011.420
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 44
TC 8
Z9 11
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-0817
J9 PATHOGENS
JI Pathogens
PD DEC
PY 2017
VL 6
IS 4
AR 49
DI 10.3390/pathogens6040049
PG 10
WC Microbiology
SC Microbiology
GA FP1CH
UT WOS:000417347700005
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Griffin, I
   Zhang, GY
   Fernandez, D
   Cordero, C
   Logue, T
   White, SL
   Llau, A
   Thomas, L
   Moore, E
   Noya-Chaveco, P
   Etienne, M
   Rojas, M
   Goldberg, C
   Rodriguez, G
   Mejia-Echeverry, A
   Rico, E
   Gillis, LD
   Cone, M
   Jean, R
   Rivera, L
AF Griffin, Isabel
   Zhang, Guoyan
   Fernandez, Danielle
   Cordero, Christina
   Logue, Teresa
   White, Stephen L.
   Llau, Anthoni
   Thomas, Lakisha
   Moore, Emily
   Noya-Chaveco, Pedro
   Etienne, Marie
   Rojas, Mercedes
   Goldberg, Cynthia
   Rodriguez, Genevie
   Mejia-Echeverry, Alvaro
   Rico, Edhelene
   Gillis, Leah D.
   Cone, Marshall
   Jean, Reynald
   Rivera, Lillian
TI Epidemiology of Pediatric Zika Virus Infections
SO PEDIATRICS
LA English
DT Article
ID DISEASE; FLORIDA; RNA
AB BACKGROUND AND OBJECTIVE: In July 2016, local transmission of Zika virus (ZIKV) was announced in Miami-Dade County, Florida. In this report, we describe the epidemiology of pediatric ZIKV infections in locally acquired and travel-associated cases.
   METHODS: All children aged 1 to 17 years tested for ZIKV between October 1, 2015, and March 29, 2017, were included. SAS 9.4 was used to analyze age, sex, race and/or ethnicity, origin of exposure, onset date, affiliation with a household cluster, clinical symptoms, hospitalizations, viremia, viruria, and antibody detection in specimens.
   RESULTS: Among 478 confirmed ZIKV cases in Miami-Dade County, 33 (6.9%) occurred in children (1-17 years). Twenty-seven (82.3%) cases were travel-associated. The median age of a pediatric Zika case patient was 11 years. Seventeen (51.5%) case patients were boys, and 23 (69.9%) were Hispanic. Among 31 symptomatic cases, all reported having rash, 25 (80.6%) reported fever, 9 (29.0%) reported conjunctivitis, and 7 (22.6%) reported arthralgia. Sixteen (48.5%) cases reported 2 of 4 and 8 (24.2%) reported 3 of 4 main symptoms.
   CONCLUSIONS: This report found that the majority of children identified during the 2016 ZIKV outbreak only presented with 2 of the 4 main symptoms. In addition, pediatric ZIKV cases were frequently associated with symptomatic household members.
C1 [Griffin, Isabel; Zhang, Guoyan; Fernandez, Danielle; Cordero, Christina; Logue, Teresa; Llau, Anthoni; Thomas, Lakisha; Moore, Emily; Noya-Chaveco, Pedro; Etienne, Marie; Rojas, Mercedes; Goldberg, Cynthia; Rodriguez, Genevie; Mejia-Echeverry, Alvaro; Rico, Edhelene; Jean, Reynald; Rivera, Lillian] Florida Dept Hlth Miami Dade Cty, Dept Epidemiol Dis Control & Immunizat Serv, 8600 NW 17th St,Suite 200, Miami, FL 33126 USA.
   [White, Stephen L.; Gillis, Leah D.; Cone, Marshall] Bur Publ Hlth Labs, Div Dis Control & Hlth Protect, Miami, FL USA.
RP Griffin, I (corresponding author), Florida Dept Hlth Miami Dade Cty, Dept Epidemiol Dis Control & Immunizat Serv, 8600 NW 17th St,Suite 200, Miami, FL 33126 USA.
EM isabel.griffin@flhealth.gov
RI Cordero, Christina/Q-1273-2019
OI Cordero, Christina/0000-0003-1032-5303; White,
   Stephen/0000-0002-2112-1560
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Centers for Disease Control and Prevention, 2017, CDC ZIK INT RESP PLA
   Centers for Disease Control and Prevention, 2017, DIAGN TESTS ZIK VIR
   Centers for Disease Control and Prevention. National Notifiable Disease Surveillance System, 2016, ZIK VIR DIS ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Florida Department of Health, 2016, ZIK FEV INF CLIN VER
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Unites States Census Bureau, 2010 2014 AM COMM SU
NR 16
TC 5
Z9 5
U1 0
U2 3
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD DEC
PY 2017
VL 140
IS 6
AR e20172044
DI 10.1542/peds.2017-2044
PG 7
WC Pediatrics
SC Pediatrics
GA FO3ZN
UT WOS:000416777100045
OA Bronze
DA 2020-07-08
ER

PT J
AU Sarno, M
   Aquino, M
   Pimentel, K
   Cabral, R
   Costa, G
   Bastos, F
   Brites, C
AF Sarno, M.
   Aquino, M.
   Pimentel, K.
   Cabral, R.
   Costa, G.
   Bastos, F.
   Brites, C.
TI Progressive lesions of central nervous system in microcephalic fetuses
   with suspected congenital Zika virus syndrome
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Article
DE Brazil; congenital Zika virus syndrome; fetal defects; microcephaly;
   ultrasound; Zika virus
AB Objective To describe the pattern and progression of central nervous system (CNS) lesions in microcephalic fetuses with suspected Zika virus (ZIKV) infection.
   Methods In this prospective study in Salvador, Brazil, we analyzed fetuses diagnosed with microcephaly and suspected ZIKV infection after a routine primary care ultrasound scan between July 2015 and February 2016 raised suspicion of fetal microcephaly. The pregnancies were followed with serial ultrasound scans until delivery at one of the three main referral centers for fetal abnormalities in Salvador, Brazil. Microcephaly was diagnosed when the head circumference was two or more SDs below the mean for gestational age and its relationship with ZIKV infection was defined according to the World Health Organization's criteria. All women were interviewed, to assess potential factors associated with fetal microcephaly. Serology test results for toxoplasmosis, cytomegalovirus, rubella, syphilis and human immunodeficiency virus (HIV) were recorded, as were previous routine ultrasound results. Signs/symptoms of infection during the pregnancy were noted.
   Results Of 60 cases of suspected ZIKV-related fetal microcephaly seen during the study period, eight were excluded due to serological evidence of other congenital infections or major ultrasound chromosomal markers. In the remaining 52 fetuses, microcephaly was diagnosed between 19 and 40 (median, 27.7; interquartile range, 23.4-32.0) weeks of gestation. The main ultrasound findings were: ventriculomegaly (65.4% of cases), cerebral calcifications (44.2%) and posterior fossa abnormalities (32.7%). 9.6% presented with arthrogryposis as an associated finding. Microcephaly was an isolated finding in four cases (7.7%). While ventriculomegaly was progressive in 41.2% of cases with this finding, the velocity of head circumference increase decreased progressively in almost all cases. Exanthematic disease was present in the majority (86.5%) of the women, 67.3% presenting in the first trimester of pregnancy. Additional lesions were detected after birth in 71.4% of the 35 cases with neonatal follow-up.
   Conclusions The majority of cases of congenital ZIKV syndrome have other ultrasonographic findings in addition to microcephaly. ZIKV-related CNS anomalies present mainly as progressive CNS lesions and slowing rate of growth of the fetal head, and this seems to be evident only in the late second trimester, even when maternal infection occurs in the first trimester. Other ultrasound findings, such as ventriculomegaly, brain calcifications and posterior fossa destruction lesions, are also common in this congenital syndrome. Posterior fossa destruction lesions and arthrogryposis are an uncommon finding in other congenital infections, perhaps suggesting a novel severe congenital syndrome associated with fetal ZIKV. Copyright (C) 2016 ISUOG. Published by John Wiley & Sons Ltd.
C1 [Sarno, M.; Aquino, M.; Pimentel, K.; Cabral, R.] Univ Fed Bahia, Maternidade Climerio Oliveira, Rua Limoeiro 137, BR-40055150 Salvador, BA, Brazil.
   [Sarno, M.; Aquino, M.; Pimentel, K.] Caliper Escola Imagem, Ultrasound Training Ctr, Salvador, BA, Brazil.
   [Sarno, M.; Pimentel, K.] Hosp Geral Roberto Santos, Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Costa, G.; Bastos, F.; Brites, C.] Univ Fed Bahia, Salvador, BA, Brazil.
RP Sarno, M (corresponding author), Univ Fed Bahia, Maternidade Climerio Oliveira, Rua Limoeiro 137, BR-40055150 Salvador, BA, Brazil.
EM manoelsarno@ufba.br
RI Brites, Carlos/D-1353-2013
OI Brites, Carlos/0000-0002-4673-6991
CR Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   [Anonymous], 2016, PROT VIG RESP OC MIC, P17
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   HADLOCK FP, 1991, J ULTRAS MED, V10, P557
   Javanbakht Javad, 2014, Diagn Pathol, V9, P223, DOI 10.1186/s13000-014-0223-7
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MILLER E, 1982, LANCET, V2, P781
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Thiebaut R, 2007, LANCET, V369, P115
   Villar J, 2014, LANCET DIABETES ENDO, V2, P781, DOI 10.1016/S2213-8587(14)70121-4
   WHO, 2016, PREGN MAN CONT ZIK V
NR 17
TC 16
Z9 17
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD DEC
PY 2017
VL 50
IS 6
BP 717
EP 722
DI 10.1002/uog.17303
PG 6
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA FP0AM
UT WOS:000417260500007
PM 27644020
OA Bronze
DA 2020-07-08
ER

PT J
AU Asif, A
   Manzoor, S
   Fatima-Tuz-Zahra
   Saalim, M
   Ashraf, M
   Ishtiyaq, J
   Khalid, M
AF Asif, Arun
   Manzoor, Sobia
   Fatima-Tuz-Zahra
   Saalim, Muhammad
   Ashraf, Maliha
   Ishtiyaq, Javeria
   Khalid, Madiha
TI Zika Virus: Immune Evasion Mechanisms, Currently Available Therapeutic
   Regimens, and Vaccines
SO VIRAL IMMUNOLOGY
LA English
DT Review
DE ZIKV; immune escape; vaccines; therapeutics; nucleoside analogs
ID WEST-NILE-VIRUS; GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS;
   JAPANESE-ENCEPHALITIS; DENDRITIC CELLS; IFITM PROTEINS; YELLOW-FEVER;
   INTERFERON; NS1; INFECTION
AB The sudden emergence of infectious pathogens such as Zika virus (ZIKV) holds global health concerns. Recent dissemination of ZIKV from Pacific to Americas with an upsurge of congenital anomalies and Guillain Barre Syndrome (GBS) in adults has created an alarming situation. High-throughput studies are in progress to understand ZIKV's mode of pathogenesis and mechanism of immune escape, yet the pathogenesis remains obscure. Mainly ZIKV's envelope (E) protein and nonstructural proteins (mainly NS1 and NS5) manipulate host cell to support viral immune escape by modulation of the interferon pathway and complement antagonism. The development of direct therapeutics for ZIKV infection is required to overcome the rapidly evolving viral threat. Currently, the existing strategies for ZIKV treatment are only supportive. Although, there is no prophylactic or therapeutic vaccine presently available, however, recent efforts have brought up ZIKV vaccines into clinical trial phase 1. This review presents the highlights of recent advances in understanding immune evasion strategies adapted by ZIKV and existing therapies against the virus.
C1 [Asif, Arun; Manzoor, Sobia; Fatima-Tuz-Zahra; Saalim, Muhammad; Ashraf, Maliha; Ishtiyaq, Javeria; Khalid, Madiha] Natl Univ Sci & Technol, Atta ur Rahman Sch Appl Biosci, Islamabad 44000, Pakistan.
RP Manzoor, S (corresponding author), Natl Univ Sci & Technol, Atta ur Rahman Sch Appl Biosci, Islamabad 44000, Pakistan.
EM lcianunique@yahoo.com
OI khalid, madiha/0000-0001-7647-354X
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beasley DWC, 2008, EXPERT OPIN BIOL TH, V8, P95, DOI 10.1517/14712598.8.1.95
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Caroline AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002790
   Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Conde JN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00213
   Conde JN, 2016, J VIROL, V90, P9570, DOI 10.1128/JVI.00912-16
   Crotty S, 2000, NAT MED, V6, P1375
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313
   Fulton BO, 2017, J VIROL, V91, DOI 10.1128/JVI.00698-17
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Holmes RS, 2011, 3 BIOTECH, V1, P99, DOI 10.1007/s13205-011-0013-9
   Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Iglesias NG, 2009, FLAVIVIRUSES VIRAL G, P41
   Izmailova E, 2003, NAT MED, V9, P191, DOI 10.1038/nm822
   Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124
   Li L, 2012, J BIOTECHNOL, V162, P171, DOI 10.1016/j.jbiotec.2012.08.012
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Maciel M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003693
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Mackenzie JM, 1996, J VIROL METHODS, V56, P67, DOI 10.1016/0166-0934(95)01916-2
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110
   May M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161355
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Monath TP, 2011, NEW ENGL J MED, V364, P1326, DOI 10.1056/NEJMoa1009303
   Monath TP, 2002, J VIROL, V76, P1932, DOI 10.1128/JVI.76.4.1932-1943.2002
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Mounce BC, 2016, CELL HOST MICROBE, V20, P167, DOI 10.1016/j.chom.2016.06.011
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Mumtaz N, 2016, CURR TREAT OPTIONS I, V8, P208, DOI [10.1007/s40506-016-0083-7, DOI 10.1007/S40506-016-0083-7]
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Orlinger KK, 2011, J INFECT DIS, V203, P1556, DOI 10.1093/infdis/jir122
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318
   Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008
   Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tartour K, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0103-y
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   Wang F, 2012, CARDIOVASC RES, V93, P190, DOI 10.1093/cvr/cvr260
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 110
TC 9
Z9 11
U1 0
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0882-8245
EI 1557-8976
J9 VIRAL IMMUNOL
JI Viral Immunol.
PD DEC
PY 2017
VL 30
IS 10
BP 682
EP 690
DI 10.1089/vim.2017.0046
PG 9
WC Immunology; Virology
SC Immunology; Virology
GA FO1XK
UT WOS:000416562200002
PM 29028178
DA 2020-07-08
ER

PT J
AU Curry, CL
   Kwal, J
   Bartlett, M
   Crane, A
   Greissman, S
   Gunaratne, N
   Lardy, M
   Picon, M
   Starker, R
   Tse, C
   Potter, J
   Rodriguez, P
   Gonzalez, I
AF Curry, C. L.
   Kwal, J.
   Bartlett, M.
   Crane, A.
   Greissman, S.
   Gunaratne, N.
   Lardy, M.
   Picon, M.
   Starker, R.
   Tse, C.
   Potter, J.
   Rodriguez, P.
   Gonzalez, I.
TI Outcomes of women with laboratory evidence of zika infection in
   pregnancy
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (ISDOG)
CY AUG 10-12, 2017
CL Park City, UT
SP Infect Dis Soc Obstet & Gynecol
C1 [Curry, C. L.; Kwal, J.; Bartlett, M.; Crane, A.; Greissman, S.; Gunaratne, N.; Lardy, M.; Picon, M.; Starker, R.; Tse, C.; Potter, J.; Rodriguez, P.; Gonzalez, I.] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA.
   [Curry, C. L.; Rodriguez, P.; Gonzalez, I.] Jackson Mem Hosp, Miami, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD DEC
PY 2017
VL 217
IS 6
MA 23
BP 722
EP 722
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FO6DA
UT WOS:000416950700058
DA 2020-07-08
ER

PT J
AU Kallam, B
   Abuhamad, A
   Hermida, J
   Nesi, F
   Joseph, ML
   Fiekowsky, E
   Noguchi, L
AF Kallam, B.
   Abuhamad, A.
   Hermida, J.
   Nesi, F.
   Joseph, Max Lelio
   Fiekowsky, E.
   Noguchi, L.
TI Development of obstetric ultrasound service delivery assessment tools in
   the context of the zika virus epidemic in five USAID priority countries
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (ISDOG)
CY AUG 10-12, 2017
CL Park City, UT
SP Infect Dis Soc Obstet & Gynecol
C1 [Kallam, B.; Fiekowsky, E.; Noguchi, L.] USAIDs Maternal & Child Survival Program MCSP, Washington, DC USA.
   [Abuhamad, A.] Soc Maternal Fetal Med, Washington, DC USA.
   [Hermida, J.] USAIDs Applying Sci Strengthen & Improve Syst ASS, Bethesda, MD USA.
   [Nesi, F.; Joseph, Max Lelio] MCSP Haiti, Port Au Prince, Haiti.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD DEC
PY 2017
VL 217
IS 6
MA 6
BP 724
EP 725
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FO6DA
UT WOS:000416950700064
DA 2020-07-08
ER

PT J
AU Curry, CL
   Kwal, J
   Bartlett, M
   Crane, A
   Greissman, S
   Gunaratne, N
   Lardy, M
   Picon, M
   Starker, R
   Tse, C
   Potter, J
   Rodriguez, P
   Gonzalez, I
AF Curry, C. L.
   Kwal, J.
   Bartlett, M.
   Crane, A.
   Greissman, S.
   Gunaratne, N.
   Lardy, M.
   Picon, M.
   Starker, R.
   Tse, C.
   Potter, J.
   Rodriguez, P.
   Gonzalez, I.
TI Challenges in universal testing for zika in the setting of local
   mosquito-borne transmission
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (ISDOG)
CY AUG 10-12, 2017
CL Park City, UT
SP Infect Dis Soc Obstet & Gynecol
C1 [Curry, C. L.; Kwal, J.; Bartlett, M.; Crane, A.; Greissman, S.; Gunaratne, N.; Lardy, M.; Picon, M.; Starker, R.; Tse, C.; Potter, J.; Rodriguez, P.; Gonzalez, I.] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA.
   [Curry, C. L.; Rodriguez, P.; Gonzalez, I.] Jackson Mem Hosp, Miami, FL 33136 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD DEC
PY 2017
VL 217
IS 6
MA 11
BP 726
EP 726
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FO6DA
UT WOS:000416950700069
DA 2020-07-08
ER

PT J
AU Curry, CL
   Kwal, J
   Bartlett, M
   Crane, A
   Greissman, S
   Gunaratne, N
   Lardy, M
   Picon, M
   Starker, R
   Tse, C
   Potter, J
   Rodriguez, P
   Gonzalez, I
AF Curry, C. L.
   Kwal, J.
   Bartlett, M.
   Crane, A.
   Greissman, S.
   Gunaratne, N.
   Lardy, M.
   Picon, M.
   Starker, R.
   Tse, C.
   Potter, J.
   Rodriguez, P.
   Gonzalez, I.
TI Disparities in insurance status and primary language spoken in women
   with zika infection in pregnancy
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (ISDOG)
CY AUG 10-12, 2017
CL Park City, UT
SP Infect Dis Soc Obstet & Gynecol
C1 [Curry, C. L.; Kwal, J.; Bartlett, M.; Crane, A.; Greissman, S.; Gunaratne, N.; Lardy, M.; Picon, M.; Starker, R.; Tse, C.; Potter, J.; Rodriguez, P.; Gonzalez, I.] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA.
   [Curry, C. L.; Rodriguez, P.; Gonzalez, I.] Jackson Mem Hosp, Miami, FL 33136 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD DEC
PY 2017
VL 217
IS 6
MA 12
BP 726
EP 727
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FO6DA
UT WOS:000416950700070
DA 2020-07-08
ER

PT J
AU Goldfarb, I
   Lopez, G
   Naqvi, M
   Riley, L
AF Goldfarb, I.
   Lopez, G.
   Naqvi, M.
   Riley, L.
TI ZIKV exposed pregnant women: testing utilization and pregnancy outcomes
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (ISDOG)
CY AUG 10-12, 2017
CL Park City, UT
SP Infect Dis Soc Obstet & Gynecol
C1 [Goldfarb, I.; Riley, L.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA.
   [Lopez, G.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   [Naqvi, M.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD DEC
PY 2017
VL 217
IS 6
MA 21
BP 730
EP 731
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FO6DA
UT WOS:000416950700079
DA 2020-07-08
ER

PT J
AU Segal, TR
   Minguez-Alarcon, L
   Chiu, YH
   Williams, PL
   Nassan, FL
   Dadd, R
   Ospina, M
   Calafat, AM
   Hauser, R
AF Segal, Thalia R.
   Minguez-Alarcon, Lidia
   Chiu, Yu-Han
   Williams, Paige L.
   Nassan, Feiby L.
   Dadd, Ramace
   Ospina, Maria
   Calafat, Antonia M.
   Hauser, Russ
CA Earth Study Team
TI Urinary concentrations of 3-(diethylcarbamoyl) benzoic acid (DCBA), a
   major metabolite of N, N-diethyl-m-toluamide (DEET) and semen parameters
   among men attending a fertility center
SO HUMAN REPRODUCTION
LA English
DT Article
DE DEET; DCBA; insect repellent; male fertility; semen parameters
ID INSECT REPELLENT N,N-DIETHYL-M-TOLUAMIDE; OXIDATIVE METABOLITES;
   EXPOSURE; PERMETHRIN; ABSORPTION; BIOMARKERS; MORPHOLOGY; PESTICIDE;
   PREGNANCY; TOXICITY
AB STUDY QUESTION: Are specific gravity (SG)-adjusted urinary concentrations of 3-(diethylcarbamoyl) benzoic acid (DCBA) associated with semen parameters among men attending an academic fertility center?
   SUMMARY ANSWER: Our study did not demonstrate any association between SG-adjusted urinary DCBA concentrations and semen parameters among men attending an academic fertility center.
   WHAT IS KNOWN ALREADY: N, N-Diethyl-m-toluamide (DEET) is the most common active ingredient in consumer insect repellents. The recent rise in public health concerns regarding mosquito-borne diseases such as Zika, have led to an increased use of DEET insect repellents, especially among couples planning pregnancy. Animal studies have observed reproductive toxicity from DEET exposure. However, the reproductive health effects of DEET and its metabolites on human reproduction are unknown.
   STUDY DESIGN, SIZE, DURATION: Between 2007 and 2015, 90 men participating in a prospective cohort study at the Massachusetts General Hospital Fertility Center provided 171 urine samples and 250 semen samples for analysis.
   PARTICIPANTS/MATERIALS, SETTING, METHODS: The urinary concentrations of DEET, N, N-diethyl-3-hydroxymethylbenzamide (DHMB) and DCBA were quantified by isotope-dilution tandem mass spectrometry and adjusted by SG. We used linear mixed models to evaluate the association between tertiles of SG-adjusted urinary DCBA concentrations and semen parameters (semen volume, sperm concentration, total sperm count, progressive motility, total progressive motility count, normal morphology and total normal morphology count), adjusting for covariates. DEET and DHMB were not considered for analysis because of the low percentage of detectable concentrations (<7%). Effect modification by BMI and smoking status was explored.
   MAIN RESULTS AND THE ROLE OF CHANCE: Participants had a median age of 36 years and BMI of 27 kg/m(2), and 68% had never smoked. The SG-adjusted geometric mean DCBA urinary concentration was 2.20 mu g/l, with 85% detection frequency. The majority of semen parameters fell within the normal range with the exception of progressive motility, where 64% of the men had values below the WHO 2010 lower reference limits. SG-adjusted urinary DCBA concentrations were not associated with semen parameters in unadjusted or adjusted models. Men in the highest tertile of SG-adjusted urinary DCBA concentrations had comparable semen parameters to men in the lowest tertile (2.59 vs. 2.88 ml for semen volume, 47.9 vs. 45.8 million/ml for sperm concentration, 116 vs. 118 million for total sperm count, 25 vs. 24% for progressive sperm motility, and 6.1 vs. 5.8% for morphologically normal sperm). In addition, BMI and smoking status did not modify the associations.
   LIMITATIONS REASONS FOR CAUTION: We had a relatively small sample size with similar socioeconomic backgrounds and with overall relatively low urinary concentrations of DEET biomarkers. However, our sample size was enough to detect moderate differences with at least 80% statistical power, between the first and third tertiles of urinary DCBA concentrations. Limitations also include possible misclassification of DCBA exposure and difficulties in extrapolating the findings to the general population.
   WIDER IMPLICATIONS OF THE FINDINGS: Our study found no associations between urinary concentrations of DCBA, a major metabolite of the insect repellent DEET, and semen parameters in men presenting for infertility treatment. While these results are reassuring, further studies including larger sample sizes and higher exposures are warranted.
C1 [Segal, Thalia R.] Univ Hosp Cleveland Med Ctr, Reprod Endocrinol & Infertil, Cleveland, OH 44122 USA.
   [Segal, Thalia R.] Case Western Reserve Univ, Cleveland, OH 44122 USA.
   [Minguez-Alarcon, Lidia; Nassan, Feiby L.; Dadd, Ramace; Hauser, Russ] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, 665 Huntington Ave, Boston, MA 02115 USA.
   [Chiu, Yu-Han] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Biostat, Boston, MA 02115 USA.
   [Williams, Paige L.; Hauser, Russ] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Biostat, Boston, MA 02115 USA.
   [Williams, Paige L.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   [Hauser, Russ] Massachusetts Gen Hosp, Vincent Obstet & Gynecol, Boston, MA 02115 USA.
   [Hauser, Russ] Harvard Med Sch, Boston, MA 02115 USA.
   [Ospina, Maria; Calafat, Antonia M.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.
RP Minguez-Alarcon, L (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, 665 Huntington Ave, Boston, MA 02115 USA.
EM lminguez@hsph.harvard.edu
RI Calafat, Antonia/N-1183-2019; Nassan, Feiby/J-5876-2019
OI Nassan, Feiby/0000-0002-3204-0694
FU National Institute of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01ES022955,
   R01ES009718]; National Institute of Environmental Health Sciences
   (NIEHS)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [P30ES000002]
FX The project was financed by National Institute of Health (NIH) grants
   R01ES022955 and R01ES009718 and by grant P30ES000002 from the National
   Institute of Environmental Health Sciences (NIEHS).
CR Abou-Donia MB, 2003, J TOXICOL ENV HEAL A, V66, P57, DOI 10.1080/15287390306463
   Aronson D, 2012, INTEGR ENVIRON ASSES, V8, P135, DOI 10.1002/ieam.271
   ATSDR, 2017, DRAFT TOX PROF DEET
   Briassoulis G, 2001, HUM EXP TOXICOL, V20, P8, DOI 10.1191/096032701676731093
   Calafat AM, 2016, ENVIRON INT, V92-93, P398, DOI 10.1016/j.envint.2016.04.021
   CDC, 2017, AV BUG BIT TRAV HLTH
   Chen-Hussey V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-173
   Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048
   Costanzo SD, 2007, SCI TOTAL ENVIRON, V384, P214, DOI 10.1016/j.scitotenv.2007.05.036
   EPA, 2017, INS REP US EFF
   EPA, 2017, RER EL DEC RED DEET
   FELDMANN RJ, 1970, J INVEST DERMATOL, V54, P399, DOI 10.1111/1523-1747.ep12259184
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]
   Kepner J., 2004, PESTICIDES YOU, V23, P17
   KRUGER TF, 1988, FERTIL STERIL, V49, P112
   Kuklenyik P, 2013, ANAL CHIM ACTA, V787, P267, DOI 10.1016/j.aca.2013.05.055
   LEBOWITZ H, 1983, DRUG CHEM TOXICOL, V6, P379, DOI 10.3109/01480548309082717
   Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010
   Merel S, 2016, ENVIRON INT, V96, P98, DOI 10.1016/j.envint.2016.09.004
   Pearson MA, 2009, J EXPO SCI ENV EPID, V19, P336, DOI 10.1038/jes.2008.48
   ROBBINS PJ, 1986, J TOXICOL ENV HEALTH, V18, P503, DOI 10.1080/15287398609530891
   Rooney KL, 2014, CURR OPIN OBSTET GYN, V26, P181, DOI 10.1097/GCO.0000000000000069
   Sandstrom MW, 2005, ENVIRON TOXICOL CHEM, V24, P1029, DOI 10.1897/04-297R.1
   SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063
   SELIM S, 1995, FUND APPL TOXICOL, V25, P95, DOI 10.1006/faat.1995.1043
   Sharma R, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-66
   Smith KW, 2012, ENVIRON HEALTH PERSP, V120, P1538, DOI 10.1289/ehp.1104614
   Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P1478, DOI 10.1289/ehp.6417
   Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035
   World Health Organization, 2010, WHO LAB MAN EX PROC
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
NR 32
TC 1
Z9 1
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD DEC
PY 2017
VL 32
IS 12
BP 2532
EP 2539
DI 10.1093/humrep/dex327
PG 8
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FO7LK
UT WOS:000417055700020
PM 29077936
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Jiang, Y
   Leib, D
AF Jiang, Yike
   Leib, David
TI Preventing neonatal herpes infections through maternal immunization
SO FUTURE VIROLOGY
LA English
DT Editorial Material
DE congenital infection; maternal immunization; neonatal HSV; vaccine
ID SIMPLEX-VIRUS-INFECTIONS; RECOMBINANT GLYCOPROTEIN VACCINE; ZIKA VIRUS;
   MICE; PROTECTION; ANTIBODIES; EFFICACY; TRANSMISSION; REPLICATION;
   DELIVERY
AB "Compared with the long-term protection required of vaccines against genital HSV, maternal vaccines would only need to induce an antibody response during the perinatal period to be effective in the newborn Compared with the long-term protection required of vaccines against genital HSV, maternal vaccines would only need to induce an antibody response during the perinatal period to be effective in the newbor"
C1 [Jiang, Yike; Leib, David] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.
RP Leib, D (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.
EM david.a.leib@dartmouth.edu
FU Munck-Pfefferkorn Education and Research Fund; Geisel School of Medicine
   Molecular and Cellular Biology Program Training Grant [T32GM8704]; NRSA
   Individual Predoctoral Fellowship from the NIH [F30EY026487];  [RO1
   EY09083];  [PO1 AI098681]
FX The authors appreciate input from Audra Charron and other Leib Lab
   members, support from the Munck-Pfefferkorn Education and Research Fund
   to DA Leib, and RO1 EY09083 and PO1 AI098681 to DA Leib. Y Jiang
   received support from Geisel School of Medicine Molecular and Cellular
   Biology Program Training Grant T32GM8704 and NRSA Individual Predoctoral
   Fellowship F30EY026487 from the NIH. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.
CR ASHLEY RL, 1992, J CLIN INVEST, V90, P511, DOI 10.1172/JCI115888
   Awasthi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006141
   Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203
   Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Demmler-Harrison GJ, 2016, UPTODATE
   Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748
   HAYASHI Y, 1983, J GEN VIROL, V64, P1007, DOI 10.1099/0022-1317-64-5-1007
   Hoshino Y, 2005, J VIROL, V79, P410, DOI 10.1128/JVI.79.1.410-418.2005
   Jiang Y, 2017, MBIO, V8, DOI [10.1128/mBio.00678-17, 10.1128/mbio.00678-17]
   Kimberlin DW, 2001, PEDIATRICS, V108, P230, DOI 10.1542/peds.108.2.230
   KOHL S, 1984, J INFECT DIS, V149, P38, DOI 10.1093/infdis/149.1.38
   Kowal C, 2015, IMMUNOL RES, V63, P18, DOI 10.1007/s12026-015-8714-5
   LANGENBERG AGM, 1995, ANN INTERN MED, V122, P889, DOI 10.7326/0003-4819-122-12-199506150-00001
   Looker KJ, 2017, LANCET GLOB HEALTH, V5, pE300, DOI [10.1016/S2214-109X(16)30362-X, 10.1016/s2214-109x(16)30362-x]
   Nelson CS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94002
   Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446
   PROBER CG, 1987, NEW ENGL J MED, V316, P240, DOI 10.1056/NEJM198701293160503
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
NR 20
TC 2
Z9 2
U1 0
U2 1
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD DEC
PY 2017
VL 12
IS 12
BP 709
EP 711
DI 10.2217/fvl-2017-0105
PG 3
WC Virology
SC Virology
GA FO6LW
UT WOS:000416975700001
PM 29339967
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Elfiky, AA
AF Elfiky, Abdo A.
TI Zika virus: novel guanosine derivatives revealed strong binding and
   possible inhibition of the polymerase
SO FUTURE VIROLOGY
LA English
DT Article
DE guanosine derivatives; molecular modeling; polymerase; protein-ligand
   docking; zika virus
ID HEPATITIS-C-VIRUS; DEPENDENT RNA-POLYMERASE; ANTI-HCV DRUGS;
   SERINE-PROTEASE; SOFOSBUVIR; OUTBREAK; THERAPY; OPTIMIZATION;
   CONFORMATION; MICRONESIA
AB Aim: During the last 2 years, the zika virus (ZIKV) outbreak has rapidly spread worldwide to more than 80 countries. In the last decade, nucleotide inhibitors (NIs) have been widely studied against different viruses such as HCV and human coronaviruses. Materials & methods: In this study, four novel guanosine derivatives were tested in silico against ZIKV polymerase. Discussion: The modified guanosines at position 2' in the ribose ring gave comparable binding energies to that of GTP; hence, it could compete with GTP for the ZIKV polymerase active site and halt viral replication. Conclusion: The suggested guanosine derivatives had a higher affinity than ribavirin (wide range antiviral drug) in binding to ZIKV polymerase.
C1 [Elfiky, Abdo A.] Cairo Univ, Biophys Dept, Fac Sci, Giza, Egypt.
   [Elfiky, Abdo A.] Abdus Salam Int Ctr Theoret Phys, Quantitat Life Sci Dept, Trieste, Italy.
RP Elfiky, AA (corresponding author), Cairo Univ, Biophys Dept, Fac Sci, Giza, Egypt.; Elfiky, AA (corresponding author), Abdus Salam Int Ctr Theoret Phys, Quantitat Life Sci Dept, Trieste, Italy.
EM abdo@sci.cu.edu.eg
RI Mohamed, Abdo/H-3595-2019
OI Mohamed, Abdo/0000-0003-4600-6240
CR Asselah T, 2014, J HEPATOL, V61, P435, DOI 10.1016/j.jhep.2014.04.042
   Beaulieu PL, 2011, BIOORG MED CHEM LETT, V21, P3658, DOI 10.1016/j.bmcl.2011.04.059
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Das D, 2011, BIOORGAN MED CHEM, V19, P4690, DOI 10.1016/j.bmc.2011.06.079
   De Francesco R, 2003, ANTIVIR RES, V58, P1, DOI 10.1016/S0166-3542(03)00028-7
   De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elfiky AA, 2017, J MED VIROL, V89, P1040, DOI 10.1002/jmv.24736
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Elfiky AA, 2015, J COMPUT THEOR NANOS, V12, P376, DOI 10.1166/jctn.2015.3739
   Elfiky AA, 2013, PROTEIN J, V32, P75, DOI 10.1007/s10930-013-9462-9
   Gonzalez-Grande R, 2016, WORLD J GASTROENTERO, V22, P1421, DOI 10.3748/wjg.v22.i4.1421
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemon SM, 2010, ANTIVIR RES, V86, P79, DOI 10.1016/j.antiviral.2010.02.003
   LII JH, 1989, J AM CHEM SOC, V111, P8576, DOI 10.1021/ja00205a003
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muegge I., 1999, VIRTUAL SCREENING AL
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Saleh NA, 2014, J COMPUT THEOR NANOS, V11, P544, DOI 10.1166/jctn.2014.3392
   STEWART JJP, 1991, J COMPUT CHEM, V12, P320, DOI 10.1002/jcc.540120306
   Summers KL, 2012, BIOCHEM BIOPH RES CO, V425, P485, DOI 10.1016/j.bbrc.2012.07.141
   Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
   Tong J, 2012, J ZHEJIANG UNIV-SC B, V13, P56, DOI 10.1631/jzus.B1100120
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
   Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17
   Yang PL, 2011, CURR OPIN VIROL, V1, P607, DOI 10.1016/j.coviro.2011.10.019
   Zumla A, 2016, INT J INFECT DIS, V45, P92, DOI 10.1016/j.ijid.2016.02.1007
NR 41
TC 8
Z9 8
U1 0
U2 4
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD DEC
PY 2017
VL 12
IS 12
BP 720
EP 727
DI 10.2217/fvl-2017-0081
PG 8
WC Virology
SC Virology
GA FO6LW
UT WOS:000416975700003
DA 2020-07-08
ER

PT J
AU Holcapkova, P
   Stloukal, P
   Kucharczyk, P
   Omastova, M
   Kovalcik, A
AF Holcapkova, Pavlina
   Stloukal, Petr
   Kucharczyk, Pavel
   Omastova, Maria
   Kovalcik, Adriana
TI Anti-hydrolysis effect of aromatic carbodiimide in poly(lactic
   acid)/wood flour composites
SO COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING
LA English
DT Article
DE Biocomposite; Environmental degradation; Rheological properties; Thermal
   analysis
ID POLYLACTIC ACID COMPOSITES; WOOD FLOUR; THERMAL-DEGRADATION;
   MECHANICAL-PROPERTIES; SURFACE MODIFICATION; PLA; BIODEGRADATION;
   MORPHOLOGY; CRYSTALLIZATION; NANOCOMPOSITES
AB Poly(lactic acid) (PLA) filled with wood flour (WF) is more susceptible to hydrolysis compared to pure PLA. This work shows that the hydrolysis reactions leading to chain scission can be hindered by using 2 wt% of bis(2,6-diisopropylphenyl)carbodiimide (ZIKA). It was found that the addition of ZIKA supports the crosslinking of PLANE composite. The crosslinking slightly hindered the annealing efficiency of wood flour and increased the stiffness of biocomposites. The thermal stability of biocomposites containing ZIKA was slightly improved. The relevante of the antihydrolysis effect of ZIKA during melt processing of biocomposites was correlated with the rheological and molar mass properties. The hydrolytic stability of biocomposites was determined under buffer solution conditions at accelerated temperature 80 C and pH of 7. The determined lower depolymerisation and hydrolysis rates of PLA/WF-ZIKA composites indicate that the service lifespan of biocomposites can be prolonged by the addition of ZIKA additive. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Holcapkova, Pavlina; Stloukal, Petr; Kucharczyk, Pavel] Tomas Bata Univ Zlin, Ctr Polymer Syst, Univ Inst, Tr T Bati 5678, Zlin 76001, Czech Republic.
   [Omastova, Maria] Slovak Acad Sci, Polymer Inst, Dubravska Cesta 9, Bratislava 84541 45, Slovakia.
   [Kovalcik, Adriana] Kompetenzzentrum Holz GmbH Wood K Plus, Altenberger Str 69, A-4040 Linz, Austria.
   [Kovalcik, Adriana] Brno Univ Technol, Dept Food Chem & Biotechnol, Fac Chem, Purkynova 118, Brno 61200, Czech Republic.
RP Kovalcik, A (corresponding author), Kompetenzzentrum Holz GmbH Wood K Plus, Altenberger Str 69, A-4040 Linz, Austria.
EM adriana.kovalcik@gmail.com
RI Kucharczyk, Pavel/H-6407-2012; UTB, CPS/O-8185-2018; Stloukal,
   Petr/D-2654-2016; Omastova, Maria/E-8059-2010
OI Stloukal, Petr/0000-0002-7787-4780; 
FU European Regional Development Fund (EFRE)European Union (EU); province
   of Upper Austria through program IWB - Upper Austria [project BioRest];
   Ministry of Education, Youth and Sport of the Czech Republic (MEYS)
   through the project "Materials Research Centre - Sustain ability and
   Development" [LO1211]; Czech Science Foundation (GACR)Grant Agency of
   the Czech Republic [17-16928Y]; Ministry of Education, Youth and Sports
   of the Czech Republic (MEYS)Ministry of Education, Youth & Sports -
   Czech Republic [LO1504]; Research & Development Operational Programme -
   ERDF
FX This work was supported by the European Regional Development Fund (EFRE)
   and the province of Upper Austria through program IWB 2014-2020 - Upper
   Austria [project BioRest]; the Ministry of Education, Youth and Sport of
   the Czech Republic (MEYS) through the project "Materials Research Centre
   - Sustain ability and Development" Nr. LO1211; the Czech Science
   Foundation (GACR) [Grant no. 17-16928Y]; and the Ministry of Education,
   Youth and Sports of the Czech Republic (MEYS) [Grant no. LO1504].
   Furthermore, this publication is the result of the project
   implementation: Centre for materials, layers and systems for
   applications and chemical processes under extreme conditions, Part II
   supported by the Research & Development Operational Programme funded by
   the ERDF. Also, we would like to thank Christian Hansmann (Wood K Plus)
   for the supplying of the thermally treated spruce wood fibres.
CR [Anonymous], 2017, RAW MAT PRICES PLAST
   [Anonymous], 2016, BIOP FACTS STAT 2016
   Arza CR, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41836
   Awal A, 2015, MECH MATER, V80, P87, DOI 10.1016/j.mechmat.2014.09.009
   Azwar E, 2012, POLYM DEGRAD STABIL, V97, P281, DOI 10.1016/j.polymdegradstab.2011.12.017
   Cailloux J, 2016, COMPOS PART A-APPL S, V88, P106, DOI 10.1016/j.compositesa.2016.05.024
   Chen F, 2008, IND ENG CHEM RES, V47, P8667, DOI 10.1021/ie800930j
   DANIELS CD, 1989, POLYM STRUCTURE PROP
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   Gaudin S, 2007, MATER TECHNOL-FR, V95, P143, DOI 10.1051/mattech:2007039
   Gregorova A, 2009, J APPL POLYM SCI, V114, P2616, DOI 10.1002/app.30819
   Gregorova A, 2011, J POLYM ENVIRON, V19, P372, DOI 10.1007/s10924-011-0292-6
   Gregorova A, 2011, POLYM ENG SCI, V51, P143, DOI 10.1002/pen.21799
   Gregoroval A, 2012, FILLER MATRIX COMPAT, P97
   Hou L, 2010, MELT STABLE HYDROLYS, P50
   Hrabalova M, 2010, J APPL POLYM SCI, V118, P1534, DOI 10.1002/app.32509
   Kim HS, 2011, J THERM ANAL CALORIM, V104, P331, DOI 10.1007/s10973-010-1098-9
   Kovalcik A., 2017, INT J BIOL MACROMOL
   Kuzdzal E, 2016, CHEMIK, V70, P189
   Laske S, 2015, POLYM ENG SCI, V55, P2849, DOI 10.1002/pen.24176
   Lee SY, 2008, J THERMOPLAST COMPOS, V21, P209, DOI 10.1177/0892705708089473
   Leejarkpai T, 2011, WASTE MANAGE, V31, P1153, DOI 10.1016/j.wasman.2010.12.011
   Li YH, 2010, POLYM INT, V59, P1099, DOI 10.1002/pi.2834
   Liu R, 2014, COMPOS SCI TECHNOL, V103, P1, DOI 10.1016/j.compscitech.2014.08.005
   Liu R, 2013, WOOD FIBER SCI, V45, P105
   Lv SS, 2016, J APPL POLYM SCI, V133, DOI 10.1002/app.43295
   Lv SS, 2015, BIORESOURCES, V10, P5426
   Mathew AP, 2006, J APPL POLYM SCI, V101, P300, DOI 10.1002/app.23346
   Meng Q., 2011, ANN TECH C SOC PLAST, V1, P792
   Najafi N, 2013, POLYM ENG SCI, V53, P1053, DOI 10.1002/pen.23355
   Najafi N, 2012, POLYM DEGRAD STABIL, V97, P554, DOI 10.1016/j.polymdegradstab.2012.01.016
   Niaounakis M, 2013, PDL HANDB SER, P1
   Petinakis E, 2012, J BIOBASED MATER BIO, V6, P388, DOI 10.1166/jbmb.2012.1233
   Petinakis E, 2010, POLYM DEGRAD STABIL, V95, P1704, DOI 10.1016/j.polymdegradstab.2010.05.027
   Petinakis E, 2009, J POLYM ENVIRON, V17, P83, DOI 10.1007/s10924-009-0124-0
   Pilla S, 2009, J APPL POLYM SCI, V111, P37, DOI 10.1002/app.28860
   Plastic Europe, 2015, PLASTICS FACTS 2015
   PlasticsEurope, 2016, PLAST FACTS 2016 AN
   Prapruddivongs C, 2013, ADV MATER RES-SWITZ, V747, P111, DOI 10.4028/www.scientific.net/AMR.747.111
   Ragaert K, 2011, J APPL POLYM SCI, V120, P2872, DOI 10.1002/app.33323
   Segerholm BK, 2012, BIORESOURCES, V7, P4575
   Shenoy A. V., 1999, RHEOLOGY FILLED POLY, DOI 10.1007/978-94-015-9213-0
   Signori F, 2009, POLYM DEGRAD STABIL, V94, P74, DOI 10.1016/j.polymdegradstab.2008.10.004
   Socrates G., 2004, INFRARED RAMAN CHARA
   Speranza V, 2014, POLYM DEGRAD STABIL, V100, P37, DOI 10.1016/j.polymdegradstab.2013.12.031
   Stloukal P, 2016, POLYM TEST, V54, P19, DOI 10.1016/j.polymertesting.2016.06.007
   Stloukal P, 2015, POLYM TEST, V41, P124, DOI 10.1016/j.polymertesting.2014.10.015
   Takahashi I, 2005, HYDROLYSIS STABILIZE
   Takahashi I, 2005, CARBODIIMIDE COMPOSI, P17
   Takatani M, 2008, J WOOD SCI, V54, P54, DOI 10.1007/s10086-007-0911-y
   Taubner V, 2001, J APPL POLYM SCI, V79, P2128, DOI 10.1002/1097-4628(20010321)79:12<2128::AID-APP1020>3.0.CO;2-#
   Tsou CY, 2015, POLYM SCI SER B+, V57, P473, DOI 10.1134/S1560090415050164
   Ulrich H., 2008, CHEM TECHNOLOGY CARB
   Verney V, 2015, LIFETIME DURABILITY, P205
   Vert M, 2005, BIOMACROMOLECULES, V6, P538, DOI 10.1021/bm0494702
   Vieira AC, 2011, J MECH BEHAV BIOMED, V4, P451, DOI 10.1016/j.jmbbm.2010.12.006
   Wachsen O, 1997, POLYM DEGRAD STABIL, V57, P87, DOI 10.1016/S0141-3910(96)00226-1
   Way C, 2012, POLYM DEGRAD STABIL, V97, P430, DOI 10.1016/j.polymdegradstab.2011.11.013
   Wu WD, 2017, POLYM ADVAN TECHNOL, V28, P252, DOI 10.1002/pat.3881
   Yang LX, 2008, POLYM DEGRAD STABIL, V93, P1923, DOI 10.1016/j.polymdegradstab.2008.06.016
   Yasuniwa M, 2008, POLYMER, V49, P1943, DOI 10.1016/j.polymer.2008.02.034
   Zhou HJ, 2006, POLYMER, V47, P7497, DOI 10.1016/j.polymer.2006.08.042
NR 62
TC 7
Z9 7
U1 2
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-835X
EI 1878-5840
J9 COMPOS PART A-APPL S
JI Compos. Pt. A-Appl. Sci. Manuf.
PD DEC
PY 2017
VL 103
BP 283
EP 291
DI 10.1016/j.compositesa.2017.10.003
PG 9
WC Engineering, Manufacturing; Materials Science, Composites
SC Engineering; Materials Science
GA FO1DO
UT WOS:000416497100029
DA 2020-07-08
ER

PT J
AU Pang, JX
   Chia, PY
   Lye, DC
   Leo, YS
AF Pang, Junxiong
   Chia, Po Ying
   Lye, David C.
   Leo, Yee Sin
TI Progress and Challenges towards Point-of-Care Diagnostic Development for
   Dengue
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE dengue fever; biotechnology; clinical diagnosis; diagnostics tools;
   flavivirus; neutralizing antibodies; point-of-care test; serology; viral
   clearance
ID REVERSE-TRANSCRIPTASE PCR; TIME RT-PCR; NS1 ANTIGEN; RAPID DETECTION;
   CHANGING EPIDEMIOLOGY; CHIKUNGUNYA-VIRUS; PAN-DENGUE; MULTIPLEX; ASSAY;
   INFECTION
AB Dengue detection strategies involve viral RNA, antigen, and/or antibody detection. Each strategy has its advantages and disadvantages. Optimal, user-friendly, rapid diagnostic tests based on immunochromatographic assays are pragmatic point-ofcare tests (POCTs) in regions where dengue is endemic where there are limited laboratory capabilities and optimal storage conditions. Increasingly, there is a greater public health significance for a multiplexing assay that differentiates dengue from Zika or pathogens with similar clinical presentations. Although there have been many assay/platform developments toward POCTs, independent validation and implementation remain very limited. This review highlights the current key progress and challenges toward the development of a dengue POCT.
C1 [Pang, Junxiong; Chia, Po Ying; Lye, David C.; Leo, Yee Sin] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore.
   [Pang, Junxiong; Leo, Yee Sin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Lye, David C.; Leo, Yee Sin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Lye, David C.; Leo, Yee Sin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
RP Pang, JX (corresponding author), Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore.; Pang, JX (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
EM pangv@hotmail.com
RI Chia, Po Ying/AAN-9657-2020
OI Chia, Po Ying/0000-0002-8797-9527; Lye, David/0000-0003-0324-0205
FU National Medical Research Council grant in Singapore [NMRC/CG/03/2013]
FX This research was supported by a National Medical Research Council grant
   in Singapore (NMRC/CG/03/2013). The funders had no role in the study
   design,
CR Anand AM, 2016, J CLIN DIAGN RES, V10, pDC1, DOI 10.7860/JCDR/2016/15758.7562
   Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476
   Andries AC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1551-x
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Chareonsook O, 1999, EPIDEMIOL INFECT, V122, P161, DOI 10.1017/S0950268898001617
   Chen HX, 2015, J MOL DIAGN, V17, P722, DOI 10.1016/j.jmoldx.2015.06.008
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Deraney RN, 2016, ANAL CHEM, V88, P6161, DOI 10.1021/acs.analchem.6b00854
   Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014
   Fatima A, 2015, PAK J PHARM SCI, V28, P271
   Gan VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090037
   Go YY, 2016, J CLIN MICROBIOL, V54, P1528, DOI 10.1128/JCM.00225-16
   GOH KT, 1995, LANCET, V346, P1098, DOI 10.1016/S0140-6736(95)91771-3
   Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Huang CY, 2014, ACM T MULTIM COMPUT, V10, DOI 10.1145/2537855
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee S, 2016, ANAL CHEM, V88, P8359, DOI 10.1021/acs.analchem.6b01828
   Mitra S, 2016, J VECTOR DIS, V53, P30
   Neeraja M, 2015, J VIROL METHODS, V211, P22, DOI 10.1016/j.jviromet.2014.10.005
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Nyan DC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17925
   Ooi Eng Eong, 2003, Int J Infect Dis, V7, P231, DOI 10.1016/S1201-9712(03)90057-9
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Pang JX, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2525-3
   Pang JX, 2015, EXPERT REV ANTI-INFE, V13, P731, DOI 10.1586/14787210.2015.1028364
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Piedrahita LD, 2016, AM J TROP MED HYG, V95, P315, DOI 10.4269/ajtmh.15-0492
   Pongsumpun P., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P255
   Shih HI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158437
   Shu PY, 2009, CLIN VACCINE IMMUNOL, V16, P589, DOI 10.1128/CVI.00475-08
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Simmons M, 2016, J CLIN MICROBIOL, V54, P1766, DOI 10.1128/JCM.00299-16
   Tan JJL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003043
   Tang RH, 2017, CRIT REV BIOTECHNOL, V37, P411, DOI 10.3109/07388551.2016.1164664
   Tantawichien T, 2012, PAEDIATR INT CHILD H, V32, P22, DOI 10.1179/2046904712Z.00000000049
   Thiha A, 2015, SENSORS-BASEL, V15, P11431, DOI 10.3390/s150511431
   Tsai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045278
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Vickers IE, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0164-9
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN VIROL, V78, P57, DOI 10.1016/j.jcv.2016.01.007
   Wang D, 2015, EUR J CLIN MICROBIOL, V34, P1327, DOI 10.1007/s10096-015-2353-6
   Wang SM, 2010, J CLIN MICROBIOL, V48, P2793, DOI 10.1128/JCM.02142-09
   Wang SY, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/3159805
   Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   Ziermann R, 2008, EXPERT REV MOL DIAGN, V8, P239, DOI 10.1586/14737159.8.3.239
NR 60
TC 11
Z9 11
U1 4
U2 21
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD DEC
PY 2017
VL 55
IS 12
BP 3339
EP 3349
DI 10.1128/JCM.00707-17
PG 11
WC Microbiology
SC Microbiology
GA FN7UV
UT WOS:000416225200007
PM 28904181
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU O'Leary, ST
   Kimberlin, DW
AF O'Leary, Sean T.
   Kimberlin, David W.
TI Update From the Advisory Committee on Immunization Practices
SO JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY
LA English
DT Article
DE ACIP; CDC; immunization
AB The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts, meets 3 times per year to develop recommendations for vaccine use in the United States. The group has 15 voting members, and each member's term is 4 years. ACIP members and Centers for Disease Control and Prevention (CDC) staff discuss the epidemiology of vaccine-preventable diseases and vaccine research, effectiveness, safety data, and clinical trial results. Representatives from the American Academy of Pediatrics (Carrie L. Byington and D. W. K.) and the Pediatric Infectious Diseases Society (S.T.O.) are present as liaisons to the ACIP. The ACIP met on June 21 to 22, 2017, to discuss catch-up vaccination for hepatitis A vaccine, influenza surveillance, influenza vaccine effectiveness, herpes zoster vaccine, the effect of varicella vaccination on the incidence of herpes zoster, meningococcal disease in patients taking eculizumab, and considerations for a potential third dose of measles, mumps, and rubella (MMR) vaccine to combat ongoing mumps outbreaks. Updates on dengue virus epidemiology, Zika virus vaccines, anthrax vaccine, yellow fever vaccine, and the Vaccine Adverse Event Reporting System were given also.
C1 [O'Leary, Sean T.] Univ Colorado Denver Anschutz Med Campus, Dept Pediat, Aurora, CO 80045 USA.
   [Kimberlin, David W.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA.
RP O'Leary, ST (corresponding author), Univ Colorado Denver Anschutz Med Campus, Dept Pediat, Aurora, CO 80045 USA.
EM sean.oleary@ucdenver.edu
NR 0
TC 2
Z9 2
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2048-7193
EI 2048-7207
J9 J PEDIATR INFECT DIS
JI J. Pediatr. Infect. Dis. Soc.
PD DEC
PY 2017
VL 6
IS 4
BP 311
EP 316
DI 10.1093/jpids/pix066
PG 6
WC Infectious Diseases; Pediatrics
SC Infectious Diseases; Pediatrics
GA FO2QB
UT WOS:000416623700003
PM 29036392
OA Bronze
DA 2020-07-08
ER

PT J
AU Sahiner, F
   Sig, AK
   Savasci, U
   Tekin, K
   Akay, F
AF Sahiner, Fatih
   Sig, Ali Korhan
   Savasci, Umit
   Tekin, Kemal
   Akay, Fahrettin
TI Zika Virus-associated Ocular and Neurologic Disorders: The Emergence of
   New Evidence
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Review
DE Zika virus; vaccines; ocular; neurologic; pregnancy
ID VECTOR-BORNE TRANSMISSION; INTERIM GUIDELINES; UNITED-STATES; INFECTION;
   OUTBREAK; BRAZIL; PROTECTION; INFANTS; BRAIN; RISK
AB Background: It has been approximately 70 years since the discovery of the Zika virus (ZIKV). It had been established that the virus causes mild infections and is confined to Africa and Asia; however, major changes in the clinical and epidemiologic patterns of ZIKV infection have occurred in recent years. The virus has attracted intense interest because of the possible association of several autoimmune and neurodevelopmental disorders.
   Methods: We present a summary of the articles that attempt to explain the ZIKV unknowns and strengthen the association with some disorders that are thought to be related to ZIKV, by describing the discovery milestones from the initial identification of the virus to the present day.
   Results: New evidence strengthens the association between ZIKV infections and Guillain-Barre syndrome (GBS), microcephaly and various neurodevelopmental and ophthalmologic disorders as a result of numerous new clinical and experimental studies.
   Conclusions: The World Health Organization declared the end of the Public Health Emergency of International Concern in December 2016, but ZIKV and associated consequences remain a significant enduring public health challenge.
C1 [Sahiner, Fatih; Sig, Ali Korhan] Univ Hlth Sci, Gulhane Med Fac, Dept Med Microbiol, Izmir, Turkey.
   [Savasci, Umit] Univ Hlth Sci, Gulhane Training & Res Hosp, Dept Infect Dis, Izmir, Turkey.
   [Tekin, Kemal] Univ Hlth Sci, Gulhane Training & Res Hosp, Dept Med Microbiol, Izmir, Turkey.
   [Akay, Fahrettin] Katip Celebi Univ, Ataturk Training & Res Hosp, Dept Ophthalmol, Izmir, Turkey.
RP Sahiner, F (corresponding author), Univ Hlth Sci, Gulhane Med Fac, Dept Med Microbiol, Ankara, Turkey.
EM fsvirol@gmail.com
RI Tekin, Kemal/H-9507-2017; Sig, Ali Korhan/Q-9216-2017
OI Tekin, Kemal/0000-0002-7461-6129; Sig, Ali Korhan/0000-0003-2907-257X
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   All countries & territories with active Zika virus transmission [US Department of Health and Human Services CDC web site], ALL COUNTR TERR ACT
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Alvino Ana Catarina Matos Ishigami, 2016, Rev. Bras. Saude Mater. Infant., V16, pS83, DOI 10.1590/1806-9304201600s100007
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Mallet HP, 2014, ZIKA VIRUSPACIFIC 02
   Medical advisory: congenital Zika virus infection confirmed in neonate with microcephaly Honolulu Hawaii, MED ADV CONG ZIK VIR
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sahiner F, 2016, MIKROBIYOL BUL, V50, P333, DOI 10.5578/mb.24167
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapshak P., 2015, Global virology I - identifying and investigating viral diseases, P477
   Situation report Zika virus microcephaly Guillain Barre syndrome, SIT REP ZIK VIR MICR
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weitzel T, 2016, AM J TROP MED HYG, V95, P255, DOI 10.4269/ajtmh.16-0096
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zika situation report neurological syndrome and congenital anomalies, ZIK SIT REP NEUR SYN
   Zika virus disease epidemic: potential association with microcephaly and Guillain Barre syndrome (first update), 2016, ZIK VIR DIS EP POT A
NR 68
TC 2
Z9 2
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD DEC
PY 2017
VL 36
IS 12
BP E341
EP E346
DI 10.1097/INF.0000000000001689
PG 6
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA FN8BW
UT WOS:000416244700011
PM 28719506
DA 2020-07-08
ER

PT J
AU Li, M
   Li, Y
   Peng, K
   Wang, Y
   Gong, T
   Zhang, ZR
   He, Q
   Sun, X
AF Li, Man
   Li, You
   Peng, Ke
   Wang, Ying
   Gong, Tao
   Zhang, Zhirong
   He, Qin
   Sun, Xun
TI Engineering intranasal mRNA vaccines to enhance lymph node trafficking
   and immune responses
SO ACTA BIOMATERIALIA
LA English
DT Article
DE mRNA vaccine; CD-PEI; Lymph node migration; Intranasal; Adjuvant
   activity
ID DENDRITIC CELLS; IN-VITRO; NANOPARTICLES TARGET; POTENT MUCOSAL; GENE
   DELIVERY; POLYETHYLENIMINE; VACCINATION; DNA; NANOCOMPLEXES;
   TRANSFECTION
AB Intranasal mRNA vaccination provides immediate immune protection against pandemic diseases. Recent studies have shown that diverse forms of polyethyleneimine (PEI) have potent mucosal adjuvant activity, which could significantly facilitate the delivery of intranasal mRNA vaccines. Nevertheless, optimizing the chemical structure of PEI to maximize its adjuvanticity and decrease its toxicity remains a challenge. Here we show that the chemical structure of PEI strongly influences how well nanocomplexes of PEI and mRNA migrate to the lymph nodes and elicit immune responses. Conjugating cyclodextrin (CD) with PEI600 or PEI2k yielded CP (CD-PEI) polymers with different CD/PEI ratios. We analyzed the delivery efficacy of CP600, CP2k, and PEI25k as intranasal mRNA vaccine carriers by evaluating the lymph nodes migration and immune responses. Among these polymers, CP2k/mRNA showed significantly higher in vitro transfection efficiency, stronger abilities to migrate to lymph nodes and stimulate dendritic cells maturation in vivo, which further led to potent humoral and cellular immune responses, and showed lower local and systemic toxicity than PEI25k/mRNA. These results demonstrate the potential of CD-PEI2k/mRNA nanocomplex as a self-adjuvanting vaccine delivery vehicle that traffics to lymph nodes with high efficiency.
   Statement of Significance
   As we face outbreaks of pandemic diseases such as Zika virus, intranasal mRNA vaccination provides instant massive protection against highly variant viruses. Various polymer-based delivery systems have been successfully applied in intranasal vaccine delivery. However, the influence of molecular structure of the polymeric carriers on the lymph node trafficking and dendritic cell maturation is seldom studied for intranasal vaccination. Therefore, engineering polymer-based vaccine delivery system and elucidating the relationship between molecular structure and the intranasal delivery efficiency are essential for maximizing the immune responses. We hereby construct self-adjuvanting polymer-based intranasal mRNA vaccines to enhance lymph node trafficking and further improve immune responses. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Li, Man; Li, You; Peng, Ke; Wang, Ying; Gong, Tao; Zhang, Zhirong; He, Qin; Sun, Xun] Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting, Minist Educ, Chengdu 610041, Sichuan, Peoples R China.
RP Sun, X (corresponding author), Sichuan Univ, Key Lab Drug Targeting, Minist Educ, 17,Sect 3,Southern Renmin Rd, Chengdu 610041, Sichuan, Peoples R China.
EM sunxun@scu.edu.cn
OI Sun, Xun/0000-0002-0218-1664
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81673362, 81690261]
FX We acknowledge the financial support of the National Natural Science
   Foundation of China (Nos. 81673362 & 81690261).
CR Andries O, 2013, J CONTROL RELEASE, V167, P157, DOI 10.1016/j.jconrel.2013.01.033
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Bettinger T, 2001, NUCLEIC ACIDS RES, V29, P3882, DOI 10.1093/nar/29.18.3882
   Bienenstock J, 2005, IMMUNOL REV, V206, P22, DOI 10.1111/j.0105-2896.2005.00299.x
   Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928
   Brandtzaeg P, 2010, IMMUNOL INVEST, V39, P303, DOI 10.3109/08820131003680369
   Cai H, 2013, ANGEW CHEM INT EDIT, V52, P6106, DOI 10.1002/anie.201300390
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Cho HJ, 2011, BIOMATERIALS, V32, P4621, DOI 10.1016/j.biomaterials.2011.03.004
   Debus H, 2010, J CONTROL RELEASE, V148, P334, DOI 10.1016/j.jconrel.2010.09.007
   Fehres CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00157
   Fotin-Mleczek M, 2011, J IMMUNOTHER, V34, P1, DOI 10.1097/CJI.0b013e3181f7dbe8
   Gebril A, 2012, EXPERT REV VACCINES, V11, P1139, DOI [10.1586/ERV.12.81, 10.1586/erv.12.81]
   Hess PR, 2006, CANCER IMMUNOL IMMUN, V55, P672, DOI 10.1007/s00262-005-0064-z
   Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213
   Hu Y, 2014, BIOMATERIALS, V35, P4236, DOI 10.1016/j.biomaterials.2014.01.065
   Huang HL, 2010, BIOMATERIALS, V31, P1830, DOI 10.1016/j.biomaterials.2009.11.012
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Jeannin P, 1999, J IMMUNOL, V162, P2044
   Jiang YH, 2014, PHARM RES-DORDR, V31, P2748, DOI 10.1007/s11095-014-1372-9
   Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200
   Kim SY, 2017, BIOMATERIALS, V130, P56, DOI 10.1016/j.biomaterials.2017.03.034
   Li JM, 2013, INT J NANOMED, V8, P2101, DOI 10.2147/IJN.S42440
   Li M, 2016, J CONTROL RELEASE, V228, P9, DOI 10.1016/j.jconrel.2016.02.043
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Liu Q., 2014, PHARM RES, V32, P22
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Midoux P, 2015, EXPERT REV VACCINES, V14, P221, DOI 10.1586/14760584.2015.986104
   Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236
   MIZUTANI S, 1985, J VIROL, V56, P628, DOI 10.1128/JVI.56.2.628-632.1985
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Muraoka D, 2014, ACS NANO, V8, P9209, DOI 10.1021/nn502975r
   Oh YK, 2001, VACCINE, V19, P4519, DOI 10.1016/S0264-410X(01)00188-8
   Pollard C, 2013, MOL THER, V21, P251, DOI 10.1038/mt.2012.202
   Purwada A, 2014, ACTA BIOMATER, V10, P1728, DOI 10.1016/j.actbio.2013.12.036
   Qian Y, 2016, BIOMATERIALS, V98, P171, DOI 10.1016/j.biomaterials.2016.05.008
   Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670
   Read ML, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni085
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]
   Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Shaw DM, 2000, IMMUNOLOGY, V100, P510, DOI 10.1046/j.1365-2567.2000.00069.x
   Shima F, 2013, ACTA BIOMATER, V9, P8894, DOI 10.1016/j.actbio.2013.06.010
   Skwarczynski M, 2010, ANGEW CHEM INT EDIT, V49, P5742, DOI 10.1002/anie.201002221
   Su XF, 2011, MOL PHARMACEUT, V8, P774, DOI 10.1021/mp100390w
   Tang GP, 2006, J GENE MED, V8, P736, DOI 10.1002/jgm.874
   Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020
   Tong HJ, 2013, INT J NANOMED, V8, P1935, DOI 10.2147/IJN.S43074
   Torrieri-Dramard L, 2011, MOL THER, V19, P602, DOI 10.1038/mt.2010.222
   Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x
   Wafa EI, 2017, ACTA BIOMATER, V50, P417, DOI 10.1016/j.actbio.2017.01.005
   Wegmann F, 2012, NAT BIOTECHNOL, V30, P883, DOI 10.1038/nbt.2344
   Yamamoto A, 2009, EUR J PHARM BIOPHARM, V71, P484, DOI 10.1016/j.ejpb.2008.09.016
   Yao H, 2013, CURR MED CHEM, V20, P2601, DOI 10.2174/0929867311320200008
   Yao H, 2009, BIOMATERIALS, V30, P5793, DOI 10.1016/j.biomaterials.2009.06.051
   Zohra FT, 2009, BIOMATERIALS, V30, P4006, DOI 10.1016/j.biomaterials.2009.02.050
NR 56
TC 10
Z9 10
U1 3
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD DEC
PY 2017
VL 64
BP 237
EP 248
DI 10.1016/j.actbio.2017.10.019
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA FO1DZ
UT WOS:000416498200021
PM 29030308
DA 2020-07-08
ER

PT J
AU Levine, D
   Jani, JC
   Castro-Aragon, I
   Cannie, M
AF Levine, Deborah
   Jani, Jacques C.
   Castro-Aragon, Ilse
   Cannie, Mieke
TI How Does Imaging of Congenital Zika Compare with Imaging of Other TORCH
   Infections?
SO RADIOLOGY
LA English
DT Review
ID PARVOVIRUS B19 INFECTION; ZOSTER-VIRUS INFECTIONS;
   CYTOMEGALOVIRUS-INFECTION; HERPES-SIMPLEX; BASAL GANGLIA; BRAIN-LESIONS;
   PREGNANCY; DIAGNOSIS; INFANTS; RUBELLA
AB The acronym TORCH is used to refer to congenital infections, such as toxoplasmosis, other infections (such as syphillis, varicella-zoster, and parvovirus B19), cytomegalovirus, and herpes simplex virus. The classic findings in patients with TORCH infections include rash in the mother during pregnancy and ocular findings in the newborn. Zika virus has emerged as an important worldwide congenital infection. It fits well with other congenital TORCH infections since there is a rash in the mother and there are commonly ocular abnormalities in the newborn. TORCH infections are recognized to have neurologic effects, such as ventriculomegaly, intraventricular adhesions, subependymal cysts, intracerebral calcifications, and microcephaly; however, the Zika virus is intensely neurotropic. Thus, it targets neural progenitor cells, leading to a more severe spectrum of central nervous system abnormalities than is typically seen in other TORCH infections, while relatively sparing the other organ systems. In this review, nonspecific findings of congenital infections initially will be described, then individual TORCH infections will be described and compared with the imaging findings associated with congenital Zika virus infection. For the radiologist, awareness of imaging features of common congenital infections may facilitate early diagnosis and may, at times, lead to prompt initiation of therapy.
C1 [Levine, Deborah] Harvard Med Sch, Dept Radiol, Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.
   [Jani, Jacques C.] Univ Libre Bruxelles, Dept Obstet & Gynecol, Univ Hosp Brugmann, Brussels, Belgium.
   [Cannie, Mieke] Univ Libre Bruxelles, Dept Radiol, Univ Hosp Brugmann, Brussels, Belgium.
   [Cannie, Mieke] Vrije Univ Brussel, UZ Brussel, Dept Radiol, Brussels, Belgium.
   [Castro-Aragon, Ilse] Boston Univ, Dept Radiol, Boston Med Ctr, Boston, MA 02215 USA.
RP Levine, D (corresponding author), Harvard Med Sch, Dept Radiol, Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.
EM dlevine@bidmc.harvard.edu
CR ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P1489
   Alarcon A, 2013, J PEDIATR-US, V163, P828, DOI 10.1016/j.jpeds.2013.03.014
   [Anonymous], 1990, LANCET, V335, P1559
   Arpino C, 2008, J NEUROVIROL, V14, P173, DOI 10.1080/13550280801908166
   Averill LW, 2015, SEMIN ULTRASOUND CT, V36, P476, DOI 10.1053/j.sult.2015.04.001
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   BARKOVICH AJ, 1994, AM J NEURORADIOL, V15, P703
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BENAMI T, 1990, PEDIATR RADIOL, V20, P575, DOI 10.1007/BF02129058
   Benoist G, 2008, ULTRASOUND OBST GYN, V32, P900, DOI 10.1002/uog.6129
   Berlin BM, 1999, OBSTET GYNECOL, V94, P135, DOI 10.1016/S0029-7844(99)00286-0
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Boppana SB, 1997, PEDIATRICS, V99, P409, DOI 10.1542/peds.99.3.409
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BRION LP, 1991, PEDIATRICS, V88, P1037
   Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203
   BROWN ZA, 1987, NEW ENGL J MED, V317, P1246, DOI 10.1056/NEJM198711123172002
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cannie MM, 2016, EUR RADIOL, V26, P3760, DOI 10.1007/s00330-015-4187-0
   Capretti MG, 2014, BRAIN DEV-JPN, V36, P203, DOI 10.1016/j.braindev.2013.04.001
   Catania VD, 2017, EUR J PEDIATR SURG, V27, P109, DOI 10.1055/s-0036-1597671
   Centers for Disease Control and Prevention, 2017, ZIK CAS US 2017 CAS
   Centers for Disease Control and Prevention, RUB GERM MEASL 3 DAY
   Centers for Disease Control and Prevention, CONG SYPH CDC FACT S
   Chakraborty R, 2008, ARCH DIS CHILD, V93, P105, DOI 10.1136/adc.2006.103515
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Chisaka H, 2003, REV MED VIROL, V13, P347, DOI 10.1002/rmv.395
   Cohen J, 2017, SCIENCE, V355, P1362, DOI 10.1126/science.355.6332.1362
   Cosmi E, 2002, AM J OBSTET GYNECOL, V187, P1290, DOI 10.1067/mob.2002.128024
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   De Jong EP, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.035
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Vries LS, 2006, EARLY HUM DEV, V82, P819, DOI 10.1016/j.earlhumdev.2006.09.006
   Degani S, 2006, OBSTET GYNECOL SURV, V61, P329, DOI 10.1097/01.ogx.0000216518.85796.88
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DRACHMAN DB, 1976, ARCH NEUROL-CHICAGO, V33, P362, DOI 10.1001/archneur.1976.00500050048009
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   DUBLIN AB, 1977, RADIOLOGY, V125, P133, DOI 10.1148/125.1.133
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duin LK, 2007, PRENATAL DIAG, V27, P81, DOI 10.1002/pd.1631
   Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8
   Eichenwald HF, 1960, HUMAN TOXOPLASMOSIS, P165
   ENDERS G, 1994, LANCET, V343, P1548, DOI 10.1016/S0140-6736(94)92943-2
   ENDERS G, 1988, LANCET, V1, P1445
   Enders M, 2004, PRENATAL DIAG, V24, P513, DOI 10.1002/pd.940
   Essary LR, 1998, HUM PATHOL, V29, P696, DOI 10.1016/S0046-8177(98)90278-7
   ESTERLY JR, 1969, ARCH PATHOL, V87, P380
   ESTROFF JA, 1992, J ULTRAS MED, V11, P686
   FRENKEL JK, 1974, B NEW YORK ACAD MED, V50, P182
   Gay-Andrieu F, 2003, PRENATAL DIAG, V23, P558, DOI 10.1002/pd.632
   Gilbert RE, 2002, J MED SCREEN, V9, P135, DOI 10.1136/jms.9.3.135
   Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623
   Graham KA, 2017, MMWR-MORBID MORTAL W, V66, P125, DOI 10.15585/mmwr.mm6605a1
   GRATACOS E, 1995, J INFECT DIS, V171, P1360, DOI 10.1093/infdis/171.5.1360
   Griffiths PD, 2005, CURR OPIN INFECT DIS, V18, P241, DOI 10.1097/01.qco.0000168385.39390.1b
   GUIDOZZI F, 1994, J REPROD MED, V39, P36
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   HAGEMAN G, 1987, NEUROPEDIATRICS, V18, P22, DOI 10.1055/s-2008-1052430
   HAYWARD JC, 1991, J CHILD NEUROL, V6, P109, DOI 10.1177/088307389100600203
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Iannetti P, 1998, ANN NEUROL, V43, P123, DOI 10.1002/ana.410430122
   Jenum PA, 1998, J CLIN MICROBIOL, V36, P2900, DOI 10.1128/JCM.36.10.2900-2906.1998
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   JONES CA, 1995, J PAEDIATR CHILD H, V31, P70, DOI 10.1111/j.1440-1754.1995.tb00749.x
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kyeong KS, 2015, FETAL PEDIATR PATHOL, V34, P49, DOI 10.3109/15513815.2014.962197
   Kylat RI, 2006, EUR J PEDIATR, V165, P773, DOI 10.1007/s00431-006-0172-6
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P175, DOI 10.1111/j.1471-0528.2010.02749.x
   Lebech M, 1999, LANCET, V353, P1834, DOI 10.1016/S0140-6736(98)11281-3
   Lipitz S, 2013, ULTRASOUND OBST GYN, V41, P508, DOI 10.1002/uog.12377
   Malinger G, 2003, AM J NEURORADIOL, V24, P28
   McNamara A, 2005, RADIOGRAPHICS, V25, P633, DOI 10.1148/rg.253045124
   MILLER E, 1982, LANCET, V2, P781
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moinuddin A, 2003, PRENATAL DIAG, V23, P797, DOI 10.1002/pd.688
   MOLLOY PM, 1963, RADIOLOGY, V80, P98, DOI 10.1148/80.1.98
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Musso D, 2016, CLIN MICROBIOL INFEC, V22, P494, DOI 10.1016/j.cmi.2016.03.032
   NAHMIAS AJ, 1971, PEDIATR RES, V5, P405, DOI 10.1203/00006450-197108000-00144
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061
   Pan American Health Organization; World Health Organization, 2017, REG ZIK EP UPD
   Picone O, 2013, PRENATAL DIAG, V33, P751, DOI 10.1002/pd.4118
   Picone O, 2008, PRENATAL DIAG, V28, P753, DOI 10.1002/pd.2037
   PRETORIUS DH, 1992, J ULTRAS MED, V11, P459
   RABINOWITZ JG, 1965, RADIOLOGY, V85, P494, DOI 10.1148/85.3.494
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RASOOL MN, 1989, J BONE JOINT SURG BR, V71, P752
   Rodis JF, 1998, OBSTET GYNECOL, V91, P125, DOI 10.1016/S0029-7844(97)00575-9
   RORKE LB, 1973, ARCH OTOLARYNGOL, V98, P249
   RUDOLPH AJ, 1965, J AMER MED ASSOC, V191, P843, DOI 10.1001/jama.1965.03080100061013
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sauerbrei A, 2007, MED MICROBIOL IMMUN, V196, P95, DOI 10.1007/s00430-006-0032-z
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   SHACKELFORD GD, 1977, RADIOLOGY, V122, P753, DOI 10.1148/122.3.753
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   STEIN B, 1995, RADIOLOGY, V197, P489, DOI 10.1148/radiology.197.2.7480699
   Tanimura K, 2013, J MED VIROL, V85, P935, DOI 10.1002/jmv.23531
   TEELE RL, 1988, RADIOLOGY, V169, P423, DOI 10.1148/radiology.169.2.2845473
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732
   van der Knaap MS, 2004, RADIOLOGY, V230, P529, DOI 10.1148/radiol.2302021459
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   WILSON CB, 1980, PEDIATRICS, V66, P767
   YAMASHITA Y, 1991, PEDIATR RADIOL, V21, P547, DOI 10.1007/BF02012592
   YOUNG N, 1984, J CLIN INVEST, V74, P2024, DOI 10.1172/JCI111625
   Zhang HJ, 2015, J OBSTET GYNAECOL RE, V41, P62, DOI 10.1111/jog.12479
   Zucca C, 2003, NEUROLOGY, V61, P710, DOI 10.1212/WNL.61.5.710
NR 118
TC 14
Z9 16
U1 1
U2 9
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD DEC
PY 2017
VL 285
IS 3
BP 744
EP 761
DI 10.1148/radiol.2017171238
PG 18
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA FO1ZY
UT WOS:000416570800009
PM 29155634
OA Other Gold
DA 2020-07-08
ER

PT J
AU Ho, HJ
   Wong, JGX
   Kyaw, WM
   Lye, DC
   Leo, YS
   Chow, A
AF Ho, Hanley J.
   Wong, Joshua G. X.
   Kyaw, Win Mar
   Lye, David C.
   Leo, Yee Sin
   Chow, Angela
TI Diagnostic Accuracy of Parameters for Zika and Dengue Virus Infections,
   Singapore
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID MICRONESIA
AB Singapore experienced its first documented Zika virus outbreak in 2016. We identified clinical and laboratory parameters that increase the probability for Zika or dengue virus infection. Early during the illness, combinations of key parameters obtained through clinical assessment and hematologic tests can help distinguish between these infections.
C1 [Ho, Hanley J.; Wong, Joshua G. X.; Kyaw, Win Mar; Lye, David C.; Leo, Yee Sin; Chow, Angela] Tan Tock Seng Hosp, Singapore, Singapore.
RP Ho, HJ (corresponding author), Tan Tock Seng Hosp, Dept Clin Epidemiol, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.
EM hanleyho@gmail.com
OI Lye, David/0000-0003-0324-0205; Wong, Joshua/0000-0001-8268-5610
FU STOP - National Research Foundation through National Medical Research
   Council, Singapore [NMRC/TCR/005/2008]
FX This work was supported by the STOP Dengue Translational Clinical
   Research program, funded by the National Research Foundation through the
   National Medical Research Council, Singapore (grant no.
   NMRC/TCR/005/2008).
CR Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hapuarachchi HC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1606-z
   Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leo YS, 2016, LANCET INFECT DIS, V16, P1317, DOI 10.1016/S1473-3099(16)30448-0
   McGee S, 2002, J GEN INTERN MED, V17, P646
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   The Straits Times, 2016, STRAITS TIMES
   World Health Organization, 2017, DENG GUID DIAGN TREA
NR 15
TC 6
Z9 6
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2017
VL 23
IS 12
BP 2085
EP 2088
DI 10.3201/eid2312.171224
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FO0PA
UT WOS:000416446000025
PM 29148371
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Passos, SRL
   dos Santos, MAB
   Cerbino-Neto, J
   Buonora, SN
   Souza, TML
   de Oliveira, RVC
   Vizzoni, A
   Barbosa-Lima, G
   Vieira, YR
   de Lima, MS
   Hokerberg, YHM
AF Lambert Passos, Sonia R.
   Borges dos Santos, Maria A.
   Cerbino-Neto, Jose
   Buonora, Sibelle N.
   Souza, Thiago M. L.
   de Oliveira, Raquel V. C.
   Vizzoni, Alexandre
   Barbosa-Lima, Giselle
   Vieira, Yasmine R.
   de Lima, Marcondes Silva
   Hokerberg, Yara H. M.
TI Detection of Zika Virus in April 2013 Patient Samples, Rio de Janeiro,
   Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID TRANSMISSION; AMERICA
AB We tested 210 dengue virus. negative samples collected from febrile patients during a dengue virus type 4 outbreak in Rio de Janeiro in April 2013 and found 3 samples positive for Zika virus. Our findings support previously published entomological data suggesting Zika virus was introduced into Brazil during October 2012-May 2013.
C1 [Lambert Passos, Sonia R.; Souza, Thiago M. L.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Lambert Passos, Sonia R.; Hokerberg, Yara H. M.] Estacio de Sa Univ, Rio De Janeiro, Brazil.
   [Borges dos Santos, Maria A.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.
   [Cerbino-Neto, Jose; Buonora, Sibelle N.; de Oliveira, Raquel V. C.; Vizzoni, Alexandre; Barbosa-Lima, Giselle; Vieira, Yasmine R.; de Lima, Marcondes Silva; Hokerberg, Yara H. M.] Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [Buonora, Sibelle N.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RP Passos, SRL (corresponding author), Evandro Chagas Natl Inst Infect Dis, Clin Epidemiol Lab, Av Brasil 4036 Sala 201 A, BR-21040361 Rio De Janeiro, RJ, Brazil.
EM sonia.lambert@ini.fiocruz.br
RI Vizzoni, Alexandre/W-8718-2019; Neto, Jose Cerbino/P-3713-2018; Lima,
   Marcondes/C-5200-2018; Oliveira, Raquel de V C de/S-7443-2016
OI Vizzoni, Alexandre/0000-0003-0004-5084; Neto, Jose
   Cerbino/0000-0001-9254-917X; Passos, Sonia/0000-0001-9947-2291; Souza,
   Thiago/0000-0003-2212-3899; Oliveira, Raquel de V C
   de/0000-0001-9387-8645; Buonora, Sibelle/0000-0002-0843-1783
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Programa
   de Excelencia em Pesquisa [402068/2012-2]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [310765/2016-1]; Universidade
   Estacio de Sa Pesquisa Produtividade; Universidade Estacio de Sao
   Pesquisa Produtividade; Fundacao de Amparo a Pesquisa do Estado do Rio
   de JaneiroCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ) [E-26/110.188/2014]
FX This work was funded by Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico, Programa de Excelencia em Pesquisa 402068/2012-2.
   S.R.L.P. was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico grant 310765/2016-1 and Universidade Estacio de
   Sa Pesquisa Produtividade. Y.H.M.H. was supported by Universidade
   Estacio de Sao Pesquisa Produtividade and Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro (E-26/110.188/2014). S.R.L.P., M.A.B.S., and
   J.C.N. are members of the Rede Nacional de Especialistas em Zika e
   Doencas Correlatas (the Brazilian National Zika Network).
CR Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Buonora SN, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1368-7
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Freitas ARR, 2016, REV INST MED TROP SP, V58, DOI 10.1590/S1678-9946201658024
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 15
Z9 16
U1 0
U2 0
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2017
VL 23
IS 12
BP 2120
EP 2121
DI 10.3201/eid2312.171375
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FO0PA
UT WOS:000416446000040
PM 28953451
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Plastic and Reconstructive Surgeons and Zika Virus Infection
SO ANNALS OF PLASTIC SURGERY
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Calotta NA, 2017, ANN PLAS SURG, V78, P467, DOI 10.1097/SAP.0000000000000988
   Deseda CC, 2017, CURR OPIN PEDIATR, V29, P97, DOI 10.1097/MOP.0000000000000442
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Raposo-Amaral CE, 2016, J CRANIOFAC SURG, V27, P1383, DOI 10.1097/SCS.0000000000002997
NR 4
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0148-7043
EI 1536-3708
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD DEC
PY 2017
VL 79
IS 6
BP 631
EP 632
DI 10.1097/SAP.0000000000001139
PG 2
WC Surgery
SC Surgery
GA FN4BP
UT WOS:000415947700024
PM 29117002
DA 2020-07-08
ER

PT J
AU Calotta, NA
AF Calotta, Nicholas A.
TI Response to: Zika Virus Practical Information for the Plastic and
   Reconstructive Surgeon
SO ANNALS OF PLASTIC SURGERY
LA English
DT Letter
ID INFECTION
C1 [Calotta, Nicholas A.] Johns Hopkins Sch Med, Baltimore, MD 21205 USA.
RP Calotta, NA (corresponding author), Johns Hopkins Sch Med, Baltimore, MD 21205 USA.
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Arnaoutakis D, 2017, JAMA OTOLARYNGOL, V143, P81, DOI 10.1001/jamaoto.2016.3427
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
NR 5
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0148-7043
EI 1536-3708
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD DEC
PY 2017
VL 79
IS 6
BP 632
EP 632
DI 10.1097/SAP.0000000000001140
PG 1
WC Surgery
SC Surgery
GA FN4BP
UT WOS:000415947700025
PM 29117003
DA 2020-07-08
ER

PT J
AU Krittanawong, C
AF Krittanawong, Chayakrit
TI Useful strategies for the emerging of Zika pandemic and its silent
   cardiovascular complications
SO EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
LA English
DT Editorial Material
ID VIRUS-INFECTION; CHILDREN
C1 [Krittanawong, Chayakrit] Icahn Sch Med Mt Sinai, Dept Internal Med, New York, NY USA.
RP Krittanawong, C (corresponding author), Mt Sinai St Lukes Hosp, Icahn Sch Med Mt Sinai, Dept Internal Med, 1000 10th Ave, New York, NY 10019 USA.; Krittanawong, C (corresponding author), Mt Sinai West Hosp, Icahn Sch Med Mt Sinai, Dept Internal Med, 1000 10th Ave, New York, NY 10019 USA.
EM Chayakrit.Krittanawong@Mountsinai.org
CR Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Awan Z, 2015, EUR J PREV CARDIOL, V22, P719, DOI 10.1177/2047487314529350
   Carta KG, 2017, J AM COLL CARDIOL, V11, P69
   Idris NS, 2015, EUR J PREV CARDIOL, V22, P1452, DOI 10.1177/2047487314560086
   Krittanawong C, 2017, CARDIOL YOUNG, V27, P1625, DOI 10.1017/S1047951117000749
   Krittanawong C, 2017, J AM COLL CARDIOL, V69, P2657, DOI 10.1016/j.jacc.2017.03.571
   Krittanawong C, 2016, INT J CARDIOL, V221, P859, DOI 10.1016/j.ijcard.2016.06.293
   Kushawaha Anurag, 2009, Cases J, V2, P7147, DOI 10.1186/1757-1626-2-7147
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Li YJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002660
   Lipshultz SE, 1998, CIRCULATION, V97, P1246, DOI 10.1161/01.CIR.97.13.1246
   Minhas AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1399
   Pergam SA, 2006, AM J TROP MED HYG, V75, P1232, DOI 10.4269/ajtmh.2006.75.1232
NR 14
TC 1
Z9 1
U1 1
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 2047-4873
EI 2047-4881
J9 EUR J PREV CARDIOL
JI Eur. J. Prev. Cardiol.
PD DEC
PY 2017
VL 24
IS 18
BP 1988
EP 1990
DI 10.1177/2047487317737182
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FN4WO
UT WOS:000416007600011
PM 29053013
DA 2020-07-08
ER

PT J
AU Pradhan, D
   Yadav, M
   Verma, R
   Khan, NS
   Jena, L
   Jain, AK
AF Pradhan, Dibyabhaba
   Yadav, Monika
   Verma, Rashi
   Khan, Noor Saba
   Jena, Lingaraja
   Jain, Arun Kumar
TI Discovery of T-cell Driven Subunit Vaccines from Zika Virus Genome: An
   Immunoinformatics Approach
SO INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES
LA English
DT Article
DE Zika virus; T-cell epitope; Subunit vaccine; IEDB; NetMHC
ID CLASS-I; PEPTIDE BINDING; EPITOPE; RESPONSES; PREDICTION; DESIGN;
   IDENTIFICATION; INDUCE
AB The recent outbreaks of Zika virus and the absence of a specific therapy have necessitated to identify T-cell-stimulating antigenic peptides as potential subunit vaccine candidates. The translated ssRNA (+) genome of Zika virus was explored in EMBOSS antigenic and VaxiJen to predict 63 peptides as potential antigens. Three MHC-II binding peptide prediction tools, viz. NetMHCIIpan, PREDIVAC and immune epitope database (IEDB) were employed in consensus on 63 antigenic peptides to propose 14 T-helper cell epitopes. Similarly, analysis on 63 antigenic peptides through NetMHC, NetCTL and IEDB MHC-I binding peptide prediction tool led to identification of 14 CTL epitopes. Seven T-cell epitopes, C:44-66, M:135-149, NS2A:124-144, NS3:421-453, NS3:540-554, NS4B:90-134 and NS4B:171-188, are observed to share overlapping MHC-I and MHC-II binding motifs and hence, are being proposed to constitute minimum T-cell antigens to elicit protective T-cell immune response against Zika. Three of them, C:44-66, NS3:421-453 and NS3:540-554 are identified to be conserved across all the selected strains of Zika virus. Moreover, the 21 T-cell epitopes are non-self to humans and exhibited good coverage in variable populations of 14 geographical locations. Therefore, 21 T-cell epitopes are proposed as potential subunit vaccines against Zika virus.
C1 [Pradhan, Dibyabhaba; Yadav, Monika; Verma, Rashi; Khan, Noor Saba; Jain, Arun Kumar] ICMR, Natl Inst Pathol, Biomed Informat Ctr, New Delhi 110029, India.
   [Jena, Lingaraja] Mahatma Gandhi Inst Med Sci, Bioinformat Ctr, Sevagram 442102, Wardha, India.
RP Jain, AK (corresponding author), ICMR, Natl Inst Pathol, Biomed Informat Ctr, New Delhi 110029, India.
EM drakjain@gmail.com
RI Jain, Arun Kumar/W-2243-2019
OI Verma, Rashi/0000-0002-2989-4162
FU Indian Council of Medical ResearchIndian Council of Medical Research
   (ICMR) [BIC/NTF/1/2013-2014]
FX The authors highly acknowledge the Indian Council of Medical Research
   for supporting facilities to carry out the research work in Biomedical
   Informatics Centre, National Institute of Pathology, New Delhi, vide RFC
   No. BIC/NTF/1/2013-2014 dated 18/02/2013.
CR ADAMS HP, 1995, J IMMUNOL METHODS, V185, P181, DOI 10.1016/0022-1759(95)00111-M
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639
   Andreatta M, 2015, IMMUNOGENETICS, V67, P641, DOI 10.1007/s00251-015-0873-y
   [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   [Anonymous], 2016, ZIK VIR POT COMPL
   Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361
   Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519
   Comber JD, 2014, HUM VACC IMMUNOTHER, V10, P3531, DOI 10.4161/21645515.2014.980210
   De Groot AS, 2014, HUM VACC IMMUNOTHER, V10, P256, DOI 10.4161/hv.28135
   De Groot AS, 2003, VACCINE, V21, P4095, DOI 10.1016/S0264-410X(03)00489-4
   De Groot AS, 2002, IMMUNOL CELL BIOL, V80, P255, DOI 10.1046/j.1440-1711.2002.01092.x
   de Melo AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001938
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Duan ZL, 2015, VIRUS RES, V196, P5, DOI 10.1016/j.virusres.2014.10.022
   Duan ZL, 2015, J MED VIROL, V87, P1077, DOI 10.1002/jmv.24167
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Iamarino A, 2015, BIORXIV, V25
   James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13
   Jiang L, 2010, VIRUS RES, V150, P49, DOI 10.1016/j.virusres.2010.02.012
   Khan AM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000272
   Khan MA, 2015, SCAND J IMMUNOL, V82, P25, DOI 10.1111/sji.12302
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   Kruger RP, 2016, CELL, V164, P585, DOI 10.1016/j.cell.2016.01.040
   Kumar S., 2016, MOL BIOL EVOL
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   Lund O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026494
   Maenaka K, 1999, CURR OPIN STRUC BIOL, V9, P745, DOI 10.1016/S0959-440X(99)00039-1
   Mathew A, 2014, FUTURE MICROBIOL, V9, P411, DOI 10.2217/fmb.13.171
   Mishra S, 2014, VACCINE, V32, P3285, DOI 10.1016/j.vaccine.2014.03.083
   Munikumar M, 2013, INTERDISCIP SCI, V5, P155, DOI 10.1007/s12539-013-0161-1
   Musso D, 2016, LANCET INFECT DIS
   Oyarzn P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-52
   Oyarzun P, 2015, HUM VACCINES IMMUNOT
   Priyadarshini V, 2014, J BIOMOL STRUCT DYN, V32, P876, DOI 10.1080/07391102.2013.795871
   Rakesh S., 2009, INT J BIOINFORMATICS, V1, P85, DOI DOI 10.9735/0975-3087.1.2.85-92
   da Silva ANMR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007425
   Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594
   Shi JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131461
   Southwood S, 1998, J IMMUNOL, V160, P3363
   STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5
   Terry FE, 2015, EXPERT REV VACCINES, V14, P21, DOI 10.1586/14760584.2015.955478
   Umamaheswari A, 2012, INTERDISCIP SCI, V4, P38, DOI 10.1007/s12539-012-0118-9
   Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568
   Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 56
TC 5
Z9 5
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1913-2751
EI 1867-1462
J9 INTERDISCIP SCI
JI Interdiscip. Sci.
PD DEC
PY 2017
VL 9
IS 4
BP 468
EP 477
DI 10.1007/s12539-017-0238-3
PG 10
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA FN6SA
UT WOS:000416145000002
PM 29094318
OA Green Published
DA 2020-07-08
ER

PT J
AU de Carvalho, OV
   Felix, DM
   de Mendonca, LR
   de Araujo, CMCS
   Franca, RFD
   Cordeiro, MT
   Silva, A
   Pena, LJ
AF de Carvalho, Otavio Valerio
   Felix, Daniele Mendes
   de Mendonca, Leila Rodrigues
   Cataldi Sabino de Araujo, Catarina Maria
   de Oliveira Franca, Rafael Freitas
   Cordeiro, Marli Tenorio
   Silva Junior, Abelardo
   Pena, Lindomar Jose
TI The thiopurine nucleoside analogue 6-methylmercaptopurine riboside
   (6MMPr) effectively blocks Zika virus replication
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article
DE Antiviral; Zika virus; Cytotoxicity; 6MMPr; Vero cells; Neuronal cells
ID INFECTION; AZATHIOPRINE; INHIBITORS; SCREEN; PREGNANCY; DISEASE;
   PROTEIN; DRUGS; WOMEN
AB Since the emergence of Zika virus (ZIKV) in Brazil in 2015, 48 countries and territories in the Americas have confirmed autochthonous cases of disease caused by the virus. ZIKV-associated neurological manifestations and congenital defects make the development of safe and effective antivirals against ZIKV of utmost importance. Here we evaluated the antiviral activity of 6-methylmercaptopurine riboside (6MMPr), a thiopurine nucleoside analogue derived fromthe prodrug azathioprine, against the epidemic ZIKV strain circulating in Brazil. In all of the assays, an epithelial (Vero) and a human neuronal (SH-SY5Y) cell line were used to evaluate the cytotoxicity and effective concentrations of 6MMPr against ZIKV. Levels of ZIKV-RNA, viral infectious titre and the percentage of infected cells in the presence or absence of 6MMPr were used to determine antiviral efficacy. 6MMPr decreased ZIKV production by >99% in both cell lines in a dose-and time-dependent manner. Interestingly, 6MMPr was 1.6 times less toxic to SH-SY5Y cells compared with Vero cells, presenting a 50% cytotoxic concentrations (CC50) of 460.3 mu M and 291 mu M, respectively. The selectivity index of 6MMPr for Vero and SH-SY5Y cells was 11.9 and 22.7, respectively, highlighting the safety profile of the drug to neuronal cells. Taken together, these results identify, for the first time, the thiopurine nucleoside analogue 6MMPr as a promising antiviral candidate against ZIKV that warrants further in vivo evaluation. (C) 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
C1 [de Carvalho, Otavio Valerio; Felix, Daniele Mendes; de Mendonca, Leila Rodrigues; Cataldi Sabino de Araujo, Catarina Maria; de Oliveira Franca, Rafael Freitas; Cordeiro, Marli Tenorio; Pena, Lindomar Jose] Oswaldo Cruz Fdn Fiocruz, Dept Virol, Ave Prof Moraes Rego, Recife, PE, Brazil.
   [Silva Junior, Abelardo] Fed Univ Vicosa UFV, Dept Vet Med, Av PH Rolfs S-N, BR-36570900 Vicosa, MG, Brazil.
RP Pena, LJ (corresponding author), Oswaldo Cruz Fdn Fiocruz, Dept Virol, Ave Prof Moraes Rego, Recife, PE, Brazil.; Silva, A (corresponding author), Fed Univ Vicosa UFV, Dept Vet Med, Av PH Rolfs S-N, BR-36570900 Vicosa, MG, Brazil.
EM asjvet@gmail.com; lindomar.pena@cpqam.fiocruz.br
FU CNPq (National Council for Scientific and Technological Development,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); FACEPE (Pernambuco State Foundation for Science and Technology,
   Brazil); FACEPE; CAPESCAPES; Scientific Initiation fellowship (PIBIC)
   from FACEPE
FX This work was supported in part by grants from CNPq (National Council
   for Scientific and Technological Development, Brazil) and FACEPE
   (Pernambuco State Foundation for Science and Technology, Brazil). OVC is
   the recipient of a postdoctoral fellowship from FACEPE. DMF is the
   recipient of a doctoral fellowship from CAPES. LRM is the recipient of a
   doctoral fellowship from FACEPE. CMCSA is the recipient of a Scientific
   Initiation fellowship (PIBIC) from FACEPE.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Cleary BJ, 2009, BIRTH DEFECTS RES A, V85, P647, DOI 10.1002/bdra.20583
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Crotty S, 2000, NAT MED, V6, P1375
   D'Abramo CM, 2004, J MOL BIOL, V337, P1, DOI 10.1016/j.jmb.2004.01.030
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Hoffmann HH, 2008, ANTIVIR RES, V80, P124, DOI 10.1016/j.antiviral.2008.05.008
   Hoover S, 2008, J GEN VIROL, V89, P1000, DOI 10.1099/vir.0.83381-0
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Konidari Anastasia, 2014, World J Gastrointest Pharmacol Ther, V5, P63, DOI 10.4292/wjgpt.v5.i2.63
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langagergaard V, 2007, ALIMENT PHARM THER, V25, P73, DOI 10.1111/j.1365-2036.2006.03162.x
   Lim PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026697
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Matalon ST, 2004, REPROD TOXICOL, V18, P219, DOI 10.1016/j.reprotox.2003.10.014
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mumtaz N, 2016, CURR TREAT OPTIONS I, V8, P208, DOI [10.1007/s40506-016-0083-7, DOI 10.1007/S40506-016-0083-7]
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Ramalho Rocha Yuri Raoni, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.e854dbf51b8075431a05b39042c00244
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Stangl JR, 2004, TRANSPLANTATION, V77, P562, DOI 10.1097/01.TP.0000114610.40412.C6
   Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726
   Wright S, 2004, GUT, V53, P1123, DOI 10.1136/gut.2003.032896
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang FB, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003326
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 37
TC 12
Z9 12
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
EI 1872-7913
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD DEC
PY 2017
VL 50
IS 6
BP 718
EP 725
DI 10.1016/j.ijantimicag.2017.08.016
PG 8
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA FN2LA
UT WOS:000415822600005
PM 28803932
DA 2020-07-08
ER

PT J
AU Cunha, MD
   dos Santos, CA
   Neto, DFD
   Schanoski, AS
   Pour, SZ
   Passos, SD
   de Souzae, MSF
   Costa, DD
   Zanotto, PMD
AF Cunha, Marielton dos Passos
   dos Santos, Cliomar Alves
   de Lima Neto, Daniel Ferreira
   Schanoski, Alessandra Soares
   Pour, Shahab Zaki
   Passos, Saulo Duarte
   Feitosa de Souzae, Mercia Simone
   Costa, Danuza Duarte
   de Andrade Zanotto, Paolo Marinho
TI Outbreak of chikungunya virus in a vulnerable population of Sergipe,
   Brazil-A molecular and serological survey
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Chikungunya virus; Re-emerging arbovirus; Infection
ID INFECTION; ZIKA; DENGUE; EPIDEMIC; STATE
AB Background: Chikungunya virus (CHIKV) is a re-emerging arbovirus that is causing outbreaks in several countries of the Americas. The virus was introduced in Brazil in 2014, and since then, several Brazilian states have notified autochthonous cases.
   Objectives: Provide additional evidence on a CHIKV outbreak and an outline of the laboratory and clinical profile of symptomatic patients in Sergipe, Brazil.
   Study design: In February 2016, we collected 142 serum samples from symptomatic patients for arboviruses in Sergipe, Brazil. All samples were submitted to qRT-PCR for the emerging arboviruses circulating in Brazil - ZIKV, CHIKV, and DENV - and later submitted to the immunoenzymatic assay. RNA positive samples were randomly selected and sequenced for characterization of the genotype involved in the outbreak.
   Results: Our study had 75.35% (107/142) positivity for CHIKV infection, with all age groups and genera being equally infected. The virus was identified in 11 of the 13 cities studied in that state, including the ECSA genotype. Importantly, fever was the only statistically significant symptoms for CHIKV infection (p < 0.05), while asthenia was significantly associated with symptomatic patients that were CHIKV-negative (p < 0.05).
   Conclusions: Our findings support the importance of fever as a clinical marker and contribute to molecular and serological surveillance data, which may help in the understanding of CHIKV circulation, emergence and clinical description.
C1 [Cunha, Marielton dos Passos; de Lima Neto, Daniel Ferreira; Pour, Shahab Zaki; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Biomed Sci Inst, Dept Microbiol, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil.
   [dos Santos, Cliomar Alves; Costa, Danuza Duarte] State Secretary Hlth, Cent Lab Publ Hlth LACEN SE, Hlth Fdn Parreiras Horta FSPH, Sergipe, Brazil.
   [Schanoski, Alessandra Soares] Butantan Inst, Bacteriol Lab 2, Sao Paulo, Brazil.
   [Passos, Saulo Duarte] Jundiai Med Fac, Dept Pediat, Sao Paulo, Brazil.
   [Feitosa de Souzae, Mercia Simone] State Secretary Hlth, Coordinat Nucleus Communicable Dis, Sergipe, Brazil.
RP Zanotto, PMD (corresponding author), Av Prof Lineu Prestes 1734, BR-05508000 Sao Paulo, SP, Brazil.
EM pzanotto@usp.br
RI de A. Zanotto, Paolo M./B-9286-2019; POUR, SHAHAB ZAKI/H-3846-2016;
   Soares Schanoski, Alessandra/H-8144-2014
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; POUR, SHAHAB
   ZAKI/0000-0002-7708-1406; Soares Schanoski,
   Alessandra/0000-0002-6514-8458
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/17766-9]; Brazilian National Council
   of Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [441105/2016-5];
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2016/08204-2, 2016/03605-9]
FX This work was supported by the Sao Paulo Research Foundation (FAPESP)
   process No. 2014/17766-9 and Brazilian National Council of Scientific
   and Technological Development (CNPq) process No. 441105/2016-5. MPC and
   DFLN received a FAPESP fellowships: No. 2016/08204-2 and No.
   2016/03605-9, respectively.
CR Alves JAB, 2011, REV SOC BRAS MED TRO, V44, P670, DOI 10.1590/S0037-86822011000600004
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   daCosta A.C., 2017, BIORXIV
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Hapuarachchi HC, 2010, J GEN VIROL, V91, P1067, DOI 10.1099/vir.0.015743-0
   Javelle E, 2014, J CLIN VIROL, V59, P270, DOI 10.1016/j.jcv.2014.01.011
   Lahariya Chandrakant, 2006, Journal of Vector Borne Diseases, V43, P151
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Keesen TSL, 2017, LANCET INFECT DIS, V17, P693, DOI 10.1016/S1473-3099(17)30333-X
   Manimunda SP, 2010, T ROY SOC TROP MED H, V104, P392, DOI 10.1016/j.trstmh.2010.01.011
   Marteis LS, 2013, CAD SAUDE PUBLICA, V29, P369
   Patel P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004953
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   SES-SE, 2016, AT SIT EP DENG CHIK
   Shrinet J., 2016, SCI REP, V6, P1
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   SVS-MS, 2017, EPIDEMIOLOGICA, V1, P2016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Vassilopoulos D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2480
   Wagner D, 2004, EMERG INFECT DIS, V10, P1872, DOI 10.3201/eid1010.031037
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wilson JAC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006155
NR 34
TC 10
Z9 10
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD DEC
PY 2017
VL 97
BP 44
EP 49
DI 10.1016/j.jcv.2017.10.015
PG 6
WC Virology
SC Virology
GA FN3VA
UT WOS:000415927900009
PM 29100064
DA 2020-07-08
ER

PT J
AU Basile, K
   Kok, J
   Dwyer, DE
AF Basile, Kerri
   Kok, Jen
   Dwyer, Dominic E.
TI Zika virus: what, where from and where to?
SO PATHOLOGY
LA English
DT Review
DE Zika virus; flavivirus; Aedes; microcephaly; Guillain-Barre syndrome
ID MALE SEXUAL TRANSMISSION; DENGUE VIRUS; GENOMIC CHARACTERIZATION;
   FRENCH-POLYNESIA; INFECTION; BRAZIL; ENHANCEMENT; AMERICA; INHIBITORS;
   TRAVELERS
AB The significance of Zika virus as a clinically significant flavivirus has previously been under-recognised, until extensive outbreaks in Yap in 2007, French Polynesia in 2013 and the Americas since 2015. Although Zika virus infection is commonly asymptomatic or mild, emerging evidence suggests a strong link to microcephaly in babies and Guillain-Barre syndrome in adults. This article reviews the epidemiology, geographic distribution, basic virology, transmission, clinical presentation, potential complications, laboratory diagnosis, treatment and prevention of Zika virus infection. Education on mosquito avoidance measures and vector control efforts currently remain key to reducing risk of transmission, whilst further research is underway to develop antiviral therapies and vaccines.
C1 [Basile, Kerri; Kok, Jen; Dwyer, Dominic E.] Univ Sydney, Ctr Infect Dis & Microbiol Lab Serv, Inst Clin Pathol & Med Res, NSW Hlth Pathol,Westmead Hosp, Westmead, NSW, Australia.
   [Basile, Kerri; Kok, Jen; Dwyer, Dominic E.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Westmead Hosp, Westmead, NSW, Australia.
   [Basile, Kerri; Kok, Jen; Dwyer, Dominic E.] Univ Sydney, Ctr Res Excellence Crit Infect, Westmead Hosp, Westmead, NSW, Australia.
RP Basile, K (corresponding author), Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Inst Clin Pathol & Med Res, NSW Hlth Pathol, Westmead, NSW 2145, Australia.
EM kerri.basile@health.nsw.gov.au
OI Basile, Kerri/0000-0003-0647-4314
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   [Anonymous], 2016, Nurs Stand, V30, P17, DOI 10.7748/ns.30.24.17.s20
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Australian Government Department of Health, FLAV LAB CAS DEF
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baronti C, 2014, GENOME ANNOUNC, V2
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Besnard M, 2014, EURO SURVEILL, V19
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Centers for Disease Control, 2016, ZIK VIR DIS ZIK VIR
   Centers for Disease Control and Prevention, CONG MICR CAS DEF
   Centers for Disease Control and Prevention, WOM THEIR PARTN TRYI
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Charles A. S., 2016, PLOS CURR, V8
   Check Hayden Erika, 2016, Nature, V530, P142, DOI 10.1038/530142a
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i383
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frankel MB, 2017, J VIROL METHODS, V246, P117, DOI 10.1016/j.jviromet.2017.05.002
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huzly D, 2016, EURO SURVEILL, V21
   Kleinman S, 2015, CURR OPIN HEMATOL, V22, P547, DOI 10.1097/MOH.0000000000000186
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lucey DR, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i781
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Maria AT, 2016, EURO SURVEILL, V21
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Maurer-Stroh S., 2016, EURO SURVEILL, V21
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 1989, ARBOVIRUSES EPIDEMIO, V5, P139
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Public Health England, 2016, ZIK VIR IMM PAT
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RATHER IA, 2017, FRONT MICROBIOL, V8
   Ren P, 2017, J CLIN MICROBIOL, V55, P2198, DOI 10.1128/jcm.00603-17
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2013, EURO SURVEILL, V19
   Thomas SJ, 2017, NEW ENGL J MED, V376, P1883, DOI 10.1056/NEJMcibr1701402
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
   United States of America CFDCaP, 2016, KEY MESS ZIK VIR DIS
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Venturi G, 2016, EURO SURVEILL, V21
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   Willis E, 2017, VIROLOGY, V508, P1, DOI 10.1016/j.virol.2017.04.031
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   WORLD HEALTH ORGANIZATION, 2016, ZIK VIR DIS
   World Health Organization, ZIK VIR COMPL QUEST
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 124
TC 15
Z9 16
U1 1
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0031-3025
EI 1465-3931
J9 PATHOLOGY
JI Pathology
PD DEC
PY 2017
VL 49
IS 7
BP 698
EP 706
DI 10.1016/j.pathol.2017.08.002
PG 9
WC Pathology
SC Pathology
GA FN3SZ
UT WOS:000415920800004
PM 29050846
DA 2020-07-08
ER

PT J
AU Frentiu, FD
AF Frentiu, Francesca D.
TI Lipids and Pathogen Blocking by Wolbachia
SO TRENDS IN PARASITOLOGY
LA English
DT Editorial Material
ID DENGUE; ZIKA; WMEL
C1 [Frentiu, Francesca D.] QUT, Sch Biomed Sci, Brisbane, Qld, Australia.
   [Frentiu, Francesca D.] QUT, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.
RP Frentiu, FD (corresponding author), QUT, Sch Biomed Sci, Brisbane, Qld, Australia.; Frentiu, FD (corresponding author), QUT, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.
EM francesca.frentiu@qut.edu.au
OI Frentiu, Francesca/0000-0001-8628-4216
CR Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   White PM, 2017, GENETICS, V205, P1473, DOI 10.1534/genetics.116.198903
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
NR 10
TC 2
Z9 2
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD DEC
PY 2017
VL 33
IS 12
BP 916
EP 918
DI 10.1016/j.pt.2017.10.007
PG 4
WC Parasitology
SC Parasitology
GA FN8DY
UT WOS:000416251400002
PM 29122518
DA 2020-07-08
ER

PT J
AU Gu, SH
   Song, DH
   Lee, D
   Jang, J
   Kim, MY
   Jung, J
   Woo, KI
   Kim, M
   Seog, W
   Oh, HS
   Choi, BS
   Ahn, JS
   Park, Q
   Jeong, ST
AF Gu, Se Hun
   Song, Dong Hyun
   Lee, Daesang
   Jang, Jeyoun
   Kim, Min Young
   Jung, Jaehun
   Woo, Koung In
   Kim, Mirang
   Seog, Woong
   Oh, Hong Sang
   Choi, Byung Seop
   Ahn, Jong-Seong
   Park, Quehn
   Jeong, Seong Tae
TI Whole-genome sequence analysis of Zika virus, amplified from urine of
   traveler from the Philippines
SO VIRUS GENES
LA English
DT Article
DE Zika virus; Next generation sequencing (NGS); Whole-genome sequence;
   South Korea; Philippines
AB Zika virus (ZIKV) (genus Flavivirus, family Flaviviridae) is an emerging pathogen associated with microcephaly and Guillain-Barr, syndrome. The rapid spread of ZIKV disease in over 60 countries and the large numbers of travel-associated cases have caused worldwide concern. Thus, intensified surveillance of cases among immigrants and tourists from ZIKV-endemic areas is important for disease control and prevention. In this study, using Next Generation Sequencing, we reported the first whole-genome sequence of ZIKV strain AFMC-U, amplified from the urine of a traveler returning to Korea from the Philippines. Phylogenetic analysis showed geographic-specific clustering. Our results underscore the importance of examining urine in the diagnosis of ZIKV infection.
C1 [Gu, Se Hun; Song, Dong Hyun; Lee, Daesang; Jeong, Seong Tae] Agcy Def Dev, R&D Inst 5, POB 35, Yuseong 34186, Daejeon, South Korea.
   [Jang, Jeyoun; Kim, Min Young; Park, Quehn] Armed Forces Med Res Inst, 90 Jaunro, Yuseong 305878, Daejeon, South Korea.
   [Jung, Jaehun; Woo, Koung In; Kim, Mirang; Seog, Woong; Oh, Hong Sang; Choi, Byung Seop; Ahn, Jong-Seong] Armed Forces Med Command, 177 Saemaeul Ro,POB 100, Seongnam Si 463040, South Korea.
RP Jeong, ST (corresponding author), Agcy Def Dev, R&D Inst 5, POB 35, Yuseong 34186, Daejeon, South Korea.
EM seongtae@add.re.kr
FU Agency for Defense Development, Republic of Korea [611665-912388501,
   611665-912543001]
FX This work was supported by grants (611665-912388501 and
   611665-912543001) from the Agency for Defense Development, Republic of
   Korea.
CR Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
NR 9
TC 4
Z9 5
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
PD DEC
PY 2017
VL 53
IS 6
BP 918
EP 921
DI 10.1007/s11262-017-1500-9
PG 4
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA FN6YA
UT WOS:000416161500020
PM 28795266
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Ajelli, M
AF Ajelli, Marco
TI Modeling mosquito-borne diseases in complex urban environments
SO ACTA TROPICA
LA English
DT Letter
ID CHIKUNGUNYA VIRUS; YELLOW-FEVER; ZIKA VIRUS; SPREAD; OUTBREAK
C1 [Ajelli, Marco] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA.
   [Ajelli, Marco] Bruno Kessler Fdn, Trento, Italy.
RP Ajelli, M (corresponding author), Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA.; Ajelli, M (corresponding author), Bruno Kessler Fdn, Trento, Italy.
EM ajelli@fbk.eu
CR Ajelli M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005851
   Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106
   Dorigatti I, 2017, EUROSURVEILLANCE, V22, P10, DOI 10.2807/1560-7917.ES.2017.22.28.30572
   Ferguson NM, 2016, SCIENCE
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Likos A., 2016, MMWR MORB MORTAL WLD, V65
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Yamey G, 2017, LANCET GLOB HEALTH, V5, pE742, DOI 10.1016/S2214-109X(17)30203-6
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhu L, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0555-0
NR 18
TC 7
Z9 7
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD DEC
PY 2017
VL 176
BP 332
EP 334
DI 10.1016/j.actatropica.2017.08.026
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FK6IH
UT WOS:000413606800047
PM 28859961
DA 2020-07-08
ER

PT J
AU Chaiworapongsa, T
   Romero, R
   Erez, O
   Tarca, AL
   Conde-Agudelo, A
   Chaemsaithong, P
   Kim, CJ
   Kim, YM
   Kim, JS
   Yoon, BH
   Hassan, SS
   Yeo, L
   Korzeniewski, SJ
AF Chaiworapongsa, Tinnakorn
   Romero, Roberto
   Erez, Offer
   Tarca, Adi L.
   Conde-Agudelo, Agustin
   Chaemsaithong, Piya
   Kim, Chong Jai
   Kim, Yeon Mee
   Kim, Jung-Sun
   Yoon, Bo Hyun
   Hassan, Sonia S.
   Yeo, Lami
   Korzeniewski, Steven J.
TI The prediction of fetal death with a simple maternal blood test at 20-24
   weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio)
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Article
DE endoglin; maternal vascular underperfusion; placenta; placental growth
   factor; preeclampsia; preterm delivery; small for gestational age;
   soluble fms-like tyrosine kinase-1; soluble vascular endothelial growth
   factor receptor-1; stillbirth
ID FACTOR RECEPTOR-1 CONCENTRATION; PERIVILLOUS FIBRIN DEPOSITION;
   UMBILICAL-CORD ACCIDENTS; ZIKA VIRUS-INFECTION; FOR-GESTATIONAL-AGE;
   RISK-FACTORS; GROWTH-FACTOR; PLACENTAL FINDINGS; SPONTANEOUS-ABORTIONS;
   PLASMA-CONCENTRATIONS
AB BACKGROUND: Fetal death is an obstetrical syndrome that annually affects 2.4 to 3 million pregnancies worldwide, including more than 20,000 in the United States each year. Currently, there is no test available to identify patients at risk for this pregnancy complication.
   OBJECTIVE: We sought to determine if maternal plasma concentrations of angiogenic and antiangiogenic factors measured at 24-28 weeks of gestation can predict subsequent fetal death.
   STUDY DESIGN: A case-cohort study was designed to include 1000 randomly selected subjects and all remaining fetal deaths (cases) from a cohort of 4006 women with a singleton pregnancy, enrolled at 6-22 weeks of gestation, in a pregnancy biomarker cohort study. The placentas of all fetal deaths were histologically examined by pathologists who used a standardized protocol and were blinded to patient outcomes. Placental growth factor, soluble endoglin, and soluble vascular endothelial growth factor receptor-1 concentrations were measured by enzyme-linked immunosorbent assays. Quantiles of the analyte concentrations (or concentration ratios) were estimated as a function of gestational age among women who delivered a live neonate but did not develop preeclampsia or deliver a small-for-gestational-age newborn. A positive test was defined as analyte concentrations (or ratios) <2.5th and 10th centiles (placental growth factor, placental growth factor/soluble vascular endothelial growth factor receptor-1 [angiogenic index-1] and placental growth factor/soluble endoglin) or >90th and 97.5th centiles (soluble vascular endothelial growth factor receptor-1 and soluble endoglin). Inverse probability weighting was used to reflect the parent cohort when estimating the relative risk.
   RESULTS: There were 11 fetal deaths and 829 controls with samples available for analysis between 24-28 weeks of gestation. Three fetal deaths occurred <28 weeks and 8 occurred >= 28 weeks of gestation. The rate of placental lesions consistent with maternal vascular underperfusion was 33.3% (1/3) among those who had a fetal death <28 weeks and 87.5% (7/8) of those who had this complication >= 28 weeks of gestation. The maternal plasma angiogenic index-1 value was <10th centile in 63.6% (7/11) of the fetal death group and in 11.1% (92/829) of the controls. The angiogenic index-1 value was <2.5th centile in 54.5% (6/11) of the fetal death group and in 3.7% (31/829) of the controls. An angiogenic index-1 value <2.5th centile had the largest positive likelihood ratio for predicting fetal death >24 weeks (14.6; 95% confidence interval, 7.7-27.7) and a relative risk of 29.1 (95% confidence interval, 8.8-97.1), followed by soluble endoglin >97.5th centile and placental growth factor/soluble endoglin <2.5th, both with a positive likelihood ratio of 13.7 (95% confidence interval, 7.3-25.8) and a relative risk of 27.4 (95% confidence interval, 8.2-91.2). Among women without a fetal death whose plasma angiogenic index-1 concentration ratio was <2.5th centile, 61% (19/31) developed preeclampsia or delivered a small-for-gestational-age neonate; when the 10th centile was used as the cut-off, 37% (34/92) of women had these adverse outcomes.
   CONCLUSION: (1) A maternal plasma angiogenic index-1 value <2.5th centile (0.126) at 24-28 weeks of gestation carries a 29-fold increase in the risk of subsequent fetal death and identifies 55% of subsequent fetal deaths with a false-positive rate of 3.5%; and (2) 61% of women who have a false-positive test result will subsequently experience adverse pregnancy outcomes.
C1 [Chaiworapongsa, Tinnakorn; Romero, Roberto; Erez, Offer; Tarca, Adi L.; Conde-Agudelo, Agustin; Chaemsaithong, Piya; Kim, Chong Jai; Kim, Yeon Mee; Kim, Jung-Sun; Yoon, Bo Hyun; Hassan, Sonia S.; Yeo, Lami; Korzeniewski, Steven J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.
   [Chaiworapongsa, Tinnakorn; Romero, Roberto; Erez, Offer; Tarca, Adi L.; Conde-Agudelo, Agustin; Chaemsaithong, Piya; Kim, Chong Jai; Kim, Yeon Mee; Kim, Jung-Sun; Yoon, Bo Hyun; Hassan, Sonia S.; Yeo, Lami; Korzeniewski, Steven J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Detroit, MI USA.
   [Chaiworapongsa, Tinnakorn; Erez, Offer; Tarca, Adi L.; Chaemsaithong, Piya; Hassan, Sonia S.; Yeo, Lami; Korzeniewski, Steven J.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI USA.
   [Romero, Roberto] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA.
   [Romero, Roberto; Korzeniewski, Steven J.] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.
   [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48202 USA.
   [Erez, Offer] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Med, Dept Obstet & Gynecol,Soroka Univ Med Ctr, Beer Sheva, Israel.
   [Kim, Chong Jai] Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea.
   [Kim, Yeon Mee] Inje Univ, Coll Med, Haeundae Paik Hosp, Dept Pathol, Busan, South Korea.
   [Kim, Jung-Sun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea.
   [Yoon, Bo Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.
RP Romero, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.; Romero, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Detroit, MI USA.; Romero, R (corresponding author), Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA.; Romero, R (corresponding author), Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.; Romero, R (corresponding author), Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48202 USA.
EM prbchiefstaff@med.wayne.edu
RI Yoon, Bo Hyun/H-6344-2011; Korzeniewski, Steven James/U-6481-2017;
   Romero, Roberto/A-5268-2019
OI Korzeniewski, Steven James/0000-0002-8895-6052; Romero,
   Roberto/0000-0002-4448-5121; Chaemsaithong, piya/0000-0002-5398-6868
FU US Department of Health and Human Services (DHHS); NICHD/NIH/DHHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [HHSN275201300006C]
FX This research was supported, in part, by the Perinatology Research
   Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of
   Intramural Research, Eunice Kennedy Shriver National Institute of Child
   Health and Human Development (NICHD), National Institutes of Health
   (NIH), US Department of Health and Human Services (DHHS); and, in part,
   with federal funds from NICHD/NIH/DHHS under contract no.
   HHSN275201300006C.
CR ACOG, 2002, OBSTET GYNECOL, V99, P869
   AHLENIUS I, 1995, ACTA OBSTET GYN SCAN, V74, P109, DOI 10.3109/00016349509008917
   Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X
   Amir H, 2009, J MATERN-FETAL NEO M, V22, P759, DOI [10.1080/14767050902929396, 10.3109/14767050902929396]
   Ananth CV, 1999, JAMA-J AM MED ASSOC, V282, P1646, DOI 10.1001/jama.282.17.1646
   Ananth CV, 2016, AM J OBSTET GYNECOL, V214, P21
   ANGELL RR, 1984, J MED GENET, V21, P39, DOI 10.1136/jmg.21.1.39
   Arnesen L, 2015, REV PANAM SALUD PUBL, V37, P422
   Aurioles-Garibay A, 2014, FETAL DIAGN THER, V36, P154, DOI 10.1159/000357841
   Baergen RN, 2007, SEMIN DIAGN PATHOL, V24, P23, DOI 10.1053/j.semdp.2007.02.004
   Baltajian K, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.01.168
   Basu MN, 2017, J PERINAT MED
   Battaloglu E, 2016, INJURY, V47, P184, DOI 10.1016/j.injury.2015.08.026
   Be C, 1997, REV MED CHILE, V125, P317
   Berger H, 2016, J OBSTET GYNAECOL CA, V38, P667, DOI 10.1016/j.jogc.2016.04.002
   Blackwell C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00248
   Blackwell S, 2003, J Matern Fetal Neonatal Med, V14, P241, DOI 10.1080/713606670
   Blackwell S, 2003, J Matern Fetal Neonatal Med, V14, P151, DOI 10.1080/713606613
   Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2
   Bodnar LM, 2015, AM J CLIN NUTR, V102, P858, DOI 10.3945/ajcn.115.112250
   Bonetti LR, 2011, ARCH GYNECOL OBSTET, V283, P231, DOI 10.1007/s00404-009-1317-4
   Breslow NE, 2009, AM J EPIDEMIOL, V169, P1398, DOI 10.1093/aje/kwp055
   Bring HS, 2014, ACTA OBSTET GYN SCAN, V93, P86, DOI 10.1111/aogs.12278
   Brownfoot FC, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.019
   Bukowski R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182874
   Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823
   Burton GJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.050
   Caluwaerts S, 2016, CLIN INFECT DIS, V62, P903, DOI 10.1093/cid/civ1024
   Castro MA, 1999, AM J OBSTET GYNECOL, V181, P389, DOI 10.1016/S0002-9378(99)70567-3
   Feitoza HAC, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00178915, 10.1590/0102-311x00178915]
   Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043
   Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V17, P3, DOI 10.1080/14767050400028816
   Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P531, DOI 10.1038/nrneph.2014.103
   Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P25, DOI 10.1080/14767050701832833
   Chaiworapongsa T, 2016, J MATERN-FETAL NEO M, V29, P1214, DOI 10.3109/14767058.2015.1048431
   Chaiworapongsa T, 2016, J MATERN-FETAL NEO M, V29, P855, DOI 10.3109/14767058.2015.1022864
   Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102
   Chaiworapongsa T, 2014, J MATERN-FETAL NEO M, V27, P132, DOI 10.3109/14767058.2013.806905
   Chaiworapongsa T, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.016
   Chaiworapongsa T, 2011, J MATERN-FETAL NEO M, V24, P1187, DOI 10.3109/14767058.2011.589932
   Chaiworapongsa T, 2010, J MATERN-FETAL NEO M, V23, P960, DOI 10.3109/14767050903410664
   Chaiworapongsa T, 2009, J MATERN-FETAL NEO M, V22, P1122, DOI 10.3109/14767050902994838
   Chalouhi GE, 2014, ULTRASOUND OBST GYN, V44, P618, DOI 10.1002/uog.13416
   Chaturvedi V, 2015, J CLIN INVEST, V125, P1713, DOI 10.1172/JCI78578
   Chen KH, 2015, PLACENTA, V36, P1039, DOI 10.1016/j.placenta.2015.06.015
   Cluver CA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008211
   Collins JH, 2002, SEMIN PERINATOL, V26, P79, DOI 10.1053/sper.2002.29860
   Collins JH, 1997, AM J OBSTET GYNECOL, V177, P1566
   Di Renzo GC, 2009, J MATERN-FETAL NEO M, V22, P633, DOI 10.1080/14767050902866804
   Edwards A, 2013, DIABETIC MED, V30, P1219, DOI 10.1111/dme.12272
   Engmann C, 2012, J PERINATOL, V32, P585, DOI 10.1038/jp.2011.154
   Erez O, 2008, J MATERN-FETAL NEO M, V21, P279, DOI 10.1080/14767050802034545
   Erez O, 2009, J MATERN-FETAL NEO M, V22, P672, DOI 10.1080/14767050902853117
   Ernst LM, 2015, PLACENTA, V36, P783, DOI 10.1016/j.placenta.2015.04.010
   Espinoza J, 2006, J MATERN-FETAL NEO M, V19, P607, DOI 10.1080/14767050600922677
   Espinoza J, 2007, J MATERN-FETAL NEO M, V20, P495, DOI 10.1080/14767050701413022
   Faiz AS, 2012, J MATERN-FETAL NEO M, V25, P699, DOI 10.3109/14767058.2011.596593
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0
   Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7
   Fretts RC, 1997, OBSTET GYNECOL, V89, P40, DOI 10.1016/S0029-7844(96)00427-9
   Friedman EA, 1997, PREGNANCY HYPERTENSI
   Froen JF, 2001, AM J OBSTET GYNECOL, V184, P694, DOI 10.1067/mob.2001.110697
   Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C
   Gardosi J, 2014, PUBLIC HEALTH, V128, P698, DOI 10.1016/j.puhe.2014.06.022
   Gerber S, 2005, AM J OBSTET GYNECOL, V193, P1472, DOI 10.1016/j.ajog.2005.02.112
   Getahun D, 2007, AM J OBSTET GYNECOL, V196, P499, DOI 10.1016/j.ajog.2006.09.017
   Gibbs RS, 2002, SEMIN PERINATOL, V26, P75, DOI 10.1053/sper.2002.29839
   Goldenberg RL, 2003, AM J OBSTET GYNECOL, V189, P861, DOI 10.1067/S0002-9378(03)00470-8
   Goldenberg RL, 2006, AM J OBSTET GYNECOL, V195, P1020, DOI 10.1016/j.ajog.2006.06.033
   Goldenberg RL, 2017, LANCET INFECT DIS, V17, P886, DOI 10.1016/S1473-3099(17)30455-3
   Goldenberg RL, 2016, CLIN PERINATOL, V43, P439, DOI 10.1016/j.clp.2016.04.004
   Goldenberg RL, 2016, ACTA OBSTET GYN SCAN, V95, P135, DOI 10.1111/aogs.12817
   Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8
   Gudmundsson S, 2017, ACTA OBSTET GYN SCAN, V96, P216, DOI 10.1111/aogs.13060
   GUERNERI S, 1987, HUM REPROD, V2, P735, DOI 10.1093/oxfordjournals.humrep.a136623
   Nunes PCG, 2016, J MED VIROL, V88, P1448, DOI 10.1002/jmv.24479
   Hadi T, 2015, FASEB J, V29, P2653, DOI 10.1096/fj.14-266783
   Heazell AEP, 2009, J OBSTET GYNAECOL, V29, P225, DOI 10.1080/01443610802716042
   Helgadottir LB, 2013, ACTA OBSTET GYN SCAN, V92, P325, DOI 10.1111/aogs.12044
   Hod M, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.005
   Horn LC, 2004, EUR J OBSTET GYN R B, V113, P134, DOI 10.1016/S0301-2115(03)00371-3
   HOVATTA O, 1983, BRIT J OBSTET GYNAEC, V90, P691, DOI 10.1111/j.1471-0528.1983.tb09296.x
   Hoyert Donna L, 2016, Natl Vital Stat Rep, V65, P1
   Huang DY, 2000, OBSTET GYNECOL, V95, P215, DOI 10.1016/S0029-7844(99)00536-0
   Hutcheon JA, 2013, EPIDEMIOLOGY, V24, P787, DOI 10.1097/EDE.0b013e3182a6d9aa
   JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703
   Kanellopoulos-Langevin Colette, 2003, Reprod Biol Endocrinol, V1, P121
   Khalil AA, 2015, AM J OBSTET GYNECOL, V213, P28
   Kidron D, 2009, PLACENTA, V30, P700, DOI 10.1016/j.placenta.2009.05.009
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Kim YM, 2015, J MATERN-FETAL NEO M, V28, P2001, DOI 10.3109/14767058.2014.976198
   Kim YM, 2015, J MATERN-FETAL NEO M, V28, P1554, DOI 10.3109/14767058.2014.960835
   KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643
   Koenker R., 2005, QUANTILE REGRESSION
   Korteweg FJ, 2009, OBSTET GYNECOL, V114, P809, DOI 10.1097/AOG.0b013e3181b72ebe
   Korzeniewski SJ, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.015
   Kusanovic J. P., 2008, AM J OBSTET GYNECOL, V198
   Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754
   LABARRERE CA, 1986, AM J REPROD IMMUNOL, V12, P78
   Labarrere CA, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.12.029
   Lamminpaa R, 2016, J MATERN-FETAL NEO M, V29, P55, DOI 10.3109/14767058.2014.986450
   Langer O, 2016, J MATERN-FETAL NEO M, V29, P186, DOI 10.3109/14767058.2014.995084
   Lannaman K, 2017, J PERINAT MED, V45, P851, DOI 10.1515/jpm-2017-0073
   Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5
   Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3
   Lee J, 2011, HISTOPATHOLOGY, V59, P928, DOI 10.1111/j.1365-2559.2011.04038.x
   Levine RJ, 2005, CLIN OBSTET GYNECOL, V48, P372, DOI 10.1097/01.grf.0000160313.82606.d7
   Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019
   Llurba E, 2012, ULTRASOUND OBST GYN, V40, P367, DOI 10.1002/uog.10136
   Lucia A, 2016, CRIT CARE CLIN, V32, P109, DOI 10.1016/j.ccc.2015.08.008
   MacDorman Marian F, 2015, Natl Vital Stat Rep, V64, P1
   Macdorman Marian F, 2009, NCHS Data Brief, P1
   Maiti K, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.06.015
   Man J, 2016, ULTRASOUND OBST GYN, V48, P579, DOI 10.1002/uog.16019
   Man J, 2016, ULTRASOUND OBST GYN, V48, P566, DOI 10.1002/uog.16016
   Maynard SE, 2005, PEDIATR RES, V57, P6
   McClure Elizabeth M, 2015, Matern Health Neonatol Perinatol, V1, P11, DOI 10.1186/s40748-015-0012-7
   Mecacci F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166514
   Meganathan HS, 2017, NEUROL INDIA, V65, P1130, DOI 10.4103/neuroindia.NI_671_16
   Melville A, 2014, J OBSTET GYNAECOL, V34, P196, DOI 10.3109/01443615.2013.840565
   Miller ES, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.08.049
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Monteith C, 2017, AM J OBSTET GYNECOL, V216, P11
   Nkwabong E, 2017, J MATERN-FETAL NEO M, V30, P1456, DOI 10.1080/14767058.2016.1219988
   Oduyebo T, 2015, OBSTET GYNECOL, V126, P1273, DOI 10.1097/AOG.0000000000001092
   Olech EM, 2016, POL J PATHOL, V67, P78, DOI 10.5114/PJP.2016.59480
   Onda K, 2017, HYPERTENSION, V69, P457, DOI 10.1161/HYPERTENSIONAHA.116.08408
   ORNOY A, 1981, TERATOLOGY, V24, P243, DOI 10.1002/tera.1420240302
   Paixao ES, 2017, LANCET INFECT DIS, V17, P957, DOI 10.1016/S1473-3099(17)30366-3
   PERKINS RP, 1971, AM J OBSTET GYNECOL, V111, P379, DOI 10.1016/0002-9378(71)90781-2
   PETITTI DB, 1987, CLIN OBSTET GYNECOL, V30, P253, DOI 10.1097/00003081-198706000-00004
   Pinar H, 2014, OBSTET GYNECOL, V123, P325, DOI 10.1097/AOG.0000000000000100
   PLACHOT M, 1989, HUM REPROD, V4, P425, DOI 10.1093/oxfordjournals.humrep.a136921
   Powers RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013263
   Premru-Srsen T, 2017, J PERINAT MED
   Price JT, 2013, OBSTET GYNECOL, V122, P493, DOI 10.1097/AOG.0b013e3182918565
   Ptacek I, 2014, PLACENTA, V35, P552, DOI 10.1016/j.placenta.2014.05.011
   Ptacek I, 2016, BMC CLIN PATHOL, V16, DOI 10.1186/s12907-016-0023-y
   Raisanen S, 2013, EUR J OBSTET GYN R B, V171, P246, DOI 10.1016/j.ejogrb.2013.09.009
   Reddy UM, 2009, OBSTET GYNECOL, V114, P901, DOI 10.1097/AOG.0b013e3181b8f6e4
   Redline R., 2011, STILLBIRTH PREDICTIO
   Redline RW, 2015, AM J OBSTET GYNECOL, V213, pS21, DOI 10.1016/j.ajog.2015.05.056
   Redline RW, 2005, PLACENTA, V26, pS114, DOI 10.1016/j.placenta.2005.02.009
   Redline RW, 2004, PEDIATR DEVEL PATHOL, V7, P237, DOI 10.1007/s10024-003-8083-2
   Reslan Ossama M., 2010, Cardiovascular & Hematological Agents in Medicinal Chemistry, V8, P204
   Roescher AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089419
   ROMERO R, 1988, SEMIN PERINATOL, V12, P302
   Romero R, 1996, J MATERN-FETAL NEO M, V2009, P636
   Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480
   Romero R, 2013, AM J REPROD IMMUNOL, V70, P285, DOI 10.1111/aji.12143
   Romero R, 2010, J MATERN-FETAL NEO M, V23, P1384, DOI 10.3109/14767051003681121
   ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270
   Ryan WD, 2012, PEDIATR DEVEL PATHOL, V15, P275, DOI 10.2350/11-12-1127-OA.1
   Saccone G, 2017, AM J OBSTET GYNECOL, V216, P30
   Sahlin E, 2014, FETAL DIAGN THER, V36, P326, DOI 10.1159/000361017
   Schoen CN, 2017, J MATERN FETAL NEONA, P1
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Serena C, 2013, J MATERN-FETAL NEO M, V26, P16, DOI 10.3109/14767058.2012.718389
   Silasi M, 2010, OBSTET GYN CLIN N AM, V37, P239, DOI 10.1016/j.ogc.2010.02.013
   Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041
   Silver RM, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.04.026
   Sinkey RG, 2015, AM J OBSTET GYNECOL, V213, P615, DOI 10.1016/j.ajog.2015.08.031
   Smith GCS, 2007, BJOG-INT J OBSTET GY, V114, P705, DOI 10.1111/j.1471-0528.2007.01343.x
   Smith GCS, 2004, JAMA-J AM MED ASSOC, V292, P2249, DOI 10.1001/jama.292.18.2249
   Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1
   Smith GCS, 2007, OBSTET GYNECOL, V109, P1316, DOI 10.1097/01.AOG.0000265804.09161.0d
   Smith GCS, 2007, OBSTET GYNECOL, V109, P144, DOI 10.1097/01.AOG.0000248536.94919.e3
   Smith GCS, 2010, CLIN OBSTET GYNECOL, V53, P597, DOI 10.1097/GRF.0b013e3181eb64a6
   Soto E, 2012, J MATERN-FETAL NEO M, V25, P498, DOI 10.3109/14767058.2011.591461
   Stanek J, 2017, J PERINATMED
   Stanek J, 2014, J PERINAT MED, V42, P457, DOI 10.1515/jpm-2013-0219
   Starikov R, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0580-y
   Stepan H, 2007, OBSTET GYNECOL, V109, P1205, DOI 10.1097/01.AOG.0000263776.46071.d1
   Takita H, 2017, J PERINAT MED
   Tellefsen CH, 2011, PEDIATR DEVEL PATHOL, V14, P99, DOI 10.2350/10-07-0870-OA.1
   Tennant PWG, 2014, DIABETOLOGIA, V57, P285, DOI 10.1007/s00125-013-3108-5
   Vaisbuch E, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.049
   Van Der Knoop BJ, 2017, J MATERN-FETAL NEO M, P1
   Varli IH, 2008, ACTA OBSTET GYN SCAN, V87, P1202, DOI 10.1080/00016340802460271
   von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060
   Whitten AE, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.017
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 183
TC 10
Z9 10
U1 0
U2 6
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD DEC
PY 2017
VL 217
IS 6
AR 682.e1-e13
DI 10.1016/j.ajog.2017.10.001
PG 13
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FO6DA
UT WOS:000416950700015
PM 29037482
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Ganguli, A
   Ornob, A
   Yu, H
   Damhorst, GL
   Chen, W
   Sun, F
   Bhuiya, A
   Cunningham, BT
   Bashir, R
AF Ganguli, A.
   Ornob, A.
   Yu, H.
   Damhorst, G. L.
   Chen, W.
   Sun, F.
   Bhuiya, A.
   Cunningham, B. T.
   Bashir, R.
TI Hands-free smartphone-based diagnostics for simultaneous detection of
   Zika, Chikungunya, and Dengue at point-of-care
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE Loop mediated isothermal amplification; Point-of-care diagnostics; Zika
   diagnostics; Smart phonediagnostics; Hands-free microfluidics
ID MEDIATED ISOTHERMAL AMPLIFICATION; VIRUS; BLOOD; PCR
AB Infectious diseases remain the world's top contributors to death and disability, and, with recent outbreaks of Zika virus infections there has been an urgency for simple, sensitive and easily translatable point-of-care tests. Here we demonstrate a novel point-of-care platform to diagnose infectious diseases from whole blood samples. A microfluidic platform performs minimal sample processing in a user-friendly diagnostics card followed by real-time reverse-transcription loop-mediated isothermal amplification (RT-LAMP) on the same card with pre-dried primers specific to viral targets. Our point-of-care platform uses a commercial smartphone to acquire real-time images of the amplification reaction and displays a visual read-out of the assay. We apply this system to detect closely related Zika, Dengue (types 1 and 3) and Chikungunya virus infections from whole blood on the same pre-printed chip with high specificity and clinically relevant sensitivity. Limit of detection of 1.56e5 PFU/mL of Zika virus from whole blood was achieved through our platform. With the ability to quantitate the target nucleic acid, this platform can also perform point-of-care patient surveillance for pathogen load or select biomarkers in whole blood.
C1 [Ganguli, A.; Ornob, A.; Damhorst, G. L.; Bhuiya, A.; Cunningham, B. T.; Bashir, R.] Univ Illinois, Dept Bioengn, Champaign, IL 61801 USA.
   [Ganguli, A.; Ornob, A.; Yu, H.; Damhorst, G. L.; Chen, W.; Sun, F.; Bhuiya, A.; Cunningham, B. T.; Bashir, R.] Univ Illinois, Micro & Nanotechnol Lab, Champaign, IL 61801 USA.
   [Damhorst, G. L.] Univ Illinois, Coll Med Urbana Champaign, Champaign, IL 61820 USA.
   [Yu, H.; Chen, W.; Sun, F.; Cunningham, B. T.; Bashir, R.] Univ Illinois, Dept Elect & Comp Engn, Champaign, IL 61801 USA.
   [Bashir, R.] Carle Illinois Coll Med, Urbana, IL USA.
RP Cunningham, BT; Bashir, R (corresponding author), Univ Illinois, Dept Bioengn, Champaign, IL 61801 USA.; Cunningham, BT; Bashir, R (corresponding author), Univ Illinois, Micro & Nanotechnol Lab, Champaign, IL 61801 USA.; Cunningham, BT; Bashir, R (corresponding author), Univ Illinois, Dept Elect & Comp Engn, Champaign, IL 61801 USA.; Bashir, R (corresponding author), Carle Illinois Coll Med, Urbana, IL USA.
EM bcunning@illinois.edu; rbashir@illinois.edu
RI Ganguli, Anurup/AAC-8145-2020
OI Ganguli, Anurup/0000-0002-6424-0084; Damhorst,
   Gregory/0000-0002-2237-1713; Ornob, Akid/0000-0002-4590-5255
FU NSFNational Science Foundation (NSF) [1534126]; University of Illinois
   at Urbana-Champaign
FX We thank the staff at the Micro and Nanotechnology Laboratory at UIUC
   for facilitating the chip fabrication. The work was funded by NSF grant
   1534126 and the University of Illinois at Urbana-Champaign.
CR Baden L. R., 2016, ENGL J MED, V374, P1552
   Curtis KA, 2016, J VIROL METHODS, V237, P132, DOI 10.1016/j.jviromet.2016.09.007
   Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432
   Damhorst G. L., 2015, BASHIR ENG, V1, P324
   Duarte C, 2013, BIOMED MICRODEVICES, V15, P821, DOI 10.1007/s10544-013-9769-5
   Duarte-Guevara C, 2016, RSC ADV, V6, P103872, DOI 10.1039/c6ra19685c
   Duarte-Guevara C, 2014, ANAL CHEM, V86, P8359, DOI 10.1021/ac501912x
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hu S., 2015, BMC MOL BIOL, P1
   Kemleu S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165506
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Lai L, 2012, TRANSFUSION, V52, P447, DOI 10.1111/j.1537-2995.2011.03289.x
   Lanciotti R. S., 2015, EMERG INFECT DIS, V22, P2015
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Lessler J., 2016, SCI, V46, P601
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D., 2015, DETECTION ZIKA VIRUS, V68
   Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004
   Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Safavieh M., 2016, SCI ENG, DOI [10.1021/acsbiomaterials.5b00449, DOI 10.1021/ACSBIOMATERIALS.5B00449]
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Watkins NN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006870
   Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524
NR 35
TC 37
Z9 38
U1 15
U2 141
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD DEC
PY 2017
VL 19
IS 4
AR 73
DI 10.1007/s10544-017-0209-9
PG 13
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA FH0PR
UT WOS:000410843500002
PM 28831630
DA 2020-07-08
ER

PT J
AU Huits, R
   De Smet, B
   Arien, KK
   Van Esbroeck, M
   Bottieau, E
   Cnops, L
AF Huits, Ralph
   De Smet, Birgit
   Arien, Kevin K.
   Van Esbroeck, Marjan
   Bottieau, Emmanuel
   Cnops, Lieselotte
TI Zika virus in semen: a prospective cohort study of symptomatic
   travellers returning to Belgium
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
ID SEXUAL TRANSMISSION; UNITED-STATES; VIRAL LOAD; INFECTION; KINETICS
AB Objective To prospectively monitor Zika viral loads in semen from Belgian travellers with confirmed Zika virus infection, who returned from the Americas during the 2016 Zika virus epidemic.
   Methods We recruited symptomatic travellers consulting our clinic and we confirmed infection with either reverse-transcriptase (RT) polymerase chain reaction (PCR) assay or virus neutralization test. The participants produced semen samples weekly, either at the clinic or at home. For the initial sample, the laboratory staff did a microscopy analysis if they received the sample within an hour of production. Using RT-PCR, we monitored Zika virus ribonucleic acid (RNA) loads in semen until we obtained two negative results.
   Findings We detected Zika virus RNA in nine of 15 participants' semen, one of whom was vasectomized. The median time to loss of RNA detection in semen was 83 days after symptom onset (95% confidence interval, CI: 57-108). The longest duration of viral shedding in semen before obtaining the first negative RT-PCR result was 144 days after symptom onset. All of the 11 participants, for whom we microscopically analysed their semen, had presence of leukocytes, 10 showed haematospermia and six showed oligospermia. These abnormalities occurred irrespective of Zika virus detection in semen.
   Conclusion The majority of men in our study had detectable Zika virus RNA in their semen. We recommend that semen from Zika virus-infected men should be analysed with RT-PCR and that health professionals should advise infected men, even if they are vasectomized, about current recommendations for prevention of sexual transmission of the virus.
C1 [Huits, Ralph; De Smet, Birgit; Van Esbroeck, Marjan; Bottieau, Emmanuel; Cnops, Lieselotte] Inst Trop Med, Dept Clin Sci, Kronenburgstraat 43-3, B-2000 Antwerp, Belgium.
   [Arien, Kevin K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.
RP Cnops, L (corresponding author), Inst Trop Med, Dept Clin Sci, Kronenburgstraat 43-3, B-2000 Antwerp, Belgium.
EM lcnops@itg.be
RI Huits, Ralph/I-8361-2019; De Smet, Birgit/F-4638-2014
OI Huits, Ralph/0000-0001-8803-9468; De Smet, Birgit/0000-0002-1790-1900;
   Cnops, Lieselotte/0000-0003-0658-1291; Van Esbroeck,
   Marjan/0000-0002-7294-6319
FU European Union's Horizon; research and innovation programme under
   ZikaPLAN grant [734584]; Belgian Ministry of Social Affairs through a
   fund within the Health Insurance System
FX Institute of Tropical Medicine is a member of the ZikaPLAN consortium
   that received funding from the European Union's Horizon 2020; research
   and innovation programme under ZikaPLAN grant agreement No 734584. The
   National Reference Center of arboviruses (Institute of Tropical
   Medicine) is partially supported by the Belgian Ministry of Social
   Affairs through a fund within the Health Insurance System. LC holds an
   innovation mandate (140779) from the Flanders Innovation &
   Entrepreneurship.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Amann RP, 2008, J ANDROL, V29, P469, DOI 10.2164/jandrol.107.004655
   [Anonymous], 2016, RAP RISK ASS ZIK VIR
   [Anonymous], 2016, ZIKA STRAT RESP FRAM
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Butler D, 2017, NATURE, V545, P396, DOI 10.1038/545396a
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huits RM, B WHO
   Joguet G, 2017, LANCET INFECT DIS, V3099, P1
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   WHO, 2016, PREV SEX TRANSM ZIK
   World Health Organization, 2010, WHO LAB MAN EX PROC
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 38
TC 14
Z9 14
U1 0
U2 7
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD DEC
PY 2017
VL 95
IS 12
BP 802
EP 809
DI 10.2471/BLT.17.181370
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FP5GW
UT WOS:000417649000010
PM 29200521
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Musso, D
   Richard, V
   Teissier, A
   Stone, M
   Lanteri, MC
   Latoni, G
   Alsina, J
   Reik, R
   Busch, MP
AF Musso, D.
   Richard, V.
   Teissier, A.
   Stone, M.
   Lanteri, M. C.
   Latoni, G.
   Alsina, J.
   Reik, R.
   Busch, M. P.
CA Recipient Epidemiology Donor
TI Detection of Zika virus RNA in semen of asymptomatic blood donors
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Blood-borne infections; Emerging diseases; Sexually transmitted;
   Vector-borne infections; Zika virus
ID SEXUAL TRANSMISSION; INFECTION; DONATIONS
AB Objectives: Zika virus (ZIKV) transmission through semen donation has never been reported but the risk is supported by the detection of ZIKV in semen and the demonstration of ZIKV sexual transmission. The potential impact of ZIKV on assisted reproductive procedures should be evaluated.
   Methods: We tested longitudinally collected semen samples provided by asymptomatic blood donors who tested positive for ZIKV RNA in plasma during ZIKV outbreaks in Puerto Rico and Florida in 2016.
   Results: Five of the 14 (35.7%) asymptomatic blood donors provided semen samples that tested positive for ZIKV RNA, with ZIKV RNA loads ranging from 8.03 x 10(3) to 2.55 x 10(6) copies/mL. Plasma collected at the same time as the semen tested negative for ZIKV RNA for most ZIKV RNA-positive semen collections; all corresponding plasma samples tested positive or equivocal for anti-ZIKV IgG antibodies and all except one tested positive for ZIKV IgM antibodies. The rate of detection of ZIKV RNA in semen in asymptomatic donors is not significantly different from the rate previously reported for symptomatic patients.
   Conclusions: Our results that show a high percentage of detection of ZIKV RNA in the semen of asymptomatic men confirm that ZIKV is a new threat for reproductive medicine and should have important implications for assisted reproductive technology. We recommend that semen donations from men at risk for ZIKV infection should be tested for ZIKV RNA, regardless of symptoms of ZIKV infection. (C) 2017 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
C1 [Musso, D.; Richard, V.; Teissier, A.] Inst Louis Malarde, Pole Rech & Veille Malad Infect Emergentes, Tahiti, French Polynesi, France.
   [Stone, M.; Lanteri, M. C.; Busch, M. P.] Blood Syst Res Inst, 270 Masonic Ave, San Francisco, CA 94118 USA.
   [Latoni, G.; Alsina, J.] Banco Sangre, San Juan, PR USA.
   [Reik, R.] One Blood, Orlando, FL USA.
RP Busch, MP (corresponding author), Blood Syst Res Inst, 270 Masonic Ave, San Francisco, CA 94118 USA.
EM mbusch@bloodsystems.org
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Richard, Vaea/0000-0001-8132-0740
FU NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [HHSN268201100001I]
CR American Association for Blood Banks, 2016, AM ASS BLOOD BANKS A
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   European Centre for Disease Prevention and Control, 2016, ZIK VIR SAF SUBST HU
   FDA, 2016, REV REC RED RISK ZIK
   Freour T., 2016, EURO SURVEILL, V21
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Paz-Bailey G, 2017, N ENGL J MED
   WHO, 2016, MAINT SAF AD BLOOD S
NR 15
TC 26
Z9 28
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD DEC
PY 2017
VL 23
IS 12
DI 10.1016/j.cmi.2017.07.006
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FN5FI
UT WOS:000416031600022
PM 28711704
OA Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU Pena-Garcia, VH
   McCracken, MK
   Christofferson, RC
AF Pena-Garcia, Victor Hugo
   McCracken, Michael K.
   Christofferson, Rebecca C.
TI Examining the Potential for South American Arboviruses to Spread Beyond
   the New World
SO CURRENT CLINICAL MICROBIOLOGY REPORTS
LA English
DT Article
DE Emerging viruses; Zika; Chikungunya; Yellow fever; Mayaro; Oropouche
AB Purpose of Review
   Zika and chikungunya viruses emerged as public health emergencies in the western hemisphere where previously they had not been reported on a large scale. Millions were infected as the viruses met with virtually no herd immunity upon emergence. We explore the histories of these two recent arbovirus experiences in South America. We then review similar three endemic South American viruses: yellow fever, Oropouche, and Mayaro viruses.
   Recent Findings We discuss the commonalities of the transmission systems and the possibility of an atypical emergence, that of the New World virus to the Old World.
   Summary We discuss the avenues for research that would increase preparedness and efficiency of response should a South American arbovirus emerge in the eastern hemisphere.
C1 [Pena-Garcia, Victor Hugo] Univ Boyaca, Fac Sci & Engn, Dept Biol & Microbiol, Tunja, Boyaca, Colombia.
   [McCracken, Michael K.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.
   [Christofferson, Rebecca C.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.
RP Christofferson, RC (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.
EM rcarri1@lsu.edu
OI Pena-Garcia, Victor Hugo/0000-0002-4856-3166; McCracken,
   Michael/0000-0002-4035-5485
FU NIH/NIGMSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [N44852-16-P-0016];  [R01GM12207]
FX This work was funded by NAMRU-6 (contract no. N44852-16-P-0016) and by
   NIH/NIGMS R01GM12207.
CR Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   ANDERSON CR, 1961, AM J TROP MED HYG, V10, P574, DOI 10.4269/ajtmh.1961.10.574
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Angeletti S, 2016, PATHOG GLOB HEALTH, V110, P269, DOI 10.1080/20477724.2016.1235337
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P553, DOI 10.1590/0037-8682-0245-2016
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Augustin G., 1909, HIST YELLOW FEVER, P1230
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EURO SURVEILL, V19
   Borborema C A, 1982, Rev Inst Med Trop Sao Paulo, V24, P132
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   CASALS J, 1957, AM J TROP MED HYG, V6, P1004, DOI 10.4269/ajtmh.1957.6.1004
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   CHAVEZ R, 1992, REV FARMACOL TERAP L, V2, P12
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christofferson RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110538
   Azevedo RDD, 2007, EMERG INFECT DIS, V13, P912
   de Oliveira Mota MT, 2015, FUTURE VIROL, V10, P73
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2012, EMERG INFECT DIS, V18, P2066, DOI 10.3201/eid1812.120471
   Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332
   Estofolete CF, 2016, REV SOC BRAS MED TRO, V49, P648, DOI 10.1590/0037-8682-0093-2016
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Fernandez-Salas I, 2016, CURR OPIN INFECT DIS, V29, P467, DOI 10.1097/QCO.0000000000000304
   Finlay Carlos J., 1833, JAMA-J AM MED ASSOC, V198, P1210
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102
   Hassing RJ, 2010, EURO SURVEILL, V15
   Heukelbach J, 2016, LANCET, V388, P846, DOI 10.1016/S0140-6736(16)30931-X
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   HOCH AL, 1981, AM J TROP MED HYG, V30, P689, DOI 10.4269/ajtmh.1981.30.689
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   Kuno G, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004101
   Lanciotti RS, 2016, AM J TROP MED HYG, V94, P800, DOI 10.4269/ajtmh.15-0375
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   LeDuc J W, 1981, Bull Pan Am Health Organ, V15, P97
   LEDUC JW, 1981, AM J TROP MED HYG, V30, P682, DOI 10.4269/ajtmh.1981.30.682
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manock SR, 2009, AM J TROP MED HYG, V81, P146, DOI 10.4269/ajtmh.2009.81.146
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2017, J MED ENTOMOL, V54, P509, DOI 10.1093/jme/tjw209
   Romano APM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002740
   Mercer DR, 2005, J MED ENTOMOL, V42, P554, DOI 10.1603/0022-2585(2005)042[0554:CIRSCO]2.0.CO;2
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X
   Navarro JC, 2016, AM J TROP MED HYG, V95, P328, DOI 10.4269/ajtmh.15-0679
   Nunes M.R.T., 2007, CADERNOS SAUDE COLET, V15, P303
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Ortiz-Martinez Yeimer, 2017, F1000Res, V6, P398, DOI 10.12688/f1000research.11280.2
   PINHEIRO F P, 1981, American Journal of Tropical Medicine and Hygiene, V30, P149
   Pinheiro F.P., 2004, TXB PEDIAT INFECT DI, P2418
   Pinheiro FM, 1962, REV SERV ESP SAUDE P, V12, P15
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P172, DOI 10.4269/ajtmh.1981.30.172
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   PINHEIRO FP, 1982, SCIENCE, V215, P1251, DOI 10.1126/science.6800036
   Powers AM, 2006, AM J TROP MED HYG, V75, P461, DOI 10.4269/ajtmh.2006.75.461
   Reed W, 1901, Public Health Pap Rep, V27, P113
   Reed W, 2001, Mil Med, V166, P44
   Reed W, 1901, J AMER MED ASSOC, V36, P431
   Renault P, 2008, EMERG INFECT DIS, V14, P1327, DOI 10.3201/eid1408.080201
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Romero-Alvarez D, 2017, MEM I OSWALDO CRUZ, V112, P292, DOI 10.1590/0074-02760160415
   Rosa A P, 1996, Rev Soc Bras Med Trop, V29, P537, DOI 10.1590/S0037-86821996000600002
   Saad LD, 2016, EPIDEMIOL SERV SAUDE, V25, P531, DOI [10.5123/S1679-49742016000300009, 10.5123/s1679-49742016000300009]
   Saeed MF, 2000, J GEN VIROL, V81, P743, DOI 10.1099/0022-1317-81-3-743
   SCHAEFFER M, 1959, AM J TROP MED HYG, V8, P372, DOI 10.4269/ajtmh.1959.8.372
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   Stokes A, 1928, J AMER MED ASSOC, V90, P253, DOI 10.1001/jama.1928.02690310005002
   TESH RB, 1994, ANN NY ACAD SCI, V740, P129, DOI 10.1111/j.1749-6632.1994.tb19863.x
   Theiler M, 1930, SCIENCE, V71, P367, DOI 10.1126/science.71.1840.367
   Tomori O, 1999, ADV VIRUS RES, V53, P5, DOI 10.1016/S0065-3527(08)60341-3
   da Rosa JFT, 2017, AM J TROP MED HYG, V96, P1019, DOI 10.4269/ajtmh.16-0672
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333
   VASCONCELOS PFD, 1989, REV INST MED TROP SP, V31, P271, DOI 10.1590/S0036-46651989000400011
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WEINBREN M P, 1958, Trans R Soc Trop Med Hyg, V52, P258
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P253, DOI 10.1016/0035-9203(58)90084-1
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
NR 110
TC 2
Z9 3
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 2196-5471
J9 CURR CLIN MICROBIOL
JI Curr. Clin. Microbiol.
PD DEC
PY 2017
VL 4
IS 4
BP 208
EP 217
DI 10.1007/s40588-017-0076-4
PG 10
WC Microbiology
SC Microbiology
GA VH8EF
UT WOS:000455400100004
PM 29785356
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Haidar, G
   Singh, N
AF Haidar, Ghady
   Singh, Nina
TI Viral infections in solid organ transplant recipients: novel updates and
   a review of the classics
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Review
DE cytomegalovirus; herpesviruses; HIV-to-HIV transplants; solid organ
   transplant; viral infections
ID EPSTEIN-BARR-VIRUS; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER;
   CELL-MEDIATED-IMMUNITY; POSITIVE LIVER-TRANSPLANTATION;
   CYTOMEGALOVIRUS-INFECTION; ANTIVIRAL PROPHYLAXIS; LUNG TRANSPLANTATION;
   CLINICAL UTILITY; KIDNEY-TRANSPLANTATION; PREEMPTIVE THERAPY
AB Purpose of review
   To summarize new discoveries in viral pathogenesis and novel therapeutic and prophylactic strategies in organ transplant recipients.
   Recent findings
   For decades, prophylaxis of cytomegalovirus (CMV) has been the standard preventive strategy, but new clinical trials are expected to determine the advantages of preemptive therapy over prophylaxis. Novel anti-CMV agents, such as maribavir and letermovir, are being studied for the treatment of resistant/refractory CMV as alternatives to foscarnet and cidofovir. CMV immune monitoring may offer individualized management plans. Epstein-Barr virus infections in transplant recipients are difficult to prevent and treat, though recent data suggest possible merit to pretransplant rituximab among high-risk transplant recipients. We review the groundbreaking HIV-to-HIV organ transplant trials, which are expected to revolutionize the care of HIV-infected individuals. Finally, we review topical developments in human herpesvirus 8, Zika virus, RNA respiratory viruses, adenovirus, norovirus, and polyoma viruses in organ transplantation.
   Summary
   Ongoing trials to optimize CMV prophylaxis and treatment, and outcomes of HIV-to-HIV organ transplantation in the United States, have significant implications to optimize management of these viruses in transplant recipients. Assessment of new antivirals and antiviral strategies, such as adoptive immunotherapy, is warranted for refractory viral infections.
C1 [Haidar, Ghady] Univ Pittsburgh, Med Ctr, Div Infect Dis, Pittsburgh, PA USA.
   [Singh, Nina] Univ Pittsburgh, Infect Dis Sect, VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA.
RP Singh, N (corresponding author), Vet Adm Med Ctr, Infect Dis Sect, Suite 2A-126,Univ Dr C, Pittsburgh, PA 15240 USA.
EM nis5@pitt.edu
RI Singh, Nouratan/N-9377-2017
OI Singh, Nouratan/0000-0002-8063-8375
CR Allen UD, 2013, AM J TRANSPLANT, V13, P107, DOI 10.1111/ajt.12104
   Andreoni M, 2002, JAMA-J AM MED ASSOC, V287, P1295, DOI 10.1001/jama.287.10.1295
   Arriola CS, 2017, CLIN INFECT DIS, P1
   Atabani SF, 2012, AM J TRANSPLANT, V12, P2457, DOI 10.1111/j.1600-6143.2012.04087.x
   Avery RK, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12674
   Avery RK, 2016, TRANSPLANTATION, V100, pE74, DOI 10.1097/TP.0000000000001418
   Blumberg EA, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14083
   Blyth E, 2016, VIRULENCE, V7, P967, DOI 10.1080/21505594.2016.1221022
   Boyarsky BJ, 2011, AM J TRANSPLANT, V11, P1209, DOI 10.1111/j.1600-6143.2011.03506.x
   Calmy A, 2016, AM J TRANSPLANT, V16, P2473, DOI 10.1111/ajt.13824
   Chiereghin A, 2017, TRANSPLANTATION, V101, P1935, DOI 10.1097/TP.0000000000001740
   Chong PP, 2017, CLIN THER, V39, P1581, DOI 10.1016/j.clinthera.2017.07.005
   Cooper C, 2011, AIDS, V25, P777, DOI 10.1097/QAD.0b013e328344febb
   Couzi L, 2009, J INFECT DIS, V200, P1415, DOI 10.1086/644509
   Egli A, 2012, CLIN INFECT DIS, V55, P1678, DOI 10.1093/cid/cis818
   Emery VC, 2001, REV MED VIROL, V11, P83, DOI 10.1002/rmv.310
   Erice A, 1999, CLIN MICROBIOL REV, V12, P286, DOI 10.1128/CMR.12.2.286
   Florescu DF, 2013, AM J TRANSPLANT, V13, P206, DOI 10.1111/ajt.12112
   Green M, 2006, AM J TRANSPLANT, V6, P1906, DOI 10.1111/j.1600-6143.2006.01394.x
   Green M, 2013, AM J TRANSPLANT, V13, P41, DOI 10.1111/ajt.12004
   Griffiths PD, 2011, LANCET, V377, P1256, DOI 10.1016/S0140-6736(11)60136-0
   Haidar G, 2017, TRANSPLANTATION, V101, P1987, DOI 10.1097/TP.0000000000001728
   Haidar G, 2017, LIVER TRANSPLANT, V23, P727, DOI 10.1002/lt.24765
   Hamad Y, 2017, J HEART LUNG TRANSPL, V36, P244, DOI 10.1016/j.healun.2016.10.009
   Hathorn E, 2016, NEW ENGL J MED, V375, P1807, DOI 10.1056/NEJMc1603850
   Heck E, 2017, AM J TRANSPLANT, V17, P2227, DOI 10.1111/ajt.14334
   Hirsch HH, 2013, AM J TRANSPLANT, V13, P179, DOI 10.1111/ajt.12110
   Ho JH, 2015, J INFECT DIS, V211, P1560, DOI 10.1093/infdis/jiu524
   Holmes-Liew CL, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.5
   Humar A, 2006, TRANSPLANTATION, V81, P856, DOI 10.1097/01.tp.0000202724.07714.a2
   Humar A, 2005, AM J TRANSPLANT, V5, P1065, DOI 10.1111/j.1600-6143.2005.00797.x
   Humar A, 2010, AM J TRANSPLANT, V10, P1228, DOI 10.1111/j.1600-6143.2010.03074.x
   Ikejezie J, 2017, AM J TRANSPLANT, V17, P1681, DOI 10.1111/ajt.14333
   JONJIC S, 1994, J EXP MED, V179, P1713, DOI 10.1084/jem.179.5.1713
   Kijpittayarit S, 2007, CLIN INFECT DIS, V44, P1315, DOI 10.1086/514339
   Kim JS, 2010, TRANSPLANTATION, V90, P837
   Kotton CN, 2013, TRANSPLANTATION, V96, P333, DOI 10.1097/TP.0b013e31829df29d
   Kumar D, 2017, AM J TRANSPLANT, V17, P2468, DOI 10.1111/ajt.14347
   Le J, 2013, AM J TRANSPLANT, V13, P128, DOI 10.1111/ajt.12106
   Lee TC, 2005, AM J TRANSPLANT, V5, P2222, DOI 10.1111/j.1600-6143.2005.01002.x
   Levitsky J, 2008, AM J TRANSPLANT, V8, P158, DOI 10.1111/j.1600-6143.2007.02026.x
   Li L, 2012, J HEART LUNG TRANSPL, V31, P839, DOI 10.1016/j.healun.2012.04.002
   Limaye AP, 2006, TRANSPLANTATION, V81, P1645, DOI 10.1097/01.tp.0000226071.12562.1a
   Lisboa LF, 2012, TRANSPLANTATION, V93, P195, DOI 10.1097/TP.0b013e31823c1cd4
   Lisboa LF, 2011, TRANSPLANTATION, V92, P1063, DOI 10.1097/TP.0b013e31822fa4b7
   Manuel O, 2013, AM J TRANSPLANT, V13, P212, DOI 10.1111/ajt.12113
   Manuel O, 2013, CURR INFECT DIS REP, V15, P491, DOI 10.1007/s11908-013-0369-6
   Martin SI, 2011, AM J TRANSPLANT, V11, P1058, DOI 10.1111/j.1600-6143.2011.03478.x
   Miller G, 2007, ADV CANCER RES, V97, P81, DOI 10.1016/S0065-230X(06)97004-3
   Mitsani D, 2010, J HEART LUNG TRANSPL, V29, P1014, DOI 10.1016/j.healun.2010.04.022
   Moore PS, 2000, NEW ENGL J MED, V343, P1411, DOI 10.1056/NEJM200011093431912
   Mularoni A, 2017, AM J TRANSPLANT, V17, P2963, DOI 10.1111/ajt.14346
   Muller E, 2015, NEW ENGL J MED, V372, P613, DOI 10.1056/NEJMoa1408896
   Palmer SM, 2010, ANN INTERN MED, V152, P761, DOI 10.7326/0003-4819-152-12-201006150-00003
   Parham P., 2015, IMMUNE SYSTEM, P47
   Pereira MS, 2017, AM J TRANSPLANT S3, V17
   Poglitsch M, 2012, AM J TRANSPLANT, V12, P1458, DOI 10.1111/j.1600-6143.2012.04002.x
   Razonable RR, 2013, AM J TRANSPLANT, V13, P93, DOI 10.1111/ajt.12103
   Richterman A, 2015, AM J TRANSPLANT, V15, P2105, DOI 10.1111/ajt.13308
   Rieder F, 2014, CLIN MICROBIOL INFEC, V20, P95, DOI 10.1111/1469-0691.12449
   Romiopoulos I, 2016, TRANSPL INFECT DIS, V18, P795, DOI 10.1111/tid.12586
   ROONEY CM, 1995, LANCET, V345, P9, DOI 10.1016/S0140-6736(95)91150-2
   Rose J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006299
   Schachtner T, 2016, TRANSPL INFECT DIS, V18, P881, DOI 10.1111/tid.12605
   Schulz U, 2016, TRANSPLANTATION, V100, pS5, DOI 10.1097/TP.0000000000001097
   Sester U, 2008, AM J TRANSPLANT, V8, P1486, DOI 10.1111/j.1600-6143.2008.02279.x
   Silveira FP, 2016, J HEART LUNG TRANSPL, V35, P560, DOI 10.1016/j.healun.2016.03.010
   Singh N, 2005, CLIN INFECT DIS, V40, P704, DOI 10.1086/427506
   Snyder LD, 2016, AM J RESP CRIT CARE, V193, P78, DOI 10.1164/rccm.201504-0733OC
   Stock PG, 2010, NEW ENGL J MED, V363, P2004, DOI 10.1056/NEJMoa1001197
   Sun HY, 2008, AM J TRANSPLANT, V8, P2111, DOI 10.1111/j.1600-6143.2008.02369.x
   Sundbom P, 2017, OXF MED CASE REPORTS, V2017
   Swerdlow SCampoEHarrisN, 2008, WHO CLASSIFICATION T
   Verghese PS, 2013, DRUG FUTURE, V38, P291, DOI 10.1358/dof.2013.038.05.1946425
   Vincenti FB, 2017, AM J TRANSPLANT S3, V17
   Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004
   Wills MR, 2015, CELL MOL IMMUNOL, V12, P128, DOI 10.1038/cmi.2014.75
   Winston DJ, 2012, AM J TRANSPLANT, V12, P3021, DOI 10.1111/j.1600-6143.2012.04231.x
NR 78
TC 23
Z9 23
U1 0
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7375
EI 1473-6527
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD DEC
PY 2017
VL 30
IS 6
BP 579
EP 588
DI 10.1097/QCO.0000000000000409
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA FL7JQ
UT WOS:000414424200009
PM 28984642
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika Virus Disease Response Protocol
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Pimpri Chinchwad, India.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ilara Mokin, Nigeria.
   [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Thailand.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Phillips JA, 2016, WORKPLACE HEALTH SAF, V64, P396, DOI 10.1177/2165079916657109
   Rosa R, DISASTER MED PUBLIC
   Vest KG, 2016, DISASTER MED PUBLIC, V10, P707, DOI 10.1017/dmp.2016.43
   Wiwanitkit V, 2016, INFECT CONT HOSP EP, V37, P1519, DOI 10.1017/ice.2016.212
   Wiwanitkit V, 2016, J FORMOS MED ASSOC, V115, P684, DOI 10.1016/j.jfma.2016.03.008
NR 5
TC 0
Z9 0
U1 0
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD DEC
PY 2017
VL 11
IS 6
BP 640
EP 640
DI 10.1017/dmp.2017.17
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FS6AF
UT WOS:000419879600002
PM 28318467
OA Bronze
DA 2020-07-08
ER

PT J
AU Darbro, J
   Halasa, Y
   Montgomery, B
   Muller, M
   Shepard, D
   Devine, G
   Mwebaze, P
AF Darbro, Jonathan
   Halasa, Yara
   Montgomery, Brian
   Muller, Mike
   Shepard, Donald
   Devine, Greg
   Mwebaze, Paul
TI An Economic Analysis of the Threats Posed by the Establishment of Aedes
   albopictus in Brisbane, Queensland
SO ECOLOGICAL ECONOMICS
LA English
DT Article
DE Mosquito; Aedes albopictus; Benefit-cost analysis; Benefit transfer;
   Willingness to pay; Vector control
ID CHIKUNGUNYA VIRUS-INFECTION; ASIAN TIGER MOSQUITO; GLOBAL DISTRIBUTION;
   CLIMATE-CHANGE; DENGUE; AUSTRALIA; OUTBREAK; PATTERNS; ECOLOGY; AEGYPTI
AB Aedes albopictus is an invasive mosquito, aggressive biter and potential disease vector. Its establishment in Europe and the Americas resulted in local disease transmission and impacted quality of outdoor recreational activities. Economic implications of its likely invasion into Australia had not been considered.
   A benefit-cost analysis of an elimination response scenario to an Ae. albopictus incursion in Brisbane was developed with a benefits transfer estimate of the local population's willingness-to-pay for an Ae. albopictus-free environment. Other costed considerations included i) necessary precautionary vector control responses to importations of mosquito-borne diseases (e.g. dengue, Zika) and ii) projected rises in complaints to local government regarding increased mosquito nuisance.
   Costs of implementing a successful elimination program were estimated between 1 and 4 AU$ per capita, and the annual benefit-cost ratio regarding the value of an unaffected outdoor environment was between 50 and 78. In the event of establishment, annual costs of local government and public health responses were between 0.5 and 1.3 AU$ per capita. The recurrent expense of permanent colonization will be magnified by loss of value associated with an Ae. albopictus-free environment.
   We conclude it is more cost-beneficial to conduct a thorough elimination program for Ae. albopictus than to allow establishment. (C) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Darbro, Jonathan] QIMR Berghofer Med Res Inst, 300 Herston Rd, Herston, Qld 4006, Australia.
   [Halasa, Yara; Shepard, Donald] Brandeis Univ, POB 549110,Mailstop MS 035,415 South St, Waltham, MA 02454 USA.
   [Montgomery, Brian] Metro South Publ Hlth Unit, 39 Kessels Rd, Coopers Plains, Qld 4108, Australia.
   [Muller, Mike] Brisbane City Council, Shed, 25 Green Sq Close, Fortitude Valley, Qld 4006, Australia.
   [Devine, Greg] QIMR Berghofer Med Res Inst, 300 Herston Rd, Herston, Qld 4006, Australia.
   [Mwebaze, Paul] CSIRO Land & Water, EcoSci Precinct, 41 Boggo Rd, Dutton Park, Qld 4102, Australia.
RP Darbro, J (corresponding author), QIMR Berghofer Med Res Inst, 300 Herston Rd, Herston, Qld 4006, Australia.
EM Jonathan.Darbro@qimrberghofer.edu.au; yara@brandeis.edu;
   brian.montgomery@health.qld.gov.au; Mike.Muller@brisbane.qld.gov.au;
   shepard@brandeis.edu; Greg.Devine@qimrberghofer.edu.au;
   Paul.Mwebaze@csiro.au
RI Mwebaze, Paul/J-5905-2013; Devine, Gregor J/H-1141-2014
OI Mwebaze, Paul/0000-0002-3596-4921; Devine, Gregor J/0000-0001-6312-0390
FU Mosquito and Arbovirus Research Committee, Queensland
FX This study was largely funded by the Mosquito and Arbovirus Research
   Committee, Queensland. This is an umbrella organization, funded by local
   government, which is concerned with developing research foci relevant to
   the immediate needs of local government mosquito control efforts
   (www.marc.net.au). We thank the Aedes albopictus Eradication Programme
   TAG (R. Russell, P. Whelan, S. Ritchie, G. Devine, A. van den Hurk, J.
   Walker) for commenting on previous drafts of this manuscript. M. Shivas,
   M. Onn and I. Myles (Brisbane City Council) and G. Cochrane (Amalgated
   Pest Control, Pty Ltd) provided technical advice on mosquito control in
   Brisbane. J. Davis (Tropical Public Health Unit, Queensland Health)
   provided technical advice and information concerning dengue control in
   Cairns. D. Allaway (Gold Coast City Council) provided service request
   numbers for the city of Gold Coast. K. Lodo and N. Burt (Communicable
   Disease Unit, Queensland Health) provided mosquito-borne disease case
   data for Brisbane. The following gave information on Ae. albopictus in
   Florida: M. Clark (City of Jacksonville), R.-D. Xue (St. John county),
   D. Carlson (Indian River county), S. Fisher (Miami and Hernando
   counties), J. Hornby (Lee county), M. Latham (Manatee county) and J.
   McNelly (Volusia county). B. Trewin provided graphical figures.
CR Angus BM, 1996, INT J PARASITOL, V26, P1341, DOI 10.1016/S0020-7519(96)00112-9
   [Australian Bureau of Statistics Statistics A.B.o.], 2013, AUSTR NAT ACC STAT A
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Boardman A, 2006, COST BENEFIT ANAL CO
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brown R., 2003, BENEFIT COST ANAL FI
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Carnegie AJ, 2012, SIREX WOODWASP AND ITS FUNGAL SYMBIONT: RESEARCH AND MANAGEMENT OF A WORLDWIDE INVASIVE PEST, P175, DOI 10.1007/978-94-007-1960-6_14
   Carrieri M, 2008, J AM MOSQUITO CONTR, V24, P377, DOI 10.2987/5612.1
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Coin News Media Group LLC, 2014, US INFL CALC
   Crans WJ, 1996, J AM MOSQUITO CONTR, V12, P307
   Dale PER, 2008, J AM MOSQUITO CONTR, V24, P427, DOI 10.2987/5680.1
   Devine G., 2013, REPORT DOHA AEDES AL
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Halasa YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089221
   Halasa YA, 2012, J AM MOSQUITO CONTR, V28, P225, DOI 10.2987/12-6243R.1
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hanley N., 2009, PRICING NATURE COST
   Heersink D.K, 2015, J PEST SCI, V89, P1
   Horwood PF, 2013, EMERG INFECT DIS, V19, P1535, DOI 10.3201/eid1909.130130
   Huang XT, 2016, SCI REP-UK, V6, DOI 10.1038/srep32236
   Johnson B., 2016, J MED ENTOMOL
   Kulback M, 2007, NO TERRITORY DIS CON, V14, P30
   Kurucz N, 2014, N TERRITORY DIS CONT, V21, P12
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Manica M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004758
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Muzari M., 2017, PLOS NEGLECT TROP D
   Muzari O, 2015, REPORT COMMONWEALTH
   Muzari OM, 2014, J MED ENTOMOL, V51, P444, DOI 10.1603/ME13141
   Mwebaze P., 2017, ENVIRON RESOUR ECON, P1
   Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167
   Nguyen H., 2009, N TERRITORY DIS CONT, V16, P14
   Nicholson J, 2014, J MED ENTOMOL, V51, P948, DOI 10.1603/ME14079
   Nicholson J, 2014, J MED ENTOMOL, V51, P661, DOI 10.1603/ME13204
   Nicholson J., 2014, J MED ENTOMOL
   O'Meara G. F., 1993, American Entomologist, V39, P163
   Pardigon N, 2009, PATHOL BIOL, V57, P127, DOI 10.1016/j.patbio.2008.02.016
   Pettigrew S, 2002, ASIA PAC ADV CONSUM, V5
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Queensland Health, 2015, QUEENSL DENG MAN PLA
   Queensland Health, 2014, QUEENSL CHIK MAN PLA
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Ritchie S. A., 2002, Dengue Bulletin, V26, P7
   Ritchie Scott, 2001, Arbovirus Research in Australia, V8, P288
   Ritchie SA, 2006, J AM MOSQUITO CONTR, V22, P358, DOI 10.2987/8756-971X(2006)22[358:DOAWIO]2.0.CO;2
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Russell RC, 2009, MED J AUSTRALIA, V190, P265, DOI 10.5694/j.1326-5377.2009.tb02393.x
   Services I.R, 2013, INSTR FORM 4562 DEPR
   Shepard DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111014
   [Trade Q.T Office Q.G.S], 2013, POP GROWTH HIGHL TRE
   Trewin BJ, 2013, INT HEALTH, V5, P251, DOI 10.1093/inthealth/iht023
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsuda Yoshio, 2012, Medical Entomology and Zoology, V63, P223, DOI 10.7601/mez.63.223
   U.S. Bureau of Economic Analysis, 2013, GROSS DOM PROD STAT
   Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999
   van den Hurk AF, 2016, ONE HEALTH, V2, P19, DOI 10.1016/j.onehlt.2016.02.001
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   WHELAN P, 2005, B MOSQUITO CONTROL A, V17, P16
   Whelan P, 2009, ARBOVIRUS RES AUST, V10, P188
   Whelan PI, 2012, NO TERRITORY DIS CON, V19, P16
   Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2
   Worobey J, 2013, J AM MOSQUITO CONTR, V29, P78, DOI 10.2987/12-6296R.1
   Wylie R, 2016, ECOL MANAG RESTOR, V17, P22, DOI 10.1111/emr.12197
NR 71
TC 4
Z9 6
U1 0
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8009
EI 1873-6106
J9 ECOL ECON
JI Ecol. Econ.
PD DEC
PY 2017
VL 142
BP 203
EP 213
DI 10.1016/j.ecolecon.2017.06.015
PG 11
WC Ecology; Economics; Environmental Sciences; Environmental Studies
SC Environmental Sciences & Ecology; Business & Economics
GA FI8NL
UT WOS:000412259200019
OA Other Gold
DA 2020-07-08
ER

PT J
AU Maxian, O
   Neufeld, A
   Talis, EJ
   Childs, LM
   Blackwood, JC
AF Maxian, Ondrej
   Neufeld, Anna
   Talis, Emma J.
   Childs, Lauren M.
   Blackwood, Julie C.
TI Zika virus dynamics: When does sexual transmission matter?
SO EPIDEMICS
LA English
DT Article
DE ZIKV; Transmission dynamics; Mathematical model; Sexual transmission;
   Vector-borne transmission
ID RIO-DE-JANEIRO; MATHEMATICAL-MODEL; DISEASE TRANSMISSION; TUBERCULOSIS;
   SENSITIVITY; UNCERTAINTY; BORNE; HIV
AB The Zika virus (ZIKV) has captured worldwide attention with the ongoing epidemic in South America and its link to severe birth defects, most notably microcephaly. ZIKV is spread to humans through a combination of vector and sexual transmission, but the relative contribution of these transmission routes to the overall epidemic remains largely unknown. Furthermore, a disparity in the reported number of infections between males and females has been observed. We develop a mathematical model that describes the transmission dynamics of ZIKV to determine the processes driving the observed epidemic patterns. Our model reveals a 4.8% contribution of sexual transmission to the basic reproductive number, Ro. This contribution is too minor to independently sustain an outbreak but suggests that vector transmission is the main driver of the ongoing epidemic. We also find a minor, yet statistically significant, difference in the mean number of cases in males and females, both at the peak of the epidemic and at equilibrium. While this suggests an intrinsic disparity between males and females, the differences do not account for the vastly greater number of reported cases for females, indicative of a large reporting bias. In addition, we identify conditions under which sexual transmission may play a key role in sparking an epidemic, including temperate areas where ZIKV mosquito vectors are less prevalent. (C) 2017 The Author(s). Published by Elsevier B.V.
C1 [Maxian, Ondrej] Case Western Reserve Univ, Dept Math Appl Math & Stat, Cleveland, OH 44106 USA.
   [Neufeld, Anna; Blackwood, Julie C.] Williams Coll, Dept Math & Stat, Williamstown, MA 01267 USA.
   [Talis, Emma J.] Marist Coll, Dept Math, Poughkeepsie, NY USA.
   [Childs, Lauren M.] Virginia Tech, Dept Math, Blacksburg, VA 24061 USA.
RP Blackwood, JC (corresponding author), Williams Coll, Dept Math & Stat, Williamstown, MA 01267 USA.
EM jcb5@williams.edu
FU National Science Foundation REU GrantNational Science Foundation (NSF)
   [DMS - 1347804]; Williams College Science Center; Clare Boothe Luce
   Program of the Henry Luce Foundation
FX We thank an anonymous reviewer for their helpful and constructive
   feedback on earlier versions of this manuscript. We also thank Andre
   Archer, Eliza Matt, Colin Okasaki for helpful discussions throughout
   this project. Our research was supported in part by the National Science
   Foundation REU Grant DMS - 1347804, the Williams College Science Center,
   and the Clare Boothe Luce Program of the Henry Luce Foundation.
CR Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   ANDERSON R M, 1991
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bastos L., 2016, BIORXIV, DOI DOI 10.1101/055475
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bewick S., 2016, ZIKA VIRUS ENDEMIC V
   BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510
   BLOWER SM, 1991, PHILOS T R SOC B, V331, P171, DOI 10.1098/rstb.1991.0006
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brazilian Institute of Geography and Statistics (IBGE), 2010, 2010 CENS
   Chandra A., 2013, INT HDB DEMOGRAPHY S, P45, DOI DOI 10.1007/978-94-007-5512-3_4
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T., 2016, EURO SURVEILL, V21
   Gaff HD, 2007, ELECTRON J DIFFER EQ
   Gammack D, 2005, MULTISCALE MODEL SIM, V3, P312, DOI 10.1137/040603127
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Hills S. L, 2016, MMWR MORBIDITY MORTA, V65
   Keeling M.J., 2007, MODELING INFECT DIS
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mckay MD, 2000, TECHNOMETRICS, V42, P55, DOI 10.2307/1271432
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nuraini N, 2007, B MALAYS MATH SCI SO, V30, P143
   Pacheco O, 2016, N ENGL J MED
   Petersen E. E., 2016, MMWR MORBIDITY MORTA, V65
   Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127
   Smith T. W., 1998, AM SEXUAL BEHAV TREN
   Turmel J. M., 2016, LANCET
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Bank, 2015, WORLD DEV IND POP DY
   World Bank, 2014, LIF EXP BIRTH TOT YE
   ZWG on behalf of the Committee to Advise on Tropical Medicine and Travel(CATMAT), 2016, CANADA COMMUNICABLE
NR 40
TC 26
Z9 26
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD DEC
PY 2017
VL 21
BP 48
EP 55
DI 10.1016/j.epidem.2017.06.003
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA FQ0RW
UT WOS:000418065400006
PM 28688996
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Agirman, G
   Broix, L
   Nguyen, L
AF Agirman, Gulistan
   Broix, Loic
   Laurent Nguyen
TI Cerebral cortex development: an outside-in perspective
SO FEBS LETTERS
LA English
DT Review
DE cerebral cortex; environmental cues; neural progenitors; neurogenesis
ID NEURAL PROGENITOR CELLS; RADIAL GLIAL-CELLS; BONE MORPHOGENETIC
   PROTEINS; OUTER SUBVENTRICULAR ZONE; HUMAN BRAIN ORGANOIDS; ZIKA VIRUS;
   VENTRICULAR ZONE; INTERMEDIATE PROGENITORS; HUMAN CYTOMEGALOVIRUS; SONIC
   HEDGEHOG
AB The cerebral cortex is a complex structure that contains different classes of neurons distributed within six layers and regionally organized into highly specialized areas. Cortical layering arises during embryonic development in an inside-out manner as forebrain progenitors proliferate and generate distinct waves of interneurons and projection neurons. Radial glial cells (RGCs) derive from neuroepithelial cells and are the founding cortical progenitors. At the onset of corticogenesis, RGCs expand their pool by proliferative divisions. As corticogenesis proceeds, they gradually undergo differentiative divisions to either generate neurons directly (direct neurogenesis) or indirectly via production of intermediate progenitors that further divide to generate pairs of neurons (indirect neurogenesis). The fate of RGCs is finely regulated during all the corticogenesis process and depends on time-scaled perception of external signals and expression of intrinsic factors. The present Review focuses on the role of physiological extracellular cues arising from the vicinity of neural progenitors on the regulation of dorsal neurogenesis and cerebral cortex patterning. It further discusses how pathogenic viral factors influence RGC behaviour and disrupt cerebral cortex development.
C1 [Agirman, Gulistan; Broix, Loic; Laurent Nguyen] GIGA Neurosci, Interdisciplinary Cluster Appl Genoprote GIGA R, B-4000 Liege, Belgium.
RP Nguyen, L (corresponding author), GIGA Neurosci, Interdisciplinary Cluster Appl Genoprote GIGA R, B-4000 Liege, Belgium.
EM lnguyen@uliege.be
OI Nguyen, Laurent/0000-0002-8560-3008
FU Belgian Fonds pour la Formation a la Recherche dans l'Industrie et dans
   l'Agriculture (FRIA); Fondation pour la Recherche Medicale
   (FRM)Fondation pour la Recherche Medicale [SPE20170336939];
   F.R.S.-F.N.R.S.Fonds de la Recherche Scientifique - FNRS; Fonds Leon
   Fredericq; Fondation Medicale Reine Elisabeth; Fondation Simone et
   Pierre Clerdent; Belgian Science Policy (IAP-VII network) [P7/20];
   ARCFondation ARC pour la Recherche sur le CancerAustralian Research
   Council [ARC11/16-01]; EUEuropean Union (EU) [734548]; ERA-NET NEURON
   STEM-MCD
FX GA is granted by a PhD fellowship from the Belgian Fonds pour la
   Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA).
   LB is funded by a postdoctoral fellowship from The Fondation pour la
   Recherche Medicale (FRM code: SPE20170336939). LN is funded by
   F.R.S.-F.N.R.S., the Fonds Leon Fredericq, the Fondation Medicale Reine
   Elisabeth, the Fondation Simone et Pierre Clerdent, the Belgian Science
   Policy (IAP-VII network P7/20, the ARC (ARC11/16-01), the EU H2020 ZIK
   Alliance (#734548), and the ERA-NET NEURON STEM-MCD.
CR Anderson SA, 2001, DEVELOPMENT, V128, P353
   Angelova M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002959
   Arellano JI, 2012, J COMP NEUROL, V520, P848, DOI 10.1002/cne.22793
   Arvanitis DN, 2013, DEVELOPMENT, V140, P2082, DOI 10.1242/dev.088203
   Bachler M, 2001, MECH DEVELOP, V100, P313, DOI 10.1016/S0925-4773(00)00518-9
   Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010
   Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403
   Baudoin JP, 2012, NEURON, V76, P1108, DOI 10.1016/j.neuron.2012.10.027
   Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007
   Bond AM, 2012, DEV NEUROBIOL, V72, P1068, DOI 10.1002/dneu.22022
   Borello U, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-17
   Cadigan KM, 2012, CURR TOP DEV BIOL, V98, P1, DOI 10.1016/B978-0-12-386499-4.00001-X
   Caronia-Brown G, 2014, DEVELOPMENT, V141, P2855, DOI 10.1242/dev.106914
   Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192
   Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680
   Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0
   COHEN E, 1987, INT J DEV NEUROSCI, V5, P43, DOI 10.1016/0736-5748(87)90047-5
   Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003
   Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117
   Dave RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014680
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Draganova K, 2015, STEM CELLS, V33, P170, DOI 10.1002/stem.1820
   Driggers RW, 2017, NEW ENGL J MED, V37, P51, DOI DOI 10.1097/01.AOA.0000512046.09676.84
   Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249
   Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005
   Fernandes M, 2007, DEVELOPMENT, V134, P3789, DOI 10.1242/dev.004325
   Fernandez V, 2016, EMBO J, V35, P1021, DOI 10.15252/embj.201593701
   Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109
   Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553
   Fuccillo M, 2004, DEVELOPMENT, V131, P5031, DOI 10.1242/dev.01349
   Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252
   Furuta Y, 1997, DEVELOPMENT, V124, P2203
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gan QN, 2014, STEM CELLS, V32, P45, DOI 10.1002/stem.1561
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9
   Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437
   Grosse SD, 2008, J CLIN VIROL, V41, P57, DOI 10.1016/j.jcv.2007.09.004
   Grove EA, 1998, DEVELOPMENT, V125, P2315
   Gutin G, 2006, DEVELOPMENT, V133, P2937, DOI 10.1242/dev.02465
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093
   Harima Y, 2014, SEMIN CELL DEV BIOL, V34, P85, DOI 10.1016/j.semcdb.2014.04.038
   Harrison-Uy SJ, 2012, COLD SPRING HARB PER, V4, P1
   Hasenpusch-Theil K, 2017, CEREB CORTEX, V27, P1137, DOI 10.1093/cercor/bhv291
   Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100
   Hebert JM, 2003, DEVELOPMENT, V130, P1101, DOI 10.1242/dev.00334
   Hebert JM, 2002, NEURON, V35, P1029, DOI 10.1016/S0896-6273(02)00900-5
   Heng X, 2017, ELIFE, V6, DOI 10.7554/eLife.23253
   Higginbotham H, 2013, NAT NEUROSCI, V16, P1000, DOI 10.1038/nn.3451
   Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165
   Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107
   Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366
   Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136
   Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4
   Iwata T, 2009, DEV GROWTH DIFFER, V51, P299, DOI 10.1111/j.1440-169X.2009.01104.x
   Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x
   Kang WF, 2009, J NEUROSCI, V29, P14571, DOI 10.1523/JNEUROSCI.3844-09.2009
   Kapoor A, 2013, ANTIMICROB AGENTS CH, V57, P2761, DOI 10.1128/AAC.00029-13
   Kawasaki H, 2015, AM J PATHOL, V185, P1304, DOI 10.1016/j.ajpath.2015.01.032
   Kelava I, 2013, EMBO J, V7, P16
   Komada M, 2008, DEVELOPMENT, V135, P2717, DOI 10.1242/dev.015891
   Komada M, 2013, NEUROSCI LETT, V547, P87, DOI 10.1016/j.neulet.2013.05.006
   Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673
   Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922
   Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417
   LaMonica BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2647
   Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Langseth AJ, 2010, J NEUROSCI, V30, P13367, DOI 10.1523/JNEUROSCI.1934-10.2010
   Lathia JD, 2007, J COMP NEUROL, V505, P630, DOI 10.1002/cne.21520
   Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023
   Lepanto P, 2016, NEUROGENESIS, V3
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li RY, 2000, TERATOLOGY, V62, P79
   Li WW, 1998, J NEUROSCI, V18, P8853
   Li XJ, 2015, J VIROL, V89, P6792, DOI 10.1128/JVI.00351-15
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu X, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006277
   Lopez CI, 2016, DEV NEUROBIOL, V76, P1360, DOI 10.1002/dneu.22397
   Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Luo MH, 2010, J VIROL, V84, P3528, DOI 10.1128/JVI.02161-09
   Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038
   Martinez-Cerdeno V, 2006, CEREB CORTEX, V16, pI152, DOI 10.1093/cercor/bhk017
   Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005
   Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189
   Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011
   Mutnal MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016211
   Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967
   Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172
   Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002
   Nonaka-Kinoshita M, 2013, EMBO J, V32, P1817, DOI 10.1038/emboj.2013.96
   Ochiai W, 2009, MOL CELL NEUROSCI, V40, P225, DOI 10.1016/j.mcn.2008.10.007
   Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200
   Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006
   Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Raballo R, 2000, J NEUROSCI, V20, P5012
   Radakovits R, 2009, J NEUROSCI, V29, P7694, DOI 10.1523/JNEUROSCI.5537-08.2009
   RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105
   Rash BG, 2013, J NEUROSCI, V33, P10802, DOI 10.1523/JNEUROSCI.3621-12.2013
   Rash BG, 2011, J NEUROSCI, V31, P15604, DOI 10.1523/JNEUROSCI.4439-11.2011
   Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740
   Sahara S, 2009, NEURON, V63, P48, DOI 10.1016/j.neuron.2009.06.006
   Shaked M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002668
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shinmura Y, 1997, ACTA NEUROPATHOL, V93, P551, DOI 10.1007/s004010050651
   Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011
   Slavuljica I, 2015, CELL MOL IMMUNOL, V12, P180, DOI 10.1038/cmi.2014.51
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010
   Stenzel D, 2014, DEVELOPMENT, V141, P795, DOI 10.1242/dev.101907
   Stinski MF, 2008, MED MICROBIOL IMMUN, V197, P223, DOI 10.1007/s00430-007-0069-7
   Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324
   Sun YM, 2010, J BIOL CHEM, V285, P39039, DOI 10.1074/jbc.M110.168351
   Tabata H, 2003, J NEUROSCI, V23, P9996
   Tabata H, 2009, CEREB CORTEX, V19, P2092, DOI 10.1093/cercor/bhn227
   Takahashi T, 1999, J NEUROSCI, V19, P10357
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tardieu M, 2013, HAND CLINIC, V112, P1103, DOI 10.1016/B978-0-444-52910-7.00029-5
   Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Theil T, 2002, DEVELOPMENT, V129, P3045
   Theil T, 1999, DEVELOPMENT, V126, P3561
   Theil T, 2008, DEV DYNAM, V237, P3417, DOI 10.1002/dvdy.21765
   Toyoda R, 2010, DEVELOPMENT, V137, P3439, DOI 10.1242/dev.055392
   Tozer S, 2017, NEURON, V93, P542, DOI 10.1016/j.neuron.2016.12.042
   Tyler WA, 2013, J NEUROSCI, V33, P5106, DOI 10.1523/JNEUROSCI.5380-12.2013
   van den Pol AN, 1999, J NEUROSCI, V19, P10948
   Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608
   Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9
   Wang L, 2016, NAT NEUROSCI, V19, P888, DOI 10.1038/nn.4307
   Wang W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10936
   Willaredt MA, 2013, MECH DEVELOP, V130, P373, DOI 10.1016/j.mod.2012.10.003
   Wilsch-Brauninger M, 2012, DEVELOPMENT, V139, P95, DOI 10.1242/dev.069294
   Wrobel CN, 2007, DEV BIOL, V309, P285, DOI 10.1016/j.ydbio.2007.07.013
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004
   Yabut OR, 2015, CELL REP, V12, P2021, DOI 10.1016/j.celrep.2015.08.031
   YOON K, 2017, STEM CELLS, V21, P349, DOI DOI 10.1016/J.STEM.2017.07.014
   Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang R, 2017, CELL TISSUE REASEARC
NR 151
TC 9
Z9 9
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD DEC
PY 2017
VL 591
IS 24
BP 3978
EP 3992
DI 10.1002/1873-3468.12924
PG 15
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA FR1KM
UT WOS:000418825700003
PM 29194577
OA Bronze
DA 2020-07-08
ER

PT J
AU Wang, XH
   Zou, P
   Wu, F
   Lu, L
   Jiang, SB
AF Wang, Xiaohuan
   Zou, Peng
   Wu, Fan
   Lu, Lu
   Jiang, Shibo
TI Development of small-molecule viral inhibitors targeting various stages
   of the life cycle of emerging and re-emerging viruses
SO FRONTIERS OF MEDICINE
LA English
DT Review
DE emerging and re-emerging viruses; small-molecule inhibitor; coronavirus;
   Ebola virus; Zika virus; life cycle
ID RESPIRATORY SYNDROME CORONAVIRUS; SARS-COV ENTRY; ZIKA VIRUS;
   BROAD-SPECTRUM; EBOLA-VIRUS; POSTEXPOSURE PROTECTION; FUNCTIONAL
   RECEPTOR; SERINE-PROTEASE; SPIKE PROTEIN; INFECTION
AB In recent years, unexpected outbreaks of infectious diseases caused by emerging and re-emerging viruses have become more frequent, which is possibly due to environmental changes. These outbreaks result in the loss of life and economic hardship. Vaccines and therapeutics should be developed for the prevention and treatment of infectious diseases. In this review, we summarize and discuss the latest progress in the development of small-molecule viral inhibitors against highly pathogenic coronaviruses, including severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus, Ebola virus, and Zika virus. These viruses can interfere with the specific steps of viral life cycle by blocking the binding between virus and host cells, disrupting viral endocytosis, disturbing membrane fusion, and interrupting viral RNA replication and translation, thereby demonstrating potent therapeutic effect against various emerging and re-emerging viruses. We also discuss some general strategies for developing small-molecule viral inhibitors.
C1 [Wang, Xiaohuan; Zou, Peng; Wu, Fan; Lu, Lu; Jiang, Shibo] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China.
   [Wang, Xiaohuan; Zou, Peng; Wu, Fan; Lu, Lu; Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol MOE MOH, Sch Basic Med Sci, Shanghai 200032, Peoples R China.
   [Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
RP Lu, L; Jiang, SB (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China.; Lu, L; Jiang, SB (corresponding author), Fudan Univ, Key Lab Med Mol Virol MOE MOH, Sch Basic Med Sci, Shanghai 200032, Peoples R China.; Jiang, SB (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
EM lulu@fudan.edu.cn; shibojiang@fudan.edu.cn
RI Lu, Lu/K-7070-2014; Jiang, Shibo/L-4500-2014
OI Lu, Lu/0000-0002-2255-0391; 
FU Shanghai Public Health Clinical Center [2016-27, KY-GW-2017-17];
   National Key Research and Development Program of China [2016YFC1201000,
   2016YFC1200405, 2016YFC-1202901]; Sanming Project of Medicine in
   Shenzhen; Hi-Tech Research and Development Program of China (863
   Program)National High Technology Research and Development Program of
   China [2015AA020930]
FX This work was supported by grants from the Shanghai Public Health
   Clinical Center (Nos. 2016-27 and KY-GW-2017-17), the National Key
   Research and Development Program of China (Nos. 2016YFC1201000 and
   2016YFC1200405 to S. J., 2016YFC-1202901 to L. L.), the Sanming Project
   of Medicine in Shenzhen to L. L. and S. J., and the Hi-Tech Research and
   Development Program of China (863 Program) (No. 2015AA020930 to L. L.).
   We also thank Guangzhou Sagene Biotech Co., Ltd. for its aid in the
   preparation of the figures.
CR Adedeji AO, 2014, ANTIMICROB AGENTS CH, V58, P4894, DOI 10.1128/AAC.02994-14
   Baez-Santos YM, 2014, J MED CHEM, V57, P2393, DOI 10.1021/jm401712t
   Basu A, 2011, J VIROL, V85, P3106, DOI 10.1128/JVI.01456-10
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Chan JFW, 2013, J INFECTION, V67, P606, DOI 10.1016/j.jinf.2013.09.029
   Channappanavar R, 2015, J INFECT DIS, V212, P1894, DOI 10.1093/infdis/jiv325
   Chu LHM, 2008, J CELL BIOCHEM, V104, P2335, DOI 10.1002/jcb.21790
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Han DP, 2006, VIROLOGY, V350, P15, DOI 10.1016/j.virol.2006.01.029
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Hoenen T, 2006, TRENDS MOL MED, V12, P206, DOI 10.1016/j.molmed.2006.03.006
   Hu HB, 2005, J COMB CHEM, V7, P648, DOI 10.1021/cc0500607
   Hunt CL, 2012, VIRUSES-BASEL, V4, P258, DOI 10.3390/v4020258
   JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0
   Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597
   Khan M, 2011, ANTIVIR RES, V89, P1, DOI 10.1016/j.antiviral.2010.10.009
   KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102
   Knecht W, 2000, CHEM-BIOL INTERACT, V124, P61, DOI 10.1016/S0009-2797(99)00144-1
   Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0
   Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Leone G, 2003, CLIN IMMUNOL, V109, P89, DOI 10.1016/S1521-6616(03)00207-9
   Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HY, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02168-16, 10.1128/aac.02168-16]
   Li HY, 2015, MICROBES INFECT, V17, P109, DOI 10.1016/j.micinf.2014.11.012
   Li T, 2005, GENE THER, V12, P751, DOI 10.1038/sj.gt.3302479
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Liu Q, 2015, ANTIMICROB AGENTS CH, V59, P742, DOI 10.1128/AAC.03977-14
   Liu SW, 2004, LANCET, V363, P938, DOI 10.1016/S0140-6736(04)15788-7
   Lu L, 2016, CURR TOP MED CHEM, V16, P1074, DOI 10.2174/1568026615666150901114527
   Lu L, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.37
   Lu L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4067
   Lu L, 2013, MICROBES INFECT, V15, P625, DOI 10.1016/j.micinf.2013.06.003
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Madelain V, 2015, ANTIVIR RES, V123, P70, DOI 10.1016/j.antiviral.2015.08.015
   Mahanty S, 2004, LANCET INFECT DIS, V4, P487, DOI 10.1016/S1473-3099(04)01103-X
   Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miller EH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207084
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121
   Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099
   Noda T, 2011, J INFECT DIS, V204, pS878, DOI 10.1093/infdis/jir310
   Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Ramharack P, 2017, J BIOMOL STRUCT DYN
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shah PP, 2010, MOL PHARMACOL, V78, P319, DOI 10.1124/mol.110.064261
   Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13
   Shoemaker CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056265
   Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Su S, 2017, AIDS, V31, P885, DOI [10.1097/QAD.0000000000001415, 10.1097/qad.0000000000001415]
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang HF, 2016, VIROL SIN, V31, P24, DOI 10.1007/s12250-015-3711-3
   Wang ZY, 2016, VIROL SIN, V31, P103, DOI 10.1007/s12250-016-3780-y
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Warren TK, 2010, NAT MED, V16, P991, DOI 10.1038/nm.2202
   WHO, MIDDL E RESP SYNDR C
   Wolf MC, 2010, P NATL ACAD SCI USA, V107, P3157, DOI 10.1073/pnas.0909587107
   World Health Organization, MED CTR ZIK VIR
   World Health Organization, EB SIT REP
   Xia S, 2014, VIRUS RES, V194, P200, DOI 10.1016/j.virusres.2014.10.007
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu W, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15576
   Yi L, 2004, J VIROL, V78, P11334, DOI 10.1128/JVI.78.20.11334-11339.2004
   Yi ZG, 2012, J VIROL, V86, P11815, DOI 10.1128/JVI.01022-12
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao GY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-266
   Zhao HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22008
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zou J, 2017, EBIOMEDICINE, V20, P11, DOI 10.1016/j.ebiom.2017.05.005
NR 94
TC 8
Z9 10
U1 1
U2 30
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 2095-0217
EI 2095-0225
J9 FRONT MED-PRC
JI Front. Med.
PD DEC
PY 2017
VL 11
IS 4
BP 449
EP 461
DI 10.1007/s11684-017-0589-5
PG 13
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA FP5ZW
UT WOS:000417702800001
PM 29170916
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Adhikari, UK
   Rahman, MM
AF Adhikari, Utpal Kumar
   Rahman, M. Mizanur
TI Overlapping CD8+and CD4+T-cell epitopes identification for the
   progression of epitope-based peptide vaccine from nucleocapsid and
   glycoprotein of emerging Rift Valley fever virus using immunoinformatics
   approach
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Rift Valley fever virus; Immunoinformatics; Peptide vaccine; CD8+T-cell
   epitope; CD4+T-cell epitope
ID T-CELL-EPITOPES; ANTIGENIC CTL EPITOPES; CONSERVED PEPTIDES;
   IMMUNE-RESPONSES; PROTECTS MICE; ZIKA VIRUS; PEP-FOLD; PREDICTION;
   PARTICLES; IMMUNOGENICITY
AB Rift Valley fever virus (RVFV) is an emergent arthropod-borne zoonotic infectious viral pathogen which causes fatal diseases in the humans and ruminants. Currently, no effective and licensed vaccine is available for the prevention of RVFV infection in endemic as well as in non-endemic regions. So, an immunoinformatics-driven genome-wide screening approach was performed for the identification of overlapping CD8 + and CD4 + T-cell epitopes and also linear B-cell epitopes from the conserved sequences of the nucleocapsid (N) and glycoprotein (G) of RVFV. We identified overlapping 99.39% conserved 1 CD8+ T-cell epitope (MMHPSFAGM) from N protein and 100% conserved 7 epitopes (AVFALAPVV, LAVFALAPV, FALAPVVFA, VFALAPVVF, IAMTVLPAL, FFDWFSGLM, and FLLIYLGRT) from G protein and also identified IL-4 and IFN-. induced (99.39% conserved) 1 N protein CD4+ T-cell epitope (HMMHPSFAGMVDPSL) and 100% conserved 5 G protein CD4 + T-cell epitopes (LPALAVFALAPVVFA, PALAVFALAPVVFAE, GIAMTVLPALAVFAL, GSWNFFDWFSGLMSW, and FFLLIYLGRTGLSKM). The overlapping CD8 + and CD4 + T-cell epitopes were bound with most conserved HLAC* 12: 03 and HLA-DRB1* 01: 01, respectively with the high binding affinity (kcal/mol). The combined population coverage analysis revealed that the allele frequencies of these epitopes are high in endemic and non-endemic regions. Besides, we found 100% conserved and non-allergenic 2 decamer B-cell epitopes, GVCEVGVQAL and RVFNCIDWVH of G protein had the sequence similarity with the nonamer CD8 + T-cell epitopes, VCEVGVQAL and RVFNCIDWV, respectively. Consequently, these epitopes may be used for the development of epitope-based peptide vaccine against emerging RVFV. However, in vivo and in vitro experiments are required for their efficient use as a vaccine.
C1 [Adhikari, Utpal Kumar; Rahman, M. Mizanur] Islamic Univ, Dept Biotechnol & Genet Engn, Kushtia 7003, Bangladesh.
RP Rahman, MM (corresponding author), Islamic Univ, Dept Biotechnol & Genet Engn, Kushtia 7003, Bangladesh.
EM rahmanmm@btge.iu.ac.bd
RI Adhikari, Utpal Kumar/V-9888-2019
OI Adhikari, Utpal Kumar/0000-0002-0754-8664
CR Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Ali MT, 2015, INTERDISCIP SCI, V7, P177, DOI 10.1007/s12539-015-0023-0
   Ali Mohammad Tuhin, 2015, Advances in Bioinformatics, V2015, P278197, DOI 10.1155/2015/278197
   Anyamba A, 2010, AM J TROP MED HYG, V83, P43, DOI 10.4269/ajtmh.2010.09-0289
   Anyangu AS, 2010, AM J TROP MED HYG, V83, P14, DOI 10.4269/ajtmh.2010.09-0293
   Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9
   Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004
   Bird BH, 2016, ANTIVIR RES, V132, P274, DOI 10.1016/j.antiviral.2016.07.005
   Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391
   Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001
   Bouloy M., 2010, OPEN VIROL J
   Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520
   Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361
   Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153
   Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266
   Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058
   Dar O., 2013, EMERG INFECT DIS
   Dash R., 2017, ADV APPL BIOINFORMA
   Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418
   DAVIES FG, 1985, B WORLD HEALTH ORGAN, V63, P941
   Dhanda SK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/263952
   Dhiman G, 2016, MICROBIOL IMMUNOL, V60, P646, DOI 10.1111/1348-0421.12436
   Dikhit MR, 2016, INFECT GENET EVOL, V45, P187, DOI 10.1016/j.meegid.2016.08.037
   Dikhit MR, 2015, INFECT GENET EVOL, V36, P369, DOI 10.1016/j.meegid.2015.10.012
   Dodd K.A., 2013, J VIROL
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Dungu B, 2010, VACCINE, V28, P4581, DOI 10.1016/j.vaccine.2010.04.085
   Dye C, 2014, PHILOS T R SOC B
   Faburay B., 2014, VECTOR BORNE ZOONOTI
   Faburay B, 2016, SCI REP-UK, V6, DOI 10.1038/srep27719
   Firbas C, 2006, VACCINE, V24, P4343, DOI 10.1016/j.vaccine.2006.03.009
   Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369
   Hartman A, 2017, CLIN LAB MED, V37, P285, DOI 10.1016/j.cll.2017.01.004
   Hassan OA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001229
   He L., 2015, SCI REP
   Ikegami T., 2011, VIRUSES
   Ikegami T., 2005, J VIROL
   Ikegami T., 2009, RIFT VALLEY FEVER VI
   Ikegami T, 2017, EXPERT REV VACCINES, V16, P601, DOI 10.1080/14760584.2017.1321482
   Islam R, 2012, FUTURE VIROL, V7, P1029, DOI 10.2217/FVL.12.95
   Jin X, 2009, VACCINE, V27, P7080, DOI 10.1016/j.vaccine.2009.09.060
   Kashyap M, 2017, INFECT GENET EVOL, V53, P107, DOI 10.1016/j.meegid.2017.05.022
   Kori Priyanka, 2015, Journal of Pharmaceutical Investigation, V45, P579, DOI 10.1007/s40005-015-0205-0
   Kortekaas J, 2012, VACCINE, V30, P3423, DOI 10.1016/j.vaccine.2012.03.027
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Lagerqvist N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-6
   Lal G, 2006, IMMUNOL CELL BIOL, V84, P145, DOI 10.1111/j.1440-1711.2005.01405.x
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   Leroux-Roels G., 2011, PERSPECT VACCINOL, V1, P115
   Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819
   Lohia N, 2015, VIRAL IMMUNOL, V28, P570, DOI 10.1089/vim.2015.0060
   Lohia N, 2014, VIRAL IMMUNOL, V27, P225, DOI 10.1089/vim.2013.0135
   Lopez-Gil E., 2013, PLOS NEGLECT TROP D, V7, P1
   Mandell R. B., 2011, Journal of Bioterrorism and Biodefense, V2, P108
   Mandell RB, 2010, HUM VACCINES, V6, P597, DOI 10.4161/hv.6.7.11761
   Mandell RB, 2010, VIROLOGY, V397, P187, DOI 10.1016/j.virol.2009.11.001
   Mansfield KL, 2015, VACCINE, V33, P5520, DOI 10.1016/j.vaccine.2015.08.020
   Metras R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001808
   Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646
   Monaco F, 2013, EMERG INFECT DIS, V19, P2025, DOI 10.3201/eid1912.130593
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Muh HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005861
   MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405
   Naslund J, 2009, VIROLOGY, V385, P409, DOI 10.1016/j.virol.2008.12.012
   Naylor P.H., 2011, CANCERS BASEL
   Nguku PM, 2010, AM J TROP MED HYG, V83, P5, DOI 10.4269/ajtmh.2010.09-0288
   Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238
   Nii-Trebi NI, 2017, BIOMED RES INT, V2017, P1, DOI 10.1155/2017/5245021
   O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33
   Oyarzun P, 2016, HUM VACC IMMUNOTHER, V12, P763, DOI 10.1080/21645515.2015.1094595
   Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132
   Pichlmair A, 2010, VECTOR-BORNE ZOONOT, V10, P701, DOI 10.1089/vbz.2009.0248
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   RANDALL R, 1964, J IMMUNOL, V93, P293
   Rolin AI, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.81
   Rosloniec EF, 2006, J IMMUNOL, V177, P3884, DOI 10.4049/jimmunol.177.6.3884
   Rusnak JM, 2011, VACCINE, V29, P3222, DOI 10.1016/j.vaccine.2011.02.037
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Sakib M. Sadman, 2014, Advances in Bioinformatics, V2014, P402492, DOI 10.1155/2014/402492
   SCHMALJOHN CS, 1989, VIROLOGY, V170, P184, DOI 10.1016/0042-6822(89)90365-6
   Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m
   Shi J, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/942159
   Sominskaya I, 2010, CLIN VACCINE IMMUNOL, V17, P1027, DOI 10.1128/CVI.00468-09
   Sow A., 2016, OPEN FORUM INFECT DI
   Sow A, 2014, EMERG INFECT DIS, V20, P296, DOI 10.3201/eid2002.131000
   Spik K, 2006, VACCINE, V24, P4657, DOI 10.1016/j.vaccine.2005.08.034
   Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351
   Terry FE, 2015, EXPERT REV VACCINES, V14, P21, DOI 10.1586/14760584.2015.955478
   Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419
   Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   van Vuren PJ, 2007, J VIROL METHODS, V140, P106, DOI 10.1016/j.jviromet.2006.11.005
   Vivona S, 2008, TRENDS BIOTECHNOL, V26, P190, DOI 10.1016/j.tibtech.2007.12.006
   Wallace DB, 2006, VACCINE, V24, P7181, DOI 10.1016/j.vaccine.2006.06.041
   Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07
   Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06
   Xu W., 2013, PLOS ONE
NR 97
TC 6
Z9 6
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD DEC
PY 2017
VL 56
BP 75
EP 91
DI 10.1016/j.meegid.2017.10.022
PG 17
WC Infectious Diseases
SC Infectious Diseases
GA FP2UL
UT WOS:000417474500009
PM 29107145
OA Green Published
DA 2020-07-08
ER

PT J
AU Sohan, K
   Cyrus, CA
AF Sohan, Karen
   Cyrus, Cathy A.
TI Ultrasonographic observations of the fetal brain in the first 100
   pregnant women with Zika virus infection in Trinidad and Tobago
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Brain abnormalities; Ultrasonography; Zika-affected pregnancy
ID CENTRAL-NERVOUS-SYSTEM
AB Objective: To evaluate the fetal brain in pregnant women infected with Zika virus in a limited-resource setting.
   Methods: In an observational study in Trinidad and Tobago, 100 pregnant women infected with Zika virus who were referred for fetal medicine services provided by a single clinician were enrolled from March 31 to September 2, 2016. Two-dimensional ultrasonography was undertaken.
   Results: The women were aged 17-41 years (mean 27.5 +/- 5.7). Six cases of fetal brain abnormalities consistent with Zika infection were detected before 26 gestational weeks. The gestational period at infection and time of presentation ranged, respectively, from 7(+3) to 16(+0) weeks and from 23(+2) to 25(+5) weeks. In all cases, centiles of the biparietal diameter and head circumference decreased progressively over time to below the third centile. The skull contour appeared irregular, owing to collapse or overlap of the fetal skull bones. In four cases, brain anomalies were not obvious on the transabdominal scan but were diagnosed on the transvaginal scan. In a further two cases, brain abnormalities presented after 26 weeks of gestation.
   Conclusion: Overall, 8.0% of women infected with Zika virus had fetuses with brain abnormalities suggestive of Zika congenital syndrome. Six cases were detected before 26 weeks and two cases after 26 weeks.
C1 [Sohan, Karen; Cyrus, Cathy A.] Zika Antenatal Screening Program, Champ Fleurs, Trinidad Tobago.
RP Sohan, K (corresponding author), 305 La Clave St,Lange Pk, Chaguanas, Trinidad Tobago.
EM diagnosticmotherbaby@gmail.com
CR Better World Campaign, UN ROL COMB ZIK VIR
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Centers for Disease Control and Prevention, GUID MAN ZIK VIR
   CHITTY LS, 1994, BRIT J OBSTET GYNAEC, V101, P35, DOI 10.1111/j.1471-0528.1994.tb13007.x
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministry of Health Trinidad and Tobago, ZIK BEING TREAT PUBL
   Ministry of Health Trinidad and Tobago, MIN HLTH CONF ITS 1
   Ministry of Health Trinidad and Tobago, MAN ZIK POS PREGN PA
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi AC, 2014, ULTRASOUND OBST GYN, V44, P388, DOI 10.1002/uog.13429
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 18
TC 6
Z9 6
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD DEC
PY 2017
VL 139
IS 3
BP 278
EP 283
DI 10.1002/ijgo.12313
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FL8CS
UT WOS:000414478000004
PM 28842988
DA 2020-07-08
ER

PT J
AU Lemon, JK
   Khil, PP
   Frank, KM
   Dekker, JP
AF Lemon, Jamie K.
   Khil, Pavel P.
   Frank, Karen M.
   Dekker, John P.
TI Rapid Nanopore Sequencing of Plasmids and Resistance Gene Detection in
   Clinical Isolates
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE MinION; nanopore; antibiotic resistance; genomics; plasmids
ID REAL-TIME; ANTIMICROBIAL RESISTANCE; IDENTIFICATION; PATHOGENS; MINION;
   SURVEILLANCE; MECHANISMS; GENOMES; VIRUS; ZIKA
AB Recent advances in nanopore sequencing technology have led to a substantial increase in throughput and sequence quality. Together, these improvements may permit real-time benchtop genomic sequencing and antimicrobial resistance gene detection in clinical isolates. In this study, we evaluated workflows and turnaround times for a benchtop long-read sequencing approach in the clinical microbiology laboratory using the Oxford Nanopore Technologies MinION sequencer. We performed genomic and plasmid sequencing of three clinical isolates with both MinION and Illumina MiSeq, using different library preparation methods (2D and rapid 1D) with the goal of antimicrobial resistance gene detection. We specifically evaluated the advantages of using plasmid DNA for sequencing and the value of supplementing MinION sequences with MiSeq reads for increasing assembly accuracy. Resequencing of three plasmids in a reference Klebsiella pneumoniae isolate demonstrated similar to 99% accuracy of draft MinION-only assembly and >99.9% accuracy of assembly polished with MiSeq reads. Plasmid DNA sequencing of previously uncharacterized clinical extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and K. pneumoniae isolates using MinION allowed successful identification of antimicrobial resistance genes in the draft assembly corresponding to all classes of observed plasmid-based phenotypic resistance. Importantly, use of plasmid DNA enabled lower depth sequencing, and assemblies sufficient for full antimicrobial resistance gene annotation were obtained with as few as 2,000 to 5,000 reads, which could be acquired in 20 min of sequencing. With a MinION-only workflow that balances accuracy against turnaround time, full annotation of plasmid resistance gene content could be obtained in under 6 h from a subcultured isolate, less time than traditional phenotypic susceptibility testing.
C1 [Lemon, Jamie K.; Khil, Pavel P.; Frank, Karen M.; Dekker, John P.] NIH, Ctr Clin, Dept Lab Med, Microbiol Serv, Bethesda, MD 20892 USA.
RP Dekker, JP (corresponding author), NIH, Ctr Clin, Dept Lab Med, Microbiol Serv, Bethesda, MD 20892 USA.
EM john.dekker@nih.gov
FU Intramural Research Program of the National Institutes of Health
   Clinical CenterUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA
FX This work was supported by the Intramural Research Program of the
   National Institutes of Health Clinical Center.
CR Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Benitez-Paez A, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0111-z
   Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380
   Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14
   [CLSI] Clinical and Laboratory Standards Institute, 2017, M100S27 CLSI
   Conlan S, 2016, MBIO, V7, DOI 10.1128/mBio.00742-16
   Conlan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009845
   Eyre DW, 2017, J ANTIMICROB CHEMOTH, V72, P1937, DOI 10.1093/jac/dkx067
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   George S, 2017, MICROB GENOM    0609
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086
   Hunt M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0849-0
   Istace B, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/giw018
   JAIN M, 2016, GENOME BIOL, V17
   Judge K, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000085
   Karamitros T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157600
   Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116
   Koren S, 2015, CURR OPIN MICROBIOL, V23, P110, DOI 10.1016/j.mib.2014.11.014
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Lee RS, 2017, J CLIN MICROBIOL, V55, P1249, DOI [10.1128/jcm.00358-17, 10.1128/JCM.00358-17]
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]
   Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555
   McDermott PF, 2016, ANTIMICROB AGENTS CH, V60, P5515, DOI 10.1128/AAC.01030-16
   Metcalf BJ, 2016, CLIN MICROBIOL INFEC, V22, P60
   Cao MD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14515
   Cao MD, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0137-2
   Nair S, 2016, J ANTIMICROB CHEMOTH, V71, P3400, DOI 10.1093/jac/dkw318
   Partridge SR, 2015, PATHOLOGY, V47, P276, DOI 10.1097/PAT.0000000000000237
   Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Quick J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0677-2
   Schmidt K, 2017, J ANTIMICROB CHEMOTH, V72, P104, DOI 10.1093/jac/dkw397
   Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129
   Szabo M, 2016, ANTIMICROB AGENTS CH, V60, P6780, DOI 10.1128/AAC.01121-16
   van der Helm E, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1328
   Vaser R, 2017, GENOME RES, V27, P737, DOI 10.1101/gr.214270.116
   Votintseva AA, 2017, J CLIN MICROBIOL, V55, P1285, DOI 10.1128/JCM.02483-16
   Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963
   Yanat B, 2017, EUR J CLIN MICROBIOL, V36, P421, DOI 10.1007/s10096-016-2847-x
   Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261
NR 43
TC 28
Z9 28
U1 1
U2 22
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD DEC
PY 2017
VL 55
IS 12
BP 3530
EP 3543
DI 10.1128/JCM.01069-17
PG 14
WC Microbiology
SC Microbiology
GA FN7UV
UT WOS:000416225200024
PM 29021151
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Blakey, SM
   Abramowitz, JS
AF Blakey, Shannon M.
   Abramowitz, Jonathan S.
TI Psychological Predictors of Health Anxiety in Response to the Zika Virus
SO JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS
LA English
DT Article
DE Health anxiety; Contamination; Zika
ID DISGUST SENSITIVITY; INDIVIDUAL-DIFFERENCES; INFORMATION-SEEKING; SAFETY
   BEHAVIORS; STRESS SCALES; UNCERTAINTY; HYPOCHONDRIASIS; CONTAMINATION;
   DETERMINANTS; TRANSMISSION
AB The threat of a United States (U.S.) Zika virus pandemic during 2015-2016 was associated with public anxiety. Such threats represent opportunities to examine hypotheses about health anxiety. The present study investigated psychological predictors of Zika-related anxiety during the 2015-2016 outbreak. U.S. adults (N = 216) completed a battery of measures assessing Zika-related anxiety as well as psychological variables hypothesized to predict anxious responding to the threat of a domestic Zika outbreak. Contrary to hypotheses, regression analyses indicated that only contamination severity overestimates and greater Zika knowledge significantly predicted Zika-related anxiety. Study limitations and clinical implications are discussed.
C1 [Blakey, Shannon M.; Abramowitz, Jonathan S.] Univ N Carolina, Dept Psychol & Neurosci, CB 3270,Davie Hall, Chapel Hill, NC 27599 USA.
RP Blakey, SM (corresponding author), Univ N Carolina, Dept Psychol & Neurosci, CB 3270,Davie Hall, Chapel Hill, NC 27599 USA.
EM sblakey@unc.edu
OI Blakey, Shannon/0000-0002-9291-3688
CR Abramowitz JS, 2007, BEHAV THER, V38, P86, DOI 10.1016/j.beth.2006.05.001
   Abramowitz JS, 2011, HYPOCHONDRIASIS HLTH
   Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176
   Bailey R, 2016, CLIN PSYCHOL-UK, V20, P129, DOI 10.1111/cp.12078
   Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826
   Blakey SM, 2015, COGNITIVE THER RES, V39, P816, DOI 10.1007/s10608-015-9701-9
   Brady RE, 2014, ANXIETY STRESS COPIN, V27, P90, DOI 10.1080/10615806.2013.772588
   Brand J, 2013, J OBSESS-COMPULS REL, V2, P200, DOI 10.1016/j.jocrd.2013.01.007
   Center for Disease Control and Prevention (CDC), 2016, ZIK VIR DIS
   Cheung EYL, 2015, INTERVENTION, V13, P70, DOI 10.1097/WTF.0000000000000079
   Cisler JM, 2010, COGNITIVE THER RES, V34, P439, DOI 10.1007/s10608-009-9253-y
   CLARK DM, 1986, BEHAV RES THER, V24, P461, DOI 10.1016/0005-7967(86)90011-2
   Davey GCL, 2006, J BEHAV THER EXP PSY, V37, P4, DOI 10.1016/j.jbtep.2005.09.001
   Deacon B, 2008, BEHAV RES THER, V46, P537, DOI 10.1016/j.brat.2008.01.010
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Devellis RF., 1991, SCALE DEV THEORY APP
   Dorfan NM, 2011, J SOC CLIN PSYCHOL, V30, P105, DOI 10.1521/jscp.2011.30.2.105
   Dugas MJ, 2001, COGNITIVE THER RES, V25, P551, DOI 10.1023/A:1005553414688
   Fan QQ, 2013, PERS INDIV DIFFER, V55, P454, DOI 10.1016/j.paid.2013.04.007
   Fergus TA, 2013, CYBERPSYCH BEH SOC N, V16, P735, DOI 10.1089/cyber.2012.0671
   Fetzner MG, 2014, COGN BEHAV THERAPY, V43, P262, DOI 10.1080/16506073.2014.929170
   Gangemi A, 2012, J BEHAV THER EXP PSY, V43, P1032, DOI 10.1016/j.jbtep.2012.04.005
   Gerolimatos LA, 2012, INT PSYCHOGERIATR, V24, P1998, DOI 10.1017/S1041610212001329
   HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7
   Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   Krautwurst S, 2014, J BEHAV THER EXP PSY, V45, P303, DOI 10.1016/j.jbtep.2014.02.001
   Lau JTF, 2008, INFECTION, V36, P434, DOI 10.1007/s15010-008-7277-Y
   Liao QY, 2011, INT J BEHAV MED, V18, P93, DOI 10.1007/s12529-010-9123-8
   Lovibond SH, 1995, MANUAL DEPRESSION AN
   McNeil Jr Donald G., 2016, NY TIMES
   Meade AW, 2012, PSYCHOL METHODS, V17, P437, DOI 10.1037/a0028085
   Niles AN, 2015, J PSYCHOSOM RES, V78, P109, DOI 10.1016/j.jpsychores.2014.11.018
   Nunnally J. C., 1994, PSYCHOMETRIC THEORY
   Olatunji BO, 2005, J SOC CLIN PSYCHOL, V24, P932, DOI 10.1521/jscp.2005.24.7.932
   Olatunji BO, 2007, PSYCHOL ASSESSMENT, V19, P281, DOI 10.1037/1040-3590.19.3.281
   Olatunji BO, 2011, BEHAV RES THER, V49, P719, DOI 10.1016/j.brat.2011.07.008
   Olatunji BO, 2009, J BEHAV THER EXP PSY, V40, P230, DOI 10.1016/j.jbtep.2008.10.003
   Reiss S., 2008, ANXIETY SENSITIVITY
   Rief W, 1998, J ABNORM PSYCHOL, V107, P587, DOI 10.1037/0021-843X.107.4.587
   Rosen NO, 2009, HEALTH COMMUN, V24, P228, DOI 10.1080/10410230902804125
   Salkovskis P. M., 2001, HLTH ANXIETY CLIN RE, P46
   Salkovskis PM, 2002, PSYCHOL MED, V32, P843, DOI 10.1017/S0033291702005822
   Santora M., 2016, NY TIMES
   Schmidt NB, 1997, J CONSULT CLIN PSYCH, V65, P214, DOI 10.1037/0022-006X.65.2.214
   Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015
   Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759
   Taylor S., 2012, HDB EVIDENCE BASED P, VII, P603
   Taylor S, 2004, TREATING HLTH ANXIET
   Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176
   Tolin DF, 2006, J BEHAV THER EXP PSY, V37, P30, DOI 10.1016/j.jbtep.2005.09.003
   WARWICK HMC, 1989, J PSYCHOSOM RES, V33, P705, DOI 10.1016/0022-3999(89)90086-X
   Weck F, 2014, ANXIETY STRESS COPIN, V27, P576, DOI 10.1080/10615806.2013.873793
   Wheaton MG, 2012, COGNITIVE THER RES, V36, P210, DOI 10.1007/s10608-011-9353-3
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Xie XF, 2011, J RISK RES, V14, P1091, DOI 10.1080/13669877.2011.571790
NR 57
TC 6
Z9 6
U1 4
U2 6
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1068-9583
EI 1573-3572
J9 J CLIN PSYCHOL MED S
JI J. Clin. Psychol. Med. Settings
PD DEC
PY 2017
VL 24
IS 3-4
SI SI
BP 270
EP 278
DI 10.1007/s10880-017-9514-y
PG 9
WC Psychology, Clinical
SC Psychology
GA FO0PP
UT WOS:000416447700009
PM 29063232
OA Green Published
DA 2020-07-08
ER

PT J
AU Sebastian, UU
   Ricardo, AVA
   Alvarez, BC
   Cubides, A
   Luna, AF
   Arroyo-Parejo, M
   Acuna, CE
   Quintero, AV
   Villareal, OC
   Pinillos, OS
   Vieda, E
   Bello, M
   Pena, S
   Duenas-Castell, C
   Rodriguez, GMV
   Ranero, JLM
   Lopez, RLM
   Olaya, SG
   Vergara, JC
   Tandazo, A
   Ospina, JPS
   Soto, IML
   Fowler, RA
   Marshall, JC
AF Ubiergo Sebastian, Ugarte
   Angel Ricardo, Arenas Villamizar
   Alvarez, Bruno C.
   Cubides, Angela
   Luna, Angelica F.
   Arroyo-Parejo, Max
   Acuna, Cayri E.
   Quintero, Agamenon V.
   Villareal, Orlando Ch.
   Pinillos, Oscar S.
   Vieda, Elias
   Bello, Manuel
   Pena, Susana
   Duenas-Castell, Carmelo
   Rodriguez, Gloria M. V.
   Ranero, Jorge L. M.
   Lopez, Rosa L. M.
   Olaya, Sandra G.
   Vergara, Jose C.
   Tandazo, Ana
   Ospina, Juan P. S.
   Leyton Soto, Igor M.
   Fowler, R. A.
   Marshall, John C.
CA LACCTIN Grp
TI Zika virus-induced neurological critical illness in Latin America:
   Severe Guillain-Barre Syndrome and encephalitis
SO JOURNAL OF CRITICAL CARE
LA English
DT Article
DE Zika virus; Epidemic outbreak; Guillain-Barre Syndrome; Critical care;
   Intensive Care Units; Latin America
ID MECHANICAL VENTILATION; TRANSMISSION; INFECTION
AB Zika virus (ZIKAV) is classically described as causing minor symptoms in adult patients, however neurologic complications have been recognized. The recent outbreak in Central and South America has resulted in serious illness in some adult patients. We report adult patients in Latin America diagnosed with ZIKAV infection admitted to Intensive Care Units (ICUs).
   Methods: Multicenter, prospective case series of adult patients with laboratory diagnosis of ZIKAV in 16 ICUs in 8 countries.
   Results: Between December 1st 2015 and April 2nd 2016, 16 ICUs in 8 countries enrolled 49 critically ill patients with diagnosis of ZIKAV infection. We included 10 critically ill patients with ZIKAV infection, as diagnosed with RT-PCR, admitted to the ICU. Neurologic manifestations concordant with Guillain-Barre Syndrome (GBS) were present in all patients, although 2 evolved into an encephalitis-like picture. 2 cases died, one due to encephalitis, the other septic shock.
   Conclusions: Differing from what was usually reported, ZIKAV infection can result in life-threatening neurologic illness in adults, including GBS and encephalitis. Collaborative reporting to identify severe illness from an emerging pathogen can provide valuable insights into disease epidemiology and clinical presentation, and inform public health authorities about acute care priorities. (c) 2017 Elsevier Inc. All rights reserved.
C1 [Ubiergo Sebastian, Ugarte] Univ Andres Bello, Clin Indisa, Crit Care Dept, Santiago, Chile.
   [Ubiergo Sebastian, Ugarte] Council WFSICCM, FEPIMCTI, Santiago, Chile.
   [Angel Ricardo, Arenas Villamizar] Clin Indisa, Santiago, Chile.
   [Alvarez, Bruno C.] Univ Texas Southwestern, Dallas, TX USA.
   [Luna, Angelica F.] Univ Santiago Cali, Cali, Colombia.
   [Cubides, Angela] Univ Valle, Cali, Colombia.
   [Luna, Angelica F.] Gen Crit Care Unit & Intermediate Care, Neiva, Colombia.
   [Arroyo-Parejo, Max] Hosp Privado Clin Santa Sofia, Caracas, Venezuela.
   [Arroyo-Parejo, Max; Acuna, Cayri E.] Hosp Vargas Caracas, Caracas, Venezuela.
   [Quintero, Agamenon V.] Imatoncomedica, Crit Care Dept, Cordoba, Colombia.
   [Villareal, Orlando Ch.] Clin Evaluamos, Cordoba, Colombia.
   [Villareal, Orlando Ch.] Univ Sinu, Fac Med, Cordoba, Colombia.
   [Pinillos, Oscar S.] Metab Disorders & Intens Care Res Grp, Cali, Colombia.
   [Vieda, Elias] Hosp Univ Valle, Cali, Colombia.
   [Bello, Manuel] Hosp Nacl San Rafael, Crit Care Dept, San Salvador, El Salvador.
   [Bello, Manuel] Salvadorean Crit Care Assoc, San Salvador, El Salvador.
   [Pena, Susana] Minist Hlth, San Salvador, El Salvador.
   [Duenas-Castell, Carmelo] Univ Cartagena, Clin Gest Salud, Cartagena, Colombia.
   [Rodriguez, Gloria M. V.] HIMA San Pablo Caguas, Caguas, PR USA.
   [Ranero, Jorge L. M.] Hosp Gen Enfermedades, Inst Guatemalteco Seguridad Social, Guatemala City, Guatemala.
   [Lopez, Rosa L. M.] Hosp Guillermo Almenara, Lima, Peru.
   [Olaya, Sandra G.] Hosp San Jorge Pereira, Obstet & Gynecol Intens Care Unit, Pereira, Colombia.
   [Vergara, Jose C.; Tandazo, Ana] Holy Spirit Univ Guayaquil Ecuador, Hosp Luis Vernaza, Guayaquil, Ecuador.
   [Ospina, Juan P. S.] Clin Medilaser, Neiva, Colombia.
   [Leyton Soto, Igor M.] Clin INDISA, Santiago, Chile.
   [Fowler, R. A.] Sunnybrook Res Inst, Clin Epidemiol, Toronto, ON, Canada.
   [Fowler, R. A.] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Fowler, R. A.] Univ Toronto, Interdepl Div Crit Care Med, Toronto, ON, Canada.
   [Marshall, John C.] Univ Toronto, Surg, Toronto, ON, Canada.
   [Marshall, John C.] Michael Hosp, Toronto, ON, Canada.
   [LACCTIN Grp] LACCTIN, Sta Maria 1810, Santiago, Region Metropol, Chile.
   [Tandazo, Ana] Univ Espiritu Santo Guayaquil, Guayaquil, Ecuador.
RP Ricardo, AVA (corresponding author), Clin Indisa, Santiago, Chile.
EM arenasvangelr@gmail.com
OI Alvare Concejo, Bruno/0000-0002-2695-8159; Cubides Munevar, Angela
   Mayerly/0000-0002-3590-8954
CR Ali MI, 2006, RESP CARE, V51, P1403
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Cao-Lormeau V. M., 2016, LANCET
   Cao-Lormeau Van-Mai, GUILLAIN BARRE SYNDR
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   CDC, REV DIAGN TEST ZIK C
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Damian MS, 2013, INTENS CARE MED, V39, P1405, DOI 10.1007/s00134-013-2960-6
   de Boisanger L, 2016, IRISH J MED SCI, V185, P11, DOI 10.1007/s11845-015-1365-7
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Emilio Dirlikov, 2016, MMWR, V65
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fletcher DD, 2000, NEUROLOGY, V54, P2311, DOI 10.1212/WNL.54.12.2311
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Frontera Jennifer A, 2016, NEW ENGL J MED, V375, P16
   Guillermo Gonzalez M, 2015, ACTA NEUROL COLOMB
   Gupta A, 2010, DISABIL REHABIL, V32, P1897, DOI 10.3109/09638281003734474
   Helleberg M, INT J STD AIDS
   Hughes R. A. C., 1990, GUILLAIN BARRE SYNDR
   Instituto Nacional de Salud/Ministerio de Salud Protocolo de Vigilancia de Salud Publica, 2016, ENF VIR ZIK
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   McVey DS, 2015, REV SCI TECH
   Ministerio de Proteccion Social Colombia, ENF VIR ZIK
   Ministerio de Salud de Peru, AL EP INT TRANSM VIR
   Ministerio de Salud gobierno de Chile, REC DENG ZIK CHIK
   Ministerio de Salud Publica y Asistencia Social de Guatemala, PROT VIG EP ENF FEBR
   Ministerio del Poder Popular para la Salud. Venezuela, GUIA VIG EP INF VIR
   Musso D, 2014, EUROSURVEILLANCE, V19, P14, DOI DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nishimoto Y, 2004, J NEUROIMMUNOL, V148, P200, DOI 10.1016/j.jneuroim.2003.11.017
   Pan American Health Organization/World Health Organization, 2016, ZIK EP UPD
   Paploski Igor AD, 2016, EMERG INFECT DIS, V22
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pinol-Ripoll G, 2008, AN MED INTERNA
   Sebastian Ugarte, 2010, CRIT CARE MED
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Sharshar T, 2003, CRIT CARE MED
   Uncini A, 2010, J NEUROL NEUROSUR PS, V81, P1157, DOI 10.1136/jnnp.2010.208538
   Villamizar ARA, 2013, TROP MED INT HEALTH, V18, P115
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Winkelmann Evandro R, 2016, W NILE VIRUS INFECT
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 43
TC 16
Z9 18
U1 0
U2 5
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0883-9441
EI 1557-8615
J9 J CRIT CARE
JI J. Crit. Care
PD DEC
PY 2017
VL 42
BP 275
EP 281
DI 10.1016/j.jcrc.2017.07.038
PG 7
WC Critical Care Medicine
SC General & Internal Medicine
GA FQ7CN
UT WOS:000418520500047
PM 28806562
OA Green Published
DA 2020-07-08
ER

PT J
AU Aldunate, F
   Gambaro, F
   Fajardo, A
   Sonora, M
   Cristina, J
AF Aldunate, Fabian
   Gambaro, Fabiana
   Fajardo, Alvaro
   Sonora, Martin
   Cristina, Juan
TI Evidence of increasing diversification of Zika virus strains isolated in
   the American continent
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE Bayesian; coalescent; evolution; Zika
ID BAYESIAN COALESCENT INFERENCE; HIGH EVOLUTIONARY RATES; SPREAD; OUTBREAK
AB Zika virus (ZIKV) is a member of the family Flaviviridae. ZIKV emerged in Brazil in 2015, causing an unprecedented epidemic and since then the virus has rapidly spread throughout the Americas. These facts highlight the need of detailed phylogenetic studies to understand the emergence, spread, and evolution of ZIKV populations. For these reasons, a Bayesian coalescent Markov Chain Monte Carlo analysis of complete genome sequences of ZIKV strains recently isolated in the American continent was performed. The results of these studies revealed an increasing diversification of ZIKV strains in different genetic lineages and co-circulation of distinct genetic lineages in several countries in the region. The time of the most recent common ancestor (tMRCA) was established to be around February 20, 2014 for ZIKV strains circulating in the American region. A mean rate of evolution of 1.55x10(-3) substitutions/site/year was obtained for ZIKV strains included in this study. A Bayesian skyline plot indicate a sharp increase in population size from February 2014 to July 2015 and a decline during 2016. These results are discussed in terms of the emergence and evolution of ZIKV populations in the American continent.
C1 [Aldunate, Fabian; Gambaro, Fabiana; Fajardo, Alvaro; Sonora, Martin; Cristina, Juan] Univ Republica, Ctr Invest Nucl, Lab Virol Mol, Fac Ciencias, Igua 4225, Montevideo 11400, Uruguay.
RP Cristina, J (corresponding author), Univ Republica, Ctr Invest Nucl, Lab Virol Mol, Fac Ciencias, Igua 4225, Montevideo 11400, Uruguay.
EM cristina@cin.edu.uy
OI Aldunate, Fabian/0000-0001-6532-8072
FU Agencia Nacional de Investigacion e Innovacion; Comision Sectorial de
   Investigacion Cientifica (Grupos I+D); PEDECIBA
FX Agencia Nacional de Investigacion e Innovacion; Comision Sectorial de
   Investigacion Cientifica, Grant number: Grupos I+D; PEDECIBA
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Anez G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002245
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Costa RL, 2015, INFEC GENET EVOL, V12, P309
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Fajardo A, 2016, J MED VIROL, V88, P1672, DOI 10.1002/jmv.24596
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Grinev A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004717
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1739
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3
   King CC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-63
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Massad E, 2017, EPIDEMIOL INFECT, P1
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Moratorio G, 2007, J GEN VIROL, V88, P3039, DOI 10.1099/vir.0.83038-0
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Perez-Parra S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168099
   Rambaut A, 2009, PLOS CURRENTS INFLUE, V1, pN1003
   Ramirez A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-329
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182
   Victoria M, 2009, INFECT GENET EVOL, V9, P927, DOI 10.1016/j.meegid.2009.06.014
   Vogel G, 2016, SCIENCE
NR 42
TC 2
Z9 3
U1 0
U2 40
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD DEC
PY 2017
VL 89
IS 12
BP 2059
EP 2063
DI 10.1002/jmv.24910
PG 5
WC Virology
SC Virology
GA FJ7IS
UT WOS:000412931100001
PM 28792064
OA Bronze
DA 2020-07-08
ER

PT J
AU Attila, T
   Tamas, H
   Istvan, K
   Balazs, T
   Narcisz, B
   Judit, P
AF Attila, Trajer
   Tamas, Hammer
   Istvan, Kacsala
   Balazs, Tanczos
   Narcisz, Bagi
   Judit, Padisak
TI Decoupling of active and passive reasons for the invasion dynamics of
   Aedes albopictus Skuse (Diptera: Culicidae): Comparisons of dispersal
   history in the Apennine and Florida peninsulas
SO JOURNAL OF VECTOR ECOLOGY
LA English
DT Article
DE Dispersal; ontogeny; temperature; USDA zonation; mosquito; climate
ID DRIVEN ABUNDANCE MODEL; ASIAN TIGER MOSQUITO; 1ST RECORD;
   ANOPHELES-GAMBIAE; AEGYPTI DIPTERA; AQUATIC STAGES; TEMPERATURE;
   SURVIVAL; VECTOR; POPULATIONS
AB Aedes albopictus is an important vector of several diseases including dengue-and Chikungunya fever and is a potential vector of Zika-fever. The invasion dynamics of Aedes albopictus was reconsidered by comparing the temperature-related development of the mosquito with the observed real geographical distribution in Florida and in Italy. The potential number of generations and the annual dispersal distances of the mosquito were calculated for the estimates. The estimated total dispersals are 3.6-4.6 km/year/generation in Italy and 4.6-5.3 km/year/generation in Florida, values that are at least five to six times higher than those derived from release and recapture studies and from the previously measured flying distances of female Asian tiger mosquitoes. Subtracting the calculated dispersal distances with the known active dispersal of female Ae. albopictus, the passive dispersal component of the total dispersal distances was found to be 2.8-4.1 km/year/generation in Italy and 3.8-4.8 km/year/generation in Florida. Our results confirm that the active dispersal of female mosquitoes plays a secondary role in determining the rate of areal expansion and, in contrast, passive factors may play a primary role. It was concluded, based on similar average values of the passive dispersal distances of the mosquito in Florida and Italy, that at large spatial scales the anthropogenic component can be well estimated.
C1 [Attila, Trajer; Tamas, Hammer; Istvan, Kacsala; Judit, Padisak] Univ Pannonia, Dept Limnol, Egyet Utca 10, H-8200 Veszprem, Hungary.
   [Balazs, Tanczos] Hungarian Inst Forens Sci, Dept Genet, Budapest, Hungary.
   [Narcisz, Bagi] Univ Pannonia, Dept Organ Chem, Veszprem, Hungary.
   [Judit, Padisak] MTA PE Limnoecol Res Grp, Veszprem, Hungary.
RP Attila, T (corresponding author), Univ Pannonia, Dept Limnol, Egyet Utca 10, H-8200 Veszprem, Hungary.
EM attilatrajer@gmail.com
FU Hungarian National Research, Development and Innovation Office [NKFIH
   K120595]; European Regional Development FundEuropean Union (EU)
   [GINOP-2.3.2-15-2016-00019]
FX This study was supported by the Hungarian National Research, Development
   and Innovation Office ("Compositional and functional biodiversity of
   aquatic assemblages along spatial and temporal gradients -
   vulnerability, resilience, implications for applied issues" NKFIH
   K120595) and the European Regional Development Fund ("Sustainable use of
   ecosystem services-research for mitigating the negative effect of
   climate change, land use change and biological invasion"
   GINOP-2.3.2-15-2016-00019).
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548
   Aranda C, 2006, MED VET ENTOMOL, V20, P150, DOI 10.1111/j.1365-2915.2006.00605.x
   Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x
   Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bockova E, 2013, ACTA PARASITOL, V58, P603, DOI 10.2478/s11686-013-0158-2
   Cailly P, 2012, ECOL MODEL, V227, P7, DOI 10.1016/j.ecolmodel.2011.10.027
   Calado DC, 2002, REV SAUDE PUBL, V36, P173, DOI 10.1590/s0034-89102002000200009
   Caminade C., 2012, J R SOC INTERFACE, DOI [10.1098/rsif2012.0138, DOI 10.1098/RSIF2012.0138]
   Cancrini G, 2003, VET PARASITOL, V118, P195, DOI 10.1016/j.vetpar.2003.10.011
   Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x
   Dalla Pozza G., 1992, Journal of the American Mosquito Control Association, V8, P318
   del ROSARIO AVELINO, 1963, PHILIPPINE JOUR SCI, V92, P89
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   EDMAN JD, 1972, ANN ENTOMOL SOC AM, V65, P848, DOI 10.1093/aesa/65.4.848
   Fischer D, 2014, EUROSURVEILLANCE, V19, P34, DOI 10.2807/1560-7917.ES2014.19.6.20696
   Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225
   Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Kampen H, 2013, PARASITOL RES, V112, P905, DOI 10.1007/s00436-012-3128-y
   Klobucar A, 2006, J AM MOSQUITO CONTR, V22, P147, DOI 10.2987/8756-971X(2006)22[147:FROAAI]2.0.CO;2
   Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177
   Lima-Camara TN, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-304
   Lima-Camara TN, 2007, J VECTOR ECOL, V32, P34, DOI DOI 10.3376/1081-1710(2007)32[34:PA0D0A]2.0.C0;2
   Lounibos LP, 2002, J VECTOR ECOL, V27, P86
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   MORI A, 1977, Tropical Medicine, V19, P141
   NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554
   Pluskota Bjorn, 2008, European Mosquito Bulletin, V26, P1
   Proestos Y, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0554
   PROVOST MAURICE W., 1952, MOSQUITO NEWS, V12, P174
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2
   ROSEN L, 1976, AM J TROP MED HYG, V25, P906, DOI 10.4269/ajtmh.1976.25.906
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   Schaffner F, 2004, J AM MOSQUITO CONTR, V20, P201
   Schaffner F., 2000, SCI VIE, V323, P373
   Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241
   Scholte Ernst-Jan, 2007, European Mosquito Bulletin, V22, P5
   Sebesta O, 2012, EUROSURVEILLANCE, V17, P6
   Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579
   Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40
   Thorpe W. H., 1951, B ANIM BEHAV, V9
   Trajer A, 2017, APPL ECOL ENV RES, V15, P275, DOI 10.15666/aeer/1501_275298
   Trajer A, 2014, IDOJARAS, V118, P19
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   VANDYK JK, 1995, J AM MOSQUITO CONTR, V11, P200
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 55
TC 3
Z9 3
U1 0
U2 3
PU SOC VECTOR ECOLOGY
PI CORONA
PA 1966 COMPTON AVE, CORONA, CA 92881 USA
EI 1948-7134
J9 J VECTOR ECOL
JI J. Vector Ecol.
PD DEC
PY 2017
VL 42
IS 2
BP 233
EP 242
DI 10.1111/jvec.12263
PG 10
WC Entomology
SC Entomology
GA FM8US
UT WOS:000415366600003
PM 29125256
OA Bronze
DA 2020-07-08
ER

PT J
AU Grifoni, A
   Pham, J
   Sidney, J
   O'Rourke, PH
   Paul, S
   Peters, B
   Martini, SR
   de Silva, AD
   Ricciardi, MJ
   Magnani, DM
   Silveira, CGT
   Maestri, A
   Costa, PR
   de-Oliveira-Pinto, LM
   de Azeredo, EL
   Damasco, PV
   Phillips, E
   Mallal, S
   de Silva, AM
   Collins, M
   Durbin, A
   Diehl, SA
   Cerpas, C
   Balmaseda, A
   Kuan, G
   Coloma, J
   Harris, E
   Crowe, JE
   Stone, M
   Norris, PJ
   Busch, M
   Vivanco-Cid, H
   Cox, J
   Graham, BS
   Ledgerwood, JE
   Turtle, L
   Solomon, T
   Kallas, EG
   Watkins, DI
   Weiskopf, D
   Sette, A
AF Grifoni, Alba
   Pham, John
   Sidney, John
   O'Rourke, Patrick H.
   Paul, Sinu
   Peters, Bjoern
   Martini, Sheridan R.
   de Silva, Aruna D.
   Ricciardi, Michael J.
   Magnani, Diogo M.
   Silveira, Cassia G. T.
   Maestri, Alvino
   Costa, Priscilla R.
   de-Oliveira-Pinto, Luzia Maria
   de Azeredo, Elzinandes Leal
   Damasco, Paulo Vieira
   Phillips, Elizabeth
   Mallal, Simon
   de Silva, Aravinda M.
   Collins, Matthew
   Durbin, Anna
   Diehl, Sean A.
   Cerpas, Cristhiam
   Balmaseda, Angel
   Kuan, Guillermina
   Coloma, Josefina
   Harris, Eva
   Crowe, James E., Jr.
   Stone, Mars
   Norris, Phillip J.
   Busch, Michael
   Vivanco-Cid, Hector
   Cox, Josephine
   Graham, Barney S.
   Ledgerwood, Julie E.
   Turtle, Lance
   Solomon, Tom
   Kallas, Esper G.
   Watkins, David I.
   Weiskopf, Daniela
   Sette, Alessandro
TI Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in
   Humans
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE ZIKV; DENV; T cells; heterologous immunity; cross-reactivity;
   immunodominance
ID ORIGINAL ANTIGENIC SIN; COMPREHENSIVE ANALYSIS; HETEROLOGOUS IMMUNITY;
   CROSS-REACTIVITY; PROTECTIVE ROLE; RESPONSES; INFECTION; VACCINE;
   ANTIBODIES; CD4(+)
AB While progress has been made in characterizing humoral immunity to Zika virus (ZIKV) in humans, little is known regarding the corresponding T cell responses to ZIKV. Here, we investigate the kinetics and viral epitopes targeted by T cells responding to ZIKV and address the critical question of whether preexisting dengue virus (DENV) T cell immunity modulates these responses. We find that memory T cell responses elicited by prior infection with DENV or vaccination with tetravalent dengue attenuated vaccines (TDLAV) recognize ZIKV-derived peptides. This cross-reactivity is explained by the sequence similarity of the two viruses, as the ZIKV peptides recognized by DENV-elicited memory T cells are identical or highly conserved in DENV and ZIKV. DENV exposure prior to ZIKV infection also influences the timing and magnitude of the T cell response. ZIKV-reactive T cells in the acute phase of infection are detected earlier and in greater magnitude in DENV-immune patients. Conversely, the frequency of ZIKV-reactive T cells continues to rise in the convalescent phase in DENV-naive donors but declines in DENV-preexposed donors, compatible with more efficient control of ZIKV replication and/or clearance of ZIKV antigen. The quality of responses is also influenced by previous DENV exposure, and ZIKV-specific CD8 T cells from DENV-preexposed donors selectively upregulated granzyme B and PD1, unlike DENV-naive donors. Finally, we discovered that ZIKV structural proteins (E, prM, and C) are major targets of both the CD4 and CD8 T cell responses, whereas DENV T cell epitopes are found primarily in nonstructural proteins.
   IMPORTANCE The issue of potential ZIKV and DENV cross-reactivity and how preexisting DENV T cell immunity modulates Zika T cell responses is of great relevance, as the two viruses often cocirculate and Zika virus has been spreading in geographical regions where DENV is endemic or hyperendemic. Our data show that memory T cell responses elicited by prior infection with DENV recognize ZIKV-derived peptides and that DENV exposure prior to ZIKV infection influences the timing, magnitude, and quality of the T cell response. Additionally, we show that ZIKV-specific responses target different proteins than DENV-specific responses, pointing toward important implications for vaccine design against this global threat.
C1 [Grifoni, Alba; Pham, John; Sidney, John; O'Rourke, Patrick H.; Paul, Sinu; Peters, Bjoern; Martini, Sheridan R.; Weiskopf, Daniela; Sette, Alessandro] Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.
   [de Silva, Aruna D.] Genetech Res Inst, Colombo, Sri Lanka.
   [Ricciardi, Michael J.; Magnani, Diogo M.; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
   [Silveira, Cassia G. T.; Maestri, Alvino; Costa, Priscilla R.; Kallas, Esper G.] Univ Sao Paulo, Div Clin Immunol & Allergy, Sch Med, Sao Paulo, Brazil.
   [de-Oliveira-Pinto, Luzia Maria; de Azeredo, Elzinandes Leal] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Damasco, Paulo Vieira] Fed Univ State Rio Janeiro UNIRIO, Rio De Janeiro, Brazil.
   [Phillips, Elizabeth; Mallal, Simon] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.
   [de Silva, Aravinda M.; Collins, Matthew] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Durbin, Anna] Johns Hopkins Univ Bloomberg, Sch Publ Hlth, Baltimore, MD USA.
   [Diehl, Sean A.] Univ Vermont, Sch Med, Burlington, VT 05405 USA.
   [Cerpas, Cristhiam; Balmaseda, Angel] Minist Hlth, Natl Ctr Diag & Reference, Natl Virol Lab, Managua, Nicaragua.
   [Kuan, Guillermina] Minist Hlth, Hlth Ctr Socrates Flores Vivas, Managua, Nicaragua.
   [Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN USA.
   [Stone, Mars; Norris, Phillip J.] Blood Syst Res Inst, San Francisco, CA USA.
   [Vivanco-Cid, Hector] Univ Veracruzana, Inst Invest Med Biolog, Veracruz, Mexico.
   [Cox, Josephine; Graham, Barney S.; Ledgerwood, Julie E.] NIH, Vaccine Res Ctr, NIAID, Bldg 10, Bethesda, MD 20892 USA.
   [Turtle, Lance] Univ Liverpool, Inst Infect & Global Hlth, Ctr Global Vaccine Res, Liverpool, Merseyside, England.
   [Turtle, Lance; Solomon, Tom] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England.
   [Turtle, Lance] Royal Liverpool Univ Hosp, Trop & Infect Dis Unit, Liverpool, Merseyside, England.
   [Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.
   [Phillips, Elizabeth; Mallal, Simon] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia.
RP Sette, A (corresponding author), Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.
EM alex@lji.org
RI Diehl, Sean/AAE-2779-2020; Graham, Barney S./AAC-5898-2019; Crowe, James
   E./B-5549-2009; /AAD-2097-2020
OI Diehl, Sean/0000-0001-9700-235X; Graham, Barney S./0000-0001-8112-0853;
   Crowe, James E./0000-0002-0049-1079; Weiskopf,
   Daniela/0000-0003-2968-7371; , Alba/0000-0002-2209-5966; Cox,
   Josephine/0000-0003-1301-7373; Solomon, Tom/0000-0001-7266-6547; Kallas,
   Esper/0000-0003-2026-6925; Turtle, Lance/0000-0002-0778-1693; Magnani,
   Diogo/0000-0002-1773-2406
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HHSN272200900042C,
   HHSN27220140045C, U19 AI118626-01, HHSN268201100001I, 1P01AI106695-01A1,
   RO1 AI127828]; ZikaPLAN - European Union [734584]; BMGF [457
   OPP1104710]; University of Miami Clinical and Translational Research
   Institute; Consejo Nacional de Ciencia y Tecnologia (CONACyT) Fonteras
   de la Ciencia [2015-02-1192]; Ciencia Basica SEP-CONACyT [256235];
   Fosiss-CONACyT [233697]
FX This work was supported by National Institutes of Health contracts and
   grants HHSN272200900042C, HHSN27220140045C, and U19 AI118626-01 to A.S.,
   HHSN268201100001I to BSRI, 1P01AI106695-01A1 to E.H., and RO1 AI127828
   to J.E.C. Further support was provided by ZikaPLAN, which has received
   funding from the European Union's Horizon 2020 research and innovation
   program under grant agreement no. 734584, to A.S., by BMGF grant 457
   OPP1104710 to A.P.D., an internal grant from the University of Miami
   Clinical and Translational Research Institute to D.I.W., and grants from
   Consejo Nacional de Ciencia y Tecnologia (CONACyT) Fonteras de la
   Ciencia 2015-02-1192, Ciencia Basica SEP-CONACyT 256235, and
   Fosiss-CONACyT 233697 to H.V.-C.
CR Ahmed R, 2011, IMMUNOL CELL BIOL, V89, P340, DOI 10.1038/icb.2010.155
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Chandele A, 2016, J VIROL, V90, P11259, DOI 10.1128/JVI.01424-16
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FERNANDEZ RJ, 1990, MEM I OSWALDO CRUZ, V85, P347, DOI 10.1590/S0074-02761990000300012
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kanakaratne N, 2009, EMERG INFECT DIS, V15, P192, DOI 10.3201/eid1502.080926
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898
   Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037
   Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul Sinu, 2016, Curr Protoc Immunol, V114, DOI 10.1002/cpim.12
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Report S, 2017, ZIK VIR MICR GUILL B
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sharma S, 2014, J LEUKOCYTE BIOL, V95, P405, DOI 10.1189/jlb.0713386
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Soares CN, 2010, INT J INFECT DIS, V14, pE150, DOI 10.1016/j.ijid.2009.03.016
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN VIROL, V78, P57, DOI 10.1016/j.jcv.2016.01.007
   Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Xu X, 2016, PLOS CURR, V8
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zehn D, 2010, J IMMUNOL, V184, P6320, DOI 10.4049/jimmunol.1000149
NR 55
TC 47
Z9 47
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2017
VL 91
IS 24
AR UNSP e01469-17
DI 10.1128/JVI.01469-17
PG 19
WC Virology
SC Virology
GA FO1TT
UT WOS:000416548700018
PM 28978707
OA Green Published
DA 2020-07-08
ER

PT J
AU Gould, E
   Pettersson, J
   Higgs, S
   Charrel, R
   de Lamballerie, X
AF Gould, Ernest
   Pettersson, John
   Higgs, Stephen
   Charrel, Remi
   de Lamballerie, Xavier
TI Emerging arboviruses: Why today?
SO ONE HEALTH
LA English
DT Review
DE Emerging arboviruses; Arthropods; Mosquitoes; Evolution; Anthropology;
   Dispersal; Global distribution
ID JAPANESE-ENCEPHALITIS-VIRUS; WEST-NILE-VIRUS; VALLEY FEVER VIRUS;
   AEDES-AEGYPTI MOSQUITOS; ONYONG-NYONG FEVER; YELLOW-FEVER; USUTU-VIRUS;
   EVOLUTIONARY HISTORY; CHIKUNGUNYA VIRUSES; DIPTERA-CULICIDAE
AB The recent global (re)emergence of arthropod-borne viruses (arboviruses), such as chikungunya and Zika virus, was widely reported in the media as though it was a new phenomenon. This is not the case. Arboviruses and other human microbial pathogens have been (re)emerging for centuries. The major difference today is that arbovirus emergence and dispersion are more rapid and geographically extensive, largely due to intensive growth of global transportation systems, arthropod adaptation to increasing urbanisation, our failure to contain mosquito population density increases and land perturbation. Here we select examples of (re)emerging pathogenic arboviruses and explain the reasons for their emergence and different patterns of dispersal, focusing particularly on the mosquito vectors which are important determinants of arbovirus emergence. We also attempt to identify arboviruses likely to (re)emerge in the future.
C1 [Gould, Ernest; Charrel, Remi; de Lamballerie, Xavier] Aix Marseille Univ, EPV, IRD 190, INSERM 1207,EHESP, Marseille, France.
   [Charrel, Remi; de Lamballerie, Xavier] Inst Hosp Univ Mediterranee Infect, APHM Publ Hosp Marseille, Marseille, France.
   [Pettersson, John] Norwegian Inst Publ Hlth, Domain Infect Control & Environm Hlth, Dept Infect Dis Epidemiol & Modelling Mol Biol, Oslo, Norway.
   [Pettersson, John] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol IMBIM, Uppsala, Sweden.
   [Higgs, Stephen] Kansas State Univ, Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.
   [Higgs, Stephen] Kansas State Univ, KS Biosecur Res Inst, Manhattan, KS 66506 USA.
RP Gould, E (corresponding author), Aix Marseille Univ, EPV, IRD 190, INSERM 1207,EHESP, Marseille, France.
EM eag@ceh.ac.uk
OI Pettersson, John H.-O./0000-0001-6665-7492
FU EU FP7 Project PREDEMICSEuropean Union (EU) [278433]; EU Horizon Project
   EVAg [653316]
FX This study was partly funded under the EU FP7 Project PREDEMICS (grant
   agreement no. 278433) and the EU Horizon 2020 Project EVAg (grant
   agreement no. 653316). EG, JP, RC, and XDL are members of the EU
   programme of the European Union, ZIKAlliance.
CR Abdo-Salem S, 2011, VECTOR-BORNE ZOONOT, V11, P773, DOI 10.1089/vbz.2010.0084
   Andriamandimby SF, 2010, EMERG INFECT DIS, V16, P963, DOI 10.3201/eid1606.091266
   [Anonymous], 2016, CDC FEAT W NIL VIR
   [Anonymous], 2013, RIFT VALLEY FEVER
   [Anonymous], 2015, JAP ENC CDC FEAT
   Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0
   Auguste AJ, 2009, INFECT GENET EVOL, V9, P709, DOI 10.1016/j.meegid.2008.07.006
   Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005
   Bennett KL, 2016, MOL ECOL, V25, P4337, DOI 10.1111/mec.13762
   BERNKOPF H, 1953, J INFECT DIS, V93, P207, DOI 10.1093/infdis/93.3.207
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bloom KJ, 1993, MISSISSIPPI VALLEYS, P1, DOI [DOI 10.1111/GWAT.12306, 10.1111/gwat.12306]
   BRES PLJ, 1986, B WORLD HEALTH ORGAN, V64, P775
   Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6
   Brown J. E., 2013, EVOLUTION LANCASTER, V68
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Buckley A, 2003, J GEN VIROL, V84, P2807, DOI 10.1099/vir.0.19341-0
   Buckley A, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-71
   C. ArboNET, 1999, MOSQ SPEC WHICH W NI
   Cadar D., 2017, EUR SURVEILL, V22
   Cadar D., 2016, EUR SURVEILL, V22
   Cadar D, 2014, EMERG INFECT DIS, V20, P1771, DOI 10.3201/eid2010.140909
   Caini S., 2011, EUR SURVEILL, V17
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Cao L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004686
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Chamchod F, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01568
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Chen RB, 2016, J VIROL, V90, P10600, DOI 10.1128/JVI.01166-16
   Christie J, 1872, Br Med J, V1, P577
   Crawford JE, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0351-0
   Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   Diallo M, 2000, AM J TROP MED HYG, V62, P702, DOI 10.4269/ajtmh.2000.62.702
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247
   FONTENILLE D, 1989, Archives de l'Institut Pasteur de Madagascar, V55, P1
   Forrester NL, 2012, J VIROL, V86, P2729, DOI 10.1128/JVI.05591-11
   Gao XY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0270-z
   Gao XY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003015
   Gao XY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002459
   Gaunt M. W., 2001, J GEN VIROL 8, V82
   Gouck H. K., 1972, B WHO, V47
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Gould E. A., 2009, ANTIVIR RES
   Gould EA, 2004, ARCH VIROL, P65
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Gould EA, 2002, CURR TOP MICROBIOL, V267, P391
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   GRESSER I, 1958, AM J TROP MED HYG, V7, P365, DOI 10.4269/ajtmh.1958.7.365
   Grottola A, 2017, CLIN MICROBIOL INFEC, V23, P33, DOI 10.1016/j.cmi.2016.09.019
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Gubler Duane J., 1997, P1
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Halstead S. B., 2008, DENGUE OVERVIEW HIST
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Hillemand Bernard, 2006, Hist Sci Med, V40, P23
   Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505
   Impoinvil DE, 2013, CURR TOP MICROBIOL, V365, P205, DOI 10.1007/82_2012_243
   Jeanmaire EM, 2011, VECTOR-BORNE ZOONOT, V11, P395, DOI 10.1089/vbz.2009.0249
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Johnson B. K., 1988, ONYONG NYONG VIRUS D
   Karabatsos N., 1985, INT CATALOGUE ARTHRO, P137
   Kenney JL, 2014, ADV VIRUS RES, V89, P39, DOI 10.1016/B978-0-12-800172-1.00002-1
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116547
   Komar N, 2002, EMERG INFECT DIS, V8, P741, DOI 10.3201/eid0807.020157
   Kopp A, 2013, MBIO, V4, DOI 10.1128/mBio.00322-13
   Kuno G, 2001, ACTA VIROL, V45, P139
   LaBeaud AD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003436
   Lanciotti R. S., 2007, EMERG INFECT DIS, V13, P5
   Lanciotti RS, 1998, VIROLOGY, V252, P258, DOI 10.1006/viro.1998.9437
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lavergne A, 2009, Med Trop (Mars), V69, P345
   Lecuit M., 2015, NEW ENGL J MED, V372, P13
   Li MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001231
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   London K. C., 2017, YELLOW FEVER CADIZ
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Manarolla G, 2010, VET MICROBIOL, V141, P159, DOI 10.1016/j.vetmic.2009.07.036
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392
   MATTINGLY PF, 1967, B WORLD HEALTH ORGAN, V36, P552
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   McNeill JR, 2004, OAH MAGAZINE HIST, V18, P9
   Mitamura T. K., 1935, KANSAI IJI, V260, P1
   Mohammed MAF, 2011, INFECT GENET EVOL, V11, P855, DOI 10.1016/j.meegid.2011.01.020
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Morillon M., 2002, YELLOW FEVER EUROPE, P1
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Muckenfuss RS, 1934, J AMER MED ASSOC, V103, P0731, DOI 10.1001/jama.1934.02750360007004
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nga PT, 2004, J GEN VIROL, V85, P1625, DOI 10.1099/vir.0.79797-0
   Nitatpattana N, 2008, EMERG INFECT DIS, V14, P1762, DOI 10.3201/eid1411.080542
   Nogueira P, 2009, YELL FEV S COMM CJ F
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Organization PAH Organization WH, 2017, EP UPD YELL FEV
   Owen J, 2006, ECOHEALTH, V3, P79, DOI 10.1007/s10393-006-0025-9
   Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906
   Patsoula E, 2017, VECTOR-BORNE ZOONOT, V17, P217, DOI 10.1089/vbz.2016.1974
   Perez-Ramirez E, 2014, VIRUSES-BASEL, V6, P752, DOI 10.3390/v6020752
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Reed W., 1901, MED REC, V60, P210
   Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135
   Rizzoli A, 2007, VECTOR-BORNE ZOONOT, V7, P411, DOI 10.1089/vbz.2006.0626
   Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088
   ROSS R. W., 1956, JOUR HYG, V54, P177
   RUDNICK ALBERT, 1960, MOSQUITO NEWS, V20, P247
   Rush A. B., 1789, ACCOUNT BILIOUS REMI
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Schuh AJ, 2013, VECTOR-BORNE ZOONOT, V13, P479, DOI 10.1089/vbz.2011.0870
   Seligman SJ, 2016, EXPERT REV VACCINES, V15, P681, DOI 10.1080/14760584.2016.1180250
   Selvey LA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002656
   Simon-Loriere E, 2017, NEW ENGL J MED, V376, P1483, DOI 10.1056/NEJMc1701600
   SIMPSON DIH, 1976, T ROY SOC TROP MED H, V70, P66, DOI 10.1016/0035-9203(76)90010-9
   SMITH C E G, 1956, J Trop Med Hyg, V59, P243
   SMITH CEG, 1986, MED HIST, V30, P322, DOI 10.1017/S0025727300045737
   Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003
   Steele K. E., 2000, N Y VET PATHOL, V37
   Strode G.K., 1951, YELLOW FEVER
   SUCHARIT S, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P611
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   Tantely LM, 2015, AM J TROP MED HYG, V92, P722, DOI 10.4269/ajtmh.14-0421
   Tantely ML, 2013, J MED ENTOMOL, V50, P603, DOI 10.1603/ME12069
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Thiberville S, 2013, PLOS NEGLECT TROP D, V7, P1
   Townroe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095325
   TRPIS M, 1978, B ENTOMOL RES, V68, P521, DOI 10.1017/S0007485300009494
   TURELL MJ, 1988, J MED ENTOMOL, V25, P262, DOI 10.1093/jmedent/25.4.262
   Urdaneta-Marquez L, 2011, INFECT GENET EVOL, V11, P253, DOI 10.1016/j.meegid.2010.11.020
   van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510
   Vanlandingham DL, 2016, J MED ENTOMOL, V53, P1024, DOI 10.1093/jme/tjw025
   Vanlandingham DL, 2006, AM J TROP MED HYG, V74, P663, DOI 10.4269/ajtmh.2006.74.663
   Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   White GS, 2016, EMERG INFECT DIS, V22, P2185, DOI 10.3201/eid2212.160805
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P248, DOI 10.1016/S1473-3099(16)30588-6
   WILLIAMS MC, 1965, T ROY SOC TROP MED H, V59, P300, DOI 10.1016/0035-9203(65)90012-X
   Yun SM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-127
   Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548
NR 157
TC 96
Z9 96
U1 1
U2 36
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2352-7714
J9 ONE HEALTH-AMSTERDAM
JI One Health
PD DEC
PY 2017
VL 4
BP 1
EP 13
DI 10.1016/j.onehlt.2017.06.001
PG 13
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FW9HG
UT WOS:000425645700001
PM 28785601
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Freitas, BD
   Zin, A
   Ko, A
   Maia, M
   Ventura, CV
   Belfort, R
AF Freitas, Bruno de Paula
   Zin, Andrea
   Ko, Albert
   Maia, Mauricio
   Ventura, Camila V.
   Belfort, Rubens, Jr.
TI Anterior-Segment Ocular Findings and Microphthalmia in Congenital Zika
   Syndrome
SO OPHTHALMOLOGY
LA English
DT Editorial Material
ID VIRUS
C1 [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
   [Freitas, Bruno de Paula; Maia, Mauricio; Ventura, Camila V.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Sao Paulo, Brazil.
   [Freitas, Bruno de Paula; Maia, Mauricio; Ventura, Camila V.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821,1st Floor, BR-04023062 Sao Paulo, Brazil.
   [Zin, Andrea] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Clin Res Unit, Rio De Janeiro, Brazil.
   [Ko, Albert] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ventura, Camila V.] Altino Ventura Fdn, Recife, PE, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821,1st Floor, BR-04023062 Sao Paulo, Brazil.
EM prof.belfort@clinicabelfort.com.br
RI Ventura, Camila V/N-2654-2018; Maia, Mauricio/I-5892-2015; Ko, Albert
   Icksang/P-2343-2015
OI Ventura, Camila V/0000-0002-2927-4684; Maia,
   Mauricio/0000-0002-7034-8091; Ko, Albert Icksang/0000-0001-9023-2339
CR Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 5
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD DEC
PY 2017
VL 124
IS 12
BP 1876
EP 1878
PG 3
WC Ophthalmology
SC Ophthalmology
GA FM9JZ
UT WOS:000415586000031
PM 28676282
DA 2020-07-08
ER

PT J
AU Kampen, H
   Schuhbauer, A
   Walther, D
AF Kampen, Helge
   Schuhbauer, Astrid
   Walther, Doreen
TI Emerging mosquito species in Germany-a synopsis after 6 years of
   mosquito monitoring (2011-2016)
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Climate change; Germany; Globalisation; Invasive species;
   'Mueckenatlas'; Vector
ID JAPONICUS-JAPONICUS THEOBALD; AEDES-ALBOPICTUS DIPTERA; ANOPHELES-DACIAE
   DIPTERA; 1ST RECORD; INVASIVE MOSQUITOS; KOREICUS DIPTERA;
   COLD-ACCLIMATION; FINLAYA KOREICUS; YELLOW-FEVER; ZIKA VIRUS
AB Globalisation and climate change are the main drivers of invasion of non-endemic regions by mosquitoes. Mass transportation of people, animals and goods facilitate accidental long-distance displacement while climate warming supports active spread and establishment of thermophilic species. In the framework of a mosquito-monitoring programme, eight non-indigenous culicid species have been registered in Germany since 2011, with four of them being more or less efficient vectors of disease agents and another four now considered established. The eight newly emerged species include Aedes albopictus, Ae. japonicus, Ae. aegypti, Ae. koreicus, Ae. berlandi, Ae. pulcritarsis, Anopheles petragnani and Culiseta longiareolata. We here review recent findings and at the same time present new findings of specimens of non-native mosquito species in Germany.
C1 [Kampen, Helge] FLI, Fed Res Inst Anim Hlth, Greifswald Insel Riems, Germany.
   [Schuhbauer, Astrid] Biogents AG, Regensburg, Germany.
   [Walther, Doreen] Leibniz Ctr Agr Landscape Res ZALF, Muencheberg, Germany.
RP Kampen, H (corresponding author), FLI, Fed Res Inst Anim Hlth, Greifswald Insel Riems, Germany.
EM helge.kampen@fli.de
FU German Federal Ministry of Food and Agriculture (BMEL) through the
   Federal Office for Agriculture and Food (BLE) [2810HS022, 2819104115,
   2819104615]; Robert Koch Institute [1362/1-982]
FX This work was financially supported by the German Federal Ministry of
   Food and Agriculture (BMEL) through the Federal Office for Agriculture
   and Food (BLE), grant numbers 2810HS022, 2819104115 and 2819104615, and
   by the Robert Koch Institute, grant number 1362/1-982. We are also
   grateful to Brigitte Dannenfeld, Jutta Falland, Christin Henke, Juliane
   Horenk, Martina Pusch and Oliver Tauchmann for excellent technical
   assistance in the laboratory, and to all the people taking care of our
   mosquito traps and submitting mosquitoes to the citizen science project
   'Mueckenatlas'.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Almeida AP, 2007, EUROSURVEILLANCE, V12, pe3311
   Becker N., 1983, Bulletin of the Society of Vector Ecologists, V8, P85
   Becker N, 1995, MITT DGAAE, V10, P407
   Becker N, 2016, PARASITOL RES, V115, P2671, DOI 10.1007/s00436-016-5014-5
   Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1
   Becker Norbert, 2011, European Mosquito Bulletin, V29, P143
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bruce-Chwatt Leonard Jan, 1980, RISE FALL MALARIA EU
   Cameron EC, 2010, J MED ENTOMOL, V47, P527, DOI 10.1603/ME09259
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Capelli G, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-188
   COLEMAN W, 1984, B HIST MED, V58, P145
   CORRADETTI A., 1968, Parassitologia, V10, P1
   Cranston P. S., 1987, SCI PUBLICATIONS FRE, V48, P1
   Dahl C.I., 1999, STUDIA DIPTEROLOGI S, V2, P51
   Deblauwe I, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-201
   Feng LC, 1930, ANN TROP MED PARASIT, V24, P347
   Fielden MA, 2015, CAN ENTOMOL, V147, P737, DOI 10.4039/tce.2015.5
   Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008
   Flacio E, 2008, EUROSURVEILLANCE, V13, pe8058
   Flacio E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0793-6
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Ganushkina LA, 2016, VECTOR-BORNE ZOONOT, V16, P58, DOI 10.1089/vbz.2014.1761
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Gutsevich AV, 1971, FAUNA USSR DIPTERA V, V3
   HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192
   Harris MC, 2015, EMERG INFECT DIS, V21, P646, DOI 10.3201/eid2104.140734
   Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218
   Heitmann A, 2017, EUROSURVEILLANCE, V22
   Horsfall WR, 1955, MOSQUITOES THEIR BIO
   Huber K, 2012, J VECTOR ECOL, V37, P462, DOI 10.1111/j.1948-7134.2012.00252.x
   Ibanez-Justicia A, 2016, 20 E SOV C
   Ibanez-Justicia Adolfo, 2014, Journal of the European Mosquito Control Association, V32, P9
   Jackson M, 2016, J MED ENTOMOL, V53, P241, DOI 10.1093/jme/tjv164
   Kalan K, 2014, PARASIT VECTORS S1, P9
   Kalan K, 2017, PARASITOL RES, V116, P2355, DOI 10.1007/s00436-017-5532-9
   Kampen H, 2003, AM J TROP MED HYG, V69, P195, DOI 10.4269/ajtmh.2003.69.195
   Kampen H, 2016, EUROSURVEILLANCE, V21
   Kampen H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167948
   Kampen Helge, 2013, Journal of the European Mosquito Control Association, V31, P36
   Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59
   Kampen H, 2013, PARASITOL RES, V112, P905, DOI 10.1007/s00436-012-3128-y
   Kampen H, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-284
   KCDC= Korean Centres for Disease Control and Prevention, 2007, EL LYMPH FIL KOR NAT
   Klobucar A, 2017, 2 CROAT S INV SPEC Z
   KNIGHT K L, 1968, Contributions of the American Entomological Institute, V2, P1
   Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177
   Krebs T, 2014, J VECTOR ECOL, V39, P437, DOI 10.1111/jvec.12119
   Kronefeld M, 2014, PARASITOL RES, V113, P2079, DOI 10.1007/s00436-014-3857-1
   Kronefeld M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-250
   Kurucz K, 2016, PARASITOL RES, V115, P4687, DOI 10.1007/s00436-016-5229-5
   Maslov AV, 1967, KROVOSOSUSHCHIE KOMA
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   MILES J. A. R., 1964, BULL WORLD HLTH ORGAN, V30, P197
   Mohrig W., 1969, Parasitologische Schriftenreihe, V18, P1
   Montarsi F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0800-y
   Morillon M, 2002, EUROPEAN ANTHR ASS B, P211
   Moussiegt O, 1986, INVENT FAUNE FLORE, V30, P1
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pluskota B, 2016, PARASITOL RES, V115, P3245, DOI 10.1007/s00436-016-5078-2
   Pluskota Bjorn, 2008, European Mosquito Bulletin, V26, P1
   Ramsdale C, 2000, JEMCA EMB, V7, P1
   RIBEIRO H, 1988, ACT 3 C IB ENT, P233
   Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2
   Roubaud PE, 1933, B SOC PATHOL EXOT, V26, P934
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Rudolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071832
   Ryba J., 1979, Acta Entomologica Bohemoslovaca, V76, P143
   Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x
   Schaffner F, 2003, J AM MOSQUITO CONTR, V19, P1
   Schaffner F, 2001, MOSQUITOES EUROPE ID
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Scholte EJ, 2010, EUROSURVEILLANCE, V15, P10
   Seidel B, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1645-8
   Seidel B, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1566-6
   Seidel Bernhard, 2012, Entomologische Zeitschrift, V122, P223
   Silaghi C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2015-x
   SMITH CEG, 1986, MED HIST, V30, P322, DOI 10.1017/S0025727300045737
   Suter T, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1010-3
   TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1
   Tippelt L, 2017, PARASITOL RES
   Versteirt V, 2012, J MED ENTOMOL, V49, P1226, DOI 10.1603/ME11170
   Versteirt V, 2009, J MED ENTOMOL, V46, P1464, DOI 10.1603/033.046.0632
   Versteirt V, 2017, P 8 C EUR MOSQ CONTR, P74
   Walther D, 2017, ACTA TROP, V166, P186, DOI 10.1016/j.actatropica.2016.11.024
   Werner D., 2014, Proceedings of the 8th International Conference on Urban Pests, 20-23 July 2014, Zurich, Switzerland, P119
   Werner D, 2012, EUROSURVEILLANCE, V17, P14
   Werner D, 2016, PARASITOL RES, V115, P1331, DOI 10.1007/s00436-015-4848-6
   Werner D, 2015, PARASITOL RES, V114, P831, DOI 10.1007/s00436-014-4244-7
   Werner D, 2013, PARASITOL RES, V112, P3665, DOI 10.1007/s00436-013-3564-3
   Yunicheva Yu. V., 2008, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P40
   Zielke DE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1447-z
NR 99
TC 14
Z9 15
U1 2
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD DEC
PY 2017
VL 116
IS 12
BP 3253
EP 3263
DI 10.1007/s00436-017-5619-3
PG 11
WC Parasitology
SC Parasitology
GA FN0UL
UT WOS:000415696100001
PM 29032497
DA 2020-07-08
ER

PT J
AU Gharbaran, R
   Somenarain, L
AF Gharbaran, Rajendra
   Somenarain, Latchman
TI Insights into the molecular roles of Zika virus in human reproductive
   complications and congenital neuropathologies
SO PATHOLOGY
LA English
DT Review
DE Zika virus; neuropathology; fetus; placenta; microcephaly; congenital
ID SEXUAL TRANSMISSION; CEREBRAL ORGANOIDS; STEM-CELLS; INFECTION; INFANTS;
   BRAZIL; BRAIN; PLACENTA; EXOSOMES; MECHANISMS
AB The recent upsurge in the association of congenital neurological disorders and infection by the Zika virus (ZIKV) has resulted in increased research focus on the biology of this flavivirus. Studies in animal models indicate that ZIKV can breach the placental barrier and selectively infect and deplete neuroprogenitor cells (NPCs) of the developing fetus, resulting in changes of brain structures, reminiscent of human microcephaly. In vitro and ex vivo studies using human cells and tissues showed that human NPCs and placental cells are targeted by ZIKV. Also of concern is the impact of ZIKV on human reproductive structures, with the potential to cause infertility, as the virus appears to remain in the genital tract for extended periods of time. This review discusses the putative roles of ZIKV on human reproductive complications and congenital neuropathologies.
C1 [Gharbaran, Rajendra; Somenarain, Latchman] CUNY, Dept Biol Sci, Bronx Community Coll, Bronx, NY 10453 USA.
RP Gharbaran, R (corresponding author), CUNY, Dept Biol Sci, Bronx Community Coll, Bronx, NY 10453 USA.
EM rajendra.gharbaran@bcc.cuny.edu
OI Gharbaran, Rajendra/0000-0002-2351-3808
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502
   Barbelanne M, 2014, BIOMED RES INT, DOI 10.1155/2014/547986
   Baronti C, 2014, GENOME ANNOUNC, V2
   Barzon L., 2016, EURO SURVEILL, V21
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Chen YM, 2009, REPRODUCTION, V138, P655, DOI 10.1530/REP-09-0101
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Tran DN, 2011, CLIN LAB, V57, P397
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Euscher E, 2001, OBSTET GYNECOL, V98, P1019, DOI 10.1016/S0029-7844(01)01625-8
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   GAUNTT CJ, 1985, PEDIATRICS, V76, P64
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jabrane-Ferrat N, 2014, IMMUNOLOGY, V141, P490, DOI 10.1111/imm.12218
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jaworski E, 2014, J BIOL CHEM, V289, P22284, DOI 10.1074/jbc.M114.549659
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Koi H, 2001, ANN NY ACAD SCI, V943, P148, DOI 10.1111/j.1749-6632.2001.tb03798.x
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   LEUNG S, 1995, MOL CELL BIOL, V15, P1312
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Linscheid CR, 2015, 62 ANN SCI M MARC 25
   Liuzzi G, 2016, EUR J INTERN MED, V33, pE20, DOI 10.1016/j.ejim.2016.04.022
   Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCARTHY M, 2016, BMJ, V353
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perez S, 2016, EURO SURVEILL, V21
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Pujhari S, 2017, HEAT SHOCK PROTEIN 7
   Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110
   REERSTED P, 1979, ACTA OPHTHALMOL, V57, P1096
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rossi SL, 2016, CELL STEM CELL, V19, P4, DOI 10.1016/j.stem.2016.06.009
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roucourt B, 2015, CELL RES, V25, P412, DOI 10.1038/cr.2015.29
   Samedi VM, 2016, AJP REP, V6, pE1, DOI 10.1055/s-0035-1563387
   Schmedt A, 2012, PRENATAL DIAG, V32, P131, DOI 10.1002/pd.2908
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sims B, 2014, INT J NANOMED, V9, P4893, DOI 10.2147/IJN.S70999
   Singh R, 2016, NEW ZEAL MED J, V129, P79
   Smith SK, 2000, HUM REPROD, V15, P59
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang BL, 2006, BIOCHEM BIOPH RES CO, V345, P911, DOI 10.1016/j.bbrc.2006.05.040
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vargas JE, 2001, J PEDIATR-US, V139, P210, DOI 10.1067/mpd.2001.115314
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhu X, 2015, CELL MICROBIOL, V17, P105, DOI 10.1111/cmi.12339
NR 121
TC 2
Z9 3
U1 1
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0031-3025
EI 1465-3931
J9 PATHOLOGY
JI Pathology
PD DEC
PY 2017
VL 49
IS 7
BP 707
EP 714
DI 10.1016/j.pathol.2017.07.008
PG 8
WC Pathology
SC Pathology
GA FN3SZ
UT WOS:000415920800005
PM 29017720
DA 2020-07-08
ER

PT J
AU Fraser, JE
   De Bruyne, JT
   Iturbe-Ormaetxe, I
   Stepnell, J
   Burns, RL
   Flores, HA
   O'Neill, SL
AF Fraser, Johanna E.
   De Bruyne, Jyotika Taneja
   Iturbe-Ormaetxe, Inaki
   Stepnell, Justin
   Burns, Rhiannon L.
   Flores, Heather A.
   O'Neill, Scott L.
TI Novel Wolbachia-transinfected Aedes aegypti mosquitoes possess diverse
   fitness and vector competence phenotypes
SO PLOS PATHOGENS
LA English
DT Article
ID DROSOPHILA-MELANOGASTER; DENGUE; ESTABLISHMENT; POPULATIONS; INFECTION;
   STRAIN; INCOMPATIBILITY; CULICIDAE; SYMBIONT; INVASION
AB Wolbachia pipientis from Drosophila melanogaster (wMel) is an endosymbiotic bacterium that restricts transmission of human pathogenic flaviviruses and alphaviruses, including dengue, Zika, and chikungunya viruses, when introduced into the mosquito vector Aedes aegypti. To date, wMel-infected Ae. aegypti have been released in field trials in 5 countries to evaluate the effectiveness of this strategy for disease control. Despite the success in establishing wMel-infected mosquitoes in wild populations, and the well-characterized antiviral capabilities of wMel, transinfecting different or additional Wolbachia strains into Ae. aegypti may improve disease impact, and perhaps more importantly, could provide a strategy to account for the possible evolution of resistant arboviruses. Here, we report the successful transinfection of Ae. aegypti with the Wolbachia strains wMelCS (D. melanogaster), wRi (D. simulans) and wPip (Culex quinquefasciatus) and assess the effects on Ae. aegypti fitness, cytoplasmic incompatibility, tissue tropism and pathogen blocking in a laboratory setting. The results demonstrate that wMelCS provides a similar degree of protection against dengue virus as wMel following an infectious blood meal, and significantly reduces viral RNA levels beyond that of wMel following a direct challenge with infectious virus in mosquitoes, with no additional fitness cost to the host. The protection provided by wRi is markedly weaker than that of wMelCS, consistent with previous characterisations of these lines in Drosophila, while wPip was found to substantially reduce the fitness of Ae. aegypti. Thus, we determine wMelCS as a key candidate for further testing in field-relevant fitness tests and viremic blood feeding challenges in a clinical setting to determine if it may represent an alternative Wolbachia strain with more desirable attributes than wMel for future field testing.
C1 [Fraser, Johanna E.; De Bruyne, Jyotika Taneja; Iturbe-Ormaetxe, Inaki; Stepnell, Justin; Burns, Rhiannon L.; Flores, Heather A.; O'Neill, Scott L.] Monash Univ, Inst Vector Borne Dis, Clayton, Vic, Australia.
RP O'Neill, SL (corresponding author), Monash Univ, Inst Vector Borne Dis, Clayton, Vic, Australia.
EM Scott.Oneill@monash.edu
RI O'Neill, Scott L/B-3568-2009; Flores, Heather/A-7403-2019; Fraser,
   Johanna/I-2938-2014
OI O'Neill, Scott L/0000-0002-4131-3615; Flores,
   Heather/0000-0001-5003-7547; Fraser, Johanna/0000-0002-8020-2985
FU Foundation for the National Institutes of Health through the Grand
   Challenges in Global Health initiative of the Bill & Melinda Gates
   FoundationGates Foundation; Wellcome TrustWellcome Trust [102591]
FX This work was funded in part by a grant from the Foundation for the
   National Institutes of Health through the Grand Challenges in Global
   Health initiative of the Bill & Melinda Gates Foundation and by a
   Wellcome Trust Award No.102591. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Axford JK, 2016, AM J TROP MED HYG, V94, P507, DOI 10.4269/ajtmh.15-0608
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Dobson SL, 2001, J MED ENTOMOL, V38, P844, DOI 10.1603/0022-2585-38.6.844
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Martinez J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005021
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Martinez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035081
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   O'Brien CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003629
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   Pang EL, 2017, ASIAN PAC J TROP MED, V10, P209, DOI 10.1016/j.apjtm.2017.03.003
   Rances E, 2013, J VIROL, V87, P11945, DOI 10.1128/JVI.01522-13
   Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354
   Simmons CP, 2015, NEW ENGL J MED, V373, P1263, DOI 10.1056/NEJMe1509442
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Walker T, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-39
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Woolfit M, 2013, GENOME BIOL EVOL, V5, P2189, DOI 10.1093/gbe/evt169
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yamada R, 2007, GENETICS, V177, P801, DOI 10.1534/genetics.106.068486
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 46
TC 23
Z9 23
U1 2
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD DEC
PY 2017
VL 13
IS 12
AR e1006751
DI 10.1371/journal.ppat.1006751
PG 19
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FR4EZ
UT WOS:000419019800017
PM 29216317
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Concomitant testicular infection by Zika virus and Schistosoma mansoni
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok 10160, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok 10160, Thailand.
EM beuyjoob@hotmail.com
CR Alves LS, 2017, REV ASSOC MED BRAS, V63, P500, DOI 10.1590/1806-9282.63.06.500
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
NR 4
TC 0
Z9 0
U1 0
U2 1
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
SN 0104-4230
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD DEC
PY 2017
VL 63
IS 12
BP 1024
EP 1024
DI 10.1590/1806-9282.63.12.1024
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA FX7KS
UT WOS:000426268800003
PM 29489972
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Willard, KA
   Demakovsky, L
   Tesla, B
   Goodfellow, FT
   Stice, SL
   Murdock, CC
   Brindley, MA
AF Willard, Katherine A.
   Demakovsky, Leah
   Tesla, Blanka
   Goodfellow, Forrest T.
   Stice, Steven L.
   Murdock, Courtney C.
   Brindley, Melinda A.
TI Zika Virus Exhibits Lineage-Specific Phenotypes in Cell Culture, in
   Aedes aegypti Mosquitoes, and in an Embryo Model
SO VIRUSES-BASEL
LA English
DT Article
DE zika virus; viral evolution; vector-borne disease; flavivirus; vector
   competence; Aedes aegypti
ID INTERFERON SYSTEM; UNITED-STATES; PROTEIN; DENGUE; INFECTION;
   GLYCOSYLATION; AFRICAN; TRANSMISSION; CHIKUNGUNYA; RESPONSES
AB Zika virus (ZIKV) has quietly circulated in Africa and Southeast Asia for the past 65 years. However, the recent ZIKV epidemic in the Americas propelled this mosquito-borne virus to the forefront of flavivirus research. Based on historical evidence, ZIKV infections in Africa were sporadic and caused mild symptoms such as fever, skin rash, and general malaise. In contrast, recent Asian-lineage ZIKV infections in the Pacific Islands and the Americas are linked to birth defects and neurological disorders. The aim of this study is to compare replication, pathogenicity, and transmission efficiency of two historic and two contemporary ZIKV isolates in cell culture, the mosquito host, and an embryo model to determine if genetic variation between the African and Asian lineages results in phenotypic differences. While all tested isolates replicated at similar rates in Vero cells, the African isolates displayed more rapid viral replication in the mosquito C6/36 cell line, yet they exhibited poor infection rates in Aedes aegypti mosquitoes compared to the contemporary Asian-lineage isolates. All isolates could infect chicken embryos; however, infection with African isolates resulted in higher embryo mortality than infection with Asian-lineage isolates. These results suggest that genetic variation between ZIKV isolates can significantly alter experimental outcomes.
C1 [Willard, Katherine A.; Demakovsky, Leah; Tesla, Blanka] Univ Georgia, Dept Infect Dis, Coll Vet Med, Athens, GA 30602 USA.
   [Goodfellow, Forrest T.; Stice, Steven L.] Univ Georgia, Dept Anim & Dairy Sci, Coll Agr & Environm Sci, Regenerat Biosci Ctr, Athens, GA 30602 USA.
   [Murdock, Courtney C.] Univ Georgia, Odum Sch Ecol,Ctr Vaccines & Immunol, Ctr Ecol Infect Dis,Coll Vet Med,Riverbasin Ctr, Ctr Trop Emerging & Global Dis,Dept Infect Dis, Athens, GA 30602 USA.
   [Brindley, Melinda A.] Univ Georgia, Dept Populat Hlth, Dept Infect Dis, Coll Vet Med,Ctr Vaccines & Immunol, Athens, GA 30602 USA.
RP Brindley, MA (corresponding author), Univ Georgia, Dept Populat Hlth, Dept Infect Dis, Coll Vet Med,Ctr Vaccines & Immunol, Athens, GA 30602 USA.
EM kwillard@uga.edu; lrdemako@gmail.com; btesla@uga.edu;
   forrestgoodfellow@gmail.com; sstice@uga.edu; cmurdock@uga.edu;
   mbrindle@uga.edu
OI Willard, Katherine/0000-0002-0044-2664
FU NSF-RAPID [1640780]
FX We would like to thank Americo David Rodriguez Ramirez for providing the
   field-collected Aedes aegypti eggs and Jeanna Wilson of the UGA poultry
   science farm for providing the embryonated chicken eggs. This study was
   funded in part by a NSF-RAPID award (1640780). Any opinions, findings,
   and conclusions or recommendations expressed in this material are those
   of the author(s) and do not necessarily reflect the views of the
   National Science Foundation.
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Blaney JE, 2008, VACCINE, V26, P817, DOI 10.1016/j.vaccine.2007.11.082
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   CDC, CDC CONCL ZIK CAUS M
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cumberworth SL, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12737
   Daffis S., 2009, INNATE IMMUN, V1, P435, DOI [10.1159/00022624820375601, DOI 10.1159/000226248]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ebel GD, 2011, J VIROL, V85, P12605, DOI 10.1128/JVI.05637-11
   EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guerbois M., 2016, INFECT DIS, V214, P1349, DOI [10.1093/infdis/jiw30227436433, DOI 10.1093/INFDIS/JIW302]
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Harris WH, 1924, J EXP MED, V40, P817, DOI 10.1084/jem.40.6.817
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Karpala AJ, 2012, J REPROD IMMUNOL, V94, P169, DOI 10.1016/j.jri.2012.02.008
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Osada N, 2014, DNA RES, V21, P673, DOI 10.1093/dnares/dsu029
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Ramakrishnan Muthannan Andavar, 2016, World J Virol, V5, P85, DOI 10.5501/wjv.v5.i2.85
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   TAYLOR RM, 1952, J IMMUNOL, V68, P473
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 72
TC 13
Z9 13
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2017
VL 9
IS 12
AR 383
DI 10.3390/v9120383
PG 19
WC Virology
SC Virology
GA FR6IY
UT WOS:000419170300028
PM 29258204
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Diniz, D
   Ambrogi, I
AF Diniz, Debora
   Ambrogi, Ilana
TI Research ethics and the Zika legacy in Brazil
SO DEVELOPING WORLD BIOETHICS
LA English
DT Editorial Material
C1 [Diniz, Debora] Univ Brasilia, Fac Law, Brasilia, DF, Brazil.
   [Ambrogi, Ilana] Fundacao Oswaldo Cruz, Brasilia, DF, Brazil.
   [Ambrogi, Ilana] Anis Inst Bioeth, Brasilia, DF, Brazil.
RP Diniz, D (corresponding author), Univ Brasilia, Fac Law, Brasilia, DF, Brazil.
RI Diniz, Debora/K-9000-2012
OI Diniz, Debora/0000-0001-6987-2569
CR Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Diniz Debora, ZIKA BRAZIL WOMEN CH
   Schuklenk U., 2014, WILEY ONLINE LIB, V14, pii
   Uruguay. Ministerio de Salud Publica. Direccion General de la Salud. Division Epidemiologia, 2017, B EPIDEMIOLOGICO
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
NR 5
TC 2
Z9 2
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1471-8731
EI 1471-8847
J9 DEV WORLD BIOETH
JI Dev. World Bioeth.
PD DEC
PY 2017
VL 17
IS 3
BP 142
EP 143
DI 10.1111/dewb.12175
PG 2
WC Ethics; Medical Ethics
SC Social Sciences - Other Topics; Medical Ethics
GA FM4HP
UT WOS:000414975900001
PM 29130259
DA 2020-07-08
ER

PT J
AU Doolabh, K
   Caviola, L
   Savulescu, J
   Selgelid, M
   Wilkinson, DJC
AF Doolabh, Keyur
   Caviola, Lucius
   Savulescu, Julian
   Selgelid, Michael
   Wilkinson, Dominic J. C.
TI Zika, contraception and the non-identity problem
SO DEVELOPING WORLD BIOETHICS
LA English
DT Article
DE bioethics; empirical ethics; ethics; health priorities; resource
   allocation
ID PARVOVIRUS B19; VIRUS; RIGHTS; BRAZIL; WOMEN; RISK
AB The 2016 outbreak of the Zika arbovirus was associated with large numbers of cases of the newly-recognised Congenital Zika Syndrome (CZS). This novel teratogenic epidemic raises significant ethical and practical issues. Many of these arise from strategies used to avoid cases of CZS, with contraception in particular being one proposed strategy that is atypical in epidemic control. Using contraception to reduce the burden of CZS has an ethical complication: interventions that impact the timing of conception alter which people will exist in the future. This so-called non-identity problem' potentially has significant social justice implications for evaluating contraception, that may affect our prioritisation of interventions to tackle Zika. This paper combines ethical analysis of the non-identity problem with empirical data from a novel survey about the general public's moral intuitions. The ethical analysis examines different perspectives on the non-identity problem, and their implications for using contraception in response to Zika. The empirical section reports the results of an online survey of 93 members of the US general public exploring their intuitions about the non-identity problem in the context of the Zika epidemic. Respondents indicated a general preference for a person-affecting intervention (mosquito control) over an impersonal intervention (contraception). However, their responses did not appear to be strongly influenced by the non-identity problem. Despite its potential philosophical significance, we conclude from both theoretical considerations and analysis of the attitudes of the community that the non-identity problem should not affect how we prioritise contraception relative to other interventions to avoid CZS.
C1 [Wilkinson, Dominic J. C.] Univ Oxford, Oxford Uehiro Ctr Pract Eth, Oxford OX1 1PT, England.
   [Doolabh, Keyur] Monash Univ, Clayton, Vic, Australia.
   [Caviola, Lucius] Univ Oxford, Dept Expt Psychol, Social & Moral Psychol, Oxford, England.
   [Caviola, Lucius] Univ Oxford, Uehiro Ctr Pract Eth, Oxford, England.
   [Savulescu, Julian] Univ Oxford, Pract Eth, Oxford, England.
   [Savulescu, Julian] Oxford Uehiro Ctr Pract Eth, Fac Philosophy, Oxford, England.
   [Savulescu, Julian] Univ Oxford, Oxford Martin Sch, Oxford Martin Programme Collect Responsibil Infec, Oxford, England.
   [Savulescu, Julian] Interdisciplinary Wellcome Ctr Eth & Humanities C, Oxford, England.
   [Selgelid, Michael] Monash Univ, Bioeth Ctr, Clayton, Vic, Australia.
   [Wilkinson, Dominic J. C.] Univ Oxford, Oxford Uehiro Ctr Pract Eth, Med Eth, Oxford, England.
   [Wilkinson, Dominic J. C.] John Radcliffe Hosp, Newborn Intens Care, Oxford, England.
RP Wilkinson, DJC (corresponding author), Univ Oxford, Oxford Uehiro Ctr Pract Eth, Oxford OX1 1PT, England.
EM dominic.wilkinson@philosophy.ox.ac.uk
OI Caviola, Lucius/0000-0003-4302-5884; Wilkinson,
   Dominic/0000-0003-3958-8633; Savulescu, Julian/0000-0003-1691-6403;
   Selgelid, Michael/0000-0003-3496-2884
FU Wellcome TrustWellcome Trust [WT104848/Z/14/Z, WT106587/Z/14/]; Oxford
   Martin Programme on Collective Responsibility for Infectious Disease
FX Julian Savulescu was supported by Wellcome Trust grant WT104848/Z/14/Z
   and by the Oxford Martin Programme on Collective Responsibility for
   Infectious Disease.r Dominic Wilkinson was supported for this work by a
   grant from the Wellcome Trust WT106587/Z/14/.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   [Anonymous], 2016, FACT SHEET AB LAT AM
   Arrhenius G., 2005, ETHICAL PERSPECT, V10, P185, DOI DOI 10.2143/EP.10.3.503884
   Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862
   Bahamondes L, 2017, HUM REPROD, V32, P88, DOI 10.1093/humrep/dew310
   Beard S., 2016, CONVERSATION
   Beck J., 2016, ATLANTIC
   Bennett R, 2009, BIOETHICS, V23, P265, DOI 10.1111/j.1467-8519.2008.00655.x
   BIRDSALL NM, 1988, J POLICY MODEL, V10, P29, DOI 10.1016/0161-8938(88)90034-8
   Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3
   British Broadcasting Corporation, 2014, MOR CAS CONTR
   Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Chong A, 2013, EFFECTIVENESS SPILLO
   COSTA SH, 1993, LANCET, V341, P1258, DOI 10.1016/0140-6736(93)91156-G
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i630
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Faundes A, 1996, ADV CONTRACEPT, V12, P1, DOI 10.1007/BF01849540
   Fennell JL, 2011, GENDER SOC, V25, P496, DOI 10.1177/0891243211416113
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Harman E, 2009, INT LIBR ETH LAW NEW, V35, P137, DOI 10.1007/978-1-4020-5697-0_7
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hope T, 2012, AM J BIOETHICS, V12, P21, DOI 10.1080/15265161.2012.692432
   Jensen IP, 2000, BRIT J OBSTET GYNAEC, V107, P637, DOI 10.1111/j.1471-0528.2000.tb13306.x
   Kahane G, 2016, SACRIFICIAL HA UNPUB
   Langer A, 2016, STUD FAMILY PLANN, V47, P179, DOI 10.1111/j.1728-4465.2016.00058.x
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martinez ME, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002520
   Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6
   MCMAHAN J, 1998, RATIONAL COMMITMENT, P208
   Miller G, 2010, ECON J, V120, P709, DOI 10.1111/j.1468-0297.2009.02306.x
   Miller ME., 2016, INDEPENDENT
   NARVESON J, 1973, MONIST, V57, P62, DOI 10.5840/monist197357134
   Parfit D., 1984, REASONS PERSONS
   PARFIT DEREK, 1984, REASONS PERSONS, P358
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rawls J., 1971, THEORY JUSTICE
   ROENNEBERG T, 1990, J BIOL RHYTHM, V5, P195, DOI 10.1177/074873049000500303
   Savulescu J, 2001, BIOETHICS, V15, P413, DOI 10.1111/1467-8519.00251
   Sher G, 2005, PHILOS PUBLIC AFF, V33, P181, DOI 10.1111/j.1088-4963.2005.00029.x
   Shiffrin Seana Valentine, 1999, LEGAL THEORY, V5, P117, DOI DOI 10.1017/S1352325299052015
   THURN J, 1988, REV INFECT DIS, V10, P1005
   Ujiie M, LANCET, V383, P1460
   Velleman JD, 2008, PHILOS PUBLIC AFF, V36, P221, DOI 10.1111/j.1088-4963.2008.00139_1.x
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
NR 48
TC 1
Z9 1
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1471-8731
EI 1471-8847
J9 DEV WORLD BIOETH
JI Dev. World Bioeth.
PD DEC
PY 2017
VL 17
IS 3
BP 173
EP 204
DI 10.1111/dewb.12176
PG 32
WC Ethics; Medical Ethics
SC Social Sciences - Other Topics; Medical Ethics
GA FM4HP
UT WOS:000414975900006
PM 29130262
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Annamalai, AS
   Pattnaik, A
   Sahoo, BR
   Muthukrishnan, E
   Natarajan, SK
   Steffen, D
   Vu, HLX
   Delhon, G
   Osorio, FA
   Petro, TM
   Xiang, SH
   Pattnaik, AK
AF Annamalai, Arun S.
   Pattnaik, Aryamav
   Sahoo, Bikash R.
   Muthukrishnan, Ezhumalai
   Natarajan, Sathish Kumar
   Steffen, David
   Vu, Hiep L. X.
   Delhon, Gustavo
   Osorio, Fernando A.
   Petro, Thomas M.
   Xiang, Shi-Hua
   Pattnaik, Asit K.
TI Zika Virus Encoding Nonglycosylated Envelope Protein Is Attenuated and
   Defective in Neuroinvasion
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; E protein glycosylation; attenuation; neuroinvasion
ID N-LINKED GLYCOSYLATION; ENDOTHELIAL-CELLS; INFECTIVITY; PATHOGENESIS;
   EMERGENCE; BRAIN; MODEL
AB Zika virus (ZIKV), a mosquito-transmitted flavivirus responsible for sporadic outbreaks of mild and febrile illness in Africa and Asia, reemerged in the last decade causing serious human diseases, including microcephaly, congenital malformations, and Guillain-Barre syndrome. Although genomic and phylogenetic analyses suggest that genetic evolution may have led to the enhanced virulence of ZIKV, experimental evidence supporting the role of specific genetic changes in virulence is currently lacking. One sequence motif, VNDT, containing an N-linked glycosylation site in the envelope (E) protein, is polymorphic; it is absent in many of the African isolates but present in all isolates from the recent outbreaks. In the present study, we investigated the roles of this sequence motif and glycosylation of the E protein in the pathogenicity of ZIKV. We first constructed a stable full-length cDNA clone of ZIKV in a novel linear vector from which infectious virus was recovered. The recombinant ZIKV generated from the infectious clone, which contains the VNDT motif, is highly pathogenic and causes lethality in a mouse model. In contrast, recombinant viruses from which the VNDT motif is deleted or in which the N-linked glycosylation site is mutated by single-amino-acid substitution are highly attenuated and nonlethal. The mutant viruses replicate poorly in the brains of infected mice when inoculated subcutaneously but replicate well following intracranial inoculation. Our findings provide the first evidence that N-linked glycosylation of the E protein is an important determinant of ZIKV virulence and neuroinvasion.
   IMPORTANCE The recent emergence of Zika virus (ZIKV) in the Americas has caused major worldwide public health concern. The virus appears to have gained significant pathogenicity, causing serious human diseases, including microcephaly and Guillain-Barre syndrome. The factors responsible for the emergence of pathogenic ZIKV are not understood at this time, although genetic changes have been shown to facilitate virus transmission. All isolates from the recent outbreaks contain an N-linked glycosylation site within the viral envelope (E) protein, whereas many isolates of the African lineage virus lack this site. To elucidate the functional significance of glycosylation in ZIKV pathogenicity, recombinant ZIKVs from infectious clones with or without the glycan on the E protein were generated. ZIKVs lacking the glycan were highly attenuated for the ability to cause mortality in a mouse model and were severely compromised for neuroinvasion. Our studies suggest glycosylation of the E protein is an important factor contributing to ZIKV pathogenicity.
C1 [Annamalai, Arun S.; Pattnaik, Aryamav; Sahoo, Bikash R.; Steffen, David; Delhon, Gustavo; Osorio, Fernando A.; Xiang, Shi-Hua; Pattnaik, Asit K.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.
   [Muthukrishnan, Ezhumalai; Natarajan, Sathish Kumar] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE USA.
   [Vu, Hiep L. X.] Univ Nebraska, Dept Anim Sci, Lincoln, NE USA.
   [Vu, Hiep L. X.; Delhon, Gustavo; Osorio, Fernando A.; Petro, Thomas M.; Xiang, Shi-Hua; Pattnaik, Asit K.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA.
   [Petro, Thomas M.] Univ Nebraska Med Ctr, Dept Oral Biol, Lincoln, NE USA.
RP Pattnaik, AK (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.; Pattnaik, AK (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA.
EM apattnaik2@unl.edu
RI Annamalai, Arun Saravanakumar/AAB-7352-2020; Driemeier,
   David/H-3461-2012; Pattnaik, Asit K./X-1531-2019; Vu, Hiep/AAA-1655-2019
OI Annamalai, Arun Saravanakumar/0000-0002-4892-4291; Driemeier,
   David/0000-0003-3766-0654; Pattnaik, Asit K./0000-0002-9581-6787; Vu,
   Hiep/0000-0001-8084-4358; Pattnaik, Aryamav/0000-0002-8325-2216
FU University of Nebraska-Lincoln
FX The research was supported in part by funds from the University of
   Nebraska-Lincoln.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Ansari IH, 2006, J VIROL, V80, P3994, DOI 10.1128/JVI.80.8.3994-4004.2006
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chambers TJ, 1998, J GEN VIROL, V79, P2375, DOI 10.1099/0022-1317-79-10-2375
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Godiska R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1181
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   May M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161355
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   RICE C M, 1989, New Biologist, V1, P285
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 56
TC 37
Z9 38
U1 1
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2017
VL 91
IS 23
AR UNSP e01348-17
DI 10.1128/JVI.01348-17
PG 16
WC Virology
SC Virology
GA FM7VW
UT WOS:000415289800035
PM 28931684
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Eyre, NS
   Johnson, SM
   Eltahla, AA
   Aloi, M
   Aloia, AL
   McDevitt, CA
   Bull, RA
   Beard, MR
AF Eyre, Nicholas S.
   Johnson, Stephen M.
   Eltahla, Auda A.
   Aloi, Maria
   Aloia, Amanda L.
   McDevitt, Christopher A.
   Bull, Rowena A.
   Beard, Michael R.
TI Genome-Wide Mutagenesis of Dengue Virus Reveals Plasticity of the NS1
   Protein and Enables Generation of Infectious Tagged Reporter Viruses
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE dengue virus; NS1; mutagenesis; virus replication; virus assembly;
   electron microscopy
ID VIRAL-RNA REPLICATION; MONOCLONAL-ANTIBODIES; CAPSID PROTEIN; NS5A
   PROTEIN; ZIKA VIRUS; CELLS; OLIGOMERIZATION; SUGGESTS; 4A
AB Dengue virus (DENV) is a major global pathogen that causes significant morbidity and mortality in tropical and subtropical areas worldwide. An improved understanding of the regions within the DENV genome and its encoded proteins that are required for the virus replication cycle will expedite the development of urgently required therapeutics and vaccines. We subjected an infectious DENV genome to unbiased insertional mutagenesis and used next-generation sequencing to identify sites that tolerate 15-nucleotide insertions during the virus replication cycle in hepatic cell culture. This revealed that the regions within capsid, NS1, and the 3' untranslated region were the most tolerant of insertions. In contrast, prM-and NS2A-encoding regions were largely intolerant of insertions. Notably, the multifunctional NS1 protein readily tolerated insertions in regions within the Wing, connector, and beta-ladder domains with minimal effects on viral RNA replication and infectious virus production. Using this information, we generated infectious reporter viruses, including a variant encoding the APEX2 electron microscopy tag in NS1 that uniquely enabled high-resolution imaging of its localization to the surface and interior of viral replication vesicles. In addition, we generated a tagged virus bearing an mScarlet fluorescent protein insertion in NS1 that, despite an impact on fitness, enabled live cell imaging of NS1 localization and traffic in infected cells. Overall, this genomewide profile of DENV genome flexibility may be further dissected and exploited in reporter virus generation and antiviral strategies.
   IMPORTANCE Regions of genetic flexibility in viral genomes can be exploited in the generation of reporter virus tools and should arguably be avoided in antiviral drug and vaccine design. Here, we subjected the DENV genome to high-throughput insertional mutagenesis to identify regions of genetic flexibility and enable tagged reporter virus generation. In particular, the viral NS1 protein displayed remarkable tolerance of small insertions. This genetic flexibility enabled generation of several novel NS1-tagged reporter viruses, including an APEX2-tagged virus that we used in highresolution imaging of NS1 localization in infected cells by electron microscopy. For the first time, this analysis revealed the localization of NS1 within viral replication factories known as "vesicle packets" (VPs), in addition to its acknowledged localization to the luminal surface of these VPs. Together, this genetic profile of DENV may be further refined and exploited in the identification of antiviral targets and the generation of reporter virus tools.
C1 [Eyre, Nicholas S.; Johnson, Stephen M.; Aloi, Maria; McDevitt, Christopher A.; Beard, Michael R.] Univ Adelaide, Res Ctr Infect Dis, Sch Biol Sci, Adelaide, SA, Australia.
   [Eyre, Nicholas S.; Johnson, Stephen M.; Eltahla, Auda A.; Beard, Michael R.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia.
   [Eltahla, Auda A.; Bull, Rowena A.] UNSW, Kirby Inst, Sch Med Sci, Viral Immunol Syst Program, Sydney, NSW, Australia.
   [Aloia, Amanda L.] Flinders Univ S Australia, Cell Screen SA, Flinders Ctr Innovat Canc, Bedford Pk, SA, Australia.
   [Johnson, Stephen M.] Australian Wine Res Inst, Glen Osmond, SA, Australia.
   [Aloi, Maria] Monash Univ, Dept Microbiol, Clayton, Vic, Australia.
RP Eyre, NS; Beard, MR (corresponding author), Univ Adelaide, Res Ctr Infect Dis, Sch Biol Sci, Adelaide, SA, Australia.; Eyre, NS; Beard, MR (corresponding author), SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia.
EM nicholas.eyre@adelaide.edu.au; michael.beard@adelaide.edu.au
RI McDevitt, Christopher A./A-4940-2009; Beard, Michael/AAS-3477-2020
OI McDevitt, Christopher A./0000-0003-1596-4841; Beard,
   Michael/0000-0002-4106-1016; Bull, Rowena/0000-0002-9844-3744; Eyre,
   Nicholas/0000-0002-5424-7573
FU National Health and Medical Research Council (NHMRC)National Health and
   Medical Research Council of Australia [1027641, 1053206]; NHMRCNational
   Health and Medical Research Council of Australia [1130128, 1084706]
FX This study was funded by grants from the National Health and Medical
   Research Council (NHMRC) (1027641 and 1053206 to M.R.B.). A.A.E. and
   R.A.B. are supported by fellowships from the NHMRC (grants 1130128 and
   1084706, respectively). The funders had no role in study design, data
   collection and interpretation, or the decision to submit the work for
   publication.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13
   Clark DC, 2007, J GEN VIROL, V88, P1175, DOI 10.1099/vir.0.82609-0
   Deen J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002182
   Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753
   Eyre NS, 2017, VIROLOGY, V507, P20, DOI 10.1016/j.virol.2017.04.003
   Eyre NS, 2016, VIROLOGY, V491, P27, DOI 10.1016/j.virol.2016.01.018
   Eyre NS, 2014, J VIROL, V88, P3636, DOI 10.1128/JVI.02490-13
   Eyre NS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001130
   Feng SY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00494-8
   Fischl Wolfgang, 2013, Methods Mol Biol, V1030, P205, DOI 10.1007/978-1-62703-484-5_17
   Fulton BO, 2017, J VIROL, V91, DOI 10.1128/JVI.00698-17
   Fulton BO, 2015, CELL REP, V11, P1331, DOI 10.1016/j.celrep.2015.04.054
   Gebhard LG, 2016, J VIROL, V90, P5451, DOI 10.1128/JVI.00206-16
   Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478
   Heaton NS, 2013, P NATL ACAD SCI USA, V110, P20248, DOI 10.1073/pnas.1320524110
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Kamiyama D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11046
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lee CM, 2015, J VIROL, V89, P6171, DOI 10.1128/JVI.00546-15
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   O'Brien CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003629
   Qi HF, 2015, CURR OPIN VIROL, V14, P62, DOI 10.1016/j.coviro.2015.08.005
   Qi H, 2014, 2014 INTERNATIONAL CONFERENCE ON INFORMATION SCIENCE, ELECTRONICS AND ELECTRICAL ENGINEERING (ISEEE), VOLS 1-3, P10, DOI 10.1109/InfoSEEE.2014.6948057
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Remenyi R, 2014, MBIO, V5, DOI 10.1128/mBio.01469-14
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Stern O, 2013, J VIROL, V87, P4080, DOI 10.1128/JVI.01900-12
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Wu RH, 2015, J VIROL, V89, P4281, DOI 10.1128/JVI.03011-14
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
NR 51
TC 9
Z9 9
U1 0
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2017
VL 91
IS 23
AR UNSP e01455-17
DI 10.1128/JVI.01455-17
PG 25
WC Virology
SC Virology
GA FM7VW
UT WOS:000415289800042
PM 28956770
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Shipley, MM
   Mangold, CA
   Kuny, CV
   Szpara, ML
AF Shipley, Mackenzie M.
   Mangold, Colleen A.
   Kuny, Chad V.
   Szpara, Moriah L.
TI Differentiated Human SH-SY5Y Cells Provide a Reductionist Model of
   Herpes Simplex Virus 1 Neurotropism
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE neuron; virus; HSV-1; differentiation; infection; SH-SY5Y; SK-N-SH;
   cGAS; herpes simplex virus
ID LATENCY-ASSOCIATED TRANSCRIPT; HUMAN NEUROBLASTOMA-CELLS; JAPANESE
   ENCEPHALITIS-VIRUS; WEST-NILE-VIRUS; CASPASE-DEPENDENT PATHWAYS;
   VESICULAR STOMATITIS-VIRUS; HUMAN NEURONAL CELLS; IN-VITRO MODEL; TYPE-1
   LATENCY; RETINOIC ACID
AB Neuron-virus interactions that occur during herpes simplex virus (HSV) infection are not fully understood. Neurons are the site of lifelong latency and are a crucial target for long-term suppressive therapy or viral clearance. A reproducible neuronal model of human origin would facilitate studies of HSV and other neurotropic viruses. Current neuronal models in the herpesvirus field vary widely and have caveats, including incomplete differentiation, nonhuman origins, or the use of dividing cells that have neuropotential but lack neuronal morphology. In this study, we used a robust approach to differentiate human SH-SY5Y neuroblastoma cells over 2.5 weeks, producing a uniform population of mature human neuronal cells. We demonstrate that terminally differentiated SH-SY5Y cells have neuronal morphology and express proteins with subcellular localization indicative of mature neurons. These neuronal cells are able to support a productive HSV-1 infection, with kinetics and overall titers similar to those seen in undifferentiated SH-SY5Y cells and the related SK-N-SH cell line. However, terminally differentiated, neuronal SH-SY5Y cells release significantly less extracellular HSV-1 by 24 h postinfection (hpi), suggesting a unique neuronal response to viral infection. With this model, we are able to distinguish differences in neuronal spread between two strains of HSV-1. We also show expression of the antiviral protein cyclic GMP-AMP synthase (cGAS) in neuronal SH-SY5Y cells, which is the first demonstration of the presence of this protein in non-epithelial cells. These data provide a model for studying neuron-virus interactions at the single-cell level as well as via bulk biochemistry and will be advantageous for the study of neurotropic viruses in vitro.
   IMPORTANCE Herpes simplex virus (HSV) affects millions of people worldwide, causing painful oral and genital lesions, in addition to a multitude of more severe symptoms such as eye disease, neonatal infection, and, in rare cases, encephalitis. Presently, there is no cure available to treat those infected or prevent future transmission. Due to the ability of HSV to cause a persistent, lifelong infection in the peripheral nervous system, the virus remains within the host for life. To better understand the basis of virus-neuron interactions that allow HSV to persist within the host peripheral nervous system, improved neuronal models are required. Here we describe a cost-effective and scalable human neuronal model system that can be used to study many neurotropic viruses, such as HSV, Zika virus, dengue virus, and rabies virus.
C1 [Szpara, Moriah L.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.
   Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.
RP Szpara, ML (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.
EM moriah@psu.edu
RI Szpara, Moriah L./I-2287-2019
OI Szpara, Moriah L./0000-0001-9859-1678; Shipley,
   Mackenzie/0000-0002-7436-5622; Kuny, Chad/0000-0002-6199-6273
FU NIH-NIAID Virus Pathogens Resource (ViPR) Bioinformatics Resource
   Center; NIH-NIAID, an American Heart Association (AHA) [AI095384];
   Pennsylvania State University
FX This work was supported by the NIH-NIAID Virus Pathogens Resource (ViPR)
   Bioinformatics Resource Center (M.L.S.), NIH-NIAID Career Transition
   Award K22 (AI095384) (M.L.S.), an American Heart Association (AHA)
   postdoctoral grant (C.A.M.), and research startup funds from the
   Pennsylvania State University.
CR Ahmed M, 2002, J VIROL, V76, P717, DOI 10.1128/JVI.76.2.717-729.2002
   Allsopp TE, 2000, CELL DEATH DIFFER, V7, P984, DOI 10.1038/sj.cdd.4400733
   Antinone SE, 2010, J VIROL, V84, P1504, DOI 10.1128/JVI.02029-09
   Bardi G, 2006, J NEUROVIROL, V12, P211, DOI 10.1080/13550280600848373
   BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819
   Benetti L, 2006, J VIROL, V80, P3341, DOI 10.1128/JVI.80.7.3341-3348.2006
   BENOWITZ LI, 1987, TRENDS NEUROSCI, V10, P527, DOI 10.1016/0166-2236(87)90135-4
   BIEDLER JL, 1973, CANCER RES, V33, P2643
   Bloom DC, 2016, ADV VIRUS RES, V94, P53, DOI 10.1016/bs.aivir.2015.10.001
   Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428
   Bowen CD, 2016, VIROLOGY, V492, P179, DOI 10.1016/j.virol.2016.02.013
   BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1
   Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013
   Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855
   Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491
   Camarena V, 2010, CELL HOST MICROBE, V8, P320, DOI 10.1016/j.chom.2010.09.007
   CARBONE KM, 1993, J VIROL, V67, P1453, DOI 10.1128/JVI.67.3.1453-1460.1993
   Castorena KM, 2008, VIROLOGY, V372, P208, DOI 10.1016/j.virol.2007.10.025
   Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558
   Chen XX, 2014, VET MICROBIOL, V170, P48, DOI 10.1016/j.vetmic.2014.01.031
   Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985
   Cheshenko N, 2013, FASEB J, V27, P2584, DOI 10.1096/fj.12-220285
   Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001
   Cho HJ, 2014, MOL CELLS, V37, P518, DOI 10.14348/molcells.2014.0024
   Christensen J, 2013, J VIROL, V87, P13719, DOI 10.1128/JVI.02293-13
   Christensen J, 2011, J VIROL, V85, P8436, DOI 10.1128/JVI.00515-11
   Chuluunbaatar U, 2011, CELL CYCLE, V10, P2064, DOI 10.4161/cc.10.13.16242
   Constantinescu R, 2007, J NEURAL TRANSM-SUPP, P17
   Danaher RJ, 2008, ARCH VIROL, V153, P1335, DOI 10.1007/s00705-008-0122-x
   Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5
   De Chiara G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013989
   De Regge N, 2006, VET MICROBIOL, V113, P251, DOI 10.1016/j.vetmic.2005.11.004
   Dhanwani R, 2012, VIRUS RES, V163, P563, DOI 10.1016/j.virusres.2011.12.009
   Diner BA, 2015, MOL CELL PROTEOMICS, V14, P2341, DOI 10.1074/mcp.M114.047068
   DINGWELL KS, 1994, J VIROL, V68, P834, DOI 10.1128/JVI.68.2.834-845.1994
   DIX RD, 1983, INFECT IMMUN, V40, P103, DOI 10.1128/IAI.40.1.103-112.1983
   Dou JL, 2009, JPN J INFECT DIS, V62, P402
   Du XL, 2015, MOL MED REP, V12, P953, DOI 10.3892/mmr.2015.3482
   Elankumaran S, 2006, J VIROL, V80, P7522, DOI 10.1128/JVI.00241-06
   Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x
   FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0
   Galvan V, 1999, J VIROL, V73, P3219, DOI 10.1128/JVI.73.4.3219-3226.1999
   Galvan V, 1998, P NATL ACAD SCI USA, V95, P3931, DOI 10.1073/pnas.95.7.3931
   Gimenez-Cassina A, 2006, J NEUROSCI RES, V84, P755, DOI 10.1002/jnr.20976
   Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836
   Hamza MA, 2006, NEUROBIOL DIS, V24, P367, DOI 10.1016/j.nbd.2006.07.011
   Harle P, 2002, VIROLOGY, V293, P295, DOI 10.1006/viro.2001.1280
   HILL JM, 1987, CURR EYE RES, V6, P91, DOI 10.3109/02713688709020074
   Howard PW, 2013, J VIROL, V87, P403, DOI 10.1128/JVI.02465-12
   Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107
   Hu LJ, 2016, APMIS, V124, P140, DOI 10.1111/apm.12494
   Huang HI, 2016, PROTEOMICS, V16, P2351, DOI 10.1002/pmic.201600098
   Irwin DJ, 1999, J NEUROVIROL, V5, P485, DOI 10.3109/13550289909045377
   Ishida H, 2004, MICROBIOL IMMUNOL, V48, P277, DOI 10.1111/j.1348-0421.2004.tb03524.x
   Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320
   Jan JT, 2000, J VIROL, V74, P8680, DOI 10.1128/JVI.74.18.8680-8691.2000
   Jha HC, 2015, MBIO, V6, DOI 10.1128/mBio.01844-15
   Kang W, 2003, VIROLOGY, V312, P233, DOI 10.1016/S0042-6822(03)00201-0
   KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V
   Kastrukoff Lorne F, 2012, Herpesviridae, V3, P4, DOI 10.1186/2042-4280-3-4
   Kato A, 2014, J VIROL, V88, P7776, DOI 10.1128/JVI.00603-14
   Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105
   Khan MB, 2016, J NEUROVIROL, V22, P179, DOI 10.1007/s13365-015-0383-6
   Khodarev NN, 1999, P NATL ACAD SCI USA, V96, P12062, DOI 10.1073/pnas.96.21.12062
   Kim GN, 2015, J VIROL, V89, P6338, DOI 10.1128/JVI.00222-15
   Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08
   Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794
   Kobayashi M, 2012, JOVE-J VIS EXP, DOI 10.3791/3823
   Kobayashi M, 2012, GENE DEV, V26, P1527, DOI 10.1101/gad.190157.112
   Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976
   Laassri M, 2011, J MED VIROL, V83, P910, DOI 10.1002/jmv.22033
   Lafon M, 2005, J VIROL, V79, P15226, DOI 10.1128/JVI.79.24.15226-15237.2005
   Monique L, 2006, J MOL NEUROSCI, V29, P185, DOI 10.1385/JMN/29:03:185
   Lagunoff M, 1996, J VIROL, V70, P1810, DOI 10.1128/JVI.70.3.1810-1817.1996
   LAMONICA N, 1989, J VIROL, V63, P2357, DOI 10.1128/JVI.63.5.2357-2360.1989
   Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663
   Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040
   Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111
   Liu XQ, 2015, VIROLOGY, V479, P568, DOI 10.1016/j.virol.2015.02.040
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Luker KE, 2006, VIROLOGY, V347, P286, DOI 10.1016/j.virol.2005.12.016
   Lyman MG, 2009, J VIROL, V83, P6978, DOI 10.1128/JVI.00598-09
   Ma Z, 2016, CELL HOST MICROBE, V19, P150, DOI 10.1016/j.chom.2016.01.010
   Macdonald SJ, 2012, J VIROL, V86, P9540, DOI 10.1128/JVI.01469-12
   Maldonado H, 2008, BIOL RES, V41, P239, DOI [10.4067/S0716-97602008000300001, /S0716-97602008000300001]
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Markus A, 2011, J VIROL, V85, P6220, DOI 10.1128/JVI.02396-10
   Mattila RK, 2015, J GEN VIROL, V96, P2304, DOI 10.1099/vir.0.000138
   MCGEOCH DJ, 1994, J MOL BIOL, V238, P9, DOI 10.1006/jmbi.1994.1264
   Menachery VD, 2010, J VIROL, V84, P9685, DOI 10.1128/JVI.00706-10
   Negatsch A, 2011, J GEN VIROL, V92, P167, DOI 10.1099/vir.0.026484-0
   Nicola AV, 2005, J VIROL, V79, P7609, DOI 10.1128/JVI.79.12.7609-7616.2005
   Ninomiya K, 2009, VACCINE, V27, P6160, DOI 10.1016/j.vaccine.2009.08.020
   NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y
   Nowack A, 2010, AM J PHYSIOL-CELL PH, V299, pC960, DOI 10.1152/ajpcell.00259.2010
   Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047
   Orzalli MH, 2015, P NATL ACAD SCI USA, V112, pE1773, DOI 10.1073/pnas.1424637112
   Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109
   PAHLMAN S, 1995, EUR J CANCER, V31A, P453, DOI 10.1016/0959-8049(95)00033-F
   Pasieka TJ, 2008, J VIROL, V82, P5527, DOI 10.1128/JVI.02047-07
   Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7
   Peng FW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047572
   Peng WP, 2005, J VIROL, V79, P6162, DOI 10.1128/JVI.79.10.6162-6171.2005
   PEREIRA RA, 1994, J EXP MED, V180, P841, DOI 10.1084/jem.180.3.841
   Pourchet A, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6020024
   Prehaud C, 2003, J VIROL, V77, P10537, DOI 10.1128/JVI.77.19.10537-10547.2003
   Prehaud C, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000510
   Qiao JB, 2012, BIOCHEM BIOPH RES CO, V424, P421, DOI 10.1016/j.bbrc.2012.06.125
   Recio JA, 2000, FEBS LETT, V469, P118, DOI 10.1016/S0014-5793(00)01249-7
   Redwine JM, 2001, AM J PATHOL, V159, P1219, DOI 10.1016/S0002-9440(10)62507-2
   Roehm PC, 2011, LARYNGOSCOPE, V121, P2268, DOI 10.1002/lary.22035
   Roizman B, 2013, FIELDS VIROLOGY, V2, P1823
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sancho-Shimizu V, 2007, CURR OPIN ALLERGY CL, V7, P495, DOI 10.1097/ACI.0b013e3282f151d2
   Sasai M, 2013, INT REV IMMUNOL, V32, P116, DOI 10.3109/08830185.2013.774391
   Sawtell NM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005877
   Sawtell NM, 1998, J VIROL, V72, P5343, DOI 10.1128/JVI.72.7.5343-5350.1998
   Schamberger CJ, 2005, EXP CELL RES, V302, P115, DOI 10.1016/j.yexcr.2004.08.026
   SEDARATI F, 1987, J GEN VIROL, V68, P2389, DOI 10.1099/0022-1317-68-9-2389
   Seo GJ, 2015, CELL REP, V13, P440, DOI 10.1016/j.celrep.2015.09.007
   Shimada S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20213
   Shingai M, 2003, J GEN VIROL, V84, P2133, DOI 10.1099/vir.0.19091-0
   Shinohara T, 1997, VIROLOGY, V228, P269, DOI 10.1006/viro.1996.8409
   Shipley MM, 2016, JOVE-J VIS EXP, DOI 10.3791/53193
   Snyder A, 2006, J VIROL, V80, P11165, DOI 10.1128/JVI.01107-06
   Song BH, 2012, J MICROBIOL, V50, P698, DOI 10.1007/s12275-012-2336-6
   Starkey HDV, 2012, J MOL NEUROSCI, V48, P111, DOI 10.1007/s12031-012-9783-8
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Takamatsu Y, 2015, J GEN VIROL, V96, P2194, DOI 10.1099/vir.0.000168
   Takenouchi A, 2015, PEDIATR SURG INT, V31, P1151, DOI 10.1007/s00383-015-3784-y
   Tao JL, 2016, IUBMB LIFE, V68, P858, DOI 10.1002/iub.1566
   TEMONEN M, 1993, J GEN VIROL, V74, P515, DOI 10.1099/0022-1317-74-3-515
   Thomas DL, 2002, J VIROL, V76, P532, DOI 10.1128/JVI.76.2.532-540.2002
   Thompson MR, 2014, J BIOL CHEM, V289, P23568, DOI 10.1074/jbc.M114.554147
   Thompson RL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000352
   Thunuguntla P, 2017, VIRUS RES, V232, P1, DOI 10.1016/j.virusres.2017.01.011
   Tiwari V, 2010, J GEN VIROL, V91, P3002, DOI 10.1099/vir.0.024166-0
   TROUSDALE MD, 1991, J VIROL, V65, P6989, DOI 10.1128/JVI.65.12.6989-6993.1991
   Tung WH, 2011, J CELL PHYSIOL, V226, P3316, DOI 10.1002/jcp.22677
   VanGuilder HD, 2010, J NEUROCHEM, V113, P1577, DOI 10.1111/j.1471-4159.2010.06719.x
   VESANEN M, 1994, J GEN VIROL, V75, P201, DOI 10.1099/0022-1317-75-1-201
   Wang H, 2013, VIRUS RES, V173, P436, DOI 10.1016/j.virusres.2013.01.001
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002
   Whitley Richard J, 2015, Continuum (Minneap Minn), V21, P1704, DOI 10.1212/CON.0000000000000243
   Whitley RJ, 1998, CLIN INFECT DIS, V26, P541, DOI 10.1086/514600
   WIEDENMANN B, 1986, P NATL ACAD SCI USA, V83, P3500, DOI 10.1073/pnas.83.10.3500
   WILLIAMS LE, 1965, ARCH OPHTHALMOL-CHIC, V73, P112
   Wilson AC, 2012, TRENDS MICROBIOL, V20, P604, DOI 10.1016/j.tim.2012.08.005
   Wisner TW, 2011, J VIROL, V85, P5919, DOI 10.1128/JVI.00116-11
   Xiang YF, 2012, J VIROL, V86, P8440, DOI 10.1128/JVI.00609-12
   Xu K, 2014, J MOL NEUROSCI, V53, P78, DOI 10.1007/s12031-013-0199-x
   Xu LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076657
   Yaiw KC, 2008, ARCH VIROL, V153, P865, DOI 10.1007/s00705-008-0059-0
   Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x
   Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522
   Zhang SC, 2012, CANCER LETT, V325, P227, DOI 10.1016/j.canlet.2012.07.008
   Zhang XW, 2016, VIRUS RES, V213, P6, DOI 10.1016/j.virusres.2015.11.006
   Zhou GY, 2000, J VIROL, V74, P11782, DOI 10.1128/JVI.74.24.11782-11791.2000
   Zhu XH, 2009, TOXICOL APPL PHARM, V240, P286, DOI 10.1016/j.taap.2009.06.020
   Zhuo BB, 2013, TUMOR BIOL, V34, P2419, DOI 10.1007/s13277-013-0792-1
NR 161
TC 12
Z9 12
U1 0
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2017
VL 91
IS 23
AR UNSP e00958-17
DI 10.1128/JVI.00958-17
PG 19
WC Virology
SC Virology
GA FM7VW
UT WOS:000415289800009
PM 28956768
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Urakami, A
   Tun, MMN
   Moi, ML
   Sakurai, A
   Ishikawa, M
   Kuno, S
   Ueno, R
   Morita, K
   Akahata, W
AF Urakami, Akane
   Tun, Mya Myat Ngwe
   Moi, Meng Ling
   Sakurai, Atsuko
   Ishikawa, Momoko
   Kuno, Sachiko
   Ueno, Ryuji
   Morita, Kouichi
   Akahata, Wataru
TI An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has
   Implications for Flavivirus Vaccine Design
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE DNA vaccine; dengue virus; flavivirus; neutralizing antibodies; vaccine;
   virus-like particle; VLP; Zika virus
ID ANTIBODY-DEPENDENT ENHANCEMENT; WEST-NILE-VIRUS; JAPANESE
   ENCEPHALITIS-VIRUS; NEUTRALIZING ANTIBODIES; MEMBRANE-FUSION; INFECTION;
   TYPE-2; CELLS; GLYCOPROTEIN; IMMUNOGENICITY
AB Dengue viruses (DENV) infect 50 to 100 million people each year. The spread of DENV-associated infections is one of the most serious public health problems worldwide, as there is no widely available vaccine or specific therapeutic for DENV infections. To address this, we developed a novel tetravalent dengue vaccine by utilizing virus-like particles (VLPs). We created recombinant DENV1 to -4 (DENV1-4) VLPs by coexpressing precursor membrane (prM) and envelope (E) proteins, with an F108A mutation in the fusion loop structure of E to increase the production of VLPs in mammalian cells. Immunization with DENV1-4 VLPs as individual, monovalent vaccines elicited strong neutralization activity against each DENV serotype in mice. For use as a tetravalent vaccine, DENV1-4 VLPs elicited high levels of neutralization activity against all four serotypes simultaneously. The neutralization antibody responses induced by the VLPs were significantly higher than those with DNA or recombinant E protein immunization. Moreover, antibody-dependent enhancement (ADE) was not observed against any serotype at a 1: 10 serum dilution. We also demonstrated that the Zika virus (ZIKV) VLP production level was enhanced by introducing the same F108A mutation into the ZIKV envelope protein. Taken together, these results suggest that our strategy for DENV VLP production is applicable to other flavivirus VLP vaccine development, due to the similarity in viral structures, and they describe the promising development of an effective tetravalent vaccine against the prevalent flavivirus.
   IMPORTANCE Dengue virus poses one of the most serious public health problems worldwide, and the incidence of diseases caused by the virus has increased dramatically. Despite decades of effort, there is no effective treatment against dengue. A safe and potent vaccine against dengue is still needed. We developed a novel tetravalent dengue vaccine by using virus-like particles (VLPs), which are noninfectious because they lack the viral genome. Previous attempts of other groups to use dengue VLPs resulted in generally poor yields. We found that a critical amino acid mutation in the envelope protein enhances the production of VLPs. Our tetravalent vaccine elicited potent neutralizing antibody responses against all four DENV serotypes. Our findings can also be applied to vaccine development against other flaviviruses, such as Zika virus or West Nile virus.
C1 [Urakami, Akane; Sakurai, Atsuko; Ishikawa, Momoko; Kuno, Sachiko; Ueno, Ryuji; Akahata, Wataru] VLP Therapeut, Gaithersburg, MD 20878 USA.
   [Tun, Mya Myat Ngwe; Moi, Meng Ling; Morita, Kouichi] Nagasaki Univ, Inst Trop Med, Dept Virol, Nagasaki, Japan.
   [Ishikawa, Momoko] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Sendai, Miyagi, Japan.
RP Akahata, W (corresponding author), VLP Therapeut, Gaithersburg, MD 20878 USA.
EM wakahata@vlptherapeutics.com
FU VLP Therapeutics; Global Health Innovative Technology Fund [G2016-109]
FX This research was funded by VLP Therapeutics and a Global Health
   Innovative Technology Fund grant (grant G2016-109).
CR Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Akahata W, 2012, J VIROL, V86, P8879, DOI 10.1128/JVI.00370-12
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Bentsi-Enchill AD, 2013, VACCINE, V31, P2603, DOI 10.1016/j.vaccine.2013.03.038
   Bodles-Brakhop AM, 2009, MOL THER, V17, P585, DOI 10.1038/mt.2009.5
   Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381
   Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4
   Charoensri N, 2014, J VIROL METHODS, V205, P116, DOI 10.1016/j.jviromet.2014.04.019
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Durbin AP, 2011, VIRUSES-BASEL, V3, P1800, DOI 10.3390/v3101800
   Esposito DLA, 2015, J GEN VIROL, V96, P1702, DOI 10.1099/vir.0.000113
   Galula JU, 2014, J VIROL, V88, P10813, DOI 10.1128/JVI.00810-14
   Guy B, 2004, VACCINE, V22, P3563, DOI 10.1016/j.vaccine.2004.03.042
   Guy B., 2010, HUM VACCINES, V6, P9, DOI DOI 10.4161/HV.6.9
   Guy B, 2009, AM J TROP MED HYG, V80, P302, DOI 10.4269/ajtmh.2009.80.302
   Guzman MG, 2010, VIRUSES-BASEL, V2, P2649, DOI 10.3390/v2122649
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HAHN YS, 1988, VIROLOGY, V162, P167, DOI 10.1016/0042-6822(88)90406-0
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Hsieh SC, 2008, VIROLOGY, V374, P338, DOI 10.1016/j.virol.2007.12.041
   Inoue S, 2010, VECTOR-BORNE ZOONOT, V10, P143, DOI 10.1089/vbz.2008.0153
   Kelly EP, 2000, VACCINE, V18, P2549, DOI 10.1016/S0264-410X(00)00032-3
   Konishi E, 2002, VACCINE, V20, P1058, DOI 10.1016/S0264-410X(01)00446-7
   Konishi E, 2010, J VIROL METHODS, V163, P360, DOI 10.1016/j.jviromet.2009.10.026
   Koprowski H, 1998, Curr Top Microbiol Immunol, V226, pV
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuwahara M, 2010, CLIN VACCINE IMMUNOL, V17, P1560, DOI 10.1128/CVI.00087-10
   Liu Yan, 2014, BMC Microbiol, V14, P233, DOI 10.1186/s12866-014-0233-3
   Ludwig C, 2007, CURR OPIN BIOTECH, V18, P537, DOI 10.1016/j.copbio.2007.10.013
   Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Moi ML, 2014, ARCH VIROL, V159, P103, DOI 10.1007/s00705-013-1787-3
   Moi ML, 2013, T ROY SOC TROP MED H, V107, P51, DOI 10.1093/trstmh/trs007
   Tun MMN, 2013, J MED VIROL, V85, P1258, DOI 10.1002/jmv.23577
   Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7
   Ohtaki N, 2010, VACCINE, V28, P6588, DOI 10.1016/j.vaccine.2010.07.055
   Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Poddar A, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0280-y
   Purdy DE, 2005, VIROLOGY, V333, P239, DOI 10.1016/j.virol.2004.12.036
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   Rockstroh A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004218
   Rodriguez-Limas WA, 2013, CURR OPIN BIOTECH, V24, P1089, DOI 10.1016/j.copbio.2013.02.008
   Sanchez MD, 2007, VIROLOGY, V359, P336, DOI 10.1016/j.virol.2006.08.047
   Schmaljohn AL McClain D, 1996, MED MICROBIOLOGY
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sugrue RJ, 1997, J GEN VIROL, V78, P1861, DOI 10.1099/0022-1317-78-8-1861
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Tripathi L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01005
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   WHO, 2016, STAT VACC DEV
   Yacoub Sophie, 2016, F1000Res, V5, DOI 10.12688/f1000research.6233.1
   Zhang S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-333
NR 56
TC 18
Z9 19
U1 1
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2017
VL 91
IS 23
AR UNSP e01181-17
DI 10.1128/JVI.01181-17
PG 16
WC Virology
SC Virology
GA FM7VW
UT WOS:000415289800023
PM 28956764
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Weisblum, Y
   Oiknine-Djian, E
   Zakay-Rones, Z
   Vorontsov, O
   Haimov-Kochman, R
   Nevo, Y
   Stockheim, D
   Yagel, S
   Panet, A
   Wolf, DG
AF Weisblum, Yiska
   Oiknine-Djian, Esther
   Zakay-Rones, Zichria
   Vorontsov, Olesya
   Haimov-Kochman, Ronit
   Nevo, Yuval
   Stockheim, David
   Yagel, Simcha
   Panet, Amos
   Wolf, Dana G.
TI APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the
   Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE APOBEC; HCMV; antiviral cellular restrictions; congenital infection;
   decidua; intrinsic immunity; placental innate immunity; viral placental
   transmission
ID URACIL-DNA GLYCOSYLASE; SIMPLEX-VIRUS 1; IN-VIVO; HUMAN-PAPILLOMAVIRUS;
   CYTIDINE DEAMINASES; RESTRICTION FACTORS; GENE-EXPRESSION; ZIKA VIRUS;
   TRANSMISSION; REPLICATION
AB Human cytomegalovirus (HCMV) is the leading cause of congenital infection and is associated with a wide range of neurodevelopmental disabilities and intrauterine growth restriction. Yet our current understanding of the mechanisms modulating transplacental HCMV transmission is poor. The placenta, given its critical function in protecting the fetus, has evolved effective yet largely uncharacterized innate immune barriers against invading pathogens. Here we show that the intrinsic cellular restriction factor apolipoprotein B editing catalytic subunit-like 3A (APOBEC3A [A3A]) is profoundly upregulated following ex vivo HCMV infection in human decidual tissues-constituting the maternal aspect of the placenta. We directly demonstrated that A3A severely restricted HCMV replication upon controlled overexpression in epithelial cells, acting by a cytidine deamination mechanism to introduce hypermutations into the viral genome. Importantly, we further found that A3 editing of HCMV DNA occurs both ex vivo in HCMV-infected decidual organ cultures and in vivo in amniotic fluid samples obtained during natural congenital infection. Our results reveal a previously unexplored role for A3A as an innate anti-HCMV effector, activated by HCMV infection in the maternal-fetal interface. These findings pave the way to new insights into the potential impact of APOBEC proteins on HCMV pathogenesis.
   IMPORTANCE In view of the grave outcomes associated with congenital HCMV infection, there is an urgent need to better understand the innate mechanisms acting to limit transplacental viral transmission. Toward this goal, our findings reveal the role of the intrinsic cellular restriction factor A3A (which has never before been studied in the context of HCMV infection and vertical viral transmission) as a potent anti-HCMV innate barrier, activated by HCMV infection in the authentic tissues of the maternal-fetal interface. The detection of naturally occurring hypermutations in clinical amniotic fluid samples of congenitally infected fetuses further supports the idea of the occurrence of A3 editing of the viral genome in the setting of congenital HCMV infection. Given the widely differential tissue distribution characteristics and biological functions of the members of the A3 protein family, our findings should pave the way to future studies examining the potential impact of A3A as well as of other A3s on HCMV pathogenesis.
C1 [Weisblum, Yiska; Oiknine-Djian, Esther; Vorontsov, Olesya; Wolf, Dana G.] Hadassah Hebrew Univ, Med Ctr, Clin Virol Unit, Jerusalem, Israel.
   [Weisblum, Yiska; Oiknine-Djian, Esther; Zakay-Rones, Zichria; Vorontsov, Olesya; Panet, Amos] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Biochem, Jerusalem, Israel.
   [Weisblum, Yiska; Oiknine-Djian, Esther; Zakay-Rones, Zichria; Vorontsov, Olesya; Panet, Amos] Hebrew Univ Jerusalem, Fac Med, IMRIC, Chanock Ctr Virol, Jerusalem, Israel.
   [Weisblum, Yiska; Oiknine-Djian, Esther; Vorontsov, Olesya; Wolf, Dana G.] Hebrew Univ Jerusalem, Fac Med, IMRIC, Lautenberg Ctr Gen & Tumor Immunol, Jerusalem, Israel.
   [Haimov-Kochman, Ronit; Yagel, Simcha] Hadassah Hebrew Univ, Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel.
   [Nevo, Yuval] Hebrew Univ Jerusalem, I CORE Computat Ctr, Bioinformat Unit, Jerusalem, Israel.
   [Nevo, Yuval] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel.
   [Stockheim, David] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Tel Hashomer, Israel.
RP Wolf, DG (corresponding author), Hadassah Hebrew Univ, Med Ctr, Clin Virol Unit, Jerusalem, Israel.; Wolf, DG (corresponding author), Hebrew Univ Jerusalem, Fac Med, IMRIC, Lautenberg Ctr Gen & Tumor Immunol, Jerusalem, Israel.
EM dana.wolf@ekmd.huji.ac.il
FU Israel Science FoundationIsrael Science Foundation; European Union
   Seventh Framework ProgrammeEuropean Union (EU) [316655]; Israeli
   Ministry of Health
FX This work was supported by grants from the Israel Science Foundation,
   European Union Seventh Framework Programme 562 FP7/2012-2016 (grant
   agreement number 316655), and the Israeli Ministry of Health.
CR Arias JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00275
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221
   Blanco-Melo D, 2012, IMMUNITY, V37, P399, DOI 10.1016/j.immuni.2012.08.013
   Boehme KW, 2004, J VIROL, V78, P1202, DOI 10.1128/JVI.78.3.1202-1211.2004
   Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187
   Caval V, 2015, NUCLEIC ACIDS RES, V43, P9340, DOI 10.1093/nar/gkv935
   Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031
   Courcelle CT, 2001, J VIROL, V75, P7592, DOI 10.1128/JVI.75.16.7592-7601.2001
   Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767
   Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981
   Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295
   Fodil-Cornu N, 2008, CELL HOST MICROBE, V3, P59, DOI 10.1016/j.chom.2008.01.005
   Gee P, 2011, J VIROL, V85, P9726, DOI 10.1128/JVI.05288-11
   Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51
   Griffiths P, 2013, VACCINE, V31, pB197, DOI 10.1016/j.vaccine.2012.10.074
   Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012
   Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kitamura K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003361
   Knisbacher BA, 2016, TRENDS GENET, V32, P16, DOI 10.1016/j.tig.2015.10.005
   Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008
   Mocarski E, 2013, FIELDS VIROLOGY, P1960
   Nakaya Y, 2016, J VIROL, V90, P8005, DOI 10.1128/JVI.00973-16
   Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439
   Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11
   Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009
   Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1
   Richardson SR, 2014, ELIFE, V3, DOI 10.7554/eLife.02008
   Rossini G, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/607276
   Siriwardena SU, 2016, CHEM REV, V116, P12688, DOI 10.1021/acs.chemrev.6b00296
   Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744
   Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102
   Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0
   Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11
   Thielen BK, 2007, PLOS PATHOG, V3, P1320, DOI 10.1371/journal.ppat.0030135
   Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Underwood MR, 1998, J VIROL, V72, P717, DOI 10.1128/JVI.72.1.717-725.1998
   Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201
   Vieira VC, 2013, BIOMED RES INT, DOI 10.1155/2013/683095
   Warren CJ, 2015, J VIROL, V89, P688, DOI 10.1128/JVI.02383-14
   Weisblum Y, 2016, J VIROL
   Weisblum Y, 2015, VIROLOGY, V485, P289, DOI 10.1016/j.virol.2015.06.023
   Weisblum Y, 2014, SEMIN IMMUNOPATHOL, V36, P615, DOI 10.1007/s00281-014-0449-1
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   White EA, 2004, J VIROL, V78, P1817, DOI 10.1128/JVI.78.4.1817-1830.2004
   Wiegand HL, 2007, J VIROL, V81, P13694, DOI 10.1128/JVI.01646-07
   Wolf DG, 2001, P NATL ACAD SCI USA, V98, P1895, DOI 10.1073/pnas.98.4.1895
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200
   Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591
   Zhu H, 1998, P NATL ACAD SCI USA, V95, P14470, DOI 10.1073/pnas.95.24.14470
NR 55
TC 5
Z9 5
U1 0
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2017
VL 91
IS 23
AR UNSP e01296-17
DI 10.1128/JVI.01296-17
PG 13
WC Virology
SC Virology
GA FM7VW
UT WOS:000415289800030
PM 28956761
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Tsai, WY
   Youn, HH
   Brites, C
   Tsai, JJ
   Tyson, J
   Pedroso, C
   Drexler, JF
   Stone, M
   Simmons, G
   Busch, MP
   Lanteri, M
   Stramer, SL
   Balmaseda, A
   Harris, E
   Wang, WK
AF Tsai, Wen-Yang
   Youn, Han Ha
   Brites, Carlos
   Tsai, Jih-Jin
   Tyson, Jasmine
   Pedroso, Celia
   Drexler, Jan Felix
   Stone, Mars
   Simmons, Graham
   Busch, Michael P.
   Lanteri, Marion
   Stramer, Susan L.
   Balmaseda, Angel
   Harris, Eva
   Wang, Wei-Kung
TI Distinguishing Secondary Dengue Virus Infection From Zika Virus
   Infection With Previous Dengue by a Combination of 3 Simple Serological
   Tests
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; dengue virus; non-structural protein 1; serological test;
   cross-reactivity
ID HUMAN-ANTIBODY RESPONSES; CROSS-REACTIVITY; TRANSMISSION; DIAGNOSIS;
   SPECIFICITY; CHIKUNGUNYA; TECHNOLOGY; INFANTS; ASSAYS; ELISA
AB An algorithm is proposed to distinguish primary Zika virus (ZIKV), ZIKV with previous dengue virus (DENV), and secondary DENV infections, which is critical for understanding the epidemiology, pathogenesis, and complications of ZIKV in dengue-endemic regions.The explosive spread of Zika virus (ZIKV) and associated microcephaly present an urgent need for sensitive and specific serodiagnostic tests, particularly for pregnant women in dengue virus (DENV)-endemic regions. Recent reports of enhanced ZIKV replication by dengue-immune sera have raised concerns about the role of previous DENV infection on the risk and severity of microcephaly and other ZIKV complications.
   Enzyme-linked immunosorbent assays (ELISAs) based on ZIKV and DENV nonstructural protein 1 (NS1) were established to test acute, convalescent phase, and post-convalescent phase serum/plasma samples from reverse-transcription polymerase chain reaction-confirmed cases including 20 primary ZIKV, 25 ZIKV with previous DENV, 58 secondary DENV, and 16 primary DENV1 infections.
   ZIKV-NS1 immunoglobulin M (IgM) and immunoglobulin G (IgG) ELISAs combined can detect ZIKV infection with a sensitivity of 95% and specificity of 66.7%. The ZIKV-NS1 IgG cross-reactivity by samples from secondary DENV infection cases ranged from 66.7% to 28.1% (within 1 month to 1-2 years post-illness, respectively). Addition of DENV1-NS1 IgG ELISA can distinguish primary ZIKV infection; the ratio of absorbance of ZIKV-NS1 to DENV1-NS1 IgG ELISA can distinguish ZIKV with previous DENV and secondary DENV infections with a sensitivity of 87.5% and specificity of 81.3%. These findings were supported by analysis of sequential samples.
   An algorithm for ZIKV serodiagnosis based on 3 simple ELISAs is proposed to distinguish primary ZIKV, ZIKV with previous DENV, and secondary DENV infections; this could be applied to serodiagnosis for ZIKV, serosurveillance, and monitoring ZIKV infection during pregnancy to understand the epidemiology, pathogenesis, and complications of ZIKV in dengue-endemic regions.
C1 [Tsai, Wen-Yang; Youn, Han Ha; Tyson, Jasmine; Wang, Wei-Kung] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
   [Brites, Carlos; Pedroso, Celia] Univ Fed Bahia, Sch Med, Lab Infect Res, Salvador, BA, Brazil.
   [Tsai, Jih-Jin] Kaohsiung Med Univ Hosp, Div Infect Dis, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univ Hosp, Trop Med Ctr, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univ, Coll Med, Dept Med, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univ, Ctr Dengue Fever Control & Res, Kaohsiung, Taiwan.
   [Drexler, Jan Felix] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.
   [Drexler, Jan Felix] German Ctr Infect Res, Bonn Cologne, Germany.
   [Stone, Mars; Simmons, Graham; Busch, Michael P.; Lanteri, Marion] Blood Syst Res Inst, San Francisco, CA USA.
   [Simmons, Graham; Busch, Michael P.; Lanteri, Marion] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Stramer, Susan L.] Amer Red Cross, Sci Support Off, Gaithersburg, MD USA.
   [Balmaseda, Angel] Minist Hlth, Natl Ctr Diag & Reference, Natl Virol Lab, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Wang, WK (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, 651 Ilalo St,BSB 325E, Honolulu, HI 96813 USA.
EM wangwk@hawaii.edu
RI Simmons, Graham/G-3523-2012; amsalu, ribka/G-8780-2019
OI Simmons, Graham/0000-0002-9615-7023; Drexler, Jan
   Felix/0000-0002-3509-0232
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI110769-01, R01 AI099631,
   P01AI106695, U19 AI118610]; National Institute of General Medical
   Sciences, NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P20GM103516]; National Heart, Lung, and Blood
   Institute, NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [RC2HL101632, HHSN268201100001I]
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases, National Institutes of Health (NIH) (grant numbers
   R01AI110769-01 to W. K. W., R01 AI099631 to A. B., P01AI106695 and U19
   AI118610 to E. H.); the National Institute of General Medical Sciences,
   NIH (grant number P20GM103516 to R.Y.); and the National Heart, Lung,
   and Blood Institute, NIH (award number RC2HL101632 and contract number
   HHSN268201100001I).
CR Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Centers for Disease Control and Prevention, GUID US LAB TEST ZIK
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   FERNANDEZ RJ, 1990, MEM I OSWALDO CRUZ, V85, P347, DOI 10.1590/S0074-02761990000300012
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lai CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002451
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Paldanius M, 2003, CLIN DIAGN LAB IMMUN, V10, P8, DOI 10.1128/CDLI.10.1.8-12.2003
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15
   US Food and Drug Administration, 2016, ZIK VIR EM US AUTH S
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635
NR 40
TC 24
Z9 26
U1 0
U2 15
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD DEC 1
PY 2017
VL 65
IS 11
BP 1829
EP 1836
DI 10.1093/cid/cix672
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FM5NA
UT WOS:000415081300013
PM 29020159
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU van den Worm, L
   Khumalo, NP
AF van den Worm, Lerinza
   Khumalo, Nonhlanhla P.
TI Skin manifestations are common and associated with a higher prevalence
   of congenital abnormalities in Zika virus infection
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Letter
ID MALE SEXUAL TRANSMISSION; MACULAR ATROPHY; BRAZIL; TRAVELERS; SYMPTOMS;
   DISEASE; BORN
C1 [van den Worm, Lerinza; Khumalo, Nonhlanhla P.] Univ Cape Town, Groote Schuur Hosp, Div Dermatol, Cape Town, South Africa.
RP van den Worm, L (corresponding author), Univ Cape Town, Groote Schuur Hosp, Div Dermatol, Cape Town, South Africa.
EM lerinzavdworm@gmail.com
RI Khumalo, Nonhlanhla/AAA-8068-2020
OI Khumalo, Nonhlanhla/0000-0002-1686-1900
CR Andersen LK, 2017, INT J DERMATOL, V56, pe84, DOI 10.1111/ijd.13509
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardona-Cardona AF, 2016, J INFECT PUBLIC HEAL, V9, P372, DOI 10.1016/j.jiph.2016.03.001
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chen L, 2017, NEW ENGL J MED, V376, P400, DOI 10.1056/NEJMc1610614
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huang ASE, 2016, J FORMOS MED ASSOC, V115, P223, DOI 10.1016/j.jfma.2016.03.002
   Jimenez Corona Maria Eugenia, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053
   Journel I, 2017, MMWR-MORBID MORTAL W, V66, P172, DOI 10.15585/mmwr.mm6606a4
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pougnet L, 2016, ANN BIOL CLIN-PARIS, V74, P712, DOI 10.1684/abc.2016.1196
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Yadav S, 2016, J TRANSL INTERN MED, V4, P42, DOI 10.1515/jtim-2016-0009
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 62
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0011-9059
EI 1365-4632
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD DEC
PY 2017
VL 56
IS 12
BP 1470
EP 1473
DI 10.1111/ijd.13700
PG 4
WC Dermatology
SC Dermatology
GA FM4PX
UT WOS:000415003200032
PM 28737215
DA 2020-07-08
ER

PT J
AU Saarman, NP
   Gloria-Soria, A
   Anderson, EC
   Evans, BR
   Pless, E
   Cosme, LV
   Gonzalez-Acosta, C
   Kamgang, B
   Wesson, DM
   Powell, JR
AF Saarman, Norah P.
   Gloria-Soria, Andrea
   Anderson, Eric C.
   Evans, Benjamin R.
   Pless, Evlyn
   Cosme, Luciano V.
   Gonzalez-Acosta, Cassandra
   Kamgang, Basile
   Wesson, Dawn M.
   Powell, Jeffrey R.
TI Effective population sizes of a major vector of human diseases, Aedes
   aegypti
SO EVOLUTIONARY APPLICATIONS
LA English
DT Article
DE arbovirus; chikungunya; dengue; effective population size; genetic
   control; temporal sampling; yellow fever; Zika
ID MARK-RELEASE-RECAPTURE; ANOPHELES-GAMBIAE; N-E; DISPERSAL; MOSQUITO;
   SURVIVAL; DENGUE; POLYMORPHISM; QUEENSLAND; PROGRAM
AB The effective population size (N-e) is a fundamental parameter in population genetics that determines the relative strength of selection and random genetic drift, the effect of migration, levels of inbreeding, and linkage disequilibrium. In many cases where it has been estimated in animals, Ne is on the order of 10%-20% of the census size. In this study, we use 12 microsatellite markers and 14,888 single nucleotide polymorphisms (SNPs) to empirically estimate Ne in Aedes aegypti, the major vector of yellow fever, dengue, chikungunya, and Zika viruses. We used the method of temporal sampling to estimate Ne on a global dataset made up of 46 samples of Ae. aegypti that included multiple time points from 17 widely distributed geographic localities. Our Ne estimates for Ae. aegypti fell within a broad range (similar to 25-3,000) and averaged between 400 and 600 across all localities and time points sampled. Adult census size (N-c) estimates for this species range between one and five thousand, so the N-e/N-c ratio is about the same as for most animals. These Ne values are lower than estimates available for other insects and have important implications for the design of genetic control strategies to reduce the impact of this species of mosquito on human health.
C1 [Saarman, Norah P.; Gloria-Soria, Andrea; Evans, Benjamin R.; Pless, Evlyn; Cosme, Luciano V.; Powell, Jeffrey R.] Yale Univ, New Haven, CT USA.
   [Anderson, Eric C.] Natl Marine Fisheries Serv, Fisheries Ecol Div, Southwest Fisheries Sci Ctr, Santa Cruz, CA USA.
   [Anderson, Eric C.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.
   [Gonzalez-Acosta, Cassandra] Ctr Nacl Programas Prevent & Control Enfermedades, Ciudad De Mexico, Cdmx, Mexico.
   [Kamgang, Basile] Org Coordinat Lutte Endemies Afrique Cent, LSTM OCEAC Res Unit, Yaounde, Cameroon.
   [Wesson, Dawn M.] Tulane Univ, Dept Trop Med, New Orleans, LA 70118 USA.
RP Saarman, NP (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
EM norah.saarman@yale.edu
RI Gloria-Soria, Andrea/AAJ-3304-2020; Saarman, Norah P/H-4542-2019
OI Gloria-Soria, Andrea/0000-0002-5401-3988; Saarman, Norah
   P/0000-0001-8974-0301; Kamgang, Basile/0000-0002-8883-4557; Gonzalez
   Acosta, Cassandra/0000-0003-2682-908X; Evans,
   Benjamin/0000-0003-2069-4938
FU United States National Institute of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   AI101112]
FX United States National Institute of Health, Grant/Award Number: R01
   AI101112
CR Anderson EC, 2005, GENETICS, V170, P955, DOI 10.1534/genetics.104.038349
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616
   Christophers R, 1960, AEDES AEGYPTI YELLOW
   Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157
   DYE C, 1984, ECOL ENTOMOL, V9, P355, DOI 10.1111/j.1365-2311.1984.tb00859.x
   Endersby NM, 2011, J MED ENTOMOL, V48, P999, DOI 10.1603/ME10264
   Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196
   FELSENSTEIN J, 2005, PHYLIP PHYLOGENY INF
   FELSENSTEIN J, 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X
   Gloria-Soria A, 2016, MED VET ENTOMOL, V30, P235, DOI 10.1111/mve.12153
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x
   Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129
   Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x
   JORDE PE, 1995, GENETICS, V139, P1077
   Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481
   KRIMBAS CB, 1971, EVOLUTION, V25, P454, DOI 10.1111/j.1558-5646.1971.tb01904.x
   Lehmann T, 1998, MOL BIOL EVOL, V15, P264, DOI 10.1093/oxfordjournals.molbev.a025923
   Lounibos LP, 2003, WAG UR FRON, V2, P33
   Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403
   Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913
   Olson-Manning CF, 2012, NAT REV GENET, V13, P867, DOI 10.1038/nrg3322
   Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329
   Pless E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005718
   Powell JR, 2014, TRENDS PARASITOL, V30, P282, DOI 10.1016/j.pt.2014.04.005
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   R Development Core Team, 2013, R LANG ENV STAT COMP
   Rasic G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1230-6
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042
   TAYLOR CE, 1993, MED VET ENTOMOL, V7, P351, DOI 10.1111/j.1365-2915.1993.tb00704.x
   Toure YT, 1998, MED VET ENTOMOL, V12, P74, DOI 10.1046/j.1365-2915.1998.00071.x
   Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x
   WAPLES RS, 1989, GENETICS, V121, P379
NR 46
TC 12
Z9 12
U1 0
U2 31
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1752-4571
J9 EVOL APPL
JI Evol. Appl.
PD DEC
PY 2017
VL 10
IS 10
BP 1031
EP 1039
DI 10.1111/eva.12508
PG 9
WC Evolutionary Biology
SC Evolutionary Biology
GA FM4AD
UT WOS:000414952000007
PM 29151858
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU dos Santos, TP
   Cruz, OG
   da Silva, KAB
   de Castro, MG
   de Brito, AF
   Maspero, RC
   de Alcantra, R
   dos Santos, FB
   Honorio, NA
   Lourenco-de-Oliveira, R
AF dos Santos, Taissa Pereira
   Cruz, Oswaldo Gonsalvez
   Barbosa da Silva, Keli Antunes
   de Castro, Marcia Goncalves
   de Brito, Anielly Ferreira
   Maspero, Renato Cesar
   de Alcantra, Rosilene
   dos Santos, Flavia Barreto
   Honorio, Nildimar A.
   Lourenco-de-Oliveira, Ricardo
TI Dengue serotype circulation in natural populations of Aedes aegypti
SO ACTA TROPICA
LA English
DT Article
DE Dengue serotypes; Arbovirus detection; Infected mosquitoes
ID RIO-DE-JANEIRO; VIRUS TYPE-4; BRAZIL; SURVEILLANCE; CHIKUNGUNYA;
   INFECTION
AB Ae. aegypti is the main vector of dengue (DENV), Zika (ZIKV), and chikungunya (CHIKV) viruses. The transmission dynamics of these arboviruses, especially the arboviral circulation in the mosquito population during low and high transmission seasons in endemic areas are still poorly understood. We conducted an entomological survey to determine dengue infection rates in Ae. aegypti and Aedes albopictus. These collections were performed in 2012-2013 during a Rio de Janeiro epidemic, just before the introduction and spread of ZIKV and CHIKV in the city. MosquiTrap and BG-Sentinel traps were installed in three fixed and seven itinerant neighborhoods each month over ten months. Mosquitoes were in supernatants pools tested and individually confirmed for DENV infection using RT-PCR. A total of 3053 Aedes mosquitos were captured and Ae. aegypti was much more frequent (92.9%) than Ae. albopictus (6.8%). Ae. aegypti females accounted for 71.8% of captured mosquitoes by MosquitTrap (c) and were the only species found naturally infected with DENV (infection rate = 0.81%). Only one Ae. aegypti male, collected by BG-sentinel, was also tested positive for DENV. The peak of DENV-positive mosquitoes coincided the season of the highest incidence of human cases. The most common serotypes detected in mosquitoes were DENV-3 (24%) and DENV-1 (24%), followed by DENV-4 (20%), DENV-2 (8%) and DENV-1 plus DENV4 (4%), while 95% of laboratory-confirmed human infections in the period were due to DENV-4. These contrasting results suggest silent maintenance of DENV serotypes during the epidemics, reinforcing the importance of entomological and viral surveillance in endemic areas.
C1 [dos Santos, Taissa Pereira; Barbosa da Silva, Keli Antunes; de Castro, Marcia Goncalves; de Brito, Anielly Ferreira; Honorio, Nildimar A.; Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Cruz, Oswaldo Gonsalvez] Fundacao Oswaldo Cruz, Programa Computacao Cientif PROCC, Rio De Janeiro, RJ, Brazil.
   [Cruz, Oswaldo Gonsalvez; Maspero, Renato Cesar; de Alcantra, Rosilene] Secretaria Municipal Saude, Prefeiticra Municipal Rio De Janeiro, Rio De Janeiro, RJ, Brazil.
   [dos Santos, Flavia Barreto] Fiocruz MS, Nucleo Operat Sentinela Mosquitos Vetores Nosmov, Rio De Janeiro, RJ, Brazil.
   [Honorio, Nildimar A.] Fundacao Oswaldo Cruz, Lab Biol Mol Flavivirus, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
RP dos Santos, TP (corresponding author), Malad Infectieuses & Vecteurs Ecol Genet Evolut &, Montpellier, France.
EM tayssadnz@gmail.com
OI Santos, Flavia/0000-0002-1309-5366
FU CAPESCAPES; CSF/CNPq; FIOCRUZ/IOC; FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ); SMS/RJ
FX We thank the Cecilia Nicolai, Marcos Nunes Ferreira, Marcos Pinheiro,
   Claudia Codeco, Bruno Oliveira Mariano, Andiaria Ramos, Maycon Neves,
   Marcelo Celestino, Renato Carvalho, Marcelo Quintela for support. This
   work were financed by CAPES, CSF/CNPq, FIOCRUZ/IOC, FAPERJ, and SMS/RJ.
CR Bangs MJ, 2007, J MED ENTOMOL, V44, P163, DOI 10.1603/0022-2585(2007)44[163:PODVRI]2.0.CO;2
   Brasil P., 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004636
   Consoli RAGB, 1994, PRINCIPALS MOSQUITOS
   Conteville LC, 2016, MEM I OSWALDO CRUZ, V111, P347, DOI 10.1590/0074-02760160004
   de Castro MG, 2012, MEM I OSWALDO CRUZ, V107, P940, DOI 10.1590/S0074-02762012000700017
   de la Mora-Covarrubias A, 2010, SALUD PUBLICA MEXICO, V52, P127, DOI 10.1590/s0036-36342010000200004
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Lambrechts L, 2012, MEM I OSWALDO CRUZ, V107, P1080, DOI 10.1590/S0074-02762012000800022
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P799, DOI 10.1590/S0074-02762002000600009
   Ministerio da Saiide, 2011, REL SIT RIO JAN
   Nogueira R. M. R., 1990, MEM I O CRUZ
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Pena-Garcia V. H., 2016, INT J ENV RES PUB HE, V13, P1
   Perez-Castro R, 2016, MEM I OSWALDO CRUZ, V111, P233, DOI 10.1590/0074-02760150363
   Pessanha José Eduardo Marques, 2011, Rev. Soc. Bras. Med. Trop., V44, P103, DOI 10.1590/S0037-86822011000100023
NR 22
TC 5
Z9 5
U1 0
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD DEC
PY 2017
VL 176
BP 140
EP 143
DI 10.1016/j.actatropica.2017.07.014
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FK6IH
UT WOS:000413606800019
PM 28743449
OA Bronze
DA 2020-07-08
ER

PT J
AU Soares-da-Silva, J
   Queiros, SG
   de Aguiar, JS
   Viana, JL
   Neta, MDAV
   da Silva, MC
   Pinheiro, VCS
   Polanczyk, RA
   Carvalho-Zilse, GA
   Tadei, WP
AF Soares-da-Silva, Joelma
   Queiros, Silmara Gomes
   de Aguiar, Jessica S.
   Viana, Juliete L.
   Neta, Maria dos R. A. V.
   da Silva, Maria C.
   Pinheiro, Valeria C. S.
   Polanczyk, Ricardo A.
   Carvalho-Zilse, Gislene A.
   Tadei, Wanderli P.
TI Molecular characterization of the gene profile of Bacillus thuringiensis
   Berliner isolated from Brazilian ecosystems and showing pathogenic
   activity against mosquito larvae of medical importance
SO ACTA TROPICA
LA English
DT Article
DE Mosquitoes vectors; Biological control; Bacteria; Genes cry e cyt
ID DIPTERAN-SPECIFIC CRY; INSECTICIDAL ACTIVITY; AEDES-AEGYPTI; SUBSP
   ISRAELENSIS; CRY11AA TOXIN; STRAINS; LEPIDOPTERA; DIVERSITY; CULICIDAE;
   TOXICITY
AB The occurrence of Aedes aegypti, Culex quinquefasciatus, and mosquitoes of the genus Anopheles potentiate the spread of several diseases, such as dengue, Zika, chikungunya, urban yellow fever, filariasis, and malaria, a situation currently existing in Brazil and in Latin America. Control of the disease vectors is the most effective tool for containing the transmission of the pathogens causing these diseases, and the bacterium Bacillus thuringiensis var. israelensis has been widely used and has shown efficacy over many years. However, new B. thuringiensis (Bt) strains with different gene combinations should be sought for use as an alternative to Bti and to prevent the resistant insects selected. Aiming to identify diversity in the Bt in different Brazilian ecosystems and to assess the pathogenicity of this bacterium to larvae of Ae. aegypti, C. quinquefasciatus, and Anopheles darlingi, Bt strains were obtained from the Amazon, Caatinga (semi-arid region), and Cerrado (Brazilian savanna) biomes and tested in pathogenicity bioassays in third-instar larvae of Ae. aegypti under controlled conditions in the laboratory. The isolates with larvicidal activity to larvae of Ae. aegypti were used in bioassays with the larvae of C. quinquefasciatus and An. darlingi and characterized according to the presence of 14 cry genes (cry1, cry2, cry4, cry10, cry11, cry24, cry32, cry44Aa, cry1Ab, cry4Aa, cry4Ba, ctyl0Aa, cry11Aa, and cry11Ba), six cyt genes (cyt1, cyt2, cyt1Aa, cyt1Ab, cyt2Aa and cyt2Ba), and the chi gene. Four hundred strains of Bt were isolated: 244 from insects, 85 from Amazon soil, and 71 from the Caatinga biome. These strains, in addition to the 153 strains isolated from Cerrado soil and obtained from the Entomopathogenic Bacillus Bank of Maranhao, were tested in bioassays with Ae. aegypti larvae. A total of 37 (6.7%) strains showed larvicidal activity, with positive amplification of the cry, cyt, and chi genes. The most frequently amplified genes were cry4Aa and cry4Ba, both occurring in 59.4% in these strains, followed by cyt1Aa and cyt2Aa, with 56.7% and 48% occurrence, respectively. Twelve (2.2%) strains that presented 100% mortality within 24 h were used in bioassays to estimate the median lethal concentration (LC50) for Ae. aegypti larvae. Two strains (BtMA-690 and BtMA-1114) showed toxicity equal to that of the Bti standard strain, and the same LC50 value (0.003 mg/L) was recorded for the three bacteria after 48 h of exposure. Detection of the presence of the Bt strains that showed pathogenicity for mosquito larvae in the three biomes studied was possible. Therefore, these strains are promising for the control of insect vectors, particularly the BtMA-1114 strain, which presents a gene profile different from that of Bti but with the same toxic effect.
C1 [Soares-da-Silva, Joelma] Univ Fed Maranhao, Curso Ciencias Nat, Campus 7,Ave Dr Jose Anselmo 2008, BR-65400000 Codo, Maranhao, Brazil.
   [Soares-da-Silva, Joelma; Tadei, Wanderli P.] Inst Natl Pesquisas Amazonia, Lab Malaria & Dengue, Programa Posgrad Entomol, Ave Andre Arauljo 2936, BR-69067375 Manaus, Amazonas, Brazil.
   [Queiros, Silmara Gomes; de Aguiar, Jessica S.; Viana, Juliete L.; Neta, Maria dos R. A. V.; da Silva, Maria C.; Pinheiro, Valeria C. S.] Univ Estadual Maranhao, Ctr Estudos Super Caxias, Dept Quim & Biol, Lab Entomol Med, Praca Duque Caxias S-N, BR-65604380 Caxias, Maranhao, Brazil.
   [Polanczyk, Ricardo A.] Univ Estadual Paulista, Dept Fitossanidade, Lab Controls Microbiano Artropodes Praga, Via Acesso Paulo Donato Castelllane S-N, BR-14884900 Sao Paulo, Brazil.
   [Carvalho-Zilse, Gislene A.] Inst Nacl de Pesquisas da Amazonia, Grpo Pesquisas Abelhas, Programa Posgrad Entomol, Ave Andre Araujo 2936, BR-69067375 Manaus, Amazonas, Brazil.
RP Soares-da-Silva, J (corresponding author), Inst Nacl de Pesquisas da Amazonia, Lab Malaria & Dengue, Ave Andre Araujo 2936, BR-69067375 Manaus, Amazonas, Brazil.
EM joelmasoares12@gmail.com
RI Pinheiro, Valeria Cristina Soares/W-8389-2019; Tadei,
   Wanderli/N-4486-2018; Carvalho-Zilse, Gislene GACZ/M-2275-2013;
   Polanczyk, Ricardo/N-7237-2017
OI Tadei, Wanderli/0000-0002-0612-3285; Carvalho-Zilse, Gislene
   GACZ/0000-0003-1933-8899; LIMA VIANA, JULIETE/0000-0002-6008-3931;
   Polanczyk, Ricardo/0000-0003-0769-9902
FU Capes (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior)CAPES; FAPEMA (Fundagao de amparo a pesquisa do Maranhao)
FX To teachers Manoel Victor Franco Lemos and Janete Aparecida Desiderio,
   Departamento de Biologia Aplicada a Agropecuaria, UNESP/JABOTICABAL. To
   Capes (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and
   FAPEMA (Fundagao de amparo a pesquisa do Maranhao) Financial support for
   conducting the research.
CR Abulreesh HH, 2012, INDIAN J MICROBIOL, V52, P500, DOI 10.1007/s12088-012-0257-z
   ALVES S. B., 1998, CONTROLE MICROBIANO, P765
   Armengol G, 2007, J APPL MICROBIOL, V102, P77, DOI 10.1111/j.1365-2672.2006.03063.x
   Assaeedi ASA, 2011, AUST J CROP SCI, V5, P1185
   Ayres M., 2007, BIOESTAT VERSAO 5 3
   Ben-Dov E, 2014, TOXINS, V6, P1222, DOI 10.3390/toxins6041222
   Bernhard K, 1997, J INVERTEBR PATHOL, V70, P59, DOI 10.1006/jipa.1997.4669
   Bravo A, 1998, APPL ENVIRON MICROB, V64, P4965
   Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022
   Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006
   Campanini EB, 2012, BRAZ J BIOL, V72, P243, DOI 10.1590/S1519-69842012000200003
   Canton PE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2240-7
   CRICKMORE N, 1995, FEMS MICROBIOL LETT, V131, P249
   Crickmore N., 2017, FULL LIST DELTA ENDO
   da Costa JRV, 2010, NEOTROP ENTOMOL, V39, P757, DOI 10.1590/S1519-566X2010000500015
   Dias D. G. S., 2002, B PESQUI DES, P1340
   Djenane Z, 2017, TOXINS, V9, DOI 10.3390/toxins9040139
   Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026
   El-Kersh TA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1922-6
   Elleuch J, 2015, TOXICON, V104, P83, DOI 10.1016/j.toxicon.2015.07.337
   Elleuch J, 2015, J INVERTEBR PATHOL, V124, P90, DOI 10.1016/j.jip.2014.11.005
   Fatoretto JC, 2007, NEOTROP ENTOMOL, V36, P737, DOI 10.1590/S1519-566X2007000500015
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Finney D.T., 1971, PROBIT ANAL
   Gobatto V, 2010, BRAZ J BIOL, V70, P1039, DOI 10.1590/S1519-69842010000500018
   Gonzalez A, 2011, REV BIOL TROP, V59, P1007
   Habib M.E., 1998, CONTROLE MICROBIANO, P383
   Hernandez CS, 2005, J INVERTEBR PATHOL, V88, P8, DOI 10.1016/j.jip.2004.10.006
   Hondrio N. A., 2015, CAD SAUDE PUBLICA, V31, P906
   Ibarra JE, 2003, APPL ENVIRON MICROB, V69, P5269, DOI 10.1128/AEM.69.9.5269-5274.2003
   Jouzani GS, 2008, J IND MICROBIOL BIOT, V35, P83, DOI 10.1007/s10295-007-0269-6
   Juarez-Hernandez EO, 2015, J APPL MICROBIOL, V119, P1692, DOI 10.1111/jam.12962
   Jung YC, 1998, J INVERTEBR PATHOL, V71, P95, DOI 10.1006/jipa.1997.4697
   Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009
   LeOra Software Company, 2003, POLOPLUS PROB LOG AN
   Lin Y, 2004, BIOTECHNOL LETT, V26, P635, DOI 10.1023/B:BILE.0000023021.50213.ed
   [Ministerio da Sadde (MS) Brasil], 2016, SIT EP FIL LINF BRAS
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Ootani M. A., 2011, Journal of Biotechnology and Biodiversity, V2, P37
   Peralta C, 2017, TOXINS, V9, DOI 10.3390/toxins9010039
   Pereira E., 2013, BT RES, V4, P8
   Perez C, 2005, P NATL ACAD SCI USA, V102, P18303, DOI 10.1073/pnas.0505494102
   Pinto L. M. N., 2003, Braz. J. Biol., V63, P301, DOI 10.1590/S1519-69842003000200015
   Polanczyk R. A., 2004, Revista Brasileira de Agrociencia, V10, P209
   Praca LB, 2004, PESQUI AGROPECU BRAS, V39, P11, DOI 10.1590/S0100-204X2004000100002
   Rebollo MP, 2017, TRENDS PARASITOL, V33, P83, DOI 10.1016/j.pt.2016.09.009
   Reyaz AL, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0756-z
   Sampson MN, 1998, MICROBIOL-UK, V144, P2189, DOI 10.1099/00221287-144-8-2189
   Santos FP, 2012, ACTA TROP, V122, P64, DOI 10.1016/j.actatropica.2011.11.018
   Seixas G., 2017, PLOS NEG TROP DIS
   Silva MC, 2012, BIOCONTROL SCI TECHN, V22, P583, DOI 10.1080/09583157.2012.670802
   Silva S. F., 2002, ISOLAMENTO IDENTIFIC, V70, P1
   Siqueira A. M., 2017, RAISING RED FLAG MAL, V5
   Soares-da-Silvaa J, 2015, REV BRAS ENTOMOL, V59, P1, DOI 10.1016/j.rbe.2015.02.001
   Stalinski R, 2016, INFECT GENET EVOL, V44, P218, DOI 10.1016/j.meegid.2016.07.009
   Tadei WP, 2017, HYDROBIOLOGIA, V789, P179, DOI 10.1007/s10750-016-2960-y
   van Frankenhuyzen K, 2013, J INVERTEBR PATHOL, V114, P76, DOI 10.1016/j.jip.2013.05.010
   van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009
   Vidal-Quist JC, 2009, J MICROBIOL BIOTECHN, V19, P749, DOI 10.4014/jmb.0810.595
   *WHO, 2005, WHOCDSWHOPESGCDPP200
   WHO-World Health Organization, 2017, GLOB VECT C IN PRESS
   WORLD HEALTH ORGANIZATION, 1985, INF CONS DEV BAC SPH
   Xu CC, 2014, TOXINS, V6, P2732, DOI 10.3390/toxins6092732
   Yousten A A, 1984, Adv Biotechnol Processes, V3, P315
   Zhang Q.-H., 2016, INSECT SCI
NR 65
TC 2
Z9 3
U1 0
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD DEC
PY 2017
VL 176
BP 197
EP 205
DI 10.1016/j.actatropica.2017.08.006
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FK6IH
UT WOS:000413606800028
PM 28823909
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Wagar, ZL
   Tree, MO
   Mpoy, MC
   Conway, MJ
AF Wagar, Z. L.
   Tree, M. O.
   Mpoy, M. C.
   Conway, M. J.
TI Low density lipopolyprotein inhibits flavivirus acquisition in Aedes
   aegypti
SO INSECT MOLECULAR BIOLOGY
LA English
DT Article
DE dengue; cholesterol; aedes aegypti; entry; blood
ID ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS-INFECTION; ZIKA VIRUS;
   LIPOPROTEIN RECEPTOR; PERITROPHIC MATRIX; PROTEIN; TRANSMISSION;
   EXPRESSION; MOSQUITOS; FEVER
AB Aedes aegypti is the primary vector of a number of human pathogens including dengue virus (DENV) and Zika virus (ZIKV). Ae.aegypti acquires these viruses during the processing of bloodmeals obtained from an infected vertebrate host. Vertebrate blood contains a number of factors that have the potential to modify virus acquisition in the mosquito. Interestingly, low density lipopolyprotein (LDL) levels are decreased during severe DENV infection. Accordingly, we hypothesized that LDL is a modifiable factor that can influence flavivirus acquisition in the mosquito. We found that LDL is endocytosed by Ae.aegypti cells in a dynamin-dependent manner. LDL is also endocytosed by midgut epithelial cells and accumulates at the luminal midgut epithelium during bloodmeal digestion. Importantly, pretreatment with LDL, but not high density lipopolyprotein (HDL), significantly inhibited both DENV and ZIKV infection in vitro, and LDL inhibited ZIKV infection in vivo. This study identifies human LDL or bad cholesterol' as a modifiable factor that can inhibit flavivirus acquisition in Ae.aegypti. Identification of modifiable blood factors and critical cellular interactions that mediate pathogen acquisition may lead to novel strategies to disrupt the transmission cycle of vector-borne diseases.
C1 [Wagar, Z. L.; Tree, M. O.; Mpoy, M. C.; Conway, M. J.] Cent Michigan Univ, Coll Med, Foundat Sci, Mt Pleasant, MI 48859 USA.
RP Conway, MJ (corresponding author), Cent Michigan Univ, Coll Med, Foundat Sci, Mt Pleasant, MI 48859 USA.
EM michael.conway@cmich.edu
FU Central Michigan University College of Medicine
FX This work was supported through start-up funds from Central Michigan
   University College of Medicine. We thank Tonya Colpitts for kindly
   providing serum-inactivated human donor blood (The Blood Center, New
   Orleans, LA, USA) for our in vivo ZIKV infection.
CR Albecka A, 2012, HEPATOLOGY, V55, P998, DOI 10.1002/hep.25501
   Biswas HH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003904
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105
   Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941
   Conway MJ, 2014, ANNU REV VIROL, V1, P71, DOI 10.1146/annurev-virology-031413-085513
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Farrance CE, 2011, HUM VACCINES, V7, P191, DOI 10.4161/hv.7.0.14588
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897
   Fu Q, 2015, J MED ENTOMOL, V52, P1124, DOI 10.1093/jme/tjv101
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SB, 2016, TRAVEL MED INFECT DI, V14, P378, DOI 10.1016/j.tmaid.2016.06.005
   Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559
   Kato N, 2008, VECTOR-BORNE ZOONOT, V8, P701, DOI 10.1089/vbz.2007.0270
   Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu SF, 2012, HEPATOLOGY, V56, P484, DOI 10.1002/hep.25665
   Londono-Renteria B, 2016, J MED ENTOMOL, V53, P505, DOI 10.1093/jme/tjw003
   Londono-Renteria B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005202
   Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002
   Mathias DK, 2012, INFECT IMMUN, V80, P1606, DOI 10.1128/IAI.06212-11
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miyata T, 2011, VACCINE, V29, P2720, DOI 10.1016/j.vaccine.2011.01.083
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seet RCS, 2009, FREE RADICAL BIO MED, V47, P375, DOI 10.1016/j.freeradbiomed.2009.04.035
   Soto-Acosta R, 2013, VIROLOGY, V442, P132, DOI 10.1016/j.virol.2013.04.003
   Syed GH, 2014, J VIROL, V88, P2519, DOI 10.1128/JVI.02727-13
   Troupin A, 2016, BBA-GEN SUBJECTS, V1860, P1898, DOI 10.1016/j.bbagen.2016.05.033
NR 34
TC 5
Z9 5
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1075
EI 1365-2583
J9 INSECT MOL BIOL
JI Insect Mol. Biol.
PD DEC
PY 2017
VL 26
IS 6
BP 734
EP 742
DI 10.1111/imb.12334
PG 9
WC Biochemistry & Molecular Biology; Entomology
SC Biochemistry & Molecular Biology; Entomology
GA FL8IO
UT WOS:000414493700007
PM 28718976
OA Bronze
DA 2020-07-08
ER

PT J
AU Shaw, R
   Simmons, M
   Nelson, C
   Bachelor, B
   Adamian, S
   Frausto, A
AF Shaw, Rebecca
   Simmons, Michaela
   Nelson, Corrine
   Bachelor, Brooke
   Adamian, Shant
   Frausto, Ana
TI Unmet contraceptive needs in rural communities in the Dominican Republic
   during an international Zika virus outbreak
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Editorial Material
DE Contraception; Dominican Republic; Family planning; Long-acting
   reversible contraception; Zika virus
C1 [Shaw, Rebecca] Des Moines Univ, Div Obstet & Gynecol, Dept Specialty Med, Des Moines, IA 50312 USA.
   [Simmons, Michaela; Nelson, Corrine; Bachelor, Brooke; Adamian, Shant] Des Moines Univ, Des Moines, IA USA.
   [Frausto, Ana] Timmy Global Hlth, Monte Cristi, Dominican Rep.
RP Shaw, R (corresponding author), Des Moines Univ, Div Obstet & Gynecol, Dept Specialty Med, Des Moines, IA 50312 USA.
EM rebecca.shaw@dmu.edu
FU Des Moines University
FX We thank Veronica Bucher (Peace Corps Volunteer, Dominican Republic),
   Amanda Buck (Des Moines University), Megan Elsenheimer (Des Moines
   University), Felix Gallagher (Drake University, Des Moines, IA, USA),
   Rebecca Grainger (Peace Corps Volunteer, Dominican Republic), Jeffrey
   Gray (Des Moines University), Elizabeth Baker (Des Moines University),
   and Yogesh Shah (Broadlawns Medical Center, Des Moines, IA, USA).
   Medical professionals' travel expenses were paid by Des Moines
   University for the purposes of providing medical services to community
   members; the funding was not related to the present study.
CR de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Lyon J, 2016, JAMA-J AM MED ASSOC, V316, P1246, DOI 10.1001/jama.2016.11054
   Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855
NR 3
TC 3
Z9 3
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD DEC
PY 2017
VL 139
IS 3
BP 370
EP 371
DI 10.1002/ijgo.12258
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FL8CS
UT WOS:000414478000021
PM 28696532
DA 2020-07-08
ER

PT J
AU Campos, R
   Araujo, M
AF Campos, Rita
   Araujo, Magnolia
TI Traditional Artistic Expressions in Science Communication in a
   Globalized World: Contributions From an Exploratory Project Developed in
   Northeast Brazil
SO SCIENCE COMMUNICATION
LA English
DT Article
DE traditional artistic expressions; cultural identity; science
   communication; informal learning; public engagement
ID ZIKA VIRUS; TRANSMISSION; DENGUE
AB Science communication projects share one main goal: to bring together academia and society. However, despite the several formats used to make this bridge, traditional artistic expressionsthose that are part of the cultural identity of a groupare seldom used. These formats can be particularly relevant in a globalized world where people from different social and cultural backgrounds meet. We present a project developed in Brazil that used a traditional type of theatre and literature to engage the public in a health control program, and reflect on the potentialities of these formats to communicate science in our multicultural societies.
C1 [Campos, Rita] Univ Porto, CIBIO InBIO, Vairao, Portugal.
   [Campos, Rita] Univ Coimbra, CES, Coimbra, Portugal.
   [Araujo, Magnolia] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
RP Campos, R (corresponding author), Ctr Invest Biodiversidade & Recursos Genet Rede I, Associate Lab CIBIO InBIO, Campus Agr Vairao, P-4485661 Vairao, Portugal.; Campos, R (corresponding author), Univ Coimbra, Ctr Estudos Sociais, Colegio S Jeronimo, Apartado 3087, P-3000995 Coimbra, Portugal.
EM rita.ml.campos@gmail.com
RI Campos, Rita/T-3575-2017
OI Campos, Rita/0000-0003-4184-3269; Araujo, Magnolia/0000-0001-8811-7921
FU POCH-Programa Operacional Capital Humano and funds from European Social
   Fund; Portuguese Ministerio da Ciencia, Tecnologia e Ensino Superior via
   Fundacao para a Ciencia e a Tecnologia Grant [SFRH/BPD/110348/2015]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: RC is
   supported by POCH-Programa Operacional Capital Humano and funds from the
   European Social Fund and the Portuguese Ministerio da Ciencia,
   Tecnologia e Ensino Superior, via Fundacao para a Ciencia e a Tecnologia
   (Grant SFRH/BPD/110348/2015).
CR Almeida Carla, 2016, Bakhtiniana, Rev. Estud. Discurso, V11, P5, DOI 10.1590/2176-457324278
   AssuncAo A. M. S., 2016, MEDIACAO CULTURAL, P15
   Bucchi M., 2014, HDB PUBLIC COMMUNICA
   Bultitude K, 2012, INT J SCI EDUC, V34, P2775, DOI 10.1080/09500693.2012.664293
   Campos R., 2013, EVOLUTION ED OUTREAC, V6, P25, DOI [10.1186/1936-6434-6-25, DOI 10.1186/1936-6434-6-25]
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CASCUDO L. da C, 2012, DICIONARIO FOLCLORE
   Catenacci V., 2005, SAO PAULO PERSPECT, V15, P2
   Chilvers J, 2013, SCI COMMUN, V35, P283, DOI 10.1177/1075547012454598
   Elias de Castro E, 2015, RESGATE REV INTERDIS, V23, P69
   Gunderson L., 2006, SCI PLAYS COME AGE
   Hoberg EP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0553
   Horst M., 2011, ETNOGRAFICA, V20, P1
   Horst M., 2011, SCI CULTURE, V20, P1
   Kahan D, 2010, NATURE, V463, P296, DOI 10.1038/463296a
   Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   McGillion C, 2017, SCI COMMUN, V39, P278, DOI 10.1177/1075547017696164
   Moreira Ildeu de Castro, 2006, Hist. cienc. saude-Manguinhos, V13, P291, DOI 10.1590/S0104-59702006000500018
   Moreira Leonardo Maciel, 2015, Ciênc. educ. (Bauru), V21, P511, DOI 10.1590/1516-731320150020015
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oliveira E. V. S., 2014, SCI PLENA, V10, P1
   Pagliuca Lorita Marlena Freitag, 2007, Texto contexto - enferm., V16, P662, DOI 10.1590/S0104-07072007000400010
   Pinto B., 2013, PUBLIC UNDERST SCI, V24, P776
   ROCHA Gilmar, 2009, MEDIACOES REV CIENCI, V14, P218
   Sa-Pinto X, 2017, AM BIOL TEACH, V79, P135, DOI 10.1525/abt.2017.79.2.135
   Sala O.E., 2012, BIODIVERSITY CHANGE
   Sardo AM, 2016, SCI COMMUN, V38, P251, DOI 10.1177/1075547016632537
   Sinatra GM, 2014, EDUC PSYCHOL HANDB, P415
   Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80
   Spiegel AN, 2013, RES SCI EDUC, V43, P2309, DOI 10.1007/s11165-013-9358-x
   Stearns SC, 2010, P NATL ACAD SCI USA, V107, P1691, DOI 10.1073/pnas.0914475107
   Tatalovic M, 2009, JCOM-J SCI COMMUN, V8, DOI 10.22323/2.08040202
   Varela Amaral S., 2015, PLOS ONE, V10
   Vila J., 2013, LIVRO EVOLUCAO, P111
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 37
TC 2
Z9 2
U1 2
U2 16
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1075-5470
EI 1552-8545
J9 SCI COMMUN
JI Sci. Commun.
PD DEC
PY 2017
VL 39
IS 6
BP 798
EP 809
DI 10.1177/1075547017721204
PG 12
WC Communication
SC Communication
GA FL8LT
UT WOS:000414502000006
DA 2020-07-08
ER

PT J
AU Reveiz, L
   Haby, MM
   Martinez-Vega, R
   Pinzon-Flores, CE
   Elias, V
   Smith, E
   Pinart, M
   Broutet, N
   Becerra-Posada, F
   Aldighieri, S
   Van Kerkhove, MD
AF Reveiz, Ludovic
   Haby, Michelle M.
   Martinez-Vega, Ruth
   Pinzon-Flores, Carlos E.
   Elias, Vanessa
   Smith, Emma
   Pinart, Mariona
   Broutet, Nathalie
   Becerra-Posada, Francisco
   Aldighieri, Sylvain
   Van Kerkhove, Maria D.
TI Risk of bias and confounding of observational studies of Zika virus
   infection: A scoping review of research protocols (vol 12, e0180220,
   2017)
SO PLOS ONE
LA English
DT Correction
RI Martinez-Vega, Ruth/AAD-3601-2019
OI Martinez-Vega, Ruth/0000-0002-6477-334X; Haby,
   Michelle/0000-0001-6203-9195
CR Reveiz L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180220
NR 1
TC 0
Z9 0
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 30
PY 2017
VL 12
IS 11
AR e0189027
DI 10.1371/journal.pone.0189027
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FO4UI
UT WOS:000416841900194
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Slomnicki, LP
   Chung, DH
   Parker, A
   Hermann, T
   Boyd, NL
   Hetman, M
AF Slomnicki, Lukasz P.
   Chung, Dong-Hoon
   Parker, Austin
   Hermann, Taylor
   Boyd, Nolan L.
   Hetman, Michal
TI Ribosomal stress and Tp53-mediated neuronal apoptosis in response to
   capsid protein of the Zika virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SYNTHASE KINASE-3-BETA-INDUCED APOPTOSIS; NUCLEAR-LOCALIZATION SIGNAL;
   POLYMERASE-I TRANSCRIPTION; UPSTREAM BINDING-FACTOR; NEURAL STEM-CELLS;
   DENGUE VIRUS; ENCEPHALITIS-VIRUS; VIRAL REPLICATION; CORE PROTEIN;
   REVEALS CHANGES
AB We report here that in rat and human neuroprogenitor cells as well as rat embryonic cortical neurons Zika virus (ZIKV) infection leads to ribosomal stress that is characterized by structural disruption of the nucleolus. The anti-nucleolar effects were most pronounced in postmitotic neurons. Moreover, in the latter system, nucleolar presence of ZIKV capsid protein (ZIKV-C) was associated with ribosomal stress and apoptosis. Deletion of 22 C-terminal residues of ZIKV-C prevented nucleolar localization, ribosomal stress and apoptosis. Consistent with a casual relationship between ZIKV-C-induced ribosomal stress and apoptosis, ZIKV-C-overexpressing neurons were protected by loss-of-function manipulations targeting the ribosomal stress effector Tp53 or knockdown of the ribosomal stress mediator RPL11. Finally, capsid protein of Dengue virus, but not West Nile virus, induced ribosomal stress and apoptosis. Thus, anti-nucleolar and pro-apoptotic effects of protein C are flavivirus-species specific. In the case of ZIKV, capsid protein-mediated ribosomal stress may contribute to neuronal death, neurodevelopmental disruption and microcephaly.
C1 [Slomnicki, Lukasz P.; Parker, Austin; Hermann, Taylor; Hetman, Michal] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA.
   [Slomnicki, Lukasz P.; Parker, Austin; Hermann, Taylor; Hetman, Michal] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA.
   [Hetman, Michal] Univ Louisville, Pharmacol & Toxicol, Louisville, KY 40292 USA.
   [Chung, Dong-Hoon] Univ Louisville, Ctr Predict Med, Louisville, KY 40292 USA.
   [Chung, Dong-Hoon] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA.
   [Boyd, Nolan L.] Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA.
   [Boyd, Nolan L.] Univ Louisville, Dept Physiol, Louisville, KY 40292 USA.
RP Hetman, M (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA.; Hetman, M (corresponding author), Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA.; Hetman, M (corresponding author), Univ Louisville, Pharmacol & Toxicol, Louisville, KY 40292 USA.
EM michal.hetman@louisville.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [8P30GM103507, 5R01AI118814]; UofL
   Executive Vice-President for Research office; Commonwealth of Kentucky
   Challenge for Excellence Fund; Center for Predictive Medicine from
   University of Louisiville; Jewish Heritage Fund for Excellence
FX This work was supported by NIH (8P30GM103507 to MH, 5R01AI118814 to DC),
   intramural research grant-II from UofL Executive Vice-President for
   Research office (MH), the Commonwealth of Kentucky Challenge for
   Excellence Fund (MH), intramural research grant from Center for
   Predictive Medicine from University of Louisiville (DC), and, The Jewish
   Heritage Fund for Excellence (NLB). The authors wish to thank Ms.
   Jing-Juan Zheng, Mr. Robert Adcock and Dr. Shivani Naik for excellent
   technical assistance and Dr. Steven R. Ellis for inspiring discussions.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057
   Balinsky CA, 2013, J VIROL, V87, P13094, DOI 10.1128/JVI.00704-13
   Banerjee R, 2005, J GEN VIROL, V86, P2315, DOI 10.1099/vir.0.80817-0
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Chung D., 2010, PROBE REPORTS NIH MO
   Chung DH, 2010, MOLECULES, V15, P1690, DOI 10.3390/molecules15031690
   Chung DH, 2016, ANTIMICROB AGENTS CH, V60, P4552, DOI 10.1128/AAC.00282-16
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Donati G, 2013, CELL REP, V4, P87, DOI 10.1016/j.celrep.2013.05.045
   Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844
   Duan ZQ, 2014, VIROLOGY, V452, P212, DOI 10.1016/j.virol.2014.01.011
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   Emmott E, 2010, J PROTEOME RES, V9, P5335, DOI 10.1021/pr100593g
   Emmott E, 2010, MOL CELL PROTEOMICS, V9, P1920, DOI 10.1074/mcp.M900345-MCP200
   Enzmann V, 2003, INVEST OPHTH VIS SCI, V44, P5417, DOI 10.1167/iovs.03-0468
   Fischl W, 2011, CURR OPIN MICROBIOL, V14, P470, DOI 10.1016/j.mib.2011.07.012
   Fraser JE, 2016, J VIROL, V90, P5797, DOI 10.1128/JVI.02727-15
   Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112
   FREGIEN N, 1986, GENE, V48, P1, DOI 10.1016/0378-1119(86)90346-X
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Gomes C, 2011, J BIOL CHEM, V286, P4357, DOI 10.1074/jbc.M110.170134
   Gouzil J, 2017, J VIROL, V91, DOI [10.1128/JVI.01263-16, 10.1128/jvi.01263-16]
   Habas A, 2006, J NEUROCHEM, V96, P335, DOI 10.1111/j.1471-4159.2005.03543.x
   Hetman M, 2002, J BIOL CHEM, V277, P49577, DOI 10.1074/jbc.M111227200
   Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x
   Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006
   Kim TH, 2014, ONCOTARGET, V5, P860, DOI 10.18632/oncotarget.1784
   Kleinschmidt-DeMasters BK, 2015, BRAIN PATHOL, V25, P625, DOI 10.1111/bpa.12280
   Lawrence FJ, 2006, J CELL SCI, V119, P2621, DOI 10.1242/jcs.02982
   Lee C, 2006, VIROLOGY, V346, P238, DOI 10.1016/j.virol.2005.11.005
   Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Mao HQ, 2015, J NEUROSCI, V35, P7003, DOI 10.1523/JNEUROSCI.0018-15.2015
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mitrea DM, 2016, ELIFE, V5, DOI 10.7554/eLife.13571
   Mlera L, 2014, PATHOG DIS, V71, P135, DOI 10.1111/2049-632X.12178
   Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005
   Musinova YR, 2015, BBA-MOL CELL RES, V1853, P101, DOI 10.1016/j.bbamcr.2014.10.007
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nishimura K, 2015, CELL REP, V10, P1310, DOI 10.1016/j.celrep.2015.01.055
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008
   Payne LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108257
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rawlinson SM, 2015, CELL MICROBIOL, V17, P1108, DOI 10.1111/cmi.12465
   Raychaudhuri S, 2009, CANCER RES, V69, P2057, DOI 10.1158/0008-5472.CAN-08-3468
   Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653
   Seah C, 2008, J NEUROSCI, V28, P12570, DOI 10.1523/JNEUROSCI.4048-08.2008
   Sepp M, 2012, HUM MOL GENET, V21, P2873, DOI 10.1093/hmg/dds112
   SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581
   Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003
   Sloan KE, 2013, CELL REP, V5, P237, DOI 10.1016/j.celrep.2013.08.049
   Slomnicki L. P., 2016, MOL NEUROBIOL
   Slomnicki LP, 2016, MOL CELL PROTEOMICS, V15, P2055, DOI 10.1074/mcp.M115.051920
   Slomnicki LP, 2016, J BIOL CHEM, V291, P5721, DOI 10.1074/jbc.M115.682161
   Subbaiah KCV, 2015, INT J BIOCHEM CELL B, V64, P97, DOI 10.1016/j.biocel.2015.03.019
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tiwary AK, 2017, VIROLOGY, V502, P48, DOI 10.1016/j.virol.2016.12.013
   Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670
   Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x
   Urbanowski MD, 2008, CELL SIGNAL, V20, P1227, DOI 10.1016/j.cellsig.2007.12.018
   Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu ZK, 2012, VIROLOGY, V433, P226, DOI 10.1016/j.virol.2012.08.011
   Yamaguchi Y, 2009, HISTOL HISTOPATHOL, V24, P133, DOI 10.14670/HH-24.133
   Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x
   Yuan L., 2017, SCIENCE
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 76
TC 12
Z9 13
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 30
PY 2017
VL 7
AR 16652
DI 10.1038/s41598-017-16952-8
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FO5JI
UT WOS:000416891400054
PM 29192272
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Coelho, FC
   Armstrong, M
   Saraceni, V
   Lemos, C
AF Coelho, Flavio Codeco
   Armstrong, Margaret
   Saraceni, Valeria
   Lemos, Cristina
TI Can Zika Account for the Missing Babies?
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE Zika; sexually transmitted diseases; infant; newborn; diseases; live
   birth rate; epidemiology
ID VIRUS-INFECTION; BRAZIL
AB The Zika virus (ZIKV) spread rapidly in Brazil in 2015 and 2016. Rio de Janeiro was among the Brazilian cities which were hit the hardest, with more that a hundred thousand confirmed cases up to the end of 2016. Given the severity of the neurological damage caused by ZIKV on fetuses, we wondered whether it would also cause an increase in the number of miscarriages, especially very early ones. As early miscarriages are unlikely to be recorded as a health event, this effect-if it occurred-would only show up as a reduction in the number of live births. In this article, we show that there was a 15% drop in live births between September and December 2016 compared with the previous year, and that this sharp drop from epidemiological week 33 onward is strongly correlated with the number of recorded cases of Zika about 40 weeks earlier. We postulate that ZIKV is directly responsible for this drop in the birth rate. Further work is required to ascertain whether other factors such as the fear of having a microcephaly baby or the economic crisis are having a significant effect.
C1 [Coelho, Flavio Codeco; Armstrong, Margaret] Fundacao Getulio Vargas, Ctr Math Epidemiol, Sch Appl Math, Brasilia, DF, Brazil.
   [Saraceni, Valeria; Lemos, Cristina] Prefeitura Cidade Rio de Janeiro, Rio De Janeiro, Brazil.
RP Coelho, FC (corresponding author), Fundacao Getulio Vargas, Ctr Math Epidemiol, Sch Appl Math, Brasilia, DF, Brazil.
EM fccoelho@fgv.br
RI Coelho, Flavio Codeco/L-1089-2018
OI Coelho, Flavio Codeco/0000-0003-0635-8989
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Coelho FC, 2016, BIORXIV, DOI 10.1101/055459
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
NR 9
TC 2
Z9 2
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD NOV 29
PY 2017
VL 5
AR UNSP 317
DI 10.3389/fpubh.2017.00317
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FO7ZJ
UT WOS:000417099200001
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gadia, CLB
   Manirakiza, A
   Tekpa, G
   Konamna, X
   Vickos, U
   Nakoune, E
AF Gadia, Christelle Luce Bobossi
   Manirakiza, Alexandre
   Tekpa, Gaspard
   Konamna, Xavier
   Vickos, Ulrich
   Nakoune, Emmanuel
TI Identification of pathogens for differential diagnosis of fever with
   jaundice in the Central African Republic: a retrospective assessment,
   2008-2010
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Febrile jaundice; Differential diagnosis; Central African Republic
ID FEBRILE CHOLESTATIC JAUNDICE; CONGO HEMORRHAGIC-FEVER;
   HEPATITIS-DELTA-VIRUS; YELLOW-FEVER; RAPID DETECTION; PCR; MALARIA;
   INFECTION; MOSQUITOS; DISEASE
AB Background: Febrile jaundice results clinically in generalized yellow coloration of the teguments and mucous membranes due to excess plasma bilirubin, accompanied by fever. Two types are found: conjugated and unconjugated bilirubin jaundice. Jaundice is a sign in several diseases due to viruses (viral hepatitis and arbovirus), parasites (malaria) and bacteria (leptospirosis). In the Central African Republic (CAR), only yellow fever is included on the list of diseases for surveillance. The aim of this study was to identify the other pathogens that can cause febrile jaundice, for better management of patients.
   Methods: Between 2008 and 2010, 198 sera negative for yellow fever IgM were randomly selected from 2177 samples collected during yellow fever surveillance. Laboratory analyses targeted four groups of pathogens: hepatitis B, C, delta and E viruses; dengue, chikungunya, Zika, Crimean-Congo haemorrhagic fever, West Nile and Rift Valley arboviruses; malaria parasites; and bacteria (leptospirosis).
   Results: Overall, 30.9% sera were positive for hepatitis B, 20.2% for hepatitis E, 12.3% for hepatitis C and 8.2% for malaria. The majority of positive sera (40.4%) were from people aged 16-30 years. Co-infection with at least two of these pathogens was also found.
   Conclusion: These findings suggest that a systematic investigation should be undertaken of infectious agents that cause febrile jaundice in the CAR.
C1 [Gadia, Christelle Luce Bobossi; Konamna, Xavier; Vickos, Ulrich; Nakoune, Emmanuel] Inst Pasteur, Virol Dept, POB 923, Bangui, Cent Afr Republ.
   [Manirakiza, Alexandre] Inst Pasteur, Epidemiol Serv, POB 923, Bangui, Cent Afr Republ.
   [Tekpa, Gaspard] Hop Amitie, Minist Publ Hlth Populat & AIDS Control, POB 883, Bangui, Cent Afr Republ.
RP Manirakiza, A (corresponding author), Inst Pasteur, Epidemiol Serv, POB 923, Bangui, Cent Afr Republ.
EM amanirak@yahoo.fr
RI Manirakiza, Alexandre/A-6801-2011; Nakoune, Emmanuel/W-2710-2019
OI Manirakiza, Alexandre/0000-0002-1873-8527; 
FU Institut Pasteur de Bangui; Ministry of Health in the CAR; WHOWorld
   Health Organization
FX The Institut Pasteur de Bangui and the Ministry of Health in the CAR
   supported the study financially. National surveillance of yellow fever
   and the pathogens targeted in this analysis was funded by WHO.
CR Abro AH, 2009, JCPSP-J COLL PHYSICI, V19, P363, DOI 06.2009/JCPSP.363366
   Andernach IE, 2014, J CLIN MICROBIOL, V52, P1629, DOI 10.1128/JCM.02297-13
   [Anonymous], 2016, INT HLTH REG
   Baba M, 2013, J INFECT DEV COUNTR, V7, P51, DOI 10.3855/jidc.2411
   Bekondi C, 2008, PATHOL BIOL, V56, P310, DOI 10.1016/j.patbio.2007.12.007
   Chang Ko, 2004, Journal of Microbiology Immunology and Infection, V37, P103
   Chung Jun Pyo, 1994, Yonsei Medical Journal, V35, P231
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Escriba JM, 2008, EMERG INFECT DIS, V14, P681, DOI 10.3201/eid1404.070833
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gordon MA, 2001, J INFECTION, V42, P44, DOI 10.1053/jinf.2000.0779
   Goumba AI, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-93
   Isa SE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002534
   Juwah AI, 2003, AM J HEMATOL, V72, P185, DOI 10.1002/ajh.10285
   Komas NP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-286
   L'Azou M, 2015, T ROY SOC TROP MED H, V109, P717, DOI 10.1093/trstmh/trv076
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   LESBORDES JL, 1987, ANN MED INTERNE, V138, P199
   Mazumder Rachna, 2002, J Indian Med Assoc, V100, P312
   Mishra D, 2008, INDIAN J PEDIATR, V75, P509, DOI 10.1007/s12098-008-0079-5
   Nabeth P, 2004, EMERG INFECT DIS, V10, P2143, DOI 10.3201/eid1012.040535
   PAWLOTSKY JM, 1995, J MED VIROL, V46, P269, DOI 10.1002/jmv.1890460318
   PORTERFIELD JS, 1989, BRIT MED J, V299, P1555, DOI 10.1136/bmj.299.6715.1555
   Rachas A, 2014, EMERG INFECT DIS, V20, P1004, DOI 10.3201/eid2006.130671
   ROINGEARD P, 1992, CLIN INFECT DIS, V14, P510, DOI 10.1093/clinids/14.2.510
   ROSE HD, 1982, DIGEST DIS SCI, V27, P1046, DOI 10.1007/BF01391755
   SALUZZO JF, 1989, RES VIROLOGY, V140, P155, DOI 10.1016/S0923-2516(89)80093-7
   Schindler M, 2014, MEDICINA-BUENOS AIRE, V74, P60
   Shah S, 2009, JCPSP-J COLL PHYSICI, V19, P367, DOI 06.2009/JCPSP.367370
   Taddio A, 2012, J PEDIATR GASTR NUTR, V55, P380, DOI 10.1097/MPG.0b013e31825513de
   Vasickova P, 2012, J VIROL METHODS, V180, P38, DOI 10.1016/j.jviromet.2011.12.007
   *WHO, 2010, WEEKLY EPIDEMIOLOGIC, V85, P461
   *WHO, WHOEPIGEN9809
   WOLFSEN HC, 1993, J CLIN GASTROENTEROL, V16, P61, DOI 10.1097/00004836-199301000-00017
   Wu SJ, 2008, AM J TROP MED HYG, V79, P505, DOI 10.4269/ajtmh.2008.79.505
   Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753
   Yesilyurt M, 2012, MIKROBIYOL BUL, V46, P480
   Zaki SA, 2009, J POSTGRAD MED, V55, DOI 10.4103/0022-3859.57395
NR 38
TC 5
Z9 5
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 29
PY 2017
VL 17
AR 735
DI 10.1186/s12879-017-2840-8
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA FO0VW
UT WOS:000416471600001
PM 29187150
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Melo, CFOR
   Delafiori, J
   de Oliveira, DN
   Guerreiro, TM
   Esteves, CZ
   Lima, ED
   Pando-Robles, V
   Catharino, RR
AF Melo, Carlos F. O. R.
   Delafiori, Jeany
   de Oliveira, Diogo N.
   Guerreiro, Tatiane M.
   Esteves, Cibele Z.
   Lima, Estela de O.
   Pando-Robles, Victoria
   Catharino, Rodrigo R.
CA Zika-Unicamp Network
TI Serum Metabolic Alterations upon Zika Infection (vol 8, 1954, 2017)
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Correction
DE Zika virus; mass spectrometry; metabolomics; viromics
ID VIRUS
C1 [Melo, Carlos F. O. R.; Delafiori, Jeany; de Oliveira, Diogo N.; Guerreiro, Tatiane M.; Esteves, Cibele Z.; Lima, Estela de O.; Catharino, Rodrigo R.; Zika-Unicamp Network] Univ Estadual Campinas, Sch Pharmaceut Sci, INNOVARE Biomarkers Lab, Campinas, SP, Brazil.
   [Pando-Robles, Victoria] Inst Nacl Salud Publ, Unidad Prote, Cuernavaca, Morelos, Mexico.
RP Catharino, RR (corresponding author), Univ Estadual Campinas, Sch Pharmaceut Sci, INNOVARE Biomarkers Lab, Campinas, SP, Brazil.
EM rrcatharino@gmail.com
RI de Oliveira Lima, Estela/G-7375-2015; de Oliveira, Diogo
   Noin/C-3939-2013; Delafiori, Jeany/G-9250-2017; Lima, Estela/W-5105-2019
OI de Oliveira Lima, Estela/0000-0003-0479-0364; de Oliveira, Diogo
   Noin/0000-0002-2725-476X; Lima, Estela/0000-0003-0479-0364;
   PANDO-ROBLES, VICTORIA/0000-0002-9633-5627
CR Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Fedson DS, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.11.03
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Saraiva VB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017174
   Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176
NR 6
TC 2
Z9 2
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD NOV 29
PY 2017
VL 8
AR 2373
DI 10.3389/fmicb.2017.02373
PG 3
WC Microbiology
SC Microbiology
GA FO0AD
UT WOS:000416403800003
PM 29211063
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Skraning, S
   Lindskog, BV
AF Skraning, Susanne
   Lindskog, Benedikte V.
TI The Zika outbreak in Brazil: An unequal burden
SO TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING
LA English
DT Editorial Material
ID VIRUS
C1 [Skraning, Susanne; Lindskog, Benedikte V.] Univ Oslo, Inst Hlth & Soc, Dept Community Med & Global Hlth, Oslo, Norway.
RP Lindskog, BV (corresponding author), Univ Oslo, Inst Hlth & Soc, Dept Community Med & Global Hlth, Oslo, Norway.
EM b.v.lindskog@medisin.uio.no
CR Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Rocha NACF, 2017, INFANT BEHAV DEV, V49, P70, DOI 10.1016/j.infbeh.2017.07.002
   Couttolenc B, 2013, BRAZILS PRIMARY HLTH
   de Carvalho BR, 2016, J BRAS REPROD ASSIST, V20, P159, DOI 10.5935/1518-0557.20160034
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Pan American Health Organization, 2017, ZIK EP REP BRAZ
   Singer M, 2017, GLOB PUBLIC HEALTH, V12, P1, DOI 10.1080/17441692.2016.1225112
   Watch HR, 2017, HUMAN RIGHTS WATCH
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2017, ONE HLTH
   Wolf M, 2015, SOC SCI MED, V129, P5, DOI 10.1016/j.socscimed.2014.06.018
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, 2016, LAB TEST ZIK VIR INF
NR 13
TC 0
Z9 0
U1 0
U2 2
PU NORWEGIAN MEDICAL ASSOC
PI OSLO
PA AKERSGATA 2, PO BOX 1152, OSLO, 0107, NORWAY
SN 0029-2001
EI 0807-7096
J9 TIDSSKR NORSKE LAEGE
JI Tidsskr. Nor. Laegeforen.
PD NOV 28
PY 2017
VL 137
IS 22
BP 1802
EP 1805
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA FO0OT
UT WOS:000416445200029
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Schafflick, D
   Kieseier, BC
   Wiendl, H
   Horste, GMZ
AF Schafflick, David
   Kieseier, Bernd C.
   Wiendl, Heinz
   Horste, Gerd Meyer Zu
TI Novel pathomechanisms in inflammatory neuropathies
SO JOURNAL OF NEUROINFLAMMATION
LA English
DT Review
DE Experimental autoimmune neuritis; Guillain-Barre syndrome; Chronic
   inflammatory demyelinating polyneuropathy; Animal model; Th17 cells
ID GUILLAIN-BARRE-SYNDROME; EXPERIMENTAL AUTOIMMUNE NEURITIS; EXPERIMENTAL
   ALLERGIC NEURITIS; REGULATORY T-CELLS; REMITTING MULTIPLE-SCLEROSIS;
   PERIPHERAL-NERVE MYELIN; CYCLOSPORINE-A TREATMENT; ZIKA VIRUS-INFECTION;
   DEMYELINATING POLYNEUROPATHY; ANIMAL-MODEL
AB Inflammatory neuropathies are rare autoimmune-mediated disorders affecting the peripheral nervous system. Considerable progress has recently been made in understanding pathomechanisms of these disorders which will be essential for developing novel diagnostic and therapeutic strategies in the future. Here, we summarize our current understanding of antigenic targets and the relevance of new immunological concepts for inflammatory neuropathies. In addition, we provide an overview of available animal models of acute and chronic variants and how new diagnostic tools such as magnetic resonance imaging and novel therapeutic candidates will benefit patients with inflammatory neuropathies in the future. This review thus illustrates the gap between pre-clinical and clinical findings and aims to outline future directions of development.
C1 [Schafflick, David; Wiendl, Heinz; Horste, Gerd Meyer Zu] Westfalische Wilhems Univ, Dept Neurol, Albert Schweitzer Campus 1, D-48149 Munster, Germany.
   [Kieseier, Bernd C.] Heinrich Heine Univ, Dept Neurol, Med Fac, Dusseldorf, Germany.
RP Horste, GMZ (corresponding author), Westfalische Wilhems Univ, Dept Neurol, Albert Schweitzer Campus 1, D-48149 Munster, Germany.
EM gerd.mzh@uni-muenster.de
RI Horste, Gerd Meyer zu/O-9549-2016
OI Horste, Gerd Meyer zu/0000-0002-4341-4719; Wiendl,
   Heinz/0000-0003-4310-3432
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [ME4050/4-1]
CR Abbas N, 2000, AUTOIMMUNITY, V32, P93, DOI 10.3109/08916930008994078
   Abraham PM, 2014, CLIN EXP IMMUNOL, V175, P181, DOI 10.1111/cei.12215
   ABROMSONLEEMAN S, 1995, J EXP MED, V182, P587, DOI 10.1084/jem.182.2.587
   Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850
   AMBROSIUS B, 2017, J NEUROINFLAMM, V14
   Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643
   Anderson SA, 2004, ANN NEUROL, V55, P654, DOI 10.1002/ana.20066
   Andreadou E, 2013, CASE REP NEUROL MED, DOI 10.1155/2013/671935
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   ARCHELOS JJ, 1994, LAB INVEST, V70, P667
   ARCHELOS JJ, 1993, BRAIN, V116, P1043, DOI 10.1093/brain/116.5.1043
   Baumer P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049742
   Balatoni B, 2007, BRAIN RES BULL, V74, P307, DOI 10.1016/j.brainresbull.2007.06.023
   Barun B, 2012, CLIN IMMUNOL, V142, P31, DOI 10.1016/j.clim.2011.04.005
   Binder M, 2006, BLOOD, V108, P1975, DOI 10.1182/blood-2006-04-014639
   Bour-Jordan W, 2005, J IMMUNOL, V175, P5649, DOI 10.4049/jimmunol.175.9.5649
   Bowes T, 2002, INFECT IMMUN, V70, P5008, DOI 10.1128/IAI.70.9.5008-5018.2002
   Brisebois M, 2006, J IMMUNOL, V177, P2403, DOI 10.4049/jimmunol.177.4.2403
   Brunn A, 2013, NEUROPATH APPL NEURO, V39, P772, DOI 10.1111/nan.12039
   Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889
   Calida DM, 2000, J NEUROIMMUNOL, V107, P1, DOI 10.1016/S0165-5728(00)00249-6
   Calik MW, 2015, ASN NEURO, P7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen PW, 2015, ACTA NEUROPATHOL, V130, P605, DOI 10.1007/s00401-015-1482-4
   Chi LJ, 2010, J PERIPHER NERV SYST, V15, P345, DOI 10.1111/j.1529-8027.2010.00294.x
   Chi LJ, 2008, J PERIPHER NERV SYST, V13, P54, DOI 10.1111/j.1529-8027.2008.00158.x
   Chin RL, 2003, J NEUROL SCI, V210, P19, DOI 10.1016/S0022-510X(03)00010-8
   Chio A, 2007, J NEUROL NEUROSUR PS, V78, P1349, DOI 10.1136/jnnp.2007.114868
   Csurhes PA, 2005, J NEUROL NEUROSUR PS, V76, P1431, DOI 10.1136/jnnp.2004.052282
   Dace DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007121
   Dalakas MC, 2011, NAT REV NEUROL, V7, P507, DOI 10.1038/nrneurol.2011.121
   Danesh FR, 2003, ARCH IMMUNOL THER EX, V51, P139
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Delmont E, 2017, BRAIN, V140, P1851, DOI 10.1093/brain/awx124
   Deretzi G, 1999, J AUTOIMMUN, V12, P81, DOI 10.1006/jaut.1998.0259
   Devaux JJ, 2016, NEUROLOGY, V86, P800, DOI 10.1212/WNL.0000000000002418
   Ding YA, 2016, J IMMUNOL, V197, P3831, DOI 10.4049/jimmunol.1601083
   Dong CL, 2017, EXP NEUROL, V292, P35, DOI 10.1016/j.expneurol.2017.02.012
   Dong CL, 2016, ACTA NEUROPATHOL, V132, P739, DOI 10.1007/s00401-016-1599-0
   Doppler K, 2015, J NEUROL NEUROSUR PS, V86, P720, DOI 10.1136/jnnp-2014-309916
   Duan RS, 2004, NEUROBIOL DIS, V16, P630, DOI 10.1016/j.nbd.2004.04.007
   DYCK PJ, 1975, MAYO CLIN PROC, V50, P621
   EYLAR EH, 1982, J NEUROIMMUNOL, V3, P91, DOI 10.1016/0165-5728(82)90043-1
   Fantini MC, 2007, NAT PROTOC, V2, P1789, DOI 10.1038/nprot.2007.258
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904
   Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658
   Gabriel CM, 2000, J NEUROIMMUNOL, V104, P139, DOI 10.1016/S0165-5728(99)00269-6
   Gabriel CM, 1998, BRAIN, V121, P1895, DOI 10.1093/brain/121.10.1895
   Gold R, 2005, PERIPHERAL NEUROPATH, V2
   GRANELLIPIPERNO A, 1988, TRANSPLANTATION, V46, pS53
   Greenwood J, 2003, FASEB J, V17, P905, DOI 10.1096/fj.02-1014fje
   Griffin JW, 2005, PERIPHERAL NEUROPATH, P2197
   Hadden RDM, 2001, J NEUROIMMUNOL, V119, P306, DOI 10.1016/S0165-5728(01)00390-3
   Halstead SK, 2005, ANN NEUROL, V58, P203, DOI 10.1002/ana.20546
   Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316
   Harness J, 2008, J CLIN NEUROSCI, V15, P1031, DOI 10.1016/j.jocn.2007.09.016
   Harness J, 2001, J NEUROL SCI, V187, P7, DOI 10.1016/S0022-510X(01)00505-6
   Hartung H-P, 2017, NEUROLOGY, P88
   HARTUNG HP, 1988, BRAIN, V111, P1039, DOI 10.1093/brain/111.5.1039
   Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277
   Heinen A, 2015, EXP NEUROL, V271, P25, DOI 10.1016/j.expneurol.2015.05.002
   Hirst C, 2006, J NEUROL NEUROSUR PS, V77, P800, DOI 10.1136/jnnp.2005.076869
   Ho MH, 2011, J ORTHOP RES, V29, P1504, DOI 10.1002/jor.21421
   Horste GMZ, 2007, NAT CLIN PRACT NEURO, V3, P198, DOI 10.1038/ncpneuro0452
   Horste GMZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108756
   Horste GMZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021223
   Horste GMZ, 2010, DRUG NEWS PERSPECT, V23, P287, DOI 10.1358/dnp.2010.23.5.1447850
   HOFFMAN PM, 1980, BRAIN RES, V195, P355, DOI 10.1016/0006-8993(80)90071-2
   Horste GMZ, 2014, J IMMUNOL, V193, P2678, DOI 10.4049/jimmunol.1400367
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2
   Hughes RAC, 2008, LANCET NEUROL, V7, P136, DOI 10.1016/S1474-4422(07)70329-0
   Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978
   Iijima M, 2008, J NEUROL NEUROSUR PS, V79, P1040, DOI 10.1136/jnnp.2007.128132
   ILLA I, 1995, ANN NEUROL, V38, P218, DOI 10.1002/ana.410380214
   Inglis HR, 2007, J NEUROL NEUROSUR PS, V78, P419, DOI 10.1136/jnnp.2006.106617
   Jiang F, 2009, INT IMMUNOL, V21, P499, DOI 10.1093/intimm/dxp020
   Joshi AR, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0711-7
   Jung S, 1995, NEUROSCI LETT, V200, P167, DOI 10.1016/0304-3940(95)12115-K
   Jung S, 2004, J NEUROSCI RES, V75, P524, DOI 10.1002/jnr.10879
   Kang HG, 2007, AM J TRANSPLANT, V7, P1907, DOI 10.1111/j.1600-6143.2007.01881.x
   Kappos L, 2011, LANCET, V378, P1779, DOI 10.1016/S0140-6736(11)61649-8
   Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494
   KHALILISHIRAZI A, 1993, J NEUROIMMUNOL, V46, P245, DOI 10.1016/0165-5728(93)90255-W
   Kharwar NK, 2017, INT J NEUROSCI, V127, P680, DOI 10.1080/00207454.2016.1231186
   Khatri BO, 2016, THER ADV NEUROL DISO, V9, P130, DOI 10.1177/1756285616628766
   Kieseier BC, 2002, BRAIN, V125, P823, DOI 10.1093/brain/awf070
   Kim HJ, 2009, J NEUROIMMUNOL, V214, P93, DOI 10.1016/j.jneuroim.2009.07.006
   Kim HJ, 2008, J IMMUNOL, V181, P8753, DOI 10.4049/jimmunol.181.12.8753
   Kirschbaum K, 2016, P NATL ACAD SCI USA, V113, P13227, DOI 10.1073/pnas.1609397113
   Kleyman I, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0563-z
   Klingenstein R, 2006, J NEUROCHEM, V98, P748, DOI 10.1111/j.1471-4159.2006.03889.x
   Koller H, 2005, NEW ENGL J MED, V352, P1343, DOI 10.1056/nejmra041347
   Kollmer J, 2015, CLIN NEURORADIOL, V25, P283, DOI 10.1007/s00062-015-0412-0
   Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kusunoki S, 1996, ANN NEUROL, V39, P424, DOI 10.1002/ana.410390404
   Kuwabara S, 2006, J NEUROL NEUROSUR PS, V77, P66, DOI 10.1136/jnnp.2005.065441
   Kuwahara M, 2011, J NEUROIMMUNOL, V239, P87, DOI 10.1016/j.jneuroim.2011.08.016
   Kwa MSG, 2001, J NEUROIMMUNOL, V116, P220, DOI 10.1016/S0165-5728(01)00307-1
   Lachance DH, 2010, LANCET NEUROL, V9, P55, DOI 10.1016/S1474-4422(09)70296-0
   Langert KA, 2014, SMALL GTPASES, P5
   Langert KA, 2017, J NEUROCHEM, V140, P334, DOI 10.1111/jnc.13892
   LASSMANN H, 1991, BRAIN, V114, P429, DOI 10.1093/brain/114.1.429
   Laughlin RS, 2009, NEUROLOGY, V73, P39, DOI 10.1212/WNL.0b013e3181aaea47
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Li SJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/740947
   Li SJ, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/260473
   Li XL, 2011, CELL IMMUNOL, V271, P455, DOI 10.1016/j.cellimm.2011.08.015
   Lin R, 2006, CURR NEUROVASC RES, V3, P41, DOI 10.2174/156720206775541796
   Louvet C, 2009, J EXP MED, V206, P507, DOI 10.1084/jem.20082113
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Lunn MPT, 2000, J NEUROCHEM, V75, P404, DOI 10.1046/j.1471-4159.2000.0750404.x
   Lunn MPT, 1999, J NEUROL NEUROSUR PS, V66, P677, DOI 10.1136/jnnp.66.5.677
   Maddur MS, 2015, CELL MOL IMMUNOL, V12, P650, DOI 10.1038/cmi.2014.117
   Madia F, 2009, J PERIPHER NERV SYST, V14, P107, DOI 10.1111/j.1529-8027.2009.00220.x
   Mahdi-Rogers M, 2014, EUR J NEUROL, V21, P28, DOI 10.1111/ene.12190
   Makowska A, 2008, J NEUROL NEUROSUR PS, V79, P664, DOI 10.1136/jnnp.2007.123943
   Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238
   Manso C, 2016, BRAIN, V139, P1700, DOI 10.1093/brain/aww062
   Marsh EA, 2010, J NEUROL, V257, P913, DOI 10.1007/s00415-009-5437-3
   Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053
   Mathey EK, 2015, J NEUROL NEUROSUR PS, V86, P973, DOI 10.1136/jnnp-2014-309697
   Maurer M, 2002, CURR OPIN NEUROL, V15, P617, DOI 10.1097/00019052-200210000-00013
   McCombe PA, 1999, J NEUROIMMUNOL, V97, P60, DOI 10.1016/S0165-5728(99)00047-8
   MCCOMBE PA, 1992, NEUROPATH APPL NEURO, V18, P171, DOI 10.1111/j.1365-2990.1992.tb00778.x
   McGonigal R, 2010, BRAIN, V133, P1944, DOI 10.1093/brain/awq119
   Mei FJ, 2005, J NEUROL SCI, V228, P75, DOI 10.1016/j.jns.2004.10.001
   Meyer zu Horste G, 2016, PLOS ONE, V11
   Miletic H, 2005, J NEUROPATH EXP NEUR, V64, P66, DOI 10.1093/jnen/64.1.66
   Milo R, 2016, AUTOIMMUN REV, V15, P714, DOI 10.1016/j.autrev.2016.03.006
   Miron VE, 2008, ANN NEUROL, V63, P61, DOI 10.1002/ana.21227
   Miroux C, 2012, TRANSPLANTATION, V94, P123, DOI 10.1097/TP.0b013e3182590d8f
   Miyamoto K, 1999, MUSCLE NERVE, V22, P1704, DOI 10.1002/(SICI)1097-4598(199912)22:12<1704::AID-MUS13>3.0.CO;2-A
   Montalban X, 2017, NEW ENGL J MED, V376, P209, DOI 10.1056/NEJMoa1606468
   Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301
   Morikawa M, 2016, J NEUROIMMUNOL, V301, P35, DOI 10.1016/j.jneuroim.2016.10.010
   Moyano AL, 2008, J NEUROL SCI, V272, P110, DOI 10.1016/j.jns.2008.05.006
   Nie J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00493
   Orlikowski D, 2003, J NEUROIMMUNOL, V134, P118, DOI 10.1016/S0165-5728(02)00393-4
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Patzig J, 2011, J NEUROSCI, V31, P16369, DOI 10.1523/JNEUROSCI.4016-11.2011
   Pollard JD, 2011, J PERIPHER NERV SYST, V16, P15, DOI 10.1111/j.1529-8027.2011.00323.x
   Prevot N, 2010, EUR J IMMUNOL, V40, P2267, DOI 10.1002/eji.201040416
   PRINEAS JW, 1976, J NEUROL SCI, V27, P427, DOI 10.1016/0022-510X(76)90213-6
   PRINEAS JW, 1972, LAB INVEST, V26, P133
   Quan S, 2016, CLIN EXP IMMUNOL, V184, P50, DOI 10.1111/cei.12756
   Querol L, 2014, NEUROLOGY, V82, P879, DOI 10.1212/WNL.0000000000000205
   Rajabally YA, 2009, MUSCLE NERVE, V39, P432, DOI 10.1002/mus.21206
   Rausch M, 2004, J MAGN RESON IMAGING, V20, P16, DOI 10.1002/jmri.20057
   Rink C, 2017, J NEUROL SCI, V372, P318, DOI 10.1016/j.jns.2016.11.078
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Said G, 2006, NEUROMUSCULAR DISORD, V16, P293, DOI 10.1016/j.nmd.2006.02.008
   Saitoh Kodai, 2016, Biochem Biophys Rep, V8, P139, DOI 10.1016/j.bbrep.2016.08.021
   Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677
   Samukawa M, 2016, J NEUROIMMUNOL, V301, P61, DOI 10.1016/j.jneuroim.2016.10.006
   Sanvito L, 2009, J NEUROL NEUROSUR PS, V80, P333, DOI 10.1136/jnnp.2008.159798
   Sarkey JP, 2007, J NEUROCHEM, V100, P1265, DOI 10.1111/j.1471-4159.2006.04309.x
   Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251
   Schneider-Hohendorf T, 2012, NEUROLOGY, V78, P402, DOI 10.1212/WNL.0b013e318245d250
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982
   Singh MP, 2009, EXP NEUROL, V215, P397, DOI 10.1016/j.expneurol.2008.10.001
   SNYDER DH, 1977, J NEUROPATH EXP NEUR, V36, P488, DOI 10.1097/00005072-197705000-00007
   Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075
   Sommer C, 2005, NEUROLOGY, V65, P1924, DOI 10.1212/01.wnl.0000188879.19900.b7
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sorensen PS, 2014, NEUROLOGY, V82, P573, DOI 10.1212/WNL.0000000000000125
   Sorensen PS, 2016, THER ADV NEUROL DISO, V9, P44, DOI 10.1177/1756285615601933
   St Charles JL, 2017, J AUTOIMMUN, V77, P11, DOI 10.1016/j.jaut.2016.09.003
   St-Amour I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-54
   Stach K, 2012, CARDIOL J, V19, P20, DOI 10.5603/CJ.2012.0005
   Stoll G, 2006, EXP NEUROL, V197, P150, DOI 10.1016/j.expneurol.2005.09.003
   Stoll G, 2004, J NEUROIMMUNOL, V149, P142, DOI 10.1016/j.jneuroim.2003.12.024
   Stoll G, 2009, NEUROSCIENCE, V158, P1151, DOI 10.1016/j.neuroscience.2008.06.045
   Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007
   Susuki K, 2012, EXP NEUROL, V233, P534, DOI 10.1016/j.expneurol.2011.11.039
   Takeuchi S, 2000, BIOCHEM BIOPH RES CO, V269, P97, DOI 10.1006/bbrc.2000.2238
   TAYLOR WA, 1985, J NEUROIMMUNOL, V8, P153, DOI 10.1016/S0165-5728(85)80055-2
   Thomas K, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0817-6
   Thomas K, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000228
   Tran GT, 2010, J NEUROIMMUNOL, V229, P98, DOI 10.1016/j.jneuroim.2010.07.010
   Tzachanis D, 2014, ACTA HAEMATOL-BASEL, V132, P240, DOI 10.1159/000358292
   Uncini A, 2013, CLIN NEUROPHYSIOL, V124, P1928, DOI 10.1016/j.clinph.2013.03.025
   Vallat JM, 2010, LANCET NEUROL, V9, P402, DOI 10.1016/S1474-4422(10)70041-7
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8
   Van Steenwinckel J, 2015, BRAIN BEHAV IMMUN, V45, P198, DOI 10.1016/j.bbi.2014.10.016
   Vidal L, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djr418
   Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605
   Vital C, 2000, ULTRASTRUCT PATHOL, V24, P363
   Vriesendorp FJ, 1998, ACTA NEUROPATHOL, V95, P297, DOI 10.1007/s004010050801
   WAKSMAN BH, 1955, J EXP MED, V102, P213, DOI 10.1084/jem.102.2.213
   Walgaard C, 2011, NEUROLOGY, V76, P968, DOI 10.1212/WNL.0b013e3182104407
   Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102
   Wang X, 2014, SCAND J IMMUNOL, V80, P180, DOI 10.1111/sji.12201
   Wang YZ, 2017, EXP NEUROL, V291, P134, DOI 10.1016/j.expneurol.2017.02.010
   Wanschitz J, 2003, BRAIN, V126, P2034, DOI 10.1093/brain/awg207
   Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015
   Weerth S, 1999, J NEUROIMMUNOL, V95, P157, DOI 10.1016/S0165-5728(99)00004-1
   Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707
   Willison HJ, 2008, J NEUROIMMUNOL, V201, P172, DOI 10.1016/j.jneuroim.2008.05.028
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Xia RH, 2010, NEUROPATH APPL NEURO, V36, P388, DOI 10.1111/j.1365-2990.2010.01092.x
   Yan WX, 2014, J NEUROIMMUNOL, V277, P13, DOI 10.1016/j.jneuroim.2014.09.012
   Yang M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-5
   Yosef N, 2012, J CELL PHYSIOL, V227, P3857, DOI 10.1002/jcp.24100
   Yoshida T, 2008, P NATL ACAD SCI USA, V105, P3533, DOI 10.1073/pnas.0710951105
   Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012
   Yuki N, 2007, MUSCLE NERVE, V35, P691, DOI 10.1002/mus.20762
   Zehntner SP, 2003, FASEB J, V17, P1910, DOI 10.1096/fj.03-0199fje
   Zeng XPL, 2013, J IMMUNOL, V190, P3895, DOI 10.4049/jimmunol.1203001
   Zephir H, 2008, J NEUROL NEUROSUR PS, V79, P1032, DOI 10.1136/jnnp.2006.108290
   Zhang Z, 2008, EXP NEUROL, V210, P681, DOI 10.1016/j.expneurol.2007.12.025
   Zhang Z, 2009, EXP NEUROL, V216, P75, DOI 10.1016/j.expneurol.2008.11.014
   Zou LP, 2000, J NEUROSCI RES, V62, P717, DOI 10.1002/1097-4547(20001201)62:5<717::AID-JNR11>3.3.CO;2-G
NR 219
TC 9
Z9 9
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-2094
J9 J NEUROINFLAMM
JI J. Neuroinflamm.
PD NOV 28
PY 2017
VL 14
AR 232
DI 10.1186/s12974-017-1001-8
PG 17
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA FN8DE
UT WOS:000416248800001
PM 29179723
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Franco, LD
   Vidal, PO
   Amorim, JH
AF Franco, Lorrany dos Santos
   Vidal, Paloma Oliveira
   Amorim, Jaime Henrique
TI In silico design of a Zika virus non-structural protein 5 aiming vaccine
   protection against zika and dengue in different human populations
SO JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Article
DE Zika virus; Dengue virus; Vaccine; Epitopes; Bioinformatics
ID MOUSE ENCEPHALITIS MODEL; NONHUMAN-PRIMATES; TETRAVALENT VACCINE;
   IMMUNE-RESPONSE; INFECTION; ANTIBODIES; SAFETY
AB Background: The arboviruses Zika virus (ZIKV) and Dengue virus (DENV) have important epidemiological impact in Brazil and other tropical regions of the world. Recently, it was shown that previous humoral immunity to DENV enhances ZIKV replication in vitro, which may lead to more severe forms of the disease. Thus, traditional approaches of vaccine development aiming to control viral infection through neutralizing antibodies may induce cross-reactive enhancing antibodies. In contrast, cellular immune response was shown to be capable of controlling DENV infection independently of antibodies. The aim of the present study was to design a flavivirus NS5 protein capable of inducing a cellular immune response against DENV and ZIKV.
   Methods: A consensus sequence of ZIKV NS5 protein was designed among isolates from various continents. Epitopes were predicted for the most prevalent alleles of class I and II HLA in the Brazilian population. Then, this epitopes were analyzed with regard to their conservation, population coverage and distribution along the whole antigen.
   Results: Nineteen epitopes predicted to be more reactive (percentile rank <1) and 100% conserved among ZIKV and DENV serotypes were selected. The distribution of such epitopes along the protein was shown on a three-dimensional model and population coverage was calculated for different regions of the world. The designed protein was predicted to be stable and the distribution of selected epitopes was shown to be homogeneous along domains. The population coverage of selected epitopes was higher than 50% for most of tropical areas of the world.
   Conclusion: Such results indicate that the proposed antigen has the potential to induce protective cellular immune response to ZIKV and DENV in different human populations of the world.
C1 [Franco, Lorrany dos Santos; Vidal, Paloma Oliveira; Amorim, Jaime Henrique] Univ Fed Oeste Bahia, Lab Microbiol, Ctr Ciencias Biol & Saude, Rua Bertioga 892,Morada Nobre 2, BR-47810059 Barreiras, BA, Brazil.
RP Amorim, JH (corresponding author), Univ Fed Oeste Bahia, Lab Microbiol, Ctr Ciencias Biol & Saude, Rua Bertioga 892,Morada Nobre 2, BR-47810059 Barreiras, BA, Brazil.
EM jaime.amorim@ufob.edu.br
RI Amorim, Jaime Henrique/O-9222-2017
OI Amorim, Jaime Henrique/0000-0002-0623-2879
FU International Society of Infectious Diseases
FX This research work was funded by International Society of Infectious
   Diseases.
CR Alves RPDS, 2016, CLIN VACCINE IMMUNOL
   Amorim JH, 2016, VIROLOGY, V487, P41, DOI 10.1016/j.virol.2015.10.006
   [Anonymous], AR ZIK VIR
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Calvet G., 2016, LANCET INFECT DIS
   Castanha PM, 2016, J INFECT DIS
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Gil L, 2009, VIRAL IMMUNOL, V22, P23, DOI 10.1089/vim.2008.0063
   Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Knipe D., 2007, FIELDS VIROLOGY
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Villar L, 2014, NEW ENGL J MED, V372
   Weiskopf D, 2014, J VIROL
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yoshida T, 2013, ARCH VIROL, V158, P1209, DOI 10.1007/s00705-013-1618-6
   Zhao BT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14586
NR 23
TC 6
Z9 7
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1021-7770
EI 1423-0127
J9 J BIOMED SCI
JI J. Biomed. Sci.
PD NOV 23
PY 2017
VL 24
AR 88
DI 10.1186/s12929-017-0395-z
PG 10
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA FN5QA
UT WOS:000416061500001
PM 29169357
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kato, F
   Tajima, S
   Nakayama, E
   Kawai, Y
   Taniguchi, S
   Shibasaki, K
   Taira, M
   Maeki, T
   Lim, CK
   Takasaki, T
   Saijo, M
AF Kato, Fumihiro
   Tajima, Shigeru
   Nakayama, Eri
   Kawai, Yasuhiro
   Taniguchi, Satoshi
   Shibasaki, Kenichi
   Taira, Masakatsu
   Maeki, Takahiro
   Lim, Chang Kweng
   Takasaki, Tomohiko
   Saijo, Masayuki
TI Characterization of large and small-plaque variants in the Zika virus
   clinical isolate ZIKV/Hu/S36/Chiba/2016
SO SCIENTIFIC REPORTS
LA English
DT Article
ID WESTERN-HEMISPHERE; MEMBRANE-PROTEIN; DENGUE VIRUS; INFECTION; MICE;
   PATHOGENESIS; MICRONESIA; VACCINE; DOMAIN; BRAZIL
AB An Asian/American lineage Zika virus (ZIKV) strain ZIKV/Hu/S36/Chiba/2016 formed 2 types in plaque size, large and small. Genomic analysis of the plaque-forming clones obtained from the isolate indicated that the clones forming small plaques commonly had an adenine nucleotide at position 796 (230(Gln) in the amino acid sequence), while clones forming large plaques had a guanine nucleotide (230(Arg)) at the same position, suggesting that this position was associated with the difference in plaque size. Growth kinetics of a large-plaque clone was faster than that of a small-plaque clone in Vero cells. Recombinant ZIKV G796A/rZIKV-MR766, which carries a missense G796A mutation, was produced using an infectious molecular clone of the ZIKV MR766 strain rZIKV-MR766/pMW119-CMVP. The plaque size of the G796A mutant was significantly smaller than that of the parental strain. The G796A mutation clearly reduced the growth rate of the parental virus in Vero cells. Furthermore, the G796A mutation also decreased the virulence of the MR766 strain in IFNAR1 knockout mice. These results indicate that the amino acid variation at position 230 in the viral polyprotein, which is located in the M protein sequence, is a molecular determinant for plaque morphology, growth property, and virulence in mice of ZIKV.
C1 [Kato, Fumihiro; Tajima, Shigeru; Nakayama, Eri; Taniguchi, Satoshi; Shibasaki, Kenichi; Maeki, Takahiro; Lim, Chang Kweng; Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
   [Kawai, Yasuhiro] Natl Inst Infect Dis, Div Biosafety Control & Res, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
   [Taira, Masakatsu] Chiba Prefectural Inst Publ Hlth, Div Virol, Chuo Ku, 666-2 Nitona, Chiba 2701422, Japan.
   [Takasaki, Tomohiko] Kanagawa Prefectural Inst Publ Hlth, 1-3-1 Shimomachiya, Chigasaki, Kanagawa 2530087, Japan.
RP Tajima, S (corresponding author), Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
EM stajima@nih.go.jp
RI Saijo, Masayuki/L-2697-2019
OI Shigeru, Tajima/0000-0002-1981-9062
FU Research Program on Emerging and Re-emerging Infectious Diseases of the
   Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED)
FX This research was supported by the Research Program on Emerging and
   Re-emerging Infectious Diseases of the Japan Agency for Medical Research
   and Development (AMED).
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Hashimoto T., 2016, EMERGING INFECT DIS, V23
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hsieh SC, 2014, J BIOL CHEM, V289, P33149, DOI 10.1074/jbc.M114.610428
   Kato F, 2014, JPN J INFECT DIS, V67, P209, DOI 10.7883/yoken.67.209
   Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EURO SURVEILLANCE B, V19
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Peng JG, 2014, J VIROL, V88, P8386, DOI 10.1128/JVI.00937-14
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Taira M., 2017, JAPANESE J INFECT DI
   Tajima S, 2010, VIROLOGY, V396, P298, DOI 10.1016/j.virol.2009.10.035
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146
   Yuan L, 2017, SCIENCE
   Zhang Q, 2012, J BIOL CHEM, V287, P40525, DOI 10.1074/jbc.M112.384446
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
NR 52
TC 9
Z9 10
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 23
PY 2017
VL 7
AR 16160
DI 10.1038/s41598-017-16475-2
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FN6MP
UT WOS:000416129200072
PM 29170504
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Khaiboullina, SF
   Uppal, T
   Sarkar, R
   Gorzalski, A
   St Jeor, S
   Verma, SC
AF Khaiboullina, S. F.
   Uppal, T.
   Sarkar, R.
   Gorzalski, A.
   St Jeor, S.
   Verma, S. C.
TI ZIKV infection regulates inflammasomes pathway for replication in
   monocytes
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VERTICAL TRANSMISSION; VIRUS-INFECTION; T-CELLS; DIFFERENTIATION;
   INTERLEUKIN-1-BETA; MACROPHAGES; INTERFERONS; INDUCTION; PLACENTA;
   RECEPTOR
AB ZIKV causes microcephaly by crossing the placental barrier, however, the mechanism of trans-placental dissemination of ZIKV remains unknown. Here, we sought to determine whether monocytes, which can cross tissue barriers, assist ZIKV dissemination to the fetus. We determined this by infecting monocytes with two strains of ZIKV: South American (PRVABC59) and Nigerian (IBH30656) and analyzing viral replication. We found that ZIKV infects and replicates in monocytes and macrophages, which results in the modulation of a large number of cellular genes. Analysis of these genes identified multiple pathways including inflammasome to be targeted by ZIKV, which was confirmed by analyzing the transcript levels of the proteins of inflammasome pathways, NLRP3, ASC, caspase 1, IL-1 and IL-18. Interestingly, IFN alpha and the IFN inducible gene, MxA were not enhanced, suggesting prevention of innate antiviral defense by ZIKV. Also, inhibition of inflammasome led to an increased transcriptional activity of IFNa, MxA and CXCL10. Based on these results we suggest that ZIKV transcription is regulated by inflammasomes.
C1 [Khaiboullina, S. F.; Uppal, T.; Sarkar, R.; St Jeor, S.; Verma, S. C.] Univ Nevada, Reno Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA.
   [Khaiboullina, S. F.] Kazan Fed Univ, Kazan, Russia.
   [Gorzalski, A.; St Jeor, S.] Genquest LLC, Sparks, NV USA.
RP Verma, SC (corresponding author), Univ Nevada, Reno Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA.
EM scverma@medicine.nevada.edu
RI ; Khaiboullina, Svetlana/M-4793-2016
OI Uppal, Timsy/0000-0001-6264-4635; Khaiboullina,
   Svetlana/0000-0002-5064-570X
CR Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003
   Ahari SE, 2007, CELL MOL NEUROBIOL, V27, P695, DOI 10.1007/s10571-007-9160-2
   Al-Husaini AM, 2009, J PERINATOL, V29, P331, DOI 10.1038/jp.2008.187
   [Anonymous], 2016, EURO SURVEILL, V21
   Arias RA, 2003, VIROLOGY, V307, P266, DOI 10.1016/S0042-6822(02)00040-5
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao WP, 2012, J IMMUNOL, V189, P2257, DOI 10.4049/jimmunol.1200168
   Carson WE, 2000, BLOOD, V96, P1465, DOI 10.1182/blood.V96.4.1465.h8001465_1465_1473
   Cugola F. R., 2016, NATURE
   Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612
   Doi A, 2016, J CARDIOVASC ELECTR, V27, P1242, DOI 10.1111/jce.12987
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Ferreri A. J., 2010, NAT REV CLIN ONCOL, V7, DOI [10.1038/nrclinonc20101039-c1031, DOI 10.1038/NRCLINONC20101039-C1031]
   Ferreri AJM, 2010, NAT REV CLIN ONCOL, V7, DOI 10.1038/nrclinonc.2010.9-c1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893
   Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Haynes M., 2007, MANUAL THERAPY, V13, pe5
   Haynes M., 2007, MANUAL THERAPY, V13, pe4
   Henry CM, 2016, CELL REP, V14, P708, DOI 10.1016/j.celrep.2015.12.072
   Karniychuk UU, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-95
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   La Morgia C, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-116
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133
   MACIEJEWSKI JP, 1992, BLOOD, V80, P170
   MACIEJEWSKI JP, 1993, VIROLOGY, V195, P327, DOI 10.1006/viro.1993.1383
   Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632
   Maestre AM, 2016, EBIOMEDICINE, V10, P7, DOI 10.1016/j.ebiom.2016.07.026
   McDonagh S, 2004, J INFECT DIS, V190, P826, DOI 10.1086/422330
   Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344
   MOH, 2015, INCR MICR NE BRAZ
   Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Parekh FK, 2010, AM J TROP MED HYG, V83, P973, DOI 10.4269/ajtmh.2010.09-0445
   Pereira L, 2003, J VIROL, V77, P13301, DOI 10.1128/JVI.77.24.13301-13314.2003
   Pirhonen J, 1999, J IMMUNOL, V162, P7322
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009
   Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936
   Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691
   Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812
   Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007
   Suptawiwat O, 2008, J CLIN VIROL, V42, P186, DOI 10.1016/j.jcv.2008.01.014
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taub DD, 1996, BLOOD, V87, P1423, DOI 10.1182/blood.V87.4.1423.bloodjournal8741423
   Uchide N, 2002, J GEN VIROL, V83, P747, DOI 10.1099/0022-1317-83-4-747
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1
   Yuan J, 2009, CIRC RES, V104, P628, DOI 10.1161/CIRCRESAHA.108.192179
   ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4
NR 60
TC 11
Z9 11
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 22
PY 2017
VL 7
AR 16050
DI 10.1038/s41598-017-16072-3
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FN6IZ
UT WOS:000416118900016
PM 29167459
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Orioli, IM
   Dolk, H
   Lopez-Camelo, JS
   Mattos, D
   Poletta, FA
   Dutra, MG
   Carvalho, FM
   Castilla, EE
AF Orioli, Ieda M.
   Dolk, Helen
   Lopez-Camelo, Jorge S.
   Mattos, Daniel
   Poletta, Fernando A.
   Dutra, Maria G.
   Carvalho, Flavia M.
   Castilla, Eduardo E.
TI Prevalence and clinical profile of microcephaly in South America
   pre-Zika, 2005-14: prevalence and case-control study
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
ID VIRUS-INFECTION; BIRTH-DEFECTS; GLOBAL BURDEN; INFANTS; BRAZIL;
   INTERGROWTH-21ST; PREGNANCY; STANDARDS; JANUARY; RUBELLA
AB OBJECTIVE
   To describe the prevalence and clinical spectrum of microcephaly in South America for the period 200514, before the start of the Zika epidemic in 2015, as a baseline for future surveillance as the Zika epidemic spreads and as other infectious causes may emerge in future.
   DESIGN
   Prevalence and case-control study.
   DATA SOURCES
   ECLAMC (Latin American Collaborative Study of Congenital Malformations) database derived from 107 hospitals in 10 South American countries, 2005 to 2014. Data on microcephaly cases, four non-malformed controls per case, and all hospital births (all births for hospital based prevalence, resident within municipality for population based prevalence). For 2010-14, head circumference data were available and compared with Intergrowth charts.
   RESULTS
   552 microcephaly cases were registered, giving a hospital based prevalence of 4.4 (95% confidence interval 4.1 to 4.9) per 10 000 births and a population based prevalence of 3.0 (2.7 to 3.4) per 10 000. Prevalence varied significantly between countries and between regions and hospitals within countries. Thirty two per cent (n=175) of cases were prenatally diagnosed; 29% (n=159) were perinatal deaths. Twenty three per cent (n=128) were associated with a diagnosed genetic syndrome, 34% (n=189) polymalformed without a syndrome diagnosis, 12% (n=65) with associated neural malformations, and 26% (n=145) microcephaly only. In addition, 3.8% (n=21) had a STORCH (syphilis, toxoplasmosis, other including HIV, rubella, cytomegalovirus, and herpes simplex) infection diagnosis and 2.0% (n=11) had consanguineous parents. Head circumference measurements available for 184/235 cases in 201014 showed 45% (n=82) more than 3 SD below the mean, 24% (n=44) between 3 SD and 2 SD below the mean, and 32% (n=58) larger than-2 SD.
   CONCLUSION
   Extrapolated to the nearly 7 million annual births in South America, an estimated 2000-2500 microcephaly cases were diagnosed among births each year before the Zika epidemic began in 2015. Clinicians are using more than simple metrics to make microcephaly diagnoses. Endemic infections are important enduring causes of microcephaly.
C1 [Orioli, Ieda M.; Mattos, Daniel] Univ Fed Rio de Janeiro, Latin Amer Collaborat Study Congenital Malformat, Dept Genet, Inst Biol, BR-21944001 Rio De Janeiro, Brazil.
   [Orioli, Ieda M.; Lopez-Camelo, Jorge S.; Mattos, Daniel; Poletta, Fernando A.; Dutra, Maria G.; Carvalho, Flavia M.; Castilla, Eduardo E.] Natl Inst Populat Med Genet INAGEMP, Porto Alegre, RS, Brazil.
   [Dolk, Helen] Ulster Univ, Inst Nursing & Hlth Res, Maternal Fetal & Infant Res Ctr, Newtownabbey, North Ireland.
   [Lopez-Camelo, Jorge S.; Poletta, Fernando A.; Castilla, Eduardo E.] Consejo Nacl Invest Cient & Tecn, ECLAMC, Ctr Med Educ & Clin Res, CEMIC, Buenos Aires, DF, Argentina.
   [Dutra, Maria G.; Carvalho, Flavia M.] Fundacao Oswaldo Cruz, FIOCRUZ, Inst Oswaldo Cruz, ECLAMC,Lab Congenital Malformat Epidemiol, Rio De Janeiro, Brazil.
RP Orioli, IM (corresponding author), Univ Fed Rio de Janeiro, Latin Amer Collaborat Study Congenital Malformat, Dept Genet, Inst Biol, BR-21944001 Rio De Janeiro, Brazil.; Orioli, IM (corresponding author), Natl Inst Populat Med Genet INAGEMP, Porto Alegre, RS, Brazil.
EM orioli@centroin.com.br
RI de Carvalho, Flavia/AAF-3922-2019
OI Mattos, Daniel/0000-0001-6179-0294; Poletta,
   Fernando/0000-0002-6102-8416
FU MRC Rapid Response Initiative [ZK/16-075]; MRC, Newton Fund; Wellcome
   TrustWellcome Trust; MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit [734584];
   Bolsista CAPES/BRASIL
FX This research was funded by the MRC Rapid Response Initiative ZK/16-075
   Zika: Establishment of enhanced birth defect surveillance in South
   America, supported jointly by MRC, Newton Fund, and Wellcome Trust, and
   was also partially supported by MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit/No
   14/2016 - Prevencao e Combate ao virus Zika, European Union Horizon 2020
   ZikaPLAN grant agreement No 734584 and Bolsista CAPES/BRASIL. Funding
   sources had no role in the study design, data acquisition, or analyses
   or in the decision to submit the article for publication.
CR Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   BALE JF, 1992, PEDIATR CLIN N AM, V39, P669
   Bhide P, 2016, BIRTH PREVALENCE MIC, P23
   Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, CDC CONCL ZIK CAUS M
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Fuchs F, 2016, FETAL DIAGN THER, V39, P74, DOI 10.1159/000364804
   Groisman B, 2016, REV ARGENT SALUD PUB, V7, P39
   Hanzlik E, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4060047
   HOFMAN MA, 1984, J NEUROL, V231, P87, DOI 10.1007/BF00313723
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leviton A, 2002, EARLY HUM DEV, V69, P91, DOI 10.1016/S0378-3782(02)00065-8
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Luteijn JM, 2014, HUM REPROD, V29, P809, DOI 10.1093/humrep/det455
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mason CA, 2005, BIRTH DEFECTS RES A, V73, P690, DOI 10.1002/bdra.20211
   McAuley JB, 2014, J PEDIAT INF DIS SOC, V3, pS30, DOI 10.1093/jpids/piu077
   MILLER E, 1982, LANCET, V2, P781
   Ministerio da Saude do Brasil, 2016, BRAS AD REC OMS RED
   Ministerio da Saude do Brasil, 2015, MIN SAUD INV AUM CAS
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   Nazer J, 2011, REV MED CHILE, V139, P72, DOI /S0034-98872011000100010
   OMIM, 2017, ONLINE MENDELIAN INH
   Porras-Hurtado GL, 2016, BIOMEDICA, V36, P556, DOI 10.7705/biomedica.v36i4.2771
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reef SE, 2000, CLIN INFECT DIS, V31, P85, DOI 10.1086/313928
   RUTTER N, 1993, ARCH DIS CHILD-FETAL, V68, P606, DOI 10.1136/adc.68.5_Spec_No.606
   Souza S W, 1976, Arch Dis Child, V51, P624
   Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   van Zuylen WJ, 2014, OBSTET MED, V7, P140, DOI 10.1177/1753495X14552719
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2016, LANCET, V387, P844, DOI 10.1016/S0140-6736(16)00384-6
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   WHO, 2006, WHO CHILD GROWTH STA
   Wijesooriya NS, 2016, LANCET GLOB HEALTH, V4, pE525, DOI 10.1016/S2214-109X(16)30135-8
   WILLIAMS J, 1977, PEDIATRICS, V59, P619
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
   World Health Organization, 2016, SCR ASS MAN NEON INF
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 65
TC 4
Z9 5
U1 0
U2 8
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD NOV 21
PY 2017
VL 359
AR j5018
DI 10.1136/bmj.j5018
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA FO0VU
UT WOS:000416471300001
PM 29162597
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Deng, YQ
   Zhang, NN
   Li, XF
   Wang, YQ
   Tian, M
   Qiu, YF
   Fan, JW
   Hao, JN
   Huang, XY
   Dong, HL
   Fan, H
   Wang, YG
   Zhang, FC
   Tong, YG
   Xu, ZH
   Qin, CF
AF Deng, Yong-Qiang
   Zhang, Na-Na
   Li, Xiao-Feng
   Wang, Ya-Qing
   Tian, Min
   Qiu, Ye-Feng
   Fan, Jun-Wan
   Hao, Jia-Nan
   Huang, Xing-Yao
   Dong, Hao-Long
   Fan, Hang
   Wang, Yu-Guang
   Zhang, Fu-Chun
   Tong, Yi-Gang
   Xu, Zhiheng
   Qin, Cheng-Feng
TI Intranasal infection and contact transmission of Zika virus in guinea
   pigs
SO NATURE COMMUNICATIONS
LA English
DT Article
ID MODEL; VECTOR; RHESUS; REPLICATION; LEADS
AB Zika virus (ZIKV) is primarily transmitted to humans through mosquito bites or sexual contact. The excretion and persistence of contagious ZIKV in various body fluids have been well documented in ZIKV patients; however, the risk of direct contact exposure remains unclear. Here, we show that guinea pigs are susceptible to ZIKV infection via subcutaneous inoculation route; infected guinea pigs exhibit seroconversion and significant viral secretion in sera, saliva, and tears. Notably, ZIKV is efficiently transmitted from infected guinea pigs to naive co-caged animals. In particular, intranasal inoculation of ZIKV is fully capable of establishing infection in guinea pigs, and viral antigens are detected in multiple tissues including brain and parotid glands. Cynomolgus macaques also efficiently acquire ZIKV infection via intranasal and intragastric inoculation routes. These collective results from animal models highlight the risk of exposure to ZIKV contaminants and raise the possibility of close contact transmission of ZIKV in humans.
C1 [Deng, Yong-Qiang; Zhang, Na-Na; Li, Xiao-Feng; Hao, Jia-Nan; Huang, Xing-Yao; Dong, Hao-Long; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing 100071, Peoples R China.
   [Deng, Yong-Qiang; Li, Xiao-Feng; Fan, Hang; Tong, Yi-Gang; Qin, Cheng-Feng] State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Wang, Ya-Qing; Fan, Jun-Wan; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.
   [Wang, Ya-Qing; Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
   [Tian, Min; Wang, Yu-Guang] Capital Med Univ, Beijing Tradit Chinese Med Hosp, Beijing 100010, Peoples R China.
   [Qiu, Ye-Feng] Acad Mil Med Sci, Lab Anim Ctr, Beijing 100071, Peoples R China.
   [Hao, Jia-Nan] Anhui Med Univ, Hefei 230032, Anhui, Peoples R China.
   [Zhang, Fu-Chun; Qin, Cheng-Feng] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
RP Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing 100071, Peoples R China.; Qin, CF (corresponding author), State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Xu, ZH (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; Xu, ZH (corresponding author), Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.; Qin, CF (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
EM zhxu@genetics.ac.cn; qincf@bmi.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Tong, Yigang/0000-0002-8503-8045;
   Xu, Zhiheng/0000-0002-4809-2851
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [81772176, 31770190, 81661148054]; National
   Key Research and Development Project of China [2016YFD0500304,
   2016YFC1201000, 2016ZX10004001-008]; National Science and Technology
   Major Project of China [2017ZX09101005, 2017ZX10304402]; Special Program
   of Guangdong Provincial Department of Science and Technology
   [2016A020248]; Guangzhou Science and Technology Program for Public
   Wellbeing [201508020263, 201704020229]; Excellent Young Scientist
   Program [81522025]; Innovative Research Group of the NSFC [81621005]; UK
   Academy of Medical Sciences [NAF003/1003]; NSFCNational Natural Science
   Foundation of China [31730108, 31430037]
FX We thank Prof. Jing An (Capital Medical University, China) for helpful
   discussion, and the veterinarians from the Laboratory Animal Center at
   the Academy of Military Medical Sciences for their excellent technical
   support. This work was supported by the National Natural Science
   Foundation of China (NSFC) (Nos. 81772176, 31770190, and 81661148054),
   the National Key Research and Development Project of China (Nos.
   2016YFD0500304, 2016YFC1201000, and 2016ZX10004001-008) the National
   Science and Technology Major Project of China (Nos. 2017ZX09101005 and
   2017ZX10304402), the Special Program of Guangdong Provincial Department
   of Science and Technology (No. 2016A020248), and the Guangzhou Science
   and Technology Program for Public Wellbeing (Nos. 201508020263 and
   201704020229). C.-F.Q. was supported by the Excellent Young Scientist
   Program (No. 81522025), the Innovative Research Group of the NSFC (No.
   81621005), and a Newton Advanced Fellowship from the UK Academy of
   Medical Sciences (No. NAF003/1003). Z.X. was supported by the NSFC (Nos.
   31730108, and 31430037).
CR Banet-Noach C, 2003, AVIAN PATHOL, V32, P489, DOI 10.1080/0307945031000154080
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bouvier NM, 2008, J VIROL, V82, P10052, DOI 10.1128/JVI.01226-08
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burger-Calderon R, 2014, J VIROL, V88, P559, DOI 10.1128/JVI.02777-13
   Chan JF, 2016, EMERG MICROBES INFEC, V5
   Chen LH, 2004, CLIN INFECT DIS, V39, pE56, DOI 10.1086/423807
   Cheng NM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005520
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Li XS, 2015, J CLIN MICROBIOL, V53, P2734, DOI 10.1128/JCM.00770-15
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   NEWMAN CM, 2017, NAT COMMUN, V8
   Ni M, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.151, 10.1038/NMICROBIOL.2016.151]
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pica N, 2012, J VIROL, V86, P4279, DOI 10.1128/JVI.06645-11
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sreenivasan C, 2015, J VIROL, V89, P11990, DOI 10.1128/JVI.01630-15
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Varble A, 2014, CELL HOST MICROBE, V16, P691, DOI 10.1016/j.chom.2014.09.020
   Walton SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002214
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Wong G, 2015, J VIROL, V89, P1314, DOI 10.1128/JVI.02836-14
   Xu P, 2013, J VIROL, V87, P8158, DOI 10.1128/JVI.01028-13
   Yin YX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.100
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang NN, 2016, HUM VACC IMMUNOTHER, V12, P3107, DOI 10.1080/21645515.2016.1219004
   Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455
NR 50
TC 23
Z9 25
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 21
PY 2017
VL 8
AR 1648
DI 10.1038/s41467-017-01923-4
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FN7UC
UT WOS:000416223300004
PM 29162827
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Whitfield, ZJ
   Dolan, PT
   Kunitomi, M
   Tassetto, M
   Seetin, MG
   Oh, S
   Heiner, C
   Paxinos, E
   Andino, R
AF Whitfield, Zachary J.
   Dolan, Patrick T.
   Kunitomi, Mark
   Tassetto, Michel
   Seetin, Matthew G.
   Oh, Steve
   Heiner, Cheryl
   Paxinos, Ellen
   Andino, Raul
TI The Diversity, Structure, and Function of Heritable Adaptive Immunity
   Sequences in the Aedes aegypti Genome
SO CURRENT BIOLOGY
LA English
DT Article
ID TRANSPOSABLE ELEMENTS; RNA VIRUSES; EVOLUTION; ALIGNMENT; ANNOTATION;
   INSIGHTS; DEFENSE; MEMORY; TREES
AB The Aedes aegypti mosquito transmits arboviruses, including dengue, chikungunya, and Zika virus. Understanding the mechanisms underlying mosquito immunity could provide new tools to control arbovirus spread. Insects exploit two different RNAi pathways to combat viral and transposon infection: short interfering RNAs (siRNAs) and PIWI-interacting RNAs (piRNAs) [1, 2]. Endogenous viral elements (EVEs) are sequences from non-retroviral viruses that are inserted into the mosquito genome and can act as templates for the production of piRNAs [3, 4]. EVEs therefore represent a record of past infections and a reservoir of potential immune memory [5]. The large-scale organization of EVEs has been difficult to resolve with short-read sequencing because they tend to integrate into repetitive regions of the genome. To define the diversity, organization, and function of EVEs, we took advantage of the contiguity associated with long-read sequencing to generate a high-quality assembly of the Ae. aegypti-derived Aag2 cell line genome, an important and widely used model system. We show EVEs are acquired through recombination with specific classes of long terminal repeat (LTR) retrotransposons and organize into large loci (>50 kbp) characterized by high LTR density. These EVE-containing loci have increased density of piRNAs compared to similar regions without EVEs. Furthermore, we detected EVE-derived piRNAs consistent with a targeted processing of persistently infecting virus genomes. We propose that comparisons of EVEs across mosquito populations may explain differences in vector competence, and further study of the structure and function of these elements in the genome of mosquitoes may lead to epidemiological interventions.
C1 [Whitfield, Zachary J.; Dolan, Patrick T.; Kunitomi, Mark; Tassetto, Michel; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, 600 16th St,GH-S572,UCSF Box 2280, San Francisco, CA 94143 USA.
   [Dolan, Patrick T.] Stanford Univ, Dept Biol, E200 Clark Ctr,318 Campus Dr, Stanford, CA 94305 USA.
   [Seetin, Matthew G.; Oh, Steve; Heiner, Cheryl; Paxinos, Ellen] Pacific Biosci, 1305 OBrien Dr, Menlo Pk, CA 94025 USA.
   [Kunitomi, Mark] IBM Corp, Almaden Res Ctr, 650 Harry Rd, San Jose, CA 95120 USA.
   [Paxinos, Ellen] Roche Mol Syst, 4300 Hacienda Dr, Pleasanton, CA 94588 USA.
RP Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, 600 16th St,GH-S572,UCSF Box 2280, San Francisco, CA 94143 USA.
EM raul.andino@ucsf.edu
RI Paxinos, Ellen/AAG-2907-2019
OI Paxinos, Ellen/0000-0002-1710-8064; Dolan, Patrick/0000-0002-4169-0058
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5T32AI060537-14, R01 AI36178, AI40085,
   P01 AI091575]; DARPA Prophecy [HR0011-11-C-0094];  [F32 GM113483-01]
FX We thank members of Judith Frydman's lab and the Andino lab for helpful
   discussions. P.T.D. acknowledges support from F32 GM113483-01. Z.J.W.
   was supported in part by NIH T32 grant 5T32AI060537-14. This work was
   supported in part by the NIH (R01 AI36178, AI40085, and P01 AI091575)
   and DARPA Prophecy (HR0011-11-C-0094).
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Bembom O, 2017, SEQLOGO SEQUENCE LOG
   Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689
   Chalopin D, 2015, GENOME BIOL EVOL, V7, P567, DOI 10.1093/gbe/evv005
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]
   Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]
   Chuong EB, 2016, SCIENCE, V351, P1083, DOI 10.1126/science.aad5497
   Conzelmann KK, 1998, ANNU REV GENET, V32, P123, DOI 10.1146/annurev.genet.32.1.123
   Cotton JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep39749
   Czech B, 2016, TRENDS BIOCHEM SCI, V41, P324, DOI 10.1016/j.tibs.2015.12.008
   Delviks-Frankenberry K, 2011, VIRUSES-BASEL, V3, P1650, DOI 10.3390/v3091650
   Dudchenko O, 2017, SCIENCE, V356, P92, DOI 10.1126/science.aal3327
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199
   Geuking MB, 2009, SCIENCE, V323, P393, DOI 10.1126/science.1167375
   Gifford WD, 2013, TRENDS CELL BIOL, V23, P218, DOI 10.1016/j.tcb.2013.01.001
   Gilbert C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000495
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086
   Hannon Lab, 2017, FASTX TOOLKIT FASTQ
   Holmes EC, 2011, CELL HOST MICROBE, V10, P368, DOI 10.1016/j.chom.2011.09.002
   Honda Tomoyuki, 2016, Mob Genet Elements, V6, pe1165785, DOI 10.1080/2159256X.2016.1165785
   Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695
   Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55
   Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258
   Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   LAN Q, 1990, AM J TROP MED HYG, V43, P669, DOI 10.4269/ajtmh.1990.43.669
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lee A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0503
   Lesbats P, 2016, CHEM REV, V116, P12730, DOI 10.1021/acs.chemrev.6b00125
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Malik HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/gr.145000
   Maringer K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3432-5
   McKinney W., 2010, P 9 PYTH SCI C, P51, DOI DOI 10.1016/S0168-0102(02)00204-3
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Mongelli V, 2016, ANNU REV VIROL, V3, P573, DOI 10.1146/annurev-virology-110615-042447
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Palatini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3903-3
   Parrish NF, 2015, RNA, V21, P1691, DOI 10.1261/rna.052092.115
   PELEG J, 1968, VIROLOGY, V35, P617, DOI 10.1016/0042-6822(68)90293-6
   Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077
   Python Software Foundation, 2017, PYTH LANG REF VERS 2
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   R Core Team, 2014, R LANG ENV STAT COMP
   Rosenkranz D, 2015, RNA, V21, P911, DOI 10.1261/rna.048603.114
   Rosenkranz D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-5
   Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351
   Smit A. F. A., 2015, REPEATMODELER
   Smit A. F. A., 2015, REPEATMASKER
   Staginnus C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-24
   STRAUSS EG, 1984, VIROLOGY, V133, P92, DOI 10.1016/0042-6822(84)90428-8
   Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Thompson PJ, 2016, MOL CELL, V62, P766, DOI 10.1016/j.molcel.2016.03.029
   van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37
   Varjak M, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00144-17, 10.1128/msphere.00144-17]
   Vicoso B, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002078
   Waskom M., 2017, SEABORN STAT DATA VI
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Yamanaka S, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-22
   Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628
NR 66
TC 40
Z9 42
U1 1
U2 22
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD NOV 20
PY 2017
VL 27
IS 22
BP 3511
EP +
DI 10.1016/j.cub.2017.09.067
PG 16
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FN2IT
UT WOS:000415815800029
PM 29129531
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Screaton, G
   Mongkolsapaya, J
AF Screaton, Gavin
   Mongkolsapaya, Juthathip
TI Evolution of neurovirulent Zika virus A Zika virus mutation leads to
   increased neurovirulence
SO SCIENCE
LA English
DT Editorial Material
ID INFECTION
C1 [Screaton, Gavin] Univ Oxford, John Radcliffe Hosp, Med Sci Div, Level 3, Oxford OX3 9DU, England.
   [Mongkolsapaya, Juthathip] Imperial Coll London, Dept Med, Commonwealth Bldg,Hammersmith Campus,Du Cane Rd, London W12 0NN, England.
RP Screaton, G (corresponding author), Univ Oxford, John Radcliffe Hosp, Med Sci Div, Level 3, Oxford OX3 9DU, England.
EM gavin.screaton@medsci.ox.ac.uk; j.mongkolsapaya@imperial.ac.uk
OI Screaton, Gavin/0000-0002-3549-4309
FU Wellcome TrustWellcome Trust; Medical Research Council, UKMedical
   Research Council UK (MRC)
FX The authors acknowledge support from Wellcome Trust and the Medical
   Research Council, UK. G.S. is a Wellcome Trust Senior Investigator.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 14
TC 3
Z9 4
U1 0
U2 21
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD NOV 17
PY 2017
VL 358
IS 6365
BP 863
EP 864
DI 10.1126/science.aaq1297
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM7XB
UT WOS:000415293000022
PM 29146794
DA 2020-07-08
ER

PT J
AU Yuan, L
   Huang, XY
   Liu, ZY
   Zhang, F
   Zhu, XL
   Yu, JY
   Ji, X
   Xu, YP
   Li, GH
   Li, C
   Wang, HJ
   Deng, YQ
   Wu, MH
   Cheng, ML
   Ye, Q
   Xie, DY
   Li, XF
   Wang, XX
   Shi, WF
   Hu, BY
   Shi, PY
   Xu, ZH
   Qin, CF
AF Yuan, Ling
   Huang, Xing-Yao
   Liu, Zhong-Yu
   Zhang, Feng
   Zhu, Xing-Liang
   Yu, Jiu-Yang
   Ji, Xue
   Xu, Yan-Peng
   Li, Guanghui
   Li, Cui
   Wang, Hong-Jiang
   Deng, Yong-Qiang
   Wu, Menghua
   Cheng, Meng-Li
   Ye, Qing
   Xie, Dong-Yang
   Li, Xiao-Feng
   Wang, Xiangxi
   Shi, Weifeng
   Hu, Baoyang
   Shi, Pei-Yong
   Xu, Zhiheng
   Qin, Cheng-Feng
TI A single mutation in the prM protein of Zika virus contributes to fetal
   microcephaly
SO SCIENCE
LA English
DT Article
ID COMPLEX; CELLS; MICE
AB Zika virus (ZIKV) has evolved into a global health threat because of its unexpected causal link to microcephaly. Phylogenetic analysis reveals that contemporary epidemic strains have accumulated multiple substitutions from their Asian ancestor. Here we show that a single serine-to-asparagine substitution [Ser(139)-> Asn(139) (S139N)] in the viral polyprotein substantially increased ZIKV infectivity in both human and mouse neural progenitor cells (NPCs) and led to more severe microcephaly in the mouse fetus, as well as higher mortality rates in neonatal mice. Evolutionary analysis indicates that the S139N substitution arose before the 2013 outbreak in French Polynesia and has been stably maintained during subsequent spread to the Americas. This functional adaption makes ZIKV more virulent to human NPCs, thus contributing to the increased incidence of microcephaly in recent ZIKV epidemics.
C1 [Yuan, Ling; Zhang, Feng; Zhu, Xing-Liang; Li, Guanghui; Li, Cui; Xu, Zhiheng] Chinese Acad Sci, State Key Lab Mol Dev Biol, Ctr Excellence Brain Sci & Intelligence Technol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.
   [Yuan, Ling; Zhang, Feng; Zhu, Xing-Liang; Li, Guanghui; Li, Cui; Xu, Zhiheng] Univ CAS, Beijing 100101, Peoples R China.
   [Huang, Xing-Yao; Liu, Zhong-Yu; Yu, Jiu-Yang; Ji, Xue; Xu, Yan-Peng; Wang, Hong-Jiang; Deng, Yong-Qiang; Cheng, Meng-Li; Ye, Qing; Xie, Dong-Yang; Li, Xiao-Feng; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Wu, Menghua; Hu, Baoyang] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.
   [Cheng, Meng-Li; Xie, Dong-Yang] Anhui Med Univ, Grad Sch, Hefei 230032, Anhui, Peoples R China.
   [Wang, Xiangxi] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100101, Peoples R China.
   [Shi, Weifeng] Taishan Med Coll, Shandong Univ Key Lab Etiol & Epidemiol Emerging, Tai An 271000, Shandong, Peoples R China.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
RP Xu, ZH (corresponding author), Chinese Acad Sci, State Key Lab Mol Dev Biol, Ctr Excellence Brain Sci & Intelligence Technol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.; Xu, ZH (corresponding author), Univ CAS, Beijing 100101, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Xu, ZH (corresponding author), Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
EM zhxu@genetics.ac.cn; qincf@bmi.ac.cn
RI Hu, Baoyang/R-8374-2016; Qin, Cheng-Feng/I-6839-2019
OI Hu, Baoyang/0000-0003-3993-4014; Qin, Cheng-Feng/0000-0002-0632-2807;
   Yuan, Ling/0000-0001-7351-5097; Liu, Zhong-Yu/0000-0001-7385-5681;
   huang, xingyao/0000-0002-3917-8100; Xu, Zhiheng/0000-0002-4809-2851;
   Zhang, Feng/0000-0003-2887-8184; Zhu, Xingliang/0000-0003-3411-8712
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [31770190, 31730108, 31430037, 81661148054,
   81661130162]; National Key Research and Development Project of China
   [2016YFD0500304]; National Science and Technology Major Project of China
   [2017ZX09101005, 2014CB942801, 2017ZX10304402]; CASDefence Research &
   Development Organisation (DRDO)Chinese Academy of Sciences
   [QYZDJ-SSW-SMC007, GJHZ1827]; Shanghai Science and Technology
   CommitteeShanghai Science & Technology Committee [16JC1420500]; Beijing
   Brain Project [Z161100002616004]; Innovative Research Group from NSFC
   [81522025, 81621005]; U.K. Academy of Medical Sciences; Taishan Scholars
   program of Shandong province [ts201511056]
FX We thank A. Davidson (University of Bristol), A.-H. Zheng (CAS), and B.
   Zhang (CAS) for helpful discussion and critical reagents. This work was
   supported by the National Natural Science Foundation of China (NSFC)
   (grants 31770190, 31730108, 31430037, 81661148054, and 81661130162), the
   National Key Research and Development Project of China (grant
   2016YFD0500304), the National Science and Technology Major Project of
   China (grants 2017ZX09101005, 2014CB942801, and 2017ZX10304402), CAS
   (grants QYZDJ-SSW-SMC007 and GJHZ1827), the Shanghai Brain-Intelligence
   Project from the Shanghai Science and Technology Committee (grant
   16JC1420500), and the Beijing Brain Project (grant Z161100002616004).
   C.-F.Q. was supported by an Excellent Young Scientist grant (81522025),
   a grant from the Innovative Research Group (81621005) from NSFC, and the
   Newton Advanced Fellowship from the U.K. Academy of Medical Sciences.
   W.S. was supported by the Taishan Scholars program of Shandong province
   (grant ts201511056). All data needed to understand and assess the
   conclusions of this research are available in the main paper and
   supplementary materials.
CR Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pama B., 2016, NEW ENGL J MED, V375, P1513
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Piorkowski G., 2016, New Microbes and New Infections, V11, P52, DOI 10.1016/j.nmni.2016.02.013
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yun SI, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004290
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 29
TC 186
Z9 196
U1 7
U2 110
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD NOV 17
PY 2017
VL 358
IS 6365
BP 933
EP +
DI 10.1126/science.aam7120
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM7XB
UT WOS:000415293000049
PM 28971967
OA Bronze
DA 2020-07-08
ER

PT J
AU Shiryaev, SA
   Mesci, P
   Pinto, A
   Fernandes, I
   Sheets, N
   Shresta, S
   Farhy, C
   Huang, CT
   Strongin, AY
   Muotri, AR
   Terskikh, AV
AF Shiryaev, Sergey A.
   Mesci, Pinar
   Pinto, Antonella
   Fernandes, Isabella
   Sheets, Nicholas
   Shresta, Sujan
   Farhy, Chen
   Huang, Chun-Teng
   Strongin, Alex Y.
   Muotri, Alysson R.
   Terskikh, Alexey V.
TI Repurposing of the anti-malaria drug chloroquine for Zika Virus
   treatment and prophylaxis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ANTIVIRAL DRUG; TRANSMISSION; SOFOSBUVIR; PHARMACOKINETICS;
   IDENTIFICATION; INHIBITORS; INFECTION; EPIDEMIC
AB One of the major challenges of the current Zika virus (ZIKV) epidemic is to prevent congenital foetal abnormalities, including microcephaly, following ZIKV infection of pregnant women. Given the urgent need for ZIKV prophylaxis and treatment, repurposing of approved drugs appears to be a viable and immediate solution. We demonstrate that the common anti-malaria drug chloroquine (CQ) extends the lifespan of ZIKV-infected interferon signalling-deficient AG129 mice. However, the severity of ZIKV infection in these mice precludes the study of foetal (vertical) viral transmission. Here, we show that interferon signalling-competent SJL mice support chronic ZIKV infection. Infected dams and sires are both able to transmit ZIKV to the offspring, making this an ideal model for in vivo validation of compounds shown to suppress ZIKV in cell culture. Administration of CQ to ZIKV-infected pregnant SJL mice during mid-late gestation significantly attenuated vertical transmission, reducing the ZIKV load in the foetal brain more than 20-fold. Given the limited side effects of CQ, its lack of contraindications in pregnant women, and its worldwide availability and low cost, we suggest that CQ could be considered for the treatment and prophylaxis of ZIKV.
C1 [Shiryaev, Sergey A.; Pinto, Antonella; Farhy, Chen; Huang, Chun-Teng; Strongin, Alex Y.; Terskikh, Alexey V.] Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Mesci, Pinar; Fernandes, Isabella; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Pediat,Stem Cell Program, Rady Childrens Hosp San Diego,Dept Cellular & Mol, La Jolla, CA 92037 USA.
   [Sheets, Nicholas; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
RP Terskikh, AV (corresponding author), Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat,Stem Cell Program, Rady Childrens Hosp San Diego,Dept Cellular & Mol, La Jolla, CA 92037 USA.
EM muotri@ucsd.edu; terskikh@sbp.edu
RI Terskikh, Alexey/U-8407-2019; Strongin, Alex/R-6609-2019
OI Strongin, Alex/0000-0003-3765-3016; Mesci, Pinar/0000-0003-3402-5671;
   Huang, Chun-Teng/0000-0003-3737-7875
FU California Institute for Regenerative MedicineCalifornia Institute for
   Regenerative Medicine [DISC2-09649]; National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [U19MH107367, R21NS100477]; NARSAD Independent
   Investigator GrantNARSAD; International Rett Syndrome Foundation
   fellowship
FX We thank all members of the Terskikh laboratory for helpful discussions
   and assistance. We gratefully acknowledge Buddy Charbono, Hilda Clarke,
   Francisco Beltranand Mary O'Rourke-Braxtan at the Animal Facility of the
   Sanford Burnham Prebys Medical Discovery Institute for their invaluable
   assistance with the animal studies. We thank Drs. P. Mesci and A. Macia
   for drawing the schematic in Fig. 2. A.R.M. is supported by grants from
   the California Institute for Regenerative Medicine (DISC2-09649), the
   National Institutes of Health through the U19MH107367, and an NARSAD
   Independent Investigator Grant. P.M. is supported by an International
   Rett Syndrome Foundation fellowship. This work was supported by National
   Institutes of Health through R21NS100477 grant to A.V.T., A.Y.S., and
   S.S.
CR Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Beckham J. D., 2016, JAMA NEUROL
   Browning DJ, 2014, HYDROXYCHLOROQUINE C, P35, DOI [DOI 10.1007/978-1-4939-0597-3_2, 10.1007/978-1-4939-0597-3_2]
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9
   Chandra RS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-122
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Fakeye T O, 2002, West Afr J Med, V21, P286
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hsieh SC, 2014, J BIOL CHEM, V289, P33149, DOI 10.1074/jbc.M114.610428
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Law I, 2008, BRIT J CLIN PHARMACO, V65, P674, DOI 10.1111/j.1365-2125.2008.03111.x
   Lee SJ, 2008, EUR J CLIN PHARMACOL, V64, P987, DOI 10.1007/s00228-008-0500-z
   LEVY M, 1991, AM J PERINAT, V8, P174, DOI 10.1055/s-2007-999371
   Li C, 2016, CELL STEM CELL
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   MACKENZIE AH, 1983, AM J MED, V75, P40, DOI 10.1016/0002-9343(83)91269-X
   Maramorosch K., 2003, FLAVIVIRUSES STRUCTU, V59
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Paz-Bailey G, 2017, N ENGL J MED
   Radeva-Petrova D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub3
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TITUS EO, 1989, THER DRUG MONIT, V11, P369, DOI 10.1097/00007691-198911040-00001
   WOLFE MS, 1985, BRIT MED J, V290, P1466, DOI 10.1136/bmj.290.6480.1466
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 43
TC 41
Z9 43
U1 4
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 17
PY 2017
VL 7
AR 15771
DI 10.1038/s41598-017-15467-6
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FN0HJ
UT WOS:000415658600016
PM 29150641
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fuller, TL
   Calvet, G
   Estevam, CG
   Angelo, JR
   Abiodun, GJ
   Halai, UA
   De Santis, B
   Sequeira, PC
   Araujo, EM
   Sampaio, SA
   de Mendonca, MCL
   Fabri, A
   Ribeiro, RM
   Harrigan, R
   Smith, TB
   Gabaglia, CR
   Brasil, P
   de Filippis, AMB
   Nielsen-Saines, K
AF Fuller, Trevon L.
   Calvet, Guilherme
   Estevam, Camila Genaro
   Angelo, Jussara Rafael
   Abiodun, Gbenga J.
   Halai, Umme-Aiman
   De Santis, Bianca
   Sequeira, Patricia Carvalho
   Araujo, Eliane Machado
   Sampaio, Simone Alves
   Lima de Mendonca, Marco Cesar
   Fabri, Allison
   Ribeiro, Rita Maria
   Harrigan, Ryan
   Smith, Thomas B.
   Gabaglia, Claudia Raja
   Brasil, Patricia
   Bispo de Filippis, Ana Maria
   Nielsen-Saines, Karin
TI Behavioral, climatic, and environmental risk factors for Zika and
   Chikungunya virus infections in Rio de Janeiro, Brazil, 2015-16
SO PLOS ONE
LA English
DT Article
ID GLOBAL BURDEN; DENGUE; TRANSMISSION; OUTBREAK; DISEASES; STATES
AB The burden of arboviruses in the Americas is high and may result in long-term sequelae with infants disabled by Zika virus infection (ZIKV) and arthritis caused by infection with Chikungunya virus (CHIKV). We aimed to identify environmental drivers of arbovirus epidemics to predict where the next epidemics will occur and prioritize municipalities for vector control and eventual vaccination. We screened sera and urine samples (n = 10,459) from residents of 48 municipalities in the state of Rio de Janeiro for CHIKV, dengue virus (DENV), and ZIKV by molecular PCR diagnostics. Further, we assessed the spatial pattern of arbovirus incidence at the municipal and neighborhood scales and the timing of epidemics and major rainfall events. Lab-confirmed cases included 1,717 infections with ZIKV (43.8%) and 2,170 with CHIKV (55.4%) and only 29 (< 1%) with DENV. ZIKV incidence was greater in neighbor-hoods with little access to municipal water infrastructure (r = -0.47, p = 1.2x10(-8)). CHIKV incidence was weakly correlated with urbanization (r = 0.2, p = 0.02). Rains began in October 2015 and were followed one month later by the largest wave of ZIKV epidemic. ZIKV cases markedly declined in February 2016, which coincided with the start of a CHIKV outbreak. Rainfall predicted ZIKV and CHIKV with a lead time of 3 weeks each time. The association between rainfall and epidemics reflects vector ecology as the larval stages of Aedes aegypti require pools of water to develop. The temporal dynamics of ZIKV and CHIKV may be explained by the shorter incubation period of the viruses in the mosquito vector; 2 days for CHIKV versus 10 days for ZIKV.
C1 [Fuller, Trevon L.; Harrigan, Ryan; Smith, Thomas B.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA.
   [Calvet, Guilherme; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Estevam, Camila Genaro] Univ Estadual Sao Paulo, Rio Claro, SP, Brazil.
   [Angelo, Jussara Rafael] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.
   [Abiodun, Gbenga J.] Fdn Profess Dev, Pretoria, Gauteng, South Africa.
   [Halai, Umme-Aiman; Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA USA.
   [De Santis, Bianca; Sequeira, Patricia Carvalho; Araujo, Eliane Machado; Sampaio, Simone Alves; Lima de Mendonca, Marco Cesar; Fabri, Allison; Ribeiro, Rita Maria; Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Referencia Flavivirus, Rio De Janeiro, Brazil.
   [Smith, Thomas B.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA.
   [Gabaglia, Claudia Raja] Cty Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Halai, Umme-Aiman] Cty Los Angeles Dept Publ Hlth, Los Angeles, CA USA.
RP Fuller, TL (corresponding author), Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA.
EM fullertl@ucla.edu
RI Fuller, Trevon/B-8087-2014; Calvet, Guilherme/G-6959-2013
OI Fuller, Trevon/0000-0001-9954-4267; Genaro Estevam,
   Camila/0000-0001-6971-9580; Calvet, Guilherme/0000-0002-3545-5238;
   Abiodun, Gbenga/0000-0002-6805-2128
FU European Union's Horizon research and innovation program (Zika action)
   [734857]; European Union's Horizon research and innovation program (Zika
   plan) [734584]; Fundacao de Amparo a Pesquisa do Estado do Rio de
   JaneiroCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-18/2015TXB]; National Council for
   Scientific and Technological Development of BrazilNational Council for
   Scientific and Technological Development (CNPq); Oswaldo Cruz
   Foundation/General Coordination of Public Health Laboratories/Ministry
   of Health; National Science FoundationNational Science Foundation (NSF)
   [1243524, AI28697, 1R21AI129534-01, D43TW009343]; University of
   California Global Health Institute; Pan American Health Organization
   Small Grants Programme for Research on the Zika Virus Outbreak in the
   Americas
FX This work was partially supported by: the European Union's Horizon 2020
   research and innovation program (Zika action grant agreement no. 734857
   and Zika plan grant agreement no. 734584), Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro grant no. E-18/2015TXB, National Council for
   Scientific and Technological Development of Brazil, Oswaldo Cruz
   Foundation/General Coordination of Public Health Laboratories/Ministry
   of Health, National Science Foundation grant number 1243524, a
   University of California Global Health Institute grant, National
   Institutes of Health grants AI28697, 1R21AI129534-01, and D43TW009343,
   and by the Pan American Health Organization Small Grants Programme for
   Research on the Zika Virus Outbreak in the Americas.
CR de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Battiston D, 2013, SOC INDIC RES, V112, P291, DOI 10.1007/s11205-013-0249-3
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   City Health Department of Rio de Janeiro, 2015, CAS CHIK MONTH SYMPT
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   de Lima-Camara TN, 2017, CABI CLIM CHANGE SER, P127, DOI 10.1079/9781780645377.0127
   de Oliveira AF, 2015, CIENC SAUDE COLETIVA, V20, P1027, DOI 10.1590/1413-81232015204.00372014
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064
   Flauzino RF, 2011, SAUDE SOC-SAO PAULO, V20, P225, DOI 10.1590/S0104-12902011000100023
   Flauzino Regina Fernandes, 2009, Rev. Saúde Pública, V43, P1035, DOI [10.1590/S0034-89102009005000064, 10.1590/s0034-89102009005000064]
   Flauzino RF, 2009, REV PANAM SALUD PUBL, V25, P456, DOI 10.1590/S1020-49892009000500012
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   INMET, 2017, BANC DAD MET GIC ENS
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360
   Keeling MJ, 2009, BRIT MED BULL, V92, P33, DOI 10.1093/bmb/ldp038
   Keeling M. J., 2008, MODELING INFECT DIS
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   LaBeaud AD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000247
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Litzba N, 2008, J VIROL METHODS, V149, P175, DOI 10.1016/j.jviromet.2008.01.004
   Ministerio da Saude, 2013, LEV RAPIND AED AEG L
   Ministerio da Saude, 2017, MON INT ALT CRESC DE
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rodriguez-Morales AJ, 2017, RHEUMATOL INT, V37, P1757, DOI 10.1007/s00296-017-3795-1
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Tompkins AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-65
   van Genderen FT, 2016, PLOS NEGLECT TROP D, V10, P18
   VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Vincenti-Gonzalez MF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005317
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Watts AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178211
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   *WHO, 2016, ZIK STRAT RESP PLAN, DOI DOI 10.1128/CMR.00072-15
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
NR 51
TC 16
Z9 17
U1 2
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 16
PY 2017
VL 12
IS 11
AR e0188002
DI 10.1371/journal.pone.0188002
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM8YO
UT WOS:000415378800048
PM 29145452
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dutra, HLC
   Rodrigues, SL
   Mansur, SB
   de Oliveira, SP
   Caragata, EP
   Moreira, LA
AF Carneiro Dutra, Heverton Leandro
   Rodrigues, Silvia Lomeu
   Mansur, Simone Brutman
   de Oliveira, Sofia Pimenta
   Caragata, Eric Pearce
   Moreira, Luciano Andrade
TI Development and physiological effects of an artificial diet for
   Wolbachia-infected Aedes aegypti
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ZIKA VIRUS; MOSQUITO; DENGUE; BLOOD; WMEL; TRANSMISSION; POPULATIONS;
   STRAIN; MEAL
AB The endosymbiotic bacterium Wolbachia spreads rapidly through populations of Aedes aegypti mosquitoes, and strongly inhibits infection with key human pathogens including the dengue and Zika viruses. Mosquito control programs aimed at limiting transmission of these viruses are ongoing in multiple countries, yet there is a dearth of mass rearing infrastructure specific to Wolbachia-infected mosquitoes. One example is the lack of a blood meal substitute, which accounts for the Wolbachiaspecific physiological changes in infected mosquitoes, that allows the bacterium to spread, and block viral infections. To that end, we have developed a blood meal substitute specifically for mosquitoes infected with the wMel Wolbachia strain. This diet, ADM, contains milk protein, and infant formula, dissolved in a mixture of bovine red blood cells and Aedes physiological saline, with ATP as a phagostimulant. Feeding with ADM leads to high levels of viable egg production, but also does not affect key Wolbachia parameters including, bacterial density, cytoplasmic incompatibility, or resistance to infection with Zika virus. ADM represents an effective substitute for human blood, which could potentially be used for the mass rearing of wMel-infected A. aegypti, and could easily be optimized in the future to improve performance.
C1 [Carneiro Dutra, Heverton Leandro; Rodrigues, Silvia Lomeu; Mansur, Simone Brutman; de Oliveira, Sofia Pimenta; Caragata, Eric Pearce; Moreira, Luciano Andrade] Fiocruz MS, Ctr Pesquisas Rene Rachou, Endossimbiontes & Interacao Patogeno Vetor, BR-30190002 Belo Horizonte, MG, Brazil.
   [Carneiro Dutra, Heverton Leandro] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA.
   [Caragata, Eric Pearce] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.
RP Moreira, LA (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Endossimbiontes & Interacao Patogeno Vetor, BR-30190002 Belo Horizonte, MG, Brazil.
EM luciano@minas.fiocruz.br
RI Dutra, Heverton Leandro Carneiro/V-7517-2019
OI Dutra, Heverton Leandro Carneiro/0000-0002-0917-4512; Moreira,
   Luciano/0000-0002-9240-3506
FU Bill and Melinda Gates FoundationGates Foundation
FX The authors wish to thank Prof Scott L O'Neill for the donation of the
   original wMel-infected line, Probiotica (Sr. Lucio Fernandes) and Growth
   Supplements for the donation of the proteins used in these experiments,
   Gustavo Mena Brandenberger Valente of Dimeza Alimentos Ltda for donation
   of cow blood, Dr Marcele N. Rocha for preparation and titration of ZIKV
   stocks, Dr Pedro Oliveira and Dr Marcos Sorgine for helpful discussion
   of results, and Eliane Moreira and Mariana Magalhaes for assistance with
   grant management. This work was supported by a development grant from
   the Bill and Melinda Gates Foundation to H.L.C.D.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Caragata EP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005158
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   de Oliveira CD, 2015, B ENTOMOL RES, V105, P305, DOI 10.1017/S0007485315000085
   Dobson SL, 2016, SCIENCE, V352, P526, DOI 10.1126/science.352.6285.526-b
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Gonzales KK, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121267
   Gonzales KK, 2015, PEERJ, V3, DOI 10.7717/peerj.938
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   KOGAN PH, 1990, J MED ENTOMOL, V27, P709, DOI 10.1093/jmedent/27.4.709
   Kosmidis S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00066
   Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630
   McMeniman CJ, 2011, J MED ENTOMOL, V48, P76, DOI 10.1603/ME09188
   MOSKALYK LA, 1994, PHYSIOL ENTOMOL, V19, P223, DOI 10.1111/j.1365-3032.1994.tb01046.x
   O'Neill SL, 2016, SCIENCE, V352, P526, DOI 10.1126/science.352.6285.526-a
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Pitts RJ, 2014, J INSECT PHYSIOL, V64, P1, DOI 10.1016/j.jinsphys.2014.02.012
   Ponton F, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2029
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Serbus LR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004777
   Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157
   Talyuli OAC, 2015, J INSECT PHYSIOL, V83, P1, DOI 10.1016/j.jinsphys.2015.11.007
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 31
TC 4
Z9 4
U1 1
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 16
PY 2017
VL 7
AR 15687
DI 10.1038/s41598-017-16045-6
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM7TG
UT WOS:000415282900002
PM 29146940
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gallichotte, EN
   Dinnon, KH
   Lim, XN
   Ng, TS
   Lim, EXY
   Menachery, VD
   Lok, SM
   Baric, RS
AF Gallichotte, Emily N.
   Dinnon, Kenneth H., III
   Lim, Xin-Ni
   Ng, Thiam-Seng
   Lim, Elisa X. Y.
   Menachery, Vineet D.
   Lok, Shee-Mei
   Baric, Ralph S.
TI CD-loop Extension in Zika Virus Envelope Protein Key for Stability and
   Pathogenesis
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; structural virology; stability; cryo-electron microscopy;
   flavivirus
ID FEVER 17D VACCINE; ANTIBODY; HISTORY; STILL
AB With severe disease manifestations including microcephaly, congenital malformation, and Guillain-Barre syndrome, Zika virus (ZIKV) remains a persistent global public health threat. Despite antigenic similarities with dengue viruses, structural studies have suggested the extended CD-loop and hydrogen-bonding interaction network within the ZIKV envelope protein contribute to stability differences between the viral families. This enhanced stability may lead to the augmented infection, disease manifestation, and persistence in body fluids seen following ZIKV infection. To examine the role of these motifs in infection, we generated a series of ZIKV recombinant viruses that disrupted the hydrogen-bonding network (350A, 351A, and 350A/351A) or the CD-loop extension (Delta 346). Our results demonstrate a key role for the ZIKV extended CD-loop in cell-type-dependent replication, virion stability, and in vivo pathogenesis. Importantly, the Delta 346 mutant maintains similar antigenicity to wild-type virus, opening the possibility for its use as a live-attenuated vaccine platform for ZIKV and other clinically relevant flaviviruses.
C1 [Gallichotte, Emily N.; Dinnon, Kenneth H., III; Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA.
   [Lim, Xin-Ni; Ng, Thiam-Seng; Lim, Elisa X. Y.; Lok, Shee-Mei] Duke Natl Univ Singapore, Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore.
   [Lim, Xin-Ni; Ng, Thiam-Seng; Lim, Elisa X. Y.; Lok, Shee-Mei] Natl Univ Singapore, Ctr BioImaging Sci, Singapore, Singapore.
   [Menachery, Vineet D.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA.
   [Menachery, Vineet D.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
RP Baric, RS (corresponding author), 3304 Michael Hooker Res Bldg,CB 7435, Chapel Hill, NC 27599 USA.
EM rbaric@email.unc.edu
OI Lok, Shee-Mei/0000-0003-4631-8041; Menachery,
   Vineet/0000-0001-8803-7606; Lim, Xin-Ni/0000-0001-8117-3613
FU Singapore Ministry of Education Tier 3 grantMinistry of Education,
   Singapore [MOE2012-T3-1-008]; National Research Foundation
   Investigatorship Award [NRF-NRFI2016-01]; National Research Foundation
   Competitive Research Project [NRF2016NRF-CRP001-063]; Duke-NUS Signature
   Research Programme - Ministry of Health, SingaporeMinistry of
   Health-SingaporeNational University of Singapore; US National Institute
   of Allergy and Infectious DiseasesUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [T32 AI1007419]; 
   [R01 AI107731];  [U19 AI109761];  [AI107810]
FX This research was supported by funding from R01 AI107731 (principal
   investigator, Aravinda de Silva), U19 AI109761 and AI107810 programs (R.
   S. B), Singapore Ministry of Education Tier 3 grant (MOE2012-T3-1-008),
   National Research Foundation Investigatorship Award (NRF-NRFI2016-01),
   National Research Foundation Competitive Research Project Grant
   (NRF2016NRF-CRP001-063), and the Duke-NUS Signature Research Programme
   funded by the Ministry of Health, Singapore, awarded to S. M. L.
   Training grant funding T32 AI1007419 from the US National Institute of
   Allergy and Infectious Diseases supported E. N. G.
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barrett ADT, 2017, VACCINE, V35, P5951, DOI 10.1016/j.vaccine.2017.03.032
   Collins ND, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0566-9
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Gallichotte EN, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00380-16, 10.1128/msphere.00380-16]
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Khromava AY, 2005, VACCINE, V23, P3256, DOI 10.1016/j.vaccine.2005.01.089
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   LILIENFELD AM, 1983, ENVIRON HEALTH PERSP, V52, P3, DOI 10.2307/3429643
   Lindsey NP, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw045
   Messer WB, 2016, J VIROL, V90, P5090, DOI 10.1128/JVI.00155-16
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Monath TP, 2005, HUM VACCINES, V1, P207, DOI 10.4161/hv.1.5.2221
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
NR 30
TC 7
Z9 7
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD NOV 15
PY 2017
VL 216
IS 10
BP 1196
EP 1204
DI 10.1093/infdis/jix473
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FP9IG
UT WOS:000417960100004
PM 28968838
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Andronico, A
   Dorleans, F
   Ferge, JL
   Salje, H
   Ghawche, F
   Signate, A
   Daudens-Vaysse, E
   Baudouin, L
   Dub, T
   Aubry, M
   Cao-Lormeau, VM
   Ledrans, M
   Noel, H
   Mallet, HP
   Fontanet, A
   Cabie, A
   Cauchemez, S
AF Andronico, Alessio
   Dorleans, Frederique
   Ferge, Jean-Louis
   Salje, Henrik
   Ghawche, Frederic
   Signate, Aissatou
   Daudens-Vaysse, Elise
   Baudouin, Laure
   Dub, Timothee
   Aubry, Maite
   Cao-Lormeau, Van-Mai
   Ledrans, Martine
   Noel, Harold
   Mallet, Henri-Pierre
   Fontanet, Arnaud
   Cabie, Andre
   Cauchemez, Simon
TI Real-Time Assessment of Health-Care Requirements During the Zika Virus
   Epidemic in Martinique
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE epidemic forecasts; Guillain-Barre syndrome; health-care planning; Zika
   virus
ID GUILLAIN-BARRE-SYNDROME; BLOOD-DONORS; TRANSMISSION; BRAZIL; INFLUENZA;
   OUTBREAK; STATES
AB The spread of Zika virus in the Americas has been associated with a surge in Guillain-Barre syndrome (GBS) cases. Given the severity of GBS, territories affected by Zika virus need to plan health-care resources to manage GBS patients. To inform such planning in Martinique, we analyzed Zika virus surveillance and GBS data from Martinique in real time with a modeling framework that captured dynamics of the Zika virus epidemic, the risk of GBS in Zika virus-infected persons, and the clinical management of GBS cases. We compared our estimates with those from the 2013-2014 Zika virus epidemic in French Polynesia. We were able to predict just a few weeks into the epidemic that, due to lower transmission potential and lower probability of developing GBS following infection in Martinique, the total number of GBS cases in Martinique would be substantially lower than suggested by simple extrapolations from French Polynesia. We correctly predicted that 8 intensive-care beds and 7 ventilators would be sufficient to treat GBS cases. This study showcased the contribution of modeling to inform local health-care planning during an outbreak. Timely studies that estimate the proportion of infected persons that seek care are needed to improve the predictive power of such approaches.
C1 [Andronico, Alessio; Salje, Henrik; Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, 28 Rue Docteur Roux, F-75015 Paris, France.
   [Andronico, Alessio; Salje, Henrik; Cauchemez, Simon] CNRS, Unite Rech Associee 3012, Paris, France.
   [Andronico, Alessio; Salje, Henrik; Cauchemez, Simon] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
   [Dorleans, Frederique; Daudens-Vaysse, Elise; Ledrans, Martine] French Natl Publ Hlth Agcy, Sante Publ France, Cellule Intervent Reg Cire Antilles, St Maurice, France.
   [Ferge, Jean-Louis; Signate, Aissatou; Cabie, Andre] CHU Martinique, Fort De France, Martinique, France.
   [Salje, Henrik] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Ghawche, Frederic; Baudouin, Laure] Ctr Hosp Polynesie Francaise, Tahiti, French Polynesi, France.
   [Dub, Timothee; Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France.
   [Aubry, Maite; Cao-Lormeau, Van-Mai] Inst Louis Malarde, Tahiti, French Polynesi, France.
   [Noel, Harold] French Natl Publ Hlth Agcy, Sante Publ France, St Maurice, France.
   [Mallet, Henri-Pierre] Bur Veille St, Direct Sante, Tahiti, French Polynesi, France.
   [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Chim Vivant Sante EPN7, Paris, France.
   [Cabie, Andre] INSERM, Ctr Invest Clin 1424, Fort De France, Martinique, France.
   [Cabie, Andre] Univ Antilles, Equipe Accueil 4537, Fort De France, Martinique, France.
RP Cauchemez, S (corresponding author), Inst Pasteur, Math Modelling Infect Dis Unit, 28 Rue Docteur Roux, F-75015 Paris, France.
EM simon.cauchemez@pasteur.fr
RI Cao-Lormeau, Van-Mai/H-4879-2018
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Noel,
   Harold/0000-0003-3011-9267; Cabie, Andre/0000-0003-0117-3061; Aubry,
   Maite/0000-0002-9913-5794
FU European Union's Horizon Programme through ZIKAlliance [734548];
   Investissement d'Avenir programFrench National Research Agency (ANR);
   Laboratoire d'Excellence Integrative Biology of Emerging Infectious
   Diseases program [ANR-10-LABX-62-IBEID]; Models of Infectious Disease
   Agent Study of the National Institute of General Medical Sciences; AXA
   Research Fund; Association Robert Debre
FX This work was supported by the European Union's Horizon 2020 Programme
   through ZIKAlliance (grant 734548), the Investissement d'Avenir program,
   the Laboratoire d'Excellence Integrative Biology of Emerging Infectious
   Diseases program (grant ANR-10-LABX-62-IBEID), the Models of Infectious
   Disease Agent Study of the National Institute of General Medical
   Sciences, the AXA Research Fund, and the Association Robert Debre.
CR Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Aubry M, 2015, 64 ANN M AM SOC TROP
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Blateau A, 2014, B VEILLE SANITAIRE, V3, P29
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2006, AM J EPIDEMIOL, V164, P591, DOI 10.1093/aje/kwj274
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   Chretien JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094130
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gilks W.R., 1996, MARKOV CHAIN MONTE C
   Institut de la Statistique de la Polynesie Francaise, 2015, ET CIV PAR AG
   Institut National de la Statistique et des Etudes Economiques, 2016, EST POP 1 JANV 2016
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JOHANSSON MA, 2016, SCI REP UK, V6
   Lazarus C, 2016, LANCET, V388, P9, DOI 10.1016/S0140-6736(16)30509-8
   Majumder MS, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.171009, DOI 10.2471/BLT.16.171009]
   Mallet H. P., 2016, Bulletin Epidemiologique Hebdomadaire, P367
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pandey A, 2013, MATH BIOSCI, V246, P252, DOI 10.1016/j.mbs.2013.10.007
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Sante Publique France, 2011, POINTS EPID ZIK
   SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109
   WHO, WHO DIR GEN SUMM OUT
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   World Health Organization (WHO), ZIK SIT REP
NR 38
TC 5
Z9 5
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9262
EI 1476-6256
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PD NOV 15
PY 2017
VL 186
IS 10
BP 1194
EP 1203
DI 10.1093/aje/kwx008
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FN9VY
UT WOS:000416392200010
PM 28200111
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Obenauer, JF
   Joyner, TA
   Harris, JB
AF Obenauer, Julie F.
   Joyner, T. Andrew
   Harris, Joseph B.
TI The importance of human population characteristics in modeling Aedes
   aegypti distributions and assessing risk of mosquito-borne infectious
   diseases
SO TROPICAL MEDICINE AND HEALTH
LA English
DT Article
DE Aedes aegypti; Zika virus; Climate change; Species distribution model;
   Maxent; Human population; Mosquito distributions
AB Background: The mosquito Aedes aegypti has long been a vector for human illness in the Southeastern United States. In the past, it has been responsible for outbreaks of dengue, chikungunya, and yellow fever and, very recently, the Zika virus that has been introduced to the region. Multiple studies have modeled the geographic distribution of Ae. aegypti as a function of climate factors; however, this ignores the importance of humans to the anthropophilic biter. Furthermore, Ae. aegypti thrives in areas where humans have created standing water sites, such as water storage containers and trash. As models are developed to examine the potential impact of climate change, it becomes increasingly important to include the most comprehensive set of predictors possible.
   Results: This study uses Maxent, a species distribution model, to evaluate the effects of adding poverty and population density to climate-only models. Performance was evaluated through model fit statistics, such as AUC, omission, and commission, as well as individual variable contributions and response curves. Models which included both population density and poverty exhibited better predictive power and produced more precise distribution maps. Furthermore, the two human population characteristics accounted for much of the model contribution-more so than climate variables.
   Conclusions: Modeling mosquito distributions without accounting for their dependence on local human populations may miss factors that are very important to niche realization and subsequent risk of infection for humans. Further research is needed to determine if additional human characteristics should be evaluated for model inclusion.
C1 [Obenauer, Julie F.] East Tennessee State Univ, Coll Publ Hlth, Dept Epidemiol & Biostat, Johnson City, TN 37614 USA.
   [Joyner, T. Andrew; Harris, Joseph B.] East Tennessee State Univ, Coll Arts & Sci, Dept Geosci, Geoinformat & Disaster Sci Lab, Johnson City, TN 37614 USA.
   [Harris, Joseph B.] Louisiana State Univ, Coll Humanities & Social Sci, Dept Geog & Anthropol, 227 Howe Russell Kniffen Geosci Complex, Baton Rouge, LA 70803 USA.
RP Harris, JB (corresponding author), East Tennessee State Univ, Coll Arts & Sci, Dept Geosci, Geoinformat & Disaster Sci Lab, Johnson City, TN 37614 USA.; Harris, JB (corresponding author), Louisiana State Univ, Coll Humanities & Social Sci, Dept Geog & Anthropol, 227 Howe Russell Kniffen Geosci Complex, Baton Rouge, LA 70803 USA.
EM jhar183@lsu.edu
OI Harris, Joseph/0000-0002-4774-5355
NR 0
TC 6
Z9 6
U1 1
U2 14
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1348-8945
EI 1349-4147
J9 TROP MED HEALTH
JI Trop. Med. Health
PD NOV 15
PY 2017
VL 45
AR 38
DI 10.1186/s41182-017-0078-1
PG 9
WC Tropical Medicine
SC Tropical Medicine
GA FN0FO
UT WOS:000415653900001
PM 29167627
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shao, Q
   Herrlinger, S
   Zhu, YN
   Yang, M
   Goodfellow, F
   Stice, SL
   Qi, XP
   Brindley, MA
   Chen, JF
AF Shao, Qiang
   Herrlinger, Stephanie
   Zhu, Ya-Nan
   Yang, Mei
   Goodfellow, Forrest
   Stice, Steven L.
   Qi, Xiao-Peng
   Brindley, Melinda A.
   Chen, Jian-Fu
TI The African Zika virus MR-766 is more virulent and causes more severe
   brain damage than current Asian lineage and dengue virus
SO DEVELOPMENT
LA English
DT Article
DE African ZIKV (MR-766); Asian ZIKV; DENV2; Brain damage; Neuronal death
ID CROSS-REACTIVITY; CEREBRAL-CORTEX; CELL-MIGRATION; INFECTION;
   COINFECTION; BRAZIL
AB The Zika virus (ZIKV) has two lineages, Asian and African, and their impact on developing brains has not been compared. Dengue virus (DENV) is a close family member of ZIKV and co-circulates with ZIKV. Here, we performed intracerebral inoculation of embryonic mouse brains with dengue virus 2 (DENV2), and found that DENV2 is sufficient to cause smaller brain size due to increased cell death in neural progenitor cells (NPCs) and neurons. Compared with the currently circulating Asian lineage of ZIKV (MEX1-44), DENV2 grows slower, causes less neuronal death and fails to cause postnatal animal death. Surprisingly, our side-by-side comparison uncovered that the African ZIKV isolate (MR-766) is more potent at causing brain damage and postnatal lethality than MEX1-44. In comparison with MEX1-44, MR-766 grows faster in NPCs and in the developing brain, and causes more pronounced cell death in NPCs and neurons, resulting in more severe neuronal loss. Together, these results reveal that DENV2 is sufficient to cause smaller brain sizes, and suggest that the ZIKV African lineage is more toxic and causes more potent brain damage than the Asian lineage.
C1 [Shao, Qiang; Yang, Mei; Chen, Jian-Fu] Univ Southern Calif, Ctr Craniofacial Mol Biol, 2250 Alcazar St, Los Angeles, CA 90033 USA.
   [Herrlinger, Stephanie; Zhu, Ya-Nan] Univ Georgia, Dept Genet, Dept Biochem & Mol Biol, Athens, GA 30602 USA.
   [Goodfellow, Forrest; Stice, Steven L.] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA.
   [Qi, Xiao-Peng] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.
   [Brindley, Melinda A.] Univ Georgia, Dept Infect Dis, Dept Populat Hlth, Athens, GA 30602 USA.
   [Brindley, Melinda A.] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA.
RP Chen, JF (corresponding author), Univ Southern Calif, Ctr Craniofacial Mol Biol, 2250 Alcazar St, Los Angeles, CA 90033 USA.
EM Jianfu@usc.edu
RI Shao, Qiang/I-1359-2019
OI Shao, Qiang/0000-0001-5307-8264; Qi, Xiaopeng/0000-0002-7982-7486;
   Brindley, Melinda/0000-0002-4929-8085
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R00HD073269,
   R01NS097231, R01NS096176]
FX The Chen lab is supported by funds from the National Institutes of
   Health (R00HD073269, R01NS097231 and R01NS096176 to J.-F.C.). Deposited
   in PMC for release after 12 months.
CR ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chen JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4885
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   MULLEN RJ, 1992, DEVELOPMENT, V116, P201
   Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322
   Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036
   NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 38
TC 30
Z9 30
U1 0
U2 9
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD NOV 15
PY 2017
VL 144
IS 22
BP 4114
EP 4124
DI 10.1242/dev.156752
PG 11
WC Developmental Biology
SC Developmental Biology
GA FM5JJ
UT WOS:000415069600006
PM 28993398
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Carta, KAG
   Britto, IJM
   Alvirez-Gonzalez, EJ
   Morr, I
   Meza, Y
   Finizola, V
   Gomez, C
   Misticchio, F
   Martinez, N
   Allison, T
   Terzic, C
   Marques, J
   Mujica, IJM
AF Carta, Karina A. Gonzalez
   Britto, Ivan J. Mendoza
   Alvirez-Gonzalez, Enrique J.
   Morr, Igor
   Meza, Yolimar
   Finizola, Vicente
   Gomez, Coromoto
   Misticchio, Francesca
   Martinez, Nahir
   Allison, Thomas
   Terzic, Carmen
   Marques, Juan
   Mujica, Ivan J. Mendoza
TI Zika Myocarditis, Risk Factors, Prior Arbovirus Infection Brings Out the
   Worst
SO CIRCULATION
LA English
DT Meeting Abstract
CT Scientific Sessions of the American-Heart-Association / Resuscitation
   Science Symposium
CY NOV 11-15, 2017
CL Anaheim, CA
SP Amer Heart Assoc
DE Heart failure; Myocarditis; Viruses; Atrial fibrillation; Pregnancy
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD NOV 14
PY 2017
VL 136
SU 1
MA 14717
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA GL3LH
UT WOS:000437035901354
DA 2020-07-08
ER

PT J
AU Mane, PC
   Chaudhari, RD
   Shinde, MD
   Kadam, DD
   Song, CK
   Amalnerkar, DP
   Lee, H
AF Mane, Pramod C.
   Chaudhari, Ravindra D.
   Shinde, Manish D.
   Kadam, Deepali D.
   Song, Chung Kil
   Amalnerkar, Dinesh P.
   Lee, Haiwon
TI Designing Ecofriendly Bionanocomposite Assembly with Improved
   Antimicrobial and Potent on-site Zika Virus Vector Larvicidal Activities
   with its Mode of Action
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SILVER NANOPARTICLES; GOLD NANOPARTICLES; SILK FIBROIN; ANTIBACTERIAL
   ACTIVITY; ESCHERICHIA-COLI; GREEN SYNTHESIS; FATTY-ACIDS; MECHANISM;
   RESISTANCE; TOXICITY
AB Dialyzed natural polymer, fibroin, from Bombyx mori was used to synthesize biocompatible silver and gold nanoparticles in-situ in dispersion form. The films of pure fibroin (PF), fibroin-silver nanocomposite (FSNC) and fibroin-gold nanocomposite (FGNC) were fabricated by drop casting method. The characterization of the resultant dispersion and films was performed by visual color change, UV-Vis spectroscopy and atomic force microscopy. The dispersions of PF, FSNC and FGNC were tested for antibacterial activity against E. coli NCIM 2065, S. aureus NCIM 5021, K. pneumoniae NCIM 2957, P. aeruginosa ATCC 9027 and antifungal activity against A. fumigatus NCIM 902. FSNC dispersion exhibited an effective antimicrobial action against all the tested microbes as compared to FGNC dispersion. The mechanism of action for FSNC and FGNC against these microorganisms is proposed. Additionally, the larvicidal activity of the films was investigated against the larvae of Aedes aegypti. The films of FSNC exhibited 100% mortality while the films of FGNC revealed 86-98% mortality against all the larval instars and pupae of A. aegypti. The phytotoxicity study of the nanocomposite films was also carried out to confirm the reusability of water. This is first noble metal nanocomposite based report on larvicidal activity of zika virus vector.
C1 [Mane, Pramod C.; Chaudhari, Ravindra D.; Kadam, Deepali D.] Shri Shiv Chhatrapati Coll Arts Commerce & Sci, PG Dept Zool, Pune 410502, Maharashtra, India.
   [Mane, Pramod C.; Chaudhari, Ravindra D.; Kadam, Deepali D.] Shri Shiv Chhatrapati Coll Arts Commerce & Sci, Res Ctr, Pune 410502, Maharashtra, India.
   [Shinde, Manish D.] Ctr Mat Elect Technol, Off Pashan Rd, Pune 411008, Maharashtra, India.
   [Song, Chung Kil; Amalnerkar, Dinesh P.; Lee, Haiwon] Hanyang Univ, Inst Nano Sci & Technol, Seoul 04763, South Korea.
   [Amalnerkar, Dinesh P.] Sungkyunkwan Univ, Sch Mech Engn, Suwon 440746, South Korea.
   [Lee, Haiwon] Hanyang Univ, Dept Chem, Seoul 04763, South Korea.
RP Chaudhari, RD (corresponding author), Shri Shiv Chhatrapati Coll Arts Commerce & Sci, PG Dept Zool, Pune 410502, Maharashtra, India.; Chaudhari, RD (corresponding author), Shri Shiv Chhatrapati Coll Arts Commerce & Sci, Res Ctr, Pune 410502, Maharashtra, India.; Amalnerkar, DP; Lee, H (corresponding author), Hanyang Univ, Inst Nano Sci & Technol, Seoul 04763, South Korea.; Amalnerkar, DP (corresponding author), Sungkyunkwan Univ, Sch Mech Engn, Suwon 440746, South Korea.; Lee, H (corresponding author), Hanyang Univ, Dept Chem, Seoul 04763, South Korea.
EM rdchaudhari2004@yahoo.co.in; dpa54@yahoo.co.in; haiwon@hanyang.ac.kr
RI Shinde, Manish/AAQ-7814-2020
FU ISRO - UoP Space Technology Cell [STC/1552]; Ministry of Science, ICT
   and Planning (MSIP, S. Korea) through KOFST; National Research
   Foundation [2012M3A7B4035286]
FX The authors are thankful to the Chairman & Trustees, Junnar Taluka
   Shivner Shikshan Prasarak Mandal and the Officiating Principal, Shri
   Shiv Chhatrapati College, Junnar for continuous encouragement. Generous
   funding from ISRO - UoP Space Technology Cell, for the research project
   no. STC/1552 is thankfully acknowledged. Dr. Dinesh Amalnerkar is
   grateful to Ministry of Science, ICT and Planning (MSIP, S. Korea) for
   financial support through Brain Pool Program of KOFST. This work was
   partly supported by National Research Foundation (Grant Number
   2012M3A7B4035286).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Agnihotri S, 2013, NANOSCALE, V5, P7328, DOI 10.1039/c3nr00024a
   Akinpelu DA, 2004, SCI FOCUS J, V7, p[64, 70]
   Ali DM, 2011, DIG J NANOMATER BIOS, V6, P385
   American Society of Health-System Pharmacists, 2016, CLOTR MON PROF
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Benko-Iseppon AM, 2010, CURR PROTEIN PEPT SC, V11, P189, DOI 10.2174/138920310791112129
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Bhattacharyya A, 2010, AFR J BIOTECHNOL, V9, P3489
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chudasama B, 2010, J NANOPART RES, V12, P1677, DOI 10.1007/s11051-009-9845-1
   Emami-Karvani Z, 2011, AFR J MICROBIOL RES, V5, P1368
   Fang B, 2015, COLLOID SURFACE B, V125, P255, DOI 10.1016/j.colsurfb.2014.10.043
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fei X, 2013, BIOMACROMOLECULES, V14, P4483, DOI 10.1021/bm4014149
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Ghosh SK, 2007, CHEM REV, V107, P4797, DOI 10.1021/cr0680282
   Gnanadesigan M, 2011, ASIAN PAC J TROP MED, V4, P799, DOI 10.1016/S1995-7645(11)60197-1
   Gopinath V, 2012, COLLOID SURFACE B, V96, P69, DOI 10.1016/j.colsurfb.2012.03.023
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   Grass G, 2011, APPL ENVIRON MICROB, V77, P1541, DOI 10.1128/AEM.02766-10
   Hatchett D. W., 2005, J PHYS CHEM, V100, P9854
   HEIPIEPER HJ, 1992, APPL ENVIRON MICROB, V58, P1847, DOI 10.1128/AEM.58.6.1847-1852.1992
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Ingle A, 2008, CURR NANOSCI, V4, P141, DOI 10.2174/157341308784340804
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   IROBI ON, 1994, J ETHNOPHARMACOL, V43, P185, DOI 10.1016/0378-8741(94)90041-8
   Karsha PV, 2010, INDIAN J NATURAL PRO, V1, P213
   Kimberlin DW, 1996, J ANTIMICROB CHEMOTH, V37, P403, DOI 10.1093/jac/37.3.403
   LEBEL M, 1988, PHARMACOTHERAPY, V8, P3
   Lei Z, 2008, BIOL TRACE ELEM RES, V121, P69, DOI 10.1007/s12011-007-8028-0
   Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maiti S, 2014, J ANAL SCI TECHNOL, V5, P40, DOI DOI 10.1186/S40543-014-0040-3
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mantsumara Y., 2003, APPL ENVIRON MICROB, V69, P4278
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Mondal N. K., 2014, Asian Pacific Journal of Tropical Disease, V4, pS204
   MOORE S, 1948, METHOD ENZYMOL, P468
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   MubarakAli D, 2011, COLLOID SURFACE B, V85, P360, DOI 10.1016/j.colsurfb.2011.03.009
   Musante C, 2012, ENVIRON TOXICOL, V27, P510, DOI 10.1002/tox.20667
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oliveira Amanda A, 2013, Springerplus, V2, P371, DOI 10.1186/2193-1801-2-371
   Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085
   Perumalsamy H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0848-8
   Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32
   Prathna TC, 2011, COLLOID SURFACE B, V82, P152, DOI 10.1016/j.colsurfb.2010.08.036
   Raffi M, 2008, J MATER SCI TECHNOL, V24, P192
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j
   Reddy KM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742324
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Salunkhe RB, 2011, PARASITOL RES, V109, P823, DOI 10.1007/s00436-011-2328-1
   Santhoshkumar T, 2011, PARASITOL RES, V108, P693, DOI 10.1007/s00436-010-2115-4
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sato K, 2003, J AM CHEM SOC, V125, P8102, DOI 10.1021/ja034876s
   Scheidner W. C., 1957, ENZYMOLOGY, P680
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Soni N, 2012, ASIAN PAC J TROP DIS, V2, pS356, DOI DOI 10.1016/S2222-1808(12)60181-9
   Sparks TC, 2013, PESTIC BIOCHEM PHYS, V107, P1, DOI 10.1016/j.pestbp.2013.05.014
   Spencer L. R., 2004, PUBLIC HLTH MICROBIO
   Sun RWY, 2005, CHEM COMMUN, P5059, DOI 10.1039/b510984a
   Ulkur E, 2005, BURNS, V31, P874, DOI 10.1016/j.burns.2005.05.002
   Nguyen VQ, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0049-1
   World Health Organization, 1996, CTDWHOPESIC96169
   Zhang YQ, 1998, APPL BIOCHEM BIOTECH, V75, P215, DOI 10.1007/BF02787776
   Zheng L, 2005, BIOL TRACE ELEM RES, V104, P83, DOI 10.1385/BTER:104:1:083
   2010, WORLD MAL REP 2010, P1
NR 73
TC 3
Z9 3
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 14
PY 2017
VL 7
AR 15531
DI 10.1038/s41598-017-15537-9
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM6MF
UT WOS:000415166000027
PM 29138496
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Alva-Urcia, C
   Aguilar-Luis, MA
   Palomares-Reyes, C
   Silva-Caso, W
   Suarez-Ognio, L
   Weilg, P
   Manrique, C
   Vasquez-Achaya, F
   del Valle, LJ
   del Valle-Mendoza, J
AF Alva-Urcia, Carlos
   Angel Aguilar-Luis, Miguel
   Palomares-Reyes, Carlos
   Silva-Caso, Wilmer
   Suarez-Ognio, Luis
   Weilg, Pablo
   Manrique, Carlos
   Vasquez-Achaya, Fernando
   del Valle, Luis J.
   del Valle-Mendoza, Juana
TI Emerging and reemerging arboviruses: A new threat in Eastern Peru
SO PLOS ONE
LA English
DT Article
ID MAYARO VIRUS-INFECTION; ZIKA VIRUS; AMAZON BASIN; DENGUE; PCR;
   EPIDEMIOLOGY; DIAGNOSIS; DISEASES; AMERICA
AB Background
   Arboviral diseases are one of the most common causes of acute febrile illness (AFI) and a significant health problem in South America. In Peru, laboratory etiologic identification of these infections occurs in less than 50% of cases, leading to underdiagnoses of important emerging arboviruses.
   Aim
   To assess the prevalence of the Dengue (DENV), Oropouche (OROV), Chikungunya (CHIKV), Mayaro (MAYV) and Zika (ZIKV) viruses in patients with acute febrile illness from Puerto Maldonado (Peru).
   Methodology
   Serum samples were obtained from patients with AFI during January 2016 to March 2016. A total of 139 specimens were analyzed for the presence of DENV, OROV, CHIKV, MAYV, and ZIKV using polymerase chain reaction (PCR).
   Results
   CHIKV in 9.4% and OROV in 8.6% were the most prevalent arboviruses, followed by DENV and ZIKV, with a prevalence of 6.5% and 5%, respectively. Among all patients, the most common symptoms accompanying fever were headaches 79.9%, muscle pain 65.5% and joint pain 63.3%.
   Conclusions
   During this short 3-month period, 4 arboviruses were detected by PCR, CHIKV and OROV being the most common arboviruses in Puerto Maldonado (Peru). Thus, it is crucial to include OROV detection in the national health surveillance. Furthermore, the etiologic clinical diagnosis of arboviral infections is not possible due to the low specificity of symptoms; therefore an increase of cases confirmed by molecular diagnostic methods will enhance arboviral surveillance in Peru.
C1 [Alva-Urcia, Carlos; Angel Aguilar-Luis, Miguel; Palomares-Reyes, Carlos; Silva-Caso, Wilmer; Suarez-Ognio, Luis; Vasquez-Achaya, Fernando; del Valle-Mendoza, Juana] Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Sch Med, Lima, Peru.
   [Angel Aguilar-Luis, Miguel; Palomares-Reyes, Carlos; Silva-Caso, Wilmer; Weilg, Pablo; Vasquez-Achaya, Fernando; del Valle-Mendoza, Juana] Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Res & Innovat Ctr, Lima, Peru.
   [Angel Aguilar-Luis, Miguel; Silva-Caso, Wilmer; del Valle-Mendoza, Juana] IIN, Lab Mol Biol, Lima, Peru.
   [Manrique, Carlos] Direcc Reg Salud Madre De Dios DIRESA Madre De D, Madre De Dios, Peru.
   [del Valle, Luis J.] UPC, Barcelona Res Ctr Multiscale Sci & Engn, Dept Engn Quim, EEBE,Barcelona Tech, Barcelona, Spain.
RP Aguilar-Luis, MA; del Valle-Mendoza, J (corresponding author), Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Sch Med, Lima, Peru.; Aguilar-Luis, MA; del Valle-Mendoza, J (corresponding author), Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Res & Innovat Ctr, Lima, Peru.; Aguilar-Luis, MA; del Valle-Mendoza, J (corresponding author), IIN, Lab Mol Biol, Lima, Peru.
EM ma23aguilar@gmail.com; jdelvall@upc.edu.pe
RI Palomares Reyes, Carlos Cesar/Q-1255-2018; Vasquez Achaya,
   Fernando/I-6380-2017; del Valle Mendoza, Juana/C-9805-2018; Caso, Wilmer
   Gianfranco Silva/D-2699-2018; Del Valle, Luis J./I-1342-2015;
   Aguilar-Luis, Miguel Angel/C-8686-2018
OI Palomares Reyes, Carlos Cesar/0000-0002-7027-1952; Vasquez Achaya,
   Fernando/0000-0003-3627-7688; del Valle Mendoza,
   Juana/0000-0002-6011-5040; Caso, Wilmer Gianfranco
   Silva/0000-0003-1086-8084; Del Valle, Luis J./0000-0001-9916-1741;
   Aguilar-Luis, Miguel Angel/0000-0001-7023-3190; Weilg Espejo, Pablo
   Renato/0000-0002-9711-2193
FU Programa Nacional de Innovacion para la Competitividad y Productividad
   (Innovate Peru) [116-PNICP-PIAP-2015]
FX This project was supported by "Programa Nacional de Innovacion para la
   Competitividad y Productividad (Innovate Peru)-contract
   116-PNICP-PIAP-2015. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315
   Aguilar-Leon Pool, 2016, Infez Med, V24, P172
   Baisley KJ, 1998, AM J TROP MED HYG, V59, P710, DOI 10.4269/ajtmh.1998.59.710
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   CHAVEZ R, 1992, REV FARMACOL TERAP L, V2, P12
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   García María P, 2016, Rev. perú. med. exp. salud publica, V33, P380, DOI 10.17843/rpmesp.2016.332.2098
   Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010
   Levy-Blitchtein S, 2016, ASIAN PAC J TROP MED, V9, P997, DOI 10.1016/j.apjtm.2016.07.030
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Lorenzi OD, 2013, AM J TROP MED HYG, V88, P472, DOI 10.4269/ajtmh.12-0373
   Ministerio de Salud del Peru (MINSA), 2016, B EP 03, V03
   Ministerio de Salud (MINSA), 2016, MINS EM AL EP ANT CI
   Ministerio de Salud (MINSA), 2016, RES MIN
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Naing C, 2012, T ROY SOC TROP MED H, V106, P331, DOI 10.1016/j.trstmh.2012.03.003
   Neumayr A, 2012, EMERG INFECT DIS, V18, P695, DOI 10.3201/eid1804.111717
   Peyrefitte CN, 2005, EMERG INFECT DIS, V11, P757, DOI 10.3201/eid1105.040959
   Red Nacional de Epidemiologia (RENACE), 2016, VIG SINDR FEBR AR AL
   Red Nacional de Epidemiologia (RENACE), 2016, CAS DENG DEP PER 201
   Salmon-Mulanovich G, 2015, AM J TROP MED HYG, V93, P684, DOI 10.4269/ajtmh.14-0755
   Simmons M, 2016, J CLIN MICROBIOL, V54, P1766, DOI 10.1128/JCM.00299-16
   Tam PYI, 2016, J PEDIAT INF DIS SOC, V5, P190, DOI 10.1093/jpids/piw016
   Tantalean-Yepez D, 2016, ASIAN PAC J TROP MED, V9, P819, DOI 10.1016/j.apjtm.2016.06.018
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   WHO, 2017, DIS OUTBREAK NE 0208
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 32
TC 10
Z9 10
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 14
PY 2017
VL 12
IS 11
AR e0187897
DI 10.1371/journal.pone.0187897
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM5YZ
UT WOS:000415121200043
PM 29136650
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rosenfeld, AB
   Doobin, DJ
   Warren, AL
   Racaniello, VR
   Vallee, RB
AF Rosenfeld, Amy B.
   Doobin, David J.
   Warren, Audrey L.
   Racaniello, Vincent R.
   Vallee, Richard B.
TI Replication of early and recent Zika virus isolates throughout mouse
   brain development
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE flavivirus; Zika virus; neurotropism; microcephaly; cortical
   malformations
ID MOLECULAR-GENETICS; ORGANOIDS; INFECTION; EXPRESSION; MIGRATION;
   REVEALS; ORIGIN; CELLS
AB Fetal infection with Zika virus (ZIKV) can lead to congenital Zika virus syndrome (cZVS), which includes cortical malformations and microcephaly. The aspects of cortical development that are affected during virus infection are unknown. Using organotypic brain slice cultures generated from embryonic mice of various ages, sites of ZIKV replication including the neocortical proliferative zone and radial columns, as well as the developing midbrain, were identified. The infected radial units are surrounded by uninfected cells undergoing apoptosis, suggesting that programmed cell death may limit viral dissemination in the brain and may constrain virus-associated injury. Therefore, a critical aspect of ZIKV-induced neuropathology may be defined by death of uninfected cells. All ZIKV isolates assayed replicated efficiently in early and midgestation cultures, and two isolates examined replicated in late-gestation tissue. Alteration of neocortical cytoarchitecture, such as disruption of the highly elongated basal processes of the radial glial progenitor cells and impairment of postmitotic neuronal migration, were also observed. These data suggest that all lineages of ZIKV tested are neurotropic, and that ZIKV infection interferes with multiple aspects of neurodevelopment that contribute to the complexity of cZVS.
C1 [Rosenfeld, Amy B.; Warren, Audrey L.; Racaniello, Vincent R.] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, 630 W 168th St, New York, NY 10032 USA.
   [Doobin, David J.; Vallee, Richard B.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, 630 W 168th St, New York, NY 10032 USA.
RP Rosenfeld, AB (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, 630 W 168th St, New York, NY 10032 USA.
EM abr22@cumc.columbia.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [GM105536, AI121944, AI102597];
   National Institute of Neurological Disorders and StrokeUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [F30NS095577]
FX We thank the members of the R.B.V. laboratory; Drs. Alex Baffett, Hynek
   Wichterle, Franck Polleux, Gregg Gundersen, Yosef Sabo, Elisa Canepa,
   Stav Kameny, and Leslie Vosshall for technical expertise and feedback;
   and Drs. Connie Cepko and Lucia Gama for providing reagents. This
   project was supported by NIH GM105536 (to R.B.V.), National Institute of
   Neurological Disorders and Stroke F30NS095577 (to D.J.D.), and NIH
   AI121944 and AI102597 (to V.R.R.).
CR Baffet AD, 2016, METHOD CELL BIOL, V131, P349, DOI 10.1016/bs.mcb.2015.06.013
   Barkovich AJ, 1996, NEUROPEDIATRICS, V27, P59, DOI 10.1055/s-2007-973750
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Carabalona A, 2012, HUM MOL GENET, V21, P1004, DOI 10.1093/hmg/ddr531
   Centers for Disease Control and Prevention, 2017, CONG ZIK VIR INF IN
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Doobin DJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12551
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3
   GAHWILER BH, 1984, NEUROSCIENCE, V13, P681, DOI 10.1016/0306-4522(84)90088-5
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mochida GH, 2009, SEMIN PEDIATR NEUROL, V16, P120, DOI 10.1016/j.spen.2009.07.001
   Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   National Research Council, 2011, GUIDE CARE USE LAB A
   Nunes AT, 2016, PROTEOMICS, V16, P2582, DOI 10.1002/pmic.201600126
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244
   RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425
   RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105
   Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7
   SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Steele RW, 2016, CLIN PEDIATR, V55, P698, DOI 10.1177/0009922816638660
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
NR 46
TC 20
Z9 20
U1 0
U2 9
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 14
PY 2017
VL 114
IS 46
BP 12273
EP 12278
DI 10.1073/pnas.1714624114
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM6OL
UT WOS:000415173300068
PM 29087938
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Alexandra, VC
   Therese, R
   Hans, H
   Annette, B
   Mathilde, HI
AF Alexandra, Voekt Cora
   Therese, Rinderknecht
   Hans, Hirsch
   Annette, Blaich
   Mathilde, Hoesli Irene
TI Ultrasound indications for maternal STORCH testing in pregnancy
SO SWISS MEDICAL WEEKLY
LA English
DT Article
DE STORCH; congenital infection; fetal ultrasound; abnormalities; CMV
ID CONGENITAL CYTOMEGALOVIRUS DISEASE; PARVOVIRUS B19 INFECTION;
   INTRAUTERINE FETAL-DEATH; HERPES-SIMPLEX VIRUSES;
   CENTRAL-NERVOUS-SYSTEM; PRENATAL-DIAGNOSIS; ZIKA VIRUS; ECHOGENIC FOCI;
   CMV INFECTION; TORCH COMPLEX
AB AIMS OF THE STUDY: Fetal abnormalities found on ultrasonography lead to a variety of diagnostic procedures, including a panel of serologies to detect possible maternal STORCH infections encompassing syphilis, Toxoplasma gondii, rubella, cytomegalovirus, herpes simplex, and others (human immunodeficiency virus, hepatitis B and C, parvovirus B19, enterovirus, varicella zoster, and Leptospira interrogans). The value of indiscriminate testing for infections upon the detection of fetal ultrasound abnormalities has been questioned. The aim of this study was to review the ultrasonographic abnormalities leading to maternal STORCH panels at the obstetrics department of a university hospital.
   METHODS: Laboratory results of all maternal STORCH tests requested after the detection of ultrasonographic abnormalities during a 5-year period (2008-2012) were analysed. The main ultrasound findings possibly caused by congenital infection were noted, and the outcomes of confirmed maternal and fetal infections were studied.
   RESULTS: In our study period, 392 maternal STORCH tests were performed because of fetal ultrasound abnormalities. The most common findings leading to STORCH testing were intrauterine growth restriction (30.4%) including microcephaly (1.5%), polyhydramnios (14.8%), and intrauterine fetal demise (13.3%). Maternal STORCH infections were found in 3.4% of growth-restricted fetuses, 5.2% of polyhydramnios, and 1.9% of intrauterine fetal demise. The leading aetiologies were cytomegalovirus and parvovirus B19. All seven congenital infections displayed multiple ultrasonographic abnormalities.
   CONCLUSION: Ultrasonographic findings associated with fetal infection are neither sensitive nor specific. Testing for STORCH infections should take into account exposure history, clinical signs and symptoms, obstetric history, and fetal ultrasound findings, but with special attention paid to cytomegalovirus and parvovirus B19.
C1 [Alexandra, Voekt Cora] Hosp Grabs, Dept Obstet, Grabs, Switzerland.
   [Therese, Rinderknecht] Univ Basel, Basel, Switzerland.
   [Hans, Hirsch] Univ Basel, Dept Biomed, Div Infect Diagnost, Basel, Switzerland.
   [Hans, Hirsch] Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland.
   [Annette, Blaich] Univ Hosp Basel, Div Clin Microbiol, Basel, Switzerland.
   [Mathilde, Hoesli Irene] Univ Hosp Basel, Dept Obstet, Basel, Switzerland.
RP Mathilde, HI (corresponding author), Univ Frauenklin, Spitalstr 31, CH-4031 Basel, Switzerland.
EM Ihoesli@uhbs.ch
OI Hirsch, Hans H./0000-0003-0883-0423
CR Abdel-Fattah SA, 2005, PRENATAL DIAG, V25, P1028, DOI 10.1002/pd.1242
   Abele H, 2012, FETAL DIAGN THER, V32, P251, DOI 10.1159/000338659
   Alanen A, 2005, BJOG-INT J OBSTET GY, V112, P50, DOI 10.1111/j.1471-0528.2004.00320.x
   AMSTEY MS, 1988, AM J OBSTET GYNECOL, V158, P775, DOI 10.1016/0002-9378(88)90071-3
   Bahlmann AS, 2016, SWISS MED FORUM, V16, P600
   Boubaker K, 2009, SWISS MED FORUM, V9, P105
   Buxmann H, 2012, J PERINAT MED, V40, P439, DOI 10.1515/jpm-2011-0257
   Canfield MA, 2006, BIRTH DEFECTS RES A, V76, P747, DOI 10.1002/bdra.20294
   Cannon MJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-70
   Carles G., 1995, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V24, P418
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   ELIZAN TS, 1969, ARCH NEUROL-CHICAGO, V20, P115, DOI 10.1001/archneur.1969.00480080015001
   Enders G, 2001, PRENATAL DIAG, V21, P362, DOI 10.1002/pd.59
   Enders M, 2008, J INFECT DIS, V197, P58, DOI 10.1086/524302
   Ergaz Z, 2006, REPROD TOXICOL, V21, P421, DOI 10.1016/j.reprotox.2005.01.006
   Fayyaz H, 2012, J MATERN-FETAL NEO M, V25, P1069, DOI 10.3109/14767058.2011.622002
   GAUNTT CJ, 1985, PEDIATRICS, V76, P64
   Gesundheit Br, 2016, BULLETIN, V30, P465
   Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8
   GRATACOS E, 1995, J INFECT DIS, V171, P1360, DOI 10.1093/infdis/171.5.1360
   Grosse SD, 2008, J CLIN VIROL, V41, P57, DOI 10.1016/j.jcv.2007.09.004
   Guerra B, 2000, AM J OBSTET GYNECOL, V183, P476, DOI 10.1067/mob.2000.106347
   Guerra B, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.052
   Ishaque S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S3
   Iwasenko JM, 2011, J INFECT DIS, V203, P1526, DOI 10.1093/infdis/jir121
   Jacquemard F, 2007, BJOG-INT J OBSTET GY, V114, P1113, DOI 10.1111/j.1471-0528.2007.01308.x
   Ji EK, 2004, J ULTRAS MED, V23, P483, DOI 10.7863/jum.2004.23.4.483
   JOHANSSON ME, 1992, SCAND J INFECT DIS, V24, P381, DOI 10.3109/00365549209061347
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Khan NA, 2000, AM J PERINAT, V17, P131, DOI 10.1055/s-2000-9288
   Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599
   Kimberlin DW, 2003, J PEDIATR-US, V143, P16, DOI 10.1016/S0022-3476(03)00192-6
   KINNEY JS, 1988, CLIN PERINATOL, V15, P727
   KNOX GE, 1978, J REPROD MED, V21, P352
   Kollmann M, 2014, ULTRASCHALL MED, V35, P350, DOI 10.1055/s-0034-1366115
   Koopman E, 1998, PRENATAL DIAG, V18, P339
   Liesnard C, 2000, OBSTET GYNECOL, V95, P881, DOI 10.1016/S0029-7844(99)00657-2
   Lipitz S, 2010, ULTRASOUND OBST GYN, V36, P709, DOI 10.1002/uog.7657
   Lipitz S, 2002, OBSTET GYNECOL, V100, P428, DOI 10.1016/S0029-7844(02)02091-4
   MODLIN JF, 1986, REV INFECT DIS, V8, P918
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NAHMIAS AJ, 1971, PEDIATR RES, V5, P405, DOI 10.1203/00006450-197108000-00144
   Nigro G, 2012, J INFECT DIS, V205, P215, DOI 10.1093/infdis/jir718
   Oliver SE, 2009, J CLIN VIROL, V46, pS22, DOI 10.1016/j.jcv.2009.08.012
   Pasquini L, 2016, PRENATAL DIAG, V36, P290, DOI 10.1002/pd.4769
   PASTUSZAK AL, 1994, NEW ENGL J MED, V330, P901, DOI 10.1056/NEJM199403313301305
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   PETRIKOVSKY BM, 1995, ULTRASOUND OBST GYN, V5, P92, DOI 10.1046/j.1469-0705.1995.05020092.x
   Plans P, 2007, BJOG-INT J OBSTET GY, V114, P1122, DOI 10.1111/j.1471-0528.2007.01454.x
   Revello MG, 2015, EBIOMEDICINE, V2, P1205, DOI 10.1016/j.ebiom.2015.08.003
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   RODIS JF, 1990, AM J OBSTET GYNECOL, V163, P1168, DOI 10.1016/0002-9378(90)90681-V
   Rudi C, 2013, SPSU JAHRESBERICHT, V2014, P615
   SHAKED Y, 1993, CLIN INFECT DIS, V17, P241, DOI 10.1093/clinids/17.2.241
   Stagno S, 1981, Birth Defects Orig Artic Ser, V17, P31
   Syridou G, 2008, J MED VIROL, V80, P1776, DOI 10.1002/jmv.21293
   Vauloup-Fellous C, 2009, J CLIN VIROL, V46, pS49, DOI 10.1016/j.jcv.2009.09.003
   von Kaisenberg CS, 2001, ULTRASOUND OBST GYN, V18, P280, DOI 10.1046/j.1469-0705.2001.00471.x
   Willame A, 2015, INT J ENV RES PUB HE, V12, P15285, DOI 10.3390/ijerph121214982
   Williams EJ, 2013, J PEDIATR-US, V163, P424, DOI 10.1016/j.jpeds.2013.02.004
   Yamamoto R, 2013, J OBSTET GYNAECOL RE, V39, P653, DOI 10.1111/j.1447-0756.2012.02012.x
NR 64
TC 0
Z9 2
U1 0
U2 4
PU E M H SWISS MEDICAL PUBLISHERS LTD
PI MUTTENZ
PA FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND
SN 1424-7860
EI 1424-3997
J9 SWISS MED WKLY
JI Swiss Med. Wkly.
PD NOV 13
PY 2017
VL 147
AR w14534
DI 10.4414/smw.2017.14534
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA FM7CZ
UT WOS:000415229600005
PM 29185251
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Wu, CC
   Chen, CH
   Shete, S
AF Wu, Chih-Chieh
   Chen, Chien-Hsiun
   Shete, Sanjay
TI Assessing current temporal and space-time anomalies of disease incidence
SO PLOS ONE
LA English
DT Article
ID SURVEILLANCE DATA; PUBLIC-HEALTH; CLUSTERS; DENGUE; INFERENCE;
   ALGORITHM; OUTBREAKS; VALUES
AB Approaches used to early and accurately characterize epidemiologic patterns of disease incidence in a temporal and spatial series are becoming increasingly important. Cluster tests are generally designed for retrospective detection of epidemiologic anomalies in a temporal or space-time series. Timely identification of anomalies of disease or poisoning incidence during ongoing surveillance or an outbreak requires the use of sensitive statistical methods that recognize an incidence pattern at the time of occurrence. This report describes 2 novel analytical methods that focus on detecting anomalies of incidence at the time of occurrence in a temporal and space-time series. The first method describes the paucity of incidence at the time of occurrence in an ongoing surveillance and is designed to evaluate whether a decline in incidence occurs on the single current day or during the most recent few days. The second method provides an overall assessment of current clustering or paucity of incidence in a space-time series, allowing for several space regions. We illustrate the application of these methods using a subsample of a temporal series of data on the largest dengue outbreak in Taiwan in 2015 since World War II and demonstrate that they are useful to efficiently monitor incoming data for current clustering and paucity of incidence in a temporal and space-time series. In light of the recent global emergence and resurgence of Zika, dengue, and chikungunya infection, these approaching for detecting current anomalies of incidence in the ongoing surveillance of disease are particularly desired and needed.
C1 [Wu, Chih-Chieh] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan, Taiwan.
   [Chen, Chien-Hsiun] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.
   [Chen, Chien-Hsiun] China Med Univ, Sch Chinese Med, Taichung, Taiwan.
   [Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA.
RP Wu, CC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan, Taiwan.
EM cc_wu@mail.ncku.edu.tw
FU Taiwan Ministry of Science and Technology [MOST104-2118-M-0 06-006,
   105-2118-M-006-008]; Academia Sinica Genomic Medicine Multicenter Study,
   TaiwanAcademia Sinica - Taiwan
FX The research presented in this manuscript was partially supported by the
   Taiwan Ministry of Science and Technology (https://www.
   most.gov.tw/en/public) grants MOST104-2118-M-0 06-006 and
   105-2118-M-006-008 to C.C.W. The grant of the Academia Sinica Genomic
   Medicine Multicenter Study, Taiwan, to C.H.C. The funder had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   EDERER F, 1964, BIOMETRICS, V20, P626, DOI 10.2307/2528500
   Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331
   Grimson RC, 2000, J TOXICOL-CLIN TOXIC, V38, P761, DOI 10.1081/CLT-100102389
   GRIMSON RC, 1993, STAT MED, V12, P1773, DOI 10.1002/sim.4780121906
   Grimson RC, 1996, STAT MED, V15, P851, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<851::AID-SIM255>3.3.CO;2-W
   GRIMSON RC, 1992, STAT MED, V11, P761, DOI 10.1002/sim.4780110607
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   HRYHORCZUK DO, 1992, J TOXICOL-CLIN TOXIC, V30, P459, DOI 10.3109/15563659209021560
   Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322
   JONES DR, 1982, INT J EPIDEMIOL, V11, P276, DOI 10.1093/ije/11.3.276
   Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186
   MANTEL N, 1976, AM J EPIDEMIOL, V104, P576, DOI 10.1093/oxfordjournals.aje.a112333
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NOBRE FF, 1994, INT J EPIDEMIOL, V23, P408, DOI 10.1093/ije/23.2.408
   Reis Ben Y, 2003, BMC Med Inform Decis Mak, V3, P2, DOI 10.1186/1472-6947-3-2
   SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737
   Sonesson C, 2003, J ROY STAT SOC A STA, V166, P5, DOI 10.1111/1467-985X.00256
   Stanaway J.D., 2016, LANCET INFECT DIS
   THOMAS DC, 1985, AM J EPIDEMIOL, V122, P1080, DOI 10.1093/oxfordjournals.aje.a114189
   WALLENSTEIN S, 1989, AM J EPIDEMIOL, V130, P1057, DOI 10.1093/oxfordjournals.aje.a115406
   WALLENSTEIN S, 1987, STAT MED, V6, P197, DOI 10.1002/sim.4780060212
   Wilder-Smith A, 2015, SCIENCE, V350, P626, DOI 10.1126/science.aab4047
   Wu CC, 2008, BIOMETRICAL J, V50, P86, DOI 10.1002/bimj.200610374
   Wu CC, 2010, COMMUN STAT-SIMUL C, V39, P612, DOI 10.1080/03610910903528335
NR 27
TC 0
Z9 0
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 13
PY 2017
VL 12
IS 11
AR e0188065
DI 10.1371/journal.pone.0188065
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM4OL
UT WOS:000414997800044
PM 29131869
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lindgren, G
   Ols, S
   Liang, F
   Thompson, EA
   Lin, A
   Hellgren, F
   Bahl, K
   John, S
   Yuzhakov, O
   Hassett, KJ
   Brito, LA
   Salter, H
   Ciaramella, G
   Lore, K
AF Lindgren, Gustaf
   Ols, Sebastian
   Liang, Frank
   Thompson, Elizabeth A.
   Lin, Ang
   Hellgren, Fredrika
   Bahl, Kapil
   John, Shinu
   Yuzhakov, Olga
   Hassett, Kimberly J.
   Brito, Luis A.
   Salter, Hugh
   Ciaramella, Giuseppe
   Lore, Karin
TI Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is
   Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+CXCR3+T
   Follicular Helper Cells
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE mRNA vaccine; adaptive immune responses; non-human primates; influenza;
   T follicular helper cells; germinal centers
ID ZIKA VIRUS-INFECTION; MEMORY TFH CELLS; GERMINAL CENTER;
   ANTIBODY-RESPONSES; T-CELLS; VACCINES PROTECT; RHESUS MACAQUES;
   PLASMA-CELLS; EFFICACY; CXCR5(+)
AB Modified mRNA vaccines have developed into an effective and well-tolerated vaccine platform that offers scalable and precise antigen production. Nevertheless, the immunological events leading to strong antibody responses elicited by mRNA vaccines are largely unknown. In this study, we demonstrate that protective levels of antibodies to hemagglutinin were induced after two immunizations of modified non-replicating mRNA encoding influenza H10 encapsulated in lipid nanoparticles (LNP) in non-human primates. While both intradermal (ID) and intramuscular (IM) administration induced protective titers, ID delivery generated this response more rapidly. Circulating H10-specific memory B cells expanded after each immunization, along with a transient appearance of plasmablasts. The memory B cell pool waned over time but remained detectable throughout the 25-week study. Following prime immunization, H10-specific plasma cells were found in the bone marrow and persisted over time. Germinal centers were formed in vaccine-draining lymph nodes along with an increase in circulating H10-specific ICOS+ PD-1+ CXCR3+ T follicular helper cells, a population shown to correlate with high avidity antibody responses after seasonal influenza vaccination in humans. Collectively, this study demonstrates that mRNA/LNP vaccines potently induce an immunological repertoire associated with the generation of high magnitude and quality antibodies.
C1 [Lindgren, Gustaf; Ols, Sebastian; Liang, Frank; Thompson, Elizabeth A.; Lin, Ang; Hellgren, Fredrika; Lore, Karin] Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, Stockholm, Sweden.
   [Lindgren, Gustaf; Ols, Sebastian; Liang, Frank; Thompson, Elizabeth A.; Lin, Ang; Hellgren, Fredrika; Lore, Karin] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.
   [Bahl, Kapil; John, Shinu; Yuzhakov, Olga; Hassett, Kimberly J.; Ciaramella, Giuseppe] Valera LLC, Cambridge, MA USA.
   [Brito, Luis A.; Salter, Hugh] Moderna Therapeut, Cambridge, MA USA.
   [Salter, Hugh] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
RP Lore, K (corresponding author), Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, Stockholm, Sweden.; Lore, K (corresponding author), Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.
EM karin.lore@ki.se
RI Thompson, Elizabeth A/M-4898-2017
OI Thompson, Elizabeth A/0000-0001-8464-9904; Ols,
   Sebastian/0000-0001-9784-7176; LIN, ANG/0000-0001-5662-1576
FU VetenskapsradetSwedish Research Council; Karolinska InstitutetKarolinska
   Institutet; China Scholarship CouncilChina Scholarship Council
FX We wish to thank Drs. Mats Spangberg and Bengt Eriksson and their
   personnel at the Astrid Fagraeus laboratory at Karolinska Institutet for
   expert assistance and care of the animals. We also thank Dr. Gunilla
   Karlsson Hedestam for advice and Tyler Sandberg and Joel Holmberg should
   be thanked for technical assistance. This study was partly supported by
   a grant to KL supported by Vetenskapsradet. GL, SO, ET, and AL are
   recipients of faculty salary grants from Karolinska Institutet. AL is
   also supported by a grant from the China Scholarship Council.
CR Bahl K, 2017, MOL THER, V25, P1316, DOI 10.1016/j.ymthe.2017.03.035
   Bentebibel SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep26494
   Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191
   Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760
   Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400
   DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443
   Geginat J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00630
   Havenar-Daughton C, 2016, CELL REP, V17, P2195, DOI 10.1016/j.celrep.2016.10.085
   Havenar-Daughton C, 2016, P NATL ACAD SCI USA, V113, P2702, DOI 10.1073/pnas.1520112113
   He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007
   Heit A, 2017, J EXP MED, V214, P2139, DOI 10.1084/jem.20161794
   Hekele A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.54
   Herati RS, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2152
   Iyer SS, 2015, J IMMUNOL, V195, P994, DOI 10.4049/jimmunol.1500083
   Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300
   Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257
   Liang F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2094
   Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031
   Ma YF, 2009, CLIN VACCINE IMMUNOL, V16, P1476, DOI 10.1128/CVI.00282-09
   Martinez-Murillo P, 2017, IMMUNITY, V46, P804, DOI 10.1016/j.immuni.2017.04.021
   Michelle DLH, 2016, F1000RES
   Michiels B, 2011, VACCINE, V29, P9159, DOI 10.1016/j.vaccine.2011.08.008
   Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012
   Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795
   Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436
   Pilkinton MA, 2017, VACCINE, V35, P329, DOI 10.1016/j.vaccine.2016.11.059
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Sage PT, 2014, J CLIN INVEST, V124, P5191, DOI 10.1172/JCI76861
   Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278
   Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002
   SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127
   Spangberg M, 2014, J IMMUNOL METHODS, V408, P137, DOI 10.1016/j.jim.2014.05.004
   Suan D, 2017, CURR OPIN IMMUNOL, V45, P97, DOI 10.1016/j.coi.2017.03.006
   Sundling C, 2013, J INFECT DIS, V207, P426, DOI 10.1093/infdis/jis696
   Trombetta CM, 2014, VACCINES-BASEL, V2, P707, DOI 10.3390/vaccines2040707
   Ulmer JB, 2016, CURR OPIN IMMUNOL, V41, P18, DOI 10.1016/j.coi.2016.05.008
   Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032
   Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004
   Zhang XM, 2014, J INFECT DIS, V210, P424, DOI 10.1093/infdis/jiu103
NR 43
TC 18
Z9 18
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD NOV 13
PY 2017
VL 8
AR 1539
DI 10.3389/fimmu.2017.01539
PG 12
WC Immunology
SC Immunology
GA FM3MF
UT WOS:000414909400001
PM 29181005
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wen, J
   Ngono, AE
   Regla-Nava, JA
   Kim, K
   Gorman, MJ
   Diamond, MS
   Shresta, S
AF Wen, Jinsheng
   Ngono, Annie Elong
   Regla-Nava, Jose Angel
   Kim, Kenneth
   Gorman, Matthew J.
   Diamond, Michael S.
   Shresta, Sujan
TI Dengue virus-reactive CD8(+) T cells mediate cross-protection against
   subsequent Zika virus challenge
SO NATURE COMMUNICATIONS
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; MOUSE MODEL; INFECTION; RESPONSES;
   CD4(+); PATHOGENESIS; LYMPHOCYTES; INSIGHTS; DISEASE; NEUTRALIZATION
AB Zika virus (ZIKV) and dengue virus (DENV) are antigenically related flaviviruses that share cross-reactivity in antibody and T cell responses, and co-circulate in increasing numbers of countries. Whether pre-existing DENV immunity can cross-protect or enhance ZIKV infection during sequential infection of the same host is unknown. Here, we show that DENV-immune Ifnar1(-/-) or wild-type C57BL/6 mice infected with ZIKV have cross-reactive immunity to subsequent ZIKV infection and pathogenesis. Adoptive transfer and cell depletion studies demonstrate that DENV-immune CD8(+) T cells predominantly mediate cross-protective responses to ZIKV. In contrast, passive transfer studies suggest that DENV-immune serum does not protect against ZIKV infection. Thus, CD8(+) T cell immunity generated during primary DENV infection can confer protection against secondary ZIKV infection in mice. Further optimization of current DENV vaccines for T cell responses might confer cross-protection and prevent antibody-mediated enhancement of ZIKV infection.
C1 [Wen, Jinsheng; Ngono, Annie Elong; Regla-Nava, Jose Angel; Kim, Kenneth; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Wen, Jinsheng; Shresta, Sujan] Wenzhou Med Univ, Sch Basic Med Sci, Inst Arboviruses, Wenzhou 325000, Zhejiang, Peoples R China.
   [Gorman, Matthew J.; Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Dept Med Mol Microbiol Pathol & Immunol, St Louis, MO 63110 USA.
   [Shresta, Sujan] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA.
RP Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.; Shresta, S (corresponding author), Wenzhou Med Univ, Sch Basic Med Sci, Inst Arboviruses, Wenzhou 325000, Zhejiang, Peoples R China.; Shresta, S (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA.
EM sujan@lji.org
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Regla-Nava, Jose
   Angel/0000-0002-5438-1369
FU NIAID/NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1R01 AI116813, R01 AI104972, P01 AI106695];
   La Jolla Institute for Allergy Immunology
FX This research was funded by NIAID/NIH grants 1R01 AI116813 (to S.S.),
   and R01 AI104972 and P01 AI106695 (to M.S.D.) and the La Jolla Institute
   for Allergy & Immunology institutional support to S.S. We would like to
   thank Anila Mamidi and Matthew Young for breeding mice and managing the
   survival study.
CR Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311
   Back Anne Tuiskunen, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.19839
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Charles A. S., 2016, PLOS CURR, V8, P97
   Clark KB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00305
   de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Ekins Sean, 2016, F1000Res, V5, P275
   Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Imrie A, 2007, J VIROL, V81, P10081, DOI 10.1128/JVI.00330-07
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   LIVINGSTON PG, 1995, J IMMUNOL, V154, P1287
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Mathew A, 1996, J CLIN INVEST, V98, P1684, DOI 10.1172/JCI118964
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Snow GE, 2014, AM J TROP MED HYG, V91, P1203, DOI 10.4269/ajtmh.14-0132
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang WW, 2015, CURR OPIN VIROL, V13, P61, DOI 10.1016/j.coviro.2015.04.007
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   Willis E, 2017, VIROLOGY, V508, P1, DOI 10.1016/j.virol.2017.04.031
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124
NR 70
TC 54
Z9 55
U1 1
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 13
PY 2017
VL 8
AR 1459
DI 10.1038/s41467-017-01669-z
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM3OH
UT WOS:000414915900021
PM 29129917
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ortiz, MR
   Le, NK
   Sharma, V
   Hoare, I
   Quizhpe, E
   Teran, E
   Naik, E
   Salihu, HM
   Izurieta, R
AF Reina Ortiz, Miguel
   Le, Nicole K.
   Sharma, Vinita
   Hoare, Ismael
   Quizhpe, Edy
   Teran, Enrique
   Naik, Eknath
   Salihu, Hamisu M.
   Izurieta, Ricardo
TI Post-earthquake Zika virus surge: Disaster and public health threat amid
   climatic conduciveness
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ECUADOR EARTHQUAKE; SWIMMING POOLS; MALARIA; HAITI; EMERGENCE; DISEASES
AB A recent major earthquake (M7.8), coupled with appropriate climatic conditions, led to significant destruction in Ecuador. Temperature variations, which may be induced by anthropogenic climate change, are often associated with changes in rainfall, humidity and pressure. Temperature and humidity are associated with ecological modifications that may favour mosquito breeding. We hypothesized that the disruptive ecological changes triggered by the earthquake, in the context of appropriate climatic conditions, led to an upsurge in Zika virus (ZIKV) infections. Here we show that, after controlling for climatic and socioeconomic conditions, earthquake severity was associated with incident ZIKV cases. Pre-earthquake mean maximum monthly temperature and post-earthquake mean monthly pressure were negatively associated with ZIKV incidence rates. These results demonstrate the dynamics of post-disaster vector-borne disease transmission, in the context of conducive/favourable climatic conditions, which are relevant in a climate change-affected world where disasters may occur in largely populated areas.
C1 [Reina Ortiz, Miguel; Hoare, Ismael; Naik, Eknath; Izurieta, Ricardo] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA.
   [Reina Ortiz, Miguel] Fdn Raices, Esmeraldas, Ecuador.
   [Le, Nicole K.; Naik, Eknath] Univ S Florida, Morsani Coll Med, Tampa, FL USA.
   [Sharma, Vinita] Univ S Florida, Coll Publ Hlth, Dept Community & Family Hlth, Tampa, FL USA.
   [Quizhpe, Edy] Minist Salud Publ Ecuador, Quito, Ecuador.
   [Quizhpe, Edy; Teran, Enrique] Univ San Francisco Quito, Colegio Ciencias Salud, Quito, Ecuador.
   [Naik, Eknath] James A Haley VA Hosp, Emergency Dept, Tampa, FL USA.
   [Salihu, Hamisu M.] Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA.
RP Izurieta, R (corresponding author), Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA.
EM rizuriet@health.usf.edu
RI Teran, Enrique/L-6000-2016
OI Teran, Enrique/0000-0001-6979-5655; Sharma, Vinita/0000-0002-5944-6264;
   Quizhpe, Edy Rolando/0000-0001-7111-5030; Reina Ortiz,
   Miguel/0000-0003-3309-6881; Hoare, Ismael/0000-0001-8853-4178
FU Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e
   Innovacion (SENESCYT), Ecuador; Fundacion Raices, Esmeraldas, Ecuador
FX We would like to thank Maria Eugenia Mejia, Ministerio de Salud Publica
   del Ecuador for her insight and review of the manuscript. The authors
   would also like to acknowledge the Ministerio de Salud Publica del
   Ecuador and the support provided by Secretaria Nacional de Educacion
   Superior, Ciencia, Tecnologia e Innovacion (SENESCYT), Ecuador and by
   Fundacion Raices, Esmeraldas, Ecuador.
CR Ajelli M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005851
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Bland SH, 1996, PSYCHOSOM MED, V58, P18, DOI 10.1097/00006842-199601000-00004
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Caillouet KA, 2008, J VECTOR ECOL, V33, P166, DOI 10.3376/1081-1710(2008)33[166:COASPB]2.0.CO;2
   Caminade C, 2016, NAT CLIM CHANGE, V6, P984, DOI 10.1038/nclimate3095
   Cash BA, 2013, NAT CLIM CHANGE, V3, P502, DOI [10.1038/nclimate1834, 10.1038/NCLIMATE1834]
   Cevallos V, 2018, ACTA TROP, V177, P74, DOI 10.1016/j.actatropica.2017.09.029
   Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928
   Contestabile M., 2014, NAT CLIM CHANGE, V4, P10
   Cordero-Reyes AM, 2017, PUBLIC HEALTH, V144, P134, DOI 10.1016/j.puhe.2016.12.003
   Costello A, 2011, NAT CLIM CHANGE, V1, P84, DOI 10.1038/nclimate1100
   Eisenberg MC, 2013, EPIDEMICS-NETH, V5, P197, DOI 10.1016/j.epidem.2013.09.004
   Escobar LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep39150
   Field C. B., 2012, IPCC MANAGING RISKS, P109
   Fuller DO, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014011
   Gharbi M, 2012, EMERG INFECT DIS, V18, P1346, DOI 10.3201/eid1808.111779
   Granda J., 2017, ANUARIO VIGILANCIA E
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Heydari N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020196
   Hodges M, 2014, NAT CLIM CHANGE, V4, P1109, DOI [10.1038/NCLIMATE2428, 10.1038/nclimate2428]
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   International Organization for Migration (IOM), 2016, DISPL EC EARTHQ SURV
   Jafari N, 2011, J RES MED SCI, V16, P956
   Jia PF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2071-2
   KINSTON W, 1974, J PSYCHOSOM RES, V18, P437, DOI 10.1016/0022-3999(74)90035-X
   Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8
   Kumari R, 2009, ACTA TROP, V112, P204, DOI 10.1016/j.actatropica.2009.07.028
   Malik A, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5902-x
   Marquetti Fernandez Maria del Carmen, 2011, Rev Cubana Med Trop, V63, P177
   MASON J, 1965, AM J TROP MED HYG, V14, P533, DOI 10.4269/ajtmh.1965.14.533
   Ministerio Coordinador de Seguridad del Ecuador, 2017, ALB OF IMPL SISM 7 8
   Ministerio de Salud Publica del Ecuador, 2016, EC CONF CAS IMP ZIK
   Moise IK, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160107
   Moise IK, 2013, ANN ASSOC AM GEOGR, V103, P1160, DOI 10.1080/00045608.2012.740362
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Ordonez A, 2016, NAT CLIM CHANGE, V6, P1104, DOI [10.1038/NCLIMATE3127, 10.1038/nclimate3127]
   Pan American Health Organization and World Health Organization, 2016, ZIK EP REP EC
   Polonsky J, 2013, PLOS CURR, V7, P5
   Poveda G, 2001, ENVIRON HEALTH PERSP, V109, P489, DOI 10.2307/3454707
   Qualls WA, 2016, J VECTOR ECOL, V41, P224, DOI 10.1111/jvec.12217
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   Reina Ortiz M., 2016, AM SOC TROP MED HYG
   Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719
   Saenz R, 1995, Prehosp Disaster Med, V10, P154
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Saleeza SNR, 2013, SE ASIAN J TROP MED, V44, P963
   Samson DM, 2015, J VECTOR ECOL, V40, P46, DOI 10.1111/jvec.12131
   Schafrick NH, 2013, AM J TROP MED HYG, V89, P758, DOI 10.4269/ajtmh.12-0485
   Semenza JC, 2013, NAT CLIM CHANGE, V3, P432, DOI 10.1038/nclimate1867
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Vasquez D, 2017, AM J PUBLIC HEALTH, V107, P1137, DOI 10.2105/AJPH.2017.303769
   Wang XN, 2017, B MATH BIOL, V79, P1155, DOI 10.1007/s11538-017-0276-3
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, ZIK VIR INF GUYAN BA
   Ye LL, 2016, EARTH PLANET SC LETT, V454, P248, DOI 10.1016/j.epsl.2016.09.006
   Zhang S, 2013, ACTA TROP, V128, P85, DOI [10.1016/j.actatropica.2013.06.015, 10.1016/j.actatropi]
NR 57
TC 5
Z9 5
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 13
PY 2017
VL 7
AR 15408
DI 10.1038/s41598-017-15706-w
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM4VF
UT WOS:000415022900044
PM 29133932
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kroelinger, CD
   Romero, L
   Lathrop, E
   Cox, S
   Morgan, I
   Frey, MT
   Warner, L
   Curtis, KM
   Pazol, K
   Barfield, WD
   Meaney-Delman, D
   Jamieson, DJ
AF Kroelinger, Charlan D.
   Romero, Lisa
   Lathrop, Eva
   Cox, Shanna
   Morgan, Isabel
   Frey, Meghan T.
   Warner, Lee
   Curtis, Kathryn M.
   Pazol, Karen
   Barfield, Wanda D.
   Meaney-Delman, Dana
   Jamieson, Denise J.
TI Meeting Summary: State and Local Implementation Strategies for
   Increasing Access to Contraception During Zika Preparedness and Response
   - United States, September 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Kroelinger, Charlan D.; Romero, Lisa; Cox, Shanna; Warner, Lee; Curtis, Kathryn M.; Pazol, Karen; Barfield, Wanda D.; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Lathrop, Eva] CDC, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA.
   [Morgan, Isabel] Associat Sch & Programs Publ Hlth, Washington, DC USA.
   [Frey, Meghan T.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Kroelinger, CD (corresponding author), CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
EM ckorelinger@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
CR Barbour RS, 2003, J EVAL CLIN PRACT, V9, P179, DOI 10.1046/j.1365-2753.2003.00371.x
   Boulet SL, 2016, MMWR-MORBID MORTAL W, V65, P780, DOI 10.15585/mmwr.mm6530e2
   Curtis KM, 2016, MMWR RECOMM REP, V65
   Dehlendorf C, 2016, CURR OBSTET GYNECOL, V5, P55, DOI 10.1007/s13669-016-0139-1
   Ellington SR, 2013, J WOMENS HEALTH, V22, P189, DOI 10.1089/jwh.2012.4178
   Gavin L, 2014, MMWR RECOMM REP, V63, P1
   Moniz MH, 2015, CONTRACEPTION, V92, P523, DOI 10.1016/j.contraception.2015.09.014
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez MI, 2014, CONTRACEPTION, V90, P468, DOI 10.1016/j.contraception.2014.07.001
NR 9
TC 6
Z9 6
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD NOV 10
PY 2017
VL 66
IS 44
BP 1230
EP 1235
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FM8BM
UT WOS:000415308700006
PM 29121000
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Faria, NR
   da Costa, AC
   Lourenco, J
   Loureiro, P
   Lopes, ME
   Ribeiro, R
   Alencar, CS
   Kraemer, MUG
   Villabona-Arenas, CJ
   Wu, CH
   Theze, J
   Khan, K
   Brent, SE
   Romano, C
   Delwart, E
   Custer, B
   Busch, MP
   Pybus, OG
   Sabino, EC
AF Faria, Nuno R.
   da Costa, Antonio Charlys
   Lourenco, Jose
   Loureiro, Paula
   Lopes, Maria Esther
   Ribeiro, Roberto
   Alencar, Cecilia Salete
   Kraemer, Moritz U. G.
   Villabona-Arenas, Christian J.
   Wu, Chieh-Hsi
   Theze, Julien
   Khan, Kamran
   Brent, Shannon E.
   Romano, Camila
   Delwart, Eric
   Custer, Brian
   Busch, Michael P.
   Pybus, Oliver G.
   Sabino, Ester C.
CA NHLBI Recipient Epidemiology
   Donor Evaluation Study
TI Genomic and epidemiological characterisation of a dengue virus outbreak
   among blood donors in Brazil
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RIO-DE-JANEIRO; AEDES-AEGYPTI; ZIKA VIRUS; REPRODUCTIVE NUMBER;
   POPULATION-DYNAMICS; CO-CIRCULATION; SEROTYPE 4; SAO-PAULO; STATE;
   SPREAD
AB Outbreaks caused by Dengue, Zika and Chikungunya viruses can spread rapidly in immunologically naive populations. By analysing 92 newly generated viral genome sequences from blood donors and recipients, we assess the dynamics of dengue virus serotype 4 during the 2012 outbreak in Rio de Janeiro. Phylogenetic analysis indicates that the outbreak was caused by genotype II, although two isolates of genotype I were also detected for the first time in Rio de Janeiro. Evolutionary analysis and modelling estimates are congruent, indicating a reproduction number above 1 between January and June, and at least two thirds of infections being unnoticed. Modelling analysis suggests that viral transmission started in early January, which is consistent with multiple introductions, most likely from the northern states of Brazil, and with an increase in within-country air travel to Rio de Janeiro. The combination of genetic and epidemiological data from blood donor banks may be useful to anticipate epidemic spread of arboviruses.
C1 [Faria, Nuno R.; Lourenco, Jose; Kraemer, Moritz U. G.; Theze, Julien; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [da Costa, Antonio Charlys; Ribeiro, Roberto; Romano, Camila; Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [da Costa, Antonio Charlys; Ribeiro, Roberto; Sabino, Ester C.] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, LIM46, Sao Paulo, Brazil.
   [Loureiro, Paula] Fundacao Hemope, Fac Ciencias Med, Recife, PE, Brazil.
   [Lopes, Maria Esther] Fundacao Hemorio, Rio De Janeiro, Brazil.
   [Alencar, Cecilia Salete] Hosp Clin Sao Paulo, Lab Invest Med LIM03, Sao Paulo, Brazil.
   [Villabona-Arenas, Christian J.] Univ Montpellier, Inst Rech Dev, Montpellier, France.
   [Wu, Chieh-Hsi] Univ Oxford, Dept Stat, Oxford, England.
   [Khan, Kamran; Brent, Shannon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Khan, Kamran] Univ Toronto, Div Infect Dis, Toronto, ON, Canada.
   [Delwart, Eric; Custer, Brian; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA.
   [Delwart, Eric; Custer, Brian; Busch, Michael P.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
RP da Costa, AC; Sabino, EC (corresponding author), Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.; da Costa, AC; Sabino, EC (corresponding author), Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, LIM46, Sao Paulo, Brazil.
EM charlysbr@yahoo.com.br; sabinoec@usp.br
RI da-Costa, Antonio Charlys/G-1548-2010; Sabino, Ester
   Cerdeira/F-7750-2010; Loureiro, Paula/A-2965-2013; Faria,
   Nuno/I-2975-2012; Romano, Camila M/C-8185-2013; Pybus, Oliver
   g/B-2640-2012
OI da-Costa, Antonio Charlys/0000-0001-5516-5177; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Loureiro, Paula/0000-0003-1849-0047;
   Faria, Nuno/0000-0001-8839-2798; Pybus, Oliver g/0000-0002-8797-2667;
   Wu, Chieh-Hsi/0000-0001-9386-725X; Lourenco, Jose/0000-0002-9318-2581
FU Sir Henry Dale Fellowship [204311/Z/16/Z]; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2012/03417-8, 2014/03417-7,
   2017/00021-9, 2016/01735-2, 2011/18955-1]; European Research Council
   under European Union's Seventh Framework Programme/ERCEuropean Research
   Council (ERC) [268904 - DIVERSITY]; Society in Science, The Branco Weiss
   Fellowship; National Institute of Child Health and Human
   DevelopmentUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [T32HD040128];
   National Library of Medicine of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM010812,
   R01LM011965]; European Research Council under European Union's Seventh
   Framework Programme/European Research Council [614725-PATHPHYLODYN]
FX N.R.F. is funded by a Sir Henry Dale Fellowship (grant 204311/Z/16/Z).
   ACC is funded by FAPESP #2012/03417-8, 2014/03417-7 and 2017/00021-9. JL
   received funding from the European Research Council under the European
   Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement
   no. 268904 - DIVERSITY. MUGK is supported by the Society in Science, The
   Branco Weiss Fellowship, administered by the ETH Zurich and acknowledges
   funding from a Training Grant from the National Institute of Child
   Health and Human Development (T32HD040128) and the National Library of
   Medicine of the National Institutes of Health (R01LM010812,
   R01LM011965). We thank Shirley Cavalcante Vasconcelos Komninakis
   (UNIFESP), Luciano Monteiro da Silva and Lucy Santos Vilas Boas,
   (IMT-USP) and Paulo Brito, director from SEOMA/RJ, for daily
   meteorological data from Rio de Janeiro municipality. This work was
   funded by FAPESP # 2016/01735-2 and 2011/18955-1, and the European
   Research Council under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/European Research Council grant agreement number
   614725-PATHPHYLODYN.
CR Acosta POA, 2011, EMERG INFECT DIS, V17, P1979, DOI 10.3201/eid1710.110776
   Andrade EHP, 2016, AM J TROP MED HYG, V94, P1080, DOI 10.4269/ajtmh.15-0892
   Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Busch MP, 2016, J INFECT DIS, V214, P49, DOI 10.1093/infdis/jiw122
   Busch MP, 2005, NEW ENGL J MED, V353, P460, DOI 10.1056/NEJMoa044029
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Codeco CT, 2009, MEM I OSWALDO CRUZ, V104, P614, DOI 10.1590/S0074-02762009000400014
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390
   Degener CM, 2014, MEM I OSWALDO CRUZ, V109, P1030, DOI 10.1590/0074-0276140234
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria N. R., 2016, PLOS CURRENTS OUTBRE, V1
   Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Gouy M, 2008, BIOCHIMIE, V90, P555, DOI 10.1016/j.biochi.2007.07.003
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Janeiro S. d. E. d. S. d. R. d., 2015, B EP 07 2015 DENG CE
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Lourenco J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003308
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Musso D., 2014, EURO SURVEILL, V19
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064
   Rambaut A., 2014, PATH O GEN V1 4
   Rasmussen DA, 2014, MOL BIOL EVOL, V31, P258, DOI 10.1093/molbev/mst203
   Rocco IM, 2012, REV INST MED TROP SP, V54, P49, DOI 10.1590/S0036-46652012000100009
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Saude S. d. V. e. S. M. d., 2016, B EPIDEMIOLOGICO
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sorichetta A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.45
   Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110
   Stadler T, 2012, MOL BIOL EVOL, V29, P347, DOI 10.1093/molbev/msr217
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694
   Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Villabona-Arenas CJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1892
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 73
TC 15
Z9 15
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 9
PY 2017
VL 7
AR 15216
DI 10.1038/s41598-017-15152-8
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM2JK
UT WOS:000414810800039
PM 29123142
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Rockstroh, A
   Moges, B
   Barzon, L
   Sinigaglia, A
   Palu, G
   Kumbukgolla, W
   Schmidt-Chanasit, J
   Sarno, M
   Brites, C
   Moreira-Soto, A
   Drexler, JF
   Ferreira, OC
   Ulbert, S
AF Rockstroh, Alexandra
   Moges, Beyene
   Barzon, Luisa
   Sinigaglia, Alessandro
   Palu, Giorgio
   Kumbukgolla, Widuranga
   Schmidt-Chanasit, Jonas
   Sarno, Manoel
   Brites, Carlos
   Moreira-Soto, Andres
   Drexler, Jan Felix
   Ferreira, Orlando C.
   Ulbert, Sebastian
TI Specific detection of dengue and Zika virus antibodies using envelope
   proteins with mutations in the conserved fusion loop
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE dengue virus; Zika virus; diagnosis; cross-reactivity; ELISA; envelope
   proteins
ID LINKED IMMUNOSORBENT ASSAYS; CROSS-REACTIVE EPITOPES; WEST-NILE;
   FLAVIVIRUS INFECTION; DIAGNOSIS; ELISA; NEUTRALIZATION; GLYCOPROTEIN;
   ENHANCEMENT; CHALLENGES
AB Detection of antibodies is widely used for the diagnosis of infections with arthropod-borne flaviviruses including dengue (DENV) and Zika virus (ZIKV). Due to the emergence of ZIKV in areas endemic for DENV, massive co-circulation is observed and methods to specifically diagnose these infections and differentiate them from each other are mandatory. However, serological assays for flaviviruses in general, and for DENV and ZIKV in particular, are compromised by the high degree of similarities in their proteins which can lead to cross-reacting antibodies and false-positive test results. Cross-reacting flavivirus antibodies mainly target the highly conserved fusion loop (FL) domain in the viral envelope (E-) protein, and we and others have shown previously that recombinant E-proteins bearing FL-mutations strongly reduce cross-reactivity. Here we investigate whether such mutant E-proteins can be used to specifically detect antibodies against DENV and ZIKV in an ELISA-format. IgM antibodies against DENV and ZIKV virus were detected with 100% and 94.2% specificity and 90.7% and 87.5% sensitivity, respectively. For IgG the mutant E-proteins showed cross-reactivity, which was overcome by pre-incubation of the sera with the heterologous antigen. This resulted in specificities of 97.1% and 97.9% and in sensitivities of 100% and 100% for the DENV and ZIKV antigens, respectively. Our results suggest that E-proteins bearing mutations in the FL-domain have a high potential for the development of serological DENV and ZIKV tests with high specificity.
C1 [Rockstroh, Alexandra; Moges, Beyene; Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Perlickstr 1, D-04103 Leipzig, Germany.
   [Barzon, Luisa; Sinigaglia, Alessandro; Palu, Giorgio] Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy.
   [Kumbukgolla, Widuranga] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Mihinthale 50008, Sri Lanka.
   [Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Schmidt-Chanasit, Jonas; Drexler, Jan Felix] Univ Fed Bahia, German Ctr Infect Res DZIF, BR-40110060 Salvador, BA, Brazil.
   [Sarno, Manoel; Brites, Carlos] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, BR-40110060 Salvador, BA, Brazil.
   [Sarno, Manoel] Univ Fed Bahia, Maternidade Climerio de Oliveira, BR-40005150 Salvador, BA, Brazil.
   [Moreira-Soto, Andres] Univ Bonn, Med Ctr, Inst Virol, D-53127 Bonn, Germany.
   [Moreira-Soto, Andres; Drexler, Jan Felix] Charite Univ Med Berlin, D-10117 Berlin, Germany.
   [Moreira-Soto, Andres; Drexler, Jan Felix] Free Univ Berlin, D-10117 Berlin, Germany.
   [Moreira-Soto, Andres; Drexler, Jan Felix] Humboldt Univ, D-10117 Berlin, Germany.
   [Moreira-Soto, Andres; Drexler, Jan Felix] Berlin Inst Hlth, Inst Virol, D-10117 Berlin, Germany.
   [Ferreira, Orlando C.] Univ Fed Rio de Janeiro, Dept Genet, Lab Mol Virol, BR-21941901 Rio de Janeiro, Brazil.
RP Ulbert, S (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Perlickstr 1, D-04103 Leipzig, Germany.
EM sebastian.ulbert@izi.fraunhofer.de
RI Barzon, Luisa/K-7961-2016
OI Barzon, Luisa/0000-0003-0720-8456; sinigaglia,
   alessandro/0000-0002-2386-1757; Drexler, Jan Felix/0000-0002-3509-0232
FU European Union (EFRE grant) [100216415]; German Academic Exchange
   Service (DAAD)Deutscher Akademischer Austausch Dienst (DAAD)
FX We thank Ulrike Ehlert and Frederik von Daak for technical assistance
   and Dr Rolf Fendel (Fraunhofer IME, Aachen, Germany) and Professor
   Matthias Niedrig (Robert-Koch Institute, Berlin, Germany) for supplying
   serum samples. Parts of the work were supported by the European Union
   (EFRE grant NO 100216415). BM was supported by a personal fellowship
   from the German Academic Exchange Service (DAAD).
CR Alagarasu K, 2016, VACCINE, V34, P2759, DOI 10.1016/j.vaccine.2016.04.070
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Barzon L, 2015, EXPERT REV ANTI-INFE, V13, P327, DOI 10.1586/14787210.2015.1007044
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chiou SS, 2008, CLIN VACCINE IMMUNOL, V15, P825, DOI 10.1128/CVI.00004-08
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Crill WD, 2007, J GEN VIROL, V88, P1169, DOI 10.1099/vir.0.82640-0
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Domingo C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0877-0
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roberson JA, 2007, J CLIN MICROBIOL, V45, P3167, DOI 10.1128/JCM.01143-07
   Rockstroh A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004218
   Sanchini A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002184
   Schwarz NG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176708
   Seligman SJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-27
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tang KF, 2012, EXPERT REV ANTI-INFE, V10, P895, DOI [10.1586/eri.12.76, 10.1586/ERI.12.76]
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 48
TC 8
Z9 9
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD NOV 8
PY 2017
VL 6
AR e99
DI 10.1038/emi.2017.87
PG 9
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FM4TR
UT WOS:000415015700004
PM 29116222
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hu, BX
   Huo, YX
   Yang, LP
   Chen, GJ
   Luo, MH
   Yang, JL
   Zhou, JM
AF Hu, Benxia
   Huo, Yongxia
   Yang, Liping
   Chen, Guijun
   Luo, Minhua
   Yang, Jinlong
   Zhou, Jumin
TI ZIKV infection effects changes in gene splicing, isoform composition and
   lncRNA expression in human neural progenitor cells
SO VIROLOGY JOURNAL
LA English
DT Article
DE lncRNA; Gene isoform; Alternative splicing; hNPC; ZIKV
ID VIRUS; REVEALS; FAMILY; RNAS; PROFILES
AB Background: The Zika virus (ZIKV) is a mosquito-borne flavivirus that causes microcephaly and Guillain-Barre syndrome in infected individuals. To obtain insights into the mechanism of ZIKV infection and pathogenesis, we analyzed the transcriptome of ZIKV infected human neural progenitor cells (hNPCs) for changes in alternative splicing (AS), gene isoform (ISO) composition and long noncoding RNAs (lncRNAs) expression.
   Methods: We analyzed differentially expressed lncRNAs, AS, ISO from RNA-seq data in ZIKV infected hNPCs.
   Results: We obtained 149 differentially expressed lncRNAs, including potential viral targets to modulate cellular processes such as cell cycle, apoptosis and immune response. The infection induced 262 cases of AS occurring in 229 genes, which were enriched in cell death, RNA processing, transport, and neuron development. Among 691 differentially expressed ISOs, upregulated ISOs were enriched in signaling, regulation of transcription, and amino acid biosynthesis, while downregulated ISOs were mostly enriched in cell cycle. Importantly, these analyses revealed specific links between ZIKV induced changes in cellular pathways and the type of changes in the host transcriptome, suggesting important regulatory mechanisms.
   Conclusions: Our analyses revealed candidate lncRNAs, AS events and ISOs which may function in ZIKV infection induced cell cycle disruption, apoptosis and attenuation of neurogenesis, and shed light on the roles of lncRNAs, AS and ISOs in virus-host interactions, and would facilitate future studies of ZIKV infection and pathogenesis.
C1 [Hu, Benxia; Huo, Yongxia; Yang, Liping; Chen, Guijun; Zhou, Jumin] Chinese Acad Sci, Key Lab Bioact Peptides Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.
   [Hu, Benxia] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming 650204, Yunnan, Peoples R China.
   [Luo, Minhua] Wuhan Inst Virol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China.
   [Yang, Jinlong] BGI Shenzhen, BGI Yunnan, Kunming 650000, Yunnan, Peoples R China.
   [Yang, Jinlong] Yunnan Univ, Coll Life Sci, Kunming 650091, Yunnan, Peoples R China.
RP Zhou, JM (corresponding author), Chinese Acad Sci, Key Lab Bioact Peptides Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.
EM zhoujm@mail.kiz.ac.cn
OI Hu, Benxia/0000-0002-7163-9018
FU Ministry of Science and Technology of the People's Republic of
   ChinaMinistry of Science and Technology, China [2016YFA0100900]; Chinese
   Academy of SciencesChinese Academy of Sciences [KSCXZ-EW-BR-6]; startup
   fund from Kunming Institute of Zoology, Chinese Academy of Sciences
   [Y102421081]; Yunnan Provincial Government [2013FA051, 2011HA005];
   National Science Foundation of ChinaNational Natural Science Foundation
   of China [NSFC 81471966, NSFC 81672040]
FX This work was supported by the Ministry of Science and Technology of the
   People's Republic of China (2016YFA0100900), by a grant from Chinese
   Academy of Sciences (KSCXZ-EW-BR-6) and a startup fund from Kunming
   Institute of Zoology, Chinese Academy of Sciences (Y102421081), by
   grants from Yunnan Provincial Government (2013FA051; 2011HA005) and by
   National Science Foundation of China (NSFC 81471966; NSFC 81672040) to
   JZ.
CR Accardi R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003186
   Adriaens C, 2016, NAT MED, V22, P861, DOI 10.1038/nm.4135
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012
   Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611
   CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1
   Collins NB, 2009, BLOOD, V113, P2181, DOI 10.1182/blood-2008-05-154294
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Denayer E, 2008, HUM MUTAT, V29, P232, DOI 10.1002/humu.20616
   Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201
   Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482
   Fahling M, 2006, J BIOL CHEM, V281, P9279, DOI 10.1074/jbc.M510925200
   Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Finci L, 2015, PROG BIOPHYS MOL BIO, V118, P153, DOI 10.1016/j.pbiomolbio.2015.04.001
   Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633
   Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798
   Hu BX, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0592-5
   Hu BX, 2016, SCI REP-UK, V6, DOI 10.1038/srep28075
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979
   KALCHEVA N, 1995, P NATL ACAD SCI USA, V92, P10894, DOI 10.1073/pnas.92.24.10894
   Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052
   Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528
   Kong R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0355-8
   Kotzin JJ, 2016, NATURE, V537, P239, DOI 10.1038/nature19346
   LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813
   Li J, 2014, CANCER CELL, V25, P118, DOI 10.1016/j.ccr.2013.12.008
   Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111
   Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Myojin R, 2004, BIOL REPROD, V71, P926, DOI 10.1095/biolreprod.104.028159
   Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597
   Neuman E, 1996, GENE, V173, P163, DOI 10.1016/0378-1119(96)00184-9
   Nojima T, 2009, NUCLEIC ACIDS RES, V37, P6515, DOI 10.1093/nar/gkp633
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pan GH, 1998, FEBS LETT, V424, P41, DOI 10.1016/S0014-5793(98)00135-5
   Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111
   Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390
   Sedlackova L, 2008, J VIROL, V82, P7443, DOI 10.1128/JVI.00388-08
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sun L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-331
   Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646
   Tamary H, 2002, ISR MED ASSOC J, V4, P819
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Tursun H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00006
   Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509
   Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041
   Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164
   Wang L, 2016, CELL PHYSIOL BIOCHEM, V38, P2389, DOI 10.1159/000445591
   Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006
   Wang LJ, 2014, INT J ONCOL, V44, P2041, DOI 10.3892/ijo.2014.2363
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003
   Wu L, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0091-4
   Zhou XX, 2014, NUCLEIC ACIDS RES, V42, P4019, DOI 10.1093/nar/gkt1387
NR 61
TC 20
Z9 20
U1 0
U2 17
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD NOV 7
PY 2017
VL 14
AR 217
DI 10.1186/s12985-017-0882-6
PG 11
WC Virology
SC Virology
GA FM2AI
UT WOS:000414785200001
PM 29116029
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chen, JL
   Liang, YJ
   Yi, PP
   Xu, LM
   Hawkins, HK
   Rossi, SL
   Soong, L
   Cai, JY
   Menon, R
   Sun, JR
AF Chen, Jinling
   Liang, Yuejin
   Yi, Panpan
   Xu, Lanman
   Hawkins, Hal K.
   Rossi, Shannan L.
   Soong, Lynn
   Cai, Jiyang
   Menon, Ramkumar
   Sun, Jiaren
TI Outcomes of Congenital Zika Disease Depend on Timing of Infection and
   Maternal-Fetal Interferon Action
SO CELL REPORTS
LA English
DT Article
ID INFLUENZA-VIRUS INFECTION; ANTIVIRAL RESPONSES; STIMULATED GENES; INNATE
   IMMUNITY; LAMBDA; TRANSMISSION; HEPATOCYTES; PROTECTION; HEPATITIS;
   BARRIER
AB Zika virus (ZIKV) infection during pregnancy in humans results in intrauterine growth restriction, spontaneous abortion, and microcephaly. Here, we found that fetus-derived type I interferon (IFN-I) signaling can enhance anti-ZIKV responses and provide clinical benefits to the fetus. Because IFN-lambda shares signaling cascades and antiviral functions with IFN-I, we investigated the in vivo effects of IFN-lambda in ZIKV-infected pregnant mice. IFN-lambda administration during mid-pregnancy reduced ZIKV burden in maternal and fetal organs and alleviated placental injuries and fetal demise. In addition, prophylactic and therapeutic treatment of IFN-lambda 1 in a human trophoblast line, as well as in primary human amniotic epithelial cells, greatly reduced the ZIKV burden. Our data highlight IFN-lambda 1 as a potential therapeutic useful for women at risk for congenital Zika disease.
C1 [Chen, Jinling] Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China.
   [Chen, Jinling; Liang, Yuejin; Yi, Panpan; Xu, Lanman; Rossi, Shannan L.; Soong, Lynn; Sun, Jiaren] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Hawkins, Hal K.; Soong, Lynn; Sun, Jiaren] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Soong, Lynn; Sun, Jiaren] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Cai, Jiyang] Univ Texas Med Branch, Dept Ophthalmol & Visual Sci, Galveston, TX 77555 USA.
   [Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA.
   [Yi, Panpan] Cent S Univ, Xiangya Hosp, Dept Infect Dis, Key Lab Viral Hepatitis Hunan, Changsha 410008, Hunan, Peoples R China.
   [Xu, Lanman] Wenzhou Med Univ, Dept Infect Dis, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China.
RP Sun, JR (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Sun, JR (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Sun, JR (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM jisun@utmb.edu
RI Liang, Yuejin/X-5250-2019
OI Chen, Jinling/0000-0003-2992-6571; Liang, Yuejin/0000-0002-9557-1847
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81401683]; Jiangsu Provincial Natural Science
   FoundationNatural Science Foundation of Jiangsu Province [BK20140435];
   Jiangsu Government [JS-2015-132]; Department of Infectious Diseases,
   Xiangya Hospital, China; Hunan Provincial Natural Science Foundation of
   ChinaNatural Science Foundation of Hunan Province [14JJ6003]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [AI126371]; Office of the UTMB Chief Research
   Officer; UTMB Institute for Human Infections and Immunity
FX We thank Ms. Rheanna Urrabaz-Garza for technical assistance with primary
   human amnion cell culture, Mr. Sasha R. Azar for plaque-forming assays,
   Dr. Mariano A. Garcia-Blanco and Dr. Ruben Soto-Acosta for JEG-3 cells,
   Dr. Yan Chen for helping with immunofluorescent staining, Mr. Yongquan
   Jiang for confocal laser-scanning imaging, and Mr. Huy Q. Nong and Dr.
   Linsey Yeager for assistance with manuscript preparation. J. Chen was
   supported by National Natural Science Foundation of China (Grant Number
   81401683), the Jiangsu Provincial Natural Science Foundation (Grant
   Number BK20140435), and the Jiangsu Government Scholarship for Overseas
   Studies (JS-2015-132). P.Y. was supported by the Department of
   Infectious Diseases, Xiangya Hospital, China and the Hunan Provincial
   Natural Science Foundation of China (#14JJ6003). This work was supported
   by grants from the NIH (AI126371), Office of the UTMB Chief Research
   Officer, and the UTMB Institute for Human Infections and Immunity.
CR Andrade D, 2015, ARTHRITIS RHEUMATOL, V67, P977, DOI 10.1002/art.39029
   Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080
   Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312
   Egli A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.51
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gad HH, 2010, J INTERF CYTOK RES, V30, P565, DOI 10.1089/jir.2010.0062
   Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025
   Galani IE, 2015, ADV EXP MED BIOL, V850, P1, DOI 10.1007/978-3-319-15774-0_1
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665
   Jie ZL, 2017, J IMMUNOL, V198, P3448, DOI 10.4049/jimmunol.1601891
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Menon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083416
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10
   Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151
   Muir AJ, 2014, J HEPATOL, V61, P1238, DOI 10.1016/j.jhep.2014.07.022
   Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108
   Potter JA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124032
   Racicot K, 2016, AM J REPROD IMMUNOL, V75, P451, DOI 10.1111/aji.12501
   Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tscherning-Casper C, 1999, J VIROL, V73, P9673, DOI 10.1128/JVI.73.11.9673-9678.1999
   Villenave R, 2015, J VIROL, V89, P12309, DOI 10.1128/JVI.02119-15
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang D, 2016, J MOL BIOL, V428, P4651, DOI 10.1016/j.jmb.2016.10.005
NR 54
TC 41
Z9 43
U1 0
U2 19
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD NOV 7
PY 2017
VL 21
IS 6
BP 1588
EP 1599
DI 10.1016/j.celrep.2017.10.059
PG 12
WC Cell Biology
SC Cell Biology
GA FL9AE
UT WOS:000414541700017
PM 29117563
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Aktepe, TE
   Liebscher, S
   Prier, JE
   Simmons, CP
   Mackenzie, JM
AF Aktepe, Turgut E.
   Liebscher, Susann
   Prier, Julia E.
   Simmons, Cameron P.
   Mackenzie, Jason M.
TI The Host Protein Reticulon 3.1A Is Utilized by Flaviviruses to
   Facilitate Membrane Remodelling
SO CELL REPORTS
LA English
DT Article
ID WEST-NILE-VIRUS; DOUBLE-STRANDED-RNA; DENGUE VIRUS; 3-DIMENSIONAL
   ARCHITECTURE; ULTRASTRUCTURAL CHARACTERIZATION; GENETIC INTERACTION;
   REPLICATION SITES; NS4A; CELLS; NS1
AB Flaviviruses are enveloped, positive-sensed single-stranded RNA viruses that remodel host membranes, incorporating both viral and host factors facilitating viral replication. In this study, we identified a key role for the membrane-bending host protein Reticulon 3.1 (RTN3.1A) during the replication cycle of three flaviviruses: West Nile virus (WNV), Dengue virus (DENV), and Zika virus (ZIKV). We observed that, during infection, RTN3.1A is redistributed and recruited to the viral replication complex, a recruitment facilitated via the WNV NS4A protein, however, not DENV or ZIKV NS4A. Critically, small interfering RNA (siRNA)-mediated knockdown of RTN3.1A expression attenuated WNV, DENV, and ZIKV replication and severely affected the stability and abundance of the NS4A protein, coinciding with a significant alternation and reduction of viral membrane structures in the endoplasmic reticulum. These observations identified a crucial role of RTN3.1A for the viral remodelling of host membranes during efficient flavivirus replication and the stabilization of viral proteins within the endoplasmic reticulum.
C1 [Aktepe, Turgut E.; Liebscher, Susann; Prier, Julia E.; Simmons, Cameron P.; Mackenzie, Jason M.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.
RP Mackenzie, JM (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.
EM jason.mackenzie@unimelb.edu.au
OI Simmons, Cameron P./0000-0002-9039-7392; Mackenzie,
   Jason/0000-0001-6613-8350; Prier, Julia/0000-0002-2653-6300
FU National Health and Medical Research Council of AustraliaNational Health
   and Medical Research Council of Australia [1004619, 1081786]
FX We thank the Bio21 Institutes' Electron Microscopy Unit for their
   equipment and the expertise of Eric Hanssen, Zlatan Trifunovic, and
   Sergey Rubanov. We also thank Alexander Khromykh, Roy Hall, and Paul
   Young for generously providing the WNV and DENV antibodies; Julian Druce
   for providing ZIKV<INF>AFR</INF>; David Jans for providing
   DENV-2<INF>NGC</INF> and DENV antibodies; Daniel Watterson (University
   of Queensland) for advice with the DENV foci-forming assay; and Paulina
   Koszalka (University of Melbourne, Peter Doherty Institute for Infection
   and Immunity) for advice and aid with the cloning on
   DENV-2<INF>NGC</INF> and ZIKV<INF>AFR</INF> GFP-NS4A constructs. This
   research was supported by project grants (1004619 and 1081786) to J.M.M.
   from the National Health and Medical Research Council of Australia.
CR Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003
   Aktepe TE, 2015, VIROLOGY, V484, P241, DOI 10.1016/j.virol.2015.06.015
   Ambrose RL, 2015, VIROLOGY, V481, P95, DOI 10.1016/j.virol.2015.02.045
   Ambrose RL, 2011, J VIROL, V85, P11274, DOI 10.1128/JVI.05864-11
   Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10
   Barajas D, 2014, VIROLOGY, V471, P72, DOI 10.1016/j.virol.2014.10.005
   Belov GA, 2012, J VIROL, V86, P302, DOI 10.1128/JVI.05937-11
   BIENZ K, 1983, VIROLOGY, V131, P39, DOI 10.1016/0042-6822(83)90531-7
   Blazquez AB, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00797
   Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Diaz A, 2010, P NATL ACAD SCI USA, V107, P16291, DOI 10.1073/pnas.1011105107
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Goldberg A.L., 2012, DEV PROTEASOME INHIB
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Hoenen A, 2007, J GEN VIROL, V88, P3013, DOI 10.1099/vir.0.83125-0
   Hoenen A, 2014, VIROLOGY, V448, P104, DOI 10.1016/j.virol.2013.10.005
   Hung YF, 2015, VIRUSES-BASEL, V7, P4119, DOI 10.3390/v7072812
   Hung YF, 2015, BBA-BIOMEMBRANES, V1848, P1119, DOI 10.1016/j.bbamem.2015.01.015
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kume H, 2009, NEUROPATH APPL NEURO, V35, P178, DOI 10.1111/j.1365-2990.2008.00974.x
   Lee CM, 2015, J VIROL, V89, P6171, DOI 10.1128/JVI.00546-15
   Li XD, 2015, J GEN VIROL, V96, P1264, DOI 10.1099/vir.0.000044
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Limpens RWAL, 2011, MBIO, V2, DOI 10.1128/mBio.00166-11
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Mackenzie J S, 1998, Commun Dis Intell, V22, P93
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Moreira EF, 1999, GENOMICS, V58, P73, DOI 10.1006/geno.1999.5807
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Oertle T, 2003, FASEB J, V17, P1238, DOI 10.1096/fj.02-1166hyp
   Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708
   Pautasso C, 2013, EXPERT OPIN DRUG MET, V9, P1371, DOI 10.1517/17425255.2013.817556
   Romero-Brey I, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060160
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996
   Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4
   Stern O, 2013, J VIROL, V87, P4080, DOI 10.1128/JVI.01900-12
   Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]
   Tang WF, 2007, J BIOL CHEM, V282, P5888, DOI 10.1074/jbc.M611145200
   Teo CSH, 2014, J VIROL, V88, P1897, DOI 10.1128/JVI.01249-13
   Tolley N, 2010, PLANT J, V64, P411, DOI 10.1111/j.1365-313X.2010.04337.x
   Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047
   Wang Robert Yl, 2012, Chang Gung Med J, V35, P111
   Wang ZP, 2013, DRUG METAB DISPOS, V41, P230, DOI 10.1124/dmd.112.047662
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1999, VIROLOGY, V258, P108, DOI 10.1006/viro.1999.9683
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Westrate LM, 2015, ANNU REV BIOCHEM, V84, P791, DOI 10.1146/annurev-biochem-072711-163501
   Wu MJ, 2014, CELL MICROBIOL, V16, P1603, DOI 10.1111/cmi.12318
   Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
   Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x
NR 62
TC 19
Z9 21
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD NOV 7
PY 2017
VL 21
IS 6
BP 1639
EP 1654
DI 10.1016/j.celrep.2017.10.055
PG 16
WC Cell Biology
SC Cell Biology
GA FL9AE
UT WOS:000414541700021
PM 29117567
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brault, AC
   Domi, A
   McDonald, EM
   Talmi-Frank, D
   McCurley, N
   Basu, R
   Robinson, HL
   Hellerstein, M
   Duggal, NK
   Bowen, RA
   Guirakhoo, F
AF Brault, Aaron C.
   Domi, Arban
   McDonald, Erin M.
   Talmi-Frank, Dalit
   McCurley, Nathanael
   Basu, Rahul
   Robinson, Harriet L.
   Hellerstein, Michael
   Duggal, Nisha K.
   Bowen, Richard A.
   Guirakhoo, Farshad
TI A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice
   in a Lethal Challenge Model
SO SCIENTIFIC REPORTS
LA English
DT Article
ID WEST-NILE-VIRUS; T-CELLS; ANTIBODY; IMMUNOGENICITY; SPECIFICITY;
   IMMUNOLOGY; PARTICLES; INFECTION; DNA
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that has rapidly extended its geographic range around the world. Its association with abnormal fetal brain development, sexual transmission, and lack of a preventive vaccine have constituted a global health concern. Designing a safe and effective vaccine requires significant caution due to overlapping geographical distribution of ZIKV with dengue virus (DENV) and other flaviviruses, possibly resulting in more severe disease manifestations in flavivirus immune vaccinees such as Antibody-Dependent Enhancement (ADE, a phenomenon involved in pathogenesis of DENV, and a risk associated with ZIKV vaccines using the envelope proteins as immunogens). Here, we describe the development of an alternative vaccine strategy encompassing the expression of ZIKV non-structural-1 (NS1) protein from a clinically proven safe, Modified Vaccinia Ankara (MVA) vector, thus averting the potential risk of ADE associated with structural proteinbased ZIKV vaccines. A single intramuscular immunization of immunocompetent mice with the MVA-ZIKV-NS1 vaccine candidate provided robust humoral and cellular responses, and afforded 100% protection against a lethal intracerebral dose of ZIKV (strain MR766). This is the first report of (i) a ZIKV vaccine based on the NS1 protein and (ii) single dose protection against ZIKV using an immunocompetent lethal mouse challenge model.
C1 [Brault, Aaron C.; McDonald, Erin M.; Talmi-Frank, Dalit; Duggal, Nisha K.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
   [Domi, Arban; McCurley, Nathanael; Basu, Rahul; Robinson, Harriet L.; Hellerstein, Michael; Guirakhoo, Farshad] Geovax, Smyrna, GA 30080 USA.
   [Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.
RP Guirakhoo, F (corresponding author), Geovax, Smyrna, GA 30080 USA.
EM fguirakhoo@geovax.com
OI Guirakhoo, Farshad/0000-0003-0124-013X
CR Aid M, 2017, CELL
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Bardina SV, 2017, SCIENCE
   Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845
   Chen H. W., 2014, J GEN VIROL
   Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07
   D'Ortenzio E, 2016, N ENGL J MED
   Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duggal N. K., 2017, AM J TROPIC IN PRESS
   Duggal N. K., 2017, AM J TROP MED HYG
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Goepfert PA, 2014, J INFECT DIS, V210, P99, DOI 10.1093/infdis/jiu003
   Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105
   Guirakhoo F., 2016, HEMORRHAGIC FEVER VI
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Ishikawa T, 2014, VACCINE
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu Y., 2017, NATURE
   McGrath EL, 2017, STEM CELL REPORTS
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Wan SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089545
   Wang ZD, 2010, VACCINE, V28, P1547, DOI 10.1016/j.vaccine.2009.11.056
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Wyatt LS, 2009, J VIROL, V83, P7176, DOI 10.1128/JVI.00687-09
   Xu X., 2016, PLOS CURRENTS, V8
   Youn S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-339
NR 41
TC 35
Z9 37
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 7
PY 2017
VL 7
AR 14769
DI 10.1038/s41598-017-15039-8
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FL9JG
UT WOS:000414569100059
PM 29116169
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Baud, D
   Gubler, DJ
   Schaub, B
   Lanteri, MC
   Musso, D
AF Baud, David
   Gubler, Duane J.
   Schaub, Bruno
   Lanteri, Marion C.
   Musso, Didier
TI An update on Zika virus infection
SO LANCET
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; PUBLIC-HEALTH EMERGENCY; SEXUAL TRANSMISSION;
   VERTICAL TRANSMISSION; CLINICAL MANAGEMENT; CROSS-REACTIVITY; DENGUE
   VIRUS; CASE SERIES; BLOOD; BRAIN
AB The epidemic history of Zika virus began in 2007, with its emergence in Yap Island in the western Pacific, followed in 2013-14 by a larger epidemic in French Polynesia, south Pacific, where the first severe complications and non-vectorborne transmission of the virus were reported. Zika virus emerged in Brazil in 2015 and was declared a national public health emergency after local researchers and physicians reported an increase in microcephaly cases. In 2016, WHO declared the recent cluster of microcephaly cases and other neurological disorders reported in Brazil a global public health emergency. Similar clusters of microcephaly cases were also observed retrospectively in French Polynesia in 2014. In 2015-16, Zika virus continued its spread to cause outbreaks in the Americas and the Pacific, and the first outbreaks were reported in continental USA, Africa, and southeast Asia. Non-vector-borne transmission was confirmed and Zika virus was established as a cause of severe neurological complications in fetuses, neonates, and adults. This Review focuses on important updates and gaps in the knowledge of Zika virus as of early 2017.
C1 [Baud, David] Univ Hosp, Dept Femme Mere Enfant, Obstet Serv, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
   [Gubler, Duane J.] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore.
   [Schaub, Bruno] CHU Martinique, Ctr Pluridisciplinaire Diagnost Prenatal Martiniq, Maison Femme Mere & Enfant, Fort De France, Martinique, France.
   [Schaub, Bruno] CHU Martinique, Registre Malformat Antilles REMALAN, Maison Femme Mere & Enfant, Fort De France, Martinique, France.
   [Lanteri, Marion C.] Blood Syst Res Inst, San Francisco, CA USA.
   [Lanteri, Marion C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Lanteri, Marion C.] Cerus Corp, Concord, CA USA.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, French Polynesi, France.
RP Baud, D (corresponding author), Univ Hosp, Dept Femme Mere Enfant, Obstet Serv, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
EM david.baud@chuv.ch
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Baud, David/0000-0001-9914-6496
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   American Association for Blood Banks, 2016, JOINT STAT FOOD DRUG
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Besnard M, 2016, EUROSURVEILLANCE, V21, P1
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castro MC, 2016, TRAVEL MED INFECT DI, V14, P384, DOI 10.1016/j.tmaid.2016.06.007
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Honein MA, 2011, JAMA-J AM MED ASSOC, V317, P59
   Katz LM, 2017, ARCH PATHOL LAB MED, V141, P85, DOI 10.5858/arpa.2016-0430-RA
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Maria F Santa, TRANSFUSION IN PRESS
   Maurice J, 2016, LANCET, V388, P449, DOI 10.1016/S0140-6736(16)31207-7
   McCarthy M., 2016, BMJ-BRIT MED J, V354, pi4235, DOI DOI 10.1136/BMJ.I4235.PMID:27480321
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, ISBT SCI SER, V12, P254
   Musso D, 2017, LANCET INFECT DIS, V17, P255, DOI 10.1016/S1473-3099(17)30070-1
   Musso D, 2016, TRANSFUSION, V56, P3143, DOI 10.1111/trf.13861
   Musso D, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0551-8
   Musso D, 2016, LANCET INFECT DIS, V16, P1108, DOI 10.1016/S1473-3099(16)30337-1
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Panchaud A, 2016, LANCET INFECT DIS, V16, P995, DOI 10.1016/S1473-3099(16)30255-9
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Report S, 2017, ZIK VIR MICR GUILL B
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   US Centers for Disease Control and Prevention, 2016, GUID US LAB TES ZIK
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vouga M, 2017, LANCET, V389, P151, DOI 10.1016/S0140-6736(17)30013-2
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Vouga M, 2016, LANCET INFECT DIS, V16, P773, DOI 10.1016/S1473-3099(16)30083-4
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270
NR 107
TC 184
Z9 188
U1 11
U2 77
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD NOV 4
PY 2017
VL 390
IS 10107
BP 2099
EP 2109
DI 10.1016/S0140-6736(17)31450-2
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA FL5DD
UT WOS:000414250800027
PM 28647173
OA Bronze
DA 2020-07-08
ER

PT J
AU Bierle, CJ
   Fernandez-Alarcon, C
   Hernandez-Alvarado, N
   Zabeli, JC
   Janus, BC
   Putri, DS
   Schleiss, MR
AF Bierle, Craig J.
   Fernandez-Alarcon, Claudia
   Hernandez-Alvarado, Nelmary
   Zabeli, Jason C.
   Janus, Bradley C.
   Putri, Dira S.
   Schleiss, Mark R.
TI Assessing Zika virus replication and the development of Zika-specific
   antibodies after a mid-gestation viral challenge in guinea pigs
SO PLOS ONE
LA English
DT Article
ID BIRTH-DEFECTS; INFECTION; MODEL; CYTOMEGALOVIRUS; PLASMA; PLACENTATION;
   PREGNANCY; MOSQUITOS; CORRELATE; DYNAMICS
AB Primary Zika virus (ZIKV) infections that occur during pregnancy can cause spontaneous abortion and profoundly disrupt fetal development. While the full range of developmental abnormalities associated with congenital Zika syndrome is not yet known, severe cases of the syndrome can present with microcephaly, extensive neurologic and ocular damage, and pronounced joint malformations. Animal models that accurately recapitulate congenital Zika syndrome are urgently needed for vaccine development and for the study of ZIKV pathogenesis. As guinea pigs have successfully been used to model transplacental infections by cytomegalovirus, syphilis, and Listeria monocytogenes, we sought to test whether ZIKV could productively infect guinea pigs and whether viral transmission with attendant fetal pathology would occur after a mid-gestation viral challenge. We found that guinea pig cells supported ZIKV replication in vitro. Experimental infection of non-pregnant animals did not result in overt disease but low-level, detectable viremia was observed. When pregnant guinea pigs were challenged with ZIKV at between 18 and 21 days gestational age, ZIKV was not detected in maternal or pup blood, plasma, or tissues and no significant differences in maternal weight gain or pup size were observed following challenge. Nonetheless, a robust antibody response against ZIKV was detected in both the pups and dams. These results suggest that, while guinea pigs can model aspects of the immune response to ZIKV infection during pregnancy, naturally circulating ZIKV strains are not pathogenic during the pregnancy of immunocompetent guinea pigs and do not interfere with normal pup development.
C1 [Bierle, Craig J.; Fernandez-Alarcon, Claudia; Hernandez-Alvarado, Nelmary; Zabeli, Jason C.; Janus, Bradley C.; Putri, Dira S.; Schleiss, Mark R.] Univ Minnesota, Dept Pediat, Div Pediat Infect Dis & Immunol, Minneapolis, MN 55455 USA.
RP Bierle, CJ; Schleiss, MR (corresponding author), Univ Minnesota, Dept Pediat, Div Pediat Infect Dis & Immunol, Minneapolis, MN 55455 USA.
EM cjbierle@umn.edu; schleiss@umn.edu
OI Bierle, Craig/0000-0002-7890-7409; Putri, Dira/0000-0002-9715-3171
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01HD044864,
   R01HD079918, R56AI114013, R03HD082273, T90DE022732, R21HD087496];
   University of Minnesota (Academic Health Center Faculty Research
   Development Grant Program) [16.55]; University of Minnesota (Masonic
   Neurogenomic and Neuroimaging Research Grant)
FX Grants from the National Institutes of Health (R01HD044864, R01HD079918,
   R56AI114013, and R03HD082273 to MRS; T90DE022732 and R21HD087496 to CJB)
   and the University of Minnesota (Academic Health Center Faculty Research
   Development Grant Program 2016 [FRD #16.55] to MRS; Masonic Neurogenomic
   and Neuroimaging Research Grant to CJB) supported this work. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR ADAMS FH, 1949, P SOC EXP BIOL MED, V70, P258, DOI 10.3181/00379727-70-16892
   Adams Waldorf K.M., 2016, NAT MED
   Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004
   Baronti C, 2014, GENOME ANNOUNC, V2
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Bierle CJ, 2012, VIROLOGY, V433, P157, DOI 10.1016/j.virol.2012.08.005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002
   CHALLIS JRG, 1971, J ENDOCRINOL, V51, P333, DOI 10.1677/joe.0.0510333
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Silva FMD, 2016, PESQUI VET BRASIL, V36, P753, DOI 10.1590/S0100-736X2016000800013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DOYLE RE, 1976, LAB ANIM SCI, V26, P573
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hashira S, 2000, PEDIATR INT, V42, P337, DOI 10.1046/j.1442-200x.2000.01245.x
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   INOUYE S, 1984, MICROBIOL IMMUNOL, V28, P569, DOI 10.1111/j.1348-0421.1984.tb00709.x
   Kaufmann P, 1977, Adv Anat Embryol Cell Biol, V53, P5
   KUMAR ML, 1978, J INFECT DIS, V138, P650, DOI 10.1093/infdis/138.5.650
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2016, CELL HOST MICROBE
   LEISSRING J, 1961, AM J ANAT, V109, P149, DOI 10.1002/aja.1001090205
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27
   Mess A, 2007, PLACENTA, V28, P1234, DOI 10.1016/j.placenta.2007.08.003
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, N ENGL J MED
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schleiss MR, 2004, J INFECT DIS, V189, P1374, DOI 10.1086/382751
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Watanabe S, 2012, J VIROL, V86, P5508, DOI 10.1128/JVI.07081-11
   WICHER K, 1992, INFECT IMMUN, V60, P271, DOI 10.1128/IAI.60.1.271-277.1992
   Xu YQ, 2015, PLACENTA, V36, P1370, DOI 10.1016/j.placenta.2015.10.018
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 48
TC 6
Z9 7
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 3
PY 2017
VL 12
IS 11
AR e0187720
DI 10.1371/journal.pone.0187720
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FL6TA
UT WOS:000414377900041
PM 29099873
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Guardado-Calvo, P
   Atkovska, K
   Jeffers, SA
   Grau, N
   Backovic, M
   Perez-Vargas, J
   de Boer, SM
   Tortorici, MA
   Pehau-Arnaudet, G
   Lepault, J
   England, P
   Rottier, PJ
   Bosch, BJ
   Hub, JS
   Rey, FA
AF Guardado-Calvo, P.
   Atkovska, K.
   Jeffers, S. A.
   Grau, N.
   Backovic, M.
   Perez-Vargas, J.
   de Boer, S. M.
   Tortorici, M. A.
   Pehau-Arnaudet, G.
   Lepault, J.
   England, P.
   Rottier, P. J.
   Bosch, B. J.
   Hub, J. S.
   Rey, F. A.
TI A glycerophospholipid-specific pocket in the RVFV class II fusion
   protein drives target membrane insertion
SO SCIENCE
LA English
DT Article
ID RIFT-VALLEY FEVER; SEMLIKI-FOREST-VIRUS; ENVELOPE GLYCOPROTEIN; LOW-PH;
   PEPTIDES; CRYSTALLOGRAPHY; CONFORMATION; ORGANIZATION; DISEASE
AB The Rift Valley fever virus (RVFV) is transmitted by infected mosquitoes, causing severe disease in humans and livestock across Africa. We determined the x-ray structure of the RVFV class II fusion protein Gc in its postfusion form and in complex with a glycerophospholipid (GPL) bound in a conserved cavity next to the fusion loop. Site-directed mutagenesis and molecular dynamics simulations further revealed a built-in motif allowing en bloc insertion of the fusion loop into membranes, making few nonpolar side-chain interactions with the aliphatic moiety and multiple polar interactions with lipid head groups upon membrane restructuring. The GPL head-group recognition pocket is conserved in the fusion proteins of other arthropod-borne viruses, such as Zika and chikungunya viruses, which have recently caused major epidemics worldwide.
C1 [Guardado-Calvo, P.; Jeffers, S. A.; Grau, N.; Backovic, M.; Perez-Vargas, J.; Tortorici, M. A.; Rey, F. A.] Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France.
   [Guardado-Calvo, P.; Jeffers, S. A.; Grau, N.; Backovic, M.; Perez-Vargas, J.; Tortorici, M. A.; Rey, F. A.] CNRS Inst Pasteur, UMR Virol 3569, 25-28 Rue Docteur Roux, F-75015 Paris, France.
   [Atkovska, K.; Hub, J. S.] Univ Goettingen, Inst Microbiol & Genet, Justus von Liebig Weg, D-37077 Gottingen, Germany.
   [de Boer, S. M.; Rottier, P. J.; Bosch, B. J.] Univ Utrecht, Virol Div, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands.
   [Pehau-Arnaudet, G.; England, P.] Inst Pasteur, CNRS, UMR 3528, 25-28 Rue Docteur Roux, F-75015 Paris, France.
   [Lepault, J.] CNRS, Inst Biol Integrat Cellule, UMR 9198, Gif Sur Yvette, France.
   [England, P.] Inst Pasteur, Proteopole Plateforme Biophys Macromol & Leurs In, 25-28 Rue Dr Roux, F-75724 Paris 15, France.
   [Jeffers, S. A.] Brammer Bio, Cambridge, MA USA.
   [Grau, N.; Perez-Vargas, J.] Univ Lyon, Ctr Int Rech Infectiol, Team Enveloped Viruses Vectors & Immunotherapy, Int Ctr Infectiol Res,INSERM U1111, Lyon, France.
   [de Boer, S. M.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
RP Guardado-Calvo, P; Rey, FA (corresponding author), Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France.; Guardado-Calvo, P; Rey, FA (corresponding author), CNRS Inst Pasteur, UMR Virol 3569, 25-28 Rue Docteur Roux, F-75015 Paris, France.; Hub, JS (corresponding author), Univ Goettingen, Inst Microbiol & Genet, Justus von Liebig Weg, D-37077 Gottingen, Germany.
EM pablo.guardado-calvo@pasteur.fr; jhub@gwdg.de; felix.rey@pasteur.fr
RI Lepault, Jean/AAN-8859-2020; Guardado-Calvo, Pablo/O-5145-2019; Hub,
   Jochen/M-6230-2015
OI Guardado-Calvo, Pablo/0000-0001-7292-5270; Atkovska,
   Kalina/0000-0001-8978-8663; Tortorici, M. Alejandra/0000-0002-2260-2577;
   pehau-arnaudet, gerard/0000-0001-6479-9470; Jeffers,
   Scott/0000-0001-5804-8742; Perez-Vargas, Jimena/0000-0002-4337-7903;
   Backovic, Marija/0000-0001-8814-4428; Hub, Jochen/0000-0001-7716-1767
FU "Integrative Biology of Emerging Infectious Diseases" Labex (Laboratoire
   d'Excellegnracnet) [ANR-10-LABX-62-IBEID]; Labex IBEID
   [ANR-10-LABX-62-IBEID 4E AAP]; Deutsche ForschungsgemeinschaftGerman
   Research Foundation (DFG) [HU 1971/1-1]; International Max Planck
   Research School for Physics of Biological and Complex Systems
FX We thank A. Haouz and the staff at the crystallogenesis facility of
   Institut Pasteur for help with the robotized system; M. Flamand and C.
   Tamietti from Institut Pasteur for discussion: all other members of the
   Institut Pasteur "Unite de Virologie Structurale"; M. C. Vaney, B.
   Saunier, P. Sylvestre, and the Risk Prevention Unit of the Institut
   Pasteur for their biosafety and biosecurity expertise; W. Shepard and P.
   Legrand from Synchrotron Soleil for help during data collection and for
   beneficial discussions; the staff at beamline ID23-2 at the European
   Synchrotron Radiation Facility (Grenoble, France); and the staff at
   beamlin PeX1 at the Swiss Light Source synchrotron (Villigen,
   Switzerland). F.A. Received funding from "Integrative Biology of
   Emerging Infectious Diseases" Labex (Laboratoire d'Excellegnracnet)
   ANR-10-LABX-62-IBEID (French government's "Investissements d'Avenir"
   program), and P.G.C and. F.A.R were funded by Labex IBEID(grant
   ANR-10-LABX-62-IBEID 4E AAP). K.A and J.S.H were supported by the
   Deutsche Forschungsgemeinschaft (grant HU 1971/1-1). K.A. received a
   stipend from the International Max Planck Research School for Physics of
   Biological and Complex Systems. We acknowledge the Gesellschaft fur
   Wissenschaftliche Datenverarbeitung (GWDG) and Norddeutscher Verbund for
   Hoch-und Hochstleistungsrechnen (HLRNc) enters for computing time. The
   coordinate files of the structures described in this manuscript have
   been submitted to the Protein Data Bank with IDs6 EGTa nd6 EGU.
CR Apellaniz B, 2014, CHEM PHYS LIPIDS, V181, P40, DOI 10.1016/j.chemphyslip.2014.03.003
   Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9
   Bitto D, 2016, J BIOL CHEM, V291, P6412, DOI 10.1074/jbc.M115.691113
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Chevalier V, 2010, EUROSURVEILLANCE, V15, P18
   Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418
   Dessau M, 2013, P NATL ACAD SCI USA, V110, P1696, DOI 10.1073/pnas.1217780110
   Freiberg AN, 2008, J VIROL, V82, P10341, DOI 10.1128/JVI.01191-08
   Gibbons DL, 2003, CELL, V114, P573, DOI 10.1016/S0092-8674(03)00683-4
   Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239
   Halldorsson S, 2016, P NATL ACAD SCI USA, V113, P7154, DOI 10.1073/pnas.1603827113
   Han X, 2000, P NATL ACAD SCI USA, V97, P13097, DOI 10.1073/pnas.230212097
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Huiskonen JT, 2009, J VIROL, V83, P3762, DOI 10.1128/JVI.02483-08
   Igonet S, 2012, CELL, V151, P1634, DOI 10.1016/j.cell.2012.11.041
   Kielian M, 2010, VIRUSES-BASEL, V2, P796, DOI 10.3390/v2040796
   Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8
   Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819
   Lorieau J. L., 2010, P NATL ACAD SCI USA, V107, P11341
   Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Murakami S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002746
   Perez-Vargas J, 2014, CELL, V157, P407, DOI 10.1016/j.cell.2014.02.020
   Qiang W, 2008, J AM CHEM SOC, V130, P5459, DOI 10.1021/ja077302m
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Sherman MB, 2009, VIROLOGY, V387, P11, DOI 10.1016/j.virol.2009.02.038
   Swanepoel R., 2004, INFECT DIS LIVESTOCK, V1, P1037
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Umashankar M, 2008, J VIROL, V82, P9245, DOI 10.1128/JVI.00975-08
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
NR 34
TC 19
Z9 20
U1 0
U2 16
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD NOV 3
PY 2017
VL 358
IS 6363
BP 663
EP 667
DI 10.1126/science.aal2712
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FL4ZP
UT WOS:000414240500041
PM 29097548
OA Bronze
DA 2020-07-08
ER

PT J
AU Mendez, N
   Oviedo-Pastrana, M
   Mattar, S
   Caicedo-Castro, I
   Arrieta, G
AF Mendez, Nelson
   Oviedo-Pastrana, Misael
   Mattar, Salim
   Caicedo-Castro, Isaac
   Arrieta, German
TI Zika virus disease, microcephaly and Guillain-Barre syndrome in
   Colombia: epidemiological situation during 21 months of the Zika virus
   outbreak, 2015-2017
SO ARCHIVES OF PUBLIC HEALTH
LA English
DT Article
DE Infectious diseases vectors; Epidemiology; Culicidae; Morbidity; Nervous
   system congenital abnormalities; Education; Public health professional;
   Population
ID INFECTION
AB Background: The Zika virus disease (ZVD) has had a huge impact on public health in Colombia for the numbers of people affected and the presentation of Guillain-Barre syndrome (GBS) and microcephaly cases associated to ZVD.
   Methods: A retrospective descriptive study was carried out, we analyze the epidemiological situation of ZVD and its association with microcephaly and GBS during a 21-month period, from October 2015 to June 2017. The variables studied were: (i) ZVD cases, (ii) ZVD cases in pregnant women, (iii) laboratory-confirmed ZVD in pregnant women, (iv) ZVD cases associated with microcephaly, (v) laboratory-confirmed ZVD associated with microcephaly, and (vi) ZVD associated to GBS cases. Average number of cases, attack rates (AR) and proportions were also calculated. The studied variables were plotted by epidemiological weeks and months. The distribution of ZVD cases in Colombia was mapped across the time using Kernel density estimator and QGIS software; we adopted Kernel Ridge Regression (KRR) and the Gaussian Kernel to estimate the number of Guillain Barre cases given the number of ZVD cases.
   Results: One hundred eight thousand eighty-seven ZVD cases had been reported in Colombia, including 19,963 (18.5%) in pregnant women, 710 (0.66%) associated with microcephaly (AR, 4.87 cases per 10,000 live births) and 453 (0.42%) ZVD associated to GBS cases (AR, 41.9 GBS cases per 10,000 ZVD cases). It appears the cases of GBS increased in parallel with the cases of ZVD, cases of microcephaly appeared 5 months after recognition of the outbreak. The kernel density map shows that throughout the study period, the states most affected by the Zika outbreak in Colombia were mainly San Andres and Providencia islands, Casanare, Norte de Santander, Arauca and Huila. The KRR shows that there is no proportional relationship between the number of GBS and ZVD cases. During the cross validation, the RMSE achieved for the second order polynomial kernel, the linear kernel, the sigmoid kernel, and the Gaussian kernel are 9.15, 9.2, 10.7, and 7.2 respectively.
   Conclusions: This study updates the epidemiological analysis of the ZVD situation in Colombia describes the geographical distribution of ZVD and shows the functional relationship between ZVD cases and GBS.
C1 [Mendez, Nelson; Oviedo-Pastrana, Misael; Mattar, Salim; Arrieta, German] Univ Cordoba, Inst Invest Biol Trip, Carrera 6, Cordoba 76103, Colombia.
   [Caicedo-Castro, Isaac] Univ Cordoba, Fac Ingn, Dept Ingn Sistemas & Telecomunicac, Monteria, Colombia.
   [Arrieta, German] Corporac Univ Caribe CECAR, Grp Salud Publ, Km 1,Via Corozal, Sincelejo, Colombia.
   [Mattar, Salim; Arrieta, German] Clin Salud Social, Carrera 16 27A,74, Sincelejo, Colombia.
RP Mattar, S (corresponding author), Univ Cordoba, Inst Invest Biol Trip, Carrera 6, Cordoba 76103, Colombia.; Mattar, S (corresponding author), Clin Salud Social, Carrera 16 27A,74, Sincelejo, Colombia.
EM mattarsalim@hotmail.com
CR Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Center for Disease Control and Prevention, 2017, MICR OTH BIRTH DEF
   Corona M E Jimenez, 2016, PLOS CURRENTS, V8
   Departamento Administrativo Nacional de Estadistica (DANE Colombia), 2017, EST VIT NAC DEF
   Departamento Administrativo Nacional de Estadistica (DANE Colombia), 2014, CAT OBJ GEOGR MARC N
   Instituto Nacional de Salud (Colombia), 2017, SEM EP NUM 52 2016
   Instituto Nacional de Salud (Colombia), 2017, B EPIDEMIOLOGICO
   Instituto Nacional de Salud (Colombia), 2017, B EP SEM
   Kloog I, 2009, COMPUT ENVIRON URBAN, V33, P55, DOI 10.1016/j.compenvurbsys.2008.09.006
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Mattar S, 2017, J INFECT PUBLIC HEAL, V10, P507, DOI 10.1016/j.jiph.2016.09.014
   Mattar S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2522-6
   Ministerio de Salud y Proteccion Social (Colombia), 2017, LIN DET MAN CLIN INT
   Ministerio de Salud y Proteccion Social - Instituto Nacional de Salud (Colombia), 2017, 00000061 MIN SAL PRO
   Ministerio de Salud y Proteccion Social - Instituto Nacional de Salud (Colombia), 2017, PROT VIG SAL PUBL EN
   Oviedo-Pastrana M, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-016-0169-1
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pan American Health Organization / World Health Organization, 2017, REG ZIK EP UPD AM MA
   Pan American Health Organization / World Health Organization, 2017, ZIKA SUSP CONF CAS R
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   Saunders C., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P515
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   [World Health Organization Pan American Health Organization], 2017, ZIK SUSP CONF CAS RE
NR 25
TC 17
Z9 19
U1 0
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0778-7367
EI 2049-3258
J9 ARCH PUBLIC HEALTH
JI Arch. PUblic Health
PD NOV 2
PY 2017
VL 75
AR 65
DI 10.1186/s13690-017-0233-5
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FL9BU
UT WOS:000414546300001
PM 29118981
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Di Luca, M
   Toma, L
   Severini, F
   Boccolini, D
   D'Avola, S
   Todaro, D
   Stancanelli, A
   Antoci, F
   La Russa, F
   Casano, S
   Sotera, SD
   Carraffa, E
   Versteirt, V
   Schaffner, F
   Romi, R
   Torina, A
AF Di Luca, Marco
   Toma, Luciano
   Severini, Francesco
   Boccolini, Daniela
   D'Avola, Salvatore
   Todaro, Diego
   Stancanelli, Alessandra
   Antoci, Francesco
   La Russa, Francesco
   Casano, Sandro
   Sotera, Salvatore D.
   Carraffa, Eugenio
   Versteirt, Veerle
   Schaffner, Francis
   Romi, Roberto
   Torina, Alessandra
TI First record of the invasive mosquito species Aedes (Stegomyia)
   albopictus (Diptera: Culicidae) on the southernmost Mediterranean
   islands of Italy and Europe
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes albopictus; First record; Invasive mosquito; Entry routes;
   Lampedusa; Linosa; Pantelleria; Italy
ID INFECTION; CROATIA; VIRUS
AB Background: Aedes albopictus, a known worldwide vector of several mosquito-borne disease pathogens including dengue, chikungunya and Zika viruses, was introduced into Europe in the late 1970s through global trade. First recorded in northern Italy in 1990, this mosquito species has rapidly spread throughout the country, where it was responsible for an outbreak of chikungunya in 2007 that affected more than 200 people. As part of the VectorNet project, which is aimed at improving preparedness and responsiveness for animal and human vector-borne diseases in Europe, a mosquito targeted study was carried out on the three southernmost Italian islands. The objective was to verify the current European southern distribution limits of Ae. albopictus and the potential occurrence of other invasive mosquito species, in the light of the introduction of high risk for vector-borne disease pathogens into Europe via migration flows.
   Results: In the summer 2015, six surveys for container-breeding mosquitoes were carried out by setting up a network of oviposition traps and BG Sentinel traps in selected areas on the islands of Pantelleria, Lampedusa and Linosa. Aedes albopictus was found on all three islands under investigation. The consequences on public health with regard to the presence of this mosquito vector and the migrant people entering the country from Africa and the Middle East are also discussed here.
   Conclusions: The detection of the Asian tiger mosquito on these islands, which represent the last European strip of land facing Africa, has important implications for public health policy and should prompt the national authorities to implement tailored surveillance activities and reinforce plans for preparedness strategies in such contexts.
C1 [Di Luca, Marco; Toma, Luciano; Severini, Francesco; Boccolini, Daniela; Romi, Roberto] Ist Super Sanita, Dept Infect Dis, Unit Vectorborne Dis, Rome, Italy.
   [D'Avola, Salvatore; Todaro, Diego] ASP Trapani, Unit Anim Hlth Serv, Dept Vet Prevent, Pantelleria, Italy.
   [Stancanelli, Alessandra; Antoci, Francesco; La Russa, Francesco; Torina, Alessandra] Ist Zooprofilatt Sperimentale Sicilia, Lab Entomol & Environm Vectors Control, Palermo, Italy.
   [Casano, Sandro] City Council Pantelleria, Pantelleria, Italy.
   [Carraffa, Eugenio] City Council Lampedusa & Linosa, Linosa, Italy.
   [Versteirt, Veerle] Avia GIS, Risschotlei 33, B-2980 Zoersel, Belgium.
   [Schaffner, Francis] Francis Schaffner Consultancy, Riehen, Switzerland.
   [Schaffner, Francis] Univ Zurich, Switzerland & Inst Parasitol, Zurich, Switzerland.
RP Di Luca, M (corresponding author), Ist Super Sanita, Dept Infect Dis, Unit Vectorborne Dis, Rome, Italy.
EM marco.diluca@iss.it
RI Torina, Alessandra/I-3029-2016; La Russa, Francesco/K-8730-2016
OI Torina, Alessandra/0000-0003-1555-8309; La Russa,
   Francesco/0000-0003-0947-853X; Schaffner, Francis/0000-0001-9166-7617
FU VectorNet; ECDC; EFSA [OC/EFSA/AHAW/2013/02]; European Commission
   Framework Program Seven Award "InfraVec"European Union (EU) [228421];
   Elanco Animal Health [BIOIT140021]
FX This study was supported by VectorNet and its funding agencies ECDC and
   EFSA (contract number OC/EFSA/AHAW/2013/02). FS was partially funded by
   the European Commission Framework Program Seven Award "InfraVec"
   (project number 228421), and by Elanco Animal Health (project number
   BIOIT140021). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR ADHAMI J, 1987, REV MJEKESORE, V1, P13
   Barcelo Carlos, 2015, Journal of the European Mosquito Control Association, V33, P1
   Bengoa Mikel, 2016, Journal of the European Mosquito Control Association, V34, P5
   Buhagiar Joseph A., 2009, European Mosquito Bulletin, V27, P65
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cuffaro S, 2008, PARASSITOLOGIA, V50, P145
   Dalla Pozza G., 1992, Journal of the American Mosquito Control Association, V8, P318
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   European Centre for Disease Prevention and Control and European Food Safety Authority, 2012, GUID SURV INV MOSQ E
   Gatt Paul, 2009, European Mosquito Bulletin, V27, P56
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Knudsen A. B., 1995, Parassitologia (Rome), V37, P91
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Madon MB, 2002, J VECTOR ECOL, V27, P149
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Medlock JM, 2017, LANCET INFECT DIS, V17, P140, DOI 10.1016/S1473-3099(17)30024-5
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Miquel Margalida, 2013, Journal of the European Mosquito Control Association, V31, P8
   Pasta L, 2015, EPIDEMIOL PREV, V39, P55
   Prestileo Tullio, 2013, Infez Med, V21, P21
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Romi R, 2008, EUR INFECT DIS, V2, P98
   Romi Roberto, 1997, Fragmenta Entomologica, V29, P1
   Sabatini A, 1990, PARASSITOLOGIA, V32, p30l
   Schaffner F, 2001, MOSQUITOES EUROPE ID
   Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209
   Schmidt-Chanasit J, 2010, EUROSURVEILLANCE, V15, P2
   Scholte EJ, 2008, MED VET ENTOMOL, V22, P352, DOI 10.1111/j.1365-2915.2008.00763.x
   Severini Francesco, 2009, Fragmenta Entomologica, V41, P213
   Torina A, 2006, PARASSITOLOGIA, V48, P166
NR 35
TC 6
Z9 6
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD NOV 2
PY 2017
VL 10
AR 543
DI 10.1186/s13071-017-2488-7
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FL6BX
UT WOS:000414331300002
PM 29096677
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Flamand, C
   Fritzell, C
   Matheus, S
   Dueymes, M
   Carles, G
   Favre, A
   Enfissi, A
   Adde, A
   Demar, M
   Kazanji, M
   Cauchemez, S
   Rousset, D
AF Flamand, Claude
   Fritzell, Camille
   Matheus, Severine
   Dueymes, Maryvonne
   Carles, Gabriel
   Favre, Anne
   Enfissi, Antoine
   Adde, Antoine
   Demar, Magalie
   Kazanji, Mirdad
   Cauchemez, Simon
   Rousset, Dominique
TI The proportion of asymptomatic infections and spectrum of disease among
   pregnant women infected by Zika virus: systematic monitoring in French
   Guiana, 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID COULD CLINICAL SYMPTOMS; TRANSMISSION; AMERICA; COMPLICATIONS;
   MICRONESIA; PREDICTOR; STATES; BRAZIL
AB Zika virus (ZIKV) infection has been associated with complications during pregnancy. Although the presence of symptoms might be a risk factor for complication, the proportion of ZIKV-infected pregnant women with symptoms remains unknown. Following the emergence of ZIKV in French Guiana, all pregnancies in the territory were monitored by RT-PCR and/or detection of ZIKV antibodies. Follow-up data collected during pregnancy monitoring interviews were analysed from 1 February to 1 June 2016. We enrolled 3,050 pregnant women aged 14-48 years and 573 (19%) had laboratory-confirmed ZIKV infection. Rash, arthralgia, myalgia and conjunctival hyperaemia were more frequently observed in ZIKV-positive women; 23% of them (95% confidence interval (CI): 20-27) had at least one symptom compatible with ZIKV infection. Women 30 years and older were significantly more likely to have symptoms than younger women (28% vs 20%). The proportion of symptomatic infections varied from 17% in the remote interior to 35% in the urbanised population near the coast (adjusted risk ratio: 1.6; 95% CI: 1.4-1.9.). These estimates put findings on cohorts of symptomatic ZIKV-positive pregnant women into the wider context of an epidemic with mainly asymptomatic infections. The proportion of symptomatic ZIKV infections appears to vary substantially between populations.
C1 [Flamand, Claude; Fritzell, Camille; Adde, Antoine; Kazanji, Mirdad] Inst Pasteur French Guiana, Epidemiol Unit, Cayenne, French Guiana, France.
   [Matheus, Severine; Enfissi, Antoine; Rousset, Dominique] Inst Pasteur French Guiana, Natl Reference Ctr Arboviruses, Cayenne, French Guiana, France.
   [Dueymes, Maryvonne; Demar, Magalie] Ctr Hosp Andree Rosemon, Lab, Cayenne, French Guiana, France.
   [Carles, Gabriel] Ctr Hosp Ouest Guyanais, Gynecol Obstet Dept, St Laurent Du Maroni, French Guiana, France.
   [Favre, Anne] Ctr Hosp Andree Rosemon, Neonatol Dept, Cayenne, French Guiana, France.
   [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France.
   [Cauchemez, Simon] CNRS, URA3012, Paris, France.
   [Cauchemez, Simon] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
RP Flamand, C (corresponding author), Inst Pasteur French Guiana, Epidemiol Unit, Cayenne, French Guiana, France.
EM cflamand@pasteur-cayenne.fr
RI Rousset, Dominique/S-5400-2019; Demar, Magalie Pierre/AAM-6913-2020
OI Rousset, Dominique/0000-0002-1473-3147; Demar, Magalie
   Pierre/0000-0003-3414-0821; Flamand, Claude/0000-0002-8064-445X
FU Institute Pasteur in French Guiana; Health Emergency Preparedness and
   Response Agency; Health Regional Agency; Cayenne Hospital Center;
   European Union ZikAlliance program; LABEX-IBEID; NIGMS MIDAS initiative;
   AXA; Association Robert Debre; EU- PREDEMICS
FX We thank Institute Pasteur in French Guiana, the Health Emergency
   Preparedness and Response Agency, the Health Regional Agency and Cayenne
   Hospital Center for their support. We are grateful to all of the
   collaborators involved in the monitoring of pregnant women in French
   Guiana and particularly the Regional Epidemiology unit of public Health
   France (Cire AG), the Regional Health Agency and the Expert Committee of
   Epidemic Diseases (CEME) of French Guiana for their support in the
   implementation of the monitoring system. We thank Ms. Stephanie BERNARD
   from the French Guiana Perinatal Database registry for her support of
   our study. Simon CAUCHEMEZ acknowledges funding from the European Union
   ZikAlliance program, LABEX-IBEID, the NIGMS MIDAS initiative, AXA
   Research Fund, Association Robert Debre, the EU- PREDEMICS.
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V388, P338, DOI 10.1016/S0140-6736(16)31017-0
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Celllule de l'Institut de Veille Sanitaire en Regions (Cire) Antilles-Guyane, 2016, SIT EP VIR ZIK ANT G
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Flamand C, 2011, STUD HEALTH TECHNOL, V169, P629, DOI 10.3233/978-1-60750-806-9-629
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Institut national de la statistique et des etudes economiques (Insee), 2016, CONT DEM TRANS FRENC
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   NORTHRIDGE ME, 1995, AM J PUBLIC HEALTH, V85, P1202, DOI 10.2105/AJPH.85.9.1202
   Pacheco O, 2016, N ENGL J MED
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Freitas ARR, 2016, LANCET, V388, P338, DOI 10.1016/S0140-6736(16)31104-7
   Sanchez J.D., 2017, REGIONAL ZIKA EPIDEM
   Tortevoye P, 2005, AM J TROP MED HYG, V73, P560, DOI 10.4269/ajtmh.2005.73.560
NR 32
TC 14
Z9 14
U1 0
U2 2
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD NOV 2
PY 2017
VL 22
IS 44
BP 23
EP 31
DI 10.2807/1560-7917.ES.2017.22.44.17-00102
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA FL7GU
UT WOS:000414415800003
PM 29113627
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhu, YB
   Zhang, RD
   Zhang, B
   Zhao, TY
   Wang, PH
   Liang, GD
   Cheng, G
AF Zhu, Yibin
   Zhang, Rudian
   Zhang, Bei
   Zhao, Tongyan
   Wang, Penghua
   Liang, Guodong
   Cheng, Gong
TI Blood meal acquisition enhances arbovirus replication in mosquitoes
   through activation of the GABAergic system
SO NATURE COMMUNICATIONS
LA English
DT Article
ID GATED CHLORIDE CHANNEL; ANOPHELES-GAMBIAE; RNA INTERFERENCE;
   INFLAMMATORY RESPONSES; INSECTICIDE RESISTANCE; DIPTERA-CULICIDAE;
   AEDES-AEGYPTI; BATAI VIRUS; ZIKA VIRUS; GABA
AB Mosquitoes are hematophagous insects that carry-on and transmit many human viruses. However, little information is available regarding the common mechanisms underlying the infection of mosquitoes by these viruses. In this study, we reveal that the hematophagous nature of mosquitoes contributes to arboviral infection after a blood meal, which suppresses antiviral innate immunity by activating the GABAergic pathway. dsRNA-mediated interruption of the GABA signaling and blockage of the GABAA receptor by the specific inhibitors both significantly impaired arbovirus replication. Consistently, inoculation of GABA enhanced arboviral infection, indicating that GABA signaling facilitates the arboviral infection of mosquitoes. The ingestion of blood by mosquitoes resulted in robust GABA production from glutamic acid derived from blood protein digestion. The oral introduction of glutamic acid increased virus acquisition by mosquitoes via activation of the GABAergic system. Our study reveals that blood meals enhance arbovirus replication in mosquitoes through activation of the GABAergic system.
C1 [Zhu, Yibin; Zhang, Rudian; Zhang, Bei; Cheng, Gong] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.
   [Zhu, Yibin; Cheng, Gong] Shenzhen Ctr Dis Control & Prevent, Inst Pathogen Organisms, Shenzhen 518055, Guangdong, Peoples R China.
   [Zhu, Yibin; Zhang, Rudian] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Zhao, Tongyan] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Wang, Penghua] New York Med Coll, Sch Med, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.
   [Liang, Guodong] Chinese Ctr Viral Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.
   [Liang, Guodong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310000, Zhejiang, Peoples R China.
RP Cheng, G (corresponding author), Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.; Cheng, G (corresponding author), Shenzhen Ctr Dis Control & Prevent, Inst Pathogen Organisms, Shenzhen 518055, Guangdong, Peoples R China.
EM gongcheng@mail.tsinghua.edu.cn
RI wang, Penghua/AAL-4011-2020
OI Zhag, Rudian/0000-0003-2214-4892
FU National Key Research and Development Plan of China [2016YFC1201000,
   2017ZX09101-005, 2016YFD0500400, 2016ZX10004001-008]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [81730063, 81422028, 81571975, 81290342]; National Institute of Health
   of the United StatesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI103807]; Shenzhen
   San-Ming Project for prevention and research on vector-borne diseases;
   Academy of Medical SciencesAcademy of Medical Sciences (AMS); Newton
   Fund
FX This work was funded by the grants from the National Key Research and
   Development Plan of China (2016YFC1201000, 2017ZX09101-005,
   2016YFD0500400, 2016ZX10004001-008), the grants from the National
   Natural Science Foundation of China (81730063, 81422028, 81571975, and
   81290342), and the grant from National Institute of Health of the United
   States (AI103807), and Shenzhen San-Ming Project for prevention and
   research on vector-borne diseases. G.C. is a Newton Advanced Fellow
   awarded by the Academy of Medical Sciences and the Newton Fund. We thank
   the technical supports from the Core Facility of Center for Life
   Sciences and Center of Biomedical Analysis (Tsinghua University).
CR Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Buddhala C, 2009, NEUROCHEM INT, V55, P9, DOI 10.1016/j.neuint.2009.01.020
   Caraballo H., 2014, EMERG MED PRACT, V16, P23
   Caraballo Hector, 2014, Emerg Med Pract, V16, P1
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136
   COLE LM, 1993, PESTIC BIOCHEM PHYS, V46, P47, DOI 10.1006/pest.1993.1035
   COLE LM, 1995, LIFE SCI, V56, P757, DOI 10.1016/0024-3205(95)00006-R
   Davari B, 2007, PESTIC BIOCHEM PHYS, V89, P97, DOI 10.1016/j.pestbp.2007.04.003
   Dionisio L, 2011, NEUROPHARMACOLOGY, V60, P513, DOI 10.1016/j.neuropharm.2010.11.007
   Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423
   FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Fuks JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003051
   Gendrin M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6921
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Huang ZJ, 2013, J VIROL, V87, P4272, DOI 10.1128/JVI.03360-12
   Huhtamo E, 2013, J GEN VIROL, V94, P1242, DOI 10.1099/vir.0.051359-0
   Jin Z, 2013, AMINO ACIDS, V45, P87, DOI 10.1007/s00726-011-1193-7
   Jupin M, 2015, MAGN RESON MED, V73, P459, DOI 10.1002/mrm.25178
   Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9
   Kim HC, 2011, J MED ENTOMOL, V48, P1250, DOI 10.1603/ME11091
   Kinel-Tahan Y, 2007, DEV DYNAM, V236, P2541, DOI 10.1002/dvdy.21284
   Kittler JT, 2002, MOL NEUROBIOL, V26, P251, DOI 10.1385/MN:26:2-3:251
   Lequime S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005548
   Liu H, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-138
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003931
   Londono-Renteria B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005202
   Lu Z, 2009, EMERG INFECT DIS, V15, P306, DOI 10.3201/eid1502.080722
   Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252
   Mendu SK, 2011, MOL IMMUNOL, V48, P399, DOI 10.1016/j.molimm.2010.08.005
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Noriega FG, 2004, INSECT BIOCHEM MOLEC, V34, P687, DOI 10.1016/j.ibmb.2004.03.021
   Onder O, 2014, NAT PROTOC, V9, P842, DOI 10.1038/nprot.2014.048
   Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505
   Ondiaka SN, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0654-3
   Pang XJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.23, 10.1038/nmicrobiol.2016.23]
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Pszczolkowski MA, 2011, J AGR FOOD CHEM, V59, P10879, DOI 10.1021/jf202386c
   Reyes-Garcia MG, 2007, J NEUROIMMUNOL, V188, P64, DOI 10.1016/j.jneuroim.2007.05.013
   Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108
   Stuckey DJ, 2005, J LEUKOCYTE BIOL, V78, P393, DOI 10.1189/jlb.1203604
   Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298
   Tian JD, 2011, AUTOIMMUNITY, V44, P465, DOI 10.3109/08916934.2011.571223
   Tremblay R, 2016, NEURON, V91, P260, DOI 10.1016/j.neuron.2016.06.033
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   Uusi-Oukari M, 2010, PHARMACOL REV, V62, P97, DOI 10.1124/pr.109.002063
   VANHANDEL E, 1965, J PHYSIOL-LONDON, V181, P478, DOI 10.1113/jphysiol.1965.sp007776
   Wang Feng-tian, 2009, Chinese Journal of Virology, V25, P83
   Wang PiYu, 2006, China Tropical Medicine, V6, P1933
   Wang Y, 2009, J IMMUNOL, V183, P3488, DOI 10.4049/jimmunol.0900767
   Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862
   Wheeler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017152
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xiao XP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004027
   Zeng R, 2017, PESTIC BIOCHEM PHYS, V138, P84, DOI 10.1016/j.pestbp.2017.03.005
NR 66
TC 14
Z9 14
U1 2
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 2
PY 2017
VL 8
AR 1262
DI 10.1038/s41467-017-01244-6
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FL5BG
UT WOS:000414245200002
PM 29093445
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bhardwaj, S
   Gokhale, MD
   Mourya, DT
AF Bhardwaj, Sumit
   Gokhale, Mangesh D.
   Mourya, Devendra T.
TI Zika virus: Current concerns in India
SO INDIAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Review
DE Aedes; chikungunya virus; mosquito; vector; Zika virus
ID CHIKUNGUNYA VIRUS; SUBCONTINENT; EPIDEMIC; STATE
AB With confirmation of Zika virus (ZIKV) presence in India, screening of a large number of febrile illness samples yielded only four positive cases. In this review, we address the current concern with context to India. The possible reasons for low level of Zika prevalence in India have been discussed, by extracting some probable explanations from previous experience of chikungunya virus-vector model/studies. In the current context, it is hypothesized that Indian mosquito strains have lower susceptibility gradient/threshold for ZIKV. The very low positivity in the humans also indicates low levels of mosquito-human-mosquito transmission cycle. There is also a need to look for the existence of any such animal cycle/sylvatic involvement in India. The recently detected four cases in India show local transmission of ZIKV suggesting that ZIKV might have been present in India since long time. The earlier vector-virus relationship studies with chikungunya suggested that in due course of time, ZIKV might become a major public health concern in the future.
C1 [Bhardwaj, Sumit] ICMR Natl Inst Virol, Influenza Grp, Pune, Maharashtra, India.
   [Gokhale, Mangesh D.] ICMR Natl Inst Virol, Entomol Grp, Pune, Maharashtra, India.
   [Mourya, Devendra T.] ICMR Natl Inst Virol, 20-A,Dr Ambedkar Rd, Pune 411001, Maharashtra, India.
RP Mourya, DT (corresponding author), ICMR Natl Inst Virol, 20-A,Dr Ambedkar Rd, Pune 411001, Maharashtra, India.
EM dtmourya@gmail.com
CR Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0
   Cherian SS, 2009, INFECT GENET EVOL, V9, P16, DOI 10.1016/j.meegid.2008.09.004
   Lahariya Chandrakant, 2006, Journal of Vector Borne Diseases, V43, P151
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministry of Health and Family Welfare Government of India, IND FIGHTS DENG STRA
   Mourya DT, 2016, INDIAN J MED RES, V143, P553, DOI 10.4103/0971-5916.187103
   Mourya DT, 1998, INDIAN J MED RES, V107, P10
   Mourya DT, 2001, ACTA VIROL, V45, P305
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2015, INCR MICR NE BRAZ EP
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sapkal GN, 2018, J INFECTION, V76, P314, DOI 10.1016/j.jinf.2017.09.020
   Subbarao SK, 1998, TECHNICAL PUBLICATIO
   Zika situation report neurological syndrome and congenital anomalies, ZIK SIT REP NEUR SYN
   Zika Virus Infection-India, 2017, DIS OUTBREAK NE 0208
NR 15
TC 7
Z9 7
U1 1
U2 4
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0971-5916
J9 INDIAN J MED RES
JI Indian J. Med. Res.
PD NOV
PY 2017
VL 146
BP 572
EP 575
DI 10.4103/ijmr.IJMR_1160_17
PG 4
WC Immunology; Medicine, General & Internal; Medicine, Research &
   Experimental
SC Immunology; General & Internal Medicine; Research & Experimental
   Medicine
GA FY6AG
UT WOS:000426920200005
PM 29512599
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Shrivastava, SR
   Shrivastava, PS
   Ramasamy, J
AF Shrivastava, Saurabh R.
   Shrivastava, Prateek S.
   Ramasamy, Jegadeesh
TI Zika virus disease outbreak in Brazil: Existing challenges and role of
   young people in containing the infection
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Editorial Material
C1 [Shrivastava, Saurabh R.; Shrivastava, Prateek S.; Ramasamy, Jegadeesh] Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, Chennai, Tamil Nadu, India.
RP Shrivastava, SR (corresponding author), Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, Kancheepuram, Tamil Nadu, India.
EM drshrishri2008@gmail.com
OI Shrivastava, Saurabh/0000-0001-6102-7475
CR [Anonymous], 2016, YOUNG PEOPL TAK LEAD
   [Anonymous], 2016, REV BRAS EPIDEMIOL, V19, P225
   Clavagnier Isabelle, 2016, Rev Infirm, V65, P41, DOI 10.1016/j.revinf.2016.04.012
   de Carvalho BR, 2016, J BRAS REPROD ASSIST, V20, P159, DOI 10.5935/1518-0557.20160034
   Shrivastava SR, 2015, J RES MED SCI, V2016, P55
   World Health Organization, 2016, ZIK SIT REP 15
NR 6
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2017
VL 10
IS 6
BP 1409
EP 1410
DI 10.4103/1755-6783.222687
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA FX8WH
UT WOS:000426375900005
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitit, V
AF Wiwanitkit, Somsri
   Wiwanitit, Viroj
TI Fast mutation rate of Zika virus: Observation in sequences in Asian
   lineage isolated from Southeast Asian countries
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Logan IS, 2016, ZOOL RES, V37, P110, DOI 10.13918/j.issn.2095-8137.2016.2.110
NR 1
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2017
VL 10
IS 6
BP 1842
EP +
DI 10.4103/1755-6783.222648
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA FX8WH
UT WOS:000426375900100
DA 2020-07-08
ER

PT J
AU Sriwijitalai, W
   Wiwanitkit, V
AF Sriwijitalai, Won
   Wiwanitkit, Viroj
TI Structural and functional analysis of Zika virus nonstructural protein 1
   by structural genomics approach
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Sriwijitalai, Won] RVT Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Sriwijitalai, W (corresponding author), RVT Med Ctr, Bangkok, Thailand.
EM wonsriwi@gmail.com
CR Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
NR 3
TC 0
Z9 0
U1 0
U2 1
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2017
VL 10
IS 6
BP 1844
EP 1845
DI 10.4103/1755-6783.222650
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA FX8WH
UT WOS:000426375900102
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Rainfall and Development of Zika Virus
SO ETHIOPIAN JOURNAL OF HEALTH SCIENCES
LA English
DT Letter
C1 [Joob, Beuy; Wiwanitkit, Viroj] Sanitat Med Acad Ctr, Bangkok, Thailand.
   [Joob, Beuy; Wiwanitkit, Viroj] Ethiopian Publ Hlth Inst, TB HIV Res Directorate, Addis Ababa, Ethiopia.
   Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat Med Acad Ctr, Bangkok, Thailand.; Joob, B (corresponding author), Ethiopian Publ Hlth Inst, TB HIV Res Directorate, Addis Ababa, Ethiopia.
EM beuyjoob@hotmail.com
CR Tosepu R, 2017, ASIAN PAC J TROP MED, V10, P300, DOI 10.1016/j.apjtm.2017.03.013
   Tosepu R, 2017, ETHIOP J HEALTH SCI, V27, P104, DOI 10.4314/ejhs.v27i1.15
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P698, DOI 10.1016/j.apjtm.2016.05.014
   Wiwanitkit Viroj, 2006, Journal of Vector Borne Diseases, V43, P73
NR 4
TC 0
Z9 0
U1 0
U2 3
PU JIMMA UNIV, ETHIOPIA
PI JIMMA
PA PO BOX 378, JIMMA, OROMIA 00000, ETHIOPIA
SN 1029-1857
EI 2413-7170
J9 ETHIOP J HEALTH SCI
JI Ethiop. J. Health Sci.
PD NOV
PY 2017
VL 27
IS 6
BP 683
EP 683
DI 10.4314/ejhs.v27i6.14
PG 1
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA FY1NW
UT WOS:000426580600014
PM 29487478
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Kraemer, MUG
   Brady, OJ
   Watts, A
   German, M
   Hay, SI
   Khan, K
   Bogoch, II
AF Kraemer, Moritz U. G.
   Brady, Oliver J.
   Watts, Alexander
   German, Matthew
   Hay, Simon I.
   Khan, Kamran
   Bogoch, Isaac I.
TI Zika virus transmission in Angola and the potential for further spread
   to other African settings
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Aedes; Africa; Air travel; Angola; Globalization; Mosquito; ZIKV
AB Background: Cases of Zika virus were recently detected in Luanda, Angola, a major travel hub in Africa. The risk of Zika virus transmission throughout the continent from Angola is evaluated.
   Methods: Travel volumes were assessed using monthly passenger-level flight data from Luanda to all locations throughout Africa. Travel data was superimposed onto seasonal environmental suitability maps that predict the potential for subsequent Zika virus transmission.
   Results and Conclusions: Windhoek, Maputo, Durban and Kinshasa have the greatest potential for Zika virus introduction and transmission during the southern hemisphere summer months, and Nairobi during the northern hemisphere summer months.
C1 [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, Moritz U. G.] Harvard Med Sch, Boston, MA USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp Informat Program, Boston, MA USA.
   [Brady, Oliver J.] Univ London, London Sch Hyg & Trop Med, Ctr Math Modeling Infect Dis, London, England.
   [Watts, Alexander; German, Matthew; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Hay, Simon I.] Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford, England.
   [Khan, Kamran; Bogoch, Isaac I.] Univ Toronto, Div Infect Dis, Dept Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada.
RP Khan, K (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.
EM khank@smh.ca
RI Hay, Simon I/F-8967-2015
OI Hay, Simon I/0000-0002-0611-7272
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR); Bill & Melinda Gates FoundationGates Foundation
   [OPP1106023, OPP1093011, OPP1132415, OPP1159934, OPP1176062]; Wellcome
   TrustWellcome Trust [209142, 206471/Z/17/Z]; Fleming Fund; Branco Weiss
   Fellowship-Society in Science; National Institute of Child Health and
   Human DevelopmentUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [T32HD040128]; National Library of Medicine of the National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)
   [R01LM010812, R01LM011965]; Sir Henry Wellcome Fellowship - Wellcome
   TrustWellcome Trust [206471/Z/17/Z]
FX This work was supported, in part, by the Canadian Institutes of Health
   Research. SIH is funded by grants from the Bill & Melinda Gates
   Foundation (OPP1106023, OPP1093011, OPP1132415, OPP1159934 and
   OPP1176062) and the Wellcome Trust (#209142) and the Fleming Fund. MUGK
   is supported by The Branco Weiss Fellowship-Society in Science,
   administered by the ETH Zurich and acknowledges funding from a Training
   Grant from the National Institute of Child Health and Human Development
   (T32HD040128) and the National Library of Medicine of the National
   Institutes of Health (R01LM010812 and R01LM011965). OJB was funded by a
   Sir Henry Wellcome Fellowship funded by the Wellcome Trust (grant number
   206471/Z/17/Z). The funders did not influence the content of this
   manuscript nor the decision to submit it for publication.
CR Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
NR 6
TC 12
Z9 12
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD NOV
PY 2017
VL 111
IS 11
BP 527
EP 529
DI 10.1093/trstmh/try001
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FX3DR
UT WOS:000425951200007
PM 29394415
OA Other Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Merlino, J
AF Merlino, John
TI Antimicrobial resistance a threat to public health
SO MICROBIOLOGY AUSTRALIA
LA English
DT Article
AB Antimicrobial resistance is a complex issue and is a threat to public health globally. While emerging and re-emerging diseases have captured news headlines with outbreaks such SARS, bird flu, Ebola and Zika virus around the world, leading health experts tells us that there is a more serious threat to public health - antimicrobial resistance (AMR)(1).
C1 [Merlino, John] Univ Sydney, Sydney Med Sch, Dept Infect Dis & Immunol, Sydney, NSW, Australia.
   [Merlino, John] Concord Hosp, NSW Hlth Pathol, Dept Microbiol & Infect Dis, Sydney, NSW, Australia.
RP Merlino, J (corresponding author), Univ Sydney, Sydney Med Sch, Dept Infect Dis & Immunol, Sydney, NSW, Australia.; Merlino, J (corresponding author), Concord Hosp, NSW Hlth Pathol, Dept Microbiol & Infect Dis, Sydney, NSW, Australia.
EM JMerlino@med.usyd.edu.au
CR Australian Commission on Safety and Quality in Health Care, 2017, ANT US RES AUSTR AUR
   Australian Government Department of Health, 2016, ANT RES AMR
   Balsalobre LC, 2014, BRAZ J MICROBIOL, V45, P1, DOI 10.1590/S1517-83822014005000033
   Boyce M., 2017, NEW THREAT PUBLIC HL
   Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096
   [Department of Health Department of Agriculture Australian Government], 2015, RESP THREAT ANT RES
   Gilbert L, 2014, MICROBIOL AUST, V35, P3, DOI 10.1071/MA14002
   Jindal A K, 2015, Med J Armed Forces India, V71, P178, DOI 10.1016/j.mjafi.2014.04.011
   O'Neill J., 2014, REV ANTIMICROBIAL RE
   Tang SS, 2014, ADV DRUG DELIVER REV, V78, P3, DOI 10.1016/j.addr.2014.08.003
   World Health Organization (WHO), 2016, ANT RES
NR 11
TC 0
Z9 0
U1 0
U2 0
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1324-4272
EI 2201-9189
J9 MICROBIOL AUST
JI Microbiol. Aust.
PD NOV
PY 2017
VL 38
IS 4
BP 165
EP 167
DI 10.1071/MA17059
PG 3
WC Microbiology
SC Microbiology
GA FU6JJ
UT WOS:000423958100006
DA 2020-07-08
ER

PT J
AU Iveson, JB
   Bradshaw, SD
   Smith, DW
AF Iveson, John B.
   Bradshaw, S. Donald
   Smith, David W.
TI The movement of humans and the spread of Salmonella into existing and
   pristine ecosystems
SO MICROBIOLOGY AUSTRALIA
LA English
DT Article
ID POPULATIONS
AB The spread of infectious diseases by the international and national movement of people, animals, insects and products has a documented history dating back several centuries(1). The role of human movements has been fundamental to this, and has increased as global travel has risen in amount and speed. This has been exemplified by international epidemics of influenza, antimicrobial resistant bacteria, SARS coronavirus, dengue, chikungunya virus, Zika viruses and many others. Foodborne pathogens have also regularly come to our attention for their ability to move internationally, and outbreaks of salmonellosis due to importation of contaminated foods are well described(2,3). An extensive collection of non-typhoidal Salmonella and related species isolated from human, food, animal and environmental sources has been accumulated within Western Australia (WA) since the mid-20th century, and has proven an important historical source of information about the role of humans in the dissemination of microorganisms across and within diverse ecosystems(4-6). It is clear that the movement of microorganisms into and out of Australia is by no means a new phenomenon, and that humans have been important contributors to that spread. These are important markers of our impact on established and pristine ecosystems.
C1 [Iveson, John B.; Smith, David W.] PathWest Lab Med WA, Dept Microbiol, Hosp Ave, Nedlands, WA 6009, Australia.
   [Bradshaw, S. Donald] Univ Western Australia, Fac Sci, Nedlands, WA 6009, Australia.
   [Smith, David W.] Univ Western Australia, Fac Med & Hlth Sci, Nedlands, WA 6009, Australia.
RP Smith, DW (corresponding author), PathWest Lab Med WA, Dept Microbiol, Hosp Ave, Nedlands, WA 6009, Australia.
EM david.smith@health.wa.gov.au
CR Ashbolt R, 2005, COMMUN DIS INTELL, V29, P164
   Australian Antarctic Division, 2017, HUM IMP ANT
   Institute of Medicine, 2006, IMP GLOB INF DIS EM
   International Association of Antarctica Tour Operators, 2017, TOURISM STAT
   Iveson JB, 2014, EPIDEMIOL INFECT, V142, P2281, DOI 10.1017/S0950268813003075
   Iveson JB, 2009, EPIDEMIOL INFECT, V137, P858, DOI 10.1017/S0950268808001222
   NICOL S, 2000, KRILL BIOL ECOLOGY F, P262
   Nygard K, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-32
   Palmgren H, 2000, EPIDEMIOL INFECT, V125, P257, DOI 10.1017/S0950268899004586
   Phillips A, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0831-3
   Taux R. V, 1999, SALMONELLA ENTERICA, P3
   Unicomb LE, 2005, EPIDEMIOL INFECT, V133, P1065, DOI 10.1017/S0950268805004085
   Yachison CA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01044
NR 13
TC 0
Z9 0
U1 0
U2 1
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1324-4272
EI 2201-9189
J9 MICROBIOL AUST
JI Microbiol. Aust.
PD NOV
PY 2017
VL 38
IS 4
BP 201
EP 203
DI 10.1071/MA17070
PG 3
WC Microbiology
SC Microbiology
GA FU6JJ
UT WOS:000423958100017
DA 2020-07-08
ER

PT J
AU Gong, Z
   Xu, XY
   Han, GZ
AF Gong, Zhen
   Xu, Xiaoyu
   Han, Guan-Zhu
TI The Diversification of Zika Virus: Are There Two Distinct Lineages?
SO GENOME BIOLOGY AND EVOLUTION
LA English
DT Article
DE phylogenetic analysis; Zika virus; parallel evolution
ID EVOLUTION; INFECTIVITY; INFERENCE; MOSQUITOS; OUTBREAK
AB Zika virus (ZIKV) has caused explosive epidemics in the Pacific and the Americas, posing a serious threat to public health. Conventional opinion advocates that ZIKV evolved into two distinct lineages, namely, African and Asian. Descendants of this latter lineage dispersed globally causing major epidemics. However, based on shared amino acid replacements and phylogenetic analyses, it was recently contentiously proposed that the Asian lineage was a direct descendant of the African lineage. To address this contentious issue, we reconstructed a phylogenetic tree of ZIKV using the method based on shared amino acid replacements and found that ZIKV evolved into two distinct lineages. This supports the conventional phylogenetic divergence pattern of ZIKV. Evidence of recombination and sequencing errors was identified among the large collection of ZIKV. As such problematic sequences could confound the phylogenetic analyses, they were removed. Bayesian phylogenetic analyses using the improved sequence data enabled estimates for the divergence time in the past of the African and Asian lineages of similar to 180 years ago. Moreover, we found that the Asian lineage viruses did not evolve at an elevated rate. Our findings provide additional support for the conventional opinion that the Asian lineage of ZIKV diverged from the African lineage.
C1 [Gong, Zhen; Xu, Xiaoyu; Han, Guan-Zhu] Nanjing Normal Univ, Coll Life Sci, Jiangsu Engn & Technol Res Ctr Microbiol, Jiangsu Key Lab Microbes & Funct Genom, Nanjing, Jiangsu, Peoples R China.
RP Han, GZ (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Engn & Technol Res Ctr Microbiol, Jiangsu Key Lab Microbes & Funct Genom, Nanjing, Jiangsu, Peoples R China.
EM guanzhu@njnu.edu.cn
RI Han, Guan-Zhu/P-4188-2019; Han, Guan-Zhu/A-6818-2011
OI Han, Guan-Zhu/0000-0002-8352-7726; Han, Guan-Zhu/0000-0002-8352-7726
FU Natural Science Foundation of Jiangsu ProvinceJiangsu Planned Projects
   for Postdoctoral Research FundsNatural Science Foundation of Jiangsu
   Province [BK20161016]; Priority Academic Program Development (PAPD) of
   Jiangsu Higher Education Institutions
FX G.-Z.H. was supported by the Natural Science Foundation of Jiangsu
   Province (BK20161016) and the Priority Academic Program Development
   (PAPD) of Jiangsu Higher Education Institutions.
CR Aiewsakun P, 2016, J VIROL, V90, P7184, DOI 10.1128/JVI.00593-16
   Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen H, 2016, MOL BIOL EVOL, V33, P3133, DOI 10.1093/molbev/msw190
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duchene S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0732
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Han GZ, 2017, TRENDS MICROBIOL, V25, P603, DOI 10.1016/j.tim.2017.05.014
   Han GZ, 2011, VIRUSES-BASEL, V3, P1358, DOI 10.3390/v3081358
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Liu H, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.109
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Morey RD, 2016, J MATH PSYCHOL, V72, P6, DOI 10.1016/j.jmp.2015.11.001
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390
   Worobey M, 2008, J VIROL, V82, P3769, DOI 10.1128/JVI.02207-07
   Worobey M, 2014, NATURE, V508, P254, DOI 10.1038/nature13016
   Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 39
TC 9
Z9 10
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1759-6653
J9 GENOME BIOL EVOL
JI Genome Biol. Evol.
PD NOV
PY 2017
VL 9
IS 11
BP 2940
EP 2945
DI 10.1093/gbe/evx223
PG 6
WC Evolutionary Biology; Genetics & Heredity
SC Evolutionary Biology; Genetics & Heredity
GA FT9GI
UT WOS:000423459700001
PM 29069354
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kothera, L
   Byrd, B
   Savage, HM
AF Kothera, Linda
   Byrd, Brian
   Savage, Harry M.
TI Duplex Real-Time PCR Assay Distinguishes Aedes aegypti From Ae.
   albopictus (Diptera: Culicidae) Using DNA From Sonicated First-Instar
   Larvae
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Zika; species identification assay;
   real-time PCR
ID RAPID IDENTIFICATION; MULTIPLEX PCR
AB Aedes aegypti (L.) and Ae. albopictus (Skuse) are important arbovirus vectors in the United States, and the recent emergence of Zika virus disease as a public health concern in the Americas has reinforced a need for tools to rapidly distinguish between these species in collections made by vector control agencies. We developed a duplex real-time PCR assay that detects both species and does not cross-amplify in any of the other seven Aedes species tested. The lower limit of detection for our assay is equivalent to similar to 0.03 of a first-instar larva in a 60-ml sample (0.016 ng of DNA per real-time PCR reaction). The assay was sensitive and specific in mixtures of both species that reflected up to a 2,000-fold difference in DNA concentration. In addition, we developed a simple protocol to extract DNA from sonicated first-instar larvae, and used that DNA to test the assay. Because it uses real-time PCR, the assay saves time by not requiring a separate visualization step. This assay can reduce the time needed for vector control agencies to make species identifications, and thus inform decisions about surveillance and control.
C1 [Kothera, Linda; Savage, Harry M.] Ctr Dis Control & Prevent, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
   [Byrd, Brian] Western Carolina Univ, CHHS 416,3971 Little Savannah Rd, Cullowhee, NC 28723 USA.
RP Kothera, L (corresponding author), Ctr Dis Control & Prevent, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM LKothera@cdc.gov; bdbyrd@email.wcu.edu; hms1@cdc.gov
FU Intramural CDC HHS [CC999999]
CR Beebe NW, 2007, J MED ENTOMOL, V44, P376, DOI 10.1603/0022-2585(2007)44[376:APCRDT]2.0.CO;2
   Das B, 2012, TROP MED INT HEALTH, V17, P235, DOI 10.1111/j.1365-3156.2011.02899.x
   Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P203, DOI 10.2987/11-6198R.1
   Genbank, 2017, NUCL BLAST BLASTN
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Higa Y, 2010, JPN J INFECT DIS, V63, P312
   Hill LA, 2008, AM J TROP MED HYG, V79, P866, DOI 10.4269/ajtmh.2008.79.866
   Hoffman K., 2017, BOXSHADE
   Life Technologies, 2012, REAL TIM PCR HDB
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   SAVAGE HM, 1994, J AM MOSQUITO CONTR, V10, P440
   van de Vossenberg BTLH, 2015, J MED ENTOMOL, V52, P336, DOI 10.1093/jme/tjv020
NR 14
TC 0
Z9 0
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD NOV
PY 2017
VL 54
IS 6
BP 1567
EP 1572
DI 10.1093/jme/tjx125
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA FT2LS
UT WOS:000422974500014
PM 28981691
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Parker, CN
   Pereira, RM
   Baldwin, RW
   Chaskopoulou, A
   Koehler, PG
AF Parker, Casey N.
   Pereira, Roberto M.
   Baldwin, Rebecca W.
   Chaskopoulou, Alexandra
   Koehler, Philip G.
TI Laboratory Evaluation of a Novel Lethal Ovitrap for Control of Aedes
   aegypti
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE lethal ovitrap; yellow fever mosquito; Aedes aegypti; Asian tiger
   mosquito; Aedes
ID ALBOPICTUS DIPTERA-CULICIDAE; INSECTICIDE RESISTANCE; SOURCE REDUCTION;
   OVIPOSITION; MOSQUITO; PATTERNS; FLORIDA; DENGUE; THAILAND; VECTOR
AB Aedes aegypti (L.) (Diptera: Culicidae) are known to flourish in a variety of natural and residential habitats and are competent vectors of at least 22 different arboviruses, including dengue, chikungunya, and Zika. Their global distribution, anthropophilic nature, and vector competency make them species of interest for control. A novel durable dual-action lethal ovitrap (DDALO) with combined larviciding and adulticiding effects, as well as a slowrelease polymer (isobutyl methacrylate), was designed to target Ae. aegypti. The use of the DDALO resulted in high adult mosquito mortality (similar to 95-100%) in no-choice laboratory cage studies targeting gravid females and successfully prevented all deposited eggs from hatching. Aging of the traps caused some loss in activity over time, but they still caused adult mortality (similar to 50%) and continued to prevent successful hatching of eggs for 6 mo. Oviposition preference studies resulted in similar to 4.5 times as many larvae developing in untreated DDALOs compared with the other containers combined. Small-cage multigenerational studies resulted in significantly lower populations of adult mosquitoes in cages containing treated DDALOs after 4 wk. Successful laboratory studies show that the DDALO appears to be a promising tool that could be used for controlling wild vector populations of Ae. aegypti in combination with other mosquito control practices.
C1 [Parker, Casey N.] Univ Florida, IFAS, Dept Entomol & Nematol, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
   [Pereira, Roberto M.; Baldwin, Rebecca W.; Koehler, Philip G.] Univ Florida, IFAS, Dept Entomol & Nematol, 970 Nat Area Dr, Gainesville, FL 32611 USA.
   [Chaskopoulou, Alexandra] ARS, European Biol Control Lab, USDA, Tsimiki 43,7th Floor, Thessaloniki 54623, Greece.
RP Parker, CN (corresponding author), Univ Florida, IFAS, Dept Entomol & Nematol, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
EM caseyparker@ufl.edu
RI Pereira, Rosa Maria Rodrigues/C-5192-2012
OI Pereira, Rosa Maria Rodrigues/0000-0002-3723-5028; Parker,
   Casey/0000-0002-4173-0881
CR Bayoumi AE, 2003, ECOTOX ENVIRON SAFE, V55, P19, DOI 10.1016/S0147-6513(02)00068-4
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chua Kaw Bing, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P599
   Connelly CR, 2009, FLORIDA COORDINATING
   Doud CW, 2014, J AM MOSQUITO CONTR, V30, P291, DOI 10.2987/14-6413.1
   Estrada-Franco JG, 1995, BIOL DIS RELATIONSHI, V42, P1
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Fonseca DM, 2015, J MED ENTOMOL, V52, P705, DOI 10.1093/jme/tjv060
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Hardstone MC, 2007, PESTIC BIOCHEM PHYS, V89, P175, DOI 10.1016/j.pestbp.2007.06.006
   Harrington LC, 2008, VECTOR-BORNE ZOONOT, V8, P415, DOI 10.1089/vbz.2007.0203
   Hatakoshi M., 1987, Japanese Journal of Sanitary Zoology, V38, P271
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   HOEDOJO ST, 1990, MOSQUITO BORNE DIS B, V7, P59
   Hoel DF, 2011, J AM MOSQUITO CONTR, V27, P245, DOI 10.2987/11-6121.1
   Liu H, 2004, J MED ENTOMOL, V41, P946, DOI 10.1603/0022-2585-41.5.946
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494
   Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2
   Neuhauser M, 2001, BIOMETRICAL J, V43, P571, DOI 10.1002/1521-4036(200109)43:5<571::AID-BIMJ571>3.0.CO;2-N
   Perich MJ, 2003, MED VET ENTOMOL, V17, P205, DOI 10.1046/j.1365-2915.2003.00427.x
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105
   Ponnusamy L, 2010, J CHEM ECOL, V36, P709, DOI 10.1007/s10886-010-9806-2
   Remmers J. L, 2001, THESIS
   Rey JR, 2014, J VECTOR ECOL, V39, P190, DOI 10.1111/j.1948-7134.2014.12086.x
   Ritchie SA, 2008, J AM MOSQUITO CONTR, V24, P47, DOI 10.2987/5658.1
   Santos S. R. A., 2003, Dengue Bulletin, V27, P156
   Seccacini E, 2006, ACTA TROP, V97, P1, DOI 10.1016/j.actatropica.2005.05.014
   Sivan A., 2015, PARASITOL RES, V42, P844
   Smith TM, 1986, RESIDUE REV, V97
   Sun DB, 2014, J AM MOSQUITO CONTR, V30, P99, DOI 10.2987/13-6394.1
   Trexler JD, 1998, J MED ENTOMOL, V35, P967, DOI 10.1093/jmedent/35.6.967
   Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999
   Womack M., 1993, WING BEATS, V5, P4
   Wong J, 2011, J MED ENTOMOL, V48, P45, DOI 10.1603/ME10149
   Zeichner BC, 1999, MED VET ENTOMOL, V13, P234, DOI 10.1046/j.1365-2915.1999.00192.x
NR 41
TC 1
Z9 1
U1 3
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD NOV
PY 2017
VL 54
IS 6
BP 1666
EP 1673
DI 10.1093/jme/tjx161
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA FT2LS
UT WOS:000422974500026
PM 28968892
DA 2020-07-08
ER

PT J
AU Reiskind, MH
   Hopperstad, KA
AF Reiskind, Michael H.
   Hopperstad, Kristen A.
TI Surveillance for Immature Mosquitoes in Windshield Wash Basins at Gas
   Stations
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes albopictus; Culex quinquefasciatus; Zika; dispersal; sampling
AB Gas stations often provide windshield wash basins (WWBs) that customers may use to clean their windshields. Motivated by casual observations, we conducted a survey of WWBs in and around Raleigh, NC, to determine whether these WWBs also serve as larval habitats for mosquitoes. We found that 27.7% (95% CI: 12.4-43.14%) of the 36 surveyed gas stations had mosquito larvae in their WWBs, and 22.4% (95% CI: 15.07-29.1%) of the 152 WWBs surveyed were positive for mosquito larvae. Two species were identified inhabiting these containers: Aedes albopictus (Skuse) and Culex quinquefasciatus Say. Aedes albopictus was associated with clear, unturbid water, whereas Cx. quinquefasciatus did not have any significant association with water characteristics. Pupae of both species were observed, suggesting these habitats could be sources of pest mosquitoes. Gas stations may be a convenient surveillance target for vector control specialists and may provide insight into human-aided mosquito dispersal.
C1 [Reiskind, Michael H.; Hopperstad, Kristen A.] North Carolina State Univ, Dept Entomol & Plant Pathol, Campus Box 7613, Raleigh, NC 27695 USA.
RP Reiskind, MH (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Campus Box 7613, Raleigh, NC 27695 USA.
EM mhreis-ki@ncsu.edu; kahopper@ncsu.edu
RI Hopperstad, Kristen/U-4728-2018; Reiskind, Michael Hay/I-5614-2012
OI Hopperstad, Kristen/0000-0002-3622-153X; Reiskind,
   Michael/0000-0001-7307-9416
FU Multistate USDA Hatch Project [NE1443]
FX We thank April Hamblin for her assistance with gas station surveys. This
   project was funded under the Multistate USDA Hatch Project: NE1443,
   "Biology, Ecology & Management of Emerging Disease Vectors."
NR 0
TC 0
Z9 0
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD NOV
PY 2017
VL 54
IS 6
BP 1775
EP 1777
DI 10.1093/jme/tjx129
PG 3
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA FT2LS
UT WOS:000422974500041
PM 28981650
DA 2020-07-08
ER

PT J
AU Rocha, NACF
   de Campos, AC
   Rocha, FCF
   Silva, FPD
AF Cicuto Ferreira Rocha, Nelci Adriana
   de Campos, Ana Carolina
   Ferreira Rocha, Fellipe Cicuto
   dos Santos Silva, Fernanda Pereira
TI Microcephaly and Zika virus: Neuroradiological aspects, clinical
   findings and a proposed framework for early evaluation of child
   development
SO INFANT BEHAVIOR & DEVELOPMENT
LA English
DT Article
DE Microcephaly; Zika virus; Early development; Infant; International
   Classification of Functionality; Disability and Health
ID MACULAR ATROPHY; INFANTS; BRAZIL; BRAIN; INFECTION; CLASSIFICATION;
   PARTICIPATION; INTERVENTION; DISABILITY; FETUSES
AB Background and aims: As the recent outbreak of microcephaly cases caused by Zika virus has been declared a global health emergency, providing assessment guidelines for multidisciplinary teams providing early developmental screening and stimulation to infants with microcephaly is much needed. Thus, the aim of this manuscript is to provide an overview on what is known about neuroradiological aspects and clinical findings in infants with microcephaly caused, by Zika virus and to propose a framework for early evaluation of child development.
   Methods: The keywords "Zika virus" and "microcephaly" were searched in PubMed database for articles published from incept to May 2017. These texts were reviewed, and the ones addressing neuroradiological and clinical findings in infants were selected. Recommendations for early assessment were made based on the International Classification of Functionality Disability and Health (ICF) model.
   Outcomes and results: The database search yielded 599 publications and 36 were selected. The studies detected microcephaly with diffuse brain malformations and calcifications, ventriculomegaly, optic nerve hypoplasia, macular atrophy, cataracts, impaired visual and hearing function, arthrogryposis, spasticity, hyperreflexia, irritability, tremors, and seizures, but very little is known about early development. Early assessments were described based on the ICF domains (Body Function and Structures, Activities and Participation and Contextual factors). Conclusion and implications: Studies published showed abnormal brain, optic, neurologic and orthopedic findings, but very little is known about other aspects of functioning in infants with microcephaly caused by Zika virus. The biopsychosocial model based on the ICF paradigm provides an adequate framework to describe the condition of the infant with microcephaly receiving rehabilitative efforts to minimize disability. Efforts towards early identification of developmental delays should be taken within the first six months of life.
C1 [Cicuto Ferreira Rocha, Nelci Adriana; de Campos, Ana Carolina; dos Santos Silva, Fernanda Pereira] Fed Univ Sao Carlos UFSCar, LADI, Dept Phys Therapy, Km 235, BR-13565905 Sao Carlos, SP, Brazil.
   [Ferreira Rocha, Fellipe Cicuto] Pontifical Catholic Univ Campinas, Med Sch, PUC Campinas, Av John Boyd Dunlop S-N, BR-13060904 Campinas, SP, Brazil.
RP Rocha, NACF (corresponding author), 310 Residencial Samanbaia, BR-13565560 Sao Carlos, SP, Brazil.
EM acicuto@gmail.com
RI de Campos, Ana Carolina/J-3676-2015; Cicuto Ferreira Rocha, Nelci
   Adriana/G-5808-2015
OI de Campos, Ana Carolina/0000-0001-7267-4467; Cicuto Ferreira Rocha,
   Nelci Adriana/0000-0002-3191-3086
CR Abbott A. L., 2000, PEDIAT PHYS THERAPY, V12, P62, DOI [DOI 10.1097/00001577-200012020-00003, 10.1097/00001577-200012020-00003]
   Abreu T. T., 2016, Revista de Ciencias Medicas e Biologicas, V15, P426, DOI 10.9771/cmbio.v15i3.18347
   Adhikari E. H., 2017, AM J OBSTET GYNECOL, V216, pe1
   [Anonymous], 2001, INT CLASS FUNCT DIS
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Baptista T, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2194
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   BARR R, 2003, INT J EARLY YEARS ED, V11, P7, DOI DOI 10.1080/0966976032000066055
   Bayley N., 2005, BAYLEY SCALES INFANT
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Blauw-Hospers CH, 2005, DEV MED CHILD NEUROL, V47, P421, DOI 10.1017/S0012162205000824
   Bly L., 1994, MOTOR SKILLS ACQUISI
   Burns Y R, 1989, Aust J Physiother, V35, P141, DOI 10.1016/S0004-9514(14)60503-1
   CALDWELL BM, 1984, HOME OBSERVATION MEA
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camargo O. A. K, 2016, BRAZILIAN J MED HUMA, V4, P29
   Campbell S. K, 2001, TEST INFANT MOTOR PE
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   CENSULLO M, 1987, NURS RES, V36, P244
   Chandler L., 1984, MOVEMENT ASSESSMENT
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   dos Santos AN, 2012, DISABIL REHABIL, V34, P1053, DOI 10.3109/09638288.2011.631678
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dunn W, 2014, SENSORY PROFILE, V2
   Einspieler C, 2005, MENT RETARD DEV D R, V11, P61, DOI 10.1002/mrdd.20051
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Haataja L, 1999, J PEDIATR-US, V135, P153, DOI 10.1016/S0022-3476(99)70016-8
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Herskind A, 2015, DEV MED CHILD NEUROL, V57, P29, DOI 10.1111/dmcn.12531
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Howie J. N., 2002, NEURODEVELOPMENTAL T
   Kimberlin CL, 2008, AM J HEALTH-SYST PH, V65, P2276, DOI 10.2146/ajhp070364
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leonardi M, 2009, DISABIL REHABIL, V31, pS83, DOI 10.3109/09638280903317948
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Mahmood S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-39
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   McIntyre S, 2011, DEV DISABIL RES REV, V17, P114, DOI 10.1002/ddrr.1106
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mochida GH, 2009, SEMIN PEDIATR NEUROL, V16, P120, DOI 10.1016/j.spen.2009.07.001
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Noreau L, 2007, DEV MED CHILD NEUROL, V49, P666, DOI 10.1111/j.1469-8749.2007.00666.x
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   OPITZ JM, 1990, J CRAN GENET DEV BIO, V10, P175
   PAHO & WHO, 2015, EP AL NEUR SYNDR CON
   Palisano RJ, 2012, DISABIL REHABIL, V34, P1041, DOI 10.3109/09638288.2011.628740
   Pavao SL, 2017, DEV NEUROREHABIL, V20, P149, DOI 10.3109/17518423.2016.1150359
   Piper M.C., 1994, MOTOR ASSESSMENT DEV
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Prechtl H., 1964, NEUROLOGICAL EXAMINA, V63
   Radecki L, 2011, PEDIATRICS, V128, P14, DOI 10.1542/peds.2010-2180
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ricci D, 2008, EARLY HUM DEV, V84, P107, DOI 10.1016/j.earlhumdev.2007.03.010
   Rocha Y. R. R., 2016, PLOS CURRENTS, V8
   Rosenbaum P, 2012, CHILD CARE HLTH DEV, V38, P457, DOI 10.1111/j.1365-2214.2011.01338.x
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sarno M, 2016, ULTRASOUND OBSTET GY
   Schiariti V, 2014, EUR J PAEDIATR NEURO, V18, P1, DOI 10.1016/j.ejpn.2013.08.001
   Schuler-Faccini L., 2016, MORBIDITY MORTALITY, V65
   Seltzer LE, 2014, AM J MED GENET C, V166, P140, DOI 10.1002/ajmg.c.31400
   Silva F. P. S., 2016, AVALIACAO HABITOS VI
   Sousa A. Q., 2017, EMERGING INFECT DIS, V23
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Stuberg W., 1994, PEDIAT PHYSICAL THER, V6, P119
   Sumner G., 1996, NCAST CAREGIVER PARE
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI 10.5123/S1679-49742016000400003
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vesnaver TV, 2017, BJOG-INT J OBSTET GY, V124, P521, DOI 10.1111/1471-0528.14423
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Volpe JJ, 2001, NEUROLOGY NEWBORN
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
NR 94
TC 6
Z9 6
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0163-6383
EI 1879-0453
J9 INFANT BEHAV DEV
JI Infant Behav. Dev.
PD NOV
PY 2017
VL 49
BP 70
EP 82
DI 10.1016/j.infbeh.2017.07.002
PG 13
WC Psychology, Developmental
SC Psychology
GA FR9VJ
UT WOS:000419420900009
PM 28755567
DA 2020-07-08
ER

PT J
AU Sudhan, SS
   Sharma, M
   Sharma, P
   Gupta, RK
   Sambyal, SS
   Sharma, S
AF Sudhan, Shashi Sharma
   Sharma, Monika
   Sharma, Preeti
   Gupta, Rajiv Kumar
   Sambyal, Sorabh Singh
   Sharma, Sonali
TI Serosurveillance of Dengue, Chikungunya and Zika in Jammu, a
   Sub-Himalayan Region of India
SO JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
LA English
DT Article
DE Aedes aegypti; Enzyme linked immunosorbent assay; Monoclonal antibody
ID OUTBREAK; VIRUS; FEVER; COINFECTION; INFECTION; EPIDEMIC
AB Introduction: Dengue and chikungunya are Aedes mosquitoborne viral diseases of major public health concern in India. Recently, there is a gradual rise in number of dengue and chikungunya positive cases in various states of Northern India and a similar emergence and increase of dengue positive cases has been observed in Jammu since 2011. Among the mosquitoborne diseases dengue has become a regular seasonal disease while chikungunya has recently emerged in 2016 and Zika the third aedes borne viral infection is needed to be under surveillance under national guidelines.
   Aim: To report the emergence of chikungunya and analyse the status and pattern of dengue over a period of one year along with serosurveillance of Zika which was done under Central Government guidelines.
   Materials and Methods: A total of eight hundred eight (808) samples from patients suspected of dengue infection over a period of one year from January 2016 to December 2016 from all the districts of Jammu Province, were tested serologically at our tertiary care centre for dengue NS1 antigen and IgM anti - dengue antibodies. Besides three clinical suspects of chikungunya, 167 dengue (7 positive and 160 negative) sera were tested by National Institute of Virology (NIV) CHIK IgM Capture ELISA, as there is an overlap of clinical symptoms. For Zika testing, the stored negative samples of dengue and Chikungunya (215) were sent to NIV Pune.
   Results: Recurring dengue infection with periodic upsurge since last few years and emergence of chikungunya was reported in Jammu region. Of the 808 sera tested for dengue and 170 tested for chikungunya, 17.82% and 18.2% were positive respectively. The results for Zika testing were negative. The association of dengue on the basis of sex was found to be highly significant (p= 0.009276).
   Conclusion: In the absence of specific treatment and vaccine for dengue and chikungunya fever, early diagnosis is important in the management of these infections. This also demands continuous seroepidemiological surveillance of the locally prevalent and emerging arthropod borne infections for timely formulation and implementation of effective arboviral control programme.
C1 [Sudhan, Shashi Sharma; Sharma, Monika; Sharma, Preeti; Sambyal, Sorabh Singh; Sharma, Sonali] GMC, Dept Microbiol, Jammu, Jammu & Kashmir, India.
   [Gupta, Rajiv Kumar] GMC, Dept PSM, Jammu, Jammu & Kashmir, India.
RP Sudhan, SS (corresponding author), GMC, Dept Microbiol, Jammu, Jammu & Kashmir, India.
EM drshashisharma.micro@gmail.com
RI SUDHAN, SHASHI S/J-5733-2019
CR Cecilia Dayaraj, 2014, WHO South East Asia J Public Health, V3, P22, DOI 10.4103/2224-3151.206879
   Chhabra M, 2008, INDIAN J MED MICROBI, V26, P5, DOI 10.4103/0255-0857.38850
   Farnon EC, 2008, CRIT CARE MED, V36, P2682, DOI 10.1097/CCM.0b013e3181843d94
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Garg A, 2011, J INFECT DIS IMMUN, V3, P85
   Gupta E, 2005, INDIAN J MED RES, V121, P36
   Halstead SB, 2008, DENGUE TROPICAL MED
   Krishnamoorthy K, 2009, J VECTOR DIS, V46, P26
   Kumar Ashwini, 2010, Indian J Community Med, V35, P386, DOI 10.4103/0970-0218.69253
   Kurukumbi M, 2001, Indian J Med Sci, V55, P149
   Manimunda SP, 2010, AM J TROP MED HYG, V83, P751, DOI 10.4269/ajtmh.2010.09-0433
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Nagpal BN, 2012, INDIAN J MED RES, V135, P351
   National Vector Borne Disease Control Programme, 2017, CHIK FEV
   Parida MM, 2002, INDIAN J MED RES, V116, P248
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Ravi V, 2006, Indian J Med Microbiol, V24, P83
   Saswat T, 2015, INFECT GENET EVOL, V35, P134, DOI 10.1016/j.meegid.2015.08.006
   Singh B., 2006, INDIAN J COMM MED, V32, P99
   Sudhan SS, 2016, INT J MED RES HLTH S, V5
   Ukey Pm, 2010, Indian J Community Med, V35, P517, DOI 10.4103/0970-0218.74366
   WHO, 2017, DIS OUTBREAK NE 0208
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 23
TC 1
Z9 1
U1 0
U2 0
PU PREMCHAND SHANTIDEVI RESEARCH FOUNDATION
PI DELHI
PA 71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA
SN 2249-782X
EI 0973-709X
J9 J CLIN DIAGN RES
JI J. Clin. Diagn. Res.
PD NOV
PY 2017
VL 11
IS 11
BP DC5
EP DC8
DI 10.7860/JCDR/2017/29210.10848
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA FR6DR
UT WOS:000419156100053
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Araujo, D
   Boas, SV
   Faluyi, U
   Medavarapu, S
AF Araujo, Denise
   Boas, Silvia Vilas
   Faluyi, Uyi
   Medavarapu, Srinivas
TI The Expanding Spectrum of Zika Virus Transmission: A Systematic Review
SO JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
LA English
DT Review
DE Blood transfusion; Mother to foetus transmission; Sexual transmission;
   Vector-borne transmission
ID VECTOR-BORNE TRANSMISSION; MALE SEXUAL TRANSMISSION; UNITED-STATES;
   INTERIM GUIDANCE; INFECTION
AB Introduction: Large numbers of confirmed Zika Virus (ZIKV) infections have been reported as a result of vector-borne and non-vector-borne transmission. With a recent ZIKV outbreak, several methods of transmission have been identified during this pandemic. Knowledge of transmission methods is essential to prevent further spread.
   Aim: To conduct a literature review on ZIKV and its methods of transmission, to improve the understanding of how the virus may spread.
   Materials and Methods: Systematic literature review was performed on methods of ZIKV transmission including: vector-borne, sexual, mother to foetus, blood transfusion, and breast milk.
   Results: A total of 18 articles were reviewed involving 2573 cases. Vector-borne transmission was most prevalent in ZIKV cases, followed by mother to foetus vertical transmission and sexual transmission. ZIKV has been detected in blood, urine, semen, saliva, amniotic fluid and breast milk. However, ZIKV is not present in all bodily fluids at one time. Blood and semen have proved to be infectious and a contributory to the spread of ZIKV. It is unknown whether breast milk is infectious to neonates.
   Conclusion: Our systematic review demonstrates the influence of different methods of ZIKV transmission possess with the spread of ZIKV. It provides significant implications on testing, prevention and control of ZIKV. Finally, it provides a guide for further research opportunities.
C1 [Araujo, Denise; Boas, Silvia Vilas; Faluyi, Uyi] All St Univ Sch Med, Hillsborough St,POB 1679, Roseau, Dominica.
   [Medavarapu, Srinivas] All St Univ Sch Med, Dept Epidemiol & Biostat, Roseau, Dominica.
RP Medavarapu, S (corresponding author), All St Univ Sch Med, Dept Epidemiol & Biostat, Roseau, Dominica.
EM srinivasmedavarapu@yahoo.co.in
OI Medavarapu, Srinivas/0000-0002-1019-3657
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chen YN, 2016, J MED ULTRASOUND, V24, P89, DOI 10.1016/j.jmu.2016.08.007
   Daniel KL, 2016, MMWR-MORBID MORTAL W, V65, P352, DOI 10.15585/mmwr.mm6513e1
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROPEAN COMMUNICABL, V2016, P21, DOI DOI 10.2807/1560-7917
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gebre Y, 2016, ASIAN PAC J TROP BIO, V6, P815, DOI 10.1016/j.apjtb.2016.08.008
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lazic S, 2016, VOJNOSANIT PREGL, V73, P225, DOI 10.2298/VSP1603225L
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P291
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Ramesh N, 2016, INT J MED SCI PUBLIC, V6
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   World Health Organization, 2016, LAB TEST ZIK VIR
   World Health Organization, 2016, SIT REP ZIK VIR
NR 33
TC 0
Z9 0
U1 0
U2 10
PU PREMCHAND SHANTIDEVI RESEARCH FOUNDATION
PI DELHI
PA 71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA
SN 2249-782X
EI 0973-709X
J9 J CLIN DIAGN RES
JI J. Clin. Diagn. Res.
PD NOV
PY 2017
VL 11
IS 11
BP OE3
EP OE8
DI 10.7860/JCDR/2017/29067.10894
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA FR6DR
UT WOS:000419156100048
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Netto, EM
   Moreira-Soto, A
   Pedroso, C
   Hoser, C
   Funk, S
   Kucharski, AJ
   Rockstroh, A
   Kummerer, BM
   Sampaio, GS
   Luz, E
   Vaz, SN
   Dias, JP
   Bastos, FA
   Cabral, R
   Kistemann, T
   Ulbert, S
   de Lamballerie, X
   Jaenisch, T
   Brady, OJ
   Drosten, C
   Sarno, M
   Brites, C
   Drexler, JF
AF Netto, Eduardo Martins
   Moreira-Soto, Andres
   Pedroso, Celia
   Hoser, Christoph
   Funk, Sebastian
   Kucharski, Adam J.
   Rockstroh, Alexandra
   Kuemmerer, Beate M.
   Sampaio, Gilmara Souza
   Luz, Estela
   Vaz, Sara Nunes
   Dias, Juarez Pereira
   Bastos, Fernanda Anjos
   Cabral, Renata
   Kistemann, Thomas
   Ulbert, Sebastian
   de lamballerie, Xavier
   Jaenisch, Thomas
   Brady, Oliver J.
   Drosten, Christian
   Sarno, Manoel
   Brites, Carlos
   Drexler, Jan Felix
TI High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits
   the Potential for Further Outbreaks
SO MBIO
LA English
DT Article
DE Zika virus; microcephaly; risk factors; serology; socioeconomic status
ID INFECTION; DENGUE; TRANSMISSION; ASSOCIATION; EPIDEMIC; RISK
AB During 2015 to 2016, Brazil reported more Zika virus (ZIKV) cases than any other country, yet population exposure remains unknown. Serological studies of ZIKV are hampered by cross-reactive immune responses against heterologous viruses. We conducted serosurveys for ZIKV, dengue virus (DENV), and Chikungunya virus (CHIKV) in 633 individuals prospectively sampled during 2015 to 2016, including microcephaly and non-microcephaly pregnancies, HIV-infected patients, tuberculosis patients, and university staff in Salvador in northeastern Brazil using enzyme-linked immunosorbent assays (ELISAs) and plaque reduction neutralization tests. Sera sampled retrospectively during 2013 to 2015 from 277 HIV-infected patients were used to assess the spread of ZIKV over time. Individuals were georeferenced, and sociodemographic indicators were compared between ZIKV-positive and -negative areas and areas with and without microcephaly cases. Epidemiological key parameters were modeled in a Bayesian framework. ZIKV seroprevalence increased rapidly during 2015 to 2016, reaching 63.3% by 2016 (95% confidence interval [CI], 59.4 to 66.8%), comparable to the seroprevalence of DENV (75.7%; CI, 69.4 to 81.1%) and higher than that of CHIKV (7.4%; CI, 5.6 to 9.8%). Of 19 microcephaly pregnancies, 94.7% showed ZIKV IgG antibodies, compared to 69.3% of 257 non-microcephaly pregnancies (P = 0.017). Analyses of sociodemographic data revealed a higher ZIKV burden in low socioeconomic status (SES) areas. High seroprevalence, combined with case data dynamics allowed estimates of the basic reproduction number R-0 of 2.1 (CI, 1.8 to 2.5) at the onset of the outbreak and an effective reproductive number R-eff of <1 in subsequent years. Our data corroborate ZIKV-associated congenital disease and an association of low SES and ZIKV infection and suggest that population immunity caused cessation of the outbreak. Similar studies from other areas will be required to determine the fate of the American ZIKV outbreak.
   IMPORTANCE The ongoing American Zika virus (ZIKV) outbreak involves millions of cases and has a major impact on maternal and child health. Knowledge of infection rates is crucial to project future epidemic patterns and determine the absolute risk of microcephaly upon maternal ZIKV infection during pregnancy. For unknown reasons, the vast majority of ZIKV-associated microcephaly cases are concentrated in northeastern Brazil. We analyzed different subpopulations from Salvador, a Brazilian metropolis representing one of the most affected areas during the American ZIKV outbreak. We demonstrate rapid spread of ZIKV in Salvador, Brazil, and infection rates exceeding 60%. We provide evidence for the link between ZIKV and microcephaly, report that ZIKV predominantly affects geographic areas with low socioeconomic status, and show that population immunity likely caused cessation of the outbreak. Our results enable stakeholders to identify target populations for vaccination and for trials on vaccine efficacy and allow refocusing of research efforts and intervention strategies.
C1 [Netto, Eduardo Martins; Pedroso, Celia; Sampaio, Gilmara Souza; Luz, Estela; Vaz, Sara Nunes; Dias, Juarez Pereira; Sarno, Manoel; Brites, Carlos] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil.
   [Netto, Eduardo Martins] IBIT FJS, Salvador, BA, Brazil.
   [Moreira-Soto, Andres; Kuemmerer, Beate M.; Drexler, Jan Felix] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.
   [Hoser, Christoph; Kistemann, Thomas] Univ Bonn, Inst Hyg & Publ Hlth, GeoHlth Ctr, WHO Collaborating Ctr Hlth Promoting Water Manage, Bonn, Germany.
   [Funk, Sebastian; Kucharski, Adam J.; Brady, Oliver J.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Rockstroh, Alexandra; Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Leipzig, Germany.
   [Kuemmerer, Beate M.; Jaenisch, Thomas; Drosten, Christian; Drexler, Jan Felix] German Ctr Infect Res DZIF, Munich, Germany.
   [Bastos, Fernanda Anjos; Cabral, Renata; Sarno, Manoel] Univ Fed Bahia, Maternidade Climerio de Oliveira, Salvador, BA, Brazil.
   [de lamballerie, Xavier] Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth 19, EPV UMR D Emergence Pathol Virales 190, Marseille, France.
   [de lamballerie, Xavier] Publ Hosp Marseille 21, AP HM, IHU Inst Hosp Univ Mediterranee Infect, Marseille, France.
   [Jaenisch, Thomas] Heidelberg Univ Hosp, INF 324, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [Drosten, Christian; Drexler, Jan Felix] Charite, Berlin, Germany.
   [de lamballerie, Xavier; Drexler, Jan Felix] Free Univ Berlin, Berlin, Germany.
   [de lamballerie, Xavier; Drexler, Jan Felix] Humboldt Univ, Berlin, Germany.
   [de lamballerie, Xavier; Drexler, Jan Felix] Berlin Inst Hlth, Inst Virol, Berlin, Germany.
RP Brites, C (corresponding author), Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil.; Drexler, JF (corresponding author), Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.; Drexler, JF (corresponding author), German Ctr Infect Res DZIF, Munich, Germany.; Drexler, JF (corresponding author), Charite, Berlin, Germany.; Drexler, JF (corresponding author), Free Univ Berlin, Berlin, Germany.; Drexler, JF (corresponding author), Humboldt Univ, Berlin, Germany.; Drexler, JF (corresponding author), Berlin Inst Hlth, Inst Virol, Berlin, Germany.
EM crbrites@ufba.br; felix.drexler@charite.de
RI Netto, Eduardo/D-1432-2013
OI Netto, Eduardo/0000-0003-1691-6761; Funk, Sebastian/0000-0002-2842-3406;
   Moreira-Soto, Andres/0000-0002-9224-5157; Drexler, Jan
   Felix/0000-0002-3509-0232
FU German Centre for Infection Research (DZIF) through the ZIKApath
   project; European Union's Horizon 2020 research and innovation program
   through the ZIKAlliance project [734548]
FX This work was supported by the German Centre for Infection Research
   (DZIF) through the ZIKApath project to J.F.D. and T.J., and the European
   Union's Horizon 2020 research and innovation program through the
   ZIKAlliance project (grant agreement 734548) to J.FD., T.J., B.M.K.,
   O.J.B., and X.D.L.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cauchemez S, 2016, LANCET, V388, P338, DOI 10.1016/S0140-6736(16)31017-0
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Ximenes RAD, 2009, INT J EPIDEMIOL, V38, P1285, DOI 10.1093/ije/dyp224
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Diario Oficial da Uniao, 2016, DIARIO OFICIAL UNIAO
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Funk S., 2016, RBI HELPERS RBI HELP
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Jacob PE, 2017, RBI R INTERFACE LIBB
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005698
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Ministerio do Planejamento, 2010, 12 CENS DEM
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Murray L.M., 2013, ARXIV13063277
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen Lyle R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7171.1
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rockstroh A, EMERG MICROBES INFEC
   Rockstroh A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004218
   Rodrigues Faria N, 2016, PLOS CURR OUTBREAKS
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Vega-Rua A, 2015, VIRUSES-BASEL, V7, P5902, DOI 10.3390/v7112917
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274
NR 56
TC 62
Z9 64
U1 0
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD NOV-DEC
PY 2017
VL 8
IS 6
AR e01390-17
DI 10.1128/mBio.01390-17
PG 14
WC Microbiology
SC Microbiology
GA FR2IC
UT WOS:000418889500015
PM 29138300
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Jurado, KA
   Iwasaki, A
AF Jurado, Kellie Ann
   Iwasaki, Akiko
TI Zika virus targets blood monocytes
SO NATURE MICROBIOLOGY
LA English
DT Editorial Material
ID SEXUAL TRANSMISSION; INFECTION
AB Two studies identify circulating monocytes as the primary cellular target of Zika virus infection in human blood. Monocytes are an ideal target as they have the potential to be used as a Trojan horse to infiltrate immune-sheltered tissues, including placenta, testes and the brain, to spread Zika virus.
C1 [Jurado, Kellie Ann; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.
   [Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
RP Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Iwasaki, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
EM akiko.iwasaki@yale.edu
RI Iwasaki, Akiko/Z-1591-2019
OI Iwasaki, Akiko/0000-0002-7824-9856
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [T32 AI007019]
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Foo S. S., 2017, NAT MICROBIOL
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Michlmayr D, 2017, NAT MICROBIOL
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Yewdell JW, 2012, CELL CYCLE, V11, P1748, DOI 10.4161/cc.20311
NR 10
TC 6
Z9 6
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD NOV
PY 2017
VL 2
IS 11
BP 1460
EP 1461
DI 10.1038/s41564-017-0049-7
PG 2
WC Microbiology
SC Microbiology
GA FP9NM
UT WOS:000417975600003
PM 29070824
DA 2020-07-08
ER

PT J
AU Heald-Sargent, T
   Muller, W
AF Heald-Sargent, Taylor
   Muller, William
TI Zika Virus: A Review for Pediatricians
SO PEDIATRIC ANNALS
LA English
DT Review
ID UPDATE INTERIM GUIDANCE; BIRTH-DEFECTS; UNITED-STATES; INFECTION;
   INFANTS; PREGNANCY; EXPOSURE; INOCULATION; BRAZIL; WOMEN
AB For the past several years, the Zika virus has been a topic of conversation among pediatric health care providers in many settings. This article provides current answers to many questions that may be posed to pediatricians, including inquiries about clinical presentation, testing, and prevention. Although infants born with congenital Zika syndrome often have microcephaly, there are other characteristic features, such as eye abnormalities, that one should recognize. Additionally, testing for the syndrome must be considered in all infants at risk for infection, including those who are asymptomatic at birth. Maternal travel to an endemic region or sexual intercourse with an exposed person shortly before or during pregnancy may put an infant at risk for infection.
C1 [Heald-Sargent, Taylor; Muller, William] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Pediat Infect Dis, Evanston, IL 60208 USA.
RP Heald-Sargent, T (corresponding author), 225 E Chicago Ave,18th Floor,Suite 110, Chicago, IL 60611 USA.
EM thsargent@luriechildrens.org
OI Heald-Sargent, Taylor/0000-0003-0856-4006; Muller, William
   J/0000-0001-7690-0695
CR [Anonymous], SEX TRANSM PREV
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Butler D, 2017, NATURE, V545, P396, DOI 10.1038/545396a
   Centers for Disease Control and Preven-tion, PROT YOURS YOUR FAM
   Centers for Disease Control and Prevention, ZIK VIR
   Centers for Disease Control and Prevention, PREGN WOM AN LAB EV
   Centers for Disease Control and Prevention, WORLD MAP AR RISK ZI
   Centers for Disease Control and Prevention, US ZIK PREGN REG
   Centers for Disease Control and Prevention, HEALTHC PROV CAR INF
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hagmann SHF, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0584-7
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   US Department of Health & Human Services. Genetic and Rare Diseases Information Center, ARTHR MULT CONG
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   World Health Organization, BREASTF CONT ZIK VIR
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 33
TC 4
Z9 4
U1 0
U2 4
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0090-4481
EI 1938-2359
J9 PEDIATR ANN
JI Pediatr. Ann.
PD NOV
PY 2017
VL 46
IS 11
BP E428
EP E432
DI 10.3928/19382359-20171025-01
PG 5
WC Pediatrics
SC Pediatrics
GA FP7ZW
UT WOS:000417859900008
PM 29131923
DA 2020-07-08
ER

PT J
AU Darbellay, J
   Cox, B
   Lai, K
   Delgado-Ortega, M
   Wheler, C
   Wilson, D
   Walker, S
   Starrak, G
   Hockley, D
   Huang, YY
   Mutwiri, G
   Potter, A
   Gilmour, M
   Safronetz, D
   Gerdts, V
   Karniychuk, U
AF Darbellay, Joseph
   Cox, Brian
   Lai, Kenneth
   Delgado-Ortega, Mario
   Wheler, Colette
   Wilson, Donald
   Walker, Stewart
   Starrak, Gregory
   Hockley, Duncan
   Huang, Yanyun
   Mutwiri, George
   Potter, Andrew
   Gilmour, Matthew
   Safronetz, David
   Gerdts, Volker
   Karniychuk, Uladzimir
TI Zika Virus Causes Persistent Infection in Porcine Conceptuses and may
   Impair Health in Offspring
SO EBIOMEDICINE
LA English
DT Article
DE Zika virus; Fetus; Offspring; Persistent infection; Behavior; Pig
ID INTRAUTERINE GROWTH RESTRICTION; JAPANESE ENCEPHALITIS-VIRUS;
   ANIMAL-MODEL; INTRAAMNIOTIC INOCULATION; PRENATAL INFECTION; MATERNAL
   INFECTION; CANDIDATE GENES; MINIATURE PIG; BRAIN GROWTH; PREGNANCY
AB Outcomes of Zika virus (ZIKV) infection in pregnant women vary from the birth of asymptomatic offspring to abnormal development and severe brain lesions in fetuses and infants. There are concerns that offspring affected in utero and born without apparent symptoms may develop mental illnesses. Therefore, animal models are important to test interventions against in utero infection and health sequelae in symptomatic and likely more widespread asymptomatic offspring. To partially reproduce in utero infection in humans, we directly inoculated selected porcine conceptuses with ZIKV. Inoculation resulted in rapid trans-fetal infections, persistent infection in conceptuses, molecular pathology in fetal brains, fetal antibody and type I interferon responses. Offspring infected in utero showed ZIKV in their fetal membranes collected after birth. Some in utero affected piglets were small, depressed, had undersized brains, and showed seizures. Some piglets showed potentially increased activity. Our data suggest that porcine model of persistent in utero ZIKV infection has a strong potential for translational research and can be used to test therapeutic interventions in vivo. (C) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
C1 [Darbellay, Joseph; Lai, Kenneth; Delgado-Ortega, Mario; Wheler, Colette; Wilson, Donald; Walker, Stewart; Potter, Andrew; Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Int Vaccine Ctr VIDO Int, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada.
   [Cox, Brian] Univ Toronto, Dept Obstet & Gynaecol, Dept Physiol, Toronto, ON M5S 1A8, Canada.
   [Starrak, Gregory; Hockley, Duncan] Univ Saskatchewan, Western Coll Vet Med, Dept Small Anim Clin Sci, Saskatoon, SK S7N 5B4, Canada.
   [Huang, Yanyun] Prairie Diagnost Serv, Saskatoon, SK S7N 5B4, Canada.
   [Mutwiri, George; Karniychuk, Uladzimir] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada.
   [Potter, Andrew; Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Dept Vet Microbiol, Western Coll Vet Med, Saskatoon, SK S7N 5B4, Canada.
   [Gilmour, Matthew; Safronetz, David] Publ Hlth Agcy Canada, Canada Natl Microbiol Lab, 1015 Arlington St, Winnipeg, MB R3E 3R2, Canada.
RP Karniychuk, U (corresponding author), Univ Saskatchewan, Int Vaccine Ctr VIDO Int, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada.
EM u.karniychuk@usask.ca
OI Karniychuk, Uladzimir/0000-0001-7802-9223; Delgado-Ortega,
   Mario/0000-0002-6921-2920
FU Genome Canada, Emerging Issue Program [418402]; Public Health Agency of
   Canada [418836]; Government of Saskatchewan through Innovation
   Saskatchewan [418836]
FX Financial support was provided by Genome Canada, Emerging Issue Program
   grant #418402, the Public Health Agency of Canada and the Government of
   Saskatchewan through Innovation Saskatchewan #418836.
CR Adams Waldorf K.M., 2016, NAT MED
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9
   Alexiades NG, 2015, STEM CELL RES, V15, P598, DOI 10.1016/j.scr.2015.10.005
   Alisky JM, 2006, MED HYPOTHESES, V67, P556, DOI 10.1016/j.mehy.2006.02.043
   Amaral AJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-374
   AMSTEY MS, 1969, AM J OBSTET GYNECOL, V104, P573, DOI 10.1016/S0002-9378(16)34249-1
   Andersen AD, 2016, AM J PHYSIOL-REG I, V310, pR481, DOI 10.1152/ajpregu.00349.2015
   Antonson A.M., 2016, BRAIN BEHAV IMMUN
   Antonson AM, 2017, BRAIN BEHAV IMMUN, V59, P300, DOI 10.1016/j.bbi.2016.09.019
   Asadi-Pooya AA, 2016, SEIZURE-EUR J EPILEP, V43, P13, DOI 10.1016/j.seizure.2016.10.011
   Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y
   Bassols A, 2014, PROTEOM CLIN APPL, V8, P715, DOI 10.1002/prca.201300099
   Bauer R, 2007, J PHYSIOL-LONDON, V584, P693, DOI 10.1113/jphysiol.2007.142778
   Baxa M, 2013, J HUNTINGTONS DIS, V2, P47, DOI 10.3233/JHD-130001
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown AS, 2012, DEV NEUROBIOL, V72, P1272, DOI 10.1002/dneu.22024
   Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361
   Burke C, 2006, BRAIN RES, V1098, P19, DOI 10.1016/j.brainres.2006.04.129
   Careaga M, 2017, BIOL PSYCHIAT, V81, P391, DOI 10.1016/j.biopsych.2016.10.020
   Cassetti MC, 2010, VACCINE, V28, P4229, DOI 10.1016/j.vaccine.2010.04.045
   Chen JJ, 2011, J HUAZHONG U SCI-MED, V31, P371, DOI 10.1007/s11596-011-0383-6
   Chen JJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-70
   COLLIE MH, 1982, BRIT J EXP PATHOL, V63, P299
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Cugola F.R., 2016, NATURE ADV
   Cui L, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3796359
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICKERSON JW, 1966, P ROY SOC MED, V59, P1088, DOI 10.1177/003591576605911P113
   DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002
   Dixit AB, 2016, GENOMICS, V107, P178, DOI 10.1016/j.ygeno.2016.04.001
   DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7
   Dohrn N, 2015, AM J MED GENET A, V167, P731, DOI 10.1002/ajmg.a.37018
   Ferenc K, 2014, REPROD BIOL, V14, P51, DOI 10.1016/j.repbio.2014.01.005
   Franca GV, 2016, LANCET
   Gerdts V, 2015, ILAR J, V56, P53, DOI 10.1093/ilar/ilv009
   Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112
   GLAUSER EM, 1966, EXP MED SURG, V24, P181
   Gonzalez-Bulnes A, 2016, CURR PHARM BIOTECHNO, V17, P848, DOI 10.2174/1389201017666160519111529
   Gotherstrom C, 2014, STEM CELL TRANSL MED, V3, P255, DOI 10.5966/sctm.2013-0090
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hecht JT, 2007, AM J MED GENET A, V143A, P2285, DOI 10.1002/ajmg.a.31927
   Heck AL, 2005, J PEDIATR ORTHOPED, V25, P598, DOI 10.1097/01.bpo.0000173248.96936.90
   Huizink AC, 2004, PSYCHOL BULL, V130, P115, DOI 10.1037/0033-2909.130.1.115
   ILKAL MA, 1994, ACTA VIROL, V38, P157
   Ishikawa Y, 2006, IN VITRO CELL DEV-AN, V42, P63
   Jaradeh S., 2006, GI MOTIL
   Jiang HY, 2016, BRAIN BEHAV IMMUN, V58, P165, DOI 10.1016/j.bbi.2016.06.005
   Jonsson DI, 2012, EUR J MED GENET, V55, P437, DOI 10.1016/j.ejmg.2012.03.001
   Kanitz E, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00227
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Karniychuk UU, 2009, PLACENTA, V30, P497, DOI 10.1016/j.placenta.2009.03.016
   Karniychuk UU, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-95
   Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001
   Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4
   Kranendonk G, 2006, HORM BEHAV, V49, P663, DOI 10.1016/j.yhbeh.2005.12.008
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Larochelle R, 1999, J VIROL METHODS, V80, P69, DOI 10.1016/S0166-0934(99)00032-4
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lefebvre DJ, 2008, J GEN VIROL, V89, P177, DOI 10.1099/vir.0.83280-0
   Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x
   Li C, 2016, J NANOMATER, V2016, P10, DOI DOI 10.3389/FPLS.2016.01356
   Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003
   Lind NM, 2005, BRAIN RES BULL, V65, P1, DOI 10.1016/j.brainresbull.2004.08.007
   Lind NM, 2004, BEHAV BRAIN RES, V155, P217, DOI 10.1016/j.bbr.2004.04.014
   Liu XL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9825
   Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179
   Mair KH, 2014, DEV COMP IMMUNOL, V45, P321, DOI 10.1016/j.dci.2014.03.022
   Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x
   MARDASSI H, 1994, J GEN VIROL, V75, P681, DOI 10.1099/0022-1317-75-3-681
   Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, N ENGL J MED
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Notwell JH, 2016, GENOME RES, V26, P1013, DOI 10.1101/gr.203612.115
   Novakovic P, 2016, VET RES, V47, DOI 10.1186/s13567-016-0364-7
   OCHS HD, 1993, J MED PRIMATOL, V22, P162
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pasternak J.A., 2014, GROUPING PIG SPECIFI
   Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x
   Prather RS, 2008, BIOTECHNOL GENET ENG, V25, P245
   Quicke K.M., 2016, ZIKA VIRUS INFECT HU
   Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Saha D, 2010, VET MICROBIOL, V145, P62, DOI 10.1016/j.vetmic.2010.03.017
   Saha Dipongkor, 2014, Virologica Sinica, V29, P176, DOI 10.1007/s12250-014-3431-0
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shyy W, 2009, CLIN ORTHOP RELAT R, V467, P1201, DOI 10.1007/s11999-008-0701-x
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Solbrig MV, 1996, BIOL PSYCHIAT, V40, P629, DOI 10.1016/0006-3223(95)00480-7
   STERZL J, 1966, FOLIA MICROBIOL, V11, P7, DOI 10.1007/BF02877148
   Tabata T, 2016, CELL HOST MICROBE
   Tang W., 2016, J SENSORS, V2016, P11, DOI DOI 10.1016/J.CELREP.2016.11.070
   Tayade C, 2006, J IMMUNOL, V176, P148, DOI 10.4049/jimmunol.176.1.148
   Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5
   Torales J, 2017, MEDWAVE, V17, DOI 10.5867/medwave.2017.01.6869
   Tuggle CK, 2007, INT J BIOL SCI, V3, P132
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Staay FJ, 2009, PSYCHOPHARMACOLOGY, V206, P715, DOI 10.1007/s00213-009-1599-z
   Vanderhaeghe C, 2010, ANIM REPROD SCI, V120, P78, DOI 10.1016/j.anireprosci.2010.02.010
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015
   WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296
   Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434
   Wilhelm S, 2006, J VIROL METHODS, V134, P257, DOI 10.1016/j.jviromet.2006.01.004
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zou J, 2017, EBIOMEDICINE, V20, P11, DOI 10.1016/j.ebiom.2017.05.005
   Zucker J, 2017, EMERG INFECT DIS, V23, P1047, DOI 10.3201/eid2306.162029
NR 120
TC 16
Z9 16
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD NOV
PY 2017
VL 25
BP 73
EP 86
DI 10.1016/j.ebiom.2017.09.021
PG 14
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA FP2IK
UT WOS:000417440500018
PM 29097124
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yi, GH
   Xu, XQ
   Abraham, S
   Petersen, S
   Guo, H
   Ortega, N
   Shankar, P
   Manjunath, N
AF Yi, Guohua
   Xu, Xuequn
   Abraham, Sojan
   Petersen, Sean
   Guo, Hua
   Ortega, Nora
   Shankar, Premlata
   Manjunath, N.
TI A DNA Vaccine Protects Human Immune Cells against Zika Virus Infection
   in Humanized Mice
SO EBIOMEDICINE
LA English
DT Article
DE Zika virus (ZIKV); DNA vaccine; Humanized DRAG mice; Neutralizing
   antibody; B cell infection
ID TRANSMISSION; BRAZIL
AB A DNA vaccine encoding prM and E protein has been shown to induce protection against Zika virus (ZIKV) infection in mice and monkeys. However, its effectiveness in humans remains undefined. Moreover, identification of which immune cell types are specifically infected in humans is unclear. We show that human myeloid cells and B cells are primary targets of ZIKV in humanized mice. We also show that a DNA vaccine encoding full length prM and E protein protects humanized mice from ZIKV infection. Following administration of the DNA vaccine, humanized DRAG mice developed antibodies targeting ZIKV as measured by ELISA and neutralization assays. Moreover, following ZIKV challenge, vaccinated animals presented virtually no detectable virus in human cells and in serum, whereas unvaccinated animals displayed robust infection, as measured by qRT-PCR. Our results utilizing humanized mice show potential efficacy for a targeted DNA vaccine against ZIKV in humans. (C) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
C1 [Yi, Guohua; Xu, Xuequn; Abraham, Sojan; Petersen, Sean; Guo, Hua; Ortega, Nora; Shankar, Premlata; Manjunath, N.] Texas Tech Univ Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, Ctr Emphasis Infect Dis, El Paso, TX 79905 USA.
   [Abraham, Sojan] Southern Res Inst, Dept Infect Dis Res, Drug Dev, Frederick, MD USA.
RP Yi, GH; Manjunath, N (corresponding author), Texas Tech Univ Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, Ctr Emphasis Infect Dis, El Paso, TX 79905 USA.
EM g.yi@ttuhsc.edu; pariswamy100@gmail.com
FU Texas Tech University Health Sciences Center at El Paso Seed Grant
   [183267]
FX The work is supported by Texas Tech University Health Sciences Center at
   El Paso Seed Grant (183267) (to G.Y.).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Allam A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10443
   Chang GJJ, 2001, ANN NY ACAD SCI, V951, P272
   Danner R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019826
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254
   Kublin J.L., 2017, VIRUS RES
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lavender KJ, 2013, BLOOD, V122, P4013, DOI 10.1182/blood-2013-06-506949
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 26
TC 21
Z9 21
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD NOV
PY 2017
VL 25
BP 87
EP 94
DI 10.1016/j.ebiom.2017.10.006
PG 8
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA FP2IK
UT WOS:000417440500019
PM 29033368
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, F
   Wang, HJ
   Wang, Q
   Liu, ZY
   Yuan, L
   Huang, XY
   Li, GH
   Ye, Q
   Yang, HZ
   Shi, L
   Deng, YQ
   Qin, CF
   Xu, ZH
AF Zhang, Feng
   Wang, Hong-Jiang
   Wang, Qin
   Liu, Zhong-Yu
   Yuan, Ling
   Huang, Xing-Yao
   Li, Guanghui
   Ye, Qing
   Yang, Haozhen
   Shi, Lei
   Deng, Yong-Qiang
   Qin, Cheng-Feng
   Xu, Zhiheng
TI American Strain of Zika Virus Causes More Severe Microcephaly Than an
   Old Asian Strain in Neonatal Mice
SO EBIOMEDICINE
LA English
DT Article
DE Zika virus; American strain; Asian strain; Microcephaly
ID GENOMIC CHARACTERIZATION; BRAIN; INFECTION; PROTEIN; CELLS
AB Zika virus (ZIKV) has evolved from an overlooked mosquito-borne flavivirus into a global health threat due to its astonishing causal link to microcephaly and other disorders. ZIKV has been shown to infect neuronal progenitor cells of the fetal mouse brain, which is comparable to the first-trimester human fetal brain, and result in microcephaly. However, whether there are different effects between the contemporary ZIKV strain and its ancestral strain in the neonatal mouse brain, which is comparable with the second-trimester human fetal brain, is unclear. Here we adopted a mouse model which enables us to study the postnatal effect of ZIKV infection. We show that even 100 pfu of ZIKV can replicate and infect neurons and oligodendrocytes inmost parts of the brain. Compared with the ancestral strain from Cambodia (CAM/2010), infection of the ZIKV strain from Venezuela (VEN/2016) leads to much more severe microcephaly, accompanied by more neuronal cell death, abolishment of oligodendrocyte development, and a more dramatic immune response. The serious brain damage caused by VEN/2016 infection would be helpful to elucidate why the American strain resulted in severe neurovirulence in infants and will provide clinical guidance for the diagnosis and treatment of infection by different ZIKV strains. (C) 2017 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
C1 [Zhang, Feng; Wang, Qin; Yuan, Ling; Li, Guanghui; Shi, Lei; Xu, Zhiheng] Chinese Acad Sci, State Key Lab Mol Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.
   [Wang, Hong-Jiang; Liu, Zhong-Yu; Huang, Xing-Yao; Li, Guanghui; Ye, Qing; Deng, Yong-Qiang; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing, Peoples R China.
   [Zhang, Feng; Wang, Qin; Yuan, Ling; Xu, Zhiheng] Univ Chinese Acad Sci, Beijing 10101, Peoples R China.
   [Yang, Haozhen] Beijing 302 Hosp, Liver Failure Therapy & Res Ctr, Beijing, Peoples R China.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing, Peoples R China.
   [Qin, Cheng-Feng] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
RP Xu, ZH (corresponding author), Chinese Acad Sci, State Key Lab Mol Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing, Peoples R China.
EM qincf@bmi.ac.cn; zhxu@genetics.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; huang, xingyao/0000-0002-3917-8100;
   Wang, Qin/0000-0001-7447-1671; Xu, Zhiheng/0000-0002-4809-2851; Yuan,
   Ling/0000-0001-7351-5097; Liu, Zhong-Yu/0000-0001-7385-5681; Zhang,
   Feng/0000-0003-2887-8184
FU National Natural Science Foundation (NSFC) of ChinaNational Natural
   Science Foundation of China [31430037/31730108]; Innovation Program of
   the Chinese Academy of SciencesKnowledge Innovation Program of the
   Chinese Academy of Sciences [QYZDJ-SSWSMC007]; Shanghai
   brain-intelligence project from STCSM [16JC1420500]; Beijing brain
   project [Z161100002616004]; NSFCNational Natural Science Foundation of
   China [81522025, 81661130162, 81661148054, 81621005]; National Key
   Research and Development Project of China [2016YFD0500304]; National
   Science and Technology Major Project of China [2017ZX09101005,
   2017ZX10304402]; UK Academy of Medical Sciences [NAF003/1003]
FX This work was supported by the National Natural Science Foundation
   (NSFC) of China (31430037/31730108), Innovation Program of the Chinese
   Academy of Sciences (QYZDJ-SSWSMC007), Shanghai brain-intelligence
   project from STCSM (16JC1420500), Beijing brain project
   (Z161100002616004) to Z.XU, and the NSFC (81522025, 81661130162,
   81661148054, 81621005), the National Key Research and Development
   Project of China (No. 2016YFD0500304), the National Science and
   Technology Major Project of China (No. 2017ZX09101005 and No.
   2017ZX10304402), and the Newton Advanced Fellowship from the UK Academy
   of Medical Sciences (NAF003/1003) to C.-F.Q. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Herculano-Houzel S, 2014, GLIA, V62, P1377, DOI 10.1002/glia.22683
   HOLNESS CL, 1993, BLOOD, V81, P1607
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Ornaghi S, 2017, J NEUROSCI, V37, P6877, DOI 10.1523/JNEUROSCI.0970-17.2017
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang F., 2014, INT J DISTRIB SENS N, V2014, P1, DOI DOI 10.3969/J.ISSN.1000-2324.2014.02.01
   Zhang F, 2016, J BIOL CHEM, V291, P11466, DOI 10.1074/jbc.M116.716811
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang Q, 2012, J BIOL CHEM, V287, P40525, DOI 10.1074/jbc.M112.384446
   Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304
NR 41
TC 22
Z9 23
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD NOV
PY 2017
VL 25
BP 95
EP 105
DI 10.1016/j.ebiom.2017.10.019
PG 11
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA FP2IK
UT WOS:000417440500020
PM 29107512
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Darbellay, J
   Cox, B
   Lai, K
   Delgado-Ortega, M
   Wheler, C
   Wilson, D
   Walker, S
   Starrak, G
   Hockley, D
   Huang, YY
   Mutwiri, G
   Potter, A
   Gilmour, M
   Safronetz, D
   Gerdts, V
   Karniychuk, U
AF Darbellay, Joseph
   Cox, Brian
   Lai, Kenneth
   Delgado-Ortega, Mario
   Wheler, Colette
   Wilson, Donald
   Walker, Stewart
   Starrak, Gregory
   Hockley, Duncan
   Huang, Yanyun
   Mutwiri, George
   Potter, Andrew
   Gilmour, Matthew
   Safronetz, David
   Gerdts, Volker
   Karniychuk, Uladzimir
TI Zika Virus Causes Persistent Infection in Porcine Conceptuses and May
   Impair Health in Offspring (vol 25, pg 73, 2017)
SO EBIOMEDICINE
LA English
DT Correction
C1 [Darbellay, Joseph; Lai, Kenneth; Delgado-Ortega, Mario; Wheler, Colette; Wilson, Donald; Walker, Stewart; Potter, Andrew; Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Vaccine & Infect Dis Org Int Vaccine Ctr VIDO Int, Saskatoon, SK S7N 5E3, Canada.
   [Cox, Brian] Univ Toronto, Dept Physiol, Dept Obstet & Gynaecol, Toronto, ON M5S 1A8, Canada.
   [Starrak, Gregory; Hockley, Duncan] Univ Saskatchewan, Dept Small Anim Clin Sci, Western Coll Vet Med, Saskatoon, SK S7N 5B4, Canada.
   [Huang, Yanyun] Prairie Diagnost Serv, Saskatoon, SK S7N 5B4, Canada.
   [Mutwiri, George; Karniychuk, Uladzimir] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada.
   [Potter, Andrew; Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Dept Vet Microbiol, Western Coll Vet Med, Saskatoon, SK S7N 5B4, Canada.
   [Gilmour, Matthew; Safronetz, David] Publ Hlth Agcy Canada, Canada Natl Microbiol Lab, 1015 Arlington St, Winnipeg, MB R3E 3R2, Canada.
RP Karniychuk, U (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org Int Vaccine Ctr VIDO Int, Saskatoon, SK S7N 5E3, Canada.
EM u.karniychuk@usask.ca
OI Delgado-Ortega, Mario/0000-0002-6921-2920
CR Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD NOV
PY 2017
VL 25
BP 187
EP 187
DI 10.1016/j.ebiom.2017.10.021
PG 1
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA FP2IK
UT WOS:000417440500029
PM 29156210
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Turner, LH
   Kinder, JM
   Wilburn, A
   D'Mello, RJ
   Braunlin, MR
   Jiang, TT
   Pham, G
   Way, SS
AF Turner, Lucien H.
   Kinder, Jeremy M.
   Wilburn, Adrienne
   D'Mello, Rahul J.
   Braunlin, Makayla R.
   Jiang, Tony T.
   Pham, Giang
   Way, Sing Sing
TI Preconceptual Zika virus asymptomatic infection protects against
   secondary prenatal infection
SO PLOS PATHOGENS
LA English
DT Article
ID WEST-NILE-VIRUS; PREGNANT-WOMEN; IMMUNE-RESPONSES; STRUCTURAL BASIS;
   UNITED-STATES; MOUSE MODEL; T-CELLS; VACCINE; ANTIBODIES; PATHOGENESIS
AB Pregnant women, and their fetal offspring, are uniquely susceptible to Zika virus and other microbial pathogens capable of congenital fetal infection. Unavoidable exposure to Zika virus in endemic areas underscores the need for identifying at-risk individuals, and protecting expecting mothers and their fetal offspring against prenatal infection. Here we show that primary Zika virus asymptomatic infection in mice confers protection against re-infection, and that these protective benefits are maintained during pregnancy. Zika virus recovery was sharply reduced in maternal tissues and amongst fetal concepti after prenatal challenge in mothers with resolved subclinical infection prior to pregnancy compared with mice undergoing primary prenatal infection. These benefits coincide with expanded accumulation of viral-specific antibodies in maternal serum and fetal tissues that protect against infection by the identical or heterologous Zika virus genotype strains. Thus, preconceptual infection primes Zika virus-specific antibodies that confer cross-genotype protection against re-infection during pregnancy.
C1 [Turner, Lucien H.; Kinder, Jeremy M.; Wilburn, Adrienne; D'Mello, Rahul J.; Braunlin, Makayla R.; Jiang, Tony T.; Pham, Giang; Way, Sing Sing] Cincinnati Childrens Hosp, Div Infect Dis & Perinatal Inst, Cincinnati, OH 45229 USA.
   [Wilburn, Adrienne; Jiang, Tony T.] Cincinnati Childrens Hosp Med Ctr, Grad Program Immunol, Cincinnati, OH 45229 USA.
   [Wilburn, Adrienne; Jiang, Tony T.] Univ Cincinnati, Coll Med, Cincinnati, OH USA.
RP Way, SS (corresponding author), Cincinnati Childrens Hosp, Div Infect Dis & Perinatal Inst, Cincinnati, OH 45229 USA.
EM singsing.way@cchmc.org
RI ; D'Mello, Rahul/H-8030-2018
OI Way, Sing Sing/0000-0001-8948-1952; Turner, Lucien/0000-0001-6612-9745;
   D'Mello, Rahul/0000-0001-8343-0572; Wilburn,
   Adrienne/0000-0003-1035-0955; Kinder, Jeremy/0000-0001-5145-1344
FU NIH-NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01-AI100934, R01-AI120202]; March of Dimes
   FoundationMarch of Dimes; HHMI Faculty Scholars program; Burroughs
   Wellcome Fund Pathogenesis of Infectious Disease award
FX This work is supported, in part, by the NIH-NIAID through awards
   R01-AI100934 and R01-AI120202, the March of Dimes Foundation, HHMI
   Faculty Scholars program, and Burroughs Wellcome Fund Pathogenesis of
   Infectious Disease award. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   ARAUJOJORGE T, 1993, INFECT IMMUN, V61, P4925, DOI 10.1128/IAI.61.11.4925-4928.1993
   Aubry M, 2017, EMERG INFECT DIS, V23
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804
   BOUE A, 1971, LANCET, V1, P1251
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chaturvedi V, 2015, J CLIN INVEST, V125, P1713, DOI 10.1172/JCI78578
   Clark DR, 2014, CELL MOL IMMUNOL, V11, P595, DOI 10.1038/cmi.2014.84
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003
   Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Halstead SB, 1988, J CHALL MOL BIO, V239, P476, DOI DOI 10.1126/SCIENCE.3277268
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   HAMMON WM, 1956, P SOC EXP BIOL MED, V91, P521
   HARCOURT GC, 1980, J INFECT DIS, V142, P145, DOI 10.1093/infdis/142.2.145
   Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   KURLANDER RJ, 1984, J IMMUNOL, V133, P855
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P1155, DOI 10.1111/j.1471-0528.2011.02983.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lobigs M, 2012, EXPERT REV VACCINES, V11, P177, DOI [10.1586/erv.11.180, 10.1586/ERV.11.180]
   Mahmud Shawn A, 2013, JAKSTAT, V2, pe23154, DOI 10.4161/jkst.23154
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517
   Mehlhop E, 2009, CELL HOST MICROBE, V6, P381, DOI 10.1016/j.chom.2009.09.003
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pacheco O, 2016, N ENGL J MED
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201
   PRICE WH, 1967, AM J EPIDEMIOL, V86, P11, DOI 10.1093/oxfordjournals.aje.a120716
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rogerson SJ, 2010, ADV EXP MED BIOL, V659, P139, DOI 10.1007/978-1-4419-0981-7_12
   Rowe JH, 2013, REPRODUCTION, V146, pR191, DOI 10.1530/REP-13-0262
   Rowe JH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002873
   Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schmidt A, 2015, J REPROD IMMUNOL, V108, P65, DOI 10.1016/j.jri.2015.03.001
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   Sorman A, 2014, MOL IMMUNOL, V61, P79, DOI 10.1016/j.molimm.2014.06.010
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tang W., 2016, J SENSORS, V2016, P11, DOI DOI 10.1016/J.CELREP.2016.11.070
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 78
TC 12
Z9 12
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD NOV
PY 2017
VL 13
IS 11
AR e1006684
DI 10.1371/journal.ppat.1006684
PG 20
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FO5IT
UT WOS:000416888500011
PM 29145516
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mutso, M
   Saul, S
   Rausalu, K
   Susova, O
   Zusinaite, E
   Mahalingam, S
   Merits, A
AF Mutso, Margit
   Saul, Sirle
   Rausalu, Kai
   Susova, Olga
   Zusinaite, Eva
   Mahalingam, Suresh
   Merits, Andres
TI Reverse genetic system, genetically stable reporter viruses and packaged
   subgenomic replicon based on a Brazilian Zika virus isolate
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE Zika virus; flavivirus; reverse genetics; Infectious cDNA; reporter
   protein; replicon
ID SEMLIKI-FOREST-VIRUS; OUTBREAK
AB Zika virus (ZIKV, genus Flavivirus) has emerged as a major mosquito-transmitted human pathogen, with recent outbreaks associated with an increased incidence of neurological complications, particularly microcephaly and the Guillain-Barre syndrome. Because the virus has only very recently emerged as an important pathogen, research is being hampered by a lack of reliable molecular tools. Here we report an infectious cDNA (icDNA) clone for ZIKV isolate BeH819015 from Brazil, which was selected as representative of South American ZIKV isolated at early stages of the outbreak. icDNA clones were assembled from synthetic DNA fragments corresponding to the consensus sequence of the BeH819015 isolate. Virus rescued from the icDNA clone had properties identical to a natural ZIKV isolate from South America. Variants of the clone- derived virus, expressing nanoluciferase, enhanced green fluorescent or mCherry marker proteins in both mammalian and insect cells and being genetically stable for multiple in vitro passages, were obtained. A ZIKV subgenomic replicon, lacking a prM- and E glycoprotein encoding region and expressing a Gaussia luciferase marker, was constructed and shown to replicate both in mammalian and insect cells. In the presence of the Semliki Forest virus replicon, expressing ZIKV structural proteins, the ZIKV replicon was packaged into virus-replicon particles. Efficient reverse genetic systems, genetically stable marker viruses and packaged replicons offer significant improvements for biological studies of ZIKV infection and disease, as well as for the development of antiviral approaches.
C1 [Mutso, Margit; Saul, Sirle; Rausalu, Kai; Zusinaite, Eva; Merits, Andres] Univ Tartu, Inst Technol, Tartu, Estonia.
   [Mutso, Margit; Mahalingam, Suresh] Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld 4222, Australia.
   [Susova, Olga] Minist Hlth Russian Federat, Blokhin Russian Canc Res Ctr, Moscow 115487, Russia.
RP Merits, A (corresponding author), Univ Tartu, Inst Technol, Tartu, Estonia.
EM andres.merits@ut.ee
RI Merits, Andres/H-3125-2015; Susova, Olga/R-9570-2019; Rausalu,
   Kai/G-6493-2019
OI Merits, Andres/0000-0001-8193-0071; Susova, Olga/0000-0001-8192-7913;
   Rausalu, Kai/0000-0002-8926-5907
FU NHMRC Senior Research FellowshipNational Health and Medical Research
   Council of Australia [APP1059167]; University of Tartu; Australian
   National Health and Medical Research CouncilNational Health and Medical
   Research Council of Australia [APP1079086]; European Regional
   Development Fund through the Centre of Excellence in Molecular Cell
   Engineering, Estonia [2014-2020.4.01.15-013]; Estonian Research
   CouncilEstonian Research Council [IUT20-27]
FX This study was supported by the University of Tartu, European Regional
   Development Fund through the Centre of Excellence in Molecular Cell
   Engineering, Estonia, 2014-2020.4.01.15-013 (AM), Estonian Research
   Council (IUT20-27; AM) and Australian National Health and Medical
   Research Council to SM (APP1079086). SM is the recipient of an NHMRC
   Senior Research Fellowship (APP1059167).
CR Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Deng CL, 2017, J GEN VIROL, V98, P1739, DOI 10.1099/jgv.0.000862
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferguson MC, 2015, J VIROL, V89, P7536, DOI 10.1128/JVI.03645-14
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hashemi A, 2012, CYTOL GENET+, V46, P347, DOI 10.3103/S0095452712060035
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   McGee CE, 2010, VECTOR-BORNE ZOONOT, V10, P267, DOI 10.1089/vbz.2009.0067
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Saul S, 2015, J VIROL, V89, P11030, DOI 10.1128/JVI.01186-15
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shabman R, 2016, COMPLETE GENOME
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan Chao, 2013, Virologica Sinica, V28, P161, DOI 10.1007/s12250-013-3332-7
   Smerdou C, 1999, J VIROL, V73, P1092, DOI 10.1128/JVI.73.2.1092-1098.1999
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Utt A, 2015, J VIROL, V89, P3145, DOI 10.1128/JVI.03213-14
   Varghese FS, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02227-16, 10.1128/aac.02227-16]
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2017, JOVE-J VIS EXP, V124
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
NR 32
TC 25
Z9 25
U1 0
U2 7
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD NOV
PY 2017
VL 98
IS 11
BP 2712
EP 2724
DI 10.1099/jgv.0.000938
PG 13
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA FP0RL
UT WOS:000417311400008
PM 29022864
OA Bronze
DA 2020-07-08
ER

PT J
AU Nag, DK
   Kramer, LD
AF Nag, Dilip K.
   Kramer, Laura D.
TI Patchy DNA forms of the Zika virus RNA genome are generated following
   infection in mosquito cell cultures and in mosquitoes
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE Arbovirus; Zika virus; endogenous viral elements; mosquito vectors;
   persistent infections; Flavivirus
ID JAPANESE ENCEPHALITIS-VIRUS; AEDES-ALBOPICTUS CELLS; DENGUE VIRUS;
   PERSISTENT INFECTION; ARBOVIRUS INFECTION; ANOPHELES-GAMBIAE; INNATE
   IMMUNITY; SINDBIS VIRUS; INTERFERENCE; INSECT
AB Zika virus (ZIKV) is a mosquito-borne flavivirus and has historically been reported to cause mild symptomatic diseases during human infections. More recently, the explosion of microcephaly among infants born to ZIKV-infected women has made ZIKV a global public health concern. While ZIKV causes acute human diseases, infections of vector mosquitoes are basically non-pathogenic, allowing persistent infections and conferring lifelong ability to transmit the virus. Recent studies have revealed that DNA forms of arboviral RNA genomes play a significant role in viral persistence in mosquitoes. We have initiated experiments to determine whether ZIKV generates viral DNA (vDNA) forms following infection in mosquitoes. Here we show that vDNAs are generated following ZIKV infection both in mosquito cell cultures and in its primary vector Aedes aegypti. vDNA formation is more extensive in RNA interference (RNAi)-deficient Aedes albopictus-derived C6/36 cells compared to RNAi-proficient mosquito cells. In addition, vDNAs are generated via multiple template-switching events.
C1 [Nag, Dilip K.; Kramer, Laura D.] New York State Dept Hlth, Wadsworth Ctr, Griffin Lab, Slingerlands, NY 12159 USA.
   [Nag, Dilip K.; Kramer, Laura D.] SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA.
RP Nag, DK; Kramer, LD (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Griffin Lab, Slingerlands, NY 12159 USA.; Nag, DK; Kramer, LD (corresponding author), SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA.
EM dilip.nag@health.ny.gov; Laura.kramer@health.ny.gov
FU Wadsworth Center
FX This work was funded by the Wadsworth Center.
CR Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen LK, 1996, VIROLOGY, V217, P220, DOI 10.1006/viro.1996.0109
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chiba S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002146
   Cirimotich CM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-49
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   DAVEY MW, 1974, J GEN VIROL, V24, P453, DOI 10.1099/0022-1317-24-3-453
   Ebner PD, 2008, VIROLOGY, V381, P98, DOI 10.1016/j.virol.2008.08.024
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fragkoudis R, 2009, J GEN VIROL, V90, P2061, DOI 10.1099/vir.0.013201-0
   Geuking MB, 2009, SCIENCE, V323, P393, DOI 10.1126/science.1167375
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Hoa NT, 2003, INSECT BIOCHEM MOLEC, V33, P949, DOI 10.1016/S0965-1748(03)00101-2
   Holmes EC, 2011, CELL HOST MICROBE, V10, P368, DOI 10.1016/j.chom.2011.09.002
   Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695
   Hussain M, 2014, P NATL ACAD SCI USA, V111, P2746, DOI 10.1073/pnas.1320123111
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006
   Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Nag DK, 2016, VIROLOGY, V498, P164, DOI 10.1016/j.virol.2016.08.022
   Olson KE, 2017, CURR OPIN INSECT SCI, V22, P45, DOI 10.1016/j.cois.2017.05.010
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Prasad AN, 2013, VIRUSES-BASEL, V5, P3142, DOI 10.3390/v5123142
   RIEDEL B, 1977, J VIROL, V23, P554, DOI 10.1128/JVI.23.3.554-561.1977
   Rizzo F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-395
   Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Skalsky RL, 2014, P NATL ACAD SCI USA, V111, pE2359, DOI 10.1073/pnas.1406854111
   Tanne E, 2005, VIROLOGY, V332, P614, DOI 10.1016/j.virol.2004.11.007
   Tsai KN, 2007, VIRUS RES, V124, P139, DOI 10.1016/j.virusres.2006.10.013
   Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 52
TC 9
Z9 9
U1 0
U2 5
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD NOV
PY 2017
VL 98
IS 11
BP 2731
EP 2737
DI 10.1099/jgv.0.000945
PG 7
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA FP0RL
UT WOS:000417311400010
PM 29039731
OA Bronze
DA 2020-07-08
ER

PT J
AU Pereira, EL
   Bezerra, JC
   Brant, JL
   de Araujo, WN
   Santos, LMP
AF Pereira, Everton Luis
   Bezerra, Josierton Cruz
   Brant, Jonas Lotufo
   de Araujo, Wildo Navegantes
   Pacheco Santos, Leonor Maria
TI Profile of demand and Continuous Cash Benefits (BCP) granted to children
   diagnosed with microcephaly in Brazil
SO CIENCIA & SAUDE COLETIVA
LA English
DT Article
DE Microcephaly; Zika virus; Children
ID ZIKA VIRUS; STATE
AB The Brazilian Federal Constitution of 1988 introduced the Continuous Cash Benefits (BCP), allowing the inclusion of people with disabilities. This is a descriptive study with aggregate municipal data about the time and geographic distribution of the incidence of microcephaly related to the Zika virus in Brazil and data of the BCP grants to children diagnosed with microcephaly. Data on the demand and BCP grants to children with microcephaly since 2009 are shown. Cases of microcephaly and/or central nervous system disorders were obtained from the Ministry of Health and totaled 2,366 confirmed cases from January 1, 2015 to December 31, 2016. The historical series of BCP granted from 2009 to 2016 was based on data from the National Institute of Social Security and showed, until 2014, a baseline with an average of 200 annual benefits for children younger than 48 months with microcephaly. In 2016, grants increased eight times, reaching 1,603 benefits granted to children of 731 municipalities spread in the 27 States. The Northeast accounted for 73% of the BCPs granted, however, this was less than 65% of the demand for incident cases. The implementation of the integrated referral system, including active search, should be strengthened to ensure access to all children entitled to BCP.
C1 [Pereira, Everton Luis; Bezerra, Josierton Cruz; Brant, Jonas Lotufo; Pacheco Santos, Leonor Maria] Univ Brasilia UnB, Dept Saude Colet, Campus Univ Darcy Ribeiro, BR-70000000 Brasilia, DF, Brazil.
   [de Araujo, Wildo Navegantes] Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil.
RP Pereira, EL (corresponding author), Univ Brasilia UnB, Dept Saude Colet, Campus Univ Darcy Ribeiro, BR-70000000 Brasilia, DF, Brazil.
EM evertonpereira@unb.br
OI Pereira, Everton Luis/0000-0002-7771-1594
CR ABBERLEY P, 1987, DISABILITY HANDICAP, V2, P5, DOI DOI 10.1080/02674648766780021
   Agencia Nacional de Vigilancia Sanitaria-Anvisa, 2004, DIARIO OFICIAL UNIAO
   [Anonymous], 2016, DIARIO OFICIAL UNIAO
   BARBOSA M. M., 2003, SER SOCIAL, V12, P221
   BARNES C., 2009, VISIONES REVISIONES, P101
   Brasil, 2009, DIARIO OFICIAL UNIAO
   Brasil, 1995, DIARIO OFICIAL UNIAO
   Brasil. Ministerio da Saude (MS), 1993, DIARIO OFICIAL UNIAO
   Brasil. Ministerio da Saude (MS), 2016, PROT VIG RESP OC MIC
   Brasil. Ministerio do Desenvolvimento Social (MDS), INSTR OP CONJ MDS MS
   Brito MB, 2016, REV BRAS GINECOL OBS, V38, P583, DOI 10.1055/s-0036-1593411
   Brunoni D, 2016, CIENC SAUDE COLETIVA, V21, P3296, DOI 10.1590/1413-812320152110.16832016
   Cabral CM, 2017, EPIDEMIOL SERV SAUDE, V26, P245, DOI [10.5123/S1679-49742017000200002, 10.5123/s1679-49742017000200002]
   Davis Lennard J., 2013, DISABILITY STUDIES R
   Di Nubila H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S4-S10
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   DINIZ Debora, 2007, O QUE E DEFICIENCIA
   dos Santos WR, 2011, CIENC SAUDE COLETIVA, V16, P787, DOI 10.1590/S1413-81232011000700009
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Farias Norma, 2005, Rev. bras. epidemiol., V8, P187, DOI 10.1590/S1415-790X2005000200011
   Governo e peritos do INSS fecham acordo por fim de greve, 2016, FOLHA SAO PAULO
   Kittay E. F., 1999, LOVES LABOR
   Masson G.A., 2011, THESIS
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oliver M., JOINT WORKSH LIV OPT
   Pereira EL, 2016, CIENC SAUDE COLETIVA, V21, P3016, DOI 10.1590/1413-812320152110.18352016
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Santos WR, 2015, OBSERVATORIO INT CAP, P61
   Shakespeare T, 1993, DISABILITY READER SO
   Shakespeare T., 2006, DISABILITY RIGHTS WR
   Sochaczevski J, 2013, SER SOCIAL, V15, P141
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI 10.5123/S1679-49742016000400003
   WHO, GEST GRAV CONT INF P
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
NR 35
TC 5
Z9 6
U1 0
U2 2
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD NOV
PY 2017
VL 22
IS 11
BP 3557
EP 3566
DI 10.1590/1413-812320172211.22182017
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FO8ZB
UT WOS:000417176100009
PM 29211161
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ryckebusch, F
   Berthet, M
   Misse, D
   Choumet, V
AF Ryckebusch, Faustine
   Berthet, Michele
   Misse, Dorothee
   Choumet, Valerie
TI Infection of a French Population of Aedes albopictus and of Aedes
   aegypti (Paea Strain) with Zika Virus Reveals Low Transmission Rates to
   These Vectors' Saliva
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Zika virus; Aedes albopictus; Aedes aegypti; dissemination;
   transmission; vector competence
ID GEOGRAPHIC STRAINS; SUSCEPTIBILITY; MOSQUITOS; OUTBREAK; AMERICA;
   BRAZIL; RISKS; FEVER
AB Disease caused by the Zika virus (ZIKV) is a public health emergency of international concern. Recent epidemics have emerged in different regions of the world and attest to the ability of the virus to spread wherever its vector, Aedes species mosquitoes, can be found. We have compared the transmission of ZIKV by Ae. aegypti (PAEA strain originating from Tahiti) and by a French population of Ae. albopictus to better assess their competence and the potential risk of the emergence of ZIKV in Europe. We assessed the transmission of ZIKV by Ae. albopictus in temperatures similar to those in Southern France during the summer. Our study shows that the extrinsic incubation period of Ae. aegypti for transmission was shorter than that of Ae. albopictus. Both vectors were able to transmit ZIKV from 10 to 14 days post-infection. Ae. aegypti, however, had a longer transmission period than the French population of Ae. albopictus. Although the salivary glands of both vectors are highly infected, transmission rates of ZIKV to saliva remain relatively low. These observations may suggest that the risk of emergence of ZIKV in Europe could be low.
C1 [Ryckebusch, Faustine; Berthet, Michele; Choumet, Valerie] Inst Pasteur, Environm & Infect Risks Unit, F-75015 Paris, France.
   [Misse, Dorothee] Univ Montpellier, CNRS, Inst Rech Dev, MIVEGEC, F-34394 Montpellier, France.
RP Choumet, V (corresponding author), Inst Pasteur, Environm & Infect Risks Unit, F-75015 Paris, France.
EM faustine.ryckebusch@gmail.com; mberthet@pasteur.fr;
   dorothee.misse@ird.fr; vchoumet@pasteur.fr
OI Ryckebusch, Faustine/0000-0002-9626-884X
FU Agence Nationale de la RechercheFrench National Research Agency (ANR)
   [ANR-12-BSV3-0004-01]; PREDEMICS, the European Union's Seventh Framework
   Program for research, technological development, and demonstration
   [278433]; ZIKAlliance, the European Union's Horizon Research and
   Innovation Program [734548]
FX This work was supported in part by grants from the Agence Nationale de
   la Recherche (grant ANR-12-BSV3-0004-01). We also received funding from
   PREDEMICS, the European Union's Seventh Framework Program for research,
   technological development, and demonstration under Grant Agreement no
   278433, and ZIKAlliance, the European Union's Horizon 2020 Research and
   Innovation Program under Grant Agreement N.734548.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Prevention and Control (ECDC) Mosquito Maps, 2017, AED AEG CURR KNOWN D
   Fagbami A. H., 1979, STATE J HYG, V83, P213, DOI [10.1017/S0022172400025997489960, DOI 10.1017/S0022172400025997489960]
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318, DOI 10.4269/ajtmh.1976.25.318
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01398
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Schuler-Faccini L, 2016, CLIN PHARMACOL THER, V100, P28, DOI 10.1002/cpt.386
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Smartt C. T., 2017, J MED ENTOMOL, V23, P880, DOI [10.1093/jme/tjx05828419254, DOI 10.1093/JME/TJX05828419254]
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 47
TC 8
Z9 8
U1 1
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD NOV
PY 2017
VL 18
IS 11
AR 2384
DI 10.3390/ijms18112384
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA FO4KK
UT WOS:000416811300157
PM 29125545
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Romao, VC
   Martins, SAM
   Germano, J
   Cardoso, FA
   Cardoso, S
   Freitas, PP
AF Romao, Veronica C.
   Martins, Sofia A. M.
   Germano, Jose
   Cardoso, Filipe A.
   Cardoso, Susana
   Freitas, Paulo P.
TI Lab-on-Chip Devices: Gaining Ground Losing Size
SO ACS NANO
LA English
DT Article
ID MAGNETIC NANOPARTICLES; ENRICHMENT; MICROFLUIDICS; PURIFICATION;
   INTEGRATION; PLATFORM
AB Portable analytical devices are notably "gaining relevance in the panorama of urgent testing. Such devices have the potential to play an important role as easy to-handle tools in critical situations. Epidemic infectious disease agents (e.g., Ebola virus, Coronavirus, Zika virus) could be controlled more easily by testing travelers on-site at the country borders to prevent outbreaks from spreading. The increasing incidence of hospital-acquired infections caused by antibiotic resistant pathogens could be minimized by point-of-care microbial analysis as well as rapid screening tests of bacteria resistance. The threat of bioterrorism using novel unknown bioweapons has never been so high, thus, in the-field early identification of the biological agent is crucial for triggering a coordinated response. Food allergies are a growing public health concern allergic reactions can result in anaphylactic shock, which can prove fatal in minutes-thus, the ability to test foods for common allergens, rapidly and locally, before ingestion, would improve food safety for those with allergies. Lab-on-chip devices are becoming widely available for diverse applications and are becoming increasingly affordable. However, to shrink in price and size simultaneously, some trade-offs must be made. In this Perspective) we present considerations about product specifications; design concepts, and application scenarios.
C1 [Romao, Veronica C.; Martins, Sofia A. M.; Germano, Jose; Cardoso, Filipe A.] Magnomics SA, Parque Tecnol Cantanhede,Nucleo 04, P-23060197 Lote, Cantanhede, Portugal.
   [Germano, Jose] INESC Invest & Desenvolvimento, Rua Alves Redol 9, P-1000049 Lisbon, Portugal.
   [Cardoso, Susana; Freitas, Paulo P.] INESC Microsistemas & Nanotecnol, Rua Alves Redol 9, P-1000049 Lisbon, Portugal.
   [Cardoso, Susana] Univ Lisbon, IST, Av Rovisco Pais, P-1649004 Lisbon, Portugal.
   [Freitas, Paulo P.] Int Iberian Nanotechnol Lab INL, Ave Mestre Jose Veiga S-N, P-4715330 Braga, Portugal.
RP Freitas, PP (corresponding author), INESC Microsistemas & Nanotecnol, Rua Alves Redol 9, P-1000049 Lisbon, Portugal.; Freitas, PP (corresponding author), Univ Lisbon, IST, Av Rovisco Pais, P-1649004 Lisbon, Portugal.
EM sfreitas@inesc-mn.pt
RI Freitas, Paulo J.P./B-6164-2013; Romao, Veronica C. Martins/E-2338-2011;
   Cardoso, Filipe Arroyo/A-2817-2009; de Freitas, Susana
   Cardoso/B-6199-2013; Martins, Sofia A/Q-2608-2017
OI Freitas, Paulo J.P./0000-0003-0015-1186; Romao, Veronica C.
   Martins/0000-0002-7032-599X; Cardoso, Filipe Arroyo/0000-0002-7042-1287;
   de Freitas, Susana Cardoso/0000-0001-6913-6529; Martins, Sofia
   A/0000-0003-0237-6370
CR Sanchez JLA, 2016, BIOSENS BIOELECTRON, V82, P224, DOI 10.1016/j.bios.2016.04.018
   Aguilar-Arteaga K, 2010, ANAL CHIM ACTA, V674, P157, DOI 10.1016/j.aca.2010.06.043
   Boyd-Moss M, 2016, LAB CHIP, V16, P3177, DOI 10.1039/c6lc00712k
   Chen GD, 2010, ANAL CHEM, V82, P723, DOI 10.1021/ac9024522
   Chen PY, 2015, ACS NANO, V9, P4173, DOI 10.1021/acsnano.5b00396
   Dincer C, 2017, TRENDS BIOTECHNOL, V35, P728, DOI 10.1016/j.tibtech.2017.03.013
   Fernandes E, 2014, BIOSENS BIOELECTRON, V52, P239, DOI 10.1016/j.bios.2013.08.053
   Fischer C, 2016, J AGR FOOD CHEM, V64, P9246, DOI 10.1021/acs.jafc.6b04435
   Freitas PP, 2012, LAB CHIP, V12, P546, DOI 10.1039/c1lc20791a
   Gaster RS, 2009, NAT MED, V15, P1327, DOI 10.1038/nm.2032
   Germano J, 2009, SENSORS-BASEL, V9, P4119, DOI 10.3390/s90604119
   Hartman MR, 2013, NANOSCALE, V5, P10141, DOI 10.1039/c3nr04015a
   Ho SL, 2016, CHEM SCI, V7, P2695, DOI 10.1039/c5sc04115e
   Huang Y, 2013, LAB CHIP, V13, P3929, DOI 10.1039/c3lc50437a
   Klapproth Holger, 2015, Sensing and Bio-Sensing Research, V5, P117, DOI 10.1016/j.sbsr.2015.08.004
   Li ZX, 2014, J NANOSCI NANOTECHNO, V14, P905, DOI 10.1166/jnn.2014.8743
   Lin H., 2017, ACS NANO, DOI [10.1021/acsna-no.7b04318, DOI 10.1021/ACSNA-N0.7B04318]
   Liu X, 2016, FOOD ANAL METHOD, V9, P2972, DOI 10.1007/s12161-016-0480-z
   Lucena R, 2011, J CHROMATOGR A, V1218, P620, DOI 10.1016/j.chroma.2010.10.069
   Martins VC, 2009, BIOSENS BIOELECTRON, V24, P2690, DOI 10.1016/j.bios.2009.01.040
   Nie F, 2017, ANAL METHODS-UK, V9, P2069, DOI 10.1039/c6ay03465a
   Ritzi-Lehnert M, 2012, EXPERT REV MOL DIAGN, V12, P189, DOI [10.1586/erm.11.98, 10.1586/ERM.11.98]
   Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118
   Sandetskaya N, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2016-0088
   Shadfan BH, 2015, CANCER PREV RES, V8, P42, DOI 10.1158/1940-6207.CAPR-14-0248
   Sharma R, 2015, BIOSENS BIOELECTRON, V74, P612, DOI 10.1016/j.bios.2015.07.017
   Soelberg SD, 2009, ANAL CHEM, V81, P2357, DOI 10.1021/ac900007c
   St John Andrew, 2014, Clin Biochem Rev, V35, P155
   Tangchaikeeree T, 2013, J BIOMED NANOTECHNOL, V9, P1768, DOI 10.1166/jbn.2013.1669
   Valenta R, 2015, GASTROENTEROLOGY, V148, P1120, DOI 10.1053/j.gastro.2015.02.006
   Volpatti LR, 2014, TRENDS BIOTECHNOL, V32, P347, DOI 10.1016/j.tibtech.2014.04.010
   Waggoner PS, 2010, SENSOR ACTUAT B-CHEM, V150, P550, DOI 10.1016/j.snb.2010.08.041
   Wei SL, 2016, J CHROMATOGR A, V1473, P19, DOI 10.1016/j.chroma.2016.10.067
NR 33
TC 16
Z9 16
U1 6
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD NOV
PY 2017
VL 11
IS 11
BP 10659
EP 10664
DI 10.1021/acsnano.7b06703
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA FO5FE
UT WOS:000416878100007
PM 29077390
DA 2020-07-08
ER

PT J
AU Connolly, J
AF Connolly, John
TI Governing Towards "One Health': Establishing Knowledge Integration in
   Global Health Security Governance
SO GLOBAL POLICY
LA English
DT Article
ID JOINED-UP GOVERNMENT; EPISTEMIC COMMUNITIES; WICKED PROBLEMS; POLICY
   TRANSFER; CHALLENGES; CAPACITY; MEDICINE; POLITICS; UK
AB Recent global threats (e.g. Ebola, avian influenza, the Zika virus) have demonstrated the need for policy makers to focus on the detection of risks at the animal-human interface. Yet epistemic knowledge across these domains is not sufficiently joined-up. The article argues that, despite some progress, in order for the policy agenda for global health security to develop towards a One Health' model there is a need for integration across public and animal health domains. This article sets out an evaluation framework for establishing knowledge integration across these sectors. The article concludes that although One Health may seem utopian, given there are key challenges when it comes to reaching integration, there are important steps that can be taken the short to medium-term. These include reforms to education and training programmes and interdisciplinary research collaborations. A key determinant of whether One Health becomes a paradigm which frames public policy, and leads to policy and institutional changes to enable public value creation and sustainability, is the presence of an epistemic community' that bridges health networks.
C1 [Connolly, John] Univ West Scotland, Publ Policy, Paisley, Renfrew, Scotland.
RP Connolly, J (corresponding author), Univ West Scotland, Publ Policy, Paisley, Renfrew, Scotland.
FU Carnegie TrustMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of Science
   [31617]
FX Research for this article has been supported by The Carnegie Trust
   (Grant Number 31617). Special thanks are due to David Heymann (Professor
   of Infectious Disease Epidemiology, London School of Hygiene and
   Tropical Medicine; Head of Global Health Security at Chatham House,
   London; and Chairman of Public Health England, UK) for giving me key
   insights into his long-standing experiences in this field.
CR ADLER E, 1992, INT ORGAN, V46, P367, DOI 10.1017/S0020818300001533
   ALLEN C, 2003, THE BRITISH JOURNAL, V54, P287, DOI DOI 10.1080/0007131032000080249
   [Anonymous], 2014, COMMUNICATION
   Baekkeskov E, 2016, POLICY SCI, V49, P395, DOI 10.1007/s11077-016-9264-y
   Bardosh K., 2016, ONE HLTH SCI POLITIC
   Bardosh K. L., 2015, THESIS
   Bardosh KL, 2016, MED ANTHROPOL, V35, P338, DOI 10.1080/01459740.2015.1101461
   Baum SE, 2017, ONE HEALTH-AMSTERDAM, V3, P5, DOI 10.1016/j.onehlt.2016.10.004
   BENNETT CJ, 1992, POLICY SCI, V25, P275, DOI 10.1007/BF00138786
   Bevir M, 2014, DEMOCRACY AND CRISIS: DEMOCRATISING GOVERNANCE IN THE TWENTY-FIRST CENTURY, P25
   Bill and Melinda Gates Foundation, 2016, ONE HLTH CONC BRING
   Brassett J, 2013, POLITICS-OXFORD, V33, P221, DOI 10.1111/1467-9256.12032
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   CLARKE M, 1997, HANDLING WICKED ISSU
   Connolly J., 2014, Eurohealth, V20, P23
   Connolly J., 2016, POLITICS CRISIS MANA
   Connolly J, 2015, DISASTER PREV MANAG, V24, P369, DOI 10.1108/DPM-09-2014-0196
   Davies JS, 2009, PUBLIC ADMIN, V87, P80, DOI 10.1111/j.1467-9299.2008.01740.x
   Davies S. E., 2015, DIS DIPLOMACY INT NO
   Demeritt D, 2015, ENVIRON PLANN A, V47, P373, DOI 10.1068/a140085p
   Dolowitz DP, 2000, GOVERNANCE, V13, P5, DOI 10.1111/0952-1895.00121
   Dunleavy P., 2010, FUTURE JOINED UP PUB
   Dunlop CA, 2014, ENVIRON PLANN C, V32, P208, DOI 10.1068/c13192j
   Dunlop CA, 2009, POLICY STUD-UK, V30, P289, DOI 10.1080/01442870902863869
   Economic and Social Research Council (ESRC), 2014, UK COMM 20 5 MILL CO
   Flinders M., 2017, REPRESENTATION, P1
   Frost N., 2005, PROFESSIONALISM PART
   Galaz V, 2015, POLITICAL EC ONE HLT
   Galaz V., 2016, ONE HLTH SCI POLITIC, P21
   Galbreath DJ, 2013, J EUR INTEGR, V35, P169, DOI 10.1080/07036337.2012.692117
   Geuijen K., 2016, PUBLIC MANAGEMENT RE
   Gibbs EPJ, 2014, VET REC, V174, P85, DOI 10.1136/vr.g143
   Grepin KA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000174
   Gronvall G, 2014, BIOSECUR BIOTERROR, V12, P221, DOI 10.1089/bsp.2014.0044
   Haas M., 2016, EPISTEMIC COMMUNITIE
   HAAS PM, 1992, INT ORGAN, V46, P1, DOI 10.1017/S0020818300001442
   Harrison M, 2015, B HIST MED, V89, P639, DOI 10.1353/bhm.2015.0116
   Head Brian, 2008, PUBLIC POLICY, V3, P101, DOI DOI 10.1128/MCB.00567-07
   Heymann D., 2014, COMMUNICATION
   Heymann DL, 2013, CURR TOP MICROBIOL, V366, P207, DOI 10.1007/82_2012_285
   Howorth J, 2004, WEST EUR POLIT, V27, P211, DOI 10.1080/0140238042000214883
   Huynen MMTE, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-14
   Kamradt-Scott A., 2015, THIRD WORLD Q, V37, P1
   Kutting G, 2015, PUBLIC ADMIN, V93, P907, DOI 10.1111/padm.12189
   Lammie PJ, 2006, TRENDS PARASITOL, V22, P313, DOI 10.1016/j.pt.2006.05.009
   Leboeuf A., 2011, IFRI HLTH ENV REPORT, V7
   Lee K, 2013, HEALTH POLICY PLANN, V28, P778, DOI 10.1093/heapol/czs127
   Legge D., 2016, WHO REFORM NEED GLOB
   Ling T, 2002, PUBLIC ADMIN, V80, P615, DOI 10.1111/1467-9299.00321
   Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3
   Martin G, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0143-2
   McConnell A, 2011, POLICY SOC, V30, P63, DOI 10.1016/j.polsoc.2011.03.002
   Moore M.H., 2013, RECOGNIZING PUBLIC V
   Nicholson-Crotty S, 2016, STATE POLIT POLICY Q, V16, P78, DOI 10.1177/1532440015588764
   One Health, 2016, ON HLTH IN
   Parsons W, 2004, AUST J PUBL ADMIN, V63, P43, DOI 10.1111/j.1467-8500.2004.00358.x
   RADAELLI C, 1997, POLITICS CORPORATE T
   Richardson J.J., 1996, EUROPEAN UNION POWER, P3
   Rose R., 1991, J PUBLIC POLICY, V11, P3, DOI DOI 10.1017/S0143814X00004918
   ROSENTHAL U, 1991, PUBLIC ADMIN, V69, P211, DOI 10.1111/j.1467-9299.1991.tb00791.x
   Rubin CS, 2013, CURR TOP MICROBIOL, V366, P173, DOI 10.1007/82_2013_310
   Sabatier A., 1987, SCI COMMUN, V8, P649
   Sabatier PA, 1998, J EUR PUBLIC POLICY, V5, P98, DOI 10.1080/13501768880000051
   Sanderson I, 2002, PUBLIC ADMIN, V80, P1, DOI 10.1111/1467-9299.00292
   Shigayeva A, 2015, HEALTH POLICY PLANN, V30, P368, DOI 10.1093/heapol/czu005
   Stone D, 2004, J EUR PUBLIC POLICY, V11, P545, DOI 10.1080/13501760410001694291
   Stone D, 2008, POLICY STUD J, V36, P19, DOI 10.1111/j.1541-0072.2007.00251.x
   Stone D, 2012, POLICY STUD-UK, V33, P483, DOI 10.1080/01442872.2012.695933
   Susskind L.E., 2014, ENV DIPLOMACY NEGOTI
   Thorson A., 2005, J CONTING CRISIS MAN, V13, P21
   Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572
   Valeix S., 2016, ONE HLTH SCI POLITIC
   Vandersmissen A, 2014, REV SCI TECH OIE, V33, P421, DOI 10.20506/rst.33.2.2297
   Waltner-Toews D, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0171
   Weber ER, 2008, PUBLIC ADMIN REV, V68, P334, DOI 10.1111/j.1540-6210.2007.00866.x
   Weiss C. H., 1999, EVALUATION, V5, P468, DOI DOI 10.1177/135638909900500408
   Wilkins P, 2002, AUST J PUBL ADMIN, V61, P114, DOI 10.1111/1467-8500.00266
   Zinsstag J, 2011, PREV VET MED, V101, P148, DOI 10.1016/j.prevetmed.2010.07.003
   Zito AR, 2001, J EUR PUBLIC POLICY, V8, P585, DOI 10.1080/13501760110064401
NR 79
TC 1
Z9 1
U1 2
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1758-5880
EI 1758-5899
J9 GLOB POLICY
JI Glob. Policy
PD NOV
PY 2017
VL 8
IS 4
BP 483
EP 494
DI 10.1111/1758-5899.12505
PG 12
WC International Relations; Political Science
SC International Relations; Government & Law
GA FO0IM
UT WOS:000416427200006
PM 32336994
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU McLinden, JH
   Bhattarai, N
   Stapleton, JT
   Chang, Q
   Kaufman, TM
   Cassel, SL
   Sutterwala, FS
   Haim, H
   Houtman, JC
   Xiang, JH
AF McLinden, James H.
   Bhattarai, Nirjal
   Stapleton, Jack T.
   Chang, Qing
   Kaufman, Thomas M.
   Cassel, Suzanne L.
   Sutterwala, Fayyaz S.
   Haim, Hillel
   Houtman, Jon C.
   Xiang, Jinhua
TI Yellow Fever Virus, but Not Zika Virus or Dengue Virus, Inhibits T-Cell
   Receptor-Mediated T-Cell Function by an RNA-Based Mechanism
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE flavivirus; yellow fever virus; T-cell receptor; PTPRE; virus-derived
   short RNA
ID INFLUENZA-A VIRUS; 17D VACCINE; REPLICATION; E2; ACTIVATION;
   INTERFERENCE; MICRORNAS; RESPONSES; PARTICLES; SELECTION
AB The Flavivirus genus within the Flaviviridae family is comprised of many important human pathogens including yellow fever virus (YFV), dengue virus (DENV), and Zika virus (ZKV), all of which are global public health concerns. Although the related flaviviruses hepatitis C virus and human pegivirus (formerly named GBV-C) interfere with T-cell receptor (TCR) signaling by novel RNA and protein-based mechanisms, the effect of other flaviviruses on TCR signaling is unknown. Here, we studied the effect of YFV, DENV, and ZKV on TCR signaling. Both YFV and ZKV replicated in human T cells in vitro; however, only YFV inhibited TCR signaling. This effect was mediated at least in part by the YFV envelope (env) protein coding RNA. Deletion mutagenesis studies demonstrated that expression of a short, YFV env RNA motif (vsRNA) was required and sufficient to inhibit TCR signaling. Expression of this vsRNA and YFV infection of T cells reduced the expression of a Src-kinase regulatory phosphatase (PTPRE), while ZKV infection did not. YFV infection in mice resulted in impaired TCR signaling and PTPRE expression, with associated reduction in murine response to experimental ovalbumin vaccination. Together, these data suggest that viruses within the flavivirus genus inhibit TCR signaling in a species-dependent manner.
C1 [McLinden, James H.; Bhattarai, Nirjal; Stapleton, Jack T.; Chang, Qing; Kaufman, Thomas M.; Cassel, Suzanne L.; Sutterwala, Fayyaz S.; Haim, Hillel; Houtman, Jon C.; Xiang, Jinhua] Iowa City Vet Affairs Med Ctr, Res Serv, Iowa City, IA USA.
   [McLinden, James H.; Bhattarai, Nirjal; Stapleton, Jack T.; Chang, Qing; Kaufman, Thomas M.; Cassel, Suzanne L.; Sutterwala, Fayyaz S.; Haim, Hillel; Houtman, Jon C.; Xiang, Jinhua] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Stapleton, Jack T.; Houtman, Jon C.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   [Bhattarai, Nirjal] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
   [Cassel, Suzanne L.; Sutterwala, Fayyaz S.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.
RP Xiang, JH (corresponding author), Iowa City VA Hosp, Res Dept, 601 Hwy 6, Iowa City, IA 52246 USA.
EM jinhua-xiang@uiowa.edu
OI Houtman, Jon/0000-0002-5307-9854; Haim, Hillel/0000-0002-6071-5089;
   Stapleton, Jack/0000-0002-2302-9055
FU Department of Veterans Affairs, Veterans Health Administration, Office
   of Research and DevelopmentUS Department of Veterans Affairs [BX001241,
   BX000207]; Carver College of Medicine/Holden Comprehensive Cancer
   Center; National Cancer Institute of the National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [P30CA086862]; University of the Vice President for Research, University
   of Iowa
FX his work was supported by grants from the Department of Veterans
   Affairs, Veterans Health Administration, Office of Research and
   Development (merit review grants BX001241 to J. X. and BX000207 to J. T.
   S.). Work performed at the University of Iowa Flow Cytometry Facility
   and DNA core research facility (University of Iowa Genomics Division,
   Iowa Institute of Human Genetics) were both supported by the Carver
   College of Medicine/Holden Comprehensive Cancer Center, which is
   supported in part by the National Cancer Institute of the National
   Institutes of Health (award number P30CA086862), and from a pilot grant
   from the University of the Vice President for Research, University of
   Iowa (to J. T. S.).
CR Ahmed F, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S14-S9
   Bhattarai N, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006232
   Bhattarai N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005183
   Bhattarai N, 2013, J IMMUNOL, V190, P6351, DOI 10.4049/jimmunol.1300589
   Bhattarai N, 2012, J IMMUNOL, V189, P2211, DOI 10.4049/jimmunol.1201324
   Bogerd HP, 2014, J VIROL, V88, P8065, DOI 10.1128/JVI.00985-14
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Ciraci C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151252
   Cullen BR, 2014, J VIROL, V88, P12934, DOI 10.1128/JVI.01179-14
   Davis SJ, 2011, TRENDS IMMUNOL, V32, P1, DOI 10.1016/j.it.2010.11.003
   Douam F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14781
   Feigelstock DA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-44
   Harwig A, 2014, CURR OPIN VIROL, V7, P47, DOI 10.1016/j.coviro.2014.03.013
   Hussain M, 2014, P NATL ACAD SCI USA, V111, P2746, DOI 10.1073/pnas.1320123111
   James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13
   Janczy JR, 2014, J IMMUNOL, V193, P5190, DOI 10.4049/jimmunol.1400628
   Jang IK, 2010, P NATL ACAD SCI USA, V107, P10620, DOI 10.1073/pnas.0905039107
   Jerome KR, 2008, J VIROL, V82, P4194, DOI 10.1128/JVI.00059-08
   Jorge TR, 2017, ACTA TROP, V166, P114, DOI 10.1016/j.actatropica.2016.09.030
   Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Levy-Apter E, 2014, J BIOL CHEM, V289, P36048, DOI 10.1074/jbc.M114.603548
   Li Y, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.250
   Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mohr EL, 2010, J IMMUNOL, V185, P4496, DOI 10.4049/jimmunol.1001980
   Muyanja E, 2014, J CLIN INVEST, V124, P3147, DOI 10.1172/JCI75429
   Silva JRN, 2011, VACCINE, V29, P6327, DOI 10.1016/j.vaccine.2011.05.019
   Nasveld PE, 2010, HUM VACCINES, V6, P906, DOI 10.4161/hv.6.11.12854
   Palmer DR, 2007, J GEN VIROL, V88, P148, DOI 10.1099/vir.0.82272-0
   Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Paules CI, 2017, JAMA-J AM MED ASSOC, V317, P691, DOI 10.1001/jama.2016.21079
   Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107
   Rato S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009276
   Rouha H, 2010, NUCLEIC ACIDS RES, V38, P8328, DOI 10.1093/nar/gkq681
   Shapiro JS, 2012, RNA, V18, P1338, DOI 10.1261/rna.032268.112
   Shapiro JS, 2010, RNA, V16, P2068, DOI 10.1261/rna.2303610
   Shi JD, 2014, FASEB J, V28, P4381, DOI 10.1096/fj.14-253534
   Shi JD, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-121
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Stapleton JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050563
   Stapleton JT, 2009, AIDS, V23, P605, DOI 10.1097/QAD.0b013e32831f1b00
   Vargas-Inchaustegui DA, 2012, J IMMUNOL, V189, P1878, DOI 10.4049/jimmunol.1201026
   Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000
   Xiang JH, 2006, P NATL ACAD SCI USA, V103, P15570, DOI 10.1073/pnas.0604728103
   Xiang JH, 2012, VIROLOGY, V430, P53, DOI 10.1016/j.virol.2012.04.019
   Xiang J, 2009, J IMMUNOL, V183, P7860, DOI 10.4049/jimmunol.0902276
   Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094
NR 50
TC 2
Z9 2
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD NOV 1
PY 2017
VL 216
IS 9
BP 1164
EP 1175
DI 10.1093/infdis/jix462
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FP0ZM
UT WOS:000417338800016
PM 28968905
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Snider, J
AF Snider, Janice
TI MASS SPECTROMETRY-BASED PROTEOMIC TECHNIQUE IDENTIFIES ZIKA VIRUS
   PEPTIDES IN SALIVA, STUDY FINDS
SO JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
LA English
DT News Item
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR); Canada Foundation for InnovationCanada Foundation for
   Innovation
FX This study was funded by grants from the Canadian Institutes of Health
   Research and the Canada Foundation for Innovation-Leaders Opportunity
   Fund.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER DENTAL ASSOC
PI CHICAGO
PA 211 E CHICAGO AVE, CHICAGO, IL 60611 USA
SN 0002-8177
EI 1943-4723
J9 J AM DENT ASSOC
JI J. Am. Dent. Assoc.
PD NOV
PY 2017
VL 148
IS 11
BP 786
EP 786
DI 10.1177/0022034517723325
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA FO8AL
UT WOS:000417103500006
DA 2020-07-08
ER

PT J
AU Torresi, J
   Steffen, R
AF Torresi, Joseph
   Steffen, Robert
TI Redefining priorities towards graded travel-related infectious disease
   research
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Review
DE travel medicine research; network studies; vaccinomics; malaria; travel
   vaccines; GRADE
ID SENTINEL SURVEILLANCE DATA; RABIES POSTEXPOSURE PROPHYLAXIS; TETRAVALENT
   DENGUE VACCINE; SYSTEMS BIOLOGY APPROACH; HUMAN GUT MICROBIOME;
   GEOSENTINEL SURVEILLANCE; RETURNED TRAVELERS; ZIKA VIRUS;
   CLINICAL-FEATURES; HEPATITIS-A
AB Our knowledge of the health problems and infections encountered by international travellers has evolved considerably in the past decades. The growth of global networks such as the GeoSentinel Surveillance network, TropNet Europe, EuroTravNet and networks based in North America have provided valuable information on the frequency of a wide array of travel-related diseases and accidents, including details on the destination of travel and trends over time. The information gained from these network studies has provided important data for the practice of travel medicine and in some instances for the development of practice guidelines. However, network data due to a lack of denominators usually cannot serve as a basis for a GRADE approach to guideline development. Although epidemiological network studies will continue to serve an important role in travel medicine we encourage an additional strong focus towards translational scientific research questions and towards the broader use of novel techniques to obtain more accurate epidemiological analyses to address the many unanswered questions in our field.
C1 [Torresi, Joseph] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia.
   [Steffen, Robert] Univ Zurich, Epidemiol Biostat & Prevent Inst, Div Communicable Dis, WHO Collaborating Ctr Travellers Hlth, Zurich, Switzerland.
   [Steffen, Robert] Univ Texas Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA.
RP Torresi, J (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia.
EM josepht@unimelb.edu.au
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alonso-Coello P, 2016, BMJ-BRIT MED J, V353, pi2016, DOI DOI 10.1136/BMJ.I2089
   Angelakis E, 2014, ANTIMICROB AGENTS CH, V58, P3342, DOI 10.1128/AAC.02437-14
   Arcilla MS, 2017, LANCET INFECT DIS, V17, P78, DOI 10.1016/S1473-3099(16)30319-X
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Aspinall Richard, 2007, Immun Ageing, V4, P9, DOI 10.1186/1742-4933-4-9
   Barbosa F, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw094
   Barker KR, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw005
   Bednarczyk RA, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw019
   Behrens RH, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-114
   Behrens RH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-266
   Bengtsson-Palme J, 2015, ANTIMICROB AGENTS CH, V59, P6551, DOI 10.1128/AAC.00933-15
   Boggild Andrea K, 2016, CMAJ Open, V4, pE352
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Cardell K, 2008, J INFECT DIS, V198, P299, DOI 10.1086/589722
   Carrara P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002209
   Carrara VI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001398
   Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P21
   Cetron Martin S, 2002, MMWR Recomm Rep, V51, P1
   CETRON MS, 2002, MMWR RECOMM REP, V51, pCE1
   Chen LH, 2013, J TRAVEL MED, V20, P29, DOI 10.1111/jtm.12002
   Cobelens F, 2003, INT J TUBERC LUNG D, V7, P758
   Cobelens FGJ, 2000, LANCET, V356, P461, DOI 10.1016/S0140-6736(00)02554-X
   Cobelens FGJ, 2002, TROP MED INT HEALTH, V7, P331, DOI 10.1046/j.1365-3156.2002.00864.x
   Connolly R, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw082
   Connor BA, 2005, CLIN INFECT DIS, V41, pS577, DOI 10.1086/432956
   Conroy AL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-35
   Cramer JP, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw011
   Nali LHD, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw026
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Doherty JF, 1995, QJM, V88, P271
   Drewett G, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw053
   DuPont HL, 2007, CLIN GASTROENTEROL H, V5, P451, DOI 10.1016/j.cgh.2007.02.004
   Ehehalt U, 2014, TRAVEL MED INFECT DI, V12, P167, DOI 10.1016/j.tmaid.2013.12.003
   Elliott JH, 2004, J TRAVEL MED, V11, P213, DOI 10.2310/7060.2004.19004
   Erdman LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017440
   Ericsson, 1997, J Travel Med, V4, P3, DOI 10.1111/j.1708-8305.1997.tb00765.x
   ERICSSON CD, 1990, JAMA-J AM MED ASSOC, V263, P257, DOI 10.1001/jama.263.2.257
   Ericsson CD, 2001, J TRAVEL MED, V8, P207, DOI 10.2310/7060.2001.24244
   Ericsson CD, 2007, J TRAVEL MED, V14, P312, DOI 10.1111/j.1708-8305.2007.00144.x
   Esposito DH, 2012, EUROSURVEILLANCE, V17, P2
   Esposito DH, 2014, CLIN INFECT DIS, V59, P1401, DOI 10.1093/cid/ciu622
   Evans AB, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-251
   Farnham A, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw056
   Field V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-330
   Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331
   Gautret P, 2012, EUROSURVEILLANCE, V17, P16
   Gautret P, 2016, EUROSURVEILLANCE, V21
   Gautret P, 2008, J TRAVEL MED, V15, P25, DOI 10.1111/j.1708-8305.2007.00164.x
   Gautret P, 2007, VACCINE, V25, P2656, DOI 10.1016/j.vaccine.2006.12.034
   Gautret P, 2007, J TRAVEL MED, V14, P136, DOI 10.1111/j.1708-8305.2007.00115_1.x
   Gautret P, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0394-0
   Gautret P, 2013, INT J INFECT DIS, V17, pE164, DOI 10.1016/j.ijid.2012.09.011
   Gautret P, 2012, J TRAVEL MED, V19, P169, DOI 10.1111/j.1708-8305.2012.00613.x
   Gautret P, 2009, EMERG INFECT DIS, V15, P1783, DOI 10.3201/eid1511.091147
   Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105
   Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588
   Greenaway C, 2014, SUMMARY STATEMENT IN, P40
   Greenwood Z, 2008, J TRAVEL MED, V15, P221, DOI 10.1111/j.1708-8305.2008.00203.x
   Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Haditsch M, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav009
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Hamer DH, 2004, J TRAVEL MED, V11, P23, DOI 10.2310/7060.2004.13577
   Haralambieva IH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160970
   Haralambieva IH, 2013, EXPERT REV VACCINES, V12, P57, DOI [10.1586/ERV.12.134, 10.1586/erv.12.134]
   Heywood AE, 2016, EPIDEMIOL INFECT, P1
   Iliaki E, 2014, J TRAVEL MED, V21, P214, DOI 10.1111/jtm.12117
   Jaeschke R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a744
   Jelinek, 1994, J Travel Med, V1, P199, DOI 10.1111/j.1708-8305.1994.tb00595.x
   Jelinek T, 2002, CLIN INFECT DIS, V35, P1047, DOI 10.1086/342906
   Jelinek T, 2002, CLIN INFECT DIS, V34, P572, DOI 10.1086/338235
   Jelinek T, 1997, ARCH INTERN MED, V157, P2367, DOI 10.1001/archinte.157.20.2367
   Jelinek T, 2000, CLIN INFECT DIS, V31, P144, DOI 10.1086/313889
   Judd MC, 2017, CDC YELLOW BOOK 2018
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Keystone JS, 2017, TRAVEL MED INFECT DI, V16, P1, DOI 10.1016/j.tmaid.2017.04.003
   Khawplod P, 2007, J TRAVEL MED, V14, P173, DOI 10.1111/j.1708-8305.2007.00120.x
   Khawplod P, 2012, VACCINE, V30, P2918, DOI 10.1016/j.vaccine.2011.12.028
   Kogelman L, 2014, J TRAVEL MED, V21, P104, DOI 10.1111/jtm.12097
   Lachish T, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw064
   Lalani T, 2015, J TRAVEL MED, V22, P152, DOI 10.1111/jtm.12179
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Leder K, 2004, CLIN INFECT DIS, V39, P1104, DOI 10.1086/424510
   Leder K, 2003, CLIN INFECT DIS, V36, P399, DOI 10.1086/346155
   Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893
   Leder K, 2015, J TRAVEL MED, V22, P13, DOI 10.1111/jtm.12170
   Leder K, 2013, EMERG INFECT DIS, V19, P1049, DOI 10.3201/eid1907.121573
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   MacIntyre CR, 2016, VACCINE, V34, P4386, DOI 10.1016/j.vaccine.2016.07.023
   Miranda IB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav024
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2002, CLIN INFECT DIS, V34, P1369, DOI 10.1086/340104
   Muhlberger N, 2003, CLIN INFECT DIS, V36, P990, DOI 10.1086/374224
   Muhlberger N, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-5
   Mutsch M, 2006, CLIN INFECT DIS, V42, P490, DOI 10.1086/499816
   Mutsch M, 2005, CLIN INFECT DIS, V40, P1282, DOI 10.1086/429243
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Nothdurft HD, 2007, J TRAVEL MED, V14, P181, DOI 10.1111/j.1708-8305.2007.00123.x
   O'Brien D, 2001, CLIN INFECT DIS, V33, P603, DOI 10.1086/322602
   O'Brien DP, 2006, J TRAVEL MED, V13, P145, DOI 10.1111/j.1708-8305.2006.00033.x
   Odolini S, 2012, CLIN MICROBIOL INFEC, V18, P468, DOI 10.1111/j.1469-0691.2011.03596.x
   Oldenburg M, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav003
   Ostholm-Balkhed A, 2013, J ANTIMICROB CHEMOTH, V68, P2144, DOI 10.1093/jac/dkt167
   Ostroff SM, 1998, INFECT DIS CLIN N AM, V12, P231, DOI 10.1016/S0891-5520(05)70420-7
   Ovsyannikova IG, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00098
   Peden AE, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav031
   Perez-Molina JA, 2011, EUROSURVEILLANCE, V16, P24
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Poland GA, 2014, CURR OPIN IMMUNOL, V29, P62, DOI 10.1016/j.coi.2014.04.005
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rasko DA, 2017, J TRAVEL MED, V24, pS52, DOI 10.1093/jtm/tax017
   Ratnam I, 2013, J CLIN VIROL, V57, P54, DOI 10.1016/j.jcv.2013.01.008
   Reed, 1994, J Travel Med, V1, P192, DOI 10.1111/j.1708-8305.1994.tb00594.x
   Ricciuto DR, 2011, CRIT CARE MED, V39, P702, DOI 10.1097/CCM.0b013e318206d285
   Riddle MS, 2017, J TRAVEL MED, V24, pS63, DOI 10.1093/jtm/tax026
   Riddle MS, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0536-7
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X
   Schlagenhauf P, 2010, CLIN INFECT DIS, V50, P826, DOI 10.1086/650575
   Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412
   Schwille-Kiuntke J, 2015, ALIMENT PHARM THER, V41, P1029, DOI 10.1111/apt.13199
   Shantavasinkul P, 2010, CLIN INFECT DIS, V50, P56, DOI 10.1086/649211
   Song JY, 2015, VACCINE, V33, P4647, DOI 10.1016/j.vaccine.2015.05.003
   STEFFEN R, 1986, REV INFECT DIS, V8, pS122
   Steffen R, 2005, J TRAVEL MED, V12, P26, DOI 10.2310/7060.2005.00006
   Steffen R, 2004, J TRAVEL MED, V11, P231, DOI 10.2310/7060.2004.19007
   STEFFEN R, 1983, JAMA-J AM MED ASSOC, V249, P1176
   STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84
   STEFFEN R, 1983, SCAND J GASTROENTERO, V18, P5
   Steffen R, 1978, SCHWEIZ MED WOCHENSC, V108, P1310
   Steffen R, 2017, J TRAVEL MED, V24, pS2, DOI 10.1093/jtm/taw072
   Stewart BT, 2016, MED CLIN N AM, V100, P331, DOI 10.1016/j.mcna.2015.07.011
   Swaminathan A, 2009, J INFECTION, V59, P19, DOI 10.1016/j.jinf.2009.05.008
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tangden T, 2010, ANTIMICROB AGENTS CH, V54, P3564, DOI 10.1128/AAC.00220-10
   Toovey S, 2004, J TRAVEL MED, V11, P16, DOI 10.2310/7060.2004.13587
   Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0
   UNWTO, 2015, UNWTO ANN REP 2015
   Van Herck K, 2004, J TRAVEL MED, V11, P3, DOI 10.2310/7060.2004.13609
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Vogt SL, 2017, J TRAVEL MED, V24, pS39, DOI 10.1093/jtm/taw086
   von Wintersdorff CJH, 2014, EMERG INFECT DIS, V20, P649, DOI [10.3201/eid2004.131718, 10.3201/eid.2004.131718]
   Warne B, 2014, J TRAVEL MED, V21, P248, DOI 10.1111/jtm.12120
   Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197
   Weisenberg SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045141
   WHO, 2012, WHO HDB GUID DEV
   Wieten RW, 2013, CLIN INFECT DIS, V56, P414, DOI 10.1093/cid/cis853
   Wilder-Smith A, 2004, J TRAVEL MED, V11, P9, DOI 10.2310/7060.2004.13600
   Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173
   Youmans BP, 2015, GUT MICROBES, V6, P110, DOI 10.1080/19490976.2015.1019693
NR 154
TC 18
Z9 18
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD NOV-DEC
PY 2017
VL 24
IS 6
AR UNSP tax064
DI 10.1093/jtm/tax064
PG 10
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA FO8WA
UT WOS:000417167600006
OA Bronze
DA 2020-07-08
ER

PT J
AU Epelboin, Y
   Talaga, S
   Epelboin, L
   Dusfour, I
AF Epelboin, Yanouk
   Talaga, Stanislas
   Epelboin, Loic
   Dusfour, Isabelle
TI Zika virus: An updated review of competent or naturally infected
   mosquitoes
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID AEDES-AEGYPTI DIPTERA; VECTOR-BORNE TRANSMISSION; YELLOW-FEVER; VERTICAL
   TRANSMISSION; INSECTICIDE RESISTANCE; CULEX-QUINQUEFASCIATUS;
   SOUTHEASTERN SENEGAL; CHIKUNGUNYA VIRUS; GLOBAL RISK; EL-NINO
AB Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) that recently caused outbreaks in the Americas. Over the past 60 years, this virus has been observed circulating among African, Asian, and Pacific Island populations, but little attention has been paid by the scientific community until the discovery that large-scale urban ZIKV outbreaks were associated with neurological complications such as microcephaly and several other neurological malformations in fetuses and newborns. This paper is a systematic review intended to list all mosquito species studied for ZIKV infection or for their vector competence. We discuss whether studies on ZIKV vectors have brought enough evidence to formally exclude other mosquitoes than Aedes species (and particularly Aedes aegypti) to be ZIKV vectors. From 1952 to August 15, 2017, ZIKV has been studied in 53 mosquito species, including 6 Anopheles, 26 Aedes, 11 Culex, 2 Lutzia, 3 Coquillettidia, 2 Mansonia, 2 Eretmapodites, and 1 Uranotaenia. Among those, ZIKV was isolated from 16 different Aedes species. The only species other than Aedes genus for which ZIKV was isolated were Anopheles coustani, Anopheles gambiae, Culex perfuscus, and Mansonia uniformis. Vector competence assays were performed on 22 different mosquito species, including 13 Aedes, 7 Culex, and 2 Anopheles species with, as a result, the discovery that A. aegypti and Aedes albopictus were competent for ZIKV, as well as some other Aedes species, and that there was a controversy surrounding Culex quinquefasciatus competence. Although Culex, Anopheles, and most of Aedes species were generally observed to be refractory to ZIKV infection, other potential vectors transmitting ZIKV should be explored.
C1 [Epelboin, Yanouk; Talaga, Stanislas; Dusfour, Isabelle] Inst Pasteur, Vectopole Amazonien Emile Abonnenc, Vector Control & Adaptat Unit, Cayenne, French Guiana.
   [Epelboin, Loic] Ctr Hosp Andree Rosemon, Infect & Trop Dis Unit, Cayenne, French Guiana.
   [Epelboin, Loic] Univ Guyane, Ecosyst Amazoniens & Pathol Tropicale EPAT, EA 3593, Cayenne, French Guiana.
RP Epelboin, Y (corresponding author), Inst Pasteur, Vectopole Amazonien Emile Abonnenc, Vector Control & Adaptat Unit, Cayenne, French Guiana.
EM yepelboin@pasteur-cayenne.fr
RI Epelboin, LoAc/AAP-6477-2020
OI Epelboin, LoAc/0000-0002-3481-5991
FU Agence Nationale de la RechercheFrench National Research Agency (ANR)
   [CEBA: ANR-10-LABX-25-01]
FX YE, ST, and ID acknowledge "an Investissement d'Avenir grant of the
   Agence Nationale de la Recherche" (CEBA: ANR-10-LABX-25-01). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Adde A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004681
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Alout H, 2014, J INFECT DIS, V210, P1464, DOI 10.1093/infdis/jiu276
   Alout H, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0389
   Alout H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063849
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brault AC, 2004, INSECT MOL BIOL, V13, P625, DOI 10.1111/j.0962-1075.2004.00521.x
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   Secundino NFC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2286-2
   de Andrade PP, 2016, B WORLD HEALTH ORGAN, V94, P766, DOI 10.2471/BLT.16.173377
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo M, 2000, AM J TROP MED HYG, V62, P151, DOI 10.4269/ajtmh.2000.62.151
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Dusfour I, 2011, MEM I OSWALDO CRUZ, V106, P346, DOI 10.1590/S0074-02762011000300015
   Eldridge BF, 2004, MED ENTOMOLOGY, P659
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Gaffigan TV, SYSTEMATIC CATALOG C
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   GERMAIN M, 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V14, P125
   GILOTRA SK, 1967, AM J EPIDEMIOL, V86, P379, DOI 10.1093/oxfordjournals.aje.a120748
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Greenberg JA, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.7501
   GUBLER DJ, 1981, AM J TROP MED HYG, V30, P1303, DOI 10.4269/ajtmh.1981.30.1303
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Huang YJS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182386
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494
   McCarroll L, 2000, NATURE, V407, P961, DOI 10.1038/35039671
   McCarroll L, 2002, INSECT BIOCHEM MOLEC, V32, P1345, DOI 10.1016/S0965-1748(02)00097-8
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   MOLAEI G, 2007, AM J TROP MED HYG, V77, P73
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   O'Donnell KL, 2017, J MED ENTOMOL, V54, P1354, DOI 10.1093/jme/tjx087
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   REINERT J. F., 2009, EUROPEAN MOSQUITO B, V27, P68
   Reinert JF, 2008, ZOOL J LINN SOC-LOND, V153, P29, DOI 10.1111/j.1096-3642.2008.00382.x
   Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   ROBERT V, 1993, B SOC PATHOL EXOT, V86, P90
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   ROSEN L, 1954, AM J TROP MED HYG, V3, P878, DOI 10.4269/ajtmh.1954.3.878
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   SALUZZO J-F, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P19
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007
   Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   TRAORELAMIZANA M, 1994, J MED ENTOMOL, V31, P623, DOI 10.1093/jmedent/31.4.623
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 125
TC 45
Z9 50
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2017
VL 11
IS 11
AR e0005933
DI 10.1371/journal.pntd.0005933
PG 22
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FO4RM
UT WOS:000416832800008
PM 29145400
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pollett, S
   Althouse, BM
   Forshey, B
   Rutherford, GW
   Jarman, RG
AF Pollett, Simon
   Althouse, Benjamin M.
   Forshey, Brett
   Rutherford, George W.
   Jarman, Richard G.
TI Internet-based biosurveillance methods for vector-borne diseases: Are
   they novel public health tools or just novelties?
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID DENGUE; SURVEILLANCE; TRENDS
AB Internet-based surveillance methods for vector-borne diseases (VBDs) using "big data' sources such as Google, Twitter, and internet newswire scraping have recently been developed, yet reviews on such "digital disease detection" methods have focused on respiratory pathogens, particularly in high-income regions. Here, we present a narrative review of the literature that has examined the performance of internet-based biosurveillance for diseases caused by vector-borne viruses, parasites, and other pathogens, including Zika, dengue, other arthropod-borne viruses, malaria, leishmaniasis, and Lyme disease across a range of settings, including low-and middle-income countries. The fundamental features, advantages, and drawbacks of each internet big data source are presented for those with varying familiarity of "digital epidemiology." We conclude with some of the challenges and future directions in using internet-based biosurveillance for the surveillance and control of VBD.
C1 [Pollett, Simon; Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.
   [Pollett, Simon; Rutherford, George W.] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA.
   [Pollett, Simon] Univ Sydney, Marie Bashir Inst, Sydney, NSW, Australia.
   [Althouse, Benjamin M.] Inst Dis Modeling, Bellevue, WA USA.
   [Althouse, Benjamin M.] Univ Washington, Informat Sch, Seattle, WA 98195 USA.
   [Althouse, Benjamin M.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Forshey, Brett] Armed Force Hlth Surveillance Branch, Global Emerging Infect Surveillance Sect, Silver Spring, MD USA.
   [Forshey, Brett] Cherokee Nation Technol Solut, Silver Spring, MD USA.
RP Pollett, S (corresponding author), Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.; Pollett, S (corresponding author), Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA.; Pollett, S (corresponding author), Univ Sydney, Marie Bashir Inst, Sydney, NSW, Australia.
EM simon.d.pollett.ctr@mail.mil
FU US Department of Defense Global Emerging Infections Surveillance and
   Response System (DoD-GEIS), a division of the Armed Forces Health
   Surveillance BranchUnited States Department of Defense
FX RG Jarman and S Pollett were supported by the US Department of Defense
   Global Emerging Infections Surveillance and Response System (DoD-GEIS),
   a division of the Armed Forces Health Surveillance Branch. The funders
   had no role in the review design, decision to publish, or preparation of
   the manuscript.
CR Alasaad S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-94
   Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0
   Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258
   Antunes MN, 2014, TRANSINFORMACAO, V26, P9, DOI 10.1590/S0103-37862014000100002
   Bahk CY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0885-0
   Barboza P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057252
   Bernardo TM, 2013, J MED INTERNET RES, V15, P239, DOI 10.2196/jmir.2740
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012
   Brownstein JS, 2007, EUROSURVEILLANCE, V12
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206
   Charles-Smith LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139701
   Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597
   Cleaton JM, 2016, CLIN INFECT DIS, V62, P24, DOI 10.1093/cid/civ748
   Generous N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003892
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713
   Gomide J., 2011, P ACM WEBSCI 11 JUN, P1, DOI [10.1145/2527031.2527049, DOI 10.1145/2527031.2527049]
   Hoen AG, 2012, EMERG INFECT DIS, V18, P1147, DOI [10.3201/eid1808.120055, 10.3201/eid1807.120055]
   Knope K, 2013, COMMUN DIS INTELL, V37, pE55
   Lau EHY, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-88
   Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Majumder Maimuna S, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.e6659013c1d7f11bdab6a20705d1e865
   Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4
   Messina JP, 2016, MAPPING GLOBAL ENV S, V5
   Milinovich GJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0690-1
   Milinovich GJ, 2014, LANCET INFECT DIS, V14, P160, DOI 10.1016/S1473-3099(13)70244-5
   Nagpal SJS, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1251-9
   Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583
   Ocampo AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-390
   Olsen J, 2014, ONLINE J PUBLIC HLTH, V6
   Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256
   PAGANO M, 2000, PRINCIPLES BIOSTATIS
   Paul MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103408
   Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098
   Pollett S, 2015, PLOS CURR, V7
   Pollett S, 2017, CLIN INFECT DIS, V64, P34, DOI 10.1093/cid/ciw657
   Roche B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05957-y
   Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616
   Santillana M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004513
   Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195
   Souza RCSNP, 2014, LECT NOTES ARTIF INT, V8864, P295, DOI 10.1007/978-3-319-12027-0_24
   Wilder-Smith A, 2012, PAEDIATR INT CHILD H, V32, P28, DOI 10.1179/2046904712Z.00000000050
   Yang S, 2017, ADV USING INTERNET S, V13
   Yuan QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064323
   Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274
NR 47
TC 8
Z9 8
U1 3
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2017
VL 11
IS 11
AR e0005871
DI 10.1371/journal.pntd.0005871
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FO4RM
UT WOS:000416832800002
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barnard, TR
   Rajah, MM
   Sagan, SM
AF Barnard, Trisha R.
   Rajah, Maaran Michael
   Sagan, Selena M.
TI Zika virus infection: induction, restriction and evasion of host
   interferon responses
SO FUTURE VIROLOGY
LA English
DT Editorial Material
DE immune evasion; interferon; interferon-stimulated genes; zika virus
ID I INTERFERON
C1 [Barnard, Trisha R.; Rajah, Maaran Michael; Sagan, Selena M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada.
RP Sagan, SM (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada.
EM selena.sagan@mcgill.ca
OI Sagan, Selena/0000-0002-8484-3632
FU McGill University; Fonds de Recherche du Quebec Nature et Technologies
   [189120]
FX This work was supported by startup funds from McGill University as well
   as operating funds from the Fonds de Recherche du Quebec Nature et
   Technologies (#189120). SM Sagan is a Tier II Canada Research Chair in
   RNA Biology and Viral Infections. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2015, SCI TRANSL MED, V7
   Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Wu Y, 2017, CELL DISCOV, V3
NR 18
TC 0
Z9 0
U1 0
U2 2
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD NOV
PY 2017
VL 12
IS 11
BP 627
EP 630
DI 10.2217/fvl-2017-0099
PG 4
WC Virology
SC Virology
GA FO6LF
UT WOS:000416973900001
OA Bronze
DA 2020-07-08
ER

PT J
AU Rovnak, J
   Perera, R
   Hopken, MW
   Read, J
   Waller, DM
   Cohrs, RJ
AF Rovnak, Joel
   Perera, Rushika
   Hopken, Matthew W.
   Read, Jenna
   Waller, Derrick M.
   Cohrs, Randall J.
TI The 17th Rocky Mountain Virology Association Meeting
SO VIRUSES-BASEL
LA English
DT Article; Proceedings Paper
CT 17th Rocky-Mountain-Virology-Association Meeting
CY SEP 22-24, 2017
CL CSU Mountain Campus, CO
SP Rocky Mountain Virol Assoc
HO CSU Mountain Campus
DE prions; viruses; Dengue; Sinbis; CWD; Zika; metabolism; herpesvirus;
   primate; transmission
ID GIANT-CELL ARTERITIS; TEMPORAL ARTERIES
AB Since 2000, scientists and students from the greater Rocky Mountain region, along with invited speakers, both national and international, have gathered at the Mountain Campus of Colorado State University to discuss their area of study, present recent findings, establish or strengthen collaborations, and mentor the next generation of virologists and prionologists through formal presentations and informal discussions concerning science, grantsmanship and network development. This year, approximately 100 people attended the 17th annual Rocky Mountain Virology Association meeting, that began with a keynote presentation, and featured 29 oral and 35 poster presentations covering RNA and DNA viruses, prions, virus-host interactions and guides to successful mentorship. Since the keynote address focused on the structure and function of Zika and related flaviviruses, a special session was held to discuss RNA control. The secluded meeting at the foot of the Colorado Rocky Mountains gave ample time for in-depth discussions amid the peak of fall colors in the aspen groves while the random bear provided excitement. On behalf of the Rocky Mountain Virology Association, this report summarizes the >50 reports.
C1 [Rovnak, Joel; Hopken, Matthew W.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Perera, Rushika; Read, Jenna] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
   [Hopken, Matthew W.] USDA, APHIS Natl Wildlife Res Ctr, Ft Collins, CO 80521 USA.
   [Waller, Derrick M.] Regis Univ, Dept Pharmaceut Sci, Sch Pharm, Denver, CO 80221 USA.
   [Cohrs, Randall J.] Univ Colorado, Dept Neurol & Immunol Microbiol, Sch Med, Aurora, CO 80045 USA.
RP Cohrs, RJ (corresponding author), Univ Colorado, Dept Neurol & Immunol Microbiol, Sch Med, Aurora, CO 80045 USA.
EM Joel.Rovnak@colostate.edu; rushika.perera@colostate.edu;
   mhopken@rams.colostate.edu; jlread@rams.colostate.edu;
   dwaller@regis.edu; randall.cohrs@ucdenver.edu
OI Waller, Derrick/0000-0002-9441-8293
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P20 RR0115635-6, C06 RR17417-01, R01
   NS052609-10]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1R13AI126813-01]; National Cancer
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
FX The research by Elizabeth A. Fortunato was funded, in part, by NIH
   grants: P20 RR0115635-6, C06 RR17417-01, R01 NS052609-10. Funding for
   this conference was made possible (in part) by 1R13AI126813-01 from the
   National Institute of Allergy and Infectious Diseases and the National
   Cancer Institute. The views expressed in written conference materials or
   publications and by speakers and moderators do not necessarily reflect
   the official policies of the Department of Health and Human Services;
   nor does the mention of trade names, commercial practices, or
   organizations imply endorsement by the U.S. Government. Additional
   financial support for the conference was provided by Charles Grose,
   Charles H. Calisher, Wendy J. Maury, Randall J. Cohrs, Rushika Perera,
   and Sandra L. Quackenbush. The research by Elizabeth A. Fortunato was
   funded, in part, by NIH grants: P20 RR0115635-6, C06 RR17417-01, R01
   NS052609-10. We wish to thank Tania Wyss, University of Denver, for
   expert editorial help.
CR Campagnola G, 2015, J VIROL, V89, P275, DOI 10.1128/JVI.01574-14
   Gilden D, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000216
   Gilden D, 2015, NEUROLOGY, V84, P1948, DOI 10.1212/WNL.0000000000001409
   Jones D, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000382
   Jones D, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000246
   Nagel MA, 2015, JAMA NEUROL, V72, P1281, DOI 10.1001/jamaneurol.2015.2101
NR 6
TC 0
Z9 0
U1 0
U2 0
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2017
VL 9
IS 11
AR 333
DI 10.3390/v9110333
PG 26
WC Virology
SC Virology
GA FO4KB
UT WOS:000416810300023
PM 29117106
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, XC
   Jia, RY
   Shen, HY
   Wang, MS
   Yin, ZQ
   Cheng, AC
AF Zhang, Xingcui
   Jia, Renyong
   Shen, Haoyue
   Wang, Mingshu
   Yin, Zhongqiong
   Cheng, Anchun
TI Structures and Functions of the Envelope Glycoprotein in Flavivirus
   Infections
SO VIRUSES-BASEL
LA English
DT Review
DE flavivirus; envelope protein; envelope domains I; II; III; membrane
   fusion; viral infection
ID WEST-NILE-VIRUS; PROTEIN DOMAIN-III; CROSS-REACTIVE EPITOPES; FREE STATE
   PROVINCE; DUCK TEMBUSU VIRUS; YELLOW-FEVER VIRUS; DENGUE VIRUS; JAPANESE
   ENCEPHALITIS; ZIKA VIRUS; MEMBRANE-FUSION
AB Flaviviruses are enveloped, single-stranded RNA viruses that widely infect many animal species. The envelope protein, a structural protein of flavivirus, plays an important role in host cell viral infections. It is composed of three separate structural envelope domains I, II, and III (EDI, EDII, and EDIII). EDI is a structurally central domain of the envelope protein which stabilizes the overall orientation of the protein, and the glycosylation sites in EDI are related to virus production, pH sensitivity, and neuroinvasiveness. EDII plays an important role in membrane fusion because of the immunodominance of the fusion loop epitope and the envelope dimer epitope. Additionally, EDIII is the major target of neutralization antibodies. The envelope protein is an important target for research to develop vaccine candidates and antiviral therapeutics. This review summarizes the structures and functions of ED I/II/III, and provides practical applications for the three domains, with the ultimate goal of implementing strategies to utilize the envelope protein against flavivirus infections, thus achieving better diagnostics and developing potential flavivirus therapeutics and vaccines.
C1 [Zhang, Xingcui; Jia, Renyong; Shen, Haoyue; Wang, Mingshu; Cheng, Anchun] Sichuan Agr Univ, Res Ctr Avian Dis, Coll Vet Med, Chengdu 611130, Sichuan, Peoples R China.
   [Zhang, Xingcui; Jia, Renyong; Shen, Haoyue; Wang, Mingshu; Cheng, Anchun] Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu 611130, Sichuan, Peoples R China.
   [Jia, Renyong; Wang, Mingshu; Yin, Zhongqiong; Cheng, Anchun] Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu 611130, Sichuan, Peoples R China.
RP Jia, RY; Cheng, AC (corresponding author), Sichuan Agr Univ, Res Ctr Avian Dis, Coll Vet Med, Chengdu 611130, Sichuan, Peoples R China.; Jia, RY; Cheng, AC (corresponding author), Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu 611130, Sichuan, Peoples R China.; Jia, RY; Cheng, AC (corresponding author), Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu 611130, Sichuan, Peoples R China.
EM zhangxc923@163.com; jiary@sicau.edu.cn; shenhaoyue0724@163.com;
   mshwang@163.com; yinzhongq@163.com; chenganchun@vip.163.com
OI Cheng, Anchun/0000-0001-6093-353X
FU National Key Research and Development Program of China [2017YFD0500800];
   National Key R D Program [2016YFD0500800]; China Agricultural Research
   System [CARS-42-17]; Sichuan Province Research Programs
   [2017JY0014/2017HH0026]
FX This work was supported by the National Key Research and Development
   Program of China (2017YFD0500800), National Key R & D Program
   (2016YFD0500800), China Agricultural Research System (CARS-42-17), and
   Sichuan Province Research Programs (2017JY0014/2017HH0026).
CR Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Alonso-Padilla J, 2011, VACCINE, V29, P1830, DOI 10.1016/j.vaccine.2010.12.081
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Arora U, 2013, VACCINE, V31, P873, DOI 10.1016/j.vaccine.2012.12.016
   Bai XF, 2015, ARCH VIROL, V160, P757, DOI 10.1007/s00705-014-2312-z
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beck C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/678084
   Blazevic J, 2016, J VIROL, V90, P6365, DOI 10.1128/JVI.00447-16
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10
   Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246
   Chakraborty Sandeep, 2016, F1000Res, V5, P1150, DOI 10.12688/f1000research.8853.1
   Chao LH, 2014, ELIFE, V3, DOI 10.7554/eLife.04389
   Chavez JH, 2010, BIOLOGICALS, V38, P613, DOI 10.1016/j.biologicals.2010.07.004
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   Chen PC, 2014, VACCINE, V32, P5271, DOI 10.1016/j.vaccine.2014.07.082
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Chiou SS, 2012, J GEN VIROL, V93, P1185, DOI 10.1099/vir.0.040238-0
   Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Deng WL, 2014, VIRUS RES, V179, P133, DOI 10.1016/j.virusres.2013.10.022
   Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Ershova AS, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1884-5
   Fahimi H, 2014, IRAN J BASIC MED SCI, V17, P836
   Fan YC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004167
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081
   Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10
   Garcia-Machorro J, 2013, HUM VACC IMMUNOTHER, V9, P2326, DOI 10.4161/hv.25673
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Guzman MG, 2010, EXPERT REV VACCINES, V9, P137, DOI 10.1586/ERV.09.139
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Hasan M. M., 2014, INDIAN J PHARM BIOL, V2, P44
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Huerta V, 2008, VIRUS RES, V137, P225, DOI 10.1016/j.virusres.2008.07.022
   Huerta V, 2014, J GEN VIROL, V95, P2668, DOI 10.1099/vir.0.068544-0
   Ji GH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139741
   Junglen S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00375-16, 10.1128/msphere.00375-16]
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kariwa H, 2013, INT J ENV RES PUB HE, V10, P7144, DOI 10.3390/ijerph10127144
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Langosch D, 2007, CELL MOL LIFE SCI, V64, P850, DOI 10.1007/s00018-007-6439-x
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Lee AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178199
   Lee E, 2008, J VIROL, V82, P6024, DOI 10.1128/JVI.02509-07
   Li CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep36288
   Li XQ, 2013, J GEN VIROL, V94, P2191, DOI 10.1099/vir.0.055178-0
   Li XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053026
   Lin Yaying, 2015, Bing Du Xue Bao, V31, P665
   Liu M, 2012, J VIROL, V86, P3398, DOI 10.1128/JVI.07086-11
   Lopez-Denman AJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010014
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Marzinek JK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19160
   Mathengtheng L, 2014, INT J INFECT DIS, V21, P456, DOI 10.1016/j.ijid.2014.03.1361
   Mathengtheng L, 2014, VECTOR-BORNE ZOONOT, V14, P261, DOI 10.1089/vbz.2013.1407
   Matsui K, 2010, J GEN VIROL, V91, P2249, DOI 10.1099/vir.0.021220-0
   McAuley AJ, 2016, J VIROL, V90, P4757, DOI 10.1128/JVI.02861-15
   Melian EB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004447
   Messer WB, 2014, P NATL ACAD SCI USA, V111, P1939, DOI 10.1073/pnas.1317350111
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13
   Peng JG, 2014, J VIROL, V88, P8386, DOI 10.1128/JVI.00937-14
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pripuzova NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061094
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Rockstroh A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004218
   Roehrig JT, 2013, VIROLOGY, V441, P114, DOI 10.1016/j.virol.2013.03.011
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sagripanti J. -L., 2011, USPTO. USA, Patent No. [US7943148 B1, 7943148]
   Sanchez MD, 2005, VIROLOGY, V336, P70, DOI 10.1016/j.virol.2005.02.020
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang CT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136328
   Vlaycheva L, 2005, J GEN VIROL, V86, P413, DOI 10.1099/vir.0.80314-0
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Volk DE, 2009, VIROLOGY, V394, P12, DOI 10.1016/j.virol.2009.09.001
   Watterson D, 2012, J GEN VIROL, V93, P72, DOI 10.1099/vir.0.037317-0
   White MA, 2003, ACTA CRYSTALLOGR D, V59, P1049, DOI 10.1107/S0907444903004475
   Widman DG, 2015, EXPERT REV VACCINES, V14, P5, DOI 10.1586/14760584.2015.961431
   Williams KL, 2012, VIROLOGY, V429, P12, DOI 10.1016/j.virol.2012.03.003
   Wu KP, 2003, J BIOL CHEM, V278, P46007, DOI 10.1074/jbc.M307776200
   Wu SC, 2003, VACCINE, V21, P2516, DOI 10.1016/S0264-410X(03)00042-2
   Yang P, 2009, LETT BIOTECHNOL
   Yin XC, 2013, J CLIN MICROBIOL, V51, P2400, DOI 10.1128/JCM.00361-13
   Yu KX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071319
   Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zhang SL, 2010, VIROLOGY, V403, P85, DOI 10.1016/j.virol.2010.03.038
   Zhu BB, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-132
   Zidane N, 2013, PROTEIN ENG DES SEL, V26, P389, DOI 10.1093/protein/gzt010
NR 108
TC 23
Z9 25
U1 4
U2 15
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2017
VL 9
IS 11
AR 338
DI 10.3390/v9110338
PG 14
WC Virology
SC Virology
GA FO4KB
UT WOS:000416810300028
PM 29137162
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gambhir, S
   Malik, SK
   Kumar, Y
AF Gambhir, Shalini
   Malik, Sanjay Kumar
   Kumar, Yugal
TI PSO-ANN based diagnostic model for the early detection of dengue disease
SO NEW HORIZONS IN TRANSLATIONAL MEDICINE
LA English
DT Article
DE Classification; Neural network; Decision tree; Naive Bayes; CART; PSO
ID FUZZY INFERENCE SYSTEM; EXPERT-SYSTEM; HEART-DISEASE; HYBRID; PREDICTION
AB Large numbers of machine learning approaches have been developed for analysis of medical data in recent years. These approaches have also proved their significance through accurate and earlier diagnosis of diseases. The objective of this work is to develop a diagnostic model for earlier diagnosis of dengue disease. Dengue fever is spread through the bite of the female mosquito (Aedes aegypti). The symptoms of this fever are similar to other fever such as that of Viral influenza, Chikungunya, Zika fever, and so on. However, in this fever, human life can be at risk due to severe depletion of blood platelets. Therefore, early diagnosis of dengue disease can help in protecting human lives by making a preventive move before it turns into an infectious disease. In this work, an effort is made to develop a PSO-ANN based diagnostic model for earlier diagnosis of dengue fever. In the proposed model, PSO technique is applied to optimize the weight and bias parameters of ANN method. Further, PSO optimized ANN approach is used to detect dengue patients. The effectiveness of the proposed model is evaluated based on accuracy, sensitivity, specificity, error rate and AUC parameters. The results of the proposed model have been compared with other existing approaches like ANN, DT, NB, and PSO. It is observed that the proposed diagnostic model is a proficient and powerful model for more accurate and earlier detection of dengue fever.
C1 [Gambhir, Shalini; Malik, Sanjay Kumar] SRM Univ, Dept Comp Sci & Engn, Sonipat, Haryana, India.
   [Kumar, Yugal] JUIT, Dept Comp Sci & Engn, Waknaghat, Himachal Pardes, India.
RP Kumar, Y (corresponding author), JUIT, Dept Comp Sci & Engn, Waknaghat, Himachal Pardes, India.
EM shalinigambhir.21@gmail.com; skmalik9876@gmail.com;
   yugalkumar.14@gmail.com
OI Kumar, Yugal/0000-0003-3451-4897
CR Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x
   Babaoglu I, 2010, EXPERT SYST APPL, V37, P3177, DOI 10.1016/j.eswa.2009.09.064
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bishop CM, 2005, NEURAL NETWORKS PATT
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Calisir D, 2011, EXPERT SYST APPL, V38, P10705, DOI 10.1016/j.eswa.2011.01.014
   Das R, 2009, EXPERT SYST APPL, V36, P7675, DOI 10.1016/j.eswa.2008.09.013
   Giri D, 2013, KNOWL-BASED SYST, V37, P274, DOI 10.1016/j.knosys.2012.08.011
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gupta E, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-92
   Hati A K, 2006, J Commun Dis, V38, P124
   Haykin S., 1998, NEURAL NETWORKS COMP
   Hsu CC, 2004, INFORM SCIENCES, V166, P231, DOI 10.1016/j.ins.2003.11.009
   Karabatak M, 2009, EXPERT SYST APPL, V36, P3465, DOI 10.1016/j.eswa.2008.02.064
   Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/ICNN.1995.488968
   Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137
   Kumar Y, 2013, TECHNOL HEALTH CARE, V21, P417, DOI 10.3233/THC-130742
   Muthukaruppan S, 2012, EXPERT SYST APPL, V39, P11657, DOI 10.1016/j.eswa.2012.04.036
   Nahar J, 2013, EXPERT SYST APPL, V40, P96, DOI 10.1016/j.eswa.2012.07.032
   OrhanEr F., 2010, J MED SYST, V34, P299
   OrhanEr N., 2012, EXP SYST APPL, V39, P1862
   Patil BM, 2010, EXPERT SYST APPL, V37, P8102, DOI 10.1016/j.eswa.2010.05.078
   Ripley B.D., 1996, PATTERN RECOGNITION
   RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0
   Sahoo AJ, 2014, TECHNOL HEALTH CARE, V22, P531, DOI 10.3233/THC-140816
   SCHAFFER C, 1993, MACH LEARN, V13, P135, DOI 10.1007/BF00993106
   Seera M, 2014, EXPERT SYST APPL, V41, P2239, DOI 10.1016/j.eswa.2013.09.022
   Sengur A, 2008, EXPERT SYST APPL, V35, P214, DOI 10.1016/j.eswa.2007.06.012
   Sengur A, 2008, COMPUT BIOL MED, V38, P329, DOI 10.1016/j.compbiomed.2007.11.004
   Ucar T, 2013, NEURAL COMPUT APPL, V23, P471, DOI 10.1007/s00521-012-0942-1
   Ubeyli ED, 2007, EXPERT SYST APPL, V33, P1054, DOI 10.1016/j.eswa.2006.08.005
   Uguz H, 2012, NEURAL COMPUT APPL, V21, P1617, DOI 10.1007/s00521-011-0610-x
   Yadav G., P NAT C COMP COMM SY, P1
   Yan HM, 2006, EXPERT SYST APPL, V30, P272, DOI 10.1016/j.eswa.2005.07.022
   Zheng BC, 2014, EXPERT SYST APPL, V41, P1476, DOI 10.1016/j.eswa.2013.08.044
NR 35
TC 15
Z9 15
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-7536
EI 2307-5023
J9 NEW HORIZ TRANSL MED
JI New Horiz. Transl. Med.
PD NOV
PY 2017
VL 4
IS 1-4
BP 1
EP 8
DI 10.1016/j.nhtm.2017.10.001
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA FN8LP
UT WOS:000416276800001
DA 2020-07-08
ER

PT J
AU Pitts, JD
   Li, PC
   de Wispelaere, M
   Yang, PL
AF Pitts, Jared D.
   Li, Pi-Chun
   de Wispelaere, Melissanne
   Yang, Priscilla L.
TI Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against
   Zika virus
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; fenretinide; N-(4-hydroxyphenyl) retinamide; 4-HPR; dengue
   virus; antiviral
ID SEXUAL TRANSMISSION; RANDOMIZED-TRIAL; ONCOLOGY-GROUP; FENRETINIDE;
   INFECTION; REPLICATION; INHIBITOR; WOMEN; MICE
AB The rapid spread of Zika virus (ZIKV) in recent years has highlighted the severe diseases associated with ZIKV infection, such as Guillain-Barre syndrome in adults and microcephaly in newborns; yet no vaccines or antivirals currently exist to prevent or treat ZIKV infection. We and others have previously identified N-(4-hydroxyphenyl) retinamide (fenretinide or 4-HPR) as an antiviral compound that inhibits dengue virus 2 (DV2) and other flaviviruses by limiting the steady-state accumulation of viral RNA. Here we show that 4-HPR potently inhibits ZIKV in mammalian cell culture and significantly reduces both serum viremia and brain viral burden in a murine model of ZIKV infection. Consistent with previous observations with dengue virus, this antiviral activity is associated with a significant reduction in the steady-state abundance of viral genomic RNA. We show this reduction is due to a major decrease in the rate of viral RNA synthesis, though not via direct inhibition of the activity of the viral replicase. These results establish 4-HPR's mode of action against DV and ZIKV and, taken with previous clinical trials that established 4-HPR's safety and tolerability, illustrate the potential utility of 4-HPR as an agent for treatment of ZIKV infection.
C1 [Pitts, Jared D.; de Wispelaere, Melissanne; Yang, Priscilla L.] Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
   [Li, Pi-Chun] Dana Farber Canc Inst, Dept Canc Biol, 360 Longwood Ave, Boston, MA 02215 USA.
RP Yang, PL (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
EM Priscilla_yang@hms.harvard.edu
RI de Wispelaere, Melissanne/S-3117-2019
OI de Wispelaere, Melissanne/0000-0002-0682-3054; Yang,
   Priscilla/0000-0001-7456-2557
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [3T32AI007245-33S1];  [R01AI095499]; 
   [U19AI109740]
FX We would like to thank Sujan Shresta for supplying breeders for the
   AG129 mice, Dominique Burri for critical reading of the manuscript,
   Didier Musso and Nathalie Pardigon for Zika virus strain PF13-251013-18,
   Congressman Michael Capuano and his staff (MA) for assistance with
   import of Zika virus, and the Medicinal Chemistry Core of the
   Dana-Farber Cancer Institute for assistance with compound acquisition
   and curation. This study was funded by grants from the R01AI095499
   (Yang) and U19AI109740 (Whelan). J.D.P was partially supported by NIH
   3T32AI007245-33S1 (Whelan).
CR Carocci M, 2015, ANTIMICROB AGENTS CH, V59, P85, DOI 10.1128/AAC.04177-14
   Costello DA, 2016, ACS INFECT DIS, V2, P852, DOI 10.1021/acsinfecdis.6b00086
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108
   Dolken L, 2013, METHODS MOL BIOL, V1064, P91, DOI 10.1007/978-1-62703-601-6_6
   Duffy Erin E, 2016, Curr Protoc Chem Biol, V8, P234, DOI 10.1002/cpch.12
   Duffy EE, 2015, MOL CELL, V59, P858, DOI 10.1016/j.molcel.2015.07.023
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Fraser JE, 2016, ANTIVIR RES, V130, P1, DOI 10.1016/j.antiviral.2016.03.006
   Fraser JE, 2014, J INFECT DIS, V210, P1780, DOI 10.1093/infdis/jiu319
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Marmor MF, 2008, DOC OPHTHALMOL, V117, P257, DOI 10.1007/s10633-008-9132-y
   Mata NL, 2013, RETINA-J RET VIT DIS, V33, P498, DOI 10.1097/IAE.0b013e318265801d
   Moore MM, 2010, CANCER CHEMOTH PHARM, V66, P845, DOI 10.1007/s00280-009-1228-x
   Musso D, 2017, CLIN MICROBIOL INFEC
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oliveira Souto I., 2016, ENFERM INFECC MICROB
   Paz-Bailey G, 2017, N ENGL J MED
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Rao RD, 2011, MED ONCOL, V28, pS39, DOI 10.1007/s12032-010-9682-1
   Schneider BJ, 2009, INVEST NEW DRUG, V27, P571, DOI 10.1007/s10637-009-9228-6
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396
   Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91
   Veronesi U, 1999, J NATL CANCER I, V91, P1847, DOI 10.1093/jnci/91.21.1847
   Villablanca JG, 2011, CLIN CANCER RES, V17, P6858, DOI 10.1158/1078-0432.CCR-11-0995
   Vratilova J, 2004, J CHROMATOGR B, V808, P125, DOI 10.1016/j.jchromb.2004.02.031
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
NR 33
TC 10
Z9 10
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD NOV
PY 2017
VL 147
BP 124
EP 130
DI 10.1016/j.antiviral.2017.10.014
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FN9WZ
UT WOS:000416394900015
PM 29051080
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Viranaicken, W
   Nativel, B
   Krejbich-Trotot, P
   Harrabi, W
   Bos, S
   El Kalamouni, C
   Roche, M
   Gadea, G
   Despres, P
AF Viranaicken, Wildriss
   Nativel, Brice
   Krejbich-Trotot, Pascale
   Harrabi, Wissal
   Bos, Sandra
   El Kalamouni, Chaker
   Roche, Marjolaine
   Gadea, Gilles
   Despres, Philippe
TI ClearColi BL21(DE3)-based expression of Zika virus antigens illustrates
   a rapid method of antibody production against emerging pathogens
SO BIOCHIMIE
LA English
DT Article
DE Polyclonal antibody; Recombinant protein; Zika antigens; inclusion
   bodies; Wistar rat
ID CROSS-REACTIVITY; DOMAIN-III; ENVELOPE; INFECTION; CELLS
AB Available rapid, simple and accurate methods for detection and diagnosis of emerging viral diseases are required. Recently, there was an urgent need for specific antibodies against mosquito-borne Zika virus (ZIKV), which is an emerging zoonotic disease of medical concern in different regions of the world. Here, we showed that overexpression of ZIKV antigens in ClearColi BL21(DE3), a bacteria strain expressing a non-endotoxic form of LPS, is suitable for the production of specific ZIKV antisera. Two major ZIKV antigenic domains, the domain III from envelope E glycoprotein, which brings the virus-specific epitopes, and the N-terminal region of nonstructural NS1 glycoprotein, which is responsible for pathophysiological conditions, were overexpressed in ClearColi BL21(DE3). Immunization of adult rat with insoluble recombinant ZIKV antigens in inclusion bodies resulted in the production of specific antibodies in a few weeks. Anti-E and anti-NS1 antibodies are efficient as biological tools for ZIKV detection by indirect ELISA and immunoblot assay. This method could successfully be applied to any emerging viruses. (C) 2017 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.
C1 [Viranaicken, Wildriss; Krejbich-Trotot, Pascale; Harrabi, Wissal; Bos, Sandra; El Kalamouni, Chaker; Roche, Marjolaine; Gadea, Gilles; Despres, Philippe] Univ La Reunion, CNRS 9192, INSERM, UMR 1187,PIMIT,IRD 249,Plateforme CYROI, 2 Rue Maxime Riviere, F-97490 St Clotilde, Reunion, France.
   [Nativel, Brice] Univ La Reunion, INSERM, UMR 1188,Plateform CYROL, DeTROI Diabete Atherothrombose Therap Reun Ocean, 2 Rue Maxime Riviere, F-97490 St Clotilde, Reunion, France.
RP Viranaicken, W (corresponding author), Univ La Reunion, CNRS 9192, INSERM, UMR 1187,PIMIT,IRD 249,Plateforme CYROI, 2 Rue Maxime Riviere, F-97490 St Clotilde, Reunion, France.
EM wildriss.viranaicken@univ-reunion.fr
RI Gilles, Gadea/M-9966-2015
OI Gilles, Gadea/0000-0001-6325-4866; El Kalamouni,
   Chaker/0000-0003-4673-6614; NATIVEL, Brice/0000-0003-3719-7903; BOS,
   Sandra/0000-0001-5036-0336; Krejbich Trotot, Pascale/0000-0001-7329-1716
FU Federation BioST from Reunion Island University; Inserm Transfert
   (ZIKAVAX) from CVT Aviesan/DVS Innovation [151567A10-ZIKAVax];
   ZIKAlliance project (European Union-Horizon 2020 programme) [735548];
   Regional Council of Reunion Island [DIRED 20131515]
FX We thank the members of PIMIT and DeTROI laboratories for helpful
   discussions and CYROI Animal facility for immunization experiments. This
   work was supported by Federation BioST from Reunion Island University,
   Inserm Transfert (ZIKAVAX) (151567A10-ZIKAVax) from CVT Aviesan/DVS
   Innovation and the ZIKAlliance project (European Union-Horizon 2020
   programme under grant agreement no735548). BN holds a fellowship (DIRED
   20131515) from the Regional Council of Reunion Island.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Fahimi H, 2014, IRAN J BASIC MED SCI, V17, P836
   Fink MP, 2014, VIRULENCE, V5, P143, DOI 10.4161/viru.26083
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Hua RH, 2014, VIRUS RES, V185, P103, DOI 10.1016/j.virusres.2014.03.001
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Lin C.-F., 1950, J IMMUNOL BALT MD, V2002, P657
   Lin CW, 2003, J VIROL, V77, P2600, DOI 10.1128/JVI.77.4.2600-2606.2003
   MASON PW, 1990, J GEN VIROL, V71, P2107, DOI 10.1099/0022-1317-71-9-2107
   Planesse C, 2015, CYTOKINE, V73, P190, DOI 10.1016/j.cyto.2015.01.028
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Sandee D, 2005, BIOTECHNOL BIOENG, V91, P418, DOI 10.1002/bit.20524
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
NR 18
TC 7
Z9 7
U1 0
U2 9
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD NOV
PY 2017
VL 142
BP 179
EP 182
DI 10.1016/j.biochi.2017.09.011
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FN1VY
UT WOS:000415780500018
PM 28942054
DA 2020-07-08
ER

PT J
AU Friedman, JM
AF Friedman, Jan M.
TI Editorial In Bed with The Devil: Recognizing Human Teratogenic Exposures
SO BIRTH DEFECTS RESEARCH
LA English
DT Editorial Material
ID ZIKA VIRUS-INFECTION; PREGNANT-WOMEN; BIRTH-DEFECTS; COMPUTATIONAL
   TOXICOLOGY; DEVELOPMENTAL TOXICITY; MULTIPLE COMPARISONS; BRADFORD HILL;
   MEDICATIONS; HEALTH; EPIDEMIOLOGY
C1 [Friedman, Jan M.] Univ British Columbia, Dept Med Genet & Genom, Vancouver, BC V6H 3N1, Canada.
RP Friedman, JM (corresponding author), Univ British Columbia, Dept Med Genet & Genom, Vancouver, BC V6H 3N1, Canada.
EM jan.friedman@ubc.ca
OI Friedman, Jan/0000-0002-7482-9570
CR Adam MP, 2011, AM J MED GENET C, V157C, P175, DOI 10.1002/ajmg.c.30313
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Augustine-Rauch K, 2011, NEW HORIZONS PREDICT, P464
   Baud D, 2017, LANCET
   Beekhuijzen Manon, 2017, Reprod Toxicol, V72, P86, DOI 10.1016/j.reprotox.2017.05.006
   Brent RL, 2004, PEDIATRICS, V113, P984
   Buschmann J, 2006, REPROD TOXICOL, V22, P157, DOI 10.1016/j.reprotox.2006.03.012
   Carmichael SL, 2003, PAEDIATR PERINAT EP, V17, P264, DOI 10.1046/j.1365-3016.2003.00498.x
   Cassina M, 2012, ARTHRITIS RHEUM-US, V64, P2085, DOI 10.1002/art.34419
   Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402
   Chambers CD, 2016, VACCINE, V34, P4443, DOI 10.1016/j.vaccine.2016.06.054
   CLARREN SK, 1978, NEW ENGL J MED, V298, P1063, DOI 10.1056/NEJM197805112981906
   Daston GP, 2011, AM J MED GENET C, V157C, P183, DOI 10.1002/ajmg.c.30312
   DeSesso John M., 2017, Current Opinion in Toxicology, V3, P1, DOI 10.1016/j.cotox.2017.04.001
   Ekins S, 2014, J PHARMACOL TOX MET, V69, P115, DOI 10.1016/j.vascn.2013.12.003
   Fedak KM, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0037-4
   Feldkamp ML, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2249
   Goodman SN, 1998, AM J EPIDEMIOL, V147, P807, DOI 10.1093/oxfordjournals.aje.a009531
   Gregg NM, 1941, T OPHTHALMOL SOC AUS, V3, P35
   He JH, 2014, NEUROTOXICOL TERATOL, V42, P35, DOI 10.1016/j.ntt.2014.01.006
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Howick J, 2009, J ROY SOC MED, V102, P186, DOI 10.1258/jrsm.2009.090020
   Ioannidis JPA, 2016, STAT MED, V35, P1749, DOI 10.1002/sim.6825
   Jones KL, 2011, AM J MED GENET C, V157C, P188, DOI 10.1002/ajmg.c.30311
   JONES KL, 1973, LANCET, V1, P1267
   Kim E, 2010, J POPUL THER CLIN PH, V17, pE272
   Koren G, 2011, J POPUL THER CLIN PH, V18, pE28
   Kucik JE, 2012, PUBLIC HEALTH REP, V127, P52, DOI 10.1177/003335491212700106
   LANDE L, 1950, J PEDIATR-US, V36, P625, DOI 10.1016/S0022-3476(50)80131-2
   LENZ W, 1962, ARCH ENVIRON HEALTH, V5, P100
   Lim JM, 2009, AUST NZ J OBSTET GYN, V49, P168, DOI 10.1111/j.1479-828X.2009.00976.x
   Lo WY, 2002, OBSTET GYNECOL, V100, P465, DOI 10.1016/S0029-7844(02)02122-1
   Mangiatordi GF, 2016, MOL INFORM, V35, P294, DOI 10.1002/minf.201501017
   McCloskey B, 2017, PUBLIC HEALTH, V150, P87, DOI 10.1016/j.puhe.2017.05.008
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Merfeld E, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.273
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oussayef NL, 2017, MMWR-MORBID MORTAL W, V65, P1482, DOI 10.15585/mmwr.mm6552e1
   Palmsten K, 2015, OBSTET GYNECOL, V126, P465, DOI 10.1097/AOG.0000000000000982
   Phillips CV, 2004, EPIDEMIOL PERSPECT I, V1, P3, DOI DOI 10.1186/1742-5573-1-3
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robinson Joshua F, 2013, Methods Mol Biol, V947, P451, DOI 10.1007/978-1-62703-131-8_31
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Scott CW, 2013, TOXICOL LETT, V219, P49, DOI 10.1016/j.toxlet.2013.02.020
   Shepard TH, 2010, CATALOG TERATOGENIC
   Singh MV, 2017, J NEUROVIROL, V23, P347, DOI 10.1007/s13365-017-0513-4
   Smolina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128312
   SPEIRS AL, 1962, LANCET, V1, P303
   Stadelmaier R, 2017, BIRTH DEFECTS RES, V109, P1134, DOI 10.1002/bdr2.1052
   Thompson JR, 1998, AM J EPIDEMIOL, V147, P801, DOI 10.1093/oxfordjournals.aje.a009530
   Toropov AA, 2014, COMPUT BIOL MED, V45, P20, DOI 10.1016/j.compbiomed.2013.11.013
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   VansNaarden Braun K, 2015, PLOS ONE, V10
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Wise LD, 2009, BIRTH DEFECTS RES B, V86, P418, DOI 10.1002/bdrb.20214
   Yang J, 2008, AM J EPIDEMIOL, V167, P145, DOI 10.1093/aje/kwm283
   Zablotsky Benjamin, 2015, Natl Health Stat Report, P1
   Zhou K, 2017, J NEUROVIROL, V23, P341, DOI 10.1007/s13365-017-0514-3
NR 60
TC 1
Z9 2
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD NOV 1
PY 2017
VL 109
IS 18
SI SI
BP 1407
EP 1413
DI 10.1002/bdr2.1134
PG 7
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA FN3AS
UT WOS:000415868500002
PM 29152923
OA Bronze
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI New Test Distinguishes Zika from Dengue
SO CHEMICAL ENGINEERING PROGRESS
LA English
DT Editorial Material
CR Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
NR 1
TC 0
Z9 0
U1 0
U2 0
PU AMER INST CHEMICAL ENGINEERS
PI NEW YORK
PA 3 PARK AVE, NEW YORK, NY 10016-5901 USA
SN 0360-7275
EI 1945-0710
J9 CHEM ENG PROG
JI Chem. Eng. Prog.
PD NOV
PY 2017
VL 113
IS 11
BP 4
EP 4
PG 1
WC Engineering, Chemical
SC Engineering
GA FN1XR
UT WOS:000415785000002
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, B.
   Wiwanitkit, V.
TI Inherited bleeding disorders and Zika virus infection
SO HAEMOPHILIA
LA English
DT Letter
C1 [Joob, B.] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, V.] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Medina SS, 2017, HAEMOPHILIA, V23, P177, DOI 10.1111/hae.13177
   Wijayaratne Dilushi, 2015, BMC Res Notes, V8, P78, DOI 10.1186/s13104-015-1043-x
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Yasri S, 2016, ANN TROP MED PUBLIC, V9, DOI 10.4103/1755-6783.193963
NR 4
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-8216
EI 1365-2516
J9 HAEMOPHILIA
JI Haemophilia
PD NOV
PY 2017
VL 23
IS 6
BP E514
EP E515
DI 10.1111/hae.13315
PG 2
WC Hematology
SC Hematology
GA FN0ZH
UT WOS:000415711500006
PM 28780769
DA 2020-07-08
ER

PT J
AU Li, Y
   Zhang, ZZ
   Phoo, WW
   Loh, YR
   Wang, WL
   Hung, AW
   Keller, TH
   Luo, DH
   Kang, CB
AF Li, Yan
   Zhang, Zhenzhen
   Phoo, Wint Wint
   Loh, Ying Ru
   Wang, Weiling
   Hung, Alvin W.
   Keller, Thomas H.
   Luo, Dahai
   Kang, CongBao
TI Structural insight into peptidic inhibitors of Zika virus NS2B-NS3
   protease
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Meeting Abstract
CT 30th International Congress of Chemotherapy and Infection (ICC)
CY NOV 24-27, 2017
CL Taipei, TAIWAN
C1 [Li, Yan; Loh, Ying Ru; Wang, Weiling; Hung, Alvin W.; Keller, Thomas H.; Kang, CongBao] ASTAR, Ctr Expt Therapeut, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.
   [Zhang, Zhenzhen; Phoo, Wint Wint; Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
EI 1872-7913
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD NOV
PY 2017
VL 50
SU 2
MA OS 3-7
BP S37
EP S37
PG 1
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA FN5EH
UT WOS:000416028900077
DA 2020-07-08
ER

PT J
AU Garcia-Bujalance, S
   Gutierrez-Arroyo, A
   De la Calle, F
   Diaz-Menendez, M
   Arribas, JR
   Garcia-Rodriguez, J
   Arsuaga, M
AF Garcia-Bujalance, S.
   Gutierrez-Arroyo, A.
   De la Calle, F.
   Diaz-Menendez, M.
   Arribas, Jose R.
   Garcia-Rodriguez, J.
   Arsuaga, M.
TI Persistence and infectivity of Zika virus in semen after returning from
   endemic areas: Report of 5 cases
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika virus; Semen samples; Arbovirus; Sexual transmission; Phylogenetic
   analysis; Zika virus persistence
ID SEXUAL TRANSMISSION; EPIDEMIC AREA; APRIL 2016; DISEASE; STATES; RNA
AB Background: There are limited data about the persistence and infectivity of Zika virus in semen of symptomatic travelers returning from endemic areas and even less data in asymptomatic cases.
   Objective: We investigated the persistence and infectivity of ZIKA virus in semen in five patients with Zika virus infection returning to Spain from endemic areas.
   Study design: We evaluated the epidemiological, clinical and virological characteristic of the five patients. In semen we detected ZIKA virus by PCR, partial sequencing and cell culture. We also performed phylogenetic analysis.
   Results: We detected Zika virus RNA (Asian lineage) by PCR in semen samples from day 14th to day 96th since the day of illness onset. Semen viral culture was positive for Zika virus in two patients at days of illness 30 and 69 by virus propagation. Phylogenetic analysis strongly suggested male to female sexual transmission in a couple returning from Maldives.
   Conclusion: This case series confirms that Zika virus RNA can be detected in semen up to three months after infection. Viral culture of semen samples shows prolonged infectivity that can lead to sexual transmission of Zika virus.
C1 [Garcia-Bujalance, S.; Gutierrez-Arroyo, A.; Garcia-Rodriguez, J.] Hosp Univ La Paz H, Dept Microbiol & Parasitol, IdiPAZ, Carlos 3, Madrid, Spain.
   [De la Calle, F.; Diaz-Menendez, M.; Arribas, Jose R.; Arsuaga, M.] Hosp Univ La Paz H, Dept Internal Med, IdiPAZ, Infect Dis Unit,Carlos 3, Madrid, Spain.
RP Garcia-Bujalance, S (corresponding author), Hosp Univ La Paz H, Dept Microbiol & Parasitol, IdiPAZ, Carlos 3, Madrid, Spain.
EM sgbujalance@salud.madrid.org
OI Gutierrez-Arroyo, Almudena/0000-0001-6815-2623
FU Red de Investigation Cooperativa en Enfermedades Tropicales (RICET)
   [RD12/0018/0023]
FX We received financial support from Red de Investigation Cooperativa en
   Enfermedades Tropicales (RICET, RD12/0018/0023).
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   BARZON L, 2016, EUROSURVEILLANCE, V21, P2
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 26
TC 17
Z9 17
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD NOV
PY 2017
VL 96
BP 110
EP 115
DI 10.1016/j.jcv.2017.10.006
PG 6
WC Virology
SC Virology
GA FN3UV
UT WOS:000415927400022
PM 29053990
DA 2020-07-08
ER

PT J
AU Oliveira, ERA
   de Alencastro, RB
   Horta, BAC
AF Oliveira, Edson R. A.
   de Alencastro, Ricardo B.
   Horta, Bruno A. C.
TI New insights into flavivirus biology: the influence of pH over
   interactions between prM and E proteins
SO JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
LA English
DT Article
DE Flavivirus; Pre-membrane; Envelope; Maturation; Molecular dynamics;
   Molecular modeling
ID TICK-BORNE ENCEPHALITIS; MOLECULAR-DYNAMICS SIMULATIONS; VIRUS ENVELOPE
   PROTEIN; MEMBRANE-FUSION; DENGUE VIRUS; HISTIDINE-RESIDUES; PREMEMBRANE
   PROTEIN; CRYSTAL-STRUCTURE; MATURATION; DIMERIZATION
AB Diseases caused by flaviviruses, such as dengue and zika, are globally recognized as major threats. During infection, a critical point in their replicative cycle is the maturation step, which occurs throughout the cellular exocytic pathway. This step is a pH-dependent process that involves the modification of the viral envelope by converting prM (pre-membrane) into M (membrane) proteins with the release of a "pr peptide". After this reaction, the pr peptides remain bound to the viral envelope while the virions cross the acidic trans-Golgi network, and are released only at neutral pH after secretion of the virus particles. Despite this current knowledge, the molecular basis of the flavivirus maturation step is largely unknown. Here, based on the crystal structure of the dengue pr-E complex ("pr peptide" bound to virus envelope protein) and using molecular dynamics simulations, we found that the pH shift from acidic to neutral yields considerable structural changes in the system. Dynamic cross correlation maps and root mean square deviation analyses revealed that the pr-E junction is clearly unstable under neutral pH. Secondary structure analysis also revealed that the fusion loop region, present in the E protein, is sensitive to pH and tends to unstructure at a neutral environment. Moreover, we found that five residues present in the E protein, Gly(102), His(244), Thr(70), Thr(68) and Asn(67) are critical to confer stability to the pr-E complex while inside the Golgi apparatus. This work brings details about the dynamical behavior of the pr-E system, helps to better understand the flavivirus biology and may also be of use in the development of novel antiviral strategies.
C1 [Oliveira, Edson R. A.; de Alencastro, Ricardo B.; Horta, Bruno A. C.] Univ Fed Rio de Janeiro, Inst Quim, Av Athos da Silveira Ramos,149 Ctr Tecnol,Bloco A, BR-21941909 Rio De Janeiro, RJ, Brazil.
RP Horta, BAC (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Av Athos da Silveira Ramos,149 Ctr Tecnol,Bloco A, BR-21941909 Rio De Janeiro, RJ, Brazil.
EM bruno@iq.ufrj.br
RI Horta, Bruno AC/L-5079-2013
OI Horta, Bruno AC/0000-0002-3952-1474; Oliveira, Edson
   RA/0000-0002-8606-7454
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/203.198/2016,
   E-26/010.002420/2016, E-26/201.258/2015]
FX This work was developed with the assistance of Nucleo Avancado de
   Computacao de Alto Desempenho (NACAD) localized at Instituto Alberto
   Luiz Coimbra de Pos-Graduacao e Pesquisa de Engenharia (COPPE),
   Universidade Federal do Rio de Janeiro (UFRJ). Edson Oliveira thanks
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for
   his post-doctoral fellowship. We also acknowledge the Brazilian
   foundations Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do Rio
   de Janeiro (FAPERJ) (Grant Numbers: E-26/203.198/2016,
   E-26/010.002420/2016, E-26/201.258/2015) for the financial support.
CR [Anonymous], PYMOL MOL GRAPH SYST
   Berendsen H.J., 1981, INTERMOLECULAR FORCE, P331, DOI DOI 10.1007/978-94-015-7658-1_21
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Carneiro FA, 2003, J BIOL CHEM, V278, P13789, DOI 10.1074/jbc.M210615200
   Horta BAC, 2008, J MOL GRAPH MODEL, V26, P1091, DOI 10.1016/j.jmgm.2007.10.001
   Degreve L, 2013, GENET MOL RES, V12, P348, DOI 10.4238/2013.February.7.5
   Degreve L, 2012, J COMPUT AID MOL DES, V26, P1311, DOI 10.1007/s10822-012-9616-4
   Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381
   Dubey KD, 2013, BBA-PROTEINS PROTEOM, V1834, P53, DOI 10.1016/j.bbapap.2012.08.014
   Dubey KD, 2011, BBA-PROTEINS PROTEOM, V1814, P1796, DOI 10.1016/j.bbapap.2011.09.012
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081
   Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10
   Fuzo CA, 2014, J BIOMOL STRUCT DYN, V32, P1563, DOI 10.1080/07391102.2013.827132
   Harrison SC, 2005, ADV VIRUS RES, V64, P231, DOI 10.1016/S0065-3527(05)64007-9
   Harrison SC, 2008, J CELL BIOL, V183, P177, DOI 10.1083/jcb.200809175
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Hockney R. W., 1970, Methods in computational physics. IX. Plasma physics, P135
   Horta BAC, 2007, PROTEINS, V67, P517, DOI 10.1002/prot.21306
   Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484
   Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12
   KONISHI E, 1993, J VIROL, V67, P1672, DOI 10.1128/JVI.67.3.1672-1675.1993
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   Luca VC, 2013, J VIROL, V87, P818, DOI 10.1128/JVI.01950-12
   Marzinek JK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19160
   Mendes YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047596
   Mueller DS, 2008, BIOCHEM SOC T, V36, P43, DOI 10.1042/BST0360043
   Oliveira ERA, 2016, EUR BIOPHYS J BIOPHY, V45, P573, DOI 10.1007/s00249-016-1147-9
   Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z
   Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003
   PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196
   Qin ZL, 2009, J VIROL, V83, P4670, DOI 10.1128/JVI.02646-08
   Rogers DM, 2015, BBA-BIOMEMBRANES, V1848, P1041, DOI 10.1016/j.bbamem.2014.12.018
   Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9
   Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035
   Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028
   Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401
   Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang Q, 2012, J BIOL CHEM, V287, P40525, DOI 10.1074/jbc.M112.384446
   Zheng AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4877
NR 53
TC 5
Z9 5
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-654X
EI 1573-4951
J9 J COMPUT AID MOL DES
JI J. Comput.-Aided Mol. Des.
PD NOV
PY 2017
VL 31
IS 11
BP 1009
EP 1019
DI 10.1007/s10822-017-0076-8
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Computer Science,
   Interdisciplinary Applications
SC Biochemistry & Molecular Biology; Biophysics; Computer Science
GA FN2OU
UT WOS:000415834000005
PM 29064083
DA 2020-07-08
ER

PT J
AU Shiao, M
   Bierle, C
   Chrostek, M
   Crane, A
   Danczyk, G
   Miller, Z
   Pearce, C
   Schaible, K
   Schleiss, M
   Sipe, C
   Straub, E
   Toman, N
   Vaid, S
   Voth, J
   Low, W
AF Shiao, Maple
   Bierle, Craig
   Chrostek, Matthew
   Crane, Andrew
   Danczyk, Georgette
   Miller, Zach
   Pearce, Clairice
   Schaible, Kyle
   Schleiss, Mark
   Sipe, Christopher
   Straub, Elizabeth
   Toman, Nikolas
   Vaid, Shivanshi
   Voth, Joseph
   Low, Walter
TI ZIKA VIRUS TARGETING OF MALIGNANT HUMAN AND MURINE BRAIN TUMORS
SO NEURO-ONCOLOGY
LA English
DT Meeting Abstract
CT Joint Conference of 22nd Annual Scientific Meeting and Education Day of
   the Society-for-Neuro-Oncology / Conference of the
   Society-for-CNS-Interstitial-Delivery-of-the-Therapeutics (SCIDOT) on
   Therapeutic Delivery to the CNS
CY NOV 15-19, 2017
CL San Francisco, CA
SP Soc Neuro Oncol, Soc CNS Interstitial Delivery Therapeut
C1 [Shiao, Maple; Bierle, Craig; Chrostek, Matthew; Crane, Andrew; Danczyk, Georgette; Miller, Zach; Pearce, Clairice; Schaible, Kyle; Schleiss, Mark; Sipe, Christopher; Straub, Elizabeth; Toman, Nikolas; Vaid, Shivanshi; Voth, Joseph; Low, Walter] Univ Minnesota, Minneapolis, MN USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1522-8517
EI 1523-5866
J9 NEURO-ONCOLOGY
JI Neuro-Oncology
PD NOV
PY 2017
VL 19
SU 6
MA EXTH-01
BP 73
EP 73
PG 1
WC Oncology; Clinical Neurology
SC Oncology; Neurosciences & Neurology
GA FM6HY
UT WOS:000415152501114
DA 2020-07-08
ER

PT J
AU Cosme-Blanco, W
   Arroyo-Flores, E
   Nazario, S
AF Cosme-Blanco, Wilfredo
   Arroyo-Flores, Erving
   Nazario, Sylvette
TI Zika virus infection as a trigger of atopic dermatitis
SO ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
LA English
DT Letter
C1 [Cosme-Blanco, Wilfredo; Arroyo-Flores, Erving; Nazario, Sylvette] Univ Puerto Rico, Dept Allergy & Immunol, Med Sci Campus, San Juan, PR 00936 USA.
RP Cosme-Blanco, W (corresponding author), Univ Puerto Rico, Dept Allergy & Immunol, Med Sci Campus, San Juan, PR 00936 USA.
EM w.cosme@gmail.com
CR Boguniewicz M, 2014, MIDDLETONS ALLERGY P, P540
   DaVeiga SP, 2012, ALLERGY ASTHMA PROC, V33, P227, DOI 10.2500/aap.2012.33.3569
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Nawas ZY, 2016, J AM ACAD DERMATOL, V75, P1, DOI 10.1016/j.jaad.2016.04.033
NR 5
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1081-1206
EI 1534-4436
J9 ANN ALLERG ASTHMA IM
JI Ann. Allergy Asthma Immunol.
PD NOV
PY 2017
VL 119
IS 5
BP 459
EP 460
DI 10.1016/j.anai.2017.07.007
PG 2
WC Allergy; Immunology
SC Allergy; Immunology
GA FN0PW
UT WOS:000415681600021
PM 28778659
DA 2020-07-08
ER

PT J
AU Tolosa, N
   Tinker, SC
   Pacheco, O
   Valencia, D
   Botero, DS
   Tong, VT
   Mercado, M
   Gilboa, SM
   Gonzalez, M
   Nelson, CA
   Pardo, L
   Rao, CY
   Rico, A
   Moore, M
   Parra, E
   Honein, MA
   Martinez, MLO
AF Tolosa, Natalia
   Tinker, Sarah C.
   Pacheco, Oscar
   Valencia, Diana
   Salas Botero, Daniela
   Tong, Van T.
   Mercado, Marcela
   Gilboa, Suzanne M.
   Gonzalez, Maritza
   Nelson, Christina A.
   Pardo, Lissethe
   Rao, Carol Y.
   Rico, Angelica
   Moore, Meredith
   Parra, Edgar
   Honein, Margaret A.
   Ospina Martinez, Martha L.
TI Zika Virus Disease in Children in Colombia, August 2015 to May 2016
SO PAEDIATRIC AND PERINATAL EPIDEMIOLOGY
LA English
DT Article
DE Zika virus; children; Colombia; epidemiology
ID GUILLAIN-BARRE-SYNDROME; INFECTION
AB BackgroundChildren are considered a potentially vulnerable population for Zika virus infection. However, data on paediatric Zika virus infection are sparse.
   MethodsWe analysed data from Colombia's national surveillance system during the 2015-2016 Zika virus outbreak on patients meeting the clinical case definition of Zika virus disease (ZVD) among children aged 1month to 18years to estimate incidence by demographic characteristics and characterize the occurrence of selected complications.
   ResultsBetween August 14, 2015, and May 28, 2016, there were 18576 reported cases of postnatal ZVD among children aged 1month to 18years. Laboratory testing was prioritized for high-risk patients (infants, pregnant women, adults aged 65years, and persons with serious co-morbidities); among 1655 that were tested by real-time reverse transcriptase polymerase chain reaction, 1207 (72.9%) were positive. The cumulative incidence of reported ZVD was 114.4 per 100000. The incidence differed by sex, depending on age group; the largest difference was observed for 15-18year olds, with females having a higher incidence than males (cumulative incidence ratio 2.5, 95% confidence interval 2.3, 2.7). At the time of report to the surveillance system, 631 patients (3.4%) were hospitalised and 96 (0.5%) had a report of an accompanying neurological diagnosis, including Guillain-Barre syndrome in 40 patients.
   ConclusionsOnly a small proportion of reported paediatric ZVD cases in Colombia were hospitalized or had reported neurological conditions following ZVD. However, the potential for some serious outcomes demonstrates the importance of preventing Zika virus infection in children.
C1 [Tolosa, Natalia; Pacheco, Oscar; Salas Botero, Daniela; Mercado, Marcela; Gonzalez, Maritza; Pardo, Lissethe; Rico, Angelica; Parra, Edgar; Ospina Martinez, Martha L.] Inst Nacl Salud, Bogota, Colombia.
   [Tinker, Sarah C.; Valencia, Diana; Tong, Van T.; Gilboa, Suzanne M.; Nelson, Christina A.; Rao, Carol Y.; Moore, Meredith; Honein, Margaret A.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
RP Tinker, SC (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
EM zzu9@cdc.gov
OI Tong, Van/0000-0002-3970-1440; Pacheco Garcia, Oscar
   Eduardo/0000-0001-5939-6407; Rao, Carol/0000-0001-7187-2189
CR ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Brazil Ministry of Health, 2015, PROT VIG RESP OC MIC
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2017, AR WITH ZIK
   Cheng Q, 2002, J NEUROL, V249, P25, DOI 10.1007/PL00007844
   Cheng Q, 2000, EUR J NEUROL, V7, P11, DOI 10.1046/j.1468-1331.2000.00006.x
   Council of State and Territorial Epidemiologists, 2016, 16ID01 COUNC STAT TE
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Instituto Nacional de Salud, 2016, B EP SEM SEM EP 15 2
   Instituto Nacional de Salud, 2016, B EP SEM EP 21 2016
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Morris AMS, 2003, J PAEDIATR CHILD H, V39, P22, DOI 10.1046/j.1440-1754.2003.00065.x
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pacheco O, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJM0A1604037]
   Pan American Health Organization, 2017, COUNTR TERR AUT TRAN
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ryan MM, 2005, J PAEDIATR CHILD H, V41, P237, DOI 10.1111/j.1440-1754.2005.00602.x
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Solomon IH, 2016, J NEUROINFECTIOUS DI, V7
   Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4
NR 28
TC 13
Z9 15
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-5022
EI 1365-3016
J9 PAEDIATR PERINAT EP
JI Paediatr. Perinat. Epidemiol.
PD NOV
PY 2017
VL 31
IS 6
BP 537
EP 545
DI 10.1111/ppe.12391
PG 9
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
GA FM8WG
UT WOS:000415371900008
PM 28806479
OA Bronze
DA 2020-07-08
ER

PT J
AU Harville, EW
AF Harville, Emily W.
TI Paediatric Zika - Beyond Pregnant Women
SO PAEDIATRIC AND PERINATAL EPIDEMIOLOGY
LA English
DT Editorial Material
ID VIRUS
C1 [Harville, Emily W.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.
RP Harville, EW (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.
EM eharvill@tulane.edu
OI Harville, Emily/0000-0003-0319-0922
CR Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Harville EW, 2016, PAEDIATR PERINAT EP, V30, P531, DOI 10.1111/ppe.12312
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   RITZ N, 2015, THE PEDIATRIC INFECT, V34, P789
   RIZZO C, 2011, THE PEDIATRIC INFECT, V30, P65, DOI DOI 10.1097/INF.0B013E31820591DC
   Tolosa N, 2017, PAEDIATR PERINAT EP, V31, P537, DOI 10.1111/ppe.12391
   Verhagen LM, 2014, J INFECTION, V69, pS77, DOI 10.1016/j.jinf.2014.07.020
NR 10
TC 0
Z9 0
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-5022
EI 1365-3016
J9 PAEDIATR PERINAT EP
JI Paediatr. Perinat. Epidemiol.
PD NOV
PY 2017
VL 31
IS 6
BP 546
EP 548
DI 10.1111/ppe.12393
PG 3
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
GA FM8WG
UT WOS:000415371900009
PM 28806481
DA 2020-07-08
ER

PT J
AU Wen, JS
   Shresta, S
AF Wen, Jinsheng
   Shresta, Sujan
TI T Cell Immunity to Zika and Dengue Viral Infections
SO JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
LA English
DT Review
DE Zika; dengue; mouse models; T cell immunity
ID VIRUS-INFECTION; PROTECTIVE ROLE; MOUSE MODEL; CYTOKINE PRODUCTION;
   RESPONSES; SEROTYPE; ENHANCEMENT; FEVER
AB The 2015-2016 Zika virus (ZIKV) outbreak in the Americas has brought this relatively unknown flavivirus into the spotlight as the etiologic agent of congenital Zika syndrome in newborns and, potentially, of Guillain-Barre syndrome in adults. ZIKV shares a high degree of amino acid sequence homology with the closely related flavivirus Dengue virus (DENV). Due to the paucity of research investigating T cell-mediated immune responses to ZIKV, the precise roles of T cells in protection against and pathogenesis of ZIKV infection are unclear. Nevertheless, knowledge gained from studies of T cell responses to other flaviviruses, such as the four DENV serotypes, provides a framework for investigating and understanding anti-ZIKV T cell responses. In this review, we summarize our current understanding of how T cells respond to primary and secondary infections with DENV and ZIKV. A thorough understanding of the role of ZIKV-specific and DENV cross-reactive T cells in controlling infection is essential for developing ZIKV- and DENV-specific vaccines with maximal safety and efficacy.
C1 [Wen, Jinsheng; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Wen, Jinsheng; Shresta, Sujan] Wenzhou Med Univ, Inst Arboviruses, Sch Basic Med Sci, Wenzhou, Peoples R China.
RP Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
EM sujan@lji.org
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [RO1 AI116813, R21 NS100477, R21
   AI127988]; La Jolla Institute for Allergy Immunology
FX This article was supported by NIH grants (RO1 AI116813, R21 NS100477,
   and R21 AI127988) and La Jolla Institute for Allergy & Immunology
   institutional support.
CR Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blitvich BJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060154
   de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gagnon SJ, 1999, J VIROL, V73, P3623, DOI 10.1128/JVI.73.5.3623-3629.1999
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   KURANE I, 1989, J EXP MED, V170, P763, DOI 10.1084/jem.170.3.763
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mathew A, 1996, J CLIN INVEST, V98, P1684, DOI 10.1172/JCI118964
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Simon-Loriere E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5088
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124
NR 40
TC 4
Z9 5
U1 2
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1079-9907
EI 1557-7465
J9 J INTERF CYTOK RES
JI J. Interferon Cytokine Res.
PD NOV
PY 2017
VL 37
IS 11
BP 475
EP 479
DI 10.1089/jir.2017.0106
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA FM6CB
UT WOS:000415133300001
PM 29135369
OA Green Published
DA 2020-07-08
ER

PT J
AU Bagasra, O
   Addanki, KC
   Goodwin, GR
   Hughes, BW
   Pandey, P
   McLean, E
AF Bagasra, Omar
   Addanki, Krishna C.
   Goodwin, Gregory R.
   Hughes, Brandon W.
   Pandey, Pratima
   McLean, Ewen
TI Cellular Targets and Receptor of Sexual Transmission of Zika Virus
SO APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
LA English
DT Article
DE blood-Sertoli barrier; spermatocytes; spermatogenesis; spermatogonia;
   spermatozoa; sperm mid-piece; Zika virus; swim-up method; Tyro3
ID INFECTION; FAMILY; SEMEN; EBOLA; TYRO3; DNA
AB Study Question:What is the mechanism of sexual transmission of Zika virus (ZIKV)?Summary Answer:By utilizing exquisite reverse transcriptase-initiated in situ polymerase chain reaction (RT-in situ PCR), which enables an improved visualization of spermatozoa's subcellular compartment, we precisely localized the mid-piece of sperm that carry receptors for ZIKV.What is Already Known:ZIKV is transmitted sexually and recent studies have verified ZIKV presence in semen of previously Zika-infected patients for >6-month postinfection when ZIKV had disappeared from blood, saliva, and urine. Strong serial analyses of various body fluids suggest that ZIKV can be transmitted between sexual partners. Currently, there is limited information on the association of the virus with human semen cell types that may carry the virus.Study Design, Size, Duration:Analyses were carried out to localize ZIKV for subcellular localization of ZIKV on cell types. The Tyro3 receptor for ZIKV was colocalized by dual immunocytochemistry with specific monoclonal antibodies.Participants/Materials, Setting, Methods:Three semen specimens were purchased from a commercial sperm bank. Motile sperm was separated from nonmotile cells by the swim-up technique. Each of the semen fractions was infected with ZIKV at the multiplicity of infection of 0.1.0 and 1.0 and evaluated for the primary targets of ZIKV in the semen cells by RT-in situ PCR and confirmed by real-time RT-PCR.Main Results and the Role of Chance:ZIKV was present primarily at the mid-piece of mature spermatozoa in about 30% of the sperm. In addition, we determined that Tyro3 receptors, primarily expressed on mid-piece of human spermatozoa, play a role in ZIKV-binding and entry into spermatozoa. Our data strongly suggest a potential sexual/horizontal route of transmission for ZIKV primarily via infected sperms; most likely ZIKV enters the sperm via the Tyro3 receptor found at the mid-piece of the mature spermatozoa.Limitations, Reasons for Caution:We are uncertain as to what phase of spermatogenesis, that in human takes about 120 days, sperms are permissive to ZIKV. If permissiveness was very early during spermatogenesis males could be infectious for approximate to 120 days after the disappearance of viremia in an infected man.Wider Implications of the Findings:Our findings bring a new focus on the current affords to develop ZIKV vaccine. Why in the presence of anti-ZIKV antibodies infected men are still able to transmit the virus sexually? We suggest that only certain subclass of immunoglobulin (Ig)G (ie, IgG4) can cross the blood-Sertoli barrier therefore, a successful vaccine must provoke a subclass of IgG can quell ZIKV inside the seminiferous tubules.
C1 [Bagasra, Omar; Addanki, Krishna C.; Goodwin, Gregory R.; Hughes, Brandon W.; Pandey, Pratima; McLean, Ewen] Claflin Univ, Dept Biol, Orangeburg, SC USA.
   [Bagasra, Omar; Addanki, Krishna C.; Goodwin, Gregory R.; Hughes, Brandon W.; Pandey, Pratima; McLean, Ewen] Claflin Univ, South Carolina Ctr Biotechnol, Orangeburg, SC USA.
RP Bagasra, O (corresponding author), Claflin Univ, Orangeburg, SC 29115 USA.
EM obagasra@claflin.edu
RI McLean, Ewen/AAO-6863-2020
CR Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   BAGASRA O, 1994, AIDS, V8, P1669, DOI 10.1097/00002030-199412000-00005
   BAGASRA O, 1992, NEW ENGL J MED, V326, P1385, DOI 10.1056/NEJM199205213262103
   BAGASRA O, 1997, SITU PCR TECHNIQUES
   Bagasra O, 2007, NAT PROTOC, V2, P2782, DOI 10.1038/nprot.2007.395
   Bagasra O, 2005, J MOL HISTOL, V36, P401, DOI 10.1007/s10735-005-9010-9
   Bagasra O, 2012, EXPERT REV VACCINES, V11, P335, DOI [10.1586/erv.11.191, 10.1586/ERV.11.191]
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Breton S, 2015, GENOME, V58, P423, DOI 10.1139/gen-2015-0090
   Centers for Disease Control and Prevention, 2016, ZIK VIR TRANSM RISKS
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Doyle TJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.110.089425
   Franca LR, 2016, ANDROLOGY-US, V4, P189, DOI 10.1111/andr.12165
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   LAI C, 1994, ONCOGENE, V9, P2567
   LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X
   Lemke G., 2013, COLD SPRING HARB LAB, V5, P5
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Mruk DD, 2015, ENDOCR REV, V36, P564, DOI [10.1210/er.2014-1101, 10.1210/er.2015-1127]
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Noorali S, 2011, J INFECT DEV COUNTR, V5, P1
   Novak CM, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12615
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047
   Quanquin N, 2017, CURR OPIN PEDIATR, V29, P114, DOI 10.1097/MOP.0000000000000441
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594
   Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06
   Wang JN, 2016, INT J ENV RES PUB HE, V13, P10
   WHO, 2016, PREV SEX TRANSM ZIK
NR 34
TC 11
Z9 12
U1 1
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1541-2016
EI 1533-4058
J9 APPL IMMUNOHISTO M M
JI Appl. Immunohistochem.
PD NOV-DEC
PY 2017
VL 25
IS 10
BP 679
EP 686
DI 10.1097/PAI.0000000000000580
PG 8
WC Anatomy & Morphology; Medical Laboratory Technology; Pathology
SC Anatomy & Morphology; Medical Laboratory Technology; Pathology
GA FM5LG
UT WOS:000415075800007
PM 28968270
DA 2020-07-08
ER

PT J
AU Anderson, JL
AF Anderson, Jessica L.
TI Zika Virus: A Review and Clinical Updates
SO INFECTIOUS DISEASES IN CLINICAL PRACTICE
LA English
DT Review
DE Zika virus; mosquito-borne illness; congenital microcephaly;
   Guillain-Barre syndrome; arbovirus
ID SEXUAL TRANSMISSION; DENGUE
AB Zika virus is a recent mosquito-borne threat, yet many providers have limited knowledge of the virus and its potential complications. Current research indicates that Zika infection is associated with severe neurological conditions such as Guillain-Barre syndrome and is causative of congenital microcephaly and other birth defects. Given increasing global travel, domestic endemic areas in Florida and Texas, and the virus' diverse transmission routes, medical providers across specialties need basic understanding of the disease and its potential complications, as well as understanding of current Centers for Disease Control and Prevention guidelines.
C1 [Anderson, Jessica L.] Chatham Univ, 1 Woodland Rd, Pittsburgh, PA 15232 USA.
RP Anderson, JL (corresponding author), Chatham Univ, 1 Woodland Rd, Pittsburgh, PA 15232 USA.
EM janderson1@chatham.edu
CR Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brown T., 2016, CDC EXPECTS LTD OUTB
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, YELL FEV BRAZ
   Centers for Disease Control and Prevention, 2016, PREGN WOM PREN DIAGN
   Centers for Disease Control and Prevention, ZIK VIR POT RANG US
   Centers for Disease Control and Prevention, ZIK VIR CAS COUNTS U
   Centers for Disease Control and Prevention, GUID US LAB TEST ZIK
   Centers for Disease Control and Prevention, ZIK VIR CLIN EV DIS
   Centers for Disease Control and Prevention, CLIN GUID HEALTHC PR
   Centers for Disease Control and Prevention, DIAGN TESTS ZIK VIR
   Chang D., MIAMI HERALD
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fox M, 2016, NBC NEWS
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Goodman B., CDC ZIKA VIRUS DEFIN
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hughes S., 2016, MEDSCAPE
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kelly JC, 2016, ZIKA VACCINE CLIN TR
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   LeMotte S., 2016, ZIKA VIRUS MASS STER
   Lowes R., 2016, SEXUAL TRANSMISSION
   Lowes R., 1 FEMALE TO MALE SEX
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pan American Health Organization/World Health Organization, EP UPD NEUR SYNDR CO
   Pan American Health Organization/World Health Organization, 2016, PAHO STAT ZIK VIR TR
   Phillips D., 2016, WASHINGTON POST
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Tavernise S, 2016, NY TIMES
   US Department of Health and Human Services, 2016, DON SCREEN REC RED R
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   WHO, 2016, ZIK VIR FACT SHEET
   World Health Organization (WHO), 2016, ZIK VIR VECT RISK SP
NR 48
TC 0
Z9 0
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-9103
EI 1536-9943
J9 INFECT DIS CLIN PRAC
JI Infect. Dis. Clin. Pract.
PD NOV
PY 2017
VL 25
IS 6
BP 289
EP 293
DI 10.1097/IPC.0000000000000546
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FM6BE
UT WOS:000415129500005
DA 2020-07-08
ER

PT J
AU Walden, A
   Curless, K
   Winn, V
   Relich, R
AF Walden, A.
   Curless, K.
   Winn, V.
   Relich, R.
TI Clinical Evaluation of the xMAP MultiFLEX ZIKA RNA Assay
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Meeting Abstract
CT Annual Meeting of the Association-for-Molecular-Pathology (AMP)
CY NOV 16-18, 2017
CL Salt Lake City, UT
SP Assoc Mol Pathol
C1 [Walden, A.; Curless, K.; Winn, V.; Relich, R.] Indiana Univ Hlth, Indianapolis, IN USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD NOV
PY 2017
VL 19
IS 6
MA ID39
BP 982
EP 982
PG 1
WC Pathology
SC Pathology
GA FL5KO
UT WOS:000414275900176
DA 2020-07-08
ER

PT J
AU Rakeman, J
AF Rakeman, J.
TI Mosquito Surveillance and Testing for Local Zika Virus in New York City
   2016
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Meeting Abstract
CT Annual Meeting of the Association-for-Molecular-Pathology (AMP)
CY NOV 16-18, 2017
CL Salt Lake City, UT
SP Assoc Mol Pathol
C1 [Rakeman, J.] New York City Dept Hlth & Mental Hyg, New York, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD NOV
PY 2017
VL 19
IS 6
MA ID55
BP 985
EP 986
PG 2
WC Pathology
SC Pathology
GA FL5KO
UT WOS:000414275900192
DA 2020-07-08
ER

PT J
AU Chen, Y
   Liu, J
   Tran, L
   Gessert, S
   Sapida, J
   Das, K
   Sergeev, N
   Holmes, E
AF Chen, Y.
   Liu, J.
   Tran, L.
   Gessert, S.
   Sapida, J.
   Das, K.
   Sergeev, N.
   Holmes, E.
TI A Novel Approach for Sensitive Detection of ZIKV RNA in Whole Blood and
   Urine Samples
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Meeting Abstract
CT Annual Meeting of the Association-for-Molecular-Pathology (AMP)
CY NOV 16-18, 2017
CL Salt Lake City, UT
SP Assoc Mol Pathol
C1 [Chen, Y.; Liu, J.; Tran, L.; Gessert, S.; Sapida, J.; Das, K.; Holmes, E.] Theranos Inc, Palo Alto, CA USA.
   [Sergeev, N.] Theranos Inc, Newark, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD NOV
PY 2017
VL 19
IS 6
MA ID58
BP 986
EP 986
PG 1
WC Pathology
SC Pathology
GA FL5KO
UT WOS:000414275900195
DA 2020-07-08
ER

PT J
AU Greiss, H
   Ramu, S
   Kaur, M
   Fishel, L
   Rotman, C
   Botros, M
   Fahim, A
AF Greiss, H.
   Ramu, S.
   Kaur, M.
   Fishel, L.
   Rotman, C.
   Botros, M.
   Fahim, A.
TI Stability of Zika Virus and Recombinant Zika Controls
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Meeting Abstract
CT Annual Meeting of the Association-for-Molecular-Pathology (AMP)
CY NOV 16-18, 2017
CL Salt Lake City, UT
SP Assoc Mol Pathol
C1 [Greiss, H.; Ramu, S.; Fishel, L.; Botros, M.; Fahim, A.] FC Lab, Downers Grove, IL USA.
   [Kaur, M.; Rotman, C.] Oakbrook Inst Endoscopy, Oak Brook, IL USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD NOV
PY 2017
VL 19
IS 6
MA ID78
BP 990
EP 991
PG 2
WC Pathology
SC Pathology
GA FL5KO
UT WOS:000414275900214
DA 2020-07-08
ER

PT J
AU Greiss, H
   Ramu, S
   Kaur, M
   Fishel, L
   Rotman, C
   Botros, M
   Fahim, A
AF Greiss, H.
   Ramu, S.
   Kaur, M.
   Fishel, L.
   Rotman, C.
   Botros, M.
   Fahim, A.
TI Evaluation of Cross Reactivity and Inhibitory Effects of Sexually
   Transmitted and Mosquito Borne Pathogens on Zika Testing Using Aptima
   Zika Virus Assay on the Fully Automated Panther System
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Meeting Abstract
CT Annual Meeting of the Association-for-Molecular-Pathology (AMP)
CY NOV 16-18, 2017
CL Salt Lake City, UT
SP Assoc Mol Pathol
C1 [Greiss, H.; Ramu, S.; Kaur, M.; Fishel, L.; Botros, M.; Fahim, A.] FC Lab, Downers Grove, IL USA.
   [Rotman, C.] Oakbrook Inst Endoscopy, Oak Brook, IL USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD NOV
PY 2017
VL 19
IS 6
MA ID79
BP 991
EP 991
PG 1
WC Pathology
SC Pathology
GA FL5KO
UT WOS:000414275900215
DA 2020-07-08
ER

PT J
AU Ellington, S
   Perez, M
   Morof, D
   Zotti, ME
   Callaghan, W
   Meaney-Delman, D
   Glover, M
   Ha, QC
   Jamieson, DJ
AF Ellington, Sascha
   Perez, Mirna
   Morof, Diane
   Zotti, Marianne E.
   Callaghan, William
   Meaney-Delman, Dana
   Glover, Maleeka
   Ha, Quynh-Chau
   Jamieson, Denise J.
TI Addressing Maternal Health During CDC's Ebola Response in the United
   States
SO JOURNAL OF WOMENS HEALTH
LA English
DT Article
DE emergency response; Ebola; maternal health; pregnant women
ID FOR-DISEASE-CONTROL; 2009 H1N1 INFLUENZA; VIRUS DISEASE; DELIVERY; LABOR
AB Previous outbreaks suggest that pregnant women with Ebola virus disease (EVD) are at increased risk for severe disease and death. Healthcare workers who treat pregnant women with EVD are at increased risk of body fluid exposure. Despite the absence of pregnant women with EVD in the United States, CDC activated the Maternal Health Team (MHT), a functional unit dedicated to emergency preparedness and response issues, on October 18, 2014. We describe major activities of the MHT. A high-priority MHT activity was to publish guiding principles early in the response. The MHT also prepared guidance documents, provided guidance and technical support for hospital preparedness, and addressed inquiries. We analyzed maternal health inquiries received through CDC-INFO, MHT, and CDC's Medical Investigations Team from August 2014 to December 2015. Internal call logs used to capture, monitor, and track inquiries for the three data sources were merged. Inquiries not related to maternal health issues and duplicates were removed. Each inquiry was categorized by route (email/phone), inquirer type, and topic. In total, 201 inquiries were received from clinicians, public health professionals, and the public. The predominant topic was related to infection control for high-risk situations such as labor and delivery. During the Ebola response, most inquiries were received via email rather than telephone, a notable shift compared to the H1N1 emergency response. Lessons learned during the H1N1 and Ebola responses are currently informing CDC's Zika Response, an unprecedented emergency response primarily focused on reproductive health issues.
C1 [Ellington, Sascha; Perez, Mirna; Morof, Diane; Zotti, Marianne E.; Callaghan, William; Jamieson, Denise J.] Ctr Dis Control & Prevent CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy, Atlanta, GA 30341 USA.
   [Meaney-Delman, Dana] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Glover, Maleeka] CDC, Div Emergency Operat, Off Publ Hlth Emergency Preparedness & Response, Atlanta, GA 30333 USA.
   [Ha, Quynh-Chau] CDC, Div Commun Serv, CDC INFO, Off Associate Director Commun, Atlanta, GA 30333 USA.
RP Ellington, S (corresponding author), Ctr Dis Control & Prevent CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy, Atlanta, GA 30341 USA.
EM sellington@cdc.gov
RI amsalu, ribka/G-8780-2019
OI Jamieson, Denise/0000-0003-2597-1201
FU Intramural CDC HHS [CC999999]
CR Agua-Agum J, 2016, NEW ENGL J MED, V375, P587, DOI 10.1056/NEJMsr1513109
   [Anonymous], 2014, REC BREASTF INF FEED
   Bell BP, 2016, MMWR-MORBID MORTAL W, V65, P4, DOI 10.15585/mmwr.su6503a2
   Centers for Disease Control and Prevention, 2014, SCREEN CAR PREGN WOM
   Jamieson DJ, 2014, OBSTET GYNECOL, V124, P1005, DOI 10.1097/AOG.0000000000000533
   Kamali A, 2016, EMERG INFECT DIS, V22, P1156, DOI 10.3201/eid2207.160269
   Koonin LM, 2015, MMWR-MORBID MORTAL W, V64, P222
   Kourtis AP, 2015, PEDIATR INFECT DIS J, V34, P893, DOI 10.1097/INF.0000000000000707
   Meaney-Delman D, 2015, AM J OBSTET GYNECOL, V212, P417, DOI 10.1016/j.ajog.2015.01.018
   Mosby LG, 2011, AM J OBSTET GYNECOL, V204, pS7, DOI 10.1016/j.ajog.2011.02.057
   Oduyebo T, 2015, OBSTET GYNECOL, V126, P1273, DOI 10.1097/AOG.0000000000001092
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Papagiotas SS, 2012, PUBLIC HEALTH REP, V127, P267, DOI 10.1177/003335491212700306
   Zotti ME, 2015, MATERN CHILD HLTH J, V19, P1179, DOI 10.1007/s10995-014-1643-4
   Zotti ME, 2013, MATERN CHILD HLTH J, V17, P783, DOI 10.1007/s10995-012-1068-x
NR 15
TC 0
Z9 0
U1 5
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1540-9996
EI 1931-843X
J9 J WOMENS HEALTH
JI J. Womens Health
PD NOV
PY 2017
VL 26
IS 11
BP 1141
EP 1145
DI 10.1089/jwh.2017.6719
PG 5
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal; Obstetrics & Gynecology; Women's Studies
SC Public, Environmental & Occupational Health; General & Internal
   Medicine; Obstetrics & Gynecology; Women's Studies
GA FM7BC
UT WOS:000415221800002
PM 29140769
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Fonseca, SN
   Sigaki, LH
   Teixeira, A
   Bezerra, EC
   Souza, M
   Silva, YB
   Cavalari, FL
   Santos, JC
   Medeiros, LF
   Freitas, MLF
   Lucca, IC
   Martins, T
   Sandri, NF
   Valori, P
   Monteiro, M
   Ferez, MA
   Chan, WT
AF Fonseca, Silvia N.
   Sigaki, Larissa H.
   Teixeira, Arthur
   Bezerra, Elaine C.
   Souza, Maysa
   Silva, Ystannyslau B.
   Cavalari, Flavio L.
   Santos, Juliano C.
   Medeiros, Luis F.
   Freitas, Maria Luiza F.
   Lucca, Ivana C.
   Martins, Talita
   Sandri, Nayara F.
   Valori, Priscila
   Monteiro, Melina
   Ferez, Marcus A.
   Chan, Woe T.
TI ENDURING A DENGUE/ZIKA EPIDEMIC IN RIBEIRAO PRETO, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Fonseca, Silvia N.; Sigaki, Larissa H.; Teixeira, Arthur; Bezerra, Elaine C.; Souza, Maysa; Silva, Ystannyslau B.; Cavalari, Flavio L.; Santos, Juliano C.; Medeiros, Luis F.; Freitas, Maria Luiza F.; Lucca, Ivana C.; Martins, Talita; Sandri, Nayara F.; Valori, Priscila; Monteiro, Melina; Ferez, Marcus A.; Chan, Woe T.] Hosp Sao Francisco, Ribeirao Preto, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 117
BP 39
EP 39
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501117
DA 2020-07-08
ER

PT J
AU Ong-ajchaowlerd, P
   Hunsawong, T
   Suthangkornkul, R
   Thaisomboonsuk, B
   Klungtong, C
   Manasatienkij, W
   Fernandez, S
   Macareo, LR
   Ellison, DW
AF Ong-ajchaowlerd, Prapapun
   Hunsawong, Taweewun
   Suthangkornkul, Rungarun
   Thaisomboonsuk, Butsaya
   Klungtong, Chonticha
   Manasatienkij, Wudtichai
   Fernandez, Stefan
   Macareo, Louis R.
   Ellison, Damon W.
TI THE ASSOCIATION BETWEEN DENGUE PRE-EXISTING ANTIBODY ON ZIKA VIRUS
   INFECTION IN THP-1 MONOCYTES CELL LINE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Ong-ajchaowlerd, Prapapun; Hunsawong, Taweewun; Suthangkornkul, Rungarun; Thaisomboonsuk, Butsaya; Klungtong, Chonticha; Manasatienkij, Wudtichai; Macareo, Louis R.; Ellison, Damon W.] Armed Forces Res Inst Med Sci, Bangkok, Thailand.
   [Fernandez, Stefan] US Army, Med Mat Dev Act, Ft Detrick, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 120
BP 40
EP 40
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501120
DA 2020-07-08
ER

PT J
AU Sirikajornpan, K
   Thaisomboonsuk, B
   Nisalak, A
   Klungthong, C
   Hunsawong, T
   Imerbsin, R
   Yoon, IK
   Ellison, DW
   Weg, AL
   Macareo, LR
AF Sirikajornpan, Kanittha
   Thaisomboonsuk, Butsaya
   Nisalak, Ananda
   Klungthong, Chonticha
   Hunsawong, Taweewun
   Imerbsin, Rawiwan
   Yoon, In-Kyu
   Ellison, Damon W.
   Weg, Alden L.
   Macareo, Louis R.
TI PREPARATION OF STANDARD ZIKA VIRUS (ZIKV) IGM FOR SEROLOGICAL DIAGNOSIS
   OF ZIKV INFECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Sirikajornpan, Kanittha; Thaisomboonsuk, Butsaya; Nisalak, Ananda; Klungthong, Chonticha; Hunsawong, Taweewun; Imerbsin, Rawiwan; Ellison, Damon W.; Weg, Alden L.; Macareo, Louis R.] Armed Forces Res Inst Med Sci, Bangkok, Thailand.
   [Yoon, In-Kyu] Int Vaccine IVI, Dengue Vaccine Initiat DVI, Seoul, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 121
BP 40
EP 40
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501121
DA 2020-07-08
ER

PT J
AU Sasmono, RT
   Perkasa, A
   Yudhaputri, F
   Haryanto, S
   Yohan, B
   Ma'roef, CN
   Antonjaya, U
   Hayati, RF
   Ledderman, JP
   Rosenberg, R
   Myint, KS
   Powers, AM
AF Sasmono, R. Tedjo
   Perkasa, Aditya
   Yudhaputri, Frilasita
   Haryanto, Sotianingsih
   Yohan, Benediktus
   Ma'roef, Chairin N.
   Antonjaya, Ungke
   Hayati, Rahma F.
   Ledderman, Jeremy P.
   Rosenberg, Ronald
   Myint, Khin S.
   Powers, Ann M.
TI CO-CIRCULATION OF ZIKA, CHIKUNGUNYA AND DENGUE VIRUSES DURING DENGUE
   OUTBREAK IN SUMATRA, INDONESIA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Sasmono, R. Tedjo; Perkasa, Aditya; Yudhaputri, Frilasita; Yohan, Benediktus; Ma'roef, Chairin N.; Hayati, Rahma F.; Myint, Khin S.] Eijkman Inst Mol Biol, Jakarta, Indonesia.
   [Haryanto, Sotianingsih] Siloam Hosp, Jambi, Indonesia.
   [Antonjaya, Ungke] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.
   [Ledderman, Jeremy P.; Rosenberg, Ronald; Powers, Ann M.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
RI Yohan, Benediktus/J-9039-2019
OI Yohan, Benediktus/0000-0003-2378-2386
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 122
BP 41
EP 41
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501122
DA 2020-07-08
ER

PT J
AU Tauro, LB
AF Tauro, Laura B.
TI POTENTIAL USE OF SALIVA SAMPLES FOR DIAGNOSIS OF ZIKA VIRUS INFECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Tauro, Laura B.] FIOCRUZ BA, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 124
BP 41
EP 41
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501124
DA 2020-07-08
ER

PT J
AU Tung, TH
   Chan, TC
   Chen, SC
   Yen, MY
   Chen, CD
   Ho, CK
   Lin, F
   King, CC
AF Tung, Tsung-Hua
   Chan, Ta-Chien
   Chen, Shao-Ching
   Yen, Muh-Yong
   Chen, Chaur-Dong
   Ho, Chi-Kung
   Lin, Fred
   King, Chwan-Chuen
TI FROM DENGUE TO ZIKA-TAIWAN'S EXPERIENCE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Tung, Tsung-Hua] Natl Taiwan Univ, Dept Publ Hlth, Taipei, Taiwan.
   [Tung, Tsung-Hua] Taipei City Govt, Dept Hlth, Taipei, Taiwan.
   [Chan, Ta-Chien] Acad Sinica, Ctr Geog Informat Sci, Res Ctr Humanities & Social Sci, Taipei, Taiwan.
   [Chen, Shao-Ching] Taipei City Govt, Dept Hlth, Taipei, Taiwan.
   [Yen, Muh-Yong] Taipei City Govt, Dept Dis Control & Prevent, Taipei City Hosp, Taipei, Taiwan.
   [Chen, Chaur-Dong] Kaohsiung City Govt, Dept Dis Control & Prevent, Kaohsiung, Taiwan.
   [Ho, Chi-Kung] Kaohsiung City Govt, Dept Hlth, Kaohsiung, Taiwan.
   [Lin, Fred] Tainan City Govt, Dept Hlth, Tainan, Taiwan.
   [King, Chwan-Chuen] Natl Taiwan Univ, Dept Publ Hlth, Taipei, Taiwan.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 123
BP 41
EP 41
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501123
DA 2020-07-08
ER

PT J
AU Collins, M
   McGowan, E
   Jadi, R
   De Silva, A
AF Collins, Matthew
   McGowan, Eileen
   Jadi, Ramesh
   De Silva, Aravinda
TI SERODIAGNOSIS OF ZIKA IN TRAVELERS RETURNING FROM FLAVIVIRUS-ENDEMIC
   REGIONS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Collins, Matthew; McGowan, Eileen; Jadi, Ramesh; De Silva, Aravinda] Univ N Carolina, Chapel Hill, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 126
BP 42
EP 42
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501126
DA 2020-07-08
ER

PT J
AU Taiwo, F
   Eversley, T
   Jillson, S
   Okafor, C
   Adams, D
   Miller, J
   Mauck, D
   Patrick, S
AF Taiwo, Femi
   Eversley, Tatiana
   Jillson, Sarah
   Okafor, Chidinma
   Adams, David
   Miller, Joseph
   Mauck, Daniel
   Patrick, Shawn
TI THE REEMERGENCE OF ZIKA VIRUS: FROM ARTHROPOD VECTOR TO POSSIBLE SEXUAL
   TRANSMISSION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Taiwo, Femi; Jillson, Sarah; Okafor, Chidinma; Miller, Joseph; Patrick, Shawn] Armstrong State Univ, Savannah, GA USA.
   [Eversley, Tatiana] Med Univ South Carolina, Charleston, SC USA.
   [Adams, David] Mercer Univ, Sch Med, Savannah, GA USA.
   [Mauck, Daniel] Univ Miami, Miami, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 125
BP 42
EP 42
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501125
DA 2020-07-08
ER

PT J
AU Dirlikov, E
   Major, C
   Mayshack, M
   Salinas, J
   Virgen, C
   Pastula, DM
   Sejvar, J
   Sharp, T
   Rivera-Garcia, B
AF Dirlikov, Emilio
   Major, Chelsea
   Mayshack, Marrielle
   Salinas, Jorge
   Virgen, Cesar
   Pastula, Daniel M.
   Sejvar, Jim
   Sharp, Tyler
   Rivera-Garcia, Brenda
TI EPIDEMIOLOGIC INVESTIGATIONS OF GUILLAIN-BARR SYNDROME INCLUDING
   CASE-CONTROL INVESTIGATION TO DEFINE ASSOCIATION WITH ZIKA VIRUS
   INFECTION PUERTO RICO, 2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Dirlikov, Emilio; Major, Chelsea; Mayshack, Marrielle; Sharp, Tyler] Ctr Dis Control & Prevent, San Juan, PR USA.
   [Salinas, Jorge; Sejvar, Jim] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Virgen, Cesar] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Pastula, Daniel M.] Univ Colorado, Denver, CO 80202 USA.
   [Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, San Juan, PR USA.
RI Pastula, Daniel M./M-1325-2019
OI Pastula, Daniel M./0000-0001-9342-4459
NR 0
TC 0
Z9 0
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 131
BP 43
EP 44
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501131
DA 2020-07-08
ER

PT J
AU Leguia, M
   Felices, V
   Torre, A
   Guevara, C
   Troncos, G
   Espejo, V
   Mores, C
AF Leguia, Mariana
   Felices, Vidal
   Torre, Armando
   Guevara, Carolina
   Troncos, Gilda
   Espejo, Victoria
   Mores, Christopher
TI FULL GENOME SEQUENCING OF ZIKA VIRUSES USING A TARGETED AMPLIFICATION
   APPROACH
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Leguia, Mariana; Felices, Vidal; Torre, Armando; Guevara, Carolina; Troncos, Gilda; Espejo, Victoria; Mores, Christopher] US Naval Med Res Unit 6 Peru, Washington, DC USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 129
BP 43
EP 43
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501129
DA 2020-07-08
ER

PT J
AU Paz-Bailey, G
   Perez-Padilla, J
   Lozier, M
   Munoz-Jordan, J
   Biggerstaff, B
   Lorenzi, O
   Garcia-Gubern, C
   Waterman, S
   Alvarado, L
   Sharp, T
AF Paz-Bailey, Gabriela
   Perez-Padilla, Janice
   Lozier, Matthew
   Munoz-Jordan, Jorge
   Biggerstaff, Brad
   Lorenzi, Olga
   Garcia-Gubern, Carlos
   Waterman, Steve
   Alvarado, Luisa
   Sharp, Tyler
TI ZIKA VIRUS PERSISTENCE IN BODY FLUIDS AMONG PATIENTS WITH ZIKA VIRUS
   INFECTION IN PUERTO RICO
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Paz-Bailey, Gabriela; Perez-Padilla, Janice; Lozier, Matthew; Munoz-Jordan, Jorge; Biggerstaff, Brad; Lorenzi, Olga; Waterman, Steve; Sharp, Tyler] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Garcia-Gubern, Carlos; Alvarado, Luisa] Ponce Hlth Sci Univ, San Juan, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 130
BP 43
EP 43
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501130
DA 2020-07-08
ER

PT J
AU Gresh, L
   Ojeda, S
   Sanchez, N
   Kuan, G
   Nunez, A
   Gordon, A
   Balmaseda, A
   Harris, E
AF Gresh, Lionel
   Ojeda, Sergio
   Sanchez, Nery
   Kuan, Guillermina
   Nunez, Andrea
   Gordon, Aubree
   Balmaseda, Angel
   Harris, Eva
TI CHARACTERIZATION OF ZIKA VIRUS INFECTIONS AND THE POTENTIAL EFFECT OF
   PRIOR DENGUE VIRUS EXPOSURE IN CHILDREN IN MANAGUA, NICARAGUA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Gresh, Lionel; Ojeda, Sergio; Sanchez, Nery] Sustainable Sci Inst, Managua, Nicaragua.
   [Kuan, Guillermina] Minist Hlth, Hlth Ctr Socrates Flores Vivas, Managua, Nicaragua.
   [Nunez, Andrea; Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Gordon, Aubree] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RI Gordon, Aubree/X-1113-2019
OI Gordon, Aubree/0000-0002-9352-7877
NR 0
TC 0
Z9 0
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 132
BP 44
EP 44
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501132
DA 2020-07-08
ER

PT J
AU Jackson, N
   Lecouturier, V
   Pugachev, K
   Burdin, N
   Kleanthous, H
   Kester, K
   Noriega, F
   Tartaglia, J
   Heinrichs, J
AF Jackson, Nicholas
   Lecouturier, Valerie
   Pugachev, Konstantin
   Burdin, Nicolas
   Kleanthous, Harry
   Kester, Kent
   Noriega, Fernando
   Tartaglia, Jim
   Heinrichs, Jon
TI ZIKA VIRUS: KNOWLEDGE GAPS AND VACCINE RESEARCH AND DEVELOPMENT
   CHALLENGES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Jackson, Nicholas] Sanofi Pasteur, Lyon, France.
   [Lecouturier, Valerie; Burdin, Nicolas] Sanofi Pasteur, Marcy Letoile, France.
   [Pugachev, Konstantin; Kleanthous, Harry] Sanofi Pasteur, Cambridge, MA USA.
   [Kester, Kent; Noriega, Fernando; Tartaglia, Jim; Heinrichs, Jon] Sanofi Pasteur, Swiftwater, PA USA.
RI Kester, Kent/AAF-8235-2020
OI Kester, Kent/0000-0002-5056-0802
NR 0
TC 0
Z9 0
U1 0
U2 9
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 134
BP 44
EP 44
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501134
DA 2020-07-08
ER

PT J
AU Ruckert, C
   Weger-Lucarelli, J
   Fauver, JR
   Garcia-Luna, SM
   Ebel, GD
AF Ruckert, Claudia
   Weger-Lucarelli, James
   Fauver, Joseph R.
   Garcia-Luna, Selene M.
   Ebel, Gregory D.
TI THE EFFECT OF CO-INFECTION WITH DENGUE, CHIKUNGUNYA AND ZIKA VIRUS ON
   VECTOR COMPETENCE OF AEDES MOSQUITOES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Ruckert, Claudia; Weger-Lucarelli, James; Fauver, Joseph R.; Garcia-Luna, Selene M.; Ebel, Gregory D.] Colorado State Univ, Arthropod Borne & Infect Dis Lab, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
NR 0
TC 1
Z9 1
U1 1
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 608
BP 191
EP 191
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502131
DA 2020-07-08
ER

PT J
AU Aliota, MT
   Peinado, SA
   Velez, ID
   Osorio, JE
AF Aliota, Matthew T.
   Peinado, Stephen A.
   Dario Velez, Ivan
   Osorio, Jorge E.
TI THE WMEL STRAIN OF WOLBACHIA REDUCES TRANSMISSION OF ZIKA VIRUS IN AEDES
   AEGYPTI
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Aliota, Matthew T.; Peinado, Stephen A.; Osorio, Jorge E.] Univ Wisconsin, Madison, WI USA.
   [Dario Velez, Ivan] PECET, Medellin, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 661
BP 208
EP 208
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502184
DA 2020-07-08
ER

PT J
AU Shelley, CD
   Barker, CM
AF Shelley, Courtney D.
   Barker, Christopher M.
TI ZIKA VIRUS IN THE AMERICAS: A MODEL-BASED ASSESSMENT OF FACTORS
   AFFECTING EMERGENCE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Shelley, Courtney D.; Barker, Christopher M.] Univ Calif Davis, Davis, CA 95616 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 663
BP 208
EP 209
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502186
DA 2020-07-08
ER

PT J
AU Hamer, DH
   Barbre, K
   Anderson, S
   Barnett, ED
   Boggild, A
   Bottieau, E
   Brunette, G
   Caumes, E
   Cetron, M
   Chen, LH
   Eperon, G
   Gautret, P
   Goorhuis, A
   Grobusch, MP
   Hagmann, S
   Hynes, N
   Kozarsky, P
   Jespersen, S
   Libman, M
   Lopez-Velez, R
   Malvy, D
   Mockenhaupt, F
   Molina, I
   Perret, C
   Rothe, C
   Schlagenhauff, P
   Schwartz, E
   Van Genderen, P
   Wilder-Smith, A
   Esposito, D
AF Hamer, Davidson H.
   Barbre, Kira
   Anderson, Susan
   Barnett, Elizabeth D.
   Boggild, Andrea
   Bottieau, Emmanuel
   Brunette, Gary
   Caumes, Eric
   Cetron, Marty
   Chen, Lin H.
   Eperon, Gilles
   Gautret, Philippe
   Goorhuis, Abraham
   Grobusch, Martin P.
   Hagmann, Stefan
   Hynes, Noreen
   Kozarsky, Phyllis
   Jespersen, Sanne
   Libman, Michael
   Lopez-Velez, Rogelio
   Malvy, Denis
   Mockenhaupt, Frank
   Molina, Israel
   Perret, Cecilia
   Rothe, Camilla
   Schlagenhauff, Patricia
   Schwartz, Eli
   Van Genderen, Perry
   Wilder-Smith, Annelies
   Esposito, Doug
TI ZIKA VIRUS DISEASE AMONG TRAVELERS RETURNING FROM THE AMERICAS BETWEEN
   JANUARY 2013 AND FEBRUARY 2016: A GEOSENTINEL ANALYSIS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Hamer, Davidson H.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [Barbre, Kira] Task Force Global Hlth, Decatur, GA USA.
   [Anderson, Susan] Palo Alto Med Fdn, Travel Med & Emergency Urgent Care, Palo Alto, CA USA.
   [Barnett, Elizabeth D.] Boston Med Ctr, Maxwell Finland Lab Infect Dis, Boston, MA USA.
   [Boggild, Andrea] Toronto Gen Hosp, Ctr Travel & Trop Med, Toronto, ON, Canada.
   [Bottieau, Emmanuel] Inst Trop Med, Antwerp, Belgium.
   [Brunette, Gary; Cetron, Marty; Esposito, Doug] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Caumes, Eric] Hop La Pitie Salpetriere, Serv Malad Infect & Trop, Paris, France.
   [Chen, Lin H.] Mt Auburn Hosp, Travel Med Ctr, Cambridge, MD USA.
   [Eperon, Gilles] Geneva Univ Hosp, Div Trop & Humanitarian Med, Travel & Trop Med, Geneva, Switzerland.
   [Gautret, Philippe] Hop Nord Marseille, Infect & Trop Dis Unit, Marseille, France.
   [Goorhuis, Abraham; Grobusch, Martin P.] Univ Amsterdam, Ctr Trop & Travel Med, Amsterdam, Netherlands.
   [Hagmann, Stefan] Bronx Lebanon Hosp Ctr, Div Pediat Infect Dis, Bronx, NY 10456 USA.
   [Hynes, Noreen] Johns Hopkins Univ, Sch Med, Div Infect Dis, Geog Med Ctr, Baltimore, MD 21205 USA.
   [Kozarsky, Phyllis] TravelWell, Atlanta, GA USA.
   [Jespersen, Sanne] Aarhus Univ Hostpital, Dept Infect Dis, Arrhus, Denmark.
   [Libman, Michael] McGill Univ, Ctr Trop Dis, Montreal Gen Hosp, Montreal, PQ, Canada.
   [Lopez-Velez, Rogelio] Hosp Ramon & Cajal, Serv Enfermedades Infecciosas, Unidad Med Trop, Madrid, Spain.
   [Malvy, Denis] Hop St Andre, Sante Voyages & Med Trop Niveau, Bordeaux, France.
   [Mockenhaupt, Frank] Charite, Inst Trop Med & Int Hlth, Berlin, Germany.
   [Molina, Israel] Hosp Gen Valle Hebron, Anexos Planta 6, Barcelona, Spain.
RI Mockenhaupt, Frank P/U-9824-2017; Hamer, Davidson/J-2020-2019; Hynes,
   Noreen/AAA-2550-2020; MALVY, Denis/T-7930-2019
OI Mockenhaupt, Frank P/0000-0002-8117-5421; Hamer,
   Davidson/0000-0002-4700-1495; 
NR 0
TC 1
Z9 1
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 691
BP 218
EP 218
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502214
DA 2020-07-08
ER

PT J
AU Figueiredo, GM
   Luna, EJ
   Cardoso, MR
   Levi, JE
   Felix, AC
   Souza, NCC
   Souza, AC
   Campos, SRCR
   Figueiredo, WM
   Costa, AA
   Pannuti, CS
AF Figueiredo, Gerusa M.
   Luna, Expedito J.
   Cardoso, Maria Regina
   Levi, Jose E.
   Felix, Alvina C.
   Souza, Nathalia C. C.
   Souza, Ana C.
   Campos, Sergio R. Campos R.
   Figueiredo, Walter M.
   Costa, Angela A.
   Pannuti, Claudio S.
TI ZIKA VIRUS INFECTION IN A COHORT STUDY TO ASSESS THE INCIDENCE OF
   DENGUE, STATE OF SAO PAULO, BRAZIL, 2015, 2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Figueiredo, Gerusa M.; Luna, Expedito J.; Levi, Jose E.; Felix, Alvina C.; Souza, Nathalia C. C.; Souza, Ana C.; Campos, Sergio R. Campos R.; Figueiredo, Walter M.; Costa, Angela A.; Pannuti, Claudio S.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Cardoso, Maria Regina] Univ Sao Paulo, Fac Saude Publ, Sao Paulo, Brazil.
RI Luna, Expedito J A/B-7948-2012; Figueiredo, Gerusa M/B-6660-2014
OI Luna, Expedito J A/0000-0002-1145-9672; Figueiredo, Gerusa
   M/0000-0001-9657-9675
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 716
BP 226
EP 226
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502239
DA 2020-07-08
ER

PT J
AU Londono-Renteria, BL
   Troupin, A
   Cardenas, JC
   Sanabria, MA
   Entrena, E
   Colpitts, TM
AF Londono-Renteria, Berlin L.
   Troupin, Andrea
   Cardenas, Jenny C.
   Sanabria, Miguel A.
   Entrena, Elsi
   Colpitts, Tonya M.
TI DENV PREEXISTING IMMUNITY EFFECT ON ZIKV INFECTION AND THE RELIABILITY
   OF DIAGNOSIS IN AN AREA WITH CO-CIRCULATION OF SEVERAL ARBOVIRUSES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Londono-Renteria, Berlin L.; Troupin, Andrea; Colpitts, Tonya M.] Univ South Carolina, Columbia, SC USA.
   [Cardenas, Jenny C.; Sanabria, Miguel A.] Hosp Los Patios, Los Patios, Colombia.
   [Entrena, Elsi] Hosp Erasmo Meoz, Cucuta, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 726
BP 229
EP 230
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502249
DA 2020-07-08
ER

PT J
AU Messer, W
   Brady, A
   Gabriel, S
   Booty, B
   Dorfman, C
   Weinstein, J
AF Messer, William
   Brady, Adam
   Gabriel, Sarah
   Booty, Brian
   Dorfman, Claire
   Weinstein, Jules
TI IMMUNITY TO ZIKV, DENV AND CHIKV IN A NON-ENDEMIC HUMAN IMMUNE COHORT IN
   PORTLAND, OREGON
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Messer, William; Brady, Adam; Gabriel, Sarah; Booty, Brian; Dorfman, Claire; Weinstein, Jules] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 739
BP 233
EP 233
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502262
DA 2020-07-08
ER

PT J
AU Moraes, FM
   Esposito, DL
   Klein, TM
   Fonseca, BA
AF Moraes, Flavia M.
   Esposito, Danillo L.
   Klein, Taline M.
   Fonseca, Benedito A.
TI EVALUATION OF SELECTED REAL-TIME RT-PCR PROTOCOLS AIMING AT THE BEST
   POSSIBLE MOLECULAR DIAGNOSIS OF ZIKA VIRUS INFECTIONS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Moraes, Flavia M.; Esposito, Danillo L.; Klein, Taline M.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
RI Esposito, Danillo L.A./N-9261-2017
OI Esposito, Danillo L.A./0000-0002-2755-4471
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 747
BP 235
EP 236
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502270
DA 2020-07-08
ER

PT J
AU Whitbeck, C
   Thomas, A
   Tucker, D
   Barnes, T
   Crowe, JE
   Davidson, E
   Doranz, BJ
AF Whitbeck, Chuck
   Thomas, Anu
   Tucker, David
   Barnes, Trevor
   Crowe, James E., Jr.
   Davidson, Edgar
   Doranz, Benjamin J.
TI ANALYZING THE IMMUNE RESPONSE TO ZIKA VIRUS: A REPORTER VIRUS PARTICLE
   (RVP) SYSTEM FOR SERUM AND ANTIBODY NEUTRALIZATION ASSAYS, AND A
   COMPREHENSIVE ALA-SCAN MUTATION LIBRARY OF ZIKV PRM/E TO EPITOPE MAP
   ANTI-ZIKV ANTIBODIES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Whitbeck, Chuck; Thomas, Anu; Tucker, David; Barnes, Trevor; Davidson, Edgar; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol, Nashville, TN USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.
RI Crowe, James E./B-5549-2009
OI Crowe, James E./0000-0002-0049-1079
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 746
BP 235
EP 235
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502269
DA 2020-07-08
ER

PT J
AU Brasil, P
   Marques, ET
   Tami, A
   Sandoval, EP
   Caprara, A
   Magalhaes, T
   Calvet, G
   Bethencourt, S
   Guzman, MG
   Simmons, CP
   Bispo, A
   Cordeiro, MT
   Wills, B
   Rosenberger, K
   Jaenisch, T
AF Brasil, Patricia
   Marques, Ernesto T.
   Tami, Adriana
   Sandoval, Ernesto Pleitess
   Caprara, Andrea
   Magalhaes, Tereza
   Calvet, Guilherme
   Bethencourt, Sarah
   Guzman, Maria G.
   Simmons, Cameron P.
   Bispo, Ana
   Cordeiro, Marli Tenorio
   Wills, Bridget
   Rosenberger, Kerstin
   Jaenisch, Thomas
TI CLINICAL CHARACTERIZATION OF ACUTE ZIKA PATIENTS IN BRAZIL, VENEZUELA,
   AND EL SALVADOR IN 2015/16
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Brasil, Patricia; Calvet, Guilherme; Bispo, Ana] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Marques, Ernesto T.; Magalhaes, Tereza; Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Recife, PE, Brazil.
   [Tami, Adriana] Univ Med Ctr Groningen, Groningen, Netherlands.
   [Sandoval, Ernesto Pleitess] Hosp Natl Ninos Benjamin Bloom, San Salvador, El Salvador.
   [Caprara, Andrea] Univ Estadual Ceara, Fortaleza, Ceara, Brazil.
   [Bethencourt, Sarah] Univ Carabobo, Valencia, Venezuela.
   [Guzman, Maria G.] Pedro Kouri Inst, Havana, Cuba.
   [Simmons, Cameron P.; Wills, Bridget] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam.
   [Rosenberger, Kerstin; Jaenisch, Thomas] Heidelberg Univ Hosp, Heidelberg, Germany.
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Tami,
   Adriana/0000-0002-1918-9144
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 749
BP 236
EP 236
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502272
DA 2020-07-08
ER

PT J
AU Soebandrio, A
   Yudhaputri, F
   Perkasa, A
   Yohan, B
   Haryanto, S
   Wiyatno, A
   Antonjaya, U
   Trimarsanto, H
   Ledermann, JP
   Rosenburg, R
   Powers, AM
   Sasmono, RT
   Myint, KSA
AF Soebandrio, Amin
   Yudhaputri, Frilasita
   Perkasa, Aditya
   Yohan, Benediktus
   Haryanto, Sotianingsih
   Wiyatno, Ageng
   Antonjaya, Ungke
   Trimarsanto, Hidayat
   Ledermann, Jeremy P.
   Rosenburg, Ronald
   Powers, Ann M.
   Sasmono, R. Tedjo
   Myint, Khin Saw Aye
TI WHOLE GENOME SEQUENCING AND PHYLOGENETIC ANALYSIS OF ZIKA VIRUS ISOLATED
   IN INDONESIA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Soebandrio, Amin; Yudhaputri, Frilasita; Perkasa, Aditya; Yohan, Benediktus; Wiyatno, Ageng; Trimarsanto, Hidayat; Sasmono, R. Tedjo; Myint, Khin Saw Aye] Eijkman Inst Mol Biol, Jakarta, Indonesia.
   [Haryanto, Sotianingsih] Siloam Hosp, Jambi, Indonesia.
   [Antonjaya, Ungke] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.
   [Ledermann, Jeremy P.; Rosenburg, Ronald; Powers, Ann M.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
RI Yohan, Benediktus/J-9039-2019
OI Yohan, Benediktus/0000-0003-2378-2386
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 748
BP 236
EP 236
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502271
DA 2020-07-08
ER

PT J
AU Weiss, C
   Bush, MM
   Cowes, A
   Nunez, D
   Santiago, FW
   Altman, A
AF Weiss, Christy
   Bush, Michele M.
   Cowes, Arturo
   Nunez, Diamela
   Santiago, Felix W.
   Altman, Amy
TI DETECTION AND DIFFERENTIATION OF IGM RESPONSE TO RECENT EXPOSURE TO ZIKA
   AND OTHER VECTOR BORNE VIRUSES USING A MULTIPLEXED, BEAD BASED SEROLOGY
   ASSAY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Weiss, Christy; Bush, Michele M.; Cowes, Arturo; Nunez, Diamela; Santiago, Felix W.; Altman, Amy] Luminex Corp, Austin, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 750
BP 236
EP 237
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502273
DA 2020-07-08
ER

PT J
AU Barr, K
AF Barr, Kelli
TI WORKING WITH ZIKA AND USUTU VIRUSES IN VITRO
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Barr, Kelli] Univ Florida, Gainesville, FL USA.
RI Barr, Kelli L./I-7508-2019
OI Barr, Kelli L./0000-0001-7943-7181
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 756
BP 238
EP 238
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502279
DA 2020-07-08
ER

PT J
AU Barraquer, IR
   Salje, H
   Lessler, J
   Cummings, DA
AF Barraquer, Isabel Rodriguez
   Salje, Henrik
   Lessler, Justin
   Cummings, Derek A.
TI PREDICTING INTENSITIES OF ZIKA INFECTION AND MICROCEPHALY USING
   TRANSMISSION INTENSITIES OF OTHER ARBOVIRUSES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Barraquer, Isabel Rodriguez; Salje, Henrik; Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Cummings, Derek A.] Univ Florida, Gainesville, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 757
BP 238
EP 239
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502280
DA 2020-07-08
ER

PT J
AU Brady, OJ
   Kraemer, MU
   Bogoch, II
   German, M
   Watts, A
   Hay, SI
   Khan, K
AF Brady, Oliver J.
   Kraemer, Moritz U.
   Bogoch, Isaac I.
   German, Matthew
   Watts, Alexander
   Hay, Simon I.
   Khan, Kamran
TI MAPPING GLOBAL SEASONAL SUITABILITY FOR ZIKA VIRUS TRANSMISSION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Brady, Oliver J.] London Sch Hyg & Trop Med, London, England.
   [Kraemer, Moritz U.] Univ Oxford, Oxford, England.
   [Bogoch, Isaac I.; German, Matthew; Watts, Alexander; Khan, Kamran] Univ Toronto, Toronto, ON, Canada.
   [Hay, Simon I.] Inst Hlth Metr & Evaluat, Seattle, WA USA.
RI Hay, Simon I/F-8967-2015
OI Hay, Simon I/0000-0002-0611-7272
NR 0
TC 0
Z9 0
U1 0
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 755
BP 238
EP 238
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502278
DA 2020-07-08
ER

PT J
AU Perera, R
   Chotiwan, N
   Brewster, CD
   Weger-Lucarelli, J
   Ruckert, C
   Nguyen, C
   Luna, SMG
   Fauver, JR
   Gray, M
   Black, WC
   Foy, B
   Kading, RC
   Ebel, GD
   Quackenbush, SL
   Rovnak, J
AF Perera, Rushika
   Chotiwan, Nunya
   Brewster, Connie D.
   Weger-Lucarelli, James
   Ruckert, Claudia
   Chilinh Nguyen
   Luna, Selene M. Garcia
   Fauver, Joseph R.
   Gray, Meg
   Black, William C.
   Foy, Brian
   Kading, Rebekah C.
   Ebel, Gregory D.
   Quackenbush, Sandra L.
   Rovnak, Joel
TI DESIGN AND VALIDATION OF A RAPID ASSAY FOR ZIKA VIRUS IN BIOFLUIDS AND
   INSECT VECTORS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Perera, Rushika; Chotiwan, Nunya; Weger-Lucarelli, James; Ruckert, Claudia; Chilinh Nguyen; Luna, Selene M. Garcia; Fauver, Joseph R.; Gray, Meg; Black, William C.; Foy, Brian; Kading, Rebekah C.; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
   [Brewster, Connie D.; Quackenbush, Sandra L.; Rovnak, Joel] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 754
BP 238
EP 238
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502277
DA 2020-07-08
ER

PT J
AU Krystosik, AR
AF Krystosik, Amy R.
TI CHIKUNGUNYA, ZIKA, AND DENGUE IN CALI, COLOMBIA: PRELIMINARY RESULTS OF
   EPIDEMIOLOGICAL AND GEOSPATIAL ANALYSES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Krystosik, Amy R.] Kent State Univ, Kent, OH 44242 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 759
BP 239
EP 239
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502282
DA 2020-07-08
ER

PT J
AU Cilek, J
   Knapp, J
   Pruszynski, C
AF Cilek, James
   Knapp, Jennifer
   Pruszynski, Catherine
TI NEW USES FOR AN OLD TECHNOLOGY TO CONTROL ZIKA VECTORS IN URBAN TROPICAL
   ENVIRONMENTS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Cilek, James; Knapp, Jennifer] Navy Entomol Ctr Excellence, Jacksonville, FL USA.
   [Pruszynski, Catherine] Keys Mosquito Control Dist, Key West, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 776
BP 244
EP 244
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502299
DA 2020-07-08
ER

PT J
AU Cravioto, A
   Stevens, W
   Mills, EJ
   Forrest, JI
   Anema, A
AF Cravioto, Alejandro
   Stevens, Warren
   Mills, Edward J.
   Forrest, Jamie I.
   Anema, Aranka
TI CREATING A HOLISTIC FRAMEWORK FOR UNDERSTANDING THE FULL IMPACT OF THE
   ZIKA VIRUS ON MOTHERS, INFANTS, HEALTH SYSTEMS AND SOCIETY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Cravioto, Alejandro; Stevens, Warren] Precis Global Hlth, Seattle, WA USA.
   [Mills, Edward J.; Forrest, Jamie I.] Precis Global Hlth, Vancouver, BC, Canada.
   [Anema, Aranka] Epidemico, Boston, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 823
BP 258
EP 259
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502346
DA 2020-07-08
ER

PT J
AU Fung, ICH
   Blankenship, EB
   Goff, ME
   Mullican, LA
   Chan, KC
   Saroha, N
   Duke, CH
   Eremeeva, ME
   Fu, KW
   Tse, ZTH
AF Fung, Isaac Chun-Hai
   Blankenship, Elizabeth B.
   Goff, M. Elizabeth
   Mullican, Lindsay A.
   Chan, Kwun Cheung
   Saroha, Nitin
   Duke, Carmen H.
   Eremeeva, Marina E.
   Fu, King-Wa
   Tse, Zion Tsz Ho
TI ZIKA VIRUS-RELATED PHOTO SHARING ON PINTEREST AND INSTAGRAM
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Fung, Isaac Chun-Hai; Blankenship, Elizabeth B.; Goff, M. Elizabeth; Mullican, Lindsay A.; Duke, Carmen H.; Eremeeva, Marina E.] Georgia Southern Univ, Statesboro, GA USA.
   [Chan, Kwun Cheung; Fu, King-Wa] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China.
   [Saroha, Nitin; Tse, Zion Tsz Ho] Univ Georgia, Athens, GA 30602 USA.
RI Fu, King-wa/A-2385-2010
OI Fu, King-wa/0000-0001-8157-5276
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 825
BP 259
EP 259
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502348
DA 2020-07-08
ER

PT J
AU Perera, R
   Anderson, K
   Webb, K
   Andre, BG
   Gresh, L
   Balmaseda, A
   Beaty, B
   Harris, E
   Blair, CD
AF Perera, Rushika
   Anderson, Kimberly
   Webb, Kristofor
   Andre, Barbara G.
   Gresh, Lionel
   Balmaseda, Angel
   Beaty, Barry
   Harris, Eva
   Blair, Carol D.
TI DISCOVERY OF SMALL MOLECULE BIOMARKERS THAT PROVIDE METABOLIC SIGNATURES
   TO DIFFERENTIATE DENGUE, CHIKUNGUNYA AND ZIKA VIRUS INFECTIONS AND
   DENGUE DISEASE SEVERITY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Perera, Rushika; Anderson, Kimberly; Webb, Kristofor; Andre, Barbara G.; Beaty, Barry; Blair, Carol D.] Colorado State Univ, Ft Collins, CO 80523 USA.
   [Gresh, Lionel] Sustainable Sci Inst, Managua, Nicaragua.
   [Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
OI Webb, Kristofor/0000-0001-8111-9756
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1231
BP 386
EP 386
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502753
DA 2020-07-08
ER

PT J
AU Villar, LA
   Paez, A
   Pardo, L
   Rico, A
   Diaz, FJ
   Gelvez, M
   Herrera, VM
AF Villar, Luis Angel
   Paez, Andres
   Pardo, Lizeth
   Rico, Angelica
   Diaz, Francisco Javier
   Gelvez, Margarita
   Herrera, Victor Mauricio
TI PERFORMANCE OF A RAPID TEST FOR THE DETECTION OF DENGUE DURING THE
   OUTBREAK OF ZIKA VIRUS IN COLOMBIA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Villar, Luis Angel; Gelvez, Margarita; Herrera, Victor Mauricio] Univ Ind Santander, Ctr Invest Epidemiol, Bucaramanga, Colombia.
   [Villar, Luis Angel; Gelvez, Margarita; Herrera, Victor Mauricio] Red AEDES Abordando Dengue & Otras Arbovirosis Ar, Bucaramanga, Colombia.
   [Paez, Andres; Pardo, Lizeth] Inst Nacl Salud, Grp Virol, Bogota, Colombia.
   [Paez, Andres; Pardo, Lizeth] Red AEDES Abordando Dengue & Otras Arbovirosis Ar, Bogota, Colombia.
   [Diaz, Francisco Javier] Univ Antioquia, Fac Med, Grp Inmunovirol, Medellin, Colombia.
   [Diaz, Francisco Javier] Red AEDES Abordando Dengue & Otras Arbovirosis Ar, Medellin, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1360
BP 427
EP 428
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502883
DA 2020-07-08
ER

PT J
AU Torres, FP
   Esposito, DL
   Klein, TM
   Moraes, FM
   Persona, MR
   Fonseca, BA
AF Torres, Fernanda P.
   Esposito, Danillo L.
   Klein, Taline M.
   Moraes, Flavia M.
   Persona, Michelli R.
   Fonseca, Benedito A.
TI DEFINING THE CLINICAL MANIFESTATIONS OF ZIKA AND DENGUE PATIENTS
   ATTENDED IN RIBEIRAO PRETO, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Torres, Fernanda P.; Esposito, Danillo L.; Klein, Taline M.; Moraes, Flavia M.; Persona, Michelli R.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, Brazil.
RI Esposito, Danillo L.A./N-9261-2017
OI Esposito, Danillo L.A./0000-0002-2755-4471
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1366
BP 429
EP 429
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502889
DA 2020-07-08
ER

PT J
AU Gusmao, AF
   Lopes, PEL
   Mondini, A
AF Gusmao, Arianne Fagotti
   Lima Lopes-Filho, Paulo Eduardo
   Mondini, Adriano
TI WHAT NOW? CIRCULATION OF ZIKA, DENGUE AND CHIKUNGUNYA VIRUSES IN A CITY
   FROM BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Gusmao, Arianne Fagotti; Lima Lopes-Filho, Paulo Eduardo; Mondini, Adriano] UNESP Sao Paulo State Univ, Araraquara, SP, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1370
BP 430
EP 431
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502893
DA 2020-07-08
ER

PT J
AU Romo, HE
   Goenaga, S
   Kenney, JL
   Ebel, GD
   Brault, AC
AF Romo, Hannah E.
   Goenaga, Silvina
   Kenney, Joan L.
   Ebel, Gregory D.
   Brault, Aaron C.
TI DECREASED ZIKA VIRUS REPLICATION IN MOSQUITO CELLS CO-INFECTED WITH
   NHUMIRIM VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Romo, Hannah E.; Ebel, Gregory D.] Colorado State Univ, Ft Collins, CO 80523 USA.
   [Goenaga, Silvina] Inst Nacl Enfermedades Virales Humanas, Pergamino, Argentina.
   [Kenney, Joan L.; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
RI Kenney, Joan L./AAE-7416-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1373
BP 431
EP 432
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502896
DA 2020-07-08
ER

PT J
AU Goryoka, G
   Chamberlain, AT
   Ellingson, MK
   Kasturi, R
   Lehnert, JD
   Maier, E
   Berkelman, RL
AF Goryoka, Grace
   Chamberlain, Allison T.
   Ellingson, Mallory K.
   Kasturi, Raghuraj
   Lehnert, Jonathan D.
   Maier, Emily
   Berkelman, Ruth L.
TI AVAILABILITY OF ZIKA VIRUS INFORMATION ON OBSTETRIC PRACTICE WEBSITES
   AND SOCIAL MEDIA ACCOUNTS IN THE UNITED STATES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Goryoka, Grace; Chamberlain, Allison T.; Ellingson, Mallory K.; Kasturi, Raghuraj; Lehnert, Jonathan D.; Maier, Emily; Berkelman, Ruth L.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
RI Chamberlain, Allison T./AAA-3835-2019
OI Chamberlain, Allison T./0000-0001-6009-537X
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1374
BP 432
EP 432
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502897
DA 2020-07-08
ER

PT J
AU Saberi, R
   Lahey, C
   Hale, J
   Wang, T
   King, A
   Robinson, D
   Schaudies, RP
   Altman, A
AF Saberi, Ramin
   Lahey, Cora
   Hale, Jamie
   Wang, Tiffany
   King, Abbegail
   Robinson, Doreen
   Schaudies, R. Paul
   Altman, Amy
TI ZIKA AND OTHER MOSQUITO-BORNE VIRUS DETECTION AND DIFFERENTIATION USING
   A MULTIPLEXED, BEAD BASED RT-PCR ASSAY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Saberi, Ramin; Lahey, Cora; Hale, Jamie; Wang, Tiffany; King, Abbegail; Altman, Amy] Luminex Corp, Austin, TX USA.
   [Robinson, Doreen; Schaudies, R. Paul] GenArraytion Inc, Rockville, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1375
BP 432
EP 432
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502898
DA 2020-07-08
ER

PT J
AU Tami, A
   Mendoza, S
   Salazar, FM
   Tovar, R
   Bethencourt, S
   Niesters, H
   Rojas, G
   Ochoa, H
   Scribani, L
AF Tami, Adriana
   Mendoza, Sandra
   Salazar, Fe M.
   Tovar, Robert
   Bethencourt, Sarah
   Niesters, Hubert
   Rojas, Guillermo
   Ochoa, Haydee
   Scribani, Luis
TI CHARACTERIZATION OF PATIENTS WITH GUILLAIN-BARRE SYNDROME DURING THE
   ZIKA EPIDEMIC IN VENEZUELA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Tami, Adriana; Niesters, Hubert] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.
   [Mendoza, Sandra] Ciudad Hosp Enrique Tejera, Serv Neurol, Valencia, Venezuela.
   [Salazar, Fe M.] Ciudad Hosp Enrique Tejera, Serv Cardiol, Valencia, Venezuela.
   [Tovar, Robert; Bethencourt, Sarah] Univ Carabobo, Unidad Invest Inmunol UNIVENIN, Fac Ciencias Salud, Valencia, Venezuela.
   [Rojas, Guillermo] Fdn Inst Carabobeno Salud INSALUD, Direcc Epidemiol Reg, Valencia, Venezuela.
   [Ochoa, Haydee] Ciudad Hosp Enrique Tejera, Direcc Med, Valencia, Venezuela.
   [Scribani, Luis] Ciudad Hosp Enrique Tejera, Serv Epidemiol, Valencia, Venezuela.
RI Niesters, Hubert/AAH-6808-2019
OI Tami, Adriana/0000-0002-1918-9144
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1377
BP 433
EP 433
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502900
DA 2020-07-08
ER

PT J
AU Waggoner, JJ
   Gresh, L
   Vargas, MJ
   Ballesteros, G
   Tellez, Y
   Nunez, A
   Balmaseda, A
   Harris, E
   Pinsky, B
AF Waggoner, Jesse J.
   Gresh, Lionel
   Vargas, Maria Jose
   Ballesteros, Gabriela
   Tellez, Yolanda
   Nunez, Andrea
   Balmaseda, Angel
   Harris, Eva
   Pinsky, Benjamin
TI VIREMIA AND CLINICAL PRESENTATION AMONG NICARAGUAN PATIENTS WITH ZIKA
   VIRUS AND DENGUE VIRUS INFECTIONS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Waggoner, Jesse J.; Pinsky, Benjamin] Stanford Univ, Palo Alto, CA 94304 USA.
   [Gresh, Lionel] Sustainable Sci Inst, Managua, Nicaragua.
   [Vargas, Maria Jose; Ballesteros, Gabriela; Tellez, Yolanda; Nunez, Andrea; Balmaseda, Angel] Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Berkeley, CA 94720 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1378
BP 433
EP 433
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502901
DA 2020-07-08
ER

PT J
AU Ebel, GD
   Weger, J
   Rueckert, C
   Grubaugh, N
   Fauver, J
AF Ebel, Gregory D.
   Weger, James
   Rueckert, Claudia
   Grubaugh, Nathan
   Fauver, Joseph
TI RELATIVE FITNESS OF ZIKA VIRUS LINEAGES IN MOSQUITOES AND CELLS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Ebel, Gregory D.; Weger, James; Rueckert, Claudia; Grubaugh, Nathan; Fauver, Joseph] Colorado State Univ, Ft Collins, CO 80523 USA.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1381
BP 434
EP 434
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502904
DA 2020-07-08
ER

PT J
AU Mier-Y-Teran, L
   Johansson, M
AF Mier-y-Teran, Luis
   Johansson, Michael
TI GUILLAIN-BARRE SYNDROME RISK AMONG INDIVIDUALS INFECTED WITH ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Mier-y-Teran, Luis] Ctr Dis Control & Prevent, Div Vector Borne Dis, Dengue Branch, Washington, DC USA.
   [Johansson, Michael] Ctr Dis Control & Prevent, Dengue Branch, Div Vector Borne Dis, San Juan, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1380
BP 434
EP 434
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502903
DA 2020-07-08
ER

PT J
AU Dowd, KA
   DeMaso, C
   Pelc, RS
   Goo, L
   Speer, S
   Smith, A
   Diamond, MS
   Mascola, JR
   Graham, BS
   Ledgerwood, JE
   Pierson, TC
AF Dowd, Kimberly A.
   DeMaso, Christina
   Pelc, Rebecca S.
   Goo, Leslie
   Speer, Scott
   Smith, Alex
   Diamond, Michael S.
   Mascola, John R.
   Graham, Barney S.
   Ledgerwood, Julie E.
   Pierson, Theodore C.
TI EVALUATING STRAIN SPECIFICITY OF THE ZIKA VIRUS NEUTRALIZING ANTIBODY
   RESPONSE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Dowd, Kimberly A.; DeMaso, Christina; Pelc, Rebecca S.; Goo, Leslie; Speer, Scott; Smith, Alex; Pierson, Theodore C.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, St Louis, MO USA.
   [Mascola, John R.; Graham, Barney S.; Ledgerwood, Julie E.] NIH, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA.
RI Diamond, Michael/AAH-1733-2019; Graham, Barney S./AAC-5898-2019
OI Diamond, Michael/0000-0002-8791-3165; Graham, Barney
   S./0000-0001-8112-0853
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1385
BP 435
EP 435
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502908
DA 2020-07-08
ER

PT J
AU Esposito, DL
   Moraes, FM
   Klein, TM
   Persona, MR
   Ribeiro, BS
   Molla, VC
   Frade, MAC
   Fonseca, BA
AF Esposito, Danillo L.
   Moraes, Flavia M.
   Klein, Taline M.
   Persona, Michelli R.
   Ribeiro, Beatriz S.
   Molla, Vinicius C.
   Frade, Marco Andrey C.
   Fonseca, Benedito A.
TI ZIKA VIRUS INFECTIONS: PAYING ATTENTION TO ATYPICAL PRESENTATIONS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Esposito, Danillo L.; Moraes, Flavia M.; Klein, Taline M.; Persona, Michelli R.; Ribeiro, Beatriz S.; Molla, Vinicius C.; Frade, Marco Andrey C.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
RI Esposito, Danillo L.A./N-9261-2017; Frade, Marco A C/G-1165-2012; FRADE,
   MARCO ANDREY/AAB-5450-2020
OI Esposito, Danillo L.A./0000-0002-2755-4471; Frade, Marco A
   C/0000-0003-2700-5971; FRADE, MARCO ANDREY/0000-0003-2700-5971
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1383
BP 435
EP 435
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502906
DA 2020-07-08
ER

PT J
AU Perkins, A
   Siraj, A
   Ruktanonchai, C
   Kraemer, M
   Tatem, A
AF Perkins, Alex
   Siraj, Amir
   Ruktanonchai, Corrine
   Kraemer, Moritz
   Tatem, Andrew
TI MODEL-BASED PROJECTIONS OF ZIKA VIRUS INFECTIONS IN CHILDBEARING WOMEN
   IN THE AMERICAS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Perkins, Alex; Siraj, Amir] Univ Notre Dame, Notre Dame, IN 46556 USA.
   [Ruktanonchai, Corrine; Tatem, Andrew] Univ Southampton, Southampton, Hants, England.
   [Kraemer, Moritz] Univ Oxford, Oxford, England.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1384
BP 435
EP 435
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502907
DA 2020-07-08
ER

PT J
AU Constenla, DO
   del Campo, JM
   Greenberg, A
   de Broucker, G
AF Constenla, Dagna O.
   del Campo, Jorge Martin
   Greenberg, Alexandra
   de Broucker, Gatien
TI THE POTENTIAL ECONOMIC IMPACT OF THE ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Constenla, Dagna O.; del Campo, Jorge Martin; Greenberg, Alexandra; de Broucker, Gatien] Johns Hopkins Univ, Baltimore, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1392
BP 437
EP 437
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502915
DA 2020-07-08
ER

PT J
AU Tauro, LB
AF Tauro, Laura B.
TI DENGUE, ZIKA AND CHIKUNGUNYA CO-INFECTIONS AMONG ACUTE FEBRILE ILLNES
   PATIENTS IN SALVADOR, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Tauro, Laura B.] FIOCRUZ BA, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1400
BP 440
EP 440
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502923
DA 2020-07-08
ER

PT J
AU Sneed, S
   Thompson, L
   Povelones, M
AF Sneed, Sarah
   Thompson, Letitia
   Povelones, Michael
TI MIDGUT COMMENSALS REGULATE INFECTION BY ZIKA AND SINDBIS VIRUSES IN
   AEDES AEGYPTI
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Sneed, Sarah; Thompson, Letitia; Povelones, Michael] Univ Penn, Philadelphia, PA 19104 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1436
BP 450
EP 450
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502959
DA 2020-07-08
ER

PT J
AU Iqbal, A
   Blair, B
   Colgrove, R
   Gardner, A
   Iacoviello, V
   Jenkins, H
   Wilson, M
   Chen, L
AF Iqbal, Aftab
   Blair, Barbra
   Colgrove, Robin
   Gardner, Andrew
   Iacoviello, Vito
   Jenkins, Helen
   Wilson, Mary
   Chen, Lin
TI ASSESSING POSSIBLE EXPOSURE TO ZIKA VIRUS IN A HOSPITAL POPULATION
   THROUGH A TRAVEL SCREENING QUESTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Iqbal, Aftab; Blair, Barbra; Colgrove, Robin; Gardner, Andrew; Iacoviello, Vito; Chen, Lin] Mt Auburn Hosp, Cambridge, MA USA.
   [Jenkins, Helen] Boston Univ, Sch Publ Hlth, Boston, MA USA.
   [Wilson, Mary] Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1708
BP 536
EP 536
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851503262
DA 2020-07-08
ER

PT J
AU Mohr, EL
   Dudley, DM
   Aliota, MT
   Weiler, A
   Lehrer-Brey, G
   Weisgrau, KL
   Mohns, MS
   Breitbach, ME
   Rasheed, MN
   Gellerup, DD
   Moncla, LH
   Post, J
   Schultz-Darken, N
   Schotkzo, ML
   Hayes, JM
   Eudailey, JA
   Moody, MA
   Permar, SR
   O'Connor, SL
   Rakasz, EG
   Simmons, HA
   Capuano, S
   Golos, TG
   Osorio, JE
   Friedrich, TC
   O'Connor, DH
AF Mohr, Emma L.
   Dudley, Dawn M.
   Aliota, Matthew T.
   Weiler, Andrea
   Lehrer-Brey, Gabrielle
   Weisgrau, Kim L.
   Mohns, Mariel S.
   Breitbach, Meghan E.
   Rasheed, Mustafa N.
   Gellerup, Dane D.
   Moncla, Louise H.
   Post, Jennifer
   Schultz-Darken, Nancy
   Schotkzo, Michele L.
   Hayes, Jennifer M.
   Eudailey, Josh A.
   Moody, M. Anthony
   Permar, Sallie R.
   O'Connor, Shelby L.
   Rakasz, Eva G.
   Simmons, Heather A.
   Capuano, Saverio, III
   Golos, Thaddeus G.
   Osorio, Jorge E.
   Friedrich, Thomas C.
   O'Connor, David H.
TI DEVELOPMENT OF A NONHUMAN PRIMATE MODEL OF ZIKA VIRUS INFECTION IN
   PREGNANT AND NON-PREGNANT RHESUS MACAQUES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Mohr, Emma L.; Dudley, Dawn M.; Aliota, Matthew T.; Weiler, Andrea; Lehrer-Brey, Gabrielle; Weisgrau, Kim L.; Mohns, Mariel S.; Breitbach, Meghan E.; Rasheed, Mustafa N.; Gellerup, Dane D.; Moncla, Louise H.; Post, Jennifer; Schultz-Darken, Nancy; Schotkzo, Michele L.; Hayes, Jennifer M.; O'Connor, Shelby L.; Rakasz, Eva G.; Simmons, Heather A.; Capuano, Saverio, III; Golos, Thaddeus G.; Osorio, Jorge E.; Friedrich, Thomas C.; O'Connor, David H.] Univ Wisconsin, Madison, WI USA.
   [Eudailey, Josh A.; Moody, M. Anthony; Permar, Sallie R.] Duke Univ, Durham, NC USA.
RI Rakasz, Eva G/H-9197-2019; Moody, M/AAB-6947-2020
OI Moody, M/0000-0002-3890-5855
NR 0
TC 0
Z9 0
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1821
BP 570
EP 570
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851503375
DA 2020-07-08
ER

PT J
AU Kawiecki, AB
   Charles, AS
   Christofferson, RC
AF Kawiecki, Anna B.
   Charles, Anu Susan
   Christofferson, Rebecca C.
TI BOOSTING ALTERS THE CROSS-NEUTRALIZING CAPACITY OF ANTIBODY-RESPONSE
   FOLLOWING ZIKA EXPOSURE IN C57BL/6 MICE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Kawiecki, Anna B.; Charles, Anu Susan; Christofferson, Rebecca C.] Louisiana State Univ, Baton Rouge, LA 70803 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1824
BP 571
EP 571
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851503378
DA 2020-07-08
ER

PT J
AU Puerta-Guardo, H
   Tabata, T
   Petitt, M
   Michlmayr, D
   Beltramello, M
   Corti, D
   Sallusto, F
   Lanzavecchia, A
   Pereira, L
   Harris, E
AF Puerta-Guardo, Henry
   Tabata, Takako
   Petitt, Matthew
   Michlmayr, Daniela
   Beltramello, Martina
   Corti, Davide
   Sallusto, Federica
   Lanzavecchia, Antonio
   Pereira, Lenore
   Harris, Eva
TI ZIKA VIRUS INFECTION OF HUMAN PLACENTAL CELLS AND EXPLANTS: THE ROLE OF
   ZIKV RECEPTORS AND ANTI-FLAVIVIRUS ANTIBODIES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Puerta-Guardo, Henry; Michlmayr, Daniela; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Tabata, Takako; Petitt, Matthew; Pereira, Lenore] Univ Calif San Francisco, Sch Dent, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.
   [Beltramello, Martina; Corti, Davide] Humabs BioMed SA, Bellinzona, Switzerland.
   [Sallusto, Federica; Lanzavecchia, Antonio] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland.
RI Michlmayr, Daniela/Q-1216-2018
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1822
BP 571
EP 571
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851503376
DA 2020-07-08
ER

PT J
AU Sirohi, D
   Chen, ZG
   Sun, L
   Klose, T
   Pierson, TC
   Rossmann, MG
   Kuhn, RJ
AF Sirohi, Devika
   Chen, Zhenguo
   Sun, Lei
   Klose, Thomas
   Pierson, Theodore C.
   Rossmann, Michael G.
   Kuhn, Richard J.
TI THE CRYO-EM STRUCTURE OF ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Sirohi, Devika; Chen, Zhenguo; Sun, Lei; Klose, Thomas; Rossmann, Michael G.; Kuhn, Richard J.] Purdue Univ, W Lafayette, IN 47907 USA.
   [Pierson, Theodore C.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
NR 0
TC 0
Z9 0
U1 0
U2 6
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1823
BP 571
EP 571
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851503377
DA 2020-07-08
ER

PT J
AU Weger-Lucarelli, JD
AF Weger-Lucarelli, James D.
TI VECTOR COMPETENCE OF AMERICAN MOSQUITOES FOR MULTIPLE STRAINS OF ZIKV
   REPRESENTING EACH GENETIC CLADE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Weger-Lucarelli, James D.] Colorado State Univ, Ft Collins, CO 80523 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1825
BP 571
EP 572
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851503379
DA 2020-07-08
ER

PT J
AU Swanstrom, J
   Plante, J
   Plante, K
   Young, E
   Heise, M
   de Silva, A
   Baric, R
AF Swanstrom, Jesica
   Plante, Jessica
   Plante, Ken
   Young, Ellen
   Heise, Mark
   de Silva, Aravinda
   Baric, Ralph
TI MAPPING ZIKA VIRUS CROSS-NEUTRALIZING EPITOPES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Swanstrom, Jesica; Plante, Jessica; Plante, Ken; Young, Ellen; Heise, Mark; de Silva, Aravinda; Baric, Ralph] Univ North Carolina Chapel Hill, Chapel Hill, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1826
BP 572
EP 572
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851503380
DA 2020-07-08
ER

PT J
AU Whitehead, SS
   Woodson, SE
   Firestone, C
   Amaro-Carambot, E
   Durbin, AP
AF Whitehead, Stephen S.
   Woodson, Sara E.
   Firestone, Caiyen
   Amaro-Carambot, Emerito
   Durbin, Anna P.
TI DEVELOPMENT AND CHARACTERIZATION OF LIVE ATTENUATED VACCINE CANDIDATES
   FOR ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Whitehead, Stephen S.; Woodson, Sara E.; Firestone, Caiyen; Amaro-Carambot, Emerito] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Durbin, Anna P.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
RI Whitehead, Stephen/AAG-2787-2019
NR 0
TC 0
Z9 0
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1827
BP 572
EP 572
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851503381
DA 2020-07-08
ER

PT J
AU Thompson, H
   Thakur, K
AF Thompson, Haley
   Thakur, Kiran
TI Infections of the Central Nervous System in Returning Travelers and
   Immigrants
SO CURRENT INFECTIOUS DISEASE REPORTS
LA English
DT Review
DE Infections in travelers and immigrants; Vaccinations; Parasitic
   infections; Encephalitis; Meningitis
ID TUBERCULOUS MENINGITIS; DIAGNOSTIC-CRITERIA; NEUROCYSTICERCOSIS;
   IMMUNIZATION; PREVENTION; DISEASE; VACCINATIONS; ENCEPHALITIS;
   GUIDELINE; CHILDREN
AB Purpose of Review This review highlights current knowledge in travel-related neuroinfectious diseases, providing insight on approaches to prevention, diagnosis, and treatment of infections of the central nervous system (CNS) in travelers and immigrants.
   Recent Findings Updates on travel vaccine recommendations including vaccine-specific interactions with immunosuppressive agents, advances in Zika virus and dengue virus vaccine development, new diagnostic criteria for neurocysticercosis, updates on treatment approaches for tuberculosis meningitis.
   Summary Increasing rates of travel are leading to the spread of known infectious diseases and the emergence of new diseases in travel medicine. Among these infections, neuroinfectious diseases carry significant morbidity and mortality. To reduce the effect of travel-related illness, appropriate pre-travel measures and up-to-date diagnostic and treatment strategies are essential for optimal outcomes. This review highlights important travel information relevant to neuroinfectious diseases for several populations including immunocompetent, immunocompromised, pregnant, and infant/children travelers. It also outlines the travel risk, clinical presentation, diagnosis, and management of a select list of neuroinfectious diseases by region, including neurocysticercosis, Zika virus, tuberculosis meningitis, rabies, and tick-borne encephalitis.
C1 [Thompson, Haley] New York Med Coll, 40 Sunshine Cottage Rd, Valhalla, NY 10595 USA.
   [Thakur, Kiran] Columbia Univ, Med Ctr, Milstein Hosp, Div Crit Care & Hospitalist Neurol,Dept Neurol, 177 Ft Washington Ave,8GS-300, New York, NY 10032 USA.
RP Thakur, K (corresponding author), Columbia Univ, Med Ctr, Milstein Hosp, Div Crit Care & Hospitalist Neurol,Dept Neurol, 177 Ft Washington Ave,8GS-300, New York, NY 10032 USA.
EM hthompso3@nymc.edu; ktt2115@cumc.columbia.edu
RI amsalu, ribka/G-8780-2019
CR [Anonymous], 2008, B WHO
   [Anonymous], 2017, UNWTO WORLD TOUR HIG
   Baird RA, 2013, NEUROLOGY, V80, P1424, DOI 10.1212/WNL.0b013e31828c2f3e
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Burneo JG, 2014, EPILEPSY CURR, V14, P23, DOI 10.5698/1535-7511-14.s2.23
   Cahill JF, 2010, IMMUNIZATION PATIENT, V2, P17, DOI DOI 10.7191/NEUR0L_
   Cantey P, 2017, CYSTICERCOSIS CDC YE
   Carabin H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001152
   Carpio A, 2016, ANN NEUROL, V80, P434, DOI 10.1002/ana.24732
   Centers for Disease Control and Prevention, 2017, ADV TRAV SPEC NEEDS
   Centers for Disease Control and Prevention, 2014, TICK BORN ENC TIS FA
   Centers for Disease Control and Prevention, 2016, ZIK TRAV INF
   Centers for Disease Control and Prevention, 2017, INF DIS REL TRAV JAP
   Centers for Disease Control and Prevention, 2017, INF DIS REL TRAV RAB
   Centers for Disease Control and Prevention, 2013, TRAV HLTH MEASL
   Centers for Disease Control and Prevention, 2017, INF DIS REL TRAV MEN
   Centers for Disease Control and Prevention, 2016, TRETM TB DIS
   Centers for Disease Control and Prevention, 2015, JAP ENC VACC
   Centers for Disease Control and Prevention, 2017, YELL INF DIS REL TRA
   Centers for Disease Control and Prevention, 2017, ZIK VIR TRANSM RISKS
   Centers for Disease Control and Prevention, 2016, BCG VACC FACT SHEET
   Centers for Disease Control and Prevention, 2017, TRAV SAF INF CHILDR
   Centers for Disease Control and Prevention, 2016, GUID VACC PREGN WOM
   Centers for Disease Control and Prevention, 2017, INF DIS REL TRAV MAL
   Centers for Disease Control and Prevention, 2015, ZIK
   Centers for Disease Control and Prevention, 2017, YELL PRETR ASS
   Centers for Disease Control and Prevention, 2016, UPD CDCS POL ER EFF
   Centers for Disease Control and Prevention, 2017, RAB VACC INF STAT
   Centers for Disease Control and Prevention, 2016, TRAV HLTH DENG
   Centers for Diseases Control and Prevention, 2017, VACC RECC INF CHILDR
   Chandran A, 2011, PEDIATR INFECT DIS J, V30, P3, DOI 10.1097/INF.0b013e3181ef25f7
   Chaurasia RN, 2015, INT J NEUROREHABIL, V2
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Cherian A, 2011, AFR HEALTH SCI, V11, P116
   Chin Jerome H, 2014, Neurol Clin Pract, V4, P199
   Confavreux C, 2001, NEW ENGL J MED, V344, P319, DOI 10.1056/NEJM200102013440501
   Dacheux L, 2008, CLIN INFECT DIS, V47, P1410, DOI 10.1086/592969
   De Broucker T, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0590-9
   Dekkiche S, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw001
   Del Brutto OH, 2017, J NEUROL SCI, V372, P202, DOI 10.1016/j.jns.2016.11.045
   Del Brutto OH, 2012, J TRAVEL MED, V19, P112, DOI 10.1111/j.1708-8305.2011.00592.x
   Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814
   Erra EO, 2015, EXPERT REV VACCINES, V14, P1167, DOI 10.1586/14760584.2015.1061939
   Fischer M, 2017, TICK BORNE ENCEPHALI
   Freedman DO, 2016, NEW ENGL J MED, V375, P247, DOI 10.1056/NEJMra1508815
   Gershman MD, 2017, CDC YELLOW BOOK 2018
   Hagmann S, 2010, PEDIATRICS, V125, pE1072, DOI 10.1542/peds.2009-1951
   Hankins DG, 2004, MAYO CLIN PROC, V79, P671, DOI 10.4065/79.5.671
   Heemskerk AD, 2016, NEW ENGL J MED, V374, P124, DOI 10.1056/NEJMoa1507062
   Hemachudha T, 2013, LANCET NEUROL, V12, P498, DOI 10.1016/S1474-4422(13)70038-3
   Herbinger KH, 2012, J TRAVEL MED, V19, P150, DOI 10.1111/j.1708-8305.2011.00589.x
   Kaiser R, 1999, BRAIN, V122, P2067, DOI 10.1093/brain/122.11.2067
   Kimura-Hayama ET, 2010, RADIOGRAPHICS, V30, P1705, DOI 10.1148/rg.306105522
   Kotton CN, 2008, EXPERT REV VACCINES, V7, P663, DOI 10.1586/14760584.7.5.663
   Krupa Kristin, 2016, Surg Neurol Int, V7, P12, DOI 10.4103/2152-7806.175881
   Lam CS, 2006, EUR J CLIN MICROBIOL, V25, P14, DOI 10.1007/s10096-005-0070-2
   Leibovitch EC, 2016, NEUROTHERAPEUTICS, V13, P562, DOI 10.1007/s13311-016-0453-3
   Leshem E, 2011, J TRAVEL MED, V18, P191, DOI 10.1111/j.1708-8305.2011.00516.x
   Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Mailand MT, 2017, J NEUROL, V264, P1035, DOI 10.1007/s00415-016-8263-4
   Mallewa M, 2007, EMERG INFECT DIS, V13, P136, DOI 10.3201/eid1301.060810
   Manning Susan E., 2008, Morbidity and Mortality Weekly Report, V57, P1
   McNamara LA, 2017, MMWR MORB MORTAL WKL
   Moyano LM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002692
   Nash TE, 2006, NEUROLOGY, V67, P1120, DOI 10.1212/01.wnl.0000238514.51747.3a
   Nash TE, 2004, NEUROLOGY, V62, P1934, DOI 10.1212/01.WNL.0000129481.12067.06
   Nash TE, 2011, NAT REV NEUROL, V7, P584, DOI 10.1038/nrneurol.2011.135
   National Institute of Allergy and Infectious Diseases, 2017, ZIK VIRU VACC
   Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870
   Perdue C, 2007, POSTGRAD MED J, V83, P437, DOI 10.1136/pgmj.2006.054593
   Prasad K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub4
   Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07
   Rubin LG, 2014, CLIN INFECT DIS, V58, pE44, DOI 10.1093/cid/cit684
   Ruslami R, 2013, LANCET INFECT DIS, V13, P27, DOI 10.1016/S1473-3099(12)70264-5
   Rutschmann OT, 2002, NEUROLOGY, V59, P1837, DOI 10.1212/WNL.59.12.1837
   Sher K, 2013, JCPSP-J COLL PHYSICI, V23, P405, DOI 06.2013/JCPSP.405408
   Singhi Pratibha, 2011, Ther Adv Neurol Disord, V4, P67, DOI 10.1177/1756285610395654
   Sriaroon Chakrapol, 2006, Travel Med Infect Dis, V4, P270, DOI 10.1016/j.tmaid.2005.06.001
   Stonehouse M, 2003, ARCH DIS CHILD, V88, P122, DOI 10.1136/adc.88.2.122
   World Health Organization, 2016, DENG VACC WHO POS PA, V91, P349
   World Health Organization, 2017, RAB FACT SHEET
   World Health Organization, 2017, TUB FACT SHEET
   World Health Organization, TICK BORN ENC VACC
   World Health Organization, 2017, ZIK VIR
   World Health Organization, 2017, INT TRAV HLTH JAP EN
NR 86
TC 4
Z9 5
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1523-3847
EI 1534-3146
J9 CURR INFECT DIS REP
JI Curr. Infect. Dis. Rep.
PD NOV
PY 2017
VL 19
IS 11
AR 45
DI 10.1007/s11908-017-0594-5
PG 14
WC Infectious Diseases
SC Infectious Diseases
GA FJ6SJ
UT WOS:000412888000003
PM 28975470
DA 2020-07-08
ER

PT J
AU Terzian, ACB
   Estofolete, CF
   da Silva, RA
   Vaz-Oliani, DCM
   Oliani, AH
   de Mattos, CCB
   de Mattos, LC
   Rahal, P
   Nogueira, ML
AF Terzian, Ana Carolina B.
   Estofolete, Cassia Fernanda
   da Silva, Rafael Alves
   Mos Vaz-Oliani, Denise Cristina
   Oliani, Antonio Helio
   Brandao de Mattos, Cinara Cassia
   de Mattos, Luiz Carlos
   Rahal, Paula
   Nogueira, Mauricio L.
TI Long-Term Viruria in Zika Virus-Infected Pregnant Women, Brazil, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID VIREMIA; URINE
AB During the 2016 Zika virus outbreak in Brazil, we detected Zika virus RNA in urine samples collected from Zika virus-positive pregnant women during different stages of pregnancy. Women had positive and negative intervals of viruria; 3 newborns had adverse outcomes. Further research is needed to clarify the relationship between viruria and outcomes for newborns.
C1 [Terzian, Ana Carolina B.; Estofolete, Cassia Fernanda; da Silva, Rafael Alves; Nogueira, Mauricio L.] Sao Jose do Rio Preto Sch Med, Sao Jose Do Rio Preto, Brazil.
   [Mos Vaz-Oliani, Denise Cristina; Oliani, Antonio Helio; Brandao de Mattos, Cinara Cassia; de Mattos, Luiz Carlos] Sao Jose do Rio Preto Sch Med Fdn, Sao Jose Do Rio Preto, Brazil.
   [Rahal, Paula] Sao Paulo State Univ, Sao Jose Do Rio Preto, Brazil.
RP Nogueira, ML (corresponding author), Ave Brigadeiro Faria Lima 5416, Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI OLIANI, ANTONIO/O-1673-2019; de Mattos, Luiz Carlos/P-4005-2019;
   Nogueira, Mauricio L/B-7599-2012; de Mattos, Luiz Carlos/P-3574-2019;
   Rahal, Paula/D-3871-2012; Estofolete, Cassia/N-6673-2019; de Mattos,
   Cinara Brandao/B-3650-2008
OI de Mattos, Luiz Carlos/0000-0002-8572-8177; Nogueira, Mauricio
   L/0000-0003-1102-2419; Rahal, Paula/0000-0001-5693-6148; Estofolete,
   Cassia/0000-0001-7324-1591; de Mattos, Cinara
   Brandao/0000-0002-4836-3113; Oliani, Antonio Helio/0000-0003-1242-4364
FU Sao Paulo Research FoundationFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2013/21719-3, 2016/15021-1]; Sao Paulo Research
   Foundation Zika Network;  [2015/12295-0]
FX This work was supported by the Sao Paulo Research Foundation through
   grant numbers 2013/21719-3 and 2016/15021-1 for M.L.N. and the
   2015/12295-0 fellowship for A.C.B.T. This work was also supported by the
   Sao Paulo Research Foundation Zika Network. M.L.N. is a Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico Research Fellow.
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brazilian Ministry of Health, EX LAB
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oliveira Souto I., 2016, ENFERM INFECC MICROB
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320
   Wiwanitkit V, 2016, INT UROL NEPHROL, V48, P2023, DOI 10.1007/s11255-016-1417-6
NR 15
TC 6
Z9 6
U1 0
U2 7
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2017
VL 23
IS 11
BP 1891
EP 1893
DI 10.3201/eid2311.170078
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FJ9PC
UT WOS:000413109500021
PM 29048293
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Matheus, S
   de Laval, F
   Moua, D
   N'Guyen, C
   Martinez, E
   Rousset, D
   Briolant, S
AF Matheus, Severine
   de Laval, Franck
   Moua, David
   N'Guyen, Christophe
   Martinez, Enguerrane
   Rousset, Dominique
   Briolant, Sebastien
TI Zika Virus Persistence and Higher Viral Loads in Cutaneous Capillaries
   Than in Venous Blood
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID DENGUE VIRUS
AB We collected venous and capillary serum samples from 21 Zika virus-infected patients on multiple days after symptom onset and found RNA load was higher and median duration of virus detection significantly longer in capillary than in venous blood. These findings raise questions about the role of the capillary compartment in virus transmission dynamics.
C1 [Matheus, Severine; Moua, David; Rousset, Dominique] Inst Pasteur, Cayenne, French Guiana.
   [de Laval, Franck] Mil Ctr Epidemiol & Publ Hlth, Marseille, France.
   [de Laval, Franck; Martinez, Enguerrane] French Armed Forces Hlth Serv, Cayenne, French Guiana.
   [N'Guyen, Christophe; Briolant, Sebastien] French Armed Forces Biomed Res Inst, Marseille, France.
RP Matheus, S (corresponding author), Inst Pasteur, Ctr Natl Reference Arbovirus, Lab Associe, 23 Ave Pasteur,BP 6010-97306, Cayenne, French Guiana.
EM smatheus@pasteur-cayenne.fr
RI Rousset, Dominique/S-5400-2019
OI Rousset, Dominique/0000-0002-1473-3147
FU Direction Centrale du Service de Sante des Armees [2016RC10]; European
   Virus Archive Goes Global project from the European Union's Horizon
   Research and Innovation Program [653316]
FX This work was funded by the Direction Centrale du Service de Sante des
   Armees (grant agreement 2016RC10) and supported by the European Virus
   Archive Goes Global project, which has received funding (grant agreement
   653316) from the European Union's Horizon 2020 Research and Innovation
   Program. Funding sources played no role in study design, patient
   recruitment, data collection, analysis and interpretation of the data,
   or writing of the manuscript or the decision to submit it for
   publication.
CR Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
NR 6
TC 4
Z9 5
U1 0
U2 8
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2017
VL 23
IS 11
BP 1910
EP 1911
DI 10.3201/eid2311.170337
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FJ9PC
UT WOS:000413109500027
PM 28930015
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Salam, AP
   Horby, PW
AF Salam, Alex P.
   Horby, Peter W.
TI The Breadth of Viruses in Human Semen
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID ZIKA VIRUS
AB Zika virus RNA is frequently detected in the semen of men after Zika virus infection. To learn more about persistence of viruses in genital fluids, we searched PubMed for relevant articles. We found evidence that 27 viruses, across a broad range of virus families, can be found in human semen.
C1 [Salam, Alex P.; Horby, Peter W.] Univ Oxford, Oxford, England.
RP Salam, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Epidem Dis Res Grp, Roosevelt Dr, Oxford OX3 7BN, England.
EM alexsalam@doctors.org.uk
OI Horby, Peter/0000-0002-9822-1586
CR Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Brainard J, 2016, PLOS NEGLECT TROP D, V10
   Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   KAHRS RF, 1980, THERIOGENOLOGY, V14, P151, DOI 10.1016/0093-691X(80)90101-6
   Li N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00152
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005
NR 9
TC 20
Z9 22
U1 1
U2 5
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2017
VL 23
IS 11
BP 1922
EP 1924
DI 10.3201/eid2311.171049
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FJ9PC
UT WOS:000413109500033
PM 29048276
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Ryan, SJ
   Carlson, CJ
   Stewart-Ibarra, AM
   Borbor-Cordova, MJ
   Romero, MM
   Cox, SA
   Mahon, R
   Trotman, A
   Ville, SS
   Ahmed, S
AF Ryan, Sadie J.
   Carlson, Colin J.
   Stewart-Ibarra, Anna M.
   Borbor-Cordova, Mercy J.
   Romero, Moory M.
   Cox, Shelly-Ann
   Mahon, Roche
   Trotman, Adrian
   Ville, Sylvester St.
   Ahmed, Shalauddin
TI Outbreak of Zika Virus Infections, Dominica, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB In February 2016, the World Health Organization declared the pandemic of Zika virus a public health emergency. On March 4, 2016, Dominica reported its first autochthonous Zika virus disease case; subsequently, 1,263 cases were reported. We describe the outbreak through November 2016, when the last known case was reported.
C1 [Ryan, Sadie J.] Univ Florida, Gainesville, FL 32611 USA.
   [Ryan, Sadie J.] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.
   [Carlson, Colin J.] Univ Calif Berkeley, Berkeley, CA 94720 USA.
   [Stewart-Ibarra, Anna M.; Romero, Moory M.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA.
   [Borbor-Cordova, Mercy J.] Escuela Super Politecn Litoral, Guayaquil, Ecuador.
   [Cox, Shelly-Ann; Mahon, Roche; Trotman, Adrian] Caribbean Inst Meteorol & Hydrol, Bridgetown, Barbados.
   [Ville, Sylvester St.; Ahmed, Shalauddin] Minist Hlth & Environm, Roseau, Dominica.
RP Ryan, SJ (corresponding author), Univ Florida, Dept Geog, 3128 Turlington Hall, Gainesville, FL 32601 USA.
EM sjryan@ufl.edu
RI Ryan, Sadie Jane/H-7488-2019
OI Ryan, Sadie Jane/0000-0002-4308-6321; Stewart-Ibarra,
   Anna/0000-0002-3383-4672; Borbor, Mercy/0000-0002-7418-141X; Carlson,
   Colin/0000-0001-6960-8434; Mahon, Roche/0000-0001-9621-7033
CR Ahmed S, 2015, EMERG INFECT DIS, V21, P909, DOI 10.3201/eid2105.141813
   [Anonymous], 2017, ZIK EP REP PUERT RIC
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pacheco O, 2016, NEW ENGL J MED
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   [World Health Organization Pan-American Health Organization], 2016, CAS DEF SUSP CAS ZIK
NR 6
TC 6
Z9 8
U1 0
U2 6
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2017
VL 23
IS 11
BP 1926
EP 1927
DI 10.3201/eid2311.171140
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FJ9PC
UT WOS:000413109500035
PM 29048289
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Song, S
   Li, YY
   Fu, SH
   Liu, H
   Li, XL
   Gao, XY
   Xu, ZQ
   Liu, GP
   Wang, DM
   Tian, ZZ
   Zhou, JZ
   He, Y
   Lei, WW
   Wang, HY
   Wang, B
   Lu, XQ
   Liang, GD
AF Song, Song
   Li, Yuanyuan
   Fu, Shihong
   Liu, Hong
   Li, Xiaolong
   Gao, Xiaoyan
   Xu, Ziqian
   Liu, Guoping
   Wang, Dingming
   Tian, Zhenzao
   Zhou, Jingzhu
   He, Ying
   Lei, Wenwen
   Wang, Huanyu
   Wang, Bin
   Lu, Xiaoqing
   Liang, Guodong
TI Could Zika virus emerge in Mainland China? Virus isolation from nature
   in Culex quinquefasciatus, 2016
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
ID PROVINCE
C1 [Song, Song; Wang, Bin; Lu, Xiaoqing] Qingdao Univ, Qingdao 266071, Peoples R China.
   [Song, Song; Li, Yuanyuan; Fu, Shihong; Li, Xiaolong; Gao, Xiaoyan; Xu, Ziqian; He, Ying; Lei, Wenwen; Wang, Huanyu; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.
   [Song, Song; Li, Yuanyuan; Fu, Shihong; Li, Xiaolong; Gao, Xiaoyan; Xu, Ziqian; He, Ying; Lei, Wenwen; Wang, Huanyu; Liang, Guodong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China.
   [Liu, Hong] Shandong Univ Technol, Sch Life Sci, Shandong Prov Res Ctr Bioinformat Engn & Tech, Zibo 255049, Peoples R China.
   [Liu, Guoping] Ctr Dis Control & Prevent Shenyang Command, Shenyang 110034, Liaoning, Peoples R China.
   [Wang, Dingming; Tian, Zhenzao; Zhou, Jingzhu] Guizhou Prov Ctr Dis Control & Prevent, Guiyang 550004, Guizhou, Peoples R China.
RP Lu, XQ (corresponding author), Qingdao Univ, Qingdao 266071, Peoples R China.; Liang, GD (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.; Liang, GD (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China.
EM Luxq532@126.com; gdliang@hotmail.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81290342, 81501757]; Special National Project on
   Research and Development of Key Biosafety Technologies [2016YFC1201904];
   National Key Plan for Scientific Research and Development of China
   [2016YFD0500300]; development grants of State Key Laboratory of
   Infectious Disease Prevention and Control [2014SKLID103, 2015SKLID505];
   National Key Research and Development Program of China [2017YFC1200202];
   Open Research Fund Program of Wuhan National Bio-Safety Level 4 Lab of
   CAS [2017SPCAS003]
FX This work was supported by grants from the National Natural Science
   Foundation of China (81290342 and 81501757); the Special National
   Project on Research and Development of Key Biosafety Technologies
   (2016YFC1201904); the National Key Plan for Scientific Research and
   Development of China (2016YFD0500300); the development grants of State
   Key Laboratory of Infectious Disease Prevention and Control
   (2014SKLID103 and 2015SKLID505); the National Key Research and
   Development Program of China (2017YFC1200202); the Open Research Fund
   Program of Wuhan National Bio-Safety Level 4 Lab of CAS (2017SPCAS003).
CR Diawo D, 2014, PLOS ONE, V9
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Karabatsos N., 1985, INT CATALOGUE ARTHRO
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Li SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169256
   Liu H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-68
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005511
   Wang JL, 2011, AM J TROP MED HYG, V84, P738, DOI 10.4269/ajtmh.2011.10-0294
   WHO, WHO DIR GEN SUMM OUT
   Ye XF, 2010, J CLIN MICROBIOL, V48, P1343, DOI 10.1128/JCM.01009-09
NR 15
TC 8
Z9 11
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD NOV 1
PY 2017
VL 6
AR e93
DI 10.1038/emi.2017.80
PG 3
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FL5BM
UT WOS:000414245900002
PM 29089591
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chu, DT
   Ngoc, VTN
   Tao, Y
AF Dinh-Toi Chu
   Vo Truong Nhu Ngoc
   Tao, Yang
TI Zika virus infection in Vietnam: current epidemic, strain origin,
   spreading risk, and perspective
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Review
AB Zika virus infection and its associated microcephaly have being receiving global concern. This infection has spread widely since the first outbreak was recorded in Africa in 1952. Now, it has been reported in over 70 countries on five continents including Africa, North and South America, Asia, and Europe. Vietnam is one of the most recent countries which had cases of Zika virus infection at the end of 2016. This country has also reported the first case of a microcephaly-born baby which was probably linked to Zika virus infection. However, information on the Zika virus epidemic in Vietnam is still limited. This brief report intends to update the current Zika virus epidemic, and to discuss challenges and perspectives in controlling this infection in Vietnam.
C1 [Dinh-Toi Chu] Duy Tan Univ, Inst Res & Dev, 03 Quang Trung, Danang, Vietnam.
   [Dinh-Toi Chu] Hanoi Natl Univ Educ, Fac Biol, Hanoi, Vietnam.
   [Vo Truong Nhu Ngoc] Hanoi Med Univ, Sch Odonto Stomatol, Hanoi, Vietnam.
   [Tao, Yang] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095 8, Jiangsu, Peoples R China.
RP Chu, DT (corresponding author), Duy Tan Univ, Inst Res & Dev, 03 Quang Trung, Danang, Vietnam.; Chu, DT (corresponding author), Hanoi Natl Univ Educ, Fac Biol, Hanoi, Vietnam.
EM chudinhtoi.hnue@gmail.com
RI Chu, Dinh Toi/I-7414-2019
OI Chu, Dinh Toi/0000-0002-4596-2022
CR [Anonymous], 2016, ZIK VIR INF VIET NAM
   Chen YN, 2016, J MED ULTRASOUND, V24, P89, DOI 10.1016/j.jmu.2016.08.007
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Ho Chi Minh City People's Committee, 2016, PLANS REP EP HEM FEV
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ohba S, 2016, JPN J INFECT DIS, V69, P262, DOI 10.7883/yoken.JJID.2014.448
   Pham M, 2016, VIETNAM REPORTS FIRS
   Vietnamnet, 2016, VIETN REP 1 2 CAS ZI
NR 9
TC 8
Z9 10
U1 2
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD NOV
PY 2017
VL 36
IS 11
BP 2041
EP 2042
DI 10.1007/s10096-017-3030-8
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FK6NH
UT WOS:000413620200006
PM 28631169
DA 2020-07-08
ER

PT J
AU Epelboin, S
   Dulioust, E
   Epelboin, L
   Benachi, A
   Merlet, F
   Patrat, C
AF Epelboin, Sylvie
   Dulioust, Emmanuel
   Epelboin, Loic
   Benachi, Alexandra
   Merlet, Francoise
   Patrat, Catherine
TI Zika virus and reproduction: facts, questions and current management
SO HUMAN REPRODUCTION UPDATE
LA English
DT Article
DE Zika virus; fertility; reproduction; human; assisted reproduction;
   pregnancy outcome
ID SEXUAL TRANSMISSION; LATIN-AMERICA; BIRTH-DEFECTS; INFECTION; BRAZIL;
   SEMEN; OUTBREAK; DISEASE; CHALLENGES; PREGNANCY
AB BACKGROUND: Zika virus (ZIKV) is an arthropod-borne virus of the family Flaviviridae, genus Flavivirus. ZIKV is currently the focus of an ongoing pandemic and worldwide public health emergency. Although originally isolated in 1947, its pathogenesis was poorly known and very few documented infections were published until recently. Its route of transmission and its impact on reproduction and pregnancy have only recently begun to be disclosed.
   OBJECTIVE AND RATIONALE: This review summarizes the most recent knowledge about ZIKV infection and pathogenesis and focuses on its impacts on male and female genital tracts, including the risks of sexual transmission and to pregnancy. The consequences of ZIKV infection for pregnancy planning and ART are also discussed.
   SEARCH METHODS: The PubMed and EMBASE databases were inter-rogated using specific terms, such as 'ZIKV', 'transmission', 'male', 'female', fertility', 'pregnancy, 'semen', 'testis', 'ovary' and 'genital tract', up to 17 March 2017.
   OUTCOMES: ZIKV has long been considered a harmless virus, but increasing evidence suggests that it has adverse effects on the neurological system and on pregnancy outcomes. In mice, ZIKV slows foetal growth and damages the foetal brain. In humans, the virus is able to cross the placental barrier and to induce foetal death and major anomalies, such as microcephaly, brain defects and long-term neurologic sequelae, i.e. the 'congenital Zika syndrome'. In addition to its transmission by mosquitoes, ZIKV may be transmitted sexually. Currently available data indicate that ZIKV RNA can remain detectable in semen for several months, whereas shedding in the female genital tract appears to be rare and of short duration. Current guidance on preventing the sexual transmission of ZIKV is based on the assumption that transmission occurs from a male partner to a receptive partner. Furthermore, in mouse models, the virus can actively replicate in male genital organs and induce severe orchitis, which raises concerns about its possible impact on human male fertility.
   WIDER IMPLICATIONS: These new and relevant findings have led many countries and institutions to release updated and regular guidance for preconception counselling and ART to prevent the sexual transmission of ZIKV. Progress in understanding the sexual transmission of ZIKV and its dissemination to genital systems would also help to better anticipate and control outbreaks of potentially sexually transmissible infectious agents.
C1 [Epelboin, Sylvie] Hop Bichat Claude Bernard, AP HP, Serv Gynecol Obstet & Reprod, 46 Rue Henri Huchard, F-75018 Paris, France.
   [Epelboin, Sylvie; Patrat, Catherine] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.
   [Dulioust, Emmanuel] Hop Cochin, AP HP, Ctr Etud & Conservat Ovocytes & Sperme, 27 Rue Faubourg St Jacques, F-75014 Paris, France.
   [Dulioust, Emmanuel] Univ Paris 05, Sorbonne Paris Cite, Paris, France.
   [Epelboin, Loic] Hop Andree Rosemon, Ave Flamboyants, F-97300 Cayenne, France.
   [Epelboin, Loic] Univ Guyana, Equipe EA 3593, Ecosyst Amazoniens & Pathol Trop, Cayenne, Guyane Francais, France.
   [Benachi, Alexandra] Hop Antoine Beclere, AP HP, Serv Gynecol Obstet, 147 Rue Porte Trivaux, F-92140 Clamart, France.
   [Benachi, Alexandra] Univ Paris Sud, Clamart, France.
   [Merlet, Francoise] Agence Biomed, 1 Ave Stade France, F-93212 La Plaine St Denis, France.
   [Patrat, Catherine] Hop Bichat Claude Bernard, AP HP, Serv Biol Reprod, 46 Rue Henri Huchard, F-75018 Paris, France.
RP Patrat, C (corresponding author), Hop Bichat Claude Bernard, Serv Biol Reprod, 46 Rue Henri Huchard, F-75018 Paris, France.
EM catherine.patrat@aphp.fr
RI Epelboin, LoAc/AAP-6477-2020
OI Epelboin, LoAc/0000-0002-3481-5991; Patrat,
   Catherine/0000-0003-4885-8885
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/S1679-49742017000100002, 10.5123/s1679-49742017000100002]
   American Society for Reproductive Medicine, GUID PROV CAR WOM ME
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   CitilDogan A, 2016, J MATERN-FETAL NEO M, V30, P386
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daudens-Vaysse E, 2016, EURO SURVEILL, V21
   Davidson A, 2016, MD CDC MORB MOR 0715
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Epelboin L, 2016, Bull Soc Pathol Exot, V109, P114, DOI 10.1007/s13149-016-0490-5
   Epelboin L, 2013, PLOS NEGLECT TROP D, V7, P9
   European Centre for Disease Prevention and Control, 2014, ZIK VIR INF OUTBR BR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Food and Drug Administration, DON SCREEN REC RED R
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Human Fertilization and Embryology Authority, HFEA ZIK VIR GUID
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P41, DOI 10.1007/s11604-016-0599-2
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V11, P21, DOI DOI 10.2807/1560-7917
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Oehler E, 2014, EURO SURVEILL, V19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pacheco O, 2016, N ENGL J MED, V15
   Panchaud A, 2016, LANCET INFECT DIS, V16, P995, DOI 10.1016/S1473-3099(16)30255-9
   Paz-Bailey G, 2017, N ENGL J MED, V15
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Pomar L, 2017, ULTRASOUND OBST GYN, V12, P10
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Roberts DJ, 2016, LANCET, V388, P847, DOI 10.1016/S0140-6736(16)30930-8
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sarno M, 2016, ULTRASOUND OBST GYN, P19
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
NR 112
TC 10
Z9 10
U1 0
U2 30
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1355-4786
EI 1460-2369
J9 HUM REPROD UPDATE
JI Hum. Reprod. Update
PD NOV-DEC
PY 2017
VL 23
IS 6
BP 629
EP 645
DI 10.1093/humupd/dmx024
PG 17
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FK5JB
UT WOS:000413533000001
PM 28961800
OA Bronze
DA 2020-07-08
ER

PT J
AU Caswell, RJ
   Manavi, K
AF Caswell, Rachel J.
   Manavi, Kaveh
TI Emerging sexually transmitted viral infections: 1. Review of Ebola virus
   disease
SO INTERNATIONAL JOURNAL OF STD & AIDS
LA English
DT Review
DE Africa; epidemiology; Europe; sexual intercourse; treatment; Ebola
   virus; sexually transmitted infection; World Health Organization
ID CONVALESCENT PLASMA; HEMORRHAGIC-FEVER; COUNSELING PROGRAM;
   SIERRA-LEONE; TRANSMISSION; SURVIVORS; OUTBREAK; LIBERIA; PERSISTENCE;
   EFFICACY
AB This is the first in a series of articles reviewing four viral infections, Ebola virus, Zika virus, human T-cell lymphotropic virus, type 1 and hepatitis C virus, with an emphasis on recent advances in our understanding of their sexual transmission. With current day speed and ease of travel it is important for staff in sexual healthcare services to know and understand these infections when patients present to them and also to be able to advise those travelling to endemic regions. Following the recent resurgence in West Africa, this first article looks at Ebola virus disease (EVD). EVD has a high mortality rate and, of note, has been detected in the semen of those who have cleared the virus from their blood and have clinically recovered from the disease. As the result of emerging data, the WHO now recommends safe sex practices for all male survivors of EVD for 12 months after the onset of the disease or after having had two consecutive negative tests of semen specimens for the virus. This review provides an up-to-date summary of what is currently known about EVD and its implications for sexual health practice.
C1 [Caswell, Rachel J.; Manavi, Kaveh] Queen Elizabeth Hosp, Dept HIV & Genitourinary Med, Birmingham, W Midlands, England.
RP Caswell, RJ (corresponding author), Queen Elizabeth Hosp, Mindelsohn Way, Birmingham B15 2TH, W Midlands, England.
EM rachelcaswell@nhs.net
CR Akerlund E, 2015, NEW ENGL J MED, V372, P2467, DOI 10.1056/NEJMc1503275
   Arribas JR, 2016, NEW ENGL J MED, V374, P2498, DOI 10.1056/NEJMc1602284
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Ayouba A, 2017, J CLIN MICROBIOL, V55, P165, DOI 10.1128/JCM.01979-16
   Baize S, 2015, CURR OPIN VIROL, V10, P70, DOI 10.1016/j.coviro.2015.01.008
   Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545
   Becquart P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009126
   BIGGAR RJ, 1985, BMJ-BRIT MED J, V290, P808, DOI 10.1136/bmj.290.6471.808
   Broadhurst MJ, 2016, CLIN MICROBIOL REV, V29, P773, DOI 10.1128/CMR.00003-16
   Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479
   Clark DV, 2015, LANCET INFECT DIS, V15, P905, DOI 10.1016/S1473-3099(15)70152-0
   Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330
   Deen GF, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1511410, DOI 10.1056/NEJMOA1511410]
   Diallo B, 2016, CLIN INFECT DIS, V63, P1353, DOI 10.1093/cid/ciw601
   Dornemann J, 2017, J INFECT DIS, V215, P171, DOI 10.1093/infdis/jiw493
   Etard JF, 2017, LANCET INFECT DIS, V17, P545, DOI 10.1016/S1473-3099(16)30516-3
   Fischer R, 2015, EMERG INFECT DIS, V21, P1243, DOI 10.3201/eid2107.150253
   Francesconi P, 2003, EMERG INFECT DIS, V9, P1430, DOI 10.3201/eid0911.030339
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Heeney JL, 2015, NATURE, V527, P453, DOI 10.1038/527453a
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Hunt L, 2015, LANCET INFECT DIS, V15, P1292, DOI 10.1016/S1473-3099(15)00144-9
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   JOHNSON E, 1995, INT J EXP PATHOL, V76, P227
   Kanapathipillai Rupa, 2014, N Engl J Med, V371, pe18, DOI 10.1056/NEJMp1410741
   Kreuels B, 2014, NEW ENGL J MED, V371, P2394, DOI 10.1056/NEJMoa1411677
   Loftis AJ, 2017, J INFECT DIS, V215, P344, DOI 10.1093/infdis/jiw562
   MacIntyre CR, 2016, INT J INFECT DIS, V43, P58, DOI 10.1016/j.ijid.2015.12.011
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Mattia JG, 2016, LANCET INFECT DIS, V16, P331, DOI 10.1016/S1473-3099(15)00489-2
   Meltzer Martin I, 2014, MMWR Suppl, V63, P1
   Nelson JM, 2016, J PERINATOL, V36, P411, DOI 10.1038/jp.2015.189
   Purpura LJ, 2016, MMWR-MORBID MORTAL W, V65, P963, DOI 10.15585/mmwr.mm6536a5
   Reed DS, 2011, MICROBES INFECT, V13, P930, DOI 10.1016/j.micinf.2011.05.002
   Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291
   Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318
   Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680
   Scott JT, 2016, EMERG INFECT DIS, V22, P641, DOI 10.3201/eid2204.151302
   Smit MA, 2017, CLIN INFECT DIS, V64, P243, DOI 10.1093/cid/ciw725
   Soka MJ, 2016, LANCET GLOB HEALTH, V4, pE736, DOI 10.1016/S2214-109X(16)30175-9
   Spengler JR, 2015, J INFECT DIS, V212, pS346, DOI 10.1093/infdis/jiv187
   Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158
   Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004
   Uyeki TM, 2016, NEW ENGL J MED, V374, P636, DOI 10.1056/NEJMoa1504874
   van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812
   van Griensven J, 2016, NEW ENGL J MED, V375, P2307, DOI 10.1056/NEJMc1609116
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Vetter P, 2016, J INFECT DIS, V214, pS177, DOI 10.1093/infdis/jiw254
   Vetter Pauline, 2016, Lancet Infect Dis, V16, pe82, DOI 10.1016/S1473-3099(16)00077-3
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Wauquier N, 2009, EMERG INFECT DIS, V15, P1136, DOI 10.3201/eid1507.090402
   World Health Organisation, EB SUR CLIN OP MONR
   World Health Organisation, EM PREP RESP FREQ AS
   World Health Organization, 2016, EB VIR DIS
   World Health Organization, 2016, EBOLA SITUATION REPO
NR 56
TC 3
Z9 3
U1 1
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0956-4624
EI 1758-1052
J9 INT J STD AIDS
JI Int. J. STD AIDS
PD NOV
PY 2017
VL 28
IS 13
BP 1352
EP 1359
DI 10.1177/0956462417703572
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FJ7HD
UT WOS:000412927000012
PM 28399710
DA 2020-07-08
ER

PT J
AU Charrel, R
   Mogling, R
   Pas, S
   Papa, A
   Baronti, C
   Koopmans, M
   Zeller, H
   Leparc-Goffart, I
   Reusken, CB
AF Charrel, Remi
   Mogling, Ramona
   Pas, Suzan
   Papa, Anna
   Baronti, Cecile
   Koopmans, Marion
   Zeller, Herve
   Leparc-Goffart, Isabelle
   Reusken, Chantal B.
TI Variable Sensitivity in Molecular Detection of Zika Virus in European
   Expert Laboratories: External Quality Assessment, November 2016
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE EQA; EVD-LabNet; laboratory response; Zika virus; laboratory
   preparedness; external quality assessment; molecular virus diagnostics
ID WHOLE-BLOOD; RT-PCR; INFECTION; ASSAY; IDENTIFICATION; FLAVIVIRUSES;
   MICRONESIA; MARTINIQUE; OUTBREAK; KINETICS
AB Zika virus (ZIKV) infections are a significant public health concern. A strong capability for ZIKV detection is an absolute requirement for adequate preparedness and response strategies and individual patient care. The objective of this study was to assess and improve the capability of European expert laboratories for molecular testing for ZIKV through an external quality assessment (EQA) scheme. Laboratories were provided a panel of 12 samples which included negative samples, samples containing African-or Asian-lineage ZIKV at various concentrations (10(3) to 10(9) copies/ml), and samples containing dengue virus, yellow fever virus, or chikungunya virus. The results were analyzed on the basis of the outcomes of testing for the samples and the extraction and detection method used. Samples with a ZIKV RNA status scored correctly by >50% of the laboratories were designated the core sample. A total of 85 panel outcomes were submitted by 50 laboratories in 31 countries. The results designated all samples as core samples. Thirty-three percent (28/85) of the panel outcomes identified all samples. Analysis at the laboratory level showed that only 40% of the laboratories (20/50), representing 45% of the countries, scored sufficiently; i.e., they had at least one test operational that scored all core samples correctly. There is a need for improvement of the molecular detection of ZIKV in 60% of the participating laboratories. While the specificity of the tests was more robust, the results of the EQA showed large variation in test sensitivity. Improvements should focus on both nucleic acid extraction and ZIKV detection methods.
C1 [Charrel, Remi; Baronti, Cecile] Aix Marseille Univ, UMR EPV Emergence Pathol Virales, Marseille, France.
   [Mogling, Ramona; Pas, Suzan; Koopmans, Marion; Reusken, Chantal B.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Papa, Anna] Aristotle Univ Thessaloniki, Dept Microbiol, Thessaloniki, Greece.
   [Zeller, Herve] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
   [Leparc-Goffart, Isabelle] Armed Forces Biomed Res Inst, French Natl Reference Ctr Arbovirus, Marseille, France.
RP Reusken, CB (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
EM c.reusken@erasmusmc.nl
RI Koopmans, Marion/Y-9170-2019
OI Koopmans, Marion/0000-0002-5204-2312
FU European Centre for Disease Prevention and Control (ECDC) [1-ECD.6277,
   ECDC/2016/002]
FX This work was supported by the European Centre for Disease Prevention
   and Control (ECDC) under specific contract no. 1-ECD.6277 for
   implementation of the framework contract ECDC/2016/002.
CR Altona, 2017, REALSTAR ZIKA VIRUS
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2016, TYP ZIK VIR TESTS
   CDC, 2016, ANN GUID US LAB TEST
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Clonit, 2017, REALT PCR INF DIS VI
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2017, MOSQ MAPS CURR KNOWN
   ECDC, 2017, EP SIT
   ECDC, 2017, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control (ECDC), 2016, INT GUID HEALTHC PRO
   EVAg, 2017, YELL FEV VIR STRAIN
   EVAg, 2017, CHIK VIR STRAIN H202
   EVAg, 2017, ZIK VIR STRAIN MR 66
   EVAg, 2017, ZIK VIR STRAIN MRS O
   Fast Track Diagnostics, 2017, FID ZIK VIR
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Genesig, 2017, ZIK VIR
   Jacobsen S, 2016, J CLIN VIROL, V76, P55, DOI 10.1016/j.jcv.2016.01.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liferiver, 2017, ZIK VIR ZIKV REAL TI
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mogling R, 2017, EURO SURVEILL, V22
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   Paz-Bailey G, 2017, N ENGL J MED
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Pyke A. T., 2014, PLOS CURR
   Roche, 2017, ROCH REC FDA EM US A
   Sacace Biotechnologies, 2017, ZIK VIR REAL TM
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Tappe D, 2014, EUROSURVEILLANCE, V19, DOI [10.2807/1560-7917.ES2014.19.4.20685, DOI 10.2807/1560-7917.ES2014.19.4.20685]
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   WHO, 2016, ZIK VIR TECHN REP WH
NR 45
TC 17
Z9 17
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD NOV
PY 2017
VL 55
IS 11
BP 3219
EP 3226
DI 10.1128/JCM.00987-17
PG 8
WC Microbiology
SC Microbiology
GA FL6LO
UT WOS:000414356400012
PM 28835479
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Reusken, CBEM
   Knoester, M
   GeurtsvanKessel, C
   Koopmans, M
   Knapen, DG
   Bierman, WFW
   Pas, S
AF Reusken, Chantal B. E. M.
   Knoester, Marjolein
   GeurtsvanKessel, Corine
   Koopmans, Marion
   Knapen, Daan G.
   Bierman, Wouter F. W.
   Pas, Suzan
TI Urine as Sample Type for Molecular Diagnosis of Natural Yellow Fever
   Virus Infections
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Letter
DE PCR; diagnostics; urine; yellow fever
ID ZIKA VIRUS; GENOME; RNA
C1 [Reusken, Chantal B. E. M.; GeurtsvanKessel, Corine; Koopmans, Marion; Pas, Suzan] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Knoester, Marjolein] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol & Infect Prevent, Groningen, Netherlands.
   [Koopmans, Marion] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.
   [Knapen, Daan G.; Bierman, Wouter F. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Infect Dis, Groningen, Netherlands.
RP Reusken, CBEM (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
EM c.reusken@erasmusmc.nl
RI Koopmans, Marion/Y-9170-2019
OI Koopmans, Marion/0000-0002-5204-2312
CR Collins ND, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0566-9
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   ECDC, 2016, RAP RISK ASS OUTBR Y
   European Centre for Disease Prevention and Control (ECDC), 2017, RAP RISK ASS YELL FE
   International Organization for Standardization (ISO), 2012, 151892012 ISO
   Lamb LE, 2016, INT UROL NEPHROL, V48, P1961, DOI 10.1007/s11255-016-1406-9
   MATHUR A, 1995, INT J EXP PATHOL, V76, P103
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   Nagy A, 2016, ARCH VIROL, V161, P1797, DOI 10.1007/s00705-016-2844-5
   PAHO, 2017, LAB DIAGN YELL FEV V
   PAHO, 2017, YELL FEV EP AL UPD
   Papa A, 2014, J MED VIROL, V86, P2142, DOI 10.1002/jmv.23949
   Paz-Bailey G, 2017, N ENGL J MED
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018
   Tonry JH, 2005, EMERG INFECT DIS, V11, P1294, DOI 10.3201/eid1108.0238
   World Health Organization, 2016, YELL FEV LAB DIAGN T
   Wouthuyzen-Bakker M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.11.30488
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 20
TC 7
Z9 7
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD NOV
PY 2017
VL 55
IS 11
BP 3294
EP 3296
DI 10.1128/JCM.01113-17
PG 3
WC Microbiology
SC Microbiology
GA FL6LO
UT WOS:000414356400021
PM 28855304
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Harris, JK
   Hawkins, JB
   Nguyen, L
   Nsoesie, EO
   Tuli, G
   Mansour, R
   Brownstein, JS
AF Harris, Jenine K.
   Hawkins, Jared B.
   Nguyen, Leila
   Nsoesie, Elaine O.
   Tuli, Gaurav
   Mansour, Raed
   Brownstein, John S.
TI Using Twitter to Identify and Respond to Food Poisoning: The Food Safety
   STL Project
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Article
DE food safety; local health department; Twitter
ID FOODBORNE ILLNESS; SOCIAL MEDIA; SURVEILLANCE; HEALTH; CARE
AB Context: Foodborne illness affects 1 in 4 US residents each year. Few of those sickened seek medical care or report the illness to public health authorities, complicating prevention efforts. Citizens who report illness identify food establishments with more serious and critical violations than found by regular inspections. New media sources, including online restaurant reviews and social media postings, have the potential to improve reporting.
   Objective: We implemented a Web-based Dashboard (HealthMap Foodborne Dashboard) to identify and respond to tweets about food poisoning from St Louis City residents.
   Design and Setting: This report examines the performance of the Dashboard in its first 7 months after implementation in the City of St Louis Department of Health.
   Main Outcome Measures: We examined the number of relevant tweets captured and replied to, the number of foodborne illness reports received as a result of the new process, and the results of restaurant inspections following each report.
   Results: In its first 7 months (October 2015-May 2016), the Dashboard captured 193 relevant tweets. Our replies to relevant tweets resulted in more filed reports than several previously existing foodborne illness reporting mechanisms in St Louis during the same time frame. The proportion of restaurants with food safety violations was not statistically different (P=.60) in restaurants inspected after reports from the Dashboard compared with those inspected following reports through other mechanisms.
   Conclusion: The Dashboard differs from other citizen engagement mechanisms in its use of current data, allowing direct interaction with constituents on issues when relevant to the constituent to provide time-sensitive education and mobilizing information. In doing so, the Dashboard technology has potential for improving foodborne illness reporting and can be implemented in other areas to improve response to public health issues such as suicidality, spread of Zika virus infection, and hospital quality.
C1 [Harris, Jenine K.] Washington Univ, Brown Sch, One Brookings Dr, St Louis, MO 63130 USA.
   [Hawkins, Jared B.; Tuli, Gaurav; Brownstein, John S.] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA.
   [Hawkins, Jared B.; Brownstein, John S.] Harvard Med Sch, Dept Pediat, Boston, MA USA.
   [Nguyen, Leila] City St Louis Dept Hlth, St Louis, MO USA.
   [Nsoesie, Elaine O.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Mansour, Raed] Chicago Dept Publ Hlth, Chicago, IL USA.
RP Harris, JK (corresponding author), Washington Univ, Brown Sch, One Brookings Dr, St Louis, MO 63130 USA.
EM harrisj@wustl.edu
RI Mansour, Raed/F-7239-2013
OI Mansour, Raed/0000-0002-8484-0730
FU Center for Dissemination and Implementation at Washington University in
   St Louis; National Library of Medicine of the National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)
   [R01LM011965]
FX Jenine Harris received pilot funding from the Center for Dissemination
   and Implementation at Washington University in St Louis to support a
   small percentage of her time and a research assistant to help implement
   and evaluate the Dashboard. Elaine Nsoesie and John Brownstein received
   a grant from National Library of Medicine of the National Institutes of
   Health (award no. R01LM011965) to support the Dashboard development work
   including supporting the time of Jared Hawkins and Gaurav Tuli. Leila
   Nguyen and Raed Mansour have no funding sources associated with this
   work. The funders did not have any role in study design, collection,
   analysis, or interpretation of data, writing the report, or the decision
   to submit for publication.
CR Arendt S, 2013, INT J ENV RES PUB HE, V10, P3684, DOI 10.3390/ijerph10083684
   Centers for Disease Control and Prevention, WINN BATTL
   DugganM Ellison NB, 2014, SOCIAL MEDIA UPDATE, P1
   Harris JK, 2014, MMWR-MORBID MORTAL W, V63, P681
   Harrison C, 2014, MMWR-MORBID MORTAL W, V63, P441
   Hawkins JB, 2016, BMJ QUAL SAF, V25, P404, DOI 10.1136/bmjqs-2015-004309
   IRWIN K, 1989, AM J PUBLIC HEALTH, V79, P586, DOI 10.2105/AJPH.79.5.586
   Li J, 2010, J FOOD PROTECT, V73, P2059, DOI 10.4315/0362-028X-73.11.2059
   Marziano S., CUTGROUP 9 FOODBORNE
   McCabe-Sellers BJ, 2004, J AM DIET ASSOC, V104, P1708, DOI 10.1016/j.jada.2004.08.028
   Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502
   Song C, 2015, PUBLIC PERFORM MANAG, V39, P430, DOI 10.1080/15309576.2015.1108798
   Ung J., 2015, THE STATE PRESS 0917
   Veil SR, 2011, J CONTING CRISIS MAN, V19, P110, DOI 10.1111/j.1468-5973.2011.00639.x
NR 14
TC 12
Z9 12
U1 4
U2 29
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD NOV-DEC
PY 2017
VL 23
IS 6
BP 577
EP 580
DI 10.1097/PHH.0000000000000516
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FI7KQ
UT WOS:000412176000013
PM 28166175
OA Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Rutkow, L
   Paul, A
   Taylor, HA
   Barnett, DJ
AF Rutkow, Lainie
   Paul, Amy
   Taylor, Holly A.
   Barnett, Daniel J.
TI Perceived Facilitators and Barriers to Local Health Department Workers'
   Participation in Infectious Disease Emergency Responses
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Article
DE communicable diseases; disasters; policy; public health practice
ID HOSPITAL WORKERS; WILLINGNESS; CARE
AB Context: Local health departments play a key role in emergency preparedness and respond to a wide range of threats including infectious diseases such as seasonal influenza, tuberculosis, H1N1, Ebola virus disease, and Zika virus disease. To successfully respond to an infectious disease outbreak, local health departments depend upon the participation of their workforce; yet, studies indicate that sizable numbers of workers would not participate in such a response. The reasons why local health department workers participate, or fail to participate, in infectious disease responses are not well understood.
   Objective: To understand why local health department workers are willing, or not willing, to report to work during an infectious disease response.
   Design: From April 2015 to January 2016, we conducted 28 semistructured interviews with local health department directors, preparedness staff, and nonpreparedness staff.
   Setting: Interviews were conducted with individuals throughout the United States.
   Participants: We interviewed 28 individuals across 3 groups: local health department directors (n = 8), preparedness staff (n = 10), and nonpreparedness staff (n = 10).
   Main Outcome Measures: Individuals' descriptions of why local health department workers are willing, or not willing, to report to work during an infectious disease response.
   Results: Factors that facilitate willingness to respond to an infectious disease emergency included availability of vaccines and personal protective equipment; flexible work schedule and childcare arrangements; information sharing via local health department trainings; and perceived commitments to one's job and community. Factors that hinder willingness to respond to an infectious disease emergency included potential disease exposure for oneself and one's family; logistical considerations for care of children, the elderly, and pets; and perceptions about one's role during an infectious disease response.
   Conclusion: Our findings highlight opportunities for local health departments to revisit their internal policies and engage in strategies likely to promote willingness to respond among their staff. As LHDs face the persistent threat of infectious diseases, they must account for response willingness when planning for and fielding emergency responses. Our findings highlight opportunities for local health departments to revisit their internal policies and engage in strategies likely to promote response willingness to infectious disease emergencies among their staff.
C1 [Rutkow, Lainie; Taylor, Holly A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Room 592, Baltimore, MD 21205 USA.
   [Barnett, Daniel J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA.
   [Paul, Amy; Taylor, Holly A.] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA.
RP Rutkow, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Room 592, Baltimore, MD 21205 USA.
EM lrutkow@jhu.edu
OI Barnett, Daniel/0000-0003-1382-6197
FU National Institutes of Health, National Institute of General Medical
   SciencesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM105956]
FX This work was supported by the National Institutes of Health, National
   Institute of General Medical Sciences (#R01GM105956).
CR Balicer RD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-99
   Barnett DJ, 2014, HEALTH COMMUN, V29, P598, DOI 10.1080/10410236.2013.785474
   Barnett DJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-164
   Barnett DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006365
   Basta NE, 2009, J PUBLIC HEALTH MAN, V15, P375, DOI 10.1097/PHH.0b013e3181a391e2
   Buttross S, 2006, PEDIATRICS, V117, pS446, DOI 10.1542/peds.2006-0099T
   Chaffee Mary, 2009, Disaster Med Public Health Prep, V3, P42, DOI 10.1097/DMP.0b013e31818e8934
   Charney RL, 2015, PEDIATR EMERG CARE, V31, P839, DOI 10.1097/PEC.0000000000000629
   Devnani M, 2012, PREHOSP DISASTER MED, V27, P551, DOI 10.1017/S1049023X12001331
   Garrett AL, 2009, DISASTER MED PUBLIC, V3, pS141, DOI 10.1097/DMP.0b013e3181c12959
   Gershon RRM, 2010, J OCCUP ENVIRON MED, V52, P995, DOI 10.1097/JOM.0b013e3181f43872
   Hunter JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079457
   Institute of Medicine, 2008, RES PRIOR EM PREP RE
   Lawlor J, 2014, DISASTER MED PUBLIC, V8, P485, DOI 10.1017/dmp.2014.118
   Miles M. B., 2013, QUALITATIVE DATA ANA
   National Association of County & City Health Officials, 2013, 2013 NAT PROF LOC HL
   Rutkow L, 2015, PUBLIC POLICY PUBLIC
   Rutkow L., 2016, LOCAL HLTH DEP RESPO
   Rutkow L, 2015, DISASTER MED PUBLIC, V9, P98, DOI 10.1017/dmp.2015.8
   Smith MJ, 2015, MONASH BIOETH REV, V33, P130, DOI 10.1007/s40592-015-0038-7
   Taylor HA, 2014, BIOSECUR BIOTERROR, V12, P178, DOI 10.1089/bsp.2014.0009
NR 21
TC 2
Z9 2
U1 3
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD NOV-DEC
PY 2017
VL 23
IS 6
BP 644
EP 650
DI 10.1097/PHH.0000000000000574
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FI7KQ
UT WOS:000412176000024
PM 28832434
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Yu, JS
   Liao, HX
   Pritchett, J
   Bowman, C
   Vivian, C
   Parks, R
   Xia, SM
   Cooper, M
   Williams, WB
   Bonsignori, M
   Reed, SG
   Chen, M
   Vandergrift, N
   Rice, CM
   Haynes, BF
AF Yu, Jae-Sung
   Liao, Hua-Xin
   Pritchett, Jamie
   Bowman, Cindy
   Vivian, Callie
   Parks, Robert
   Xia, Shi-Mao
   Cooper, Melissa
   Williams, Wilton B.
   Bonsignori, Mattia
   Reed, Steven G.
   Chen, Meng
   Vandergrift, Nathan
   Rice, Charles M.
   Haynes, Barton F.
TI Development of a recombinant yellow fever vector expressing a HIV Glade
   C founder envelope gp120
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE HIV; HIV envelope; YFV17D; Antibodies; Neutralization;
   Transmitter/founder
ID ZIKA VIRUS; MONOCLONAL-ANTIBODIES; DOUBLE-BLIND; PHASE-III; MUCOSAL;
   STRAIN; GAG; IMMUNOGENICITY; REPLICATION; RESPONSES
AB Development of a HIV-1 vaccine is a major global priority. The yellow fever virus (YFV) attenuated vaccine 17D is among the most effective of currently used vaccines. However, the stability of the YFV17D vector when carrying non-flavivirus genes has been problematic. We have constructed and expressed HIV-1 Env in YFV17D with either single transmembrane (STM) or double transmembrane (DTM) YFV E protein domains for the development of anti-HIV antibodies. Here we describe modifications of the YFV17D vector such that HIV-1 Env gp120 is expressed in up to 5 passages in Vero cells. Immunization with recombinant YFV17D vector prime followed by HIV-1 CH505 TF gp120 protein boosts were able to induce neutralizing antibodies for a HIV-1 tier 1 isolate in mice. This modified YFV vector may be a starting point for constructing HIV-1 vaccine candidate priming vectors.
C1 [Yu, Jae-Sung; Liao, Hua-Xin; Pritchett, Jamie; Bowman, Cindy; Vivian, Callie; Parks, Robert; Xia, Shi-Mao; Cooper, Melissa; Williams, Wilton B.; Bonsignori, Mattia; Chen, Meng; Vandergrift, Nathan; Haynes, Barton F.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA.
   [Reed, Steven G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.
   [Rice, Charles M.] Infect Dis Res Inst, Seattle, WA 98102 USA.
   Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.
   [Liao, Hua-Xin] Jinan Univ, Coll Life Sci & Technol, 704 2nd Sci & Engn Bldg,601 Huang Pu Ave West, Guangzhou 510632, Guangdong, Peoples R China.
RP Yu, JS (corresponding author), Duke Univ, Med Ctr, 109 Res Pk Bldg 1,2 Circuit Dr, Durham, NC 27710 USA.; Haynes, BF (corresponding author), Duke Human Vaccine Inst, Freder M Hanes Prof Med & Immunol, MSRBII Bldg,Room 4090,DUMC 103020, Durham, NC 27710 USA.
EM jaesung.yu@duke.edu; hayne002@mc.duke.edu
RI Bonsignori, Mattia/AAE-7678-2019
OI Bonsignori, Mattia/0000-0003-2973-2101
FU Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVIID)
   grant from NIH/National Institute of Allergy and Infectious
   Diseases/Division of AIDS, United States [UMI-AI100645]
FX This work was supported by the Center for HIV/AIDS Vaccine
   Immunology-Immunogen Discovery (CHAVIID; UMI-AI100645) grant from
   NIH/National Institute of Allergy and Infectious Diseases/Division of
   AIDS, United States. Vendors described were related to the reagents and
   services used in the study for identification purposes only and do not
   imply endorsement.
CR Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144
   Auclair SM, 2012, PROTEIN SCI, V21, P13, DOI 10.1002/pro.757
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Bonaldo MC, 2014, HUM VACC IMMUNOTHER, V10, P1256, DOI 10.4161/hv.28117
   Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franco D, 2010, VACCINE, V28, P5676, DOI 10.1016/j.vaccine.2010.06.052
   Galler R, 1998, VACCINE, V16, P1024, DOI 10.1016/S0264-410X(97)00278-8
   Gao F, 2009, VIROLOGY, V394, P91, DOI 10.1016/j.virol.2009.07.041
   Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7
   HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2019, DOI 10.1073/pnas.84.7.2019
   Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053
   Lindenbach B.D., 2001, FLAVIVIRIDAE VIRUSES
   MARINARO M, 1995, J IMMUNOL, V155, P4621
   Martins MA, 2014, J VIROL, V88, P7493, DOI 10.1128/JVI.00601-14
   Martins MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054434
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533
   Montefiori D.C., 2005, CURR PROTOC IMMUNOL, V12, P11, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]
   Nabel GJ, 2001, NATURE, V410, P1002, DOI 10.1038/35073500
   Parks CL, 2013, CURR OPIN HIV AIDS, V8, P402, DOI 10.1097/COH.0b013e328363d389
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Ryu D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5504
   Sambrook J., 1989, MOL CLONING LAB MANU
   Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09
   VanCott JL, 1996, J IMMUNOL, V156, P1504
   de Santana MGV, 2014, VIROLOGY, V452, P202, DOI 10.1016/j.virol.2014.01.017
   Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659
NR 36
TC 2
Z9 2
U1 0
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD NOV
PY 2017
VL 249
BP 85
EP 93
DI 10.1016/j.jviromet.2017.08.012
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA FK0NQ
UT WOS:000413177000013
PM 28837840
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Glasner, A
   Oiknine-Djian, E
   Weisblum, Y
   Diab, M
   Panet, A
   Wolf, DG
   Mandelboim, O
AF Glasner, Ariella
   Oiknine-Djian, Esther
   Weisblum, Yiska
   Diab, Mohammad
   Panet, Amos
   Wolf, Dana G.
   Mandelboim, Ofer
TI Zika Virus Escapes NK Cell Detection by Upregulating Major
   Histocompatibility Complex Class I Molecules
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; MHC class I; NK cells; NK escape mechanisms
ID NATURAL-KILLER-CELLS; FLAVIVIRUS INFECTION; RECEPTOR NKP46; INHIBITORY
   RECEPTOR; MISSING SELF; WEST-NILE; RECOGNITION; EXPRESSION;
   CYTOTOXICITY; HOST
AB NK cells are innate lymphocytes that participate in many immune processes encompassing cancer, bacterial and fungal infection, autoimmunity, and even pregnancy and that specialize in antiviral defense. NK cells express inhibitory and activating receptors and kill their targets when activating signals overpower inhibitory signals. The NK cell inhibitory receptors include a uniquely diverse array of proteins named killer cell immunoglobulin-like receptors (KIR5), the CD94 family, and the leukocyte immunoglobulin-like receptor (LIR) family. The NK cell inhibitory receptors recognize mostly major histocompatibility complex (MHC) class I (MHC-I) proteins. Zika virus has recently emerged as a major threat due to its association with birth defects and its pandemic potential. How Zika virus interacts with the immune system, and especially with NK cells, is unclear. Here we show that Zika virus infection is barely sensed by NK cells, since little or no increase in the expression of activating NK cell ligands was observed following Zika infection. In contrast, we demonstrate that Zika virus infection leads to the upregulation of MHC class I proteins and consequently to the inhibition of NK cell killing. Mechanistically, we show that MHC class I proteins are upregulated via the RIGI-IRF3 pathway and that this upregulation is mediated via beta interferon (IFN-beta). Potentially, countering MHC class I upregulation during Zika virus infection could be used as a prophylactic treatment against Zika virus.
   IMPORTANCE NK cells are innate lymphocytes that recognize and eliminate various pathogens and are known mostly for their role in controlling viral infections. NK cells express inhibitory and activating receptors, and they kill or spare their targets based on the integration of inhibitory and activating signals. Zika virus has recently emerged as a major threat to humans due to its pandemic potential and its association with birth defects. The role of NK cells in Zika virus infection is largely unknown. Here we demonstrate that Zika virus infection is almost undetected by NK cells, as evidenced by the fact that the expression of activating ligands for NK cells is not induced following Zika infection. We identified a mechanism whereby Zika virus sensing via the RIGI-IRF3 pathway resulted in IFN-beta-mediated upregulation of MHC-I molecules and inhibition of NK cell activity. Countering MHC class I upregulation and boosting NK cell activity may be employed as prophylactic measures to combat Zika virus infection.
C1 [Glasner, Ariella; Diab, Mohammad; Mandelboim, Ofer] Hebrew Univ Jerusalem, Med Sch, Lautenberg Ctr Gen & Tumur Immunol, Dep Immunol & Canc Res,IMRIC,Fac Med, Jerusalem, Israel.
   [Oiknine-Djian, Esther; Weisblum, Yiska; Wolf, Dana G.] Hadassah Hebrew Univ, Med Ctr, Clin Virol Unit, Jerusalem, Israel.
   [Panet, Amos] Hebrew Univ Jerusalem, Dept Biochem, Fac Med, Jerusalem, Israel.
   [Panet, Amos] Hebrew Univ Jerusalem, Chanock Ctr Virol, IMRIC, Fac Med, Jerusalem, Israel.
RP Mandelboim, O (corresponding author), Hebrew Univ Jerusalem, Med Sch, Lautenberg Ctr Gen & Tumur Immunol, Dep Immunol & Canc Res,IMRIC,Fac Med, Jerusalem, Israel.
EM oferm@ekmd.huji.ac.il
FU European Research Council under the European Union's Seventh Framework
   Programme (FP) (ERC grant agreement) [320473-BacNK]; Israel Science
   FoundationIsrael Science Foundation; European Union Seventh Framework
   Programme (562 FP7) [316655]
FX This work was supported by the European Research Council under the
   European Union's Seventh Framework Programme (FP/2007-2013) (ERC grant
   agreement 320473-BacNK). Further support came from the Israel Science
   Foundation, the GIF, the ICRF professorship grant, the Helmholtz
   Foundation, and the Rosetrees Trust (all to O.M.). O.M. is a Crown
   Professor of Molecular Immunology. The work was also supported by grants
   from the Israel Science Foundation and the European Union Seventh
   Framework Programme (562 FP7/2012-2016) (grant agreement 316655) to
   D.G.W.
CR Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716
   Babic M, 2010, J EXP MED, V207, P2663, DOI 10.1084/jem.20100921
   Bar-On Y, 2014, J INFECT DIS, V210, P410, DOI 10.1093/infdis/jiu094
   Bar-On Y, 2013, CELL REP, V3, P1044, DOI 10.1016/j.celrep.2013.03.034
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L
   Chaushu S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002601
   Cheng Y, 2004, J INFECT DIS, V189, P658, DOI 10.1086/381501
   Diab M, 2017, EUR J IMMUNOL
   Diab M, 2016, ONCOTARGET
   Elboim M, 2010, J IMMUNOL, V184, P5637, DOI 10.4049/jimmunol.0901644
   Ghadially H, 2014, CELL REP, V7, P1809, DOI 10.1016/j.celrep.2014.05.011
   Ghadially H, 2013, EUR J IMMUNOL, V43, P3006, DOI 10.1002/eji.201343388
   Glasner A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40944
   Glasner A, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.36
   Glasner A, 2015, J IMMUNOL, V195, P3959, DOI 10.4049/jimmunol.1501234
   Glasner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036837
   Glasner A, 2012, J IMMUNOL, V188, P2509, DOI 10.4049/jimmunol.1102461
   Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010
   Gur C, 2013, CELL HOST MICROBE, V14, P664, DOI 10.1016/j.chom.2013.11.004
   Gur C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074033
   Gur C, 2012, GUT, V61, P885, DOI 10.1136/gutjnl-2011-301400
   Gur C, 2011, J IMMUNOL, V187, P3096, DOI 10.4049/jimmunol.1101269
   Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834
   Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452
   Hirayasu K, 2015, J HUM GENET, V60, P703, DOI 10.1038/jhg.2015.64
   Jarahian M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002195
   Jarahian M, 2009, J VIROL, V83, P8108, DOI 10.1128/JVI.00211-09
   Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x
   Kesson AM, 2001, J INFECT DIS, V184, P947, DOI 10.1086/323603
   KING NJC, 1988, J GEN VIROL, V69, P2535, DOI 10.1099/0022-1317-69-10-2535
   Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lam VC, 2017, CURR OPIN IMMUNOL, V44, P43, DOI 10.1016/j.coi.2016.11.003
   Lankry D, 2010, J IMMUNOL, V185, P2877, DOI 10.4049/jimmunol.0903347
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   LIU Y, 1989, J NEUROIMMUNOL, V21, P157, DOI 10.1016/0165-5728(89)90171-9
   Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913
   Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110
   Markel G, 2002, J IMMUNOL, V168, P2803, DOI 10.4049/jimmunol.168.6.2803
   Momburg F, 2001, J VIROL, V75, P5663, DOI 10.1128/JVI.75.12.5663-5671.2001
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nachmani D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003963
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Seidel E, 2015, CELL REP, V10, P968, DOI 10.1016/j.celrep.2015.01.029
   Seidel E, 2012, CELL MOL LIFE SCI, V69, P3911, DOI 10.1007/s00018-012-1001-x
   Shen J, 1997, J VIROL, V71, P9323, DOI 10.1128/JVI.71.12.9323-9332.1997
   Stanietsky N, 2013, EUR J IMMUNOL, V43, P2138, DOI 10.1002/eji.201243072
   Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106
   Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942
   Vitenshtein A, 2016, CELL HOST MICROBE, V20, P527, DOI 10.1016/j.chom.2016.09.008
   Vitenshtein A, 2016, CELL REP, V15, P2331, DOI 10.1016/j.celrep.2016.05.036
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674
NR 70
TC 12
Z9 12
U1 0
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2017
VL 91
IS 22
AR UNSP e00785-17
DI 10.1128/JVI.00785-17
PG 11
WC Virology
SC Virology
GA FL1WP
UT WOS:000414005400006
PM 28878071
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wang, SB
   Liu, Y
   Guo, J
   Wang, PL
   Zhang, LK
   Xiao, GF
   Wang, W
AF Wang, Shaobo
   Liu, Yang
   Guo, Jiao
   Wang, Peilin
   Zhang, Leike
   Xiao, Gengfu
   Wang, Wei
TI Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis
   Virus Infection
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE FDA-approved drugs; Japanese encephalitis virus; NS4B; flavivirus;
   high-throughput screening; manidipine
ID VIRAL NS4B PROTEIN; DENGUE VIRUS; WEST-NILE; IN-VITRO; NELFINAVIR
   MESYLATE; ANTIVIRAL ACTIVITY; RNA REPLICATION; FLAVIVIRUSES; MANIDIPINE;
   MANAGEMENT
AB Japanese encephalitis virus (JEV), an arthropod-borne flavivirus, is a major cause of acute viral encephalitis in humans. No approved drug is available for the specific treatment of JEV infections, and the available vaccines are not effective against all clinical JEV isolates. In the study described here, a high-throughput screening of an FDA-approved drug library for inhibitors of JEV was performed. Five hit drugs that inhibited JEV infection with a selective index of >10 were identified. The antiviral activities of these five hit drugs against other flavivirus, including Zika virus, were also validated. As three of the five hit drugs were calcium inhibitors, additional types of calcium inhibitors that confirmed that calcium is essential for JEV infection, most likely during viral replication, were utilized. Adaptive mutant analysis uncovered that replacement of Q130, located in transmembrane domain 3 of the nonstructural NS4B protein, which is relatively conserved in flaviviruses, with R or K conferred JEV resistance to manidipine, a voltage-gated Ca2(+) channel (VGCC) inhibitor, without an apparent loss of the viral growth profile. Furthermore, manidipine was indicated to protect mice against JEV-induced lethality by decreasing the viral load in the brain, while it abrogated the histopathological changes associated with JEV infection. This study provides five antiflavivirus candidates and identifies cytoplasmic calcium to be a novel antiviral target for the treatment of JEV infection. The findings reported here provide therapeutic possibilities for combating infections caused by flaviviruses.
   IMPORTANCE No approved therapy for the treatment of Japanese encephalitis virus infection is currently available. Repurposing of approved drugs would accelerate the development of a therapeutic stratagem. In this study, we screened a library of FDA-approved drugs and identified five hit drugs, especially calcium inhibitors, exerting antiflavivirus activity that blocked viral replication. The in vivo efficacy and toxicity of manidipine were investigated with a mouse model of JEV infection, and the viral target was identified by generating an adaptive mutant. KEYWORDS FDA-approved drugs, Japanese encephalitis virus, NS4B, flavivirus, high-throughput screening, manidipine
C1 [Wang, Shaobo; Liu, Yang; Guo, Jiao; Wang, Peilin; Zhang, Leike; Xiao, Gengfu; Wang, Wei] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.
   [Wang, Shaobo; Guo, Jiao; Wang, Peilin; Zhang, Leike; Xiao, Gengfu; Wang, Wei] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Wang, Shaobo] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.
RP Wang, W (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.; Wang, W (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.
EM wangwei@wh.iov.cn
OI Wang, Wei/0000-0002-8696-9773
FU National Natural Sciences Foundation of ChinaNational Natural Science
   Foundation of China [31670165, 31000089]
FX This work was supported by the National Natural Sciences Foundation of
   China (31670165 and 31000089).
CR Bonilla JJA, 2015, WORLD J MICROB BIOT, V31, P1801, DOI 10.1007/s11274-015-1933-z
   Bagan J, 2012, CURR PHARM DESIGN, V18, P5470, DOI 10.2174/138161212803307617
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Chami M, 2006, BBA-MOL CELL RES, V1763, P1344, DOI 10.1016/j.bbamcr.2006.09.025
   Cheer SM, 2001, DRUGS, V61, P1777, DOI 10.2165/00003495-200161120-00010
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   de Wispelaere M, 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13
   Ding W, 2002, J VIROL, V76, P10374, DOI 10.1128/JVI.76.20.10374-10382.2002
   Fang JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078425
   Gagliano T, 2014, ENDOCRINE, V47, P943, DOI 10.1007/s12020-014-0374-z
   Gantt S, 2011, ANTIMICROB AGENTS CH, V55, P2696, DOI 10.1128/AAC.01295-10
   Guo F, 2016, J VIROL, V90, P10774, DOI 10.1128/JVI.01253-16
   Han ZY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005220
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Jackson KA, 2000, ANTIMICROB AGENTS CH, V44, P1832, DOI 10.1128/AAC.44.7.1832-1837.2000
   Jin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052909
   Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597
   Kalu NN, 2014, J VIROL, V88, P5455, DOI 10.1128/JVI.03790-13
   Lavanya M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006827
   Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Li Kuohan, 2014, Virologica Sinica, V29, P74, DOI 10.1007/s12250-014-3438-6
   Liu HB, 2015, J VIROL, V89, P5668, DOI 10.1128/JVI.00293-15
   Otero ML, 2007, VASC HEALTH RISK MAN, V3, P255
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   McKeage K, 2004, DRUGS, V64, P1923, DOI 10.2165/00003495-200464170-00011
   Mercorelli B, 2016, CELL CHEM BIOL, V23, P340, DOI 10.1016/j.chembiol.2015.12.012
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Mizuno K, 1992, Blood Press Suppl, V3, P119
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Nagata N, 2015, J NEUROPATH EXP NEUR, V74, P250, DOI 10.1097/NEN.0000000000000166
   Osorio Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000962
   Palit P, 2008, ANTIMICROB AGENTS CH, V52, P374, DOI 10.1128/AAC.00522-07
   Patick AK, 1997, ANTIMICROB AGENTS CH, V41, P2159, DOI 10.1128/AAC.41.10.2159
   Patkar CG, 2009, ANTIMICROB AGENTS CH, V53, P4103, DOI 10.1128/AAC.00074-09
   Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005
   Roca-Cusachs A, 2005, DRUGS, V65, P11
   Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758
   Scherbik SV, 2010, J VIROL, V84, P8721, DOI 10.1128/JVI.00144-10
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   van Cleef KWR, 2016, ANTIMICROB AGENTS CH, V60, P2554, DOI 10.1128/AAC.02462-15
   van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011
   Wang QY, 2015, J VIROL, V89, P8233, DOI 10.1128/JVI.00855-15
   Wang SB, 2016, VIROLOGY, V498, P116, DOI 10.1016/j.virol.2016.08.013
   Xie XP, 2011, J VIROL, V85, P11183, DOI 10.1128/JVI.05468-11
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Zu XY, 2014, ANTIVIR RES, V104, P7, DOI 10.1016/j.antiviral.2014.01.011
NR 48
TC 18
Z9 18
U1 6
U2 19
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2017
VL 91
IS 21
AR UNSP e01055-17
DI 10.1128/JVI.01055-17
PG 14
WC Virology
SC Virology
GA FK0UI
UT WOS:000413195400027
PM 28814523
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Barzon, L
   Lavezzo, E
   Palu, G
AF Barzon, Luisa
   Lavezzo, Enrico
   Palu, Giorgio
TI Zika virus infection in semen: effect on human reproduction
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID SEXUAL TRANSMISSION; MALE-INFERTILITY; MICE
C1 [Barzon, Luisa; Lavezzo, Enrico; Palu, Giorgio] Univ Padua, Dept Mol Med, I-35121 Padua, Italy.
RP Barzon, L (corresponding author), Univ Padua, Dept Mol Med, I-35121 Padua, Italy.
EM luisa.barzon@unipd.it
RI Barzon, Luisa/K-7961-2016; Lavezzo, Enrico/K-7962-2016
OI Barzon, Luisa/0000-0003-0720-8456; Lavezzo, Enrico/0000-0002-3902-8356
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Garolla A, 2013, J REPROD IMMUNOL, V100, P20, DOI 10.1016/j.jri.2013.03.004
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Joguet G, 2017, LANCET INFECT DIS
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paz-Bailey G, 2017, NEW ENGL J MED, DOI [10.1056/NEJMoa1613108, DOI 10.1056/NEJM0A1613108]
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
NR 13
TC 8
Z9 8
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD NOV
PY 2017
VL 17
IS 11
BP 1107
EP 1109
DI 10.1016/S1473-3099(17)30495-4
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA FL2PP
UT WOS:000414059800012
PM 28838638
OA Bronze
DA 2020-07-08
ER

PT J
AU Halstead, SB
AF Halstead, Scott B.
TI Achieving safe, effective, and durable Zika virus vaccines: lessons from
   dengue
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID FLAVIVIRUS-NAIVE ADULTS; T-CELL RESPONSES; PROTECTIVE ROLE; SECONDARY
   INFECTION; THAI SCHOOLCHILDREN; CROSS-REACTIVITY; IMMUNITY; EFFICACY;
   ANTIBODY; VACCINATION
AB Newly proposed candidate Zika virus vaccines might or might not succeed in raising safe, effective, and durable protection against human Zika virus infections or syndromes. Analyses of a clinically tested and licensed dengue vaccine that failed to protect seronegative individuals from breakthrough or enhanced dengue infections suggest that poor T-cell immunity might have contributed to protection failure. Because of the similarity of Zika and dengue viruses, an analogous unwanted outcome might occur with some Zika virus vaccine designs. A successful Zika virus vaccine requires challenge experiments that are done at long intervals after immunisation and that identify protection as the absence of viraemia and the absence of an anamnestic antibody response. T-cell immunity might be an essential component of safe, efficacious, and durable Zika virus vaccines.
C1 [Halstead, Scott B.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
RP Halstead, SB (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
EM halsteads@erols.com
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akondy RS, 2015, P NATL ACAD SCI USA, V112, P3050, DOI 10.1073/pnas.1500475112
   Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P266
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brault AC, 2016, AM J TROP MED HYG, V94, P1187, DOI 10.4269/ajtmh.16-0277
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chaudhri G, 2015, J VIROL, V89, P1889, DOI 10.1128/JVI.02572-14
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075
   Gil L, 2014, VIROLOGY, V456, P70, DOI 10.1016/j.virol.2014.03.011
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Grifoni A, 2017, J VIROL, V91, DOI 10.1128/JVI.02133-16
   Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000
   Guirakhoo F, 2006, HUM VACCINES, V2, P60, DOI 10.4161/hv.2.2.2555
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1973, AM J TROP MED HYG, V22, P365, DOI 10.4269/ajtmh.1973.22.365
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Halstead SB, 2013, VACCINE, V31, P4501, DOI 10.1016/j.vaccine.2013.06.079
   Halstead SB, 2012, LANCET, V380, P1535, DOI 10.1016/S0140-6736(12)61510-4
   Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012
   KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lin WHW, 2014, MBIO, V5, DOI 10.1128/mBio.01047-14
   LIVINGSTON PG, 1995, J IMMUNOL, V154, P1287
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Moi ML, 2013, LANCET, V381, P1094, DOI 10.1016/S0140-6736(13)60754-0
   Morrison D, 2010, J INFECT DIS, V201, P370, DOI 10.1086/649916
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   Ouwendijk WJD, 2013, CURR OPIN VIROL, V3, P452, DOI 10.1016/j.coviro.2013.04.004
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sabchareon A, 2013, LANCET, V381, P1094, DOI 10.1016/S0140-6736(13)60755-2
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Tian Y, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00531
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   WHO Secretariat, 2016, BACKGR PAP DENG VACC
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yoo KH, 2010, ALLERGY ASTHMA PROC, V31, P499, DOI 10.2500/aap.2010.31.3399
   Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723
   Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124
NR 71
TC 19
Z9 20
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD NOV
PY 2017
VL 17
IS 11
BP E378
EP E382
DI 10.1016/S1473-3099(17)30362-6
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA FL2PP
UT WOS:000414059800005
PM 28711586
OA Bronze
DA 2020-07-08
ER

PT J
AU Delatorre, E
   Mir, D
   Bello, G
AF Delatorre, Edson
   Mir, Daiana
   Bello, Gonzalo
TI Tracing the origin of the NS1 A188V substitution responsible for recent
   enhancement of Zika virus Asian genotype infectivity
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika Virus; NS1; infectivity; evolution
ID CD-HIT; AMERICA; SEQUENCES
AB A recent study showed that infectivity of Zika virus (ZIKV) Asian genotype was enhanced by an alanine-to-valine amino acid substitution at residue 188 of the NS1 protein, but the precise time and location of origin of this mutation were not formally estimated. Here, we applied a Bayesian coalescent-based framework to estimate the age and location of the ancestral viral strain carrying the A188V substitution. Our results support that the ancestral ZIKV strain carrying the A188V substitution arose in Southeastern Asia at the early 2000s and circulated in that region for some time (5-10 years) before being disseminated to Southern Pacific islands and the Americas.
C1 [Delatorre, Edson; Mir, Daiana; Bello, Gonzalo] Fundacao Oswaldo Cruz, FIOCRUZ, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.
RP Bello, G (corresponding author), Fundacao Oswaldo Cruz, FIOCRUZ, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.
EM gbellobr@gmail.com
RI Bello, Gonzalo/E-6842-2013; Bentancor, Gonzalo Jose Bello/N-7377-2019;
   Delatorre, Edson/J-8330-2015; , daiana/J-5515-2019
OI Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Delatorre,
   Edson/0000-0002-5746-0820; , daiana/0000-0002-3172-4867
FU FIOCRUZ; PNPD/CAPESCAPES; ANII-Uruguay; CAPES-BrazilCAPES
FX FIOCRUZ; ED is a fellowship from PNPD/CAPES; DM is funded by fellowships
   from ANII-Uruguay and CAPES-Brazil.
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Freire CCM, 2015, BIORXIV
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
NR 18
TC 8
Z9 8
U1 0
U2 3
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD NOV
PY 2017
VL 112
IS 11
BP 793
EP 795
DI 10.1590/0074-02760170299
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FL2CW
UT WOS:000414023000011
PM 28876359
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wood, H
AF Wood, Heather
TI A new role for Zika virus in glioblastoma therapy?
SO NATURE REVIEWS NEUROLOGY
LA English
DT Editorial Material
NR 0
TC 1
Z9 1
U1 1
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-4758
EI 1759-4766
J9 NAT REV NEUROL
JI Nat. Rev. Neurol.
PD NOV
PY 2017
VL 13
IS 11
DI 10.1038/nrneurol.2017.138
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA FL1LI
UT WOS:000413975900004
DA 2020-07-08
ER

PT J
AU Fryk, JJ
   Marks, DC
   Hobson-Peters, J
   Watterson, D
   Hall, RA
   Young, PR
   Reichenberg, S
   Tolksdorf, F
   Sumian, C
   Gravemann, U
   Seltsam, A
   Faddy, HM
AF Fryk, Jesse J.
   Marks, Denese C.
   Hobson-Peters, Jody
   Watterson, Daniel
   Hall, Roy A.
   Young, Paul R.
   Reichenberg, Stefan
   Tolksdorf, Frank
   Sumian, Chryslain
   Gravemann, Ute
   Seltsam, Axel
   Faddy, Helen M.
TI Reduction of Zika virus infectivity in platelet concentrates after
   treatment with ultraviolet C light and in plasma after treatment with
   methylene blue and visible light
SO TRANSFUSION
LA English
DT Article
ID WEST-NILE-VIRUS; PATHOGEN REDUCTION; TRANSFUSION; TRANSMISSION;
   INACTIVATION; CHIKUNGUNYA; IMPACT; DENGUE; WORLDWIDE; OUTBREAK
AB BACKGROUNDZika virus (ZIKV) has emerged as a potential threat to transfusion safety worldwide. Pathogen inactivation is one approach to manage this risk. In this study, the efficacy of the THERAFLEX UV-Platelets system and THERAFLEX MB-Plasma system to inactivate ZIKV in platelet concentrates (PCs) and plasma was investigated.
   STUDY DESIGN AND METHODSPCs spiked with ZIKV were treated with the THERAFLEX UV-Platelets system at 0.05, 0.10, 0.15, and 0.20 J/cm(2) UVC. Plasma spiked with ZIKV was treated with the THERAFLEX MB-Plasma system at 20, 40, 60, and 120 J/cm(2) light at 630 nm with at least 0.8 mu mol/L methylene blue (MB). Samples were taken before the first and after each illumination dose and tested for residual virus. For each system the level of viral reduction was determined.
   RESULTSTreatment of PCs with THERAFLEX UV-Platelets system resulted in a mean of 5 log reduction in ZIKV infectivity at the standard UVC dose (0.20 J/cm(2)), with dose dependency observed with increasing UVC dose. For plasma treated with MB and visible light, ZIKV infectivity was reduced by a mean of at least 5.68 log, with residual viral infectivity reaching the detection limit of the assay at 40 J/cm(2) (one-third the standard dose).
   CONCLUSIONSOur study demonstrates that the THERAFLEX UV-Platelets system and THERAFLEX MB-Plasma system can reduce ZIKV infectivity in PCs and pooled plasma to the detection limit of the assays used. These findings suggest both systems have the capacity to be an effective option to manage potential ZIKV transfusion transmission risk.
C1 [Fryk, Jesse J.; Marks, Denese C.; Faddy, Helen M.] Univ Queensland, Australian Red Cross Blood Serv, Res & Dev, Brisbane, Qld, Australia.
   [Hobson-Peters, Jody; Watterson, Daniel; Hall, Roy A.; Young, Paul R.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.
   [Reichenberg, Stefan; Tolksdorf, Frank] MacoPharma Int GmbH, Langen, Germany.
   [Sumian, Chryslain] MacoPharma, Tourcoing, France.
   [Gravemann, Ute; Seltsam, Axel] German Red Cross Blood Serv NSTOB, Springe, Germany.
   [Faddy, Helen M.] Univ Queensland, Sch Med, Brisbane, Qld, Australia.
RP Faddy, HM (corresponding author), 44 Musk Ave, Kelvin Grove, Qld 4059, Australia.
EM hfaddy@redcrossblood.org.au
RI Reichenberg, Stefan/AAB-3159-2020; Marks, Denese C/A-5267-2018
OI Marks, Denese C/0000-0002-3674-6934; Watterson,
   Daniel/0000-0001-5957-2853; Faddy, Helen/0000-0002-3446-8248
FU MacoPharma; Australian governmentAustralian Government
FX This work was partly supported by MacoPharma, in the form of reagents,
   equipment, and grants. The Australian government funds the Australian
   Red Cross Blood Service for the provision of blood, blood products, and
   services to the Australian community.
CR Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bashir S, 2013, TRANSFUSION, V53, P990, DOI 10.1111/j.1537-2995.2012.03854.x
   Begue S, 2009, TRANSFUSION, V49, p83A
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Cardigan R, 2009, TRANSFUSION, V49, P696, DOI 10.1111/j.1537-2995.2008.02039.x
   Faddy HM, 2016, TRANSFUSION, V56, P1548, DOI 10.1111/trf.13519
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fryk JJ, 2016, TRANSFUSION, V56, P2278, DOI 10.1111/trf.13729
   Harrington T, 2003, TRANSFUSION, V43, P1018, DOI 10.1046/j.1537-2995.2003.00481.x
   Johnson L, 2011, VOX SANG, V101, P208, DOI 10.1111/j.1423-0410.2011.01477.x
   Johnson L, 2016, TRANSFUS MED HEMOTH, V43, P190, DOI 10.1159/000441830
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Levi JE, 2015, TRANSFUSION, V55, P961, DOI 10.1111/trf.12944
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Mohr H, 2004, TRANSFUSION, V44, P886, DOI 10.1111/j.1537-2995.2004.03424.x
   Mohr H, 2009, TRANSFUSION, V49, P2612, DOI 10.1111/j.1537-2995.2009.02334.x
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2017, BLOOD TRANSFUS-ITALY, V15, P272, DOI 10.2450/2016.0003-16
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Petersen LR, 2010, TRANSFUS MED REV, V24, P15, DOI 10.1016/j.tmrv.2009.09.002
   Rapaille A, 2014, BLOOD TRANSFUS-ITALY, V12, P226, DOI 10.2450/2014.0176-13
   Reichenberg S, 2008, VOX SANG, V95, P305
   Sandgren P, 2011, VOX SANG, V101, P35, DOI 10.1111/j.1423-0410.2010.01454.x
   Santa-Maria F, 2016, TRANSFUSION, V56, p11A
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seghatchian J, 2012, TRANSFUS APHER SCI, V46, P221, DOI 10.1016/j.transci.2012.01.008
   Seghatchian J, 2011, TRANSFUS MED HEMOTH, V38, P55, DOI 10.1159/000323786
   Seltsam A, 2013, BRIT J HAEMATOL, V162, P442, DOI 10.1111/bjh.12403
   Seltsam A, 2011, TRANSFUS MED HEMOTH, V38, P43, DOI 10.1159/000323845
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Steinmann E, 2013, TRANSFUSION, V53, P1010, DOI 10.1111/j.1537-2995.2012.03858.x
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Thiele T, 2012, TRANSFUSION, V52, P529, DOI 10.1111/j.1537-2995.2011.03317.x
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
NR 40
TC 14
Z9 14
U1 4
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD NOV
PY 2017
VL 57
IS 11
BP 2677
EP 2682
DI 10.1111/trf.14256
PG 6
WC Hematology
SC Hematology
GA FL9WY
UT WOS:000414611800018
PM 28718518
OA Bronze
DA 2020-07-08
ER

PT J
AU Mordecai, E
   Cohen, J
   Evans, M
   Johnson, LR
   Gudapati, P
   Miazgowicz, K
   Murdock, CC
   Rohr, J
   Ryan, SJ
   Savage, V
   Ibarra, AS
   Thomas, MB
   Shocket, M
   Weikel, D
AF Mordecai, Erin
   Cohen, Jeremy
   Evans, Michelle
   Johnson, Leah R.
   Gudapati, Prithvi
   Miazgowicz, Kerri
   Murdock, Courtney C.
   Rohr, Jason
   Ryan, Sadie J.
   Savage, Van
   Ibarra, Anna Stewart
   Thomas, Matthew B.
   Shocket, Marta
   Weikel, Daniel
TI EFFECTS OF TEMPERATURE ON ZIKA, DENGUE AND CHIKUNGUNYA TRANSMISSION BY
   AEDES AEGYPTI AND AE-ALBOPICTUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Mordecai, Erin; Gudapati, Prithvi; Shocket, Marta] Stanford Univ, Stanford, CA 94305 USA.
   [Cohen, Jeremy; Rohr, Jason] Univ S Florida, Tampa, FL USA.
   [Evans, Michelle; Miazgowicz, Kerri; Murdock, Courtney C.] Univ Georgia, Athens, GA 30602 USA.
   [Johnson, Leah R.] Virginia Polytech Inst & State Univ, Blacksburg, VA USA.
   [Ryan, Sadie J.] Univ Florida, Gainesville, FL USA.
   [Savage, Van] Univ Calif Los Angeles, Los Angeles, CA USA.
   [Ibarra, Anna Stewart] SUNY Upstate Med Univ, Syracuse, NY 13210 USA.
   [Thomas, Matthew B.] Penn State Univ, State Coll, PA USA.
   [Weikel, Daniel] Univ Michigan, Ann Arbor, MI 48109 USA.
RI Ryan, Sadie Jane/H-7488-2019
OI Ryan, Sadie Jane/0000-0002-4308-6321
NR 0
TC 0
Z9 0
U1 0
U2 12
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1379
BP 433
EP 434
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502902
DA 2020-07-08
ER

PT J
AU Hersh, AM
   Gundacker, ND
   Boltax, J
AF Hersh, Andrew M.
   Gundacker, Nathan D.
   Boltax, Jonathan
TI Zika-associated Shock and Multi-Organ Dysfunction
SO ANNALS OF THE AMERICAN THORACIC SOCIETY
LA English
DT Editorial Material
ID VIRUS-INFECTION; CROSS-REACTIVITY; COLOMBIA
C1 [Hersh, Andrew M.; Boltax, Jonathan] Univ Utah, Div Pulm & Crit Care Med, 30 N 1900 E,701 Wintrobe, Salt Lake City, UT 84132 USA.
   [Hersh, Andrew M.] Intermt Med Ctr, Div Pulm & Crit Care Med, Murray, UT USA.
   [Gundacker, Nathan D.] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA.
RP Hersh, AM (corresponding author), Univ Utah, Div Pulm & Crit Care Med, 30 N 1900 E,701 Wintrobe, Salt Lake City, UT 84132 USA.
EM andrew.hersh@hsc.utah.edu
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, MMWR-MORBID MORTAL W, V65, P484
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Desakorn V, 2012, AM J TROP MED HYG, V86, P524, DOI 10.4269/ajtmh.2012.11-0423
   European Centre for Disease Prevention and Control, 2015, ZIK VIR INF
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Halstead SB, 2015, MICROBIOL MOL BIOL R, V79, P281, DOI 10.1128/MMBR.00009-15
   Leblebicioglu H, 2016, INT J INFECT DIS, V48, P113, DOI 10.1016/j.ijid.2016.04.019
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
NR 16
TC 3
Z9 3
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1546-3222
EI 2325-6621
J9 ANN AM THORAC SOC
JI Ann. Am. Thoracic Society
PD NOV
PY 2017
VL 14
IS 11
BP 1706
EP 1708
DI 10.1513/AnnalsATS.201612-988CC
PG 3
WC Respiratory System
SC Respiratory System
GA FL5BT
UT WOS:000414246700017
PM 29090994
DA 2020-07-08
ER

PT J
AU Behrendt, P
   Perin, P
   Menzel, N
   Banda, D
   Pfaender, S
   Alves, MP
   Thiel, V
   Meuleman, P
   Colpitts, CC
   Schang, LM
   Vondran, FWR
   Anggakusuma
   Manns, MP
   Steinmann, E
   Pietschmann, T
AF Behrendt, Patrick
   Perin, Paula
   Menzel, Nicolas
   Banda, Dominic
   Pfaender, Stephanie
   Alves, Marco P.
   Thiel, Volker
   Meuleman, Philip
   Colpitts, Che C.
   Schang, Luis M.
   Vondran, Florian W. R.
   Anggakusuma
   Manns, Michael P.
   Steinmann, Eike
   Pietschmann, Thomas
TI Pentagalloylglucose, a highly bioavailable polyphenolic compound present
   in Cortex moutan, efficiently blocks hepatitis C virus entry
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Hepatitis C virus; Natural compounds; Antivirals; Cortex moutan;
   Penta-O-Galloyl-Glucose; Entry inhibitor; Bioavailability
ID CELL-CULTURE; LIVER-TRANSPLANTATION; HUMAN HEPATOCYTES; HUMANIZED MICE;
   LOW-DENSITY; D-GLUCOSE; INFECTION; REPLICATION; INHIBITOR; THERAPY
AB Approximately 142 million people worldwide are infected with hepatitis C virus (HCV). Although potent direct acting antivirals are available, high costs limit access to treatment. Chronic hepatitis C virus infection remains a major cause of orthotopic liver transplantation. Moreover, re-infection of the graft occurs regularly. Antivirals derived from natural sources might be an alternative and cost-effective option to complement therapy regimens for global control of hepatitis C virus infection.
   We tested the antiviral properties of a mixture of different Chinese herbs/roots named Zhi Bai Di Huang Wan (ZBDHW) and its individual components on HCV. One of the ZBDHW components, Penta-OGalloyl-Glucose (PGG), was further analyzed for its mode of action in vitro, its antiviral activity in primary human hepatocytes as well as for its bioavailability and hepatotoxicity in mice.
   ZBDHW, its component Cortex Moutan and the compound PGG efficiently block entry of HCV of all major genotypes and also of the related flavivirus Zika virus. PGG does not disrupt HCV virion integrity and acts primarily during virus attachment. PGG shows an additive effect when combined with the well characterized HCV inhibitor Daclatasvir. Analysis of bioavailability in mice revealed plasma levels above tissue culture IC50 after a single intraperitoneal injection.
   In conclusion, PGG is a pangenotypic HCV entry inhibitor with high bioavailability. The low cost and wide availability of this compound make it a promising candidate for HCV combination therapies, and also emerging human pathogenic flaviviruses like ZIKV. (C) 2017 Published by Elsevier B.V.
C1 [Behrendt, Patrick; Perin, Paula; Menzel, Nicolas; Banda, Dominic; Anggakusuma; Steinmann, Eike; Pietschmann, Thomas] Med Sch Hannover MHH & Helmholtz Ctr Infect Res H, Inst Expt Virol, Twincore Ctr Expt & Clin Infect Res, Hannover, Germany.
   [Behrendt, Patrick; Manns, Michael P.] Med Sch Hannover, Clin Gastroenterol Hepatol & Endocrinol, Hannover, Germany.
   [Behrendt, Patrick; Vondran, Florian W. R.; Pietschmann, Thomas] German Ctr Infect Res, Hannover Braunschweig Site, Braunschweig, Germany.
   [Pfaender, Stephanie; Alves, Marco P.; Thiel, Volker] Univ Bern, Dept Infect Dis & Pathobiol, Bern, Switzerland.
   [Pfaender, Stephanie; Alves, Marco P.; Thiel, Volker] Inst Immunol & Virol, Fed Dept Home Affairs, Bern, Switzerland.
   [Pfaender, Stephanie; Alves, Marco P.; Thiel, Volker] Inst Immunol & Virol, Fed Dept Home Affairs, Mittelhausern, Switzerland.
   [Meuleman, Philip] Univ Ghent, Dept Clin Chem Microbiol & Immunol, Ctr Vaccinol, Ghent, Belgium.
   [Colpitts, Che C.; Schang, Luis M.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.
   [Colpitts, Che C.; Schang, Luis M.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.
   [Schang, Luis M.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada.
   [Vondran, Florian W. R.] Hannover Med Sch, Dept Gen Visceral & Transplant Surg, Hannover, Germany.
RP Pietschmann, T (corresponding author), Twincore, Ctr Expt & Clin Infect Res, Inst Expt Virol, Feodor Lynen Str 7-9, D-30625 Hannover, Germany.
EM Thomas.pietschmann@twincore.de
RI Colpitts, Che C./AAD-2768-2019; Thiel, Volker/AAI-2391-2019; Meuleman,
   Philip/H-2899-2013
OI Colpitts, Che C./0000-0003-2474-1834; Thiel, Volker/0000-0002-5783-0887;
   Schang, Luis/0000-0002-5789-8590; Meuleman, Philip/0000-0001-6821-234X;
   Pfaender, Stephanie/0000-0002-3957-5448; Steinmann,
   Eike/0000-0002-3654-9965
FU Ghent UniversityGhent University [01G01712]; Belgian Science Policy
   Office (BELSPO)Belgian Federal Science Policy Office [IUAP
   P7/47-HEPRO-2]; DZIF (German Centre for Infection Research); Helmholtz
   Centre for Infection Research; German Ministry for Education and
   Research (BMBF)Federal Ministry of Education & Research (BMBF)
   [16GW0105]; Helmholtz Alberta Initiative for Infectious Disease Research
   (HAI-IDR)
FX PM was funded by the Ghent University (Concerted Action Grant 01G01712)
   and the Belgian Science Policy Office (BELSPO; IUAP P7/47-HEPRO-2).; PB
   received funding by the DZIF (German Centre for Infection Research).; TP
   and ES were supported by the Helmholtz Centre for Infection Research and
   by a grant (GINACIO, 16GW0105) of the German Ministry for Education and
   Research (BMBF). Moreover, TP and L.M.S. were supported by the Helmholtz
   Alberta Initiative for Infectious Disease Research (HAI-IDR).
CR Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002
   Anggakusuma, 2014, GUT, V63, P1137, DOI 10.1136/gutjnl-2012-304299
   Ashfaq UA, 2014, WORLD J GASTROENTERO, V20, P2941, DOI 10.3748/wjg.v20.i11.2941
   Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972
   Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083
   Cao YY, 2014, J NAT MED-TOKYO, V68, P465, DOI 10.1007/s11418-014-0823-2
   Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610
   Colpitts CC, 2014, J VIROL, V88, P7806, DOI 10.1128/JVI.00896-14
   Colpitts CC, 2013, J VIROL, V87, P3640, DOI 10.1128/JVI.02882-12
   Desombere I, 2016, HEPATOLOGY, V63, P1120, DOI 10.1002/hep.28428
   Duan DL, 2004, BIOORG MED CHEM LETT, V14, P6041, DOI 10.1016/j.bmcl.2004.09.067
   Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073
   Gentzsch J, 2011, ANTIVIR RES, V89, P136, DOI 10.1016/j.antiviral.2010.12.005
   Haid S, 2016, J VIROL, V90, P3065, DOI 10.1128/JVI.03074-15
   Haid S, 2012, GASTROENTEROLOGY, V143, P213, DOI 10.1053/j.gastro.2012.03.036
   He Q, 2006, CHEM PHARM BULL, V54, P1271, DOI 10.1248/cpb.54.1271
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12
   Kleine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101386
   Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05
   Lam BP, 2015, THER ADV GASTROENTER, V8, P298, DOI 10.1177/1756283X15587481
   Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x
   Lee SJ, 2006, BIOL PHARM BULL, V29, P2131, DOI 10.1248/bpb.29.2131
   Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562
   Li L, 2011, J PHARMACEUT BIOMED, V54, P545, DOI 10.1016/j.jpba.2010.09.028
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Liu G, 2011, ARCH VIROL, V156, P1359, DOI 10.1007/s00705-011-0989-9
   Mailly L, 2015, M S-MED SCI, V31, P1075, DOI 10.1051/medsci/20153112009
   McQuaid T, 2015, J CLIN TRANSL HEPATO, V3, P27, DOI 10.14218/JCTH.2014.00041
   Menzel N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002829
   Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259
   Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006
   O'Shea D, 2016, LIVER TRANSPLANT, V22, P324, DOI 10.1002/lt.24344
   Okubo T, 2000, BIOL PHARM BULL, V23, P199, DOI 10.1248/bpb.23.199
   Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025
   Pei Y, 2011, BIOCHEM BIOPH RES CO, V405, P186, DOI 10.1016/j.bbrc.2011.01.006
   Perin PM, 2016, HEPATOLOGY, V63, P49, DOI 10.1002/hep.28111
   Petta S, 2015, LIVER INT, V35, P4, DOI 10.1111/liv.12714
   Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103
   Poon TYC, 2011, J DIABETES, V3, P184, DOI 10.1111/j.1753-0407.2011.00130.x
   Rubin A, 2011, CLIN RES HEPATOL GAS, V35, P805, DOI 10.1016/j.clinre.2011.04.009
   Sarrazin C, 2016, J HEPATOL, V64, P486, DOI 10.1016/j.jhep.2015.09.011
   THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849
   Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006
   Vercauteren K, 2016, GUT, V65, P2029, DOI 10.1136/gutjnl-2014-309045
   Vercauteren K, 2014, HEPATOLOGY, V60, P1508, DOI 10.1002/hep.27196
   Vieyres G, 2013, METHODS, V59, P233, DOI 10.1016/j.ymeth.2012.09.005
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   Xiao CN, 2015, PHYTOCHEM ANALYSIS, V26, P86, DOI 10.1002/pca.2539
   Yeo SJ, 2002, ARCH VIROL, V147, P229, DOI 10.1007/s705-002-8316-1
   Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014
   Zhang JH, 2009, PHARM RES-DORDR, V26, P2066, DOI 10.1007/s11095-009-9932-0
NR 52
TC 10
Z9 10
U1 3
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD NOV
PY 2017
VL 147
BP 19
EP 28
DI 10.1016/j.antiviral.2017.09.006
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FN9WZ
UT WOS:000416394900003
PM 28923507
DA 2020-07-08
ER

PT J
AU Liu, BW
   Tang, LD
   Zhang, XH
   Ma, JL
   Sehgal, M
   Cheng, JJ
   Zhang, XX
   Zhou, Y
   Du, YM
   Kulp, J
   Guo, JT
   Chang, JH
AF Liu, Bowei
   Tang, Liudi
   Zhang, Xiaohui
   Ma, Julia
   Sehgal, Mohit
   Cheng, Junjun
   Zhang, Xuexiang
   Zhou, Yan
   Du, Yanming
   Kulp, John
   Guo, Ju-Tao
   Chang, Jinhong
TI A cell-based high throughput screening assay for the discovery of
   cGAS-STING pathway agonists
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE High throughput assay; STING; Innate immune; Antiviral
ID YELLOW-FEVER VIRUS; CYCLIC GMP-AMP; INNATE IMMUNE-RESPONSE; HEPATITIS-B;
   I INTERFERON; DNA; RECOGNITION; POTENT; SENSOR; REPLICATION
AB Stimulator of interferon genes (STING) is an endoplasmic reticulum transmembrane protein that serves as a molecular hub for activation of interferon and inflammatory cytokine response by multiple cellular DNA sensors. Not surprisingly, STING has been demonstrated to play an important role in host defense against microorganisms and pharmacologic activation of STING is considered as an attractive strategy to treat viral diseases and boost antitumor immunity. In light of this we established a HepAD38-derived reporter cell line that expresses firefly luciferase in response to the activation of cyclic GMP-AMP synthase (cGAS)-STING pathway for high throughput screening (HTS) of small molecular human STING agonists. This cell-based reporter assay required only 4 h treatment with a reference STING agonist to induce a robust luciferase signal and was demonstrated to have an excellent performance in HTS format. By screening 16,000 compounds, a dispiro diketopiperzine (DSDP) compound was identified to induce cytokine response in a manner dependent on the expression of functional human STING, but not mouse STING. Moreover, we showed that DSDP induced an interferon-dominant cytokine response in human skin fibroblasts and peripheral blood mononuclear cells, which in turn potently suppressed the replication of yellow fever virus, dengue virus and Zika virus. We have thus established a robust cell-based assay system suitable for rapid discovery and mechanistic analyses of cGAS-STING pathway agonists. Identification of DSDP as a human STING agonist enriches the pipelines of STING-targeting drug development for treatment of viral infections and cancers.
C1 [Liu, Bowei; Zhang, Xiaohui; Ma, Julia; Sehgal, Mohit; Cheng, Junjun; Zhang, Xuexiang; Du, Yanming; Kulp, John; Guo, Ju-Tao; Chang, Jinhong] Hepatitis B Fdn, Baruch S Blumberg Inst, Doylestown, PA 18902 USA.
   [Liu, Bowei] Zhengzhou Univ, Dept Gastroenterol, Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China.
   [Tang, Liudi] Drexel Univ, Microbiol & Immunol Grad Program, Coll Med, Philadelphia, PA 19104 USA.
   [Zhang, Xiaohui] Capital Med Univ, Artificial Liver Ctr, Beijing Youan Hosp, Beijing, Peoples R China.
   [Zhou, Yan] Fox Chase Canc Ctr, Biostat & Bioinformat Facil, 7701 Burholme Ave, Philadelphia, PA 19111 USA.
RP Guo, JT; Chang, JH (corresponding author), Hepatitis B Fdn, Baruch S Blumberg Inst, Doylestown, PA 18902 USA.
EM ju-tao.guo@bblumberg.org; jinhong.chang@bblumberg.org
OI Kulp, John/0000-0003-2586-9207
FU National Institutes of Health, USAUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI113267];
   Arbutus Biopharma Inc.; Commonwealth of Pennsylvania through the
   Hepatitis B Foundation
FX We thank Dr. Wade Bresnahan at University of Minnesota for providing THF
   cells and Dr. Eain Murphy at Forge Life Science for providing the early
   passage of HFF cells. A cDNA clone of serotype 2 dengue virus,
   pACYC177-NGC-DENV-2, was a gift from Dr. Pei-Yong Shi at University of
   Texas Medical Branch. A cDNA clone of Yellow fever virus 17D strain,
   pACNR/FLYF-17Dx, was a gift from Dr. Charles Rice at Rockefeller
   University. This work was supported by grant from the National
   Institutes of Health, USA (AI113267), Arbutus Biopharma Inc. and the
   Commonwealth of Pennsylvania through the Hepatitis B Foundation.
CR Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Bresnahan WA, 2000, J VIROL, V74, P10816, DOI 10.1128/JVI.74.22.10816-10818.2000
   Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429
   Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040
   Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86
   Chang JH, 2015, ANTIVIR RES, V121, P152, DOI 10.1016/j.antiviral.2015.07.006
   Chang JH, 2013, ANTIVIR RES, V98, P432, DOI 10.1016/j.antiviral.2013.03.023
   Chang JH, 2012, ANTIVIR RES, V96, P405, DOI 10.1016/j.antiviral.2012.10.001
   Chang JH, 2009, ANTIMICROB AGENTS CH, V53, P1501, DOI 10.1128/AAC.01457-08
   Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558
   Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097
   Corrales L, 2016, J CLIN INVEST, V126, P2404, DOI 10.1172/JCI86892
   Corrales L, 2015, CLIN CANCER RES, V21, P4774, DOI 10.1158/1078-0432.CCR-15-1362
   Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031
   Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019
   Fu J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4306
   Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023
   Guo F, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00771-17
   Guo F, 2016, J VIROL, V90, P10774, DOI 10.1128/JVI.01253-16
   Guo F, 2015, ANTIMICROB AGENTS CH, V59, P1273, DOI 10.1128/AAC.04321-14
   Hanson MC, 2015, J CLIN INVEST, V125, P2532, DOI 10.1172/JCI79915
   Israelow B, 2014, HEPATOLOGY, V60, P1170, DOI 10.1002/hep.27227
   Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123
   Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110
   Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715
   LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383
   Li LY, 2014, NAT CHEM BIOL, V10, P1043, DOI [10.1038/nchembio.1661, 10.1038/NChemBio.1661]
   Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040
   Lioux T, 2016, J MED CHEM, V59, P10253, DOI 10.1021/acs.jmedchem.6b01300
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Sali TM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005324
   Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521
   Wang H, 2017, P NATL ACAD SCI USA, V114, P1637, DOI 10.1073/pnas.1621363114
   Woo SR, 2015, TRENDS IMMUNOL, V36, P250, DOI 10.1016/j.it.2015.02.003
   Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
   Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022
   Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003
NR 44
TC 10
Z9 11
U1 4
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD NOV
PY 2017
VL 147
BP 37
EP 46
DI 10.1016/j.antiviral.2017.10.001
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FN9WZ
UT WOS:000416394900005
PM 28982551
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Roze, B
   Najioullah, F
   Ferge, JL
   Dorleans, F
   Apetse, K
   Barnay, JL
   Daudens-Vaysse, E
   Brouste, Y
   Cesaire, R
   Fagour, L
   Valentino, R
   Ledrans, M
   Mehdaoui, H
   Abel, S
   Leparc-Goffart, I
   Signate, A
   Cabie, A
AF Roze, Benoit
   Najioullah, Fatiha
   Ferge, Jean-Louis
   Dorleans, Frederique
   Apetse, Kossivi
   Barnay, Jose-Luis
   Daudens-Vaysse, Elise
   Brouste, Yannick
   Cesaire, Raymond
   Fagour, Laurence
   Valentino, Ruddy
   Ledrans, Martine
   Mehdaoui, Hossein
   Abel, Sylvie
   Leparc-Goffart, Isabelle
   Signate, Aissatou
   Cabie, Andre
CA Guillain-Barre Syndrome Zika
TI Guillain-Barre Syndrome Associated With Zika Virus Infection in
   Martinique in 2016: A Prospective Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Guillain-Barre syndrome; Zika virus infection; Martinique; vector-borne
   infections; outbreaks
ID OUTBREAK; BRAZIL; URINE
AB Background. Guillain-Barre syndrome (GBS) has been reported to be associated with Zika virus (ZIKV) infection in case reports and retrospective studies, mostly on the basis of serological tests, with the problematic cross-reacting antibodies of the Flavivirus genus. Some GBS cases do not exhibit a high level of diagnostic certainty. This prospective study aimed to describe the clinical profiles and the frequency of GBS associated with ZIKV during the ZIKV outbreak in Martinique in 2016.
   Methods. We recorded prospective data from GBS meeting levels 1 or 2 of diagnostic certainty for the Brighton Collaboration, with proof of recent ZIKV infection and negative screening for etiologies of GBS.
   Results. Of the sample of 34 patients with suspected GBS during the outbreak, 30 had a proven presence of GBS, and 23 had a recent ZIKV infection. The estimated GBS incidence rate ratio (2016 vs 2006-2015) was 4.52 (95% confidence interval, 2.80-7.64; P =.0001). Recent ZIKV infection was confirmed by urine reverse-transcription polymerase chain reaction (RT-PCR) analysis in 17 cases and by serology in 6 cases. Patients, 65% of whom were male, had a median age of 61 years (interquartile range, 56-71 years) and experienced severe GBS. Electrophysiological tests were consistent with the primary demyelinating form of the disease.
   Conclusions. ZIKV infection is usually benign, when symptomatic, but in countries at risk of ZIKV epidemics, adequate intensive care bed capacity is required for management of severe GBS cases. Arbovirus RNA detection by RT-PCR should be part of the management of GBS cases.
C1 [Roze, Benoit; Abel, Sylvie] Univ Antilles, Infect & Trop Dis Unit, Univ Hosp Martinique, EA4537, Fort De France, Martinique, France.
   [Roze, Benoit; Ferge, Jean-Louis; Valentino, Ruddy; Mehdaoui, Hossein] Univ Antilles, Intens Care Unit, Univ Hosp Martinique, EA4537, Fort De France, Martinique, France.
   [Najioullah, Fatiha; Cesaire, Raymond] Univ Antilles, Lab Virol, Univ Hosp Martinique, EA4537, Fort De France, Martinique, France.
   [Dorleans, Frederique; Daudens-Vaysse, Elise; Ledrans, Martine] French Natl Publ Hlth Agcy, Reg Unit Antilles Guyane, St Maurice, France.
   [Apetse, Kossivi] Univ Hosp Martinique, Electrophysiol Dept, Fort De France, Martinique, France.
   [Barnay, Jose-Luis] Univ Hosp Martinique, Rehabil Unit, Fort De France, Martinique, France.
   [Brouste, Yannick] Univ Hosp Martinique, Emergency Dept, Fort De France, Martinique, France.
   [Fagour, Laurence] Univ Hosp Martinique, Lab Virol, Fort De France, Martinique, France.
   [Leparc-Goffart, Isabelle] French Armed Forces Biomed Res Inst, Marseille, France.
   [Signate, Aissatou] Univ Antilles, EA4537, INSERM CIC1424, Neurol Dept,Univ Hosp Martinique, Fort De France, Martinique, France.
   [Cabie, Andre] Univ Antilles, EA4537, INSERM CIC1424, Infect & Trop Dis Unit,Univ Hosp Martinique, Fort De France, Martinique, France.
RP Roze, B (corresponding author), CHU Martinique, Serv Malad Infect & Trop, Site PZQ,CS 90632, F-97261 Fort De France, Martinique, France.
EM benoit.roze@chu-martinique.fr
RI Mehdaoui, Hossein/A-2466-2019
OI Mehdaoui, Hossein/0000-0001-8647-5215; PASQUIER,
   Jeremie/0000-0003-3200-5132; ABEL, Sylvie/0000-0002-3351-0547; mejdoubi,
   mehdi/0000-0001-9422-9356; Cabie, Andre/0000-0003-0117-3061
FU University Hospital of Martinique (UHM); Clinical Research Hospital
   Program from the French Ministry of Health (PHRC) [NCT01099852]; French
   network for Research and Action targeting emerging infectious diseases
   (REACTING)
FX This research was sponsored by University Hospital of Martinique (UHM)
   for regulatory and ethic submission and supported by the Clinical
   Research Hospital Program from the French Ministry of Health (PHRC 2009;
   NCT01099852). This research was support by the French network for
   Research and Action targeting emerging infectious diseases (REACTING).
CR [Anonymous], 2017, CUM CAS 2015 2017
   [Anonymous], 2016, ZIK EP UPD 14 APR 20
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Balavoine S, 2017, AM J TROP M IN PRESS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0
   Daudens-Vaysse E, 2016, EUROSURVEILLANCE, P21
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Eldar AH, 2014, AUTOIMMUN REV, V13, P525, DOI 10.1016/j.autrev.2014.01.033
   Emergence du virus Zika aux Antilles Guyane, 2016, CIRE ANTILLES GUYANE, P1
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hadden RDM, 2001, NEUROLOGY, V56, P758, DOI 10.1212/WNL.56.6.758
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793
   Instituto Nacional De Salud, 2016, B EPIDEMIOLOGICO SEM
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Kamm C, 2012, AUTOIMMUN REV, V11, P196, DOI 10.1016/j.autrev.2011.05.012
   Kang JH, 2010, CLIN INFECT DIS, V51, P525, DOI 10.1086/655136
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   L'Azou M, 2015, AM J TROP MED HYG, V92, P1137, DOI 10.4269/ajtmh.14-0211
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Orlikowski D, 2011, CLIN INFECT DIS, V52, P837, DOI 10.1093/cid/cir074
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rajabally YA, 2015, J NEUROL NEUROSUR PS, V86, P115, DOI 10.1136/jnnp-2014-307815
   RAVI V, 1994, ACTA NEUROL SCAND, V90, P67
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Visser LH, 1999, NEUROLOGY, V53, P598, DOI 10.1212/WNL.53.3.598
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 38
TC 24
Z9 29
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 1
PY 2017
VL 65
IS 9
BP 1462
EP 1468
DI 10.1093/cid/cix588
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FJ8KI
UT WOS:000413015700004
PM 29020245
OA Bronze
DA 2020-07-08
ER

PT J
AU Freitas, BD
   Ventura, CV
   Maia, M
   Belfort, R
AF Freitas, Bruno de Paula
   Ventura, Camila V.
   Maia, Mauricio
   Belfort, Rubens, Jr.
TI Zika virus and the eye
SO CURRENT OPINION IN OPHTHALMOLOGY
LA English
DT Review
DE congenital Zika syndrome; ocular findings; Zika virus
ID INFECTION; INFANTS; BRAZIL; CLINICIAN
AB Purpose of review
   The aim of this study was to review the ocular findings related to the Zika virus (ZIKV) based on the main studies published to date, describe the patterns of the lesions and risk factors, and identify the public health implications and scientific importance of this emerging disease.
   Recent findings
   In most studies, the ZIKV seems related to congenital ocular lesions and most mothers reported mild symptoms during the first pregnancy trimester. Five fundus patterns were seen most often: macular chorioretinal atrophy, chorioretinal atrophy elsewhere, focal pigmentary changes in the macular region, optic nerve abnormalities and combined types. A few studies have suggested that the ZIKV might damage the anterior segment of these babies' eyes. Few reports have described the ocular complications seen in adults during the acute infection, including conjunctivitis, iridocyclitis and chorioretinitis.
   Summary
   Infants with congenital Zika syndrome might have vision-threatening fundus abnormalities. Although the full spectrum of ocular lesions caused by the ZIKV infection is not yet determined, a distinctive new disease has been observed. Recognition of these lesions by ophthalmologists can help ensure appropriate etiologic evaluation and clinical investigation to define the range of anomalies in an affected infant and determine essential follow-up and ongoing care.
C1 [Freitas, Bruno de Paula; Ventura, Camila V.; Maia, Mauricio; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Paulista Med Sch, Dept Ophthalmol, Sao Paulo, Brazil.
   [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
   [Ventura, Camila V.] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.] HOPE Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
RP Freitas, BD (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821,1st Floor, BR-04023062 Sao Paulo, SP, Brazil.
EM brunodepaulafreitas@hotmail.com
RI Maia, Mauricio/I-5892-2015; Ventura, Camila V/N-2654-2018
OI Maia, Mauricio/0000-0002-7034-8091; Ventura, Camila
   V/0000-0002-2927-4684
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira Dias JR, 2017, RETIN CASES BRIEF RE
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 25
TC 16
Z9 16
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8738
EI 1531-7021
J9 CURR OPIN OPHTHALMOL
JI Curr. Opin. Ophthalmol.
PD NOV
PY 2017
VL 28
IS 6
BP 595
EP 599
DI 10.1097/ICU.0000000000000420
PG 5
WC Ophthalmology
SC Ophthalmology
GA FQ3GP
UT WOS:000418245600008
PM 28795959
DA 2020-07-08
ER

PT J
AU Sharma, N
   Murali, A
   Singh, SK
   Giri, R
AF Sharma, Nitin
   Murali, Aarthy
   Singh, Sanjeev Kumar
   Giri, Rajanish
TI Epigallocatechin gallate, an active green tea compound inhibits the Zika
   virus entry into host cells via binding the envelope protein
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Envelope protein; Zika virus; Epigallocatechin gallate
ID SEXUAL TRANSMISSION; FUSION PROTEINS; KIX DOMAIN; C-MYB; RECOGNITION;
   MECHANISM; EGCG; HEALTH
AB Emerging infections of Zika virus (ZIKV) are associated with serious consequences like microcephaly and Guillain-Barre syndrome. It leads to a situation of global health emergency and demand an intensive research investigation to develop safe and effective therapeutics. Various efforts have been made to reduce the pathological pressure of ZIKV, but no effective drug has been introduced against ZIKV infections. A recent study has reported the inhibition of ZIKV entry into the host cells by an active green tea ingredient, Epigallocatechin Gallate (EGCG) in Vero E6cells. The effect of EGCG seems remarkable but lacking the information of the mechanism of action. In this study, we have investigated the binding site (Sites) of EGCG on envelope protein and provided the insights into various interactions of molecule with the binding site using molecular docking studies. Further, using molecular dynamics approaches we proposed the possible associated mechanism of inhibition of ZIKV entry by EGCG molecule. EGCG has found to interact with several residues and providing stability to the protein conformations up to 50 ns simulations. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Sharma, Nitin; Giri, Rajanish] Indian Inst Technol Mandi, Mandi, Himachal Prades, India.
   [Murali, Aarthy; Singh, Sanjeev Kumar] Alagappa Univ, Dept Bioinformat, Comp Aided Drug Design & Mol Modeling Lab, Sci Block, Karaikkudi 630003, Tamil Nadu, India.
RP Giri, R (corresponding author), Indian Inst Technol Mandi, Mandi, Himachal Prades, India.; Singh, SK (corresponding author), Alagappa Univ, Dept Bioinformat, Comp Aided Drug Design & Mol Modeling Lab, Sci Block, Karaikkudi 630003, Tamil Nadu, India.
EM skysanjeev@gmail.com; rajanishgiri@iitmandi.ac.in
RI Singh, Kumar/AAP-1954-2020; Giri, Rajanish/Q-6530-2018
OI Singh, Kumar/0000-0003-4153-6437; Giri, Rajanish/0000-0002-2046-836X;
   Sharma, Nitin/0000-0002-8176-7056
FU DST grant, India [YSS/2015/000613]; Indian Institute of Technology Mandi
FX This work has been funded by DST grant, India (YSS/2015/000613) that
   belongs to Rajanish Giri and Indian Institute of Technology Mandi.
CR [Anonymous], 2016, LANCET INFECT DIS, V16, P619, DOI 10.1016/S1473-3099(16)30069-X
   [Anonymous], 2012, DESM VERS 3 1
   Brasil P, 2016, N ENGL J MED
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Chavan SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121860
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dolan PT, 2015, PROTEIN SCI, V24, P221, DOI 10.1002/pro.2608
   Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6
   Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gupta S, 2017, INT J BIOL MACROMOL, V94, P621, DOI 10.1016/j.ijbiomac.2016.10.008
   Halegoua-De D. Marzio, 2012, CLIN THER, V34
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P651, DOI 10.1016/j.fct.2005.11.002
   Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760
   Khan N, 2013, CURR PHARM DESIGN, V19, P6141, DOI 10.2174/1381612811319340008
   Khrustalev VV, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00044
   Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326
   Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar D, 2017, CANCER INFORM, V16, DOI 10.1177/1176935117699408
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075
   Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331
   Maurice J, 2016, LANCET, V388, P449, DOI 10.1016/S0140-6736(16)31207-7
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Qian XJ, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.3
   Samad FA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153999
   Saudagar P, 2013, EUR J PHARM BIOPHARM, V85, P569, DOI 10.1016/j.ejpb.2013.08.014
   Sherman Woody, 2005, J MED CHEM
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Shukla H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01235-z
   Shukla R, 2018, J BIOMOL STRUCT DYN, V36, P2045, DOI 10.1080/07391102.2017.1341337
   Singh BK, 2008, BMB REP, V41, P444, DOI 10.5483/BMBRep.2008.41.6.444
   Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009
   Stiasny K, 2007, PLOS PATHOG, V3, P191, DOI 10.1371/journal.ppat.0030020
   Suryanarayanan V, 2015, J RECEPT SIG TRANSD, V35, P370, DOI 10.3109/10799893.2014.956756
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Toto A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21994
   Toto A, 2014, PROTEIN SCI, V23, P962, DOI 10.1002/pro.2480
   Tripathi SK, 2014, MOL BIOSYST, V10, P2189, DOI 10.1039/c4mb00077c
   Wang QY, 2015, ACS INFECT DIS, V1, P428, DOI 10.1021/acsinfecdis.5b00066
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Zheng Y, 2011, J VIROL, V85, P6334, DOI 10.1128/JVI.00596-11
NR 51
TC 34
Z9 34
U1 2
U2 19
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD NOV
PY 2017
VL 104
BP 1046
EP 1054
DI 10.1016/j.ijbiomac.2017.06.105
PN A
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA FJ7SN
UT WOS:000412959300118
PM 28666829
DA 2020-07-08
ER

PT J
AU Fernandez, MP
   Saad, EP
   Martinez, MO
   Corchuelo, S
   Reyes, MM
   Herrera, MJ
   Saavedra, MP
   Rico, A
   Fernandez, AM
   Lee, RK
   Ventura, CV
   Berrocal, AM
   Dubovy, SR
AF Fernandez, Maria P.
   Saad, Edgar Parra
   Martinez, Martha Ospina
   Corchuelo, Sheryl
   Reyes, Marcela Mercado
   Herrera, Maria Jose
   Saavedra, Miguel Parra
   Rico, Angelica
   Fernandez, Angela M.
   Lee, Richard K.
   Ventura, Camila V.
   Berrocal, Audina M.
   Dubovy, Sander R.
TI Ocular Histopathologic Features of Congenital Zika Syndrome
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID EXTRAMEDULLARY HEMATOPOIESIS; VIRUS-INFECTION; CASE SERIES; INFANTS;
   PATHOLOGY; HEALTH; BRAZIL
AB IMPORTANCE Congenital Zika syndrome (CZS) is known to be associated with severe malformations in newborns. Although microcephaly is the hallmark of this disease, the ocular findings are important given the severe visual impairment that has been observed in these patients. Regardless of the increased number of CZS cases reported, to date, no studies have described the ocular histopathologic findings of this entity.
   OBJECTIVES To evaluate the presence of Zika virus (ZIKV) antigens and describe the associated ocular histopathologic features of 4 cases of CZS.
   DESIGN, SETTING, AND PARTICIPANTS In this observational case series performed from June 19, 2015, through April 30, 2017, ocular tissue samples from 4 deceased fetuses with a diagnosis of CZS from the National Institute of Health in Colombia were sent to the Florida Lions Ocular Pathology Laboratory for evaluation.
   MAIN OUTCOMES AND MEASURES The microscopic features of each specimen were described, and immunostaining was performed using a ZIKV NS2B protein antibody.
   RESULTS Ocular tissue samples from the 4 deceased fetuses (2 female, 2 male) ranging from 21.5 to 29 weeks' gestation with a diagnosis of CZS were studied. The 4 eyes manifested with pupillary membranes, immature anterior chamber angles, loss of pigment and thinning of the retinal pigment epithelium, choroidal thinning, undifferentiated nuclear layers of the retina, and a perivascular inflammatory infiltrate within the choroid. The optic nerve, present in 2 of the eyes, demonstrated atrophy. Expression of ZIKV antigen was present in the iris in cases 1, 3, and 4; the neural retina and choroid in case 1; and in the optic nerve in case 4.
   CONCLUSIONS AND RELEVANCE Loss of retinal pigment epithelium, the presence of a thin choroid, a perivascular choroidal inflammatory infiltrate, and atrophic changes within the optic nerve were consistently present. These findings may be attributed to ZIKV infection and warrant further study.
C1 [Fernandez, Maria P.; Dubovy, Sander R.] Univ Miami, Miller Sch Med, Florida Lions Ocular Pathol Lab, Bascom Palmer Eye Inst, Miami, FL 33136 USA.
   [Fernandez, Maria P.; Lee, Richard K.; Ventura, Camila V.; Berrocal, Audina M.; Dubovy, Sander R.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, 900 NW 17th St,Room 350, Miami, FL 33136 USA.
   [Saad, Edgar Parra; Martinez, Martha Ospina; Corchuelo, Sheryl; Reyes, Marcela Mercado; Rico, Angelica] Inst Nacl Salud, Bogota, Colombia.
   [Herrera, Maria Jose] Univ Norte, Fac Ciencias Salud, Antigua Via Puerto Colombia, Barranquilla, Colombia.
   [Saavedra, Miguel Parra] CEDIUL Diagnost Images, Dept Perinatol, Barranquilla, Colombia.
   [Fernandez, Angela M.] Soc Colombiana Oftalmol, Bogota, Colombia.
RP Dubovy, SR (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, 900 NW 17th St,Room 350, Miami, FL 33136 USA.
EM sdubovy@med.miami.edu
RI Ventura, Camila V/N-2654-2018
OI Ventura, Camila V/0000-0002-2927-4684; HERRERA BEDOYA, MARIA
   JOSE/0000-0003-2395-7457; CORCHUELO CHAVARRO, SHERYLL
   YOHANA/0000-0003-2950-9102; Fernandez, Angela/0000-0002-1096-1791
FU Florida Lions Eye Bank; Bascom Palmer Eye Institute National Institutes
   of Health Center [P30EY014801]; Research to Prevent BlindnessResearch to
   Prevent Blindness (RPB); US Department of DefenseUnited States
   Department of Defense [W81XWH-09-1-0675]
FX This research was supported by the Florida Lions Eye Bank, the Bascom
   Palmer Eye Institute National Institutes of Health Center Core Grant
   P30EY014801, an unrestricted grant from the Research to Prevent
   Blindness, grant W81XWH-09-1-0675 from the US Department of Defense.
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   Deseda CC, 2017, CURR OPIN PEDIATR, V29, P97, DOI 10.1097/MOP.0000000000000442
   Fischer OG, 2016, INVEST OPHTH VIS SCI, V57
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Herwig MC, 2011, INVEST OPHTH VIS SCI, V52, P2712, DOI 10.1167/iovs.10-6301
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mann I., 1957, DEV ABNORMALITIES EY, P224
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, JAMA PEDIAT
   Mudhar HS, 2005, HISTOPATHOLOGY, V46, P694, DOI 10.1111/j.1365-2559.2005.02154.x
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Pan American Health Organization World Health Organization, REG ZIK EP UPD AM
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Roos RP, 2016, JAMA NEUROL, V73, P1395, DOI 10.1001/jamaneurol.2016.3677
   Science, 2016, SCIENCE
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Verdijk RM, 2013, INT J OPHTHALMIC PAT, V2, P2
NR 28
TC 19
Z9 19
U1 0
U2 13
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD NOV
PY 2017
VL 135
IS 11
BP 1163
EP 1169
DI 10.1001/jamaophthalmol.2017.3595
PG 7
WC Ophthalmology
SC Ophthalmology
GA FM2ER
UT WOS:000414798100008
PM 28975230
OA Green Published
DA 2020-07-08
ER

PT J
AU Colombo, TE
   Estofolete, CF
   Reis, AFN
   da Silva, NS
   Aguiar, ML
   Cabrera, EMS
   dos Santos, INP
   Costa, FR
   Cruz, LEAA
   Rombola, PL
   Terzian, ACB
   Nogueira, ML
AF Colombo, Tatiana Elias
   Estofolete, Cassia Fernanda
   Negri Reis, Andreia Francesli
   da Silva, Natal Santos
   Aguiar, Morgana Lima
   Sotello Cabrera, Eliana Marcia
   Penha dos Santos, Izalco Nuremberg
   Costa, Fabiana Rodrigues
   Arao Antonio Cruz, Lilian Elisa
   Rombola, Patricia Lopes
   Bernardes Terzian, Ana Carolina
   Nogueira, Mauricio Lacerda
TI Clinical, laboratory and virological data from suspected ZIKV patients
   in an endemic arbovirus area
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika; Dengue; Arboviruses
ID MEDIUM-SIZED CITY; DENGUE VIRUS; CHIKUNGUNYA-VIRUS; COINFECTION;
   INFECTION; STATE
AB Background: The emergence of Zika virus (ZIKV) presents new challenges to both clinicians and public health authorities. Overlapping clinical features between the diseases caused by ZIKV, dengue (DENV) and chi-kungunya (CHIKV) and the lack of validated serological assays for ZIKV make accurate diagnosis difficult. Brazilian authorities largely rely on clinical and epidemiological data for the epidemiological and clinical classifications of most ZIKV cases.
   Objective: : To report the laboratory and clinical profiles of patients diagnosed with Zika fever based only on clinical and epidemiological data.
   Study design: We analyzed 433 suspected cases of ZIKV identified by the attending physician based on proposed clinical criteria. The samples were also screened for ZIKV, DENV and CHIKV using PCR.
   Results: Of the 433 patients analyzed, 168 (38.8%) were laboratory-confirmed for arboviruses: 96 were positive for ZIKV, 67 were positive for DENV (56 for DENV-2, 9 for DENV-1, and 2 for DENV-4), four were positive for co-infection with ZIKV/DENV-2, and one was positive for CHIKV. The most common signs or symptoms in the patients with laboratory-confirmed ZIKV were rash (100%), arthralgia (77.1%), fever (74.0%), myalgia (74.0%) and non-purulent conjunctivitis (69.8%). In patients with laboratory-confirmed DENV infections, the most frequently observed symptoms were rash (100%), fever (79.1%), myalgia (74.6%), headache (73.1%) and arthralgia (70.1%). The measure of association between clinical manifestations and laboratory manifestations among patients with ZIKV and DENV detected a statistically significant difference only in abdominal pain (p = 0.04), leukopenia (p = 0.003), and thrombocytopenia (p = 0.01).
   Conclusion: Our data suggests that clinical and epidemiological criteria alone are not a good tool for ZIKV and DENV differentiation, and that laboratory diagnosis should be mandatory.
C1 [Colombo, Tatiana Elias; Estofolete, Cassia Fernanda; Sotello Cabrera, Eliana Marcia; Bernardes Terzian, Ana Carolina; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
   [Colombo, Tatiana Elias; Aguiar, Morgana Lima] Univ Paulista UNIP, Sao Jose Do Rio Preto, SP, Brazil.
   [Negri Reis, Andreia Francesli; Penha dos Santos, Izalco Nuremberg; Costa, Fabiana Rodrigues; Arao Antonio Cruz, Lilian Elisa; Rombola, Patricia Lopes] Prefeitura Sao Jose do Rio Preto, Dept Vigilancia Saude, Sao Jose Do Rio Preto, SP, Brazil.
   [da Silva, Natal Santos] Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, Sao Jose Do Rio Preto, SP, Brazil.
RP Nogueira, ML (corresponding author), Infecciosas & Parasitarias FAMERP Sao Jose do Rio, Dept Doencas Dermatol, Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI da Silva, Natal Santos/E-9579-2015; Estofolete, Cassia/N-6673-2019;
   Nogueira, Mauricio L/B-7599-2012
OI da Silva, Natal Santos/0000-0002-0856-1748; Estofolete,
   Cassia/0000-0001-7324-1591; Nogueira, Mauricio L/0000-0003-1102-2419
FU Sao Paulo State Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3, 2015/12295-0];
   FAPESP Zika Network
FX This work was supported by the Sao Paulo State Research Foundation
   (FAPESP) under Grant #2013/21719-3 to MLN and the 2015/12295-0
   fellowship to ACBT. The FAPESP Zika Network supported this work. MLN is
   a CNPq fellow.
CR Amancio FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129046
   [Anonymous], 1998, Wkly Epidemiol Rec, V73, P182
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Arshad I., 2011, PROF MED J, V18, P7
   Back Anne Tuiskunen, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.19839
   Banerjee M., 2008, MJAF, V64, P4
   Bashir A. B., 2015, J INFECT DIS IMMUN, V7, P7
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Perdigao ACB, 2016, MEM I OSWALDO CRUZ, V111, P588, DOI 10.1590/0074-02760160140
   Brasil J.P., 2016, NEW ENGL J MED, V375, P1
   Brasil. Ministerio da Saude, 2016, DENG DIAGN MAN CLIN
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2009, GUIA VIG EP MIN SAUD
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Chacon R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140890
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   Codeco CT, 2009, MEM I OSWALDO CRUZ, V104, P614, DOI 10.1590/S0074-02762009000400014
   Colombo TE, 2016, ACTA TROP, V164, P84, DOI 10.1016/j.actatropica.2016.09.004
   Colombo TE, 2013, REV INST MED TROP SP, V55, P275, DOI 10.1590/S0036-46652013000400009
   Control ECfDPa, 2015, RAP RISK ASS ZIK VIR
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Favaro EA, 2013, REV SAUDE PUBL, V47, P588, DOI 10.1590/S0034-8910.2013047004506
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heukelbach J, 2016, INFECT DEV CTRIES, V2, P116
   Ho TS, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-75
   Hosmer Jr D.W., 2013, APPL LOGISTIC REGRES
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Ministerio da Saude Nota informativa - SVS/MS, 2016, PROC SER AB VIG FEBR
   Ministerio Secretaria General de la Presidencia, 2015, PROT AT SAUD RESP OC, P1
   Mondini A, 2005, REV SAUDE PUBL, V39, P444, DOI [10.1590/S0034-89102005000300016, 10.1590/s0034-89102005000300016]
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Pan American Health Organization/World Health Organization (PAHO), 2015, GUIA VIG ENF VIR ZIK
   Tukasan C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2128-4
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   WHO, 2009, DENG GUID DIAGN TREA, P160
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 48
TC 13
Z9 13
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD NOV
PY 2017
VL 96
BP 20
EP 25
DI 10.1016/j.jcv.2017.09.002
PG 6
WC Virology
SC Virology
GA FN3UV
UT WOS:000415927400005
PM 28918127
DA 2020-07-08
ER

PT J
AU Wang, C
   Zhang, N
   Qi, LT
   Yuan, JL
   Wang, K
   Wang, KL
   Ma, SC
   Wang, HL
   Lou, WJ
   Hu, PD
   Awais, M
   Cao, SB
   Fu, ZF
   Cui, M
AF Wang, Chong
   Zhang, Nan
   Qi, Luting
   Yuan, Jiaolong
   Wang, Ke
   Wang, Kunlun
   Ma, Sicong
   Wang, Haili
   Lou, Wenjuan
   Hu, Pingdong
   Awais, Muhammad
   Cao, Shengbo
   Fu, Zhen F.
   Cui, Min
TI Myeloid-Derived Suppressor Cells Inhibit T Follicular Helper Cell Immune
   Response in Japanese Encephalitis Virus Infection
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID WEST-NILE VIRUS; ZIKA VIRUS; BONE-MARROW; B-CELLS; TUMOR PROGRESSION;
   GERMINAL-CENTERS; VIRAL-INFECTION; DIFFERENTIATION; MICE; EXPRESSION
AB Resolution of viral infections requires activation of innate cells to initiate and maintain adaptive immune responses. In this study, we examined Japanese encephalitis virus (JEV) infection leading to acute encephalopathy depending on suppression of the adaptive immune responses mediated by innate cells. Infection with P3 strains of JEV enhanced myeloid-derived suppressor cell (MDSC) populations, and the survival rate of JEV-infected mice improved after MDSC depletion. Mechanically, P3-induced MDSCs suppressed CD4(+) T cell immune responses, especially responses of T follicular helper (Tfh) cells, leading to decreased splenic B cells (CD19(+)) and blood plasma cells (CD19(+) CD138(+)) and reduced levels of total IgM and JEV-specific neutralizing Abs. Upon depleting P3-induced MDSCs in vivo, the Tfh cell population, B cells, plasma cells, and Ab production recovered. These findings provide unique insights regarding MDSC functions in mediating immune suppression via inhibiting Tfh cell responses and further impairing humoral immunity, which facilitate the progression of infection.
C1 [Wang, Chong; Zhang, Nan; Qi, Luting; Yuan, Jiaolong; Wang, Ke; Wang, Kunlun; Ma, Sicong; Wang, Haili; Lou, Wenjuan; Hu, Pingdong; Awais, Muhammad; Cao, Shengbo; Fu, Zhen F.; Cui, Min] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Lab Anim Virol, Wuhan 430070, Hubei, Peoples R China.
   [Fu, Zhen F.] Univ Georgia, Dept Pathol, Coll Vet Med, Athens, GA 30602 USA.
RP Cui, M (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.
EM cuimin@mail.hzau.edu.cn
FU National Program on Key Research Project of China [2016YFD0500406];
   Chinese Department of Agriculture (Special Fund for Agro-Scientific
   Research in the Public Interest) [201303042]; Fundamental Research Fund
   for the Central Universities Project [2662016PY013]
FX This work was supported by National Program on Key Research Project of
   China Grant 2016YFD0500406, the Chinese Department of Agriculture
   (Special Fund for Agro-Scientific Research in the Public Interest,
   Project 201303042), and Fundamental Research Fund for the Central
   Universities Project 2662016PY013.
CR Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009
   [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   Avery DT, 2008, J IMMUNOL, V181, P1767, DOI 10.4049/jimmunol.181.3.1767
   Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181
   BUESSOW SC, 1984, J NATL CANCER I, V73, P249
   Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354
   Chatterjee S, 2013, IMMUNOBIOLOGY, V218, P718, DOI 10.1016/j.imbio.2012.08.271
   Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092
   Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400
   Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837
   Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178
   De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264
   Dilek N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00208
   Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506
   Gould EA, 2008, ANTIVIR RES, V78, P140, DOI 10.1016/j.antiviral.2007.10.005
   Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x
   Hartmann W, 2015, EUR J IMMUNOL, V45, P2568, DOI 10.1002/eji.201545503
   Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099
   Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020
   Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870
   KING NJC, 1989, P NATL ACAD SCI USA, V86, P911, DOI 10.1073/pnas.86.3.911
   Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241
   Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989
   Lai CY, 2012, J NEUROCHEM, V123, P250, DOI 10.1111/j.1471-4159.2012.07889.x
   LARUSSA VF, 1995, BAILLIERE CLIN HAEM, V8, P249, DOI 10.1016/S0950-3536(05)80240-9
   Lee JM, 2012, INT J CANCER, V131, P741, DOI 10.1002/ijc.26411
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Li YM, 2011, VACCINE, V29, P855, DOI 10.1016/j.vaccine.2010.09.108
   Lobigs M, 2003, IMMUNOL CELL BIOL, V81, P217, DOI 10.1046/j.1440-1711.2003.01161.x
   Lu IN, 2017, CELL MOL IMMUNOL, V14, P511, DOI 10.1038/cmi.2016.20
   MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001
   Manzke N, 2013, J VIROL, V87, P6306, DOI 10.1128/JVI.00432-13
   Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x
   MATHUR A, 1984, IMMUNOLOGY, V52, P395
   Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689
   MONATH TP, 1981, AM J TROP MED HYG, V30, P431, DOI 10.4269/ajtmh.1981.30.431
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nagaraj S, 2013, J IMMUNOL, V191, P17, DOI 10.4049/jimmunol.1300654
   Ochando JC, 2012, IMMUNOL RES, V54, P275, DOI 10.1007/s12026-012-8335-1
   Pan PY, 2010, CANCER RES, V70, P99, DOI 10.1158/0008-5472.CAN-09-1882
   Park MJ, 2016, ARTHRITIS RHEUMATOL, V68, P2717, DOI 10.1002/art.39767
   Pene J, 2004, J IMMUNOL, V172, P5154, DOI 10.4049/jimmunol.172.9.5154
   Pritchard GH, 2015, J IMMUNOL, V194, P1131, DOI 10.4049/jimmunol.1401617
   Qin AP, 2013, J VIROL, V87, P1477, DOI 10.1128/JVI.01759-12
   Ren JP, 2016, IMMUNOLOGY, V148, P377, DOI 10.1111/imm.12616
   Robertson SJ, 2006, J IMMUNOL, V176, P3342, DOI 10.4049/jimmunol.176.6.3342
   Rothwell SW, 1996, AM J TROP MED HYG, V54, P503, DOI 10.4269/ajtmh.1996.54.503
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553
   SEUNG LP, 1995, P NATL ACAD SCI USA, V92, P6254, DOI 10.1073/pnas.92.14.6254
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Stoop JN, 2007, VIROLOGY, V361, P141, DOI 10.1016/j.virol.2006.11.018
   SUGAMATA M, 1988, J MED VIROL, V26, P243, DOI 10.1002/jmv.1890260304
   Tacke RS, 2012, HEPATOLOGY, V55, P343, DOI 10.1002/hep.24700
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tebartz C, 2015, J IMMUNOL, V194, P1100, DOI 10.4049/jimmunol.1400196
   THORBECKE GJ, 1994, FASEB J, V8, P832
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013
   Valanparambil RM, 2017, MUCOSAL IMMUNOL, V10, P238, DOI 10.1038/mi.2016.36
   Venken K, 2007, J IMMUNOL METHODS, V322, P1, DOI 10.1016/j.jim.2007.01.025
   Vollbrecht T, 2012, AIDS, V26, pF31, DOI 10.1097/QAD.0b013e328354b43f
   Wan YY, 2014, TRENDS IMMUNOL, V35, P233, DOI 10.1016/j.it.2014.04.002
   Wang L, 2016, AIDS, V30, P1521, DOI 10.1097/QAD.0000000000001083
   Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229
   Yang M, 2012, AM J PATHOL, V180, P2375, DOI 10.1016/j.ajpath.2012.03.010
   Yi HF, 2012, J IMMUNOL, V189, P4295, DOI 10.4049/jimmunol.1200086
   YOUNG MR, 1987, CANCER RES, V47, P100
   Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao AM, 2016, J REPROD IMMUNOL, V113, P35, DOI 10.1016/j.jri.2015.11.001
   Zhu JG, 2012, J VIROL, V86, P13689, DOI 10.1128/JVI.01595-12
NR 74
TC 8
Z9 9
U1 0
U2 13
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD NOV 1
PY 2017
VL 199
IS 9
BP 3094
EP 3105
DI 10.4049/jimmunol.1700671
PG 12
WC Immunology
SC Immunology
GA FK4LT
UT WOS:000413466400011
PM 28978693
OA Bronze
DA 2020-07-08
ER

PT J
AU Johnson, TL
   Haque, U
   Monaghan, AJ
   Eisen, L
   Hahn, MB
   Hayden, MH
   Savage, HM
   McAllister, J
   Mutebi, JP
   Eisen, RJ
AF Johnson, Tammi L.
   Haque, Ubydul
   Monaghan, Andrew J.
   Eisen, Lars
   Hahn, Micah B.
   Hayden, Mary H.
   Savage, Harry M.
   McAllister, Janet
   Mutebi, John-Paul
   Eisen, Rebecca J.
TI Modeling the Environmental Suitability for Aedes (Stegomyia) aegypti and
   Aedes (Stegomyia) albopictus (Diptera: Culicidae) in the Contiguous
   United States
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; risk model; environmental suitability;
   MaxEnt
ID ASIAN TIGER MOSQUITO; GLOBAL DISTRIBUTION; ZIKA VIRUS; CHIKUNGUNYA
   VIRUS; SOUTH FLORIDA; DENGUE; VECTOR; TEMPERATURE; SPREAD; FEVER
AB The mosquitoes Aedes (Stegomyia) aegypti (L.)(Diptera: Culicidae) and Ae. (Stegomyia) albopictus (Skuse) (Diptera: Culicidae) transmit dengue, chikungunya, and Zika viruses and represent a growing public health threat in parts of the United States where they are established. To complement existing mosquito presence records based on discontinuous, non-systematic surveillance efforts, we developed county-scale environmental suitability maps for both species using maximum entropy modeling to fit climatic variables to county presence records from 1960-2016 in the contiguous United States. The predictive models for Ae. aegypti and Ae. albopictus had an overall accuracy of 0.84 and 0.85, respectively. Cumulative growing degree days (GDDs) during the winter months, an indicator of overall warmth, was the most important predictive variable for both species and was positively associated with environmental suitability. The number (percentage) of counties classified as environmentally suitable, based on models with 90 or 99% sensitivity, ranged from 1,443 (46%) to 2,209 (71%) for Ae. aegypti and from 1,726 (55%) to 2,329 (75%) for Ae. albopictus. Increasing model sensitivity results in more counties classified as suitable, at least for summer survival, from which there are no mosquito records. We anticipate that Ae. aegypti and Ae. albopictus will be found more commonly in counties classified as suitable based on the lower 90% sensitivity threshold compared with the higher 99% threshold. Counties predicted suitable with 90% sensitivity should therefore be a top priority for expanded mosquito surveillance efforts while still keeping in mind that Ae. aegypti and Ae. albopictus may be introduced, via accidental transport of eggs or immatures, and potentially proliferate during the warmest part of the year anywhere within the geographic areas delineated by the 99% sensitivity model.
C1 [Johnson, Tammi L.; Eisen, Lars; Hahn, Micah B.; Savage, Harry M.; McAllister, Janet; Mutebi, John-Paul; Eisen, Rebecca J.] Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
   [Haque, Ubydul; Monaghan, Andrew J.; Hayden, Mary H.] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.
RP Eisen, RJ (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM dyn2@cdc.gov
OI Johnson, Tammi/0000-0002-0752-0012
FU Climate and Health Program of the National Center for Environmental
   Health, U.S. Centers for Disease Control and Prevention; National
   Science FoundationNational Science Foundation (NSF)
FX We thank the state and local health departments, mosquito control
   agencies, and universities that submitted records to the U.S. Stegomyia
   survey. This work was funded by the Climate and Health Program of the
   National Center for Environmental Health, U.S. Centers for Disease
   Control and Prevention. The National Science Foundation sponsors the
   National Center for Atmospheric Research. The authors declared no
   conflict of interest.
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854
   Bargielowski I, 2015, ANN ENTOMOL SOC AM, V108, P513, DOI 10.1093/aesa/sav037
   Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bennett JK, 2005, J AM MOSQUITO CONTR, V21, P341, DOI 10.2987/8756-971X(2006)21[341:NSRFTA]2.0.CO;2
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Byers JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056812
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Capinha C, 2014, ECOHEALTH, V11, P420, DOI 10.1007/s10393-014-0918-y
   Castilho R., 2015, SPECIES DISTRIBUTION
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Centers for Disease Control and Prevention, 2017, CAS COUNTS US
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Cunze S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162116
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x
   Erguler K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149282
   Faraji A, 2016, J MED ENTOMOL, V53, P1029, DOI 10.1093/jme/tjw096
   Farajollahi A, 2009, J MED ENTOMOL, V46, P1220, DOI 10.1603/033.046.0533
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   GAO JZ, 1984, ACTA ENTOMOL SINICA, V27, P182
   Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Hahn M.B., 2017, J MED ENTOM IN PRESS
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   HAWLEY WA, 1989, J MED ENTOMOL, V26, P122, DOI 10.1093/jmedent/26.2.122
   Hayden MH, 2010, ECOHEALTH, V7, P64, DOI 10.1007/s10393-010-0288-z
   Higgins RW, 1997, J CLIMATE, V10, P2600, DOI 10.1175/1520-0442(1997)010<2600:IOTNAM>2.0.CO;2
   Hijmans R. J., 2016, R PACKAGE DISMO SPEC
   Joy JE, 2004, J AM MOSQUITO CONTR, V20, P12
   Joy JE, 2003, J MED ENTOMOL, V40, P73, DOI 10.1603/0022-2585-40.1.73
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x
   Lounibos LP, 2010, ANN ENTOMOL SOC AM, V103, P757, DOI 10.1603/AN09142
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Metzger ME, 2017, J MED ENTOMOL, V54, P533, DOI 10.1093/jme/tjw237
   MOGI M, 1988, MED VET ENTOMOL, V2, P319, DOI 10.1111/j.1365-2915.1988.tb00203.x
   Monaghan A. J., 2016, CLIMATIC CHANGE, P1
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Nix H. A., 1986, AUSTR FLORA FAUNA SE, P4
   Ogden NH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0532-4
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554
   PATTERSON KD, 1992, SOC SCI MED, V34, P855, DOI 10.1016/0277-9536(92)90255-O
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Phillips SJ, 2006, BRIEF TUTORIAL MAXEN
   Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x
   Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1
   Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494
   Proestos Y, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0554
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   SMITH GC, 1988, J AM MOSQUITO CONTR, V4, P557
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Thornton P. E., 2016, DAYMET DAILY SURFACE
   Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Vasconcelos PFC, 2017, ARTHROPOD BORNE DIS, P101
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 86
TC 21
Z9 21
U1 2
U2 23
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD NOV
PY 2017
VL 54
IS 6
BP 1605
EP 1614
DI 10.1093/jme/tjx163
PG 10
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA FT2LS
UT WOS:000422974500018
PM 29029153
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Lehnert, JD
   Ellingson, MK
   Goryoka, GW
   Kasturi, R
   Maier, E
   Chamberlain, AT
AF Lehnert, Jonathan D.
   Ellingson, Mallory K.
   Goryoka, Grace W.
   Kasturi, Raghuraj
   Maier, Emily
   Chamberlain, Allison T.
TI Use of Obstetric Practice Web Sites to Distribute Zika Virus Information
   to Pregnant Women During a Zika Virus Outbreak
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Article
DE emergency response; obstetric care; public health; public health
   preparedness; risk communication; Zika virus
ID UNITED-STATES; COMMUNICATION; LESSONS
AB Objective: To describe the current use of obstetric practice Web sites to disseminate Zika virus information to patients.
   Design: Review of 913 randomly selected practice Web sites and associated social media accounts in January and August 2016.
   Setting: Obstetric practice Web sites and associated social media accounts, United States of America.
   Participants: N/A.
   Main Outcome Measures: Proportion of obstetric practice Web sites and linked social media accounts providing Zika virus information.
   Results: Twenty-five percent and 35% of obstetric practice Web sites had information posted about Zika virus in January 2016 and August 2016, respectively. Between the 2 time points, the proportion of practices posting Zika virus content on Facebook and Twitter declined (Facebook: 15% in January, 9% in August; Twitter: 12% in January, 8% in August). In August, the most frequently observed Zika virus-related content themes were the use of insect repellent (14%) and travel advisories (14%). At both time points, practices affiliated with large university hospitals were more likely to have posted information on Zika virus than independent OB/GYN-only practices: January: odds ratio (OR) (95% confidence interval [CI]) = 5.68 (3.50-9.20); August: OR (95% CI) = 8.37 (5.31-13.17). Similarly, practices associated with nonuniversity hospitals were more likely to have posted information than independent OB/GYN-only practices: January: OR (95% CI) = 2.71 (1.88-3.92); August: OR (95% CI) = 6.75 (4.75-9.60).
   Conclusion: Obstetric care practices are not fully utilizing their practice Web sites to relay Zika virus information to their patients. Since practitioner-sponsored Web sites have the capacity to directly reach the populations at greatest risk for Zika virus complications, public health professionals should consider adapting their materials and provider outreach campaigns to more easily accommodate Web site-based information dissemination during this type of public health emergency. There must be greater recognition of the value information gains in the eyes of the patient when it is validated by their own provider, especially when that patient is part of the highest-risk population for a given emergency. Public health organizations should strive to minimize the burden it takes for providers to relay useful resources to patients in order to maximize the impact that those resources can have.
C1 [Lehnert, Jonathan D.; Ellingson, Mallory K.; Maier, Emily; Chamberlain, Allison T.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd, Atlanta, GA 30322 USA.
   [Goryoka, Grace W.; Kasturi, Raghuraj] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, 1518 Clifton Rd, Atlanta, GA 30322 USA.
RP Lehnert, JD (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd, Atlanta, GA 30322 USA.
EM jonathan.dieter.lehnert@emory.edu
RI Chamberlain, Allison T./AAA-3835-2019
OI Chamberlain, Allison T./0000-0001-6009-537X; Ellingson,
   Mallory/0000-0003-2729-0661
FU Centers for Disease Control and Prevention's (CDC's) Collaboration;
   Academia to Strengthen Public Health Workforce Capacity - CDC, Office of
   Public Health Preparedness and Response through the Association of
   Schools and Programs of Public Health (ASPPH) [3 U36 OE000002-04 S05]
FX This publication was supported under cooperative agreement, the Centers
   for Disease Control and Prevention's (CDC's) Collaboration with Academia
   to Strengthen Public Health Workforce Capacity (grant no. 3 U36
   OE000002-04 S05) funded by CDC, Office of Public Health Preparedness and
   Response, through the Association of Schools and Programs of Public
   Health (ASPPH). The authors acknowledge the following graduate students
   from the Emory University Rollins School of Public Health Student
   Outbreak and Response Team [SORT]) for their voluntary contributions to
   data collection: Christie Camero Chadwell, Miranda Delahoy, Laura de
   Mondesert, Katie Forsberg, Laura King, Jasmine Ko, Amelia Mazzei,
   Catherine Nguyen, Caroline Pratt, David Roth, Anirudh Rao, Aalisha Sahu
   Khan, Emma Seagle, Tara Serio, Kelley VanMaldeghem, Maria Varvoutis,
   Marissa Vereen, and Amanda Vincent.
CR American Congress of Obstetricians and Gynecologists, ZIK VIR RES SUMM OB
   American Congress of Obstetricians and Gynecologists, ACOG STAT ZIK VIR
   Beck F, 2014, J MED INTERNET RES, V16, P193, DOI 10.2196/jmir.2934
   Bedrosian SR, 2016, MMWR-MORBID MORTAL W, V65, P68, DOI 10.15585/mmwr.su6503a10
   Blendon RJ, 2004, CLIN INFECT DIS, V38, P925, DOI 10.1086/382355
   Centers for Disease Control and Prevention, ZIK COMM TOOLK HEALT
   Centers for Disease Control and Prevention, INF SPEC GROUPS
   Centers for Disease Control and Prevention, FLOR INV LINKS 4 REC
   Chamberlain AT, 2016, OBSTET GYNECOL, V127, P119, DOI 10.1097/AOG.0000000000001183
   Dickmann P, 2016, EUROSURVEILLANCE, V21, P24, DOI 10.2807/1560-7917.ES.2016.21.14.30188
   Fergie G, 2013, J YOUTH STUD, V16, P579, DOI 10.1080/13676261.2012.744811
   Jardine CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140028
   Lagu T, 2010, J GEN INTERN MED, V25, P942, DOI 10.1007/s11606-010-1383-0
   Lin LS, 2014, PUBLIC HEALTH REP, V129, P49, DOI 10.1177/00333549141296S408
   Mayo Clinic, ZIK VIR DIS
   Mendes A, 2017, HEALTH COMMUN, V32, P1076, DOI 10.1080/10410236.2016.1199081
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   World Health Organisation, ZIK VIR COMPL
NR 18
TC 4
Z9 4
U1 8
U2 22
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD NOV-DEC
PY 2017
VL 23
IS 6
BP 608
EP 613
DI 10.1097/PHH.0000000000000537
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FI7KQ
UT WOS:000412176000018
PM 28125540
OA Green Published
DA 2020-07-08
ER

PT J
AU Vijaykumar, S
   Meurzec, RW
   Jayasundar, K
   Pagliari, C
   Fernandopulle, Y
AF Vijaykumar, Santosh
   Meurzec, Rianne Wally
   Jayasundar, Karthikayen
   Pagliari, Claudia
   Fernandopulle, Yohan
TI What's buzzing on your feed? Health authorities' use of Facebook to
   combat Zika in Singapore
SO JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
LA English
DT Article
DE Zika virus; social media; policy making; health communication; public
   health; public engagement
ID SOCIAL MEDIA; ENGAGEMENT; VIRUS
AB In 2016, Singapore grappled with one of the largest Zika outbreaks in Southeast Asia. This study examines the use of Facebook for Zika-related outreach by the Ministry of Health (MOH) and the National Environmental Agency (NEA) from March 1, 2015, to September 1, 2016, and public response to this effort. Despite nearly equivalent outreach, MOH's Facebook posts received more likes (A mu = 3.49) and shares (A mu = 30.11), whereas NEA's posts received more comments (A mu = 4.55), with NEA posting mostly on prevention (N = 30) and MOH on situational updates (N = 24). Thematic analyses identified prevention-related posts as garnering the most likes (N = 1277), while update-related posts were most shared (N = 1059) and commented upon (N = 220). Outreach ceased briefly for 2 months after Singapore's first imported case of Zika, but increased following the outbreak of locally transmitted cases in August 2016. Public engagement was significantly higher during Zika compared with prior haze and dengue outbreaks. The results indicate the value of Facebook as a tool for rapid outreach during infectious disease outbreaks, and as a "listening" platform for those managing the situation. We discuss implications for public health communication research and policy.
C1 [Vijaykumar, Santosh] Northumbria Univ, Dept Psychol, NB 142,Northumberland Bldg, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.
   [Meurzec, Rianne Wally; Fernandopulle, Yohan] Nanyang Technol Univ, Sch Comp Sci & Engn, Singapore, Singapore.
   [Jayasundar, Karthikayen] Nanyang Technol Univ, Wee Kim Wee Sch Commun & Informat, Singapore, Singapore.
   [Pagliari, Claudia] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland.
RP Vijaykumar, S (corresponding author), Northumbria Univ, Dept Psychol, NB 142,Northumberland Bldg, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.
EM santosh.vijaykumar@northumbria.ac.uk
RI Pagliari, Claudia/P-6412-2018
OI Pagliari, Claudia/0000-0001-5791-7723; Jayasundar,
   Karthikayen/0000-0001-7207-391X
CR Barot Trushar, 2015, BBC EBOLA WHATSAPP S
   Biswas M., 2013, J NEW COMMUNICATIONS, V5, P46
   Bonson E, 2013, ONLINE INFORM REV, V37, P787, DOI 10.1108/OIR-03-2012-0054
   Charles-Smith LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139701
   Chew H.M, 2016, STRAITS TIMES
   Cho M, 2014, PUBLIC RELAT REV, V40, P565, DOI 10.1016/j.pubrev.2014.01.008
   Forsyth T, 2014, GLOBAL ENVIRON CHANG, V25, P76, DOI 10.1016/j.gloenvcha.2014.01.013
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   Goy P, 2016, STRAITS TIMES
   Hapuarachchi HC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1606-z
   Kemp S, 2016, WE ARE SOCIAL
   Khalik S., 2016, STRAITS TIMES
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lazard AJ, 2015, AM J INFECT CONTROL, V43, P1109, DOI 10.1016/j.ajic.2015.05.025
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lin Y., 2016, STRAITS TIMES
   Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591
   Moong CM, 2016, FIGHTING ZIKA IT NEE
   Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933
   Nair S, 2016, STRAITS TIMES
   Pagliari C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004795
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Strekalova YA, 2016, HEALTH EDUC BEHAV, V44, P332
   Thackeray R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-242
   Thomas J., 2016, WHATSAPP EARLY WARNI
   Vijaykumar S, 2015, J HOMEL SECUR EMERG, V12, P653, DOI 10.1515/jhsem-2014-0072
   Wong P.T., 2016, TODAY ONLINE
   World Health Organization, 2008, WHO OUTBR COMM PLANN
NR 28
TC 5
Z9 5
U1 0
U2 18
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1067-5027
EI 1527-974X
J9 J AM MED INFORM ASSN
JI J. Am. Med. Inf. Assoc.
PD NOV
PY 2017
VL 24
IS 6
BP 1155
EP 1159
DI 10.1093/jamia/ocx028
PG 5
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Health Care Sciences & Services;
   Information Science & Library Science; Medical Informatics
SC Computer Science; Health Care Sciences & Services; Information Science &
   Library Science; Medical Informatics
GA FL6YJ
UT WOS:000414392100016
PM 28449047
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Batovska, J
   Lynch, SE
   Rodoni, BC
   Sawbridge, TI
   Cogan, NOI
AF Batovska, Jana
   Lynch, Stacey E.
   Rodoni, Brendan C.
   Sawbridge, Tim I.
   Cogan, Noel O. I.
TI Metagenomic arbovirus detection using MinION nanopore sequencing
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Mosquito; Culicidae; Ross River virus; MinION; MiSeq; Surveillance
ID REAL-TIME; IDENTIFICATION; BACTERIAL; VIRUS; ZIKA
AB With its small size and low cost, the hand-held MinION sequencer is a powerful tool for in-field surveillance. Using a metagenomic approach, it allows non-targeted detection of viruses in a sample within a few hours. This study aimed to determine the ability of the MinION to metagenomically detect and characterise a virus from an infected mosquito. RNA was extracted from an Aedes notoscriptus mosquito infected with Ross River virus (RRV), converted into cDNA and sequenced on the MinION. Bioinformatic analysis of the MinION reads led to detection of full-length RRV, with reads of up to 2.5 kb contributing to the assembly. The cDNA was also sequenced on the MiSeq sequencer, and both platforms recovered the RRV genome with > 98% accuracy. This proof of concept study demonstrates the metagenomic detection of an arbovirus, using the MinION, directly from a mosquito with minimal sample purification.
C1 [Batovska, Jana; Lynch, Stacey E.; Rodoni, Brendan C.; Sawbridge, Tim I.; Cogan, Noel O. I.] Agr Victoria Res, AgriBio Ctr AgriBiosci, 5 Ring Rd, Bundoora, Vic 3083, Australia.
   [Batovska, Jana; Rodoni, Brendan C.; Sawbridge, Tim I.; Cogan, Noel O. I.] La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic 3086, Australia.
RP Batovska, J (corresponding author), Agr Victoria Res, AgriBio Ctr AgriBiosci, 5 Ring Rd, Bundoora, Vic 3083, Australia.
EM jana.batovska@ecodev.vic.gov.au; stacey.lynch@ecodev.vic.gov.au;
   brendan.rodoni@ecodev.vic.gov.au; tim.sawbridge@ecodev.vic.gov.au;
   noel.cogan@ecodev.vic.gov.au
RI Batovska, Jana/N-4926-2015
OI Batovska, Jana/0000-0002-0919-568X
FU Biosciences Research Innovation Fund Program by Department of Economic
   Development, Jobs, Transport and Resources
FX The authors thank Jonathan Darbro and Elise Kho for providing the
   mosquito specimen used in this study, and Simone Warner for critically
   reading and approving the manuscript. This project was funded through a
   Biosciences Research Innovation Fund Program provided by the Department
   of Economic Development, Jobs, Transport and Resources.
CR Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861
   Batovska J., 2017, MOL ECOL RESOUR
   Batovska J, 2016, ECOL EVOL, V6, P3001, DOI 10.1002/ece3.2095
   David M, 2017, BIOINFORMATICS, V33, P49, DOI 10.1093/bioinformatics/btw569
   Eckert SE, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000087
   Garalde D.R., 2016, 068809 BIORXIV
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Hall RA, 2011, MOL DETECTION HUMAN, P349
   Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796
   Houldcroft CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/nrmicro.2016.182
   JANSEN HJ, 2017, SCI REP UK, V7
   Jaworski E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006365
   Jones A, 2010, J GEN VIROL, V91, P182, DOI 10.1099/vir.0.014209-0
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kilianski A, 2016, EMERG INFECT DIS, V22, P1448, DOI 10.3201/eid2208.160270
   Kilianski A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0051-z
   Knope KE, 2016, COMMUN DIS INTELL, V40, pE401
   Krueger F., 2015, TRIM GALORE WRAPPER
   LI H, 2013, 13033997 ARXIV, V1303, P3997, DOI DOI 10.1093/BI0INF0RMATICS/BTP352
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lindsay MDA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004114
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]
   Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555
   Lu HY, 2016, GENOM PROTEOM BIOINF, V14, P265, DOI 10.1016/j.gpb.2016.05.004
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   MITSUHASHI S, 2017, SCI REP UK, V7
   MONGAN AE, 2015, AM J MICROBIOL RES, V3, P118
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Temmam S, 2014, INT J MOL SCI, V15, P10377, DOI 10.3390/ijms150610377
   Tyson J., 2017, 099143 BIORXIV
   Vaux AGC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0936-9
   Walter MC, 2017, J BIOTECHNOL, V250, P16, DOI 10.1016/j.jbiotec.2016.12.006
   Wang J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00766
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068586
NR 37
TC 22
Z9 25
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD NOV
PY 2017
VL 249
BP 79
EP 84
DI 10.1016/j.jviromet.2017.08.019
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA FK0NQ
UT WOS:000413177000012
PM 28855093
OA Other Gold
DA 2020-07-08
ER

PT J
AU Eyer, L
   Kondo, H
   Zouharova, D
   Hirano, M
   Valdes, JJ
   Muto, M
   Kastl, T
   Kobayashi, S
   Haviernik, J
   Igarashi, M
   Kariwa, H
   Vaculovicova, M
   Cerny, J
   Kizek, R
   Kroger, A
   Lienenklaus, S
   Dejmek, M
   Nencka, R
   Palus, M
   Salat, J
   De Clercq, E
   Yoshii, K
   Ruzek, D
AF Eyer, Ludek
   Kondo, Hirofumi
   Zouharova, Darina
   Hirano, Minato
   Valdes, James J.
   Muto, Memi
   Kastl, Tomas
   Kobayashi, Shintaro
   Haviernik, Jan
   Igarashi, Manabu
   Kariwa, Hiroaki
   Vaculovicova, Marketa
   Cerny, Jiri
   Kizek, Rene
   Kroeger, Andrea
   Lienenklaus, Stefan
   Dejmek, Milan
   Nencka, Radim
   Palus, Martin
   Salat, Jiri
   De Clercq, Erik
   Yoshii, Kentaro
   Ruzek, Daniel
TI Escape of Tick-Borne Flavivirus from 2'-C-Methylated Nucleoside
   Antivirals Is Mediated by a Single Conservative Mutation in NS5 That Has
   a Dramatic Effect on Viral Fitness
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE antiviral agents; antiviral therapy; escape mutant; tick-borne;
   encephalitis virus; tick-borne pathogens
ID C VIRUS-REPLICATION; DEPENDENT RNA-POLYMERASE; NUCLEOSIDE/NUCLEOTIDE
   ANALOG INHIBITORS; INFECTIOUS CDNA-CLONE; ENCEPHALITIS-VIRUS; ZIKA
   VIRUS; JAPANESE ENCEPHALITIS; ACTIVE-SITE; RESISTANCE; DENGUE
AB borne encephalitis virus (TBEV) causes a severe and potentially fatal neuroinfection in humans. Despite its high medical relevance, no specific antiviral therapy is currently available. Here we demonstrate that treatment with a nucleoside analog, 7-deaza-2'-C-methyladenosine (7-deaza-2'-CMA), substantially improved disease outcomes, increased survival, and reduced signs of neuroinfection and viral titers in the brains of mice infected with a lethal dose of TBEV. To investigate the mechanism of action of 7-deaza-2'-CMA, two drug-resistant TBEV clones were generated and characterized. The two clones shared a signature amino acid substitution, S603T, in the viral NS5 RNA-dependent RNA polymerase (RdRp) domain. This mutation conferred resistance to various 2'-C-methylated nucleoside derivatives, but no cross-resistance was seen with other nucleoside analogs, such as 4'-C-azidocytidine and 2'-deoxy-2'-beta-hydroxy-4'-azidocytidine (RO-9187). All-atom molecular dynamics simulations revealed that the S603T RdRp mutant repels a water molecule that coordinates the position of a metal ion cofactor as 2'-C-methylated nucleoside analogs approach the active site. To investigate its phenotype, the S603T mutation was introduced into a recombinant TBEV strain (Oshima-IC) generated from an infectious cDNA clone and into a TBEV replicon that expresses a reporter luciferase gene (Oshima-REP- luc2A). The mutants were replication impaired, showing reduced growth and a small plaque size in mammalian cell culture and reduced levels of neuroinvasiveness and neurovirulence in rodent models. These results indicate that TBEV resistance to 2'-C-methylated nucleoside inhibitors is conferred by a single conservative mutation that causes a subtle atomic effect within the active site of the viral NS5 RdRp and is associated with strong attenuation of the virus.
   IMPORTANCE This study found that the nucleoside analog 7-deaza-2'-C-methyl-adenosine (7-deaza-2'-CMA) has high antiviral activity against tick-borne encephalitis virus (TBEV), a pathogen that causes severe human neuroinfections in large areas of Europe and Asia and for which there is currently no specific therapy. Treating mice infected with a lethal dose of TBEV with 7-deaza-2'-CMA resulted in significantly higher survival rates and reduced the severity of neurological signs of the disease. Thus, this compound shows promise for further development as an anti-TBEV drug. It is important to generate drug-resistant mutants to understand how the drug works and to develop guidelines for patient treatment. We generated TBEV mutants that were resistant not only to 7-deaza-2'-CMA but also to a broad range of other 2'-C-methylated antiviral medications. Our findings suggest that combination therapy may be used to improve treatment and reduce the emergence of drug-resistant viruses during nucleoside analog therapy for TBEV infection.
C1 [Eyer, Ludek; Zouharova, Darina; Valdes, James J.; Kastl, Tomas; Haviernik, Jan; Cerny, Jiri; Palus, Martin; Salat, Jiri; Ruzek, Daniel] Vet Res Inst, Dept Virol, Brno, Czech Republic.
   [Eyer, Ludek; Valdes, James J.; Cerny, Jiri; Palus, Martin; Ruzek, Daniel] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic.
   [Kondo, Hirofumi; Hirano, Minato; Muto, Memi; Kobayashi, Shintaro; Kariwa, Hiroaki; Yoshii, Kentaro] Hokkaido Univ, Grad Sch Vet Med, Lab Publ Hlth, Sapporo, Hokkaido, Japan.
   [Igarashi, Manabu] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.
   [Vaculovicova, Marketa] Mendel Univ Brno, Dept Chem & Biochem, Brno, Czech Republic.
   [Vaculovicova, Marketa] Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic.
   [Kizek, Rene] Univ Vet & Pharmaceut Sci, Cent Labs, Fac Pharm, Brno, Czech Republic.
   [Kroeger, Andrea] Otto von Guericke Univ, Inst Med Microbiol, Magdeburg, Germany.
   [Lienenklaus, Stefan] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany.
   [Dejmek, Milan; Nencka, Radim] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic.
   [De Clercq, Erik] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium.
RP Ruzek, D (corresponding author), Vet Res Inst, Dept Virol, Brno, Czech Republic.; Ruzek, D (corresponding author), Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic.
EM ruzekd@paru.cas.cz
RI Ruzek, Daniel/G-9275-2014; Igarashi, Manabu/F-6871-2012; Eyer,
   Ludek/U-4883-2018; Salat, Jiri/F-6295-2019; Valdes, James J/G-9812-2014;
   Palus, Martin/N-1263-2017; Vaculovicova, Marketa/E-5583-2016; Cerny,
   Jiri/Q-4140-2016
OI Ruzek, Daniel/0000-0003-4655-2380; Eyer, Ludek/0000-0001-7761-0702;
   Valdes, James J/0000-0002-0237-8061; Palus, Martin/0000-0002-4279-7092;
   Vaculovicova, Marketa/0000-0002-6771-1304; Cerny,
   Jiri/0000-0003-0891-0693; Salat, Jiri/0000-0002-9915-8953; De Clercq,
   Erik/0000-0002-2985-8890; Kizek, Rene/0000-0002-0467-6169
FU Ministry of Health of the Czech RepublicMinistry of Health, Czech
   Republic [16-34238A]; Project FIT (Pharmacology, Immunotherapy,
   nanoToxicology) - European Regional Development Fund; Ministry of
   Education, Culture, Sports, Science and Technology of JapanMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)
   [26660220, 16K15032]; Ichiro Kanehara Foundation
FX This study was supported by a grant from the Ministry of Health of the
   Czech Republic (grant 16-34238A); by Project FIT (Pharmacology,
   Immunotherapy, nanoToxicology), which was funded by the European
   Regional Development Fund (to D.R.); by grants-in-aid for scientific
   research (grants 26660220 and 16K15032) from the Ministry of Education,
   Culture, Sports, Science and Technology of Japan; and by a grant
   provided by the Ichiro Kanehara Foundation (to K.Y.).
CR Arnold JJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003030
   Atrasheuskaya AV, 2003, CLIN EXP IMMUNOL, V131, P148, DOI 10.1046/j.1365-2249.2003.02050.x
   Berger KL, 2015, ANTIMICROB AGENTS CH, V59, P6017, DOI 10.1128/AAC.00932-15
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811
   Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002
   Chen YL, 2015, ANTIVIR RES, V122, P12, DOI 10.1016/j.antiviral.2015.07.010
   Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014
   Cohen J., 1988, STAT POWER ANAL BEHA
   Curti E, 2013, J VIROL, V87, P199, DOI 10.1128/JVI.06968-11
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
   Dobson BM, 2014, VIROLOGY, V456, P145, DOI 10.1016/j.virol.2014.03.020
   Dumpis U, 1999, CLIN INFECT DIS, V28, P882, DOI 10.1086/515195
   Dutta K, 2010, IMMUNOBIOLOGY, V215, P884, DOI 10.1016/j.imbio.2009.12.003
   Eyer L, 2016, ANTIVIR RES, V133, P119, DOI 10.1016/j.antiviral.2016.07.018
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Flint M, 2014, ANTIMICROB AGENTS CH, V58, P3206, DOI 10.1128/AAC.02393-14
   Giannotti MI, 2015, J PHYS CHEM B, V119, P12050, DOI 10.1021/acs.jpcb.5b06382
   Hayasaka D, 2004, J GEN VIROL, V85, P1007, DOI 10.1099/vir.0.19668-0
   HEINZ FX, 1993, APMIS, V101, P735, DOI 10.1111/j.1699-0463.1993.tb00174.x
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001
   Klumpp K, 2006, J BIOL CHEM, V281, P3793, DOI 10.1074/jbc.M510195200
   Klumpp K, 2008, J BIOL CHEM, V283, P2167, DOI 10.1074/jbc.M708929200
   KOZUCH O, 1975, ACTA VIROL, V19, P498
   Kumar R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1385-6
   Laara E, 2009, ANN ZOOL FENN, V46, P138
   Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853
   Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277
   Madadkar-Sobhani A, 2013, NUCLEIC ACIDS RES, V41, pW322, DOI 10.1093/nar/gkt454
   Mateo R, 2015, MBIO, V6, DOI 10.1128/mBio.01960-15
   Mateu CG, 2011, SEX TRANSM DIS, V38, P555, DOI 10.1097/OLQ.0b013e3182084d99
   McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07
   Menendez-Arias L, 2014, CURR OPIN VIROL, V8, P1, DOI 10.1016/j.coviro.2014.04.005
   Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200
   Mishra MK, 2008, J NEUROCHEM, V105, P1582, DOI 10.1111/j.1471-4159.2008.05238.x
   Mishra MK, 2009, NEUROCHEM INT, V55, P717, DOI 10.1016/j.neuint.2009.07.006
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Palus M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-77
   POSPISIL L, 1954, Lek List, V9, P3
   Potisopon S, 2017, ANTIVIR RES, V140, P25, DOI 10.1016/j.antiviral.2016.12.021
   Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015
   Rubio MP, 2005, J VIROL, V79, P11280, DOI 10.1128/JVI.79.17.11280-11290.2005
   Ruzek D, 2009, VIROLOGY, V384, P1, DOI 10.1016/j.virol.2008.11.023
   Ruzek D, 2008, VIROLOGY, V374, P249, DOI 10.1016/j.virol.2008.01.010
   Ruzek D, 2010, TRAVEL MED INFECT DI, V8, P223, DOI 10.1016/j.tmaid.2010.06.004
   Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423
   Schrodinger LLC, 2016, REL 2016 3 MAESTR
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Sofia MJ, 2012, J MED CHEM, V55, P2481, DOI 10.1021/jm201384j
   STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498
   Takashima I, 1997, J CLIN MICROBIOL, V35, P1943, DOI 10.1128/JCM.35.8.1943-1947.1997
   Valdes JJ, 2016, J GEN VIROL, V97, P2552, DOI 10.1099/jgv.0.000569
   Valdes JJ, 2017, BIOCHEM BIOPH RES CO, V2017
   Weber E, 2014, J VIROL, V88, P12202, DOI 10.1128/JVI.01215-14
   Wu RZ, 2010, J MED CHEM, V53, P7958, DOI 10.1021/jm100593s
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Yoshii K, 2011, VIRUS RES, V155, P61, DOI 10.1016/j.virusres.2010.08.023
   Yoshii K, 2009, J VIROL METHODS, V161, P173, DOI 10.1016/j.jviromet.2009.05.016
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x
NR 66
TC 11
Z9 12
U1 2
U2 31
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2017
VL 91
IS 21
AR UNSP e01028-17
DI 10.1128/JVI.01028-17
PG 20
WC Virology
SC Virology
GA FK0UI
UT WOS:000413195400026
PM 28814513
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Huang, HR
   Li, SH
   Zhang, YL
   Han, XJ
   Jia, BQ
   Liu, HT
   Liu, DD
   Tan, SG
   Wang, QH
   Bi, YH
   Liu, WJ
   Hou, BD
   Gao, GF
   Zhang, FP
AF Huang, Huarong
   Li, Shihua
   Zhang, Yongli
   Han, Xiaojuan
   Jia, Baoqian
   Liu, Hongtao
   Liu, Dandan
   Tan, Shuguang
   Wang, Qihui
   Bi, Yuhai
   Liu, William J.
   Hou, Baidong
   Gao, George Fu
   Zhang, Fuping
TI CD8(+) T Cell Immune Response in Immunocompetent Mice during Zika Virus
   Infection
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE CD8(+) T cell; ZIKV; central nervous system; cross protection;
   immunocompetent mouse model
ID MOUSE MODEL; DENGUE
AB Zika virus (ZIKV) infection causees neurologic complications, including Guillain-Barre syndrome in adults and central nervous system (CNS) abnormalities in fetuses. We investigated the immune response, especially the CD8(+) T cell response in C57BL/6 (B6) wild-type (WT) mice, during ZIKV infection. We found that a robust CD8(+) T cell response was elicited, major histocompatibility complex class I-restricted CD8(+) T cell epitopes were identified, a tetramer that recognizes ZIKV-specific CD8(+) T cells was developed, and virus-specific memory CD8(+) T cells were generated in these mice. The CD8(+) T cells from these infected mice were functional, as evidenced by the fact that the adoptive transfer of ZIKV-specific CD8(+) T cells could prevent ZIKV infection in the CNS and was cross protective against dengue virus infection. Our findings provide comprehensive insight into immune responses against ZIKV and further demonstrate that WT mice could be a natural and easy-access model for evaluating immune responses to ZIKV infection.
   IMPORTANCE ZIKV infection has severe clinical consequences, including Guillain-Barre syndrome in adults, microcephaly, and congenital malformations in fetuses and newborn infants. Therefore, study of the immune response, especially the adaptive immune response to ZIKV infection, is important for understanding diseases caused by ZIKV infection. Here, we characterized the CD8(+) T cell immune response to ZIKV in a comprehensive manner and identified ZIKV epitopes. Using the identified immunodominant epitopes, we developed a tetramer that recognizes ZIKV-specific CD8(+) T cells in vivo, which simplified the detection and evaluation of ZIKV-specific immune responses. In addition, the finding that tetramer-positive memory CD8(+) T cell responses were generated and that CD8(+) T cells can traffic to a ZIKV-infected brain greatly enhances our understanding of ZIKV infection and provides important insights for ZIKV vaccine design.
C1 [Huang, Huarong; Li, Shihua; Han, Xiaojuan; Jia, Baoqian; Liu, Hongtao; Liu, Dandan; Tan, Shuguang; Wang, Qihui; Bi, Yuhai; Gao, George Fu; Zhang, Fuping] Chinese Acad Sci, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China.
   [Huang, Huarong; Han, Xiaojuan; Liu, Hongtao; Liu, Dandan] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Hou, Baidong] Chinese Acad Sci, Inst Biophys, Beijing, Peoples R China.
   [Gao, George Fu; Zhang, Fuping] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.
   [Zhang, Yongli; Liu, William J.; Gao, George Fu] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
   [Gao, George Fu] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing, Peoples R China.
RP Gao, GF; Zhang, FP (corresponding author), Chinese Acad Sci, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China.; Gao, GF; Zhang, FP (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing, Peoples R China.
EM gaof@im.ac.cn; zhangfp@im.ac.cn
OI Tan, Shuguang/0000-0002-2599-4959
FU National Key Research and Development Project grant [2016YFC1200302];
   National Key Research and Development Program of China grant
   [2017YFC1200202]; Zika Special Project of the Ministry of Science and
   Technology Reform and Development Project; External Cooperation Program
   of Chinese Academy of SciencesChinese Academy of Sciences
   [153211KYSB20160001]; NSFC Innovative Research group [81621091]
FX This study was supported by National Key Research and Development
   Project grant 2016YFC1200302, National Key Research and Development
   Program of China grant 2017YFC1200202, the Zika Special Project of the
   Ministry of Science and Technology Reform and Development Project, and
   the External Cooperation Program of Chinese Academy of Sciences (grant
   153211KYSB20160001). G.F.G. is a leading principal investigator of the
   NSFC Innovative Research group (grant 81621091).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Cupovic J, 2016, IMMUNITY, V44, P622, DOI 10.1016/j.immuni.2015.12.022
   Diamond MS, 2003, IMMUNOL CELL BIOL, V81, P196, DOI 10.1046/j.1440-1711.2003.01157.x
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Hastings AK, 2015, J VIROL, V89, P4405, DOI 10.1128/JVI.03275-14
   Hou HQ, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0202-3
   Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778
   Korn T, 2017, NAT REV IMMUNOL, V17, P179, DOI 10.1038/nri.2016.144
   Krzych U, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00370
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu J, 2013, EUR J IMMUNOL, V43, P2055, DOI 10.1002/eji.201343417
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   McDermott DS, 2011, J IMMUNOL, V187, P5568, DOI 10.4049/jimmunol.1102104
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moseman EA, 2013, IMMUNOL REV, V255, P110, DOI 10.1111/imr.12093
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407
   Rai D, 2009, J IMMUNOL, V183, P7672, DOI 10.4049/jimmunol.0902874
   Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   [王强 Wang Qiang], 2016, [科学通报, Chinese Science Bulletin], V61, P2463
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Zust R, 2014, J VIROL, V88, P7276, DOI 10.1128/JVI.03827-13
NR 36
TC 46
Z9 47
U1 3
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2017
VL 91
IS 22
AR UNSP e00900-17
DI 10.1128/JVI.00900-17
PG 15
WC Virology
SC Virology
GA FL1WP
UT WOS:000414005400011
PM 28835502
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Liu, ZY
   Yu, JY
   Huang, XY
   Fan, H
   Li, XF
   Deng, YQ
   Ji, X
   Cheng, ML
   Ye, Q
   Zhao, H
   Han, JF
   An, XP
   Jiang, T
   Zhang, B
   Tong, YG
   Qin, CF
AF Liu, Zhong-Yu
   Yu, Jiu-Yang
   Huang, Xing-Yao
   Fan, Hang
   Li, Xiao-Feng
   Deng, Yong-Qiang
   Ji, Xue
   Cheng, Meng-Li
   Ye, Qing
   Zhao, Hui
   Han, Jian-Feng
   An, Xiao-Ping
   Jiang, Tao
   Zhang, Bo
   Tong, Yi-Gang
   Qin, Cheng-Feng
TI Characterization of cis-Acting RNA Elements of Zika Virus by Using a
   Self-Splicing Ribozyme-Dependent Infectious Clone
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; self-splicing intron; infectious cDNA clone; cis-acting RNA
   elements; reverse genetics
ID SUBGENOMIC FLAVIVIRUS RNA; ALGA PYLAIELLA-LITTORALIS; DENGUE-VIRUS;
   CODING REGION; SECONDARY STRUCTURE; GENOME CYCLIZATION; CDNA-CLONE;
   REPLICATION; VACCINE; INTRON
AB Zika virus (ZIKV) has caused significant outbreaks and epidemics in the Americas recently, raising global concern due to its ability to cause microcephaly and other neurological complications. A stable and efficient infectious clone of ZIKV is urgently needed. However, the instability and toxicity of flavivirus cDNA clones in Escherichia coli hosts has hindered the development of ZIKV infectious clones. Here, using a novel self-splicing ribozyme-based strategy, we generated a stable infectious cDNA clone of a contemporary ZIKV strain imported from Venezuela to China in 2016. The constructed clone contained a modified version of the group II self-splicing intron P.li.LSUI2 near the junction between the E and NS1 genes, which were removed from the RNA transcripts by an easy-to-establish in vitro splicing reaction. Transfection of the spliced RNAs into BHK-21 cells led to the production of infectious progeny virus that resembled the parental virus. Finally, potential cis-acting RNA elements in ZIKV genomic RNA were identified based on this novel reverse genetics system, and the critical role of 5'-SLA promoter and 5'-3' cyclization sequences were characterized by a combination of different assays. Our results provide another stable and reliable reverse genetics system for ZIKV that will help study ZIKV infection and pathogenesis, and the novel self-splicing intron-based strategy could be further expanded for the construction of infectious clones from other emerging and reemerging flaviviruses.
   IMPORTANCE The ongoing Zika virus (ZIKV) outbreaks have drawn global concern due to the unexpected causal link to fetus microcephaly and other severe neurological complications. The infectious cDNA clones of ZIKV are critical for the research community to study the virus, understand the disease, and inform vaccine design and antiviral screening. A panel of existing technologies have been utilized to develop ZIKV infectious clones. Here, we successfully generated a stable infectious clone of a 2016 ZIKV strain using a novel self-splicing ribozyme-based technology that abolished the potential toxicity of ZIKV cDNA clones to the E. coli host. Moreover, two crucial cis-acting replication elements (5'-SLA and 5'-CS) of ZIKV were first identified using this novel reverse genetics system. This novel self-splicing ribozyme-based reverse genetics platform will be widely utilized in future ZIKV studies and provide insight for the development of infectious clones of other emerging viruses.
C1 [Liu, Zhong-Yu; Yu, Jiu-Yang; Huang, Xing-Yao; Fan, Hang; Li, Xiao-Feng; Deng, Yong-Qiang; Ji, Xue; Cheng, Meng-Li; Ye, Qing; Zhao, Hui; Han, Jian-Feng; An, Xiao-Ping; Jiang, Tao; Tong, Yi-Gang; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Cheng, Meng-Li] Anhui Med Univ, Hefei, Anhui, Peoples R China.
   [Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, CAS Key Lab Special Pathogens & Biosafety, Wuhan, Hubei, Peoples R China.
RP Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
EM qincf@bmi.ac.cn
RI Tao, Jiang/AAE-6623-2019; Qin, Cheng-Feng/I-6839-2019
OI Tao, Jiang/0000-0003-1908-2926; Qin, Cheng-Feng/0000-0002-0632-2807;
   Liu, Zhong-Yu/0000-0001-7385-5681
FU National Science and Technology Major Project of China [2017ZX09101005,
   2017ZX10304402]; National Key Research and Development Project of China
   [2016YFD0500304]; National Natural Science Foundation of China
   (NSFC)National Natural Science Foundation of China [31770190,
   81661148054, 81661130162]; Excellent Young Scientist [81522025];
   Innovative Research Group [81621005]; Newton Advanced Fellowship from
   the UK Academy of Medical Sciences [NAF003\1003]
FX This study was supported by the National Science and Technology Major
   Project of China (grants 2017ZX09101005 and 2017ZX10304402), the
   National Key Research and Development Project of China (grant
   2016YFD0500304), the National Natural Science Foundation of China (NSFC;
   grants 31770190, 81661148054 and 81661130162). C.-F.Q. was supported by
   the Excellent Young Scientist (grant 81522025), Innovative Research
   Group (grant 81621005), and the Newton Advanced Fellowship from the UK
   Academy of Medical Sciences (NAF003\1003).
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Diaz-Quinonez JA, 2016, EMERG INFECT DIS, V22, P937, DOI 10.3201/eid2205.160190
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Blaney JE, 2004, AM J TROP MED HYG, V71, P811, DOI 10.4269/ajtmh.2004.71.811
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Costa M, 1997, J MOL BIOL, V274, P353, DOI 10.1006/jmbi.1997.1416
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong HP, 2008, VIROLOGY, V381, P123, DOI 10.1016/j.virol.2008.07.040
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edmonds J, 2013, J VIROL, V87, P2367, DOI 10.1128/JVI.03162-12
   Enyeart PJ, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-2
   Fabrizius RG, 2016, AM J TROP MED HYG, V95, P1161, DOI 10.4269/ajtmh.16-0397
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   FONTAINE JM, 1995, J MOL BIOL, V251, P378, DOI 10.1006/jmbi.1995.0441
   Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018197
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Liu ZY, 2016, ELIFE, V5, DOI 10.7554/eLife.17636
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Matsuura M, 2001, EMBO J, V20, P7259, DOI 10.1093/emboj/20.24.7259
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   RICE C M, 1989, New Biologist, V1, P285
   Robart AR, 2014, NATURE, V514, P193, DOI 10.1038/nature13790
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Santos JJS, 2014, AN ACAD BRAS CIENC, V86, P1749, DOI 10.1590/0001-3765201420130332
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   SUMIYOSHI H, 1992, J VIROL, V66, P5425, DOI 10.1128/JVI.66.9.5425-5431.1992
   Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   WEGERLUCARELLI J, 2017, J VIROL, V91
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Yamshchikov V, 2001, VIROLOGY, V281, P272, DOI 10.1006/viro.2000.0793
   Yamshchikov VF, 2001, VIROLOGY, V281, P294, DOI 10.1006/viro.2000.0795
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0
   Zerbato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058263
   Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016
   Zuker M, 1998, RNA, V4, P669, DOI 10.1017/S1355838298980116
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 63
TC 18
Z9 17
U1 1
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2017
VL 91
IS 21
AR UNSP e00484-17
DI 10.1128/JVI.00484-17
PG 14
WC Virology
SC Virology
GA FK0UI
UT WOS:000413195400003
PM 28814522
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Siemann, DN
   Strange, DP
   Maharaj, PN
   Shi, PY
   Verma, S
AF Siemann, David N.
   Strange, Daniel P.
   Maharaj, Payal N.
   Shi, Pei-Yong
   Verma, Saguna
TI Zika Virus Infects Human Sertoli Cells and Modulates the Integrity of
   the In Vitro Blood-Testis Barrier Model
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; blood-testis barrier; cell adhesion molecules; human Sertoli
   cells; in vitro Sertoli cell barrier; innate immune response;
   macrophages; sexual transmission; tight junction proteins
ID WEST-NILE-VIRUS; MOUSE SERTOLI; IMMUNE-RESPONSES; LEYDIG-CELLS;
   TRANSMISSION; MACROPHAGES; EXPRESSION; ADHESION; PROTEIN
AB Confirmed reports of Zika virus (ZIKV) in human seminal fluid for months after the clearance of viremia suggest the ability of ZIKV to establish persistent infection in the seminiferous tubules, an immune-privileged site in the testis protected by the blood-testis barrier, also called the Sertoli cell (SC) barrier (SCB). However, cellular targets of ZIKV in human testis and mechanisms by which the virus enters seminiferous tubules remain unclear. We demonstrate that primary human SCs were highly susceptible to ZIKV compared to the closely related dengue virus and induced the expression of alpha interferon (IFN-alpha), key cytokines, and cell adhesion molecules (vascular cell adhesion molecule 1 [VCAM-1] and intracellular adhesion molecule 1 [ICAM-1]). Furthermore, using an in vitro SCB model, we show that ZIKV was released on the adluminal side of the SCB model with a higher efficiency than in the blood-brain barrier model. ZIKV-infected SCs exhibited enhanced adhesion of leukocytes that correlated with decreases in SCB integrity. ZIKV infection did not affect the expression of tight and adherens junction proteins such as ZO-1, claudin, and JAM-A; however, exposure of SCs to inflammatory mediators derived from ZIKV-infected macrophages led to the degradation of the ZO-1 protein, which correlated with increased SCB permeability. Taken together, our data suggest that infection of SCs may be one of the crucial steps by which ZIKV gains access to the site of spermatozoon development and identify SCs as a therapeutic target to clear testicular infections. The SCB model opens up opportunities to assess interactions of SCs with other testicular cells and to test the ability of anti-ZIKV drugs to cross the barrier.
   IMPORTANCE Recent outbreaks of ZIKV, a neglected mosquito-borne flavivirus, have identified sexual transmission as a new route of disease spread, which has not been reported for other flaviviruses. To be able to sexually transmit for months after the clearance of viremia, ZIKV must establish infection in the seminiferous tubules, the site of spermatozoon development. However, little is known about the cell types that support ZIKV infection in the human testis. Currently, there are no models to study mechanisms of virus persistence in the seminiferous tubules. We provide evidence that ZIKV infection of human Sertoli cells, which are an important component of the seminiferous tubules, is robust and induces a strong antiviral response. The use of an in vitro Sertoli cell barrier to describe how ZIKV or inflammatory mediators derived from ZIKV-infected macrophages compromise barrier integrity will enable studies to explore the interactions of other testicular cells with Sertoli cells and to test novel antivirals for clearing testicular ZIKV infection.
C1 [Siemann, David N.; Strange, Daniel P.; Maharaj, Payal N.; Verma, Saguna] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John Bums Sch Med, Honolulu, HI 96822 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Dept Pharmacol & Toxicol, Galveston, TX USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX USA.
RP Verma, S (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John Bums Sch Med, Honolulu, HI 96822 USA.
EM saguna@hawaii.edu
FU Centers of Biomedical Research ExcellenceUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Research Resources (NCRR) [P30GM114737]; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; University of Hawaii
   institutional funds;  [R21AI129465-01]
FX This work was partially supported by grant R21AI129465-01 and the
   Centers of Biomedical Research Excellence (P30GM114737), the National
   Institutes of Health, and University of Hawaii institutional funds.
CR Aubry F, 2000, EUR CYTOKINE NETW, V11, P690
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Centers for Disease Control, 2017, ZIK VIR CAS COUNTS U
   Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790
   Chui K, 2011, CELL TRANSPLANT, V20, P619, DOI 10.3727/096368910X536563
   Deen GF, 2015, N ENGL J MED
   Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hedger MP, 2003, J REPROD IMMUNOL, V58, P1, DOI 10.1016/S0165-0378(02)00060-8
   Her Z, 2017, J INFECT DIS, V215, P42, DOI 10.1093/infdis/jiw494
   Hiebl B, 2008, CLIN HEMORHEOL MICRO, V39, P221, DOI 10.3233/CH-2008-1086
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12
   Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Le Tortorec A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001792
   Li MWM, 2009, INT J BIOCHEM CELL B, V41, P2302, DOI 10.1016/j.biocel.2009.05.016
   Li N, 2016, SEMIN CELL DEV BIOL, V59, P141, DOI 10.1016/j.semcdb.2016.01.003
   Lydka Marta, 2012, Spermatogenesis, V2, P294
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Mital P, 2011, BIOL REPROD, V84, P851, DOI 10.1095/biolreprod.110.087452
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nelson J, 2015, ANTIVIR RES, V122, P39, DOI 10.1016/j.antiviral.2015.07.008
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paz-Bailey G, 2017, N ENGL J MED
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Report S, 2017, ZIK VIR MICR GUILL B
   RICCIOLI A, 1995, P NATL ACAD SCI USA, V92, P5808, DOI 10.1073/pnas.92.13.5808
   Roe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102598
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Starace D, 2008, BIOL REPROD, V79, P766, DOI 10.1095/biolreprod.108.068619
   Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Willey S, 2003, AIDS, V17, P183, DOI 10.1097/00002030-200301240-00007
   Winnall WR, 2013, J REPROD IMMUNOL, V97, P147, DOI 10.1016/j.jri.2013.01.001
   Wu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19507
   Zhao ST, 2014, CELL MOL IMMUNOL, V11, P428, DOI 10.1038/cmi.2014.38
NR 41
TC 33
Z9 34
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2017
VL 91
IS 22
AR UNSP e00623-17
DI 10.1128/JVI.00623-17
PG 17
WC Virology
SC Virology
GA FL1WP
UT WOS:000414005400003
PM 28878076
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Joguet, G
   Mansuy, JM
   Matusali, G
   Hamdi, S
   Walschaerts, M
   Pavili, L
   Guyomard, S
   Prisant, N
   Lamarre, P
   Dejucq-Rainsford, N
   Pasquier, C
   Bujan, L
AF Joguet, Guillaume
   Mansuy, Jean-Michel
   Matusali, Giulia
   Hamdi, Safouane
   Walschaerts, Marie
   Pavili, Lynda
   Guyomard, Stefanie
   Prisant, Nadia
   Lamarre, Pierre
   Dejucq-Rainsford, Nathalie
   Pasquier, Christophe
   Bujan, Louis
TI Effect of acute Zika virus infection on sperm and virus clearance in
   body fluids: a prospective observational study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID SEXUAL TRANSMISSION; IMMUNODEFICIENCY-VIRUS; SEMEN; RNA
AB Background Evidence of human sexual transmission during Zika virus emergence is a matter of concern, particularly in procreation, but to date, kinetics of seminal shedding and the effects of infection on human reproductive function have not been described. To investigate the effects of Zika virus infection on semen and clearance of Zika virus from semen and body fluids, we aimed to study a cohort of Zika virus-infected men.
   Methods This prospective observational study recruited men presenting with acute Zika virus infection at Pointe-a-Pitre University Hospital in Guadeloupe, French Caribbean, where a Zika virus outbreak occurred between April and November, 2016. Blood, urine, and semen were collected at days 7, 11, 20, 30, 60, 90, and 120 after symptom onset, and semen characteristics, such as total sperm count, sperm motility, vitality, and morphology, and reproductive hormone concentrations, such as testosterone, inhibin, follicle-stimulating hormone, and luteinising hormone, were assessed. At days 7, 11, and 20, semen was processed to isolate motile spermatozoa. Zika virus RNA was detected by RT-PCR using whole blood, serum, urine, seminal plasma, semen cells, and motile spermatozoa fractions. Zika virus was isolated from different sperm fractions on Vero E6 cultures.
   Findings 15 male volunteers (mean age 35 years [SD 5; range 25-44) with acute Zika virus infection and positive Zika virus RNA detection in blood or urine were enrolled. Total sperm count was decreased from median 11(9) x 10(6) spermatozoa (IQR 22-234) at day 7 to 45.2 x 10(6) (16.5-89.6) at day 30 and 70 x 10(6) (28.5-81.4) at day 60, respectively, after Zika virus infection. Inhibin values increased from 93.5 pg/mL (IQR 55-162) at day 7 to 150 pg/mL (78-209) at day 120 when total sperm count recovered. In motile spermatozoa obtained after density gradient separation, Zika virus RNA was found in three of 14 patients at day 7, four of 15 at day 11, and four of 15 at day 20, and replication-competent virus was found in the tested patient. Seminal shedding kinetics seemed heterogeneous among patients. Whole blood was the fluid most frequently positive for Zika virus RNA (62 of 92 samples) and three patients remained positive at day 120.
   Interpretation Semen alterations early after acute Zika virus infection might affect fertility and could be explained by virus effects on the testis and epididymis. Frequency of shedding and high viral load in semen, together with the presence of replicative virus in a motile spermatozoa fraction, can lead to Zika virus transmission during sexual contact and assisted reproduction procedures. Whole blood seems to be the best specimen for Zika virus RNA detection, diagnosis, and follow-up.
C1 [Joguet, Guillaume; Pavili, Lynda; Prisant, Nadia] CHU Pointe A Pitre, CCMR, CECOS CARAIBES, Pointe a Pitre, Guadeloupe, France.
   [Mansuy, Jean-Michel; Pasquier, Christophe] CHU Toulouse, Lab Virol, Inst Federatif Biol, Toulouse, France.
   [Hamdi, Safouane] CHU Toulouse, Dept Biochim & Hormonol, Inst Federatif Biol, Toulouse, France.
   [Hamdi, Safouane; Walschaerts, Marie; Bujan, Louis] Univ Paul Sabatier Toulouse III CECOS, Res Grp Human Fertil EA 3694, Hop Paule de Viguier, CHU Toulouse, Toulouse, France.
   [Matusali, Giulia; Dejucq-Rainsford, Nathalie] UMS CNRS 3480, US Inserm 018, INSERM,Struct Federat Rech Biosit, Inst Rech Sante Environm & Travail Irset Inserm U, Rennes, France.
   [Pavili, Lynda] Lab Synergibio Basse Terre, Basse Terre, Guadeloupe, France.
   [Guyomard, Stefanie] Inst Pasteur Pointe A Pitre, Unite Environm Sante, Pointe a Pitre, Guadeloupe, France.
   [Lamarre, Pierre] Ctr Med Aeroport, Ies Abymes, Guadeloupe, France.
RP Bujan, L (corresponding author), CHU Toulouse, Hop Paule de Viguier, Res Grp Human Fertil, F-31059 Toulouse, France.; Bujan, L (corresponding author), CHU Toulouse, Hop Paule de Viguier, CECOS, F-31059 Toulouse, France.
EM bujan.l@chu-toulouse.fr
RI DEJUCQ-RAINSFORD, Nathalie/I-2571-2015; HAMDI, Safouane/AAC-4205-2019;
   matusali, giulia/N-7201-2015
OI HAMDI, Safouane/0000-0002-2434-3441; matusali,
   giulia/0000-0002-2948-4243; Bujan, Louis/0000-0003-1540-0536;
   Dejucq-Rainsford, Nathalie/0000-0002-1788-2690; PASQUIER,
   Christophe/0000-0001-9223-0150; Walschaerts, Marie/0000-0002-9114-1663
FU Agence de la Biomedecine/Agence Regionale de Sante de la
   Guadeloupe/Inserm-REACTing
FX Agence de la Biomedecine/Agence Regionale de Sante de la
   Guadeloupe/Inserm-REACTing.
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Bujan L, 2004, AIDS, V18, P757, DOI 10.1097/00002030-200403260-00006
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Evenson DP, 2000, J ANDROL, V21, P739
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Gornet ME, 2016, SEMIN REPROD MED, V34, P285, DOI 10.1055/s-0036-1592312
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Houzet L, 2014, J INFECT DIS, V210, pS622, DOI 10.1093/infdis/jiu328
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Matusali G, 2015, J VIROL, V89, P5772, DOI 10.1128/JVI.03628-14
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paz-Bailey G, 2017, NEW ENGL J MED, DOI [10.1056/NEJMoa161310, DOI 10.1056/NEJM0A161310]
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Politch JA, 2004, FERTIL STERIL, V81, P440, DOI 10.1016/j.fertnstert.2003.06.028
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Sergerie M, 2007, FERTIL STERIL, V88, DOI 10.1016/j.fertnstert.2006.12.045
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Uraki R, 2017, ADV SCI, V3
NR 30
TC 76
Z9 76
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD NOV
PY 2017
VL 17
IS 11
BP 1200
EP 1208
DI 10.1016/S1473-3099(17)30444-9
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA FL2PP
UT WOS:000414059800043
PM 28838639
OA Bronze
DA 2020-07-08
ER

PT J
AU Etebari, K
   Hegde, S
   Saldana, MA
   Widen, SG
   Wood, TG
   Asgari, S
   Hughes, GL
AF Etebari, Kayvan
   Hegde, Shivanand
   Saldana, Miguel A.
   Widen, Steven G.
   Wood, Thomas G.
   Asgari, Sassan
   Hughes, Grant L.
TI Global Transcriptome Analysis of Aedes aegypti Mosquitoes in Response to
   Zika Virus Infection
SO MSPHERE
LA English
DT Article
DE Aedes aegypti; RNA-Seq; Zika virus; behavior; long noncoding RNA;
   microRNA; odorant binding protein; transcriptome
ID LONG NONCODING RNAS; MICRORNAS; HISTORY
AB Zika virus (ZIKV) of the Flaviviridae family is a recently emerged mosquitoborne virus that has been implicated in the surge of the number of microcephaly instances in South America. The recent rapid spread of the virus led to its declaration as a global health emergency by the World Health Organization. The virus is transmitted mainly by the mosquito Aedes aegypti, which is also the vector of dengue virus; however, little is known about the interactions of the virus with the mosquito vector. In this study, we investigated the transcriptome profiles of whole A. aegypti mosquitoes in response to ZIKV infection at 2, 7, and 14 days postinfection using transcriptome sequencing. Results showed changes in the abundance of a large number of transcripts at each time point following infection, with 18 transcripts commonly changed among the three time points. Gene ontology analysis revealed that most of the altered genes are involved in metabolic processes, cellular processes, and proteolysis. In addition, 486 long intergenic noncoding RNAs that were altered upon ZIKV infection were identified. Further, we found changes of a number of potential mRNA target genes correlating with those of altered host microRNAs. The outcomes provide a basic understanding of A. aegypti responses to ZIKV and help to determine host factors involved in replication or mosquito host antiviral response against the virus.
   IMPORTANCE Vector-borne viruses pose great risks to human health. Zika virus has recently emerged as a global threat, rapidly expanding its distribution. Understanding the interactions of the virus with mosquito vectors at the molecular level is vital for devising new approaches in inhibiting virus transmission. In this study, we embarked on analyzing the transcriptional response of Aedes aegypti mosquitoes to Zika virus infection. Results showed large changes in both coding and long noncoding RNAs. Analysis of these genes showed similarities with other flaviviruses, including dengue virus, which is transmitted by the same mosquito vector. The outcomes provide a global picture of changes in the mosquito vector in response to Zika virus infection.
C1 [Etebari, Kayvan; Asgari, Sassan] Univ Queensland, Australian Infect Dis Res Ctr, Sch Biol Sci, Brisbane, Qld, Australia.
   [Hegde, Shivanand] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Saldana, Miguel A.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Widen, Steven G.; Wood, Thomas G.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Hughes, Grant L.] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Ctr Trop Dis,Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
RP Asgari, S (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Biol Sci, Brisbane, Qld, Australia.; Hughes, GL (corresponding author), Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Ctr Trop Dis,Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
EM s.asgari@uq.edu.au; glhughes@utmb.edu
RI Etebari, Kayvan/C-6436-2008; Hegde, Shivanand/L-4999-2019; Asgari,
   Sassan/G-2678-2011
OI Etebari, Kayvan/0000-0001-5213-6362; Asgari, Sassan/0000-0001-7885-6544;
   Saldana, Miguel/0000-0003-0470-1667; hegde,
   shivanand/0000-0001-7249-6795
FU NIH grantUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21AI124452, R21AI129507]; University
   of Texas Rising Star award; Australian Research CouncilAustralian
   Research Council [DP150101782]; Australian Infectious Disease Research
   Centre grant; Western Gulf Center of Excellence for Vector-borne
   Diseases (CDC grant) [CK17-005]; NIH T32 fellowshipUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [2T32AI007526]; James W. McLaughlin postdoctoral fellowship at the
   University of Texas Medical Branch
FX This project was supported by NIH grants (R21AI124452 and R21AI129507)
   and a University of Texas Rising Star award to G.L.H. and an Australian
   Research Council (DP150101782) and an Australian Infectious Disease
   Research Centre grant to S.A. G.L.H. is additionally supported by the
   Western Gulf Center of Excellence for Vector-borne Diseases (CDC grant
   CK17-005). M.A.S. was supported by an NIH T32 fellowship (2T32AI007526),
   while S.H. was supported by a James W. McLaughlin postdoctoral
   fellowship at the University of Texas Medical Branch.
CR Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Blair CD, 2014, CURR OPIN INSECT SCI, V3, P22, DOI 10.1016/j.cois.2014.07.005
   Bonasio R, 2014, ANNU REV GENET, V48, P433, DOI 10.1146/annurev-genet-120213-092323
   Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512
   Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425
   Cator LJ, 2012, TRENDS PARASITOL, V28, P466, DOI 10.1016/j.pt.2012.08.004
   Cator LJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0711
   Chauhan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047350
   Clark MB, 2011, SEMIN CELL DEV BIOL, V22, P366, DOI 10.1016/j.semcdb.2011.01.001
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Enright AJ, 2004, GENOME BIOL, V5
   Etebari K, 2016, INSECT MOL BIOL, V25, P788, DOI 10.1111/imb.12263
   Etebari K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005069
   Etebari K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15968
   Fitzgerald KA, 2014, CURR OPIN IMMUNOL, V26, P140, DOI 10.1016/j.coi.2013.12.001
   Gibbs Gerard M., 2007, P261
   Isoe J, 2011, P NATL ACAD SCI USA, V108, pE211, DOI 10.1073/pnas.1102637108
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243
   Lakhotia SC, 2012, WIRES RNA, V3, P779, DOI 10.1002/wrna.1135
   Liu YX, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0009-y
   Londono-Renteria B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005202
   Maciel-de-Freitas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065252
   Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031
   Mizutani R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034949
   Murdock CC, 2017, CURR OPIN INSECT SCI, V20, P28, DOI 10.1016/j.cois.2017.03.001
   Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sylvestre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059933
   Tani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106282
   Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149
   Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460
   Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Winterling C, 2014, RNA BIOL, V11, P66, DOI 10.4161/rna.27504
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
NR 43
TC 22
Z9 23
U1 3
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD NOV-DEC
PY 2017
VL 2
IS 6
AR e00456-17
DI 10.1128/mSphere.00456-17
PG 14
WC Microbiology
SC Microbiology
GA FO6TW
UT WOS:000417000900020
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fernandez, E
   Dejnirattisai, W
   Cao, C
   Scheaffer, SM
   Supasa, P
   Wongwiwat, W
   Esakky, P
   Drury, A
   Mongkolsapaya, J
   Moley, KH
   Mysorekar, IU
   Screaton, GR
   Diamond, MS
AF Fernandez, Estefania
   Dejnirattisai, Wanwisa
   Cao, Bin
   Scheaffer, Suzanne M.
   Supasa, Piyada
   Wongwiwat, Wiyada
   Esakky, Prabagaran
   Drury, Andrea
   Mongkolsapaya, Juthathip
   Moley, Kelle H.
   Mysorekar, Indira U.
   Screaton, Gavin R.
   Diamond, Michael S.
TI Human antibodies to the dengue virus E-dimer epitope have therapeutic
   activity against Zika virus infection
SO NATURE IMMUNOLOGY
LA English
DT Article
ID MALE SEXUAL TRANSMISSION; NEUTRALIZING ANTIBODIES; DEPENDENT
   ENHANCEMENT; CROSS-REACTIVITY; STRUCTURAL BASIS; BIRTH-DEFECTS; IN-VIVO;
   PROTECTION; DISEASE; MICE
AB The Zika virus (ZIKV) epidemic has resulted in congenital abnormalities in fetuses and neonates. Although some cross-reactive dengue virus (DENV)-specific antibodies can enhance ZIKV infection in mice, those recognizing the DENV E-dimer epitope (EDE) can neutralize ZIKV infection in cell culture. We evaluated the therapeutic activity of human monoclonal antibodies to DENV EDE for their ability to control ZIKV infection in the brains, testes, placentas, and fetuses of mice. A single dose of the EDE1-B10 antibody given 3 d after ZIKV infection protected against lethality, reduced ZIKV levels in brains and testes, and preserved sperm counts. In pregnant mice, wild-type or engineered LALA variants of EDE1-B10, which cannot engage Fc gamma receptors, diminished ZIKV burden in maternal and fetal tissues, and protected against fetal demise. Because neutralizing antibodies to EDE have therapeutic potential against ZIKV, in addition to their established inhibitory effects against DENV, it may be possible to develop therapies that control disease caused by both viruses.
C1 [Fernandez, Estefania; Mysorekar, Indira U.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Dejnirattisai, Wanwisa; Supasa, Piyada; Wongwiwat, Wiyada; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Imperial Coll, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London, England.
   [Cao, Bin; Scheaffer, Suzanne M.; Esakky, Prabagaran; Drury, Andrea; Moley, Kelle H.; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok, Thailand.
   [Screaton, Gavin R.] Univ Oxford, John Radcliffe Hosp, Med Sci Div Off, Oxford, England.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Screaton, GR (corresponding author), Imperial Coll, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London, England.; Screaton, GR (corresponding author), Univ Oxford, John Radcliffe Hosp, Med Sci Div Off, Oxford, England.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
EM g.screaton@imperial.ac.uk; diamond@wusm.wustl.edu
RI amsalu, ribka/G-8780-2019; Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Screaton,
   Gavin/0000-0002-3549-4309
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 AI127828, R01
   HD091218, HHSN272201400018C, T32 AI007163]; WellcomeTrustWellcome Trust;
   MRC-NEWTON UK; National Institute for Health Research Biomedical
   Research Centre funding scheme UK
FX We thank Haina Shin for advice on the intravaginal infection
   experiments, S. Whitehead (US National Institutes of Health (NIH)) for
   ZIKV-Brazil (Paraiba, 2015), S. Shresta(La Jolla Institute of Allergy
   and Immunology) for DENV-2 strain D2S20, P. Malasit and S. Noisakran
   (Mahidol University) for DENV-1, DENV-3, and DENV-4 isolates from
   patients, C. Simmons (University of Melbourne) for DENV-2 strain DF-699,
   A. Kohl, R.F. de Oliveira Freitas, and L.J. Pena (University of Glasgow)
   for ZIKV-Brazil PE243, and A. Sakuntabhai (Institut Pasteur) for
   ZIKV-Africa HD78788. Supported by grants and contracts from the NIH (R01
   AI073755 (M.S.D.), R01 AI127828 (M.S.D.), R01 HD091218 (I.U.M. and
   M.S.D.), HHSN272201400018C (M.S.D.), T32 AI007163 (E.F.)), the
   WellcomeTrust (G.R.S.), MRC-NEWTON UK (J.M.), and the National Institute
   for Health Research Biomedical Research Centre funding scheme UK
   (G.R.S.).
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hansen DA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108845
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Hiatt A, 2014, P NATL ACAD SCI USA, V111, P5992, DOI 10.1073/pnas.1402458111
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Magdelaine-Beuzelin C, 2010, MABS-AUSTIN, V2, P176, DOI 10.4161/mabs.2.2.11205
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   National Research Council, 2011, GUIDE CARE USE LAB A
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pierson TC, 2015, PROG MOL BIOL TRANSL, V129, P141, DOI 10.1016/bs.pmbts.2014.10.005
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schaub B, 2017, LANCET, V3099, P26
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 55
TC 46
Z9 46
U1 0
U2 23
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD NOV
PY 2017
VL 18
IS 11
BP 1261
EP +
DI 10.1038/ni.3849
PG 13
WC Immunology
SC Immunology
GA FK4IU
UT WOS:000413457300012
PM 28945244
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Michlmayr, D
   Andrade, P
   Gonzalez, K
   Balmaseda, A
   Harris, E
AF Michlmayr, Daniela
   Andrade, Paulina
   Gonzalez, Karla
   Balmaseda, Angel
   Harris, Eva
TI CD14(+)CD16(+) monocytes are the main target of Zika virus infection in
   peripheral blood mononuclear cells in a paediatric study in Nicaragua
SO NATURE MICROBIOLOGY
LA English
DT Article
ID WEST-NILE-VIRUS; DENGUE VIRUS; SEXUAL TRANSMISSION; NERVOUS-SYSTEM;
   IN-VIVO; ENCEPHALITIS; PCR; NEUTROPHILS; PATHOGENESIS; REPLICATION
AB The recent Zika pandemic in the Americas is linked to congenital birth defects and Guillain-Barre syndrome. White blood cells (WBCs) play an important role in host immune responses early in arboviral infection. Infected WBCs can also function as 'Trojan horses' and carry viruses into immune-sheltered spaces, including the placenta, testes and brain. Therefore, defining which WBCs are permissive to Zika virus (ZIKV) is critical. Here, we analyse ZIKV infectivity of peripheral blood mononuclear cells (PBMCs) in vitro and from Nicaraguan Zika patients and show CD14(+)CD16(+) monocytes are the main target of infection, with ZIKV replication detected in some dendritic cells. The frequency of CD14(+) monocytes was significantly decreased, while the CD14(+)CD16(+) monocyte population was significantly expanded during ZIKV infection compared to uninfected controls. Viral RNA was detected in PBMCs from all patients, but in serum from only a subset, suggesting PBMCs may be a reservoir for ZIKV. In Zika patients, the frequency of infected cells was lower but the percentage of infected CD14(+)CD16(+) monocytes was significantly higher compared to dengue cases. The gene expression profile in monocytes isolated from ZIKV- and dengue virus-infected patients was comparable, except for significant differences in interferon-gamma, CXCL12, XCL1, interleukin-6 and interleukin-10 levels. Thus, our study provides a detailed picture of the innate immune profile of ZIKV infection and highlights the important role of monocytes, and CD14(+)CD16(+) monocytes in particular.
C1 [Michlmayr, Daniela; Andrade, Paulina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Andrade, Paulina] Univ San Francisco Quito, Quito 170157, Ecuador.
   [Gonzalez, Karla; Balmaseda, Angel] Sustainable Sci Inst, Managua 14007, Nicaragua.
   [Gonzalez, Karla; Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua 16064, Nicaragua.
RP Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu
RI Michlmayr, Daniela/Q-1216-2018
OI Harris, Eva/0000-0002-7238-4037
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U19AI118610, R33AI100186]
FX The authors thank C. Wang for optimizing primers, probes and standards
   for use of the CDC qRT-PCR assay with Nicaraguan ZIKV strains and J.
   Waggoner for advice and technical support regarding quantitation of
   viral RNA using the ZCD qRT-PCR assay. The authors also thank R.
   Ben-Shachar for help with statistical analysis and graphs, and D.
   Glasner for his invaluable assistance with figure preparation. Past and
   present members of the study team based at the Hospital Infantil Manuel
   de Jesus Rivera, the National Virology Laboratory in the Centro Nacional
   de Diagnostico y Referencia of the Nicaraguan Ministry of Health, and
   the Sustainable Sciences Institute in Managua, Nicaragua, are thanked
   for their dedication and high-quality work, particularly S. Arguello, W.
   Aviles, C. Cerpas, D. Elizondo, F. McNally, B. Moraga, F. Narvaez, A.
   Nunez, M. de los Angeles Perez, M. Vega, R. Zapata and other study
   personnel. The authors are also grateful to the children who
   participated in the study and their families. This work was supported by
   grants U19AI118610 (to E.H.) and R33AI100186 (to A.B. and E.H.) from the
   National Institute of Allergy and Infectious Diseases, National
   Institutes of Health (NIH).
CR Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132
   BenNathan D, 1996, ARCH VIROL, V141, P459, DOI 10.1007/BF01718310
   Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360
   Cerny D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004548
   Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141
   Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028
   Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FDA, 2017, TRIOPL REAL TIM RT P
   Garcia-Tapia D, 2006, VET IMMUNOL IMMUNOP, V110, P229, DOI 10.1016/j.vetimm.2005.10.003
   Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Juffrie M, 2000, INFECT IMMUN, V68, P702, DOI 10.1128/IAI.68.2.702-707.2000
   Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   McCandless EE, 2008, P NATL ACAD SCI USA, V105, P11270, DOI 10.1073/pnas.0800898105
   McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Michlmayr D, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00264
   Michlmayr D, 2014, J VIROL, V88, P9553, DOI 10.1128/JVI.03421-13
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236
   PAHO / WHO, 2017, ZIK EP UPD
   Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Rios M, 2006, TRANSFUSION, V46, P659, DOI 10.1111/j.1537-2995.2006.00769.x
   Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Srivastava S, 1999, INT J EXP PATHOL, V80, P17, DOI 10.1046/j.1365-2613.1999.00092.x
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Vremec D, 2007, BLOOD, V109, P1165, DOI 10.1182/blood-2006-05-015354
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002
   Zompi S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001568
NR 46
TC 62
Z9 63
U1 1
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD NOV
PY 2017
VL 2
IS 11
BP 1462
EP 1470
DI 10.1038/s41564-017-0035-0
PG 9
WC Microbiology
SC Microbiology
GA FP9NM
UT WOS:000417975600004
PM 28970482
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Foo, SS
   Chen, WQ
   Chan, Y
   Bowman, JW
   Chang, LC
   Choi, Y
   Yoo, JS
   Ge, JN
   Cheng, GH
   Bonnin, A
   Nielsen-Saines, K
   Brasil, P
   Jung, JU
AF Foo, Suan-Sin
   Chen, Weiqiang
   Chan, Yen
   Bowman, James W.
   Chang, Lin-Chun
   Choi, Younho
   Yoo, Ji Seung
   Ge, Jianning
   Cheng, Genhong
   Bonnin, Alexandre
   Nielsen-Saines, Karin
   Brasil, Patricia
   Jung, Jae U.
TI Asian Zika virus strains target CD14(+) blood monocytes and induce
   M2-skewed immunosuppression during pregnancy
SO NATURE MICROBIOLOGY
LA English
DT Article
ID INFECTION; MACROPHAGES; DIFFERENTIATION; RECRUITMENT; ACTIVATION;
   CLEARANCE; PROFILES; VIREMIA; CXCL10; SYSTEM
AB Blood CD14(+) monocytes are frontline immunomodulators categorized into classical, intermediate or non-classical subsets, and subsequently differentiated into M1 pro-or M2 anti-inflammatory macrophages on stimulation. Although the Zika virus (ZIKV) rapidly establishes viraemia, the target cells and immune responses, particularly during pregnancy, remain elusive. Furthermore, it is unknown whether African-and Asian-lineage ZIKV have different phenotypic impacts on host immune responses. Using human blood infection, we identified CD14(+) monocytes as the primary target for African-or Asian-lineage ZIKV infection. When immunoprofiles of human blood infected with ZIKV were compared, a classical/ intermediate monocytemediated M1-skewed inflammation by the African-lineage ZIKV infection was observed, in contrast to a non-classical monocyte-mediated M2-skewed immunosuppression by the Asian-lineage ZIKV infection. Importantly, infection of the blood of pregnant women revealed an enhanced susceptibility to ZIKV infection. Specifically, Asian-lineage ZIKV infection of pregnant women's blood led to an exacerbated M2-skewed immunosuppression of non-classical monocytes in conjunction with a global suppression of type I interferon-signalling pathway and an aberrant expression of host genes associated with pregnancy complications. Also, 30 ZIKV(+) sera from symptomatic pregnant patients showed elevated levels of M2-skewed immunosuppressive cytokines and pregnancy-complication-associated fibronectin-1. This study demonstrates the differential immunomodulatory responses of blood monocytes, particularly during pregnancy, on infection with different lineages of ZIKV.
C1 [Foo, Suan-Sin; Chen, Weiqiang; Bowman, James W.; Chang, Lin-Chun; Choi, Younho; Yoo, Ji Seung; Ge, Jianning; Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.
   [Chan, Yen] Univ Southern Calif, Keck Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med,Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.
   [Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Bonnin, Alexandre] Univ Southern Calif, Keck Sch Med, Dept Cell & Neurobiol, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Marion Davies Childrens Hlth Ctr, Div Pediat Infect Dis, 10833 LeConte Ave, Los Angeles, CA 90095 USA.
   [Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, 4365 Ave Brasil, BR-21040360 Rio De Janeiro, RJ, Brazil.
RP Jung, JU (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.
EM jaeujung@med.usc.edu
RI Yoo, Ji Seung/P-9688-2019; Choi, Younho/Y-7282-2019
OI Yoo, Ji Seung/0000-0002-3708-8240; Choi, Younho/0000-0003-4719-3279
FU Hastings Foundation; Fletcher Jones Foundation; National Institute of
   Allergy and Infectious Diseases/National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [MH106806, 2T90DE021982-06, AI28697, 1R21AI129534-01];
   Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do
   Brasil [CAPES/88887.116627/2016-01]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES;  [CA200422];  [CA180779];  [DE023926]; 
   [AI073099];  [AI116585]
FX We thank M. Diamond and C. Baronti for providing the ZIKV H/PF/2013
   strain, and all the healthy volunteers for blood donations. This work
   was partly supported by CA200422, CA180779, DE023926, AI073099,
   AI116585, Hastings Foundation and Fletcher Jones Foundation (J.U.J.),
   MH106806 (A.B.) and 2T90DE021982-06 (J.W.B.), AI28697 and
   1R21AI129534-01 from the National Institute of Allergy and Infectious
   Diseases/National Institutes of Health (K.N.S.), and
   CAPES/88887.116627/2016-01 from Departamento de Ciencia e Tecnologia
   (DECIT) do Ministerio da Saude do Brasil and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (P.B.).
CR [Anonymous], 2017, ZIK SIT REP 20 JAN 2
   Audoy-Remus J, 2008, J NEUROSCI, V28, P10187, DOI 10.1523/JNEUROSCI.3510-08.2008
   Benitez MA, 2009, LANCET, V373, P1070, DOI 10.1016/S0140-6736(09)60634-6
   Bhowmick S, 2007, NEUROSCI LETT, V414, P45, DOI 10.1016/j.neulet.2006.11.070
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948
   Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492
   Brown MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00606
   Bruchova H, 2010, PLACENTA, V31, P186, DOI 10.1016/j.placenta.2009.12.016
   Chaemsaithong P, 2013, J PERINAT MED, V41, P665, DOI 10.1515/jpm-2013-0086
   Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095
   Chen Chun-Kai, 1994, Journal of the Formosan Medical Association, V93, P921
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faas MM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00298
   Fischer-Smith T, 2008, AIDS RES HUM RETROV, V24, P417, DOI 10.1089/aid.2007.0193
   Halai U. A., 2017, CLIN INFECT DIS, V2017, P472
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Hou WQ, 2012, BLOOD, V119, P3128, DOI 10.1182/blood-2011-09-379479
   Ishida J, 2011, J BIOCHEM, V150, P5, DOI 10.1093/jb/mvr069
   Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mack Ines, 2015, Mol Cell Pediatr, V2, P3, DOI 10.1186/s40348-015-0014-6
   Magatti M, 2017, J TISSUE ENG REGEN M, V11, P2895, DOI 10.1002/term.2193
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Melgert BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045229
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Palmer C., 2015, J IMMUNOL, V194, P215
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Rasanen J, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.07.052
   Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3
   Robinson TO, 2017, VIROLOGY, V504, P79, DOI 10.1016/j.virol.2017.01.018
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086
   Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
NR 58
TC 55
Z9 55
U1 0
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD NOV
PY 2017
VL 2
IS 11
BP 1558
EP 1570
DI 10.1038/s41564-017-0016-3
PG 13
WC Microbiology
SC Microbiology
GA FP9NM
UT WOS:000417975600015
PM 28827581
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Colon-Gonzalez, FJ
   Peres, CA
   Sao Bernardo, CS
   Hunter, PR
   Lake, IR
AF Colon-Gonzalez, Felipe J.
   Peres, Carlos A.
   Sao Bernardo, Christine Steiner
   Hunter, Paul R.
   Lake, Iain R.
TI After the epidemic: Zika virus projections for Latin America and the
   Caribbean
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI; GLOBAL DISTRIBUTION; MOSQUITO-BORNE; CLIMATE-CHANGE;
   DENGUE; IMPACT; TRANSMISSION; TEMPERATURE; DISEASE; BURDEN
AB Background
   Zika is one of the most challenging emergent vector-borne diseases, yet its future public health impact remains unclear. Zika was of little public health concern until recent reports of its association with congenital syndromes. By 3 August 2017 similar to 217,000 Zika cases and similar to 3,400 cases of associated congenital syndrome were reported in Latin America and the Caribbean. Some modelling exercises suggest that Zika virus infection could become endemic in agreement with recent declarations from the The World Health Organisation.
   Methodology/Principal findings
   We produced high-resolution spatially-explicit projections of Zika cases, associated congenital syndromes and monetary costs for Latin America and the Caribbean now that the epidemic phase of the disease appears to be over. In contrast to previous studies which have adopted a modelling approach to map Zika potential, we project case numbers using a statistical approach based upon reported dengue case data as a Zika surrogate. Our results indicate that similar to 12.3 (0.7-162.3) million Zika cases could be expected across Latin America and the Caribbean every year, leading to similar to 64.4 (0.2-5159.3) thousand cases of Guillain-Barre A syndrome and similar to 4.7 (0.0-0116.3) thousand cases of microcephaly. The economic burden of these neurological sequelae are estimated to be USD similar to 2.3 (USD 0-159.3) billion per annum.
   Conclusions/Significance
   Zika is likely to have significant public health consequences across Latin America and the Caribbean in years to come. Our projections inform regional and federal health authorities, offering an opportunity to adapt to this public health challenge.
C1 [Colon-Gonzalez, Felipe J.; Peres, Carlos A.; Lake, Iain R.] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England.
   [Sao Bernardo, Christine Steiner] Univ Estado Mato Grosso, Rua Sao Pedro S-N, Caceres, Mato Grosso, Brazil.
   [Hunter, Paul R.] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England.
RP Colon-Gonzalez, FJ (corresponding author), Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England.
EM F.Colon@uea.ac.uk
RI Peres, Carlos A./B-1276-2013; Hunter, Paul R/A-7172-2008; lake, iain
   r/C-9917-2011; Peres, Carlos/N-8275-2019; Hunter, Paul/N-9021-2019
OI Peres, Carlos A./0000-0002-1588-8765; Hunter, Paul
   R/0000-0002-5608-6144; Peres, Carlos/0000-0002-1588-8765; Hunter,
   Paul/0000-0002-5608-6144; Colon-Gonzalez, Felipe de
   Jesus/0000-0002-9671-3405
FU National Institute for Health Research Health Protection Research Unit
   (NIHR HPRU) in Emergency Preparedness and Response at King's College
   London; Public Health England (PHE); University of East Anglia
   [HPRU-2012-10141]
FX FJCG, PRH and IRL were funded by the National Institute for Health
   Research Health Protection Research Unit (NIHR HPRU) in Emergency
   Preparedness and Response at King's College London in partnership with
   Public Health England (PHE), and the University of East Anglia (Grant
   number HPRU-2012-10141, www.nihr.ac.uk). The views expressed are those
   of the authors and not necessarily those of the NHS, the NIHR or the
   Department of Health. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Aguiar M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08462
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   [Anonymous], 2016, INFORMACOES EPIDEMIO
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bergmeir C, 2012, INFORM SCIENCES, V191, P192, DOI 10.1016/j.ins.2011.12.028
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bouzid M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005176
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Collucci C, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6716
   Colon-Gonzalez FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002503
   Colon-Gonzalez FJ, 2011, AM J TROP MED HYG, V84, P757, DOI 10.4269/ajtmh.2011.10-0609
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Dejnirattisai W, DENGUE VIRUS SERO CR
   Desai SK, 2017, AM J STEM CELLS, V6, P13
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Feldstein LR, 2015, T ROY SOC TROP MED H, V109, P303, DOI 10.1093/trstmh/trv012
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Hijmans R. J., 2013, RASTER GEOGRAPHIC DA
   Hyndman R.J., 2014, FORECASTING PRINCIPL
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lake IR, 2009, EPIDEMIOL INFECT, V137, P1538, DOI 10.1017/S0950268809002477
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   NOAA, 2016, HIST EL NIN NIN EP 1
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Overgaard HJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2295-1
   Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Perry PO, 2009, BCV CROSS VALIDATION
   Piontek F, 2014, P NATL ACAD SCI USA, V111, P3233, DOI 10.1073/pnas.1222471110
   Poveda G, 2005, MON WEATHER REV, V133, P228, DOI 10.1175/MWR-2853.1
   R Development Core Team, 2010, R LANG ENV STAT COMP
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Rodriguez-Morales AJ, 2017, TRAVEL MED INFECT DI, P30075
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   SEDAC, 2012, GRIDD POP WORLD VERS
   Spracklen DV, 2012, NATURE, V489, P282, DOI 10.1038/nature11390
   SSA, 2016, AN MORB 1984 2015
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Tompkins AM, 2015, J APPL METEOROL CLIM, V54, P521, DOI 10.1175/JAMC-D-14-0156.1
   Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520
   UNWPP, 2016, CRUD BIRTH RAT
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Worrall E, 2004, AM J TROP MED HYG, V71, P136, DOI 10.4269/ajtmh.2004.71.136
NR 73
TC 27
Z9 27
U1 2
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2017
VL 11
IS 11
AR e0006007
DI 10.1371/journal.pntd.0006007
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FO4RM
UT WOS:000416832800011
PM 29091713
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Magalhaes, T
   Braga, C
   Cordeiro, MT
   Oliveira, ALS
   Castanha, PMS
   Maciel, APR
   Amancio, NML
   Gouveia, PN
   Peixoto-da-Silva, VJ
   Peixoto, TFL
   Britto, H
   Lima, PV
   Lima, ARS
   Rosenberger, KD
   Jaenisch, T
   Marques, ETA
AF Magalhaes, Tereza
   Braga, Cynthia
   Cordeiro, Marli T.
   Oliveira, Andre L. S.
   Castanha, Priscila M. S.
   Maciel, Ana Paula R.
   Amancio, Nathalia M. L.
   Gouveia, Pollyanne N.
   Peixoto-da-Silva, Valter J., Jr.
   Peixoto, Thaciana F. L.
   Britto, Helena
   Lima, Priscilla V.
   Lima, Andreza R. S.
   Rosenberger, Kerstin D.
   Jaenisch, Thomas
   Marques, Ernesto T. A.
TI Zika virus displacement by a chikungunya outbreak in Recife, Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
AB Background
   Several arboviruses, including dengue virus (DENV), Zika virus (ZIKV) and chikungunya virus (CHIKV), transmitted by Aedes mosquitoes, circulate in northeast Brazil. Diseases caused by these viruses are of great public health relevance, however, their epidemiological features in areas where the three viruses co-circulate are scarce. Here, we present analyses of molecular and serological diagnostics in a prospective study of acute febrile patients recruited from May 2015 to May 2016 in Recife, Brazil.
   Methods
   Two hundred sixty-three acute febrile patients with symptoms suggestive of an arboviral disease who attended an urgent heath care clinic in the Recife Metropolitan Region in northeast Brazil were enrolled. Acute and convalescent blood samples were collected and tested using molecular and serological assays for infection with DENV, ZIKV and CHIKV.
   Results
   Quantitative real-time reverse-transcriptase polymerase chain reactions (qRTPCR) performed on acute phase sera detected no patients positive for DENV, but 26 (9.9%) positive for ZIKV and 132 (50.2%) positive for CHIKV. There were a few suspected and only one confirmed dengue case. Specific serological assays for ZIKV and CHIKV confirmed the qRTPCR data. Analyses of DENV IgM and IgG ELISAs in the context of qRTPCR results suggested high levels of cross reactive antibodies in ZIKV-positive samples. Results from neutralization assays highly corroborated those from qRTPCR and ZIKV ELISA, indicating very few positive DENV cases. ZIKV infections were temporally clustered in the first months of the study and started to decrease concomitantly with an increase in CHIKV infections in August 2015. The proportion of CHIKV infections increased significantly in September 2015 and remained high until the end of the study period, with an average of 84.7% of recruited patients being diagnosed from August 2015 to May 2016. ZIKV infections exhibited a female bias and the cases were spread over the study site, while CHIKV cases had a male bias and were spatially clustered in each month.
   Conclusions
   In 2015 +/- 2016 in the Recife Metropolitan Region, we detected the tail end of a Zika epidemic, which was displaced by a chikungunya epidemic. Few dengue cases were identified despite a high number of official dengue notifications in the area during this period. We show here important epidemiological features of these cases.
C1 [Magalhaes, Tereza; Cordeiro, Marli T.; Castanha, Priscila M. S.; Lima, Priscilla V.; Lima, Andreza R. S.; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Lab Virol & Expt Therapeut, Recife, PE, Brazil.
   [Magalhaes, Tereza] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab AIDL, Ft Collins, CO 80523 USA.
   [Braga, Cynthia] Fiocruz MS, IAM, Dept Parasitol, Recife, PE, Brazil.
   [Braga, Cynthia; Britto, Helena] Inst Integral Med Prof Fernando Figueira, Recife, PE, Brazil.
   [Oliveira, Andre L. S.] Fiocruz MS, IAM, Stat & Geoproc Lab, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Fac Med Sci, Recife, PE, Brazil.
   [Maciel, Ana Paula R.; Amancio, Nathalia M. L.; Gouveia, Pollyanne N.; Peixoto-da-Silva, Valter J., Jr.; Peixoto, Thaciana F. L.] IMIP, Urgent Hlth Care Unit, Paulista, Brazil.
   [Rosenberger, Kerstin D.; Jaenisch, Thomas] Heidelberg Univ Hosp, Sect Clin Trop Med, Dept Infect Dis, Heidelberg, Germany.
   [Jaenisch, Thomas] German Ctr Infect Res DZIF, Partner Site Heidelberg, Heidelberg, Germany.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
RP Magalhaes, T; Marques, ETA (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Lab Virol & Expt Therapeut, Recife, PE, Brazil.; Magalhaes, T (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab AIDL, Ft Collins, CO 80523 USA.; Marques, ETA (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
EM tereza.magalhaes@colostate.edu; emarques@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013; Braga, Maria Cynthia/A-8204-2013;
   Magalhaes, Tereza/V-6632-2019; CASTANHA, PRISCILA/G-1785-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; Braga, Maria
   Cynthia/0000-0002-7862-6455; CASTANHA, PRISCILA/0000-0002-1220-5308
FU European Union's Seventh Framework Programme for research, technological
   development and demonstrationEuropean Union (EU) [FP7-281803 IDAMS,
   IDAMS 45]; State of Pernambuco funding agency (Fundacao de Amparo a
   Ciencia e Tecnologia do Estado de Pernambuco-FACEPE) [PPSUS
   APQ-0302-4.01/13]; European Union's Horizon 2020 Research and Innovation
   Programme under ZIKAlliance [734548]; National Institute of Allergy and
   Infectious Diseases of the National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI129464]; ZikaCura (PITT-FIOCRUZ Alliance); Brazilian national
   funding agency (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico of Brazil-CNPq) [472360/2013-2]
FX This study was funded by the European Union's Seventh Framework
   Programme for research, technological development and demonstration
   (grant FP7-281803 IDAMS; http://www.idams.eu/), where it has been
   designated with publication reference number IDAMS 45; the State of
   Pernambuco funding agency (Fundacao de Amparo a Ciencia e Tecnologia do
   Estado de Pernambuco-FACEPE; grant PPSUS APQ-0302-4.01/13); the European
   Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance
   (grant 734548); the National Institute of Allergy and Infectious
   Diseases of the National Institutes of Health (grant R21AI129464); the
   ZikaCura (PITT-FIOCRUZ Alliance); and the Brazilian national funding
   agency (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of
   Brazil-CNPq; grant 472360/2013-2). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the funding agencies. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P668, DOI 10.1590/0037-8682-0279-2016
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P553, DOI 10.1590/0037-8682-0245-2016
   Aubry M, 2017, EMERG INFECT DIS, V23
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Governo do Estado de Pernambuco, 2015, B PLUV
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Jaenisch T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1440-3
   Jaenisch T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002320
   Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   Ministerio da Saude Brasil, 2017, MON CAS DENG FEBR CH, V52
   Ministerio da Saude Brasil, 2015, PROT VIG RESP PEL VI
   Ministerio da Saude Brasil, 2015, MON CAS DENG FEBR CH, V48
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Organizaco Pan-Americana da Saude, 2016, B SEM
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Warrilow D, 2002, J MED VIROL, V66, P524, DOI 10.1002/jmv.2176
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
   Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005
NR 42
TC 16
Z9 16
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2017
VL 11
IS 11
AR e0006055
DI 10.1371/journal.pntd.0006055
PG 25
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA VI3XC
UT WOS:000480724600001
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gregianini, TS
   Ranieri, T
   Favreto, C
   Nunes, ZMA
   Giannini, GLT
   Sanberg, ND
   da Rosa, MTM
   da Veiga, ABG
AF Gregianini, Tatiana Schaffer
   Ranieri, Tani
   Favreto, Catia
   Alves Nunes, Zenaida Marion
   Tumioto Giannini, Gabriela Luchiari
   Sanberg, Nara Druck
   Mar da Rosa, Marilda Tereza
   Gorini da Veiga, Ana Beatriz
TI Emerging arboviruses in Rio Grande do Sul, Brazil: Chikungunya and Zika
   outbreaks, 2014-2016
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Review
DE arboviral diseases; Chikungunya virus-CHIKV; congenital Zika syndrome;
   microcephaly; Zika virus-ZIKV
ID VIRUS OUTBREAK; AEDES-ALBOPICTUS; TRANSMISSION; STATES; FEVER
AB Questions investigated: The recent emergence of arboviruses such as Chikungunya virus (CHIKV) and Zika virus (ZIKV) in Brazil has posed a threat to human health and to the country's economy. Outbreaks occur mainly in tropical areas; however, increasing number of cases have been observed in Rio Grande do Sul (RS), the Southernmost state; therefore, surveillance of these arboviruses is essential for public health measures.
   Design: In this study, we analyzed 1276 samples from patients with clinically suspected arboviral diseases between 2014 and 2016. Demographic and clinical data were collected and described; cases of microcephaly associated with congenital infection were analyzed.
   Essential findings: Results show that CHIKV and ZIKV entered RS in 2014 and 2015, respectively, with imported cases confirmed. Autochthonous infections occurred in 2016 for both viruses, with a total of 5 autochthonous cases for CHIKV and 44 for ZIKV. Most patients were older than 21years; the main symptoms were fever, arthralgia, myalgia, and headache; rash, conjunctivitis, and pruritus were also reported in ZIKV cases. Three cases of congenital Zika syndrome were confirmed in our study, while another 20 cases of microcephaly associated with congenital infection were confirmed (10 positive for syphilis, 6 for toxoplasmosis and 4 for cytomegalovirus).
   Main conclusions: Considering co-circulation of different arbovirus in RS, including Dengue virus, CHIKV, and ZIKV, and the presence of Aedes aegypti and Aedes albopictus in the area, surveillance of patients infected by these viruses contributes to the control and prevention of such diseases. Practical difficulties in diagnosing these infections are discussed.
C1 [Gregianini, Tatiana Schaffer; Alves Nunes, Zenaida Marion; Tumioto Giannini, Gabriela Luchiari; Sanberg, Nara Druck; Mar da Rosa, Marilda Tereza] Secretaria Saude Estado Rio Grande Do Sul SES RS, IPB LACEN RS, Lab Cent Saude Publ Estado Rio Grande Do Sul, Porto Alegre, RS, Brazil.
   [Ranieri, Tani; Favreto, Catia] Secretaria Saude Estado Rio Grande Do Sul SES RS, CEVS, Porto Alegre, RS, Brazil.
   [Gorini da Veiga, Ana Beatriz] UFCSPA, Lab Biol Mol, Porto Alegre, RS, Brazil.
RP da Veiga, ABG (corresponding author), UFCSPA, Lab Biol Mol, Porto Alegre, RS, Brazil.
EM anabgv@ufcspa.edu.br
RI Veiga, Ana B. G./N-8581-2013
OI Veiga, Ana B. G./0000-0003-1462-5506
CR Alis S, 2017, PLOS NEGLECT TROP D, V11
   Brasil Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Brasil Ministerio da Saude, 2017, VIR ZIK BRAS RESP SU
   Brasil Ministerio da Saude, 2014, MAN PREP RESP INTR V
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   CDC Centers for Disease Control and Prevention, 2016, REC MAN REP ZIK VIR
   CDC Centers for Disease Control and Prevention, 2016, CHIK VIR SYMPT DIAGN
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Gomes AD, 2008, EPIDEMIOL SERV SAUDE, V17, P71
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   IBGE Instituto Brasileiro de Geografia e Estatistica, 2016, AR TERR BRAS 2016
   IBGE Instituto Brasileiro de Geografia e Estatistica, 2017, PROJ POP BRAS UN FED
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lanciottis RS, 2008, EMERG INFECT DIS, V14, P8
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   PAHO Pan American Health Organization, 2017, CHIK
   PAHO Pan American Health Organization, 2017, ZIK VIR INF 2017
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rodriguez-Morales AJ, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12688
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   SES/RS Secretaria Estadual da Saude do Estado do Rio Grande do Sul, 2017, FEBR CHIK
   SES/RS Secretaria Estadual da Saude do Estado do Rio Grande do Sul, 2017, MON ALT CRESC DES RE
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tumioto GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104394
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vest KG, 2016, DISASTER MED PUBLIC, V10, P707, DOI 10.1017/dmp.2016.43
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 8
Z9 8
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD NOV
PY 2017
VL 27
IS 6
AR e1943
DI 10.1002/rmv.1943
PG 10
WC Virology
SC Virology
GA FN3EF
UT WOS:000415879400002
PM 28929534
OA Bronze
DA 2020-07-08
ER

PT J
AU Lin, MY
   Wang, YL
   Wu, WL
   Wolseley, V
   Tsai, MT
   Radic, V
   Thornton, ME
   Grubbs, BH
   Chow, RH
   Huang, IC
AF Lin, Ming-Yi
   Wang, Yi-Ling
   Wu, Wan-Lin
   Wolseley, Victoria
   Tsai, Ming-Ting
   Radic, Vladimir
   Thornton, Matthew E.
   Grubbs, Brendan H.
   Chow, Robert H.
   Huang, I-Chueh
TI Zika Virus Infects Intermediate Progenitor Cells and Post-mitotic
   Committed Neurons in Human Fetal Brain Tissues
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CEREBRAL-CORTEX; STEM-CELLS; RADIAL GLIA; DIFFERENTIATION; EXPRESSION;
   DEFECTS; SURFACE; MARKER; GROWTH; ARISE
AB Zika virus (ZIKV) infection is associated with microcephaly in fetuses, but the pathogenesis of ZIKV-related microcephaly is not well understood. Here we show that ZIKV infects the subventricular zone in human fetal brain tissues and that the tissue tropism broadens with the progression of gestation. Our research demonstrates also that intermediate progenitor cells (IPCs) are the main target cells for ZIKV. Post-mitotic committed neurons become susceptible to ZIKV infection as well at later stages of gestation. Furthermore, activation of microglial cells, DNA fragmentation, and apoptosis of infected or uninfected cells could be found in ZIKV-infected brain tissues. Our studies identify IPCs as the main target cells for ZIKV. They also suggest that immune activation after ZIKV infection may play an important role in the pathogenesis of ZIKV-related microcephaly.
C1 [Lin, Ming-Yi; Wolseley, Victoria; Chow, Robert H.] Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.
   [Wang, Yi-Ling; Wu, Wan-Lin; Tsai, Ming-Ting; Radic, Vladimir; Huang, I-Chueh] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
   [Thornton, Matthew E.; Grubbs, Brendan H.] Univ Southern Calif, Keck Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA.
RP Chow, RH (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.; Huang, IC (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
EM rchow@usc.edu; ichuehhu@usc.edu
OI Thornton, Matthew/0000-0002-1083-2703; Grubbs,
   Brendan/0000-0002-1963-4922
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1R01AI100953]; NIH/NIMHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [U01 MH098937];
   NIH/NEIUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01
   EY022931]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P30 DK048522];
   Whittier Foundation
FX We thank Drs M.L. Wilson (Department of Preventive Medicine, Keck School
   of Medicine, USC, CA, USA) and R. Steward (Family Planning Associates,
   CA, USA) for tissue procurement. We acknowledge Cell and Tissue Imaging
   Core of USC Research Center for Liver Diseases for the microscopy
   services. This work is funded by NIH/NIAID (1R01AI100953), NIH/NIMH (U01
   MH098937), and NIH/NEI (R01 EY022931). Microscopy services are funded by
   NIH (P30 DK048522). In addition, we acknowledge generous support of the
   Whittier Foundation.
CR Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993
   Borsini A, 2015, TRENDS NEUROSCI, V38, P145, DOI 10.1016/j.tins.2014.12.006
   Brasil P, 2016, N ENGL J MED
   Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028
   Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006
   Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134
   Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100
   HO PPK, 1976, J GEN VIROL, V33, P143, DOI 10.1099/0022-1317-33-1-143
   Howard BM, 2008, NEUROSCIENTIST, V14, P459, DOI 10.1177/1073858407313512
   Jakovcevski I, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.005.2009
   Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Liang Q., 2016, CELL STEM CELL
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lodato S, 2015, TRENDS NEUROSCI, V38, P117, DOI 10.1016/j.tins.2014.11.003
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MALEWICZ B, 1979, J CLIN MICROBIOL, V9, P609
   Messam CA, 2002, DEV BRAIN RES, V134, P87, DOI 10.1016/S0165-3806(01)00325-X
   Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Paridaen JTML, 2014, EMBO REP, V15, P351, DOI 10.1002/embr.201438447
   Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ray B, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0063-0
   ROESSMANN U, 1986, ACTA NEUROPATHOL, V70, P308, DOI 10.1007/BF00686089
   Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soltani MH, 2005, AM J PATHOL, V166, P1841, DOI 10.1016/S0002-9440(10)62493-5
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vasistha NA, 2015, CEREB CORTEX, V25, P3290, DOI 10.1093/cercor/bhu125
   WILKINSON M, 1990, NEUROPATH APPL NEURO, V16, P193, DOI 10.1111/j.1365-2990.1990.tb01156.x
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 51
TC 18
Z9 18
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 1
PY 2017
VL 7
AR 14883
DI 10.1038/s41598-017-13980-2
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FL4XE
UT WOS:000414234000002
PM 29093521
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brand, C
   Bisaillon, M
   Geiss, BJ
AF Brand, Carolin
   Bisaillon, Martin
   Geiss, Brian J.
TI Organization of the Flavivirus RNA replicase complex
SO WILEY INTERDISCIPLINARY REVIEWS-RNA
LA English
DT Review
ID WEST-NILE-VIRUS; YELLOW-FEVER VIRUS; TYPE-2 NONSTRUCTURAL PROTEIN-3;
   DE-NOVO SYNTHESIS; DENGUE VIRUS; NS3 PROTEIN; CRYSTAL-STRUCTURE;
   SERINE-PROTEASE; MEMBRANE TOPOLOGY; IN-VITRO
AB Flaviviruses, such as dengue, Japanese encephalitis, West Nile, yellow fever, and Zika viruses, are serious human pathogens that cause significant morbidity and mortality globally each year. Flaviviruses are single-stranded, positive-sense RNA viruses, and encode two multidomain proteins, NS3 and NS5, that possess all enzymatic activities required for genome replication and capping. NS3 and NS5 interact within virus-induced replication compartments to form the RNA genome replicase complex. Although the individual enzymatic activities of both proteins have been extensively studied and are well characterized, there are still gaps in our understanding of how they interact to efficiently coordinate their respective activities during positive-strand RNA synthesis and capping. Here, we discuss what is known about the structures and functions of the NS3 and NS5 proteins and propose a preliminary NS3:NS5:RNA interaction model based on a large body of literature about how the viral enzymes function, physical restraints between NS3 and NS5, as well as critical steps in the replication process. (C) 2017 Wiley Periodicals, Inc.
C1 [Brand, Carolin; Bisaillon, Martin] Univ Sherbrooke, Det Biochim, Fac Med & Sci Sante, Sherbrooke, PQ, Canada.
   [Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Geiss, Brian J.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
RP Geiss, BJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.; Geiss, BJ (corresponding author), Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
EM Brian.Geiss@colostate.edu
FU Faculte de Medecine et des Sciences de la Sante de l'Universite de
   Sherbrooke; Natural Sciences and Engineering Research Council of
   CanadaNatural Sciences and Engineering Research Council of Canada
   [RGPIN-2016-03916]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [5 R01 AI114675]
FX This work was supported by a graduate training award from the Faculte de
   Medecine et des Sciences de la Sante de l'Universite de Sherbrooke to
   C.B., a grant from the Natural Sciences and Engineering Research Council
   of Canada (RGPIN-2016-03916) to M.B., and a grant from the National
   Institutes of Health (5 R01 AI114675) to B.J.G.
CR Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504
   BAZAN JF, 1989, VIROLOGY, V171, P637, DOI 10.1016/0042-6822(89)90639-9
   Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004
   Benzaghou I, 2006, FEBS LETT, V580, P867, DOI 10.1016/j.febslet.2006.01.006
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1993, J VIROL, V67, P6797, DOI 10.1128/JVI.67.11.6797-6807.1993
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997
   Choi KH, 2009, CURR OPIN STRUC BIOL, V19, P746, DOI 10.1016/j.sbi.2009.10.015
   Ciota AT, 2013, VIRUSES-BASEL, V5, P3021, DOI 10.3390/v5123021
   Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715
   Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Elizondo-Quiroga D, 2013, J GLOB INFECT DIS, V5, P168, DOI 10.4103/0974-777X.122014
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244
   Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058
   Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107
   Guyatt KJ, 2001, J VIROL METHODS, V92, P37, DOI 10.1016/S0166-0934(00)00270-6
   Henderson BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025795
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Li Kuohan, 2014, Virologica Sinica, V29, P74, DOI 10.1007/s12250-014-3438-6
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P2244, DOI 10.1016/j.bbamem.2015.06.010
   LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Mastrangelo E, 2007, J MOL BIOL, V372, P444, DOI 10.1016/j.jmb.2007.06.055
   Mastrangelo E, 2012, BIOCHEM BIOPH RES CO, V417, P84, DOI 10.1016/j.bbrc.2011.11.060
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Moreland NJ, 2012, J VIROL METHODS, V179, P97, DOI 10.1016/j.jviromet.2011.10.006
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Saeedi BJ, 2013, WIRES RNA, V4, P723, DOI 10.1002/wrna.1191
   Sampath A, 2006, J VIROL, V80, P6686, DOI 10.1128/JVI.02215-05
   Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026
   Selisko B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002912
   Shiryaev SA, 2009, J GEN VIROL, V90, P2081, DOI 10.1099/vir.0.012864-0
   STOHLMAN SA, 1975, J VIROL, V16, P1017, DOI 10.1128/JVI.16.4.1017-1026.1975
   Takahashi H, 2012, ANTIVIR RES, V96, P305, DOI 10.1016/j.antiviral.2012.09.023
   TAKEGAMI T, 1995, VIRUS GENES, V9, P105, DOI 10.1007/BF01702653
   Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200
   Umareddy I, 2006, J GEN VIROL, V87, P2605, DOI 10.1099/vir.0.81844-0
   Utama A, 2000, FEBS LETT, V465, P74, DOI 10.1016/S0014-5793(99)01705-6
   Valle RPC, 1998, J VIROL, V72, P624, DOI 10.1128/JVI.72.1.624-632.1998
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Vasudevan SG, 2001, FARMACO, V56, P33, DOI 10.1016/S0014-827X(01)01014-X
   Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008
   WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WENGLER G, 1991, J GEN VIROL, V72, P851, DOI 10.1099/0022-1317-72-4-851
   WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M
   WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   World Health Organization, 2017, HIST ZIK VIR
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Xu Ting, 2006, Novartis Found Symp, V277, P87, DOI 10.1002/0470058005.ch7
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200
   Yotmanee P, 2015, J MOL GRAPH MODEL, V60, P24, DOI 10.1016/j.jmgm.2015.05.008
   Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
NR 101
TC 11
Z9 11
U1 6
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-7004
EI 1757-7012
J9 WIRES RNA
JI Wiley Interdiscip. Rev.-RNA
PD NOV-DEC
PY 2017
VL 8
IS 6
AR e1437
DI 10.1002/wrna.1437
PG 14
WC Cell Biology
SC Cell Biology
GA FJ7CV
UT WOS:000412915800008
PM 28815931
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Fontes-Garfias, CR
   Shan, C
   Luo, HL
   Muruato, AE
   Medeiros, DBA
   Mays, E
   Xie, XP
   Zou, J
   Roundy, CM
   Wakamiya, M
   Rossi, SL
   Wang, T
   Weaver, SC
   Shi, PY
AF Fontes-Garfias, Camila R.
   Shan, Chao
   Luo, Huanle
   Muruato, Antonio E.
   Medeiros, Daniele B. A.
   Mays, Elizabeth
   Xie, Xuping
   Zou, Jing
   Roundy, Christopher M.
   Wakamiya, Maki
   Rossi, Shannan L.
   Wang, Tian
   Weaver, Scott C.
   Shi, Pei-Yong
TI Functional Analysis of Glycosylation of Zika Virus Envelope Protein
SO CELL REPORTS
LA English
DT Article
ID WEST-NILE-VIRUS; DENGUE-VIRUS; DC-SIGN; IN-VITRO; INFECTION; VACCINE;
   HETEROGENEITY; ENCEPHALITIS; MOSQUITOS; SEQUENCE
AB Zika virus (ZIKV) infection causes devastating congenital abnormities and Guillain-Barre syndrome. The ZIKV envelope (E) protein is responsible for viral entry and represents a major determinant for viral pathogenesis. Like other flaviviruses, the ZIKV E protein is glycosylated at amino acid N154. To study the function of E glycosylation, we generated a recombinant N154Q ZIKV that lacks the E glycosylation and analyzed the mutant virus in mammalian and mosquito hosts. In mouse models, the mutant was attenuated, as evidenced by lower viremia, decreased weight loss, and no mortality; however, knockout of E glycosylation did not significantly affect neurovirulence. Mice immunized with the mutant virus developed a robust neutralizing antibody response and were completely protected from wild-type ZIKV challenge. In mosquitoes, the mutant virus exhibited diminished oral infectivity for the Aedes aegypti vector. Collectively, the results demonstrate that E glycosylation is critical for ZIKV infection of mammalian and mosquito hosts.
C1 [Fontes-Garfias, Camila R.; Shan, Chao; Medeiros, Daniele B. A.; Xie, Xuping; Zou, Jing; Wakamiya, Maki; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Muruato, Antonio E.; Roundy, Christopher M.; Rossi, Shannan L.; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Muruato, Antonio E.; Roundy, Christopher M.; Weaver, Scott C.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Medeiros, Daniele B. A.] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Para, Brazil.
   [Luo, Huanle; Mays, Elizabeth; Wang, Tian; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Wang, Tian] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Wang, Tian] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Wang, Tian; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
EM peshi@utmb.edu
RI Weaver, Scott C/D-6490-2011; Xie, Xuping/AAD-7406-2019
OI Weaver, Scott C/0000-0001-8016-8556; Shan, Chao/0000-0002-3953-3782
FU UTMB; University of Texas; Centers for Disease Control and
   PreventionUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA [SCON2016-01353]; Robert J. Kleberg,
   Jr. and Helen C. Kleberg Foundation award; UTMB [UL1TR-001439];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI127744, AI120942, AI099123]
FX We thank Allan Barrett and other colleagues at University of Texas
   Medical Branch for helpful discussions and support during the course of
   this study. P.-Y.S.'s lab was supported by a UTMB startup award, a
   University of Texas STARs award, a Centers for Disease Control and
   Prevention grant for the Western Gulf Center of Excellence for
   Vector-Borne Diseases, Pan American Health Organization grant
   SCON2016-01353, a Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
   award, UTMB Clinical Translational Sciences Award UL1TR-001439, and NIH
   grant AI127744. This research was also partially supported by NIH grants
   AI120942 and AI099123 to S.C.W and T.W., respectively.
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beasley DWC, 2004, EMERG INFECT DIS, V10, P2221, DOI 10.3201/eid1012.040647
   Bernhard OK, 2004, J BIOL CHEM, V279, P51828, DOI 10.1074/jbc.M402741200
   Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293
   Bryant JE, 2007, VIROLOGY, V366, P415, DOI 10.1016/j.virol.2007.05.007
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Daffis S, 2008, J VIROL, V82, P8465, DOI 10.1128/JVI.00918-08
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Liu Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003931
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Moudy RM, 2009, VIROLOGY, V387, P222, DOI 10.1016/j.virol.2009.01.038
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Murata R, 2010, AM J TROP MED HYG, V82, P696, DOI 10.4269/ajtmh.2010.09-0262
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   POST PR, 1992, VIROLOGY, V188, P160, DOI 10.1016/0042-6822(92)90745-B
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   VORNDAM V, 1993, J GEN VIROL, V74, P2653, DOI 10.1099/0022-1317-74-12-2653
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
NR 39
TC 47
Z9 50
U1 0
U2 19
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD OCT 31
PY 2017
VL 21
IS 5
BP 1180
EP 1190
DI 10.1016/j.celrep.2017.10.016
PG 11
WC Cell Biology
SC Cell Biology
GA FL2OZ
UT WOS:000414057600007
PM 29091758
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Valderrama, A
   Diaz, Y
   Lopez-Verges, S
AF Valderrama, Anayansi
   Diaz, Yamilka
   Lopez-Verges, Sandra
TI Interaction of Flavivirus with their mosquito vectors and their impact
   on the human health in the Americas
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Vector transmission; Dengue virus; Zika
   virus; Yellow fever virus
ID FUSING AGENT VIRUS; AEDES-AEGYPTI; YELLOW-FEVER; DENGUE VIRUS; VERTICAL
   TRANSMISSION; ORAL-SUSCEPTIBILITY; ALBOPICTUS; CHIKUNGUNYA; INFECTION;
   DIPTERA
AB Some of the major arboviruses with public health importance, such as dengue, yellow fever, Zika and West Nile virus are mosquito-borne or mosquito-transmitted Flavivirus. Their principal vectors are from the family Culicidae, Aedes aegypti and Aedes albopictus being responsible of the urban cycles of dengue, Zika and yellow fever virus. These vectors are highly competent for transmission of many arboviruses. The genetic variability of the vectors, the environment and the viral diversity modulate the vector competence, in this context, it is important to determine which vector species is responsible of an outbreak in areas where many vectors coexist. As some vectors can transmit several flaviviruses and some flaviviruses can be transmitted by different species of vectors, through this review we expose importance of yellow fever, dengue and Zika virus in the world and the Americas, as well as the updated knowledge about these flaviviruses in their interaction with their mosquito vectors, guiding us on what is probably the beginning of a new stage in which the simultaneity of outbreaks will occur more frequently. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Valderrama, Anayansi] Gorgas Mem Inst Hlth Studies, Dept Res Med Entomol, Panama City, Panama.
   [Diaz, Yamilka; Lopez-Verges, Sandra] Gorgas Mem Inst Hlth Studies, Dept Res Virol & Biotechnol, Panama City, Panama.
RP Lopez-Verges, S (corresponding author), Gorgas Mem Inst Hlth Studies, Dept Res Virol & Biotechnol, Panama City, Panama.
EM slopez@gorgas.gob.pa
FU Ministry of Economy and Finance of Panama [009044.51]
FX This work was financed by the project 009044.51 (SLV) from the Ministry
   of Economy and Finance of Panama. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aliota M.T., PLOS NEGL TROP DIS, V10
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Amraoui F., 2016, FRENCH AEDES ALBOPIC, P14
   Arauz D, 2016, EMERG INFECT DIS, V22, P1515, DOI 10.3201/eid2208.160292
   Baba MM, 2017, BIOCHEM BIOPH RES CO, V492, P548, DOI 10.1016/j.bbrc.2017.01.079
   Barrett A.D.T., 2017, VACCINE
   Borkent A, 2004, ANN ENTOMOL SOC AM, V97, P882, DOI 10.1603/0013-8746(2004)097[0882:TEFMDC]2.0.CO;2
   BOROMISA RD, 1987, J AM MOSQUITO CONTR, V3, P378
   Calisher C.H., 2013, LIFTING IMPENETRABLE
   Calisher CH, 2016, EMERG INFECT DIS, V22, P1859, DOI 10.3201/eid2210.160875
   Calzolari M, 2016, INFECT GENET EVOL, V40, P381, DOI 10.1016/j.meegid.2015.07.032
   Carpenter DN, 1905, J AMER MED ASSOC, V44, P214
   CARPENTER STANLEY J., 1952, MOSQUITO NEWS, V12, P156
   Carrera JP, 2015, AM J TROP MED HYG, V93, P1014, DOI 10.4269/ajtmh.15-0117
   Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488
   Chaves LF, 2010, B ENTOMOL RES, P1
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Chouin-carneiro T., 2016, DIFFERENTIAL SUSCEPT, P1
   Christofferson R.C., 2016, ENV HLTH INSIGHTS, P119
   Clem RJ, 2016, J GEN VIROL, V97, P1033, DOI 10.1099/jgv.0.000429
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0
   Diaz Y, 2015, AM J TROP MED HYG, V92, P482, DOI 10.4269/ajtmh.14-0404
   Eng MW, 2016, INSECT BIOCHEM MOLEC, V76, P70, DOI 10.1016/j.ibmb.2016.07.004
   Ferraguti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29002
   Fragkoudis R, 2009, J GEN VIROL, V90, P2061, DOI 10.1099/vir.0.013201-0
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   GALINDO P, 1967, AM J TROP MED HYG, V16, P525, DOI 10.4269/ajtmh.1967.16.525
   Gorgas W.C., 1918, SANITATION IN PANAMA
   Grard G., ZIKA VIRUS GABON CEN, DOI [10.1371/journal.pntd.0002681, DOI 10.1371/JOURNAL.PNTD.0002681]
   Gubler DJ, 2001, ANN NY ACAD SCI, V951, P13
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Haddow AD, 2013, VIROLOGY, V440, P134, DOI 10.1016/j.virol.2012.12.008
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Ibanez-Bernal S, 1997, MED VET ENTOMOL, V11, P305, DOI 10.1111/j.1365-2915.1997.tb00413.x
   IGARASHI A, 1976, VIROLOGY, V74, P174, DOI 10.1016/0042-6822(76)90139-2
   Iwamoto M., 2003, NEW ENGL J MED, P2196
   Jain J, 2017, BIOCHEM BIOPH RES CO, V492, P608, DOI 10.1016/j.bbrc.2017.02.008
   Jeslyn P.S., 2013, PLOS NEGL TROP DIS, V7
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kim DY, 2009, VIROLOGY, V386, P154, DOI 10.1016/j.virol.2008.12.034
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lourenco R., 2003, AM J TROP MED HYG, V69
   Lukashevich ED, 2003, PALEONTOL J+, V37, P153
   Manni M., 2017, AEDES ALBOPICTUS
   Maurer-Stroh S., 2016, EURO SURVEILL, V21
   Medlock J.M., 2015, IMPACTS CREATION EXP
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   MITCHELL CJ, 1987, J AM MOSQUITO CONTR, V3, P460
   MITCHELL CJ, 1990, J AM MOSQUITO CONTR, V6, P251
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mogi M, 2015, J MED ENTOMOL, V52, P647, DOI 10.1093/jme/tjv038
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Oliveira R.L.D.E., 2003, LARGE GENETIC DIFFER, V69, P105
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Paupy C, 2003, GENET RES, V82, P171, DOI 10.1017/S0016672303006463
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Prata A, 2000, MEM I OSWALDO CRUZ, V95, P183, DOI 10.1590/S0074-02762000000700031
   Quiroz E, 1997, Rev Cubana Med Trop, V49, P86
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   ROSEN L, 1974, AM J TROP MED HYG, V23, P1205, DOI 10.4269/ajtmh.1974.23.1205
   Roundy C.M., 2017, MOSQUITO COMPETENCE, P23
   Schneider JR, 2011, INFECT GENET EVOL, V11, P11, DOI 10.1016/j.meegid.2010.10.019
   SERUFO JC, 1993, MEM I OSWALDO CRUZ, V88, P503, DOI 10.1590/S0074-02761993000300025
   Severson DW, 2016, INSECTS, V7, DOI 10.3390/insects7040058
   Shrinet J, 2017, BIOCHEM BIOPH RES CO, V492, P617, DOI 10.1016/j.bbrc.2017.01.162
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   Stramer SL, 2005, NEW ENGL J MED, V353, P451, DOI 10.1056/NEJMoa044333
   Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Van der Stuyft P., 1999, LANCET, V353
   Vazeille M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1666-0
   Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Watson M. Shipp, 1967, AEDES STEGOMYIA ALBO
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Weger-Lucarelli J., 2016, VECTOR COMPETENCE AM
   Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587
   Womack M., 1993, WING BEATS, V5, P4
   Yamanaka A, 2013, INFECT GENET EVOL, V19, P188, DOI 10.1016/j.meegid.2013.07.012
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 96
TC 13
Z9 13
U1 2
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 28
PY 2017
VL 492
IS 4
SI SI
BP 541
EP 547
DI 10.1016/j.bbrc.2017.05.050
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FK3OB
UT WOS:000413393300003
PM 28499872
DA 2020-07-08
ER

PT J
AU da Fonseca, NJ
   Afonso, MQL
   Pedersolli, NG
   de Oliveira, LC
   Andrade, DS
   Bleicher, L
AF da Fonseca, Neli Jose, Jr.
   Lima Afonso, Marcelo Querino
   Pedersolli, Natan Goncalves
   de Oliveira, Lucas Carrijo
   Andrade, Dhiego Souto
   Bleicher, Lucas
TI Sequence, structure and function relationships in flaviviruses as
   assessed by evolutive aspects of its conserved non-structural protein
   domains
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Flaviviruses; Decomposition of residue coevolution networks; Dengue;
   Zika
ID WEST-NILE-VIRUS; NO-KNOWN-VECTOR; DENGUE-VIRUS; NS3 PROTEASE; MEMBRANE
   TOPOLOGY; NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE; OCTAPEPTIDE SEQUENCE;
   INTERACTION NETWORKS; NS1-NS2A CLEAVAGE
AB Flaviviruses are responsible for serious diseases such as dengue, yellow fever, and zika fever. Their genomes encode a polyprotein which, after cleavage, results in three structural and seven non-structural proteins. Homologous proteins can be studied by conservation and coevolution analysis as detected in multiple sequence alignments, usually reporting positions which are strictly necessary for the structure and/or function of all members in a protein family or which are involved in a specific sub-class feature requiring the coevolution of residue sets. This study provides a complete conservation and coevolution analysis on all flaviviruses non-structural proteins, with results mapped on all well-annotated available sequences. A literature review on the residues found in the analysis enabled us to compile available information on their roles and distribution among different flaviviruses. Also, we provide the mapping of conserved and coevolved residues for all sequences currently in SwissProt as a supplementary material, so that particularities in different viruses can be easily analyzed. (C) 2017 Elsevier Inc. All rights reserved.
C1 [da Fonseca, Neli Jose, Jr.; Lima Afonso, Marcelo Querino; Pedersolli, Natan Goncalves; de Oliveira, Lucas Carrijo; Andrade, Dhiego Souto; Bleicher, Lucas] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, Ave Antonio Carlos,6627, BR-31270901 Belo Horizonte, MG, Brazil.
RP Bleicher, L (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, Ave Antonio Carlos,6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM nelijfjr@gmail.com; marceloqla@gmail.com; natanpedersolli@gmail.com;
   lucas.carrijodeoliveira@gmail.com; dsouto49@gmail.com;
   lbleicher@icb.ufmg.br
RI Bleicher, Lucas/R-5153-2019; Bleicher, Lucas/B-7967-2013
OI Bleicher, Lucas/0000-0001-7121-4952; da Fonseca Junior, Neli
   Jose/0000-0001-6466-8083
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [457851/2014-7]; CAPESCAPES [051/2013]
FX We thank CNPq (grant 457851/2014-7) and CAPES (grant 051/2013) for
   financial support.
CR Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Ambrose RL, 2011, J VIROL, V85, P11274, DOI 10.1128/JVI.05864-11
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Blaney JE, 2003, ARCH VIROL, V148, P999, DOI 10.1007/s00705-003-0007-y
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bleicher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027786
   Bollati M, 2009, BIOCHEM BIOPH RES CO, V382, P200, DOI 10.1016/j.bbrc.2009.03.008
   BOMBARDIERI S, 1992, ISRAEL J MED SCI, V28, P117
   BRANDT WE, 1970, J VIROL, V6, P500, DOI 10.1128/JVI.6.4.500-506.1970
   Busso C, 2015, BIOCHIMIE, V119, P92, DOI 10.1016/j.biochi.2015.10.016
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan YK, 2016, NAT IMMUNOL, V17, P523, DOI 10.1038/ni.3393
   Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09
   Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200
   Chappell KJ, 2005, J BIOL CHEM, V280, P2896, DOI 10.1074/jbc.M409931200
   Chatel-Chaix L, 2015, J VIROL, V89, P7170, DOI 10.1128/JVI.00867-15
   Chen MC, 2009, J IMMUNOL, V183, P1797, DOI 10.4049/jimmunol.0800672
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3
   Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07
   Droll DA, 2000, VIROLOGY, V275, P335, DOI 10.1006/viro.2000.0488
   Eddy Sean R, 2009, Genome Inform, V23, P205
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993
   FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995
   Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344
   Gupta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134823
   Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.22.12225-12235.2004
   Henikoff S., 1994, POSITION BASED SEQUE, V243
   HORI H, 1990, J VIROL, V64, P4573, DOI 10.1128/JVI.64.9.4573-4577.1990
   Jansson AM, 2009, ACTA CRYSTALLOGR D, V65, P796, DOI 10.1107/S0907444909017260
   Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   JOYCE CM, 1995, J BACTERIOL, V177, P6321, DOI 10.1128/jb.177.22.6321-6329.1995
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kondo MY, 2011, BIOCHEM BIOPH RES CO, V407, P640, DOI 10.1016/j.bbrc.2011.03.054
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   L.L.C. Schrodinger, 2010, PYMOL MOL GRAPHICS S
   Lai HG, 2013, ANTIVIR RES, V97, P74, DOI 10.1016/j.antiviral.2012.10.009
   Lee CM, 2015, J VIROL, V89, P6171, DOI 10.1128/JVI.00546-15
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P3150, DOI 10.1016/j.bbamem.2015.09.016
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577
   Mastrangelo E, 2007, PROTEIN SCI, V16, P1133, DOI 10.1110/ps.072758107
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   Matusan AE, 2001, J GEN VIROL, V82, P1647, DOI 10.1099/0022-1317-82-7-1647
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Naik NG, 2015, J VIROL, V89, P6746, DOI 10.1128/JVI.00423-15
   Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200
   Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/NMETH.1938, 10.1038/nmeth.1938]
   Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   PETHEL M, 1992, J VIROL, V66, P7225, DOI 10.1128/JVI.66.12.7225-7231.1992
   Rothan HA, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-140
   Salaemae W, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-68
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Takamatsu Y, 2015, J VIROL, V89, P6126, DOI 10.1128/JVI.00370-15
   ul Qamar MT, 2014, BANGL J PHARMACOL, V9, P262, DOI 10.3329/bjp.v9i3.18555
   Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146
   van der Linden MG, 2014, PROTEINS, V82, P1186, DOI 10.1002/prot.24483
   Werme K, 2008, CELL MICROBIOL, V10, P696, DOI 10.1111/j.1462-5822.2007.01076.x
   Wu CF, 2003, J VIROL METHODS, V114, P45, DOI 10.1016/j.jviromet.2003.09.001
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
   Zou J, 2014, J VIROL, V88, P3379, DOI 10.1128/JVI.02782-13
   Zuo ZL, 2009, J VIROL, V83, P1060, DOI 10.1128/JVI.01325-08
NR 90
TC 5
Z9 5
U1 0
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 28
PY 2017
VL 492
IS 4
SI SI
BP 565
EP 571
DI 10.1016/j.bbrc.2017.01.041
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FK3OB
UT WOS:000413393300006
PM 28087275
OA Bronze
DA 2020-07-08
ER

PT J
AU Mossenta, M
   Marchese, S
   Poggianella, M
   Campos, JLS
   Burrone, OR
AF Mossenta, M.
   Marchese, S.
   Poggianella, M.
   Campos, J. L. Slon
   Burrone, O. R.
TI Role of N-glycosylation on Zika virus E protein secretion, viral
   assembly and infectivity
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Zika virus; Glycosylation; Envelope protein; Flavivirus; Infectivity;
   Secretion
ID WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN; DENGUE
   VIRUS; IN-VITRO; LINKED GLYCOSYLATION; KUNJIN VIRUS; OUTBREAK;
   GLYCOPROTEIN; ANTIBODY
AB Zika virus has rapidly spread reaching a global distribution pattern similar to that of dengue virus, and has been associated with serious neurological and developmental pathologies, like congenital malformation during pregnancy and Guillain-Barre syndrome. Sequence analysis of different clinical and laboratory isolates has shown the existence of mutants with loss of the conserved N-glycosylation motif on domain I of protein E that is common to all flaviviruses. We found that loss of E N-linked glycosylation leads to compromised expression and secretion of E ectodomain from mammalian cells. For both, wild type and glycosylation-negative mutant, secretion was independent of co-expression of the PrM viral protein, but highly dependent on temperature. Low temperature (28 degrees C) favoured secretion, although the glycosylation mutant E ectodomain showed impaired secretion and membrane display compared to the wild type. Production of pseudoviral particles with a West Nile virus replicon packaged with the Zika virus structural proteins C-PrM-E was significantly reduced with the non-glycosylated E. Similarly, glycosylation-negative pseudoviral particles showed impaired infectivity of Vero cells and reduced ability to infect K562 cells upon particles opsonisation with anti-E antibodies. (C) 2017 Published by Elsevier Inc.
C1 [Mossenta, M.; Marchese, S.; Poggianella, M.; Campos, J. L. Slon; Burrone, O. R.] Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, I-34149 Trieste, Italy.
RP Campos, JLS; Burrone, OR (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, I-34149 Trieste, Italy.
EM slon@icgeb.org; burrone@icgeb.org
OI Slon Campos, Jose Luis/0000-0002-0012-5247
CR ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001
   Alen MMF, 2012, ANTIVIR RES, V96, P280, DOI 10.1016/j.antiviral.2012.10.007
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Bryant JE, 2007, VIROLOGY, V366, P415, DOI 10.1016/j.virol.2007.05.007
   Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos JLS, 2015, J GEN VIROL, V96, P3265, DOI 10.1099/jgv.0.000278
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000
   Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Finkelstein Y, 1999, J BIOTECHNOL, V75, P33, DOI 10.1016/S0168-1656(99)00131-5
   Goto A, 2005, VACCINE, V23, P3043, DOI 10.1016/j.vaccine.2004.11.068
   GUIRAKHOO F, 1993, VIROLOGY, V194, P219, DOI 10.1006/viro.1993.1252
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hsieh SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100641
   JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481
   Kariwa H, 2013, INT J ENV RES PUB HE, V10, P7144, DOI 10.3390/ijerph10127144
   KAWANO H, 1993, J VIROL, V67, P6567, DOI 10.1128/JVI.67.11.6567-6575.1993
   KONISHI E, 1993, J VIROL, V67, P1672, DOI 10.1128/JVI.67.3.1672-1675.1993
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Li EQ, 1997, PROTEIN ENG, V10, P731, DOI 10.1093/protein/10.6.731
   Li J, 2006, J GEN VIROL, V87, P613, DOI 10.1099/vir.0.81320-0
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003
   McMinn PC, 1996, J GEN VIROL, V77, P2085, DOI 10.1099/0022-1317-77-9-2085
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Moudy RM, 2011, AM J TROP MED HYG, V85, P374, DOI 10.4269/ajtmh.2011.10-0697
   Moudy RM, 2009, VIROLOGY, V387, P222, DOI 10.1016/j.virol.2009.01.038
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murata R, 2010, AM J TROP MED HYG, V82, P696, DOI 10.4269/ajtmh.2010.09-0262
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Poggianella M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003947
   POST PR, 1992, VIROLOGY, V188, P160, DOI 10.1016/0042-6822(92)90745-B
   Raman R, 2016, CURR OPIN STRUC BIOL, V40, P153, DOI 10.1016/j.sbi.2016.10.003
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Sambrook J., 1989, MOL CLONING LAB MANU
   Scherret JH, 2001, ANN NY ACAD SCI, V951, P361, DOI 10.1111/j.1749-6632.2001.tb02719.x
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stanley P., 2011, COLD SPRING HARB PER, V3
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsai WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052600
   Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003
   VORNDAM V, 1993, J GEN VIROL, V74, P2653, DOI 10.1099/0022-1317-74-12-2653
   Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005
   Wu SF, 2002, J VIROL, V76, P3596, DOI 10.1128/JVI.76.8.3596-3604.2002
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zheng A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001157
NR 63
TC 28
Z9 29
U1 1
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 28
PY 2017
VL 492
IS 4
SI SI
BP 579
EP 586
DI 10.1016/j.bbrc.2017.01.022
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FK3OB
UT WOS:000413393300008
PM 28069378
DA 2020-07-08
ER

PT J
AU Russo, FB
   Beltrao-Braga, PCB
AF Russo, Fabiele Baldino
   Baleeiro Beltrao-Braga, Patricia Cristina
TI The impact of Zika virus in the brain
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Zika; ZIKV; Microcephaly; Brain damage; Flavivirus; Neuroprogenitor
   cells
ID TOLL-LIKE RECEPTOR-3; NEURAL PROGENITORS; STEM-CELLS; SEXUAL
   TRANSMISSION; NEGATIVE REGULATOR; CEREBRAL ORGANOIDS; INFECTION;
   NEUROGENESIS; ACTIVATION; INHIBITORS
AB The recent outbreak of ZIKV in Brazil called the attention of the world because the effects of viral infection in the brain under development in fetuses. Consequences of vertical infection comprise brain malformation, especially microcephaly, eye and musculoskeletal abnormalities, among others. In adults, outcomes of infection include meningoencephalitis and Guillain-Barre Syndrome. Recent data specific suggest that neural progenitor cells are the main targets of ZIKV infection, causing massive cellular death and impairment in the neurogenesis process. Here we review the fetal and adult brain damage after ZIKV exposure, exploring models to study the mechanisms underlying the pathways related to microcephaly and cell death. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Russo, Fabiele Baldino; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Dept Surg, Stem Cell Lab, BR-05508270 Sao Paulo, Brazil.
   [Baleeiro Beltrao-Braga, Patricia Cristina] Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.
RP Beltrao-Braga, PCB (corresponding author), Av Prof Dr Orlando Marques de Paiva, BR-05508270 Sao Paulo, SP, Brazil.
EM patriciacbbbraga@usp.br
RI Beltrao-Braga, Patricia C B/D-6450-2013; Russo, Fabiele/N-4340-2017
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; Russo,
   Fabiele/0000-0002-4076-1846
FU Zika Network FAPESP [2011/18703-2, 2014/17766-9]; NGO
FX We would like to thank Anita J. Brito for the writing review. This work
   was supported by grants from the Zika Network FAPESP projects
   2011/18703-2 and 2014/17766-9 and the NGO "The Tooth Fairy Project".
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Ashwal S., 2009, PRACTICE PARAMETER E
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Bell T.M., 1971, ZIKA VIRUS INFECT CE, V193
   Besnard M., 2013, EVIDENCE PERINATAL T, P8
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007
   Cao-Lormeau V.M., 2014, EMERG INFECT DIS, V20, P5
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   De Fatima M., 2015, CLIN FEATURES NEUROI
   Di Guardo G, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.103
   Dick G.W.A., 1952, T R SOC, V46
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall S.D., 2016, SUSCEPTIBLE MOUSE MO, P1
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gotz H.W., 2005, NAT REV MOL CELL BIO, V6, P777
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140
   Johnson K, 2015, NEURAL REGEN RES, V10, P344, DOI 10.4103/1673-5374.153671
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008
   Lee DY, 2015, EXP NEUROBIOL, V24, P177, DOI 10.5607/en.2015.24.3.177
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Marton RM, 2016, CELL STEM CELL, V19, P145, DOI 10.1016/j.stem.2016.07.017
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Namba T, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.256
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen S.A., 2016, SPECIAL REPORT ZIKA
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Schwartz D.A., 2016, ARCH PATHOL LAB MED
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Velho T., 2016, ASS ZIKA VIRUS INFEC, V3099, P1
   Wahane SD, 2014, J NEUROCHEM, V130, P255, DOI 10.1111/jnc.12718
   Wang J, 2011, STEM CELLS, V29, P1589, DOI 10.1002/stem.699
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 62
TC 9
Z9 9
U1 1
U2 23
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 28
PY 2017
VL 492
IS 4
SI SI
BP 603
EP 607
DI 10.1016/j.bbrc.2017.01.074
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FK3OB
UT WOS:000413393300011
PM 28108286
DA 2020-07-08
ER

PT J
AU Mottin, M
   Braga, RC
   da Silva, RA
   da Silva, JHM
   Perryman, AL
   Ekins, S
   Andrade, CH
AF Mottin, Melina
   Braga, Rodolpho C.
   da Silva, Roosevelt A.
   Martins da Silva, Joao H.
   Perryman, Alexander L.
   Ekins, Sean
   Andrade, Carolina Horta
TI Molecular dynamics simulations of Zika virus NS3 helicase: Insights into
   RNA binding site activity
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Zika virus; Flavivirus; NS3 helicase; Molecular dynamics; FTMap; Drug
   discovery
ID RELAXED COMPLEX SCHEME; CRYSTAL-STRUCTURE; NS2B-NS3 PROTEASE; DRUG
   DESIGN; RECEPTOR FLEXIBILITY; DENGUE VIRUS; INHIBITOR; PROTEINS;
   REPLICATION
AB America is still suffering with the outbreak of Zika virus (ZIKV) infection. Congenital ZIKV syndrome has already caused a public health emergency of international concern. However, there are still no vaccines to prevent or drugs to treat the infection caused by ZIKV. The ZIKV NS3 helicase (NS3h) protein is a promising target for drug discovery due to its essential role in viral genome replication. NS3h unwinds the viral RNA to enable the replication of the viral genome by the NS5 protein. NS3h contains two important binding sites: the NTPase binding site and the RNA binding site. Here, we used molecular dynamics (MD) simulations to study the molecular behavior of ZIKV NS3h in the presence and absence of ssRNA and the potential implications for NS3h activity and inhibition. Although there is conformational variability and poor electron densities of the RNA binding loop in various apo flaviviruses NS3h crystallographic structures, the MD trajectories of NS3h-ssRNA demonstrated that the RNA binding loop becomes more stable when NS3h is occupied by RNA. Our results suggest that the presence of RNA generates important interactions with the RNA binding loop, and these interactions stabilize the loop sufficiently that it remains in a closed conformation. This closed conformation likely keeps the ssRNA bound to the protein for a sufficient duration to enable the unwinding/replication activities of NS3h to occur. In addition, conformational changes of this RNA binding loop can change the nature and location of the optimal ligand binding site, according to ligand binding site prediction results. These are important findings to help guide the design and discovery of new inhibitors of NS3h as promising compounds to treat the ZIKV infection. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Mottin, Melina; Braga, Rodolpho C.; Andrade, Carolina Horta] Univ Fed Goias, Fac Pharm, LabMol, BR-74605170 Goiania, Go, Brazil.
   [da Silva, Roosevelt A.] Univ Fed Goias, NCBios, BR-74605170 Jatai, Go, Brazil.
   [Martins da Silva, Joao H.] Fiocruz MS, Ceara Fundacao Oswaldo Cruz, Fortaleza, Ceara, Brazil.
   [Perryman, Alexander L.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA.
   [Ekins, Sean] Collaborat Pharmaceut Inc, 5616 Hilltop Needmore Rd, Fuquay Varina, NC 27526 USA.
RP Andrade, CH (corresponding author), Univ Fed Goias, Fac Pharm, LabMol, BR-74605170 Goiania, Go, Brazil.
EM carolhandrade@gmail.com
RI Braga, Rodolpho C/A-9655-2011; Mottin, Melina/D-8700-2016; da Silva,
   Roosevelt/Y-5923-2019; da Silva, Roosevelt/AAF-1577-2019; Andrade,
   Carolina/C-3960-2014
OI Braga, Rodolpho C/0000-0003-3814-3464; Mottin,
   Melina/0000-0003-0878-9029; da Silva, Roosevelt/0000-0001-5624-4790;
   Andrade, Carolina/0000-0003-0101-1492
FU IBM World Community Grid team
FX We kindly acknowledge all of our collaborators on this project
   (http://openzika.ufg.br), the wonderful ongoing support and
   encouragement from the IBM World Community Grid team, and the community
   of volunteers who donate their computer time to our drug discovery
   efforts. MM is PDJ fellow of Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico in Brazil (CNPq) (150729/2016-2); CHA is
   productivity fellow of CNPq.
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Amaro RE, 2008, J COMPUT AID MOL DES, V22, P693, DOI 10.1007/s10822-007-9159-2
   [Anonymous], 2016, GEN SUMM OUTC EM COM
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Borowski P, 2002, ACTA BIOCHIM POL, V49, P597
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ekins S., 2016, F1000RESEARCH, P1
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Ekins Sean, 2016, F1000Res, V5, P275
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1
   GROMACS, GROMACS V5 1 2
   Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Hall DR, 2012, METHODS MOL BIOL, V819, P13, DOI 10.1007/978-1-61779-465-0_2
   Harris R, 2008, PROTEINS, V70, P1506, DOI 10.1002/prot.21645
   Hintze B.J., 2016, PROTEINS STRUCT FUNC, V84
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043
   Leach A. R., 2001, MOL MODELLING PRINCI
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lin JH, 2002, J AM CHEM SOC, V124, P5632, DOI 10.1021/ja0260162
   Mastrangelo E, 2007, J MOL BIOL, V372, P444, DOI 10.1016/j.jmb.2007.06.055
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Nichols SE, 2011, J CHEM INF MODEL, V51, P1439, DOI 10.1021/ci200117n
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Sweeney N.L., 2016, BENZOTHIAZOLE PYRROL, V1, P140
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Trueblood KN, 1996, ACTA CRYSTALLOGR A, V52, P770, DOI 10.1107/S0108767396005697
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 53
TC 16
Z9 18
U1 1
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 28
PY 2017
VL 492
IS 4
SI SI
BP 643
EP 651
DI 10.1016/j.bbrc.2017.03.070
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FK3OB
UT WOS:000413393300016
PM 28341122
DA 2020-07-08
ER

PT J
AU Aguilera-Pesantes, D
   Mendez, MA
AF Aguilera-Pesantes, Daniel
   Mendez, Miguel A.
TI Structure and sequence based functional annotation of Zika virus NS2b
   protein: Computational insights
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Zika virus; NS3; NS2b; Computational alanine scanning mutagenesis;
   Protein disorder; Transmembrane domains; Flavivirus
ID WEST-NILE; CRYSTAL-STRUCTURE; SIGNAL PEPTIDE; SERINE-PROTEASE; HOMOLOGY
   MODEL; YELLOW-FEVER; NS3 PROTEASE; DENGUE; CLEAVAGE; PREDICTION
AB While Zika virus (ZIKV) outbreaks are a growing concern for global health, a deep understanding about the virus is lacking. Here we report a contribution to the basic science on the virus- a detailed computational analysis of the non structural protein NS2b. This protein acts as a cofactor for the NS3 protease (NS3Pro) domain that is important on the viral life cycle, and is an interesting target for drug development. We found that ZIKV NS2b cofactor is highly similar to other virus within the Flavivirus genus, especially to West Nile Virus, suggesting that it is completely necessary for the protease complex activity. Furthermore, the ZIKV NS2b has an important role to the function and stability of the ZIKV NS3 protease domain even when presents a low conservation score. In addition, ZIKV NS2b is mostly rigid, which could imply a non dynamic nature in substrate recognition. Finally, by performing a computational alanine scanning mutagenesis, we found that residues Gly 52 and Asp 83 in the NS2b could be important in substrate recognition. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Aguilera-Pesantes, Daniel; Mendez, Miguel A.] Univ San Francisco Quito, Inst Simulac Computac ISC USFQ, Diego de Robles Sn & Via Interocednica, Quito 171200841, Ecuador.
   [Aguilera-Pesantes, Daniel; Mendez, Miguel A.] Univ San Francisco Quito, Grp Quim Computac & Teor, Diego Robles Sn & Via Interoceanica, Quito 171200841, Ecuador.
   [Mendez, Miguel A.] Univ San Francisco Quito, Escuela Med, Colegio Ciencias Salud COCSA, Av Interocednica Km 12 1-2 & Av Florencia, Cumbaya 171200841, Quito, Ecuador.
RP Mendez, MA (corresponding author), Univ San Francisco Quito, Inst Simulac Computac ISC USFQ, Diego de Robles Sn & Via Interocednica, Quito 171200841, Ecuador.
EM mmendez@usfq.edu.ec
RI Mendez, Miguel/M-2603-2019
OI Mendez, Miguel/0000-0001-9281-2644; Aguilera-Pesantes,
   Daniel/0000-0002-6769-2086
FU USFQ
FX This work was supported by Chancellor Grant - USFQ 2014-2015 (granted to
   CS, JT and MM).
CR Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   [Anonymous], 2014, S REL 2 PRIM VERS 3
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bessaud M, 2006, VIRUS RES, V120, P79, DOI 10.1016/j.virusres.2006.01.021
   BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835
   Brinkworth RI, 1999, J GEN VIROL, V80, P1167, DOI 10.1099/0022-1317-80-5-1167
   Butkiewicz NJ, 1996, VIROLOGY, V225, P328, DOI 10.1006/viro.1996.0607
   Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604
   CAHOUR A, 1992, J VIROL, V66, P1535, DOI 10.1128/JVI.66.3.1535-1542.1992
   Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018
   Chernov AV, 2008, J BIOL CHEM, V283, P17270, DOI 10.1074/jbc.M801719200
   CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Condotta SA, 2010, BIOL CHEM, V391, P549, DOI 10.1515/BC.2010.051
   de Almeida H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072402
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Du J, 2011, J COMPUT CHEM, V32, P2800, DOI 10.1002/jcc.21859
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+
   Edwards YJK, 2003, MOL BIOTECHNOL, V23, P139, DOI 10.1385/MB:23:2:139
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gesto D., 2014, J MOL MODEL, V20, P1
   Kaddumukasa MA, 2014, J MED ENTOMOL, V51, P104, DOI 10.1603/ME12269
   Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Khan AM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000272
   Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993
   Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARKOFF L, 1989, J VIROL, V63, P3345, DOI 10.1128/JVI.63.8.3345-3352.1989
   Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339
   Mueller NH, 2007, INT J BIOCHEM CELL B, V39, P606, DOI 10.1016/j.biocel.2006.10.025
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200
   Narayanan R., 2016, MOJ PROTEOMICS BIOIN, V3
   NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159
   Ortiz JF, 2013, GENOME BIOL EVOL, V5, P504, DOI 10.1093/gbe/evt026
   others, 2016, GENOME ANNOUNC, V4
   Panchenko AR, 2004, PROTEIN SCI, V13, P884, DOI 10.1110/ps.03465504
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Piorkowski G., 2016, New Microbes and New Infections, V11, P52, DOI 10.1016/j.nmni.2016.02.013
   Quinan BR, 2014, VACCINE, V32, P2972, DOI 10.1016/j.vaccine.2014.03.093
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8
   Schuck-Paim C., 2016, PLOS CURR OUTBREAKS
   Schuller A, 2011, ANTIVIR RES, V92, P96, DOI 10.1016/j.antiviral.2011.07.002
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Srivastava M, 2010, CURR RES J BIOL SCI, V2, P83
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Urbanowski MD, 2013, J VIROL, V87, P872, DOI 10.1128/JVI.02030-12
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Wang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-385
   Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Youn S, 2010, J VIROL, V84, P9516, DOI 10.1128/JVI.00775-10
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
   ZHANG LW, 1992, J VIROL, V66, P7549, DOI 10.1128/JVI.66.12.7549-7554.1992
   Zuo ZL, 2009, J VIROL, V83, P1060, DOI 10.1128/JVI.01325-08
NR 82
TC 4
Z9 4
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 28
PY 2017
VL 492
IS 4
SI SI
BP 659
EP 667
DI 10.1016/j.bbrc.2017.02.035
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FK3OB
UT WOS:000413393300018
PM 28188791
DA 2020-07-08
ER

PT J
AU Tricarico, PM
   Caracciolo, I
   Crovella, S
   D'Agaro, P
AF Tricarico, Paola Maura
   Caracciolo, Ilaria
   Crovella, Sergio
   D'Agaro, Pierlanfranco
TI Zika virus induces inflammasome activation in the glial cell line U87-MG
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE ZIKV; U87 glial cell; Neuroinflammation; Inflammasome NLRP3; Oxidative
   stress; IL-1 beta
ID OXIDATIVE STRESS; INFECTION; BRAZIL; BRAIN; APOPTOSIS
AB In the last years, neurological complications related to Zika virus (ZIKV) infection have emerged as an important threat to public health worldwide. ZIKV infection has been associated to neurological disorders such as congenital microcephaly in newborns and Guillain-Barre syndrome, myelopathy and encephalitis in adults. ZIKV is characterized by neurotropism and neurovirulence. Several studies have identified microglial nodules, gliosis, neuronal and glial cells degeneration and necrosis in the brain of ZIKV infected infants, suggesting that ZIKV could play a role in these neurological disorders through neuroinflammation and microglial activation.
   Little information is available about neuroinflammation and ZIKV-related neurological disorders. Therefore, we investigated if ZIKV is able to infect a glial cell line (U87-MG) and how the glial cell line responds to this infection in terms of inflammation (IL-1 beta, NLRP-3 and CASP-1), oxidative stress (SOD2 and HemeOX) and cell death.
   We observed a significant increase of ZIKV load in both cells and supernatants after 72 h, compared to 48 h of infection. We found that ZIKV infection induces an increase of 1L-1 beta, NLRP-3 and CASP-1 genes expression. Significant increase of IL-1 beta and unchanged pro-IL-1 beta protein levels have also been detected. Moreover, we observed SOD2 and HemeOX increased gene expression mainly after 72 h post ZIKV infection. Subsequently, we found a decrease of U87-MG cell viability, after both 48 h and 72 h of ZIKV infection.
   Our results show that U87-MG cells are susceptible to ZIKV infection. ZIKV is able to successfully replicate in infected cells causing oxidative stress, NLRP3 inflammasome activation and subsequent release of mature IL-1 beta; this process culminates in cell death. Thus, considering the central role of neuroinflammation in neurological disorders, it is important to comprehend every aspect of this mechanism in order to better understand the pathogenesis of ZIKV infection and to identify possible strategies to fight the virus by rescuing cell death. (C) 2017 Published by Elsevier Inc.
C1 [Tricarico, Paola Maura; Crovella, Sergio; D'Agaro, Pierlanfranco] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
   [Caracciolo, Ilaria; Crovella, Sergio; D'Agaro, Pierlanfranco] Univ Trieste, Dept Med Surg & Publ Hlth, Trieste, Italy.
RP D'Agaro, P (corresponding author), Univ Trieste, Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Med Surg & Publ Hlth, Via Istria,65-1, I-34137 Trieste, Italy.
EM tricaricopa@gmail.com; crc.ilaria@gmail.com;
   sergio.crovella@burlo.trieste.it; pierlanfranco.dagaro@burlo.trieste.it
OI TRICARICO, PAOLA MAURA/0000-0002-1954-4126
FU Institute for Maternal and Child Health IRCCS "Burlo Garofolo" [RC
   42/11]; Brazilian Minister of Health (Chamada
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit/No) [440371/2016-3]
FX This work was supported by a grant from the Institute for Maternal and
   Child Health IRCCS "Burlo Garofolo" (RC 42/11) and by a grant from the
   Brazilian Minister of Health (Chamada
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit/No 14/2016 Project no
   440371/2016-3).
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Bansal S, 2014, REDOX BIOL, V2, P273, DOI 10.1016/j.redox.2013.07.004
   Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084953
   Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Jimenez A, 2017, MED REV, V31, P1, DOI DOI 10.1016/J.TMRV.2016.08.001
   Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270
   Kramer BC, 2002, NEUROSCIENCE, V114, P361, DOI 10.1016/S0306-4522(02)00310-X
   Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liao SL, 2002, NEUROSCI LETT, V324, P133, DOI 10.1016/S0304-3940(02)00236-7
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Rabaan A. A., 2016, J INFECT PUBLIC HEAL, P30063
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Schipper HM, 2009, CURR ALZHEIMER RES, V6, P424, DOI 10.2174/156720509789207985
   Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1
   Sugaya K, 1998, MOL BRAIN RES, V58, P1, DOI 10.1016/S0169-328X(97)00365-3
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   Tricarico PM, 2013, INT J MOL SCI, V14, P23274, DOI 10.3390/ijms141223274
   Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638
   Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090
NR 35
TC 27
Z9 27
U1 1
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 28
PY 2017
VL 492
IS 4
SI SI
BP 597
EP 602
DI 10.1016/j.bbrc.2017.01.158
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FK3OB
UT WOS:000413393300010
PM 28153732
DA 2020-07-08
ER

PT J
AU Zhang, CY
   Feng, TT
   Cheng, JB
   Li, YJ
   Yin, XY
   Zeng, WH
   Jin, XY
   Li, YL
   Guo, F
   Jin, TC
AF Zhang, Caiying
   Feng, Tingting
   Cheng, Jinbo
   Li, Yajuan
   Yin, Xueying
   Zeng, Weihong
   Jin, Xiangyu
   Li, Yuelong
   Guo, Feng
   Jin, Tengchuan
TI Structure of the NS5 methyltransferase from Zika virus and implications
   in inhibitor design
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Flavivirus family virus; Zika virus; Methyltransferase; RNA cap;
   Antiviral inhibitor design
ID CRYSTAL-STRUCTURE; PROTEIN; METHYLATION; DOMAIN; FAMILY
AB Recent outbreak of flavivirus Zika virus (ZIKV) in America has urged the basic as well as translational studies of this important human pathogen. The nonstructural protein 5 (NS5) of the flavivirus has an N-terminal methyltransferase (MTase) domain that plays critical roles in viral RNA genome capping. The null mutant of NS5 MTase is lethal for virus. Therefore, NS5 is a potential drug target for the treatment of Zika virus infection. In this study, we determined crystal structures of the ZIKV MTase in complex with GTP and RNA cap analogue (7me)GpppA. Structural analyses revealed highly conserved GTP/cap-binding pocket and S-adenosylmethionine (SAM)-binding pocket. Two conformations of the second base of the cap were identified, which suggests the flexibility of RNA conformation. In addition, the ligand-binding pockets identified a continuous region of hotspots suitable for drug design. Docking calculation shows that the Dengue virus inhibitor compound 10 may bind to the ZIKV MTase. (C) 2016 The Authors. Published by Elsevier Inc.
C1 [Zhang, Caiying; Feng, Tingting; Cheng, Jinbo; Li, Yajuan; Yin, Xueying; Zeng, Weihong; Jin, Xiangyu; Li, Yuelong; Jin, Tengchuan] Univ Sci & Technol China, Lab Struct Immunol, Key Lab Innate Immun & Chron Dis, CAS,Ctr Excellence Mol Cell Sci,Sch Life Sci, Hefei 230027, Anhui, Peoples R China.
   [Zhang, Caiying; Feng, Tingting; Cheng, Jinbo; Li, Yajuan; Yin, Xueying; Zeng, Weihong; Jin, Xiangyu; Li, Yuelong; Jin, Tengchuan] Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China.
   [Guo, Feng] Stanford Univ, Sch Med, Stanford, CA 94305 USA.
RP Jin, TC (corresponding author), Univ Sci & Technol China, Lab Struct Immunol, Key Lab Innate Immun & Chron Dis, CAS,Ctr Excellence Mol Cell Sci,Sch Life Sci, Hefei 230027, Anhui, Peoples R China.; Jin, TC (corresponding author), Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China.
EM jint@ustc.edu.cn
RI Jin, Tengchuan/B-5883-2014; li, yue long/G-6811-2018
OI Jin, Tengchuan/0000-0002-1395-188X; li, yue long/0000-0001-5466-779X;
   Cheng, Jinbo/0000-0003-0808-8660
FU Chinese Academy of Sciences (CAS)Chinese Academy of Sciences;
   Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities; CASDefence Research &
   Development Organisation (DRDO)Chinese Academy of Sciences; China
   Postdoctoral Science FoundationChina Postdoctoral Science Foundation
   [2015M582007]; CAS Key Laboratory of Innate Immunity and Chronic
   Diseases
FX This work was supported. by the Task Force of Zika Virus Research from
   the Chinese Academy of Sciences (CAS). T.J. is supported by the
   Fundamental Research Funds for the Central Universities and the 100
   Talents Program of CAS. Yajuan Li. is supported by the China
   Postdoctoral Science Foundation (Grant No.: 2015M582007). F.G. is
   supported by funding for collaborative projects of the CAS Key
   Laboratory of Innate Immunity and Chronic Diseases.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Assenberg R, 2007, J GEN VIROL, V88, P2228, DOI 10.1099/vir.0.82757-0
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Huang BD, 2009, OMICS, V13, P325, DOI 10.1089/omi.2009.0045
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043
   Li C, 2016, CELL STEM CELL
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lindenbach BD, 2007, J VIROL, V81, P8905, DOI 10.1128/JVI.00937-07
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Noble CG, 2014, ANTIVIR RES, V111, P78, DOI 10.1016/j.antiviral.2014.09.003
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
NR 29
TC 27
Z9 31
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 28
PY 2017
VL 492
IS 4
SI SI
BP 624
EP 630
DI 10.1016/j.bbrc.2016.11.098
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FK3OB
UT WOS:000413393300014
PM 27866982
OA Other Gold
DA 2020-07-08
ER

PT J
AU Kuiper, BD
   Slater, K
   Spellmon, N
   Holcomb, J
   Medapureddy, P
   Muzzarelli, KM
   Yang, Z
   Ovadia, R
   Amblard, F
   Kovari, IA
   Schinazi, RF
   Kovari, LC
AF Kuiper, Benjamin D.
   Slater, Kristin
   Spellmon, Nicholas
   Holcomb, Joshua
   Medapureddy, Prasanna
   Muzzarelli, Kendall M.
   Yang, Zhe
   Ovadia, Reuben
   Amblard, Franck
   Kovari, Iulia A.
   Schinazi, Raymond F.
   Kovari, Ladislau C.
TI Increased activity of unlinked Zika virus NS2B/NS3 protease compared to
   linked Zika virus protease
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Zika virus; NS2B/NS3 protease; Flavivirus; Protease inhibitor
ID NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE; INHIBITORS; DENGUE; AMERICA
AB Zika virus (ZIKV) is a flavivirus spread by daytime-active Aedes spp. mosquitoes such as A. aegypti and A. albopictus. Previously thought to be a mild infection, the latest ZIKV outbreak in the Americas is causally associated with more severe symptoms as well as severe birth defects, such as microcephaly. Currently no vaccine or antiviral exists. However, recent progress has demonstrated the viral NS2B/NS3 protease may be a suitable target for the development of small-molecule antiviral agents. To better understand the ZIKV protease, we expressed, purified, and characterized unlinked and linked NS2B/NS3 protease corresponding to an isolate from the recent outbreak in Puerto Rico. Unlinked ZIKV protease is more active and binds substrate with greater affinity than linked ZIKV protease. Therefore, we propose that unlinked ZIKV protease be used when evaluating or designing ZIKV protease inhibitors. Additionally, potent inhibitors of related viral proteases, like West Nile Virus and Dengue virus, may serve as advanced starting points to identify and develop ZIKV protease inhibitors. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Kuiper, Benjamin D.; Slater, Kristin; Spellmon, Nicholas; Holcomb, Joshua; Medapureddy, Prasanna; Muzzarelli, Kendall M.; Yang, Zhe; Kovari, Iulia A.; Kovari, Ladislau C.] Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48201 USA.
   [Ovadia, Reuben; Amblard, Franck; Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Lab Biochem Pharmacol,Ctr AIDS Res, Atlanta, GA 30322 USA.
RP Kovari, LC (corresponding author), Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48201 USA.
EM kovari@med.wayne.edu
RI Reske, Andreas W/E-8141-2010
OI Reske, Andreas W/0000-0002-2759-0245
FU Wayne State University; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1R21AI-129607];
   Center for AIDS Research NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [2P30AI-050409]
FX We thank Wayne State University for a Rumble Fellowship supporting the
   Ph.D. studies of BDK. RFS is supported in part by NIH grant
   1R21AI-129607 and by the Center for AIDS Research NIH grant
   2P30AI-050409. We thank Dr. Leda Bassit for assisting with the
   virological portion of this paper.
CR Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Nguyen HN, 2016, CELL RES, V26, P753, DOI 10.1038/cr.2016.68
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Koh-Stenta X, 2015, DRUG DES DEV THER, V9, P6389, DOI 10.2147/DDDT.S94207
   Kuiper Benjamin D, 2015, Biochem Biophys Rep, V2, P160, DOI 10.1016/j.bbrep.2015.06.003
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lima AB, 2015, BIOORGAN MED CHEM, V23, P5748, DOI 10.1016/j.bmc.2015.07.012
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Schrodinger L., 2010, PYMOL MOL GRAPHICS S
   Schrodinger L, 2016, SCHRODINGER RELEASE
   Shannon AE, 2016, PROTEIN EXPRES PURIF, V119, P124, DOI 10.1016/j.pep.2015.11.022
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Wang JZ, 2017, BRAIN DEV-JPN, V39, P294, DOI 10.1016/j.braindev.2016.10.012
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 33
TC 11
Z9 12
U1 2
U2 13
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 28
PY 2017
VL 492
IS 4
SI SI
BP 668
EP 673
DI 10.1016/j.bbrc.2017.03.108
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FK3OB
UT WOS:000413393300019
PM 28342876
DA 2020-07-08
ER

PT J
AU Raekiansyah, M
   Mori, M
   Nonaka, K
   Agoh, M
   Shiomi, K
   Matsumoto, A
   Morita, K
AF Raekiansyah, Muhareva
   Mori, Mihoko
   Nonaka, Kenichi
   Agoh, Masanobu
   Shiomi, Kazuro
   Matsumoto, Atsuko
   Morita, Kouichi
TI Identification of novel antiviral of fungus-derived brefeldin A against
   dengue viruses
SO TROPICAL MEDICINE AND HEALTH
LA English
DT Article
AB Microbial natural products possess a wide range of biological and biochemical potential. Among them, fungal secondary metabolites are one of the most important sources for discovering new drugs or lead compounds. In the present study, we explored substances produced by the strain Penicillium sp. FKI-7127 for its antiviral activity. We identified brefeldin A as a novel antiviral agent against dengue viruses. The inhibitory effect of brefeldin A was confirmed by virus titer and immunofluorescence assay. Brefeldin A inhibited dengue viruses regardless of serotypes and other related viruses including Zika virus and Japanese encephalitis virus. Time-of-addition study showed that brefeldin A exerts its antiviral effect at an early stage of the dengue virus (DENV) life cycle. These studies demonstrate that (i) brefeldin A could be used as a lead compound for drug development of anti-DENV and other related viruses and (ii) fungal metabolites are a potential and valuable source for dengue virus drug discovery.
C1 [Raekiansyah, Muhareva; Agoh, Masanobu; Morita, Kouichi] Nagasaki Univ, Inst Trop Med, Dept Virol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
   [Mori, Mihoko; Nonaka, Kenichi; Shiomi, Kazuro; Matsumoto, Atsuko] Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.
   [Mori, Mihoko; Nonaka, Kenichi; Shiomi, Kazuro; Matsumoto, Atsuko] Kitasato Univ, Grad Sch Infect Control Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.
RP Morita, K (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Virol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
EM moritak@nagasaki-u.ac.jp
OI Shiomi, Kazuro/0000-0003-1264-5116
FU Japan Initiative for Global Research Network on Infectious Diseases
   (J-GRID) of Japan Agency for Medical Research and Development
   (AMED)Japan Agency for Medical Research and Development (AMED)
FX This research was supported by the Japan Initiative for Global Research
   Network on Infectious Diseases (J-GRID) of Japan Agency for Medical
   Research and Development (AMED).
NR 0
TC 13
Z9 14
U1 0
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1348-8945
EI 1349-4147
J9 TROP MED HEALTH
JI Trop. Med. Health
PD OCT 26
PY 2017
VL 45
AR 32
DI 10.1186/s41182-017-0072-7
PG 7
WC Tropical Medicine
SC Tropical Medicine
GA FK9GX
UT WOS:000413820700001
PM 29093640
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Atieh, T
   Nougairede, A
   Klitting, R
   Aubry, F
   Failloux, AB
   de Lamballerie, X
   Priet, S
AF Atieh, Therese
   Nougairede, Antoine
   Klitting, Raphaelle
   Aubry, Fabien
   Failloux, Anna-Bella
   de Lamballerie, Xavier
   Priet, Stephane
TI New reverse genetics and transfection methods to rescue arboviruses in
   mosquito cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DENGUE VIRUS TYPE-2; AEDES-AEGYPTI; CONSTRUCTION; CLONE; FLAVIVIRUS;
   EXPRESSION; DISEASES; SYSTEMS; SINGLE; MARKER
AB Reverse genetics is a critical tool to decrypt the biological properties of arboviruses. However, whilst reverse genetics methods have been usually applied to vertebrate cells, their use in insect cells remains uncommon due to the conjunction of laborious molecular biology techniques and of specific difficulties surrounding the transfection of such cells. To leverage reverse genetics studies in both vertebrate and mosquito cells, we designed an improved DNA transfection protocol for insect cells and then demonstrated that the simple and flexible ISA (Infectious Subgenomic Amplicons) reversegenetics method can be efficiently applied to both mammalian and mosquito cells to generate in days recombinant infectious positive-stranded RNA viruses belonging to genera Flavivirus (Japanese encephalitis, Yellow fever, West Nile and Zika viruses) and Alphavirus (Chikungunya virus). This method represents an effective option to potentially overcome technological issues related to the study of arboviruses.
C1 [Atieh, Therese; Nougairede, Antoine; Klitting, Raphaelle; Aubry, Fabien; de Lamballerie, Xavier; Priet, Stephane] Aix Marseille Univ, Inserm 1207, IRD 190, UMR Emergence Pathol Virales EPV,EHESP,IHU Medit, Marseille, France.
   [Failloux, Anna-Bella] Pasteur Inst, Dept Virol, Arboviruses & Insect Vectors Unit, Paris, France.
RP Priet, S (corresponding author), Aix Marseille Univ, Inserm 1207, IRD 190, UMR Emergence Pathol Virales EPV,EHESP,IHU Medit, Marseille, France.
EM stephane.priet@univ-amu.fr
RI Priet, Stephane/N-7952-2017
OI Priet, Stephane/0000-0001-7102-3654
FU French "Agence Nationale de la Recherche"French National Research Agency
   (ANR) [ANR-14-CE14-0001]; Zikalliance project (European Union - Horizon
   programme) [734548]; European Virus Archive goes global project (EVAg;
   European Union - Horizon programme) [653316]; Zoonotic Anticipation and
   Preparedness Initiative (ZAPI project) [115760]; IMI; European
   CommissionEuropean Commission Joint Research Centre
FX We wish to thank Geraldine Piorkowski for excellent assistance in the
   next generation sequencing and Gilles Querat for providing antibodies.
   This work was supported by the French "Agence Nationale de la Recherche"
   (grant agreement no. ANR-14-CE14-0001), by the Zikalliance project
   (European Union - Horizon 2020 programme under grant agreement no.
   734548), the European Virus Archive goes global project (EVAg; European
   Union - Horizon 2020 programme under grant agreement no. 653316;
   http://www.european-virusarchive.com/) and the Zoonotic Anticipation and
   Preparedness Initiative (ZAPI project; IMI grant agreement no. 115760),
   with the assistance and financial support of IMI and the European
   Commission, and in-kind contributions from EFPIA partners.
CR Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Aubry F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138703
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0
   Baronti C, 2010, VIROLOGY, V404, P319, DOI 10.1016/j.virol.2010.05.020
   Blaney JE, 2008, VACCINE, V26, P817, DOI 10.1016/j.vaccine.2007.11.082
   Boylan BT, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005394
   Groat-Carmona AM, 2012, VIROLOGY, V432, P511, DOI 10.1016/j.virol.2012.06.028
   Gromowski GD, 2014, VACCINE, V32, P3010, DOI 10.1016/j.vaccine.2014.03.062
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Huynh CQ, 1999, J MOL BIOL, V288, P13, DOI 10.1006/jmbi.1999.2674
   Isawa H, 2012, ARCH VIROL, V157, P975, DOI 10.1007/s00705-012-1240-z
   Ishikawa T, 2015, VIRUS RES, V195, P153, DOI 10.1016/j.virusres.2014.10.010
   Junglen S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00375-16, 10.1128/msphere.00375-16]
   Kohl A, 2004, J VIROL, V78, P5679, DOI 10.1128/JVI.78.11.5679-5685.2004
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kroschewski H, 2009, J GEN VIROL, V90, P2457, DOI 10.1099/vir.0.011486-0
   Nougairede A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003172
   Pfeifer TA, 1997, GENE, V188, P183, DOI 10.1016/S0378-1119(96)00756-1
   Pierro DJ, 2006, J GEN VIROL, V87, P2263, DOI 10.1099/vir.0.81958-0
   Pierson TC, 2005, VIROLOGY, V334, P28, DOI 10.1016/j.virol.2005.01.021
   Pinkerton AC, 2000, INSECT MOL BIOL, V9, P1, DOI 10.1046/j.1365-2583.2000.00133.x
   Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Schiotz Berit L, 2011, BMC Res Notes, V4, P136, DOI 10.1186/1756-0500-4-136
   Stobart CC, 2014, VIRUSES-BASEL, V6, P2531, DOI 10.3390/v6072531
   Tsai KN, 2007, VIRUS RES, V124, P139, DOI 10.1016/j.virusres.2006.10.013
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 29
TC 4
Z9 4
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 25
PY 2017
VL 7
AR 13983
DI 10.1038/s41598-017-14522-6
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FK7PS
UT WOS:000413700200022
PM 29070887
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Palmer, JRB
   Oltra, A
   Collantes, F
   Delgado, JA
   Lucientes, J
   Delacour, S
   Bengoa, M
   Eritja, R
   Bartumeus, F
AF Palmer, John R. B.
   Oltra, Aitana
   Collantes, Francisco
   Antonio Delgado, Juan
   Lucientes, Javier
   Delacour, Sarah
   Bengoa, Mikel
   Eritja, Roger
   Bartumeus, Frederic
TI Citizen science provides a reliable and scalable tool to track
   disease-carrying mosquitoes
SO NATURE COMMUNICATIONS
LA English
DT Article
ID AEDES-ALBOPICTUS; ECONOMIC COSTS; PARTICIPATION; ESTABLISHMENT;
   CULICIDAE; INVASIONS; DRIVERS; ECOLOGY; DIPTERA; SKUSE
AB Recent outbreaks of Zika, chikungunya and dengue highlight the importance of better understanding the spread of disease-carrying mosquitoes across multiple spatio-temporal scales. Traditional surveillance tools are limited by jurisdictional boundaries and cost constraints. Here we show how a scalable citizen science system can solve this problem by combining citizen scientists' observations with expert validation and correcting for sampling effort. Our system provides accurate early warning information about the Asian tiger mosquito (Aedes albopictus) invasion in Spain, well beyond that available from traditional methods, and vital for public health services. It also provides estimates of tiger mosquito risk comparable to those from traditional methods but more directly related to the human-mosquito encounters that are relevant for epidemiological modelling and scalable enough to cover the entire country. These results illustrate how powerful public participation in science can be and suggest citizen science is positioned to revolutionize mosquito-borne disease surveillance worldwide.
C1 [Palmer, John R. B.; Oltra, Aitana; Bartumeus, Frederic] Ctr Estudis Avancats Blanes CEAB CSIC, Blanes 17300, Spain.
   [Palmer, John R. B.] Univ Pompeu Fabra, Barcelona 08005, Spain.
   [Palmer, John R. B.; Oltra, Aitana; Eritja, Roger; Bartumeus, Frederic] CREAF, Cerdanyola Del Valles 08193, Spain.
   [Collantes, Francisco; Antonio Delgado, Juan] Univ Murcia, Murcia 30100, Spain.
   [Lucientes, Javier; Delacour, Sarah; Bengoa, Mikel] Univ Zaragoza, Zaragoza 50013, Spain.
   [Bartumeus, Frederic] ICREA, Barcelona 08010, Spain.
RP Palmer, JRB; Bartumeus, F (corresponding author), Ctr Estudis Avancats Blanes CEAB CSIC, Blanes 17300, Spain.; Palmer, JRB (corresponding author), Univ Pompeu Fabra, Barcelona 08005, Spain.; Palmer, JRB; Bartumeus, F (corresponding author), CREAF, Cerdanyola Del Valles 08193, Spain.; Bartumeus, F (corresponding author), ICREA, Barcelona 08010, Spain.
EM john.palmer@upf.edu; fbartu@ceab.csic.es
RI Collantes, Francisco/M-4798-2017; Collantes, Francisco/L-5937-2019;
   Palmer, John R.B./N-8620-2014; Bartumeus, Frederic/D-1911-2010
OI Collantes, Francisco/0000-0002-8085-6399; Collantes,
   Francisco/0000-0002-8085-6399; Palmer, John R.B./0000-0002-2648-7860;
   Oltra, Aitana/0000-0001-9276-8217; Bartumeus,
   Frederic/0000-0001-6908-3797; Eritja, Roger/0000-0001-5749-8370
FU Spanish Ministry of Public Health; CCAES (Centro de Coordinacion de
   Alertas y Emergencias Sanitarias); Health Department of the Generalitat
   de CatalunyaGeneralitat de Catalunya; European Union's Horizon research
   and innovation programme under Marie Sklodowska-Curie grant [657956];
   Spanish Ministry of Economy and Competitiveness (MINECO) [Plan Estatal
   I+D+I CGL2013-43139-R]; 'la Caixa' Banking FoundationLa Caixa Foundation
FX We gratefully acknowledge the work of the entire Mosquito Alert team and
   all the anonymous citizen scientists who have volunteered their time and
   energy to participate in this project. We also gratefully acknowledge A.
   Torrell (Departament de Territori i Sostenibilitat, Generalitat de
   Catalunya) and the support of the Spanish Ministry of Public Health,
   CCAES (Centro de Coordinacion de Alertas y Emergencias Sanitarias) and
   the Health Department of the Generalitat de Catalunya. J.R.B.P. is
   funded by the European Union's Horizon 2020 research and innovation
   programme under Marie Sklodowska-Curie grant agreement no. 657956. The
   research leading to these results has received funding from the Spanish
   Ministry of Economy and Competitiveness (MINECO, Plan Estatal I+D+I
   CGL2013-43139-R) and 'la Caixa' Banking Foundation. Mosquito Alert is
   currently promoted by 'la Caixa' Banking Foundation. Other contributors
   during 2014-15 are the Fundacion Espanola de Ciencia y Tecnologia
   (FCT-13-7019), the program RecerCaixa-2013, and the company Lokimica
   S.A.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Amano Tatsuya, 2013, P ROYAL SOC B, V280, P1
   Aranda C, 2006, MED VET ENTOMOL, V20, P150, DOI 10.1111/j.1365-2915.2006.00605.x
   Benallal KE, 2016, ACTA TROP, V164, P411, DOI 10.1016/j.actatropica.2016.09.027
   Bird TJ, 2014, BIOL CONSERV, V173, P144, DOI 10.1016/j.biocon.2013.07.037
   Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01
   CHRISMAN NR, 1984, CARTOGRAPHICA, V21, P79, DOI DOI 10.3138/7146-4332-6J78-0671
   Collantes F, 2016, ACTA TROP, V164, P64, DOI 10.1016/j.actatropica.2016.08.023
   Collantes F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1262-y
   Crall AW, 2011, CONSERV LETT, V4, P433, DOI 10.1111/j.1755-263X.2011.00196.x
   Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151
   Delacour-Estrella S., 2016, B SEA, V58, P157
   Delacour-Estrella S, 2014, AN BIOL, V36, P93, DOI DOI 10.6018/ANALESBI0.36.16
   Devisch O, 2013, J URBAN TECHNOL, V20, P63, DOI 10.1080/10630732.2013.769313
   Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636
   Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010
   Flanagin AJ, 2008, GEOJOURNAL, V72, P137, DOI 10.1007/s10708-008-9188-y
   Franzoni C, 2014, RES POLICY, V43, P1, DOI 10.1016/j.respol.2013.07.005
   Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136
   Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191
   Goldman N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159273
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Haklay M., 2013, CROWDSOURCING GEOGRA, P105, DOI DOI 10.1007/978-94-007-4587-2_7
   Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013
   Hobbs SJ, 2012, J NAT CONSERV, V20, P364, DOI 10.1016/j.jnc.2012.08.002
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662
   Instituto Geografico Nacional, 2015, LIN LIM MUN REC PROV
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Kampen H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0604-5
   LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506
   LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447
   Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Madon MB, 2002, J VECTOR ECOL, V27, P149
   Alarcon-Elbal PM, 2014, MEM I OSWALDO CRUZ, V109, P782, DOI 10.1590/0074-0276140214
   Miller-Rushing A, 2012, FRONT ECOL ENVIRON, V10, P285, DOI 10.1890/110278
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oltra A., 2016, EUROPEAN HDB CROWDSO, P295, DOI DOI 10.5334/BAX.V
   Palmer J. R. B., 2017, DATASET ARTICLE CITI, DOI [10.5281/zenodo.646531, DOI 10.5281/ZENODO.646531]
   Palmer J. R. B., 2017, CODE ARTICLE CITIZEN, DOI [10.5281/zenodo.646576, DOI 10.5281/ZENODO.646576]
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Phillips B. L., 2016, BIOL INVASIONS ANIMA
   Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002
   Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2
   Proestos Y., 2015, PHILOS T R SOC B, V370, P1
   R Core Team, 2016, R LANG ENV STAT COMP
   Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77
   Rodriguez A., 2016, P 1 WORKSH DAT SCI S, V1831, P1
   Rodriguez A., 2016, DATA CLASSIFICATION
   Roiz D., 2007, Boletin de la SEA, V40, P523
   Silvertown J, 2015, ZOOKEYS, P125, DOI 10.3897/zookeys.480.8803
   Stan Development Team, 2015, STAN C LIB PROB SAMP
   Stan Development Team, 2016, RSTAN BAYES APPL REG
   Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007
   Tian HD, 2011, P NATL ACAD SCI USA, V108, P14521, DOI 10.1073/pnas.1100189108
   U.N. Environment, 2017, POIN ALL MOSQ BORN D
   U.N. Global Pulse, 2012, BIG DAT DEV CHALL OP, DOI [10.1089/big.2012.1502, DOI 10.1089/BIG.2012.1502]
   Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140
   Vehtari A., 2016, LOO EFFICIENT LEAVE
   Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4
   WHO, 2016, ZIK VIR MICR GUILL B, P1
   Zagheni E, 2012, PROCEEDINGS OF THE 3RD ANNUAL ACM WEB SCIENCE CONFERENCE, 2012, P348
NR 65
TC 31
Z9 34
U1 1
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD OCT 24
PY 2017
VL 8
AR 916
DI 10.1038/s41467-017-00914-9
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FK5TV
UT WOS:000413564800001
PM 29066710
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Anglero-Rodriguez, YI
   MacLeod, HJ
   Kang, S
   Carlson, JS
   Jupatanakul, N
   Dimopoulos, G
AF Anglero-Rodriguez, Yesseinia I.
   MacLeod, Hannah J.
   Kang, Seokyoung
   Carlson, Jenny S.
   Jupatanakul, Natapong
   Dimopoulos, George
TI Aedes aegypti Molecular Responses to Zika Virus: Modulation of Infection
   by the Toll and Jak/Stat Immune Pathways and Virus Host Factors
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; dengue virus; Aedes aegypti; innate immunity; vector
   competence
ID PEPTIDOGLYCAN RECOGNITION PROTEINS; YELLOW-FEVER MOSQUITO; VECTOR
   COMPETENCE; SERINE PROTEASES; INNATE IMMUNITY; DISEASE-VECTOR; GENE
   DRIVE; DENGUE; DROSOPHILA; DEFENSE
AB Zika (ZIKV) and dengue virus (DENV) are transmitted to humans by Aedes mosquitoes. However, the molecular interactions between the vector and ZIKV remain largely unexplored. In this work, we further investigated the tropism of ZIKV in two different Aedes aegypti strains and show that the virus infection kinetics, tissue migration, and susceptibility to infection differ between mosquito strains. We also compare the vector transcriptome changes upon ZIKV or DENV infection demonstrating that 40% of the mosquito's midgut infection-responsive transcriptome is virus-specific at 7 days after virus ingestion. Regulated genes included key factors of the mosquito's antiviral immunity. Comparison of the ZIKV and DENV infection-responsive transcriptome data to those available for yellow fever virus and West Nile virus identified 26 genes likely to play key roles in virus infection of Aedes mosquitoes. Through reverse genetic analyses, we show that the Toll and the Jak/Stat innate immune pathways mediate increased resistance to ZIKV infection, and the conserved DENV host factors vATPase and inosine-5'-monophosphate dehydrogenase are also utilized for ZIKV infection.
C1 [Anglero-Rodriguez, Yesseinia I.; MacLeod, Hannah J.; Kang, Seokyoung; Carlson, Jenny S.; Jupatanakul, Natapong; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.
RP Dimopoulos, G (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.
EM gdimopo1@jhu.edu
FU National Institutes of Health, National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI101431]
FX This work has been supported by National Institutes of Health, National
   Institute of Allergy and Infectious Diseases, R01AI101431.
CR Adelman ZN, 2008, INSECT BIOCHEM MOLEC, V38, P705, DOI 10.1016/j.ibmb.2008.04.002
   Adelman ZN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002239
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512
   BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972
   Brackney DE, 2010, J INSECT PHYSIOL, V56, P736, DOI 10.1016/j.jinsphys.2010.01.003
   Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Clayton AM, 2014, J INNATE IMMUN, V6, P169, DOI 10.1159/000353602
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   Dong SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122353
   Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052
   Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458
   Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011
   Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x
   Fragkoudis R, 2009, J GEN VIROL, V90, P2061, DOI 10.1099/vir.0.013201-0
   Franz AWE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002833
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Garver LS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003622
   Gonda RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042369
   Guo XA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-380
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002
   Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084
   Kanost MR, 2015, CURR OPIN INSECT SCI, V11, P47, DOI 10.1016/j.cois.2015.09.003
   Kaushal A, 2016, DEV COMP IMMUNOL, V63, P171, DOI 10.1016/j.dci.2016.05.018
   KURZIKDUMKE U, 1995, GENE, V154, P171, DOI 10.1016/0378-1119(94)00827-F
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003931
   Londono-Renteria B, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1802-0
   McElroy KL, 2008, VECTOR-BORNE ZOONOT, V8, P675, DOI 10.1089/vbz.2007.0269
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006
   Sandiford SL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004631
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Shi XZ, 2012, INSECT BIOCHEM MOLEC, V42, P545, DOI 10.1016/j.ibmb.2012.04.002
   Shin SW, 2003, P NATL ACAD SCI USA, V100, P2616, DOI 10.1073/pnas.0537347100
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678
   Simoes ML, 2017, DEV COMP IMMUNOL, V67, P257, DOI 10.1016/j.dci.2016.09.012
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x
   Stokes BA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00019
   Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Ye YXH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066482
   Zheng ZJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00686-17
   Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394
NR 74
TC 26
Z9 27
U1 2
U2 17
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD OCT 23
PY 2017
VL 8
AR 2050
DI 10.3389/fmicb.2017.02050
PG 12
WC Microbiology
SC Microbiology
GA FK3VV
UT WOS:000413415100001
PM 29109710
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Suroengrit, A
   Yuttithamnon, W
   Srivarangkul, P
   Pankaew, S
   Kingkaew, K
   Chavasiri, W
   Boonyasuppayakorn, S
AF Suroengrit, Aphinya
   Yuttithamnon, Wanchalerm
   Srivarangkul, Pimsiri
   Pankaew, Saran
   Kingkaew, Krongkan
   Chavasiri, Warinthorn
   Boonyasuppayakorn, Siwaporn
TI Halogenated Chrysins Inhibit Dengue and Zika Virus Infectivity
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NS2B-NS3 PROTEASE; ANTIVIRAL ACTIVITY; IN-VITRO; REPLICATION;
   FLAVONOIDS; TRANSLATION; NARINGENIN; FUSION; ASSAY
AB Dengue virus infection is a global threat for which no specific treatment has not been established. Previous reports suggested chrysin and flavanone derivatives were potential flaviviral inhibitors. Here, we reported two halogenated chrysins, abbreviated FV13 and FV14, were highly potent against DENV1-4 and ZIKV infectivities with the FV13 EC50 values of 2.30 +/- 1.04, 1.47 +/- 0.86, 2.32 +/- 1.46, 1.78 +/- 0.72 and 1.65 +/- 0.86 mu M; and FV14 EC50 values of 2.30 +/- 0.92, 2.19 +/- 0.31, 1.02 +/- 0.31, 1.29 +/- 0.60 and 1.39 +/- 0.11 mu M, respectively. The CC(50)s to LLC/MK2 of FV13 and FV14 were 44.28 +/- 2.90 mu M, 42.51 +/- 2.53 mu M, respectively. Mechanism of drug action studies suggested multiple targets but maximal efficiency was achieved with early post infection treatment. This is the first report showing a high potency of halogenated chrysins for development as a broad-spectrum anti-flaviviral drug.
C1 [Suroengrit, Aphinya] Chulalongkorn Univ, Grad Program, Fac Med, Bangkok 10330, Thailand.
   [Yuttithamnon, Wanchalerm; Srivarangkul, Pimsiri; Pankaew, Saran] Chulalongkorn Univ, Dept Biol, Fac Sci, Bangkok 10330, Thailand.
   [Kingkaew, Krongkan; Chavasiri, Warinthorn] Chulalongkorn Univ, Dept Chem, Fac Sci, Bangkok 10330, Thailand.
   [Boonyasuppayakorn, Siwaporn] Chulalongkorn Univ, Chula Vaccine Res Ctr, Fac Med, Bangkok 10330, Thailand.
   [Boonyasuppayakorn, Siwaporn] Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok 10330, Thailand.
RP Boonyasuppayakorn, S (corresponding author), Chulalongkorn Univ, Chula Vaccine Res Ctr, Fac Med, Bangkok 10330, Thailand.; Boonyasuppayakorn, S (corresponding author), Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok 10330, Thailand.
EM siwaporn.b@chula.ac.th
FU National Research Council of ThailandNational Research Council of
   Thailand (NRCT); Health Systems Research Institute (HSRI);
   Ratchadapiseksompotch Endowment Fund Part of the "Research Grant for New
   Scholar CU Researcher's Project" [RGN_2557_008_02_30];
   Ratchadapiseksompotch Endowment Funds [RA60/018]; Graduate school,
   Chulalongkorn UniversityChulalongkorn University
FX This work was supported by National Research Council of Thailand and
   Health Systems Research Institute (HSRI) and Ratchadapiseksompotch
   Endowment Fund Part of the "Research Grant for New Scholar CU
   Researcher's Project" (RGN_2557_008_02_30) to S.B.,
   Ratchadapiseksompotch Endowment Funds (RA60/018) and Research Assistant
   Scholarship from Graduate school, Chulalongkorn University to A.S.
   Reference dengue viruses were gifts from Drs Kiat Ruxrungtham, Chutitorn
   Ketloy, and Padet Siriyasatien, Faculty of Medicine, Chulalongkorn
   University. HepG2, Vero, HEK-293, and THP-1 cells were gifted from Drs
   Nattiya Hirankarn, Parvapan Bhattarakosol, Tanapat Palaga, Chulalongkorn
   University, respectively. We thanked the Armed Forces Research Institute
   of Medical Science, and the Department of Disease Control, Ministry of
   Public Health, Thailand for Zika virus. We thanked Drs. Anuradha
   Balasubramanian and Radhakrishnan Padmanabhan, Georgetown University,
   Washington, D.C., for an in vitro protease experiment and DENV2/BHK
   replicon cells.
CR Boonyasuppayakorn S, 2016, J VIROL METHODS, V237, P25, DOI 10.1016/j.jviromet.2016.08.009
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Brave Michael, 2016, PHARM COMP ADV COMM
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JF, 2016, EMERG MICROBES INFEC, V5
   Chu JJH, 2015, ANTIVIR RES, V118, P68, DOI 10.1016/j.antiviral.2015.03.010
   Coulerie P, 2013, PLANTA MED, V79, P1313, DOI 10.1055/s-0033-1350672
   Do T.-H., 2009, 13 INT EL C SYNTH OR
   Du J, 2016, SCI CHINA LIFE SCI, V59, P832, DOI 10.1007/s11427-016-5050-5
   Frabasile S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41864
   de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015
   Ichiyama K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002188
   Ismail N. A., 2016, INTERDISCIPLINARY SC
   Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Khachatoorian R, 2014, VIROLOGY, V454, P118, DOI 10.1016/j.virol.2014.02.016
   Kiat TS, 2006, BIOORG MED CHEM LETT, V16, P3337, DOI 10.1016/j.bmcl.2005.12.075
   Lani R, 2016, ANTIVIR RES, V133, P50, DOI 10.1016/j.antiviral.2016.07.009
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Alcaraz-Estrada SL, 2010, FUTURE VIROL, V5, P575, DOI 10.2217/FVL.10.49
   Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Moghaddam E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05452
   Noh K, 2016, BIOMOL THER, V24, P446, DOI 10.4062/biomolther.2015.197
   Park H, 2005, EUR J MED CHEM, V40, P943, DOI 10.1016/j.ejmech.2005.04.013
   Poh MK, 2009, ANTIVIR RES, V84, P260, DOI 10.1016/j.antiviral.2009.09.011
   Pozo-Aguilar JO, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0590-7
   RANDOLPH VB, 1990, J GEN VIROL, V71, P1845, DOI 10.1099/0022-1317-71-8-1845
   Senthilvel P, 2013, BIOINFORMATION, V9, P889, DOI 10.6026/97320630009889
   Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003
   St John A. L., 2013, PLOS PATHOG, V9
   SUMMERS PL, 1989, VIRUS RES, V12, P383, DOI 10.1016/0168-1702(89)90095-6
   Takhampunya R, 2006, J GEN VIROL, V87, P3003, DOI 10.1099/vir.0.81880-0
   Wang J, 2003, J BIOL CHEM, V278, P21751, DOI 10.1074/jbc.M212662200
   Wang QY, 2011, ANTIMICROB AGENTS CH, V55, P4072, DOI 10.1128/AAC.00620-11
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yakimovich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138760
   Zandi K, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-214
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
   Zandi K, 2011, J MED PLANTS RES, V5, P5534
   Zhang Q, 2009, TOXICOL IN VITRO, V23, P797, DOI 10.1016/j.tiv.2009.04.007
NR 42
TC 5
Z9 5
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 20
PY 2017
VL 7
AR 13696
DI 10.1038/s41598-017-14121-5
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FK3AX
UT WOS:000413357500062
PM 29057920
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Adebanjo, T
   Godfred-Cato, S
   Viens, L
   Fischer, M
   Staples, JE
   Kuhnert-Tallman, W
   Walke, H
   Oduyebo, T
   Polen, K
   Peacock, G
   Meaney-Delman, D
   Honein, MA
   Rasmussen, SA
   Moore, CA
AF Adebanjo, Tolulope
   Godfred-Cato, Shana
   Viens, Laura
   Fischer, Marc
   Staples, J. Erin
   Kuhnert-Tallman, Wendi
   Walke, Henry
   Oduyebo, Titilope
   Polen, Kara
   Peacock, Georgina
   Meaney-Delman, Dana
   Honein, Margaret A.
   Rasmussen, Sonja A.
   Moore, Cynthia A.
TI Update: Interim Guidance for the Diagnosis, Evaluation, and Management
   of Infants with Possible Congenital Zika Virus Infection - United
   States, October 2017
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID BRAZIL; FETUSES; IDENTIFICATION; DYSPHAGIA
C1 [Adebanjo, Tolulope] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Adebanjo, Tolulope] CDC, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Godfred-Cato, Shana] Eagle Med Serv LLC, Wichita, KS USA.
   [Viens, Laura] Chickasaw Nation Ind Inc, Norman, OK USA.
   [Fischer, Marc; Staples, J. Erin] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Div Vector Borne Dis, Atlanta, GA 30333 USA.
   [Kuhnert-Tallman, Wendi; Meaney-Delman, Dana] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Off Director, Atlanta, GA 30333 USA.
   [Walke, Henry] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.
   [Oduyebo, Titilope] Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA USA.
   [Polen, Kara; Honein, Margaret A.; Moore, Cynthia A.] CDC, Natl Ctr Birth Defects & Dev Disabil, Div Congenital & Dev Disorders, Atlanta, GA 30333 USA.
   [Peacock, Georgina] CDC, Natl Ctr Birth Defects & Dev Disabil, Div Human Dev & Disabil, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Ctr Surveillance Epidemiol & Lab Serv, Div Publ Hlth Informat Disseminat, Atlanta, GA 30333 USA.
RP Adebanjo, T (corresponding author), CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.; Adebanjo, T (corresponding author), CDC, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
EM zikamch@cdc.gov
RI Gaw, Stephanie/K-4592-2019
OI Gaw, Stephanie/0000-0003-0891-6964; Dolan, Siobhan/0000-0001-8890-8045;
   Prakalapakorn, Sasapin/0000-0001-6788-7425; Mulkey,
   Sarah/0000-0002-8084-526X
CR American Academy of Pediatrics, 2016, PEDIATRICS, V137, pe20153596
   Arvedson JC, 2008, DEV DISABIL RES REV, V14, P118, DOI 10.1002/ddrr.17
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Chibueze EC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01991-y
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231
   Food and Drug Administration, 2017, ZIK VIR RESP UPD FDA
   Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Herrera K, 2016, CASE REP PERINAT MED, V5, P131, DOI 10.1515/crpm-2016-0027
   Kuo DZ, 2012, MATERN CHILD HLTH J, V16, P297, DOI 10.1007/s10995-011-0751-7
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Masuzaki H, 2004, CLIN CHEM, V50, P1709, DOI 10.1373/clinchem.2004.036517
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richerson JE, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0254
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sarno M, 2016, ULTRASOUND OBSTET GY
   Scharf RJ, 2016, PEDIATR REV, V37, P25, DOI 10.1542/pir.2014-0103
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Souza Alex Sandro Rolland, 2016, Rev. Bras. Saude Mater. Infant., V16, P467, DOI 10.1590/1806-93042016000400007
   van der Linden V, 2017, ZIKA IN FOCUS
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Villamil-Gomez WE, 2017, J CLIN VIROL, V95, P52, DOI 10.1016/j.jcv.2017.08.010
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Wax JR, 2016, OBSTET GYNECOL, V128, pE231
   WHO, 2010, WHO REC DIAGN HIV IN
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 47
TC 68
Z9 72
U1 1
U2 7
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD OCT 20
PY 2017
VL 66
IS 41
BP 1089
EP 1099
DI 10.15585/mmwr.mm6641a1
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FK1PM
UT WOS:000413254100001
PM 29049277
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Morain, SR
   Wootton, SH
   Eppes, C
AF Morain, Stephanie R.
   Wootton, Susan H.
   Eppes, Catherine
TI A Devastating Delay - Zika and the Implementation Gap
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
C1 [Morain, Stephanie R.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.
   [Eppes, Catherine] Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA.
   [Wootton, Susan H.] Univ Texas Hlth Sci Ctr Houston UTHlth, McGovern Med Sch, Dept Pediat, Div Infect Dis, Houston, TX USA.
RP Morain, SR (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.
OI Morain, Stephanie/0000-0001-7278-7517
CR Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458
   McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615
   Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180
   North Texas Regional Extension Center, 2015, PHYS WORKF TEX
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
NR 5
TC 8
Z9 8
U1 0
U2 2
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD OCT 19
PY 2017
VL 377
IS 16
BP 1505
EP 1507
DI 10.1056/NEJMp1707273
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA FK1LU
UT WOS:000413243900001
PM 29045206
DA 2020-07-08
ER

PT J
AU Ayres, C
   Guedes, D
   Paiva, M
   Donato, M
   Barbosa, P
   Krokovsky, L
   Rocha, S
   Saraiva, K
   Crespo, M
   Rezende, T
   Wallau, G
   Barbosa, R
   Oliveira, C
   Melo-Santos, MA
   Pena, L
   Cordeiro, M
   Franca, R
   Oliveira, A
   Peixoto, C
   Leal, WS
AF Ayres, Constancia
   Guedes, Duschinka
   Paiva, Marcelo
   Donato, Mariana
   Barbosa, Priscilla
   Krokovsky, Larissa
   Rocha, Sura
   Saraiva, Karina
   Crespo, Monica
   Rezende, Tatiana
   Wallau, Gabriel
   Barbosa, Rosangela
   Oliveira, Claudia
   Melo-Santos, Maria Alice
   Pena, Lindomar
   Cordeiro, Marli
   Franca, Rafael
   Oliveira, Andre
   Peixoto, Christina
   Leal, Walter S.
TI Response to: 'Lack of evidence for Zika virus transmission by Culex
   mosquitoes'
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
ID AEDES-AEGYPTI MOSQUITOS; YELLOW-FEVER; BRAZIL; ISOLATIONS
C1 [Ayres, Constancia; Guedes, Duschinka; Paiva, Marcelo; Donato, Mariana; Barbosa, Priscilla; Krokovsky, Larissa; Rocha, Sura; Saraiva, Karina; Crespo, Monica; Rezende, Tatiana; Wallau, Gabriel; Barbosa, Rosangela; Oliveira, Claudia; Melo-Santos, Maria Alice; Pena, Lindomar; Cordeiro, Marli; Franca, Rafael; Oliveira, Andre; Peixoto, Christina] Fundacao Oswaldo Cruz, FIOCRUZ, IAM, Av Moraes Rego,S-N Campus UFPE,Cidade Univ, BR-50670420 Recife, PE, Brazil.
   [Paiva, Marcelo] Univ Fed Pernambuco, Ctr Acad Agreste, BR-55002970 Caruaru, PE, Brazil.
   [Leal, Walter S.] Univ Calif Davis, Davis, CA 95616 USA.
RP Ayres, C (corresponding author), Fundacao Oswaldo Cruz, FIOCRUZ, IAM, Av Moraes Rego,S-N Campus UFPE,Cidade Univ, BR-50670420 Recife, PE, Brazil.
EM tans@cpqam.fiocruz.br
RI Barbosa, Rosangela/AAC-3339-2020; Wallau, Gabriel Luz/B-5911-2008;
   PEIXOTO, CHRISTINA/AAD-9608-2019; Ayres, Constancia/AAQ-3448-2020
OI Barbosa, Rosangela/0000-0002-1171-598X; Wallau, Gabriel
   Luz/0000-0002-1419-5713; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007; Donato, Mariana/0000-0002-3361-2789
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Elizondo-Quiroga D, 2017, BIORXIV
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HADDOW A. J., 1964, BULL WORLD HEALTH ORGAN, V31, P57
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Tabachnick WJ, 2016, CURR OPIN VIROL, V21, P124, DOI 10.1016/j.coviro.2016.09.008
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   World Health Organization, COMMUNICATION
NR 15
TC 4
Z9 4
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD OCT 18
PY 2017
VL 6
AR e91
DI 10.1038/emi.2017.86
PG 2
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FK4EV
UT WOS:000413443300002
PM 29044194
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Roundy, CM
   Azar, SR
   Brault, AC
   Ebel, GD
   Failloux, AB
   Fernandez-Salas, I
   Kitron, U
   Kramer, LD
   Lourenco-de-Oliveira, R
   Osorio, JE
   Paploski, ID
   Vazquez-Prokopec, GM
   Ribeiro, GS
   Ritchie, SA
   Tauro, LB
   Vasilakis, N
   Weaver, SC
AF Roundy, Christopher M.
   Azar, Sasha R.
   Brault, Aaron C.
   Ebel, Gregory D.
   Failloux, Anna-Bella
   Fernandez-Salas, Ildefonso
   Kitron, Uriel
   Kramer, Laura D.
   Lourenco-de-Oliveira, Ricardo
   Osorio, Jorge E.
   Paploski, Igor D.
   Vazquez-Prokopec, Gonzalo M.
   Ribeiro, Guilherme S.
   Ritchie, Scott A.
   Tauro, Laura B.
   Vasilakis, Nikos
   Weaver, Scott C.
TI Lack of evidence for Zika virus transmission by Culex mosquitoes
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
ID AEDES-ALBOPICTUS; QUINQUEFASCIATUS; AMERICA; BRAZIL
C1 [Roundy, Christopher M.; Azar, Sasha R.; Weaver, Scott C.] Univ Texas Med Branch, Inst Translat Res, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Roundy, Christopher M.; Azar, Sasha R.; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO USA.
   [Ebel, Gregory D.] Colorado State Univ, Arthropod Borne & Infect Dis Lab, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.
   [Fernandez-Salas, Ildefonso] Ctr Reg Invest Salud Publ INSP, Tapachula, Chiapas, Mexico.
   [Kitron, Uriel; Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Kramer, Laura D.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.
   [Lourenco-de-Oliveira, Ricardo] Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Paploski, Igor D.; Ribeiro, Guilherme S.; Tauro, Laura B.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Ritchie, Scott A.] James Cook Univ, Australian Inst Trop Hlth & Med, Smithfield, Qld, Australia.
   [Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Translat Res, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
RI Weaver, Scott C/D-6490-2011; Paploski, Igor AD/D-7015-2014; Ribeiro,
   Guilherme/B-6624-2008
OI Weaver, Scott C/0000-0001-8016-8556; Paploski, Igor
   AD/0000-0002-3689-2042; Ribeiro, Guilherme/0000-0002-6798-2059
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01 AI115577]
CR Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Barnett HC, 1962, P 11 INT C ENT, P341
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005511
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
NR 15
TC 14
Z9 15
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD OCT 18
PY 2017
VL 6
AR e90
DI 10.1038/emi.2017.85
PG 2
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FK4EV
UT WOS:000413443300001
PM 29044195
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kurosaki, Y
   Martins, DBG
   Kimura, M
   Catena, AD
   Borba, MACSM
   Mattos, SD
   Abe, H
   Yoshikawa, R
   de Lima, JL
   Yasuda, J
AF Kurosaki, Yohei
   Gondim Martins, Danyelly Bruneska
   Kimura, Mayuko
   Catena, Andriu dos Santos
   Souto Maior Borba, Maria Amelia Carlos
   Mattos, Sandra da Silva
   Abe, Haruka
   Yoshikawa, Rokusuke
   de Lima Filho, Jose Luiz
   Yasuda, Jiro
TI Development and evaluation of a rapid molecular diagnostic test for Zika
   virus infection by reverse transcription loop-mediated isothermal
   amplification
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BRAZIL; URINE; SALIVA; TRANSMISSION; EPIDEMIC; AREAS; STATE; RNA
AB The recent outbreak of Zika virus (ZIKV) disease caused an enormous number of infections in Central and South America, and the unusual increase in the number of infants born with microcephaly associated with ZIKV infection aroused global concern. Here, we developed a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay using a portable device for the detection of ZIKV. The assay specifically detected ZIKV strains of both Asian and African genotypes without cross-reactivity with other arboviruses, including Dengue and Chikungunya viruses. The assay detected viral RNA at 14.5 TCID50/mL in virus-spiked serum or urine samples within 15 min, although it was slightly less sensitive than reference real time RT-PCR assay. We then evaluated the utility of this assay as a molecular diagnostic test using 90 plasma or serum samples and 99 urine samples collected from 120 suspected cases of arbovirus infection in the states of Paraiba and Pernambuco, Brazil in 2016. The results of this assay were consistent with those of the reference RT-PCR test. This portable RT-LAMP assay was highly specific for ZIKV, and enable rapid diagnosis of the virus infection. Our results provide new insights into ZIKV molecular diagnostics and may improve preparedness for future outbreaks.
C1 [Kurosaki, Yohei; Kimura, Mayuko; Abe, Haruka; Yoshikawa, Rokusuke; Yasuda, Jiro] Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 8528523, Japan.
   [Gondim Martins, Danyelly Bruneska; Catena, Andriu dos Santos; Souto Maior Borba, Maria Amelia Carlos; Mattos, Sandra da Silva; de Lima Filho, Jose Luiz] Fed Univ Pernambuco UFPE, Lab Immunopathol Keizo Asami, BR-50670901 Recife, PE, Brazil.
   [Yasuda, Jiro] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528523, Japan.
   [Yasuda, Jiro] Nagasaki Univ, Program Nurturing Global Leaders Trop & Emerging, Nagasaki 8528523, Japan.
RP Yasuda, J (corresponding author), Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 8528523, Japan.; Yasuda, J (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528523, Japan.; Yasuda, J (corresponding author), Nagasaki Univ, Program Nurturing Global Leaders Trop & Emerging, Nagasaki 8528523, Japan.
EM j-yasuda@nagasaki-u.ac.jp
RI Filho, Jose Luiz Lima/M-8076-2019
OI Abe, Haruka/0000-0003-0141-5059
FU Japan Agency for Medical Research and DevelopmentJapan Agency for
   Medical Research and Development (AMED); Japan Society for the Promotion
   of Science Research Fellowship PD [15J06242]; National Council for
   Scientific and Technological Development of BrazilNational Council for
   Scientific and Technological Development (CNPq) [CNPq - 459406/2014-0];
   Foundation for Science and Technology of Pernambuco [FACEPE -
   APQ-0142-2.08/2016]
FX The authors would like to thank Sayaka Okada, Shota Koyano and Olamide
   K. Oloniniyi for technical assistance with the experiments at Nagasaki
   University, Renato P. Melo Neto and Carlos Henrique M. Castelletti for
   bioinformatics support at LIKA, and all members of the staff for their
   hospitality during the visit when the main results of this paper were
   obtained. This work was supported by the Japan Agency for Medical
   Research and Development, Japan Society for the Promotion of Science
   Research Fellowship PD (15J06242), National Council for Scientific and
   Technological Development of Brazil (CNPq - 459406/2014-0), and
   Foundation for Science and Technology of Pernambuco (FACEPE -
   APQ-0142-2.08/2016).
CR Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kurosaki Y, 2016, J INFECT DIS, V214, pS229, DOI 10.1093/infdis/jiw255
   Kurosaki Y, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004472
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J., 2017, CLIN MICROBIOL INFEC
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Pan American Health Organization ; World Health Organization, 2016, ZIK EP UPD
   Paz-Bailey G, 2017, N ENGL J MED
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Sanabani SS, 2017, PLOS CURR, V9
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Tappe D, 2013, EURO SURVEILL, V19
   Thai HTC, 2004, J CLIN MICROBIOL, V42, P1956, DOI 10.1128/JCM.42.5.1956-1961.2004
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yun SI, 2016, GENOME ANNOUNC, V4
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 40
TC 21
Z9 22
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 18
PY 2017
VL 7
AR 13503
DI 10.1038/s41598-017-13836-9
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FK0RW
UT WOS:000413188600027
PM 29044149
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dirlikov, E
   Medina, NA
   Major, CG
   Munoz-Jordan, JL
   Luciano, CA
   Rivera-Garcia, B
   Sharp, TM
AF Dirlikov, Emilio
   Medina, Nicole A.
   Major, Chelsea G.
   Munoz-Jordan, Jorge L.
   Luciano, Carlos A.
   Rivera-Garcia, Brenda
   Sharp, Tyler M.
TI Acute Zika Virus Infection as a Risk Factor for Guillain-Barre Syndrome
   in Puerto Rico
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Letter
C1 [Dirlikov, Emilio] Ctr Dis Control & Prevent, Div Sci Educ & Profess Dev, 1324 Calle Canada, San Juan, PR 00920 USA.
   [Medina, Nicole A.; Munoz-Jordan, Jorge L.; Sharp, Tyler M.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, San Juan, PR USA.
   [Major, Chelsea G.] Ctr Dis Control & Prevent, Off State Tribal Local & Terr Support, San Juan, PR USA.
   [Luciano, Carlos A.] Univ Puerto Rico, San Juan, PR 00936 USA.
   [Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR USA.
RP Dirlikov, E (corresponding author), Ctr Dis Control & Prevent, Div Sci Educ & Profess Dev, 1324 Calle Canada, San Juan, PR 00920 USA.
EM klt9@cdc.gov
OI Dirlikov, Emilio/0000-0003-4631-2643
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [U54MD007587]
FX This work was supported by grant U54MD007587 from the National
   Institutes of Health (NIH; Dr Luciano).
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
NR 5
TC 10
Z9 10
U1 1
U2 7
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD OCT 17
PY 2017
VL 318
IS 15
BP 1498
EP 1500
DI 10.1001/jama.2017.11483
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA FK0RM
UT WOS:000413187300024
PM 29049645
OA Green Published
DA 2020-07-08
ER

PT J
AU Biassou, NM
AF Biassou, Nadia M.
TI New cerebral findings in infants with congenital Zika syndrome
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Editorial Material
C1 [Biassou, Nadia M.] NIH, Div Neuroradiol, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA.
   [Biassou, Nadia M.] George Washington Univ, Sch Med, Washington, DC 20037 USA.
RP Biassou, NM (corresponding author), NIH, Div Neuroradiol, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA.; Biassou, NM (corresponding author), George Washington Univ, Sch Med, Washington, DC 20037 USA.
EM biassoun@cc.nih.gov
CR Petribu NCD, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4188
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 7
TC 0
Z9 0
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD OCT 16
PY 2017
VL 359
AR j4522
DI 10.1136/bmj.j4522
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA FK1UW
UT WOS:000413270100002
PM 29038290
DA 2020-07-08
ER

PT J
AU Hapairai, LK
   Mysore, K
   Chen, Y
   Harper, EI
   Scheel, MP
   Lesnik, AM
   Sun, L
   Severson, DW
   Wei, N
   Duman-Scheel, M
AF Hapairai, Limb K.
   Mysore, Keshava
   Chen, Yingying
   Harper, Elizabeth I.
   Scheel, Max P.
   Lesnik, Alexandra M.
   Sun, Longhua
   Severson, David W.
   Wei, Na
   Duman-Scheel, Molly
TI Lure-and-Kill Yeast Interfering RNA Larvicides Targeting Neural Genes in
   the Human Disease Vector Mosquito Aedes aegypti
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BACILLUS-THURINGIENSIS-ISRAELENSIS; YELLOW-FEVER MOSQUITO;
   SACCHAROMYCES-CEREVISIAE; RESISTANCE; DROSOPHILA; DENGUE; EXPRESSION;
   STRAINS; LARVAL; SYSTEM
AB New mosquito control strategies are vitally needed to address established arthropod-borne infectious diseases such as dengue and yellow fever and emerging diseases such as Zika and chikungunya, all of which are transmitted by the disease vector mosquito Aedes aegypti. In this investigation, Saccharomyces cerevisiae (baker's yeast) was engineered to produce short hairpin RNAs (shRNAs) corresponding to the Aedes aegypti orthologs of fasciculation and elongation protein zeta 2 (fez2) and leukocyte receptor cluster (lrc) member, two genes identified in a recent screen for A. aegypti larval lethal genes. Feeding A. aegypti with the engineered yeasts resulted in silenced target gene expression, disrupted neural development, and highly significant larval mortality. Larvicidal activities were retained following heat inactivation and drying of the yeast into tabular formulations that induced > 95% mortality and were found to attract adult females to oviposit. These ready-to-use inactivated yeast interfering RNA tablets may one day facilitate the seamless integration of this new class of lure-and-kill species-specific biorational mosquito larvicides into integrated mosquito control programs.
C1 [Hapairai, Limb K.; Mysore, Keshava; Harper, Elizabeth I.; Scheel, Max P.; Severson, David W.; Duman-Scheel, Molly] Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46617 USA.
   [Hapairai, Limb K.; Mysore, Keshava; Chen, Yingying; Harper, Elizabeth I.; Lesnik, Alexandra M.; Sun, Longhua; Severson, David W.; Wei, Na; Duman-Scheel, Molly] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Sun, Longhua; Severson, David W.; Duman-Scheel, Molly] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Chen, Yingying; Wei, Na] Univ Notre Dame, Dept Civil & Environm Engn, Notre Dame, IN 46556 USA.
RP Duman-Scheel, M (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46617 USA.; Duman-Scheel, M (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.; Duman-Scheel, M (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
EM mscheel@nd.edu
RI Mysore, Keshava/P-6248-2019
OI Mysore, Keshava/0000-0003-2794-7029; Hapairai, Limb/0000-0002-2943-1061
FU Ralph W. and Grace M. Showalter Research Trust (through Indiana
   University School of Medicine); United States AgencyUnited States Agency
   for International Development (USAID) [AID-OAA-F-16-00097];
   NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1 R21 AI128116-01]
FX Thanks to Jacob Realey and Ping Li for their technical assistance and to
   Nicole Achee, John Grieco, and Kathy Eggleson for useful discussions.
   Ralph W. and Grace M. Showalter Research Trust Funds (through Indiana
   University School of Medicine) to MDS supported the siRNA screen and
   delivery system analyses. Yeast formulation analyses were funded by
   United States Agency for International Development Award
   AID-OAA-F-16-00097 to MDS. Detailed characterization of the stable
   transformants was funded by NIH/NIAID Award 1 R21 AI128116-01 to MDS,
   DWS, and NW. The funding sources were not involved in study design, data
   collection and interpretation, or the decision to submit the work for
   publication.
CR Basf S. E., 2014, ABATE STOP DIS CAUSI
   BASSEL J, 1971, J BACTERIOL, V108, P179, DOI 10.1128/JB.108.1.179-183.1971
   Becker J., 2015, REREGISTRATION ELIGI
   Blitzer EJ, 2005, INSECT MOL BIOL, V14, P301, DOI 10.1111/j.1365-2583.2005.00560.x
   Bonin A, 2015, INFECT GENET EVOL, V35, P204, DOI 10.1016/j.meegid.2015.07.034
   Borovsky D., 2011, PESTYCYDY, V1, P5
   CDC, 2016, SURV CONTR AED AEG A
   Clemons A, 2010, COLD SPRING HARB PRO, V2010
   Clemons A, 2010, COLD SPRING HARB PRO, V2010
   Clemons A., 2010, COLD SPRING HARB PRO
   Despres L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-926
   Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954
   DOUGLAS HC, 1954, J BACTERIOL, V68, P662, DOI 10.1128/JB.68.6.662-670.1954
   Environmental Protection Agency, 2000, YOUR INF LARV MOSQ C
   Gindhart JG, 2003, MOL BIOL CELL, V14, P3356, DOI 10.1091/mbc.E02-12-0800
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Haugen M, 2010, COLD SPRING HARB PRO, V2010
   Jankovics F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022229
   Kang DS, 2017, ACTA TROP, V174, P97, DOI 10.1016/j.actatropica.2017.06.018
   Kucherenko MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002418
   Lau KW, 2015, J MED ENTOMOL, V52, P199, DOI 10.1093/jme/tju019
   Li HC, 2015, PLANT CELL ENVIRON, V38, P2277, DOI 10.1111/pce.12546
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315
   MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7
   Murphy KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep22587
   Mysore K., 2014, DEV DYN
   Mysore K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004213
   Mysore K, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-9
   Mysore K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002215
   Mysore K, 2011, DEV GENES EVOL, V221, P281, DOI 10.1007/s00427-011-0376-2
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Patel Nipam H., 1996, P357
   Obregon FP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1888-3
   Polson KA, 2010, J AM MOSQUITO CONTR, V26, P403, DOI 10.2987/10-6019.1
   Rawlins SC, 1998, J AM MOSQUITO CONTR, V14, P131
   Rossi L, 2015, PESTICIDE PRODUCT NE
   Rozendaal J.A., 1997, VECTOR CONTROL METHO
   Saavedra-Rodriguez K, 2014, INSECT MOL BIOL, V23, P199, DOI 10.1111/imb.12073
   San Miguel K, 2016, PEST MANAG SCI, V72, P801, DOI 10.1002/ps.4056
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Singh AD, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.6901
   Snetselaar J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-200
   Tomchaney M, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0010-x
   van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9
   Van Ekert E, 2014, J INSECT PHYSIOL, V70, P143, DOI 10.1016/j.jinsphys.2014.08.001
   Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zhang X, 2015, JOVE-J VIS EXP, DOI 10.3791/52523
NR 52
TC 6
Z9 6
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 16
PY 2017
VL 7
AR 13223
DI 10.1038/s41598-017-13566-y
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FJ8VZ
UT WOS:000413048000034
PM 29038510
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pessoa, A
   Delfino, A
   Furtado, T
   Ribeiro, E
AF Pessoa, A.
   Delfino, A.
   Furtado, T.
   Ribeiro, E.
TI Neurological manifestations of congenital zika syndrome
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Meeting Abstract
CT 23rd World Congress of Neurology (WCN)
CY SEP 16-21, 2017
CL Kyoto, JAPAN
SP World Federat Neurol
C1 [Pessoa, A.] Univ Estadual Ceara UECE, Hosp Infantil Albert Sabin, Pediat Neurol Neurogenet, Fortaleza, Ceara, Brazil.
   [Delfino, A.] Univ Estadual Ceara UECE, Med, Fortaleza, Ceara, Brazil.
   [Furtado, T.] Univ Christus, Med, Fortaleza, Ceara, Brazil.
   [Ribeiro, E.] Univ Christus, Hosp Infantil Albert Sabin, Med, Fortaleza, Ceara, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2017
VL 381
SU S
MA 84
BP 24
EP 25
DI 10.1016/j.jns.2017.08.109
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FZ2YT
UT WOS:000427450300085
DA 2020-07-08
ER

PT J
AU van der Linden, V
   van der Linden, H
   van der Linden, A
AF van der Linden, V.
   van der Linden, H., Jr.
   van der Linden, A.
TI congenital zika virus syndromes
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Meeting Abstract
CT 23rd World Congress of Neurology (WCN)
CY SEP 16-21, 2017
CL Kyoto, JAPAN
SP World Federat Neurol
C1 [van der Linden, V.] Barao de Lucena Hosp, Pediat, Recife, PE, Brazil.
   [van der Linden, H., Jr.] Dr Henrique Santillo Rehabil Ctr, Pediat Neurol, Goiania, Go, Brazil.
   [van der Linden, A.] Prof Fernando Figueira Integral Med Inst, Pediat Neurol, Recife, PE, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2017
VL 381
SU S
MA 112
BP 32
EP 32
DI 10.1016/j.jns.2017.08.137
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FZ2YT
UT WOS:000427450300113
DA 2020-07-08
ER

PT J
AU Pena, S
   Torres, EL
   Minero, RLA
AF Pena, S.
   Lopez Torres, E.
   Ayala Minero, R. L.
TI Guillain-barre syndrome during the Zika outbreak in El Salvador
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Meeting Abstract
CT 23rd World Congress of Neurology (WCN)
CY SEP 16-21, 2017
CL Kyoto, JAPAN
SP World Federat Neurol
C1 [Pena, S.; Lopez Torres, E.] Hosp Nacl Rosales, Neurol, San Salvador, El Salvador.
   [Ayala Minero, R. L.] Univ Jose Matias Delgado, Med, San Salvador, El Salvador.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2017
VL 381
SU S
MA 2298
BP 827
EP 828
DI 10.1016/j.jns.2017.08.2329
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FZ2YT
UT WOS:000427450303194
DA 2020-07-08
ER

PT J
AU Thompson, A
   Villalobos, K
   Ramirez, N
   Castellanos, W
   Vijil, M
   Medina, MT
AF Thompson, A.
   Villalobos, K.
   Ramirez, N.
   Castellanos, W.
   Vijil, M.
   Medina, M. T.
TI Incidence of guillain-barre syndrome in association with zika in
   Honduras
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Meeting Abstract
CT 23rd World Congress of Neurology (WCN)
CY SEP 16-21, 2017
CL Kyoto, JAPAN
SP World Federat Neurol
C1 [Thompson, A.; Villalobos, K.; Vijil, M.] Natl Autonomous Univ Honduras, Med, San Pedro Sula, Honduras.
   [Ramirez, N.] Hosp Mario Rivas, Neurol, Cortes, Honduras.
   [Castellanos, W.] Ctr Rehabil Integral Teleton San Pedro Sula, Phisiatry, San Pedro Sula, Honduras.
   [Medina, M. T.] Natl Autonomous Univ Honduras, Med, Tegucigalpa, Honduras.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2017
VL 381
SU S
MA 3018
BP 1081
EP 1081
DI 10.1016/j.jns.2017.08.3049
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FZ2YT
UT WOS:000427450304248
DA 2020-07-08
ER

PT J
AU Salinas, JL
   Walteros, DM
   Styczynski, A
   Garzon, F
   Quijada, H
   Bravo, E
   Chaparro, P
   Madero, J
   Acosta-Reyes, J
   Ledermann, J
   Arteta, Z
   Borland, E
   Burns, P
   Gonzalez, M
   Powers, AM
   Mercado, M
   Solano, A
   Sejvar, JJ
   Ospina, ML
AF Salinas, Jorge L.
   Walteros, Diana M.
   Styczynski, Ashley
   Garzon, Flavio
   Quijada, Hernan
   Bravo, Elsa
   Chaparro, Pablo
   Madero, Javier
   Acosta-Reyes, Jorge
   Ledermann, Jeremy
   Arteta, Zuleima
   Borland, Erin
   Burns, Paul
   Gonzalez, Maritza
   Powers, Ann M.
   Mercado, Marcela
   Solano, Alma
   Sejvar, James J.
   Ospina, Martha L.
TI Zika virus disease-associated Guillain-Barre syndrome-Barranquilla,
   Colombia 2015-2016
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Guillain-Barre syndrome; Zika virus; Case-control studies; Colombia
AB Background: An outbreak of Guillain-Barre syndrome (GBS), a disorder characterized by acute, symmetric limb weakness with decreased or absent deep-tendon reflexes, was reported in Barranquilla, Colombia, after the introduction of Zika virus in 2015. We reviewed clinical data for GBS cases in Barranquilla and performed a case control investigation to assess the association of suspect and probable Zika virus disease with GBS.
   Methods: We used the Brighton Collaboration Criteria to confirm reported GBS patients in Barranquilla during October 2015-April 2016. In April 2016, two neighborhood and age range-matched controls were selected for each confirmed GBS case-patient. We obtained demographics and antecedent symptoms in the 2-month period before GBS onset for case-patients and the same period for controls. Sera were collected for Zika virus antibody testing. Suspected Zika virus disease was defined as a history of rash and >= 2 other Zika-related symptoms (fever, arthralgia, myalgia, or conjunctivitis). Probable Zika virus disease was defined as suspected Zika virus disease with laboratory evidence of a recent Zika virus or flavivirus infection. Conditional logistic regression adjusted for sex and race/ethnicity was used to calculate odds ratios (ORs) and 95% confidence intervals (Cis).
   Results: We confirmed 47 GBS cases. Incidence increased with age (10-fold higher in those >= 60 years versus those < 20 years). We interviewed 40 case-patients and 79 controls. There was no significant difference in laboratory evidence of recent Zika virus or flavivirus infection between case-patients and controls (OR: 2.2; 95% CI: 0.9-5.1). GBS was associated with having suspected (OR: 3.0, 95% CI: 1.1-8.6) or probable Zika virus disease (OR: 4.6, CI: 1.1-19.0).
   Conclusions: Older individuals and those with suspected and probable Zika virus disease had higher odds of developing GBS.
C1 [Salinas, Jorge L.; Styczynski, Ashley; Ledermann, Jeremy; Borland, Erin; Burns, Paul; Powers, Ann M.; Sejvar, James J.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E-10, Atlanta, GA 30329 USA.
   [Walteros, Diana M.; Garzon, Flavio; Quijada, Hernan; Chaparro, Pablo; Madero, Javier; Gonzalez, Maritza; Mercado, Marcela; Ospina, Martha L.] Inst Nacl Salud, Bogota, Colombia.
   [Bravo, Elsa; Arteta, Zuleima; Solano, Alma] Secretaria Salud Barranquilla, Barranquilla, Colombia.
   [Acosta-Reyes, Jorge] Univ Norte, Barranquilla, Colombia.
RP Salinas, JL (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E-10, Atlanta, GA 30329 USA.
EM jsalinas@cdc.gov
RI Borland, Erin/K-6607-2019; Acosta-Reyes, Jorge/D-1906-2011
OI Acosta-Reyes, Jorge/0000-0003-4303-3243; Bravo,
   Elsa/0000-0003-2985-3843; Borland, Erin/0000-0001-8631-9466
FU United States Centers for Disease Control and PreventionUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA; Colombian Instituto Nacional de Salud; Secretaria de
   Salud de Barranquilla
FX We are grateful to the patients, family members, and neighborhood
   controls that participated in this investigation. We also thank Eloina
   Goenaga, Maribel Perez, Eberto Messino, Gabriel Rivera, Paula Matos,
   Nineth Pabon, Sandra Silvera, Jenner Suarez, Edilma Loayza, Rosa Aljure,
   Elina Ruiz, Yesenia Rambal, Angelica Carrillo, Jemima Camargo, Margarita
   Villanueva, Sandra Teran, Sebastian Vergara, Ediie Jimenez, Remberto
   Quintero, Yamile Sanchez, Eva Imitola, Joveth Llanos, Maria Gonzalez,
   Elena Bula, Jazmin Leon, Ingrid Cepeda, Mabel de La Hoz,
   <SUP>-</SUP>Alejandra Ortega, Arturo Coba, Dellys Guzman, Fedra
   Contreras, Kupertino Bravo, Manuel Toro, Orieta Donado, Ruth Gueto,
   Yulisca Realez, and Zuleima Cera from the Equipo de Vigilancia
   Epidemiologica de la Secretaria de Salud de Barraquilla for
   collaboration in patient tracing, phlebotomy support, and patient
   interviews. We thank Ibrahim Zaganjor, Christina Renquist, Diana
   Valencia, and Carol Rao from CDC's Zika incident management system for
   logistic and scientific support. We would like to thank Dr. Larry
   Schonberger and Dr. Ermias Belay from CDC's Division of High-Consequence
   Pathogens and Pathology for valuable input and review of data analysis.
   We thank Mariluz Gunturiz for laboratory assistance. We thank senior
   staff at Instituto Nacional de Salud de Colombia and CDC for support for
   this investigation. This study was funded by the United States Centers
   for Disease Control and Prevention, the Colombian Instituto Nacional de
   Salud, and the Secretaria de Salud de Barranquilla. The findings and
   conclusions in this report are those of the authors and do not
   necessarily represent the official position of the Centers for Disease
   Control and Prevention.
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DANE, 2017, PROY POBL NAC DEP 20
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dos Santos T, 2016, N ENGL J MED
   Kimachi T, 2017, MUSCLE NERVE, V55, P281, DOI 10.1002/mus.25242
   Mahecha M. P., 2016, IMMUNOL RES
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Pacheco O, 2016, N ENGL J MED
   Parra B., 2016, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   ROPPER AH, 1986, ARCH NEUROL-CHICAGO, V43, P1150, DOI 10.1001/archneur.1986.00520110044012
   SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Uncini A., 2016, J NEUROL NEUROSURG P
   van den Berg B, 2014, NEUROLOGY, V82, P1984, DOI 10.1212/WNL.0000000000000481
   Willison H. J., 2016, LANCET LONDON ENGLAN
NR 24
TC 18
Z9 18
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2017
VL 381
BP 272
EP 277
DI 10.1016/j.jns.2017.09.001
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FM2MO
UT WOS:000414819100056
PM 28991697
DA 2020-07-08
ER

PT J
AU Terzian, ACB
   Schanoski, AS
   Mota, MTD
   Da Silva, RA
   Estofolete, CF
   Colombo, TE
   Rahal, P
   Hanley, KA
   Vasilakis, N
   Kalil, J
   Nogueiral, ML
AF Bernardes Terzian, Ana Carolina
   Schanoski, Alessandra Soares
   de Oliveira Mota, Minh' Tasso
   da Silva, Rafael Alves
   Estofolete, Cassia Fernanda
   Colombo, Tatiana Elias
   Rahal, Paula
   Hanley, Kathryn A.
   Vasilakis, Nikos
   Kalil, Jorge
   Nogueiral, Mauricio Lacerda
TI Viral Load and Cytokine Response Profile Does Not Support
   Antibody-Dependent Enhancement in Dengue-Primed Zika Virus-Infected
   Patients
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE ZIKV; DENV; ADE; cytokines
ID HEMORRHAGIC-FEVER; SHOCK-SYNDROME; DISEASE; STORMS
AB Background. The pathogenesis of severe dengue disease involves immune components as biomarkers. The mechanism by which some dengue virus (DENV)-infected individuals progress to severe disease is poorly understood. Most studies on the pathogenesis of severe dengue disease focus on the process of antibody-dependent enhancement (ADE) as a primary risk factor. With the circulation of Zika virus (ZIKV) in DENV-endemic areas, many people infected by ZIKV were likely exposed to DENV. The influence of such exposure on Zika disease outcomes remains unknown.
   Methods. We investigated whether patients previously exposed to DENV exhibited higher viremia when exposed to a subsequent, heterologous dengue or Zika infection than those patients not previously exposed to dengue. We measured viral loads and cytokine profile during patients' acute infections.
   Results. Neither dengue nor Zika viremia was higher in patients with prior DENV infection, although the power to detect such a difference was only adequate in the ZIKV analysis. Of the 10 cytokines measured, only 1 significant difference was detected: Levels of interleukin 1 beta (IL-1 beta) were lower in dengue-infected patients who had experienced a previous dengue infection than patients infected with dengue for the first time. However, power to detect differences between groups was low. In Zika-infected patients, levels of IL-1 beta showed a significant, positive correlation with viral load.
   Conclusions. No signs of ADE were observed in vivo in patients with acute ZIKV infection who had prior exposure to DENV.
C1 [Bernardes Terzian, Ana Carolina; de Oliveira Mota, Minh' Tasso; da Silva, Rafael Alves; Estofolete, Cassia Fernanda; Colombo, Tatiana Elias; Nogueiral, Mauricio Lacerda] Sao Paulo State Univ, Sao Jose do Rio Preto Sch Med, Sao Jose Do Rio Preto, Brazil.
   [Schanoski, Alessandra Soares] Sao Paulo State Univ, Butantan Inst, Sao Jose Do Rio Preto, Brazil.
   [Rahal, Paula] Sao Paulo State Univ, Dept Biol, Inst Biosci Letters & Exact Sci, Sao Jose Do Rio Preto, Brazil.
   [Hanley, Kathryn A.] New Mexico State Univ, Las Cruces, NM 88003 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Kalil, Jorge] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
RP Nogueiral, ML (corresponding author), Sao Jose do Rio Preto Sch Med FAMERP, Ave Brigadeiro Faria Lima,5416 Vila Sao Pedro, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Estofolete, Cassia/N-6673-2019; Nogueira, Mauricio L/B-7599-2012; de
   Oliveira Mota, Manlio Tasso/E-2619-2013; Rahal, Paula/D-3871-2012;
   Schanoski, Alessandra/H-8144-2014; KALIL, JORGE/C-8029-2012
OI Estofolete, Cassia/0000-0001-7324-1591; Nogueira, Mauricio
   L/0000-0003-1102-2419; Rahal, Paula/0000-0001-5693-6148; Schanoski,
   Alessandra/0000-0002-6514-8458; KALIL, JORGE/0000-0001-8415-4274
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/21719-3, 2015/12295-0]; Butantan
   Institute; Brazilian National Institutes for Science and Technology for
   Dengue Studies (INCT em Dengue); FAPESP Zika Network; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1U01AI115577-01]
FX This study was supported by the Sao Paulo Research Foundation (FAPESP)
   (grant number 2013/21719-3 to M. L. N. and fellowship grant number
   2015/12295-0 to A. C. B. T.); by the Butantan Institute; the Brazilian
   National Institutes for Science and Technology for Dengue Studies (INCT
   em Dengue); and the FAPESP Zika Network. M. L. N. is a Brazilian
   National Research Council (CNPq) fellow. N. V. and K. A. H. were
   supported by the National Institutes of Health (grant number
   1U01AI115577-01).
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Chutinimitkul S, 2005, J VIROL METHODS, V129, P8, DOI 10.1016/j.jviromet.2005.05.006
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   Guzman MG, 2005, SCIENCE, V309, P1495, DOI 10.1126/science.1115177
   HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324
   John DV, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0191-6
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Milligan GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125476
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Nielsen DG, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-211
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pawitan Jeanne A, 2011, Acta Med Indones, V43, P129
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Suharti C, 2002, THROMB HAEMOSTASIS, V87, P42
   Tsai TT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003320
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 25
TC 50
Z9 51
U1 1
U2 12
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD OCT 15
PY 2017
VL 65
IS 8
BP 1260
EP 1265
DI 10.1093/cid/cix558
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FI5KR
UT WOS:000412022500002
PM 29017246
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Cross, SN
   Potter, JA
   Aldo, P
   Kwon, JY
   Pitruzzello, M
   Tong, M
   Guller, S
   Rothlin, CV
   Mor, G
   Abrahams, VM
AF Cross, Sarah N.
   Potter, Julie A.
   Aldo, Paulomi
   Kwon, Ja Young
   Pitruzzello, Mary
   Tong, Mancy
   Guller, Seth
   Rothlin, Carla V.
   Mor, Gil
   Abrahams, Vikki M.
TI Viral Infection Sensitizes Human Fetal Membranes to Bacterial
   Lipopolysaccharide by MERTK Inhibition and Inflammasome Activation
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID RECEPTOR TYROSINE KINASE; TOLL-LIKE RECEPTOR; GENERATE DISTINCT
   CYTOKINE; INDUCED PRETERM LABOR; DOUBLE-STRANDED-RNA; NF-KAPPA-B; NLRP3
   INFLAMMASOME; VIRUS-INFECTION; ANIMAL-MODELS; TNF-ALPHA
AB Chorioamnionitis, premature rupture of fetal membranes (FMs), and subsequent preterm birth are associated with local infection and inflammation, particularly IL-1 beta production. Although bacterial infections are commonly identified, other microorganisms may play a role in the pathogenesis. Because viral pandemics, such as influenza, Ebola, and Zika, are becoming more common, and pregnant women are at increased risk for associated complications, this study evaluated the impact that viral infection had on human FM innate immune responses. This study shows that a herpes viral infection of FMs sensitizes the tissue to low levels of bacterial LPS, giving rise to an exaggerated IL-1 beta response. Using an ex vivo human FM explant system and an in vivo mouse model of pregnancy, we report that the mechanism by which this aggravated inflammation arises is through the inhibition of the TAM receptor, MERTK, and activation of the inflammasome. The TAM receptor ligand, growth arrest specific 6, re-establishes the normal FM response to LPS by restoring and augmenting TAM receptor and ligand expression, as well as by preventing the exacerbated IL-1 beta processing and secretion. These findings indicate a novel mechanism by which viruses alter normal FM immune responses to bacteria, potentially giving rise to adverse pregnancy outcomes.
C1 [Cross, Sarah N.; Potter, Julie A.; Aldo, Paulomi; Kwon, Ja Young; Pitruzzello, Mary; Tong, Mancy; Guller, Seth; Mor, Gil; Abrahams, Vikki M.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, 333 Cedar St,LSOG 305C, New Haven, CT 06510 USA.
   [Rothlin, Carla V.] Yale Univ, Sch Med, Dept Immunobiol & Pharmacol, 333 Cedar St, New Haven, CT 06510 USA.
   [Kwon, Ja Young] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.
RP Abrahams, VM (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, 333 Cedar St,LSOG 305C, New Haven, CT 06510 USA.
EM vikki.abrahams@yale.edu
RI amsalu, ribka/G-8780-2019
OI Rothlin, Carla V/0000-0002-5693-5572; Mor, Gil/0000-0002-5499-3912;
   Kwon, Ja-Young/0000-0003-3009-6325
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI121183, R56AI124356];
   McKern Scholar Award for Perinatal Research
FX This work was supported in part by Grants R01AI121183 (to V.M.A.) and
   R56AI124356 (to G.M.) from the National Institute of Allergy and
   Infectious Diseases, National Institutes of Health and by the McKern
   Scholar Award for Perinatal Research (to V.M.A.).
CR Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599
   Abrahams VM, 2013, AM J REPROD IMMUNOL, V69, P33, DOI 10.1111/aji.12016
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Bakaletz LO, 2004, NAT REV MICROBIOL, V2, P552, DOI 10.1038/nrmicro928
   Bakaysa SL, 2014, MOL HUM REPROD, V20, P701, DOI 10.1093/molehr/gau028
   Beigi RH, 2014, OBSTET GYN CLIN N AM, V41, P535, DOI 10.1016/j.ogc.2014.08.002
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Bosurgi L, 2013, P NATL ACAD SCI USA, V110, P13091, DOI 10.1073/pnas.1302507110
   Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203
   Burd I, 2010, J NEUROSCI RES, V88, P1872, DOI 10.1002/jnr.22368
   Camenisch TD, 1999, J IMMUNOL, V162, P3498
   Cardenas I, 2011, J IMMUNOL, V187, P980, DOI 10.4049/jimmunol.1100578
   Cardenas I, 2011, AM J REPROD IMMUNOL, V65, P110, DOI 10.1111/j.1600-0897.2010.00908.x
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Chen YH, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.025
   Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002
   Czikk MJ, 2011, CLIN MICROBIOL INFEC, V17, P1304, DOI 10.1111/j.1469-0691.2011.03574.x
   Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203
   de Carvalho NS, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12616
   DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001
   DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056
   Elefsiniotis I, 2010, INT J GYNECOL OBSTET, V110, P241, DOI 10.1016/j.ijgo.2010.04.020
   Elovitz MA, 2006, PEDIATR RES, V59, P50, DOI 10.1203/01.pdr.0000191141.21932.b6
   Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009
   Fatemi SH, 2012, NEUROPHARMACOLOGY, V62, P1290, DOI 10.1016/j.neuropharm.2011.01.011
   Finger-Jardim F, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12689
   Flores-Herrera H, 2012, PLACENTA, V33, P271, DOI 10.1016/j.placenta.2012.01.007
   Ganu RS, 2013, AM J PERINAT, V30, P613, DOI 10.1055/s-0032-1329693
   Gibson CS, 2008, BJOG-INT J OBSTET GY, V115, P492, DOI 10.1111/j.1471-0528.2007.01653.x
   Gibson CS, 2011, J MATERN-FETAL NEO M, V24, P847, DOI 10.3109/14767058.2010.531324
   Goldenberg RL, 2002, NUTR REV, V60, pS19, DOI 10.1301/00296640260130696
   Gomez-Lopez N, 2017, REPROD SCI, V24, P934, DOI 10.1177/1933719116675058
   Gomez-Lopez N, 2017, REPROD SCI, V24, P1382, DOI 10.1177/1933719116687656
   Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008
   Gotsch F, 2008, J MATERN-FETAL NEO M, V21, P605, DOI 10.1080/14767050802212109
   Han J, 2016, AUTOPHAGY, V12, P2326, DOI 10.1080/15548627.2016.1235124
   He Y, 2014, J BIOL CHEM, V289, P1142, DOI 10.1074/jbc.M113.515080
   Hecht JL, 2008, PEDIATR DEVEL PATHOL, V11, P15, DOI 10.2350/07-06-0285.1
   Herve R, 2008, J IMMUNOL, V181, P2196, DOI 10.4049/jimmunol.181.3.2196
   Hoang M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115428
   Huang QT, 2015, J VIRAL HEPATITIS, V22, P1033, DOI 10.1111/jvh.12430
   Ilievski V, 2010, BIOL REPROD, V83, P767, DOI 10.1095/biolreprod.110.085464
   Jennings RN, 2014, J VIROL, V88, P14040, DOI 10.1128/JVI.02360-14
   Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3
   Johansson S, 2008, REPROD TOXICOL, V26, P298, DOI 10.1016/j.reprotox.2008.09.012
   Johnson KE, 2013, J VIROL, V87, P5005, DOI 10.1128/JVI.00082-13
   Kalu EI, 2015, NIGER J CLIN PRACT, V18, P453, DOI 10.4103/1119-3077.154210
   Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517
   Kemp MW, 2010, REPROD SCI, V17, P619, DOI 10.1177/1933719110373148
   Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x
   Kwon JY, 2014, AM J REPROD IMMUNOL, V71, P387, DOI 10.1111/aji.12243
   Lamont RF, 2003, CURR OPIN OBSTET GYN, V15, P91, DOI 10.1097/00001703-200304000-00002
   Lappas M, 2014, AM J REPROD IMMUNOL, V71, P189, DOI 10.1111/aji.12174
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Luo GY, 2010, REPROD SCI, V17, P532, DOI 10.1177/1933719110363618
   Marques CP, 2004, GLIA, V47, P358, DOI 10.1002/glia.20045
   Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038
   Meijer WJ, 2015, ACTA OBSTET GYN SCAN, V94, P797, DOI 10.1111/aogs.12680
   Menon R, 2010, PLACENTA, V31, P113, DOI 10.1016/j.placenta.2009.11.012
   Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084
   Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661
   O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004
   Payne MS, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00595
   Pettker CM, 2007, OBSTET GYNECOL, V109, P739, DOI 10.1097/01.AOG.0000255663.47512.23
   Pirianov G, 2009, ENDOCRINOLOGY, V150, P699, DOI 10.1210/en.2008-1178
   Potter JA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124032
   Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661
   Robertson SA, 2006, J IMMUNOL, V177, P4888, DOI 10.4049/jimmunol.177.7.4888
   Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x
   Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Srinivas SK, 2006, AM J OBSTET GYNECOL, V195, P797, DOI 10.1016/j.ajog.2006.05.049
   Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90
   STRONG BS, 1995, AM J PERINAT, V12, P78, DOI 10.1055/s-2007-994407
   Tsekoura EA, 2010, J MED VIROL, V82, P1379, DOI 10.1002/jmv.21820
   Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Wiley CA, 2012, INFLUENZA OTHER RESP, V6, pe1, DOI 10.1111/j.1750-2659.2011.00310.x
   Zaga V, 2004, BIOL REPROD, V71, P1296, DOI 10.1095/biolreprod.104.028621
NR 83
TC 20
Z9 20
U1 0
U2 13
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD OCT 15
PY 2017
VL 199
IS 8
BP 2885
EP 2895
DI 10.4049/jimmunol.1700870
PG 11
WC Immunology
SC Immunology
GA FJ4CR
UT WOS:000412682900027
PM 28916522
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Petribu, NCD
   Aragao, MDV
   van der Linden, V
   Parizel, P
   Jungmann, P
   Araujo, L
   Abath, M
   Fernandes, A
   Brainer-Lima, A
   Holanda, A
   Mello, R
   Sarteschi, C
   Duarte, MDMB
AF de Lima Petribu, Natacha Calheiros
   Vasco Aragao, Maria de Fatima
   van der Linden, Vanessa
   Parizel, Paul
   Jungmann, Patricia
   Araujo, Luziany
   Abath, Marilia
   Fernandes, Andrezza
   Brainer-Lima, Alessandra
   Holanda, Arthur
   Mello, Roberto
   Sarteschi, Camila
   Menezes Bezerra Duarte, Maria do Carmo
TI Follow-up brain imaging of 37 children with congenital Zika syndrome:
   case series study
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
ID VIRUS-INFECTION; APOPTOSIS; BIRTH
AB OBJECTIVE
   To compare initial brain computed tomography (CT) scans with follow-up CT scans at one year in children with congenital Zika syndrome, focusing on cerebral calcifications.
   DESIGN
   Case series study.
   SETTING
   Barao de Lucena Hospital, Pernambuco state, Brazil.
   PARTICIPANTS
   37 children with probable or confirmed congenital Zika syndrome during the microcephaly outbreak in 2015 who underwent brain CT shortly after birth and at one year follow-up.
   MAIN OUTCOME MEASURE
   Differences in cerebral calcification patterns between initial and follow-up scans.
   RESULTS
   37 children were evaluated. All presented cerebral calcifications on the initial scan, predominantly at cortical-white matter junction. At follow-up the calcifications had diminished in number, size, or density, or a combination in 34 of the children (92%, 95% confidence interval 79% to 97%), were no longer visible in one child, and remained unchanged in two children. No child showed an increase in calcifications. The calcifications at the cortical-white matter junction which were no longer visible at follow-up occurred predominately in the parietal and occipital lobes. These imaging changes were not associated with any clear clinical improvements.
   CONCLUSION
   The detection of cerebral calcifications should not be considered a major criterion for late diagnosis of congenital Zika syndrome, nor should the absence of calcifications be used to exclude the diagnosis.
C1 [de Lima Petribu, Natacha Calheiros; van der Linden, Vanessa; Araujo, Luziany; Abath, Marilia; Fernandes, Andrezza] Barao Lucena Hosp, Recife, PE, Brazil.
   [de Lima Petribu, Natacha Calheiros] Fac Pernambucana Saude, Recife, PE, Brazil.
   [Vasco Aragao, Maria de Fatima] Ctr Diagnost Multimagem, Recife, PE, Brazil.
   [Vasco Aragao, Maria de Fatima] Univ Catolica Pernambuco, Recife, PE, Brazil.
   [van der Linden, Vanessa] Assoc Assistance Disabled Children, Recife, PE, Brazil.
   [Parizel, Paul] Antwerp Univ Hosp, Edegem, Belgium.
   [Jungmann, Patricia] Univ Pernambuco, Dept Pathol, Recife, PE, Brazil.
   [Brainer-Lima, Alessandra] Univ Pernambuco, PROCAPE, Recife, PE, Brazil.
   [Holanda, Arthur; Mello, Roberto] Univ Fed Pernambuco, Med Sch, Recife, PE, Brazil.
   [Sarteschi, Camila] Oswaldo Cruz Fdn Fiocruz Unit, Res Ctr Aggeu Magalhaes CPqAM, Recife, PE, Brazil.
   [Menezes Bezerra Duarte, Maria do Carmo] Esperanca Hosp, Recife, PE, Brazil.
   [Menezes Bezerra Duarte, Maria do Carmo] Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil.
RP Petribu, NCD (corresponding author), Barao Lucena Hosp, Recife, PE, Brazil.; Petribu, NCD (corresponding author), Fac Pernambucana Saude, Recife, PE, Brazil.
EM natachacalheiros@yahoo.com.br
OI Parizel, Paul M./0000-0002-0221-2854
CR [Anonymous], 2016, PROTOCOLO VIGILANCIA
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   AragAo MF, 2017, ZIKA IN FOCUS, P63
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Fujita H, 2014, CELL BIOCHEM FUNCT, V32, P77, DOI 10.1002/cbf.2974
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Holanda ACMR., 2017, ZIKA FOCUS FIRST, P139
   Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748
   Jungmann P, 2017, ACTA OBSTET GYN SCAN, V96, P1039, DOI 10.1111/aogs.13184
   Kim KM, 1995, SCANNING MICROSCOPY, V9, P1137
   Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432
   Marin-Teva JL, 2011, NEURON GLIA BIOL, V7, P25, DOI 10.1017/S1740925X12000014
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nickerson JP, 2012, J NEUROIMAGING, V22, pe52, DOI 10.1111/j.1552-6569.2011.00699.x
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2017, ZIKA IN FOCUS
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
NR 28
TC 7
Z9 8
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD OCT 13
PY 2017
VL 359
AR j4188
DI 10.1136/bmj.j4188
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA FK1TT
UT WOS:000413267000001
PM 29030384
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Wong, LP
   Alias, H
   Hassan, J
   AbuBakar, S
AF Wong, Li Ping
   Alias, Haridah
   Hassan, Jamiyah
   AbuBakar, Sazaly
TI Attitudes towards Zika screening and vaccination acceptability among
   pregnant women in Malaysia
SO VACCINE
LA English
DT Article
DE Zika; Pregnant women; Screening; Vaccination
AB The aim of this study was to examine the willingness of pregnant women to have prenatal screening for the Zika virus (ZIKV). Secondly, the study also assessed the acceptability of a hypothetical Zika vaccination and its association with the health belief model (HBM) constructs. A cross-sectional study was conducted from 4th October to 11th November 2016, among pregnant women who attended antenatal care at the University Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia. The majority (81.8%) was willing to be tested for ZIKV and 78% felt that their spouse would be willing to be tested for ZIKV. A total of 94% expressed a willingness to receive a Zika vaccination if available. The participants expressed high perceived benefits of a ZIKV vaccination. Although many have a high perception of the severity of ZIKV, the proportion with a strong perception of their susceptibility to ZIKV was low. In the multivariate analysis of all the HBM constructs, cue-to-action, namely physician recommendation (odds ratio [OR] = 2.288; 95% confidence interval [CI] 1.093-4.793) and recommendation from friends or relatives (OR = 4.030; 95% CI 1.694-9.587), were significantly associated with a willingness to be vaccinated against ZIKV. The favourable response to a Zika vaccination implies that more research attention has to be given to develop a vaccine against ZIKV. Should the vaccine be available in the future, publicity and healthcare providers would play a vital role in ensuring vaccine uptake among pregnant women. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Wong, Li Ping; Alias, Haridah] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur 50603, Malaysia.
   [Wong, Li Ping] Univ Malaya, JCUM, Kuala Lumpur 50603, Malaysia.
   [Hassan, Jamiyah] Univ Malaya, Fac Med, Dept Obstet & Gynaecol, Kuala Lumpur 50603, Malaysia.
   [AbuBakar, Sazaly] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.
   [Wong, Li Ping; AbuBakar, Sazaly] Univ Malaya, TIDREC, Kuala Lumpur 50603, Malaysia.
RP Wong, LP (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur 50603, Malaysia.
EM wonglp@ummc.edu.my; haridahalias@gmail.com; jamiyah@ummc.edu.my;
   sazaly@um.edu.my
RI Wong, Li Ping/B-2782-2010; Lahuddin, Haslinda/S-1588-2017; ALIAS,
   HARIDAH/A-8075-2017; abubakar, sazaly/B-3957-2010
OI Wong, Li Ping/0000-0002-0107-0532; ALIAS, HARIDAH/0000-0002-1830-4761;
   abubakar, sazaly/0000-0002-9267-1420
FU Ministry of Education Malaysia [UM.C/625/1/HIR/MOE/MED/02
   (E000013-20001)]
FX This study received financial supports from High Impact Research Grant
   [UM.C/625/1/HIR/MOE/MED/02 (E000013-20001)] from the Ministry of
   Education Malaysia.
CR Ahmed S, 2012, PRENATAL DIAG, V32, P954, DOI 10.1002/pd.3940
   [Anonymous], 2016, STUDY FINDS ZIKA DAM
   Becker M H, 1977, Med Care, V15, P27, DOI 10.1097/00005650-197705001-00005
   Becker M.H., 1974, HLTH BELIEF MODEL PE, V2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Coe Antoinette B, 2012, Innov Pharm, V3, P1
   Coughlin SS, 2002, CANCER, V94, P2801, DOI 10.1002/cncr.10577
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   [Department of Statistics Malaysia Vital Statistics], 2015, DEP STAT MALAYSIA
   Er AC, 2010, WORLD ACAD SCI ENG T, V67, P29
   Fahey N, 2016, ANN GLOBAL HLTH
   Gargano LM, 2011, HUM VACCINES, V7, P89, DOI 10.4161/hv.7.1.13460
   Gitsels-van Der Wal JT, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-237
   Jamal I, 2016, MED J MALAYSIA, V71
   Lemeshow S., 2004, APPL LOGISTIC REGRES
   Malaysia Remote Sensing Agency MOSTI, MAL DENG INC RAT CAS
   Mokhele I, 2016, SAMJ S AFR MED J, V106, P58, DOI [10.7196/SAMJ.2016.V106I12.11224, 10.7196/SAMJ.2016.v106.i12.11224, 10.7196/SAMJ.2016.v106i12.11224]
   Pacheco O, 2016, N ENGL J MED
   WHO- Western Pacific Region, 2008, AS PAC DENG PROGR MA, P83
   Wong LP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163156
   Wong LP, 2017, FACTORS ASS PREV CON
NR 21
TC 7
Z9 7
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD OCT 13
PY 2017
VL 35
IS 43
BP 5912
EP 5917
DI 10.1016/j.vaccine.2017.08.074
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FJ8ZR
UT WOS:000413057700029
PM 28886944
DA 2020-07-08
ER

PT J
AU Spiteri, G
   Sudre, B
   Septfons, A
   Beaute, J
AF Spiteri, G.
   Sudre, B.
   Septfons, A.
   Beaute, J.
CA European Zika Surveillance Network
TI Surveillance of Zika virus infection in the EU/EEA, June 2015 to January
   2017
SO EUROSURVEILLANCE
LA English
DT Article
AB Surveillance of Zika virus (ZIKV) infection in the European Union/European Economic Area (EU/EEA) was implemented in 2016 in response to the large outbreak reported in the Americas in 2015 associated with an increased number of infants born with microcephaly. Between June 2015 and January 2017, 21 EU/EEA countries reported 2,133 confirmed cases of ZIKV infection, of whom 106 were pregnant women. Cases infected in the Caribbean constituted 71% of reported cases. Almost all cases (99%) were most probably infected by mosquito bite during travel outside continental Europe, while only 1% were transmitted sexually. Considering that 584 imported cases were reported between May and October 2016 among residents of areas with established presence of Aedes albopictus, the absence of autochthonous vector-borne cases suggests that Ae. albopictus is not an efficient vector for ZIKV infection.
C1 [Spiteri, G.; Sudre, B.; Beaute, J.] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
   [Septfons, A.] Sante Publ France, Paris, France.
   [Septfons, A.] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden.
RP Spiteri, G (corresponding author), European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
EM gianfranco.spiteri@ecdc.europa.eu
OI Van Esbroeck, Marjan/0000-0002-7294-6319; Koch,
   Anders/0000-0001-9205-1048; Freedman, Joanne/0000-0002-7840-473X; Rizzo,
   Caterina/0000-0002-5583-7508; Fernandez-Martinez,
   Beatriz/0000-0001-8831-3164
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   European Centre for Disease Prevention and Control (ECDC), 2016, INT GUID HEALTHC PRO
   European Centre for Disease Prevention and Control (ECDC), INT CAS DEF SURV ZIK
   European Centre for Disease Prevention and Control (ECDC), EX MOSQ DISTR MAPS
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Lammert S, 2017, EMERG INFECT DIS, V23, P324, DOI 10.3201/eid2302.161292
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Mollet T, 2012, EUROSURVEILLANCE, V17, P30
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pan American Health Organization (PAHO)/ World Health Organization (WHO), 2016, ZIK EP UPD
   Petersen L.R., 2016, N ENGL J MED
   Septfons A, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.32.30315
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
NR 19
TC 11
Z9 11
U1 0
U2 9
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD OCT 12
PY 2017
VL 22
IS 41
BP 14
EP 20
AR 17-00254
DI 10.2807/1560-7917.ES.2017.22.41.17-00254
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA FJ5TT
UT WOS:000412816600003
PM 29043960
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lombardo, F
   Salvemini, M
   Fiorillo, C
   Nolan, T
   Zwiebel, LJ
   Ribeiro, JM
   Arca, B
AF Lombardo, Fabrizio
   Salvemini, Marco
   Fiorillo, Carmine
   Nolan, Tony
   Zwiebel, Laurence J.
   Ribeiro, Jose M.
   Arca, Bruno
TI Deciphering the olfactory repertoire of the tiger mosquito Aedes
   albopictus
SO BMC GENOMICS
LA English
DT Article
DE Mosquito; Aedes albopictus; Olfaction; Antennae; Maxillary palps;
   mRNA-sequencing; Chemosensory genes
ID ODORANT-BINDING-PROTEINS; AUTOCHTHONOUS DENGUE-FEVER;
   GLUTATHIONE-S-TRANSFERASE; SOUTHERN HOUSE MOSQUITO; ANOPHELES-GAMBIAE;
   CARBON-DIOXIDE; DIFFERENTIAL EXPRESSION; MAXILLARY PALP; IONOTROPIC
   RECEPTORS; COMPARATIVE GENOMICS
AB Background: The Asian tiger mosquito Aedes albopictus is a highly invasive species and competent vector of several arboviruses (e.g. dengue, chikungunya, Zika) and parasites (e.g. dirofilaria) of public health importance. Compared to other mosquito species, Ae. albopictus females exhibit a generalist host seeking as well as a very aggressive biting behaviour that are responsible for its high degree of nuisance. Several complex mosquito behaviours such as host seeking, feeding, mating or oviposition rely on olfactory stimuli that target a range of sensory neurons localized mainly on specialized head appendages such as antennae, maxillary palps and the mouthparts.
   Results: With the aim to describe the Ae. albopictus olfactory repertoire we have used RNA-seq to reveal the transcriptome profiles of female antennae and maxillary palps. Male heads and whole female bodies were employed as reference for differential expression analysis. The relative transcript abundance within each tissue (TPM, transcripts per kilobase per million) and the pairwise differential abundance in the different tissues (fold change values and false discovery rates) were evaluated. Contigs upregulated in the antennae (620) and maxillary palps (268) were identified and relative GO and PFAM enrichment profiles analysed. Chemosensory genes were described: overall, 77 odorant binding proteins (OBP), 82 odorant receptors (OR), 60 ionotropic receptors (IR) and 30 gustatory receptors (GR) were identified by comparative genomics and transcriptomics. In addition, orthologs of genes expressed in the female/male maxillary palps and/or antennae and involved in thermosensation (e.g. pyrexia and arrestin1), mechanosensation (e.g. piezo and painless) and neuromodulation were classified.
   Conclusions: We provide here the first detailed transcriptome of the main Ae. albopictus sensory appendages, i.e. antennae and maxillary palps. A deeper knowledge of the olfactory repertoire of the tiger mosquito will help to better understand its biology and may pave the way to design new attractants/repellents.
C1 [Lombardo, Fabrizio; Fiorillo, Carmine; Arca, Bruno] Sapienza Univ Rome, Div Parasitol, Dept Publ Hlth & Infect Dis, Rome, Italy.
   [Salvemini, Marco] Univ Naples Federico II, Dept Biol, Naples, Italy.
   [Nolan, Tony] Imperial Coll London, Dept Life Sci, London, England.
   [Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.
   [Ribeiro, Jose M.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.
RP Lombardo, F (corresponding author), Sapienza Univ Rome, Div Parasitol, Dept Publ Hlth & Infect Dis, Rome, Italy.
EM fabrizio.lombardo@uniroma1.it
RI ; Arca, Bruno/C-8383-2012
OI Zwiebel, Laurence/0000-0001-6686-7289; SALVEMINI,
   Marco/0000-0003-2297-9267; Arca, Bruno/0000-0002-4029-0984; Nolan,
   Tony/0000-0002-2982-8333
FU FL [228421]; Sapienza University of Rome [C26A14AKKH]; European Union
   grant INFRAVEC [228421]; intramural program of the National Institute of
   Allergy and Infectious DiseasesUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID)
FX This work was supported in the framework of the European network
   INFRAVEC (2011) by funding FL for the project: "Defining the olfactory
   repertoire of the tiger mosquito Aedes albopictus" (Integrating Activity
   number 228421). The work was also supported by Sapienza University of
   Rome, thanks to a Research Project (2014) funded to BA (C26A14AKKH). BA
   was also supported by funds from the European Union grant INFRAVEC
   (228421). JMR was supported by the intramural program of the National
   Institute of Allergy and Infectious Diseases. Because JMR is a
   government employee and this is a government work, the work is in the
   public domain in the United States. Notwithstanding any other
   agreements, the NIH reserves the right to provide the work to
   PubMedCentral for display and use by the public, and PubMedCentral may
   tag or modify the work consistent with its customary practices. You can
   establish rights outside of the U.S. subject to a government use
   license.
CR Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X
   Arca B, 2007, INSECT BIOCHEM MOLEC, V37, P107, DOI 10.1016/j.ibmb.2006.10.007
   Armbruster P, 2009, J MED ENTOMOL, V46, P271, DOI 10.1603/033.046.0211
   Balabanidou V, 2016, P NATL ACAD SCI USA, V113, P9268, DOI 10.1073/pnas.1608295113
   Ben-Shahar Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009395
   Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328
   Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471
   Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x
   Bohbot JD, 2015, FRONT ECOL EVOL, V3, P1
   Bohbot JD, 2014, INSECT BIOCHEM MOLEC, V48, P29, DOI 10.1016/j.ibmb.2014.02.007
   Bohbot JD, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00039
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108
   Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834
   Chen C, 2015, NATURE, V527, P516, DOI 10.1038/nature16148
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Corfas RA, 2015, ELIFE, V4, DOI [10.7554/eLife.11751, 10.7554/eLife.11750]
   Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064
   Deng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068836
   DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831
   Dritsou V, 2015, PATHOG GLOB HEALTH, V109, P207, DOI 10.1179/2047773215Y.0000000031
   Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x
   Erdelyan CNG, 2012, INSECT MOL BIOL, V21, P119, DOI 10.1111/j.1365-2583.2011.01120.x
   Foster WA, 2004, B ENTOMOL RES, V94, P145, DOI 10.1079/BER2003288
   Fowler MA, 2013, LIFE SCI, V92, P394, DOI 10.1016/j.lfs.2012.07.029
   Freeman EG, 2015, CURR OPIN NEUROBIOL, V34, P140, DOI 10.1016/j.conb.2015.06.001
   Garneau NL, 2008, J VIROL, V82, P880, DOI 10.1128/JVI.01205-07
   Gingl E, 2005, J NEUROPHYSIOL, V94, P176, DOI 10.1152/jn.01164.2004
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236
   Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646
   Hodges TK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1089
   Hoel DF, 2007, J AM MOSQUITO CONTR, V23, P11, DOI 10.2987/8756-971X(2007)23[11:EOCDOA]2.0.CO;2
   Hussain A, 2016, PLOS BIOL, V14, P1, DOI DOI 10.1371/J0URNAL.PBI0.1002454
   Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102
   Ramirez GIJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048698
   Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105
   Johnson WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032878
   Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x
   Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789
   Kent LB, 2008, CHEM SENSES, V33, P79, DOI 10.1093/chemse/bjm067
   Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801
   Kim SM, 2016, CURR BIOL, V26, pR408, DOI 10.1016/j.cub.2016.04.040
   Krieger J, 1999, INSECT BIOCHEM MOLEC, V29, P255, DOI 10.1016/S0965-1748(98)00134-9
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lagarde A, 2011, J MOL BIOL, V414, P401, DOI 10.1016/j.jmb.2011.10.005
   Leal WS, 2013, P NATL ACAD SCI USA, V110, P18704, DOI 10.1073/pnas.1316059110
   Leal WS, 2013, ANNU REV ENTOMOL, V58
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li CX, 2012, J MED ENTOMOL, V49, P573, DOI 10.1603/ME11239
   Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467
   Liu HM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1644-9
   Liu S, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev082
   Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062
   Manoharan M, 2013, GENOME BIOL EVOL, V5, P163, DOI 10.1093/gbe/evs131
   Mao W, 2015, INSECT MOL BIOL, V24, P582, DOI 10.1111/imb.12183
   Matthews BJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2239-0
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Merrill CE, 2002, P NATL ACAD SCI USA, V99, P1633, DOI 10.1073/pnas.022505499
   MILLAR JG, 1992, J AM MOSQUITO CONTR, V8, P11
   Montell C, 2016, ADV INSECT PHYSIOL, V51, P293, DOI 10.1016/bs.aiip.2016.04.007
   Murphy EJ, 2013, J BIOL CHEM, V288, P4475, DOI 10.1074/jbc.M112.436386
   Musacchia F, 2015, BIOINFORMATICS, P2
   Neafsey D, 2015, SCIENCE, P1
   Ni LN, 2013, NATURE, V500, P580, DOI 10.1038/nature12390
   Omondi BA, 2015, J EXP BIOL, V218, P2482, DOI 10.1242/jeb.116798
   Park SK, 2006, CURR BIOL, V16, P1154, DOI 10.1016/j.cub.2006.04.028
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pelletier J, 2011, J INSECT PHYSIOL, V57, P915, DOI 10.1016/j.jinsphys.2011.04.003
   Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237
   Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040
   Pitts RJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-26
   Pitts RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40297
   Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271
   R Development Core Team, 2011, LANG ENV STAT COMP
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792
   Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065
   Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y
   Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007
   Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Scialo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036538
   Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4
   Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904
   Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011
   Sparks JT, 2014, INSECT BIOCHEM MOLEC, V48, P8, DOI 10.1016/j.ibmb.2014.02.004
   Sparks JT, INSECT BIOCH MOL BIO
   Stengl M, 2013, J COMP PHYSIOL A, V199, P897, DOI 10.1007/s00359-013-0837-3
   Suh E, 2014, CURR OPIN INSECT SCI, V6, P86, DOI 10.1016/j.cois.2014.10.006
   Sun W, 2012, INT J BIOL SCI, V8, P125, DOI 10.7150/ijbs.8.125
   Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618
   Tan X, 2014, INT J MOL SCI, V15, P7429, DOI 10.3390/ijms15057429
   Taparia T, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3779-2
   Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1
   Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033
   VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827
   Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007
   Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229
   Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x
   Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011
   Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wu D, 2012, NATURE, V484, P214, DOI 10.1038/nature10931
   Yin J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00056
   Zhang W, 2013, P NATL ACAD SCI USA, V110, P13612, DOI 10.1073/pnas.1312477110
   Zhou YH, 2016, INSECT BIOCHEM MOLEC, V75, P45, DOI 10.1016/j.ibmb.2016.05.001
   Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017
NR 114
TC 5
Z9 5
U1 2
U2 22
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD OCT 11
PY 2017
VL 18
AR 770
DI 10.1186/s12864-017-4144-1
PG 23
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA FK4LP
UT WOS:000413466000005
PM 29020917
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hoffmann, HH
   Schneider, WM
   Blomen, VA
   Scull, MA
   Hovnanian, A
   Brummelkamp, TR
   Rice, CM
AF Hoffmann, H. -Heinrich
   Schneider, William M.
   Blomen, Vincent A.
   Scull, Margaret A.
   Hovnanian, Alain
   Brummelkamp, Thijn R.
   Rice, Charles M.
TI Diverse Viruses Require the Calcium Transporter SPCA1 for Maturation and
   Spread
SO CELL HOST & MICROBE
LA English
DT Article
ID RESPIRATORY SYNCYTIAL VIRUS; HAILEY-HAILEY-DISEASE; GREEN FLUORESCENT
   PROTEIN; FUSION PROTEIN; IN-VITRO; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS;
   ENTRY REQUIRES; CLEAVAGE SITE; HOST FACTORS
AB Respiratory and arthropod-borne viral infections are a global threat due to the lack of effective antivirals and vaccines. A potential strategy is to target host proteins required for viruses but non-essential for the host. To identify such proteins, we performed a genome-wide knockout screen in human haploid cells and identified the calcium pump SPCA1. SPCA1 is required by viruses from the Paramyxoviridae, Flaviviridae, and Togaviridae families, including measles, dengue, West Nile, Zika, and chikungunya viruses. Calcium transport activity is required for SPCA1 to promote virus spread. SPCA1 regulates proteases within the trans-Golgi network that require calcium for their activity and are critical for virus glycoprotein maturation. Consistent with these findings, viral glycoproteins fail to mature in SPCA1-deficient cells preventing viral spread, which is evident even in cells with partial loss of SPCA1. Thus, SPCA1 is an attractive antiviral host target for a broad spectrum of established and emerging viral infections.
C1 [Hoffmann, H. -Heinrich; Schneider, William M.; Scull, Margaret A.; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.
   [Blomen, Vincent A.; Brummelkamp, Thijn R.] Netherlands Canc Inst, Biochem Div, NL-1066 CX Amsterdam, Netherlands.
   [Hovnanian, Alain] INSERM, UMR 1163, F-75015 Paris, France.
   [Hovnanian, Alain] Imagine Inst, F-75015 Paris, France.
   [Hovnanian, Alain] Univ Paris V Descartes, Sorbonne Paris Cite, F-75006 Paris, France.
   [Hovnanian, Alain] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France.
   [Brummelkamp, Thijn R.] Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands.
RP Rice, CM (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.
EM ricec@rockefeller.edu
RI Scull, Margaret/K-9963-2019; blomen, vincent/AAE-1477-2020
OI Scull, Margaret/0000-0002-6860-2468
FU Greenberg Medical Research Institute; Robertson Foundation; National
   Institute of Diabetes and Digestive and Kidney Diseases National
   Research Service award [DK095666]; Parker B. Francis Fellowship Program;
   Cancer Genomics Center; European Research Council (ERC) starting
   grantEuropean Research Council (ERC) [ERC-2012-StG 309634]
FX We thank the following investigators for contributing viral molecular
   clones or viral stocks: R. Cattaneo (MeV), P. Collins (RSV, hPIV-3), I.
   Frolov (WNV, VEEV), S. Higgs (CHIKV), J. Rose (VSV), M. MacDonald
   (HSV-1), R. Elliott (BUNV), M. Heise (RRV), J.C. de la Torre (LCMV), and
   the CDC (ZIKV). Wethank A. Moscona for providing the monoclonal hPIV-3 F
   protein antibody 176635-7. We are thankful for the technical advice of
   S. Mazel, S. Semova, S. Tadesse, and S. Han at The Rockefeller
   University Flow Cytometry Resource Center. We thank M. Saeed, K.
   Rozen-Gagnon, and J. Luna for critical reading and helpful comments on
   the manuscript. We also wish to acknowledge S. M. Pecoraro Di Vittorio,
   J. Palarca, G. Santiago, M. Pearce, M. E. Castillo, A. Webson, and S.
   Shirley for outstanding administrative and/or technical support. This
   work was supported in part by a grant from the Greenberg Medical
   Research Institute, the Robertson Foundation, and several generous
   donors. W.M.S. was supported by National Institute of Diabetes and
   Digestive and Kidney Diseases National Research Service award DK095666
   and M.A.S. was supported by the Parker B. Francis Fellowship Program.
   T.R.B. received funding from the Cancer Genomics Center (CGC. nl;
   http://cgc.nl) and the European Research Council (ERC) starting grant
   ERC-2012-StG 309634. T.R.B. is a co-founder and member of the scientific
   advisory board of Haplogen GmbH and a co-founder of Scenic Biotech B. V.
CR Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200
   BANDO H, 1991, VIROLOGY, V184, P87, DOI 10.1016/0042-6822(91)90824-U
   Bassi DE, 2001, MOL CARCINOGEN, V31, P224, DOI 10.1002/mc.1057
   Behne MJ, 2003, J INVEST DERMATOL, V121, P688, DOI 10.1046/j.1523-1747.2003.12528.x
   Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200
   Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003
   Biacchesi S, 2004, VIROLOGY, V321, P247, DOI 10.1016/j.virol.2003.12.020
   Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557
   Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10
   Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348
   Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955
   Chang A, 2012, VIRUSES-BASEL, V4, P613, DOI 10.3390/v4040613
   COELINGH KV, 1989, J VIROL, V63, P3755, DOI 10.1128/JVI.63.9.3755-3760.1989
   COELINGH KV, 1990, J VIROL, V64, P1329, DOI 10.1128/JVI.64.3.1329-1334.1990
   COLLINS MS, 1993, ARCH VIROL, V128, P363, DOI 10.1007/BF01309446
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Dalton KP, 2001, VIROLOGY, V279, P414, DOI 10.1006/viro.2000.0736
   del Valle JR, 2007, J VIROL, V81, P10597, DOI 10.1128/JVI.00923-07
   Dode L, 2005, J BIOL CHEM, V280, P39124, DOI 10.1074/jbc.M506181200
   Fairclough RJ, 2003, J BIOL CHEM, V278, P24721, DOI 10.1074/jbc.M300509200
   Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951
   GLICKMAN RL, 1988, J VIROL, V62, P354, DOI 10.1128/JVI.62.1.354-356.1988
   Gordon VM, 1997, INFECT IMMUN, V65, P4130, DOI 10.1128/IAI.65.10.4130-4134.1997
   GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994
   Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877
   Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548
   Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701
   Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480
   Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675
   Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604
   KAUFMAN RJ, 1994, BIOCHEMISTRY-US, V33, P9813, DOI 10.1021/bi00199a001
   Krahling V, 2009, J VIROL, V83, P2298, DOI 10.1128/JVI.01245-08
   Lissandron V, 2010, P NATL ACAD SCI USA, V107, P9198, DOI 10.1073/pnas.1004702107
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   McGee CE, 2010, VECTOR-BORNE ZOONOT, V10, P267, DOI 10.1089/vbz.2009.0067
   Micaroni M, 2010, TRAFFIC, V11, P1315, DOI 10.1111/j.1600-0854.2010.01096.x
   Moerdyk-Schauwecker M, 2009, ANTIVIR RES, V84, P131, DOI 10.1016/j.antiviral.2009.07.020
   MOLLOY SS, 1992, J BIOL CHEM, V267, P16396
   Moulton HM, 2010, BBA-BIOMEMBRANES, V1798, P2296, DOI 10.1016/j.bbamem.2010.02.012
   Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1
   Ngo N, 2015, J VIROL, V89, P10924, DOI 10.1128/JVI.01587-15
   ODA K, 1992, J BIOL CHEM, V267, P17465
   Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200
   Petrakova O, 2005, J VIROL, V79, P7597, DOI 10.1128/JVI.79.12.7597-7608.2005
   Pillay S, 2016, NATURE, V530, P108, DOI 10.1038/nature16465
   Pillay S, 2015, ANNU REV VIROL, V2, P219, DOI 10.1146/annurev-virology-100114-055119
   Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200
   Riblett AM, 2016, J VIROL, V90, P1414, DOI 10.1128/JVI.02055-15
   Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Shabman RS, 2007, J VIROL, V81, P237, DOI 10.1128/JVI.01590-06
   Shadman KA, 2011, EXPERT OPIN BIOL TH, V11, P1455, DOI 10.1517/14712598.2011.608062
   Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440
   Shi XH, 2010, J VIROL, V84, P8460, DOI 10.1128/JVI.00902-10
   SMITH DW, 1991, NEW ENGL J MED, V325, P24, DOI 10.1056/NEJM199107043250105
   Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131
   TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565
   TASHIRO M, 1988, VIROLOGY, V165, P577, DOI 10.1016/0042-6822(88)90601-0
   Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325
   Vanoevelen J., 2007, V45, P385
   Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003
   Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]
   Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 66
TC 15
Z9 15
U1 0
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD OCT 11
PY 2017
VL 22
IS 4
BP 460
EP +
DI 10.1016/j.chom.2017.09.002
PG 16
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FJ5EG
UT WOS:000412768900009
PM 29024641
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Nitsche, C
   Mahawaththa, MC
   Becker, W
   Huber, T
   Otting, G
AF Nitsche, Christoph
   Mahawaththa, Mithun C.
   Becker, Walter
   Huber, Thomas
   Otting, Gottfried
TI Site-selective tagging of proteins by pnictogen-mediated self-assembly
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID PARAMAGNETIC NMR-SPECTROSCOPY; LANTHANIDE-BINDING TAG; BIOORTHOGONAL
   CHEMISTRY; PSEUDOCONTACT SHIFTS; LABELING PROTEINS; ARSENIC BINDING;
   LIVING CELLS; ACID; BIOCONJUGATION; FLUORESCENT
AB Site-selective chemical protein modification is achieved by self-assembly of a specific di-cysteine motif, trivalent pnictogens (As, Sb or Bi) and an aromatic mercaptomethyl-based probe. The strategy is demonstrated with a quaternary complex involving Zika virus protease and a lanthanide ion, enabling paramagnetic nuclear magnetic resonance spectroscopy and luminescence measurements.
C1 [Nitsche, Christoph; Mahawaththa, Mithun C.; Becker, Walter; Huber, Thomas; Otting, Gottfried] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.
   [Becker, Walter] Karl Franzens Univ Graz, Inst Chem, A-8010 Graz, Austria.
RP Nitsche, C; Otting, G (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.
EM christoph.nitsche@anu.edu.au; gottfried.otting@anu.edu.au
RI Otting, Gottfried/H-8413-2014; Don, Mithun Mahawaththage/N-9503-2019;
   Huber, Thomas/A-5278-2008
OI Otting, Gottfried/0000-0002-0563-0146; Huber,
   Thomas/0000-0002-3680-8699; Becker, Walter/0000-0002-4511-0698;
   Mahawaththa, Mithun/0000-0001-5171-6744
FU Alexander von Humboldt FoundationAlexander von Humboldt Foundation;
   Australian Research CouncilAustralian Research Council
FX C. N. thanks the Alexander von Humboldt Foundation for a Feodor Lynen
   fellowship. Financial support by the Australian Research Council is
   gratefully acknowledged.
CR Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n
   Brieger A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031863
   Cangelosi VM, 2010, INORG CHEM, V49, P9985, DOI 10.1021/ic1012186
   Cangelosi VM, 2010, CRYST GROWTH DES, V10, P3531, DOI 10.1021/cg100444n
   Chen BB, 2015, METALLOMICS, V7, P39, DOI 10.1039/c4mt00222a
   Chen JL, 2016, ANGEW CHEM INT EDIT, V55, P13744, DOI 10.1002/anie.201606223
   Collins MS, 2015, CHEM SCI, V6, P2444, DOI 10.1039/c4sc04042b
   Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269
   Huang CS, 2014, J AM CHEM SOC, V136, P14237, DOI 10.1021/ja5079656
   Jia XY, 2011, CHEM-EUR J, V17, P6830, DOI 10.1002/chem.201003573
   Jing CR, 2011, ACCOUNTS CHEM RES, V44, P784, DOI 10.1021/ar200099f
   Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w
   Lang K, 2014, ACS CHEM BIOL, V9, P16, DOI 10.1021/cb4009292
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Ma FH, 2014, CHEM-ASIAN J, V9, P1808, DOI 10.1002/asia.201402095
   Man B, 2010, CHEM-EUR J, V16, P3827, DOI 10.1002/chem.200902904
   McKay CS, 2014, CHEM BIOL, V21, P1075, DOI 10.1016/j.chembiol.2014.09.002
   Nitsche C, 2017, PROG NUCL MAG RES SP, V98-99, P20, DOI 10.1016/j.pnmrs.2016.11.001
   Patterson DM, 2014, ACS CHEM BIOL, V9, P592, DOI 10.1021/cb400828a
   Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407
   Rodriguez EA, 2017, TRENDS BIOCHEM SCI, V42, P111, DOI 10.1016/j.tibs.2016.09.010
   Sample V, 2009, CHEM SOC REV, V38, P2852, DOI 10.1039/b913033k
   Schmitz C, 2008, J BIOMOL NMR, V41, P179, DOI 10.1007/s10858-008-9249-z
   Shen SW, 2013, CHEM REV, V113, P7769, DOI 10.1021/cr300015c
   Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942
   Stavila V, 2006, COORDIN CHEM REV, V250, P2782, DOI 10.1016/j.ccr.2006.02.032
   Studer RA, 2013, BIOCHEM J, V449, P581, DOI 10.1042/BJ20121221
   Su XC, 2008, J AM CHEM SOC, V130, P10486, DOI 10.1021/ja803741f
   Takaoka Y, 2013, ANGEW CHEM INT EDIT, V52, P4088, DOI 10.1002/anie.201207089
   Wang K, 2014, J CELL BIOCHEM, V115, P1007, DOI 10.1002/jcb.24762
   Wang YY, 2016, CHEM SCI, V7, P518, DOI 10.1039/c5sc02824h
   Watt MM, 2013, ACCOUNTS CHEM RES, V46, P955, DOI 10.1021/ar300100g
   Wilson P, 2015, J AM CHEM SOC, V137, P4215, DOI 10.1021/jacs.5b01140
NR 33
TC 5
Z9 5
U1 2
U2 30
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PD OCT 11
PY 2017
VL 53
IS 79
BP 10894
EP 10897
DI 10.1039/c7cc06155b
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA FI7IF
UT WOS:000412169700008
PM 28890978
DA 2020-07-08
ER

PT J
AU Wu, YL
   Li, S
   Du, LY
   Wang, CY
   Zou, P
   Hong, BB
   Yuan, MJ
   Ren, XN
   Tai, WB
   Kong, Y
   Zhou, C
   Lu, L
   Zhou, XH
   Jiang, SB
   Ying, TL
AF Wu, Yanling
   Li, Shun
   Du, Lanying
   Wang, Chunyu
   Zou, Peng
   Hong, Binbin
   Yuan, Mengjiao
   Ren, Xiaonan
   Tai, Wanbo
   Kong, Yu
   Zhou, Chen
   Lu, Lu
   Zhou, Xiaohui
   Jiang, Shibo
   Ying, Tianlei
TI Neutralization of Zika virus by germline-like human monoclonal
   antibodies targeting cryptic epitopes on envelope domain III
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE cryptic epitope; human monoclonal antibodies; Zika virus
ID RESPIRATORY SYNDROME CORONAVIRUS; DENGUE-VIRUS; THERAPEUTIC ANTIBODIES;
   STRUCTURAL BASIS; INFECTION; POTENT; VACCINE; MICE; IDENTIFICATION;
   GLYCOPROTEIN
AB The Zika virus (ZIKV), a flavivirus transmitted by Aedes mosquitoes, has emerged as a global public health concern. Pre-existing cross-reactive antibodies against other flaviviruses could modulate immune responses to ZIKV infection by antibody-dependent enhancement, highlighting the importance of understanding the immunogenicity of the ZIKV envelope protein. In this study, we identified a panel of human monoclonal antibodies (mAbs) that target domain III (DIII) of the ZIKV envelope protein from a very large phage-display naive antibody library. These germline-like antibodies, sharing 98%-100% hoLogy with their corresponding germline IGHV genes, bound ZIKV DIII specifically with high affinities. One mAb, m301, broadly neutralized the currently circulating ZIKV strains and showed a synergistic effect with another mAb, m302, in neutralizing ZIKV in vitro and in a mouse model of ZIKV infection. Interestingly, epitope mapping and competitive binding studies suggest that m301 and m302 bind adjacent regions of the DIII C-C' loop, which represents a recently identified cryptic epitope that is intermittently exposed in an uncharacterized virus conformation. This study extended our understanding of antigenic epitopes of ZIKV antibodies and has direct implications for the design of ZIKV vaccines.
C1 [Wu, Yanling; Wang, Chunyu; Hong, Binbin; Kong, Yu; Lu, Lu; Jiang, Shibo; Ying, Tianlei] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol, Minist Educ, Shanghai 200032, Peoples R China.
   [Wu, Yanling; Wang, Chunyu; Hong, Binbin; Kong, Yu; Lu, Lu; Jiang, Shibo; Ying, Tianlei] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol, Minist Hlth, Shanghai 200032, Peoples R China.
   [Li, Shun; Zou, Peng; Yuan, Mengjiao; Ren, Xiaonan; Lu, Lu; Zhou, Xiaohui] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China.
   [Du, Lanying; Tai, Wanbo; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
   [Zhou, Chen] Biomissile Corp, Shanghai 201203, Peoples R China.
RP Jiang, SB; Ying, TL (corresponding author), Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol, Minist Educ, Shanghai 200032, Peoples R China.; Jiang, SB; Ying, TL (corresponding author), Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol, Minist Hlth, Shanghai 200032, Peoples R China.; Zhou, XH (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China.; Jiang, SB (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
EM zhouxiaohui@shaphc.org; shibojiang@fudan.edu.cn; tlying@fudan.edu.cn
RI Lu, Lu/K-7070-2014; Jiang, Shibo/L-4500-2014; Tai, Wanbo/G-3838-2018; 应,
   天雷/P-5396-2019
OI Lu, Lu/0000-0002-2255-0391; Tai, Wanbo/0000-0002-9864-8993; 应,
   天雷/0000-0002-9597-2843
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31570936, 81561128006]; Shanghai Public Health
   Clinical Center [SPHCC-2016-27]; National Key Research and Development
   Program of China [2016YFC1201000, 2016YFC1200405, 2016YFC1202900,
   2016YFC1202901]; Shanghai Science and Technology CommissionScience &
   Technology Commission of Shanghai Municipality (STCSM)Shanghai Science &
   Technology Committee [15DZ2290200]; Technology Service Platform for
   detecting high-level biological safety pathogenic microorganisms
FX We thank Prof Cheng-Feng Qin for the gift of ZIKV strain SZ01. The
   following reagents were obtained through BEI Resources, NIAID, NIH
   (Bethesda, MD, USA): Zika Virus, R103451, NR-50355; PRVABC59, NR-50240;
   H/PAN/2015/CDC-259359, NR-50219; and FLR, NR-50183. This work was
   supported by the National Natural Science Foundation of China (31570936,
   81561128006), the Shanghai Public Health Clinical Center
   (SPHCC-2016-27), the National Key Research and Development Program of
   China (2016YFC1201000, 2016YFC1200405, 2016YFC1202900, and
   2016YFC1202901), and the Technology Service Platform for detecting
   high-level biological safety pathogenic microorganisms supported by the
   Shanghai Science and Technology Commission (15DZ2290200).
CR Agrawal AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31629
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Coloma J, 2015, NAT IMMUNOL, V16, P135, DOI 10.1038/ni.3081
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Feng Y, 2016, MABS-AUSTIN, V8, P799, DOI 10.1080/19420862.2016.1155014
   Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Gong Rui, 2012, Methods Mol Biol, V899, P85, DOI 10.1007/978-1-61779-921-1_6
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Li XQ, 2013, J GEN VIROL, V94, P2191, DOI 10.1099/vir.0.055178-0
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Poggianella M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003947
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Puligujja P, 2015, BIOMATERIALS, V41, P141, DOI 10.1016/j.biomaterials.2014.11.012
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07
   Teplyakov A, 2016, MABS-AUSTIN, V8, P1045, DOI 10.1080/19420862.2016.1190060
   Thomas SJ, 2017, NEW ENGL J MED, V376, P1883, DOI 10.1056/NEJMcibr1701402
   Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06
   Tsai WY, 2013, J VIROL, V87, P12562, DOI 10.1128/JVI.00871-13
   Vratskikh O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003458
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Ying TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9223
   Ying TL, 2014, J VIROL, V88, P7796, DOI 10.1128/JVI.00912-14
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep25856
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 58
TC 18
Z9 19
U1 2
U2 19
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD OCT 11
PY 2017
VL 6
AR e89
DI 10.1038/emi.2017.79
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FK4ER
UT WOS:000413442900005
PM 29018252
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Voelker, R
AF Voelker, Rebecca
TI Virgin Islands' Zika Awareness
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD OCT 10
PY 2017
VL 318
IS 14
BP 1315
EP 1315
DI 10.1001/jama.2017.14435
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA FJ6BP
UT WOS:000412838900007
PM 29049592
DA 2020-07-08
ER

PT J
AU Watanabe, M
   Buth, JE
   Vishlaghi, N
   de la Torre-Ubieta, L
   Taxidis, J
   Khakh, BS
   Coppola, G
   Pearson, CA
   Yamauchi, K
   Gong, DY
   Dai, XH
   Damoiseaux, R
   Aliyari, R
   Liebscher, S
   Schenke-Layland, K
   Caneda, C
   Huang, EJ
   Zhang, Y
   Cheng, GH
   Geschwind, DH
   Golshani, P
   Sun, R
   Novitch, BG
AF Watanabe, Momoko
   Buth, Jessie E.
   Vishlaghi, Neda
   de la Torre-Ubieta, Luis
   Taxidis, Jiannis
   Khakh, Baljit S.
   Coppola, Giovanni
   Pearson, Caroline A.
   Yamauchi, Ken
   Gong, Danyang
   Dai, Xinghong
   Damoiseaux, Robert
   Aliyari, Roghiyh
   Liebscher, Simone
   Schenke-Layland, Katja
   Caneda, Christine
   Huang, Eric J.
   Zhang, Ye
   Cheng, Genhong
   Geschwind, Daniel H.
   Golshani, Peyman
   Sun, Ren
   Novitch, Bennett G.
TI Self-Organized Cerebral Organoids with Human-Specific Features Predict
   Effective Drugs to Combat Zika Virus Infection
SO CELL REPORTS
LA English
DT Article
ID EMBRYONIC STEM-CELLS; OUTER RADIAL GLIA; CORTICAL DEVELOPMENT; HUMAN
   BRAIN; NEURAL PROGENITORS; DIFFERENTIATION; NEOCORTEX; PRECURSORS;
   DISORDERS; EVOLUTION
AB The human cerebral cortex possesses distinct structural and functional features that are not found in the lower species traditionally used to model brain development and disease. Accordingly, considerable attention has been placed on the development of methods to direct pluripotent stem cells to form human brain-like structures termed organoids. However, many organoid differentiation protocols are inefficient and display marked variability in their ability to recapitulate the three-dimensional architecture and course of neurogenesis in the developing human brain. Here, we describe optimized organoid culture methods that efficiently and reliably produce cortical and basal ganglia structures similar to those in the human fetal brain in vivo. Neurons within the organoids are functional and exhibit network-like activities. We further demonstrate the utility of this organoid system for modeling the teratogenic effects of Zika virus on the developing brain and identifying more susceptibility receptors and therapeutic compounds that can mitigate its destructive actions.
C1 [Watanabe, Momoko; Buth, Jessie E.; Vishlaghi, Neda; Khakh, Baljit S.; Pearson, Caroline A.; Yamauchi, Ken; Novitch, Bennett G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.
   [Watanabe, Momoko; Buth, Jessie E.; Vishlaghi, Neda; Yamauchi, Ken; Geschwind, Daniel H.; Novitch, Bennett G.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.
   [Watanabe, Momoko; Buth, Jessie E.; Vishlaghi, Neda; de la Torre-Ubieta, Luis; Coppola, Giovanni; Pearson, Caroline A.; Yamauchi, Ken; Caneda, Christine; Zhang, Ye; Geschwind, Daniel H.; Golshani, Peyman; Novitch, Bennett G.] Univ Calif Los Angeles, Intellectual & Dev Disabil Res Ctr, Los Angeles, CA 90095 USA.
   [de la Torre-Ubieta, Luis; Coppola, Giovanni; Geschwind, Daniel H.; Golshani, Peyman] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA.
   [de la Torre-Ubieta, Luis; Coppola, Giovanni; Geschwind, Daniel H.; Golshani, Peyman] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Program Neurobehav Genet, Los Angeles, CA 90095 USA.
   [de la Torre-Ubieta, Luis; Taxidis, Jiannis; Coppola, Giovanni; Geschwind, Daniel H.; Golshani, Peyman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.
   [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.
   [de la Torre-Ubieta, Luis; Coppola, Giovanni; Caneda, Christine; Zhang, Ye; Golshani, Peyman] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.
   [Gong, Danyang; Dai, Xinghong; Damoiseaux, Robert; Sun, Ren] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   [Gong, Danyang; Dai, Xinghong; Damoiseaux, Robert; Sun, Ren] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.
   [Aliyari, Roghiyh; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Schenke-Layland, Katja] Univ Calif Los Angeles, David Geffen Sch Med, Dept Cardiol, Los Angeles, CA 90095 USA.
   [Liebscher, Simone; Schenke-Layland, Katja] Eberhard Karls Univ Tubingen, Res Inst Womens Hlth, Dept Womens Hlth, D-72076 Tubingen, Germany.
   [Schenke-Layland, Katja] Fraunhofer Inst Interfacial Engn & Biotechnol, Dept Cell & Tissue Engn, D-70569 Stuttgart, Germany.
   [Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA.
RP Novitch, BG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.; Novitch, BG (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.; Novitch, BG (corresponding author), Univ Calif Los Angeles, Intellectual & Dev Disabil Res Ctr, Los Angeles, CA 90095 USA.
EM bnovitch@ucla.edu
RI Damoiseaux, Robert/F-1086-2011; Huang, Eric J./AAH-7997-2019
OI Damoiseaux, Robert/0000-0002-7611-7534; Huang, Eric
   J./0000-0002-5381-3801; Novitch, Bennett/0000-0002-2696-3708; Dai,
   Xinghong/0000-0002-4102-3175
FU UCLA Eli; Edythe Broad Center of Regenerative Medicine and Stem Cell
   Research; Rose Hills Foundation; Binder Family Foundation; UCLA Clinical
   and Translational Science Institute; California Institute for
   Regenerative Medicine (CIRM)California Institute for Regenerative
   Medicine [DISC1-08819]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01NS089817,
   R01NS085227, R01MH060233, R01MH100027, U01MH103339, R01MH110927,
   R01MH094714, R01AI069120, R01AI056154, R01AI078389, R00NS089780,
   P01NS083513]; UCLA Broad Stem Cell Research Center; Uehara Memorial
   FoundationUehara Memorial Foundation; UCLA-California State University
   Northridge CIRM-Bridges [TB1-00183]; California Institute for
   Regenerative Medicine (CIRM)-BSCRC [TG2-01169]; Ministry of Science,
   Research and Arts of Baden-Wurttemberg [Az.: 33-729.55-3/214]; NINDS
   Informatics Center for Neurogenetics and Neurogenomics [P30NS062691];
   NICHDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [U54HD087101]
FX We are grateful to B. Van Handel, K. Morizono, and the Broad Stem Cell
   Research Center (BSCRC) Stem Cell Core for materials; D. Moore and D.
   Sivalingam for technical assistance; the UCLA Clinical Microarray Core
   and F. Gao (Informatics Center for Neurogenetics and Neurogenomics) for
   assistance with RNA sequencing experiments and data analysis; and the
   Molecular Screening Shared Resource and BSCRC Microscopy Core for access
   to imaging facilities. We also thank S. Butler, W. Lowry, and D. Silver
   for invaluable discussions and comments on the manuscript. M.W. is
   thankful to Y. Sasai for mentorship and H. Sakaguchi and T. Kadoshima
   for invaluable technical and intellectual interactions. This work was
   supported by research awards from the UCLA Eli and Edythe Broad Center
   of Regenerative Medicine and Stem Cell Research, the Rose Hills
   Foundation, the Binder Family Foundation, and the UCLA Clinical and
   Translational Science Institute and by grants from the California
   Institute for Regenerative Medicine (CIRM) (DISC1-08819) and the NIH
   (R01NS089817 and R01NS085227) to B.G.N. M.W. was supported by
   postdoctoral training awards provided by the UCLA Broad Stem Cell
   Research Center and the Uehara Memorial Foundation; J.E.B. and N.V. were
   supported partly by the UCLA-California State University Northridge
   CIRM-Bridges training program (TB1-00183); D.H.G. was supported by the
   NIH (R01MH060233, R01MH100027, U01MH103339, R01MH110927, and
   R01MH094714); L.T.-U. was supported by a California Institute for
   Regenerative Medicine (CIRM)-BSCRC training grant (TG2-01169); G. Cheng
   was supported by the NIH (R01AI069120, R01AI056154, and R01AI078389);
   Y.Z. was supported by the NIH (R00NS089780); E.J.H. was supported by the
   NIH (P01NS083513); and S.L. and K. S.-L. were supported by the Ministry
   of Science, Research and Arts of Baden-Wurttemberg (Az.:
   33-729.55-3/214). We also acknowledge the support of the NINDS
   Informatics Center for Neurogenetics and Neurogenomics (P30NS062691) to
   G. Coppola and both Cells, Circuits, and Systems Analysis and Genetics
   and Genomics Cores of the Semel Institute of Neuroscience at UCLA, which
   are supported by the NICHD (U54HD087101).
CR Adams KL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7778
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571
   Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06
   Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Golshani P, 2009, J NEUROSCI, V29, P10890, DOI 10.1523/JNEUROSCI.2012-09.2009
   Gregg C, 2005, DEVELOPMENT, V132, P565, DOI 10.1242/dev.01592
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mi HY, 2001, J NEUROSCI, V21, P1538
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore AR, 2009, CEREB CORTEX, V19, P1795, DOI 10.1093/cercor/bhn206
   Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479
   Ng YP, 2006, J BIOL CHEM, V281, P15636, DOI 10.1074/jbc.M601863200
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   O'Driscoll M, 2008, DNA REPAIR, V7, P1039, DOI 10.1016/j.dnarep.2008.03.018
   Otsuji TG, 2014, STEM CELL REP, V2, P734, DOI [10.1016/j.stemcr.2014.03.012, 10.1016/j.stemcr.2014.04.013]
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016
   Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2016, NAT MED, V22, P1220, DOI 10.1038/nm.4214
   Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719
   Renner M, 2017, EMBO J, V36, P1316, DOI 10.15252/embj.201694700
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Simamura E, 2010, ENDOCRINOLOGY, V151, P1853, DOI 10.1210/en.2009-0985
   Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035
   Stubbs D, 2009, CEREB CORTEX, V19, pI32, DOI 10.1093/cercor/bhp040
   Sullivan KD, 2016, ELIFE, V5, DOI 10.7554/eLife.16220
   Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
NR 54
TC 84
Z9 84
U1 2
U2 21
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD OCT 10
PY 2017
VL 21
IS 2
BP 517
EP 532
DI 10.1016/j.celrep.2017.09.047
PG 16
WC Cell Biology
SC Cell Biology
GA FJ4DR
UT WOS:000412686100020
PM 29020636
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Melo, CFOR
   Delafiori, J
   de Oliveira, DN
   Guerreiro, TM
   Esteves, CZ
   Lima, ED
   Pando-Robles, V
   Catharino, RR
AF Melo, Carlos Fernando O. R.
   Delafiori, Jeany
   de Oliveira, Diogo N.
   Guerreiro, Tatiane M.
   Esteves, Cibele Z.
   Lima, Estela de O.
   Pando-Robles, Victoria
   Catharino, Rodrigo R.
CA Zika-Unicamp Network
TI Serum Metabolic Alterations upon Zika Infection
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; mass spectrometry; metabolomics; viromics
ID RENIN-ANGIOTENSIN SYSTEM; CONVERTING ENZYME 2; SEXUAL TRANSMISSION;
   ALDOSTERONE SYSTEM; LIPID PROFILE; APRIL 2016; VIRUS; DENGUE; RECEPTORS;
   MAS
AB Zika virus (ZIKV) infection has recently emerged as a major concern worldwide due to its strong association with nervous system malformation (microcephaly) of fetuses in pregnant women infected by the virus. Signs and symptoms of ZIKV infection are often mistaken with other common viral infections. Since transmission may occur through biological fluids exchange and coitus, in addition to mosquito bite, this condition is an important infectious disease. Thus, understanding the mechanism of viral infection has become an important research focus, as well as providing potential targets for assertive clinical diagnosis and quality screening for hemoderivatives. Within this context, the present work analyzed blood plasma from 79 subjects, divided as a control group and a ZIKV-infected group. Samples underwent direct-infusion mass spectrometry and statistical analysis, where eight markers related to the pathophysiological process of ZIKV infection were elected and characterized. Among these, Angiotensin (1-7) and Angiotensin I were upregulated under infection, showing an attempt to induce autophagy of the infected cells. However, this finding is concerning about hypertensive individuals under treatment with inhibitors of the Renin-Angiotensin System (RAS), which could reduce this response against the virus and exacerbate the symptoms of the infection. Moreover, one of the most abundant glycosphingolipids in the nervous tissue, Ganglioside GM2, was also elected in the present study as an infection biomarker. Considered an important pathogen receptor at membrane's outer layer, this finding represents the importance of gangliosides for ZIKV infection and its association with brain tropism. Furthermore, a series of phosphatidylinositols were also identified as biomarkers, implying a significant role of the PI3K-AKT-mTOR Pathway in this mechanism. Finally, these pathways may also be understood as potential targets to be considered in pharmacological intervention studies on ZIKV infection management.
C1 [Melo, Carlos Fernando O. R.; Delafiori, Jeany; de Oliveira, Diogo N.; Guerreiro, Tatiane M.; Esteves, Cibele Z.; Lima, Estela de O.; Catharino, Rodrigo R.] Univ Estadual Campinas, Sch Pharmaceut Sci, INNOVARE Biomarkers Lab, Campinas, SP, Brazil.
   [Pando-Robles, Victoria] Inst Nacl Salud Publ, Unidad Prote, Cuernavaca, Morelos, Mexico.
RP Catharino, RR (corresponding author), Univ Estadual Campinas, Sch Pharmaceut Sci, INNOVARE Biomarkers Lab, Campinas, SP, Brazil.
EM rrcatharino@gmail.com
RI Colella-Santos, Maria Francisca/A-6008-2013; amsalu, ribka/G-8780-2019;
   de Oliveira Lima, Estela/G-7375-2015; Delafiori, Jeany/G-9250-2017; de
   Souza Barnabe, Ana Caroline/AAJ-9487-2020; Milanez,
   Guilherme/G-6457-2016; Fertrin, Kleber/M-4175-2013; de Oliveira, Diogo
   Noin/C-3939-2013; Modena, Jose Luiz Proenca/C-8231-2014; Lima,
   Estela/W-5105-2019; Freitas, Andre Ricardo Ribas/L-1969-2016; Angerami,
   Rodrigo Nogueira/A-8926-2013; Arns, Clarice/F-2762-2015; Judice,
   Carla/P-4738-2014
OI Colella-Santos, Maria Francisca/0000-0002-7456-9502; de Oliveira Lima,
   Estela/0000-0003-0479-0364; de Souza Barnabe, Ana
   Caroline/0000-0002-8481-8226; Milanez, Guilherme/0000-0002-8599-1098;
   Fertrin, Kleber/0000-0003-2637-3297; de Oliveira, Diogo
   Noin/0000-0002-2725-476X; Modena, Jose Luiz Proenca/0000-0002-4996-3153;
   Lima, Estela/0000-0003-0479-0364; Freitas, Andre Ricardo
   Ribas/0000-0003-0291-7771; Angerami, Rodrigo
   Nogueira/0000-0002-4976-9238; Arns, Clarice/0000-0002-7308-460X;
   Ribeiro-do-Valle, Carolina/0000-0002-2630-9909; Vinolo, Marco
   Aurelio/0000-0003-1335-760X; de Toledo Teixeira, Daniel
   Augusto/0000-0002-4055-058X; Calil, Roseli/0000-0001-5120-6955; Melo,
   Carlos/0000-0003-0334-1065; Judice, Carla/0000-0003-1839-053X;
   PANDO-ROBLES, VICTORIA/0000-0002-9633-5627; Guerreiro,
   Tatiane/0000-0002-4114-1243
FU Sao Paulo Research FoundationFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [FAPESP 17/20614-4, 16/17066-2, 14/00302-0,
   11/50400-0, 15/06809-1]; CAPESCAPES [PNPD 1578388, PROEX 1489740]; Plano
   Nacional de Enfrentamento ao Aedes aegypti e Microcefalia from the
   Brazilian Ministry of Health [88887.137889/2017-00]
FX The authors would like to thank the Sao Paulo Research Foundation
   (FAPESP 17/20614-4) for the fellowships of CM (16/17066-2) and CL
   (14/00302-0), and the grants for RC (11/50400-0 and 15/06809-1). We also
   acknowledge CAPES for the scholarships for EL (PNPD 1578388) and TG
   (PROEX 1489740). DdO acknowledges the Plano Nacional de Enfrentamento ao
   Aedes aegypti e Microcefalia from the Brazilian Ministry of Health for
   the fellowship (88887.137889/2017-00).
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Cabandugama PK, 2017, MED CLIN N AM, V101, P129, DOI 10.1016/j.mcna.2016.08.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Center for Biologics Evaluation and Research, 2016, DON SCREEN REC RED R
   Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108
   Cui L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002373
   Daumas RP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-77
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dunn WB, 2013, METABOLOMICS, V9, pS44, DOI 10.1007/s11306-012-0434-4
   Duran A, 2015, ARCH VIROL, V160, P1687, DOI 10.1007/s00705-015-2433-z
   Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005
   EIDELS L, 1983, MICROBIOL REV, V47, P596, DOI 10.1128/MMBR.47.4.596-620.1983
   Fedson DS, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.11.03
   Ferrario CM, 1998, REGUL PEPTIDES, V78, P13, DOI 10.1016/S0167-0115(98)00134-7
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Giani JF, 2007, AM J PHYSIOL-HEART C, V293, pH1154, DOI 10.1152/ajpheart.01395.2006
   Gu HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19840
   Junot C, 2014, MASS SPECTROM REV, V33, P471, DOI 10.1002/mas.21401
   Katz LM, 2017, ARCH PATHOL LAB MED, V141, P85, DOI 10.5858/arpa.2016-0430-RA
   Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lima ED, 2015, ANAL CHEM, V87, P3585, DOI 10.1021/acs.analchem.5b00097
   Lumbers ER, 2014, AM J PHYSIOL-REG I, V306, pR91, DOI 10.1152/ajpregu.00034.2013
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Mazzon M, 2014, CELL MICROBIOL, V16, P1493, DOI 10.1111/cmi.12340
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Melo CFOR, 2016, PARASITOL RES, V115, P4107, DOI 10.1007/s00436-016-5183-2
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Hernandez-Fonseca JP, 2015, ARCH VIROL, V160, P2861, DOI 10.1007/s00705-015-2581-1
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Passos-Silva DG, 2013, CLIN SCI, V124, P443, DOI 10.1042/CS20120461
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sampaio WO, 2007, HYPERTENSION, V49, P185, DOI 10.1161/01.HYP.0000251865.35728.2f
   Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341
   Saraiva VB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017174
   Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176
   Tikellis C, 2011, CURR OPIN NEPHROL HY, V20, P62, DOI 10.1097/MNH.0b013e328341164a
   Tokuda S, 2011, HUM MOL GENET, V20, P988, DOI 10.1093/hmg/ddq544
   Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439
   van Doorn PA, 2016, BRAIN, V139, P1622, DOI 10.1093/brain/aww078
   van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539
   van Vark LC, 2012, EUR HEART J, V33, P2088, DOI 10.1093/eurheartj/ehs075
   Wang KZ, 2016, INT J BIOL SCI, V12, P872, DOI 10.7150/ijbs.15641
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
   Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11
   Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319
   Zou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4594
NR 54
TC 13
Z9 13
U1 0
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD OCT 10
PY 2017
VL 8
AR 1954
DI 10.3389/fmicb.2017.01954
PG 10
WC Microbiology
SC Microbiology
GA FJ2PM
UT WOS:000412571700005
PM 29067015
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kamgang, B
   Yougang, AP
   Tchoupo, M
   Riveron, JM
   Wondji, C
AF Kamgang, Basile
   Yougang, Aurelie P.
   Tchoupo, Micareme
   Riveron, Jacob M.
   Wondji, Charles
TI Temporal distribution and insecticide resistance profile of two major
   arbovirus vectors Aedes aegypti and Aedes albopictus in Yaounde, the
   capital city of Cameroon
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Arboviruses; Temporal distribution;
   Spatial distribution; Insecticide resistance
ID SODIUM-CHANNEL GENE; DENGUE VECTORS; CENTRAL-AFRICA; PYRETHROID
   RESISTANCE; DIPTERA-CULICIDAE; CHIKUNGUNYA-VIRUS; THAILAND; REGION;
   STATE
AB Background: Aedes aegypti and Ae. albopictus are the major epidemic vectors of several arbovirus diseases such as yellow fever, dengue, Zika and chikungunya worldwide. Both Aedes vectors are presents in Cameroon; however, knowledge on the dynamic of the distribution of these species across cities and their resistance profile to insecticide are limited. Here, we assessed the current distribution of Ae. aegypti and Ae. albopictus in Yaounde, the Capital City, established the resistance profile to insecticides and explored the resistance mechanisms involved.
   Methods: Immature stages of Aedes were sampled in several breeding sites in December 2015 (dry season) and June 2016 (rainy season) in three central neighborhoods and four peripheral neighborhoods and reared to adult stage. The G0 adults were used for molecular identification and genotyping of F1534C mutation in Ae. aegypti. Bioassays and piperonyl butoxide (PBO) assays were carried out according to WHO guidelines.
   Results: Analysis revealed that both species Ae. aegypti and Ae. albopictus are present in all prospected sites in Yaounde. However, in the dry season Ae. aegypti is most abundant in neighborhoods located in downtown. In contrast, Ae. albopictus was found most prevalent in suburbs whatever the season and in downtown during the rainy season. Bioassay analysis showed that both Ae. aegypti and Ae. albopictus, are resistant to 0.05% deltamethrin, 0.1% bendiocarb and 4% dichlorodiphenyltrichloroethane (DDT). A decreased of susceptibility to 0.75% permethrin and a full susceptibility to malathion 5% was observed. The mortality rate was increased after pre-exposure to synergist PBO. None of Ae. aegypti assayed revealed the presence of F1534C mutation.
   Conclusion: These findings are useful to planning vector control programme against arbovirus vectors in Cameroon and can be used as baseline in Africa where data on Aedes resistance is very scarce to plan further works.
C1 [Kamgang, Basile; Yougang, Aurelie P.; Tchoupo, Micareme; Riveron, Jacob M.; Wondji, Charles] Univ Liverpool Liverpool Sch Trop Med, Org Coordinat Lutte Endemies Afrique Cent, Res Unit, POB 288, Yaounde, Cameroon.
   [Yougang, Aurelie P.] Univ Yaounde I, Fac Sci, Dept Anim Biol, Yaounde, Cameroon.
   [Riveron, Jacob M.; Wondji, Charles] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
RP Kamgang, B (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Org Coordinat Lutte Endemies Afrique Cent, Res Unit, POB 288, Yaounde, Cameroon.
EM kamgang_d@yahoo.fr
RI Wondji, Charles/AAG-1510-2020
OI Kamgang, Basile/0000-0002-8883-4557; Wondji, Charles
   S./0000-0003-0791-3673
FU LSTM/OCEAC research unit through the Wellcome Trust [083515/Z/07/Z]
FX This work was supported by the LSTM/OCEAC research unit through the
   Wellcome Trust 083515/Z/07/Z awarded to Charles Wondji. The funders had
   no role in study design, data collection or analysis, decision to
   publish or preparation of the manuscript.
CR Ayorinde A, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev045
   Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110
   Beebe NW, 2007, J MED ENTOMOL, V44, P376, DOI 10.1603/0022-2585(2007)44[376:APCRDT]2.0.CO;2
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Macoris MDD, 2014, REV SOC BRAS MED TRO, V47, P573, DOI 10.1590/0037-8682-0141-2014
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franco L, 2010, EURO SURVEILL, V15
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Ishak IH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005302
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Jirakanjanakit N, 2007, J ECON ENTOMOL, V100, P545, DOI 10.1603/0022-0493(2007)100[545:IRSIAS]2.0.CO;2
   Jupp P.G., 1996, MOSQUITOES SO AFRICA
   Kamgang B, 2010, MED VET ENTOMOL, V24, P132, DOI 10.1111/j.1365-2915.2010.00869.x
   Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kanesa-thasan N, 1998, EMERG INFECT DIS, V4, P299, DOI 10.3201/eid0402.980220
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kawada H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004780
   Labbe P, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P363, DOI 10.1016/B978-0-12-384890-1.00014-5
   Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104
   LIVAK KJ, 1984, GENETICS, V107, P611
   Lounibos LP, 2002, J VECTOR ECOL, V27, P86
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745
   Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392
   Menze BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163261
   Mohsin Muhammad, 2016, International Journal of Mosquito Research, V3, P41
   Mouchet J, 1972, WHOVBC72381, P12
   Ngoagouni C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1887-5
   Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003
   Ranson H, 2010, TROPIKANET, V1, P277
   Ridde V, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0120-2
   Rodier GR, 1996, T ROY SOC TROP MED H, V90, P237, DOI 10.1016/S0035-9203(96)90228-X
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Sathantriphop S, 2006, TROP BIOMED, V23, P97
   Schwartz E, 2013, EURO SURVEILL, V18
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   Tene BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061408
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   WHO, 2013, TEST PROC INREMO
   WHO, 2005, WHO STAT 1 M INT HLT, P2016
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   World Health Organization, 2016, ENT SURV AED SPP CON
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
NR 54
TC 16
Z9 16
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD OCT 10
PY 2017
VL 10
AR 469
DI 10.1186/s13071-017-2408-x
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FJ4GE
UT WOS:000412693600012
PM 29017606
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Hiolski, E
AF Hiolski, Emma
TI Distinguishing between Zika and dengue
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD OCT 9
PY 2017
VL 95
IS 40
BP 7
EP 7
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA FJ3IM
UT WOS:000412625500004
DA 2020-07-08
ER

PT J
AU Edgington, MP
   Alphey, LS
AF Edgington, Matthew P.
   Alphey, Luke S.
TI Conditions for success of engineered underdominance gene drive systems
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
ID AEDES-AEGYPTI; POPULATIONS; INTROGRESSION; SUPPRESSION; RESISTANCE;
   DOMINANT; RELEASE; IMPACT; RATES; AGE
AB Engineered underdominance is one of a number of different gene drive strategies that have been proposed for the genetic control of insect vectors of disease. Here we model a two-locus engineered under dominance based gene drive system that is based on the concept of mutually suppressing lethals. In such a system two genetic constructs are introduced, each possessing a lethal element and a suppressor of the lethal at the other locus. Specifically, we formulate and analyse a population genetics model of this system to assess when different combinations of release strategies (i.e. single or multiple releases of both sexes or males only) and genetic systems (i.e. bisex lethal or female-specific lethal elements and different strengths of suppressors) will give population replacement or fail to do so. We anticipate that results presented here will inform the future design of engineered underdominance gene drive systems as well as providing a point of reference regarding release strategies for those looking to test such a system. Our discussion is framed in the context of genetic control of insect vectors of disease. One of several serious threats in this context are Aedes aegypti mosquitoes as they are the primary vectors of dengue viruses. However, results are also applicable to Ae. aegypti as vectors of Zika, yellow fever and chikungunya viruses and also to the control of a number of other insect species and thereby of insect-vectored pathogens. (C) 2017 The Authors. Published by Elsevier Ltd.
C1 [Edgington, Matthew P.; Alphey, Luke S.] Pirbright Inst, Ash Rd, Woking GU24 0NF, Surrey, England.
RP Edgington, MP (corresponding author), Pirbright Inst, Ash Rd, Woking GU24 0NF, Surrey, England.
EM matt.edgington@pirbright.ac.uk
OI Alphey, Luke/0000-0002-2916-3802
FU Wellcome TrustWellcome Trust [110117/Z/15/Z]; UK Biotechnology and
   Biological Sciences Research Council (BBSRC)Biotechnology and Biological
   Sciences Research Council (BBSRC) [BBS/E/I/00001892]
FX The authors would like to acknowledge useful discussions with Nina
   Alphey and Anthony Wilson regarding the modelling work and for providing
   comments on draft versions of the paper. MPE is funded through a
   Wellcome Trust Investigator Award [110117/Z/15/Z] made to LSA. LSA is
   supported by core funding from the UK Biotechnology and Biological
   Sciences Research Council (BBSRC) to The Pirbright Institute
   [BBS/E/I/00001892].
CR Akbari OS, 2013, CURR BIOL, V23, P671, DOI 10.1016/j.cub.2013.02.059
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Alphey N, 2014, CABI BIOTECH SER, P263, DOI 10.1079/9781780644516.0263
   Alphey N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1071
   Altrock PM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002260
   Altrock PM, 2010, J THEOR BIOL, V267, P62, DOI 10.1016/j.jtbi.2010.08.004
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349
   Barrera R., 2006, SCI WORK GROUP M DEN, P92
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Buchman A., 2016, BIORXIV, DOI [10.1101/088393, DOI 10.1101/088393]
   Burt A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0432
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Davis S, 2001, J THEOR BIOL, V212, P83, DOI 10.1006/jtbi.2001.2357
   Franz AWE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002833
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283
   Gould F, 2008, P ROY SOC B-BIOL SCI, V275, P2823, DOI 10.1098/rspb.2008.0846
   Hay BA, 2010, J INSECT PHYSIOL, V56, P1402, DOI 10.1016/j.jinsphys.2010.05.022
   Heinrich JC, 2000, P NATL ACAD SCI USA, V97, P8229, DOI 10.1073/pnas.140142697
   Huang YX, 2011, EVOL APPL, V4, P415, DOI 10.1111/j.1752-4571.2010.00153.x
   Huang YX, 2009, EVOL APPL, V2, P143, DOI 10.1111/j.1752-4571.2008.00049.x
   James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004
   Legros M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052235
   Magori K, 2006, GENETICS, V172, P2613, DOI 10.1534/genetics.105.051789
   Marshall JM, 2008, GENETICS, V178, P1673, DOI 10.1534/genetics.107.082099
   Marshall JM, 2012, J THEOR BIOL, V294, P153, DOI 10.1016/j.jtbi.2011.10.032
   Marshall John M, 2011, Bioeng Bugs, V2, P235, DOI 10.4161/bbug.2.5.15801
   Marshall JM, 2010, NAT BIOTECHNOL, V28, P896, DOI 10.1038/nbt0910-896
   MCINNIS DO, 1994, ANN ENTOMOL SOC AM, V87, P231, DOI 10.1093/aesa/87.2.231
   Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Pitisuttithum P., 2016, EXPER REV VACCINES, V15
   Reeves RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097557
   SOUTHWOOD T R E, 1972, Bulletin of the World Health Organization, V46, P211
   Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   World Health Organization, 2016, DENG SEV DENG WHO FA
NR 38
TC 9
Z9 10
U1 0
U2 111
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
EI 1095-8541
J9 J THEOR BIOL
JI J. Theor. Biol.
PD OCT 7
PY 2017
VL 430
BP 128
EP 140
DI 10.1016/j.jtbi.2017.07.014
PG 13
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA FE7QK
UT WOS:000408401800014
PM 28728996
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Mejdoubi, M
   Monthieux, A
   Cassan, T
   Lombard, C
   Flechelles, O
   Adenet, C
AF Mejdoubi, Mehdi
   Monthieux, Alice
   Cassan, Tiphaine
   Lombard, Catherine
   Flechelles, Olivier
   Adenet, Clara
TI Brain MRI in Infants after Maternal Zika Virus Infection during
   Pregnancy
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Mejdoubi, Mehdi; Monthieux, Alice; Cassan, Tiphaine; Lombard, Catherine; Flechelles, Olivier; Adenet, Clara] Univ Hosp Martinique, Fort De France, Martinique, France.
RP Mejdoubi, M (corresponding author), Univ Hosp Martinique, Fort De France, Martinique, France.
EM mehdi.mejdoubi@chu-martinique.fr
OI mejdoubi, mehdi/0000-0001-9422-9356
CR Aiken ARA, 2017, BJOG-INT J OBSTET GY, V124, P546, DOI 10.1111/1471-0528.14296
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
NR 5
TC 6
Z9 6
U1 1
U2 7
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD OCT 5
PY 2017
VL 377
IS 14
BP 1399
EP 1400
DI 10.1056/NEJMc1612813
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA FJ0CB
UT WOS:000412375000001
PM 28976853
DA 2020-07-08
ER

PT J
AU Bonyah, E
   Khan, MA
   Okosun, KO
   Islam, S
AF Bonyah, Ebenezer
   Khan, Muhammad Altaf
   Okosun, K. O.
   Islam, Saeed
TI A theoretical model for Zika virus transmission
SO PLOS ONE
LA English
DT Article
ID BRUCELLOSIS MODEL; INFECTION; DYNAMICS; OUTBREAK
AB In this paper, we present and analyze an SEIR Zika epidemic model. Firstly, we investigate the model with constant controls. The steady states of the model is found to be locally and globally asymptotically stable. Thereafter, we incorporate time dependent controls into the model in order to investigate the optimal effects of bednets, treatments of infective and spray of insecticides on the disease spread. Furthermore, we used Pontryagin's Maximum Principle to determine the necessary conditions for effective control of the disease. Also, the numerical results were presented.
C1 [Bonyah, Ebenezer] Kumasi Tech Univ, Dept Math & Stat, Kumasi, Ghana.
   [Khan, Muhammad Altaf] City Univ Sci & Informat Technol, Dept Math, Peshawar 25000, KP, Pakistan.
   [Bonyah, Ebenezer; Okosun, K. O.] Vaal Univ Technol, Dept Math, Vanderbijlpark, South Africa.
   [Islam, Saeed] Univ Mardan, Dept Math Abdul Wali Khan, KP, Pakistan.
RP Bonyah, E (corresponding author), Kumasi Tech Univ, Dept Math & Stat, Kumasi, Ghana.; Bonyah, E (corresponding author), Vaal Univ Technol, Dept Math, Vanderbijlpark, South Africa.
EM ebbonya@yahoo.com
RI Khan, Muhammad Altaf/K-2201-2013; Saeed, Islam/AAD-6067-2020
OI Khan, Muhammad Altaf/0000-0002-4483-7879; 
CR Allenl LJS, 2007, INTRO MATH BIOL
   Birkhoff G., 1982, ORDINARY DIFFERENTIA
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bonyah E, 2014, COMPUT MATH METHOD M, DOI 10.1155/2014/576039
   Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fleming W. H., 1975, DETERMINISTIC STOCHA
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gui HL, 2017, PLOS ONE, V12
   Guo H, P AM MATH SOC, V136, P2793
   Javidi M, 2014, WOR J MOD SIMUL, V10, P163
   KHAN MA, 2015, ADV STUD BIOL, V7, P65
   KHAN MA, 2017, SCI REP UK, V7, P87323
   Khan MA, 2015, INT J APPL COMPUT MA, V2, P1
   L MT, 2016, J MATH ANAL APPL, P1
   LaSalle J. P., 1976, STABILITY DYNAMICAL
   Lee Eva K, 2016, AMIA Annu Symp Proc, V2016, P743
   Li L, 2016, J BIOL SYST, V24, P519, DOI 10.1142/S0218339016500261
   Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094
   Mojumder MS, B WHO IN PRESS
   Musso D, 2014, CLIN MICR INFECT, V20, P59
   Musso D., 2014, EURO SURVEILL, V19
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Okosun KO, 2014, MATH BIOSCI, V258, P19, DOI 10.1016/j.mbs.2014.09.008
   Okosun KO, 2013, BIOSYSTEMS, V111, P83, DOI 10.1016/j.biosystems.2012.09.008
   Peng M, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/842614
   Piqueira JRC, 2008, COMPUT SECUR, V27, P355, DOI 10.1016/j.cose.2008.07.006
   Pontryagin L. S., 1962, MATH THEORY OPTIMAL
   Shi XY, 2011, TURK J MATH, V35, P649, DOI 10.3906/mat-1006-333
   Simpson DI, 1964, T ROY SOC TROP MED H, V58, P33
   Sun GQ, 2016, TRANSMISSION DYNAMIC
   Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007
   Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Wan H, 2013, J APPL MATH, V2013, P1
   Xing Y, 2017, APPL MATH COMPUT, V309, P192, DOI 10.1016/j.amc.2017.04.007
   Yu P, 2016, J BIOL DYNAM, V10, P263, DOI 10.1080/17513758.2016.1166270
   Zhang J, 2014, SCI WORLD J, V2014, P1, DOI DOI 10.1111/NPH.13030
NR 39
TC 17
Z9 17
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 4
PY 2017
VL 12
IS 10
AR e0185540
DI 10.1371/journal.pone.0185540
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FI7FU
UT WOS:000412163100026
PM 28977007
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Maslow, JN
AF Maslow, Joel N.
TI Vaccine development for emerging virulent infectious diseases
SO VACCINE
LA English
DT Article; Proceedings Paper
CT 11th Annual Conference on New Technologies, New Vaccines
CY MAR 20-23, 2016
CL Wilmington, DE
DE Emerging infectious diseases; Zika virus; Ebola virus; MERS coronavirus;
   Vaccine
ID RESPIRATORY SYNDROME-CORONAVIRUS; ZIKA VIRUS-INFECTION; DNA VACCINE;
   NEUTRALIZING ANTIBODY; HEALTHY-ADULTS; OUTBREAK; EBOLA; TRANSMISSION;
   INDUCTION; RESPONSES
AB The recent outbreak of Zaire Ebola virus in West Africa altered the classical paradigm of vaccine development and that for emerging infectious diseases (EIDs) in general. In this paper, the precepts of vaccine discovery and advancement through pre-clinical and clinical assessment are discussed in the context of the recent Ebola virus, Middle East Respiratory Syndrome coronavirus (MERS-CoV), and Zika virus outbreaks. Clinical trial design for diseases with high mortality rates and/or high morbidity in the face of a global perception of immediate need and the factors that drive design in the face of a changing epidemiology are presented. Vaccines for EIDs thus present a unique paradigm to standard development precepts. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Maslow, Joel N.] GeneOne Life Sci Inc, 1040 DeKalb Pike,Suite 200, Blue Bell, PA 19422 USA.
   [Maslow, Joel N.] Morristown Med Ctr, Morristown, NJ USA.
RP Maslow, JN (corresponding author), GeneOne Life Sci Inc, 1040 DeKalb Pike,Suite 200, Blue Bell, PA 19422 USA.
EM jmaslow@geneonels-us.com
CR Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Barlan A, 2014, J VIROL, V88, P4953, DOI 10.1128/JVI.00161-14
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, N ENGL J MED
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cha RH, 2015, J KOREAN MED SCI, V30, P1807, DOI 10.3346/jkms.2015.30.12.1807
   Cohen J, 2015, SCIENCE, V349, P1272, DOI 10.1126/science.349.6254.1272
   Cohen J, 2014, SCIENCE, V345, P1441, DOI 10.1126/science.345.6203.1441
   Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951
   Cramer G, 2016, EMERG INFECT DIS, V22, P6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Drosten C, 2014, NEW ENGL J MED, V371, P1359, DOI 10.1056/NEJMc1409847
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Falzarano D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004250
   Farag Elmoubasher A. B. A., 2015, Infection Ecology & Epidemiology, V5, DOI 10.3402/iee.v5.28305
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Geisbert TW, 2011, J INFECT DIS, V204, pS1075, DOI 10.1093/infdis/jir349
   Geisbert TW, 2008, VACCINE, V26, P6894, DOI 10.1016/j.vaccine.2008.09.082
   Gorman VM, 2012, EURO SURVEILL, V17
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haagmans BL, 2015, J VIROL, V89, P6131, DOI 10.1128/JVI.00661-15
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Henao-Restrepo AM, 2015, LANCET
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Larocca RA, 2016, NATURE
   Ledgerwood JE, 2014, N ENGL J MED
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Macdonald LE, 2014, P NATL ACAD SCI USA, V111, P5147, DOI 10.1073/pnas.1323896111
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Sadde (Brazil), 2016, MICR MIN SAUD DIV B
   Muller MA, 2015, LANCET INFECT DIS, V15, P559, DOI 10.1016/S1473-3099(15)70090-3
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oh MD, 2015, J KOREAN MED SCI, V30, P1701, DOI 10.3346/jkms.2015.30.11.1701
   PAHO/WHO, 2015, EP AL ZIK VIR INF
   PAHO & WHO, 2015, EP AL NEUR SYNDR CON
   Park WB, 2015, EMERG INFECT DIS, V21, P2186, DOI 10.3201/eid2112.151421
   Payne DC, 2016, EMERG INFECT DIS, V22, P1824, DOI 10.3201/eid2210.160706
   Ramanathan MP, 2009, VACCINE, V27, P4370, DOI 10.1016/j.vaccine.2009.01.137
   Saad M, 2014, INT J INFECT DIS, V29, P301, DOI 10.1016/j.ijid.2014.09.003
   Sardesai N, 2016, WORLD VACC C 2016 29
   Shedlock DJ, 2013, MOL THER, V21, P1432, DOI 10.1038/mt.2013.61
   Tang F, 2011, J IMMUNOL, V186, P7264, DOI 10.4049/jimmunol.0903490
   Trimble CL, 2015, LANCET, V386, P2078, DOI 10.1016/S0140-6736(15)00239-1
   van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812
   Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712
   Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200
   Yang JS, 2001, J INFECT DIS, V184, P809, DOI 10.1086/323395
   Zhao GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145561
   Zhao J, 2014, P NATL ACAD SCI USA, V111, P5
NR 63
TC 9
Z9 9
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD OCT 4
PY 2017
VL 35
IS 41
SI SI
BP 5437
EP 5443
DI 10.1016/j.vaccine.2017.02.015
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FJ7TT
UT WOS:000412963100002
PM 28216184
OA Green Published
DA 2020-07-08
ER

PT J
AU Magnani, DM
   Rogers, TF
   Beutler, N
   Ricciardi, MJ
   Bailey, VK
   Gonzalez-Nieto, L
   Briney, B
   Sok, D
   Le, K
   Strubel, A
   Gutman, MJ
   Pedreno-Lopez, N
   Grubaugh, ND
   Silveira, CGT
   Maxwell, HS
   Domingues, A
   Martins, MA
   Lee, DE
   Okwuazi, EE
   Jean, S
   Strobert, EA
   Chahroudi, A
   Silvestri, G
   Vanderford, TH
   Kallas, EG
   Desrosiers, RC
   Bonaldo, MC
   Whitehead, SS
   Burton, DR
   Watkins, DI
AF Magnani, Diogo M.
   Rogers, Thomas F.
   Beutler, Nathan
   Ricciardi, Michael J.
   Bailey, Varian K.
   Gonzalez-Nieto, Lucas
   Briney, Bryan
   Sok, Devin
   Le, Khoa
   Strubel, Alexander
   Gutman, Martin J.
   Pedreno-Lopez, Nuria
   Grubaugh, Nathan D.
   Silveira, Cassia G. T.
   Maxwell, Helen S.
   Domingues, Aline
   Martins, Mauricio A.
   Lee, David E.
   Okwuazi, Erica E.
   Jean, Sherrie
   Strobert, Elizabeth A.
   Chahroudi, Ann
   Silvestri, Guido
   Vanderford, Thomas H.
   Kallas, Esper G.
   Desrosiers, Ronald C.
   Bonaldo, Myrna C.
   Whitehead, Stephen S.
   Burton, Dennis R.
   Watkins, David I.
TI Neutralizing human monoclonal antibodies prevent Zika virus infection in
   macaques
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID DENGUE VIRUS; DEPENDENT ENHANCEMENT; STRUCTURAL BASIS; RHESUS-MONKEYS;
   PROTECTION; VACCINE; DISEASE; BINDING
AB Therapies to prevent maternal Zika virus (ZIKV) infection and its subsequent fetal developmental complications are urgently required. We isolated three potent ZIKV-neutralizing monoclonal antibodies (nmAbs) from the plasma-blasts of a ZIKV-infected patient-SMZAb1, SMZAb2, and SMZAb5-directed against two different domains of the virus. We engineered these nmAbs with Fc LALA mutations that abrogate Fc gamma receptor binding, thus eliminating potential therapy-mediated antibody-dependent enhancement. We administered a cocktail of these three nmAbs to nonhuman primates 1 day before challenge with ZIKV and demonstrated that the nmAbs completely prevented viremia in serum after challenge. Given that numerous antibodies have exceptional safety profiles in humans, the cocktail described here could be rapidly developed to protect uninfected pregnant women and their fetuses.
C1 [Magnani, Diogo M.; Ricciardi, Michael J.; Bailey, Varian K.; Gonzalez-Nieto, Lucas; Gutman, Martin J.; Pedreno-Lopez, Nuria; Maxwell, Helen S.; Domingues, Aline; Martins, Mauricio A.; Desrosiers, Ronald C.; Watkins, David I.] Univ Miami, Dept Pathol, Leonard M Miller Sch Med, Miami, FL 33136 USA.
   [Rogers, Thomas F.; Beutler, Nathan; Briney, Bryan; Sok, Devin; Le, Khoa; Strubel, Alexander; Grubaugh, Nathan D.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.
   [Rogers, Thomas F.; Beutler, Nathan; Briney, Bryan; Sok, Devin; Le, Khoa; Strubel, Alexander; Grubaugh, Nathan D.; Burton, Dennis R.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA.
   [Silveira, Cassia G. T.; Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, SP, Brazil.
   [Lee, David E.; Okwuazi, Erica E.; Jean, Sherrie; Strobert, Elizabeth A.; Chahroudi, Ann; Silvestri, Guido; Vanderford, Thomas H.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.
   [Chahroudi, Ann] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.
   [Bonaldo, Myrna C.] Fiocruz MS, Lab Biol Mol Flavivirus, Inst Oswaldo Cruz, BR-21040360 Rio De Janeiro, Brazil.
   [Whitehead, Stephen S.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.
   [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
RP Watkins, DI (corresponding author), Univ Miami, Dept Pathol, Leonard M Miller Sch Med, Miami, FL 33136 USA.; Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
EM burton@scripps.edu; dwatkins@med.miami.edu
RI Whitehead, Stephen/AAG-2787-2019; amsalu, ribka/G-8780-2019
OI Grubaugh, Nathan/0000-0003-2031-1933; Beutler,
   Nathan/0000-0003-3240-9524; Kallas, Esper/0000-0003-2026-6925; Strubel,
   Alexander/0000-0002-8175-962X; Magnani, Diogo/0000-0002-1773-2406;
   Martins, Mauricio/0000-0001-8336-216X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [4P01AI094420-05, P30AI073961, P51
   OD011132]; Wallace H. Coulter Center for Translational Research at the
   University of Miami; Miami Clinical and Translational Science Institute
   (CTSI); National Institute of Allergy and Infectious Diseases, NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID); Defense Advanced Research Projects Agency (DARPA)
   Autonomous Diagnostics to Enable Prevention and Therapeutics:
   Prophylactic Options to Environmental and Contagious Threats
   (ADEPT-PROTECT) program [W31P4Q-13-1-0011]
FX This work was supported by NIH grant 4P01AI094420-05, the Wallace H.
   Coulter Center for Translational Research at the University of Miami,
   the Miami Clinical and Translational Science Institute (CTSI), and the
   Intramural Research Program of the National Institute of Allergy and
   Infectious Diseases, NIH. This research was also supported in part by
   the Defense Advanced Research Projects Agency (DARPA) Autonomous
   Diagnostics to Enable Prevention and Therapeutics: Prophylactic Options
   to Environmental and Contagious Threats (ADEPT-PROTECT) program
   (W31P4Q-13-1-0011), as well as NIH grant P30AI073961 to the Miami Center
   for AIDS Research and grant P51 OD011132 to the YNPRC. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the NIH. The funders had no role in
   study design, data collection, and analysis, decision to publish, or
   preparation of the manuscript.
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   de Alwis R, 2014, METHODS MOL BIOL, V1138, P27, DOI 10.1007/978-1-4939-0348-1_3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405
   Fuss I.J., 2009, CURR PROTOC IMMUNOL
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Juckstock J, 2015, PHARMACOLOGY, V95, P209, DOI 10.1159/000381626
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Lai CJ, 2007, J VIROL, V81, P12766, DOI 10.1128/JVI.01420-07
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Magnani D. M., 2017, MOL THER
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
   World Health Organization, 2016, 5 M EM COMM INT HLTH
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 35
TC 44
Z9 44
U1 0
U2 16
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD OCT 4
PY 2017
VL 9
IS 410
AR eaan8184
DI 10.1126/scitranslmed.aan8184
PG 7
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA FI7HJ
UT WOS:000412167400005
PM 28978754
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Voelker, R
AF Voelker, Rebecca
TI NewTool to Aid Zika Diagnostics
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD OCT 3
PY 2017
VL 318
IS 13
BP 1214
EP 1214
DI 10.1001/jama.2017.13881
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA FI8CW
UT WOS:000412229600006
PM 28973235
DA 2020-07-08
ER

PT J
AU Leder, K
   Grobusch, MP
   Gautret, P
   Chen, LH
   Kuhn, S
   Lim, PL
   Yates, J
   McCarthy, AE
   Rothe, C
   Kato, Y
   Bottieau, E
   Huber, K
   Schwartz, E
   Stauffer, W
   Malvy, D
   Shaw, MTM
   Rapp, C
   Blumberg, L
   Jensenius, M
   van Genderen, PJJ
   Hamer, DH
AF Leder, Karin
   Grobusch, Martin P.
   Gautret, Philippe
   Chen, Lin H.
   Kuhn, Susan
   Lim, Poh Lian
   Yates, Johnnie
   McCarthy, Anne E.
   Rothe, Camilla
   Kato, Yasuyuki
   Bottieau, Emmanuel
   Huber, Kristina
   Schwartz, Eli
   Stauffer, William
   Malvy, Denis
   Shaw, Marc T. M.
   Rapp, Christophe
   Blumberg, Lucille
   Jensenius, Mogens
   van Genderen, Perry J. J.
   Hamer, Davidson H.
CA GeoSentinel Surveillance Network
TI Zika beyond the Americas: Travelers as sentinels of Zika virus
   transmission. A GeoSentinel analysis, 2012 to 2016
SO PLOS ONE
LA English
DT Article
ID SEXUAL TRANSMISSION; UNITED-STATES; DISEASE; SPECIFICITY; INFECTION;
   INDONESIA; PACIFIC
AB Background
   Zika virus (ZIKV) was first isolated in Africa; decades later, caused large outbreaks in the Pacific, and is considered endemic in Asia. We aim to describe ZIKV disease epidemiology outside the Americas, the importance of travelers as sentinels of disease transmission, and discrepancies in travel advisories from major international health organizations.
   Methods and findings
   This descriptive analysis using GeoSentinel Surveillance Network records involves sixty-four travel and tropical medicine clinics in 29 countries. Ill returned travelers with a confirmed or probable diagnosis of ZIKV disease acquired in Africa, Asia and the Pacific seen between 1 January 2012 and 31 December 2016 are included, and the frequencies of demographic, trip, and diagnostic characteristics described. ZIKV was acquired in Asia (18), the Pacific (10) and Africa (1). For five countries (Indonesia, Philippines, Thailand, Vietnam, Cameroon), GeoSentinel patients were sentinel markers of recent Zika activity. Additionally, the first confirmed ZIKV infection acquired in Kiribati was reported to GeoSentinel (2015), and a probable case was reported from Timor Leste (April 2016), representing the only case known to date. Review of Zika situation updates from major international health authorities for country risk classifications shows heterogeneity in ZIKV country travel advisories.
   Conclusions
   Travelers are integral to the global spread of ZIKV, serving as sentinel markers of disease activity. Although GeoSentinel data are collected by specialized clinics and do not capture all imported cases, we show that surveillance of imported infections by returned travelers augments local surveillance system data regarding ZIKV epidemiology and can assist with risk categorization by international authorities. However, travel advisories are variable due to risk uncertainties.
C1 [Leder, Karin] Monash Univ, Sch Epidemiol & Prevent Med, Melbourne, Vic, Australia.
   [Leder, Karin] Royal Melbourne Hosp, Doherty Inst Infect & Immun, Victorian Infect Dis Serv, Melbourne, Vic, Australia.
   [Grobusch, Martin P.] Univ Amsterdam, Ctr Trop Med & Travel Med, Dept Infect Dis, Div Internal Med,Acad Med Ctr, Amsterdam, Netherlands.
   [Gautret, Philippe] Aix Marseille Univ, CNRS 7278, IRD 198, UM63,INSERM 1095,IHU Mediterranee Infect, Marseillle, France.
   [Chen, Lin H.] Mt Auburn Hosp, Travel Med Ctr, Cambridge, MA USA.
   [Chen, Lin H.] Harvard Med Sch, Boston, MA USA.
   [Kuhn, Susan] Univ Calgary, Calgary, AB, Canada.
   [Lim, Poh Lian] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore.
   [Lim, Poh Lian] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Yates, Johnnie] Hawaii Permenente Med Grp, Honolulu, HI USA.
   [McCarthy, Anne E.] Ottawa Hosp, Dept Med, Ottawa, ON, Canada.
   [McCarthy, Anne E.] Univ Ottawa, Ottawa, ON, Canada.
   [Rothe, Camilla] Univ Hamburg, Div Trop Med & Infect Dis, Hamburg, Germany.
   [Kato, Yasuyuki] Natl Ctr Global Hlth & Med, Div Preparedness & Emerging Infect, Dis Control & Prevent Ctr, Tokyo, Japan.
   [Bottieau, Emmanuel] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium.
   [Huber, Kristina] Univ Munich LMU, Div Infect Dis & Trop Med, Med Ctr, Munich, Germany.
   [Schwartz, Eli] Chaim Sheba Med Ctr, Ctr Geog Med & Trop Dis, Tel Hashomer, Tel Aviv, Israel.
   [Schwartz, Eli] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.
   [Stauffer, William] Univ Minnesota, Dept Med & Pediat Infect Dis & Internal Med, Minneapolis, MN USA.
   [Malvy, Denis] Univ Bordeaux, Univ Hosp Ctr, Bordeaux, France.
   [Malvy, Denis] Univ Bordeaux, Inserm 1219, Bordeaux, France.
   [Shaw, Marc T. M.] James Cook Univ, Townsville, Qld, Australia.
   [Rapp, Christophe] Begin Mil Hosp, Dept Infect & Trop Dis, CMETE Travel Clin Paris, St Mande, France.
   [Blumberg, Lucille] Natl Inst Communicable Dis, Johannesburg, South Africa.
   [Jensenius, Mogens] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway.
   [van Genderen, Perry J. J.] Harbour Hosp, Inst Trop Dis, Rotterdam, Netherlands.
   [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA.
   [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA.
   [Hamer, Davidson H.] Boston Univ, Sch Med, Sect Infect Dis, Dept Med, Boston, MA USA.
RP Leder, K (corresponding author), Monash Univ, Sch Epidemiol & Prevent Med, Melbourne, Vic, Australia.; Leder, K (corresponding author), Royal Melbourne Hosp, Doherty Inst Infect & Immun, Victorian Infect Dis Serv, Melbourne, Vic, Australia.
EM karin.leder@monash.edu
RI MALVY, Denis/T-7930-2019; Hamer, Davidson/J-2020-2019; Leder,
   Karin/AAD-2388-2019
OI Hamer, Davidson/0000-0002-4700-1495; Leder, Karin/0000-0003-1368-1039;
   Chen, Lin/0000-0002-5684-8436
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U50CK00189]; ISTM; Public Health Agency of Canada
FX This project was supported by a cooperative agreement (U50CK00189)
   between the Centers for Disease Control and Prevention
   (https://www.cdc.gov/ncezid/dgmq/) to the International Society of
   Travel Medicine (ISTM) and funding from the ISTM (http://www.istm.org/)
   and the Public Health Agency of Canada
   (http://www.phac-aspc.gc.ca/index-engphp). The funding agencies
   supported the collection of GeoSentinel data, but had no role in the
   writing or content of this manuscript, or in the decision to submit the
   paper for publication.
CR Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   CDC, ZIK TRAV INF
   Centers for Diseases Control and Prevention (CDC), ZIK VIR SE AS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   ECDC, ZIK VIR SIT REP
   ECDC, PLAC INF IMP CAS EU
   ECDC, 2017, ZIK VIR DIS EP
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goorhuis A, 2016, LANCET INFECT DIS, V16, P1204, DOI 10.1016/S1473-3099(16)30316-4
   Hamer DH, 2016, ANN INTERNAL MED
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Harvey K, 2013, MMWR SURVEILL SUMM, V62, P1
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lobigs M, 2009, J VIROL, V83, P2436, DOI 10.1128/JVI.02273-08
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   NaTHNaC, ZIK VIR COUNTR SPEC
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
   Veasna D, 2016, INT J INFECT DIS IJI
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WHO, ZIK VIR SIT REP
   WHO, ZIK VIR COUNTR CLASS
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2016, 5 M EM COMM INT HLTH
NR 46
TC 26
Z9 27
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 3
PY 2017
VL 12
IS 10
AR e0185689
DI 10.1371/journal.pone.0185689
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FI6UJ
UT WOS:000412131900036
PM 28973011
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Halford, B
AF Halford, Bethany
TI Mutation in Zika virus protein linked to microcephaly
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD OCT 2
PY 2017
VL 95
IS 39
BP 11
EP 11
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA FI5SI
UT WOS:000412043700018
DA 2020-07-08
ER

PT J
AU Harmand, TJ
   Pattabiraman, VR
   Bode, JW
AF Harmand, Thibault J.
   Pattabiraman, Vijaya R.
   Bode, Jeffrey W.
TI Chemical Synthesis of the Highly Hydrophobic Antiviral
   Membrane-Associated Protein IFITM3 and Modified Variants
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE chemical protein synthesis; IFITM3; KAHA ligation; membrane proteins;
   protein modifications
ID HYDROXYLAMINE KAHA LIGATION; INDUCED TRANSMEMBRANE PROTEIN-3;
   S-PALMITOYLATION; ALPHA-KETOACIDS; DENGUE VIRUS; INFLUENZA;
   UBIQUITINATION; RESISTANCE
AB Interferon-induced transmembrane protein3 (IFITM3) is an antiviral transmembrane protein that is thought to serve as the primary factor for inhibiting the replication of a large number of viruses, including West Nile virus, Dengue virus, Ebola virus, and Zika virus. Production of this 14.5 kDa, 133-residue transmembrane protein, especially with essential posttranslational modifications, by recombinant expression is challenging. In this report, we document the chemical synthesis of IFTIM3 in multi-milligram quantities (>15 mg) and the preparation of phosphorylated and fluorescent variants. The synthesis was accomplished by using KAHA ligations, which operate under acidic aqueous/organic mixtures that excel at solubilizing even the exceptionally hydrophobic C-terminal region of IFITM3. The synthetic material is readily incorporated into model vesicles and forms the basis for using synthetic, homogenous IFITM3 and its derivatives for further studying its structure and biological mode of action.
C1 [Harmand, Thibault J.; Pattabiraman, Vijaya R.; Bode, Jeffrey W.] ETH, Dept Chem & Appl Biosci, Lab Organ Chem, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.
   [Bode, Jeffrey W.] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648602, Japan.
RP Bode, JW (corresponding author), ETH, Dept Chem & Appl Biosci, Lab Organ Chem, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.; Bode, JW (corresponding author), Nagoya Univ, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648602, Japan.
EM bode@org.chem.ethz.ch
FU ETH ZurichETH Zurich; SNSFSwiss National Science Foundation (SNSF)
   [150073, 169451]
FX This work was supported by the ETH Zurich and the SNSF (150073, 169451).
   We thank the LOC MS Service and the Functional genomic center Zurich for
   analyses.
CR [Anonymous], 2014, ANGEW CHEM, V126, P12445
   [Anonymous], 2015, ANGEW CHEM, V127, P13188
   Bondalapati S, 2017, CHEM SCI, V8, P4027, DOI 10.1039/c7sc00488e
   Bondalapati S, 2016, NAT CHEM, V8, P407, DOI [10.1038/NCHEM.2476, 10.1038/nchem.2476]
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Chesarino NM, 2014, FUTURE MICROBIOL, V9, P1151, DOI [10.2217/FMB.14.65, 10.2217/fmb.14.65]
   Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694
   Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454
   Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337
   Harmand TJ, 2016, NAT PROTOC, V11, P1130, DOI 10.1038/nprot.2016.052
   He CM, 2015, ANGEW CHEM INT EDIT, V54, P12996, DOI 10.1002/anie.201505379
   Hossain MA, 2009, BIOCONJUGATE CHEM, V20, P1390, DOI 10.1021/bc900181a
   Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13
   Johnson ECB, 2007, J AM CHEM SOC, V129, P11480, DOI 10.1021/ja072870n
   Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124
   Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10
   Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613
   Mudhasani R, 2013, J VIROL, V87, P8451, DOI 10.1128/JVI.03382-12
   Payne RJ, 2010, CHEM COMMUN, V46, P21, DOI 10.1039/b913845e
   Pusterla I, 2015, NAT CHEM, V7, P668, DOI [10.1038/NCHEM.2282, 10.1038/nchem.2282]
   Rohrbacher F, 2017, CHEM SCI, V8, P4051, DOI 10.1039/c7sc00789b
   Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Shan Z, 2013, J BIOL CHEM, V288, P35093, DOI 10.1074/jbc.M113.511949
   Thuaud F, 2016, HELV CHIM ACTA, V99, P868, DOI 10.1002/hlca.201600264
   Tilley SD, 2006, J AM CHEM SOC, V128, P1080, DOI 10.1021/ja057106k
   Wucherpfennig TG, 2016, HELV CHIM ACTA, V99, P897, DOI 10.1002/hlca.201600160
   Wucherpfennig TG, 2014, ANGEW CHEM INT EDIT, V53, P12248, DOI 10.1002/anie.201407014
   Xu X., 2012, PROTEIN-STRUCT FUNCT, V80, P1715
   Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095
   Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]
   Zheng JS, 2016, J AM CHEM SOC, V138, P3553, DOI 10.1021/jacs.6b00515
   Zheng JS, 2014, J AM CHEM SOC, V136, P3695, DOI 10.1021/ja500222u
NR 37
TC 15
Z9 15
U1 2
U2 36
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1433-7851
EI 1521-3773
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PD OCT 2
PY 2017
VL 56
IS 41
BP 12639
EP 12643
DI 10.1002/anie.201707554
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA FI2WO
UT WOS:000411810600040
PM 28834009
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carneiro, RG
AF Carneiro, Rosamaria Giatti
TI Zika Virus, a research agenda for (thinking about) the Social and Human
   Health Sciences
SO INTERFACE-COMUNICACAO SAUDE EDUCACAO
LA English
DT Editorial Material
C1 [Carneiro, Rosamaria Giatti] Univ Brasilia, Fac Ceilandia, Ctr Metropolitan, Conjunto A,Lote 01, BR-72220275 Brasilia, DF, Brazil.
RP Carneiro, RG (corresponding author), Univ Brasilia, Fac Ceilandia, Ctr Metropolitan, Conjunto A,Lote 01, BR-72220275 Brasilia, DF, Brazil.
EM rosacarneiro@unb.br
CR ARENDT H., 2004, RESPONSABILIDADE JUL
   DINIZ Debora, 2016, ZIKA SERTAO NORDESTI
   Guattari F, 2011, MIL PLATOS, V2
   Ingold T, 2007, LINES BRIEF HIST
   Jeffrey A., 1986, 10 ENC AN ANPOCS ASS
   Latour B., 2012, REAGREGANDO SOCIAL I
   Menendez EL, 2009, SUJEITOS SABERES EST
   MORIN Edgar, 2007, INTRO PENSAMENTO COM
   Rego Sergio, 2016, Rev. Bioét., V24, P430, DOI 10.1590/1983-80422016243141
NR 9
TC 2
Z9 3
U1 0
U2 4
PU UNIV ESTADUAL PAULISTA-UNESP
PI BOTUCATU
PA CAMPUS DE BOTUCATU, DIST RUBIAO JR S N, CAIXA POSTAL 592, BOTUCATU, SP
   18618-000, BRAZIL
SN 1414-3283
EI 1807-5762
J9 INTERFACE-BOTUCATU
JI Interface-Comun. Saude Educ.
PD OCT-DEC
PY 2017
VL 21
IS 63
BP 753
EP 757
DI 10.1590/1807-57622017.0404
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GT2UA
UT WOS:000444354200001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Mune, A
   Pandey, A
   Pandey, KM
AF Mune, Anjusha
   Pandey, Ajay
   Pandey, Khushhali Menaria
TI Genome-wide comparative analysis of the codon usage pattern in
   Flaviviridae family
SO BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS
LA English
DT Article
DE EFFECTIVE NUMBER OF CODON; MUTATION PRESSURE; NUCLEOTIDE CONTENTS;
   PRINCIPAL COMPONENT ANALYSIS; RELATIVE SYNONYMOUS CODON USAGE
ID RNA VIRUSES; BIAS; COLI
AB Flaviviridae family is a group of viruses that cause several deadly diseases like Dengue Fever Virus, Zika Virus, Japanese Encephalitis Virus, and Hepatitis C Virus etc. The codon usage analysis can serve as a tool to understand about the molecular evolution and regulation of viral gene expression. The objective of this study is to find the key determinants of codon usage in the family. In this study, the codon usage pattern for 114 genomes of Flaviviridae family (with four genus Flavivirus, Hepacivirus, Pegivirus, Pestivirus) was analysed through codon usage indices (like NC, RSCU, ENC, PCA) and multivariate statistical methods. Our results show that among the four genus Flavivirus and Pestivirus show similarity in preferred base on the count of being AG rich. On the other hand, Pegivirus and Hepacivirus show similarity in preferred base on the count of being GC rich. The overall codon usage bias in the entire family is slightly biased. RSCU analysis showed that Flavivirus and Pestivirus prefer AG ending codons, whereas Pegivirus and Hepacivirus show preference to GC ending codons. Many unclassified members show similarity with members of genus Flavivirus in choices of codon. The ENC -GC3 plot show that mutation pressure is dominating evolutionary driving force in making codon usage preferences. The study represents comprehensive analysis of codon usage pattern and help to better understand the mechanism of codon usage bias.
C1 [Mune, Anjusha; Pandey, Khushhali Menaria] MANIT, Dept Biol Sci & Engn, Bhopal, MP, India.
   [Pandey, Ajay] MANIT, Dept Appl Mech, Bhopal, MP, India.
RP Pandey, KM (corresponding author), MANIT, Dept Biol Sci & Engn, Bhopal, MP, India.
EM kmpbiomanit@gmail.com
CR Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Brand C, 2017, WILEY INTERDISCIP RE, V8
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Butt TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081686
   Chen Y., 2013, BIOMED RES INT, V2013
   Cristina J, 2015, VIRUS RES, V196, P87, DOI 10.1016/j.virusres.2014.11.005
   Dorn A, 2008, CURR OPIN MOL THER, V10, P10
   Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Kanaya S, 2001, GENE, V276, P89, DOI 10.1016/S0378-1119(01)00673-4
   Krieg AM, 2003, SCAND J INFECT DIS, V35, P653, DOI 10.1080/00365540310015999
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Lu G, 2017, PLOS ONE, V7, P12
   Lu H, 2005, ACTA BIOCH BIOPH SIN, V37, P1, DOI 10.1093/abbs/37.1.1
   Ma JJ, 2013, J ANIM VET ADV, V12, P88
   Moosavi F, 2011, J CELL MOL RES, V3, P1
   Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001
   SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207
   Su MW, 2009, J COMPUT BIOL, V16, P1539, DOI 10.1089/cmb.2009.0046
   Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z
   Tatarinova TV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-308
   Tautz N, 2015, ADV VIRUS RES, V93, P47, DOI 10.1016/bs.aivir.2015.03.002
   Theze J, 2015, GENOME BIOL EVOL, V7, P2996, DOI 10.1093/gbe/evv202
   Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Velazquez-Salinas L., 2016, PLOS ONE, V25, P11
   Wang M, 2011, VIRUS GENES, V42, P245, DOI 10.1007/s11262-011-0574-z
   Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0
   Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Xiang H, 2015, PLOS ONE, V10, P6
   Yadav MK, 2012, BIOINFORMATION, V8, P1230, DOI 10.6026/97320630081230
   Zhang J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-146
   Zhang XC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110338
   Zhong J, 2007, VIRUS GENES, V35, P767, DOI 10.1007/s11262-007-0159-z
   Zhou JH, 2012, VIRUS GENES, V44, P475, DOI 10.1007/s11262-012-0731-z
   Zhou T, 2005, BIOSYSTEMS, V81, P77, DOI 10.1016/j.biosystems.2005.03.002
NR 38
TC 2
Z9 2
U1 0
U2 1
PU SOC SCIENCE & NATURE
PI BHOPAL
PA C-52 HOUSING BOARD COLONY, KOHE FIZA, BHOPAL, MADHYA PRADESH 462 001,
   INDIA
SN 0974-6455
J9 BIOSCI BIOTECHNO RES
JI Biosci. Biotechnol. Res. Commun.
PD OCT-DEC
PY 2017
VL 10
IS 4
BP 680
EP 688
DI 10.21786/bbrc/10.4/11
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA GB8JV
UT WOS:000429323100011
OA Bronze
DA 2020-07-08
ER

PT J
AU Taitson, PF
   de Souza, VGM
   Santos, ML
AF Taitson, Paulo F.
   de Souza, Vanessa G. M.
   Santos, Mariana L.
TI Zika virus outbreak: reproductive effects and decreases in the number of
   births in Brazil
SO JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA
LA English
DT Editorial Material
C1 [Taitson, Paulo F.; de Souza, Vanessa G. M.; Santos, Mariana L.] Pontificia Univ Catolica Minas Gerais, DCB, Unit Human Reprod, Belo Horizonte, MG, Brazil.
RP Taitson, PF (corresponding author), Pontificia Univ Catolica Minas Gerais, DCB, Unit Human Reprod, Belo Horizonte, MG, Brazil.
CR Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   de Carvalho BR, 2016, J BRAS REPROD ASSIST, V20, P159, DOI 10.5935/1518-0557.20160034
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Washington CI, 2016, SEMIN REPROD MED, V34, P293, DOI 10.1055/s-0036-1592067
NR 4
TC 1
Z9 1
U1 0
U2 0
PU SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA
PI RIBEIRAO
PA SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA, RIBEIRAO, 00000, BRAZIL
SN 1517-5693
EI 1518-0557
J9 J BRAS REPROD ASSIST
JI J. Bras. Reprod. Assist.
PD OCT-DEC
PY 2017
VL 21
IS 4
BP 293
EP 294
DI 10.5935/1518-0557.20170064
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FV1FQ
UT WOS:000424307200001
PM 29192746
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Bullivant, G
   Martinou, AF
AF Bullivant, G.
   Martinou, A. F.
TI Ascension Island: a survey to assess the presence of Zika virus vectors
SO JOURNAL OF THE ROYAL ARMY MEDICAL CORPS
LA English
DT Article
ID INVASIVE MOSQUITOS; EUROPE
AB Background and aim Following concerns regarding the spread of Zika virus, Joint Services Health Unit (Cyprus) were tasked to carry out a mosquito survey on the Ascension Island, South Atlantic. This was to determine if vectors of the virus such as Aedes aegypti and Aedes albopictus were introduced and established on the Island.
   Methods An extensive survey of residential areas and natural habitats was initiated in order to collect mosquito larvae and adults by methods such as larval sampling, adult trapping and human landing catches.
   Results A. aegypti or A. albopictus were not collected by any of the three methods employed. Culex quinque-fasciatus was the only species collected by all three methods. C. quinquefasciatus is a vector of lymphatic filariasis that can easily be transported by human means by air or sea. It is a container breeding species that lives in close proximity to human settlements and can cause significant amount of nuisance.
   Discussion Ascension Island is connected by air and sea with areas of the world where container breeding species such as A. albopictus and A. aegypti are established, therefore, it is not unlikely that these species become introduced to Ascension in the future. Sound surveillance on Ascension is imperative in order to act as an early warning and rapid response system for invasive mosquito species as well as a guide for the implementation of control measures against C. quinquefasciatus.
C1 [Bullivant, G.] RAF Akrotiri, Joint Serv Hlth Unit Cyprus, BFPO 57, Akrotiri, Cyprus.
   [Martinou, A. F.] RAF Akrotiri, Joint Serv Hlth Unit Cyprus, Entomol Dept, Akrotiri, Cyprus.
RP Bullivant, G (corresponding author), RAF Akrotiri, Joint Serv Hlth Unit Cyprus, BFPO 57, Akrotiri, Cyprus.
EM glen.bullivant671@mod.uk
RI Martinou, Kelly/AAN-5691-2020
OI Martinou, Kelly/0000-0003-2892-8583
CR Ascension Island Government, 2016, ASC ISL S ATL OC
   ASMAN SM, 1981, ANNU REV ENTOMOL, V26, P289, DOI 10.1146/annurev.en.26.010181.001445
   Bataille A, 2009, P NATL ACAD SCI USA, V106, P10230, DOI 10.1073/pnas.0901308106
   Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023
   Wilke ABB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0959-2
   CABI, 2016, INV SPEC COMP
   CDC, 2012, W NIL VIR STAT SURV
   CDC, 2016, SURV CONTR AED AEG A
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Cutwa MM, PHOTOGRAPHIC GUIDE C
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Darsie RF, 2000, TECHNICAL B FLORIDA, V1, P148
   DUFFEY ERIC A. G., 1964, J APPL ECOL, V1, P219, DOI 10.2307/2401310
   European Centre for Disease Prevention and Control, AED ALB
   European Centre for Disease Prevention and Control, AED AEG
   European Centre for Disease Prevention and Control and European Food Safety Authority, 2012, GUID SURV INV MOSQ E
   Howard L, 1912, MOSQUITOES N CENTRAL, V1, P520
   Hughes JH, 1976, MOSQ NEWS, V16, P106
   Larish LB, 2005, J AM MOSQUITO CONTR, V21, P318, DOI 10.2987/8756-971X(2005)21[318:IAEOAF]2.0.CO;2
   Laurence BR, 1964, T R SOC TROP MED HYG, V58, P289
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Noda Shinichi, 2005, Medical Entomology and Zoology, V56, P349
   PATTERSON RS, 1970, SCIENCE, V168, P1368, DOI 10.1126/science.168.3937.1368
   PROCTER D, 1999, BIODIVERSITY UK OVER
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Seixas G, 1983, MEM I O CRUZ, V108, P3
   The Florida Department of Health, 2016, ZIK
   Vaux AGC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0936-9
   WHO, 2012, LYMPHATIC FILARIASIS
NR 30
TC 0
Z9 0
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0035-8665
EI 2052-0468
J9 J ROY ARMY MED CORPS
JI J. R. Army Med. Corps
PD OCT
PY 2017
VL 163
IS 5
BP 347
EP 354
DI 10.1136/jramc-2016-000730
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA FR9MV
UT WOS:000419398700010
PM 28331047
DA 2020-07-08
ER

PT J
AU Yeo, GSH
   Qi, ML
   Du, RC
   Mahavadi, PL
   Yung, CF
   Thoon, KC
   Thia, EWH
   Tan, KL
   Lai, FM
   Lee, NKL
AF Yeo, George S. H.
   Qi, Maili
   Du, Ruochen
   Mahavadi, Padma Lata
   Yung, Chee Fu
   Thoon, Koh Cheng
   Thia, Edwin W. H.
   Tan, Kai Lit
   Lai, Fon Min
   Lee, Nicole K. L.
TI Gender-Specific Reference Charts of Fetal Head Circumference in a
   Singaporean Population
SO ANNALS ACADEMY OF MEDICINE SINGAPORE
LA English
DT Article
DE Microcephaly; Nomogram; Zika
ID ZIKA VIRUS-INFECTION; INTRAUTERINE GROWTH; NASAL BONE; SEX; ULTRASOUND;
   PREGNANCY; SIZE
AB Introduction: With the global outbreak of Zika virus and its association with microcephaly, an up-to-date fetal head circumference (HC) nomogram is crucial to offer a reference standard in order to make an accurate diagnosis. This study was conducted to revise the local fetal HC nomogram. Materials and Methods: In this retrospective study, ultrasound data was used for construction of the fetal HC nomogram from a total of 6155 pregnancies in the ethnic Chinese population with low risk profile at KK Women's and Children's Hospital over a 10-year period. Regression model was fitted to calculate the mean and standard deviation of HC at each gestational age (GA). Comparison of HC between ethnic groups (no significant differences) and genders were made. The revised chart was compared with another commonly used reference chart (Hadlock). In an independent test population, different reference charts were used to estimate number of cases with microcephaly. Results: A statistically significant difference of HC between the genders was observed across all gestational ages. Gender-specific reference charts and equation were computed. Our revised fetal HC chart showed a different distribution from the Hadlock chart. Compared with the gender-specific charts, the Hadlock HC chartwould significantly under-report microcephaly cases in male fetuses, and tend to over-report in female fetuses. Conclusion: This study provides a new set of gender-specific fetal HC charts in the Singaporean population for antenatal ultrasound surveillance of microcephaly.
C1 [Yeo, George S. H.; Du, Ruochen; Mahavadi, Padma Lata; Thia, Edwin W. H.; Tan, Kai Lit; Lai, Fon Min; Lee, Nicole K. L.] KK Womens & Childrens Hosp, Dept Maternal Fetal Med, 100 Bukit Timah Rd, Singapore 229899, Singapore.
   [Qi, Maili] KK Womens & Childrens Hosp, Dept Obstet & Gynaecol, Singapore, Singapore.
   [Yung, Chee Fu; Thoon, Koh Cheng] KK Womens & Childrens Hosp, Dept Paediat Med, Infect Dis Serv, Singapore, Singapore.
RP Yeo, GSH (corresponding author), KK Womens & Childrens Hosp, Dept Maternal Fetal Med, 100 Bukit Timah Rd, Singapore 229899, Singapore.
EM dr.george.sh.yeo@gmail.com
FU Department of Maternal Fetal Medicine, KK Women's and Children's
   Hospital
FX The authors are grateful to the doctors and sonographers who have
   contributed to data collection. The study research was supported by
   departmental funding from the Department of Maternal Fetal Medicine, KK
   Women's and Children's Hospital.
CR ALTMAN DG, 1994, BRIT J OBSTET GYNAEC, V101, P29, DOI 10.1111/j.1471-0528.1994.tb13006.x
   BROMLEY B, 1993, ULTRASOUND OBST GYN, V3, P395, DOI 10.1046/j.1469-0705.1993.03060395.x
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   HADLOCK FP, 1982, J ULTRAS MED, V1, P359
   HADLOCK FP, 1984, RADIOLOGY, V152, P497, DOI 10.1148/radiology.152.2.6739822
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lai F. M., 1995, Singapore Medical Journal, V36, P628
   Lai F. M., 1998, SMJ, V39, P69
   Melamed N, 2013, J ULTRAS MED, V32, P35
   Napolitano R, 2016, ULTRASOUND OBST GYN, V48, P80, DOI 10.1002/uog.15956
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   PARKER AJ, 1984, AM J OBSTET GYNECOL, V149, P665, DOI 10.1016/0002-9378(84)90255-2
   Schwarzler P, 2004, ULTRASOUND OBST GYN, V23, P23, DOI 10.1002/uog.966
   Thia EWH, 2011, ULTRASOUND OBST GYN, V38, P533, DOI 10.1002/uog.9042
   WALD N, 1986, BRIT MED J, V292, P137, DOI 10.1136/bmj.292.6513.137
   WHO, FACT SHEET MICR
   World Health Organisation, INT GUID UPD PREGN M
   Yeo G. S. H., 1994, Annals Academy of Medicine Singapore, V23, P371
   Yeo GSH, 2012, FETAL DIAGN THER, V32, P166, DOI 10.1159/000338656
NR 20
TC 0
Z9 1
U1 0
U2 0
PU ACAD MEDICINE SINGAPORE
PI REPUBLIC SINGAPORE
PA 142 NEIL RD, REPUBLIC SINGAPORE 088871, SINGAPORE
SN 0304-4602
J9 ANN ACAD MED SINGAP
JI Ann. Acad. Med. Singap.
PD OCT
PY 2017
VL 46
IS 10
BP 367
EP 373
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA FR0DT
UT WOS:000418732000002
PM 29177365
DA 2020-07-08
ER

PT J
AU Banerjee, S
AF Banerjee, Soumya
TI A COMPUTATIONAL TECHNIQUE TO ESTIMATE WITHIN-HOST PRODUCTIVELY INFECTED
   CELL LIFETIMES IN EMERGING VIRAL INFECTIONS
SO INTERDISCIPLINARY DESCRIPTION OF COMPLEX SYSTEMS
LA English
DT Article
DE viral infections; West Nile virus; replicon studies
ID WEST-NILE-VIRUS; LUCIFERASE; REPLICON; DYNAMICS; SEARCH; ASSAYS; MODEL
AB Emerging viruses cause a lot of fatalities as they jump to humans from other species. Here we develop a novel technique to computationally estimate an important parameter of within-host viral infection: the lifespan of infected cells. Our approach is general and can be applied to a large class of viruses and leverages experimental data from replicon studies. Current techniques have difficulties reliably estimating infected cell lifetimes due to parameter identifiability and correlation of parameters. The infected cell lifetime is an important parameter that gives an estimate of how fast virus levels will decline. Our method would also help determine if some infected cells are short-lived or have longer lifespans with the consequence that longer lived cells could be reservoirs of infection. This would give a mechanistic understanding of why particular cell types are reservoirs of infection and may motivate therapy targeted towards these cell types. We apply our technique to West Nile virus (WNV), an emerging disease of public health relevance related to Zika virus. Our analysis suggests that the most abundant infectible cells are short-lived and could motivate therapy that targets these particular cells. Our approach is very general and can be combined with more traditional methods of using differential equation models to simulate viremia in hosts: the combination of these two techniques will likely yield results that may not be achievable using the models in isolation. This will be of great interest especially in modelling emerging diseases.
C1 [Banerjee, Soumya] Univ Oxford, Oxford, England.
   [Banerjee, Soumya] Ronin Inst, Montclair, NJ USA.
   [Banerjee, Soumya] Complex Biol Syst Alliance, N Andover, MA USA.
RP Banerjee, S (corresponding author), Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA.
EM soumya.banerjee@ronininstitute.org
CR Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006
   Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649
   Balch C, 2015, BIOESSAYS, V37, P119, DOI 10.1002/bies.201400167
   Banerjee S., 2010, ARXIV10082799CSDC
   Banerjee S., 2016, 2 ANN CYB EARL CAR R
   Banerjee S., 2015, COMPL SYST DIG CAMP
   Banerjee S., 2011, ART IMM SYST 10 INT
   Banerjee S., 2015, ARXIV151200844QBIOCB
   Banerjee S, 2015, ARXIV150907313CSSI
   Banerjee S., 2013, THESIS
   Banerjee S., 2009, LECT NOTES COMPUTER
   Banerjee S, 2009, ARXIV09052649CSNE
   Banerjee S, 2015, PALGR COMMUN, V1, DOI 10.1057/palcomms.2015.22
   Banerjee S, 2016, INTERDISCIP DESCR CO, V14, P314, DOI 10.7906/indecs.14.3.4
   Banerjee S, 2016, INTERDISCIP DESCR CO, V14, P10, DOI 10.7906/indecs.14.1.2
   Banerjee S, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0130
   Banerjee S, 2010, SWARM INTELL-US, V4, P301, DOI 10.1007/s11721-010-0048-2
   Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249
   Ceausu Em., 1997, Romanian Journal of Virology, V48, P3
   HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0
   Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059
   Levin D, 2016, J THEOR BIOL, V398, P52, DOI 10.1016/j.jtbi.2016.02.022
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Liu P., 2014, ANGEW CHEM INT EDITI, V53
   Moses M., 2011, 2011 IEEE SSCI Symposium on Artificial Life (ALIFE), P30, DOI 10.1109/ALIFE.2011.5954663
   Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582
   PERELSON AS, 1993, MATH BIOSCI, V114, P81, DOI 10.1016/0025-5564(93)90043-A
   Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0
   Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009
   Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005
   Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511
   Weite I., 2011, J GEN VIROL, V90, P2660
   Yang CC, 2013, ANTIVIR RES, V98, P228, DOI 10.1016/j.antiviral.2013.03.001
   Ye CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017889
NR 34
TC 1
Z9 1
U1 0
U2 0
PU CROATIAN INTERDISCIPLINARY SOC
PI SESVETE
PA SIMUNCEVECKA 38B, SESVETE, HR-10360, CROATIA
SN 1334-4684
EI 1334-4676
J9 INTERDISCIP DESCR CO
JI Interdiscip. Descr. Complex Syst.
PD OCT
PY 2017
VL 15
IS 3
BP 190
EP 198
DI 10.7906/indecs.15.3.3
PG 9
WC Social Sciences, Interdisciplinary
SC Social Sciences - Other Topics
GA FQ7RO
UT WOS:000418560400003
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rios, N
   Stashenko, EE
   Duque, JE
AF Rios, Natalia
   Stashenko, Elena E.
   Duque, Jonny E.
TI Evaluation of the insecticidal activity of essential oils and their
   mixtures against Aedes aegypti (Diptera: Culicidae)
SO REVISTA BRASILEIRA DE ENTOMOLOGIA
LA English
DT Article
DE Essential oil; Larvicidal activity; Mosquito control
ID TRIBOLIUM-CASTANEUM; ISRAELENSIS BTI; LARVAE DIPTERA; PLANT OILS; ZIKA
   VIRUS; ANOPHELES; DENGUE; REPELLENCY; MOSQUITOS; TOXICITY
AB The search for new insecticides to control dengue fever, chikungunya, and Zika vectors has gained relevance in the past decades. The aim of the present study was to evaluate the larvicidal action of essential oils (EOs) from Thymus vulgaris, Salvia officinalis, Lippia origanoides, Eucalyptus globulus, Cymbopogon nardus, Cymbopogon martinii, Lippia alba, Pelargonium graveolens, Turnera diffusa, and Swinglea glutinosa on Aedes (Stegomyia) aegypti. The EOs were extracted by microwave-assisted hydrodistillation and characterized by gas chromatography/mass spectrometry (GC/MS). The chemical components of the EOs were identified by linear retention indices and mass spectra. Lethal concentrations (LC50 and LC95) were determined by probit analysis using larvae of Ae. aegypti between the third and the fourth instars. All EOs achieved larvicidal activity at LC50 values lower than 115 mg/L. The lowest LC50 value (45.73 mg/L) corresponded to T. vulgaris EO, whereas C. martinii EO showed the highest LC50 (LC50 = 114.65 mg/L). Some EO mixtures showed lower LC50 than oils used individually, such as the mixtures of L. origanoides + S. glutinosa (LC50 = 38.40 mg/L), T. diffusa + S. glutinosa (LC50 = 63.71 mg/L), and L. alba + S. glutinosa (LC50 = 48.87 mg/L). The main compounds of the EOs with highest larvicidal activity were thymol (42%) and p-cymene (26.4%). (C) 2017 Sociedade Brasileira de Entomologia. Published by Elsevier Editora Ltda.
C1 [Rios, Natalia] Univ Ind Santander, Ctr Invest Enfermedades Trop CINTROP, Escuela Quim, Bucaramanga, Colombia.
   [Stashenko, Elena E.] Univ Ind Santander, Escuela Quim, Ctr Invest Biomol CIBIMOL, Bucaramanga, Colombia.
   [Stashenko, Elena E.] Univ Ind Santander, Ctr Nacl Invest Agroindustrializac Plantas Aromat, Bucaramanga, Colombia.
   [Duque, Jonny E.] Univ Ind Santander, Dept Ciencias Basicas, Ctr Invest Enfermedades Trop CINTROP, Escuela Med, Bucaramanga, Colombia.
RP Duque, JE (corresponding author), Univ Ind Santander, Dept Ciencias Basicas, Ctr Invest Enfermedades Trop CINTROP, Escuela Med, Bucaramanga, Colombia.
EM jonedulu@uis.edu.co
OI Duque, Jonny Edward/0000-0003-2245-0558; Stashenko,
   Elena/0000-0001-7052-932X
FU Patrimonio Autonomo, Fondo Nacional de Financiamiento para la Ciencia
   [RC-0572-2012-Bio-Red-CENIVAM]; COLCIENCIAS scholarship [617]; Union
   Temporal Bio-Red-CO-CENIVAM [0812]
FX This study was possible thanks to the Patrimonio Autonomo, Fondo
   Nacional de Financiamiento para la Ciencia, Francisco Jose de Caldas,
   contract no. RC-0572-2012-Bio-Red-CENIVAM. Natalia Rios received a
   COLCIENCIAS scholarship for young researchers in the period of 2014-2015
   (617). We would like to thank the Ministerio de Ambiente y Desarrollo
   Sostenible (MADS), through its Direccion de Bosques, Biodiversidad y
   Servicios Ecosistemicos for their permission to conduct this research
   and the access to genetic resources and derived products for the program
   ran by the Union Temporal Bio-Red-CO-CENIVAM (Resolution 0812, June 4,
   2014).
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Aciole SDG, 2011, REV COLOMB ENTOMOL, V37, P262
   Agudelo-Gomez L., 2010, SALUD UIS, V42, P230
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Brandler S, 2013, VACCINE, V31, P3718, DOI 10.1016/j.vaccine.2013.05.086
   Caballero-Gallardo K, 2012, J STORED PROD RES, V50, P62, DOI 10.1016/j.jspr.2012.05.002
   Otero ALC, 2014, EUR J MED CHEM, V78, P392, DOI 10.1016/j.ejmech.2014.03.067
   Castillo RM, 2017, J AM MOSQUITO CONTR, V33, P25, DOI 10.2987/16-6585.1
   Cheng SS, 2003, BIORESOURCE TECHNOL, V89, P99, DOI 10.1016/S0960-8524(03)00008-7
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   FINNEY D J, 1971, P333
   Finney D. J., 1971, PROBIT ANAL STAT TRE
   Howard AFV, 2009, J MED ENTOMOL, V46, P107, DOI 10.1603/033.046.0114
   Kishore N., 2011, REV NATURAL PRODUCTS
   Manimaran A., 2012, Advances in Bioscience and Biotechnology, V3, P855
   Mansour SA, 2015, IND CROP PROD, V63, P92, DOI 10.1016/j.indcrop.2014.10.038
   Massebo F, 2009, AFR J BIOTECHNOL, V8, P4183
   MAZID S, 2011, INT J SC ADV TECHNOL, V1, P169, DOI DOI 10.1007/S10886-005-4244-2
   Mosm A. P., 2017, REV CROP PROT, V92, P16
   Olivero-Verbel J, 2013, J STORED PROD RES, V55, P145, DOI 10.1016/j.jspr.2013.09.003
   Opender Koul, 2008, Biopesticides International, V4, P63
   Pavela R, 2008, PARASITOL RES, V102, P555, DOI 10.1007/s00436-007-0821-3
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Ritchie SA, 2010, AM J TROP MED HYG, V82, P1053, DOI 10.4269/ajtmh.2010.09-0603
   Rodriguez Quintanilla R., 2012, Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas, V11, P77
   Shaalan EAS, 2005, ENVIRON INT, V31, P1149, DOI 10.1016/j.envint.2005.03.003
   Vera SS, 2014, PARASITOL RES, V113, P2647, DOI 10.1007/s00436-014-3917-6
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Stashenko EE, 2004, J CHROMATOGR A, V1025, P93, DOI 10.1016/j.chroma.2003.10.058
   Stashenko E, 2015, J ESSENT OIL RES, V27, P276, DOI 10.1080/10412905.2015.1045087
   Stashenko EE, 2010, J SEP SCI, V33, P93, DOI 10.1002/jssc.200900452
   Tennyson S., 2013, Middle East Journal of Scientific Research, V13, P64
   Thangavel P., 2015, ENV SUSTAIN ROLE GRE, P1
   WHO, 1996, REP WHO INF CONS EV
NR 37
TC 20
Z9 20
U1 2
U2 11
PU SOC BRASILEIRA ENTOMOLOGIA
PI CURITIBA
PA CAIXA POSTAL 19030, CURITIBA, PR 81531-980, BRAZIL
SN 0085-5626
EI 1806-9665
J9 REV BRAS ENTOMOL
JI Rev. Bras. Entomol.
PD OCT-DEC
PY 2017
VL 61
IS 4
BP 307
EP 311
DI 10.1016/j.rbe.2017.08.005
PG 5
WC Entomology
SC Entomology
GA FQ8FK
UT WOS:000418598100008
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lin, JJ
   Chin, TY
   Chen, CP
   Chan, HL
   Wu, TY
AF Lin, Jhe-Jhih
   Chin, Ting-Yu
   Chen, Chih-Ping
   Chan, Hong-Lin
   Wu, Tzong-Yuan
TI Zika virus: An emerging challenge for obstetrics and gynecology
SO TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY
LA English
DT Review
DE Flavivirus; Microcephaly; miRNA-34; Wnt/beta-catenin signaling pathway;
   Zika virus
ID WEST-NILE-VIRUS; CENTROSOMAL PROTEIN; PLASMA-MEMBRANE; I INTERFERON;
   INFECTION; MUTATIONS; SPINDLE; BINDING; DNA; CPAP
AB Microcephaly is a rare birth defect, however, the re-emerging mosquito and sexual transmitted flavivirus, Zika virus (ZIKV), had changed the situation and caused an urgent challenge for the obstetrics and gynecology. This review will brief summarize the epidemiology and virology of ZIKV. And compared the animal models that had developed for the ZIKV infections. These animal models will be benefit for the development of vaccines and anti-ZIKV drugs. Furthermore, the genes that are involved in the causation of microcephaly were also summarized. Finally, the Wnt signal is critical for the brain development as well as innate immune response. Based on previous literatures, we proposed that ZIKV-induced microcephaly might result from the influence of Wnt/beta-catenin signaling pathway through the regulation of miRNA-34. (C) 2017 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.
C1 [Lin, Jhe-Jhih; Chan, Hong-Lin] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.
   [Chin, Ting-Yu; Wu, Tzong-Yuan] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan.
   [Wu, Tzong-Yuan] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.
   [Chen, Chih-Ping] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.
   [Chen, Chih-Ping] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.
   [Chen, Chih-Ping] Asia Univ, Dept Biotechnol, Taichung, Taiwan.
   [Chen, Chih-Ping] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan.
   [Chen, Chih-Ping] Natl Yang Ming Univ, Inst Clin & Community Hlth Nursing, Taipei, Taiwan.
   [Chen, Chih-Ping] Natl Yang Ming Univ, Sch Med, Dept Obstet & Gynecol, Taipei, Taiwan.
RP Chan, HL (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.; Wu, TY (corresponding author), Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan.
EM hlchan@life.nthu.edu.tw; tywu@cycu.edu.tw
FU Ministry of Science and Technology of TaiwanMinistry of Science and
   Technology, Taiwan [MOST- 106-2321-B-033 -001 -]
FX This work was supported by grants (MOST- 106-2321-B-033 -001 -) to T. Y.
   Wu from the Ministry of Science and Technology of Taiwan.
CR Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313
   Alsara M, 2015, CANCER RES, V75, P777, DOI 10.1158/0008-5472.CAN-14-3431
   Alvarado-Socarras JL, 2016, ULTRASOUND OBST GYN, V47, P525, DOI 10.1002/uog.15885
   Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408
   Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733
   Baril M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003416
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327
   Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065
   Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141
   Brault V, 2001, DEVELOPMENT, V128, P1253
   Brown NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069986
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campaner S, 2005, MOL CELL BIOL, V25, P6660, DOI 10.1128/MCB.25.15.6660-6672.2005
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051
   Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192
   Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599
   Cho JH, 2006, BIOCHEM BIOPH RES CO, V339, P742, DOI 10.1016/j.bbrc.2005.11.074
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226
   Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1
   Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318
   Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha M. S., 2016, GENOME ANNOUNC, V4
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Falnikar A, 2011, MOL BIOL CELL, V22, P1561, DOI 10.1091/mbc.E10-11-0905
   FAYE O, 2014, PLONEGL TROP DIS, V8, DOI DOI 10.1371/JOURNAL.PNTD.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248
   Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hillesheim A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-29
   Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ji JL, 2015, EUR J HUM GENET, V23, P1473, DOI 10.1038/ejhg.2015.71
   Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002
   Kaufmann T, 2016, J CELL SCI, V129, P4607, DOI 10.1242/jcs.192633
   Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X
   Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005
   Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389
   Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220
   Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010
   Lee SMK, 2000, DEVELOPMENT, V127, P457
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lindenbach BD, 2007, HAVIVIRIDAE VIRUSES
   Liu L., 2016, GENOME ANNOUNC, V4
   Lopez-Valenzuela M, 2012, MOL BIOL EVOL, V29, P1797, DOI 10.1093/molbev/mss023
   Lucas EP, 2007, J CELL BIOL, V178, P725, DOI 10.1083/jcb.200704081
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216
   McLean E, 2017, LIBYAN J MED, V12, DOI 10.1080/19932820.2017.1304505
   MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mirzaa GM, 2014, HUM GENET, V133, P1023, DOI 10.1007/s00439-014-1443-3
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Najas S, 2015, EBIOMEDICINE, V2, P120, DOI 10.1016/j.ebiom.2015.01.010
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606
   Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373
   Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07
   Qin YF, 2016, CELL RES, V26, P613, DOI 10.1038/cr.2016.27
   Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360
   Riparbelli MG, 2002, J CELL SCI, V115, P913
   Rossi SL, 2016, CELL STEM CELL, V19, P4, DOI 10.1016/j.stem.2016.06.009
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roth A, 2014, EURO SURVEILL, V19
   Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Schuler-Faccini L, 2016, MMWR MORB MORTAL WKL, V65
   Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028
   Slonchak A, 2016, J VIROL, V90, P2388, DOI 10.1128/JVI.02608-15
   Smith JL, 2017, J VIROL, V91, DOI 10.1128/JVI.02388-16
   Smith JL, 2012, J VIROL, V86, P5278, DOI 10.1128/JVI.06883-11
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Song JL, 2015, CELL SIGNAL, V27, P1380, DOI 10.1016/j.cellsig.2015.03.018
   Spindler KR, 2001, J VIROL, V75, P12039, DOI 10.1128/JVI.75.24.12039-12046.2001
   Stamos JL, 2013, COLD SPRING HARB PER, V5
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319
   Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855
   Trimborn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009242
   Van Camp J, 2014, STEM CELL REV REP, V10, P207, DOI 10.1007/s12015-013-9486-8
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Wijdicks EFM, 2017, MAYO CLIN PROC, V92, P467, DOI 10.1016/j.mayocp.2016.12.002
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Wu DJ, 2016, J AUTOIMMUN, V73, P73, DOI 10.1016/j.jaut.2016.06.004
   Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200
   Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002
   Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876
   You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002
   Youn S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-339
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683
   Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang XY, 2009, CELL CYCLE, V8, P1206, DOI 10.4161/cc.8.8.8205
   Zhu JZ, 2011, EMBO J, V30, P4838, DOI 10.1038/emboj.2011.351
NR 132
TC 1
Z9 1
U1 0
U2 5
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1028-4559
J9 TAIWAN J OBSTET GYNE
JI Taiwan. J. Obstet. Gynecol.
PD OCT
PY 2017
VL 56
IS 5
BP 585
EP 592
DI 10.1016/j.tjog.2017.08.003
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FQ4GS
UT WOS:000418316300003
PM 29037541
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Tucci, V
   Moukaddam, N
   Meadows, J
   Shah, S
   Galwankar, SC
   Kapur, GB
AF Tucci, Veronica
   Moukaddam, Nidal
   Meadows, Jonathan
   Shah, Suhal
   Galwankar, Sagar C.
   Kapur, G. Bobby
TI The Forgotten Plague: Psychiatric Manifestations of Ebola, Zika, and
   Emerging Infectious Diseases
SO JOURNAL OF GLOBAL INFECTIOUS DISEASES
LA English
DT Article
DE Ebola; emerging disease; psychiatry; Zika
ID HEALTH; SURVIVORS; EPIDEMIC; ILLNESS
AB The media and public health generally focus on the biological and physical ramifications of epidemics. Mental health issues that coincide with emerging diseases and epidemics are rarely examined and sometimes, even eschewed due to cultural considerations. Psychiatric manifestations of various infectious diseases, especially with a focus on Ebola Virus disease (EVD) and Zika Virus, are discussed in this commentary to illustrate the continued need of care after the resolution of the actual illness. Various infectious diseases have associations with mental illness, such as an increased risk of obsessive-compulsive disorders and Tourette syndrome in children with Group B streptococcal infection. Current EVD literature does not demonstrate a strong association of mental illness symptoms or diseases but there is a necessity of care that extends beyond the illness. Patients and their families experience depression, anxiety, trauma, suicidal ideation, panic and other manifestations. Zika virus has been associated neuronal injury, genetic alteration that affects fetal development and detrimental maternal mental health symptoms are being documented. While funding calls from the international community are present, there are no specific epidemiological data or fiscal estimates solely for mental health during or after infectious diseases epidemics or disasters that support health care providers and strengthen policies and procedures for responding to such situations. Therefore, those on the frontlines of epidemics including emergency physicians, primary care providers and infectious disease specialists should serve communicate this need and advocate for sustained and increased funding for mental health programs to heighten public awareness regarding acute psychiatric events during infectious diseases outbreaks and offer treatment and support when necessary.
C1 [Tucci, Veronica] Merit Hlth Wesley, Dept Emergency Med, Hattiesburg, MS USA.
   [Moukaddam, Nidal] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA.
   [Meadows, Jonathan; Shah, Suhal] Touro Coll Osteopath Med, Dept Res, Undergrad Med Educ, New York, NY USA.
   [Galwankar, Sagar C.] Univ Florida, Dept Emergency Med, Jacksonville, FL USA.
   [Kapur, G. Bobby] Jackson Mem Hosp, Dept Emergency Med, Miami, FL 33136 USA.
RP Tucci, V (corresponding author), Merit Hlth Wesley Emergency Med Residency Program, 5001 Hardy St, Hattiesburg, MS 39402 USA.
EM vtuccimd@gmail.com
CR American Psychiatric Association, 2013, DESK REF DIAGN CRIT
   [Anonymous], 2016, HLTH NEWS FLORIDA
   [Anonymous], 2017, CONTAGION LIVE INFEC
   Bray M, 2016, CLIN MANIFESTATIONS
   Centers for Disease Control and Prevention, 2016, SUIC RISK PROT FACT
   Chiappelli F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0362-3
   COCKBURN A, 1963, EVOLUTION ERADICATIO
   De Roo A, 1998, TROP MED INT HEALTH, V3, P883, DOI 10.1046/j.1365-3156.1998.00322.x
   Department of Mental Health and Substance Abuse at WHO, 2015, MHGAP HUM INT GUID
   FALLON BA, 1994, AM J PSYCHIAT, V151, P1571, DOI 10.1176/ajp.151.11.1571
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   Gostin LO, 2015, JAMA-J AM MED ASSOC, V314, P113, DOI 10.1001/jama.2015.6940
   Greenberg N, 2015, J MENT HEALTH, V24, P1, DOI 10.3109/09638237.2014.1000676
   Hatalski CG, 1997, EMERG INFECT DIS, V3, P129
   LeBeaud A., 2016, ZIKA VIRUS INFECT OV
   Lever AG, 2016, J AUTISM DEV DISORD, V46, P1916, DOI 10.1007/s10803-016-2722-8
   Li KJ, 2016, BRAZILS ZIKA MOTHERS
   Massey TH, 2016, J NEUROL, V263, P1255, DOI 10.1007/s00415-016-8165-5
   McNeil Jr Donald G., 2016, NY TIMES
   McSweegan E, 1998, EMERG INFECT DIS, V4, P123, DOI 10.3201/eid0401.980118
   Mohammed A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2167-6
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   MUMFORD C, 1990, POSTGRAD MED J, V66, P218, DOI 10.1136/pgmj.66.773.218
   Pfefferbaum B, 2012, DISASTER MED PUBLIC, V6, P67, DOI 10.1001/dmp.2012.2
   Reardon S, 2015, NATURE, V519, P13, DOI 10.1038/519013a
   Renwick D, 2014, COUNCIL FOREIGN RELA
   Shultz JM, 2015, JAMA-J AM MED ASSOC, V313, P567, DOI 10.1001/jama.2014.17934
   Silva ACSE, 2016, NEUROPSYCH DIS TREAT, V12, P1747, DOI 10.2147/NDT.S113037
   Strom S., 2014, NY TIMES
   Swedo SE, 1997, AM J PSYCHIAT, V154, P110
   US Food and Drug Adminstration, 2016, ADV BLOOD COLL EST N
   WHO, 2016, EB SIT REP, P2
   World Health Organization, 2014, SUIC DAT MENT HLTH
   World Health Organization, 2014, MENT HLTH PSYCH SUPP
   World Health Organization, 2014, BUILD BACK BETT SUST
   World Health Organization, 2016, CURR ZIK PROD PIP
   World Health Organization, 2015, WHO DEF EM
   World Health Organization CBM World Vision International and UNICEF, 2014, PSYCH 1 AID EB VIR D
   World Health Organizatoin, 2016, ZIK VIR DIS DIS
NR 39
TC 7
Z9 7
U1 5
U2 7
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0974-777X
EI 0974-8245
J9 J GLOB INFECT DIS
JI J. Glob. Insect. Dis.
PD OCT-DEC
PY 2017
VL 9
IS 4
BP 151
EP 156
DI 10.4103/jgid.jgid_66_17
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA FQ4LD
UT WOS:000418328000006
PM 29302150
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Abrams, RPM
   Solis, J
   Nath, A
AF Abrams, Rachel P. M.
   Solis, Jamie
   Nath, Avindra
TI Therapeutic Approaches for Zika Virus Infection of the Nervous System
SO NEUROTHERAPEUTICS
LA English
DT Article
DE Zika virus; Drug discovery; Antiviral agents; Microcephaly; Congenital
   Zika syndrome; Guillain-Barre syndrome
ID SMALL-MOLECULE INHIBITORS; BORNE ENCEPHALITIS-VIRUS; DENGUE VIRUS;
   NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE; HEPATITIS-C; STRUCTURAL BASIS;
   ANTIRETROVIRAL THERAPY; ENVELOPE GLYCOPROTEIN; APPROVED DRUGS
AB Zika virus has spread rapidly in the Americas and has caused devastation of human populations affected in these regions. The virus causes teratogenic effects involving the nervous system, and in adults and children can cause a neuropathy similar to Guillain-Barr, syndrome, an anterior myelitis, or, rarely, an encephalitis. While major efforts have been undertaken to control mosquito populations that spread the virus and to develop a vaccine, drug development that directly targets the virus in an infected individual to prevent or treat the neurological manifestations is necessary. Rational and targeted drug development is possible since the viral life cycle and the structure of the key viral proteins are now well understood. While several groups have identified therapeutic candidates, their approaches differ in the types of screening processes and viral assays used. Animal studies are available for only a few compounds. Here we provide an exhaustive review and compare each of the classes of drugs discovered, the methods used for drug discovery, and their potential use in humans for the prevention or treatment of neurological complications of Zika virus infection.
C1 [Abrams, Rachel P. M.; Solis, Jamie; Nath, Avindra] NINDS, Sect Infect Nervous Syst, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
RP Nath, A (corresponding author), NINDS, Sect Infect Nervous Syst, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
EM natha@ninds.nih.gov
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NS003130]
CR Adams J, 1999, CANCER RES, V59, P2615
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Albulescu IC, 2015, ANTIVIR RES, V121, P39, DOI 10.1016/j.antiviral.2015.06.013
   Anderson J, 2009, HDB EXPT PHARM, V189
   Andronico A, 2017, AM J EPIDEMIOL
   Arnold JJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003030
   Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504
   Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468
   BACQ Y, 1991, HEPATOLOGY, V14, P1066, DOI 10.1002/hep.1840140620
   Baker R, 1995, BETA, V9
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barbosa-Lima G, 2017, EUR J MED CHEM, V127, P434, DOI 10.1016/j.ejmech.2017.01.007
   Barbosa-Limaa G, 2017, EUR J MED CHEM, V127, P334, DOI 10.1016/j.ejmech.2016.12.058
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Baudry S, 1997, J PHARM PHARMACOL, V49, P1086, DOI 10.1111/j.2042-7158.1997.tb06047.x
   BAUGHMAN RD, 1964, ARCH DERMATOL, V90, P153, DOI 10.1001/archderm.1964.01600020021003
   Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOECK LD, 1973, ANTIMICROB AGENTS CH, V3, P49, DOI 10.1128/AAC.3.1.49
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Brecher Matthew, 2013, Virologica Sinica, V28, P326, DOI 10.1007/s12250-013-3390-x
   Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009
   CAO X, 2016, NUCLEIC ACIDS RES, DOI DOI 10.1093/nar/gkw941
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carrada-Bravo T, 2002, REV GASTROENTEROL ME, V68, P135
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004058
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davidson A, 2016, MMWR MORB MORTAL WKL, V65
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Derissen EJB, 2013, ONCOLOGIST, V18, P619, DOI 10.1634/theoncologist.2012-0465
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dinur AB, 2013, ANTIMICROB AGENTS CH, V57, P3307, DOI 10.1128/AAC.01691-12
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053
   Duan W, 2017, EMBO J
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Eleuteri S, 2015, NEUROBIOL DIS, V74, P144, DOI 10.1016/j.nbd.2014.08.017
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fang JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078425
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Garber K, 2007, NAT BIOTECHNOL, V25, P1379, DOI 10.1038/nbt1207-1379
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Gonzalez R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-75
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Hartwig A., 2013, MAK COLLECTION OCCUP, V27
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   HENNEQUIN C, 1994, ARCH INTERN MED, V154, P2360, DOI 10.1001/archinte.154.20.2360
   Henss L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0607-2
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Ho YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133511
   HORWITZ JP, 1964, J ORG CHEM, V29, P2076, DOI 10.1021/jo01030a546
   Iyengar S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002032
   Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Jaruratanasirikul S, 1996, ANTIMICROB AGENTS CH, V40, P825, DOI 10.1128/AAC.40.3.825
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Kaminskas E, 2005, ONCOLOGIST, V10, P176, DOI 10.1634/theoncologist.10-3-176
   Kampmann T, 2009, ANTIVIR RES, V84, P234, DOI 10.1016/j.antiviral.2009.09.007
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuiper B. D., 2017, BIOCH BIOPHYS RES CO
   Kullar R, 2011, ANTIMICROB AGENTS CH, V55, P3505, DOI 10.1128/AAC.01741-10
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853
   Lawn ND, 1999, NEUROLOGY, V52, P635, DOI 10.1212/WNL.52.3.635
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leonardi W, 2016, SCI REP-UK, V6, DOI 10.1038/srep34475
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Leyssen P, 2008, ANTIVIR RES, V78, P9, DOI 10.1016/j.antiviral.2008.01.004
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Lucas-Hourani M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003678
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mahajan R, 2009, INDIAN J PHARMACOL, V41, P197, DOI 10.4103/0253-7613.56070
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379
   Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mukherjee S, 2012, NUCLEIC ACIDS RES
   Murphy MFG, 2006, TWIN RES HUM GENET, V9, P279, DOI 10.1375/twin.9.2.279
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   NWOKOLO C, 1974, B WORLD HEALTH ORGAN, V50, P569
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   OSTERTAG W, 1974, P NATL ACAD SCI USA, V71, P4980, DOI 10.1073/pnas.71.12.4980
   PERERA DR, 1970, AM J TROP MED HYG, V19, P610, DOI 10.4269/ajtmh.1970.19.610
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Perez R, 2008, J VET PHARMACOL THER, V31, P406, DOI 10.1111/j.1365-2885.2008.00971.x
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Popat R, 2013, BRIT J HAEMATOL, V160, P714, DOI 10.1111/bjh.12154
   Potisopon S, 2017, ANTIVIR RES, V140, P25, DOI 10.1016/j.antiviral.2016.12.021
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Ramsey PS, 2003, AM J OBSTET GYNECOL, V188, P714, DOI 10.1067/mob.2003.141
   Raub TJ, 2015, DRUG METAB DISPOS, V43, P1360, DOI 10.1124/dmd.114.062745
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sacramento CQ, 2016, BIORXIV, P61671
   Saeedi BJ, 2013, WIRES RNA, V4, P723, DOI 10.1002/wrna.1191
   Salam RA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005547.pub3
   Sarkar Moumita, 2006, BMC Pregnancy Childbirth, V6, P18, DOI 10.1186/1471-2393-6-18
   Saw WG, 2017, ANTIVIR RES, V141, P73, DOI 10.1016/j.antiviral.2017.02.005
   Shi ZX, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-10
   Shiffman ML, 2010, ALIMENT PHARM THER, V31, P969, DOI 10.1111/j.1365-2036.2010.04264.x
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Soultanas P, 2001, TRENDS BIOCHEM SCI, V26, P47, DOI 10.1016/S0968-0004(00)01734-5
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Sweeney NL, 2015, ACS INFECT DIS, V1, P140, DOI 10.1021/id5000458
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Takahashi T, 1969, RADIOISOTOPES, V18, P552
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   TOJI L, 1969, P NATL ACAD SCI USA, V63, P871, DOI 10.1073/pnas.63.3.871
   Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092
   Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270
   Turrini F, 2016, NEW MICROBIOL, V39, P86
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vilhena C, 2012, MINI-REV MED CHEM, V12, P202, DOI 10.2174/1389557511209030202
   Wald A, 2016, JAMA-J AM MED ASSOC, V316, P2495, DOI 10.1001/jama.2016.18189
   Wald A, 2014, NEW ENGL J MED, V370, P201, DOI 10.1056/NEJMoa1301150
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   World Health Organization, 2016, SAUDI MED J, V37, P334
   Wu JQ, 2015, J VIROL, V89, P249, DOI 10.1128/JVI.02085-14
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   YARCHOAN R, 1987, NEW ENGL J MED, V316, P557, DOI 10.1056/NEJM198702263160925
   YARCHOAN R, 1987, LANCET, V1, P132, DOI 10.1016/S0140-6736(87)91968-4
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yu YQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14364
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zhang C, 2016, BIOCH BIOPHYS RES CO
   Zhang Z., 2016, SCIENCE
   Zhao BT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14586
   Zhou H, 2017, ONCOTARGET, V8, P14830, DOI 10.18632/oncotarget.14780
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 187
TC 10
Z9 10
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1933-7213
EI 1878-7479
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD OCT
PY 2017
VL 14
IS 4
BP 1027
EP 1048
DI 10.1007/s13311-017-0575-2
PG 22
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA FP5XB
UT WOS:000417695200019
PM 28952036
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Ribeiro, BG
   Werner, H
   Lopes, FPPL
   da Cruz, LCH
   Fazecas, TM
   Daltro, PAN
   Nogueira, RA
AF Ribeiro, Bianca Guedes
   Werner, Heron
   Lopes, Flavia P. P. L.
   Celso Hygino da Cruz, L., Jr.
   Fazecas, Tatiana M.
   Daltro, Pedro A. N.
   Nogueira, Renata A.
TI Central Nervous System Effects of Intrauterine Zika Virus Infection: A
   Pictorial Review
SO RADIOGRAPHICS
LA English
DT Review
ID PREGNANCY
AB Relatively few agents have been associated with congenital infections involving the brain. One such agent is the Zika virus, which has caused several outbreaks worldwide and has spread in the Americas since 2015. The Zika virus is an arbovirus transmitted by infected female mosquito vectors, such as the Aedes aegypti mosquito. This virus has been commonly associated with congenital infections of the central nervous system and has greatly increased the rates of microcephaly. Ultrasonography (US) remains the method of choice for fetal evaluation of congenital Zika virus infection. For improved assessment of the extent of the lesions, US should be complemented by magnetic resonance (MR) imaging. Postnatal computed tomography and MR imaging can also unveil additional findings of central nervous system involvement, such as microcephaly with malformation of cortical development, ventriculomegaly, and multifocal calcifications in the cortical-subcortical junction, along with associated cortical atrophy. The calcifications may be punctate, dystrophic, linear, or coarse and may follow a predominantly bandlike distribution. A small anterior fontanelle with prematurely closed sutures is also observed with Zika virus infection. In this review, the prenatal and postnatal neurologic imaging findings of congenital Zika virus infection are covered. Radiologists must be aware of this challenging entity and have knowledge of the various patterns that may be depicted with each imaging modality and the main differential diagnosis of the disease. As in other neurologic infections, serial imaging is able to help demonstrate the progression of the findings. (C)RSNA, 2017
C1 [Ribeiro, Bianca Guedes; Werner, Heron; Lopes, Flavia P. P. L.; Celso Hygino da Cruz, L., Jr.; Fazecas, Tatiana M.; Daltro, Pedro A. N.; Nogueira, Renata A.] Clin Diagnost Imagem CDPI DASA, Ctr Med Barrashopping, Dept Radiol, Av Amer 4666,Sala 325,3 Piso, BR-22640902 Rio De Janeiro, Brazil.
   [Ribeiro, Bianca Guedes; Fazecas, Tatiana M.] Hosp Municipal Jesus, Rio De Janeiro, Brazil.
   [Ribeiro, Bianca Guedes; Celso Hygino da Cruz, L., Jr.; Nogueira, Renata A.] Amer Med City, Rio De Janeiro, Brazil.
   [Daltro, Pedro A. N.] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Lopes, Flavia P. P. L.] Univ Fed Rio de Janeiro UFRJ, Dept Radiol, Rio De Janeiro, Brazil.
RP Ribeiro, BG (corresponding author), Clin Diagnost Imagem CDPI DASA, Ctr Med Barrashopping, Dept Radiol, Av Amer 4666,Sala 325,3 Piso, BR-22640902 Rio De Janeiro, Brazil.
EM drabiancaribeiro@gmail.com
RI Werner, Heron/W-1578-2019
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Araujo E, 2014, J ULTRAS MED, V33, P1185, DOI 10.7863/ultra.33.7.1185
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vivarelli R, 2001, BRAIN DEV-JPN, V23, P18, DOI 10.1016/S0387-7604(00)00188-1
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
NR 27
TC 7
Z9 9
U1 0
U2 2
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0271-5333
J9 RADIOGRAPHICS
JI Radiographics
PD OCT
PY 2017
VL 37
IS 6
BP 1840
EP 1850
DI 10.1148/rg.2017170023
PG 11
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA FP3GO
UT WOS:000417506900014
PM 29019762
OA Bronze
DA 2020-07-08
ER

PT J
AU Levine, D
AF Levine, Deborah
TI Invited Commentary on "Central Nervous System Effects of Intrauterine
   Zika Virus Infection"
SO RADIOGRAPHICS
LA English
DT Editorial Material
C1 [Levine, Deborah] Beth Israel Deaconess Med Ctr, Dept Radiol, 330 Brookline Ave, Boston, MA 02215 USA.
RP Levine, D (corresponding author), Beth Israel Deaconess Med Ctr, Dept Radiol, 330 Brookline Ave, Boston, MA 02215 USA.
CR [Anonymous], EM ZIK SIT REP
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Cannie MM, 2016, EUR RADIOL, V26, P3760, DOI 10.1007/s00330-015-4187-0
   Centers for Disease Control and Prevention, PAR CAR CLIN MAN PRE
   Centers for Disease Control and Prevention, 2017, GUID USLABORATORIES
   Centers for Disease Control and Prevention, 2015, ZIK CAS US CUM ZIK V
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ribeiro BG, 2017, RADIOGRAPHICS, V37, P1840, DOI 10.1148/rg.2017170023
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 13
TC 1
Z9 1
U1 0
U2 0
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0271-5333
J9 RADIOGRAPHICS
JI Radiographics
PD OCT
PY 2017
VL 37
IS 6
BP 1850
EP 1853
PG 4
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA FP3GO
UT WOS:000417506900015
PM 29019746
OA Bronze
DA 2020-07-08
ER

PT J
AU Fontes-Dantas, F
   Araujo, A
   Franca, L
   Farinhas, J
   Paschoal, I
   Barbosa, R
   Nogueira, B
   Abboud, F
   Rego, C
   Pereira, V
   Malfetano, F
   Scherpenhuijzen, S
   Oliveira, A
   Neri, V
   Vasconcelos, C
   Alves-Leon, S
AF Fontes-Dantas, F.
   Araujo, A.
   Franca, L.
   Farinhas, J.
   Paschoal, I.
   Barbosa, R.
   Nogueira, B.
   Abboud, F.
   Rego, C.
   Pereira, V.
   Malfetano, F.
   Scherpenhuijzen, S.
   Oliveira, A.
   Neri, V.
   Vasconcelos, C.
   Alves-Leon, S.
TI A comprehensive in silico analysis of transcripts upregulated in
   multiple scleroses patients and ZIkV infection: identification of
   similar pathways
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Joint
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
   (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Scle
   rosis (ACTRIMS)
CY OCT 25-28, 2017
CL Paris, FRANCE
SP European Comm Treatment & Res Multiple Sclerosis, Americas Comm Treatment & Res Multiple Sclerosis
C1 [Fontes-Dantas, F.; Araujo, A.; Franca, L.; Farinhas, J.; Paschoal, I.; Barbosa, R.; Nogueira, B.; Abboud, F.; Neri, V.; Vasconcelos, C.; Alves-Leon, S.] Univ Fed Estado Rio de Janeiro, Hosp Univ Gaffree & Guinle, Posgrad Neurol, Rio de Janeiro, Brazil.
   [Rego, C.; Pereira, V.; Malfetano, F.; Scherpenhuijzen, S.; Oliveira, A.; Alves-Leon, S.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Neurol, Rio de Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD OCT
PY 2017
VL 23
SU 3
MA EP1607
BP 841
EP 842
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FK8AS
UT WOS:000413730205093
DA 2020-07-08
ER

PT J
AU Loose, MW
AF Loose, Matthew W.
TI The potential impact of nanopore sequencing on human genetics
SO HUMAN MOLECULAR GENETICS
LA English
DT Review
ID REAL-TIME; ZIKA VIRUS; GENOME; DNA; SURVEILLANCE; METHYLATION;
   CHROMOSOME; CYTOSINE
AB Nanopore sequencing has been available to researchers for a little over 3 years. Recently, the milestone of sequencing and assembling a human genome on this platform was achieved for the first time. Significant improvements to the platform in yield and accuracy, coupled with higher throughput nanopore sequencers, mean that human genome sequencing at scale is now possible. Here, a brief recent history of the nanopore platform is provided, key papers and innovations are highlighted and some of the challenges for the future are discussed.
C1 [Loose, Matthew W.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England.
RP Loose, MW (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England.
EM matt.loose@nottingham.ac.uk
OI Loose, Matthew/0000-0002-5264-0929
FU Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC) [BB/N017099/1]
FX ML is supported by awards from the Biotechnology and Biological Sciences
   Research Council (BB/N017099/1).
CR Baker M, 2012, NAT METHODS, V9, P333, DOI 10.1038/nmeth.1935
   Bickhart DM, 2017, NAT GENET, V49, P643, DOI 10.1038/ng.3802
   Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10
   Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495
   Brown CG, 2016, NAT BIOTECHNOL, V34, P810, DOI 10.1038/nbt.3622
   Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727
   Carter Jean-Michel, 2017, Wellcome Open Res, V2, P23, DOI 10.12688/wellcomeopenres.11246.3
   Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147
   David M, 2017, BIOINFORMATICS, V33, P49, DOI 10.1093/bioinformatics/btw569
   Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986
   Euskirchen P., 2017, ACTA NEUROPATHOL, DOI DOI 10.1007/S00401-017-1743-5.
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Gabrieli T., 2017, CAS9 ASSISTED TARGET, DOI [10.1101/110163., DOI 10.1101/110163.]
   Garalde DR, 2016, BIORXIV, DOI [10.1101/068809, DOI 10.1101/068809]
   Gigante Scott, 2017, F1000Res, V6, P227, DOI 10.12688/f1000research.11022.2
   Hastie AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055864
   Jain M., 2017, NANOPORE SEQUENCING, DOI [10.1101/128835, DOI 10.1101/128835.]
   Jain M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1103-0
   Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]
   Jaworski E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006365
   Karamitros T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157600
   Koren S., 2017, CANU SCALABLE ACCURA, DOI [10.1101/gr.215087.116., DOI 10.1101/GR.215087.116.]
   Koren S, 2015, CURR OPIN MICROBIOL, V23, P110, DOI 10.1016/j.mib.2014.11.014
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Li H, 2016, BIOINFORMATICS, V32, P2103, DOI 10.1093/bioinformatics/btw152
   Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]
   Loman NJ, 2015, NAT METHODS, V12, P303, DOI 10.1038/nmeth.3327
   Loose M, 2016, NAT METHODS, V13, P751, DOI [10.1038/NMETH.3930, 10.1038/nmeth.3930]
   Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171
   McIntyre A.B.R., 2017, NANOPORE DETECTION B, DOI DOI 10.1101/127100.
   Mitsuhashi S., 2017, NANOPORE BASED SINGL, DOI [10.1101/157040, DOI 10.1101/157040.]
   Norris AL, 2016, CANCER BIOL THER, V17, P246, DOI 10.1080/15384047.2016.1139236
   Patterson M, 2014, LECT N BIOINFORMAT, V8394, P237, DOI 10.1007/978-3-319-05269-4_19
   Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/NMETH.3454, 10.1038/nmeth.3454]
   Quick J., 2017, MULTIPLEX PCR METHOD, DOI [10.1101/098913, DOI 10.1101/098913]
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rand AC, 2017, NAT METHODS, V14, P411, DOI 10.1038/nmeth.4189
   Schmidt M.H.-W., 2017, RECONSTRUCTING GIGAB, DOI [10.1101/129148, DOI 10.1101/129148.]
   Schneider VA, 2017, GENOME RES, V27, P849, DOI 10.1101/gr.213611.116
   Schreiber J, 2013, P NATL ACAD SCI USA, V110, P18910, DOI 10.1073/pnas.1310615110
   Simpson JT, 2017, NAT METHODS, V14, P407, DOI 10.1038/nmeth.4184
   Simpson JT, 2015, ANNU REV GENOM HUM G, V16, P153, DOI 10.1146/annurev-genom-090314-050032
   Smith A.M., 2017, READING CANONICAL MO, DOI DOI 10.1101/132274.
   Stancu M.C., 2017, MAPPING PHASING STRU, DOI [10.1101/129379, DOI 10.1101/129379.]
   Stoiber M., 2017, BASECRAWLLER STREAMI, DOI DOI 10.1101/133058.
   Stoiber M.H., 2016, DE NOVO IDENTIFICATI, DOI [10.1101/094672, DOI 10.1101/094672.]
   Suzuki A., 2017, DNA RES, DOI [10.1093/dnares/dsx027., DOI 10.1093/DNARES/DSX027.]
   Szalay T, 2015, NAT BIOTECHNOL, V33, P1087, DOI 10.1038/nbt.3360
   Tyson J.R., 2017, WHOLE GENOME SEQUENC, DOI [10.1101/099143, DOI 10.1101/099143.]
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   Votintseva AA, 2017, J CLIN MICROBIOL, V55, P1285, DOI 10.1128/JCM.02483-16
   Yamagishi J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03734-5
   Zaaijer S., 2016, DEMOCRATIZING DNA FI, DOI [10.1101/061556, DOI 10.1101/061556.]
NR 55
TC 16
Z9 16
U1 1
U2 31
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD OCT 1
PY 2017
VL 26
IS R2
BP R202
EP R207
DI 10.1093/hmg/ddx287
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA FO9CD
UT WOS:000417184700013
PM 28977449
OA Bronze
DA 2020-07-08
ER

PT J
AU Ahmad, S
   Wong, IX
   Mazlan, NAA
   Ismail, NE
AF Ahmad, S.
   Wong, I. X.
   Mazlan, Ahmad N. A.
   Ismail, N. E.
TI LINGUISTIC VALIDATION OF KNOWLEDGE, ATTITUDES AND PRACTICE OF ZIKA VIRUS
   DISEASE QUESTIONNAIRE AMONG THE MALAYSIAN GENERAL PUBLIC USING RAS CH
   MODEL: A CROSS-SECTIONAL STUDY
SO VALUE IN HEALTH
LA English
DT Meeting Abstract
C1 [Ahmad, S.; Wong, I. X.; Mazlan, Ahmad N. A.] MAHSA Univ, Bandar Saujana Putra, Malaysia.
   [Ismail, N. E.] MAHSA Univ, Jenjarom Kuala Langat, Selangor, Malaysia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1098-3015
EI 1524-4733
J9 VALUE HEALTH
JI Value Health
PD OCT-NOV
PY 2017
VL 20
IS 9
MA PRM161
BP A759
EP A759
PG 1
WC Economics; Health Care Sciences & Services; Health Policy & Services
SC Business & Economics; Health Care Sciences & Services
GA FK6FX
UT WOS:000413599902679
DA 2020-07-08
ER

PT J
AU Manuelyan, KL
   Bogdanov, IA
   Darlenski, RB
AF Manuelyan, Karen L.
   Bogdanov, Ivan A.
   Darlenski, Razvigor B.
TI Skin signs of systemic infections and neoplastic diseases
SO GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA
LA English
DT Review
DE Meningococcal infections; Ebola hemorrhagic fever; Zika virus infection;
   Hand, foot and mouth disease; Acanthosis nigricans Necrolytic; migratory
   erythema
ID HYPERTRICHOSIS-LANUGINOSA-ACQUISITA; CONGO HEMORRHAGIC-FEVER; CUTANEOUS
   MANIFESTATIONS; ACANTHOSIS NIGRICANS; MOUTH-DISEASE; ACROKERATOSIS
   PARANEOPLASTICA; INTERNAL MALIGNANCY; PURPURA FULMINANS; JANEWAY
   LESIONS; ENTEROVIRUS 71
AB In recent years, emphasis on the physical examination has made way for a plethora of laboratory tests and sophisticated imaging diagnostic techniques. In addition, we are witnessing an underestimation of dermatology as a specialty around the world, which is accepted as an ambulatory specialty on the border of cosmetology and beautification. However, recognizing specific cutaneous clinical signs can facilitate timely diagnosis of various systemic infections and neoplastic diseases. Thus, a skilled dermatologist can play an essential role in the multidisciplinary team, involved in the care for systemically ill patients. In this article, we will focus on some life threatening systemic infections in which the skin changes can be a major clue for the diagnosis. Recent deadly epidemics will also be focused. Classic examples of paraneoplastic skin conditions will also be provided.
C1 [Manuelyan, Karen L.; Darlenski, Razvigor B.] Trakia Univ, Fac Med, Prof Dr Stoyan Kirkovich Univ Hosp, Dept Dermatol & Venereol, Stara Zagora, Bulgaria.
   [Bogdanov, Ivan A.; Darlenski, Razvigor B.] Tokuda Hosp, Acibadem City Clin, Dept Dermatol & Venereol, Sofia, Bulgaria.
RP Darlenski, RB (corresponding author), Trakia Univ, Dept Dermatol & Venereol, Ul Armeyska 11, Stara Zagora 6000, Bulgaria.
EM darlenski@abv.bg
RI Manuelyan, Karen/AAA-3539-2020; Bogdanov, Ivan/I-8164-2019
OI Bogdanov, Ivan/0000-0002-2845-6224; Manuelyan, Karen/0000-0003-1978-4696
CR Andreev V C, 1978, Curr Probl Dermatol, V8, P1
   ANDREEV VC, 1981, DERMATOLOGICA, V163, P19, DOI 10.1159/000250136
   Andreev VC, 1963, STOMATOLOGIA, V11, P5
   Anhalt GJ, 2004, J INVEST DERM SYMP P, V9, P29, DOI 10.1111/j.1087-0024.2004.00832.x
   Bakos Noemi, 1997, Pathol Oncol Res, V3, P59
   Baquero-Sanchez E, 2015, AN PEDIATR, V83, P397, DOI 10.1016/j.anpedi.2015.01.001
   BASSETSEGUIN N, 1990, ARCH DERMATOL, V126, P633, DOI 10.1001/archderm.126.5.633
   Beasley K, 2016, DERMATOL ONLINE J, V22
   Blattner CM, 2015, DERMATOL ONLINE J, V21
   BODEY GP, 1974, JAMA-J AM MED ASSOC, V229, P1466, DOI 10.1001/jama.229.11.1466
   BOLOGNIA JL, 1995, SEMIN DERMATOL, V14, P84, DOI 10.1016/S1085-5629(05)80002-1
   BOYD AS, 1992, J AM ACAD DERMATOL, V26, P757, DOI 10.1016/0190-9622(92)70107-Q
   BREATHNACH SM, 1980, CLIN EXP DERMATOL, V5, P181, DOI 10.1111/j.1365-2230.1980.tb01686.x
   CARDULLO AC, 1990, J AM ACAD DERMATOL, V22, P1088, DOI 10.1016/0190-9622(90)70157-D
   Chen SM, 2015, ASIA-PAC J PUBLIC HE, V27, P715, DOI 10.1177/1010539515579123
   Chen YJ, 2001, BRIT J DERMATOL, V144, P825, DOI 10.1046/j.1365-2133.2001.04140.x
   Cohen N, 2015, ACTA PAEDIATR, V104, pE134, DOI 10.1111/apa.12889
   COHEN PR, 1995, DERMATOL CLIN, V13, P79, DOI 10.1016/S0733-8635(18)30110-4
   COHN MS, 1993, CUTIS, V51, P255
   Costa MC, 2012, AN BRAS DERMATOL, V87, P498, DOI 10.1590/S0365-05962012000300030
   Curth HO, 1976, CANCER SKIN, P1308
   da Silva JA, 2013, AN BRAS DERMATOL, V88, P9, DOI 10.1590/S0365-05962013000100001
   De La Torre-Lugo Eneida M, 2011, J Am Acad Dermatol, V64, pe89, DOI 10.1016/j.jaad.2010.10.006
   Donato C, 2016, VIROLOGY, V495, P1, DOI 10.1016/j.virol.2016.04.026
   Dourmishev L, 2004, CEED VA, V6, P27
   Dourmishev LA, 2002, INT J DERMATOL, V41, P625, DOI 10.1046/j.1365-4362.2002.01482.x
   Dourmishev LA, 1999, ADV EXP MED BIOL, V455, P193
   Dourmishev LA, 2009, WORLD J GASTROENTERO, V15, P4372, DOI 10.3748/wjg.15.4372
   FANNING WL, 1977, ARCH DERMATOL, V113, P648, DOI 10.1001/archderm.113.5.648
   GAMMEL JA, 1952, AMA ARCH DERM SYPH, V66, P494, DOI 10.1001/archderm.1952.01530290070010
   Gan ZK, 2015, HUM VACC IMMUNOTHER, V11, P2400, DOI 10.1080/21645515.2015.1059980
   Hazen PG, 2014, CUTIS, V93, P251
   HOVENDEN AL, 1993, CLIN DERMATOL, V11, P99, DOI 10.1016/0738-081X(93)90104-K
   Hsu YS, 2000, J GASTROENTEROL, V35, P460, DOI 10.1007/s005350070092
   Ibrahim Aliyu, 2013, J Family Med Prim Care, V2, P393, DOI 10.4103/2249-4863.123938
   Ivanaviciene Jurate, 2016, Int J Womens Dermatol, V2, P89, DOI 10.1016/j.ijwd.2016.05.004
   Jabbour SA, 2010, DERMATOL THER, V23, P643, DOI 10.1111/j.1529-8019.2010.01369.x
   Jiang YP, 2016, MYCOPATHOLOGIA, V181, P759, DOI 10.1007/s11046-016-0031-6
   Kalvatchev N, 2012, BIOTECHNOL BIOTEC EQ, V26, P3079, DOI 10.5504/BBEQ.2011.0135
   Karadag A S, 2012, Indian J Dermatol, V57, P503, DOI 10.4103/0019-5154.103079
   KINGSTON ME, 1986, REV INFECT DIS, V8, P1
   Krawczyk M, 2009, POL ARCH MED WEWN, V119, P180, DOI 10.20452/pamw.642
   Lecuyer H, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx027
   Leser E., 1901, MUNCHEN MED WOCHEN, V51, P2035
   Ljubenovic MS, 2009, INDIAN J DERMATOL VE, V75, DOI 10.4103/0378-6323.51249
   LYNCH HT, 1981, ARCH INTERN MED, V141, P607, DOI 10.1001/archinte.141.5.607
   MADDEN RM, 1990, BRIT J HAEMATOL, V75, P112, DOI 10.1111/j.1365-2141.1990.tb02625.x
   Maltezou HC, 2010, EUROSURVEILLANCE, V15, P48
   Navjyot Kaur, 2016, J Assoc Physicians India, V64, P55
   Nawas ZY, 2016, J AM ACAD DERMATOL, V75, P1, DOI 10.1016/j.jaad.2016.04.033
   Nguyen NTB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-341
   NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0
   Nkoghe D, 2012, INT J DERMATOL, V51, P1037, DOI 10.1111/j.1365-4632.2011.05379.x
   Pan American Health Organization, 2016, FREQ ASK QUEST ZIK V
   Pancar GS, 2013, J EUR ACAD DERMATOL
   Pipkin CA, 2008, DERMATOL CLIN, V26, P1, DOI 10.1016/j.det.2007.08.002
   RAMPEN FHJ, 1989, J AM ACAD DERMATOL, V21, P50, DOI 10.1016/S0190-9622(89)70147-X
   Roth A, 2014, EURO SURVEILL, V19
   Servy A, 2014, JAMA DERMATOL, V150, P494, DOI 10.1001/jamadermatol.2013.8727
   Simmons BJ, 2015, JAMA DERMATOL, V151, P400, DOI 10.1001/jamadermatol.2014.4505
   SLATER DN, 1982, J ROY SOC MED, V75, P875
   Slee PHTJ, 2007, BRIT J DERMATOL, V157, P1087, DOI 10.1111/j.1365-2133.2007.08253.x
   Smith OP, 1999, BRIT J HAEMATOL, V104, P202, DOI 10.1046/j.1365-2141.1999.01186.x
   Stertz G., 1916, BERL KLIN WOCHENSCHR, V53, P489
   Targoff Ira N., 1997, Current Opinion in Rheumatology, V9, P527, DOI 10.1097/00002281-199711000-00008
   Thiers BH, 2009, CA-CANCER J CLIN, V59, P73, DOI 10.3322/caac.20005
   Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4
   Tierney Emily P, 2004, MedGenMed, V6, P4
   USA Centers for Disease Control and Prevention, 2017, CLIN EV DIS ZIK VIR
   VanderWielen B, 2017, CAN J ANESTH, V64, P542, DOI 10.1007/s12630-017-0832-1
   Vassileva S, 2014, CLIN DERMATOL, V32, P364, DOI 10.1016/j.clindermatol.2013.11.003
   Ventarola D, 2015, CLIN DERMATOL, V33, P340, DOI 10.1016/j.clindermatol.2014.12.011
   VOTION V, 1982, DERMATOLOGICA, V165, P660
   Yeh YW, 2010, EUR J DERMATOL, V20, P535, DOI 10.1684/ejd.2010.0989
   ZHANG XT, 2017, MEDICINE BALTIMORE, V96
   Zhao YY, 2015, EPIDEMIOL INFECT, V143, P3094, DOI 10.1017/S095026881500028X
NR 76
TC 0
Z9 0
U1 0
U2 1
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0392-0488
EI 1827-1820
J9 GIORN ITAL DERMAT V
JI G. Ital. Dermatol. Venereol.
PD OCT
PY 2017
VL 152
IS 5
BP 489
EP 499
DI 10.23736/S0392-0488.17.05719-4
PG 11
WC Dermatology
SC Dermatology
GA FN9NQ
UT WOS:000416365500011
PM 28748685
DA 2020-07-08
ER

PT J
AU Stein, DR
   Golden, JW
   Griffin, BD
   Warner, BM
   Ranadheera, C
   Scharikow, L
   Sloan, A
   Frost, KL
   Kobasa, D
   Booth, SA
   Josleyn, M
   Ballantyne, J
   Sullivan, E
   Jiao, JA
   Wu, H
   Wang, ZD
   Hooper, JW
   Safronetz, D
AF Stein, Derek R.
   Golden, Joseph W.
   Griffin, Bryan D.
   Warner, Bryce M.
   Ranadheera, Charlene
   Scharikow, Leanne
   Sloan, Angela
   Frost, Kathy L.
   Kobasa, Darwyn
   Booth, Stephanie A.
   Josleyn, Matthew
   Ballantyne, John
   Sullivan, Eddie
   Jiao, Jin-an
   Wu, Hua
   Wang, Zhongde
   Hooper, Jay W.
   Safronetz, David
TI Human polyclonal antibodies produced in transchromosomal cattle prevent
   lethal Zika virus infection and testicular atrophy in mice
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika; Trans-chromosomal bovine; Human polyclonal antibody; Testicular
   atrophy
ID DNA VACCINE; IN-VITRO; REPLICATION; CHALLENGE; RECEPTOR; ANTIGEN; MOUSE
AB Zika virus (ZIKV) is rapidly spreading throughout the Americas and is associated with significant fetal complications, most notably microcephaly. Treatment with polyclonal antibodies for pregnant women at risk of ZIKV-related complications could be a safe alternative to vaccination. We found that large quantities of human polyclonal antibodies could be rapidly produced in transchromosomal bovines (TcB) and successfully used to protect mice from lethal infection. Additionally, antibody treatment eliminated ZIKV induced tissue damage in immunologically privileged sites such as the brain and testes and protected against testicular atrophy. These data indicate that rapid development and deployment of human polyclonal antibodies could be a viable countermeasure against ZIKV. Crown Copyright (C) 2017 Published by Elsevier B.V. All rights reserved.
C1 [Stein, Derek R.; Griffin, Bryan D.; Warner, Bryce M.; Ranadheera, Charlene; Scharikow, Leanne; Sloan, Angela; Frost, Kathy L.; Kobasa, Darwyn; Booth, Stephanie A.; Safronetz, David] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada.
   [Griffin, Bryan D.; Warner, Bryce M.; Kobasa, Darwyn; Booth, Stephanie A.; Safronetz, David] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.
   [Golden, Joseph W.; Josleyn, Matthew; Hooper, Jay W.] US Army, Inst Infect Dis, Virol Div, Ft Detrick, MD USA.
   [Ballantyne, John] Aldevron, Fargo, ND USA.
   [Sullivan, Eddie; Jiao, Jin-an; Wu, Hua] SAB Biotherapeut, Sioux Falls, SD USA.
   [Wang, Zhongde] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.
RP Safronetz, D (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada.; Safronetz, D (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.; Hooper, JW (corresponding author), US Army, Inst Infect Dis, Virol Div, Ft Detrick, MD USA.
RI Hooper, Jay/K-2362-2017
OI Hooper, Jay/0000-0002-4475-0415; Sullivan, Eddie/0000-0001-7468-2006;
   Safronetz, David/0000-0002-9024-728X; Golden,
   Joseph/0000-0002-9709-313X; Wang, Zhongde/0000-0003-2441-4729
FU NSERC visiting scientist post-doctoral fellowship; DARPAUnited States
   Department of DefenseDefense Advanced Research Projects Agency (DARPA)
FX The authors would like to acknowledge the staff of the veterinary
   technical services division at the National Microbiology Laboratory, in
   particular, Stephanie Kukas, Christine DeGraff, Kimberly Azaransky,
   Michelle French, and Julie Kubay. We would also like to thank Michael
   Lindquist for assistance with microscopy. D.R.S was supported by a NSERC
   visiting scientist post-doctoral fellowship. J.W.G and J.W.H. were
   supported by DARPA. Opinions, interpretations, conclusions, and
   recommendations are those of the authors and not necessarily endorsed by
   the U.S. Army or the Department of Defense.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Bischoff AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056700
   Bounds CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137786
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   GROSHEIDE PM, 1993, EUR J OBSTET GYN R B, V50, P53, DOI 10.1016/0028-2243(93)90164-8
   Hooper JW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010082
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521
   Ladner J. T, 2016, GENOME ANNOUNC, V4
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Matsushita H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130699
   Matsushita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090383
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Pollack W, 1968, RHESUS HAEMOLYTIC, P211
   Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078119
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
NR 35
TC 11
Z9 11
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD OCT
PY 2017
VL 146
BP 164
EP 173
DI 10.1016/j.antiviral.2017.09.005
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FN1SV
UT WOS:000415772400021
PM 28893603
DA 2020-07-08
ER

PT J
AU de Castro, JDV
   Pereira, LP
   Dias, DA
   Aguiar, LB
   Maia, JCN
   da Costa, JIF
   de Castro, ECM
   Feitosa, FED
   Carvalho, FHC
AF Vieira de Castro, Jose Daniel
   Pereira, Licia Pacheco
   Dias, Daniel Aguiar
   Aguiar, Lindenberg Barbosa
   Nogueira Maia, Joanira Costa
   Fernandes da Costa, Jesus Irajacy
   Monteiro de Castro, Eveline Campos
   de Lucena Feitosa, Francisco Edson
   Costa Carvalho, Francisco Herlanio
TI Presumed Zika virus-related congenital brain malformations: the spectrum
   of CT and MRI findings in fetuses and newborns
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE Zika virus; microcephaly; tomography; X-ray computed; magnetic resonance
   imaging
ID CENTRAL-NERVOUS-SYSTEM; INFECTION; BRAZIL; GUIDELINES
AB The new epidemic of Zika virus infection raises grave concerns, especially with the increasingly-recognized link between emerging cases of microcephaly and this infectious disease. Besides small cranial dimensions, there are striking morphologic anomalies in the fetal brain. Key anomalies include cortical developmental malformations and a peculiar distribution of pathologic calcifications. These potentially indicate a new pattern of congenital central nervous system infection. Methods: Eight women underwent fetal MRI. Four infants also underwent postnatal CT. Five of the women underwent amniocentesis. Results: All neonates were born with microcephaly. On fetal MRI, ventriculomegaly, marked reduction of white matter thickness, severe sylvian fissure simplification, abnormal sulcation, and diffuse volumetric loss of cerebellar hemispheres were consistently seen. On postnatal CT, diffuse subcortical and basal ganglia calcifications were observed. The Zika virus was detected in two amniocenteses by polymerase chain reaction assays. Conclusion: We hope to assist the medical community in recognizing the spectrum of encephalic changes related to congenital Zika virus infection.
C1 [Vieira de Castro, Jose Daniel; Pereira, Licia Pacheco; Dias, Daniel Aguiar; Aguiar, Lindenberg Barbosa; Nogueira Maia, Joanira Costa; Fernandes da Costa, Jesus Irajacy] Univ Fed Ceara, Hosp Univ Walter Cantidio, Setor Radiol, Fortaleza, CE, Brazil.
   [Monteiro de Castro, Eveline Campos; de Lucena Feitosa, Francisco Edson; Costa Carvalho, Francisco Herlanio] Univ Fed Ceara, Dept Saude Maternoinfantil, Programa Posgrad Saude Publ, Fortaleza, CE, Brazil.
RP de Castro, JDV (corresponding author), Ave Prof Euclides Cesar 420, BR-60177200 Fortaleza, CE, Brazil.
EM danielcastrorevisor@gmail.com
OI Luna, Licia P./0000-0003-3539-4831
CR Adachi Y, 2011, AM J NEURORADIOL, V32, P1123, DOI 10.3174/ajnr.A2440
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias COES-Microcefalias, 2016, INF EP
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fink KR, 2010, RADIOGRAPHICS, V30, P1779, DOI 10.1148/rg.307105043
   Ghai S, 2006, RADIOGRAPHICS, V26, P389, DOI 10.1148/rg.262055059
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Ministerio da Saude (BR), 2016, OR INT VIG AT SAUD A
   Ministerio da Saude (BR), 2016, PROT VIG RESP OC MIC
   Ministerio da Saude (BR), 2015, PROT VIG RESP OC MIC
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Salomon LJ, 2011, ULTRASOUND OBST GYN, V37, P116, DOI 10.1002/uog.8831
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   vanderKnaap MS, 1996, RADIOLOGY, V200, P389, DOI 10.1148/radiology.200.2.8685331
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 31
TC 1
Z9 2
U1 0
U2 3
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD OCT
PY 2017
VL 75
IS 10
BP 703
EP 710
DI 10.1590/0004-282X20170134
PG 8
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FN4VF
UT WOS:000416004100006
PM 29166461
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Congenital Zika virus infection in twin pregnancies
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Editorial Material
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, AM J REPROD IMMUNOL, V76, P97, DOI 10.1111/aji.12521
   Zacharias N, 2017, AJP REP, V7, P68, DOI 10.1055/s-0037-1601890
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD OCT
PY 2017
VL 75
IS 10
BP 762
EP 762
DI 10.1590/0004-282X20170115
PG 1
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FN4VF
UT WOS:000416004100017
PM 29166472
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Luna, F
AF Luna, Florencia
TI Public health agencies' obligations and the case of Zika
SO BIOETHICS
LA English
DT Article
DE abortion; international public health agencies; public health; local
   public health agencies; sexual and reproductive health; sexual and
   reproductive rights; Zika
AB This article focuses on the initial reactions to the Zika epidemic by national and international public health agencies. It presents and analyzes some responses public officials made about sexual and reproductive health at the inception of the epidemic. It also describes the different challenges and obligations faced by local and international public health agencies, as these have not been clearly outlined. The article argues that these agencies have different obligations and should fulfill them despite existing obstacles. While international agencies should honor their leadership role and make recommendations at a meta-level, local agencies should provide, in the case of Zika, a framework for empowerment and grant women the freedom to achieve sexual and reproductive health so that they can avoid the consequences of this epidemic.
C1 [Luna, Florencia] FLACSO, San Jose, Costa Rica.
   [Luna, Florencia] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.
   [Luna, Florencia] Brocher Fdn, Geneva, Switzerland.
RP Luna, F (corresponding author), Ugarteche 3050,487,C1425EVF, Buenos Aires, DF, Argentina.
EM florlunaflacso@gmail.com
CR Ahmed Azam, 2016, NY TIMES
   [Anonymous], 2015, SAF AB TECHN POL GUI
   Ariza S, 2015, DERECHO CRITICA SOCI, V1, P181
   Cortez R, 2015, ADOLESCENT SEXUAL RE
   Daniels N., 2008, JUST HLTH M HLTH NEE
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Gonzalez Velez A., 2008, CAUSAL SALUD INTERRU
   Johnson R., 2016, WALL STREET J
   Luna F., 2016, REV BIOETICA DERECHO, V36, P5
   Marmot M., 2015, HLTH GAP CHALLENGE U
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   OMS (Organizacion Mundial de la Salud), 2012, AB SIN RIESG GUIA TE
   PAHO, 2012, 28 PAN AM SAN C 64 S
   Pan American Health Organization (PAHO), 2016, ZIK ETH CONS ETH GUI, P5
   Powers M., 2006, SOCIAL JUSTICE MORAL
   Rasmussen S. A., 2016, NEW ENGLAND J MED
   Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8
   Sen A., 2011, IDEA JUSTICE, P238
   Steinbock B., 2008, LECT MAY SEM FLACSO
   Sun L., 2016, WASHINGTON POST
   World Health Organisation, 2016, INT TECHN NOT US CHO, P1
   World Health Organization, 2016, PSYCH SUPP PREGN WOM
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
   Zeid Y. F., 2016, UPHOLDING WOMENS HUM
NR 24
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-9702
EI 1467-8519
J9 BIOETHICS
JI Bioethics
PD OCT
PY 2017
VL 31
IS 8
SI SI
BP 575
EP 581
DI 10.1111/bioe.12388
PG 7
WC Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Social Issues;
   Biomedical Social Sciences
GA FN2JY
UT WOS:000415819400002
PM 28901598
OA Bronze
DA 2020-07-08
ER

PT J
AU Culshaw, A
   Mongkolsapaya, J
   Screaton, GR
AF Culshaw, Abigail
   Mongkolsapaya, Juthathip
   Screaton, Gavin R.
TI The immunopathology of dengue and Zika virus infections
SO CURRENT OPINION IN IMMUNOLOGY
LA English
DT Review
ID ANTIBODY-DEPENDENT ENHANCEMENT; CD8(+) T-CELLS; GUILLAIN-BARRE-SYNDROME;
   HEMORRHAGIC-FEVER; NONSTRUCTURAL PROTEIN-1; DISEASE SEVERITY; IMMUNE
   ACTIVATION; CROSS-REACTIVITY; PROTECTIVE ROLE; SHOCK SYNDROME
AB A large proportion of the world's population live in areas with dengue virus (DENV) transmission resulting in tens of millions of symptomatic dengue cases each year. Serious complications following DENV infection occur more frequently in those suffering from a second or subsequent infection implicating virus-specific immunity as having a role in pathogenesis. In recent years outbreaks of the related Zika virus (ZIKV) have been associated with birth defects and neurological complications. As DENV and ZIKV share a viral vector sequential infections can occur. Given the sequence homology between the two viruses, the generation of cross-reactive immune responses is highly likely. This review examines the role immunopathogenesis plays during DENV infection as well as highlighting recent studies that demonstrate DENV immunity may have an effect on the outcome of ZIKV infection.
C1 [Culshaw, Abigail; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Imperial Coll London, Dept Med, London, England.
RP Screaton, GR (corresponding author), Imperial Coll London, Dept Med, London, England.
EM g.screaton@imperial.ac.uk
OI Screaton, Gavin/0000-0002-3549-4309
FU Medical Research Council UKMedical Research Council UK (MRC); Wellcome
   TrustWellcome Trust [078121/Z/05/Z]
FX This work was supported by the Medical Research Council UK and the
   Wellcome Trust (078121/Z/05/Z).
CR Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   [Anonymous], 2016, ZIK VIRUS FACT SHEET
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bethell DB, 1998, J INFECT DIS, V177, P778, DOI 10.1086/517807
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Calvert AE, 2006, J GEN VIROL, V87, P339, DOI 10.1099/vir.0.81256-0
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072
   Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P261
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Limonta D, 2007, J CLIN VIROL, V40, P50, DOI 10.1016/j.jcv.2007.04.024
   Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395
   LITTAUA R, 1990, J IMMUNOL, V144, P3183
   MARCHETTE NJ, 1973, J INFECT DIS, V128, P23, DOI 10.1093/infdis/128.1.23
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N., 2017, IMMUNOL CELL BIOL
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   MORENS DM, 1987, J MED VIROL, V22, P163, DOI 10.1002/jmv.1890220207
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen TPD, 2010, J IMMUNOL, V184, P7281, DOI 10.4049/jimmunol.0903262
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodrigues LC, 2016, AM J PUBLIC HEALTH, V106, P2016
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   ZHANG YM, 1988, J VIROL, V62, P3027, DOI 10.1128/JVI.62.8.3027-3031.1988
   Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 68
TC 16
Z9 16
U1 0
U2 4
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0952-7915
EI 1879-0372
J9 CURR OPIN IMMUNOL
JI Curr. Opin. Immunol.
PD OCT
PY 2017
VL 48
BP 1
EP 6
DI 10.1016/j.coi.2017.07.001
PG 6
WC Immunology
SC Immunology
GA FN8TX
UT WOS:000416299500003
PM 28738211
DA 2020-07-08
ER

PT J
AU Mitchell, RD
   Wallace, AD
   Hodgson, E
   Roe, RM
AF Mitchell, Robert D., III
   Wallace, Andrew D.
   Hodgson, Ernest
   Roe, R. Michael
TI Differential Expression Profile of lncRNAs from Primary Human
   Hepatocytes Following DEET and Fipronil Exposure
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE DEET; fipronil; long non-coding RNA; lncRNA; primary liver cells;
   epigenetics; RNA-Seq; transcriptomics; Zika virus; human hepatocytes
ID LONG NONCODING RNAS; MESSENGER-RNAS; GENE; METABOLISM; PATHWAY;
   CYTOCHROME-P450; CYTOTOXICITY; PSEUDOGENES; HALLMARKS; CHEMICALS
AB While the synthesis and use of new chemical compounds is at an all-time high, the study of their potential impact on human health is quickly falling behind, and new methods are needed to assess their impact. We chose to examine the effects of two common environmental chemicals, the insect repellent N, N-diethyl-m-toluamide (DEET) and the insecticide fluocyanobenpyrazole (fipronil), on transcript levels of long non-protein coding RNAs (lncRNAs) in primary human hepatocytes using a global RNA-Seq approach. While lncRNAs are believed to play a critical role in numerous important biological processes, many still remain uncharacterized, and their functions and modes of action remain largely unclear, especially in relation to environmental chemicals. RNA-Seq showed that 100 mu M DEET significantly increased transcript levels for 2 lncRNAs and lowered transcript levels for 18 lncRNAs, while fipronil at 10 mu M increased transcript levels for 76 lncRNAs and decreased levels for 193 lncRNAs. A mixture of 100 mu M DEET and 10 mu M fipronil increased transcript levels for 75 lncRNAs and lowered transcript levels for 258 lncRNAs. This indicates a more-than-additive effect on lncRNA transcript expression when the two chemicals were presented in combination versus each chemical alone. Differentially expressed lncRNA genes were mapped to chromosomes, analyzed by proximity to neighboring protein-coding genes, and functionally characterized via gene ontology and molecular mapping algorithms. While further testing is required to assess the organismal impact of changes in transcript levels, this initial analysis links several of the dysregulated lncRNAs to processes and pathways critical to proper cellular function, such as the innate and adaptive immune response and the p53 signaling pathway.
C1 [Mitchell, Robert D., III; Roe, R. Michael] North Carolina State Univ, North Carolina Agromed Inst, Dept Entomol & Plant Pathol, Campus Box 7647,3230 Ligon St, Raleigh, NC 27695 USA.
   [Wallace, Andrew D.; Hodgson, Ernest] North Carolina State Univ, Dept Biol, Toxicol Program, Raleigh, NC 27695 USA.
   [Hodgson, Ernest] North Carolina State Univ, North Carolina Agromed Inst, Dept Biol, Dept Appl Ecol,Toxicol Program, Raleigh, NC 27695 USA.
RP Roe, RM (corresponding author), North Carolina State Univ, North Carolina Agromed Inst, Dept Entomol & Plant Pathol, Campus Box 7647,3230 Ligon St, Raleigh, NC 27695 USA.
EM rdmitche@ncsu.edu; adwallacnc@gmail.com; ernest_hodgson@ncsu.edu;
   michael_roe@ncsu.edu
RI Mitchell, Robert/S-1726-2019
OI Mitchell, Bobby/0000-0001-6011-960X; Roe, Richard/0000-0002-6386-0994
FU U.S. Central Appalachian Regional Education and Research Center (CARERC)
   Pilot Study; North Carolina Agromedicine Institute (Raleigh, NC);
   Entomology Department Teaching Assistantship; Graduate School Doctoral
   Dissertation Completion Grant at North Carolina State University
FX The authors gratefully acknowledge Jeffrey Roach, Ph.D. from the
   University of North Carolina-Chapel Hill Information Technology Services
   and Elizabeth Scholl, Ph.D. from the North Carolina State University
   Bioinformatics Consulting Core for their assistance with bioinformatics
   analyses. This research was supported in part by the U.S. Central
   Appalachian Regional Education and Research Center (CARERC) Pilot Study
   and the North Carolina Agromedicine Institute (Raleigh, NC). Robert D.
   Mitchell III was supported by an Entomology Department Teaching
   Assistantship and a Graduate School Doctoral Dissertation Completion
   Grant at North Carolina State University.
CR Acland A, 2013, NUCLEIC ACIDS RES, V41, pD8, DOI 10.1093/nar/gks1189
   Aken BL, 2016, ENSEMBL GENE ANNOTAT, V2016, DOI DOI 10.1093/DATABASE/BAW09327337980
   Baselt R. C., 1994, DISPOSITION TOXIC DR
   Bernhardt ES, 2017, FRONT ECOL ENVIRON, V15, P84, DOI 10.1002/fee.1450
   Branca RMM, 2014, NAT METHODS, V11, P59, DOI [10.1038/NMETH.2732, 10.1038/nmeth.2732]
   Carrington D., EU BAN FIPRONIL PROT
   Das PC, 2006, CHEM-BIOL INTERACT, V164, P200, DOI 10.1016/j.cbi.2006.09.013
   Das Parikshit C., 2008, Drug Metabolism and Drug Interactions, V23, P237
   Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766
   Dundar F., 2015, APPL BIOINFORMATICS, V1, P67
   Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074
   Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236
   Gray K. A., 2014, NUCLEIC ACIDS RES, V43, P1079, DOI [10.1093/nar/gku107125361968, DOI 10.1093/NAR/GKU107125361968]
   Hamon N., 1996, P BELTW COTT C NASHV
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615
   Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531
   Heffernan AL, 2016, ENVIRON SCI POLLUT R, V23, P23436, DOI 10.1007/s11356-016-7571-7
   Herin F, 2011, THYROID, V21, P701, DOI 10.1089/thy.2010.0449
   Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455
   Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704
   LeCluyse E, 2000, J BIOCHEM MOL TOXIC, V14, P177, DOI 10.1002/(SICI)1099-0461(2000)14:4<177::AID-JBT1>3.0.CO;2-4
   Liu YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep10159
   Maemets-Allas K, 2015, MOL CANCER THER, V14, P2486, DOI 10.1158/1535-7163.MCT-15-0281
   McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630
   Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138
   Milligan MJ, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00026
   Milligan MJ, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00476
   Mitchell RD, 2016, J BIOCHEM MOL TOXIC, V30, P375, DOI 10.1002/jbt.21801
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohamed F, 2004, J TOXICOL-CLIN TOXIC, V42, P955, DOI 10.1081/CLT-200041784
   Moll UM, 2003, MOL CANCER RES, V1, P1001
   Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022
   Morris H., ZIKA LATEST ADVICE T
   Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646
   Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654
   Oliveros J, 2007, INTERACTIVE TOOL COM
   Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144
   Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738
   Read A., 1999, HUM MOL GENET, V2
   Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902
   Roy DN, 2017, ENVIRON TOXICOL PHAR, V50, P91, DOI 10.1016/j.etap.2017.01.019
   Schoenig GP, 1999, TOXICOL SCI, V47, P99, DOI 10.1093/toxsci/47.1.99
   SELIM S, 1995, FUND APPL TOXICOL, V25, P95, DOI 10.1006/faat.1995.1043
   Stamatoyannopoulos JA, 2010, NAT METHODS, V7, P501, DOI 10.1038/nmeth0710-501
   Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904
   Tang J, 2004, CHEM-BIOL INTERACT, V147, P319, DOI 10.1016/j.cbi.2004.03.002
   Tingle C. C., 2003, FIPRONIL ENV FATE EC, P1
   Tomar Namrata, 2014, Methods Mol Biol, V1184, P13, DOI 10.1007/978-1-4939-1115-8_2
   Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Usmani KA, 2002, DRUG METAB DISPOS, V30, P289, DOI 10.1124/dmd.30.3.289
   van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247
   Vargo EL, 2012, J ECON ENTOMOL, V105, P523, DOI 10.1603/EC11155
   VELTRI JC, 1994, J TOXICOL-CLIN TOXIC, V32, P1, DOI 10.3109/15563659409000426
   Villegas VE, 2015, INT J MOL SCI, V16, P3251, DOI 10.3390/ijms16023251
   Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018
   Watanabe T, 2015, GENOME RES, V25, P368, DOI 10.1101/gr.180802.114
   WHO. U. N, ISS LIST 12 MOST WOR
   Zhang A, 2014, J MOL CELL BIOL, V6, P181, DOI 10.1093/jmcb/mju013
   Zhang XD, 2010, ACTA PHARMACOL SIN, V31, P1208, DOI 10.1038/aps.2010.151
   Zhang Y, 2016, CELL MOL IMMUNOL, V13, P138, DOI 10.1038/cmi.2015.68
NR 64
TC 4
Z9 4
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD OCT
PY 2017
VL 18
IS 10
AR 2104
DI 10.3390/ijms18102104
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA FM0QL
UT WOS:000414671800088
PM 28991164
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Addressing the Global Zika Epidemic and Interprofessional Model of
   Universal Screening
SO JOURNAL OF PERINATAL & NEONATAL NURSING
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Navi Mumbai, India.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ilara Mokin, Nigeria.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
CR Forman RN, 2017, J PERINAT NEONAT NUR, V31, P216, DOI 10.1097/JPN.0000000000000266
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 2
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0893-2190
EI 1550-5073
J9 J PERINAT NEONAT NUR
JI J. Perinat. Neonatal Nurs.
PD OCT-DEC
PY 2017
VL 31
IS 4
BP 284
EP 284
DI 10.1097/JPN.0000000000000283
PG 1
WC Nursing; Obstetrics & Gynecology; Pediatrics
SC Nursing; Obstetrics & Gynecology; Pediatrics
GA FM5KS
UT WOS:000415074200002
PM 29068843
DA 2020-07-08
ER

PT J
AU Wahid, B
   Ali, A
   Rafique, S
   Idrees, M
AF Wahid, Braira
   Ali, Amjad
   Rafique, Shazia
   Idrees, Muhammad
TI Current status of therapeutic and vaccine approaches against Zika virus
SO EUROPEAN JOURNAL OF INTERNAL MEDICINE
LA English
DT Review
DE ZIKV; Current; Therapeutics; Approaches; Vaccines; Anti-ZIKV
ID TETRAVALENT DENGUE VACCINE; INFECTION; INHIBITORS; EFFICACY; PROTECTION;
   FLAVIVIRUSES; REPLICATION; ANTIVIRALS; ANTIBODIES; CHILDREN
AB Zika virus (ZIKV) is a global threat because it is spreading at an alarming rate because of its wider range of transmission routes. The neuroteratogenic nature of ZIKV infection is posing serious threats to unborn lives therefore, it is necessary to develop an ideal ZIKV prophylactic or therapeutic agent urgently. Researchers are having tough time finding a treatment for ZIKV in part because of serious consequences of vaccines and drugs to unborn lives and pregnant women. However, in vitro and in vivo evaluation of therapeutic efficacy of DNA vaccine, recombinant subunit vaccine, and ZIKV purified inactivated vaccine offers hope for human protection. Large number of food and drug administration ( FDA) approved drugs as wells as compounds with anti-ZIKV activity offer valuable opportunity to control the massive bio-burden of this catastrophic epidemic. Some evidences suggest that immunotherapeutics might prove to be winning strategy in pregnant females. Here, we review the recent advances and current knowledge regarding therapeutic interventions against ZIKV infection. This article will provide baseline data and roadmap to prosecute further research for the development of novel therapeutic strategy to curb the explosive rise in ZIKV. (C) 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
C1 [Wahid, Braira; Ali, Amjad; Idrees, Muhammad] Univ Punjab, Ctr Appl Mol Biol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan.
   [Rafique, Shazia] Univ Punjab, Ctr Excellence Mol Biol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan.
   [Idrees, Muhammad] Hazara Univ Mansehra, Dhodial, Pakistan.
RP Ali, A (corresponding author), Univ Punjab, Ctr Appl Mol Biol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan.
EM amjad.camb@pu.edu.pk; shazia.rafique@cemb.edu.pk; idrees.camb@pu.edu.pk
RI Idrees, Muhammad/K-6032-2012; amsalu, ribka/G-8780-2019
OI Idrees, Muhammad/0000-0002-3081-7631; 
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   [Anonymous], 2017, VIROLOGY
   Awasthi S, 2016, J ANTIVIRALS ANTIRET, V8
   Awasthi S, 2016, J ANTIVIR ANTIRETROV, V8
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barbosa-Limaa G, 2017, EUR J MED CHEM, V127, P334, DOI 10.1016/j.ejmech.2016.12.058
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   BARRETT ADT, 2016, NPJ VACCINES, V1
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Basu R, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0623-2
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Dowd KA, 2016, SCIENCE
   Durbin AP, 2016, SEMINARS REPROD MED
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3588
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ge L, 2016, DEV RECOMBINANT ZIKV
   Global Research Collaboration for Infectious Disease Preparedness, 2016, GLOB RES COLL INF DI
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gupta AK, 2016, SCI REP, P6
   Hamdy RF, 2015, J PEDIAT INF DIS SOC, V4, P389, DOI 10.1093/jpids/piv056
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Heslop HE, 2013, HEMATOL-AM SOC HEMAT, P342, DOI 10.1182/asheducation-2013.1.342
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kennedy RB, 2016, EBIOMEDICINE, V13, P29, DOI 10.1016/j.ebiom.2016.10.016
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kuivanen S, 2016, ANTIVIR RES
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kuperman AA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0636-0
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Mukherjee R, 2017, MED J DR DY PATIL U, V10, P10
   Mumtaz N, 2016, CURR TREAT OPTIONS I, V8, P208, DOI [10.1007/s40506-016-0083-7, DOI 10.1007/S40506-016-0083-7]
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Narayanan R., 2016, MOJ PROTEOMICS BIOIN, V3
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Palacios R, 2016, VACCINE, V34, P2291, DOI 10.1016/j.vaccine.2016.03.059
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pascoalino BS, 2016, F1000RESEARCH, P5
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Plotkin SA, 2016, CLIN MICROBIOL INFEC, V22, P294, DOI 10.1016/j.cmi.2016.03.001
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sacramento CQ, 2016, BIORXIV
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Saiz J-C, 2017, ANTIMICROB AGENTS CH
   Salam AP, 2017, ANN INTERN MED, V28, P411
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sautto G, 2013, BIOMED RES INT, DOI 10.1155/2013/838491
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Tripp RA, 2016, DEV ZIKA VACCINE
   Turanek J, 2016, INT ZIKA SUMMIT 2016
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Viranaicken W, 2016, ABSTRACTS INT ZIKA S
   Wahid B, 2016, ASIAN PAC J TROP MED, V9, P723, DOI 10.1016/j.apjtm.2016.06.019
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Whitehorn J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003025
   World Health Organization (WHO), 2016, WHO MED CTR
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 87
TC 14
Z9 14
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0953-6205
EI 1879-0828
J9 EUR J INTERN MED
JI Eur. J. Intern. Med.
PD OCT
PY 2017
VL 44
BP 12
EP 18
DI 10.1016/j.ejim.2017.08.001
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA FM2KA
UT WOS:000414812400024
PM 28797534
DA 2020-07-08
ER

PT J
AU Bandyopadhyay, D
   Hajra, A
AF Bandyopadhyay, Dhrubajyoti
   Hajra, Adrija
TI ZIKA virus: A new threat to the eyes
SO EUROPEAN JOURNAL OF INTERNAL MEDICINE
LA English
DT Letter
ID INFECTION
C1 [Bandyopadhyay, Dhrubajyoti] Mt Sinai St Lukes Roosevelt, Dept Internal Med, New York, NY 10025 USA.
   [Hajra, Adrija] IPGMER, Dept Internal Med, Kolkata, India.
RP Bandyopadhyay, D (corresponding author), Mt Sinai St Lukes Roosevelt, Dept Internal Med, New York, NY 10025 USA.
EM drdhrubajyoti87@gmail.com
RI Bandyopadhyay, Dhrubajyoti/AAQ-5622-2020; Hajra, Adrija/AAM-5736-2020
OI Bandyopadhyay, Dhrubajyoti/0000-0002-0709-4324; 
CR Agrawal R, 2018, OCUL IMMUNOL INFLAMM, V26, P654, DOI 10.1080/09273948.2017.1294184
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura L. O., 2017, J AAPOS
   Yepez JB, 2017, JAMA OPHTHALMOL, V13
NR 10
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0953-6205
EI 1879-0828
J9 EUR J INTERN MED
JI Eur. J. Intern. Med.
PD OCT
PY 2017
VL 44
BP E9
EP E10
DI 10.1016/j.ejim.2017.05.022
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA FM2KA
UT WOS:000414812400005
PM 28571894
DA 2020-07-08
ER

PT J
AU Sun, JF
   Wu, D
   Zhong, HJ
   Guan, DW
   Zhang, H
   Tan, QQ
   Zhou, HQ
   Zhang, M
   Ning, D
   Zhang, BH
   Ke, CW
   Song, T
   Lin, JY
   Zhang, YH
   Koopmans, M
   Gao, GF
AF Sun, Jiufeng
   Wu, De
   Zhong, Haojie
   Guan, Dawei
   Zhang, Huan
   Tan, Qiqi
   Zhou, Huiqiong
   Zhang, Meng
   Ning, Dan
   Zhang, Baohuan
   Ke, Changwen
   Song, Tie
   Lin, Jinyan
   Zhang, Yonghui
   Koopmans, Marion
   Gao, George F.
TI Returning ex-patriot Chinese to Guangdong, China, increase the risk for
   local transmission of Zika virus
SO JOURNAL OF INFECTION
LA English
DT Article
DE Zika virus; Imported case; Ex-patriot Chinese; Guangdong; China
ID SEXUAL TRANSMISSION; INTERIM GUIDELINES; UNITED-STATES; OUTBREAK;
   IDENTIFICATION; INFECTION; PROVINCE; DISEASE
AB Objectives: Fast expansion and linkage to microcephaly and Guillain Barre syndrome have made Zika virus (ZIKV) track attention of global health authority concerns. The epidemiology, virological characteristics and genetic evolution of introduced ZIKV to Guang-dong, China, were investigated.
   Methods: Analyses of the epidemiological characteristics and genetic diversity of ZIKV isolates were performed.
   Results: A total of twenty-eight confirmed ZIKV infection cases were imported into China in 2016, of which 19 were imported into Guangdong, China from Venezuela (16), the Samoa Islands (1), Suriname (1) and Guatemala (1). Serial sampling studies of the cases indicated longer shedding times of ZIKV particles from urine and saliva samples than from serum and conjunctiva swab samples. Seven ZIKV strains were successfully isolated from serum, urine and conjunctiva swab samples using cell culture and neonatal mouse injection methods. Genomic analysis indicated that all viruses belonged to the Asian lineage but had different evolutionary transmission routes with different geographic origins. The molecular clock phylogenetic analysis of the ZIKV genomes indicated independent local transmission that appeared to have been previously established in Venezuela and Samoa. Additionally, we found 7 unique non-synonymous mutations in the genomes of ZIKV that were imported to China. The mutations may indicate that ZIKV has undergone independent evolutionary history not caused by sudden adaptation to Chinese hosts.
   Conclusion: The increasing number of ex-patriot Chinese returning from ZIKV hyper-endemic areas to Guangdong combined with the presence of a variety of Aedes species indicate the potential for autochthonous transmission of ZIKV in Guangdong. (C) 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
C1 [Sun, Jiufeng; Wu, De; Zhong, Haojie; Guan, Dawei; Zhang, Huan; Tan, Qiqi; Zhou, Huiqiong; Zhang, Meng; Ning, Dan; Zhang, Baohuan; Ke, Changwen; Song, Tie; Lin, Jinyan; Zhang, Yonghui] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 511430, Guangdong, Peoples R China.
   [Sun, Jiufeng; Wu, De; Zhong, Haojie; Guan, Dawei; Zhang, Huan; Tan, Qiqi; Zhou, Huiqiong; Zhang, Meng; Ning, Dan; Zhang, Baohuan; Ke, Changwen; Song, Tie; Lin, Jinyan; Zhang, Yonghui] WHO Collaborating Ctr Surveillance, Res & Training Emerging Infect Dis, Guangzhou, Guangdong, Peoples R China.
   [Koopmans, Marion] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.
RP Ke, CW; Song, T; Lin, JY (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 511430, Guangdong, Peoples R China.
EM kecw1965@aliyun.com
RI Koopmans, Marion/Y-9170-2019; Zhou, Huiqiong/S-1276-2016
OI Koopmans, Marion/0000-0002-5204-2312; Zhou,
   Huiqiong/0000-0003-2124-6563; sun, jiufeng/0000-0003-1047-929X
FU Guangdong Provincial Science and Technology Program [2015A020213004,
   2016A020251001]; National Key Development Program [2016YFC1200201]
FX We thank all of the related laboratory and administrative personnel at
   Guangdong Provincial Center for Disease Control and Prevention and the
   Jiangmen Center for Disease Control and Prevention for their
   contribution to the followup investigation. The present study was
   supported by grants from the Guangdong Provincial Science and Technology
   Program (2015A020213004 and 2016A020251001) and the National Key
   Development Program (2016YFC1200201).
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Di Luca M, 2016, EURO SURVEILL, V21
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria N. R., 2017, NATURE
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Freitas B de Paula, 2017, JAMA OPHTHALMOL
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Li X, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2170-2
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Ramaiah A, 2017, INFECT GENET EVOL, V51, P74, DOI 10.1016/j.meegid.2017.03.012
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Sun JF, 2016, J INFECTION, V72, P80, DOI 10.1016/j.jinf.2015.10.007
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wong PS, 2016, PLOS NEGLECT TROP D, V7, pe2348
   Wu D, 2016, J INFECTION, V73, P300, DOI 10.1016/j.jinf.2016.06.008
   Wu D, 2012, EMERG INFECT DIS, V18, P493, DOI 10.3201/eid1803.110034
   Xu RM, 1990, VECTOR DENGUE FEVER, P51
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 49
TC 7
Z9 8
U1 0
U2 5
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD OCT
PY 2017
VL 75
IS 4
BP 356
EP 367
DI 10.1016/j.jinf.2017.07.001
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA FM6BQ
UT WOS:000415131400009
PM 28712937
DA 2020-07-08
ER

PT J
AU Hurtado-Villa, P
   Puerto, AK
   Victoria, S
   Gracia, G
   Guasmayan, L
   Arce, P
   Alvarez, G
   Blandon, E
   Rengifo, N
   Holguin, JA
   Duran, A
   Zarante, I
AF Hurtado-Villa, Paula
   Puerto, Angie K.
   Victoria, Salome
   Gracia, Gloria
   Guasmayan, Lesly
   Arce, Patricia
   Alvarez, Gilberto
   Blandon, Esperanza
   Rengifo, Nubia
   Holguin, Jorge A.
   Duran, Alexander
   Zarante, Ignacio
TI RAISED FREQUENCY OF MICROCEPHALY RELATED TO ZIKA VIRUS INFECTION IN TWO
   BIRTH DEFECTS SURVEILLANCE SYSTEMS IN BOGOTA AND CALI, COLOMBIA
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE central nervous system malformations; zika virus; microcephaly
AB Zika virus infection during pregnancy is now known to cause congenital microcephaly and severe brain defects. In 2016, rates of microcephaly appeared to start increasing around May, peaking in July, and declining through December. The occurrence of microcephaly appears to have increased nearly 4-fold in 2 large cities in Colombia, concurrently with the reported Zika virus epidemic in the country.
C1 [Hurtado-Villa, Paula] Pontificia Univ Javeriana Cali, Cali, Colombia.
   [Puerto, Angie K.] Pontificia Univ Javeriana, Congenital Malformat Surveillance Programme, Bogota, Colombia.
   [Victoria, Salome] Pontificia Univ Javeriana Cali, Congenital Birth Defects Surveillance Programme C, Cali, Colombia.
   [Gracia, Gloria] Pontificia Univ Javeriana Bogota, Congenital Malformat Surveillance Programme Bogot, Secretaria Salud Bogot, Bogota, Colombia.
   [Guasmayan, Lesly; Arce, Patricia; Alvarez, Gilberto] Secretaria Salud Bogota, Bogota, Colombia.
   [Blandon, Esperanza; Rengifo, Nubia; Holguin, Jorge A.; Duran, Alexander] Secretaria Salud Publ Municipal Cali, Cali, Colombia.
   [Zarante, Ignacio] Pontificia Univ Javeriana Bogota, Hosp Univ San Ignacio, Bogota, Colombia.
RP Zarante, I (corresponding author), Pontificia Univ Javeriana Bogota, Hosp Univ San Ignacio, Inst Genet Humana, Cra 7 40-62 Edificio 31, Bogota, Colombia.
EM izarante@javeriana.edu.co
RI Zarante, Ignacio/L-6467-2017; Hurtado-Villa, Paula/O-2543-2014
OI Zarante, Ignacio/0000-0002-0729-6866; GRACIA CHARRY, GLORIA
   MILENA/0000-0002-5323-7138; Hurtado-Villa, Paula/0000-0003-3822-7780
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Groisman B, 2016, REV ARGENT SALUD PUB, V7, P39
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Zarante Ignacio, 2016, J Registry Manag, V41, P116
NR 9
TC 12
Z9 12
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD OCT
PY 2017
VL 36
IS 10
BP 1017
EP 1019
DI 10.1097/INF.0000000000001670
PG 4
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA FM6QO
UT WOS:000415181000027
PM 28914749
DA 2020-07-08
ER

PT J
AU Li, CF
   Zhu, XL
   Ji, X
   Quanquin, N
   Deng, YQ
   Tian, M
   Aliyari, R
   Zuo, XY
   Yuan, L
   Afridi, SK
   Li, XF
   Jung, JU
   Nielsen-Saines, K
   Qin, FXF
   Qin, CF
   Xu, ZH
   Cheng, GH
AF Li, Chunfeng
   Zhu, Xingliang
   Ji, Xue
   Quanquin, Natalie
   Deng, Yong-Qiang
   Tian, Min
   Aliyari, Roghiyh
   Zuo, Xiangyang
   Yuan, Ling
   Afridi, Shabbir Khan
   Li, Xiao-Feng
   Jung, Jae U.
   Nielsen-Saines, Karin
   Qin, Frank Xiao-Feng
   Qin, Cheng-Feng
   Xu, Zhiheng
   Cheng, Genhong
TI Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its
   Associated Congenital Microcephaly in Mice
SO EBIOMEDICINE
LA English
DT Article
DE FDA-approved drug; Chloroquine; ZIKV entry; Microcephaly; Antiviral
   effects
ID ANTIVIRAL ACTIVITY; IDENTIFICATION; SCREEN; TRANSMISSION; INFERTILITY;
   INHIBITORS; SEROTYPE; LEADS
AB Zika virus (ZIKV) has become a global public health emergency due to its rapidly expanding range and its ability to cause severe congenital defects such as microcephaly. However, there are no FDA-approved therapies or vaccines against ZIKV infection. Through our screening of viral entry inhibitors, we found that chloroquine (CQ), a commonly used antimalarial and a FDA-approved drug that has also been repurposed against other pathogens, could significantly inhibit ZIKV infection in vitro, by blocking virus internalization. We also demonstrated that CQ attenuates ZIKV-associated morbidity and mortality in mice. Finally, we proved that CQ protects fetal mice from microcephaly caused by ZIKV infection. Our methodology of focusing on previously identified antivirals in screens for effectiveness against ZIKV proved to be a rapid and efficient means of discovering new ZIKV therapeutics. Selecting drugs that were previously FDA-approved, such as CQ, also improves the likelihood that they may more quickly reach stages of clinical testing and use by the public. (C) 2017 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
C1 [Li, Chunfeng; Zuo, Xiangyang; Qin, Frank Xiao-Feng; Cheng, Genhong] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.
   [Li, Chunfeng; Zuo, Xiangyang; Qin, Frank Xiao-Feng; Cheng, Genhong] Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Li, Chunfeng; Zuo, Xiangyang; Qin, Frank Xiao-Feng; Cheng, Genhong] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
   [Li, Chunfeng; Deng, Yong-Qiang; Tian, Min; Li, Xiao-Feng; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Zhu, Xingliang; Yuan, Ling; Afridi, Shabbir Khan; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.
   [Ji, Xue; Qin, Cheng-Feng] Guangxi Med Univ, Nanning 530021, Peoples R China.
   [Quanquin, Natalie; Aliyari, Roghiyh; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Tian, Min] Capital Med Univ, Beijing Tradit Med Chinese Hosp, Beijing 100069, Peoples R China.
   [Jung, Jae U.] Univ Southern Calif, Dept Mol Microbiol & Immunol, Zilkha Neurogenet Inst, 1501,11 San Pablo St, Los Angeles, CA 90033 USA.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Infect Dis, Marion Davies Childrens Hlth Ctr, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
   [Xu, Zhiheng] Parkinsons Dis Ctr, Beijing Inst Brain Disorders, Beijing 100101, Peoples R China.
RP Qin, FXF; Cheng, GH (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.; Qin, FXF; Cheng, GH (corresponding author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Qin, FXF; Cheng, GH (corresponding author), Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Xu, ZH (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
EM qinxiaof@mail.sysu.edu.cn; qincf@bmi.ac.cn; zhxu@genetics.ac.cn;
   gcheng@mednet.ucla.edu
RI Qin, Cheng-Feng/I-6839-2019; Li, Chunfeng/S-3185-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Li, Chunfeng/0000-0001-8883-9078;
   Xu, Zhiheng/0000-0002-4809-2851; Zhu, Xingliang/0000-0003-3411-8712
FU MOST (China)Ministry of Science and Technology, China [2016YFD0500304];
   State Key Laboratory of Pathogen and Biosecurity [SKLPBS1601]; NSFC
   Excellent Young Scientist [81522025]; Innovative Research Group
   [81621005]; Newton Advanced Fellowship from the UK Academy of Medical
   Sciences [81661130162]; CAMS Initiative for Innovative Medicine
   [2016-I2M-1-005]; NSFC (China)National Natural Science Foundation of
   China [91542201, 81590765, 31670883]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   AI069120, AI056154, AI078389 502]; PUMC Youth Fund [3332016125];
   NSFCNational Natural Science Foundation of China [31500145, 31430037];
   Shanghai brain-intelligence project from STCSM [16JC1420500]; Beijing
   Brain Project [Z161100002616004]; MOST [2014CB942801, 2012YQ03026006];
   National Science and Technology Major Project for "Significant New Drugs
   Innovation and Development" [2015ZX09102023]
FX This work was supported by MOST (China, 2016YFD0500304) and the State
   Key Laboratory of Pathogen and Biosecurity (SKLPBS1601), the NSFC
   Excellent Young Scientist (81522025), the Innovative Research Group
   (81621005), and the Newton Advanced Fellowship from the UK Academy of
   Medical Sciences (81661130162) to C-F.Q., the CAMS Initiative for
   Innovative Medicine (No. 2016-I2M-1-005), NSFC (China, 91542201,
   81590765), NIH R01 AI069120, AI056154 and AI078389 502 grants, the NSFC
   of China (31670883) to G.C., and PUMC Youth Fund (No. 3332016125) and
   NSFC (No. 31500145) to C.L., NSFC (31430037), Shanghai
   brain-intelligence project from STCSM (16JC1420500), Beijing Brain
   Project (Z161100002616004) and MOST (2014CB942801 and 2012YQ03026006) to
   Z.X. National Science and Technology Major Project for "Significant New
   Drugs Innovation and Development" (2015ZX09102023) to G.C. and F. X-F.Q.
   We thank all members in our team for help discussions.
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Borges MC, 2013, MEM I OSWALDO CRUZ, V108, P596, DOI 10.1590/S0074-02762013000500010
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Debnath A, 2012, NAT MED, V18, P956, DOI 10.1038/nm.2758
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597
   Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Keyaerts E, 2009, ANTIMICROB AGENTS CH, V53, P3416, DOI 10.1128/AAC.01509-08
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nabel GJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4548
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 39
TC 47
Z9 49
U1 2
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD OCT
PY 2017
VL 24
BP 189
EP 194
DI 10.1016/j.ebiom.2017.09.034
PG 6
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA FL6YR
UT WOS:000414392900031
PM 29033372
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sparks, JT
   Dickens, JC
AF Sparks, Jackson T.
   Dickens, Joseph C.
TI Mini review: Gustatory reception of chemicals affecting host feeding in
   aedine mosquitoes
SO PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY
LA English
DT Review
DE Mosquito; Taste; Feeding deterrent; Feeding stimulant; Gustatory
   receptor
ID YELLOW-FEVER-MOSQUITO; AEDES-ALBOPICTUS SKUSE; MALARIA MOSQUITO; INSECT
   REPELLENTS; ANOPHELES-GAMBIAE; CIBARIAL SENSILLA; FINE-STRUCTURE;
   AEGYPTI L.; DIPTERA; DEET
AB Mosquitoes vector dangerous human diseases during blood feeding. Gustatory (taste) receptor neurons in the mosquito provide important chemical information including the nature and suitability of a potential host. Here we discuss the behavior, neurophysiology and molecular mechanisms associated with feeding in aedine mosquitoes, important vectors of emerging diseases including Zika fever, chikungunya and dengue fever. We describe how interactions between feeding stimulation and deterrency at the peripheral neural receptor level provide input to higher order neural processing centers affecting decisions to feed. A better understanding of gustatory mechanisms involved in the female's decision to bite will provide the framework for novel strategies aimed at preventing the spread of vector-borne disease. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Sparks, Jackson T.; Dickens, Joseph C.] ARS, USDA, Henry A Wallace Beltsville Agr Res Ctr, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA.
   [Sparks, Jackson T.] High Point Univ, Dept Biol, Congdon Hall Sci,Room 218A, High Point, NC 27268 USA.
RP Sparks, JT (corresponding author), High Point Univ, Dept Biol, Congdon Hall Sci,Room 218A, High Point, NC 27268 USA.
EM jsparks@highpoint.edu
FU Deployed War Fighter Protection (DWFP) Research Program - US Department
   of Defense through the Armed Forces Pest Management Board (AFPMB)
FX This work was supported in part by a grant to J.C.D. from the Deployed
   War Fighter Protection (DWFP) Research Program, funded by the US
   Department of Defense through the Armed Forces Pest Management Board
   (AFPMB). The authors thank Dr. Gary Bauchan, USDA, ARS, BARC, Electron
   and Confocal Microscopy Unit for help technical assistance with scanning
   electron microscopy.
CR Ali A, 2012, J MED ENTOMOL, V49, P1370, DOI 10.1603/ME12026
   Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BISHOP A, 1946, PARASITOLOGY, V37, P85, DOI 10.1017/S0031182000013202
   Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010
   Bohbot JD, 2014, INSECT BIOCHEM MOLEC, V48, P29, DOI 10.1016/j.ibmb.2014.02.007
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Chaika S., 1971, P 1 ALL UN S INS CHE, P67
   Clements A. N., 1992, BIOL MOSQUITOES, P220
   Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4
   Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830
   DAVIS EE, 1984, J INSECT PHYSIOL, V30, P211, DOI 10.1016/0022-1910(84)90005-2
   Debboun M, 2013, MED VET ENTOMOL, V27, P1, DOI 10.1111/j.1365-2915.2012.01020.x
   DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206
   DEVINE TERRY L., 1965, J INSECT PHYSIOL, V11, P347, DOI 10.1016/0022-1910(65)90082-X
   Dickens JC, 2013, PESTIC BIOCHEM PHYS, V106, P149, DOI 10.1016/j.pestbp.2013.02.006
   DService M. W., 1971, B ENTOMOL RES, V60, P653
   Elizarov Yu.A., 1974, Zoologicheskii Zh, V53, P577
   Erdelyan CNG, 2012, INSECT MOL BIOL, V21, P119, DOI 10.1111/j.1365-2583.2011.01120.x
   FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303
   FRIEND WG, 1977, ANNU REV ENTOMOL, V22, P309, DOI 10.1146/annurev.en.22.010177.001521
   GALUN R, 1963, SCIENCE, V142, P1674, DOI 10.1126/science.142.3600.1674
   GALUN R, 1985, PHYSIOL ENTOMOL, V10, P275, DOI 10.1111/j.1365-3032.1985.tb00048.x
   Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585
   GILLETT JD, 1967, PROC R SOC SER B-BIO, V167, P316, DOI 10.1098/rspb.1967.0029
   GORDON R. M., 1939, ANN TROP MED AND PARASITOL, V33, P259
   GROSSMAN GL, 1991, J MED ENTOMOL, V28, P456, DOI 10.1093/jmedent/28.3.456
   GWADZ RW, 1969, J INSECT PHYSIOL, V15, P2039, DOI 10.1016/0022-1910(69)90071-7
   Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039
   Hill SR, 1999, INT J INSECT MORPHOL, V28, P281, DOI 10.1016/S0020-7322(99)00031-8
   HOSOI T, 1959, J INSECT PHYSIOL, V3, P191, DOI 10.1016/0022-1910(59)90001-0
   Ignell R, 2005, J COMP NEUROL, V492, P214, DOI 10.1002/cne.20691
   Ignell R, 2010, PHYSIOL ENTOMOL, V35, P274, DOI 10.1111/j.1365-3032.2010.00740.x
   Isono K, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00020
   Joseph RM, 2015, TRENDS GENET, V31, P683, DOI 10.1016/j.tig.2015.09.005
   Kent LB, 2008, CHEM SENSES, V33, P79, DOI 10.1093/chemse/bjm067
   Kessler S, 2015, J COMP PHYSIOL A, V201, P317, DOI 10.1007/s00359-015-0978-7
   Kessler S, 2014, PHYSIOL ENTOMOL, V39, P172, DOI 10.1111/phen.12061
   Kessler S, 2013, J EXP BIOL, V216, P1292, DOI 10.1242/jeb.076588
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   KLOWDEN MJ, 1979, J INSECT PHYSIOL, V25, P231, DOI 10.1016/0022-1910(79)90048-9
   KLOWDEN MJ, 1987, J INSECT PHYSIOL, V33, P83, DOI 10.1016/0022-1910(87)90078-3
   Klun JA, 2006, J MED ENTOMOL, V43, P34, DOI 10.1603/0022-2585(2006)043[0034:RADEOS]2.0.CO;2
   KUPFERMANN I, 1974, BEHAV BIOL, V10, P1, DOI 10.1016/S0091-6773(74)91644-7
   Kwon H, 2016, P NATL ACAD SCI USA, V113, P6880, DOI 10.1073/pnas.1520404113
   LEE R, 1974, Quaestiones Entomologicae, V10, P187
   LEE RMKW, 1983, CAN J ZOOL, V61, P633, DOI 10.1139/z83-085
   Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lima E. P., 2011, VECTORS, V4, P1
   Liman ER, 2014, NEURON, V81, P984, DOI 10.1016/j.neuron.2014.02.022
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   MACGREGOR MALCOLM E., 1931, TRANS ROY SOC TROP MED AND HYG, V24, P465, DOI 10.1016/S0035-9203(30)80008-7
   Matthews BJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2239-0
   MCIVER S, 1981, INT J INSECT MORPHOL, V10, P355, DOI 10.1016/0020-7322(81)90006-4
   MCIVER S, 1978, J MORPHOL, V155, P137, DOI 10.1002/jmor.1051550202
   MCIVER SB, 1982, J MED ENTOMOL, V19, P489, DOI 10.1093/jmedent/19.5.489
   Miyazaki T, 2010, J COMP NEUROL, V518, P4147, DOI 10.1002/cne.22433
   Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001
   OWEN WB, 1963, J INSECT PHYSIOL, V9, P73, DOI 10.1016/0022-1910(63)90085-4
   PAPPAS LG, 1978, PHYSIOL ENTOMOL, V3, P115, DOI 10.1111/j.1365-3032.1978.tb00141.x
   Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438
   PETERSON DG, 1951, B ENTOMOL RES, V42, P535, DOI 10.1017/S0007485300028935
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Pontes G, 2014, J EXP BIOL, V217, P3708, DOI 10.1242/jeb.107722
   Raad H, 2016, CELL REP, V15, P1442, DOI 10.1016/j.celrep.2016.04.040
   Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x
   Riabinina O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13010
   ROSSIGNOL PA, 1977, J MORPHOL, V151, P419, DOI 10.1002/jmor.1051510307
   SALAMA HS, 1966, J INSECT PHYSIOL, V12, P1051, DOI 10.1016/0022-1910(66)90120-X
   Sanford JL, 2013, NATURWISSENSCHAFTEN, V100, P269, DOI 10.1007/s00114-013-1021-x
   Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108
   Seenivasagan T, 2009, J VECTOR DIS, V46, P125
   Shelton JF, 2014, ENVIRON HEALTH PERSP, V122, P1103, DOI 10.1289/ehp.1307044
   Sinitzina E. E., 1971, Entomologicheskoe Obozrenie, V50, P151
   Slifer E. H., 1962, ANN ENTOMOL SOC AM, V55, P532
   Sparks J. T., 2016, SCI OF NATURE, V103
   Sparks JT, 2016, J MED ENTOMOL, V53, P1148, DOI 10.1093/jme/tjw073
   Sparks JT, 2015, PROG MOL BIOL TRANSL, V130, P81, DOI 10.1016/bs.pmbts.2014.11.004
   Sparks JT, 2014, INSECT BIOCHEM MOLEC, V48, P8, DOI 10.1016/j.ibmb.2014.02.004
   Sparks JT, 2013, INSECT BIOCHEM MOLEC, V43, P1161, DOI 10.1016/j.ibmb.2013.10.005
   STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372
   Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618
   UCHIDA K, 1979, INT J INSECT MORPHOL, V8, P159, DOI 10.1016/0020-7322(79)90014-X
   Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602
   Zhang YV, 2016, NEURON, V91, P863, DOI 10.1016/j.neuron.2016.07.013
NR 87
TC 1
Z9 1
U1 0
U2 13
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0048-3575
EI 1095-9939
J9 PESTIC BIOCHEM PHYS
JI Pest. Biochem. Physiol.
PD OCT
PY 2017
VL 142
BP 15
EP 20
DI 10.1016/j.pestbp.2016.12.009
PG 6
WC Biochemistry & Molecular Biology; Entomology; Physiology
SC Biochemistry & Molecular Biology; Entomology; Physiology
GA FM2OI
UT WOS:000414823700003
PM 29107239
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, B.
   Wiwanitkit, V.
TI Spinal Cord, Spinal Root, and Brain MRI Abnormalities in Congenital Zika
   Syndrome
SO AMERICAN JOURNAL OF NEURORADIOLOGY
LA English
DT Letter
C1 [Joob, B.] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, V.] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
CR Aragao MFVV, 2017, AJNR AM J NEURORADIO
   Joob Beuy, 2017, Pediatr Neurol, V68, pe1, DOI 10.1016/j.pediatrneurol.2016.11.009
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC NEURORADIOLOGY
PI DENVILLE
PA PO BOX 3000, DENVILLE, NJ 07834-9349 USA
SN 0195-6108
EI 1936-959X
J9 AM J NEURORADIOL
JI Am. J. Neuroradiol.
PD OCT
PY 2017
VL 38
IS 10
BP E77
EP E77
DI 10.3174/ajnr.A5268
PG 1
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA FI4PQ
UT WOS:000411955100003
PM 28572149
OA Other Gold
DA 2020-07-08
ER

PT J
AU Khachatoorian, R
   Buzzanco, A
   Cohn, W
   Quach, A
   Ruchala, P
   Faull, K
   Whitelegge, J
   Arumugaswami, V
   Dasgupta, A
   French, SW
AF Khachatoorian, R.
   Buzzanco, A.
   Cohn, W.
   Quach, A.
   Ruchala, P.
   Faull, K.
   Whitelegge, J.
   Arumugaswami, V.
   Dasgupta, A.
   French, S. W.
TI A Potential Broad-Spectrum Host-Targeting Antiviral Peptide Blocks Zika
   Virus Infection
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Pathobiology-for-Investigators-Students-and-Academicians (PISA) on
   Genome and Environment - Implications in Development, Regeration,
   Injury, Immunity, and Malignancy
CY SEP 25-27, 2017
CL Pittsburgh, PA
SP Pathobiol Investigators, Students & Academicians
C1 [Khachatoorian, R.; Buzzanco, A.; Cohn, W.; Quach, A.; Ruchala, P.; Faull, K.; Whitelegge, J.; Dasgupta, A.; French, S. W.] Univ Calif Los Angeles, Los Angeles, CA USA.
   [Arumugaswami, V.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD OCT
PY 2017
VL 187
IS 10
MA ID6
BP 2358
EP 2358
PG 1
WC Pathology
SC Pathology
GA FI0ZQ
UT WOS:000411658900050
DA 2020-07-08
ER

PT J
AU Fernandes, A
   Rua, E
   Vianna, R
   Sant'Anna, R
   Carvalho, F
   Lovero, K
   Douglass-Jaimes, G
   da Silva, T
   dos Santos, TC
   Fontes, C
   de Oliveira, S
   Riley, L
   Cardoso, CA
AF Fernandes, A.
   Rua, E.
   Vianna, R.
   Sant'Anna, R.
   Carvalho, F.
   Lovero, K.
   Douglass-Jaimes, G.
   da Silva, T.
   dos Santos, T. C.
   Fontes, C.
   de Oliveira, S.
   Riley, L.
   Cardoso, C. A.
TI Preliminary Neurological Findings from a Prospective Cohort of Children
   Exposed to Zika Virus During Pregnancy
SO ANNALS OF NEUROLOGY
LA English
DT Meeting Abstract
CT 46th Annual Meeting of the Child-Neurology-Society (CNS)
CY OCT 04-07, 2017
CL Kansas City, MO
SP Child Neurol Soc
DE Infections/Neuroimmunology; Neurimaging
RI Carvalho, Felix/D-4914-2013
OI Carvalho, Felix/0000-0003-3858-3494
NR 0
TC 0
Z9 0
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2017
VL 82
SU 21
SI SI
MA 8
BP S272
EP S272
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FK0VP
UT WOS:000413198700493
DA 2020-07-08
ER

PT J
AU Mochida, G
   Nakayama, T
   Vaughan, D
   Kodani, A
   Gonzalez, D
   Durbin, A
   Bosch, I
   Teixeira, M
   Gehrke, L
AF Mochida, G.
   Nakayama, T.
   Vaughan, D.
   Kodani, A.
   Gonzalez, D.
   Durbin, A.
   Bosch, I
   Teixeira, M.
   Gehrke, L.
TI Reduced Embryonic Survival and Microcephaly in a New Mouse Model of
   Congenital Zika Virus Infection
SO ANNALS OF NEUROLOGY
LA English
DT Meeting Abstract
CT 46th Annual Meeting of the Child-Neurology-Society (CNS)
CY OCT 04-07, 2017
CL Kansas City, MO
SP Child Neurol Soc
DE Infections/Neuroimmunology
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2017
VL 82
SU 21
SI SI
MA 13
BP S274
EP S275
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FK0VP
UT WOS:000413198700498
DA 2020-07-08
ER

PT J
AU Curtis, A
   Quinn, M
   Obenauer, J
   Renk, BM
AF Curtis, Andrew
   Quinn, Megan
   Obenauer, Julie
   Renk, Becca Mohally
TI Supporting local health decision making with spatial video: Dengue,
   Chikungunya and Zika risks in a data poor, informal community in
   Nicaragua
SO APPLIED GEOGRAPHY
LA English
DT Article
DE GIS & health; Spatial video; Dengue; Zika; Nicaragua; Informal
   settlement
ID VECTOR CONTROL INTERVENTIONS; RIO-DE-JANEIRO; AEDES-AEGYPTI;
   ENVIRONMENTAL DETERMINANTS; LATIN-AMERICA; URBAN AREA; FEVER;
   LEPTOSPIROSIS; CULICIDAE; KNOWLEDGE
AB One challenge facing spatial scientists trying to support public health outreach and intervention in challenging environments is the lack of fine scale spatial data. These data are required to gain a better understanding of both physical and social systems; why disease occurs where it does, and how to disrupt it. While data options exist, including high resolution aerial imagery, remotely.sensed data, and even online mapping products like Google Street View, these all come with limitations. One option that has previously been utilized to assess cholera risk is spatial video. Here it is used to map potential mosquito breeding sites in an endemic Dengue and Chikungunya, and emerging Zika impacted community. We show how this method can provide mapping support in the hands of non-specialist public health workers who, working in collaboration with out-of-area geographic information systems (GIS) teams, can identify whereto target limited intervention resources. We use a case study of an impoverished informal style Nicaraguan community suffering from a high disease burden to show spatial variation in potential mosquito breeding habitats. A field team collected street-by-street spatial video data to produce fine scale risk maps of standing water and trash locations, which, when interpreted with the associated spatial video imagery, were used to suggest where intervention strategies should be targeted. We also discuss how these same data layers can be used to address other health concerns traditionally found in informal settlements. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Curtis, Andrew] Kent State Univ, Dept Geog, Hlth & Hazards Lab, Kent, OH 44242 USA.
   [Quinn, Megan; Obenauer, Julie] East Tennessee State Univ, Coll Publ Hlth, Dept Biostat & Epidemiol, Johnson City, TN USA.
   [Renk, Becca Mohally] Jubilee House Community, Ctr Dev Cent Amer, Managua, Nicaragua.
RP Curtis, A (corresponding author), Kent State Univ, Dept Geog, Hlth & Hazards Lab, Kent, OH 44242 USA.
EM obenauermotl@mail.etsu.edu
RI Curtis, Andrew/U-8674-2019
FU GIS Health and Hazards Lab
FX The authors would like to thank the Center for Development Central
   America and the Nueva Vida clinic for their assistance with the project.
   Andrew Curtis would like to thank the Health Community Research
   initiative at Kent State, and Kenneth R. Wilson for his inspiration and
   support of the GIS Health and Hazards Lab.
CR Akullian A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004212
   Albonico M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000126
   Alfonso-Sierra E, 2016, PATHOG GLOB HEALTH, V110, P14, DOI 10.1080/20477724.2016.1142057
   Alimi TO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1052-1
   Anno S, 2015, GEOSPATIAL HEALTH, V10, P215, DOI 10.4081/gh.2015.376
   Martinez-Vega RA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004296
   Barcellos C, 2000, INT J ENVIRON HEAL R, V10, P301, DOI 10.1080/0960312002001500
   Bartram J, 2014, INT J ENV RES PUB HE, V11, P8137, DOI 10.3390/ijerph110808137
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Caprara A, 2015, T ROY SOC TROP MED H, V109, P99, DOI 10.1093/trstmh/tru187
   Casas I, 2017, J TRANSP HEALTH, V4, P18, DOI 10.1016/j.jth.2016.08.001
   Chaikoolvatana A., 2013, Dengue Bulletin, V37, P123
   Chang AY, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-49
   Chen B, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-31
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Curtis A, 2016, ANN AM ASSOC GEOGR, P1
   Curtis A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020187
   Curtis A, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0014-8
   Curtis A, 2014, APPL GEOGR, V51, P58, DOI 10.1016/j.apgeog.2014.02.003
   Curtis A, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-21
   Curtis JW, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-53
   de Almeida AS, 2009, REV SAUDE PUBL, V43, P666, DOI 10.1590/s0034-89102009000400013
   Delmelle E, 2016, ACTA TROP, V164, P169, DOI 10.1016/j.actatropica.2016.08.028
   Delmelle EM, 2014, APPL GEOGR, V52, P144, DOI 10.1016/j.apgeog.2014.05.007
   Dewan AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001998
   Dhewantara PW, 2015, GEOSPATIAL HEALTH, V10, P255, DOI 10.4081/gh.2015.373
   Dickin SK, 2014, APPL GEOGR, V46, P71, DOI 10.1016/j.apgeog.2013.11.003
   Eisen L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000411
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Finkelman J, 2015, T ROY SOC TROP MED H, V109, P89, DOI 10.1093/trstmh/tru201
   Gualberto Danny, 2015, Advances in Environmental Biology, V9, P1
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Haklay M, 2010, ENVIRON PLANN B, V37, P682, DOI 10.1068/b35097
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Hohl A, 2015, ISPRS International Workshop on Spatiotemporal Computing, P7, DOI 10.5194/isprsannals-II-4-W2-7-2015
   Jeelani S, 2015, PUBLIC HEALTH, V129, P790, DOI 10.1016/j.puhe.2015.02.026
   Kanungo S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-830
   Kauhl B, 2015, HEALTH PLACE, V31, P111, DOI 10.1016/j.healthplace.2014.11.002
   Kienberger S, 2013, GEOSPATIAL HEALTH, V8, P313, DOI 10.4081/gh.2013.76
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Mbuya MNN, 2015, CLIN INFECT DIS, V61, pS703, DOI 10.1093/cid/civ845
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Ocampo CB, 2014, ACTA TROP, V132, P15, DOI 10.1016/j.actatropica.2013.12.019
   Paar P, 2011, FUTURE INTERNET, V3, P228, DOI 10.3390/fi3040228
   Pan American Health Organization (PAHO), 2016, HLTH AM
   Penrose K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000631
   Porter G, 2013, SOC SCI MED, V88, P90, DOI 10.1016/j.socscimed.2013.04.010
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Ram PK, 2007, EPIDEMIOL INFECT, V135, P458, DOI 10.1017/S0950268806007114
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177
   Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Schouten MAC, 2010, PHYS CHEM EARTH, V35, P815, DOI 10.1016/j.pce.2010.07.002
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Ibarra AMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1135
   Tapia-Conyer R, 2009, J CLIN VIROL, V46, pS3, DOI 10.1016/S1386-6532(09)70286-0
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Teng HJ, 1999, J MED ENTOMOL, V36, P468, DOI 10.1093/jmedent/36.4.468
   Wen TH, 2015, APPL GEOGR, V62, P256, DOI 10.1016/j.apgeog.2015.05.003
   WHO, 2016, ZIK VIR INF REG AM
   World Health Organization (WHO), 2016, ZIK VIR TECHN REP
   Worrell CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150744
NR 68
TC 5
Z9 5
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0143-6228
EI 1873-7730
J9 APPL GEOGR
JI Appl. Geogr.
PD OCT
PY 2017
VL 87
BP 197
EP 206
DI 10.1016/j.apgeog.2017.08.008
PG 10
WC Geography
SC Geography
GA FJ5JS
UT WOS:000412788400018
DA 2020-07-08
ER

PT J
AU Parry, E
AF Parry, E.
TI The Zika Virus
SO AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
LA English
DT Meeting Abstract
C1 [Parry, E.] Middlemore Hosp, Auckland, New Zealand.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0004-8666
EI 1479-828X
J9 AUST NZ J OBSTET GYN
JI Aust. N. Z. J. Obstet. Gynaecol.
PD OCT
PY 2017
VL 57
SU 1
SI SI
BP 20
EP 20
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FL1CA
UT WOS:000413949900080
DA 2020-07-08
ER

PT J
AU Devhare, P
   Meyer, K
   Steele, R
   Ray, RB
   Ray, R
AF Devhare, Pradip
   Meyer, Keith
   Steele, Robert
   Ray, Ratna B.
   Ray, Ranjit
TI Zika virus infection dysregulates human neural stem cell growth and
   inhibits differentiation into neuroprogenitor cells
SO CELL DEATH & DISEASE
LA English
DT Article
ID DNA-DAMAGE RESPONSE; GENOTOXIC STRESS; BRAIN; REPAIR; PHOSPHORYLATION;
   PROGENITORS; ACTIVATION; CHK1; GFAP; MAINTENANCE
AB The current outbreak of Zika virus-associated diseases in South America and its threat to spread to other parts of the world has emerged as a global health emergency. A strong link between Zika virus and microcephaly exists, and the potential mechanisms associated with microcephaly are under intense investigation. In this study, we evaluated the effect of Zika virus infection of Asian and African lineages (PRVABC59 and MR766) in human neural stem cells (hNSCs). These two Zika virus strains displayed distinct infection pattern and growth rates in hNSCs. Zika virus MR766 strain increased serine 139 phosphorylation of histone H2AX (gamma H2AX), a known early cellular response proteins to DNA damage. On the other hand, PRVABC59 strain upregulated serine 15 phosphorylation of p53, p21 and PUMA expression. MR766-infected cells displayed poly (ADP-ribose) polymerase (PARP) and caspase-3 cleavage. Interestingly, infection of hNSCs by both strains of Zika virus for 24 h, followed by incubation in astrocyte differentiation medium, induced rounding and cell death. However, astrocytes generated from hNSCs by incubation in differentiation medium when infected with Zika virus displayed minimal cytopathic effect at an early time point. Infected hNSCs incubated in astrocyte differentiating medium displayed PARP cleavage within 24-36 h. Together, these results showed that two distinct strains of Zika virus potentiate hNSC growth inhibition by different mechanisms, but both viruses strongly induce death in early differentiating neuroprogenitor cells even at a very low multiplicity of infection. Our observations demonstrate further mechanistic insights for impaired neuronal homeostasis during active Zika virus infection.
C1 [Devhare, Pradip; Steele, Robert; Ray, Ratna B.] St Louis Univ, Dept Pathol, St Louis, MO 63103 USA.
   [Meyer, Keith; Ray, Ratna B.; Ray, Ranjit] St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA.
RP Ray, R (corresponding author), Edward A Doisy Res Ctr, Div Infect Dis Allergy & Immunol, 1100S Grand Blvd,8th Floor, St Louis, MO 63104 USA.
EM rayr@slu.edu
OI Devhare, Pradip/0000-0002-6546-3407
FU Blue Ribbon Research Fund from the Dean of School of Medicine; Doisy
   Research Fund from Saint Louis University
FX This work was supported by Blue Ribbon Research Fund (RR) from the Dean
   of School of Medicine, and Doisy Research Fund (RBR) from Saint Louis
   University.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001
   Bartek J, 2003, NATURE, V421, P486, DOI 10.1038/421486a
   Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016
   Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019
   Clairembault T, 2014, J NEUROCHEM, V130, P805, DOI 10.1111/jnc.12742
   Dahl J, 2005, J VIROL, V79, P13007, DOI 10.1128/JVI.79.20.13007-13017.2005
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Devhare PB, 2017, J VIROL, V91, DOI 10.1128/JVI.00349-17
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509
   Firsanov DV, 2011, CLIN EPIGENETICS, V2, P283, DOI 10.1007/s13148-011-0044-4
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Griffin DE, 2017, SCIENCE, V357, P33, DOI 10.1126/science.aan8626
   Guerrero-Cazares H, 2011, J COMP NEUROL, V519, P1165, DOI 10.1002/cne.22566
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kanda T, 2009, J VIROL, V83, P8463, DOI 10.1128/JVI.00751-09
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lim DA, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018820
   Massirer KB, 2011, WIRES SYST BIOL MED, V3, P107, DOI 10.1002/wsbm.100
   Matsuura K, 2008, J BIOL CHEM, V283, P25485, DOI 10.1074/jbc.M803111200
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Niedernhofer LJ, 2008, DNA REPAIR, V7, P523, DOI 10.1016/j.dnarep.2007.11.012
   O'Driscoll M, 2008, DNA REPAIR, V7, P1039, DOI 10.1016/j.dnarep.2008.03.018
   Okita N, 2007, BIOL PHARM BULL, V30, P359, DOI 10.1248/bpb.30.359
   Okita N, 2013, BBA-GEN SUBJECTS, V1830, P2204, DOI 10.1016/j.bbagen.2012.10.009
   Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546
   Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798
   Ryan EL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010002
   Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301
   Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129
   Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241
   Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X
   Shrivastava S, 2016, J VIROL, V90, P1387, DOI 10.1128/JVI.02383-15
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Solier S, 2014, CELL MOL LIFE SCI, V71, P2289, DOI 10.1007/s00018-013-1555-2
   Sullivan SM, 2014, J NEUROCHEM, V130, P729, DOI 10.1111/jnc.12754
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252
   Trevathan E, 2016, BIRTH DEFECTS RES A, V106, P869, DOI 10.1002/bdra.23582
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Wei PC, 2016, CELL, V164, P644, DOI 10.1016/j.cell.2015.12.039
NR 51
TC 23
Z9 23
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD OCT
PY 2017
VL 8
AR e3106
DI 10.1038/cddis.2017.517
PG 8
WC Cell Biology
SC Cell Biology
GA FL2CV
UT WOS:000414022900053
PM 29022904
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Patel, S
   Rani, A
   Goyal, A
AF Patel, Seema
   Rani, Aruna
   Goyal, Arun
TI Insights into the immune manipulation mechanisms of pollen allergens by
   protein domain profiling
SO COMPUTATIONAL BIOLOGY AND CHEMISTRY
LA English
DT Article
DE Pollen; Allergen; Protein domain; Profilin; Expansin; Pectate lyase
ID BET V 1; MAJOR ALLERGEN; CROSS-REACTIVITY; HAMP DOMAIN; IDENTIFICATION;
   GENE; MUTATIONS; GALANIN; KINASE; POLYGALACTURONASE
AB Plant pollens are airborne allergens, as their inhalation causes immune activation, leading to rhinitis, conjunctivitis, sinusitis and oral allergy syndrome. A myriad of pollen proteins belonging to profilin, expansin, polygalacturonase, glucan endoglucosidase, pectin esterase, and lipid transfer protein class have been identified. In the present in silico study, the protein domains of fifteen pollen sequences were extracted from the UniProt database and submitted to the interactive web tool SMART (Simple Modular Architecture Research Tool), for finding the protein domain profiles. Analysis of the data based on custom-made scripts revealed the conservation of pathogenic domains such as OmpH, PROF, PreSET, Bet_v_1, Cpl-7 and GAS2. Further, the retention of critical domains like CHASE2, Galanin, Data DALR_1, HAMP, PWI, EFh, Excalibur, CT, PbH1, HELICc, and Kelch in pollen proteins, much like cockroach allergens and lethal viruses (such as HIV, HCV, Ebola, Dengue and Zika) was observed. Based on the shared motifs in proteins of taxonomicall-ydispersed organisms, it can be hypothesized that allergens and pathogens manipulate the human immune system in a similar manner. Allergens, being inanimate, cannot replicate in human body, and are neutralized by immune system. But, when the allergens are unremitting, the immune system becomes persistently hyper-sensitized, creating an inflammatory milieu. This study is expected to contribute to the understanding of pollen allergenicity and pathogenicity. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Patel, Seema] San Diego State Univ, Bioinformat & Med Informat Res Ctr, San Diego, CA 92182 USA.
   [Rani, Aruna; Goyal, Arun] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati 781039, Assam, India.
RP Patel, S (corresponding author), San Diego State Univ, Bioinformat & Med Informat Res Ctr, San Diego, CA 92182 USA.
EM seemabiotech83@gmail.com
CR Absmeier E, 2015, ACTA CRYSTALLOGR D, V71, P762, DOI 10.1107/S1399004715001005
   Ahmed A, 2010, IRAN J PUBLIC HEALTH, V39, P109
   Airola MV, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001479
   Airola MV, 2010, STRUCTURE, V18, P436, DOI 10.1016/j.str.2010.01.013
   An S, 2013, MOL CELL PROTEOMICS, V12, P1818, DOI 10.1074/mcp.M112.027136
   Asam C, 2014, CLIN EXP ALLERGY, V44, P1083, DOI 10.1111/cea.12361
   Asano E, 2014, CELL CYCLE, V13, P2744, DOI 10.4161/15384101.2015.945840
   Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895
   Baxi Sachin N, 2010, Adolesc Med State Art Rev, V21, P57
   Binda O, 2010, EPIGENETICS-US, V5, P767, DOI 10.4161/epi.5.8.13278
   Bodeau AL, 2001, J CELL SCI, V114, P2795
   Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000
   D'Amato G, 2010, J INVEST ALLERG CLIN, V20, P95
   de Punder K, 2013, NUTRIENTS, V5, P771, DOI 10.3390/nu5030771
   Fritsch R, 1998, J ALLERGY CLIN IMMUN, V102, P679, DOI 10.1016/S0091-6749(98)70287-8
   Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35
   Garcia-Gago JA, 2009, PLANT SIGNAL BEHAV, V4, P766, DOI 10.1104/pp.109.138297
   Giebeler N, 2016, TOXINS, V8, DOI 10.3390/toxins8040122
   Gilles S, 2012, CURR PHARM DESIGN, V18, P2314, DOI 10.2174/138161212800166040
   Goldfeder RL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0269-0
   Grinchuk OV, 2010, NUCLEIC ACIDS RES, V38, P534, DOI 10.1093/nar/gkp954
   Gunay-Aygun M, 2010, MOL GENET METAB, V99, P160, DOI 10.1016/j.ymgme.2009.10.010
   Guzzo CR, 2007, PROTEINS, V69, P644, DOI 10.1002/prot.21556
   Hartz C, 2007, MOL IMMUNOL, V44, P2820, DOI 10.1016/j.molimm.2007.01.030
   Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1
   Huang X, 2003, DEVELOPMENT, V130, P3147, DOI 10.1242/dev.00518
   Huang XL, 2015, J BACTERIOL, V197, P2517, DOI 10.1128/JB.00176-15
   Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058
   Ibarrola I, 2004, J ALLERGY CLIN IMMUN, V113, P1185, DOI 10.1016/j.jaci.2004.02.031
   Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42
   Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33
   Jimenez-Lopez JC, 2012, J MOL MODEL, V18, P4965, DOI 10.1007/s00894-012-1492-2
   Kask K, 1996, EMBO J, V15, P236, DOI 10.1002/j.1460-2075.1996.tb00354.x
   Kishii R, 2007, J BIOL CHEM, V282, P26401, DOI 10.1074/jbc.M701342200
   Koonin E.V., 2000, CURR BIOL
   Lang R, 2015, PHARMACOL REV, V67, P118, DOI 10.1124/pr.112.006536
   Lavin JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-397
   Lee J, 2007, J MICROBIOL, V45, P179
   Levin M, 2014, CLIN EXP ALLERGY, V44, P288, DOI 10.1111/cea.12230
   Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06
   Matamouros S, 2015, MBIO, V6, DOI 10.1128/mBio.00616-15
   Menezes LF, 2006, BRAZ J MED BIOL RES, V39, P1537, DOI 10.1590/S0100-879X2006001200004
   Michaelsen-Preusse K, 2016, P NATL ACAD SCI USA, V113, P3365, DOI 10.1073/pnas.1516697113
   Miertzschke M, 2011, EMBO J, V30, P4185, DOI 10.1038/emboj.2011.291
   Nolle A, 2011, HUM MOL GENET, V20, P4865, DOI 10.1093/hmg/ddr425
   Okay S, 2012, ACTA MICROBIOL IMM H, V59, P485, DOI 10.1556/AMicr.59.2012.4.6
   Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7
   Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111
   Pichler U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120038
   Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229
   Popescu Florin-Dan, 2015, World J Methodol, V5, P31, DOI 10.5662/wjm.v5.i2.31
   Poritsanos NJ, 2009, INT J OBESITY, V33, P1381, DOI 10.1038/ijo.2009.187
   Price Alexandra, 2015, Dermatitis, V26, P78, DOI 10.1097/DER.0000000000000087
   Rhee SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2186-9
   Salamanca G, 2010, FEBS J, V277, P2729, DOI 10.1111/j.1742-4658.2010.07689.x
   Santos A, 2011, INT ARCH ALLERGY IMM, V155, P191, DOI 10.1159/000321178
   Schyth BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132434
   Shaw PE, 2002, EMBO REP, V3, P521, DOI 10.1093/embo-reports/kvf118
   Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266
   Shi Yang, 2014, Yichuan, V36, P809, DOI 10.3724/SP.J.1005.2014.0809
   Smole U, 2010, ALLERGY, V65, P1388, DOI 10.1111/j.1398-9995.2010.02407.x
   Stevenson L, 2012, CLIN CANCER RES, V18, P5412, DOI 10.1158/1078-0432.CCR-12-1780
   Suzuki M, 2014, CELL HOST MICROBE, V16, P581, DOI 10.1016/j.chom.2014.09.015
   Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368
   Wang Q, 2014, J VIROL, V88, P4853, DOI 10.1128/JVI.02923-13
   Warr A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00338
   Wensing M, 2002, J ALLERGY CLIN IMMUN, V110, P435, DOI 10.1067/mai.2002.126380
   Wong KR, 1998, MOL GEN GENET, V257, P693, DOI 10.1007/s004380050699
   Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280
   Wu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13434
   Wuichet K, 2015, GENOME BIOL EVOL, V7, P57, DOI 10.1093/gbe/evu264
   Xiao J, 2011, ARTERIOSCL THROM VAS, V31, P2261, DOI 10.1161/ATVBAHA.111.229609
   Yadav PK, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1049, DOI 10.1134/S0006297909090144
   Yoon SH, 2014, KOREAN J ANESTHESIOL, V67, P412, DOI 10.4097/kjae.2014.67.6.412
   Zakharenko A M, 2009, Bioorg Khim, V35, P62
   Zhang T., 2011, PLOS ONE, V6
   Zhulin IB, 2003, J BACTERIOL, V185, P285, DOI 10.1128/JB.185.1.285-294.2003
   Zubini P, 2009, PLANT PHYSIOL, V150, P1235, DOI 10.1104/pp.109.139543
NR 78
TC 2
Z9 2
U1 4
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1476-9271
EI 1476-928X
J9 COMPUT BIOL CHEM
JI Comput. Biol. Chem.
PD OCT
PY 2017
VL 70
BP 31
EP 39
DI 10.1016/j.compbiolchem.2017.07.006
PG 9
WC Biology; Computer Science, Interdisciplinary Applications
SC Life Sciences & Biomedicine - Other Topics; Computer Science
GA FJ7TB
UT WOS:000412960700005
PM 28780227
DA 2020-07-08
ER

PT J
AU Gutierrez, Y
   Ramos, GS
   Tome, HVV
   Oliveira, EE
   Salaro, AL
AF Gutierrez, Yeisson
   Ramos, Gabryele S.
   Tome, Hudson V. V.
   Oliveira, Eugenio E.
   Salaro, Ana L.
TI Bt(i)-based insecticide enhances the predatory abilities of the
   backswimmer Buenoa tarsalis (Hemiptera: Notonectidae)
SO ECOTOXICOLOGY
LA English
DT Article
DE Bacilus thuringiesnsis; aquatic predators; Natural enemies; Pesticides
ID NONTARGET AQUATIC INVERTEBRATES; BACILLUS-THURINGIENSIS;
   MOSQUITO-CONTROL; AEDES-AEGYPTI; ZIKA VIRUS; PYRETHROID INSECTICIDES;
   QUINQUEFASCIATUS SAY; SODIUM-CHANNEL; RESISTANCE; ISRAELENSIS
AB The backswimmer Buenoa tarsalis (Hemiptera: Notonectidae) is a naturally occurring predator of immature stages of mosquitoes. These aquatic predators can suffer from non-targeted exposure to insecticides that are commonly used in aquatic environments to control mosquitoes. Here, we evaluated whether insecticide formulations containing the bacterium Bacillus thuringiensis var. israelensis (Bt(i)) or the organophosphate pirimiphos-methyl would affect the survival and the predatory abilities of B. tarsalis. First, we conducted survival bioassays to estimate the median survival time (LT50) of B. tarsalis when exposed to Bti-based insecticide (at 0.25 and 25 mg a. i./L) and pirimiphos-methyl (at 1, 10 and 1000 mg a. i./L). The highest concentrations of the insecticides were equivalent to the label-recommended field rates. Second, the predatory abilities of B. tarsalis exposed to insecticides were evaluated at three prey densities (3, 6 and 9 mosquito larvae/100 mL water) just after insecticide exposure or after a 24 h recovery time. While the survival of B. tarsalis was significantly reduced with pirimiphos-methyl concentrations +/- 10 mg a. i./L, the Bt(i)-exposed predators exhibited similar survival as unexposed predators. Interestingly, after a recovery time of 24 h, B. tarsalis sublethally exposed to pirimiphos-methyl or Bti-based insecticide consistently killed more A. aegypti larvae (at the intermediate density) than unexposed predators. However, for the withoutrecovery bioassays, the pirimiphos-methyl-exposed predators exhibited reduced predatory abilities at the lowest prey density. Because they do not reduce the survival or the predatory abilities of B. tarsalis, Bt(i)-based insecticides can be considered a safe insecticide to use in the presence of backswimmers.
C1 [Gutierrez, Yeisson; Ramos, Gabryele S.; Tome, Hudson V. V.; Oliveira, Eugenio E.] Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil.
   [Gutierrez, Yeisson] Univ Munster, Inst Landscape Ecol, D-48149 Munster, Germany.
   [Tome, Hudson V. V.] EAG Labs, 13709 Progress Blvd 24 Suite S163, Alachua, FL 32615 USA.
   [Salaro, Ana L.] Univ Fed Vicosa, Dept Biol Anim, BR-36570900 Vicosa, MG, Brazil.
RP Oliveira, EE (corresponding author), Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil.; Salaro, AL (corresponding author), Univ Fed Vicosa, Dept Biol Anim, BR-36570900 Vicosa, MG, Brazil.
EM eugenio@ufv.br; salaro@ufv.br
RI de Oliveira, Eugenio Eduardo/F-4045-2016; Tome, Hudson V.V./E-6957-2014;
   Salaro, Ana Lucia/A-4755-2017
OI Salaro, Ana Lucia/0000-0003-1178-427X; Gutierrez Lopez,
   Yeisson/0000-0002-0166-2933
FU Arthur Bernardes Foundation (FUNARBE); Minas Gerais State Foundation for
   Research Aid (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG);
   National Council of Scientific and Technological Development (CNPq;
   Brazilian Ministry of Science and Technology)National Council for
   Scientific and Technological Development (CNPq); CAPES Foundation
   (Brazilian Ministry of Education)CAPES
FX This study was supported by grants from the Arthur Bernardes Foundation
   (FUNARBE), Minas Gerais State Foundation for Research Aid (FAPEMIG),
   National Council of Scientific and Technological Development (CNPq;
   Brazilian Ministry of Science and Technology) and the CAPES Foundation
   (Brazilian Ministry of Education). The authors would like to thank
   reviewers' valuable comments and suggestions.
CR Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763
   ALY C, 1987, J APPL ENTOMOL, V103, P113, DOI 10.1111/j.1439-0418.1987.tb00966.x
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Boisvert M, 2000, BIOCONTROL SCI TECHN, V10, P517, DOI 10.1080/095831500750016361
   Campero M, 2007, ECOL APPL, V17, P2111, DOI 10.1890/07-0442.1
   Coelho JS, 2009, CHEMOSPHERE, V77, P934, DOI 10.1016/j.chemosphere.2009.08.022
   Crickmore N, 2006, J APPL MICROBIOL, V101, P616, DOI 10.1111/j.1365-2672.2006.02936.x
   Davis RS, 2008, J AM MOSQUITO CONTR, V24, P270, DOI 10.2987/5654.1
   Melo ALD, 2016, CRIT REV BIOTECHNOL, V36, P317, DOI 10.3109/07388551.2014.960793
   Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440
   FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032
   Gutierrez Y, 2017, ENVIRON TOXICOL CHEM, V36, P1235, DOI 10.1002/etc.3645
   Gutierrez Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152383
   Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549
   Halstead NT, 2015, CHEMOSPHERE, V135, P265, DOI 10.1016/j.chemosphere.2015.03.091
   Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067
   Jakob C, 2016, INSECT CONSERV DIVER, V9, P161, DOI 10.1111/icad.12155
   Janssens L, 2013, AQUAT TOXICOL, V132, P92, DOI 10.1016/j.aquatox.2013.02.003
   Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395
   Kroeger I, 2013, J VECTOR ECOL, V38, P82, DOI 10.1111/j.1948-7134.2013.12012.x
   Kuivila KM, 2012, ENVIRON SCI TECHNOL, V46, P4297, DOI 10.1021/es2044882
   LACEY LA, 2004, ENV IMPACTS MICROBIA, P151
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Lagadic L, 2016, SCI TOTAL ENVIRON, V553, P486, DOI 10.1016/j.scitotenv.2016.02.096
   Lagadic L, 2014, J APPL ECOL, V51, P102, DOI 10.1111/1365-2664.12165
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Marina CF, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-55
   Martins AJ, 2009, AM J TROP MED HYG, V81, P108, DOI 10.4269/ajtmh.2009.81.108
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Ndiaye E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1383-y
   Olejnicek J, 1986, Wiad Parazytol, V32, P539
   Op de Beeck L, 2016, ECOL APPL, V26, P355, DOI 10.1890/15-0326
   Paine MD, 1996, ENVIRON TOXICOL CHEM, V15, P1439, DOI 10.1002/etc.5620150901
   Painter MK, 1996, ENVIRON ENTOMOL, V25, P184, DOI 10.1093/ee/25.1.184
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   PURCELL BH, 1981, MOSQ NEWS, V41, P476
   Qin GQ, 2011, ENVIRON TOXICOL CHEM, V30, P1926, DOI 10.1002/etc.575
   Quiroz Martinez H, 1996, SW ENTOMOL, V21, P483
   Quiroz-Martinez H, 2007, J AM MOSQUITO CONTR, V23, P110, DOI 10.2987/8756-971X(2007)23[110:AIAPOM]2.0.CO;2
   Rasmussen JJ, 2013, AQUAT TOXICOL, V140, P340, DOI 10.1016/j.aquatox.2013.06.019
   Relyea RA, 2008, OIKOS, V117, P1647, DOI 10.1111/j.1600-0706.2008.16933.x
   Rodriguez MM, 2007, J AM MOSQUITO CONTR, V23, P420, DOI 10.2987/5588.1
   Schulz R, 2004, J ENVIRON QUAL, V33, P419, DOI 10.2134/jeq2004.0419
   Shaalan EAS, 2009, TROP BIOMED, V26, P223
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Statistical Analysis System (SAS), 2008, SAS STAT USERS GUIDE
   Swale DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36954
   von Ende Carl N., 1993, P113
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 52
TC 7
Z9 7
U1 0
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0963-9292
EI 1573-3017
J9 ECOTOXICOLOGY
JI Ecotoxicology
PD OCT
PY 2017
VL 26
IS 8
BP 1147
EP 1155
DI 10.1007/s10646-017-1840-1
PG 9
WC Ecology; Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA FI9ET
UT WOS:000412308100012
DA 2020-07-08
ER

PT J
AU Castanha, PMS
   Montarroyos, UR
   Silveira, SMM
   Albuquerque, GDM
   Mello, MJG
   Lopes, KGS
   Cordeiro, MT
   Marques, ETA
   Martelli, CMT
   Braga, C
AF Castanha, P. M. S.
   Montarroyos, U. R.
   Silveira, S. M. M.
   Albuquerque, G. D. M.
   Mello, M. J. G.
   Lopes, K. G. S.
   Cordeiro, M. T.
   Marques, E. T. A., Jr.
   Martelli, C. M. T.
   Braga, C.
TI Incidence and risk factors for Dengue virus (DENV) infection in the
   first 2 years of life in a Brazilian prospective birth cohort
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Children; cohort; dengue virus; incidence
ID HEMORRHAGIC-FEVER; ANTIBODIES; CHILDREN; TRANSMISSION; NORTHEAST;
   RESPONSES; SEVERITY; KINETICS; INFANTS
AB This study assessed the incidence and risk factors for dengue virus (DENV) infection among children in a prospective birth cohort conducted in the city of Recife, a hyperendemic dengue area in Northeast Brazil. Healthy pregnant women (n = 415) residing in Recife who agreed to have their children followed were enrolled. Children were followed during their first 24 months of age (May/2011-June/2014), before the 2015 Zika virus outbreak. DENV infection was detected by reverse-transcriptase polymerase chain reaction and/or serology (anti-DENV IgM/IgG). The incidence rates per 1000 person-years (py) and its association with risk factors by age bands (0-12, > 12-30 months) were estimated through Poisson regression models. Forty-nine dengue infections were detected; none progressed to severe forms. The incidence rates were 107.6/1000py (95% CI 76.8-150.6) and 93.3/1000py (95% CI 56.1-154.4) in the first and second years of age, respectively. Male children (risk ratios (RR) = 2.33; 95% CI 1.09-4.98) and those born to DENV-naive mothers (RR = 2.42; 95% CI 1.01-5.80) were at greater risk of infection in the first year of age. In the second year, children born to Caucasian/Asian descent skin colour mothers had a threefold higher risk of infection (RR = 3.34; 95% CI: 1.08-10.33). These data show the high exposure of children to DENV infection in our setting and highlight the role of biological factors in this population's susceptibility to infection.
C1 [Castanha, P. M. S.; Albuquerque, G. D. M.; Lopes, K. G. S.; Cordeiro, M. T.; Marques, E. T. A., Jr.; Martelli, C. M. T.; Braga, C.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Av Prof Moraes Rego S-N,Campus UFPE, Recife, PE, Brazil.
   [Castanha, P. M. S.; Montarroyos, U. R.] Univ Pernambuco, Fac Med Sci, Biol Sci Inst, Recife, PE, Brazil.
   [Silveira, S. M. M.; Mello, M. J. G.; Braga, C.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Marques, E. T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Marques, E. T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
RP Castanha, PMS (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Av Prof Moraes Rego S-N,Campus UFPE, Recife, PE, Brazil.
EM castanha.priscila@gmail.com
RI Montarroyos, Ulisses/AAJ-7527-2020; amsalu, ribka/G-8780-2019; Marques,
   Ernesto T. A/L-4967-2013; Braga, Maria Cynthia/A-8204-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Braga, Maria
   Cynthia/0000-0002-7862-6455; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU National Council for Scientific and Technological Development of the
   Brazilian government [482915/2010-2 MCT/CNPq-14/2010]; Strategic Program
   to Support Health Research/PAPES VI [407697/2012-8]
FX We thank the mothers and their infants, for participating in the study;
   and the nurses and clinical staff from IMIP who assisted with the study.
   This work was supported by the National Council for Scientific and
   Technological Development of the Brazilian government (C.B., grant
   482915/2010-2 MCT/CNPq-14/2010); and the Strategic Program to Support
   Health Research/PAPES VI (C.B., grant 407697/2012-8).
CR Anker M, 2011, WEST PAC SURVEILL RE, V2, P17, DOI [10.5365/WPSAR.2011.2.1.002, 10.5365/wpsar.2011.2.1.002]
   Arguello DF, 2015, AM J TROP MED HYG, V92, P486, DOI 10.4269/ajtmh.14-0231
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga C, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00095815
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117
   Clapham H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004262
   Clayton D, 1993, STAT MODELS EPIDEMIO, P3421
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Sierra BDL, 2007, ARCH VIROL, V152, P533, DOI 10.1007/s00705-006-0869-x
   Del Principe D, 2013, CURR MOL MED, V13, P499
   Endy TP, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00183
   Endy TP, 2010, CURR TOP MICROBIOL, V338, P1, DOI 10.1007/978-3-642-02215-9_1
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Jain A, 2010, FEMS IMMUNOL MED MIC, V59, P119, DOI 10.1111/j.1574-695X.2010.00670.x
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Leite RC, 2014, J CLIN VIROL, V60, P16, DOI [10.1016/j.jcv.2014.02.009, 10.1016/J.JCV.2014.02.009]
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Raza FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089868
   Ribeiro CF, 2013, J PEDIATR-US, V163, P1514, DOI 10.1016/j.jpeds.2013.06.040
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Teixeira MG, 2012, TROP MED INT HEALTH, V17, P1391, DOI 10.1111/j.1365-3156.2012.03086.x
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x
   Alera MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004337
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
   Verhagen LM, 2014, J INFECTION, V69, pS77, DOI 10.1016/j.jinf.2014.07.020
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
NR 38
TC 3
Z9 3
U1 0
U2 5
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD OCT
PY 2017
VL 145
IS 14
BP 2971
EP 2979
DI 10.1017/S095026881700214X
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FK0ZG
UT WOS:000413208700011
PM 28918772
OA Bronze
DA 2020-07-08
ER

PT J
AU Xavier-Carvalho, C
   Cezar, RDD
   Freire, NM
   de Vasconcelos, CMM
   Solorzano, VEF
   de Toledo-Pinto, TG
   Fialho, LG
   do Carmo, RF
   Vasconcelos, LRS
   Cordeiro, MT
   Baptista, P
   de Azeredo, EL
   da Cunha, RV
   de Souza, LJ
   Pacheco, AG
   Kubelka, CF
   de Moura, PMMF
   Moraes, MO
AF Xavier-Carvalho, Caroline
   da Silva Cezar, Renata Duarte
   Freire, Naishe Matos
   Mola de Vasconcelos, Carla Maria
   Fiestas Solorzano, Victor Edgar
   de Toledo-Pinto, Thiago Gomes
   Fialho, Luciana Gomes
   do Carmo, Rodrigo Feliciano
   Silva Vasconcelos, Luydson Richardson
   Cordeiro, Marli Tenorio
   Baptista, Paulo
   de Azeredo, Elzinandes Leal
   da Cunha, Rivaldo Venancio
   de Souza, Luiz Jose
   Pacheco, Antonio Guilherme
   Kubelka, Claire Fernandes
   Freire de Moura, Patricia Muniz Mendes
   Moraes, Milton Ozorio
TI Association of rs1285933 single nucleotide polymorphism in CLEC5A gene
   with dengue severity and its functional effects
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE Dengue; CLEC5A; Polymorphisms; Severe dengue; SNPs; TNF
ID DAP12-ASSOCIATING LECTIN (MDL)-1; VIRUS; ACTIVATION; RECEPTOR; BINDING;
   INFLAMMATION; DISEASE; PATTERN; SHOCK
AB Outbreaks of the Zika, dengue, and chikungunya viruses, especially in the Americas, pose a global threat due to their rapid spread and difficulty controlling the vector. Extreme phenotypes are often observed, from asymptomatic to severe clinical manifestations, which are well-studied in dengue. Host variations are also important contributors to disease outcomes, and many case-control studies have associated single nucleotide polymorphisms (SNPs) with severe dengue. Here, we found that the TC genotype and T-carriers for SNP rs1285933 in the C-type lectin superfamily member 5 (CLEC5A) gene was associated with severe dengue in a Northern Brazilian population (OR= 2.75 and p-value = 0.01, OR= 2.11 and p-value = 0.04, respectively). We also tested the functional effect of the CLEC5A protein and found that it is upregulated on the surface of human monocytes after in vitro dengue infection. CLEC5A was correlated with viral load inside the monocytes (Spearman r = 0.55, p = 0.008) and TNF production in culture supernatants (Spearman r = 0.72, p = 0.03). Analysis of mRNA in blood samples from DENV4-infected patients exhibiting mild symptoms showed that CLEC5A mRNA expression is correlated with TNF (r = 0.67, p = 0.0001) and other immune mediators. Monocytes from rs1285933 TT/TC individuals showed lower CLEC5A expression compared to CC genotypes. However, in these cells, CLEC5A was not correlated with TNF production. In summary, we confirmed that CLEC5A is genetically associated with dengue severity outcome, playing a central role during the immune response triggered by a dengue viral infection, and rs1285933 is a relevant SNP that is able to regulate signaling pathways after interactions between the dengue virus and CLEC5A receptors. (C) 2017 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Xavier-Carvalho, Caroline; de Toledo-Pinto, Thiago Gomes; Moraes, Milton Ozorio] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, RJ, Brazil.
   [Xavier-Carvalho, Caroline; Fiestas Solorzano, Victor Edgar; Fialho, Luciana Gomes; de Azeredo, Elzinandes Leal; Kubelka, Claire Fernandes] Inst Oswaldo Cruz FIOCRUZ, Lab Imunol Viral, Rio De Janeiro, RJ, Brazil.
   [da Silva Cezar, Renata Duarte; Mola de Vasconcelos, Carla Maria; Freire de Moura, Patricia Muniz Mendes] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil.
   [Freire, Naishe Matos; Silva Vasconcelos, Luydson Richardson; Baptista, Paulo] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
   [do Carmo, Rodrigo Feliciano] Univ Fed Vale Sao Francisco, Colegiado Ciencias Farmaceut, Petrolina, PE, Brazil.
   [Silva Vasconcelos, Luydson Richardson; Freire de Moura, Patricia Muniz Mendes] Fiocruz MS, Dept Parasitol, Lab Doencas Transmissiveis, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fiocruz MS, CPqAM, LAVITE, Recife, PE, Brazil.
   [Pacheco, Antonio Guilherme] Programa Comp Cient PROCC FIOCRUZ, Rio De Janeiro, RJ, Brazil.
   [da Cunha, Rivaldo Venancio] Univ Fed Mato Grosso do Sul, FM, Dept Clin Med, Campo Grande, MS, Brazil.
   [de Souza, Luiz Jose] Ctr Referencia Dengue, Campos Dos Goytacazes, RJ, Brazil.
   [de Souza, Luiz Jose] Fac Med, Campos Dos Goytacazes, RJ, Brazil.
RP Moraes, MO (corresponding author), Oswaldo Cruz Inst FIOCRUZ, Av Brasil 4365 Manguinhos, BR-21040360 Rio De Janeiro, Brazil.
EM milton.moraes@fiocruz.br
RI Vasconcelos, Luydson/AAC-4907-2020; Kubelka, Claire F/C-5558-2009;
   Fiestas, Victor/J-6894-2019; Pacheco, Antonio Guilherme/E-6378-2013;
   Moraes, Milton Ozorio/G-9753-2011; Carmo, Rodrigo Feliciano
   do/V-9795-2017
OI Vasconcelos, Luydson/0000-0002-1625-3358; Fiestas,
   Victor/0000-0002-5554-3542; Pacheco, Antonio
   Guilherme/0000-0003-3095-1774; Moraes, Milton
   Ozorio/0000-0003-2653-0037; Carmo, Rodrigo Feliciano
   do/0000-0001-9601-6995; Moura, Patricia/0000-0003-4259-388X; Cezar,
   Renata/0000-0002-7278-5682
FU Agency for Science Development of Pernambuco State (FACEPE); Agency for
   Research Support of Rio de Janeiro State (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Oswaldo Cruz Institute (IOC)-Oswaldo Cruz Foundation (FIOCRUZ)
FX The authors wish to thank the Agency for Science Development of
   Pernambuco State (FACEPE), the Agency for Research Support of Rio de
   Janeiro State (FAPERJ), and the Oswaldo Cruz Institute (IOC)-Oswaldo
   Cruz Foundation (FIOCRUZ). We also thank Scribendi for manuscript
   proofreading and editing.
CR Guerreiro LTA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064748
   [Anonymous], 2008, LANG ENV STAT COMP
   Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792
   Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655
   Cheng YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32000
   Cheung R, 2011, J CLIN INVEST, V121, P4446, DOI 10.1172/JCI57682
   Coelho A.V.C., 2015, BRAZIL, V14, P2876
   Faria NRD, 2016, T ROY SOC TROP MED H, V110, P228, DOI 10.1093/trstmh/trw013
   Fang X, 2012, FEMS IMMUNOL MED MIC, V66, P134, DOI 10.1111/j.1574-695X.2012.00995.x
   Figueiredo GG, 2016, HUM IMMUNOL, V77, P571, DOI 10.1016/j.humimm.2016.05.006
   Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124
   Gandini M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002257
   Halstead SB, 2003, AM J TROP MED HYG, V69, P5
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762
   Inoue S, 2010, VECTOR-BORNE ZOONOT, V10, P143, DOI 10.1089/vbz.2008.0153
   Joyce-Shaikh B, 2010, J EXP MED, V207, P579, DOI 10.1084/jem.20090516
   Kehdy FSG, 2015, P NATL ACAD SCI USA, V112, P8696, DOI 10.1073/pnas.1504447112
   Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lawrence TB, 2009, INSTITUTIONAL WORK: ACTORS AND AGENCY IN INSTITUTIONAL STUDIES OF ORGANIZATIONS, P1, DOI 10.1017/CBO9780511596605.001
   Lin CC, 2010, AM J TROP MED HYG, V82, P731, DOI 10.4269/ajtmh.2010.09-0549
   Lo Y., 2016, PLOS ONE, P1
   Lo YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166474
   Musso D., 2016, LANCET, V386, P243
   Pacheco AG, 2009, DIS MARKERS, V27, P173, DOI [10.1155/2009/685618, 10.3233/DMA-2009-0654]
   Paradowska-Gorycka A, 2013, HUM IMMUNOL, V74, P730, DOI 10.1016/j.humimm.2013.02.003
   Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Stephens H.A.F., 2010, HLA OTHER GENE ASS D, P99
   Thamizhmani R., 2014, BRAZ J INFECT DIS, V8, P4, DOI DOI 10.1016/J.BJID
   Torrentes-Carvalho A, 2016, CLIN IMMUNOL, V164, P95, DOI 10.1016/j.clim.2016.01.005
   Tung YT, 2014, NANOMED-NANOTECHNOL, V10, P1335, DOI 10.1016/j.nano.2014.03.009
   Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014
   Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478
   Ward PA, 2011, J CLIN INVEST, V121, P4234, DOI 10.1172/JCI60122
   Watson AA, 2011, J BIOL CHEM, V286, P24208, DOI 10.1074/jbc.M111.226142
   World Health Organization, 2009, SPEC PROGRAM RES TRA, Vx, P147
   Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090
   Xavier-Carvalho C, 2013, INFECT GENET EVOL, V20, P197, DOI 10.1016/j.meegid.2013.08.017
   Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693
NR 44
TC 7
Z9 7
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD OCT
PY 2017
VL 78
IS 10
BP 649
EP 656
DI 10.1016/j.humimm.2017.07.013
PG 8
WC Immunology
SC Immunology
GA FL6UW
UT WOS:000414382700009
PM 28764923
OA Green Published
DA 2020-07-08
ER

PT J
AU Aleman, TS
   Ventura, CV
   Cavalcanti, MM
   Serrano, LW
   Traband, A
   Nti, AA
   Gois, AL
   Bravo-Filho, V
   Martins, TT
   Nichols, CW
   Maia, M
   Belfort, R
AF Aleman, Tomas S.
   Ventura, Camila V.
   Cavalcanti, Milena M.
   Serrano, Leona W.
   Traband, Anastasia
   Nti, Akosua A.
   Gois, Adriana L.
   Bravo-Filho, Vasco
   Martins, Thayze T.
   Nichols, Charles W.
   Maia, Mauricio
   Belfort, Rubens
TI Quantitative Assessment of Microstructural Changes of the Retina in
   Infants With Congenital Zika Syndrome
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID OPTICAL COHERENCE TOMOGRAPHY; HUMAN FOVEAL DEVELOPMENT; VIRUS-INFECTION;
   NEURAL PROGENITORS; OCULAR FINDINGS; BRAZIL; BRAIN; MACULOPATHY;
   MUTATIONS; ORGANOIDS
AB IMPORTANCE A better pathophysiologic understanding of the neurodevelopmental abnormalities observed in neonates exposed in utero to Zika virus (ZIKV) is needed to develop treatments. The retina as an extension of the diencephalon accessible to in vivo microcopy with spectral-domain optical coherence tomography (SD-OCT) can provide an insight into the pathophysiology of congenital Zika syndrome (CZS).
   OBJECTIVE To quantify the microstructural changes of the retina in CZS and compare these changes with those of cobalamin C (cblC) deficiency, a disease with potential retinal maldevelopment.
   DESIGN, SETTING, AND PARTICIPANTS This case series included 8 infants with CZS and 8 individuals with cblC deficiency. All patients underwent ophthalmologic evaluation at 2 university teaching hospitals and SD-OCT imaging in at least 1 eye. Patients with cblC deficiency were homozygous or compound heterozygotes for mutations in the methylmalonic aciduria and homocystinuria type C (MMACHC) gene. Data were collected from January 1 to March 17, 2016, for patients with CZS and from May 4, 2015, to April 23, 2016, for patients with cblC deficiency.
   MAIN OUTCOMES AND MEASURES The SD-OCT cross-sections were segmented using automatic segmentation algorithms embedded in the SD-OCT systems. Each retinal layer thickness was measured at critical eccentricities using the position of the signal peaks and troughs on longitudinal reflectivity profiles.
   RESULTS Eight infants with CZS (5 girls and 3 boys; age range, 3-5 months) and 8 patients with cblC deficiency (3 girls and 5 boys; age range, 4 months to 15 years) were included in the analysis. All 8 patients with CZS had foveal abnormalities in the analyzed eyes (8 eyes), including discontinuities of the ellipsoid zone, thinning of the central retina with increased backscatter, and severe structural disorganization, with 3 eyes showing macular pseudocolobomas. Pericentral retina with normal lamination showed a thinned (< 30% of normal thickness) ganglion cell layer (GCL) that colocalized in 7 of 8 eyes with a normal photoreceptor layer. The inner nuclear layer was normal or had borderline thinning. The central retinal degeneration was similar to that of cblC deficiency.
   CONCLUSIONS AND RELEVANCE Congenital Zika syndrome showed a central retinal degeneration with severe GCL loss, borderline inner nuclear layer thinning, and less prominent photoreceptor loss. The findings provide the first, to date, in vivo evidence in humans for possible retinal maldevelopment with a predilection for retinal GCL loss in CZS, consistent with a murine model of the disease and suggestive of in utero depletion of this neuronal population as a consequence of Zika virus infection.
C1 [Aleman, Tomas S.; Serrano, Leona W.; Traband, Anastasia; Nti, Akosua A.; Nichols, Charles W.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Ctr Adv Med,Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Ventura, Camila V.; Gois, Adriana L.; Bravo-Filho, Vasco; Martins, Thayze T.] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Gois, Adriana L.; Bravo-Filho, Vasco; Martins, Thayze T.] HOPE Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Belfort, Rubens] Univ Fed Sao Paulo, Dept Ophthalmol, Paulista Med Sch, Sao Paulo, Brazil.
   [Cavalcanti, Milena M.] Altino Ventura Fdn, Rehabil Ctr Menina Olhos, Recife, PE, Brazil.
RP Aleman, TS (corresponding author), Univ Penn, Dept Ophthalmol, Scheie Eye Inst, Perelman Ctr Adv Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM aleman@mail.med.upenn.edu
RI Ventura, Camila V/N-2654-2018; Filho, Vasco/N-6993-2018; Maia,
   Mauricio/I-5892-2015
OI Ventura, Camila V/0000-0002-2927-4684; Filho, Vasco/0000-0003-4460-3236;
   Maia, Mauricio/0000-0002-7034-8091; Gois, Adriana/0000-0001-5542-1097
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NEI-K12EY015398-10,
   R01-EY025287]; Hope for Vision; Foundation Fighting Blindness;
   Pennsylvania Lions Sight Conservation; National Council for Scientific
   and Technological Development of BrazilNational Council for Scientific
   and Technological Development (CNPq)
FX This study was supported by grants NEI-K12EY015398-10 and R01-EY025287
   from the National Institutes of Health, Hope for Vision, the Foundation
   Fighting Blindness, the Pennsylvania Lions Sight Conservation, and the
   National Council for Scientific and Technological Development of Brazil.
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Bonafede L, 2015, INVEST OPHTH VIS SCI, V56, P7875, DOI 10.1167/iovs.15-17857
   Cideciyan AV, 2013, HUM GENE THER, V24, P993, DOI 10.1089/hum.2013.153
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   Drasdo N, 2007, VISION RES, V47, P2901, DOI 10.1016/j.visres.2007.01.007
   Dubis AM, 2012, ARCH OPHTHALMOL-CHIC, V130, P1291, DOI 10.1001/archophthalmol.2012.2270
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Hendrickson A, 2006, EXP EYE RES, V83, P920, DOI 10.1016/j.exer.2006.04.017
   Henry CR, 2017, JAMA OPHTHALMOL, V135, P386, DOI 10.1001/jamaophthalmol.2017.0098
   Huang YJ, 1998, INVEST OPHTH VIS SCI, V39, P2405
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P946, DOI 10.1001/jamaophthalmol.2016.1307
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Maldonado RS, 2011, OPHTHALMOLOGY, V118, P2315, DOI 10.1016/j.ophtha.2011.05.028
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Ostergaard P, 2012, AM J HUM GENET, V90, P356, DOI 10.1016/j.ajhg.2011.12.018
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Provis JM, 2013, PROG RETIN EYE RES, V35, P63, DOI 10.1016/j.preteyeres.2013.01.005
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vajzovic L, 2012, AM J OPHTHALMOL, V154, P779, DOI 10.1016/j.ajo.2012.05.004
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wong Chee Wai, 2019, Retin Cases Brief Rep, V13, P171, DOI 10.1097/ICB.0000000000000552
   World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 47
TC 17
Z9 17
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD OCT
PY 2017
VL 135
IS 10
BP 1069
EP 1076
DI 10.1001/jamaophthalmol.2017.3292
PG 8
WC Ophthalmology
SC Ophthalmology
GA FJ6LL
UT WOS:000412869200016
PM 28880978
OA Green Published
DA 2020-07-08
ER

PT J
AU Capiz, D
   Grossniklaus, HE
   Yeh, S
AF Capiz, Daniel
   Grossniklaus, Hans E.
   Yeh, Steven
TI Pathogenesis of Ocular Findings in Congenital Zika Syndrome
SO JAMA OPHTHALMOLOGY
LA English
DT Editorial Material
C1 [Capiz, Daniel; Grossniklaus, Hans E.; Yeh, Steven] Emory Univ, Sch Med, Dept Ophthalmol, 1365 Clifton Rd NE, Atlanta, GA 30322 USA.
RP Grossniklaus, HE (corresponding author), Emory Univ, Sch Med, Dept Ophthalmol, 1365 Clifton Rd NE, Atlanta, GA 30322 USA.
EM ophtheg@emory.edu
CR Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Baud D, LANCET
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Marquezan MC, SURV OPHTHALMOL
   Pardigon N., TRANSFUS CLIN BIOL
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Ventura LO, J AAPOS
   Vercosa I, J AAPOS
NR 8
TC 0
Z9 0
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD OCT
PY 2017
VL 135
IS 10
BP 1077
EP 1077
DI 10.1001/jamaophthalmol.2017.3285
PG 1
WC Ophthalmology
SC Ophthalmology
GA FJ6LL
UT WOS:000412869200017
PM 28880974
DA 2020-07-08
ER

PT J
AU Dubaut, JP
   Higuita, NIA
   Quaas, AM
AF Dubaut, Jamie P.
   Higuita, Nelson I. Agudelo
   Quaas, Alexander M.
TI Impact of Zika virus for infertility specialists: current literature,
   guidelines, and resources
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Review
DE Zika; Sexual transmission; Reproduction; Infertility
ID VECTOR-BORNE TRANSMISSION; UPDATE INTERIM GUIDANCE; SEXUAL TRANSMISSION;
   UNITED-STATES; INFECTION; PREGNANCY; RNA; VACCINE; OUTBREAK; EXPOSURE
AB In the past 2 years, Zika virus has emerged from obscurity onto the world stage-traversing and transcending clinical specialties, basic science disciplines, and public health efforts. The spread of Zika virus has serious implications for the specialty of reproductive endocrinology and infertility. Our patients, practices, and labs-worldwide and specifically in the USA-have been impacted by this teratogenic, sexually transmitted, largely asymptomatic virus. While the World Health Organization's Public Emergency of International Concern designation has lapsed as major epidemics have subsided and understanding of risks is in part clarified, the acute and long-term threat to pregnant patients is not over. The risk of wider spread in the USA is not insignificant, the subtler and long-ranging consequences beyond microcephaly are not fully known, large geographic areas of risk still contain na < ve populations, and whether Zika will continue to be an intermittent risk in endemic areas is uncertain. Staying up to date with the burgeoning research on Zika virus is an important objective for the infertility specialist. Here, we review in detail the most relevant recent developments, discuss applicable guidelines, and propose strategies for contributing to a reduction in the risk and burden of Zika virus.
C1 [Dubaut, Jamie P.; Quaas, Alexander M.] Univ Oklahoma, Sect Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Hlth Sci Ctr, POB 26901,COMB 2400, Oklahoma City, OK 73126 USA.
   [Higuita, Nelson I. Agudelo] Univ Oklahoma, Infect Dis Sect, Dept Internal Med, Hlth Sci Ctr, Oklahoma City, OK 73014 USA.
RP Dubaut, JP (corresponding author), Univ Oklahoma, Sect Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Hlth Sci Ctr, POB 26901,COMB 2400, Oklahoma City, OK 73126 USA.
EM Jamie-Dubaut@ouhsc.edu
OI Peregrine, Jamie/0000-0001-6705-3957
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Agence de la Biomedicine, 2017, PROF REC ASS REPR PR
   Ahrens KA, 2017, MATERN CHILD HLTH J, V21, P982, DOI 10.1007/s10995-017-2275-2
   American Academy of Pediatrics, 2013, VACC SAF EX EV
   American College of Pediatricians, 2016, NEW CONC HUM PAP VAC
   American Congress of Obstetricians and Gynecologists, 2016, ZIK TOOLK
   American Society for Reproductive Medicine, 2016, GUID PROV CAR WOM ME
   [Anonymous], 2017, Am J Transplant, V17, P572, DOI 10.1111/ajt.14179
   [Anonymous], 2017, ZIK VIR COUNTR CLASS
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Awadh Asma, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.2fced6e886074f6db162a00d4940133b
   Bahamondes L, 2017, HUM REPROD, V32, P88, DOI 10.1093/humrep/dew310
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Belluck P, 2017, NY TIMES
   Benjamin I, 2017, FERTIL STERIL, V107, P1319, DOI 10.1016/j.fertnstert.2017.02.112
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bradt DL, 2017, J AM MOSQUITO CONTR, V33, P56, DOI 10.2987/16-6627.1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Byron K, 2017, J MED ETHICS, V43, P334, DOI 10.1136/medethics-2016-103862
   Centers for Disease Control and Prevention, 2016, UPD LAB GUID FREQ AS
   Centers for Disease Control and Prevention, 2017, CDC US ZIK PREGN REG
   Centers for Disease Control and Prevention, 2017, CDC ID POT RISK ZIK
   Centers for Disease Control and Prevention, 2017, TRIPL REAL TIM RT PC
   Centers for Disease Control and Prevention, 2017, MAPS ZIK US
   Centers for Disease Control and Prevention, 2016, ZIK WIDG
   Centers for Disease Control and Prevention, 2016, TEST ZIK VIR
   Centers for Disease Control and Prevention, 2017, ZIK VIR PRINT SOURC
   Centers for Disease Control and Prevention, 2017, CAS COUNTS US
   Centres for Disease Control and Prevention, 2017, WORLD MAP AR RISK ZI
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   COUSINS S, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J2654
   de Carvalho BR, 2016, J BRAS REPROD ASSIST, V20, P159, DOI 10.5935/1518-0557.20160034
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   de Souza MDB, 2016, J BRAS REPROD ASSIST, V20, P195, DOI 10.5935/1518-0557.20160038
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diniz D, 2017, J FAM PLAN REPROD H, V43, P80, DOI 10.1136/jfprhc-2016-101678
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dzieciolowska S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40067
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goldthwaite LM, 2016, CURR OPIN OBSTET GYN, V28, P499, DOI 10.1097/GCO.0000000000000323
   Gornet ME, 2016, SEMIN REPROD MED, V34, P285, DOI 10.1055/s-0036-1592312
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Greer SL, 2017, AM J PUBLIC HEALTH, V107, P861, DOI 10.2105/AJPH.2017.303772
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   HealthLandscape, 2017, ZIK MAPP TOOL
   HealthMap.org, 2017, 2016 ZIK OUTBR
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jimenez A, 2017, TRANSFUS MED REV, V31, P1, DOI 10.1016/j.tmrv.2016.08.001
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Leal WS, 2017, SCI REP-UK, V7, DOI 10.1038/srep42826
   Lehnert JD, 2017, J PUBLIC HEALTH MAN, V23, P608, DOI 10.1097/PHH.0000000000000537
   Leo P, 2017, ULTRASOUND OBST GYN, DOI [10.1002/uog.17404, DOI 10.1002/UOG.17404]
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   MotherToBaby, 2017, ZIK VIR PREGN
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oklahoma State Department of Health, 2016, ZIK OTH TRAV ASS ARB
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Oussayef NL, 2017, MMWR-MORBID MORTAL W, V65, P1482, DOI 10.15585/mmwr.mm6552e1
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Pan American Health Organization, 2017, COUNTR TERR AM CONF
   Panchaud A, 2016, LANCET INFECT DIS, V16, P995, DOI 10.1016/S1473-3099(16)30255-9
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pfaender S, 2017, VIRUS RES, V228, P58, DOI 10.1016/j.virusres.2016.11.025
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Richardson E, 2016, GLOB HEALTH-SCI PRAC, V4, P696, DOI 10.9745/GHSP-D-16-00282
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   SHEPARD TH, 1994, TERATOLOGY, V50, P97, DOI 10.1002/tera.1420500202
   Singh Tulika, 2017, Indian J Community Med, V42, P69, DOI 10.4103/0970-0218.205221
   Snopes.com, 2016, FACT CHECK ZIK MICR
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   U.S. Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   U.S. Food and Drug Administration, 2016, DON SCREEN REC RED R
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Washington CI, 2016, SEMIN REPROD MED, V34, P293, DOI 10.1055/s-0036-1592067
   Weisblum Y, 2017, J VIROL, V91, DOI [10.1128/jvi.01905-16, 10.1128/JVI.01905-16]
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WHO, 2016, PREV SEX TRANSM ZIK
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2016, WHO 1 EM COMM ZIK VI
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Wu D, 2016, J INFECTION, V73, P300, DOI 10.1016/j.jinf.2016.06.008
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zafer M, 2016, FERTIL STERIL, V105, P645, DOI 10.1016/j.fertnstert.2015.11.028
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
NR 129
TC 3
Z9 3
U1 0
U2 6
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD OCT
PY 2017
VL 34
IS 10
BP 1237
EP 1250
DI 10.1007/s10815-017-0988-1
PG 14
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA FJ3WL
UT WOS:000412663100002
PM 28687969
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Machado, MR
   Gonzalez, HC
   Pantano, S
AF Machado, Matias R.
   Gonzalez, Humberto C.
   Pantano, Sergio
TI MD Simulations of Viruslike Particles with Supra CG Solvation Affordable
   to Desktop Computers
SO JOURNAL OF CHEMICAL THEORY AND COMPUTATION
LA English
DT Article
ID SESBANIA-MOSAIC-VIRUS; MOLECULAR-DYNAMICS SIMULATIONS; LINEAR CONSTRAINT
   SOLVER; MULTIPLE TIME-STEP; DENGUE VIRUS; CRYOELECTRON MICROSCOPY;
   AQUEOUS SOLVATION; MESH EWALD; ZIKA VIRUS; MODELS
AB Viruses are tremendously efficient molecular devices that optimize the packing of genetic material using a minimalistic number of proteins to form a capsid or envelope that protects them from external threats, being also part of cell recognition, fusion, and budding machineries. Progress in experimental techniques has provided a large number of high resolution structures of viruses and viruslike particles (VLP), while molecular dynamics simulations may furnish lively and complementary insights on the fundamental forces ruling viral assembly, stability, and dynamics. However, the large size and complexity of these macromolecular assemblies pose significant computational challenges. Alternatively, Coarse-Grained (CG) methods, which resign atomistic resolution privileging computational efficiency, can be used to characterize the dynamics of VLPs. Still, the massive amount of solvent present in empty capsids or envelopes suggests that hybrid schemes keeping a higher resolution on regions of interest (i.e., the viral proteins and their surroundings) and a progressively coarser description on the bulk may further improve efficiency. Here we introduce a mesoscale explicit water model to be used in double- or triple-scale simulations in combination with popular atomistic parameters and the CG water used by the SIRAH force field. Simulations performed on VLPs of different sizes, along with a comprehensive analysis of the PDB, indicate that most of the VLPs so far reported are amenable to be handled on a GPU-accelerated desktop computer using this simulation scheme.
C1 [Machado, Matias R.; Gonzalez, Humberto C.; Pantano, Sergio] Inst Pasteur Montevideo, Biomol Simulat Grp, Mataojo 2020, Montevideo 11400, Uruguay.
RP Pantano, S (corresponding author), Inst Pasteur Montevideo, Biomol Simulat Grp, Mataojo 2020, Montevideo 11400, Uruguay.
EM spantano@pasteur.edu.uy
OI Machado, Matias Rodrigo/0000-0002-9971-4710
FU FOCEM (MERCOSUR Structural Convergence Fund ) [COF 03/11]; Brazilian
   Supercomputer Center Santos Dumont [VICBF1]
FX This work was partially funded by FOCEM (MERCOSUR Structural Convergence
   Fund), COF 03/11. M.R.M. and S.P. belong to the SNI program of ANII.
   Some of the Tesla K40c used for this research were donated by the NVIDIA
   Corporation. Simulations on the Zika Virus were partially conducted at
   the Brazilian Supercomputer Center Santos Dumont under the grant VICBF1.
CR Agirre J, 2013, J GEN VIROL, V94, P1058, DOI 10.1099/vir.0.048553-0
   Antosiewicz JM, 2011, MOL BIOSYST, V7, P2923, DOI 10.1039/c1mb05170a
   Ayton GS, 2010, BIOPHYS J, V99, P2757, DOI 10.1016/j.bpj.2010.08.018
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barrera EE, 2017, J MOL MODEL, V23, DOI 10.1007/s00894-017-3426-5
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Dans PD, 2010, J CHEM THEORY COMPUT, V6, P1711, DOI 10.1021/ct900653p
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Darre L, 2015, J CHEM THEORY COMPUT, V11, P723, DOI 10.1021/ct5007746
   Darre L, 2012, WIRES COMPUT MOL SCI, V2, P921, DOI 10.1002/wcms.1097
   Darre L, 2012, J CHEM THEORY COMPUT, V8, P3880, DOI 10.1021/ct3001816
   Darre L, 2010, J CHEM THEORY COMPUT, V6, P3793, DOI 10.1021/ct100379f
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Di Pasquale N, 2014, J COMPUT CHEM, V35, P1199, DOI 10.1002/jcc.23594
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Ferrarotti MJ, 2015, J CHEM THEORY COMPUT, V11, P139, DOI 10.1021/ct5007086
   Fogarty AC, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4921347
   Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014
   Gonzalez HC, 2013, J PHYS CHEM B, V117, P14438, DOI 10.1021/jp4079579
   Gulati A, 2016, VIROLOGY, V489, P34, DOI 10.1016/j.virol.2015.11.029
   Hagan MF, 2014, ADV CHEM PHYS, V155, P1
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b
   Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123
   Hsieh YC, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00085
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Ingolfsson HI, 2014, WIRES COMPUT MOL SCI, V4, P225, DOI 10.1002/wcms.1169
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kmiecik S, 2016, CHEM REV, V116, P7898, DOI 10.1021/acs.chemrev.6b00163
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kovalenko A, 2005, CHEMINFORM, V36
   Lardeux F, 2010, TROP MED INT HEALTH, V15, P1037, DOI 10.1111/j.1365-3156.2010.02573.x
   Lokesh GL, 2001, ARCH VIROL, V146, P209, DOI 10.1007/s007050170170
   Machado MR, 2016, BIOINFORMATICS, V32, P1568, DOI 10.1093/bioinformatics/btw020
   Machado MR, 2015, J CHEM THEORY COMPUT, V11, P5012, DOI 10.1021/acs.jctc.5b00575
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mansour AA, 2015, VACCINE, V33, P5890, DOI 10.1016/j.vaccine.2015.05.099
   Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224
   Marzinek JK, 2016, STRUCTURE, V24, P1410, DOI 10.1016/j.str.2016.05.014
   May ER, 2014, MOL SIMULAT, V40, P878, DOI 10.1080/08927022.2014.907899
   May ER, 2012, BIOPHYS J, V102, P606, DOI 10.1016/j.bpj.2011.12.016
   NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851
   Omelyan I, 2015, J CHEM THEORY COMPUT, V11, P1875, DOI 10.1021/ct5010438
   Omelyan I, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4848716
   Onufriev A., 2010, MODELING SOLVENT ENV, P127, DOI DOI 10.1002/9783527629251.CH6
   Pall S., 2014, SOLVING SOFTWARE CHA, P3
   PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693
   Perilla JR, 2015, CURR OPIN STRUC BIOL, V31, P64, DOI 10.1016/j.sbi.2015.03.007
   Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
   Reddy T, 2016, BBA-BIOMEMBRANES, V1858, P1610, DOI 10.1016/j.bbamem.2016.02.007
   Reddy T, 2016, STRUCTURE, V24, P375, DOI 10.1016/j.str.2015.12.011
   Reddy T, 2015, STRUCTURE, V23, P584, DOI 10.1016/j.str.2014.12.019
   Rey FA, 2013, NATURE, V497, P443, DOI 10.1038/497443a
   Riniker S, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739068
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Russo FB, 2017, BIOCHEM BIOPH RES CO, V492, P603, DOI 10.1016/j.bbrc.2017.01.074
   Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Sangita V, 2005, ACTA CRYSTALLOGR D, V61, P1406, DOI [10.1107/S0907444905024030, 10.1107/S090744905024030]
   Satheshkumar PS, 2005, J MOL BIOL, V353, P447, DOI 10.1016/j.jmb.2005.08.021
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Snijder J, 2013, NAT CHEM, V5, P502, DOI [10.1038/NCHEM.1627, 10.1038/nchem.1627]
   Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938
   Squires G, 2013, ACTA CRYSTALLOGR D, V69, P1026, DOI 10.1107/S0907444913004617
   Vaney MC, 2011, CELL MICROBIOL, V13, P1451, DOI 10.1111/j.1462-5822.2011.01653.x
   Yildiz I, 2011, CURR OPIN BIOTECH, V22, P901, DOI 10.1016/j.copbio.2011.04.020
   Zavadlav J, 2016, J CHEM THEORY COMPUT, V12, P4138, DOI 10.1021/acs.jctc.6b00536
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162
NR 72
TC 13
Z9 13
U1 0
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1549-9618
EI 1549-9626
J9 J CHEM THEORY COMPUT
JI J. Chem. Theory Comput.
PD OCT
PY 2017
VL 13
IS 10
BP 5106
EP 5116
DI 10.1021/acs.jctc.7b00659
PG 11
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA FJ7UR
UT WOS:000412965700042
PM 28876928
DA 2020-07-08
ER

PT J
AU Villamil-Gomez, WE
   Guijarro, E
   Castellanos, J
   Rodriguez-Morales, AJ
AF Villamil-Gomez, Wilmer E.
   Guijarro, Ezequiel
   Castellanos, Jaime
   Rodriguez-Morales, Alfonso J.
TI Congenital Zika syndrome with prolonged detection of Zika virus RNA
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Letter
C1 [Villamil-Gomez, Wilmer E.] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Atlantico, SUE Caribe, Programa Doctorado Med Trop, Barranquilla, Colombia.
   [Guijarro, Ezequiel] IPS Costa, Monteria, Cordoba, Colombia.
   [Castellanos, Jaime] Univ El Bosque, Grp Virol, Bogota, DC, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Grp Res, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Grp Res, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016; Castellanos, Jaime/W-2635-2019
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Castellanos,
   Jaime/0000-0003-1596-8383
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Paz-Bailey G, 2017, N ENGL J MED
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
NR 8
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD OCT
PY 2017
VL 95
BP 52
EP 54
DI 10.1016/j.jcv.2017.08.010
PG 3
WC Virology
SC Virology
GA FL4NX
UT WOS:000414208300011
PM 28866135
DA 2020-07-08
ER

PT J
AU Misyura, L
   Yerushalmi, GY
   Donini, A
AF Misyura, Lidiya
   Yerushalmi, Gil Y.
   Donini, Andrew
TI A mosquito entomoglyceroporin, Aedes aegypti AQP5, participates in water
   transport across the Malpighian tubules of larvae
SO JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE Mosquito; Water transport; Transcellular; Osmoregulation; Ion-selective
   microelectrode; Hemolymph
ID YELLOW-FEVER MOSQUITO; DROSOPHILA-MELANOGASTER; ANOPHELES-GAMBIAE; ANAL
   PAPILLAE; FUNCTIONAL-CHARACTERIZATION; MALARIA VECTOR; CHANNEL;
   AQUAPORIN; EXPRESSION; SECRETION
AB The mosquito Aedes aegypti is the primary vector for arboviral diseases such as Zika fever, dengue fever, chikungunya and yellow fever. The larvae reside in hypo-osmotic freshwater habitats, where they face dilution of their body fluids from osmotic influx of water. The Malpighian tubules help maintain ionic and osmotic homeostasis by removing excess water from the hemolymph; however, the transcellular pathway for this movement remains unresolved. Aquaporins are transmembrane channels thought to permit transcellular transport of water from the hemolymph into the Malpighian tubule lumen. Immunolocalization of A. aegypti aquaporin 5 (AaAQP5) revealed expression by Malpighian tubule principal cells of the larvae, with localization to both the apical and basolateral membranes. Knockdown of AaAQP5 with doubl-estranded RNA decreased larval survival, reduced rates of fluid, K+ and Na+ secretion by the Malpighian tubules, and reduced Cl- concentrations in the hemolymph. These findings indicate that AaAQP5 participates in transcellular water transport across the Malpighian tubules of larval A. aegypti where global AaAQP5 expression is important for larval survival.
C1 [Misyura, Lidiya; Yerushalmi, Gil Y.; Donini, Andrew] York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.
RP Donini, A (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.
EM adonini@yorku.ca
FU Natural Sciences and Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of Canada [355910-2013]
FX This study was funded by the Natural Sciences and Engineering Research
   Council of Canada (grant 355910-2013).
CR AITKEN THG, 1979, AM J TROP MED HYG, V28, P119, DOI 10.4269/ajtmh.1979.28.119
   Akhter H, 2017, COMP BIOCHEM PHYS A, V203, P144, DOI 10.1016/j.cbpa.2016.09.008
   Benoit JB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002517
   Beyenbach KW, 2011, ACTA PHYSIOL, V202, P387, DOI 10.1111/j.1748-1716.2010.02195.x
   Beyenbach KW, 2003, J EXP BIOL, V206, P3845, DOI 10.1242/jeb.00639
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BRADLEY TJ, 1989, AM J PHYSIOL, V257, pR1096
   BRADLEY TJ, 1987, ANNU REV ENTOMOL, V32, P439, DOI 10.1146/annurev.en.32.010187.002255
   Campbell EM, 2008, J COMP PHYSIOL B, V178, P935, DOI 10.1007/s00360-008-0288-2
   Chasiotis H, 2016, J EXP BIOL, V219, P1346, DOI 10.1242/jeb.134494
   Clark TM, 1996, J INSECT PHYSIOL, V42, P593, DOI 10.1016/0022-1910(95)00124-7
   Cymer F, 2010, BIOCHEMISTRY-US, V49, P279, DOI 10.1021/bi901660t
   Donini A, 2006, PHYSIOL BIOCHEM ZOOL, V79, P645, DOI 10.1086/501059
   Donini A, 2005, J EXP BIOL, V208, P603, DOI 10.1242/jeb.01422
   Drake LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep07795
   Drake LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015578
   Echevarria M, 2001, PFLUG ARCH EUR J PHY, V442, P27, DOI 10.1007/s004240000494
   Esquivel CJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1784
   Finn RN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8814
   Garcia F, 2001, J BIOL CHEM, V276, P12147, DOI 10.1074/jbc.M009403200
   Gonzales KK, 2015, PEERJ, V3, DOI 10.7717/peerj.938
   HEGARTY JL, 1992, J INSECT PHYSIOL, V38, P329, DOI 10.1016/0022-1910(92)90057-K
   Hendriks G, 2004, J BIOL CHEM, V279, P2975, DOI 10.1074/jbc.M310767200
   Jonusaite S, 2011, J COMP PHYSIOL B, V181, P343, DOI 10.1007/s00360-010-0526-2
   Kambara K, 2009, APPL ENTOMOL ZOOL, V44, P315, DOI 10.1303/aez.2009.315
   Kaufmann N, 2005, AM J PHYSIOL-CELL PH, V289, pC397, DOI 10.1152/ajpcell.00612.2004
   Kobayashi H, 2006, BRAIN RES, V1123, P12, DOI 10.1016/j.brainres.2006.09.066
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Liu K, 2016, BIOL CELL, V108, P294, DOI 10.1111/boc.201600030
   Liu K, 2011, P NATL ACAD SCI USA, V108, P6062, DOI 10.1073/pnas.1102629108
   Martini SV, 2004, ARCH INSECT BIOCHEM, V57, P133, DOI 10.1002/arch.20017
   Marusalin J, 2012, J COMP PHYSIOL B, V182, P1047, DOI 10.1007/s00360-012-0679-2
   Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s
   O'Connor KR, 2001, J EXP BIOL, V204, P367
   ODonnell MJ, 1996, J EXP BIOL, V199, P1163
   Overend G, 2015, INSECT BIOCHEM MOLEC, V67, P47, DOI 10.1016/j.ibmb.2015.05.007
   Petzel DH, 1999, J INSECT PHYSIOL, V45, P973, DOI 10.1016/S0022-1910(99)00076-1
   Pietrantonio PV, 2000, INSECT MOL BIOL, V9, P407, DOI 10.1046/j.1365-2583.2000.00201.x
   PRESTON GM, 1993, J BIOL CHEM, V268, P17
   Rueda LM, 2008, HYDROBIOLOGIA, V595, P477, DOI 10.1007/s10750-007-9037-x
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   SMITH BL, 1991, J BIOL CHEM, V266, P6407
   Smith PJS, 1999, MICROSC RES TECHNIQ, V46, P398, DOI 10.1002/(SICI)1097-0029(19990915)46:6<398::AID-JEMT8>3.0.CO;2-H
   STOBBART RH, 1971, J EXP BIOL, V54, P67
   Tomkowiak E., 2010, ADV CELL BIOL, V2, P91, DOI DOI 10.2478/v10052-010-0005-7
   Tsujimoto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075888
   Van Ekert E, 2016, INSECT BIOCHEM MOLEC, V77, P39, DOI 10.1016/j.ibmb.2016.07.010
   Weng XH, 2003, J EXP BIOL, V206, P2211, DOI 10.1242/jeb.00385
   Wigglesworth VB, 1933, J EXP BIOL, V10, P16
   WILLIAMS JC, 1983, J COMP PHYSIOL, V149, P511, DOI 10.1007/BF00690010
   WRIGHT PA, 1995, J EXP BIOL, V198, P273
   Yerushalmi GY, 2016, J INSECT PHYSIOL, V95, P89, DOI 10.1016/j.jinsphys.2016.09.006
   Yu MJ, 2001, J INSECT PHYSIOL, V47, P263, DOI 10.1016/S0022-1910(00)00084-6
NR 53
TC 6
Z9 6
U1 0
U2 17
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0022-0949
EI 1477-9145
J9 J EXP BIOL
JI J. Exp. Biol.
PD OCT 1
PY 2017
VL 220
IS 19
BP 3536
EP 3544
DI 10.1242/jeb.158352
PG 9
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA FI8GK
UT WOS:000412240500023
PM 28760831
OA Bronze
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Vaccine against Zika virus must remain a priority
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
NR 0
TC 2
Z9 2
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2017
VL 17
IS 10
BP 1003
EP 1003
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA FH5NI
UT WOS:000411213600004
PM 28948916
DA 2020-07-08
ER

PT J
AU van den Hurk, AF
   Hall-Mendelin, S
   Jansen, CC
   Higgs, S
AF van den Hurk, Andrew F.
   Hall-Mendelin, Sonja
   Jansen, Cassie C.
   Higgs, Stephen
TI Zika virus and Culex quinquefasciatus mosquitoes: a tenuous link
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID AEDES-AEGYPTI; COMPETENCE; AMERICA; RISK
C1 [van den Hurk, Andrew F.; Hall-Mendelin, Sonja] Queensland Govt, Dept Hlth, Publ Hlth Virol Forens & Sci Serv, Coopers Plains, Qld 4108, Australia.
   [Jansen, Cassie C.] Queensland Hlth, Metro North Publ Hlth Unit, Windsor, Qld, Australia.
   [Higgs, Stephen] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
RP van den Hurk, AF (corresponding author), Queensland Govt, Dept Hlth, Publ Hlth Virol Forens & Sci Serv, Coopers Plains, Qld 4108, Australia.
EM andrew.vandenhurk@health.qld.gov.au
RI Jansen, Cassie C/C-1465-2009; van den Hurk, Andrew/X-9831-2019
OI Jansen, Cassie C/0000-0002-0655-2725; van den Hurk,
   Andrew/0000-0001-6262-831X
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Baud D, 2017, LANCET
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Prada P, 2016, RES INDICATES ANOTHE
   Richard V, 2017, ACTA TROP, V173, P200, DOI 10.1016/j.actatropica.2017.04.036
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 21
TC 23
Z9 23
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2017
VL 17
IS 10
BP 1014
EP 1016
DI 10.1016/S1473-3099(17)30518-2
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA FH5NI
UT WOS:000411213600012
PM 28948917
OA Bronze
DA 2020-07-08
ER

PT J
AU Wiley, CA
   Chimelli, L
AF Wiley, Clayton A.
   Chimelli, Leila
TI Human Zika and West Nile virus neurological infections: What is the
   difference?
SO NEUROPATHOLOGY
LA English
DT Review
ID ENCEPHALITIS; RISK; TRANSMISSION; PERSISTENCE; EPIDEMIC; VIREMIA;
   BRAZIL; WOMEN
AB The recent epidemic of West Nile Virus (WNV) infection in the United States was associated with severe neurological disease in immunocompromised hosts, while the emergence of Zika virus infection in the Americas has been notable for an association with increased microcephaly in the fetuses of infected mothers. Rare autopsies of WNV infected humans have shown multiple organ involvement with a clear neurotropism. We have recently had the opportunity to examine the distribution of Zika virus in autopsies of newborns from infected pregnancies. While both viruses infect multiple organs, Zika appears to cause neurological disease in the fetus through two different mechanisms. Infection during the first trimester showed the potential to infect neural progenitor cells causing severe developmental abnormalities, while infection later in gestation was associated with meningeal infection and destructive ischemic lesions of the brain. Both viruses infect kidney tubules but Zika shares a prominent hepatotropism characteristic of other flaviviruses (e.g., Dengue). Limited transplacental Zika infection would be consistent with restriction to primary maternal infections with high viremia. In the absence of a vaccine, restriction of travel by immunosuppressed and pregnant non-immune individuals to endemic regions seems prudent.
C1 [Wiley, Clayton A.] Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St,Scaife Hall S-701, Pittsburgh, PA 15238 USA.
   [Chimelli, Leila] State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rio De Janeiro, Brazil.
RP Wiley, CA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St,Scaife Hall S-701, Pittsburgh, PA 15238 USA.
EM wileyca@upmc.edu
RI amsalu, ribka/G-8780-2019
CR Armah HB, 2007, BRAIN PATHOL, V17, P354, DOI 10.1111/j.1750-3639.2007.00080.x
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Bharucha T, 2016, NEUROPATH APPL NEURO, V42, P317, DOI 10.1111/nan.12326
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   Bissel SJ, 2015, J NEUROPATH EXP NEUR, V74, P767, DOI 10.1097/NEN.0000000000000215
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chimelli L, 2017, ACTA NEUROPATHOL
   DeSalvo D, 2004, TRANSPLANTATION, V77, P466, DOI 10.1097/01.TP.0000101434.98873.CB
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268
   Guarner J, 2004, HUM PATHOL, V35, P983, DOI 10.1016/j.humpath.2004.04.008
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kleinschmidt-DeMasters BK, 2004, ARCH NEUROL-CHICAGO, V61, P1210, DOI 10.1001/archneur.61.8.1210
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lopez M, 2010, FETAL DIAGN THER, V28, P1, DOI 10.1159/000309155
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Michielsen PP, 1999, ACTA GASTRO-ENT BELG, V62, P21
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Novak CM, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12615
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Petrovsky N, 2013, J VIROL, V87, P10324, DOI 10.1128/JVI.00480-13
   POGODINA VV, 1983, ARCH VIROL, V75, P71, DOI 10.1007/BF01314128
   Ratterree MS, 2004, J INFECT DIS, V189, P669, DOI 10.1086/381461
   Samuel CE, 2002, P NATL ACAD SCI USA, V99, P11555, DOI 10.1073/pnas.202448899
   Smith RD, 2004, HUM PATHOL, V35, P254, DOI 10.1016/j.humpath.2003.09.007
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522
NR 39
TC 3
Z9 3
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0919-6544
EI 1440-1789
J9 NEUROPATHOLOGY
JI Neuropathology
PD OCT
PY 2017
VL 37
IS 5
BP 393
EP 397
DI 10.1111/neup.12385
PG 5
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA FI6HY
UT WOS:000412096400002
PM 28493351
OA Bronze
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Human Zika and West Nile virus neurological infections
SO NEUROPATHOLOGY
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Wiley CA, 2017, NEUROPATHOLOGY
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, AM J REPROD IMMUNOL, V76, P97, DOI 10.1111/aji.12521
NR 3
TC 0
Z9 0
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0919-6544
EI 1440-1789
J9 NEUROPATHOLOGY
JI Neuropathology
PD OCT
PY 2017
VL 37
IS 5
BP 482
EP 482
DI 10.1111/neup.12400
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA FI6HY
UT WOS:000412096400014
PM 28707334
DA 2020-07-08
ER

PT J
AU Blanco, A
   Chen, L
AF Blanco, Ashley
   Chen, Lei
TI Zika Virus What Pediatric Emergency Medicine Physicians Need to Know
SO PEDIATRIC EMERGENCY CARE
LA English
DT Review
DE mosquito-borne infections; Zika
ID VACCINE DEVELOPMENT; CLINICAL-MANIFESTATIONS; EPIDEMIOLOGY; INFECTION;
   HISTORY
AB Zika virus is amosquito-borne Flavivirus. It has emerged as an important infectious agent in the recent past, mainly because of its teratogenic effects on the fetus. This reviewhighlights the epidemiology, diagnosis, and treatment of this emerging infection.
C1 [Blanco, Ashley; Chen, Lei] Yale Univ, Sch Med, Dept Pediat, Suite 1F,100 York St, New Haven, CT 06510 USA.
RP Chen, L (corresponding author), Yale Univ, Sch Med, Dept Pediat, Suite 1F,100 York St, New Haven, CT 06510 USA.
EM lei.chen@yale.edu
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   FRIEDRICH M, 2017, JAMA, V317, P246
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Koenig KL, 2016, WEST J EMERG MED, V17, P238, DOI 10.5811/westjem.2016.3.30188
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lin HH, 2017, J NURS RES, V25, P3, DOI 10.1097/jnr.0000000000000205
   Long D, 2016, J EMERG MED, V50, P832, DOI 10.1016/j.jemermed.2016.03.033
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Salam A. P, 2017, ANN INTERN MED
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Shastry Siri, 2016, Emerg Med Clin North Am, V34, pe25, DOI 10.1016/j.emc.2016.04.001
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
NR 20
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0749-5161
EI 1535-1815
J9 PEDIATR EMERG CARE
JI Pediatr. Emerg. Care
PD OCT
PY 2017
VL 33
IS 10
BP 694
EP 697
DI 10.1097/PEC.0000000000001270
PG 4
WC Emergency Medicine; Pediatrics
SC Emergency Medicine; Pediatrics
GA FI7YG
UT WOS:000412215500016
PM 28968305
DA 2020-07-08
ER

PT J
AU de Oliveira, S
   Villela, DAM
   Dias, FBS
   Moreira, LA
   de Freitas, RM
AF de Oliveira, Suellen
   Maciel Villela, Daniel Antunes
   Stehling Dias, Fernando Braga
   Moreira, Luciano Andrade
   de Freitas, Rafael Maciel
TI How does competition among wild type mosquitoes influence the
   performance of Aedes aegypti and dissemination of Wolbachia pipientis?
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ALBOPICTUS DIPTERA-CULICIDAE; RIO-DE-JANEIRO; INVASIVE MOSQUITO; ZIKA
   VIRUS; LARVAL COMPETITION; HABITAT SEGREGATION; ADULT SIZE; DENGUE;
   POPULATIONS; BRAZIL
AB Background
   Wolbachia has been deployed in several countries to reduce transmission of dengue, Zika and chikungunya viruses. During releases, Wolbachia-infected females are likely to lay their eggs in local available breeding sites, which might already be colonized by local Aedes sp. mosquitoes. Therefore, there is an urgent need to estimate the deleterious effects of intra and interspecific larval competition on mosquito life history traits, especially on the duration of larval development time, larval mortality and adult size.
   Methodology/principal findings
   Three different mosquito populations were used: Ae. aegypti infected with Wolbachia (wMelBr strain), wild Ae. aegypti and wild Ae. albopictus. A total of 21 treatments explored intra and interspecific larval competition with varying larval densities, species proportions and food levels. Each treatment had eight replicates with two distinct food levels: 0.25 or 0.50 g of Chitosan and fallen avocado leaves. Overall, overcrowding reduced fitness correlates of the three populations. Ae. albopictus larvae presented lower larval mortality, shorter development time to adult and smaller wing sizes than Ae. aegypti. The presence of Wolbachia had a slight positive effect on larval biology, since infected individuals had higher survivorship than uninfected Ae. aegypti larvae.
   Conclusions/significance
   In all treatments, Ae. albopictus outperformed both wild Ae. aegypti and the Wolbachia-infected group in larval competition, irrespective of larval density and the amount of food resources. The major force that can slow down Wolbachia invasion is the population density of wild mosquitoes. Given that Ae. aegypti currently dominates in Rio, in comparison with Ae. albopictus frequency, additional attention must be given to the population density of Ae. aegypti during releases to increase the likelihood of Wolbachia invasion.
C1 [de Oliveira, Suellen; de Freitas, Rafael Maciel] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Fiocruz RJ, Rio De Janeiro, Brazil.
   [Maciel Villela, Daniel Antunes] Fundacao Oswaldo Cruz, Fiocruz RJ, Programa Comp Cient, Rio De Janeiro, Brazil.
   [Stehling Dias, Fernando Braga] Fundacao Oswaldo Cruz, Fiocruz CE, Rio De Janeiro, Brazil.
   [Moreira, Luciano Andrade] Fundacao Oswaldo Cruz, Fiocruz MG, Inst Rene Rachou, Mosquitos Vetores Endossimbiontes & Interacao Pat, Rio De Janeiro, Brazil.
RP de Freitas, RM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Fiocruz RJ, Rio De Janeiro, Brazil.
EM freitas@ioc.fiocruz.br
RI Villela, Daniel/AAG-6445-2019
OI Villela, Daniel/0000-0001-8371-2959; Maciel-de-Freitas,
   Rafael/0000-0002-2198-6492
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [23038.007199/2012-17]; Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/110.168/2014]
FX We thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (grant number 23038.007199/2012-17) and Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (grant number
   E-26/110.168/2014) for funding RMF. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497
   Alto BW, 2015, J MED ENTOMOL, V52, P163, DOI 10.1093/jme/tju062
   Bagny Beilhe L, 2013, MED VET ENTOMOL, V27, P387, DOI 10.1111/j.1365-2915.2012.01062.x
   Bargielowski IE, 2015, INFECT GENET EVOL, V36, P456, DOI 10.1016/j.meegid.2015.08.016
   Bargielowski I, 2015, ANN ENTOMOL SOC AM, V108, P513, DOI 10.1093/aesa/sav037
   Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110
   Bargielowski IE, 2016, INSECT SCI, V23, P162, DOI 10.1111/1744-7917.12291
   Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   Breaux JA, 2012, ENT SOC ANN M JUN N
   BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1559-5
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   CLEMENTS NA, 1992, BIOL MOSQUITOES
   Consoli RAGB, PRINCIPAIS MOSQUITOS, V1
   Costanzo KS, 2005, J MED ENTOMOL, V42, P559, DOI 10.1603/0022-2585(2005)042[0559:ACAPOA]2.0.CO;2
   Cox J, 2007, AM J TROP MED HYG, V76, P820, DOI 10.4269/ajtmh.2007.76.820
   Daugherty MP, 2000, J MED ENTOMOL, V37, P364, DOI 10.1603/0022-2585(2000)037[0364:ICAARF]2.0.CO;2
   EDMAN JD, 1992, J MED ENTOMOL, V29, P1033
   Evans O, 2009, J EXP BIOL, V212, P1436, DOI 10.1242/jeb.028951
   Garcia GD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160196
   Gavotte L, 2010, J INVERTEBR PATHOL, V105, P341, DOI 10.1016/j.jip.2010.08.005
   Hancock PA, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0319-5
   Harbach R.E., 1980, TAXONOMISTS GLOSSARY
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8
   Hopperstad KA, 2016, J MED ENTOMOL, V53, P836, DOI 10.1093/jme/tjw050
   IRVINGBELL RJ, 1987, MED VET ENTOMOL, V1, P243, DOI 10.1111/j.1365-2915.1987.tb00350.x
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2
   Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301
   LIVDAHL TP, 1984, J ANIM ECOL, V53, P573, DOI 10.2307/4535
   Lord CC, 1998, J MED ENTOMOL, V35, P825, DOI 10.1093/jmedent/35.5.825
   Lounibos LP, 2002, J VECTOR ECOL, V27, P86
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Villela DAM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005682
   Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   Maciel-de-Freitas R, 2014, B WORLD HEALTH ORGAN, V92, P685, DOI 10.2471/BLT.13.119081
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202
   McIntyre GS, 2000, HEREDITY, V85, P480, DOI 10.1046/j.1365-2540.2000.00787.x
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61
   NASCI RS, 1994, J MED ENTOMOL, V31, P123, DOI 10.1093/jmedent/31.1.123
   NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P447
   Nuno RF, 2016, PLOS CURRENTS OUTBRE, V1
   O'Donnell DL, 2007, J MED ENTOMOL, V44, P984, DOI 10.1603/0022-2585(2007)44[984:COLFBO]2.0.CO;2
   O'Neal PA, 2013, J ANIM ECOL, V82, P256, DOI 10.1111/j.1365-2656.2012.02017.x
   PANT CP, 1973, J MED ENTOMOL, V10, P219, DOI 10.1093/jmedent/10.2.219
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Camara DCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157120
   Rasic G, 2015, EVOL APPL, V8, P901, DOI 10.1111/eva.12301
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Reiskind MH, 2010, BIOL INVASIONS, V12, P2319, DOI 10.1007/s10530-009-9646-6
   RIBEIRO JMC, 1986, AM NAT, V128, P513, DOI 10.1086/284584
   Ritchie SA, 2013, J MED ENTOMOL, V50, P624, DOI 10.1603/ME12201
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   Ross PA, 2014, AM J TROP MED HYG, V91, P198, DOI 10.4269/ajtmh.13-0576
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Suh E, 2013, J INVERTEBR PATHOL, V114, P173, DOI 10.1016/j.jip.2013.08.001
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355
   Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677
   Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Turley AP, 2009, PLOS NEGLECT TROP D, V3
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Yee DA, 2004, ANN ENTOMOL SOC AM, V97, P720, DOI 10.1603/0013-8746(2004)097[0720:IDIFBA]2.0.CO;2
NR 80
TC 8
Z9 8
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2017
VL 11
IS 10
AR e0005947
DI 10.1371/journal.pntd.0005947
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FL5JJ
UT WOS:000414271400024
PM 28991902
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McDonald, EM
   Duggal, NK
   Brault, AC
AF McDonald, Erin M.
   Duggal, Nisha K.
   Brault, Aaron C.
TI Pathogenesis and sexual transmission of Spondweni and Zika viruses
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MURINE MODEL; MOUSE MODEL; INFECTION; MICE; DISEASE; LEADS
AB The Spondweni serogroup of viruses (Flaviviridae, Flavivirus) is comprised of Spondweni virus (SPONV) and Zika virus (ZIKV), which are mosquito-borne viruses capable of eliciting human disease. Numerous cases of ZIKV sexual transmission in humans have been documented following the emergence of the Asian genotype in the Americas. The African ZIKV genotype virus was previously implicated in the first reported case of ZIKV sexual transmission. Reports of SPONV infection in humans have been associated with non-specific febrile illness, but no association with sexual transmission has been reported. In order to assess the relative efficiency of sexual transmission of different ZIKV strains and the potential capacity of SPONV to be sexually transmitted, viral loads in the male reproductive tract and in seminal fluids were assessed in interferon alpha/beta and -gamma. receptor deficient (AG129) mice. Male mice were inoculated subcutaneously with Asian genotype ZIKV strains PRVABC59 (Puerto Rico, 2015), FSS13025 (Cambodia, 2010), or P6-740 (Malaysia, 1966); African genotype ZIKV strain DakAr41524 (Senegal, 1984); or SPONV strain SAAr94 (South Africa, 1955). Infectious virus was detected in 60-72% of ejaculates collected from AG129 mice inoculated with ZIKV strains. In contrast, only 4% of ejaculates from SPONV-inoculated AG129 males were found to contain infectious virus, despite viral titers in the testes that were comparable to those of ZIKV-inoculated mice. Based on these results, future studies should be undertaken to assess the role of viral genetic determinants and host tropism that dictate the differential sexual transmission potential of ZIKV and SPONV.
C1 [McDonald, Erin M.; Duggal, Nisha K.; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging Zoonot Infect Dis, Ft Collins, CO 80521 USA.
RP Brault, AC (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging Zoonot Infect Dis, Ft Collins, CO 80521 USA.
EM abrault@cdc.gov
CR Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   CDC, LAB SAF WORK ZIK VIR
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   DRAPER C C, 1965, West Afr Med J, V14, P16
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   KOKERNOT R. H., 1957, S AFRICAN JOUR MED SCI, V22, P103
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   McINTOSH B. M., 1961, S AFRICAN MED JOUR, V35, P647
   Milligan GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125476
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarathy VV, 2015, J VIROL, V89, P1254, DOI 10.1128/JVI.01320-14
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   WOLFE MS, 1982, LANCET, V2, P1306
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 32
TC 17
Z9 18
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2017
VL 11
IS 10
AR e005990
DI 10.1371/journal.pntd.0005990
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FL5JJ
UT WOS:000414271400048
PM 28985234
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nazerai, L
   Scholler, AS
   Buus, S
   Buus, AS
   Christensen, JP
   Thomsen, AR
AF Nazerai, Loulieta
   Scholler, Amalie Skak
   Buus, Soren
   Buus, Anette Stryhn
   Christensen, Jens Peter
   Thomsen, Allan Randrup
TI Zika virus infection: a new in vivo model to define protective immunity
SO SCANDINAVIAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 44th Annual Meeting of the Scandinavian-Society-for-Immunology (SSI)
CY OCT 17-20, 2017
CL Stockholm, SWEDEN
SP Scandinavian Soc Immunol
C1 [Nazerai, Loulieta; Scholler, Amalie Skak; Buus, Soren; Buus, Anette Stryhn; Christensen, Jens Peter; Thomsen, Allan Randrup] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark.
RI Christensen, Jan/I-4782-2017
OI Christensen, Jan/0000-0002-4299-9479; Stryhn,
   Anette/0000-0002-4581-3553; Thomsen, Allan Randrup/0000-0002-2392-9803;
   Nazerai, Loulieta/0000-0002-1090-9029
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-9475
EI 1365-3083
J9 SCAND J IMMUNOL
JI Scand. J. Immunol.
PD OCT
PY 2017
VL 86
IS 4
MA A-31425
BP 287
EP 288
PG 2
WC Immunology
SC Immunology
GA FI3LZ
UT WOS:000411865200096
DA 2020-07-08
ER

PT J
AU Oikkonen, V
AF Oikkonen, Venla
TI Affect, technoscience and textual analysis: Interrogating the affective
   dynamics of the Zika epidemic through media texts
SO SOCIAL STUDIES OF SCIENCE
LA English
DT Article
DE affect; emerging infectious diseases; emotion; epidemics; media;
   microcephaly; qualitative methods; Zika
ID SCIENCE; REPRESENTATIONS; NARRATIVES; COVERAGE; POLITICS; RESPONSES;
   STORIES; ECONOMY; CLONING
AB Science and Technology Studies has become increasingly interested in the roles of affect and emotions in science and technology. Researchers have examined, for example, emotions in the production of scientific knowledge, patients' or users' affective experiences of technologies, and emotionally charged cultural representations of science. However, less attention has been paid to the underlying affective dynamics that connect these sites, experiences and representations. This article builds on the premises that, first, unpacking these underlying affective dynamics is pivotal to understanding emerging technoscientific phenomena, and, second, that such affective dynamics often need to be accessed through cultural texts such as media. This necessitates developing tools of textual analysis that can capture cultural emotions, affective intensities and the tensions and resonances that arise when affective intensities and culturally circulating emotions become entangled. To this end, the article develops methods of textual analysis through a case study: the affective dynamics underlying the Zika epidemic. Focusing on the New York Times coverage of the epidemic, the article identifies affective concentrations centering on temporality, invisibility, and the dissolution of material boundaries. It shows that there are considerable tensions both within and between these concentrations, and that such tensions engender affective intensities and emotional investments. By combining discursive and non-discursive dimensions of the affective dynamic of Zika, the analysis contributes to the growing STS methodological literature on affect and emotion in technoscience.
C1 [Oikkonen, Venla] Univ Helsinki, Helsinki Coll Adv Studies, POB 4,Fabianinkatu 24, FIN-00014 Helsinki, Finland.
RP Oikkonen, V (corresponding author), Univ Helsinki, Helsinki Coll Adv Studies, POB 4,Fabianinkatu 24, FIN-00014 Helsinki, Finland.
EM venla.oikkonen@helsinki.fi
OI Oikkonen, Venla/0000-0001-8613-0428
CR Adams V, 2009, SUBJECTIVITY, V28, P246, DOI 10.1057/sub.2009.18
   Ahmed S., 2004, CULTURAL POLITICS EM
   [Anonymous], 2016, NY TIMES, pA28
   Barad K., 2007, M UNIVERSE HALFWAY Q
   Beer G., 2000, DARWINS PLOTS EVOLUT
   Belluck P., 2016, NY TIMES, pA1
   Belluck P, 2016, NY TIMES, pA9
   Belluck P, 2016, NY TIMES, pD1
   Berlant L, 2011, CRUEL OPTIMIS
   Blackman L., 2012, IMMATERIAL BODIES AF
   Clough PT, 2008, THEOR CULT SOC, V25, P1, DOI 10.1177/0263276407085156
   Cumming-Bruce N., 2016, NY TIMES
   Danet A, 2015, PUBLIC UNDERST SCI, V24, P641, DOI 10.1177/0963662513506144
   Davis Julie Hirschfeld, 2016, NY TIMES, pA15
   de la Bellacasa MP, 2015, SOC STUD SCI, V45, P691, DOI 10.1177/0306312715599851
   Dudo AD, 2007, SCI COMMUN, V28, P429, DOI 10.1177/1075547007302211
   Evensen DT, 2012, SCI COMMUN, V34, P392, DOI 10.1177/1075547011421020
   Franklin S, 2007, DOLLY MIXTURES REMAK
   Garrett L, 2016, NY TIMES, pC5
   Gillis J, 2016, NY TIMES, pA6
   Goodwin R, 2011, PUBLIC UNDERST SCI, V20, P477, DOI 10.1177/0963662510392484
   Han S, 2009, IMAGINING FETUS UNBO, P275
   Haran J, 2009, PUBLIC UNDERST SCI, V18, P634, DOI 10.1177/0963662509338324
   Hausman B L, 2000, NWSA J, V12, P114, DOI 10.2979/NWS.2000.12.3.114
   Hird MJ, 2009, ORIGINS OF SOCIABLE LIFE: EVOLUTION AFTER SCIENCE STUDIES, P1, DOI 10.1057/9780230242210
   Hoijer B, 2010, PUBLIC UNDERST SCI, V19, P717, DOI 10.1177/0963662509348863
   Hong H, 2015, PUBLIC UNDERST SCI, V24, P697, DOI 10.1177/0963662514544919
   Horst M, 2005, PUBLIC UNDERST SCI, V14, P185, DOI 10.1177/0963662505050994
   Horst M, 2007, SCI TECHNOL HUM VAL, V32, P150, DOI 10.1177/0162243906296852
   Hotez PJ., 2016, NY TIMES, pA19
   Hustak C, 2012, DIFFERENCES, V23, P74, DOI 10.1215/10407391-1892907
   Irni S, 2016, SIGNS, V41, P507, DOI 10.1086/684236
   Jacobs A, 2016, NY TIMES, pA4
   Jensen E, 2008, PUBLIC UNDERST SCI, V17, P123, DOI 10.1177/0963662506065874
   Joffe H, 2011, PUBLIC UNDERST SCI, V20, P446, DOI 10.1177/0963662510391604
   Joyce KA, 2008, MAGNETIC APPEAL MRI
   Kim J, 2009, PUBLIC UNDERST SCI, V18, P670, DOI 10.1177/0963662508096778
   Kimura AH, 2018, SCI CULT-UK, V27, P98, DOI 10.1080/09505431.2017.1325458
   Koppman S, 2015, SCI TECHNOL HUM VAL, V40, P30, DOI 10.1177/0162243914537527
   Kowal E, 2013, SOC STUD SCI, V43, P577, DOI 10.1177/0306312712471739
   Landecker H, 2016, BODY SOC, V22, P19, DOI 10.1177/1357034X14561341
   Levina M., 2015, PANDEMICS MEDIA
   Lorimer J, 2008, SOC STUD SCI, V38, P377, DOI 10.1177/0306312707084396
   Macur J, 2016, NY TIMES, pD1
   Mansfield B, 2017, SCI CULTURE, DOI [10.1080/09505431.2017.1294575, DOI 10.1080/09505431]
   Masco J, 2008, CULT ANTHROPOL, V23, P361, DOI 10.1111/j.1548-1360.2008.00012.x
   Massumi B., 2002, PARABLES VIRTUAL
   Mayor E, 2013, PUBLIC UNDERST SCI, V22, P1011, DOI 10.1177/0963662512443326
   McNeil DG, 2016, NY TIMES, pA7
   McNeil Jr DG, 2016, NY TIMES, pA3
   McNeil Jr DG, 2016, NY TIMES, pA14
   McNeil M., 2017, HDB SCI TECHNOLOGY S, P435
   McNeil M., 2007, FEMINIST CULTURAL ST
   Meskus M, 2015, EUR J WOMENS STUD, V22, P70, DOI 10.1177/1350506814530691
   Myers Natasha, 2015, RENDERING LIFE MOLEC
   Nading A.M., 2014, MOSQUITO TRAILS ECOL
   Oikkonen V, 2015, SIGNS, V40, P747, DOI 10.1086/679527
   Oikkonen Venla, 2013, GENDER SEXUALITY REP
   Osterholm MT, 2016, NY TIMES, pSR5
   Oudshoorn N, 2015, SOC STUD SCI, V45, P56, DOI 10.1177/0306312714557377
   Palmer J, 2009, FEM THEOR, V10, P173, DOI 10.1177/1464700109104923
   Parker JN, 2012, AM SOCIOL REV, V77, P21, DOI 10.1177/0003122411433763
   Pedwell C, 2014, THINK GENDER TRANSNA, P1, DOI 10.1057/9781137275264
   Pickersgill M, 2012, SCI TECHNOL HUM VAL, V37, P579, DOI 10.1177/0162243911433057
   Prasad A, 2005, SCI TECHNOL HUM VAL, V30, P291, DOI 10.1177/0162243904271758
   Protevi John., 2009, POLITICAL AFFECT CON
   Rabin RC, 2016, NY TIMES, pA1
   Ramzy A, 2016, NY TIMES, pA12
   Rees A, 2007, SOC STUD SCI, V37, P881, DOI 10.1177/0306312707077368
   Roche JP, 2003, SCI COMMUN, V24, P353, DOI 10.1177/1075547002250300
   Romero S, 2016, NY TIMES
   Romero S, 2015, NY TIMES, pA1
   Roof J., 1996, COME YOU ARE SEXUALI
   Roof Judith, 2007, THE POETICS OF DNA
   Santora M, 2016, NY TIMES, pA15
   Santora M, 2016, NY TIMES, pA16
   Schell H, 1997, CONFIGURATIONS, V5, P93, DOI 10.1353/con.1997.0006
   Sleenhoff S, 2015, PUBLIC UNDERST SCI, V24, P858, DOI 10.1177/0963662513517071
   Stacey J., 2010, CINEMATIC LIFE GENE
   Tavernise S, 2016, NY TIMES, pA10
   Tavernise S, 2016, NY TIMES, pA1
   TREICHLER PA, 1999, HAVE THEORY EPIDEMIC
   Turner SS, 2007, LIT MED, V26, P55, DOI 10.1353/lm.2008.0007
   Valiverronen E, 2004, PUBLIC UNDERST SCI, V13, P363, DOI 10.1177/0963662504046635
   Van Dijck J, 1998, IMAGENATION POPULAR
   Wald P, 2008, CONTAGIOUS CULTURES
   Washer P., 2010, EMERGING INFECT DIS
NR 87
TC 5
Z9 5
U1 5
U2 11
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0306-3127
EI 1460-3659
J9 SOC STUD SCI
JI Soc. Stud. Sci.
PD OCT
PY 2017
VL 47
IS 5
BP 681
EP 702
DI 10.1177/0306312717723760
PG 22
WC History & Philosophy Of Science
SC History & Philosophy of Science
GA FK0IJ
UT WOS:000413163200005
PM 28782432
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Cuypers, L
   Libin, P
   Abecasis, A
   Vandamme, AM
   Theys, K
AF Cuypers, L.
   Libin, P.
   Abecasis, A.
   Vandamme, A. -M.
   Theys, K.
TI Zika virus genetic diversity and selective pressure: importance for
   diagnostics, vaccines and therapeutics
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Cuypers, L.; Libin, P.; Vandamme, A. -M.; Theys, K.] KU Leuven Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium.
   [Libin, P.] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Lab, Brussels, Belgium.
   [Abecasis, A.; Vandamme, A. -M.] Univ Nova Lisboa, Inst Hyg & Trop Med, Ctr Global Hlth & Trop Med, Lisbon, Portugal.
RI Vandamme, Anne-Mieke/I-4127-2012; Abecasis, Ana B/B-6295-2009
OI Vandamme, Anne-Mieke/0000-0002-6594-2766; Abecasis, Ana
   B/0000-0002-3903-5265
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 1S4.3
BP 9
EP 9
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900017
DA 2020-07-08
ER

PT J
AU Cnops, L
   Nakayama, EE
   Caron, E
   Eggermont, K
   Van Esbroeck, M
   Bottieau, E
   Jacobs, J
   Shioda, T
   Huits, R
AF Cnops, L.
   Nakayama, E. E.
   Caron, E.
   Eggermont, K.
   Van Esbroeck, M.
   Bottieau, E.
   Jacobs, J.
   Shioda, T.
   Huits, R.
TI Detection of zika virus NS1 antigen in semen by a prototype rapid test
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Cnops, L.; Caron, E.; Eggermont, K.; Van Esbroeck, M.; Bottieau, E.; Jacobs, J.; Huits, R.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium.
   [Nakayama, E. E.; Shioda, T.] Osaka Univ, Microbial Dis Res Inst, MOCID, Osaka, Japan.
RI Huits, Ralph/I-8361-2019
OI Huits, Ralph/0000-0001-8803-9468
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 3S1.3
BP 27
EP 27
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900062
DA 2020-07-08
ER

PT J
AU Soriano-Arandes, A
   Lopez-Hortelano, MG
   Frick, MA
   Tato, LP
   Fumado, V
   Navarro, ML
   Sulleiro, E
   Martin-Nalda, A
   Mellado, MJ
   Soler-Palacin, P
AF Soriano-Arandes, A.
   Garcia Lopez-Hortelano, M.
   Frick, M. A.
   Prieto Tato, L.
   Fumado, V.
   Navarro, M. L.
   Sulleiro, E.
   Martin-Nalda, A.
   Mellado, M. J.
   Soler-Palacin, P.
TI Epidemiological and clinical data of children exposed to zika virus
   registered in Spanish database - how often is microcephaly?
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Soriano-Arandes, A.; Frick, M. A.; Martin-Nalda, A.; Soler-Palacin, P.] Univ Hosp Vall dHebron, Vall dHebron Res Inst, Paediat Infect Dis & Immunodeficiencies Unit, Barcelona, Spain.
   [Garcia Lopez-Hortelano, M.; Mellado, M. J.] Hosp Univ Infantil La Paz, Dept Infect Dis & Trop Paediat, 2014 2016 CSUR Natl Reference Ctr Minist Hlth Imp, Madrid, Spain.
   [Prieto Tato, L.] Hosp Univ Getafe, Dept Paediat, Madrid, Spain.
   [Fumado, V.] Univ Hosp St Joan de Deu, Natl Referral Unit Trop Dis, Infect & Imported Dis, Barcelona, Spain.
   [Navarro, M. L.] Univ Complutense, Hosp Univ Gregorio Maranon, Pediat Infect Dis Unit, Madrid, Spain.
   [Sulleiro, E.] Univ Hosp Vall dHebron, Vall dHebron Res Inst, Dept Microbiol, Barcelona, Spain.
RI Arandes, Antonio Soriano/Q-3348-2016; Soriano-Arandes,
   Antoni/G-6851-2013
OI Arandes, Antonio Soriano/0000-0001-9613-7228; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 3S1.4
BP 28
EP 28
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900063
DA 2020-07-08
ER

PT J
AU Huits, R
   Van den Bossche, D
   Feyen, A
   Potters, I
   Lotgering, E
   Eggermont, K
   Cnops, L
   Jacobs, J
   Van Esbroeck, M
   Bottieau, E
AF Huits, R.
   Van den Bossche, D.
   Feyen, A.
   Potters, I.
   Lotgering, E.
   Eggermont, K.
   Cnops, L.
   Jacobs, J.
   Van Esbroeck, M.
   Bottieau, E.
TI Incidence of travel-associated zika virus infection in 2016: preliminary
   results of a prospective cohort study in Belgian travellers to the
   Americas
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Huits, R.; Van den Bossche, D.; Feyen, A.; Potters, I.; Lotgering, E.; Eggermont, K.; Cnops, L.; Jacobs, J.; Van Esbroeck, M.; Bottieau, E.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium.
   [Jacobs, J.] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.
RI Potters, Idzi/N-7486-2019; Huits, Ralph/I-8361-2019
OI Potters, Idzi/0000-0001-7394-7033; Huits, Ralph/0000-0001-8803-9468
NR 0
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 3S1.6
BP 29
EP 29
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900065
DA 2020-07-08
ER

PT J
AU Lanko, K
   Kaptein, S
   Eggermont, K
   Patel, A
   Claes, C
   Guo, W
   Van Damme, P
   Van den Bosch, L
   Delang, L
   Verfaillie, C
   Neyts, J
AF Lanko, K.
   Kaptein, S.
   Eggermont, K.
   Patel, A.
   Claes, C.
   Guo, W.
   Van Damme, P.
   Van den Bosch, L.
   Delang, L.
   Verfaillie, C.
   Neyts, J.
TI Induced pluripotent stem cell-derived neuronal cultures as a model to
   study ZIKA virus infections and antivirals
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Lanko, K.; Kaptein, S.; Delang, L.; Neyts, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.
   [Eggermont, K.; Patel, A.; Claes, C.; Verfaillie, C.] Katholieke Univ Leuven, Stem Cell Inst, Leuven, Belgium.
   [Guo, W.; Van Damme, P.; Van den Bosch, L.] Katholieke Univ Leuven, Lab Neurobiol, Leuven, Belgium.
RI Neyts, Johan/U-8267-2017; Delang, Leen/D-9548-2018; Lanko, Kristina
   M/D-9579-2018; Kaptein, Suzanne JF/O-8855-2018
OI Neyts, Johan/0000-0002-0033-7514; Delang, Leen/0000-0002-8874-675X;
   Lanko, Kristina M/0000-0002-0749-0079; Kaptein, Suzanne
   JF/0000-0002-7935-0219
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 1P8
BP 117
EP 118
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900276
DA 2020-07-08
ER

PT J
AU Tricot, T
   Helsen, N
   Kaptein, S
   Neyts, J
   Verfaillie, C
AF Tricot, T.
   Helsen, N.
   Kaptein, S.
   Neyts, J.
   Verfaillie, C.
TI Human stem cell-derived hepatocyte-like cells support Zika virus
   replication and provide a relevant model to assess efficacy of potential
   antivirals
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Tricot, T.; Helsen, N.; Verfaillie, C.] Katholieke Univ Leuven, Stem Cell Inst, Dept Dev & Regenerat, Leuven, Belgium.
   [Kaptein, S.; Neyts, J.] Katholieke Univ Leuven, Rega Inst Med Res, Lab Virol & Expt Chemotherapy, Leuven, Belgium.
RI Neyts, Johan/U-8267-2017; Kaptein, Suzanne JF/O-8855-2018
OI Neyts, Johan/0000-0002-0033-7514; Kaptein, Suzanne
   JF/0000-0002-7935-0219
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 1P6
BP 117
EP 117
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900274
DA 2020-07-08
ER

PT J
AU Van den Bossche, D
   Foque, N
   Michiels, J
   Arien, KK
   Van Esbroeck, M
AF Van den Bossche, D.
   Foque, N.
   Michiels, J.
   Arien, K. K.
   Van Esbroeck, M.
TI Can a ZIKA IGM and IGG immunoblot replace the virus neutralisation test
   to confirm screening test results?
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Van den Bossche, D.; Foque, N.; Van Esbroeck, M.] Inst Trop Med, Dept Clin Sci, Natl Reference Ctr Arboviruses, Antwerp, Belgium.
   [Michiels, J.; Arien, K. K.] Inst Trop Med, Dept Biomed Sci, Virol Unit, Antwerp, Belgium.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 1P18
BP 122
EP 122
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900286
DA 2020-07-08
ER

PT J
AU Pou, D
   Sanchez-Montalva, A
   Sulleiro, E
   Salvador, F
   Bocanegra, C
   Trevino, B
   Rando, A
   Serre, N
   Molina, I
AF Pou, D.
   Sanchez-Montalva, A.
   Sulleiro, E.
   Salvador, F.
   Bocanegra, C.
   Trevino, B.
   Rando, A.
   Serre, N.
   Molina, I.
TI Zika virus dynamics in body fluids and risk of sexual trasmission in a
   non-endemic area
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Pou, D.; Sanchez-Montalva, A.; Salvador, F.; Bocanegra, C.; Trevino, B.; Serre, N.; Molina, I.] Vall dHebron Univ Hosp, Trop Med Unit, Dept Infect Dis, PROSICS, Barcelona, Spain.
   [Sulleiro, E.; Rando, A.] Vall dHebron Univ Hosp, Dept Microbiol, Barcelona, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 2P28
BP 154
EP 154
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900362
DA 2020-07-08
ER

PT J
AU Schwarz, NG
   Mertens, E
   Winter, D
   Maiga-Ascofare, O
   Dekker, D
   Jansen, S
   Tappe, D
   Randriamampionona, N
   May, J
   Rakotozandrindrainy, R
   Schmidt-Chanasit, J
AF Schwarz, N. G.
   Mertens, E.
   Winter, D.
   Maiga-Ascofare, O.
   Dekker, D.
   Jansen, S.
   Tappe, D.
   Randriamampionona, N.
   May, J.
   Rakotozandrindrainy, R.
   Schmidt-Chanasit, J.
TI Low probability for Zika virus (ZIKV) circulation in pregnant women from
   Madagascar in 2010 and evidence for cross-reactivity in malaria infected
   individuals leading to false positive anti-ZIKV IgG ELISA tests
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Schwarz, N. G.; Mertens, E.; Winter, D.; Maiga-Ascofare, O.; Dekker, D.; Jansen, S.; Tappe, D.; May, J.; Schmidt-Chanasit, J.] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Maiga-Ascofare, O.; Dekker, D.; May, J.] German Ctr Infect Res, Hamburg, Germany.
   [Maiga-Ascofare, O.] Kumasi Ctr Collaborat Res, Kumasi, Ghana.
   [Randriamampionona, N.; Rakotozandrindrainy, R.] Univ Antananarivo, Antananarivo, Madagascar.
RI Schwarz, Norbert G/C-8797-2012
OI Schwarz, Norbert G/0000-0002-8387-2837
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 3P13
BP 171
EP 172
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900404
DA 2020-07-08
ER

PT J
AU Sulleiro, E
   Romero, D
   Rando, A
   Moure, Z
   Suy, A
   Esperalba, J
   Moreno, R
   Rodo, C
   Espasa, M
   Sanchez-Seco, P
   Pumarola, T
AF Sulleiro, E.
   Romero, D.
   Rando, A.
   Moure, Z.
   Suy, A.
   Esperalba, J.
   Moreno, R.
   Rodo, C.
   Espasa, M.
   Sanchez-Seco, P.
   Pumarola, T.
TI Comparison of two Zika virus serological techniques and the influence of
   previous dengue infection for the screening of asymptomatic pregnant
   women in a reference centre in Barcelona
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Sulleiro, E.; Romero, D.; Rando, A.; Moure, Z.; Esperalba, J.; Moreno, R.; Espasa, M.; Pumarola, T.] Hosp Univ Vall dHebron, Serv Microbiol, Barcelona, Spain.
   [Suy, A.; Rodo, C.] Hosp Univ Vall dHebron, Serv Obstet, Barcelona, Spain.
   [Sanchez-Seco, P.] Inst Salud Carlos III, Area Virol, Madrid, Spain.
RI ESPASA, MATEU/L-4587-2014; RODO, CARLOTA/K-9179-2017; amsalu,
   ribka/G-8780-2019
OI ESPASA, MATEU/0000-0003-4822-1024; RODO, CARLOTA/0000-0001-8801-5677; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 3P18
BP 174
EP 174
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900409
DA 2020-07-08
ER

PT J
AU Cavalcanti, MG
   Pimenta, ES
   Roimicher, L
   Santana, LS
   Goncalves, JLS
   Cabral-Castro, MJ
   Peralta, JM
AF Cavalcanti, M. G.
   Pimenta, E. S.
   Roimicher, L.
   Santana, L. S.
   Goncalves, J. L. S.
   Cabral-Castro, M. J.
   Peralta, J. M.
TI Intra-articular virus RNA shedding in ZIKA virus (ZIKV) and Chikungunya
   virus (CHIKV) co-infection correlates with long-lasting infection,
   higher severity and systemic poor viral clearance
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Cavalcanti, M. G.; Pimenta, E. S.] Univ Fed Rio de Janeiro HUCFF UFRJ, Hosp Clementino Fraga Filho, Serv Doencas Infecciosas & Parasitarias, Rio De Janeiro, Brazil.
   [Cavalcanti, M. G.; Santana, L. S.; Goncalves, J. L. S.; Cabral-Castro, M. J.; Peralta, J. M.] Univ Fed Rio de Janeiro IMPG UFRJ, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
   [Roimicher, L.] Univ Fed Rio de Janeiro HUCFF UFRJ, Hosp Clementino Fraga Filho, Serv Reumatol, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 3P49
BP 187
EP 187
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900440
DA 2020-07-08
ER

PT J
AU Anfasa, F
   Widagdo, W
   Goeijenbier, M
   Siegers, JY
   Mumtaz, N
   Okba, N
   Victor, SR
   van Riel, D
   Koopmans, MPG
   Meijers, JCM
   Martina, BEE
AF Anfasa, F.
   Widagdo, W.
   Goeijenbier, M.
   Siegers, J. Y.
   Mumtaz, N.
   Okba, N.
   Victor, S. R.
   van Riel, D.
   Koopmans, M. P. G.
   Meijers, J. C. M.
   Martina, B. E. E.
TI Zika virus infection on human umbilical vein endothelial cells induces
   cell death and activation of secondary hemostasis
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Anfasa, F.; Widagdo, W.; Goeijenbier, M.; Siegers, J. Y.; Mumtaz, N.; Okba, N.; Victor, S. R.; van Riel, D.; Koopmans, M. P. G.; Martina, B. E. E.] Erasmus Univ, Dept Virosci, Med Ctr, Rotterdam, Netherlands.
   [Anfasa, F.] Univ Indonesia, Fac Med, Jakarta, Indonesia.
   [Meijers, J. C. M.] Sanquin Res, Dept Plasma Prot, Amsterdam, Netherlands.
   [Meijers, J. C. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, Amsterdam, Netherlands.
   [Martina, B. E. E.] Artemis One Hlth Res Inst, Utrecht, Netherlands.
RI Okba, Nisreen MA/K-9984-2017; Meijers, J.C.M./S-5981-2019
OI Okba, Nisreen MA/0000-0002-2394-1079; Meijers,
   J.C.M./0000-0002-4198-6780
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 3P60
BP 191
EP 192
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900451
DA 2020-07-08
ER

PT J
AU Rodo, C
   Soriano-Arandes, A
   Suy, A
   Sulleiro, E
   Garcia, I
   Frick, A
   Rando, A
   Arevalo, S
   Pumarola, T
   Carreras, E
AF Rodo, C.
   Soriano-Arandes, A.
   Suy, A.
   Sulleiro, E.
   Garcia, I.
   Frick, A.
   Rando, A.
   Arevalo, S.
   Pumarola, T.
   Carreras, E.
TI Epidemiological, microbiological and clinical data of traveller pregnant
   women returning from vector-borne endemic areas for Zika virus
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Rodo, C.; Suy, A.; Garcia, I.; Arevalo, S.; Carreras, E.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Obstet, Maternal Fetal Med Unit, Barcelona, Spain.
   [Soriano-Arandes, A.; Frick, A.] Hosp Univ Vall dHebron, Vall dHebron Res Inst, Paediat Infect Dis & Immunodeficiencies Unit, Barcelona, Spain.
   [Sulleiro, E.; Rando, A.; Pumarola, T.] Hosp Univ Vall dHebron, Dept Microbiol, Barcelona, Spain.
RI RODO, CARLOTA/K-9179-2017; Soriano-Arandes, Antoni/G-6851-2013; Arandes,
   Antonio Soriano/Q-3348-2016
OI RODO, CARLOTA/0000-0001-8801-5677; Arandes, Antonio
   Soriano/0000-0001-9613-7228
NR 0
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 3P79
BP 200
EP 200
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900470
DA 2020-07-08
ER

PT J
AU Sulleiro, E
   Rando, A
   Romero, D
   Esperalba, J
   Pou, D
   Montalva, AS
   Seco, MPS
   Suy, A
   Molina, I
   Pumarola, T
AF Sulleiro, E.
   Rando, A.
   Romero, D.
   Esperalba, J.
   Pou, D.
   Sanchez Montalva, A.
   Sanchez Seco, M. P.
   Suy, A.
   Molina, I.
   Pumarola, T.
TI Zika virus infection - the experience of a reference laboratory for its
   surveillance in Catalonia
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 3P90
BP 205
EP 205
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900481
DA 2020-07-08
ER

PT J
AU Kum, DB
   Mishra, N
   Schmid, MA
   Boudewijns, R
   Kaptein, S
   Neyts, J
   Dallmeier, K
AF Kum, D. Buh
   Mishra, N.
   Schmid, M. A.
   Boudewijns, R.
   Kaptein, S.
   Neyts, J.
   Dallmeier, K.
TI Full protection from fatal Zika virus infection by a novel chimeric
   live-attenuated Zika virus vaccine
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 KU Leuven Univ Leuven, Rega Inst Med Res, Lab Virol Antiviral Drug & Vaccine Dev, Leuven, Belgium.
   KU Leuven Univ Leuven, Leuven, Belgium.
RI Kaptein, Suzanne JF/O-8855-2018; Neyts, Johan/U-8267-2017
OI Kaptein, Suzanne JF/0000-0002-7935-0219; Neyts,
   Johan/0000-0002-0033-7514
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA LBS1.1
BP 346
EP 346
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900828
DA 2020-07-08
ER

PT J
AU De Pijper, CA
   Koens, G
   Schinkel, CJ
   Goorhuis, A
   Grobusch, MP
   Stijnis, C
AF De Pijper, C. A.
   Koens, G.
   Schinkel, C. J.
   Goorhuis, A.
   Grobusch, M. P.
   Stijnis, C.
TI 6 Risk of Zika virus infection in asymptomatic Dutch military personnel
   after deployment in high endemic areas
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [De Pijper, C. A.; Goorhuis, A.; Grobusch, M. P.; Stijnis, C.] Univ Amsterdam, Acad Med Ctr, Dept Infect Dis, Ctr Trop & Travel Med, Amsterdam, Netherlands.
   [Koens, G.; Schinkel, C. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol,Div Lab Specialism, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA LBP.23
BP 361
EP 361
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900863
DA 2020-07-08
ER

PT J
AU Ospina, J
   Hincapie-Palacio, D
   Ochoa, J
   Molina, A
   Rua, G
   Pajaro, D
   Arrubla, M
   Almanza, R
   Paredes, M
   Mubayi, A
AF Ospina, Juan
   Hincapie-Palacio, Doracelly
   Ochoa, Jesus
   Molina, Adriana
   Rua, Guillermo
   Pajaro, Duban
   Arrubla, Marcela
   Almanza, Rita
   Paredes, Marlio
   Mubayi, Anuj
TI Stratifying the potential local transmission of Zika in municipalities
   of Antioquia, Colombia
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE Zika; basic reproductive number; mathematical model; Colombia
ID VIRUS OUTBREAK; REPRODUCTION NUMBER; DENGUE TRANSMISSION; AMERICA;
   HISTORY
AB OBJECTIVE To stratify and understand the potential transmission processes of Zika virus in Colombia, in order to effectively address the efforts on surveillance and disease control.
   METHODS We compare R-0 of Zika for municipalities based on data from the regional surveillance system of Antioquia, Colombia. The basic reproduction number (R-0) and its 95% confidence intervals were estimated from an SIR model with implicit vector dynamics, in terms of recovered individuals in each time unit, using an approximate solution. These parameters were estimated fitting the solution of the model to the daily cumulative frequency of each Zika case according to symptoms onset date relative to the index case reported to the local surveillance system.
   RESULTS R-0 was estimated for 20 municipalities with a median of 30 000 inhabitants, all located less than 2200 m above sea level. The reported cases ranged from 17 to 347 between these municipalities within 4 months (January to April of 2016). The results suggest that 15 municipalities had a high transmission potential (R-0 > 1), whereas in five municipality transmissions were potentially not sustaining (R-0 < 1), although the upper bound of the confidence interval of the R-0 for 3 of these 5 was greater than one, indicating the possibility of an outbreak later on.
   CONCLUSION The study identified high-risk municipalities (R-0 > 1) and provide a technique to optimise surveillance and control of Zika. Health authorities should promote the collection, analysis, modelling and sharing of anonymous data onto individual cases to estimate R-0.
C1 [Ospina, Juan] Eafit Univ, Medellin, Colombia.
   [Hincapie-Palacio, Doracelly; Ochoa, Jesus; Molina, Adriana] Univ Antioquia, Natl Sch Publ Hlth, Epidemiol Grp, Medellin, Colombia.
   [Rua, Guillermo] Univ Antioquia, Fac Med, Grp Entomol, Medellin, Colombia.
   [Pajaro, Duban; Arrubla, Marcela] Secretary Reg Hlth & Social Protect Antioquia, Medellin, Colombia.
   [Almanza, Rita] Secretary Hlth, Medellin, Colombia.
   [Paredes, Marlio; Mubayi, Anuj] Arizona State Univ, Simon A Levin Math Computat & Modeling Sci Ctr, Tempe, AZ USA.
   [Paredes, Marlio] Univ Puerto Rico, Dept Math & Phys, Cayey, PR USA.
RP Hincapie-Palacio, D (corresponding author), Univ Antioquia, Natl Sch Publ Hlth, Epidemiol Grp, Medellin, Colombia.
EM doracely@gmail.com
RI Hincapie-Palacio, Doracelly/V-7486-2019
OI Hincapie-Palacio, Doracelly/0000-0002-7476-0411; Paredes,
   Marlio/0000-0002-9375-3743; Pajaro Cantillo, Duban
   Enrique/0000-0002-3728-8699; Ochoa, Jesus/0000-0001-9132-2328; Ospina,
   Juan/0000-0002-1968-4196
FU University of Antioquia
FX We gratefully acknowledge useful comments on earlier drafts by Gerardo
   Chowell, Georgia State University, and Francisco J. Diaz, University of
   Antioquia. This work was partially funded by University of Antioquia.
CR Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   BAILEY NTJ, 1957, MATH THEORY EPIDEMIC
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Boyer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091170
   Calle D, 2011, REV FAC NAC SALUD PU, V5, P77
   Chowell G, 2016, PLOS CURR, V31, P1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121
   Focks D, 2006, TDRIRMDEN06156
   Focks D., 2004, UNDP WORLD BANK WHO
   Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042
   Hsieh YH, 2017, PEERJ, V5, DOI 10.7717/peerj.3015
   Instituto Nacional de Salud, 2016, B EP SEM
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   King AA, 1806, P BIOL SCI, V2015
   Lee S, 2015, J THEOR BIOL, V374, P152, DOI 10.1016/j.jtbi.2015.03.005
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   *PAHO, 1994, DENG DENG HEM FEV AM
   Pandey A, 2013, MATH BIOSCI, V246, P252, DOI 10.1016/j.mbs.2013.10.007
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P1
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 28
TC 3
Z9 3
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
IS 10
BP 1249
EP 1265
DI 10.1111/tmi.12924
PG 17
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FI6PZ
UT WOS:000412120000004
PM 28686321
OA Bronze
DA 2020-07-08
ER

PT J
AU Segal, NL
AF Segal, Nancy L.
TI Twin Studies in Brazil: Projects and Plans / Twin Research: Infant
   Twins' Viewing of Social Scenes; Religiosity and Substance Abuse; Down
   Syndrome Among Twins; Twin Case of Chronic Periodontitis / In the News:
   The Twin 'Property Brothers', Twins With Cerebral Palsy; Twins Affected
   With the Zika Virus; Twin Writers Derek and Roddy; Twins on Sports
   Teams; Local Quads
SO TWIN RESEARCH AND HUMAN GENETICS
LA English
DT Editorial Material
ID RISK-FACTORS
C1 [Segal, Nancy L.] Calif State Univ Fullerton, Dept Psychol, Fullerton, CA 92834 USA.
RP Segal, NL (corresponding author), Calif State Univ Fullerton, Dept Psychol, Fullerton, CA 92834 USA.
EM nsegal@fullerton.edu
CR Barrionuevo Alexei, 2011, NY TIMES
   Belluck P., 2017, NY TIMES, VD1, P6
   Constantino JN, 2017, NATURE, V547, P340, DOI 10.1038/nature22999
   Ferreira PH, 2016, TWIN RES HUM GENET, V19, P687, DOI 10.1017/thg.2016.83
   Grech S., 2015, DENTISTRY 3000, V3, P1
   Lefkowitz A., 2017, BUZZ
   LYKKEN DT, 1993, J PERS SOC PSYCHOL, V65, P56, DOI 10.1037/0022-3514.65.1.56
   Martens MA, 2008, J CHILD PSYCHOL PSYC, V49, P576, DOI 10.1111/j.1469-7610.2008.01887.x
   Martin Joyce A, 2012, NCHS Data Brief, P1
   MICHALOWICZ BS, 1994, J PERIODONTOL, V65, P479, DOI 10.1902/jop.1994.65.5s.479
   Munro I., 2010, R WALCOTT LIT ENCY
   MURPHY MB, 1990, AM J MED GENET, P97
   Nedelec JL, 2017, J DRUG ISSUES, V47, P340, DOI 10.1177/0022042617693382
   Oliveira VC, 2015, SPINE J, V15, P50, DOI 10.1016/j.spinee.2014.06.021
   Otta E, 2016, TWIN RES HUM GENET, V19, P679, DOI 10.1017/thg.2016.75
   Peneira Cultural, 2017, MIL FACES GUIGNARD R
   Poetry Foundation, 2017, DER WALC
   Saldanha P.H., 1967, METODO GEMEOSPARA ME
   Saldanha P.H., 1980, GEMEOS HEREDITARIEDA
   Segal N. L., 2017, TWIN MYTHCONCEPTIONS
   Segal N. L., 2012, BORN TOGETHER REARED
   SEGAL NL, 1985, PSYCHOL TODAY, V19, P52
   Sparks TN, 2016, OBSTET GYNECOL, V128, P1127, DOI 10.1097/AOG.0000000000001690
   Tollanes MC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4294
   Villani-York M., 2009, THE RIVERDALE PRESS
   Whiting D., 2017, ORANGE COUNTY REGIST, P1
   Wikipedia, 2017, R WALCOTT
   Williams Syndrome Association, 2014, FREQ ASK QUEST WILL
NR 28
TC 0
Z9 0
U1 0
U2 5
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1832-4274
EI 1839-2628
J9 TWIN RES HUM GENET
JI Twin Res. Hum. Genet.
PD OCT
PY 2017
VL 20
IS 5
BP 481
EP 488
DI 10.1017/thg.2017.50
PG 8
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA FJ2YP
UT WOS:000412597600010
PM 28975876
OA Bronze
DA 2020-07-08
ER

PT J
AU Bulanova, D
   Ianevski, A
   Bugai, A
   Akimov, Y
   Kuivanen, S
   Paavilainen, H
   Kakkola, L
   Nandania, J
   Turunen, L
   Ohman, T
   Ala-Hongisto, H
   Pesonen, HM
   Kuisma, MS
   Honkimaa, A
   Walton, EL
   Oksenych, V
   Lorey, MB
   Guschin, D
   Shim, J
   Kim, J
   Than, TT
   Chang, SY
   Hukkanen, V
   Kulesskiy, E
   Marjomaki, VS
   Julkunen, I
   Nyman, TA
   Matikainen, S
   Saarela, JS
   Sane, F
   Hober, D
   Gabriel, G
   De Brabander, JK
   Martikainen, M
   Windisch, MP
   Min, JY
   Bruzzone, R
   Aittokallio, T
   Vaha-Koskela, M
   Vapalahti, O
   Pulk, A
   Velagapudi, V
   Kainov, DE
AF Bulanova, Daria
   Ianevski, Aleksandr
   Bugai, Andrii
   Akimov, Yevhen
   Kuivanen, Suvi
   Paavilainen, Henrik
   Kakkola, Laura
   Nandania, Jatin
   Turunen, Laura
   Ohman, Tiina
   Ala-Hongisto, Hanna
   Pesonen, Hanna M.
   Kuisma, Marika S.
   Honkimaa, Anni
   Walton, Emma L.
   Oksenych, Valentyn
   Lorey, Martina B.
   Guschin, Dmitry
   Shim, Jungmin
   Kim, Jinhee
   Than, Thoa T.
   Chang, So Young
   Hukkanen, Veijo
   Kulesskiy, Evgeny
   Marjomaki, Varpu S.
   Julkunen, Ilkka
   Nyman, Tuula A.
   Matikainen, Sampsa
   Saarela, Jani S.
   Sane, Famara
   Hober, Didier
   Gabriel, Guelsah
   De Brabander, Jef K.
   Martikainen, Miika
   Windisch, Marc P.
   Min, Ji-Young
   Bruzzone, Roberto
   Aittokallio, Tero
   Vaha-Koskela, Markus
   Vapalahti, Olli
   Pulk, Arto
   Velagapudi, Vidya
   Kainov, Denis E.
TI Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic
   Bcl-2 Proteins
SO VIRUSES-BASEL
LA English
DT Article
DE apoptosis; antiviral agent; innate immunity; host response
ID CHRONIC LYMPHOCYTIC-LEUKEMIA; ZIKA VIRUS-INFECTION; INFLUENZA-A;
   SYSTEMATIC ANALYSIS; GLOBAL BURDEN; CELLS; POTENT; SALIPHENYLHALAMIDE;
   TRANSCRIPTION; DISCOVERIES
AB Viral diseases remain serious threats to public health because of the shortage of effective means of control. To combat the surge of viral diseases, new treatments are urgently needed. Here we show that small-molecules, which inhibit cellular anti-apoptotic Bcl-2 proteins (Bcl-2i), induced the premature death of cells infected with different RNA or DNA viruses, whereas, at the same concentrations, no toxicity was observed in mock-infected cells. Moreover, these compounds limited viral replication and spread. Surprisingly, Bcl-2i also induced the premature apoptosis of cells transfected with viral RNA or plasmid DNA but not of mock-transfected cells. These results suggest that Bcl-2i sensitizes cells containing foreign RNA or DNA to apoptosis. A comparison of the toxicity, antiviral activity, and side effects of six Bcl-2i allowed us to select A-1155463 as an antiviral lead candidate. Thus, our results pave the way for the further development of Bcl-2i for the prevention and treatment of viral diseases.
C1 [Bulanova, Daria; Ianevski, Aleksandr; Akimov, Yevhen; Nandania, Jatin; Turunen, Laura; Kulesskiy, Evgeny; Saarela, Jani S.; Aittokallio, Tero; Vaha-Koskela, Markus; Velagapudi, Vidya; Kainov, Denis E.] Univ Helsinki, FIMM, Inst Mol Med Finland, FIN-00290 Helsinki, Finland.
   [Bugai, Andrii] Univ Helsinki, Dept Biochem & Dev Biol, FIN-00290 Helsinki, Finland.
   [Kuivanen, Suvi] Univ Helsinki, Dept Virol, Haartmaninkatu 3, FIN-00290 Helsinki, Finland.
   [Paavilainen, Henrik; Kakkola, Laura; Hukkanen, Veijo; Julkunen, Ilkka] Univ Turku, Dept Virol, FIN-20520 Turku, Finland.
   [Ohman, Tiina; Nyman, Tuula A.] Univ Helsinki, Inst Biotechnol, Valimotie 7, Helsinki 00014, Finland.
   [Ala-Hongisto, Hanna; Pesonen, Hanna M.; Kuisma, Marika S.] Biomed Funct Genom Unit FuGU, Helsinki 00290, Helsinki, Finland.
   [Honkimaa, Anni] Univ Tampere, Dept Virol, Tampere 33520, Finland.
   [Walton, Emma L.; Oksenych, Valentyn; Kainov, Denis E.] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, N-7028 Trondheim, Norway.
   [Lorey, Martina B.; Matikainen, Sampsa] Univ Helsinki, FIN-00290 Helsinki, Finland.
   [Lorey, Martina B.; Matikainen, Sampsa] Helsinki Univ Hosp, Rheumatol, Helsinki 00290, Finland.
   [Guschin, Dmitry; Shim, Jungmin; Kim, Jinhee; Than, Thoa T.; Chang, So Young; Windisch, Marc P.; Min, Ji-Young; Bruzzone, Roberto; Kainov, Denis E.] Inst Pasteur Korea, Gyeonggi Do 13488, South Korea.
   [Marjomaki, Varpu S.] Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, Jyvaskyla 40500, Finland.
   [Nyman, Tuula A.] Univ Oslo, Dept Immunol, N-0424 Oslo, Norway.
   [Sane, Famara; Hober, Didier] Univ Lille, CHU Lille, Lab Virol, EA3610, F-59037 Lille, France.
   [Gabriel, Guelsah] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany.
   [De Brabander, Jef K.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.
   [Martikainen, Miika] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, S-75237 Uppsala, Sweden.
   [Bruzzone, Roberto] Univ Hong Kong, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Hong Kong, Peoples R China.
   [Bruzzone, Roberto] Inst Pasteur, Dept Cell Biol & Infect, F-75015 Paris, France.
   [Vapalahti, Olli] Univ Helsinki, Dept Virol & Immunol, FIN-00014 Helsinki, Finland.
   [Vapalahti, Olli] Helsinki Univ Hosp, Helsinki 00014, Finland.
   [Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, FIN-00014 Helsinki, Finland.
   [Pulk, Arto; Kainov, Denis E.] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia.
RP Kainov, DE (corresponding author), Univ Helsinki, FIMM, Inst Mol Med Finland, FIN-00290 Helsinki, Finland.; Kainov, DE (corresponding author), Norwegian Univ Sci & Technol, Dept Clin & Mol Med, N-7028 Trondheim, Norway.; Kainov, DE (corresponding author), Inst Pasteur Korea, Gyeonggi Do 13488, South Korea.; Kainov, DE (corresponding author), Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia.
EM daria.bulanova@helsinki.fi; aleksandr.ianevski@helsinki.fi;
   andrii.bugai@helsinki.fi; yevhen.akimov@helsinki.fi;
   suvi.kuivanen@helsinki.fi; hojpaa@utu.fi; laura.kakkola@utu.fi;
   jatin.nandania@helsinki.fi; laura.turunen@helsinki.fi;
   tiina.ohman@helsinki.fi; hanna.ala-hongisto@helsinki.fi;
   hanna.m.pesonen@helsinki.fi; marika.kuisma@helsinki.fi;
   Anni.Honkimaa@uta.fi; emma.l.walton@ntnu.no; valentyn.oksenych@ntnu.no;
   martina.lorey@helsinki.fi; albanec2@gmail.com;
   jungmin.shim@ip-korea.org; jinhee.kim@ip-korea.org;
   thoa.than@ip-korea.org; soyoung.chang@ip-korea.org;
   veijo.hukkanen@utu.fi; evgeny.kulesskiy@helsinki.fi;
   varpu.s.marjomaki@jyu.fi; ilkka.julkunen@utu.fi;
   t.a.nyman@medisin.uio.no; sampsa.matikainen@helsinki.fi;
   jani.saarela@helsinki.fi; famara.sane@chru-lille.fr;
   didier.hober@chru-lille.fr; guelsah.gabriel@hpi.uni-hamburg.de;
   jef.debrabander@utsouthwestern.edu; miika.martikainen@igp.uu.se;
   marc.windisch@ip-korea.org; jiyoung.min@ip-korea.org;
   bruzzone@hkucc.hku.hk; tero.aittokallio@helsinki.fi;
   markus.vaha-koskela@helsinki.fi; olli.vapalahti@helsinki.fi;
   arto.pulk@ut.ee; vidya.velagapudi@helsinki.fi; denikaino@gmail.com
RI Guschin, Dmitry/O-7594-2018; Kainov, Denis/I-5526-2019; Guschin,
   Dmitry/U-3731-2019; Aittokallio, Tero/B-6583-2009; Bruzzone,
   Roberto/G-9355-2017; Lorey, Martina/AAK-4371-2020; Saarela,
   Jani/AAK-5033-2020; Velagapudi, Vidya/L-7278-2015; Oksenych,
   Valentyn/J-6216-2019; Bugai, Andrii/J-6674-2017
OI Guschin, Dmitry/0000-0002-4184-0001; Kainov, Denis/0000-0001-7716-6955;
   Guschin, Dmitry/0000-0002-4184-0001; Aittokallio,
   Tero/0000-0002-0886-9769; Bruzzone, Roberto/0000-0003-4373-1447; Lorey,
   Martina/0000-0001-5605-6714; Saarela, Jani/0000-0001-7306-7175;
   Velagapudi, Vidya/0000-0002-8261-7164; Oksenych,
   Valentyn/0000-0002-5088-3791; Bugai, Andrii/0000-0003-1920-6044; Chang,
   So Young/0000-0002-6390-6462; Pulk, Arto/0000-0001-8793-3038; Kakkola,
   Laura/0000-0001-9271-4059; Nyman, Tuula/0000-0001-8787-5886; Ianevski,
   Aleksandr/0000-0002-7780-482X; Marjomaki, Varpu/0000-0002-4592-5926;
   Ohman, Tiina/0000-0001-6647-8873; SANE, Famara/0000-0003-1972-9312;
   Vaha-Koskela, Markus/0000-0001-7764-7820; Vapalahti,
   Olli/0000-0003-2270-6824
FU JAMP;A Erkko foundation; European Regional Development FundEuropean
   Union (EU); Mobilitas Pluss Project [MOBTT39]; University of Helsinki
   [465/51/2014]; Academy of FinlandAcademy of Finland [SA259725]; Sigrid
   Juselius FoundationSigrid Juselius Foundation; Robert A. Welch
   FoundationThe Welch Foundation [I-1422]; University of Lille 2 [EA3610];
   CHRU Lille; BioAMP;Medical Technology Development Program of the NRF;
   Ministry of Science, ICT and Future Planning, Republic of Korea
   [1601-0302]; JAMP;A Erkko foundation; European Regional Development
   FundEuropean Union (EU); Mobilitas Pluss Project [MOBTT39]; University
   of Helsinki [465/51/2014]; Academy of FinlandAcademy of Finland
   [SA259725]; Sigrid Juselius FoundationSigrid Juselius Foundation; Robert
   A. Welch FoundationThe Welch Foundation [I-1422]; University of Lille 2
   [EA3610]; CHRU Lille; BioAMP;Medical Technology Development Program of
   the NRF; Ministry of Science, ICT and Future Planning, Republic of Korea
   [1601-0302]
FX We thank Michelle Becker and Dominic Roy at the Ottawa Hospital Research
   Institute for generating VA7-mCherry virus. We thank Maria Nurmi from
   the Institute for Molecular Medicine Finland (FIMM) High Throughput
   Biomedicine unit (HTB) for preparing pre-drugged assay plates and for
   assistance with the live cell microscopy. We thank Anirban Maitra from
   Anderson, USA, for the kind gift of pancreatic cancer cells Pa02C. This
   study was supported by the J&A Erkko foundation (to Denis E. Kainov.),
   the European Regional Development Fund, the Mobilitas Pluss Project
   MOBTT39 (to Denis E. Kainov), a University of Helsinki three-year
   research grant (No. 465/51/2014, to Denis E. Kainov), the Academy of
   Finland (grant No. SA259725 to Olli Vapalahti), the Sigrid Juselius
   Foundation (to Olli Vapalahti), the Robert A. Welch Foundation (grant
   No. I-1422, to Jef K. De Brabander), EA3610 University of Lille 2 and
   CHRU Lille grants (to Didier Hober), and the Bio&Medical Technology
   Development Program of the NRF, funded by the Ministry of Science, ICT
   and Future Planning, Republic of Korea (grant No. 1601-0302, to Ji-Young
   Min).
CR ALLEN DM, 1974, TECHNOMETRICS, V16, P125, DOI 10.2307/1267500
   Anastasina M, 2016, BBA-GENE REGUL MECH, V1859, P1440, DOI 10.1016/j.bbagrm.2016.09.005
   Ashkenazi A, 2017, NAT REV DRUG DISCOV, V16, P273, DOI 10.1038/nrd.2016.253
   Biacchesi S, 2005, J VIROL METHODS, V128, P192, DOI 10.1016/j.jviromet.2005.05.005
   Cummins NW, 2017, J VIROL, V91, DOI 10.1128/JVI.00012-17
   Cummins NW, 2016, J VIROL, V90, P4032, DOI 10.1128/JVI.03179-15
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17
   Denisova OV, 2012, J BIOL CHEM, V287, P35324, DOI 10.1074/jbc.M112.392142
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ebert G, 2015, P NATL ACAD SCI USA, V112, P5803, DOI 10.1073/pnas.1502400112
   Fu Y, 2016, ANTIVIR RES, V133, P23, DOI 10.1016/j.antiviral.2016.07.008
   Gaelings L, 2017, FEBS J, V284, P222, DOI 10.1111/febs.13966
   Gentile DA, 1997, J ALLERGY CLIN IMMUN, V99, P367
   Herold S, 2012, J LEUKOCYTE BIOL, V92, P75, DOI 10.1189/jlb.1011530
   HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994
   Kakkola L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.267
   Kim SH, 2016, CLIN INFECT DIS, V63, P363, DOI 10.1093/cid/ciw239
   Ko C, 2015, ANTIVIR THER, V20, P835, DOI 10.3851/IMP2965
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Kvansakul M, 2015, APOPTOSIS, V20, P136, DOI 10.1007/s10495-014-1051-7
   Lebreton S, 2008, BIOORG MED CHEM LETT, V18, P5879, DOI 10.1016/j.bmcl.2008.07.003
   Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178
   Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]
   Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642
   Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340
   Mansour DEAA, 2012, OPHTHALMIC RES, V48, P134, DOI 10.1159/000337138
   McLean JE, 2009, J VIROL, V83, P8233, DOI 10.1128/JVI.02672-08
   Michaelis M, 2009, INVEST OPHTH VIS SCI, V50, P5419, DOI 10.1167/iovs.09-3752
   Muller KH, 2011, BRIT J PHARMACOL, V164, P344, DOI 10.1111/j.1476-5381.2011.01346.x
   Nguyen ML, 2009, VIRUSES-BASEL, V1, P965, DOI 10.3390/v1030965
   Nygardas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064200
   Ohman T, 2010, J PROTEOME RES, V9, P1549, DOI 10.1021/pr901040u
   Ong JDH, 2017, J LEUKOCYTE BIOL, V101, P863, DOI 10.1189/jlb.4MR0616-288R
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Roberts AW, 2017, CLIN PHARMACOL THER, V101, P89, DOI 10.1002/cpt.553
   Ruokola P, 2014, J VIROL, V88, P8504, DOI 10.1128/JVI.03398-13
   Ryan J, 2013, METHODS, V61, P156, DOI 10.1016/j.ymeth.2013.04.006
   Saint-Marcoux F, 2009, CLIN PHARMACOKINET, V48, P667, DOI 10.2165/11317140-000000000-00000
   Samuel S, 2013, MOL THER, V21, P1413, DOI 10.1038/mt.2013.91
   Schneider J, 2009, J VIROL, V83, P701, DOI 10.1128/JVI.01858-08
   Shim JM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080223
   Singh N, 2002, CLIN SCI, V102, P595, DOI 10.1042/CS20010262
   Smura T, 2013, INFECT GENET EVOL, V16, P234, DOI 10.1016/j.meegid.2013.02.011
   Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048
   Subramanian T, 2015, VIROLOGY, V483, P21, DOI 10.1016/j.virol.2015.04.015
   Tao ZF, 2014, ACS MED CHEM LETT, V5, P1088, DOI 10.1021/ml5001867
   Tran AT, 2013, J VIROL, V87, P1049, DOI 10.1128/JVI.02017-12
   Vaha-Koskela MJV, 2003, J NEUROVIROL, V9, P1, DOI 10.1080/13550280390173382
   Vandenberg CJ, 2013, BLOOD, V121, P2285, DOI 10.1182/blood-2013-01-475855
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1
   Werner JL, 2014, J IMMUNOL, V193, P3842, DOI 10.4049/jimmunol.1400978
NR 53
TC 9
Z9 9
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2017
VL 9
IS 10
AR UNSP 271
DI 10.3390/v9100271
PG 15
WC Virology
SC Virology
GA FL9ZD
UT WOS:000414617500008
PM 28946654
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Kozak, RA
   Majer, A
   Biondi, MJ
   Medina, SJ
   Goneau, LW
   Sajesh, BV
   Slota, JA
   Zubach, V
   Severini, A
   Safronetz, D
   Hiebert, SL
   Beniac, DR
   Booth, TF
   Booth, SA
   Kobinger, GP
AF Kozak, Robert A.
   Majer, Anna
   Biondi, Mia J.
   Medina, Sarah J.
   Goneau, Lee W.
   Sajesh, Babu V.
   Slota, Jessy A.
   Zubach, Vanessa
   Severini, Alberto
   Safronetz, David
   Hiebert, Shannon L.
   Beniac, Daniel R.
   Booth, Timothy F.
   Booth, Stephanie A.
   Kobinger, Gary P.
TI MicroRNA and mRNA Dysregulation in Astrocytes Infected with Zika Virus
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; microRNA; human astrocytes; host response; pathogenesis;
   flavivirus
ID WEST-NILE-VIRUS; PLATELET-ACTIVATING-FACTOR; UNFOLDED PROTEIN RESPONSE;
   NEURAL PROGENITORS; GLIAL-CELLS; REPLICATION; INDUCTION; ORGANOIDS;
   GENES
AB The Zika virus (ZIKV) epidemic is an ongoing public health concern. ZIKV is a flavivirus reported to be associated with microcephaly, and recent work in animal models demonstrates the ability of the virus to cross the placenta and affect fetal brain development. Recent findings suggest that the virus preferentially infects neural stem cells and thereby deregulates gene expression, cell cycle progression, and increases cell death. However, neuronal stem cells are not the only brain cells that are susceptible to ZIKV and infection of other brain cells may contribute to disease progression. Herein, we characterized ZIKV replication in astrocytes, and profiled temporal changes in host microRNAs (miRNAs) and transcriptomes during infection. We observed the deregulation of numerous processes known to be involved in flavivirus infection, including genes involved in the unfolded protein response pathway. Moreover, a number of miRNAs were upregulated, including miR-30e-3p, miR-30e-5p, and, miR-17-5p, which have been associated with other flavivirus infections. This study highlights potential miRNAs that may be of importance in ZIKV pathogenesis.
C1 [Kozak, Robert A.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada.
   [Majer, Anna; Medina, Sarah J.; Slota, Jessy A.; Booth, Stephanie A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Mol Patho Biol, Winnipeg, MB R3E 3R2, Canada.
   [Majer, Anna; Hiebert, Shannon L.; Beniac, Daniel R.; Booth, Timothy F.] Publ Hlth Agcy Canada, Div Viral Dis, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada.
   [Biondi, Mia J.] Publ Hlth Agcy Canada, Special Pathogens Program, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada.
   [Goneau, Lee W.] Publ Hlth Ontario Lab, Med Microbiol, Toronto, ON M5G 1M1, Canada.
   [Sajesh, Babu V.] Canc Care Manitoba, Res Inst Oncol & Hematol, Winnipeg, MB R3E 0V9, Canada.
   [Zubach, Vanessa; Severini, Alberto] Publ Hlth Agcy Canada, Natl Microbiol Lab, Viral Exanthemata & STD, Winnipeg, MB R3E 3R2, Canada.
   [Safronetz, David] Publ Hlth Agcy Canada, Natl Microbiol Lab, Viral Zoonoses, Winnipeg, MB R3E 3R2, Canada.
   [Kobinger, Gary P.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Kobinger, Gary P.] Univ Laval, Infect Dis Res Ctr, Quebec City, PQ G1V 4G2, Canada.
RP Kobinger, GP (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.; Kobinger, GP (corresponding author), Univ Laval, Infect Dis Res Ctr, Quebec City, PQ G1V 4G2, Canada.
EM Rob.kozak@gmail.com; anna.majer@canada.ca; mia.biondi@mail.mcgill.ca;
   sarah.medina@canada.ca; Lee.goneau@oahpp.ca; bsajesh@cancercare.mb.ca;
   jessy.slota@canada.ca; vanessa.zubach@canada.ca;
   alberto.severini@canada.ca; david.safronetz@canada.ca;
   shannon.hiebert@canada.ca; daniel.beniac@canada.ca; tim.booth@canada.ca;
   stephanie.booth@canada.ca; gary.kobinger@crchudequebec.ulaval.ca
OI Slota, Jessy/0000-0002-9025-8368
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [143521]; Public Health Agency of Canada
FX The authors thank the members of the Viral Zoonoses group at the
   National Microbiology Laboratory for their technical assistance. We
   would like to thank the Rocky Mountain Laboratory for the Zika antibody
   used in this study and Kirk McManus for access to Imaris software. This
   work was supported by the Canadian Institutes of Health Research (grant
   #143521) and the Public Health Agency of Canada.
CR Ashraf U, 2016, J VIROL, V90, P4780, DOI 10.1128/JVI.02586-15
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bavia L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0541-3
   Bazan HEP, 2002, PROG RETIN EYE RES, V21, P449, DOI 10.1016/S1350-9462(02)00011-3
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bhattacharyya S, 2014, J GEN VIROL, V95, P71, DOI 10.1099/vir.0.057265-0
   Bomont P, 2005, EMBO J, V24, P3927, DOI 10.1038/sj.emboj.7600848
   Bracci-Laudiero L, 2003, J NEUROIMMUNOL, V136, P130, DOI 10.1016/S0165-5728(03)00007-9
   Casseb S. M., 2016, MOL RES GMR, V15, P1, DOI [10.4238/gmr.1502789127173348, DOI 10.4238/GMR.1502789127]
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cho H, 2013, J VIROL, V87, P8363, DOI 10.1128/JVI.01097-13
   Coarfa C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S2
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005
   Faul EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001016
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Majer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003002
   MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257
   Makkoch J, 2016, EXP BIOL MED, V241, P409, DOI 10.1177/1535370215611764
   McMahon M., 2017, AM J PHYSIOL-CELL PH, DOI [10.1152/ajpcell.00293.201628637678, DOI 10.1152/AJPCELL.00293.201628]
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nellimarla S, 2014, J INTERF CYTOK RES, V34, P419, DOI 10.1089/jir.2014.0002
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Ottino P, 2001, CURR EYE RES, V23, P77, DOI 10.1076/ceyr.23.2.77.5471
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Riehle K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S13-S11
   Sajesh BV, 2015, ONCOTARGET, V6, P27907, DOI 10.18632/oncotarget.4875
   Sarnow P, 2006, NAT REV MICROBIOL, V4, P651, DOI 10.1038/nrmicro1473
   Scagnolari C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-311
   Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606
   Slonchak A, 2016, J VIROL, V90, P2388, DOI 10.1128/JVI.02608-15
   Smith JL, 2017, J VIROL, V91, DOI 10.1128/JVI.02388-16
   So EY, 2006, GLIA, V53, P858, DOI 10.1002/glia.20346
   Tan CL, 2013, SCIENCE, V342, P1254, DOI 10.1126/science.1244193
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403
   Waters AM, 2015, J MED GENET, V52, P147, DOI 10.1136/jmedgenet-2014-102691
   Zhang WD, 2014, GENET MOL RES, V13, P1015, DOI 10.4238/2014.February.20.3
   Zhao MJ, 2015, MOL MED REP, V12, P3697, DOI 10.3892/mmr.2015.3828
   Zheng S, 2016, J MED VIROL, V88, P760, DOI 10.1002/jmv.24397
   Zheng ZH, 2013, J VIROL, V87, P5645, DOI 10.1128/JVI.02655-12
   Zhu X, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003088
NR 65
TC 15
Z9 15
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2017
VL 9
IS 10
AR 297
DI 10.3390/v9100297
PG 18
WC Virology
SC Virology
GA FL9ZD
UT WOS:000414617500034
PM 29036922
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sze, A
   Olagnier, D
   Bel Hadj, S
   Han, XY
   Tian, XH
   Xu, HT
   Yang, L
   Shi, QW
   Wang, PH
   Wainberg, MA
   Wu, JH
   Lin, RT
AF Sze, Alexandre
   Olagnier, David
   Bel Hadj, Samar
   Han, Xiaoying
   Tian, Xiao Hong
   Xu, Hong-Tao
   Yang, Long
   Shi, Qingwen
   Wang, Penghua
   Wainberg, Mark A.
   Wu, Jian Hui
   Lin, Rongtuan
TI Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA
   Polymerase Interference
SO VIRUSES-BASEL
LA English
DT Article
DE flavivirus; Zika virus; Dengue virus; antiviral; therapy; RNA polymerase
ID SOPHORA-FLAVESCENS; IN-VIVO; INHIBITORS; MECHANISMS
AB Flaviviruses including Zika, Dengue and Hepatitis C virus cause debilitating diseases in humans, and the former are emerging as global health concerns with no antiviral treatments. We investigated Sophora Flavecens, used in Chinese medicine, as a source for antiviral compounds. We isolated Sophoraflavenone G and found that it inhibited Hepatitis C replication, but not Sendai or Vesicular Stomatitis Virus. Pre- and post-infection treatments demonstrated anti-flaviviral activity against Dengue and Zika virus, via viral RNA polymerase inhibition. These data suggest that Sophoraflavenone G represents a promising candidate regarding anti-Flaviviridae research.
C1 [Sze, Alexandre; Olagnier, David; Bel Hadj, Samar; Han, Xiaoying; Tian, Xiao Hong; Xu, Hong-Tao; Wainberg, Mark A.; Wu, Jian Hui; Lin, Rongtuan] McGill Univ, Lady Davis Inst, Dept Med, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada.
   [Yang, Long; Wang, Penghua] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.
   [Shi, Qingwen] Hebei Med Univ, Sch Pharmaceut Sci, Shijiazhuang 050017, Hebei, Peoples R China.
RP Lin, RT (corresponding author), McGill Univ, Lady Davis Inst, Dept Med, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada.
EM alexandre.sze@mail.mcgill.ca; olagnier@biomed.au.dk;
   sbelhadj@jgh.mcgill.ca; xiaoying.han@mail.mcgill.ca;
   tianxiao037@gmail.com; hongtaoxu_00@yahoo.com; langyangrich@hotmail.com;
   shiqingwen@hebmu.edu.cn; penghua_wang@nymc.edu; mark.wainberg@mcgill.ca;
   Jian.h.wu@mcgill.ca; rongtuan.lin@mcgill.ca
RI wang, Penghua/AAL-4011-2020; lin, rongtuan/A-1442-2008
OI lin, rongtuan/0000-0002-2238-3503; Olagnier, David/0000-0001-6912-0674
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [MOP130401]; Peter Quinlan McGill Postdoctoral
   Fellowship; Fond de Recherche Sante Quebec (FRSQ) Fellowship award
FX The authors wish to thank Takaji Wakita (Tokyo Metropolitan Institute
   for Neuroscience, Toray Industries, Inc.) and David Safronetz (National
   Microbiology Laboratory, Public Health Agency of Canada) for kindly
   providing the pJFH1 plasmid and ZIKV, respectively. The authors also
   wish to thank John Hiscott (Pasteur Institute Rome) for sharing DENV as
   well as the mouse IgG2a mAb, specific for DENV and ZIKV envelope protein
   (clone 4G2). This research work was supported by Canadian Institutes of
   Health Research (MOP130401) to Rongtuan Lin. David Olagnier is supported
   by a Peter Quinlan McGill Postdoctoral Fellowship. Alexandre Sze is
   supported by a Fond de Recherche Sante Quebec (FRSQ) Fellowship award.
   The funders had no role in study design, data collection and
   interpretation, or the decision to submit the work for publication.
CR Azzam H. S., 2007, INT J INT ASS STUD L, V27, P17, DOI [10.1111/j.1478-3231.2006.01408.x 17241377, DOI 10.1111/J.1478-3231.2006.01408.X]
   Bharucha T, 2016, NEUROPATH APPL NEURO, V42, P317, DOI 10.1111/nan.12326
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen XS, 2001, WORLD J GASTROENTERO, V7, P49
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Gao Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020238
   He XR, 2015, J ETHNOPHARMACOL, V172, P10, DOI 10.1016/j.jep.2015.06.010
   Kim CS, 2013, ANAEROBE, V19, P17, DOI 10.1016/j.anaerobe.2012.11.003
   Li ZY, 2016, AM J CHINESE MED, V44, P165, DOI 10.1142/S0192415X16500117
   McCarthy M, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3097
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Shi Z, 2014, ACTA PHARMACOL SIN, V35, P248, DOI 10.1038/aps.2013.151
   Vescovo T, 2016, CLIN MICROBIOL INFEC, V22, P853, DOI 10.1016/j.cmi.2016.07.019
   Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu HT, 2016, ANTIMICROB AGENTS CH, V60, P600, DOI 10.1128/AAC.02203-15
NR 24
TC 2
Z9 2
U1 1
U2 2
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2017
VL 9
IS 10
AR 287
DI 10.3390/v9100287
PG 7
WC Virology
SC Virology
GA FL9ZD
UT WOS:000414617500024
PM 28972551
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU De Broucker, T
   Mailles, A
   Stahl, JP
AF De Broucker, Thomas
   Mailles, Alexandra
   Stahl, Jean-Paul
TI Neurological Presentation of Zika Virus Infection Beyond the Perinatal
   Period
SO CURRENT INFECTIOUS DISEASE REPORTS
LA English
DT Review
DE Zika; Arbovirus; Guillain-Barre syndrome; Encephalitis; Myelitis; Acute
   disseminated encephalomyelitis (ADEM)
ID GUILLAIN-BARRE-SYNDROME; PUERTO-RICO; TRANSMISSION; COLOMBIA; OUTBREAK;
   ENCEPHALITIS; AUTOIMMUNITY; MICRONESIA; EPIDEMIC; AMERICA
AB Purpose of Review Our purpose was to summarize the current knowledge about the neurological presentation of Zika virus infection after the perinatal period. Other Flaviviruses infections, such as West Nile virus (WNV) or Japanese encephalitis virus (JEV), can result in neuroinvasive disease such as myelitis, encephalitis, or meningitis. We aimed at describing the specificities of ZV neurological infection.
   Recent Findings The recent outbreaks demonstrated clearly the neurotropism of ZV. However, by contrast with other Flaviviruses, the most frequent neurological presentation of ZV infection beyond the perinatal period was Guillain-Barre syndrome, especially the demyelination form of GBS. Encephalitis and myelitis seem to occur less frequently after ZV infection than after WNV or JEV infection.
   Summary The pathophysiology of neurological ZV infections is still poorly understood and no specific treatment is available. Moreover, no data is available about long-termpersisting symptoms and possible impairment of patients after the acute clinical episode.
C1 [De Broucker, Thomas] Ctr Hosp St Denis, Neurol, F-93200 St Denis, France.
   [Mailles, Alexandra] Sante Publ France, F-94410 St Maurice, France.
   [Stahl, Jean-Paul] Univ Hosp, Infect Dis & Trop Med, F-38700 Grenoble, France.
RP Mailles, A (corresponding author), Sante Publ France, F-94410 St Maurice, France.
EM alexandra.mailles@santepubliquefrance.fr
RI Stahl, Jean Paul/AAM-6425-2020
OI Mailles, Alexandra/0000-0002-8739-1168; Stahl, Jean
   Paul/0000-0002-0086-3557
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   [Anonymous], 2017, LANCET, V389, P573, DOI 10.1016/S0140-6736(17)30325-2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Doughty CT, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0724-3
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Machado-Alba JE, 2016, INT J INFECT DIS, V51, P133, DOI 10.1016/j.ijid.2016.09.010
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grossi-Soyster EN, 2017, CURR OPIN PEDIATR, V29, P102, DOI 10.1097/MOP.0000000000000449
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Molko N, 2017, NEUROLOGY, V88, P1097, DOI 10.1212/WNL.0000000000003697
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Palacios E, 2019, NEUROLOGIA, V34, P204, DOI 10.1016/j.nrl.2016.08.006
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pastula DM, 2017, NEUROCRIT CARE, V26, P457, DOI 10.1007/s12028-016-0333-z
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Roth W, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000349
   Routhu NK, 2017, J NEUROIMMUNE PHARM, V12, P219, DOI 10.1007/s11481-017-9736-7
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Villamil-Gomez WE, 2017, TRAVEL MED INFECT DI, V16, P62, DOI 10.1016/j.tmaid.2017.03.012
   Watrin I., 2017, JOURNEES NEUROLOGIE
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   WHO, 2017, DIS OUTBREAK NE 0208
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organization, 2016, ZIK SIT REP ZIK POT
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 58
TC 6
Z9 6
U1 0
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1523-3847
EI 1534-3146
J9 CURR INFECT DIS REP
JI Curr. Infect. Dis. Rep.
PD OCT
PY 2017
VL 19
IS 10
AR 35
DI 10.1007/s11908-017-0590-9
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA FH4SH
UT WOS:000411150800003
PM 28815404
DA 2020-07-08
ER

PT J
AU Dempsey, LA
AF Dempsey, Laurie A.
TI Distinct Zika responses
SO NATURE IMMUNOLOGY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD OCT
PY 2017
VL 18
IS 10
BP 1067
EP 1067
DI 10.1038/s41564-017-0016-3
PG 1
WC Immunology
SC Immunology
GA FH4OF
UT WOS:000411134000006
PM 28926538
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Bloch, EM
AF Bloch, Evan M.
TI Residual risk of bacterial contamination: what are the options?
SO TRANSFUSION
LA English
DT Editorial Material
ID ZIKA VIRUS; TRANSFUSION; INTERVENTIONS; PLATELETS; SAFETY
C1 [Bloch, Evan M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
RP Bloch, EM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
EM ebloch2@jhmi.edu
RI Bloch, Evan/G-7676-2018
OI Bloch, Evan/0000-0001-8181-9517
CR [Anonymous], 2016, BACT RISK CONTR STRA
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Benjamin RJ, 2008, TRANSFUSION, V48, P2348, DOI 10.1111/j.1537-2995.2008.01853.x
   Blajchman MA, 2004, TRANSFUS MED REV, V18, P11, DOI 10.1016/j.tmrv.2003.10.002
   Butler C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009072.pub2
   de Korte D, 2002, VOX SANG, V83, P13, DOI 10.1046/j.1423-0410.2002.00189.x
   Ellingson KD, 2017, TRANSFUSION, V57, P1625, DOI 10.1111/trf.14164
   Fast LD, 2013, TRANSFUSION, V53, P373, DOI 10.1111/j.1537-2995.2012.03715.x
   Grass JA, 1999, BLOOD, V93, P3140
   Hassall O, 2009, TRANSFUSION, V49, P2594, DOI 10.1111/j.1537-2995.2009.02344.x
   Heaton WA, 2014, TRANSFUSION, V54, P1634, DOI 10.1111/trf.12603
   Hume HA, 2016, TRANSFUSION, V56, P1951, DOI 10.1111/trf.13594
   Jacobs MR, 2008, CLIN INFECT DIS, V46, P1214, DOI 10.1086/529143
   Larsen CP, 2005, VOX SANG, V88, P93, DOI 10.1111/j.1423-0410.2005.00596.x
   Li JW, 2017, TRANSFUSION, V57, P2321, DOI 10.1111/trf.14216
   McDonald CP, 2011, TRANSFUS MED HEMOTH, V38, P255, DOI 10.1159/000330474
   Mertens G, 1999, TRANSFUSION, V39, P539, DOI 10.1046/j.1537-2995.1999.39050539.x
   Mohr H, 2006, TRANSFUSION, V46, P41, DOI 10.1111/j.1537-2995.2005.00668.x
   Murphy WG, 2008, VOX SANG, V95, P13, DOI 10.1111/j.1423-0410.2008.01051.x
   Ramirez-Arcos S, 2017, TRANSFUSION, V57, P2174, DOI 10.1111/trf.14202
   US Food and Drug Administration, 2015, FAT REP FDA FOLL BLO
   Verax Biomedical, 2009, PLAT PGD TEST
   Vollmer Tanja, 2013, Methods Mol Biol, V943, P91, DOI 10.1007/978-1-60327-353-4_5
   Wald M., 2014, BLOOD IND SHRINKS TR
NR 24
TC 6
Z9 6
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD OCT
PY 2017
VL 57
IS 10
BP 2289
EP 2292
DI 10.1111/trf.14306
PG 4
WC Hematology
SC Hematology
GA FI2CD
UT WOS:000411743400001
PM 28944544
OA Bronze
DA 2020-07-08
ER

PT J
AU Li, JW
   Brecher, ME
   Jacobson, JL
   Harm, SK
   Chen, D
   El-Gamil, A
   Dobson, A
   Mintz, PD
AF Li, Justin W.
   Brecher, Mark E.
   Jacobson, Jessica L.
   Harm, Sarah K.
   Chen, Dorothy
   El-Gamil, Audrey
   Dobson, Al
   Mintz, Paul D.
TI Addressing the risk of bacterial contamination in platelets: a hospital
   economic perspective
SO TRANSFUSION
LA English
DT Article
ID ACTIVITY-BASED COSTS; PATHOGEN-REDUCTION; APHERESIS PLATELETS; CLINICAL
   EFFECTIVENESS; ADDITIVE SOLUTION; BLOOD COMPONENTS; SPRINT TRIAL;
   TRANSFUSION; INACTIVATION; SAFETY
AB BACKGROUNDBacterially contaminated platelets (PLTs) remain a serious risk. The Food and Drug Administration has issued draft guidance recommending hospitals implement secondary testing or transfuse PLTs that have been treated with pathogen reduction technology (PRT). The cost implications of these approaches are not well understood.
   STUDY DESIGN AND METHODSWe modeled incurred costs when hospitals acquire, process, and transfuse PLTs that are PRT treated with INTERCEPT (Cerus Corp.) or secondary tested with the PLT PGD Test (Verax Biomedical).
   RESULTSHospitals will spend $221.27 (30.0%) more per PRT-treated apheresis PLT unit administered compared to a Zika-tested apheresis PLT unit that is irradiated and PGD tested in hospital. This difference is reflected in PRT PLT units having: 1) a higher hospital purchase price ($100.00 additional charge compared to an untreated PLT); 2) lower therapeutic effectiveness than untreated PLTs among hematologic-oncologic patients, which contributes to additional transfusions ($96.05); or 3) fewer PLT storage days, which contributes to higher outdating cost from expired PLTs ($67.87). Only a small portion of the incremental costs for PRT-treated PLTs are offset by costs that may be avoided, including primary bacterial culture, secondary bacterial testing ($26.65), hospital irradiation ($8.50), Zika testing ($4.47), and other costs ($3.03).
   CONCLUSIONThe significantly higher cost of PRT-treated PLTs over PGD-tested PLTs should interest stakeholders. For hospitals that outdate PLTs, savings associated with expiration extension to 7 days by adding PGD testing will likely be substantially greater than the cost of implementing PGD-testing. Our findings might usefully inform a hospital's decision to select a particular blood safety approach.
C1 [Li, Justin W.; Chen, Dorothy; El-Gamil, Audrey; Dobson, Al] Dobson DaVanzo & Associates LLC, Vienna, VA USA.
   [Brecher, Mark E.] Lab Corp Amer Holdings, Burlington, NC USA.
   [Brecher, Mark E.] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA.
   [Jacobson, Jessica L.] NYU, Sch Med, New York, NY USA.
   [Harm, Sarah K.] Univ Vermont, Med Ctr, Burlington, VT USA.
   [Mintz, Paul D.] Verax Biomed Inc, 148 Bartlett St, Marlborough, MA 01752 USA.
RP Mintz, PD (corresponding author), Verax Biomed Inc, 148 Bartlett St, Marlborough, MA 01752 USA.
EM pmintz@veraxbiomedical.com
OI Jacobson, Jessica/0000-0001-8847-2763
FU Verax Biomedical, Incorporated
FX This study was funded by Verax Biomedical, Incorporated.
CR Abraham I, 2012, TRANSFUSION, V52, P1983, DOI 10.1111/j.1537-2995.2011.03532.x
   [Anonymous], 2015, MED CLIN LAB TECHN T
   [Anonymous], 2009 NAT BLOOD COLL
   [Anonymous], 2016, COMMUNICATION
   [Anonymous], 2011 NATL BLOOD COLL
   [Anonymous], 2016, REV REC RED RISK ZIK
   [Anonymous], 2016, BACT RISK CONTR STRA
   Butler C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009072.pub2
   Dumont LJ, 2010, TRANSFUSION, V50, P589, DOI 10.1111/j.1537-2995.2009.02460.x
   Dunbar NM, 2016, TRANSFUSION, V56, P1262, DOI 10.1111/trf.13577
   Dunbar NM, 2013, TRANSFUSION, V53, P2307, DOI 10.1111/trf.12083
   Good CE, 2010, TRANSFUSION, V50, p194A
   Hay SN, 2007, J CLIN APHERESIS, V22, P283, DOI 10.1002/jca.20147
   Hess JR, 2016, TRANSFUSION, V56, P1236, DOI 10.1111/trf.13512
   Hong H, 2016, BLOOD, V127, P496, DOI 10.1182/blood-2015-07-655944
   Jacobs MR, 2011, TRANSFUSION, V51, P2573, DOI 10.1111/j.1537-2995.2011.03308.x
   Kerkhoffs JLH, 2010, BRIT J HAEMATOL, V150, P209, DOI 10.1111/j.1365-2141.2010.08227.x
   McCullough J, 2004, BLOOD, V104, P1534, DOI 10.1182/blood-2003-12-4443
   McCullough J, 2015, TRANSFUSION, V55, P2312, DOI 10.1111/trf.13149
   Mintz PD, 2011, TRANSFUSION, V51, P1369, DOI 10.1111/j.1537-2995.2011.03201.x
   Ramsey G, 2016, SEMIN THROMB HEMOST, V42, P172, DOI 10.1055/s-0035-1564845
   Rebulla P, 2017, TRANSFUSION, V57, P1171, DOI 10.1111/trf.14042
   Riley W, 2012, TRANSFUSION, V52, P1957, DOI 10.1111/j.1537-2995.2011.03539.x
   Shander A, 2016, VOX SANG, V111, P55, DOI 10.1111/vox.12386
   Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x
   Slichter SJ, 2010, NEW ENGL J MED, V362, P600, DOI 10.1056/NEJMoa0904084
   Snyder E, 2005, TRANSFUSION, V45, P1864, DOI 10.1111/j.1537-2995.2005.00639.x
   Sorkin EJ, 2016, TRANSFUSION, V56, p213A
   US Food and Drug Administration, 2014, SUMM SAF EFF DAT SSE
   Vamvakas EC, 2012, VOX SANG, V102, P302, DOI 10.1111/j.1423-0410.2011.01555.x
   Vauthrin M, 2016, TRANSFUSION, V56, p198A
   Webert KE, 2008, TRANSFUS MED REV, V22, P1, DOI 10.1016/j.tmrv.2007.09.001
   Whitaker B, 2016, TRANSFUSION, V56, P2173, DOI 10.1111/trf.13676
NR 33
TC 14
Z9 14
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD OCT
PY 2017
VL 57
IS 10
BP 2321
EP 2328
DI 10.1111/trf.14216
PG 8
WC Hematology
SC Hematology
GA FI2CD
UT WOS:000411743400008
PM 28703862
OA Other Gold
DA 2020-07-08
ER

PT J
AU Chesarino, NM
   Compton, AA
   McMichael, TM
   Kenney, AD
   Zhang, L
   Soewarna, V
   Davis, M
   Schwartz, O
   Yount, JS
AF Chesarino, Nicholas M.
   Compton, Alex A.
   McMichael, Temet M.
   Kenney, Adam D.
   Zhang, Lizhi
   Soewarna, Victoria
   Davis, Matthew
   Schwartz, Olivier
   Yount, Jacob S.
TI IFITM3 requires an amphipathic helix for antiviral activity
SO EMBO REPORTS
LA English
DT Article
DE amphipathic helix; fusion; IFITM; restriction factor; virus
ID INFLUENZA-VIRUS HEMAGGLUTININ; INDUCED TRANSMEMBRANE PROTEIN-3; ACID
   CHEMICAL REPORTER; WEST NILE VIRUS; MEMBRANE-FUSION; A VIRUS;
   S-PALMITOYLATION; INTRACELLULAR-LOCALIZATION; STRUCTURE PREDICTION;
   FATTY ACYLATION
AB Interferon-induced transmembrane protein 3 (IFITM3) is a cellular factor that blocks virus fusion with cell membranes. IFITM3 has been suggested to alter membrane curvature and fluidity, though its exact mechanism of action is unclear. Using a bioinformatic approach, we predict IFITM3 secondary structures and identify a highly conserved, short amphipathic helix within a hydrophobic region of IFITM3 previously thought to be a transmembrane domain. Consistent with the known ability of amphipathic helices to alter membrane properties, we show that this helix and its amphipathicity are required for the IFITM3-dependent inhibition of influenza virus, Zika virus, vesicular stomatitis virus, Ebola virus, and human immunodeficiency virus infections. The homologous amphipathic helix within IFITM1 is also required for the inhibition of infection, indicating that IFITM proteins possess a conserved mechanism of antiviral action. We further demonstrate that the amphipathic helix of IFITM3 is required to block influenza virus hemagglutinin-mediated membrane fusion. Overall, our results provide evidence that IFITM proteins utilize an amphipathic helix for inhibiting virus fusion.
C1 [Chesarino, Nicholas M.; McMichael, Temet M.; Kenney, Adam D.; Zhang, Lizhi; Soewarna, Victoria; Davis, Matthew; Yount, Jacob S.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.
   [Compton, Alex A.; Schwartz, Olivier] Inst Pasteur, Virus & Immun Unit, Dept Virol, Paris, France.
   [Compton, Alex A.; Schwartz, Olivier] CNRS, URA 3015, Paris, France.
   [Compton, Alex A.] NCI, HIV Dynam & Replicat Program, NIH, Frederick, MD 21701 USA.
RP Yount, JS (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.
EM yount.37@osu.edu
OI Chesarino, Nicholas/0000-0002-3582-8508; SCHWARTZ,
   OLIVIER/0000-0002-0729-1475; Yount, Jacob/0000-0002-6128-4575; Compton,
   Alex/0000-0002-7508-4953
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI130110]; Ohio State University
   Systems and Integrative Biology Training Program - NIH [GM068412]; Ohio
   State University Presidential FellowshipOhio State University; Howard
   Hughes Medical InstituteHoward Hughes Medical Institute;
   "CHIKV-Viro-Immuno" project [ANR-14-CE14-0015-01]; "TIMTAMDEN" project
   [ANR-14-CE14-0029]; Labex IBEID program [ANR-10-IHUB-0002];
   ANRSANRSFrench National Research Agency (ANR); Institut Pasteur
FX JSY is supported by NIH grant AI130110. NMC and ADK received support
   from the Ohio State University Systems and Integrative Biology Training
   Program funded by NIH grant GM068412. NMC was also supported by an Ohio
   State University Presidential Fellowship. TMM is supported by a Gilliam
   Fellowship for Advanced Study from the Howard Hughes Medical Institute.
   Work performed by OS and AAC was supported by grants from the
   "CHIKV-Viro-Immuno" ANR-14-CE14-0015-01 and "TIMTAMDEN" ANR-14-CE14-0029
   projects, the Labex IBEID program ANR-10-IHUB-0002, the ANRS, and
   Institut Pasteur. We thank Dr. Mark Peeples (Nationwide Children's
   Research Institute) for assistance in developing the cell-cell fusion
   assay, Dr. Jonathan Yewdell (NIH) for providing anti-HA antibodies, and
   Dr. Dominique Garcin (Universite de Geneve) for providing VSV-GFP.
CR Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006
   BACHI T, 1985, J VIROL, V55, P307
   Bailey CC, 2013, J BIOL CHEM, V288, P32184, DOI 10.1074/jbc.M113.514356
   Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909
   Battles MB, 2016, NAT CHEM BIOL, V12, P87, DOI [10.1038/NCHEMBIO.1982, 10.1038/nchembio.1982]
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Brewer KD, 2011, P NATL ACAD SCI USA, V108, P12723, DOI 10.1073/pnas.1105128108
   CHERNOMORDIK L, 1995, BIOPHYS J, V69, P922, DOI 10.1016/S0006-3495(95)79966-0
   Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455
   CHERNOMORDIK LV, 1987, BIOCHIM BIOPHYS ACTA, V906, P309, DOI 10.1016/0304-4157(87)90016-5
   Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504
   Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369
   Chesarino NM, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0091-3
   Chesarino NM, 2014, FUTURE MICROBIOL, V9, P1151, DOI [10.2217/FMB.14.65, 10.2217/fmb.14.65]
   Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694
   Chutiwitoonchai N, 2013, MICROBES INFECT, V15, P280, DOI 10.1016/j.micinf.2012.12.003
   Compton AA, 2016, EMBO REP, V17, P1657, DOI 10.15252/embr.201642771
   Compton AA, 2014, CELL HOST MICROBE, V16, P736, DOI 10.1016/j.chom.2014.11.001
   Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675
   D'SOUZA-SCHOREY C, 1995, EXP CELL RES, V221, P153, DOI 10.1006/excr.1995.1362
   Das SR, 2013, CELL HOST MICROBE, V13, P314, DOI 10.1016/j.chom.2013.02.008
   Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048
   Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022
   EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337
   Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392
   GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0
   Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16
   Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002
   Hach JC, 2013, J VIROL, V87, P9923, DOI 10.1128/JVI.00621-13
   Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258
   Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262
   Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12
   John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13
   KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1
   Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284
   Li K, 2015, J BIOL CHEM, V290, P4248, DOI 10.1074/jbc.M114.630780
   Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124
   Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033
   Ling SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24029
   Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10
   Magadan JG, 2013, J VIROL, V87, P9742, DOI 10.1128/JVI.00471-13
   MARKIN VS, 1983, BIOFIZIKA+, V28, P72
   Melikyan GB, 1999, MOL BIOL CELL, V10, P1821, DOI 10.1091/mbc.10.6.1821
   Melvin WJ, 2015, VIRUSES-BASEL, V7, P3035, DOI 10.3390/v7062759
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.E03-11-0798
   Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346
   Peng T, 2016, J AM CHEM SOC, V138, P14423, DOI 10.1021/jacs.6b08733
   Peng T, 2015, J AM CHEM SOC, V137, P556, DOI 10.1021/ja502109n
   Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113
   Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024
   Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51
   Poddar S, 2016, J VIROL, V90, P8780, DOI 10.1128/JVI.00655-16
   Porollo AA, 2004, BIOINFORMATICS, V20, P2460, DOI 10.1093/bioinformatics/bth248
   Prinz WA, 2009, CRIT REV BIOCHEM MOL, V44, P278, DOI 10.1080/10409230903183472
   Razinkov VI, 1998, J GEN PHYSIOL, V112, P409, DOI 10.1085/jgp.112.4.409
   Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377
   RUSS G, 1991, CELL REGUL, V2, P549
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m
   Smith SE, 2014, CURR OPIN VIROL, V4, P71, DOI 10.1016/j.coviro.2013.11.004
   Suetsugu S, 2014, PHYSIOL REV, V94, P1219, DOI 10.1152/physrev.00040.2013
   Tartour K, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0103-y
   Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419
   Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111
   Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10
   Wrensch F, 2015, J INFECT DIS, V212, pS210, DOI 10.1093/infdis/jiv255
   Wrensch F, 2014, VIRUSES-BASEL, V6, P3683, DOI 10.3390/v6093683
   Xuan Y, 2015, EPIDEMIOL INFECT, V143, P2975, DOI 10.1017/S0950268815000278
   Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366
   Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   YEWDELL JW, 1993, J VIROL, V67, P933, DOI 10.1128/JVI.67.2.933-942.1993
   YEWDELL JW, 1988, CELL, V52, P843, DOI 10.1016/0092-8674(88)90426-6
   Yount JS, 2013, CURR OPIN CHEM BIOL, V17, P27, DOI 10.1016/j.cbpa.2012.11.008
   Yount Jacob S, 2011, Curr Protoc Chem Biol, V3, P65
   Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095
   Yount JS, 2012, BIOORGAN MED CHEM, V20, P650, DOI 10.1016/j.bmc.2011.03.062
   Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]
   Yu JY, 2015, CELL REP, V13, P145, DOI 10.1016/j.celrep.2015.08.055
   Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433
   Zhang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049265
   Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784
NR 85
TC 22
Z9 23
U1 2
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD OCT
PY 2017
VL 18
IS 10
BP 1740
EP 1751
DI 10.15252/embr.201744100
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA FI6OR
UT WOS:000412116400011
PM 28835547
OA Green Published
DA 2020-07-08
ER

PT J
AU Shan, C
   Ortiz, DA
   Yang, YJ
   Wong, SJ
   Kramer, LD
   Shi, PY
   Loeffelholz, MJ
   Ren, P
AF Shan, Chao
   Ortiz, Daniel A.
   Yang, Yujiao
   Wong, Susan J.
   Kramer, Laura D.
   Shi, Pei-Yong
   Loeffelholz, Michael J.
   Ren, Ping
TI Evaluation of a Novel Reporter Virus Neutralization Test for Serological
   Diagnosis of Zika and Dengue Virus Infection
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE Zika virus; dengue virus; neutralization assay; sensitivity; specificity
ID VACCINE
AB Currently, the laboratory diagnosis of Zika virus (ZIKV) infection is primarily through the detection of ZIKV RNA or antibodies against ZIKV proteins. The detection of viral RNA is highly sensitive and specific, but periods of viremia and viruria are brief, limiting the utility of ZIKV RNA assays. Instead, most ZIKV infections are diagnosed serologically, using an IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) for screening, followed by a confirmatory plaque reduction neutralization test (PRNT). Typical turnaround times vary, due to assay incubation periods and a lack of clinical laboratories performing these tests. Recently, a novel luciferase-ZIKV-and -dengue virus (DENV)-based serological assay, which considerably improves the turnaround times and throughput for ZIKV diagnosis, was described. Using the traditional PRNT as a reference method, we evaluated the performance characteristics of the reporter virus neutralization test (RVNT) with 258 clinical serum specimens. The ZIKV RVNT produced primary ZIKV screening and secondary confirmation results in 4 days, with 100% reproducibility. As a screening assay, the ZIKV RVNT displayed excellent diagnostic accuracy, sensitivity, and specificity of 98.2%, 100%, and 98.1%, respectively. As a confirmatory assay, the ZIKV RVNT titers displayed 93.1% agreement with the traditional ZIKV PRNT titers. Overall, the RVNT accurately and reliably detects neutralizing antibodies in patient serum specimens, with improved turnaround times, and can be used for the serological detection of ZIKV infections. Due to the homogeneous 96-well format, the RVNT has also significantly improved the assay throughput to allow testing of a large number of specimens in a single run.
C1 [Shan, Chao; Yang, Yujiao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Ortiz, Daniel A.; Loeffelholz, Michael J.; Ren, Ping] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Yang, Yujiao] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China.
   [Wong, Susan J.; Kramer, Laura D.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.
RP Ren, P (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM piren@utmb.edu
OI Ren, Ping/0000-0002-4022-6667; Ortiz, Daniel/0000-0001-6100-1822
FU NCATS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1 TR001439]
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Centers for Disease Control and Prevention, 2016, GUID US LAB TEST ZIK
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 15
TC 16
Z9 18
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD OCT
PY 2017
VL 55
IS 10
BP 3028
EP 3036
DI 10.1128/JCM.00975-17
PG 9
WC Microbiology
SC Microbiology
GA FI0LN
UT WOS:000411617400019
PM 28768729
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Wilson, HL
   Tran, T
   Druce, J
   Dupont-Rouzeyrol, M
   Catton, M
AF Wilson, Heather L.
   Tran, Thomas
   Druce, Julian
   Dupont-Rouzeyrol, Myrielle
   Catton, Michael
TI Neutralization Assay for Zika and Dengue Viruses by Use of Real-TimePCR-
   Based Endpoint Assessment
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE dengue; flavivirus; serology; Zika
ID CROSS-REACTIVITY; ANTIBODIES; CHIKUNGUNYA; OUTBREAK; KINETICS
AB The global spread and infective complications of Zika virus (ZKV) and dengue virus (DENV) have made them flaviviruses of public health concern. Serological diagnosis can be challenging due to antibody cross-reactivity, particularly in secondary flavivirus infections or when there is a history of flavivirus vaccination. The virus neutralization assay is considered to be the most specific assay for measurement of anti-flavivirus antibodies. This study describes an assay where the neutralization endpoint is measured by real-time PCR, providing results within 72 h. It demonstrated 100% sensitivity (24/24 ZKV and 15/15 DENV) and 100% specificity (11/11 specimens) when testing well-characterized sera. In addition, the assay was able to determine the correct DENV serotype in 91.7% of cases. The high sensitivity and specificity of the real-time PCR neutralization assay makes it suitable to use as a confirmatory test for sera that are reactive in commercial IgM/IgG enzyme immunoassays. Results are objective and the PCR-based measurement of the neutralization endpoint lends itself to automation so that throughput may be increased in times of high demand.
C1 [Wilson, Heather L.; Tran, Thomas; Druce, Julian; Catton, Michael] Royal Melbourne Hosp, Peter Doherty Inst, Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia.
   [Dupont-Rouzeyrol, Myrielle] Inst Pasteur New Caledonia, Int Inst Pasteur Network, Res & Expertise Unit Dengue & Arboviruses, Noumea, New Caledonia.
   [Wilson, Heather L.] Canberra Hosp & Hlth Serv, Canberra, ACT, Australia.
RP Wilson, HL (corresponding author), Royal Melbourne Hosp, Peter Doherty Inst, Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia.; Wilson, HL (corresponding author), Canberra Hosp & Hlth Serv, Canberra, ACT, Australia.
EM Heather.Wilson@act.gov.au
OI Druce, Julian/0000-0002-3521-3298
CR Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Catton M, 2011, EMERG INFECT DIS, V17, P963, DOI [10.3201/eid/1706.101747, 10.3201/eid1706.101747]
   Clapham HE, 2016, J INFECT DIS, V213, P1428, DOI 10.1093/infdis/jiv759
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47
   Kramski M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-139
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Teferedegne B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056023
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Tomashek KM, 2011, TRANSFUSION, V51, P1654, DOI 10.1111/j.1537-2995.2011.03269.x
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   Varada JC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-195
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yamada KI, 2003, CLIN DIAGN LAB IMMUN, V10, P725, DOI 10.1128/CDLI.10.4.725-728.2003
   Zompi S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001568
NR 37
TC 7
Z9 7
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD OCT
PY 2017
VL 55
IS 10
BP 3104
EP 3112
DI 10.1128/JCM.00673-17
PG 9
WC Microbiology
SC Microbiology
GA FI0LN
UT WOS:000411617400025
PM 28794181
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Zhu, Z
   Gorman, MJ
   McKenzie, LD
   Chai, JNN
   Hubert, CG
   Prager, BC
   Fernandez, E
   Richner, JM
   Zhang, R
   Shan, C
   Tycksen, E
   Wang, XX
   Shi, PY
   Diamond, MS
   Rich, JN
   Chheda, MG
AF Zhu, Zhe
   Gorman, Matthew J.
   McKenzie, Lisa D.
   Chai, Jiani N.
   Hubert, Christopher G.
   Prager, Briana C.
   Fernandez, Estefania
   Richner, Justin M.
   Zhang, Rong
   Shan, Chao
   Tycksen, Eric
   Wang, Xiuxing
   Shi, Pei-Yong
   Diamond, Michael S.
   Rich, Jeremy N.
   Chheda, Milan G.
TI Zika virus has oncolytic activity against glioblastoma stem cells
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID NEURAL PROGENITORS; BRAIN ORGANOIDS; MEASLES-VIRUS; IN-VIVO; GLIOMA;
   EXPRESSION; INFECTION; THERAPY; SYSTEM; TUMORS
AB Glioblastoma is a highly lethal brain cancer that frequently recurs in proximity to the original resection cavity. We explored the use of oncolytic virus therapy against glioblastoma with Zika virus (ZIKV), a flavivirus that induces cell death and differentiation of neural precursor cells in the developing fetus. ZIKV preferentially infected and killed glioblastoma stem cells (GSCs) relative to differentiated tumor progeny or normal neuronal cells. The effects against GSCs were not a general property of neurotropic flaviviruses, as West Nile virus indiscriminately killed both tumor and normal neural cells. ZIKV potently depleted patient-derived GSCs grown in culture and in organoids. Moreover, mice with glioblastoma survived substantially longer and at greater rates when the tumor was inoculated with a mouse-adapted strain of ZIKV. Our results suggest that ZIKV is an oncolytic virus that can preferentially target GSCs; thus, genetically modified strains that further optimize safety could have therapeutic efficacy for adult glioblastoma patients.
C1 [Zhu, Zhe; Wang, Xiuxing; Rich, Jeremy N.] Univ Calif San Diego, Sch Med, Dept Med, Div Regenerat Med, La Jolla, CA 92093 USA.
   [Zhu, Zhe; Hubert, Christopher G.; Prager, Briana C.; Wang, Xiuxing; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA.
   [Gorman, Matthew J.; Fernandez, Estefania; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.
   [McKenzie, Lisa D.; Chai, Jiani N.; Richner, Justin M.; Zhang, Rong; Diamond, Michael S.; Chheda, Milan G.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [McKenzie, Lisa D.; Chheda, Milan G.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63130 USA.
   [Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Tycksen, Eric] Washington Univ, Dept Genet, Genome Technol Access Ctr, St Louis, MO 63110 USA.
RP Rich, JN (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Div Regenerat Med, La Jolla, CA 92093 USA.; Rich, JN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Diamond, MS; Chheda, MG (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Chheda, MG (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63130 USA.
EM diamond@wusm.wustl.edu; drjeremyrich@gmail.com; mchheda@wustl.edu
RI Wang, Xiuxing/N-6759-2019; Diamond, Michael/AAH-1733-2019; Zhu,
   Zhe/H-6009-2019; Zhang, Rong/J-5434-2018
OI Wang, Xiuxing/0000-0002-5993-9368; Diamond, Michael/0000-0002-8791-3165;
   Zhu, Zhe/0000-0002-5385-948X; McKenzie, Lisa/0000-0002-1432-6496; Shan,
   Chao/0000-0002-3953-3782; Zhang, Rong/0000-0003-2941-4808; Richner,
   Justin/0000-0002-5344-118X; Tycksen, Eric/0000-0001-6362-0141
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI073755,
   R01 AI104972, CA197718, CA154130, CA169117, CA171652, NS087913,
   NS089272]; Elsa U. Pardee Foundation; Concern Foundation; Cancer
   Research Foundation; Mc-Donnell Center for Cellular and Molecular
   Neurobiology of Washington University; National Center for Advancing
   Translational Sciences (NCATS) ICTS/CTSA [UL1 TR002345]; NCI Cancer
   CenterUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30
   CA91842, P50 CA094056]; National Center for Research Resources (NCRR)
   ICTS/CTSA, a component of the NIH [UL1TR000448]; NIH Roadmap for Medical
   ResearchUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA; Moderna; Visterra
FX National Institutes of Health (NIH) grants (R01 AI073755 and R01
   AI104972 awarded to M.S. Diamond and CA197718, CA154130, CA169117,
   CA171652, NS087913, and NS089272 awarded to J.N. Rich) and grants from
   the Elsa U. Pardee Foundation, the Concern Foundation, the Cancer
   Research Foundation, and the Mc-Donnell Center for Cellular and
   Molecular Neurobiology of Washington University (awarded to M.G. Chheda)
   supported this work. The Genome Technology Access Center of Washington
   University in St. Louis is supported by National Center for Advancing
   Translational Sciences (NCATS) ICTS/CTSA grant UL1 TR002345 and NCI
   Cancer Center support grant P30 CA91842. The Imaging Program is
   supported by NCI Cancer Center support grant P50 CA094056. The Center is
   partially supported by NCI Cancer Center support grant P30 CA91842 to
   the Siteman Cancer Center and by National Center for Research Resources
   (NCRR) ICTS/CTSA grant UL1TR000448, a component of the NIH, and the NIH
   Roadmap for Medical Research.; M.S. Diamond is a consultant for Inbios
   and Visterra, is on the Scientific Advisory Boards of Moderna and
   OvaGene, and is a recipient of grants from Moderna and Visterra. The
   authors declare no additional competing conflicts of interest. This
   publication is solely the responsibility of the authors and does not
   necessarily represent the official views of the NCRR or NIH.
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alonso MM, 2012, METHODS MOL BIOL, V797, P111, DOI 10.1007/978-1-61779-340-0_9
   Alvarado AG, 2017, CELL STEM CELL, V20, P450, DOI 10.1016/j.stem.2016.12.001
   Bach P, 2013, CANCER RES, V73, P865, DOI 10.1158/0008-5472.CAN-12-2221
   Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236
   Cassady KA, 2017, MOL THER-ONCOLYTICS, V5, P1, DOI 10.1016/j.omto.2017.02.001
   Cattaneo R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006190
   Cheema TA, 2013, P NATL ACAD SCI USA, V110, P12006, DOI 10.1073/pnas.1307935110
   Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Dobrikova EY, 2008, MOL THER, V16, P1865, DOI 10.1038/mt.2008.184
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gromeier M, 2000, P NATL ACAD SCI USA, V97, P6803, DOI 10.1073/pnas.97.12.6803
   Hardcastle J, 2017, NEURO-ONCOLOGY, V19, P493, DOI 10.1093/neuonc/now179
   Hubert CG, 2016, CANCER RES, V76, P2465, DOI 10.1158/0008-5472.CAN-15-2402
   Jiang H, 2016, NAT MED, V22, P851, DOI 10.1038/nm.4123
   Kaufmann JK, 2014, NEURO-ONCOLOGY, V16, P334, DOI 10.1093/neuonc/not310
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Miska J, 2016, CANCER IMMUNOL IMMUN, V65, P1555, DOI 10.1007/s00262-016-1912-8
   MOORE AE, 1954, ANNU REV MICROBIOL, V8, P393, DOI 10.1146/annurev.mi.08.100154.002141
   Oh T, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-107
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   SOUTHAM CM, 1952, CANCER, V5, P1025, DOI 10.1002/1097-0142(195209)5:5<1025::AID-CNCR2820050518>3.0.CO;2-Q
   Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030
   WALLNER KE, 1989, INT J RADIAT ONCOL, V16, P1405, DOI 10.1016/0360-3016(89)90941-3
   Wang XX, 2017, NAT NEUROSCI, V20, P661, DOI 10.1038/nn.4537
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
NR 42
TC 54
Z9 57
U1 5
U2 51
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD OCT
PY 2017
VL 214
IS 10
BP 2843
EP 2857
DI 10.1084/jem.20171093
PG 15
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FI5IJ
UT WOS:000412015600004
PM 28874392
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Robinson, AJ
   Ederies, MA
AF Robinson, Ashley J.
   Ederies, M. Ashraf
TI Neuroimaging of Fetal Infection
SO JOURNAL OF PEDIATRIC NEUROLOGY
LA English
DT Article
DE Toxoplasma; cytomegalovirus; sensorineural hearing loss; human herpes
   virus; herpes simplex virus; fetal MRI; congenital zika virus;
   pseudo-TORCH
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; LYMPHOCYTIC CHORIOMENINGITIS
   VIRUS; VARICELLA SYNDROME; IMAGING FINDINGS; INTRACRANIAL CALCIFICATION;
   PRENATAL ULTRASOUND; CEREBRAL-LESIONS; TEMPORAL CYSTS; FOLLOW-UP;
   IN-UTERO
AB Infection during pregnancy is common and the developing fetal brain is vulnerable to vertical transmission due to immaturity of the fetal immune system. Infection is a major cause of multiple organ abnormalities, including the neuraxis, due to the neurotropism of the infectious agents. This review sets out to give an overview of fetal infection, review the general principles of the nature and timing of the infectious insult with respect to outcomes, review the neuroimaging of infection by ultrasound and magnetic resonance imaging (MRI), and review the various pathogens involved, including the two most common, cytomegalovirus (CMV) and Toxoplasma, and also other common viral and nonviral infections.
C1 [Robinson, Ashley J.; Ederies, M. Ashraf] Sidra Med & Res Ctr, Dept Diagnost Imaging, Doha, Qatar.
   [Robinson, Ashley J.; Ederies, M. Ashraf] Weill Cornell Med Coll, Dept Clin Radiol, New York, NY USA.
RP Robinson, AJ (corresponding author), Sidra Med & Res Ctr, Dept Diagnost Imaging, Doha, Qatar.
EM ash@radiologist.net
OI ROBINSON, ASHLEY/0000-0002-7561-9276
CR AlShahwan S, 1996, J NEUROL SCI, V139, P156, DOI 10.1016/0022-510X(96)00047-0
   Amir J, 2016, ARCH DIS CHILD-FETAL, V101, pF428, DOI 10.1136/archdischild-2015-308357
   Anderson JL, 2014, J CHILD NEUROL, V29, P837, DOI 10.1177/0883073813486295
   Araujo E, 2017, CURR OPIN OBSTET GYN, V29, P95, DOI 10.1097/GCO.0000000000000345
   Auriti C, 2009, FETAL DIAGN THER, V25, P224, DOI 10.1159/000220602
   Averill LW, 2015, SEMIN ULTRASOUND CT, V36, P476, DOI 10.1053/j.sult.2015.04.001
   Bailao Luiz Antonio, 2005, Ultrasound Q, V21, P295, DOI 10.1097/01.ruq.0000187025.61943.ff
   Bailao Luiz Antonio, 2006, Ultrasound Q, V22, P137, DOI 10.1097/00013644-200606000-00026
   Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005
   BARKOVICH AJ, 1994, AM J NEURORADIOL, V15, P703
   Barkovich AJ, 2003, CHILD NERV SYST, V19, P501, DOI 10.1007/s00381-003-0763-8
   Beke A, 2011, PRENATAL DIAG, V31, P945, DOI 10.1002/pd.2762
   Benoist G, 2008, ULTRASOUND OBST GYN, V32, P900, DOI 10.1002/uog.6129
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bonthius DJ, 2007, ANN NEUROL, V62, P347, DOI 10.1002/ana.21161
   Cannie MM, 2016, EUR RADIOL, V26, P3760, DOI 10.1007/s00330-015-4187-0
   Carletti A, 2009, PRENATAL DIAG, V29, P389, DOI 10.1002/pd.2244
   Cluver C, 2013, ULTRASOUND OBST GYN, V42, P235, DOI 10.1002/uog.12399
   Courtier J, 2012, ULTRASOUND OBST GYN, V40, P604, DOI 10.1002/uog.11121
   Crino JP, 1999, CLIN OBSTET GYNECOL, V42, P71, DOI 10.1097/00003081-199903000-00013
   Crow YJ, 2008, DEV MED CHILD NEUROL, V50, P410, DOI 10.1111/j.1469-8749.2008.02062.x
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   De Vries LS, 2004, NEUROPEDIATRICS, V35, P113, DOI 10.1055/s-2004-815833
   Deasy NP, 1999, NEURORADIOLOGY, V41, P205, DOI 10.1007/s002340050736
   DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315
   Dhombres F, 2017, FETAL DIAGN THER, V41, P8, DOI 10.1159/000445113
   Dimova PS, 2001, J CHILD NEUROL, V16, P595, DOI 10.1177/088307380101600811
   Dogan Y, 2011, FETAL DIAGN THER, V30, P141, DOI 10.1159/000330636
   Doneda C, 2010, RADIOLOGY, V255, P613, DOI 10.1148/radiol.10090749
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Farkas N, 2011, PRENATAL DIAG, V31, P360, DOI 10.1002/pd.2694
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   FREIJ BJ, 1988, CLIN PERINATOL, V15, P203
   Garcia-Flores J, 2013, J MATERN-FETAL NEO M, V26, P1517, DOI 10.3109/14767058.2013.791275
   Gay-Andrieu F, 2003, PRENATAL DIAG, V23, P558, DOI 10.1002/pd.632
   Girard N, 2003, CHILD NERV SYST, V19, P490, DOI 10.1007/s00381-003-0761-x
   Guibaud L, 2004, PRENATAL DIAG, V24, P727, DOI 10.1002/pd.914
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Inaba Y, 2016, PEDIATR NEUROL, V55, P52, DOI 10.1016/j.pediatrneurol.2015.11.014
   Jayaram PM, 2010, J OBSTET GYNAECOL, V30, P316, DOI 10.3109/01443610903585218
   Joob Beuy, 2017, Pediatr Neurol, V68, pe1, DOI 10.1016/j.pediatrneurol.2016.11.009
   Kulkarni AM, 2010, AM J MED GENET A, V152A, P930, DOI 10.1002/ajmg.a.33358
   Leyder M, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.06.003
   Lipitz S, 2013, ULTRASOUND OBST GYN, V41, P508, DOI 10.1002/uog.12377
   Lipitz S, 2010, ULTRASOUND OBST GYN, V36, P709, DOI 10.1002/uog.7657
   Livingston JH, 2014, DEV MED CHILD NEUROL, V56, P612, DOI 10.1111/dmcn.12359
   Livingston JH, 2013, DEV MED CHILD NEUROL, V55, P46, DOI 10.1111/j.1469-8749.2012.04437.x
   Malinger G, 2011, PRENATAL DIAG, V31, P881, DOI 10.1002/pd.2795
   Malinger G, 2003, AM J NEURORADIOL, V24, P28
   Malinger G, 2002, ULTRASOUND OBST GYN, V20, P447, DOI 10.1046/j.1469-0705.2002.00840.x
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
   Malm G, 2000, PEDIATR NEUROL, V22, P407, DOI 10.1016/S0887-8994(00)00126-0
   Malm G, 2007, SEMIN FETAL NEONAT M, V12, P154, DOI 10.1016/j.siny.2007.01.012
   MARQUIS JR, 1994, CLIN PERINATOL, V21, P125
   Massoud M, 2014, ULTRASOUND OBST GYN, V44, P447, DOI 10.1002/uog.13217
   Mehta NM, 2001, PEDIATR NEUROL, V24, P222, DOI 10.1016/S0887-8994(00)00256-3
   Meyberg-Solomayer GC, 2006, FETAL DIAGN THER, V21, P296, DOI 10.1159/000091360
   O'Rourke D, 2010, J NEUROIMAGING, V20, P292, DOI 10.1111/j.1552-6569.2008.00301.x
   Ong CL, 1998, PEDIATR RADIOL, V28, P94, DOI 10.1007/s002470050301
   Oosterom N, 2015, NEONATOLOGY, V107, P289, DOI 10.1159/000375439
   PARISOT S, 1991, PEDIATR RADIOL, V21, P229, DOI 10.1007/BF02011057
   Picone O, 2014, PRENATAL DIAG, V34, P518, DOI 10.1002/pd.4340
   Picone O, 2008, PRENATAL DIAG, V28, P753, DOI 10.1002/pd.2037
   Pistorius LR, 2008, FETAL DIAGN THER, V24, P491, DOI 10.1159/000180119
   Pugash D, 2012, ULTRASOUND OBST GYN, V40, P642, DOI 10.1002/uog.11164
   Rac MWF, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.049
   Ramenghi LA, 1997, J CLIN ULTRASOUND, V25, P169, DOI 10.1002/(SICI)1097-0096(199705)25:4<169::AID-JCU3>3.0.CO;2-C
   Reitter A, 2013, INFECT DIS OBSTET GY, V2013
   Salmaso R, 2007, J MATERN-FETAL NEO M, V20, P559, DOI 10.1080/14767050701412081
   Sanapo L, 2017, J MATERN-FETAL NEO M, V30, P1887, DOI 10.1080/14767058.2016.1228103
   Sanin-Blair J E, 2017, FETAL DIAGN THER
   Severino M, 2014, PEDIATR INFECT DIS J, V33, P422, DOI 10.1097/INF.0000000000000134
   Simonazzi G, 2010, AM J OBSTET GYNECOL, V202
   Soussotte C, 2000, FETAL DIAGN THER, V15, P219, DOI 10.1159/000021010
   STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904
   Steinlin MI, 1996, PEDIATR NEUROL, V15, P249, DOI 10.1016/S0887-8994(96)00170-1
   Suzuki Y, 2008, BRAIN DEV-JPN, V30, P420, DOI 10.1016/j.braindev.2007.12.004
   TOMA P, 1989, NEURORADIOLOGY, V31, P278, DOI 10.1007/BF00344360
   TWICKLER DM, 1993, AM J PERINAT, V10, P404, DOI 10.1055/s-2007-994773
   Vorona GA, 2016, PEDIATR NEUROL, V65, P98, DOI 10.1016/j.pediatrneurol.2016.07.014
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   WATTMORSE ML, 1995, PRENATAL DIAG, V15, P567, DOI 10.1002/pd.1970150610
   White AL, 2014, PEDIATR NEUROL, V50, P218, DOI 10.1016/j.pediatrneurol.2013.11.005
   YAMASHITA Y, 1991, PEDIATR RADIOL, V21, P547, DOI 10.1007/BF02012592
NR 86
TC 0
Z9 0
U1 0
U2 6
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 1304-2580
EI 1875-9041
J9 J PEDIATR NEUROL
JI J. Pediatr. Neurol.
PD OCT
PY 2017
VL 15
IS 5
BP 192
EP 200
DI 10.1055/s-0037-1604219
PG 9
WC Pediatrics
SC Pediatrics
GA FI4RZ
UT WOS:000411964300002
DA 2020-07-08
ER

PT J
AU Ellika, SK
   Desai, SV
AF Ellika, Shehanaz K.
   Desai, Sunali V.
TI Neonatal Central Nervous System Infection
SO JOURNAL OF PEDIATRIC NEUROLOGY
LA English
DT Article
DE neonatal intracranial infection; pediatric; ultrasound; CT; magnetic
   resonance imaging
ID HERPES-SIMPLEX ENCEPHALITIS; ZIKA VIRUS OUTBREAK;
   CYTOMEGALOVIRUS-INFECTION; PRENATAL-DIAGNOSIS; CRANIAL ULTRASOUND;
   RUBELLA-VIRUS; WHITE-MATTER; RISK-FACTOR; BRAIN; INFANTS
AB In this review article, neuroimaging features of common bacterial, viral, fungal, and parasitic infections of the pediatric central nervous system (CNS) are discussed. Imaging modalities used by pediatric neuroradiologists include cranial ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI). After a brief discussion of the clinical presentation of each disease entity, imaging strategies and findings are reviewed. The role of advanced neuroimaging techniques is discussed wherever appropriate.
C1 [Ellika, Shehanaz K.] LSU Hlth Sci Ctr, Dept Radiol, Shreveport, LA 71103 USA.
   [Desai, Sunali V.] Infocus Diagnost, Dept Radiol, Ahmadabad, Gujarat, India.
RP Ellika, SK (corresponding author), LSU Hlth Sci Ctr, Dept Radiol, Shreveport, LA 71103 USA.
EM drshehanaz@gmail.com
CR AICARDI J, 1992, DIS NERVOUS SYSTEM C
   BALE JF, 1987, PEDIATR INFECT DIS J, V6, P644, DOI 10.1097/00006454-198707000-00005
   BALE JF, 1992, PEDIATR CLIN N AM, V39, P669
   Bale JF, 1997, CLIN PERINATOL, V24, P787
   BARKER PB, 1995, RADIOLOGY, V195, P58, DOI 10.1148/radiology.195.1.7892496
   BARKOVICH AJ, 1994, AM J NEURORADIOL, V15, P703
   Barkovich AJ, 2012, PEDIAT NEUROIMAGING
   Baskin HJ, 2007, PEDIATR RADIOL, V37, P949, DOI 10.1007/s00247-007-0506-1
   BAUMAN NM, 1994, J PEDIATR-US, V124, P71, DOI 10.1016/S0022-3476(94)70256-X
   BECKER LE, 1992, AM J NEURORADIOL, V13, P537
   BELMAN AL, 1990, NEUROL CLIN, V8, P571, DOI 10.1016/S0733-8619(18)30336-0
   BENATOR RM, 1985, AM J NEURORADIOL, V6, P539
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Blaser S, 2002, MRI NEONATAL BRAIN, P201
   Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chang YC, 1997, PEDIATR NEUROL, V17, P144, DOI 10.1016/S0887-8994(97)00078-7
   CHANTLER JK, 1995, LAB INVEST, V72, P334
   Christophe C, 1999, NEUROPEDIATRICS, V30, P218, DOI 10.1055/s-2007-973494
   CLEVELAND RH, 1987, AM J PERINAT, V4, P215, DOI 10.1055/s-2007-999776
   COREY L, 1988, LANCET, V1, P1
   CORTEY A, 1994, AM J NEURORADIOL, V15, P1853
   Daneman A, 1998, PEDIATR RADIOL, V28, P83, DOI 10.1007/s002470050298
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   De Vries LS, 2004, NEUROPEDIATRICS, V35, P113, DOI 10.1055/s-2004-815833
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   DUNN DW, 1982, ARCH NEUROL-CHICAGO, V39, P650, DOI 10.1001/archneur.1982.00510220048011
   Egelhof J C, 1997, PEDIAT NEURORADIOLOG, P273
   ENZMANN D, 1990, J COMPUT ASSIST TOMO, V14, P453, DOI 10.1097/00004728-199005000-00025
   EPPS RE, 1995, SEMIN DERMATOL, V14, P179, DOI 10.1016/S1085-5629(05)80016-1
   ESTROFF JA, 1992, J ULTRAS MED, V11, P686
   Felderhoff-Mueser U, 1999, AM J NEURORADIOL, V20, P1349
   Fitz C R, 1985, HEAD SPINE IMAGING, P537
   Ford-Jones E L, 1999, Paediatr Child Health, V4, P109
   Foulon W, 1999, AM J OBSTET GYNECOL, V180, P410, DOI 10.1016/S0002-9378(99)70224-3
   Frey TK, 1997, INTERVIROLOGY, V40, P167, DOI 10.1159/000150543
   FRIEDE RL, 1989, DEV NEUROPATHOLOGY
   Friedman S, 1999, Paediatr Child Health, V4, P35
   Friedman S, 1999, PRENATAL DIAG, V19, P330, DOI 10.1002/(SICI)1097-0223(199904)19:4&lt;330::AID-PD549&gt;3.0.CO;2-V
   GRAY PH, 1992, PEDIATR RADIOL, V22, P529, DOI 10.1007/BF02013003
   GRIFFITH BP, 1994, NEUROL CLIN, V12, P541
   HARTY MP, 1994, SEMIN ROENTGENOL, V29, P303, DOI 10.1016/S0037-198X(05)80042-2
   HAYWARD JC, 1991, J CHILD NEUROL, V6, P109, DOI 10.1177/088307389100600203
   HERMAN TE, 1985, AM J NEURORADIOL, V6, P773
   Huang CC, 1998, RADIOLOGY, V209, P49, DOI 10.1148/radiology.209.1.9769811
   Hunter J V, 2003, Semin Pediatr Infect Dis, V14, P140, DOI 10.1053/spid.2003.127321
   HWA HL, 1994, OBSTET GYNECOL, V84, P415
   Incesu L, 1994, J Belge Radiol, V77, P278
   JAY V, 1995, PEDIATR PATHOL LAB M, V15, P131, DOI 10.3109/15513819509026945
   Kanamalla US, 2000, NEUROIMAG CLIN N AM, V10, P309
   KANG G H, 1990, Journal of Korean Medical Science, V5, P59
   Kastrup O, 2008, SEMIN NEUROL, V28, P511, DOI 10.1055/s-0028-1083688
   Kremer S, 2006, J NEURORADIOLOGY, V33, P285, DOI 10.1016/S0150-9861(06)77286-8
   KUBOTA T, 1985, ACTA NEUROPATHOL, V68, P77, DOI 10.1007/BF00688960
   Kubota T, 2007, BRAIN DEV-JPN, V29, P171, DOI 10.1016/j.braindev.2006.08.003
   Lane B, 1996, AM J NEURORADIOL, V17, P99
   LIM KO, 1995, BIOL PSYCHIAT, V37, P764, DOI 10.1016/0006-3223(94)00219-S
   Lu DF, 1996, RADIOLOGY, V199, P423, DOI 10.1148/radiology.199.2.8668788
   MATHEWS VP, 1989, AM J ROENTGENOL, V152, P131, DOI 10.2214/ajr.152.1.131
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moinuddin A, 2003, PRENATAL DIAG, V23, P797, DOI 10.1002/pd.688
   Morriss MC, 1997, NEURORADIOLOGY, V39, P142, DOI 10.1007/s002340050383
   NATHAN L, 1993, J ULTRAS MED, V12, P97
   Nonaka H, 2003, J NEUROPATH EXP NEUR, V62, P154, DOI 10.1093/jnen/62.2.154
   Patel DV, 1996, RADIOLOGY, V199, P433, DOI 10.1148/radiology.199.2.8668790
   Patsalides AD, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.4.1790999
   Pavlakis SG, 1998, AM J NEURORADIOL, V19, P383
   Picone O, 2008, PRENATAL DIAG, V28, P753, DOI 10.1002/pd.2037
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schneider JF, 2011, PEDIATR RADIOL, V41, pS143, DOI 10.1007/s00247-011-2041-3
   Snyder R D, 1984, GREENFIELDS PATHOLOG, P236
   SUGITA K, 1991, NEURORADIOLOGY, V33, P239, DOI 10.1007/BF00588225
   SYRJANEN J, 1993, EUR HEART J, V14, P17
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   TIEN RD, 1993, AM J ROENTGENOL, V161, P167, DOI 10.2214/ajr.161.1.8390790
   TOMA P, 1989, NEURORADIOLOGY, V31, P278, DOI 10.1007/BF00344360
   Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786
   Tortori-Donati P, 2005, PEDIAT NEURORADIOLOG
   Vossough A, 2008, NEURORADIOLOGY, V50, P355, DOI 10.1007/s00234-007-0349-3
   WEINGARTEN K, 1989, AM J ROENTGENOL, V152, P615, DOI 10.2214/ajr.152.3.615
   Whitley RJ., 1990, INFECT DIS, P282
   WOODS CR, 1992, J INFECT DIS, V166, P1034, DOI 10.1093/infdis/166.5.1035
   Yamaguchi Katsuyuki, 1993, No To Hattatsu, V25, P369
   Yoshimura Masaki, 1996, No To Hattatsu, V28, P385
NR 86
TC 0
Z9 0
U1 1
U2 7
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 1304-2580
EI 1875-9041
J9 J PEDIATR NEUROL
JI J. Pediatr. Neurol.
PD OCT
PY 2017
VL 15
IS 5
BP 201
EP 220
DI 10.1055/s-0037-1604234
PG 20
WC Pediatrics
SC Pediatrics
GA FI4RZ
UT WOS:000411964300003
DA 2020-07-08
ER

PT J
AU Garg, H
   Sedano, M
   Plata, G
   Punke, EB
   Joshi, A
AF Garg, Himanshu
   Sedano, Melina
   Plata, Gabrielle
   Punke, Erin B.
   Joshi, Anjali
TI Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika
   Virus
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE C-prM-E; diagnostics; microneutralization; neutralization; PRNT;
   reporter; reporter virus particles; vaccine; Zika; prM-E
ID WEST-NILE-VIRUS; TICK-BORNE ENCEPHALITIS; LETHAL JEV INFECTION; CAPSID
   PROTEIN; DNA VACCINE; NS2B-NS3 PROTEASE; CROSS-REACTIVITY; PROTECTION;
   MICE; REPLICATION
AB Recent worldwide outbreaks of Zika virus (ZIKV) infection and the lack of an approved vaccine raise serious concerns regarding preparedness to combat this emerging virus. We used a virus-like particle (VLP)-based approach to develop a vaccine and a microneutralization assay for ZIKV. A synthetic capsid-premembrane-envelope (C-prM- E) gene construct of ZIKV was used to generate reporter virus particles (RVPs) that package a green fluorescent protein (GFP) reporter-expressing West Nile virus (WNV) replicon. The assay was adapted to a 96-well format, similar to the plaque reduction neutralization test (PRNT), and showed high reproducibility with specific detection of ZIKV neutralizing antibodies. Furthermore, C-prM-E and prM-E VLPs were tested as vaccine candidates in mice and compared to DNA vaccination. While the ZIKV prM-E construct alone was sufficient for generating VLPs, efficient VLP production from the C-prM-E construct could be achieved in the presence of the WNV NS2B-3 protease, which cleaves C from prM, allowing virus release. Immunization studies in mice showed that VLPs generated higher neutralizing antibody titers than those with the DNA vaccines, with C-prM-E VLPs giving slightly higher titers than those with prM-E VLPs. The superiority of C-prM-E VLPs suggests that inclusion of capsid may have benefits for ZIKV and other flaviviral VLP vaccines. To facilitate the VLP platform, we generated a stable cell line expressing high levels of ZIKV prM-E proteins that constitutively produce VLPs as well as a cell line expressing ZIKV C-prM-E proteins for RVP production. While several vaccine platforms have been proposed for ZIKV, this study describes a safe, effective, and economical VLP-based vaccine against ZIKV.
   IMPORTANCE To address the growing Zika virus epidemic, we undertook this study with two objectives: first, to develop a safe, effective, and economical vaccine for ZIKV, and second, to develop a rapid and versatile assay to detect the anti-ZIKV immune response. We generated a cell line stably expressing ZIKV prM-E that produces large amounts of VLPs in the supernatant and a ZIKV C-prM-E cell line that produces reporter virus particles upon transfection with a GFP replicon plasmid. The prM-E VLPs induced a strong neutralizing antibody response in mice that was better when the capsid was included. VLP-based vaccines showed significantly better neutralizing antibody responses than those with their DNA counterparts. The RVP-based microneutralization assay worked similarly to the PRNT assay, with a rapid GFP readout in a 96-well format. Our VLP-based platform provides a source for a ZIKV vaccine and diagnosis that can rapidly be adapted to current outbreaks.
C1 [Garg, Himanshu; Sedano, Melina; Plata, Gabrielle; Punke, Erin B.; Joshi, Anjali] Texas Tech Univ, Ctr Emphasis Infect Dis, Dept Biomed Sci, Hlth Sci Ctr, El Paso, TX 79905 USA.
RP Garg, H; Joshi, A (corresponding author), Texas Tech Univ, Ctr Emphasis Infect Dis, Dept Biomed Sci, Hlth Sci Ctr, El Paso, TX 79905 USA.
EM himanshu.garg@ttuhsc.edu; anjali.joshi@ttuhsc.edu
FU TTUHSC; NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1R21AI131696-01]
FX This study was supported by the TTUHSC intramural seed grant program and
   in part by NIH grant 1R21AI131696-01 to A.J.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aihara H, 1998, J VIROL, V72, P8032, DOI 10.1128/JVI.72.10.8032-8036.1998
   Bera AK, 2007, J BIOL CHEM, V282, P12883, DOI 10.1074/jbc.M611318200
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Duenas-Carrera S, 2000, VACCINE, V19, P992, DOI 10.1016/S0264-410X(00)00209-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Gagnon SJ, 1996, J VIROL, V70, P141, DOI 10.1128/JVI.70.1.141-147.1996
   Garg H, 2016, VIROLOGY, V493, P86, DOI 10.1016/j.virol.2016.03.010
   Garg H, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-197
   Gehrke R, 2003, J VIROL, V77, P8924, DOI 10.1128/JVI.77.16.8924-8933.2003
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hunt AR, 2001, J VIROL METHODS, V97, P133, DOI 10.1016/S0166-0934(01)00346-9
   Jeong H, 2017, J MICROBIOL, V55, P220, DOI 10.1007/s12275-017-7058-3
   Joshi A, 2011, J BIOL CHEM, V286, P36404, DOI 10.1074/jbc.M111.281659
   Khromykh AA, 1998, J VIROL, V72, P5967, DOI 10.1128/JVI.72.7.5967-5977.1998
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazo L, 2007, VACCINE, V25, P1064, DOI 10.1016/j.vaccine.2006.09.068
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lo MK, 2003, J VIROL, V77, P12901, DOI 10.1128/JVI.77.23.12901-12906.2003
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   MASON PW, 1991, VIROLOGY, V180, P294, DOI 10.1016/0042-6822(91)90034-9
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pattenden LK, 2005, TRENDS BIOTECHNOL, V23, P523, DOI 10.1016/j.tibtech.2005.07.011
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pijlman GP, 2015, BIOTECHNOL J, V10, P659, DOI 10.1002/biot.201400427
   PINCUS S, 1992, VIROLOGY, V187, P290, DOI 10.1016/0042-6822(92)90317-I
   PUGACHEV KV, 1995, VIROLOGY, V212, P587, DOI 10.1006/viro.1995.1516
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shi PY, 2002, VIROLOGY, V296, P219, DOI 10.1006/viro.2002.1453
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08
   Xing YP, 2005, WORLD J GASTROENTERO, V11, P4583, DOI 10.3748/wjg.v11.i29.4583
   YAMSHCHIKOV VF, 1995, J VIROL, V69, P1995, DOI 10.1128/JVI.69.4.1995-2003.1995
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 69
TC 28
Z9 30
U1 0
U2 24
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD OCT
PY 2017
VL 91
IS 20
AR UNSP e00834-17
DI 10.1128/JVI.00834-17
PG 16
WC Virology
SC Virology
GA FI3GC
UT WOS:000411845000017
PM 28794019
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Wang, QH
   Yan, JH
   Gao, GF
AF Wang, Qihui
   Yan, Jinghua
   Gao, George Fu
TI Monoclonal Antibodies against Zika Virus: Therapeutics and Their
   Implications for Vaccine Design
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; therapeutics; monoclonal antibodies; neutralizing epitopes;
   vaccine design; clinical therapeutics
ID DENGUE VIRUS; CROSS-REACTIVITY; STRUCTURAL BASIS; DOMAIN-III; INFECTION;
   PROTEIN; NEUTRALIZATION; PROTECTION
AB Zika virus (ZIKV) has caused global concern due to its association with neurological complications in newborns and adults. Although no vaccines or antivirals against ZIKV infection have been approved to date, hundreds of monoclonal antibodies (MAbs) have been developed in a short period. Here, we first present a complete picture of the ZIKV MAbs and then focus on the neutralizing mechanisms and immune hot spots uncovered through structural studies, which provide insight for therapeutics and vaccine design.
C1 [Wang, Qihui; Yan, Jinghua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China.
   [Wang, Qihui; Yan, Jinghua; Gao, George Fu] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.
   [Yan, Jinghua; Gao, George Fu] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Yan, Jinghua; Gao, George Fu] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing, Peoples R China.
   [Yan, Jinghua; Gao, George Fu] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.
   [Gao, George Fu] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.
   [Gao, George Fu] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
RP Wang, QH (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China.; Wang, QH (corresponding author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.
EM wangqihui@im.ac.cn
FU State Key Research Development Program of ChinaState Key Development
   Program for Basic Research of China [2016YFC1200300]; National Natural
   Science Foundation of China (NSFC)National Natural Science Foundation of
   China [31502078]; Young Elite Scientist Sponsorship Program of the China
   Association for Science and Technology (CAST) [YESS20150040]; 
   [81621091]
FX This work was supported by the State Key Research Development Program of
   China (grant no. 2016YFC1200300) and the National Natural Science
   Foundation of China (NSFC; grant no. 31502078). Q.W. is supported by the
   Young Elite Scientist Sponsorship Program of the China Association for
   Science and Technology (CAST; grant no. YESS20150040). G.F.G. is a
   leading principal investigator in the NSFC Innovative Research Group
   (grant no. 81621091).
CR Angeletti D, 2017, NAT IMMUNOL, V18, P456, DOI 10.1038/ni.3680
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Bhardwaj S, 2001, J VIROL, V75, P4002, DOI 10.1128/JVI.75.8.4002-4007.2001
   Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Knipe D.M., 2013, FIELDS VIROLOGY
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   WHO, 2017, ZIK VIR DIS
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 33
TC 15
Z9 16
U1 1
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD OCT
PY 2017
VL 91
IS 20
AR UNSP e01049-17
DI 10.1128/JVI.01049-17
PG 6
WC Virology
SC Virology
GA FI3GC
UT WOS:000411845000028
PM 28768876
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Sanchez-Purra, M
   Carre-Camps, M
   de Puig, H
   Bosch, I
   Gehrke, L
   Hamad-Schifferli, K
AF Sanchez-Purra, Maria
   Carre-Camps, Marc
   de Puig, Helena
   Bosch, Irene
   Gehrke, Lee
   Hamad-Schifferli, Kimberly
TI Surface-Enhanced Raman Spectroscopy-Based Sandwich Immunoassays for
   Multiplexed Detection of Zika and Dengue Viral Biomarkers
SO ACS INFECTIOUS DISEASES
LA English
DT Article
DE surface-enhanced Raman spectroscopy; gold nanostars; Zika; dengue;
   sandwich immunoassay; lateral flow assay; immunochemistry; NS1
ID LATERAL FLOW ASSAYS; GOLD NANOSTARS; SCATTERING; VIRUS; SERS;
   NANOPARTICLES; CHIKUNGUNYA; DIAGNOSTICS; AU; OPTIMIZATION
AB Zika and dengue are mosquito-borne diseases that present similar nonspecific symptoms but possess dramatically different outcomes. The first line of defense in epidemic outbreaks are rapid point-of-care diagnostics. Because many outbreaks occur in areas that are resource poor, assays that are easy to use, inexpensive, and require no power have become invaluable in patient treatment, quarantining, and surveillance. Paper-based sandwich immunoassays such as lateral flow assays (LFAs) are attractive as point-of-care solutions as they have the potential for wider deployability than lab-based assays such as PCR. However, their low sensitivity imposes limitations on their ability to detect low biomarker levels and early diagnosis. Here, we exploit the high sensitivity of surface-enhanced Raman spectroscopy (SERS) in a multiplexed assay that can distinguish between Zika and dengue nonstructural protein 1 (NS1) biomarkers. SERS-encoded gold nanostars were conjugated to specific antibodies for both diseases and used in a dipstick immunoassay, which exhibited 15-fold and 7-fold lower detection limits for Zika NS1 and dengue NS1, respectively. This platform combines the simplicity of a LFA with the high sensitivity of SERS and could not only improve Zika diagnosis but also detect diseases sooner after infection when biomarker levels are low.
C1 [Sanchez-Purra, Maria; Hamad-Schifferli, Kimberly] Univ Massachusetts, Dept Engn, 100 Morrissey Blvd, Boston, MA 02125 USA.
   [Carre-Camps, Marc] IQS Sch Engn, Via Augusta 390, Barcelona 08018, Spain.
   [de Puig, Helena; Hamad-Schifferli, Kimberly] MIT, Dept Mech Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Bosch, Irene; Gehrke, Lee] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Gehrke, Lee] Harvard Med Sch, Dept Microbiol & Immunol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
RP Hamad-Schifferli, K (corresponding author), Univ Massachusetts, Dept Engn, 100 Morrissey Blvd, Boston, MA 02125 USA.; Hamad-Schifferli, K (corresponding author), MIT, Dept Mech Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM kim.hamad@umb.edu
OI /0000-0002-5368-6996; Bosch, Irene/0000-0003-1352-5888
FU NIH NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI100190]; MIT/SUTD International Design
   Centre; Rafael del Pino Fellowship; Broshy Fellowship; MIT Tata Center
   for Technology and Design Fellowship; NIGMSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [P41-GM103311]
FX This work was supported by the NIH NIAID (AI100190). We thank CMSE at
   MIT for TEM facilities and the Department of Chemistry at UMB for SERS
   instrumentation. We thank Dr. Justina Tam, Dr. Vladimir Liberman, and
   Diego Lopez for experimental assistance, Daniela M. Graf-Stillfried
   Barreto for help with Senterra II, and Biel Roig-Solvas for help with
   signal processing. H.d.P. was supported by the MIT/SUTD International
   Design Centre, a Rafael del Pino Fellowship, a Broshy Fellowship, and a
   MIT Tata Center for Technology and Design Fellowship. Part of the
   abstract graphic was created with the UCSF Chimera package. Chimera is
   developed by the Resource for Biocomputing, Visualization, and
   Informatics at the University of California, San Francisco (supported by
   NIGMS P41-GM103311).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Bodelon G, 2015, SMALL, V11, P4149, DOI 10.1002/smll.201500269
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578
   Chirumamilla M, 2012, MICROELECTRON ENG, V97, P189, DOI 10.1016/j.mee.2012.05.004
   Chirumamilla M, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/23/235303
   Cho IH, 2010, J CHROMATOGR B, V878, P271, DOI 10.1016/j.jchromb.2009.07.016
   Dam DHM, 2012, ACS NANO, V6, P3318, DOI 10.1021/nn300296p
   de Puig H, 2017, BIOCONJUGATE CHEM, V28, P230, DOI 10.1021/acs.bioconjchem.6b00523
   de Puig H, 2015, J PHYS CHEM C, V119, P17408, DOI 10.1021/acs.jpcc.5b03624
   de Puig H, 2011, SMALL, V7, P2477, DOI 10.1002/smll.201100530
   Dinish US, 2014, SCI REP-UK, V4, DOI 10.1038/srep04075
   Esenturk EN, 2009, J RAMAN SPECTROSC, V40, P86, DOI 10.1002/jrs.2084
   Grimes J. M., 2014, THESIS
   Guerrero-Martinez A, 2011, CURR OPIN COLLOID IN, V16, P118, DOI 10.1016/j.cocis.2010.12.007
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   HAALAND DM, 1980, APPL SPECTROSC, V34, P539, DOI 10.1366/0003702804731258
   Hwang J, 2016, NANOSCALE, V8, P11418, DOI 10.1039/c5nr07243c
   Kearns H, 2015, PHYS CHEM CHEM PHYS, V17, P1980, DOI 10.1039/c4cp04281f
   Khoury CG, 2008, J PHYS CHEM C, V112, P18849, DOI 10.1021/jp8054747
   Knowlton K, 2009, NATURAL RESOURCES DE, P1
   Kumar S, 2008, NAT PROTOC, V3, P314, DOI 10.1038/nprot.2008.1
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lu XM, 2009, ANNU REV PHYS CHEM, V60, P167, DOI 10.1146/annurev.physchem.040808.090434
   Michota A, 2003, J RAMAN SPECTROSC, V34, P21, DOI 10.1002/jrs.928
   Moghadam BY, 2015, ANAL CHEM, V87, P1009, DOI 10.1021/ac504552r
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Mulvaney SP, 2003, LANGMUIR, V19, P4784, DOI 10.1021/la026706j
   Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167
   Park H, 2009, PHYS CHEM CHEM PHYS, V11, P7444, DOI 10.1039/b904592a
   Parolo C, 2013, CHEM SOC REV, V42, P450, DOI 10.1039/c2cs35255a
   Paul AM, 2015, J PHYS CHEM C, V119, P23669, DOI 10.1021/acs.jpcc.5b07387
   Porter MD, 2008, CHEM SOC REV, V37, P1001, DOI 10.1039/b708461g
   Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2
   Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377
   Qin ZP, 2016, SCI REP-UK, V6, DOI 10.1038/srep29836
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Tam Justina O, 2017, J Immunoassay Immunochem, V38, P355, DOI 10.1080/15321819.2016.1269338
   Tan YH, 2008, ACS NANO, V2, P2374, DOI 10.1021/nn800508f
   Taranova NA, 2015, BIOSENS BIOELECTRON, V63, P255, DOI 10.1016/j.bios.2014.07.049
   Tatem AJ, 2014, INT HEALTH, V6, P5, DOI 10.1093/inthealth/ihu006
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Watanabe S, 2012, J VIROL, V86, P5508, DOI 10.1128/JVI.07081-11
   Wen TH, 2016, APPL GEOGR, V76, P137, DOI 10.1016/j.apgeog.2016.09.020
   Xia XH, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0092
   Xie JP, 2007, CHEM MATER, V19, P2823, DOI 10.1021/cm0700100
   Xie QY, 2014, BIOSENS BIOELECTRON, V54, P262, DOI 10.1016/j.bios.2013.11.002
   Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h
   Zavaleta CL, 2009, P NATL ACAD SCI USA, V106, P13511, DOI 10.1073/pnas.0813327106
   ZEMAN EJ, 1987, J PHYS CHEM-US, V91, P634, DOI 10.1021/j100287a028
NR 53
TC 44
Z9 44
U1 17
U2 100
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD OCT
PY 2017
VL 3
IS 10
BP 767
EP 776
DI 10.1021/acsinfecdis.7b00110
PG 10
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA FK0OK
UT WOS:000413179000010
PM 28875696
DA 2020-07-08
ER

PT J
AU Islam, J
   Zaman, K
   Tyagi, V
   Duarah, S
   Dhiman, S
   Chattopadhyay, P
AF Islam, Johirul
   Zaman, Kamaruz
   Tyagi, Varun
   Duarah, Sanjukta
   Dhiman, Sunil
   Chattopadhyay, Pronobesh
TI Protection against mosquito vectors Aedes aegypti, Anopheles stephensi
   and Culex quinquefasciatus using a novel insect repellent, ethyl
   anthranilate
SO ACTA TROPICA
LA English
DT Article
DE Arbovirus; Dengue; Ethyl anthranilate; Malaria; Mosquito repellent; Zika
   fever
ID HERBAL ESSENTIAL OILS; IN-VITRO; DIPTERA-CULICIDAE; DIRUS PEYTON;
   SYNTHESIZED NANOPARTICLES; VETERINARY IMPORTANCE; SILVER NANOPARTICLES;
   BORNE DISEASES; DENGUE; EFFICACY
AB Growing concern on the application of synthetic mosquito repellents in the recent years has instigated the identification and development of better alternatives to control different mosquito-borne diseases. In view of above, present investigation evaluates the repellent activity of ethyl anthranilate (EA), a non-toxic, FDA approved volatile food additive against three known mosquito vectors namely, Aedes aegypti, Anopheles stephensi and Culex quinquefasciatus under laboratory conditions following standard protocols. Three concentration levels (2%, 5% and 10% w/v) of EA were tested against all the three selected mosquito species employing K & D module and arm-in-cage method to determine the effective dose (ED50) and complete protection time (CPT), respectively. The repellent activity of EA was further investigated by modified arm-in-cage method to determine the protection over extended spatial ranges against all mosquito species. All behavioural situations were compared with the well-documented repellent N,N-diethylphenyl acetamide (DEPA) as a positive control. The findings demonstrated that EA exhibited significant repellent activity against all the three mosquitoes species. The ED50 values of EA, against Aedes aegypti Anopheles stephensi and Culex quinquefasciatus were found to be 0.96%, 5.4% and 3.6% w/v, respectively. At the concentration of 10% w/v, it provided CPTs of 60, 60 and 30 min, respectively, against Aedes aegypti, Anopheles stephensi and Culex quinquefasciatus mosquitoes. Again in spatial repellency evaluation, EA was found to be extremely effective in repelling all the three tested species of mosquitoes. Ethyl anthranilate provided comparable results to standard repellent DEPA during the study. Results have concluded that the currently evaluated chemical, EA has potential repellent activity against some well established mosquito vectors. The study emphasizes that repellent activity of EA could be exploited for developing effective, eco-friendly, acceptable and safer alternative to the existing harmful repellents for personal protection against different hematophagous mosquito species.
C1 [Islam, Johirul; Tyagi, Varun; Duarah, Sanjukta; Chattopadhyay, Pronobesh] Def Res Lab, Tezpur 784001, Assam, India.
   [Islam, Johirul; Zaman, Kamaruz] Dibrugarh Univ, Dept Pharmaceut Sci, Dibrugarh 786004, Assam, India.
   [Dhiman, Sunil] Def Res & Dev Estab, Gwalior 474002, Madhya Pradesh, India.
RP Chattopadhyay, P (corresponding author), Def Res Lab, Tezpur 784001, Assam, India.
EM chattopadhyay.drl@gmail.com
RI Duarah, Sanjukta/P-8927-2019; Zaman, Kamaruz/AAR-6444-2020
OI Duarah, Sanjukta/0000-0003-4762-3443; Zaman,
   Kamaruz/0000-0002-1688-4117; Dhiman, Sunil/0000-0003-4547-6603
FU University Grant Commission, Govt. of IndiaUniversity Grants Commission,
   India
FX One of the authors, Johirul Islam is thankful to University Grant
   Commission, Govt. of India, for providing financial support in the form
   of research fellowship. Authors are thankful to Defence Research
   Laboratory, Tezpur, Assam, India, and Dibrugarh University, Dibrugarh,
   Assam, India, for providing necessary support for carrying out the
   research work. Authors also extend gratitude to Dr. D. R. Bhattacharyya,
   Scientist-E, Indian Council of Medical Research (ICMR), Dibrugarh,
   Assam, India, for supplying the colony of Anopheles stephensi. All
   anonymous reviewers are also gratefully acknowledged for their specific
   comments that help a lot in improving this manuscript.
CR Afify A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103765
   Aguiar M, 2016, LANCET INFECT DIS, V16, P882, DOI 10.1016/S1473-3099(16)30168-2
   [Anonymous], 2007, FLAVORS FRAGRANCES 2
   [Anonymous], 2009, GUID EFF TEST MOSQ R
   Api A M, 2015, Food Chem Toxicol, V82 Suppl, pS97, DOI 10.1016/j.fct.2015.03.017
   Auysawasdi N, 2016, PARASITOL RES, V115, P99, DOI 10.1007/s00436-015-4725-3
   Baden L. R., 2016, NEW ENGL J MED, V374, P1552, DOI [DOI 10.1056/NEJMRA1602113, 10.1056/NEJMra1602113]
   Barradas TN, 2016, CURR DRUG DELIV, V13, P221, DOI 10.2174/1567201813666151207110515
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P2131, DOI 10.1007/s00436-016-5037-y
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Bharati M, 2017, ACTA TROP, V170, P112, DOI 10.1016/j.actatropica.2017.02.029
   Bigoga JD, 2012, ACTA TROP, V124, P210, DOI 10.1016/j.actatropica.2012.08.010
   Chattopadhyay P, 2015, ACTA TROP, V147, P45, DOI 10.1016/j.actatropica.2015.03.027
   Das NG, 2015, J INFECT PUBLIC HEAL, V8, P323, DOI 10.1016/j.jiph.2015.02.005
   Deletre E, 2016, CHEMOECOLOGY, V26, P127, DOI 10.1007/s00049-016-0214-0
   Delong W., 2016, RSC ADV, V6, P27301
   Demirci B, 2013, ACTA TROP, V128, P557, DOI 10.1016/j.actatropica.2013.08.003
   Govindarajan M, 2016, PARASITOL RES, V115, P2771, DOI 10.1007/s00436-016-5025-2
   Guda T., 2015, BIORXIV
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Islam J., 2016, J FOOD DRUG ANAL
   Islam J, 2017, ACTA TROP, V167, P216, DOI 10.1016/j.actatropica.2016.12.031
   Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594
   Klun JA, 2000, J MED ENTOMOL, V37, P177, DOI 10.1603/0022-2585-37.1.177
   Klun JA, 2005, J AM MOSQUITO CONTR, V21, P64, DOI 10.2987/8756-971X(2005)21[64:ANIVBS]2.0.CO;2
   Kumar PM, 2016, PARASITOL RES, V115, P751, DOI 10.1007/s00436-015-4799-y
   Lalthazuali, 2017, PARASITOL RES, V116, P821, DOI 10.1007/s00436-016-5351-4
   Leal WS, 2014, CURR OPIN INSECT SCI, V6, P93, DOI 10.1016/j.cois.2014.10.007
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Maia M. F., 2015, COCHRANE DATABASE SY
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Misni N, 2009, J AM MOSQUITO CONTR, V25, P442, DOI 10.2987/09-0006.1
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Opdyke D. L. J., 1979, MONOGRAPHS FRAGRANCE
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Phasomkusolsil S, 2011, SE ASIAN J TROP MED, V42, P1083
   Pohlit AM, 2011, PLANTA MED, V77, P598, DOI 10.1055/s-0030-1270723
   Qualls WA, 2012, ACTA TROP, V122, P284, DOI 10.1016/j.actatropica.2012.01.012
   Ray A., 2015, US Patent, Patent No. [US20150126437A1, 20150126437]
   Ray A, 2015, CURR OPIN NEUROBIOL, V34, P158, DOI 10.1016/j.conb.2015.06.014
   Revay EE, 2013, ACTA TROP, V125, P226, DOI 10.1016/j.actatropica.2012.10.009
   Roy DN, 2017, ENVIRON TOXICOL PHAR, V50, P91, DOI 10.1016/j.etap.2017.01.019
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Solomon B, 2012, EUR J PHARM BIOPHARM, V80, P61, DOI 10.1016/j.ejpb.2011.08.003
   Soonwera M., 2014, African Journal of Microbiology Research, V8, P1819
   Soonwera M, 2015, PARASITOL RES, V114, P4531, DOI 10.1007/s00436-015-4699-1
   Soonwera M, 2015, ACTA TROP, V142, P127, DOI 10.1016/j.actatropica.2014.11.010
   Spitzen J, 2017, ACTA TROP, V172, P180, DOI 10.1016/j.actatropica.2017.05.008
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Tawatsin A, 2001, J VECTOR ECOL, V26, P76
   Tisgratog R, 2016, ACTA TROP, V157, P136, DOI 10.1016/j.actatropica.2016.01.024
   US EPA, 1970, WHAT AR BIOP
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2016, VECT BORN DIS
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
NR 68
TC 8
Z9 9
U1 1
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD OCT
PY 2017
VL 174
BP 56
EP 63
DI 10.1016/j.actatropica.2017.06.024
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FE6DD
UT WOS:000408299300009
PM 28666890
DA 2020-07-08
ER

PT J
AU Nicolini, AM
   Toth, TD
   Kim, SY
   Mandel, MA
   Galbraith, DW
   Yoon, JY
AF Nicolini, Ariana M.
   Toth, Tyler D.
   Kim, Samuel Y.
   Mandel, M. Alejandra
   Galbraith, David W.
   Yoon, Jeong-Yeol
TI Mie Scatter and Interfacial Tension Based Real-Time Quantification of
   Colloidal Emulsion Nucleic Acid Amplification
SO ADVANCED BIOSYSTEMS
LA English
DT Article
DE LAMP; loop-mediated isothermal amplification; Mie scatter; real-time
   quantification; w/o emulsions
ID POLYMERASE-CHAIN-REACTION; SINGLE-MOLECULE PCR; ON-CHIP; STABILITY; HEAT
AB This work demonstrates for the first time rapid, real-time Mie scatter sensing of colloidal emulsion nucleic acid amplification directly from emulsion droplets. Loop-mediated isothermal amplification is used in this study, and, to our knowledge, has not previously been used in a colloidal emulsion platform. Interfacial tension values (gamma) associated with bulk protein adsorption and denaturation at the oil-water interface exhibit characteristic changes in the absence or presence of amplification. In the presence of target and amplicon, emulsions maintain a constant 300-400 nm diameter, whereas emulsions formed with no target control show a rapid decrease in droplet diameter to <100 nm over the first 20 min of incubation. This method is validated using whole bacteria (Staphylococcus aureus MSSA and Escherichia coli O157:H7) and whole virus (Potato virus Y and Zika virus) samples suspended in water, buffer, or serum-like matrices. Short-term formation of colloidal emulsion is quantified via 60 degrees scatter monitoring, where the initial slope of scattering intensity is utilized to confirm target amplification in less than 5 min. The unique benefits of this method render it more cost-effective and field-deployable than existing methods, while being adaptable to a multitude of targets, sample matrices, and nucleic acid amplification tests.
C1 [Nicolini, Ariana M.; Toth, Tyler D.; Kim, Samuel Y.; Yoon, Jeong-Yeol] Univ Arizona, Biomed Engn Grad Interdisciplinary Program, Tucson, AZ 85721 USA.
   [Nicolini, Ariana M.; Toth, Tyler D.; Kim, Samuel Y.; Yoon, Jeong-Yeol] Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA.
   [Mandel, M. Alejandra; Galbraith, David W.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.
RP Yoon, JY (corresponding author), Univ Arizona, Biomed Engn Grad Interdisciplinary Program, Tucson, AZ 85721 USA.; Yoon, JY (corresponding author), Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA.
EM jyyoon@email.arizona.edu
FU U.S. National Science Foundation (NSF)National Science Foundation (NSF)
   [CBET-1511093]; U.S. Department of Defense and American Society for
   Engineering Education (ASEE)
FX The authors would like to thank the following undergraduate and graduate
   researchers for their experimental contributions: Elizabeth Budiman,
   Timothy Shimon, Alexander Day, and Tiffany-Heather Ulep. They would also
   like to thank the Aspinwall Lab at the University of Arizona for use of
   their Malvern Zetasizer Nano, and Dr. Zhongguo Xiong for the PVY
   cultures. This work was supported by the U.S. National Science
   Foundation (NSF; Grant No. CBET-1511093) to D.W.G. and J.Y.Y. A.M.N.
   acknowledges a SMART scholarship from the U.S. Department of Defense and
   American Society for Engineering Education (ASEE).
CR Beer NR, 2008, ANAL CHEM, V80, P1854, DOI 10.1021/ac800048k
   Beer NR, 2007, ANAL CHEM, V79, P8471, DOI 10.1021/ac701809w
   Chen CM, 2000, COLLOID SURFACE A, V170, P173, DOI 10.1016/S0927-7757(00)00480-5
   Chen GL, 2005, FUEL PROCESS TECHNOL, V86, P499, DOI 10.1016/j.fuproc.2004.03.010
   Claesson PM, 2001, ENCY HDB EMULSION TE, P305, DOI 10.1201/9781420029581.ch13
   Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]
   Dickinson E, 2009, FOOD HYDROCOLLOID, V23, P1473, DOI 10.1016/j.foodhyd.2008.08.005
   Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898
   Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x
   Harshman DK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400061
   Hoar TP, 1943, NATURE, V152, P102, DOI 10.1038/152102a0
   Hori M, 2007, BIOCHEM BIOPH RES CO, V352, P323, DOI 10.1016/j.bbrc.2006.11.037
   Kiss MM, 2008, ANAL CHEM, V80, P8975, DOI 10.1021/ac801276c
   Laven P., MIEPLOT V4 6
   Leal-Calderon F., 1968, EMULSION SCI BASIC P
   Leamon JH, 2006, NAT METHODS, V3, P541, DOI 10.1038/nmeth0706-541
   Lee HH, 1996, BIOLOGICALS, V24, P197, DOI 10.1006/biol.1996.0026
   Mahony J, 1998, J CLIN MICROBIOL, V36, P3122, DOI 10.1128/JCM.36.11.3122-3126.1998
   McClements DJ, 2004, CURR OPIN COLLOID IN, V9, P305, DOI 10.1016/j.cocis.2004.09.003
   Millqvist-Fureby A, 2001, COLLOID SURFACE B, V21, P47, DOI 10.1016/S0927-7765(01)00183-7
   Misawa Yoshiki, 2007, Journal of Infection and Chemotherapy, V13, P134, DOI 10.1007/s10156-007-0508-9
   Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005
   Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921
   Nakano M, 2005, J BIOSCI BIOENG, V99, P293, DOI 10.1263/jbb.99.293
   Nakano M, 2003, J BIOTECHNOL, V102, P117, DOI 10.1016/S0168-1656(03)00023-3
   Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007
   Norde W., 2003, COLLOIDS INTERFACES, P199
   Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Raikos V, 2010, FOOD HYDROCOLLOID, V24, P259, DOI 10.1016/j.foodhyd.2009.10.014
   Schutze T, 2011, ANAL BIOCHEM, V410, P155, DOI 10.1016/j.ab.2010.11.029
   Shao KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024910
   Sliwinski EL, 2003, COLLOID SURFACE B, V31, P231, DOI 10.1016/S0927-7765(03)00143-7
   Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   VANDERVLIET GME, 1993, J GEN MICROBIOL, V139, P2423
   Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896
   Zhao XF, 2010, MOL BIOL REP, V37, P81, DOI [10.1007/s11033-009-9533-3, 10.1007/s11033-009-9700-6]
NR 38
TC 2
Z9 2
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 2366-7478
J9 ADV BIOSYST
JI Adv. Biosyst.
PD OCT
PY 2017
VL 1
IS 10
AR 1700098
DI 10.1002/adbi.201700098
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA GW5HP
UT WOS:000446962800007
OA Bronze
DA 2020-07-08
ER

PT J
AU Kamiyama, N
   Soma, R
   Hidano, S
   Watanabe, K
   Umekita, H
   Fukuda, C
   Noguchi, K
   Gendo, Y
   Ozaki, T
   Sonoda, A
   Sachi, N
   Runtuwene, LR
   Miura, Y
   Matsubara, E
   Tajima, S
   Takasaki, T
   Eshita, Y
   Kobayashi, T
AF Kamiyama, Naganori
   Soma, Ryusuke
   Hidano, Shinya
   Watanabe, Kei
   Umekita, Hiroshi
   Fukuda, Chiaki
   Noguchi, Kaori
   Gendo, Yoshiko
   Ozaki, Takashi
   Sonoda, Akira
   Sachi, Nozomi
   Runtuwene, Lucky Ronald
   Miura, Yumako
   Matsubara, Etsuro
   Tajima, Shigeru
   Takasaki, Tomohiko
   Eshita, Yuki
   Kobayashi, Takashi
TI Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses
   viremia in ZIKV-infected STAT1-deficient mice
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; Ribavirin; STAT1-deficient mice
ID HEPATITIS-C VIRUS; ANTIVIRAL ACTIVITY; GENE-EXPRESSION; RNA-POLYMERASE;
   LASSA FEVER; MOUSE MODEL; DENGUE; DRUG; INTERFERON-ALPHA-2B; GANCICLOVIR
AB Zika fever, a mosquito-borne infectious disease caused by Zika virus (ZIKV), is an epidemic disease for which no effective therapy has been established. The recent outbreaks of ZIKV in Brazil and French Polynesia have been linked to a considerable increase in the incidence of fetal microcephaly and other diseases such as Guillain-Barre syndrome. Because there is currently no specific therapy or vaccine, the early exploitation of a method to prevent expansion of ZIKV is a high priority. To validate commonly used antiviral drugs, we evaluated the effect of ribavirin, a drug used to treat hepatitis C with interferon-beta (IFN-beta), on ZIKV replication. In mammalian cells, we observed an inhibitory effect of ribavirin on ZIKV replication and ZIKV-induced cell death without cytotoxic effect. Furthermore, we found that STAT1-deficient mice, which lack type I IFN signaling, were highly sensitive to ZIKV infection and exhibited lethal outcome. Ribavirin abrogated viremia in ZIKV-infected STAT-1-deficient mice. These data suggest that the inhibition of viral RNA-dependent RNA polymerases may be effective for treatment of ZIKV infection. Our data provide a new insight into the mechanisms for inhibition of ZIKV replication and prevention of Zika fever. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Kamiyama, Naganori; Soma, Ryusuke; Hidano, Shinya; Watanabe, Kei; Umekita, Hiroshi; Fukuda, Chiaki; Noguchi, Kaori; Gendo, Yoshiko; Ozaki, Takashi; Sonoda, Akira; Sachi, Nozomi; Runtuwene, Lucky Ronald; Eshita, Yuki; Kobayashi, Takashi] Oita Univ, Fac Med, Dept Infect Dis Control, Oita 8795593, Japan.
   [Miura, Yumako; Matsubara, Etsuro] Oita Univ, Fac Med, Dept Neurol, Oita 8795593, Japan.
   [Tajima, Shigeru; Takasaki, Tomohiko] Natl Inst Infect Dis, Dept Virol 1, Tokyo 1628640, Japan.
RP Kamiyama, N; Kobayashi, T (corresponding author), Oita Univ, Fac Med, Dept Infect Dis Control, Oita 8795593, Japan.
EM kamiyama@oita-u.ac.jp; takashik@oita-u.ac.jp
OI Shigeru, Tajima/0000-0002-1981-9062
FU Suzuken Memorial Foundation; GSK Japan Research Grant;  [15H06512]; 
   [26305014]
FX We thank Chiharu Aoki for excellent secretarial assistance, Ichiro
   Kurane for providing essential materials and members of Kobayashi's lab
   for valuable discussions. This work was supported by a Grant-in-Aid for
   Young Scientists (Start-up) (Grant No. 15H06512), Grant-in-Aid for
   Scientific Research (B) (Grant No. 26305014), Suzuken Memorial
   Foundation and GSK Japan Research Grant 2016.
CR Abdel-Hady M, 2014, ARCH DIS CHILD, V99, P505, DOI 10.1136/archdischild-2013-304601
   Bansal S, 2015, WORLD J HEPATOL, V7, P806, DOI 10.4254/wjh.v7.i5.806
   Bausch DG, 2010, CLIN INFECT DIS, V51, P1435, DOI 10.1086/657315
   Bougie I, 2003, J BIOL CHEM, V278, P52471, DOI 10.1074/jbc.M308917200
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brochot E, 2010, ANTIVIR THER, V15, P687, DOI 10.3851/IMP1609
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Chang JH, 2011, ANTIVIR RES, V89, P26, DOI 10.1016/j.antiviral.2010.11.002
   Crumpacker CS, 1996, NEW ENGL J MED, V335, P721, DOI 10.1056/NEJM199609053351007
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362
   Falzarano D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01686
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853
   FERM VH, 1978, TERATOLOGY, V17, P93, DOI 10.1002/tera.1420170117
   GOSWAMI BB, 1979, BIOCHEM BIOPH RES CO, V89, P830, DOI 10.1016/0006-291X(79)91853-9
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Highlights of Prescribing Information, 2013, SOV
   Highlights of Prescribing Information, 2014, HARV
   Izumi K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7748
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Koren G, 2003, CAN MED ASSOC J, V168, P1289
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leming MT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1128
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200
   MATTHEWS T, 1988, REV INFECT DIS, V10, pS490
   MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104
   Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4
   Rattanaburee T, 2015, ANTIVIR RES, V124, P83, DOI 10.1016/j.antiviral.2015.10.005
   Russmann S, 2006, CURR MED CHEM, V13, P3351, DOI 10.2174/092986706778773059
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Solomon T, 2016, INT J INFECT DIS, V45, P24, DOI 10.1016/j.ijid.2016.02.086
   Tanaka M, 2004, MICROBES INFECT, V6, P485, DOI 10.1016/j.micinf.2004.01.011
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TOLTZIS P, 1988, ANTIMICROB AGENTS CH, V32, P492, DOI 10.1128/AAC.32.4.492
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Zhang YH, 2003, J VIROL, V77, P5933, DOI 10.1128/JVI.77.10.5933-5947.2003
NR 49
TC 29
Z9 31
U1 1
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD OCT
PY 2017
VL 146
BP 1
EP 11
DI 10.1016/j.antiviral.2017.08.007
PG 11
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FN1SV
UT WOS:000415772400001
PM 28818572
OA Green Published
DA 2020-07-08
ER

PT J
AU Mumtaz, N
   Jimmerson, LC
   Bushman, LR
   Kiser, JJ
   Aron, G
   Reusken, CBEM
   Koopmans, MPG
   van Kampen, JJA
AF Mumtaz, Noreen
   Jimmerson, Leah C.
   Bushman, Lane R.
   Kiser, Jennifer J.
   Aron, Georgina
   Reusken, Chantal B. E. M.
   Koopmans, Marion P. G.
   van Kampen, Jeroen J. A.
TI Cell-line dependent antiviral activity of sofosbuvir against Zika virus
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID POLYMERASE INHIBITOR SOFOSBUVIR; HEPATITIS-C; METABOLIC-ACTIVATION;
   NUCLEOSIDE INHIBITOR; INFECTION; RIBAVIRIN
AB The recent epidemic of Zika virus (ZIKV) in the Americas and its association with fetal and neurological complications has shown the need to develop a treatment. Repurposing of drugs that are already FDA approved or in clinical development may shorten drug development timelines in case of emerging viral diseases like ZIKV. Initial studies have shown conflicting results when testing sofosbuvir developed for treatment of infections with another Flaviviridae virus, hepatitis C virus. We hypothesized that the conflicting results could be explained by differences in intracellular processing of the compound. We assessed the antiviral activity of sofosbuvir and mericitabine against ZIKV using Vero, A549, and Huh7 cells and measured the level of the active sofosbuvir metabolite by mass spectrometry. Mericitabine did not show activity, while sofosbuvir inhibited ZIKV with an IC50 of similar to 4 mu M, but only in Huh7 cells. This correlated with differences in intracellular concentration of the active triphosphate metabolite of sofosbuvir, GS-461203 or 007-TP, which was 11-342 times higher in Huh7 cells compared to Vero and A549 cells. These results show that a careful selection of cell system for repurposing trials of prodrugs is needed for evaluation of antiviral activity. Furthermore, the intracellular levels of 007-TP in tissues and cell types that support ZIKV replication in vivo should be determined to further investigate the potential of sofosbuvir as anti-ZIKV compound. (C) 2017 The Authors. Published by Elsevier B.V.
C1 [Mumtaz, Noreen; Aron, Georgina; Reusken, Chantal B. E. M.; Koopmans, Marion P. G.; van Kampen, Jeroen J. A.] Erasmus MC, Unit Clin Virol, Dept Virosci, Room Na-1018,Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.
   [Jimmerson, Leah C.; Bushman, Lane R.; Kiser, Jennifer J.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA.
RP van Kampen, JJA (corresponding author), Erasmus MC, Unit Clin Virol, Dept Virosci, Room Na-1018,Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.
EM j.vankampen@erasmusmc.nl
RI Koopmans, Marion/Y-9170-2019
OI Koopmans, Marion/0000-0002-5204-2312
FU EU FP7 project PREPAREEuropean Union (EU) [602525]; EU FP7 project
   ZIKALLIANCEEuropean Union (EU) [734548]
FX This work received funding from EU FP7 projects PREPARE (grant number
   602525; CR) and ZIKALLIANCE (grant number 734548; NM, MK).
CR Bassit Leda, 2008, Antiviral Chemistry & Chemotherapy, V19, P25
   Bluemling G. R., 2014, MERICITABINE SOFOSBU
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Deng Y. -Q, 2016, ADENOSINE ANALOG NIT
   Ekins S., 2016, OPEN DRUG DISCOVERY
   Eyer L, 2016, J INFECT DIS
   Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953
   Guo DH, 2014, DNA CELL BIOL, V33, P20, DOI 10.1089/dna.2013.2193
   Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412
   Hurwitz SJ, 2013, CURR OPIN HIV AIDS, V8, P556, DOI 10.1097/COH.0000000000000007
   Kirby BJ, 2015, CLIN PHARMACOKINET, V54, P677, DOI 10.1007/s40262-015-0261-7
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Ma H, 2007, J BIOL CHEM, V282, P29812, DOI 10.1074/jbc.M705274200
   Mumtaz N, 2016, CURR TREAT OPTIONS I, V8, P208, DOI [10.1007/s40506-016-0083-7, DOI 10.1007/S40506-016-0083-7]
   Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802
   Rower JE, 2015, ANTIMICROB AGENTS CH, V59, P7671, DOI 10.1128/AAC.01693-15
   Sacramento C. Q, 2016, 061671 BIORXIV
   Satoh T, 2002, DRUG METAB DISPOS, V30, P488, DOI 10.1124/dmd.30.5.488
   Serrano BC, 2012, ANTIVIR THER, V17, P1133, DOI 10.3851/IMP2425
   Sung JM, 2008, BIOCHEM BIOPH RES CO, V371, P163, DOI 10.1016/j.bbrc.2008.04.038
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 23
TC 16
Z9 17
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD OCT
PY 2017
VL 146
BP 161
EP 163
DI 10.1016/j.antiviral.2017.09.004
PG 3
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FN1SV
UT WOS:000415772400020
PM 28912011
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chandrasekaran, N
   Gressick, K
   Singh, V
   Kwal, J
   Cap, N
   Koru-Sengul, T
   Curry, CL
AF Chandrasekaran, Neeraja
   Gressick, Kimberly
   Singh, Vivek
   Kwal, Jaclyn
   Cap, Natalia
   Koru-Sengul, Tulay
   Curry, Christine L.
TI The Utility of Social Media in Providing Information on Zika Virus
SO CUREUS
LA English
DT Article
DE public health; zika virus; social media
ID TWITTER; MEDICINE; YOUTUBE; KNOWLEDGE
AB Introduction
   In 2015, there was an outbreak of Zika virus in Brazil that spread throughout the Americas. The association of Zika virus with birth defects in infants born to infected pregnant women created concern for women of childbearing age. Social media is an important platform for health promotion, communication, and education on preventative methods during Zika virus outbreaks.
   Methods
   We evaluated the utility of social media on providing information regarding Zika virus. Facebook, Instagram, Twitter, and YouTube were utilized for our study. A search of the term "#Zikavirus" on Twitter and Instagram, and "Zika virus" on Facebook and YouTube was performed. The first 50 search results were analyzed from each source. Only English, Spanish, or Portuguese results were included. Results were categorized into three groups: "Useful", "Not Useful", or "Misleading".
   Results
   Search was conducted on December 17th, 2016, with 185 results. Forty (21.6%) were from Facebook, 50 (27%) from Twitter, 48 (25.9%) from YouTube, and 47 (25.4%) from Instagram. A total of 104 (56.22%) results were "Useful", 67 (36.2%) "Not Useful", and 14 (7.5%) were "Misleading". There were significantly more "Useful" results compared to "Not Useful" and "Misleading" results (Fisher's exact: p < 0.0001).
   Conclusion
   Social media is a useful resource for providing relevant information on Zika virus. Young women can utilize social media for Zika virus information. The role of social media in public health should be further investigated and established. Patient education interventions should focus on social media impact on behavior modification and education of public to recognize useful information.
C1 [Chandrasekaran, Neeraja; Singh, Vivek; Koru-Sengul, Tulay] Univ Miami, Miller Sch Med, Publ Hlth Sci, Miami, FL 33136 USA.
   [Kwal, Jaclyn] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
   [Curry, Christine L.] Univ Miami, Dept Ob Gyn, Coral Gables, FL 33124 USA.
RP Chandrasekaran, N (corresponding author), Univ Miami, Miller Sch Med, Publ Hlth Sci, Miami, FL 33136 USA.
EM mdneeruthimma@gmail.com
CR [Anonymous], 2016, ZIKA SOCIAL MEDIA CO
   [Anonymous], 2016, BIRTH CONTROL FAMILY
   [Anonymous], 2011, MANY GOOGLE SEARCHER
   [Anonymous], 2017, ZIKA VIRUS
   [Anonymous], 2017, HIST ZIKA VIRUS
   [Anonymous], 2013, NEWS USE SOCIAL MEDI
   [Anonymous], 2016, SOCIAL MEDIA UPDATE
   Bosslet GT, 2011, J GEN INTERN MED, V26, P1168, DOI 10.1007/s11606-011-1761-2
   Boulos MNK, 2016, FUTURE INTERNET, V8, DOI 10.3390/fi8030037
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Chisolm MS, 2015, INT REV PSYCHIATR, V27, P83, DOI 10.3109/09540261.2015.1026239
   Choo EK, 2015, MED TEACH, V37, P411, DOI 10.3109/0142159X.2014.993371
   Djuricich AM, 2015, INT REV PSYCHIATR, V27, P133, DOI 10.3109/09540261.2014.1000270
   Farnan JM, 2008, PERSPECT BIOL MED, V51, P517, DOI 10.1353/pbm.0.0048
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   George DR, 2013, CLIN OBSTET GYNECOL, V56, P453, DOI 10.1097/GRF.0b013e318297dc38
   Lenhart, 2015, TEENS SOCIAL MEDIA T
   Madathil KC, 2015, HEALTH INFORM J, V21, P173, DOI 10.1177/1460458213512220
   Nagpal SJS, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1251-9
   Ovadia S., 2009, BEHAV SOCIAL SCI LIB, V28, P202, DOI DOI 10.1080/01639260903280888
   Page R, 2012, DISCOURSE COMMUN, V6, P181, DOI 10.1177/1750481312437441
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Top 15 most popular travel websites, 2017, TOP 15 MOST POPULAR
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   Williams Shirley Ann, 2013, Med 2 0, V2, pe2, DOI 10.2196/med20.2269
NR 26
TC 6
Z9 6
U1 0
U2 2
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
SN 2168-8184
J9 CUREUS
JI Cureus
PD OCT
PY 2017
VL 9
IS 10
AR UNSP e1792
DI 10.7759/cureus.1792
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA HE7WF
UT WOS:000453650800058
PM 29282437
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Duttal, D
   Clevers, H
AF Duttal, Devanjali
   Clevers, Hans
TI Organoid culture systems to study host-pathogen interactions
SO CURRENT OPINION IN IMMUNOLOGY
LA English
DT Review
ID PLURIPOTENT STEM-CELLS; ZIKA VIRUS-INFECTION; CEREBRAL ORGANOIDS;
   IN-VITRO; INTESTINAL ORGANOIDS; CLOSTRIDIUM-DIFFICILE; NEURAL
   PROGENITORS; BRAIN ORGANOIDS; HUMAN LIVER; DISEASE
AB Recent advances in host microbe interaction studies in organoid cultures have shown great promise and have laid the foundation for much more refined future studies using these systems. Modeling of Zika virus (ZIKV) infection in cerebral organoids have helped us understand its association with microcephaly. Similarly, the pathogenesis of bacterial (Helicobacter pylori, Clostridium difficile) and viral (Norovirus, Rotaviruses) infections have been precisely dissected in organoid cultures. Additionally, direct associations between microbial colonization of tissues and diseases like cancer have also been deciphered. Here we discuss the most recent and striking studies on host microbe interactions in organoid cultures, highlighting various methods which can be used for developing microbe-organoid co-culture systems.
C1 [Duttal, Devanjali; Clevers, Hans] Royal Netherlands Acad Arts & Sci & Univ, Hubrecht Inst, Amsterdam, Netherlands.
   [Clevers, Hans] Utrecht Med Ctr, NL-3584 CT Utrecht, Netherlands.
RP Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci & Univ, Hubrecht Inst, Amsterdam, Netherlands.; Clevers, H (corresponding author), Utrecht Med Ctr, NL-3584 CT Utrecht, Netherlands.
EM h.clevers@hubrecht.eu
OI Dutta, Devanjali/0000-0002-4993-9639
FU Netherlands Organisation for Scientific Research (NWO-ALW)Netherlands
   Organization for Scientific Research (NWO) [016.Veni.171.015]
FX We are thankful to Dr. Inha Heo (Clevers lab) and Dr. Antoni Hendrickx
   (UMC, Utrecht) for scientific discussions and help with illustrations.
   DD is the recipient of a VENI grant from the Netherlands Organisation
   for Scientific Research (NWO-ALW, 016.Veni.171.015). H.C. is named as
   the inventor of several patents related to Lgr5 stem-cell-based organoid
   technology.
CR Amieva M, 2016, GASTROENTEROLOGY, V150, P64, DOI 10.1053/j.gastro.2015.09.004
   Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013
   Bartfeld S, 2015, JOVE-J VIS EXP, DOI 10.3791/53359
   Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042
   Bloom DE, 2017, P NATL ACAD SCI USA, V114, P4055, DOI 10.1073/pnas.1701410114
   Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021
   Caballero S, 2017, CELL HOST MICROBE, V21, P592, DOI 10.1016/j.chom.2017.04.002
   Casanova JL, 2015, P NATL ACAD SCI USA, V112, pE7118, DOI 10.1073/pnas.1521644112
   Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082
   Cugola F. R., 2016, NATURE
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415
   Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007
   Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098
   Engevik MA, 2015, AM J PHYSIOL-GASTR L, V308, pG497, DOI 10.1152/ajpgi.00090.2014
   Ettayebi K, 2016, SCIENCE, V3, P1
   Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211
   Farin HF, 2014, J EXP MED, V211, P1388, DOI 10.1084/jem.20130753
   Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312
   Finkbeiner SR, 2012, MBIO, V3, DOI 10.1128/mBio.00159-12
   Forbester JL, 2015, INFECT IMMUN, V83, P2926, DOI 10.1128/IAI.00161-15
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Glorevski N, 2016, NATURE, V539, P560, DOI 10.1038/nature20168
   Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909
   Huang JY, 2015, CELL HOST MICROBE, V18, P147, DOI 10.1016/j.chom.2015.07.002
   Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050
   Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006
   Klotz C, 2012, INT J MED MICROBIOL, V302, P203, DOI 10.1016/j.ijmm.2012.07.010
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Leffler EM, 2017, SCIENCE, V356, DOI 10.1126/science.aam6393
   Leslie JL, 2015, INFECT IMMUN, V83, P138, DOI 10.1128/IAI.02561-14
   Liu X, 2017, DROSOPHILA MODEL HOM
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Macpherson AJ, 2015, MUCOSAL IMMUNOL, V8, P476, DOI 10.1038/mi.2014.113
   McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863
   Ootani A., 2010, NAT MED, V15, P701, DOI DOI 10.1038/NM.1951.SUSTAINED
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rolig AS, 2015, CELL HOST MICROBE, V18, P613, DOI 10.1016/j.chom.2015.10.009
   Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Scanu T, 2015, CELL HOST MICROBE, V17, P763, DOI 10.1016/j.chom.2015.05.002
   Schlaermann P, 2016, GUT, V65, P202, DOI 10.1136/gutjnl-2014-307949
   Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002
   Spano S, 2016, CELL HOST MICROBE, V19, P216, DOI 10.1016/j.chom.2016.01.004
   Sterkel AK, 2016, CELL HOST MICROBE, V19, P361, DOI 10.1016/j.chom.2016.02.001
   Takebe T, 2014, NAT PROTOC, V9, P396, DOI 10.1038/nprot.2014.020
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053
   Walsh NC, 2017, ANN REV PATHOL MECH, V12
   Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wilson SS, 2015, MUCOSAL IMMUNOL, V8, P352, DOI 10.1038/mi.2014.72
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yin YB, 2015, ANTIVIR RES, V123, P120, DOI 10.1016/j.antiviral.2015.09.010
   Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015
NR 57
TC 24
Z9 25
U1 4
U2 30
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0952-7915
EI 1879-0372
J9 CURR OPIN IMMUNOL
JI Curr. Opin. Immunol.
PD OCT
PY 2017
VL 48
BP 15
EP 22
DI 10.1016/j.coi.2017.07.012
PG 8
WC Immunology
SC Immunology
GA FN8TX
UT WOS:000416299500005
PM 28756233
OA Green Published
DA 2020-07-08
ER

PT J
AU Nascimento, OJM
   da Silva, IRF
AF Nascimento, Osvaldo J. M.
   da Silva, Ivan R. F.
TI Guillain - Barre syndrome and Zika virus outbreaks
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Review
DE acute polyneuropathy; chronic inflammatory demyelinating
   polyradiculoneuropathy; Guillain-Barre syndrome; imaging; zika
ID IMAGING FINDINGS; INFECTION; BRAZIL; AMERICA; CLASSIFICATION;
   GUIDELINES; ANTIBODIES; DISORDERS; COLOMBIA; SPINE
AB Purpose of review
   Arboviruses have been associated with central and peripheral nervous system injuries, in special the flaviviruses. Guillain-Barre 'syndrome (GBS), transverse myelitis, meningoencephalitis, ophthalmological manifestations, and other neurological complications have been recently associated to Zika virus (ZIKV) infection. In this review, we aim to analyze the epidemiological aspects, possible pathophysiology, and what we have learned about the clinical and laboratory findings, as well as treatment of patients with ZIKV-associated neurological complications.
   Recent findings
   In the last decades, case series have suggested a possible link between flaviviruses and development of GBS. Recently, large outbreaks of ZIKV infection in Asia and the Americas have led to an increased incidence of GBS in these territories. Rapidly, several case reports and case series have reported an increase of all clinical forms and electrophysiological patterns of GBS, also including cases with associated central nervous system involvement. Finally, cases suggestive of acute transient polyneuritis, as well as acute and progressive postinfectious neuropathies associated to ZIKV infection have been reported, questioning the usually implicated mechanisms of neuronal injury.
   Summary
   The recent ZIKV outbreaks have triggered the occurrence of a myriad of neurological manifestations likely associated to this arbovirosis, in special GBS and its variants.
C1 [Nascimento, Osvaldo J. M.] Univ Fed Fluminense, Neurol Dept, Rio De Janeiro, Brazil.
   [da Silva, Ivan R. F.] Rush Univ, Neurocrit Care Sect, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA.
RP Nascimento, OJM (corresponding author), Rua Siqueira Campos 53-1204, BR-22031071 Copacabana, RJ, Brazil.
EM osvaldo_nascimento@hotmail.com
CR [Anonymous], 2016, INTERIM GUIDANCE INT
   [Anonymous], 2016, FACT SHEET HEALTHC P
   [Anonymous], 2016, LAB TESTING ZIKA VIR
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1
   Byun WM, 1998, RADIOLOGY, V208, P137, DOI 10.1148/radiology.208.1.9646804
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   DaSilva I, 2017, JAMA NEUROL
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Fabrizius RG, 2016, AM J TROP MED HYG, V95, P1161, DOI 10.4269/ajtmh.16-0397
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GEORGY BA, 1994, AM J NEURORADIOL, V15, P300
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Hart J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-248
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Langerak T, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00233
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Nascimento O, 2017, NEUROLOGY
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Penot P, 2017, REV MED INTERNE
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Relich RF, 2017, CLIN LAB MED, V37, P253, DOI 10.1016/j.cll.2017.01.002
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Song BH, 2017, J NEUROIMMUNOL
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   van den Berg B, 2016, Ned Tijdschr Geneeskd, V160, pD155
   Villamil-Gomez WE, 2017, TRAVEL MED INFECT DI, V16, P62, DOI 10.1016/j.tmaid.2017.03.012
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Yikilmaz A, 2010, CHILD NERV SYST, V26, P1103, DOI 10.1007/s00381-010-1197-8
   Yuki N, 2012, J NEUROL, V259, P1181, DOI 10.1007/s00415-011-6330-4
   Zhang Q, 2017, P NATL ACAD SCI US
NR 50
TC 21
Z9 21
U1 0
U2 33
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD OCT
PY 2017
VL 30
IS 5
BP 500
EP 507
DI 10.1097/WCO.0000000000000471
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FF5AK
UT WOS:000408979900009
PM 28617719
DA 2020-07-08
ER

EF